Citrus Sinensis ID: 019642
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 338 | 2.2.26 [Sep-21-2011] | |||||||
| Q08467 | 409 | Casein kinase II subunit | yes | no | 0.928 | 0.767 | 0.917 | 1e-162 | |
| Q08466 | 403 | Casein kinase II subunit | no | no | 0.928 | 0.779 | 0.917 | 1e-161 | |
| P28523 | 332 | Casein kinase II subunit | N/A | no | 0.928 | 0.945 | 0.911 | 1e-159 | |
| O64817 | 333 | Probable casein kinase II | no | no | 0.928 | 0.942 | 0.895 | 1e-156 | |
| O64816 | 432 | Casein kinase II subunit | no | no | 0.923 | 0.722 | 0.843 | 1e-149 | |
| P40231 | 332 | Casein kinase II subunit | yes | no | 0.866 | 0.882 | 0.730 | 1e-128 | |
| Q8TG13 | 336 | Casein kinase II subunit | N/A | no | 0.926 | 0.931 | 0.755 | 1e-128 | |
| Q60737 | 391 | Casein kinase II subunit | yes | no | 0.899 | 0.777 | 0.750 | 1e-128 | |
| P19139 | 391 | Casein kinase II subunit | yes | no | 0.928 | 0.803 | 0.730 | 1e-127 | |
| P68400 | 391 | Casein kinase II subunit | yes | no | 0.917 | 0.792 | 0.734 | 1e-127 |
| >sp|Q08467|CSK21_ARATH Casein kinase II subunit alpha-1 OS=Arabidopsis thaliana GN=CKA1 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 572 bits (1474), Expect = e-162, Method: Compositional matrix adjust.
Identities = 289/315 (91%), Positives = 305/315 (96%), Gaps = 1/315 (0%)
Query: 25 FWNVSSYVI-FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREI 83
+W+ S ++ + +QDDYEVVRKVGRGKYSEVFEGINVN+ E+CIIKILKPVKKKKI+REI
Sbjct: 94 YWDYESLIVQWGEQDDYEVVRKVGRGKYSEVFEGINVNSKEKCIIKILKPVKKKKIRREI 153
Query: 84 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 143
KILQNLCGGPN+VKLLD+VRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK
Sbjct: 154 KILQNLCGGPNIVKLLDVVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 213
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
ALD+CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL
Sbjct: 214 ALDFCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 273
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN DQLVKIAKVLGTDELNAYLNKY
Sbjct: 274 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIAKVLGTDELNAYLNKYQ 333
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
LELDPQL+ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA+EAMAH
Sbjct: 334 LELDPQLEALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAKEAMAHA 393
Query: 324 YFAQVRAAESSRTRA 338
YFAQVRAAE+SR R+
Sbjct: 394 YFAQVRAAETSRMRS 408
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q08466|CSK22_ARATH Casein kinase II subunit alpha-2 OS=Arabidopsis thaliana GN=CKA2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 566 bits (1459), Expect = e-161, Method: Compositional matrix adjust.
Identities = 289/315 (91%), Positives = 303/315 (96%), Gaps = 1/315 (0%)
Query: 25 FWNVSSY-VIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREI 83
+W+ S V + +QDDYEVVRKVGRGKYSEVFEGIN+N NE+CIIKILKPVKKKKI+REI
Sbjct: 88 YWDYESLNVQWGEQDDYEVVRKVGRGKYSEVFEGINMNNNEKCIIKILKPVKKKKIRREI 147
Query: 84 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 143
KILQNLCGGPN+VKLLD+VRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK
Sbjct: 148 KILQNLCGGPNIVKLLDVVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 207
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
ALD+CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL
Sbjct: 208 ALDFCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 267
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN DQLVKIAKVLGTDELNAYLNKY
Sbjct: 268 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIAKVLGTDELNAYLNKYQ 327
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
LELD QL+ALVGRHSRKPWSKFINADN+HLVSPEAID+LDKLLRYDHQDRLTA+EAMAHP
Sbjct: 328 LELDTQLEALVGRHSRKPWSKFINADNRHLVSPEAIDYLDKLLRYDHQDRLTAKEAMAHP 387
Query: 324 YFAQVRAAESSRTRA 338
YFAQVRAAESSR R
Sbjct: 388 YFAQVRAAESSRMRT 402
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P28523|CSK2A_MAIZE Casein kinase II subunit alpha OS=Zea mays GN=ACK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 560 bits (1444), Expect = e-159, Method: Compositional matrix adjust.
Identities = 287/315 (91%), Positives = 301/315 (95%), Gaps = 1/315 (0%)
Query: 25 FWNVSSYVI-FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREI 83
+W+ + + + +QDDYEVVRKVGRGKYSEVFEGINVN NE+CIIKILKPVKKKKIKREI
Sbjct: 18 YWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREI 77
Query: 84 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 143
KILQNLCGGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLYPTLTDYDIRYYIYELLK
Sbjct: 78 KILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYDIRYYIYELLK 137
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL
Sbjct: 138 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 197
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD LN YLNKY
Sbjct: 198 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYR 257
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
+ELDPQL+ALVGRHSRKPW KF+NADNQHLVSPEAIDFLDKLLRYDHQ+RLTA EAM HP
Sbjct: 258 IELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHP 317
Query: 324 YFAQVRAAESSRTRA 338
YF QVRAAE+SRTRA
Sbjct: 318 YFQQVRAAENSRTRA 332
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64817|CSK23_ARATH Probable casein kinase II subunit alpha OS=Arabidopsis thaliana GN=At2g23080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 552 bits (1422), Expect = e-156, Method: Compositional matrix adjust.
Identities = 282/315 (89%), Positives = 299/315 (94%), Gaps = 1/315 (0%)
Query: 25 FWNVSSYVI-FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREI 83
+W+ S V+ + QDDYEVVRKVGRGKYSEVFEG NVNTNERC+IKILKPVKKKKIKREI
Sbjct: 18 YWDYESLVVQWGHQDDYEVVRKVGRGKYSEVFEGKNVNTNERCVIKILKPVKKKKIKREI 77
Query: 84 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 143
KILQNLCGGPN+VKL DIVRD+HSKTPSL+FE+VNS DFKVLYPTLTDYDIRYYIYELLK
Sbjct: 78 KILQNLCGGPNIVKLYDIVRDEHSKTPSLVFEFVNSVDFKVLYPTLTDYDIRYYIYELLK 137
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
ALD+CHSQGIMHRDVKPHNVMIDH+LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL
Sbjct: 138 ALDFCHSQGIMHRDVKPHNVMIDHQLRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 197
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT+EL+ YLNKY
Sbjct: 198 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTNELDHYLNKYQ 257
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
L+LDPQL+ALVGRH KPWSKFINADNQHLVSPEAIDFLDKLL+YDHQDRLTAREAM HP
Sbjct: 258 LDLDPQLEALVGRHVPKPWSKFINADNQHLVSPEAIDFLDKLLQYDHQDRLTAREAMDHP 317
Query: 324 YFAQVRAAESSRTRA 338
YFAQV+AAESSR R
Sbjct: 318 YFAQVKAAESSRLRT 332
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64816|CSK2P_ARATH Casein kinase II subunit alpha, chloroplastic OS=Arabidopsis thaliana GN=At2g23070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 526 bits (1356), Expect = e-149, Method: Compositional matrix adjust.
Identities = 264/313 (84%), Positives = 291/313 (92%), Gaps = 1/313 (0%)
Query: 25 FWNVSSYVI-FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREI 83
+W+ S + + QDDYEVVRKVGRGKYSEVFEGI+ NE+C+IKILKPVKKKKIKREI
Sbjct: 116 YWDYESLAVQWGVQDDYEVVRKVGRGKYSEVFEGIHATDNEKCVIKILKPVKKKKIKREI 175
Query: 84 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 143
KILQNLCGGPN+VKLLDIVRDQ SKTPSLIFE+VN+ DFKVLYPTL+DYD+RYYI+ELLK
Sbjct: 176 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNKDFKVLYPTLSDYDVRYYIFELLK 235
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
ALD+CHS+GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL
Sbjct: 236 ALDFCHSRGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 295
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
LVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN+DQLVKIAKVLGTDELNAYLNKY
Sbjct: 296 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYR 355
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
+ELDP L +LVGRHSRKPW+KFIN++NQHL PEA+DF+DKLLRYDHQ+R TA+EAMAHP
Sbjct: 356 IELDPNLTSLVGRHSRKPWTKFINSENQHLAVPEAVDFVDKLLRYDHQERPTAKEAMAHP 415
Query: 324 YFAQVRAAESSRT 336
YF +R AESSRT
Sbjct: 416 YFYPIRNAESSRT 428
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P40231|CSK2A_SCHPO Casein kinase II subunit alpha OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=cka1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 459 bits (1182), Expect = e-128, Method: Compositional matrix adjust.
Identities = 214/293 (73%), Positives = 253/293 (86%)
Query: 33 IFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGG 92
+F QD+YE++RKVGRGKYSEVFEG+NV N +CIIK+LKPVK KKIKREIKILQNL GG
Sbjct: 36 VFGYQDNYEIIRKVGRGKYSEVFEGLNVLNNSKCIIKVLKPVKYKKIKREIKILQNLAGG 95
Query: 93 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQG 152
PN++ LLDIVRD SKTPSLIFE+V++ DF+ LYPTL+DYDIRYY YELLKALD+CHS+G
Sbjct: 96 PNIISLLDIVRDPESKTPSLIFEFVDNIDFRTLYPTLSDYDIRYYSYELLKALDFCHSRG 155
Query: 153 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 212
IMHRDVKPHNVMIDH+ RKLRLIDWGLAEFYH G EYNVRVASRYFKGPELLVD ++YDY
Sbjct: 156 IMHRDVKPHNVMIDHKKRKLRLIDWGLAEFYHAGMEYNVRVASRYFKGPELLVDFREYDY 215
Query: 213 SLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA 272
SLD+WS G MFA +IF+K+ FF G DN+DQLVKIAKVLGTDEL AY+ KY + LD Q D
Sbjct: 216 SLDIWSFGVMFAALIFKKDTFFRGRDNYDQLVKIAKVLGTDELFAYVQKYQIVLDRQYDN 275
Query: 273 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325
++G++ ++ W F+N DN+ L + EAID L++LLRYDHQ+RLT +EAMAHPYF
Sbjct: 276 ILGQYPKRDWYSFVNRDNRSLANDEAIDLLNRLLRYDHQERLTCQEAMAHPYF 328
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Plays a role in the translation of cell polarity into polarized growth. The alpha and alpha' chains contain the catalytic site. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8TG13|CSK2A_NEUCR Casein kinase II subunit alpha OS=Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) GN=cka PE=2 SV=1 | Back alignment and function description |
|---|
Score = 457 bits (1177), Expect = e-128, Method: Compositional matrix adjust.
Identities = 238/315 (75%), Positives = 269/315 (85%), Gaps = 2/315 (0%)
Query: 24 CFWNVSSYVI-FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKRE 82
+W+ S I + ++YEVVRK+GRGKYSEVFEGINV ++C+IK+LKPVKKKKIKRE
Sbjct: 15 AYWDYDSVNISWGVLENYEVVRKIGRGKYSEVFEGINVVNYQKCVIKVLKPVKKKKIKRE 74
Query: 83 IKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELL 142
IKILQNL GGPN+V LLD+VRD SKTPSLIFEYVN+T+F+ LYP D+D+RYYI+ELL
Sbjct: 75 IKILQNLAGGPNIVALLDVVRDSQSKTPSLIFEYVNNTEFRTLYPRFNDFDVRYYIFELL 134
Query: 143 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 202
KALD+CHS+GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG EYNVRVASRYFKGPE
Sbjct: 135 KALDFCHSKGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGTEYNVRVASRYFKGPE 194
Query: 203 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262
LLVD Q+YDYSLDMWSLG MFA MIFRKEPFF+G N DQLVKIAKVLGTDEL YL+KY
Sbjct: 195 LLVDFQEYDYSLDMWSLGAMFASMIFRKEPFFHGQSNSDQLVKIAKVLGTDELFDYLDKY 254
Query: 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322
+ELD Q D ++GR RKPW FINA+NQ VS EAIDFLDKLLRYDH +RLTA+EAMAH
Sbjct: 255 EIELDAQYDDILGRFQRKPWHSFINAENQRFVSNEAIDFLDKLLRYDHNERLTAKEAMAH 314
Query: 323 PYFAQVRAAESSRTR 337
PYFA VR E++R R
Sbjct: 315 PYFAPVR-DEATRAR 328
|
Phosphorylates the frq clock protein thus regulating the circadian clock. Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) (taxid: 367110) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q60737|CSK21_MOUSE Casein kinase II subunit alpha OS=Mus musculus GN=Csnk2a1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 456 bits (1174), Expect = e-128, Method: Compositional matrix adjust.
Identities = 229/305 (75%), Positives = 274/305 (89%), Gaps = 1/305 (0%)
Query: 25 FWNVSSYVI-FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREI 83
+W+ S+V+ + +QDDY++VRK+GRGKYSEVFE IN+ NE+ ++KILKPVKKKKIKREI
Sbjct: 23 YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREI 82
Query: 84 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 143
KIL+NL GGPN++ L DIV+D S+TP+L+FE+VN+TDFK LY TLTDYDIR+Y+YE+LK
Sbjct: 83 KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK 142
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
ALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG+EYNVRVASRYFKGPEL
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 202
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
LVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV+IAKVLGT++L Y++KY+
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
+ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDKLLRYDHQ RLTAREAM HP
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 322
Query: 324 YFAQV 328
YF V
Sbjct: 323 YFYTV 327
|
Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P19139|CSK21_RAT Casein kinase II subunit alpha OS=Rattus norvegicus GN=Csnk2a1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 456 bits (1173), Expect = e-127, Method: Compositional matrix adjust.
Identities = 230/315 (73%), Positives = 278/315 (88%), Gaps = 1/315 (0%)
Query: 25 FWNVSSYVI-FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREI 83
+W+ S+V+ + +QDDY++VRK+GRGKYSEVFE IN+ NE+ ++KILKPVKKKKIKREI
Sbjct: 23 YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREI 82
Query: 84 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 143
KIL+NL GGPN++ L DIV+D S+TP+L+FE+VN+TDFK LY TLTDYDIR+Y+YE+LK
Sbjct: 83 KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK 142
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
ALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG+EYNVRVASRYFKGPEL
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 202
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
LVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV+IAKVLGT++L Y++KY+
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
+ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDKLLRYDHQ RLTAREAM HP
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 322
Query: 324 YFAQVRAAESSRTRA 338
YF V ++ + A
Sbjct: 323 YFYTVVKDQARMSSA 337
|
Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P68400|CSK21_HUMAN Casein kinase II subunit alpha OS=Homo sapiens GN=CSNK2A1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 456 bits (1173), Expect = e-127, Method: Compositional matrix adjust.
Identities = 232/316 (73%), Positives = 277/316 (87%), Gaps = 6/316 (1%)
Query: 25 FWNVSSYVI-FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREI 83
+W+ S+V+ + +QDDY++VRK+GRGKYSEVFE IN+ NE+ ++KILKPVKKKKIKREI
Sbjct: 23 YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREI 82
Query: 84 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 143
KIL+NL GGPN++ L DIV+D S+TP+L+FE+VN+TDFK LY TLTDYDIR+Y+YE+LK
Sbjct: 83 KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK 142
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
ALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG+EYNVRVASRYFKGPEL
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 202
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
LVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV+IAKVLGT++L Y++KY+
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
+ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDKLLRYDHQ RLTAREAM HP
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 322
Query: 324 YF-----AQVRAAESS 334
YF Q R SS
Sbjct: 323 YFYTVVKDQARMGSSS 338
|
Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins. During viral infection, phosphorylates various proteins involved in the viral life cycles of EBV, HSV, HBV, HCV, HIV, CMV and HPV. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 338 | ||||||
| 391605 | 333 | casein kinase II catalytic subunit [Arab | 0.928 | 0.942 | 0.911 | 1e-169 | |
| 388510076 | 333 | unknown [Medicago truncatula] | 0.928 | 0.942 | 0.936 | 1e-166 | |
| 357476359 | 388 | Casein kinase 2 alpha subunit [Medicago | 0.985 | 0.858 | 0.896 | 1e-165 | |
| 356511951 | 411 | PREDICTED: casein kinase II subunit alph | 0.928 | 0.763 | 0.949 | 1e-164 | |
| 224074233 | 333 | predicted protein [Populus trichocarpa] | 0.928 | 0.942 | 0.946 | 1e-164 | |
| 363814459 | 398 | uncharacterized protein LOC100820471 pre | 0.928 | 0.788 | 0.942 | 1e-164 | |
| 356541665 | 333 | PREDICTED: casein kinase II subunit alph | 0.928 | 0.942 | 0.949 | 1e-164 | |
| 388510032 | 333 | unknown [Medicago truncatula] | 0.926 | 0.939 | 0.945 | 1e-164 | |
| 356496963 | 333 | PREDICTED: casein kinase II subunit alph | 0.902 | 0.915 | 0.973 | 1e-164 | |
| 224081839 | 333 | predicted protein [Populus trichocarpa] | 0.928 | 0.942 | 0.942 | 1e-163 |
| >gi|391605|dbj|BAA01091.1| casein kinase II catalytic subunit [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 602 bits (1551), Expect = e-169, Method: Compositional matrix adjust.
Identities = 287/315 (91%), Positives = 302/315 (95%), Gaps = 1/315 (0%)
Query: 25 FWNVSSY-VIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREI 83
+W+ S V + +QDDYEVVRKVGRGKYSEVFEGIN+N NE+CIIKILKPVKKK+I+REI
Sbjct: 18 YWDYESLNVQWGEQDDYEVVRKVGRGKYSEVFEGINMNNNEKCIIKILKPVKKKEIRREI 77
Query: 84 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 143
KILQNLCGGPN+VKLLD+VRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK
Sbjct: 78 KILQNLCGGPNIVKLLDVVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 137
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
ALD+CHSQGIMHRDVKPHNVMIDH LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL
Sbjct: 138 ALDFCHSQGIMHRDVKPHNVMIDHGLRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 197
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN DQLVKIAKVLGTDELNAYLNKY
Sbjct: 198 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIAKVLGTDELNAYLNKYQ 257
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
LELD QL+ALVGRHSRKPWSKFINADN+HLVSPEAID+LDKLLRYDHQDRLTA+EAMAHP
Sbjct: 258 LELDTQLEALVGRHSRKPWSKFINADNRHLVSPEAIDYLDKLLRYDHQDRLTAKEAMAHP 317
Query: 324 YFAQVRAAESSRTRA 338
YFAQVRAAESSR R
Sbjct: 318 YFAQVRAAESSRMRT 332
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|388510076|gb|AFK43104.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 590 bits (1520), Expect = e-166, Method: Compositional matrix adjust.
Identities = 295/315 (93%), Positives = 306/315 (97%), Gaps = 1/315 (0%)
Query: 25 FWNVSSYVI-FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREI 83
+W+ S + + DQDDYEVVRKVGRGKYSEVFEGINVN++ERC+IKILKPVKKKKIKRE+
Sbjct: 18 YWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNSSERCVIKILKPVKKKKIKREM 77
Query: 84 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 143
KILQNLCGGPN+VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRY IYELLK
Sbjct: 78 KILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYCIYELLK 137
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL
Sbjct: 138 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 197
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH
Sbjct: 198 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 257
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAID+LDKLLRYDHQDRLTAREAMAHP
Sbjct: 258 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDYLDKLLRYDHQDRLTAREAMAHP 317
Query: 324 YFAQVRAAESSRTRA 338
YF+QVRAAESSR R
Sbjct: 318 YFSQVRAAESSRMRT 332
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357476359|ref|XP_003608465.1| Casein kinase 2 alpha subunit [Medicago truncatula] gi|355509520|gb|AES90662.1| Casein kinase 2 alpha subunit [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 588 bits (1516), Expect = e-165, Method: Compositional matrix adjust.
Identities = 304/339 (89%), Positives = 316/339 (93%), Gaps = 6/339 (1%)
Query: 6 VSFIRSFFSEIMVYSYCLC-----FWNVSSYVI-FSDQDDYEVVRKVGRGKYSEVFEGIN 59
VS I S S+ VY+ +W+ S + + DQDDYEVVRKVGRGKYSEVFEGIN
Sbjct: 49 VSQISSTMSKARVYTDVNVIRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGIN 108
Query: 60 VNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS 119
VN++ERC+IKILKPVKKKKIKREIKILQNLCGGPN+VKLLDIVRDQHSKTPSLIFEYVNS
Sbjct: 109 VNSSERCVIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNS 168
Query: 120 TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 179
TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL
Sbjct: 169 TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 228
Query: 180 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 239
AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN
Sbjct: 229 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 288
Query: 240 HDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAI 299
HDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAI
Sbjct: 289 HDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAI 348
Query: 300 DFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 338
D+LDKLLRYDHQDRLTAREAMAHPYF+QVRAAESSR R
Sbjct: 349 DYLDKLLRYDHQDRLTAREAMAHPYFSQVRAAESSRMRT 387
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356511951|ref|XP_003524685.1| PREDICTED: casein kinase II subunit alpha-2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 585 bits (1507), Expect = e-164, Method: Compositional matrix adjust.
Identities = 299/315 (94%), Positives = 307/315 (97%), Gaps = 1/315 (0%)
Query: 25 FWNVSSYVI-FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREI 83
+W+ S + + DQDDYEVVRKVGRGKYSEVFEGINVN+NERCIIKILKPVKKKKIKREI
Sbjct: 96 YWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNSNERCIIKILKPVKKKKIKREI 155
Query: 84 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 143
KILQNLCGGPN+VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK
Sbjct: 156 KILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 215
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
A+DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL
Sbjct: 216 AIDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 275
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH
Sbjct: 276 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 335
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP
Sbjct: 336 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 395
Query: 324 YFAQVRAAESSRTRA 338
YF+QVRAAESSR R
Sbjct: 396 YFSQVRAAESSRMRT 410
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224074233|ref|XP_002304312.1| predicted protein [Populus trichocarpa] gi|222841744|gb|EEE79291.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 585 bits (1507), Expect = e-164, Method: Compositional matrix adjust.
Identities = 298/315 (94%), Positives = 307/315 (97%), Gaps = 1/315 (0%)
Query: 25 FWNVSSYVI-FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREI 83
+W+ S + + DQDDYEVVRKVGRGKYSEVFEGINVN+NERC+IKILKPVKKKKIKREI
Sbjct: 18 YWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNSNERCVIKILKPVKKKKIKREI 77
Query: 84 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 143
KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK
Sbjct: 78 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 137
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL
Sbjct: 138 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 197
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH
Sbjct: 198 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 257
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
LELDPQLDALVGRHSRKPWSKFIN+DNQHLVSPEA+DFLDKLLRYDHQDRLTAREAMAHP
Sbjct: 258 LELDPQLDALVGRHSRKPWSKFINSDNQHLVSPEALDFLDKLLRYDHQDRLTAREAMAHP 317
Query: 324 YFAQVRAAESSRTRA 338
YF+QVRAAESSR R
Sbjct: 318 YFSQVRAAESSRMRT 332
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|363814459|ref|NP_001242864.1| uncharacterized protein LOC100820471 precursor [Glycine max] gi|255638871|gb|ACU19738.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 584 bits (1505), Expect = e-164, Method: Compositional matrix adjust.
Identities = 297/315 (94%), Positives = 305/315 (96%), Gaps = 1/315 (0%)
Query: 25 FWNVSSYVI-FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREI 83
+W+ S + + DQDDYEVVRKVGRGKYSEVFEGINVN+NERC+IKILKPVKKKKIKREI
Sbjct: 83 YWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNSNERCVIKILKPVKKKKIKREI 142
Query: 84 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 143
KILQNLCGGPN+VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK
Sbjct: 143 KILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 202
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
ALDYCHSQ IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY KGPEL
Sbjct: 203 ALDYCHSQSIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYIKGPEL 262
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH
Sbjct: 263 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 322
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP
Sbjct: 323 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 382
Query: 324 YFAQVRAAESSRTRA 338
YF+QVRAAESSR R
Sbjct: 383 YFSQVRAAESSRMRT 397
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356541665|ref|XP_003539294.1| PREDICTED: casein kinase II subunit alpha-2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 583 bits (1503), Expect = e-164, Method: Compositional matrix adjust.
Identities = 299/315 (94%), Positives = 307/315 (97%), Gaps = 1/315 (0%)
Query: 25 FWNVSSYVI-FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREI 83
+W+ S + + DQDDYEVVRKVGRGKYSEVFEGINVN+NERCIIKILKPVKKKKIKREI
Sbjct: 18 YWDYESLTLQWGDQDDYEVVRKVGRGKYSEVFEGINVNSNERCIIKILKPVKKKKIKREI 77
Query: 84 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 143
KILQN+CGGPN+VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK
Sbjct: 78 KILQNICGGPNIVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 137
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL
Sbjct: 138 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 197
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH
Sbjct: 198 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 257
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP
Sbjct: 258 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 317
Query: 324 YFAQVRAAESSRTRA 338
YF+QVRAAESSR R
Sbjct: 318 YFSQVRAAESSRMRT 332
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|388510032|gb|AFK43082.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 582 bits (1501), Expect = e-164, Method: Compositional matrix adjust.
Identities = 297/314 (94%), Positives = 306/314 (97%), Gaps = 1/314 (0%)
Query: 26 WNVSSYVI-FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIK 84
W+ S + + DQDDYEVVRKVGRGKYSEVFEGINVN++ERC+IKILKPVKKKKIKREIK
Sbjct: 19 WDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNSSERCVIKILKPVKKKKIKREIK 78
Query: 85 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKA 144
ILQNLCGGPN+VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKA
Sbjct: 79 ILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKA 138
Query: 145 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 204
LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL
Sbjct: 139 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 198
Query: 205 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264
VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL
Sbjct: 199 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 258
Query: 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 324
ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAID+LDKLLRYDHQDRLTAREAMAHPY
Sbjct: 259 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDYLDKLLRYDHQDRLTAREAMAHPY 318
Query: 325 FAQVRAAESSRTRA 338
F+QVRAAESSR R
Sbjct: 319 FSQVRAAESSRMRT 332
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356496963|ref|XP_003517334.1| PREDICTED: casein kinase II subunit alpha-1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 582 bits (1500), Expect = e-164, Method: Compositional matrix adjust.
Identities = 297/305 (97%), Positives = 302/305 (99%)
Query: 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGP 93
+ DQDDYEVVRKVGRGKYSEVFEGINVN+NERCIIKILKPVKKKKIKREIKILQN+CGGP
Sbjct: 28 WGDQDDYEVVRKVGRGKYSEVFEGINVNSNERCIIKILKPVKKKKIKREIKILQNICGGP 87
Query: 94 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 153
N+VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGI
Sbjct: 88 NIVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 147
Query: 154 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 213
MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS
Sbjct: 148 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 207
Query: 214 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL 273
LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL
Sbjct: 208 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL 267
Query: 274 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 333
VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF+QVRAAES
Sbjct: 268 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFSQVRAAES 327
Query: 334 SRTRA 338
SR R
Sbjct: 328 SRMRT 332
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224081839|ref|XP_002306500.1| predicted protein [Populus trichocarpa] gi|222855949|gb|EEE93496.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 581 bits (1498), Expect = e-163, Method: Compositional matrix adjust.
Identities = 297/315 (94%), Positives = 307/315 (97%), Gaps = 1/315 (0%)
Query: 25 FWNVSSYVI-FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREI 83
+W+ S + + DQDDYEVVRKVGRGKYSEVFEGINVN+NERCIIKILKPVKKKKIKREI
Sbjct: 18 YWDYESLAVQWGDQDDYEVVRKVGRGKYSEVFEGINVNSNERCIIKILKPVKKKKIKREI 77
Query: 84 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 143
KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK
Sbjct: 78 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 137
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL
Sbjct: 138 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 197
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK+AKVLGTDELNAYLNKYH
Sbjct: 198 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKVAKVLGTDELNAYLNKYH 257
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
LELDPQLDALVGRHSRKPWS+FIN+DNQHLVSPEA+DFLDKLLRYDHQDRLTAREAMAHP
Sbjct: 258 LELDPQLDALVGRHSRKPWSRFINSDNQHLVSPEALDFLDKLLRYDHQDRLTAREAMAHP 317
Query: 324 YFAQVRAAESSRTRA 338
YF+QVRAAESSR R
Sbjct: 318 YFSQVRAAESSRMRT 332
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 338 | ||||||
| UNIPROTKB|Q9AR27 | 333 | OSCKA2 "Casein kinase II alpha | 0.926 | 0.939 | 0.863 | 5.4e-150 | |
| TAIR|locus:2045349 | 333 | CKA3 "casein kinase II, alpha | 0.926 | 0.939 | 0.840 | 1.1e-144 | |
| TAIR|locus:2045339 | 432 | AT2G23070 [Arabidopsis thalian | 0.923 | 0.722 | 0.785 | 1.2e-136 | |
| FB|FBgn0264492 | 336 | CkIIalpha "casein kinase IIalp | 0.899 | 0.904 | 0.701 | 4.1e-120 | |
| UNIPROTKB|P68399 | 391 | CSNK2A1 "Casein kinase II subu | 0.899 | 0.777 | 0.695 | 1.4e-119 | |
| UNIPROTKB|E2RHZ1 | 391 | CSNK2A1 "Uncharacterized prote | 0.899 | 0.777 | 0.695 | 1.4e-119 | |
| UNIPROTKB|E7EU96 | 385 | CSNK2A1 "Casein kinase II subu | 0.899 | 0.789 | 0.695 | 1.4e-119 | |
| UNIPROTKB|P68400 | 391 | CSNK2A1 "Casein kinase II subu | 0.899 | 0.777 | 0.695 | 1.4e-119 | |
| UNIPROTKB|F2Z5I5 | 391 | CSNK2A1 "Uncharacterized prote | 0.899 | 0.777 | 0.695 | 1.4e-119 | |
| MGI|MGI:88543 | 391 | Csnk2a1 "casein kinase 2, alph | 0.899 | 0.777 | 0.695 | 1.4e-119 |
| UNIPROTKB|Q9AR27 OSCKA2 "Casein kinase II alpha subunit" [Oryza sativa Indica Group (taxid:39946)] | Back alignment and assigned GO terms |
|---|
Score = 1464 (520.4 bits), Expect = 5.4e-150, P = 5.4e-150
Identities = 271/314 (86%), Positives = 285/314 (90%)
Query: 25 FWNVSSYVI-FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXX 83
+W+ + + + +QDDYEVVRKVGRGKYSEVFEGINVN NE+C
Sbjct: 18 YWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREI 77
Query: 84 XXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 143
LQNLCGGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLYPTLTDYDIRYYIYELLK
Sbjct: 78 KILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYDIRYYIYELLK 137
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL
Sbjct: 138 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 197
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT+ LNAYLNKYH
Sbjct: 198 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTEALNAYLNKYH 257
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
+ELDPQL+ALVGRHSRKPWSKFINADNQHLVSPEA+DFLDKLLRYDHQDRLTAREAMAHP
Sbjct: 258 IELDPQLEALVGRHSRKPWSKFINADNQHLVSPEAVDFLDKLLRYDHQDRLTAREAMAHP 317
Query: 324 YFAQVRAAESSRTR 337
YF QVRAAE+SR R
Sbjct: 318 YFLQVRAAENSRAR 331
|
|
| TAIR|locus:2045349 CKA3 "casein kinase II, alpha chain 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1414 (502.8 bits), Expect = 1.1e-144, P = 1.1e-144
Identities = 264/314 (84%), Positives = 280/314 (89%)
Query: 25 FWNVSSYVI-FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXX 83
+W+ S V+ + QDDYEVVRKVGRGKYSEVFEG NVNTNERC
Sbjct: 18 YWDYESLVVQWGHQDDYEVVRKVGRGKYSEVFEGKNVNTNERCVIKILKPVKKKKIKREI 77
Query: 84 XXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 143
LQNLCGGPN+VKL DIVRD+HSKTPSL+FE+VNS DFKVLYPTLTDYDIRYYIYELLK
Sbjct: 78 KILQNLCGGPNIVKLYDIVRDEHSKTPSLVFEFVNSVDFKVLYPTLTDYDIRYYIYELLK 137
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
ALD+CHSQGIMHRDVKPHNVMIDH+LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL
Sbjct: 138 ALDFCHSQGIMHRDVKPHNVMIDHQLRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 197
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT+EL+ YLNKY
Sbjct: 198 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTNELDHYLNKYQ 257
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
L+LDPQL+ALVGRH KPWSKFINADNQHLVSPEAIDFLDKLL+YDHQDRLTAREAM HP
Sbjct: 258 LDLDPQLEALVGRHVPKPWSKFINADNQHLVSPEAIDFLDKLLQYDHQDRLTAREAMDHP 317
Query: 324 YFAQVRAAESSRTR 337
YFAQV+AAESSR R
Sbjct: 318 YFAQVKAAESSRLR 331
|
|
| TAIR|locus:2045339 AT2G23070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1338 (476.1 bits), Expect = 1.2e-136, P = 1.2e-136
Identities = 246/313 (78%), Positives = 272/313 (86%)
Query: 25 FWNVSSYVI-FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXX 83
+W+ S + + QDDYEVVRKVGRGKYSEVFEGI+ NE+C
Sbjct: 116 YWDYESLAVQWGVQDDYEVVRKVGRGKYSEVFEGIHATDNEKCVIKILKPVKKKKIKREI 175
Query: 84 XXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 143
LQNLCGGPN+VKLLDIVRDQ SKTPSLIFE+VN+ DFKVLYPTL+DYD+RYYI+ELLK
Sbjct: 176 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNKDFKVLYPTLSDYDVRYYIFELLK 235
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
ALD+CHS+GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL
Sbjct: 236 ALDFCHSRGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 295
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
LVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN+DQLVKIAKVLGTDELNAYLNKY
Sbjct: 296 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYR 355
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
+ELDP L +LVGRHSRKPW+KFIN++NQHL PEA+DF+DKLLRYDHQ+R TA+EAMAHP
Sbjct: 356 IELDPNLTSLVGRHSRKPWTKFINSENQHLAVPEAVDFVDKLLRYDHQERPTAKEAMAHP 415
Query: 324 YFAQVRAAESSRT 336
YF +R AESSRT
Sbjct: 416 YFYPIRNAESSRT 428
|
|
| FB|FBgn0264492 CkIIalpha "casein kinase IIalpha" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 1182 (421.1 bits), Expect = 4.1e-120, P = 4.1e-120
Identities = 214/305 (70%), Positives = 255/305 (83%)
Query: 25 FWNVSSYVI-FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXX 83
+W+ +YV+ + +QDDY++VRK+GRGKYSEVFE IN+ T E+C
Sbjct: 21 YWDYENYVVDWGNQDDYQLVRKLGRGKYSEVFEAINITTTEKCVVKILKPVKKKKIKREI 80
Query: 84 XXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 143
L+NL GG N++ LL +V+D S+TP+LIFE+VN+TDFK LY TLTDY+IRYY++ELLK
Sbjct: 81 KILENLRGGTNIITLLAVVKDPVSRTPALIFEHVNNTDFKQLYQTLTDYEIRYYLFELLK 140
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
ALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG+EYNVRVASRYFKGPEL
Sbjct: 141 ALDYCHSMGIMHRDVKPHNVMIDHENRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 200
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
LVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV+IAKVLGT+EL AYL+KY+
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELYAYLDKYN 260
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
++LDP+ ++ RHSRK W +F+++DNQHLVSPEA+DFLDKLLRYDH DRLTAREAMAHP
Sbjct: 261 IDLDPRFHDILQRHSRKRWERFVHSDNQHLVSPEALDFLDKLLRYDHVDRLTAREAMAHP 320
Query: 324 YFAQV 328
YF +
Sbjct: 321 YFLPI 325
|
|
| UNIPROTKB|P68399 CSNK2A1 "Casein kinase II subunit alpha" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 1177 (419.4 bits), Expect = 1.4e-119, P = 1.4e-119
Identities = 212/305 (69%), Positives = 255/305 (83%)
Query: 25 FWNVSSYVI-FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXX 83
+W+ S+V+ + +QDDY++VRK+GRGKYSEVFE IN+ NE+
Sbjct: 23 YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREI 82
Query: 84 XXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 143
L+NL GGPN++ L DIV+D S+TP+L+FE+VN+TDFK LY TLTDYDIR+Y+YE+LK
Sbjct: 83 KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK 142
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
ALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG+EYNVRVASRYFKGPEL
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 202
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
LVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV+IAKVLGT++L Y++KY+
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
+ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDKLLRYDHQ RLTAREAM HP
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 322
Query: 324 YFAQV 328
YF V
Sbjct: 323 YFYTV 327
|
|
| UNIPROTKB|E2RHZ1 CSNK2A1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 1177 (419.4 bits), Expect = 1.4e-119, P = 1.4e-119
Identities = 212/305 (69%), Positives = 255/305 (83%)
Query: 25 FWNVSSYVI-FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXX 83
+W+ S+V+ + +QDDY++VRK+GRGKYSEVFE IN+ NE+
Sbjct: 23 YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREI 82
Query: 84 XXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 143
L+NL GGPN++ L DIV+D S+TP+L+FE+VN+TDFK LY TLTDYDIR+Y+YE+LK
Sbjct: 83 KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK 142
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
ALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG+EYNVRVASRYFKGPEL
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 202
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
LVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV+IAKVLGT++L Y++KY+
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
+ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDKLLRYDHQ RLTAREAM HP
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 322
Query: 324 YFAQV 328
YF V
Sbjct: 323 YFYTV 327
|
|
| UNIPROTKB|E7EU96 CSNK2A1 "Casein kinase II subunit alpha" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1177 (419.4 bits), Expect = 1.4e-119, P = 1.4e-119
Identities = 212/305 (69%), Positives = 255/305 (83%)
Query: 25 FWNVSSYVI-FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXX 83
+W+ S+V+ + +QDDY++VRK+GRGKYSEVFE IN+ NE+
Sbjct: 23 YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREI 82
Query: 84 XXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 143
L+NL GGPN++ L DIV+D S+TP+L+FE+VN+TDFK LY TLTDYDIR+Y+YE+LK
Sbjct: 83 KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK 142
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
ALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG+EYNVRVASRYFKGPEL
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 202
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
LVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV+IAKVLGT++L Y++KY+
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
+ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDKLLRYDHQ RLTAREAM HP
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 322
Query: 324 YFAQV 328
YF V
Sbjct: 323 YFYTV 327
|
|
| UNIPROTKB|P68400 CSNK2A1 "Casein kinase II subunit alpha" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1177 (419.4 bits), Expect = 1.4e-119, P = 1.4e-119
Identities = 212/305 (69%), Positives = 255/305 (83%)
Query: 25 FWNVSSYVI-FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXX 83
+W+ S+V+ + +QDDY++VRK+GRGKYSEVFE IN+ NE+
Sbjct: 23 YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREI 82
Query: 84 XXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 143
L+NL GGPN++ L DIV+D S+TP+L+FE+VN+TDFK LY TLTDYDIR+Y+YE+LK
Sbjct: 83 KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK 142
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
ALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG+EYNVRVASRYFKGPEL
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 202
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
LVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV+IAKVLGT++L Y++KY+
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
+ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDKLLRYDHQ RLTAREAM HP
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 322
Query: 324 YFAQV 328
YF V
Sbjct: 323 YFYTV 327
|
|
| UNIPROTKB|F2Z5I5 CSNK2A1 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 1177 (419.4 bits), Expect = 1.4e-119, P = 1.4e-119
Identities = 212/305 (69%), Positives = 255/305 (83%)
Query: 25 FWNVSSYVI-FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXX 83
+W+ S+V+ + +QDDY++VRK+GRGKYSEVFE IN+ NE+
Sbjct: 23 YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREI 82
Query: 84 XXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 143
L+NL GGPN++ L DIV+D S+TP+L+FE+VN+TDFK LY TLTDYDIR+Y+YE+LK
Sbjct: 83 KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK 142
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
ALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG+EYNVRVASRYFKGPEL
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 202
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
LVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV+IAKVLGT++L Y++KY+
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
+ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDKLLRYDHQ RLTAREAM HP
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 322
Query: 324 YFAQV 328
YF V
Sbjct: 323 YFYTV 327
|
|
| MGI|MGI:88543 Csnk2a1 "casein kinase 2, alpha 1 polypeptide" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 1177 (419.4 bits), Expect = 1.4e-119, P = 1.4e-119
Identities = 212/305 (69%), Positives = 255/305 (83%)
Query: 25 FWNVSSYVI-FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXX 83
+W+ S+V+ + +QDDY++VRK+GRGKYSEVFE IN+ NE+
Sbjct: 23 YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREI 82
Query: 84 XXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 143
L+NL GGPN++ L DIV+D S+TP+L+FE+VN+TDFK LY TLTDYDIR+Y+YE+LK
Sbjct: 83 KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK 142
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
ALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG+EYNVRVASRYFKGPEL
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 202
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
LVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV+IAKVLGT++L Y++KY+
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
+ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDKLLRYDHQ RLTAREAM HP
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 322
Query: 324 YFAQV 328
YF V
Sbjct: 323 YFYTV 327
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P19454 | CSK22_YEAST | 2, ., 7, ., 1, 1, ., 1 | 0.6341 | 0.8461 | 0.8436 | yes | no |
| O64817 | CSK23_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8952 | 0.9289 | 0.9429 | no | no |
| P21869 | CSK22_CHICK | 2, ., 7, ., 1, 1, ., 1 | 0.7170 | 0.9171 | 0.8857 | no | no |
| P21868 | CSK21_CHICK | 2, ., 7, ., 1, 1, ., 1 | 0.7549 | 0.8905 | 0.7698 | yes | no |
| Q8TG13 | CSK2A_NEUCR | 2, ., 7, ., 1, 1, ., 1 | 0.7555 | 0.9260 | 0.9315 | N/A | no |
| P20427 | CSK22_BOVIN | 2, ., 7, ., 1, 1, ., 1 | 0.7202 | 0.9171 | 0.8857 | no | no |
| P68399 | CSK21_BOVIN | 2, ., 7, ., 1, 1, ., 1 | 0.7341 | 0.9171 | 0.7928 | yes | no |
| P28523 | CSK2A_MAIZE | 2, ., 7, ., 1, 1, ., 1 | 0.9111 | 0.9289 | 0.9457 | N/A | no |
| P18334 | CSK2A_CAEEL | 2, ., 7, ., 1, 1, ., 1 | 0.7193 | 0.9142 | 0.8583 | yes | no |
| P08181 | CSK2A_DROME | 2, ., 7, ., 1, 1, ., 1 | 0.7573 | 0.8994 | 0.9047 | yes | no |
| P19139 | CSK21_RAT | 2, ., 7, ., 1, 1, ., 1 | 0.7301 | 0.9289 | 0.8030 | yes | no |
| O76484 | CSK2A_SPOFR | 2, ., 7, ., 1, 1, ., 1 | 0.7483 | 0.8905 | 0.8526 | N/A | no |
| P28547 | CSK2A_THEPA | 2, ., 7, ., 1, 1, ., 1 | 0.6907 | 0.8757 | 0.8505 | yes | no |
| P68400 | CSK21_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.7341 | 0.9171 | 0.7928 | yes | no |
| Q8SRU0 | CSK2A_ENCCU | 2, ., 7, ., 1, 1, ., 1 | 0.5049 | 0.8698 | 0.9216 | yes | no |
| P40231 | CSK2A_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.7303 | 0.8668 | 0.8825 | yes | no |
| Q02720 | CSK2A_DICDI | 2, ., 7, ., 1, 1, ., 1 | 0.7185 | 0.8905 | 0.8931 | yes | no |
| P33674 | CSK21_RABIT | 2, ., 7, ., 1, 1, ., 1 | 0.7341 | 0.9171 | 0.7928 | yes | no |
| P19784 | CSK22_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.7138 | 0.9171 | 0.8857 | no | no |
| O54833 | CSK22_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.7202 | 0.9171 | 0.8857 | no | no |
| P28020 | CSK21_XENLA | 2, ., 7, ., 1, 1, ., 1 | 0.7549 | 0.8905 | 0.7678 | N/A | no |
| Q60737 | CSK21_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.7508 | 0.8994 | 0.7774 | yes | no |
| Q08467 | CSK21_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9174 | 0.9289 | 0.7677 | yes | no |
| Q08466 | CSK22_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9174 | 0.9289 | 0.7791 | no | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.994 |
| 3rd Layer | 2.7.11 | 0.998 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 338 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-73 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-72 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-66 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-64 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-62 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-59 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-58 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-58 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-57 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-50 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-50 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-49 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-49 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-48 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-47 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-47 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-47 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-46 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-46 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-45 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-45 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-45 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-45 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-44 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-44 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-43 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-43 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-43 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-43 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-43 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-42 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-42 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-41 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-41 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-40 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-39 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-39 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-38 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-38 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-36 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-36 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-35 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-35 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-34 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-34 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-34 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-34 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-34 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-33 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-33 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-32 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-32 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-32 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-31 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-31 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-28 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-28 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-27 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-26 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-25 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-25 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-24 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-23 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-23 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-22 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-22 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-21 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-18 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-18 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-17 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-16 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-16 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-15 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-14 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-14 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-14 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-14 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-14 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-13 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-13 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-13 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 6e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-12 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-12 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-11 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-11 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 7e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-11 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-11 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-10 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-10 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-09 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-09 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-08 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-07 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-07 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-06 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-06 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-06 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 4e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-05 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-05 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 9e-05 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-05 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 1e-04 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-04 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-04 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-04 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-04 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-04 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-04 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 4e-04 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-04 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-04 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 0.001 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.001 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 0.002 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.002 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 0.003 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 0.003 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 0.004 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 0.004 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 0.004 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 0.004 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 0.004 | |
| COG0478 | 304 | COG0478, COG0478, RIO-like serine/threonine protei | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 225 bits (577), Expect = 6e-73
Identities = 86/295 (29%), Positives = 136/295 (46%), Gaps = 44/295 (14%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-----REIKILQNLCGGPN 94
YE++RK+G G + V++ + T + +KILK +K K REI+IL+ L PN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRL-SHPN 59
Query: 95 VVKLLDIVRDQHSKTPSLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYCHSQ 151
+V+L+D D L+ EY D L++ + + ++L+ L+Y HS
Sbjct: 60 IVRLIDAFED--KDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 152 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQDY 210
GI+HRD+KP N+++D +++ D+GLA+ V + ++ PE+L+ Y
Sbjct: 118 GIIHRDLKPENILLDENGV-VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 211 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 270
+D+WSLG + ++ K PF G + DQL I ++LG LE D
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPF-SGENILDQLQLIRRILGPP----------LEFDEPK 225
Query: 271 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325
S EA D + K L D R TA E + HP+F
Sbjct: 226 W--------------------SSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 223 bits (571), Expect = 5e-72
Identities = 94/293 (32%), Positives = 151/293 (51%), Gaps = 46/293 (15%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPNV 95
YE++ K+G G + +V+ + T + IK++K K KK I REIKIL+ L PN+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKL-KHPNI 59
Query: 96 VKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL--YPTLTDYDIRYYIYELLKALDYCHSQG 152
V+L D+ D+ L+ EY D F +L L++ + R+Y+ ++L AL+Y HS+G
Sbjct: 60 VRLYDVFEDEDK--LYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117
Query: 153 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 212
I+HRD+KP N+++D + ++L D+GLA PG++ V + + PE+L+ + Y
Sbjct: 118 IVHRDLKPENILLDED-GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLG-KGYGK 175
Query: 213 SLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA 272
++D+WSLG + ++ K P F G D +L K
Sbjct: 176 AVDIWSLGVILYELLTGK-PPFPGDDQLLELFKK-------------------------- 208
Query: 273 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325
+G+ + +SPEA D + KLL D + RLTA EA+ HP+F
Sbjct: 209 -IGKPKPPFPPPEWD------ISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 210 bits (537), Expect = 2e-66
Identities = 101/296 (34%), Positives = 161/296 (54%), Gaps = 24/296 (8%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-IK----REIKILQNLCGGPN 94
YE + K+G G Y V++ + T E +K ++ +++ I REI +L+ L PN
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPN 59
Query: 95 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYCHS 150
+VKLLD++ + L+FEY + D K L+ I+ +Y+LL+ L YCHS
Sbjct: 60 IVKLLDVIH--TERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 151 QGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQD 209
I+HRD+KP N++I+ + L+L D+GLA F P + Y V + +++ PE+L+ +
Sbjct: 117 HRILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKH 175
Query: 210 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 269
Y ++D+WS+GC+FA MI +P F G DQL KI ++LGT ++ L P
Sbjct: 176 YSTAVDIWSVGCIFAEMI-TGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL---PD 231
Query: 270 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325
+ K K + + PE ID L K+L+Y+ R++A+EA+ HPYF
Sbjct: 232 YKPTFPKFPPKDLEKVLPR-----LDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 205 bits (524), Expect = 6e-64
Identities = 112/315 (35%), Positives = 177/315 (56%), Gaps = 45/315 (14%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK----KKIKREIKILQNLCGGPN 94
YE+++ +G G Y V ++ T + IK I K+I REIK+L++L N
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHEN 60
Query: 95 VVKLLDIVRDQHSKTPS---LIFEYVNSTDF-KVLY--PTLTDYDIRYYIYELLKALDYC 148
++ LLDI+R + + ++ E + TD KV+ LTD I+Y++Y++L+ L Y
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYL 119
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-----EFYHPGK--EYNVRVASRYFKGP 201
HS ++HRD+KP N++++ L++ D+GLA + G EY V +R+++ P
Sbjct: 120 HSANVIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDEDEKGFLTEY---VVTRWYRAP 175
Query: 202 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAY 258
ELL+ Y ++D+WS+GC+FA ++ RK P F G D DQL I +VLGT ++L
Sbjct: 176 ELLLSSSRYTKAIDIWSVGCIFAELLTRK-PLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234
Query: 259 LN---KYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRL 314
+ + +L+ P+ +KP SK F A SPEAID L+K+L +D + R+
Sbjct: 235 TSEKARNYLKSLPK-------KPKKPLSKLFPGA------SPEAIDLLEKMLVFDPKKRI 281
Query: 315 TAREAMAHPYFAQVR 329
TA EA+AHPY AQ+
Sbjct: 282 TADEALAHPYLAQLH 296
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 199 bits (509), Expect = 2e-62
Identities = 96/301 (31%), Positives = 158/301 (52%), Gaps = 29/301 (9%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGGPN 94
YE + ++G G Y +V++ N T E +K ++ +K+ REIK+LQ L PN
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRH-PN 59
Query: 95 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYCHS 150
+V+L +IV + + ++FEY+ D L T+ I+ Y+ +LL+ L Y HS
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYM-DHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS 118
Query: 151 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--GKEYNVRVASRYFKGPELLVDLQ 208
GI+HRD+K N++I+++ L+L D+GLA Y +Y RV + +++ PELL+
Sbjct: 119 NGILHRDIKGSNILINNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT 177
Query: 209 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268
Y +DMWS+GC+ A + F +P F G +QL KI ++ G+ + P
Sbjct: 178 RYGPEVDMWSVGCILAEL-FLGKPIFQGSTELEQLEKIFELCGSPTDENW---------P 227
Query: 269 QLDALVG----RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 324
+ L + + + +HL+ P A+D LDKLL D + R++A +A+ H Y
Sbjct: 228 GVSKLPWFENLKPKKPYKRRLREFF-KHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286
Query: 325 F 325
F
Sbjct: 287 F 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 190 bits (486), Expect = 7e-59
Identities = 100/299 (33%), Positives = 155/299 (51%), Gaps = 26/299 (8%)
Query: 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKKKKIK----REIKILQNLCGGP 93
Y+++ ++G G + VF+ + T E +K + + I REIK LQ C P
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQA-CQHP 59
Query: 94 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYCH 149
VVKLLD+ H L+ EY+ S +VL P L + ++ Y+ LLK + Y H
Sbjct: 60 YVVKLLDVFP--HGSGFVLVMEYMPSDLSEVLRDEERP-LPEAQVKSYMRMLLKGVAYMH 116
Query: 150 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDL 207
+ GIMHRD+KP N++I L++ D+GLA + + Y+ +VA+R+++ PELL
Sbjct: 117 ANGIMHRDLKPANLLIS-ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 208 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267
+ YD +D+W++GC+FA ++ P F G ++ +QL + + LGT + L
Sbjct: 176 RKYDPGVDLWAVGCIFAELL-NGSPLFPGENDIEQLAIVFRTLGTPNEETWPG---LTSL 231
Query: 268 PQLDALVGRHS-RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325
P + + S P + SPEA+D L LL YD RL+A EA+ HPYF
Sbjct: 232 PDYNKITFPESKPIPLEEIFPD-----ASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 1e-58
Identities = 104/304 (34%), Positives = 144/304 (47%), Gaps = 36/304 (11%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPN 94
YEV+ VG G Y V + N T E IK K KK RE+K+L+ L N
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHEN 61
Query: 95 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYD-IRYYIYELLKALDYCHSQ 151
+V L + R L+FEYV T ++L P D +R YI++LL+A+ YCHS
Sbjct: 62 IVNLKEAFR--RKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH 119
Query: 152 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH--PGKEYNVRVASRYFKGPELLVDLQD 209
I+HRD+KP N+++ L+L D+G A P VA+R+++ PELLV +
Sbjct: 120 NIIHRDIKPENILVSES-GVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 210 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 269
Y +D+W++GC+ A ++ EP F G + DQL I K LG L P
Sbjct: 179 YGKPVDVWAIGCIMAELL-DGEPLFPGDSDIDQLYLIQKCLGP-------------LPPS 224
Query: 270 LDALVGRHSRKPWSKFINADNQH--------LVSPEAIDFLDKLLRYDHQDRLTAREAMA 321
L + R F VS A+DFL LR D ++RLT E +
Sbjct: 225 HQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284
Query: 322 HPYF 325
HPYF
Sbjct: 285 HPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 189 bits (481), Expect = 3e-58
Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 31/300 (10%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPN 94
Y+ + K+G G Y V++ + T E IK +K K REIK+L+ L PN
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPN 59
Query: 95 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYCHS 150
++KLLD+ R + L+FE++++ +K++ L + I+ Y+Y+LL+ L +CHS
Sbjct: 60 IIKLLDVFRHK--GDLYLVFEFMDTDLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHS 116
Query: 151 QGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQD 209
GI+HRD+KP N++I+ E L+L D+GLA F P + Y V +R+++ PELL+ +
Sbjct: 117 HGILHRDLKPENLLINTE-GVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 210 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL-ELDP 268
Y +D+WS+GC+FA ++ R+ P F G DQL KI + LGT + +
Sbjct: 176 YSTPVDIWSVGCIFAELLSRR-PLFPGKSEIDQLFKIFRTLGT------PDPEVWPKFTS 228
Query: 269 QLDALVGRHSRK---PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325
+K P K SP+A+D L ++L YD R+TA +A+AHPYF
Sbjct: 229 LARNYKFSFPKKAGMPLPKLFPN-----ASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 4e-57
Identities = 102/305 (33%), Positives = 162/305 (53%), Gaps = 38/305 (12%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNLCG 91
YE +K+G G Y+ V++ + T IK +K ++K+ K REIK+LQ L
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-K 60
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDY 147
PN++ LLD+ H +L+FE++ TD + + LT DI+ Y+ L+ L+Y
Sbjct: 61 HPNIIGLLDVF--GHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEY 117
Query: 148 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVD 206
HS I+HRD+KP+N++I + L+L D+GLA + P ++ +V +R+++ PELL
Sbjct: 118 LHSNWILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFG 176
Query: 207 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN----AYLNKY 262
+ Y +DMWS+GC+FA ++ R PF G + DQL KI + LGT
Sbjct: 177 ARHYGVGVDMWSVGCIFAELLLRV-PFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235
Query: 263 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321
++E P P + F A + +A+D L +LL + R+TAR+A+
Sbjct: 236 YVEFKPF--------PPTPLKQIFPAASD------DALDLLQRLLTLNPNKRITARQALE 281
Query: 322 HPYFA 326
HPYF+
Sbjct: 282 HPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 2e-50
Identities = 105/311 (33%), Positives = 164/311 (52%), Gaps = 42/311 (13%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI-------------KREIKIL 86
YE+++K+G+G Y V++ I+ T E V KKI REI L
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEV--------VALKKIFDAFRNATDAQRTFREIMFL 60
Query: 87 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKAL 145
Q L PN+VKLL++++ ++ K L+FEY+ + V+ L D RY +Y+LLKAL
Sbjct: 61 QELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKAL 120
Query: 146 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR------VASRYFK 199
Y HS ++HRD+KP N++++ + R ++L D+GLA +E VA+R+++
Sbjct: 121 KYIHSGNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATRWYR 179
Query: 200 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG---TDELN 256
PE+L+ Y +DMWS+GC+ M+ K P F G +QL KI +V+G +++
Sbjct: 180 APEILLGSTRYTKGVDMWSVGCILGEMLLGK-PLFPGTSTLNQLEKIIEVIGPPSAEDIE 238
Query: 257 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 316
+ + + LD+L R + A S +A+D L KLL ++ RLTA
Sbjct: 239 SIKSPF---AATMLDSLPSRPRKPLDELLPKA------SDDALDLLKKLLVFNPNKRLTA 289
Query: 317 REAMAHPYFAQ 327
EA+ HPY AQ
Sbjct: 290 EEALEHPYVAQ 300
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 169 bits (429), Expect = 3e-50
Identities = 103/317 (32%), Positives = 162/317 (51%), Gaps = 52/317 (16%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-----------REIKIL 86
D YE + K+G G Y +V++ + NT + L +KK +++ REI +L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGK------LVALKKTRLEMDEEGIPPTALREISLL 54
Query: 87 QNLCGGPNVVKLLDIVR-DQHSKTPSL--IFEYVNSTDFKVLYPT--------LTDYDIR 135
Q L +V+LLD+ ++ + PSL +FEY+ +D K + L I+
Sbjct: 55 QMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIK 113
Query: 136 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVA 194
++Y+LLK + +CH G+MHRD+KP N+++D + L++ D GL F P K Y +
Sbjct: 114 SFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173
Query: 195 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 254
+ +++ PE+L+ Y +D+WS+GC+FA M RK+P F G QL+ I K+LGT
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS-RKQPLFPGDSELQQLLHIFKLLGT-- 230
Query: 255 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRY 308
P G + W +F Q L +SPE +D L K+LRY
Sbjct: 231 -------------PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRY 277
Query: 309 DHQDRLTAREAMAHPYF 325
D R++A+ A+ HPYF
Sbjct: 278 DPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 1e-49
Identities = 100/305 (32%), Positives = 160/305 (52%), Gaps = 41/305 (13%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIKIL 86
Y+ V K+G G Y V++ + T E V KKI+ REI +L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEI--------VALKKIRLETEDEGVPSTAIREISLL 52
Query: 87 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK-----VLYPTLTDYDIRYYIYEL 141
+ L PN+V+LLD+V ++ L+FE+++ D K L I+ Y+Y+L
Sbjct: 53 KEL-NHPNIVRLLDVVHSENKLY--LVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQL 108
Query: 142 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKG 200
L+ + YCHS ++HRD+KP N++ID E L+L D+GLA F P + Y V + +++
Sbjct: 109 LQGIAYCHSHRVLHRDLKPQNLLIDRE-GALKLADFGLARAFGVPVRTYTHEVVTLWYRA 167
Query: 201 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 260
PE+L+ + Y +D+WS+GC+FA M+ R+ P F G DQL +I + LGT + + +
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRR-PLFPGDSEIDQLFRIFRTLGTPDEDVWPG 226
Query: 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 320
L P + +R+ SK + + + +D L K+L YD R++A+ A+
Sbjct: 227 VTSL---PDYKPTFPKWARQDLSKVVPN-----LDEDGLDLLSKMLVYDPAKRISAKAAL 278
Query: 321 AHPYF 325
HPYF
Sbjct: 279 QHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 5e-49
Identities = 96/305 (31%), Positives = 149/305 (48%), Gaps = 41/305 (13%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNLCG 91
Y+V++++G G + V+ N T E IK +K KK RE+K L+ L
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWEECMNLREVKSLRKLNE 56
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD--------IRYYIYELLK 143
PN+VKL ++ R+ + +FEY+ LY + D IR IY++L+
Sbjct: 57 HPNIVKLKEVFRE--NDELYFVFEYMEGN----LYQLMKDRKGKPFSESVIRSIIYQILQ 110
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
L + H G HRD+KP N+++ +++ D+GLA Y V++R+++ PE+
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVS-GPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEI 169
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
L+ Y +D+W+LGC+ A + + P F G DQL KI VLGT + Y
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAEL-YTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228
Query: 264 L--ELDPQLDALVGRHSRKPWSKFI-NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 320
L +L + + I NA SPEAID + +LR+D + R TA +A+
Sbjct: 229 LASKLGFRFPQFAP----TSLHQLIPNA------SPEAIDLIKDMLRWDPKKRPTASQAL 278
Query: 321 AHPYF 325
HPYF
Sbjct: 279 QHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 3e-48
Identities = 97/316 (30%), Positives = 168/316 (53%), Gaps = 29/316 (9%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-----KPVKKKKIKREIKILQNLCGG 92
Y+ + +G G Y V I+ + ++ IK + P K+ RE+KIL++
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KH 63
Query: 93 PNVVKLLDIVR--DQHSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYC 148
N++ + DI+R K ++ + + S +++ LT+ IRY++Y+LL+ L Y
Sbjct: 64 DNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY------HPG--KEYNVRVASRYFKG 200
HS ++HRD+KP N++++ + +LR+ D+G+A H EY VA+R+++
Sbjct: 124 HSANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGLSSSPTEHKYFMTEY---VATRWYRA 179
Query: 201 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 260
PELL+ L +Y ++DMWS+GC+FA M+ R++ F G + QL I VLG+ LN
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ-LFPGKNYVHQLKLILSVLGSPS-EEVLN 237
Query: 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 320
+ + + + R PWSK SPEA+D L ++L++D ++R+T +A+
Sbjct: 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPK-----ASPEALDLLSQMLQFDPEERITVEQAL 292
Query: 321 AHPYFAQVRAAESSRT 336
HP+ AQ + T
Sbjct: 293 QHPFLAQYHDPDDEPT 308
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 1e-47
Identities = 106/310 (34%), Positives = 165/310 (53%), Gaps = 34/310 (10%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCG 91
D YE V K+G G Y V++ + TNE +K ++ V I REI +L+ +
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI-REISLLKEMQH 60
Query: 92 GPNVVKLLDIVRDQHS-KTPSLIFEYVNSTDFKVLYPTLTDYD-----IRYYIYELLKAL 145
G N+V+L D+V HS K L+FEY++ D K + D+ I+ Y+Y++L+ +
Sbjct: 61 G-NIVRLQDVV---HSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGI 115
Query: 146 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELL 204
YCHS ++HRD+KP N++ID L+L D+GLA F P + + V + +++ PE+L
Sbjct: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEIL 175
Query: 205 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264
+ + Y +D+WS+GC+FA M+ +K P F G D+L KI ++LGT +
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQK-PLFPGDSEIDELFKIFRILGTPNEETW------ 228
Query: 265 ELDPQLDALVGRHSRKPWSKFINADNQHLV---SPEAIDFLDKLLRYDHQDRLTAREAMA 321
P + +L S P K+ D +V P +D L K+LR D R+TAR A+
Sbjct: 229 ---PGVTSLPDYKSAFP--KWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283
Query: 322 HPYFAQVRAA 331
H YF + A
Sbjct: 284 HEYFKDLGDA 293
|
Length = 294 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 1e-47
Identities = 93/303 (30%), Positives = 163/303 (53%), Gaps = 38/303 (12%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNLCG 91
Y+++ K+G G +SEV + + T + IK +K K K REI+ L+ L
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMK----KHFKSLEQVNNLREIQALRRLSP 56
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDY 147
PN+++L++++ D+ + +L+FE ++ ++++ P L + ++ Y+Y+LLK+LD+
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRP-LPEKRVKSYMYQLLKSLDH 115
Query: 148 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 207
H GI HRD+KP N++I ++ L+L D+G + Y +++R+++ PE L+
Sbjct: 116 MHRNGIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTD 173
Query: 208 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT--DELNAYLNKY-HL 264
Y +D+W++GC+F ++ P F G + DQ+ KI VLGT E+ K H+
Sbjct: 174 GYYGPKMDIWAVGCVFFEILSLF-PLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232
Query: 265 ELDPQLDALVGRHSRKP--WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322
+ S+K K + S E +D L KLL YD +R+TA++A+ H
Sbjct: 233 NYNFP--------SKKGTGLRKLL-----PNASAEGLDLLKKLLAYDPDERITAKQALRH 279
Query: 323 PYF 325
PYF
Sbjct: 280 PYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 1e-47
Identities = 98/310 (31%), Positives = 164/310 (52%), Gaps = 32/310 (10%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTN--ERCIIKILKPVKKKKIK-----REIKILQNLCGG 92
YE+++++G+G Y V N T+ E IK + V KKI RE+K+L++ G
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 93 PNVVKL--LDIVRDQHSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYC 148
N+ L +DIV + L E + + +++ LTD + +IY++L L Y
Sbjct: 62 KNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYI 121
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-----VASRYFKGPEL 203
HS ++HRD+KP N++++ + +L++ D+GLA + N VA+R+++ PE+
Sbjct: 122 HSANVLHRDLKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEI 180
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLN 260
++ Q Y ++D+WS+GC+ A ++ RK P F G D DQL +I +VLGT + L+ +
Sbjct: 181 MLSFQSYTKAIDVWSVGCILAELLGRK-PVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239
Query: 261 KYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 319
L + +KP+ F NA +P A+D L+KLL +D R++ EA
Sbjct: 240 PKAQNYIRSLPNIP----KKPFESIFPNA------NPLALDLLEKLLAFDPTKRISVEEA 289
Query: 320 MAHPYFAQVR 329
+ HPY A
Sbjct: 290 LEHPYLAIWH 299
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 2e-46
Identities = 97/309 (31%), Positives = 171/309 (55%), Gaps = 35/309 (11%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK----KIKREIKILQNLCGGP 93
Y+ + +G G Y V + T + IK + P + + + REIKIL+
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-KHE 63
Query: 94 NVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLYP-TLTDYDIRYYIYELLKALDYCH 149
N++ +LDI+R ++ + ++ E + + +K++ L++ I+Y++Y++L+ L Y H
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIH 123
Query: 150 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-----EFYHPGK--EYNVRVASRYFKGPE 202
S ++HRD+KP N++++ L++ D+GLA E H G EY VA+R+++ PE
Sbjct: 124 SANVLHRDLKPSNLLLNTNC-DLKICDFGLARIADPEHDHTGFLTEY---VATRWYRAPE 179
Query: 203 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYL 259
++++ + Y ++D+WS+GC+ A M+ + P F G D QL I VLGT ++LN +
Sbjct: 180 IMLNSKGYTKAIDIWSVGCILAEMLSNR-PLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238
Query: 260 NKYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 318
+ + +L + + PW+K F NAD P+A+D LDK+L ++ R+T E
Sbjct: 239 SLRARNY---IKSLPFK-PKVPWNKLFPNAD------PKALDLLDKMLTFNPHKRITVEE 288
Query: 319 AMAHPYFAQ 327
A+AHPY Q
Sbjct: 289 ALAHPYLEQ 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 7e-46
Identities = 92/318 (28%), Positives = 157/318 (49%), Gaps = 63/318 (19%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIKIL 86
YE + ++G G Y V++ ++NT + V KK++ REI +L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTG--------RFVALKKVRVPLSEEGIPLSTLREIALL 52
Query: 87 QNL--CGGPNVVKLLDI---VRDQHSKTPSLIFEYVNS--TDF--KVLYPTLTDYDIRYY 137
+ L PN+V+LLD+ R +L+FE+V+ + K P L I+
Sbjct: 53 KQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDL 112
Query: 138 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----V 193
+ +LL+ +D+ HS I+HRD+KP N+++ + + +++ D+GLA Y + + V
Sbjct: 113 MRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ-VKIADFGLARIY----SFEMALTSVV 167
Query: 194 ASRYFKGPELLVDLQD-YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 252
+ +++ PE+L LQ Y +DMWS+GC+FA + FR+ P F G DQL KI V+G
Sbjct: 168 VTLWYRAPEVL--LQSSYATPVDMWSVGCIFAEL-FRRRPLFRGTSEADQLDKIFDVIGL 224
Query: 253 ---DE--LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 307
+E N L + ++ + + F+ + E +D L K+L
Sbjct: 225 PSEEEWPRNVSLPRSSFP----------SYTPRSFKSFVPE-----ICEEGLDLLKKMLT 269
Query: 308 YDHQDRLTAREAMAHPYF 325
++ R++A EA+ HPYF
Sbjct: 270 FNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 1e-45
Identities = 91/299 (30%), Positives = 149/299 (49%), Gaps = 29/299 (9%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------KKKIKREIKILQNLCG 91
YE + K+G G Y VF+ N T+E I LK V+ REI +L+ L
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHE---IVALKRVRLDDDDEGVPSSALREICLLKEL-K 57
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY----DIRYYIYELLKALDY 147
N+V+L D++ T L+FEY + D K + + ++ ++++LLK L +
Sbjct: 58 HKNIVRLYDVLHSDKKLT--LVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAF 114
Query: 148 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVD 206
CHS ++HRD+KP N++I+ +L+L D+GLA + P + Y+ V + +++ P++L
Sbjct: 115 CHSHNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 173
Query: 207 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266
+ Y S+DMWS GC+FA + P F G+D DQL +I ++LGT ++ L
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL-- 231
Query: 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325
P + + ++ D L LL + R++A EA+ HPYF
Sbjct: 232 -PDYKPYPMYPATTSLVNVVPK-----LNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 4e-45
Identities = 97/311 (31%), Positives = 165/311 (53%), Gaps = 43/311 (13%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-----KPVKKKKIKREIKILQNLCGG 92
D Y+ + VG G Y +V + T + IK L + K+ RE+++L+++
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDH- 73
Query: 93 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP-------------TLTDYDIRYYIY 139
NV+ LLD+ TP+ E + D ++ L+D I++ +Y
Sbjct: 74 ENVIGLLDVF------TPASSLE--DFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVY 125
Query: 140 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 199
++L+ L Y HS GI+HRD+KP N+ ++ E +L+++D+GLA H E VA+R+++
Sbjct: 126 QILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYR 182
Query: 200 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT--DELNA 257
PE++++ Y+ ++D+WS+GC+ A ++ K F G D+ DQL +I ++GT +EL
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLTGK-TLFPGSDHIDQLKRIMNLVGTPDEEL-- 239
Query: 258 YLNKYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 316
L K E + + +K + + F A +P AID L+K+L D R+TA
Sbjct: 240 -LQKISSESARNYIQSLPQMPKKDFKEVFSGA------NPLAIDLLEKMLVLDPDKRITA 292
Query: 317 REAMAHPYFAQ 327
EA+AHPY A+
Sbjct: 293 AEALAHPYLAE 303
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 7e-45
Identities = 99/319 (31%), Positives = 160/319 (50%), Gaps = 40/319 (12%)
Query: 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKKKKIK----REIKILQNL 89
S DYE++ K+G G + EV++ + T +K IL +K REIKIL+ L
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL 64
Query: 90 CGGPNVVKLLDIV---RDQHSKTPS---LIFEYVNSTDFKVLYP---TLTDYDIRYYIYE 140
PNVV L+D+ D+ + ++ Y++ +L LT+ I+ Y+ +
Sbjct: 65 -KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQ 123
Query: 141 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY--------HPG----KE 188
LL+ ++Y H I+HRD+K N++ID++ L++ D+GLA Y G ++
Sbjct: 124 LLEGINYLHENHILHRDIKAANILIDNQ-GILKIADFGLARPYDGPPPNPKGGGGGGTRK 182
Query: 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 248
Y V +R+++ PELL+ + Y ++D+W +GC+FA M R+ P G + DQL I K
Sbjct: 183 YTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR-PILQGKSDIDQLHLIFK 241
Query: 249 VLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHL--VSPEAIDFLDKLL 306
+ GT + E P +L G ++ + + + PE +D L KLL
Sbjct: 242 LCGT------PTE---ETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLL 292
Query: 307 RYDHQDRLTAREAMAHPYF 325
D RLTA +A+ HPYF
Sbjct: 293 SLDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 9e-45
Identities = 56/190 (29%), Positives = 96/190 (50%), Gaps = 12/190 (6%)
Query: 46 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPNVVKLLDI 101
+G G + V+ + T ++ IKI+K + REI+IL+ L PN+VKL +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGV 59
Query: 102 VRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRD 157
D+ L+ EY K L L++ +I + ++L+ L+Y HS GI+HRD
Sbjct: 60 FEDE--NHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 158 VKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDM 216
+KP N+++D + K++L D+GL++ V + + PE+L+ Y D+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 217 WSLGCMFAGM 226
WSLG + +
Sbjct: 178 WSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 1e-44
Identities = 92/297 (30%), Positives = 160/297 (53%), Gaps = 25/297 (8%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCGGP 93
++ V K+G G Y V++ N T E +K ++ V I REI +L+ L P
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHP 59
Query: 94 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT----LTDYDIRYYIYELLKALDYCH 149
N+VKLLD++ + L+FE+++ K + + + I+ Y+++LL+ L +CH
Sbjct: 60 NIVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 150 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 208
S ++HRD+KP N++I+ ++L D+GLA F P + Y V + +++ PE+L+ +
Sbjct: 118 SHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 176
Query: 209 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268
Y ++D+WSLGC+FA M+ R+ F G DQL +I + LGT + + L P
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRR-ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL---P 232
Query: 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325
+ +R+ +SK + + + D L ++L YD R++A+ A+AHP+F
Sbjct: 233 DYKPSFPKWARQDFSKVVP-----PLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 9e-44
Identities = 97/308 (31%), Positives = 162/308 (52%), Gaps = 44/308 (14%)
Query: 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIKI 85
DY + K+G G Y V++G N T + V KKI+ REI +
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTG--------QIVAMKKIRLESEEEGVPSTAIREISL 52
Query: 86 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD------IRYYIY 139
L+ L PN+V L D++ Q S+ LIFE++ S D K +L ++ Y+Y
Sbjct: 53 LKEL-QHPNIVCLQDVLM-QESRL-YLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLY 108
Query: 140 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYF 198
++L+ + +CHS+ ++HRD+KP N++ID++ ++L D+GLA F P + Y V + ++
Sbjct: 109 QILQGILFCHSRRVLHRDLKPQNLLIDNK-GVIKLADFGLARAFGIPVRVYTHEVVTLWY 167
Query: 199 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 258
+ PE+L+ Y +D+WS+G +FA M +K P F+G DQL +I ++LGT + +
Sbjct: 168 RAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK-PLFHGDSEIDQLFRIFRILGTPTEDVW 226
Query: 259 LNKYHLELDPQLDALVGRHSRKP-WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 317
P + +L + P W K + + +D L+K+L YD R++A+
Sbjct: 227 ---------PGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAK 277
Query: 318 EAMAHPYF 325
+A+ HPYF
Sbjct: 278 KALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 1e-43
Identities = 86/300 (28%), Positives = 156/300 (52%), Gaps = 31/300 (10%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-------KKKIKREIKILQNLCGG 92
++ + K+G G Y+ V++G N T E I LK + REI +++ L
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGE---IVALKEIHLDAEEGTPSTAIREISLMKEL-KH 57
Query: 93 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY------DIRYYIYELLKALD 146
N+V+L D++ ++ L+FEY++ D K T ++ + Y+LLK +
Sbjct: 58 ENIVRLHDVIHTENKLM--LVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114
Query: 147 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 205
+CH ++HRD+KP N++I+ L+L D+GLA F P ++ V + +++ P++L+
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGE-LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLL 173
Query: 206 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265
+ Y S+D+WS+GC+ A MI + P F G +N DQL+KI +++GT + + +
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR-PLFPGTNNEDQLLKIFRIMGTPTESTWPG---IS 229
Query: 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325
P+ R+ + + P ID L +LL+ + + R++A +A+ HP+F
Sbjct: 230 QLPEYKPTFPRYPPQDLQQLFPH-----ADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 2e-43
Identities = 103/311 (33%), Positives = 164/311 (52%), Gaps = 48/311 (15%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-------PVKKKKIKREIKILQNLC 90
+ YE + K+G G Y VF+ N T + I+ I K PV KK REI++L+ L
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQ--IVAIKKFVESEDDPVIKKIALREIRMLKQL- 57
Query: 91 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPT-LTDYDIRYYIYELLKALDY 147
PN+V L+++ R + L+FEY + T L P + ++ I+ I++ L+A+++
Sbjct: 58 KHPNLVNLIEVFR--RKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNF 115
Query: 148 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV- 205
CH +HRDVKP N++I + +++L D+G A PG +Y VA+R+++ PELLV
Sbjct: 116 CHKHNCIHRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVG 174
Query: 206 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL---------- 255
D Q Y +D+W++GC+FA ++ +P + G + DQL I K LG +L
Sbjct: 175 DTQ-YGPPVDVWAIGCVFAELL-TGQPLWPGKSDVDQLYLIRKTLG--DLIPRHQQIFST 230
Query: 256 NAYLNKYHLELDPQLDALVGRHSRKPW-SKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 314
N + + +P+ +R+P SKF N S A+ FL L+ D +RL
Sbjct: 231 NQFFKGLSIP-EPE--------TREPLESKFPNI------SSPALSFLKGCLQMDPTERL 275
Query: 315 TAREAMAHPYF 325
+ E + HPYF
Sbjct: 276 SCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 5e-43
Identities = 83/293 (28%), Positives = 132/293 (45%), Gaps = 47/293 (16%)
Query: 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK---IKREIKILQNLCGGPNV 95
+E++ K+G+G + EV++ + T + IK++K K+K I EI+IL+ C PN+
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILK-KCKHPNI 59
Query: 96 VKLLDIVRDQHSKTPSLIFEYVN----STDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 151
VK ++ E+ + K TLT+ I Y ELLK L+Y HS
Sbjct: 60 VKYYGSY--LKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 152 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 211
GI+HRD+K N+++ + +++LID+GL+ K N V + Y+ PE++ + YD
Sbjct: 118 GIIHRDIKAANILLTSD-GEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPYD 175
Query: 212 YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD 271
Y D+WSLG + K P+ EL P
Sbjct: 176 YKADIWSLGITAIELAEGKPPYS------------------------------ELPPMK- 204
Query: 272 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 324
AL + + N S E DFL K L+ + + R TA + + HP+
Sbjct: 205 ALF-KIATNGPPGL---RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 6e-43
Identities = 98/318 (30%), Positives = 157/318 (49%), Gaps = 53/318 (16%)
Query: 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK------------R 81
F + Y+ + K+G G Y+ V++G + T + V K+I+ R
Sbjct: 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQL--------VALKEIRLEHEEGAPFTAIR 52
Query: 82 EIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTD-YDIRYY 137
E +L++L N+V L DI+ + KT +L+FEY++ TD K +++R +
Sbjct: 53 EASLLKDL-KHANIVTLHDIIHTK--KTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLF 108
Query: 138 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASR 196
+++LL+ L YCH + ++HRD+KP N++I E +L+L D+GLA P K Y+ V +
Sbjct: 109 LFQLLRGLAYCHQRRVLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVTL 167
Query: 197 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH-DNHDQLVKIAKVLGTD-- 253
+++ P++L+ +Y SLDMW +GC+F M P F G D DQL KI +VLGT
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMA-TGRPLFPGSTDVEDQLHKIFRVLGTPTE 226
Query: 254 ------ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 307
N Y + +P IN + P + K L+
Sbjct: 227 ETWPGVSSNPEFKPYSF----------PFYPPRP---LINHAPRLDRIPHGEELALKFLQ 273
Query: 308 YDHQDRLTAREAMAHPYF 325
Y+ + R++A EAM HPYF
Sbjct: 274 YEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 6e-43
Identities = 100/309 (32%), Positives = 167/309 (54%), Gaps = 34/309 (11%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KPVKK----KKIKREIKILQNLCGGPN 94
Y +++VG G Y V I+ T E+ IK L +P + K+ RE+ +L+++ N
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-QHEN 75
Query: 95 VVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHS 150
V+ LLD+ S + L+ Y+ + K++ L++ ++Y +Y++L L Y HS
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHS 135
Query: 151 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 210
GI+HRD+KP N+ ++ + +L+++D+GLA H E V +R+++ PE++++ Y
Sbjct: 136 AGIIHRDLKPGNLAVNEDC-ELKILDFGLAR--HADAEMTGYVVTRWYRAPEVILNWMHY 192
Query: 211 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG------TDELNAYLNKYHL 264
+ ++D+WS+GC+ A M+ K F G D DQL +I KV G +L K ++
Sbjct: 193 NQTVDIWSVGCIMAEMLTGKT-LFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYI 251
Query: 265 ELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
+ P+ RK +S F A SP+A+D L+K+L D RLTA EA+ HP
Sbjct: 252 KSLPKY-------PRKDFSTLFPKA------SPQAVDLLEKMLELDVDKRLTATEALEHP 298
Query: 324 YFAQVRAAE 332
YF R A+
Sbjct: 299 YFDSFRDAD 307
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 151 bits (381), Expect = 2e-42
Identities = 87/319 (27%), Positives = 143/319 (44%), Gaps = 55/319 (17%)
Query: 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK------IKREIKILQNLCGG 92
Y ++RK+G G + EV+ + + +K+L + K REI+IL +L
Sbjct: 1 SYRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 93 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALD 146
PN+VKL D Q + L+ EYV+ + L L++ + + + ++L AL+
Sbjct: 58 PNIVKLYDFF--QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE 115
Query: 147 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-------HPGKEYNVRVASRYFK 199
Y HS+GI+HRD+KP N+++D + R ++LID+GLA+ + V + +
Sbjct: 116 YLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 200 GPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPF--FYGHDNHDQLVKIAKVLGTDEL 255
PE+L+ L S D+WSLG ++ PF Q +KI L T L
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 256 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT 315
+ L+ N L+S A D L KLL D ++RL+
Sbjct: 236 ASPLSP---------------------------SNPELISKAASDLLKKLLAKDPKNRLS 268
Query: 316 AREAMAHPYFAQVRAAESS 334
+ ++H A ++ ES
Sbjct: 269 SSSDLSHDLLAHLKLKESD 287
|
Length = 384 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 3e-42
Identities = 83/308 (26%), Positives = 160/308 (51%), Gaps = 34/308 (11%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGG 92
D ++++ ++G G Y +V++ + +T E +K ++ +K+ REIKIL+ L
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-NH 65
Query: 93 PNVVKLLDIVRDQHSKTP--------SLIFEYVNSTDFKVLYPTLTDYD---IRYYIYEL 141
N+V L +IV D+ L+FEY++ +L L + I+ ++ +L
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL 125
Query: 142 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG--KEYNVRVASRYFK 199
L+ L+YCH + +HRD+K N++++++ +++L D+GLA Y+ + Y +V + +++
Sbjct: 126 LEGLNYCHKKNFLHRDIKCSNILLNNK-GQIKLADFGLARLYNSEESRPYTNKVITLWYR 184
Query: 200 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259
PELL+ + Y ++D+WS GC+ G +F K+P F + QL I+++ G+ +
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCIL-GELFTKKPIFQANQELAQLELISRLCGSPCPAVW- 242
Query: 260 NKYHLELDPQLDALVGRHSRKP---WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 316
P + L ++ KP + + + + + A+D LD +L D R TA
Sbjct: 243 --------PDVIKLPYFNTMKPKKQYRRRLREEFSFI-PTPALDLLDHMLTLDPSKRCTA 293
Query: 317 REAMAHPY 324
EA+ P+
Sbjct: 294 EEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-41
Identities = 98/317 (30%), Positives = 170/317 (53%), Gaps = 43/317 (13%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KPVKK----KKIKREIKILQNLCG 91
D Y +++VG G Y V ++ T + IK L +P + K+ RE+++L+++
Sbjct: 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-K 72
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP-------------TLTDYDIRYYI 138
NV+ LLD+ TP L + + DF ++ P L++ I++ +
Sbjct: 73 HENVIGLLDVF------TPDLSLDRFH--DFYLVMPFMGTDLGKLMKHEKLSEDRIQFLV 124
Query: 139 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF 198
Y++LK L Y H+ GI+HRD+KP N+ ++ + +L+++D+GLA E V +R++
Sbjct: 125 YQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLAR--QTDSEMTGYVVTRWY 181
Query: 199 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 258
+ PE++++ Y ++D+WS+GC+ A M+ K P F GHD+ DQL++I KV GT
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK-PLFKGHDHLDQLMEIMKVTGTPS---- 236
Query: 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHL---VSPEAIDFLDKLLRYDHQDRLT 315
E +L + ++ K +F D + L +P A++ L+K+L D + R+T
Sbjct: 237 -----KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRIT 291
Query: 316 AREAMAHPYFAQVRAAE 332
A EA+AHPYF + E
Sbjct: 292 AAEALAHPYFEEFHDPE 308
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 5e-41
Identities = 106/308 (34%), Positives = 165/308 (53%), Gaps = 34/308 (11%)
Query: 33 IFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKP----VKKKKIKREIKILQ 87
+F + Y ++ VG G + V + T + IK I+KP V K+ RE+K+L+
Sbjct: 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLK 64
Query: 88 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN---STDFKVLYPT--LTDYDIRYYIYELL 142
+L N++ L DI +P +V TD L + L I+Y++Y++L
Sbjct: 65 HL-RHENIISLSDIF-----ISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQIL 118
Query: 143 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 202
+ L Y HS G++HRD+KP N++I+ E L++ D+GLA P + V++RY++ PE
Sbjct: 119 RGLKYVHSAGVVHRDLKPSNILIN-ENCDLKICDFGLARIQDP--QMTGYVSTRYYRAPE 175
Query: 203 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYL 259
+++ Q YD +D+WS GC+FA M +P F G D+ +Q I +LGT D +N
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEM-LEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234
Query: 260 NKYHLELDPQLDALVGRHSRKPWS-KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 318
++ L L + P+S KF NAD P AID L+K+L +D Q R++A E
Sbjct: 235 SENTLRFVQSLP----KREPVPFSEKFKNAD------PSAIDLLEKMLVFDPQKRISAAE 284
Query: 319 AMAHPYFA 326
A+AHPY A
Sbjct: 285 ALAHPYLA 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 1e-40
Identities = 95/298 (31%), Positives = 151/298 (50%), Gaps = 26/298 (8%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCGGP 93
YE + VG G Y V + + T + IK K VKK + REI++L+ L
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM-REIRMLKQL-RHE 60
Query: 94 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYD-IRYYIYELLKALDYCHS 150
N+V L+++ R + K L+FE+V+ T L YP D +R Y++++L+ +++CHS
Sbjct: 61 NLVNLIEVFRRK--KRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 151 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQD 209
I+HRD+KP N+++ ++L D+G A PG+ Y VA+R+++ PELLV
Sbjct: 119 HNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK 177
Query: 210 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 269
Y ++D+W++GC+ M EP F G + DQL I K LG L H E+ +
Sbjct: 178 YGRAVDIWAVGCLVTEM-LTGEPLFPGDSDIDQLYHIIKCLGN------LIPRHQEIFQK 230
Query: 270 LDALVGRHSRKPWSKFINADNQHL--VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325
G R P K I + +S +D + LR D DR ++ + + H +F
Sbjct: 231 NPLFAG--MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-39
Identities = 100/309 (32%), Positives = 168/309 (54%), Gaps = 42/309 (13%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-----KPVKKKKIKREIKILQNLCGGPN 94
Y ++ +GRG Y V N TNE+ IK + + K+ REIK+L++L N
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHEN 65
Query: 95 VVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYC 148
V+ + DI+ H + + +++E ++ TD + TL+D +Y++Y+LL+ L Y
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYI 124
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-------EFYHPGKEYNVRVASRYFKGP 201
HS ++HRD+KP N++++ L++ D+GLA +F EY V +R+++ P
Sbjct: 125 HSANVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFM---TEY---VVTRWYRAP 177
Query: 202 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAY 258
ELL++ +Y ++D+WS+GC+FA ++ RK P F G D QL I ++LG+ ++L
Sbjct: 178 ELLLNCSEYTTAIDVWSVGCIFAELLGRK-PLFPGKDYVHQLKLITELLGSPSEEDLGFI 236
Query: 259 LNKYHLELDPQLDALVGRHSRKPWS-KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 317
N+ L R+ ++ F +A +P AID L+K+L +D R+T
Sbjct: 237 RNEKARRYIRSL----PYTPRQSFARLFPHA------NPLAIDLLEKMLVFDPSKRITVE 286
Query: 318 EAMAHPYFA 326
EA+AHPY A
Sbjct: 287 EALAHPYLA 295
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 139 bits (354), Expect = 1e-39
Identities = 79/299 (26%), Positives = 132/299 (44%), Gaps = 51/299 (17%)
Query: 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIK--ILKPVKKKK---IKREIKILQNLCGGP 93
++ +GRG + V+ ++ +T E +K L +++ ++REI+IL +L P
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHP 59
Query: 94 NVVKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHS 150
N+V+ RD+ T ++ EYV+ + + L + IR Y ++L+ L Y HS
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 151 QGIMHRDVKPHNVMIDHELRKLRLIDWGLA---EFYHPGKEYNVRVASRYFKGPELLVDL 207
GI+HRD+K N+++D + ++L D+G A G+ + Y+ PE++
Sbjct: 120 NGIVHRDIKGANILVDSDGV-VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG- 177
Query: 208 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKVLGTDELNAYLNKYHLEL 266
++Y + D+WSLGC M K P + N + KI E+ +L
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPP-WSELGNPMAALYKIGSSGEPPEIPEHL------- 229
Query: 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325
S EA DFL K LR D + R TA E + HP+
Sbjct: 230 ----------------------------SEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 4e-39
Identities = 94/302 (31%), Positives = 157/302 (51%), Gaps = 27/302 (8%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK---IK--REIKILQNLCGG 92
D+YE + ++ G Y V+ + T E +K LK K+K+ I REI IL L
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QH 63
Query: 93 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY----DIRYYIYELLKALDYC 148
PN+V + ++V + ++ EYV D K L T+ +++ + +LL + +
Sbjct: 64 PNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHL 122
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 207
H I+HRD+K N+++++ L++ D+GLA E+ P K Y V + +++ PELL+
Sbjct: 123 HDNWILHRDLKTSNLLLNNRGI-LKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGA 181
Query: 208 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267
++Y ++DMWS+GC+FA ++ K+P F G DQL KI K+LGT +
Sbjct: 182 KEYSTAIDMWSVGCIFAELL-TKKPLFPGKSEIDQLNKIFKLLGTPTEKIW--------- 231
Query: 268 PQLDALVG----RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
P L G ++ P+++ +S D L++LL YD R++A +A+ HP
Sbjct: 232 PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHP 291
Query: 324 YF 325
YF
Sbjct: 292 YF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 1e-38
Identities = 95/310 (30%), Positives = 161/310 (51%), Gaps = 45/310 (14%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KP----VKKKKIKREIKILQNLCGGPN 94
Y+ + VG G Y V + ++ +K L +P + ++ RE+++L+++ N
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-KHEN 75
Query: 95 VVKLLDIVRDQHSKTPSLIFEYVNS---------TDFK--VLYPTLTDYDIRYYIYELLK 143
V+ LLD+ TP+ E N D V L+D +++ IY+LL+
Sbjct: 76 VIGLLDVF------TPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLR 129
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
L Y HS GI+HRD+KP NV ++ + +LR++D+GLA E VA+R+++ PE+
Sbjct: 130 GLKYIHSAGIIHRDLKPSNVAVNEDC-ELRILDFGLAR--QADDEMTGYVATRWYRAPEI 186
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
+++ Y+ ++D+WS+GC+ A ++ + + F G+D DQL +I +V+GT
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELL-KGKALFPGNDYIDQLKRIMEVVGTPSPEV------ 239
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTAR 317
L + H+RK + Q L +P AID L+K+L D R++A
Sbjct: 240 ------LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISAS 293
Query: 318 EAMAHPYFAQ 327
EA+AHPYF+Q
Sbjct: 294 EALAHPYFSQ 303
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 139 bits (350), Expect = 3e-38
Identities = 92/306 (30%), Positives = 157/306 (51%), Gaps = 33/306 (10%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KP----VKKKKIKREIKILQNLCGG 92
+ Y+ + VG G Y V + T R +K L +P + K+ RE+++L+++
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KH 75
Query: 93 PNVVKLLDIVRDQHSKTPSLIFEYVNS---------TDFK--VLYPTLTDYDIRYYIYEL 141
NV+ LLD+ TP+ E N D V LTD +++ IY++
Sbjct: 76 ENVIGLLDVF------TPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 129
Query: 142 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 201
L+ L Y HS I+HRD+KP N+ ++ + +L+++D+GLA H E VA+R+++ P
Sbjct: 130 LRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRWYRAP 186
Query: 202 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261
E++++ Y+ ++D+WS+GC+ A ++ + F G D+ DQL I +++GT
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTPGAELLKKI 245
Query: 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321
+ +L + FI A+ P A+D L+K+L D R+TA +A+A
Sbjct: 246 SSESARNYIQSLTQMPKMNFANVFIGAN------PLAVDLLEKMLVLDSDKRITAAQALA 299
Query: 322 HPYFAQ 327
H YFAQ
Sbjct: 300 HAYFAQ 305
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 2e-36
Identities = 91/311 (29%), Positives = 158/311 (50%), Gaps = 37/311 (11%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK---REIKILQNLCGGPNVV 96
Y +R +G G VF ++ + ++R +K + + +K REIKI++ L N+V
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIV 65
Query: 97 KLLDIVRDQHSKTPS------------LIFEYVNSTDFKVL--YPTLTDYDIRYYIYELL 142
K+ +++ S ++ EY+ TD + L++ R ++Y+LL
Sbjct: 66 KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLL 124
Query: 143 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYF 198
+ L Y HS ++HRD+KP NV I+ E L++ D+GLA P + + + ++++
Sbjct: 125 RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWY 184
Query: 199 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK---VLGTDEL 255
+ P LL+ +Y ++DMW+ GC+FA M+ K P F G +Q+ I + V+ ++
Sbjct: 185 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-PLFAGAHELEQMQLILESVPVVREEDR 243
Query: 256 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT 315
N LN P G R+P + V+PEA+DFL+++L ++ DRLT
Sbjct: 244 NELLNV-----IPSFVRNDGGEPRRPLRDLLPG-----VNPEALDFLEQILTFNPMDRLT 293
Query: 316 AREAMAHPYFA 326
A EA+ HPY +
Sbjct: 294 AEEALMHPYMS 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-36
Identities = 89/306 (29%), Positives = 159/306 (51%), Gaps = 29/306 (9%)
Query: 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNL 89
F Y + K+G G Y+ V++GI+ + +K++ ++ + RE +L+ L
Sbjct: 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL 60
Query: 90 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNS--TDFKVLYPT-LTDYDIRYYIYELLKALD 146
N+V L DI+ + + T +FEY+++ + + +P L Y++R ++++LL+ L
Sbjct: 61 -KHANIVLLHDIIHTKETLT--FVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLA 117
Query: 147 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV 205
Y H Q I+HRD+KP N++I + L +L+L D+GLA P + Y+ V + +++ P++L+
Sbjct: 118 YIHGQHILHRDLKPQNLLISY-LGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLL 176
Query: 206 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN-HDQLVKIAKVLGTDELNAY-----L 259
DY +LD+W GC+F M + +P F G + +QL KI VLG + + L
Sbjct: 177 GATDYSSALDIWGAGCIFIEM-LQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235
Query: 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 319
Y E + R W + P+A D ++L +DR++A++A
Sbjct: 236 PNYKPEWFLPCKP---QQLRVVWKRLSRP-------PKAEDLASQMLMMFPKDRISAQDA 285
Query: 320 MAHPYF 325
+ HPYF
Sbjct: 286 LLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 5e-35
Identities = 85/309 (27%), Positives = 144/309 (46%), Gaps = 45/309 (14%)
Query: 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNLC 90
++E + ++G G Y V+ + + E I LK V+ + REI +L N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGE---IVALKKVRMDNERDGIPISSLREITLLLN-L 63
Query: 91 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDY 147
PN+V+L ++V +H + L+ EY +L ++ ++ + +LL+ L Y
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQY 123
Query: 148 CHSQGIMHRDVKPHNV-MIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLV 205
H I+HRD+K N+ + D L++ D+GLA Y P K +V + +++ PELL+
Sbjct: 124 LHENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLL 181
Query: 206 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---------DELN 256
Y ++DMW++GC+ A + +P G +QL I ++LGT +L
Sbjct: 182 GCTTYTTAIDMWAVGCILAEL-LAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240
Query: 257 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 316
K+ L P + +H + PW +S + L+ LL YD + R TA
Sbjct: 241 LV-GKFTLPKQPYNNL---KH-KFPW-----------LSEAGLRLLNFLLMYDPKKRATA 284
Query: 317 REAMAHPYF 325
EA+ YF
Sbjct: 285 EEALESSYF 293
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 5e-35
Identities = 94/311 (30%), Positives = 162/311 (52%), Gaps = 31/311 (9%)
Query: 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKKKKIKREIKILQNLCGGP 93
S Y++ +G G + V+E I ++T+E+ IK +L+ + K RE+ I++NL
Sbjct: 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN--RELLIMKNL-NHI 119
Query: 94 NVVKLLD------IVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYEL 141
N++ L D +++ + +++ E++ T K + L + ++ Y Y+L
Sbjct: 120 NIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL 179
Query: 142 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 201
+AL Y HS+ I HRD+KP N++ID L+L D+G A+ G+ + SR+++ P
Sbjct: 180 CRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAP 239
Query: 202 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAY 258
EL++ +Y +D+WSLGC+ A MI P F G + DQLV+I +VLGT D+L
Sbjct: 240 ELMLGATNYTTHIDLWSLGCIIAEMIL-GYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEM 298
Query: 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 318
Y D + + + +K + K +AI+F+ + L+Y+ RL E
Sbjct: 299 NPNY---ADIKFPDVKPKDLKKVFPKG--------TPDDAINFISQFLKYEPLKRLNPIE 347
Query: 319 AMAHPYFAQVR 329
A+A P+F +R
Sbjct: 348 ALADPFFDDLR 358
|
Length = 440 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 2e-34
Identities = 91/326 (27%), Positives = 140/326 (42%), Gaps = 84/326 (25%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKK---IKREIKILQNLCG 91
DD++ + +G G +S V TN+ IKIL +K+KK +K E ++L L G
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 92 GPNVVKLLDIVRDQHSKTPSLIF--EYVNSTDFKVL---YPTLTDYDIRYYIYELLKALD 146
P ++KL +D+ + L F EY + + Y +L + R+Y E+L AL+
Sbjct: 61 HPGIIKLYYTFQDEEN----LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE 116
Query: 147 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---------------EYNV 191
Y HS+GI+HRD+KP N+++D ++ +++ D+G A+ P
Sbjct: 117 YLHSKGIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 192 RVASRYFKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV- 244
R F G PELL + + S D+W+LGC+ M+ K PF +++ L
Sbjct: 176 RRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPF---RGSNEYLTF 231
Query: 245 -KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLD 303
KI K LE + D A D ++
Sbjct: 232 QKILK---------------LEYS--------------FPPNFPPD--------AKDLIE 254
Query: 304 KLLRYDHQDRLTA----REAMAHPYF 325
KLL D QDRL E AHP+F
Sbjct: 255 KLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 2e-34
Identities = 92/312 (29%), Positives = 165/312 (52%), Gaps = 44/312 (14%)
Query: 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNL 89
F + Y + K+G G Y+ V++G + T+ +K ++ ++ RE+ +L++L
Sbjct: 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL 61
Query: 90 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTD-------YDIRYYIYELL 142
N+V L DI+ + K+ +L+FEY++ K L L D ++++ ++++LL
Sbjct: 62 -KHANIVTLHDIIHTE--KSLTLVFEYLD----KDLKQYLDDCGNSINMHNVKLFLFQLL 114
Query: 143 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGP 201
+ L+YCH + ++HRD+KP N++I+ E +L+L D+GLA P K Y+ V + +++ P
Sbjct: 115 RGLNYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPP 173
Query: 202 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261
++L+ DY +DMW +GC+F M + P F G +QL I ++LGT
Sbjct: 174 DILLGSTDYSTQIDMWGVGCIFYEMSTGR-PLFPGSTVEEQLHFIFRILGT--------- 223
Query: 262 YHLELDPQLDALVGRHSRKPWSKF----INADNQHLVSP----EAIDFLDKLLRYDHQDR 313
P + G S + + + AD H +P + + L KLL+++ + R
Sbjct: 224 ------PTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKR 277
Query: 314 LTAREAMAHPYF 325
++A EAM HPYF
Sbjct: 278 ISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 4e-34
Identities = 92/306 (30%), Positives = 166/306 (54%), Gaps = 23/306 (7%)
Query: 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNL 89
F D YE + K+G G Y+ V++G + + +K+++ +++ RE +L+ L
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL 60
Query: 90 CGGPNVVKLLDIVRDQHSK-TPSLIFEYVNSTDFKVL--YPT-LTDYDIRYYIYELLKAL 145
N+V L DI+ H+K T +L+FEYV++ + + +P L +++ ++++LL+ L
Sbjct: 61 -KHANIVLLHDII---HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGL 116
Query: 146 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELL 204
Y H + I+HRD+KP N++I + +L+L D+GLA P Y+ V + +++ P++L
Sbjct: 117 SYIHQRYILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVL 175
Query: 205 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264
+ +Y LDMW +GC+F MI F D DQL +I VLGT + + + L
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235
Query: 265 -ELDPQLDALV-GRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322
P+ L ++ R+ W+K ++ A D KLL+ ++RL+A+ A++H
Sbjct: 236 PHFKPERFTLYSPKNLRQAWNKLSYVNH-------AEDLASKLLQCFPKNRLSAQAALSH 288
Query: 323 PYFAQV 328
YF+ +
Sbjct: 289 EYFSDL 294
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 7e-34
Identities = 94/314 (29%), Positives = 156/314 (49%), Gaps = 36/314 (11%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPN 94
Y++ +G+G Y V I+ +T E+ IK + V +I REIK+L+
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLR------- 54
Query: 95 VVKLLDIVRDQHSKTPS---------LIFEYVNSTDFKVLYPT--LTDYDIRYYIYELLK 143
+++ DIV +H P ++FE + S +V+ LT ++++Y+LL+
Sbjct: 55 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLR 114
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV----RVASRYFK 199
AL Y H+ + HRD+KP N++ + + KL++ D+GLA + VA+R+++
Sbjct: 115 ALKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 200 GPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 258
PEL Y ++D+WS+GC+FA ++ K P F G + QL I +LGT
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQLDLITDLLGTPSPETI 232
Query: 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 318
+ + L ++ + KF NAD P A+ L++LL +D +DR TA E
Sbjct: 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNAD------PLALRLLERLLAFDPKDRPTAEE 286
Query: 319 AMAHPYFAQVRAAE 332
A+A PYF + E
Sbjct: 287 ALADPYFKGLAKVE 300
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 7e-34
Identities = 94/303 (31%), Positives = 158/303 (52%), Gaps = 32/303 (10%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNLCG 91
YE V ++G G Y +VF+ ++ R + LK V+ + + RE+ +L++L
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVA--LKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 92 --GPNVVKLLDIV---RDQHSKTPSLIFEYVNS--TDF--KVLYPTLTDYDIRYYIYELL 142
PNVV+L D+ R +L+FE+V+ T + KV P + I+ +++LL
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 143 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 202
+ LD+ HS ++HRD+KP N+++ +++L D+GLA Y V + +++ PE
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 179
Query: 203 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262
+L+ Y +D+WS+GC+FA M FR++P F G + DQL KI V+G +
Sbjct: 180 VLLQ-SSYATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237
Query: 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322
L P+ A + + +P KF+ D L D L K L ++ R++A A++H
Sbjct: 238 AL---PR-QAFHSKSA-QPIEKFV-TDIDEL----GKDLLLKCLTFNPAKRISAYSALSH 287
Query: 323 PYF 325
PYF
Sbjct: 288 PYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 4e-33
Identities = 95/314 (30%), Positives = 159/314 (50%), Gaps = 48/314 (15%)
Query: 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNL 89
F + Y + K+G G Y+ VF+G + T +K ++ ++ RE+ +L++L
Sbjct: 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL 61
Query: 90 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKAL 145
N+V L DIV S T L+FEY++ D K ++ ++++ ++Y++L+ L
Sbjct: 62 -KHANIVTLHDIVHTDKSLT--LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGL 117
Query: 146 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELL 204
YCH + ++HRD+KP N++I+ E +L+L D+GLA P K Y+ V + +++ P++L
Sbjct: 118 AYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 176
Query: 205 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------------ 252
+ +Y +DMW +GC+F M + P F G D+L I ++LGT
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGR-PLFPGSTVEDELHLIFRLLGTPTEETWPGISSN 235
Query: 253 DELNAY-LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQ 311
DE Y KY PQ IN + + E I+ L K L+Y+ +
Sbjct: 236 DEFKNYNFPKY----KPQ--------------PLINHAPR--LDTEGIELLTKFLQYESK 275
Query: 312 DRLTAREAMAHPYF 325
R++A EAM H YF
Sbjct: 276 KRISAEEAMKHAYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 6e-33
Identities = 93/301 (30%), Positives = 149/301 (49%), Gaps = 27/301 (8%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGG 92
+ +EV+ VG G Y V + + T E IK K + K+ RE+K+L+ L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQ 59
Query: 93 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYD-IRYYIYELLKALDYCH 149
N+V+L + R + L+FEYV ++L P + +R YIY+L+KA+ +CH
Sbjct: 60 ENIVELKEAFRRRGKLY--LVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH 117
Query: 150 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDL 207
I+HRD+KP N++I H L+L D+G A G Y VA+R+++ PELL+
Sbjct: 118 KNDIVHRDIKPENLLISHN-DVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG- 175
Query: 208 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG---TDELNAYLNKYHL 264
Y ++DMWS+GC+ G + +P F G DQL I KVLG +++ + +
Sbjct: 176 APYGKAVDMWSVGCIL-GELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS---- 230
Query: 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 324
+P+ L P S + ++S +D + LL+ + DR + + HP
Sbjct: 231 --NPRFHGLRFPAVNHPQS--LERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPA 286
Query: 325 F 325
F
Sbjct: 287 F 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 92/325 (28%), Positives = 155/325 (47%), Gaps = 49/325 (15%)
Query: 40 YEVVRKVGRGKYSEVFE--GINVNTNERCIIKILKPVKKKKIK------REIKILQNLCG 91
YE+ +GRG Y V++ N + IK K K++ REI +L+ L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-K 60
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYV----------NSTDFKVLYPTLTDYDIRYYIYEL 141
NVV L+++ + K+ L+F+Y + +V P ++ ++++
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSM---VKSLLWQI 117
Query: 142 LKALDYCHSQGIMHRDVKPHN--VMIDHELR-KLRLIDWGLAEFYH----PGKEYNVRVA 194
L + Y HS ++HRD+KP N VM + R +++ D GLA ++ P + + V
Sbjct: 118 LNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177
Query: 195 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD---------NHDQLVK 245
+ +++ PELL+ + Y ++D+W++GC+FA ++ EP F G + DQL +
Sbjct: 178 TIWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TLEPIFKGREAKIKKSNPFQRDQLER 236
Query: 246 IAKVLG--TDELNAYLNKYHLELDPQLDALVGRHSRK--PWSKFINADNQHL-VSPEAID 300
I +VLG T++ + K P+ D L+ K P + +H + D
Sbjct: 237 IFEVLGTPTEKDWPDIKKM-----PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFD 291
Query: 301 FLDKLLRYDHQDRLTAREAMAHPYF 325
L KLL YD R+TA EA+ HPYF
Sbjct: 292 LLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 4e-32
Identities = 89/309 (28%), Positives = 157/309 (50%), Gaps = 38/309 (12%)
Query: 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNL 89
F + Y + K+G G Y+ VF+G + T +K ++ ++ RE+ +L+NL
Sbjct: 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL 60
Query: 90 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT----LTDYDIRYYIYELLKAL 145
N+V L DI+ + T L+FEY++S D K ++ ++++ ++++LL+ L
Sbjct: 61 -KHANIVTLHDIIHTERCLT--LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGL 116
Query: 146 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELL 204
YCH + I+HRD+KP N++I+ E +L+L D+GLA P K Y+ V + +++ P++L
Sbjct: 117 SYCHKRKILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 175
Query: 205 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264
+ +Y +DMW +GC+ M + P F G ++L I ++LGT
Sbjct: 176 LGSTEYSTPIDMWGVGCILYEMATGR-PMFPGSTVKEELHLIFRLLGT------------ 222
Query: 265 ELDPQLDALVGRHSRKPWSK--FINADNQHLVS------PEAIDFLDKLLRYDHQDRLTA 316
P + G S + + F Q L++ + ID L LL Y+ + R++A
Sbjct: 223 ---PTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISA 279
Query: 317 REAMAHPYF 325
A+ H YF
Sbjct: 280 EAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 9e-32
Identities = 84/302 (27%), Positives = 149/302 (49%), Gaps = 31/302 (10%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-PVKKKKIK----REIKILQNL--CGG 92
YE V ++G G Y V++ + ++ +K ++ + + RE+ +L+ L
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 93 PNVVKLLDIV----RDQHSKTPSLIFEYVNSTDF-----KVLYPTLTDYDIRYYIYELLK 143
PN+V+L+D+ D+ +K +L+FE+V+ D KV P L I+ + + L+
Sbjct: 62 PNIVRLMDVCATSRTDRETKV-TLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
LD+ H+ I+HRD+KP N+++ +++L D+GLA Y V + +++ PE+
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSG-GQVKLADFGLARIYSCQMALTPVVVTLWYRAPEV 178
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
L+ Y +DMWS+GC+FA M FR++P F G+ DQL KI ++G
Sbjct: 179 LLQ-STYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLIGLPP--------- 227
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
E D D + R + P + L ++L ++ R++A A+ HP
Sbjct: 228 -EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHP 286
Query: 324 YF 325
+F
Sbjct: 287 FF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 93/311 (29%), Positives = 148/311 (47%), Gaps = 31/311 (9%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKKKKIK----REIKILQNLC 90
+ YE + K+G+G + EVF+ + T + +K +L +K+ REIKILQ L
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL- 68
Query: 91 GGPNVVKLLDIVRDQHSK------TPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYE 140
NVV L++I R + + + L+FE+ D L T +I+ +
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKM 127
Query: 141 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-----YNVRVAS 195
LL L Y H I+HRD+K N++I + L+L D+GLA + K Y RV +
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKD-GILKLADFGLARAFSLSKNSKPNRYTNRVVT 186
Query: 196 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL 255
+++ PELL+ +DY +DMW GC+ A M R P G+ QL I+++ G+
Sbjct: 187 LWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR-SPIMQGNTEQHQLTLISQLCGSITP 245
Query: 256 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVS-PEAIDFLDKLLRYDHQDRL 314
+ LEL +++ G+ + + V P A+D +DKLL D R+
Sbjct: 246 EVWPGVDKLELFKKMELPQGQKRKVK------ERLKPYVKDPHALDLIDKLLVLDPAKRI 299
Query: 315 TAREAMAHPYF 325
A A+ H +F
Sbjct: 300 DADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-31
Identities = 89/307 (28%), Positives = 154/307 (50%), Gaps = 28/307 (9%)
Query: 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGP 93
D E R +G G + V+ + +R +K + V K++ RE+K+L
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKML-CFFKHD 59
Query: 94 NVVKLLDIVRDQHSKTPSLIF---EYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYC 148
NV+ LDI++ H I+ E + S K++ L+ ++ ++Y++L+ L Y
Sbjct: 60 NVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYL 119
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--GKEYNVRVASRYFKGPELLVD 206
HS GI+HRD+KP N++++ L++ D+GLA P K V ++Y++ PE+L+
Sbjct: 120 HSAGILHRDIKPGNLLVNSNCV-LKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMG 178
Query: 207 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266
+ Y ++D+WS+GC+FA ++ R+ F QL I +LGT L A + E
Sbjct: 179 SRHYTSAVDIWSVGCIFAELLGRR-ILFQAQSPIQQLDLITDLLGTPSLEAM--RSACE- 234
Query: 267 DPQLDALVGRHSRKPWSK----FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322
A + R KP S +++ H EA+ L ++L +D R++A +A+AH
Sbjct: 235 --GARAHILRGPHKPPSLPVLYTLSSQATH----EAVHLLCRMLVFDPDKRISAADALAH 288
Query: 323 PYFAQVR 329
PY + R
Sbjct: 289 PYLDEGR 295
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 75/290 (25%), Positives = 121/290 (41%), Gaps = 51/290 (17%)
Query: 46 VGRGKYSEVFEGINVNTNERCIIKILKPVKK--------KKIKREIKILQNLCGGPNVVK 97
+G G + V+EG+N++ + +K + K++++EI +L L PN+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH-PNIVQ 66
Query: 98 LLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGIM 154
L R+ + E V L Y + + IR Y ++L L+Y H + +
Sbjct: 67 YLGTERE--EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTV 124
Query: 155 HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 214
HRD+K N+++D ++L D+G+A+ S Y+ PE++ Y +
Sbjct: 125 HRDIKGANILVDTN-GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAA 183
Query: 215 DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALV 274
D+WSLGC M K P+ QL +A V +
Sbjct: 184 DIWSLGCTVLEMATGKPPW-------SQLEGVAAVFK----------------------I 214
Query: 275 GRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 324
GR P HL S EA DF+ K L+ D R TA E + HP+
Sbjct: 215 GRSKELP------PIPDHL-SDEAKDFILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (284), Expect = 2e-29
Identities = 78/301 (25%), Positives = 129/301 (42%), Gaps = 72/301 (23%)
Query: 46 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---------EIKILQNLCGGPNVV 96
+G+G + +V +T + +K+LK KKKI + E IL + P +V
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLK---KKKIIKRKEVEHTLTERNILSRINH-PFIV 56
Query: 97 KLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLKALDYC 148
KL H +T L+ EY + F L ++ R+Y E++ AL+Y
Sbjct: 57 KL-------HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYL 109
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 207
HS GI++RD+KP N+++D + ++L D+GLA E G N + + PE+L
Sbjct: 110 HSLGIIYRDLKPENILLDAD-GHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVL-LG 167
Query: 208 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267
+ Y ++D WSLG + M+ K PF+ ++ ++ + L+
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLTGKPPFY--AEDRKEIY----------------EKILKDP 209
Query: 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA---MAHPY 324
+ +SPEA D + LL+ D RL + A AHP+
Sbjct: 210 LRFPE--------------------FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPF 249
Query: 325 F 325
F
Sbjct: 250 F 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 1e-28
Identities = 81/303 (26%), Positives = 132/303 (43%), Gaps = 51/303 (16%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIK--ILKPVKKKKIKREIKILQNLCGGPNVVK 97
Y+ + K+G G EV++ + T + IK L+ K+ I EI I+++ C PN+V
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKD-CKHPNIVD 79
Query: 98 LLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQ 151
D ++ EY++ TD ++ + + I Y E+L+ L+Y HSQ
Sbjct: 80 YYDSYLVG--DELWVVMEYMDGGSLTD--IITQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135
Query: 152 GIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQDY 210
++HRD+K N+++ + ++L D+G A+ + N V + Y+ PE++ +DY
Sbjct: 136 NVIHRDIKSDNILLSKDGS-VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR-KDY 193
Query: 211 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 270
+D+WSLG M M EP YL +P L
Sbjct: 194 GPKVDIWSLGIMCIEMA-EGEP------------------------PYLR------EPPL 222
Query: 271 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330
AL + K N SPE DFL+K L D + R +A E + HP+ +
Sbjct: 223 RALF-LITTKGIPPL---KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP 278
Query: 331 AES 333
E
Sbjct: 279 KEE 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 7e-28
Identities = 81/321 (25%), Positives = 146/321 (45%), Gaps = 58/321 (18%)
Query: 46 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-----------------REIKILQN 88
+G G Y +V + + T + IK +K ++ RE+KI+
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 89 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALD 146
+ N++ L+D+ + +L+ + + S KV+ LT+ ++ + ++L L+
Sbjct: 77 I-KHENIMGLVDVYVEG--DFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLN 133
Query: 147 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA---------------EFYHPGKEYNV 191
H MHRD+ P N+ I+ + ++ D+GLA E +E
Sbjct: 134 VLHKWYFMHRDLSPANIFINSK-GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTS 192
Query: 192 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 251
+V + +++ PELL+ + Y +++DMWS+GC+FA ++ K P F G + DQL +I ++LG
Sbjct: 193 KVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK-PLFPGENEIDQLGRIFELLG 251
Query: 252 TDELNAYLNKYHLELDPQLDALVGRHSRKPWS-----KFINADNQHLVSPEAIDFLDKLL 306
T + + L L + RKP + D AID L LL
Sbjct: 252 TPNEDNWPQAKKLPLYTEFTP------RKPKDLKTIFPNASDD--------AIDLLQSLL 297
Query: 307 RYDHQDRLTAREAMAHPYFAQ 327
+ + +R++A+EA+ H YF
Sbjct: 298 KLNPLERISAKEALKHEYFKS 318
|
Length = 335 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 6e-27
Identities = 83/306 (27%), Positives = 129/306 (42%), Gaps = 66/306 (21%)
Query: 46 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNLCGGPNVVK 97
+ +G Y VF +T + IK++K K I++ E IL P VVK
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIK--KADMIRKNQVDQVLTERDILSQ-AQSPYVVK 57
Query: 98 LLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGIM 154
L Q K L+ EY+ D L +L + R YI E++ AL+Y HS GI+
Sbjct: 58 LYYSF--QGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGII 115
Query: 155 HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR---------YFKGPELLV 205
HRD+KP N++ID L+L D+GL++ ++ N+ + + PE+++
Sbjct: 116 HRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174
Query: 206 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265
Q + ++D WSLGC+ + PF H + + +L K
Sbjct: 175 -GQGHSKTVDWWSLGCILYEFLVGIPPF---HGETPEEI-FQNILN--------GKI--- 218
Query: 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR---EAMAH 322
W + + VS EAID + KLL D + RL A+ E H
Sbjct: 219 ---------------EWPEDVE------VSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257
Query: 323 PYFAQV 328
P+F +
Sbjct: 258 PFFKGI 263
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 4e-26
Identities = 79/305 (25%), Positives = 152/305 (49%), Gaps = 30/305 (9%)
Query: 40 YEVVRKVGRGKYSEVFE------GINVNTNERCIIKILKPVKK----KKIKREIKILQNL 89
Y+ ++ +G G V GINV + K+ +P + K+ RE+ +L+ +
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINV-----AVKKLSRPFQNQTHAKRAYRELVLLKCV 77
Query: 90 CGGPNVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKAL 145
N++ LL++ Q S + L+ E +++ +V++ L + Y +Y++L +
Sbjct: 78 -NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGI 136
Query: 146 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 205
+ HS GI+HRD+KP N+++ + L+++D+GLA V +RY++ PE+++
Sbjct: 137 KHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVIL 195
Query: 206 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN----- 260
+ Y ++D+WS+GC+ ++ + F G D+ DQ K+ + LGT ++N
Sbjct: 196 GMG-YKENVDIWSVGCIMGELV-KGSVIFQGTDHIDQWNKVIEQLGTPSAE-FMNRLQPT 252
Query: 261 -KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 319
+ ++E PQ + W ++ L + +A D L K+L D R++ EA
Sbjct: 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312
Query: 320 MAHPY 324
+ HPY
Sbjct: 313 LRHPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 78/305 (25%), Positives = 151/305 (49%), Gaps = 29/305 (9%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPN 94
Y+ ++ +G G V + T + IK L K+ RE+ +++ L N
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMK-LVNHKN 76
Query: 95 VVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHS 150
++ LL++ Q S + L+ E +++ +V+ L + Y +Y++L + + HS
Sbjct: 77 IIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHS 136
Query: 151 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 210
GI+HRD+KP N+++ + L+++D+GLA V +RY++ PE+++ + Y
Sbjct: 137 AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GY 194
Query: 211 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 270
++D+WS+GC+ MI R F G D+ DQ KI + LGT + ++++ L P +
Sbjct: 195 KENVDIWSVGCIMGEMI-RGTVLFPGTDHIDQWNKIIEQLGTPS-DEFMSR----LQPTV 248
Query: 271 DALV---GRHSRKPWSKFI--------NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 319
V +++ + + + + L + +A D L K+L D + R++ +A
Sbjct: 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDA 308
Query: 320 MAHPY 324
+ HPY
Sbjct: 309 LQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-25
Identities = 82/301 (27%), Positives = 131/301 (43%), Gaps = 50/301 (16%)
Query: 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGG 92
D++++ +VG+G Y +VF +T E +K +K + + + E IL
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKS 60
Query: 93 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCH 149
+VKLL +D + L EYV DF+ L L++ R+Y+ E+ +A+D H
Sbjct: 61 EWLVKLLYAFQD--DEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH 118
Query: 150 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVDLQ 208
G +HRD+KP N +ID ++L D+GL++ Y N V S + PE+L +
Sbjct: 119 ELGYIHRDLKPENFLID-ASGHIKLTDFGLSK---GIVTYANSVVGSPDYMAPEVLRG-K 173
Query: 209 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268
YD+++D WSLGCM + PF +E L + L
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPF--SGST------------PNETWENLKYWKETLQ- 218
Query: 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE-AMAHPYFAQ 327
R + D + +S EA D + KL+ D R + E HP+F +
Sbjct: 219 ----------RPVYD-----DPRFNLSDEAWDLITKLIN-DPSRRFGSLEDIKNHPFFKE 262
Query: 328 V 328
V
Sbjct: 263 V 263
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 2e-24
Identities = 78/298 (26%), Positives = 127/298 (42%), Gaps = 53/298 (17%)
Query: 43 VRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKI---KREIKILQNLCGGPNVV 96
++ + +G + V+ +T + IK+LK + K ++ K E I+ P V
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 97 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCHSQGI 153
KL Q L+ EY+N D L TL + YI E++ ++ H +GI
Sbjct: 61 KLYYSF--QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGI 118
Query: 154 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 213
+HRD+KP N++ID + L+L D+GL+ K++ V + + PE ++ + D D
Sbjct: 119 IHRDIKPENLLID-QTGHLKLTDFGLSRNGLENKKF---VGTPDYLAPETILGVGD-DKM 173
Query: 214 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL 273
D WSLGC+ +F PF H V +L
Sbjct: 174 SDWWSLGCVIFEFLFGYPPF---HAETPDAV-FDNIL----------------------- 206
Query: 274 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA---REAMAHPYFAQV 328
R W + + SPEA+D +++LL D RL A +E +HP+F +
Sbjct: 207 ---SRRINWPEEVK----EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 3e-24
Identities = 85/303 (28%), Positives = 137/303 (45%), Gaps = 67/303 (22%)
Query: 44 RKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPNVVKL 98
K+G G + +V+ +N++T E +K ++ P K+I E+K+L+ L PN+VK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKY 64
Query: 99 --LDIVRDQHSKTPSLIF-EYVN-STDFKVL-YPTLTDYD-IRYYIYELLKALDYCHSQG 152
+++ R++ IF EY + T ++L + + D IR Y +LL+ L Y HS G
Sbjct: 65 YGVEVHREK-----VYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG 119
Query: 153 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---------PEL 203
I+HRD+KP N+ +DH ++L D+G A + PE+
Sbjct: 120 IVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNT----TTMGEEVQSLAGTPAYMAPEV 174
Query: 204 LV--DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261
+ + + + D+WSLGC+ M K P + DN Q++
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRP-WSELDNEFQIM----------------- 216
Query: 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321
+H VG + P I Q +SPE DFLD+ L D + R TA E +
Sbjct: 217 FH----------VGAGHKPP----IPDSLQ--LSPEGKDFLDRCLESDPKKRPTASELLQ 260
Query: 322 HPY 324
HP+
Sbjct: 261 HPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 8e-24
Identities = 80/304 (26%), Positives = 146/304 (48%), Gaps = 28/304 (9%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KPVKK----KKIKREIKILQNLCGGPN 94
Y+ ++ +G G V + IK L +P + K+ RE+ +L N
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYREL-VLMKCVNHKN 84
Query: 95 VVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHS 150
++ LL++ Q S + ++ E +++ +V+ L + Y +Y++L + + HS
Sbjct: 85 IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 144
Query: 151 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 210
GI+HRD+KP N+++ + L+++D+GLA V +RY++ PE+++ + Y
Sbjct: 145 AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GY 202
Query: 211 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 270
++D+WS+GC+ MI F G D+ DQ K+ + LGT ++ +L P +
Sbjct: 203 KENVDIWSVGCIMGEMIKGG-VLFPGTDHIDQWNKVIEQLGTP-----CPEFMKKLQPTV 256
Query: 271 DALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAM 320
V + F AD++H L + +A D L K+L D R++ EA+
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 321 AHPY 324
HPY
Sbjct: 317 QHPY 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 1e-23
Identities = 51/209 (24%), Positives = 99/209 (47%), Gaps = 20/209 (9%)
Query: 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGGP 93
YE+++++G+G + +V+ + + ++K + +++ E+KIL+ L P
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHP 59
Query: 94 NVVKLLD-IVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKAL 145
N++K + ++ EY + D K + I + +L AL
Sbjct: 60 NIIKYYESFEEKGKL---CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 146 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELL 204
Y HS+ I+HRD+KP N+ + ++L D+G+++ + V + Y+ PEL
Sbjct: 117 KYLHSRKILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC 175
Query: 205 VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 233
+ + Y+Y D+WSLGC+ + K PF
Sbjct: 176 QN-KPYNYKSDIWSLGCVLYELCTLKHPF 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 1e-23
Identities = 51/201 (25%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNV 95
+E+V +G G Y +V++ + T + IKI+ ++ +++IK E IL+ PN+
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNI 65
Query: 96 VKLLDIVRDQHSKTPS----LIFEYVNS---TD----FKVLYPTLTDYDIRYYIYELLKA 144
++ L+ E TD + L + I Y + E L+
Sbjct: 66 ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRG 125
Query: 145 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPE- 202
L Y H ++HRD+K N+++ ++L+D+G+ A+ N + + Y+ PE
Sbjct: 126 LAYLHENKVIHRDIKGQNILLTKNAE-VKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEV 184
Query: 203 LLVDLQD---YDYSLDMWSLG 220
+ D Q YD D+WSLG
Sbjct: 185 IACDEQPDASYDARSDVWSLG 205
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 1e-23
Identities = 81/304 (26%), Positives = 148/304 (48%), Gaps = 28/304 (9%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KPVKK----KKIKREIKILQNLCGGPN 94
Y+ ++ +G G V + + IK L +P + K+ RE+ +L N
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL-VLMKCVNHKN 77
Query: 95 VVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHS 150
++ LL++ Q S + L+ E +++ +V+ L + Y +Y++L + + HS
Sbjct: 78 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 137
Query: 151 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 210
GI+HRD+KP N+++ + L+++D+GLA V +RY++ PE+++ + Y
Sbjct: 138 AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GY 195
Query: 211 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 270
++D+WS+GC+ M+ R + F G D DQ K+ + LGT ++ +L P +
Sbjct: 196 KENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPTV 249
Query: 271 DALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAM 320
V + F AD++H L + +A D L K+L D R++ EA+
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEAL 309
Query: 321 AHPY 324
HPY
Sbjct: 310 QHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 6e-23
Identities = 73/299 (24%), Positives = 135/299 (45%), Gaps = 57/299 (19%)
Query: 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGGP 93
+Y++ +GRG + V++G+N+ T + IK + K K+ I +EI +L+NL P
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHP 59
Query: 94 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD------IRYYIYELLKALDY 147
N+VK + + S + +I EY + L + + + Y+Y++L+ L Y
Sbjct: 60 NIVKYIGSIET--SDSLYIILEYA---ENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAY 114
Query: 148 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVD 206
H QG++HRD+K N++ + ++L D+G+A + K+ V + Y+ PE +++
Sbjct: 115 LHEQGVIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPE-VIE 172
Query: 207 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266
+ + D+WSLGC ++ P++ +LN + +
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPPYY-------------------DLNPMAALFRIVQ 213
Query: 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325
D H P +SPE DFL + + D R TA++ + HP+
Sbjct: 214 DD--------HPPLPEG----------ISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 1e-22
Identities = 71/297 (23%), Positives = 134/297 (45%), Gaps = 50/297 (16%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLCGGPN 94
++ ++++ K+G G Y V++ I+ T + IK++ PV++ ++I +EI IL+ C P
Sbjct: 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQ-CDSPY 59
Query: 95 VVKLL-DIVRDQHSKTPSLIFEYVNSTDF----KVLYPTLTDYDIRYYIYELLKALDYCH 149
+VK ++ ++ EY + K+ TLT+ +I +Y+ LK L+Y H
Sbjct: 60 IVKYYGSYFKNTDL---WIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH 116
Query: 150 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 208
S +HRD+K N++++ E + +L D+G++ + + N + + ++ PE++ +
Sbjct: 117 SNKKIHRDIKAGNILLNEE-GQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-I 174
Query: 209 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268
Y+ D+WSLG M K P+ H + I
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDIHPMR-AIFMIPN-------------------- 213
Query: 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325
KP + SPE DF+ K L D ++R +A + + HP+
Sbjct: 214 -----------KPPPTLSD---PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-22
Identities = 80/314 (25%), Positives = 146/314 (46%), Gaps = 37/314 (11%)
Query: 45 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNLCGGPNVVKLLD 100
KVGRG Y V++ + + LK ++ I REI +L+ L PNV+ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYA-LKQIEGTGISMSACREIALLREL-KHPNVIALQK 65
Query: 101 IVRDQHSKTPSLIFEYVNSTDFKVLY-----------PTLTDYDIRYYIYELLKALDYCH 149
+ + L+F+Y + ++ L ++ +Y++L + Y H
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 150 SQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYH----PGKEYNVRVASRYFKGPE 202
+ ++HRD+KP N+++ E ++++ D G A ++ P + + V + +++ PE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 203 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD---------NHDQLVKIAKVLGTD 253
LL+ + Y ++D+W++GC+FA ++ EP F+ +HDQL +I V+G
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP 244
Query: 254 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDF--LDKLLRYDHQ 311
+ + + P L R + S I +H V P++ F L KLL D
Sbjct: 245 ADKDWEDIRKMPEYPTLQKDF-RRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPT 303
Query: 312 DRLTAREAMAHPYF 325
R+T+ +A+ PYF
Sbjct: 304 KRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-22
Identities = 81/316 (25%), Positives = 148/316 (46%), Gaps = 41/316 (12%)
Query: 45 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNLCGGPNVVKLLD 100
KVGRG Y V++ + + LK ++ I REI +L+ L PNV+ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYA-LKQIEGTGISMSACREIALLREL-KHPNVISLQK 65
Query: 101 IVRDQHSKTPSLIFEYVNSTDFKVLY-----------PTLTDYDIRYYIYELLKALDYCH 149
+ + L+F+Y + ++ L ++ +Y++L + Y H
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 150 SQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYH----PGKEYNVRVASRYFKGPE 202
+ ++HRD+KP N+++ E ++++ D G A ++ P + + V + +++ PE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 203 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD---------NHDQLVKIAKVLGTD 253
LL+ + Y ++D+W++GC+FA ++ EP F+ +HDQL +I V+G
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG-- 242
Query: 254 ELNAYLNKYHLELDPQLDALVGRHSRKPWSK--FINADNQHLVSPE--AIDFLDKLLRYD 309
A + ++ P+ L+ R ++ I +H V P+ A L KLL D
Sbjct: 243 -FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMD 301
Query: 310 HQDRLTAREAMAHPYF 325
R+T+ +AM PYF
Sbjct: 302 PIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-21
Identities = 56/211 (26%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCG 91
++++ +K+G+G++S V++ I + +K ++ ++ +EI +L+ L
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-D 60
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKA 144
PNV+K L + + ++ E ++ D FK + + I Y +L A
Sbjct: 61 HPNVIKYLASFIENNELN--IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 145 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPEL 203
L++ HS+ IMHRD+KP NV I ++L D GL F+ + V + Y+ PE
Sbjct: 119 LEHMHSKRIMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 234
+ + Y++ D+WSLGC+ M + PF+
Sbjct: 178 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-21
Identities = 77/299 (25%), Positives = 130/299 (43%), Gaps = 55/299 (18%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIK---REIKILQNLCGGP 93
+E++R +G+G + +V +T + +K + K V+K ++ E +ILQ L P
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHP 60
Query: 94 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYC 148
+V L +D + L+ + + D + Y ++ ++++I E++ AL+Y
Sbjct: 61 FLVNLWYSFQD--EENMYLVVDLLLGGDLR--YHLSQKVKFSEEQVKFWICEIVLALEYL 116
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 208
HS+GI+HRD+KP N+++D E + + D+ +A P + + PE+L Q
Sbjct: 117 HSKGIIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR-Q 174
Query: 209 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268
Y ++D WSLG + K P + GH + AK D L
Sbjct: 175 GYSVAVDWWSLGVTAYECLRGKRP-YRGHSRTIRDQIRAKQETADVL------------- 220
Query: 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL--TAREAMAHPYF 325
WS EAID ++KLL D Q RL ++ HPYF
Sbjct: 221 ---------YPATWST------------EAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 3e-21
Identities = 89/334 (26%), Positives = 136/334 (40%), Gaps = 92/334 (27%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKI-----KREIKILQNL 89
DD+EV++ +GRG + EV+ + +T + +K+L+ +K+ +I +R+I +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD- 59
Query: 90 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALD 146
P +VKL +D+ L+ EY+ D L + R+YI EL+ ALD
Sbjct: 60 --SPWIVKLYYSFQDEEHLY--LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALD 115
Query: 147 YCHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLA----------------------- 180
H G +HRD+KP N++ID H ++L D+GL
Sbjct: 116 SVHKLGFIHRDIKPDNILIDADGH----IKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 181 ---EFYHPGKEYNVR----VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 233
K+ VR V + + PE+L Y D WSLG + M++ P
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPP- 229
Query: 234 FYGHDNHDQLVKIAKVLGTDELNAYLN-KYHLELDPQLDALVGRHSRKPWSKFINADNQH 292
FY + KI +N K L P
Sbjct: 230 FYSDTLQETYNKI------------INWKESLRFPP----------------------DP 255
Query: 293 LVSPEAIDFLDKLLRYDHQDRLT-AREAMAHPYF 325
VSPEAID + +LL D +DRL E +HP+F
Sbjct: 256 PVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFF 288
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-19
Identities = 75/305 (24%), Positives = 134/305 (43%), Gaps = 68/305 (22%)
Query: 46 VGRGKYSEVFEGINVNTNERCIIKILKPVKK-------------KKIKREIKILQNLCGG 92
+G+G Y V+ +NV T E +K ++ K ++ EI+ L++L
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DH 67
Query: 93 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCH 149
N+V+ L + + S+ EYV T ++ +R++ ++L+ L Y H
Sbjct: 68 LNIVQYLGFETTE--EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 150 SQGIMHRDVKPHNVMIDHELRKLRLIDWGL----AEFYHPGKEYNVRVASRYFKGPELLV 205
S+GI+HRD+K N+++D + ++ D+G+ + Y + +++ S ++ PE ++
Sbjct: 126 SKGILHRDLKADNLLVDAD-GICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAPE-VI 182
Query: 206 DLQDYDYS--LDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259
YS +D+WSLGC MFAG + P+ +E A +
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAG----RRPW-----------------SDEEAIAAM 221
Query: 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 319
K +G P I D +SP A+DFL+ + +R TARE
Sbjct: 222 FK------------LGNKRSAP---PIPPDVSMNLSPVALDFLNACFTINPDNRPTAREL 266
Query: 320 MAHPY 324
+ HP+
Sbjct: 267 LQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-19
Identities = 73/301 (24%), Positives = 128/301 (42%), Gaps = 64/301 (21%)
Query: 46 VGRGKYSEVFEGINVNTNERCIIKIL-------KPVKKKK-----IKREIKILQNLCGGP 93
+G G + V+ G+N ++ E +K + +K+ + REI +L+ L
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHE 66
Query: 94 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHS 150
N+V+ L D + EYV L Y + +R ++ ++LK L+Y H+
Sbjct: 67 NIVQYLGSSLDADHLN--IFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 151 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR-------YFKGPEL 203
+GI+HRD+K N+++D++ +++ D+G+++ +R ++ PE
Sbjct: 125 RGIIHRDIKGANILVDNK-GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE- 182
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
+V Y D+WSLGC+ M+ K PF + QL I K+
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHPF----PDCTQLQAIFKI-------------- 224
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
+ + + +S EAIDFL+K DH R TA E + HP
Sbjct: 225 -------------------GENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHP 265
Query: 324 Y 324
+
Sbjct: 266 F 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-18
Identities = 75/297 (25%), Positives = 122/297 (41%), Gaps = 57/297 (19%)
Query: 46 VGRGKYSEVFEGINVNTNERCIIKIL--KPVKKKKIKR----EIKILQNLCGGPNVVKLL 99
+G+G + EV T + K L K +KK+K ++ E KIL+ +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILE-KVSSRFIVSL- 58
Query: 100 DIVRDQHSKTP-SLIFEYVNSTDFK-----VLYPTLTDYDIRYYIYELLKALDYCHSQGI 153
+K L+ +N D K V P + +Y +++ L++ H + I
Sbjct: 59 --AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRI 116
Query: 154 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 213
++RD+KP NV++D + +R+ D GLA GK+ R + + PE+L + YD+S
Sbjct: 117 VYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQG-EVYDFS 174
Query: 214 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL 273
+D ++LGC MI + PF K
Sbjct: 175 VDWFALGCTLYEMIAGRSPF----------------------RQRKEK------------ 200
Query: 274 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYF 325
V + K + + + SPEA D + LL+ D + RL +A E HP F
Sbjct: 201 VEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLF 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 4e-18
Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 18/200 (9%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLCGGPNV 95
D +E++ +G+G Y +V++ N +KIL P+ ++I+ E ILQ+L PNV
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNV 81
Query: 96 VKLLDIV--RDQHSKTPS-LIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKAL 145
VK + D+ L+ E N L L + I Y +Y L L
Sbjct: 82 VKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL 141
Query: 146 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELL 204
+ H+ I+HRDVK +N+++ E ++L+D+G+ A+ N V + ++ PE++
Sbjct: 142 QHLHNNRIIHRDVKGNNILLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 200
Query: 205 VDLQDYDYSL----DMWSLG 220
Q YDYS D+WSLG
Sbjct: 201 ACEQQYDYSYDARCDVWSLG 220
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 7e-18
Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 46 VGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGG--PNVVKLL 99
+GRG Y V+ G +V T +KI+ I+RE+ +L L PN+ K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 100 DIVRDQHSKTPSL--IFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMH 155
+ K P L I EY + L + + I I E+L AL Y H G++H
Sbjct: 69 G----SYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIH 124
Query: 156 RDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 214
RD+K N+++ + ++L D+G+ A + + V + Y+ PE++ + + YD
Sbjct: 125 RDIKAANILVTNT-GNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKA 183
Query: 215 DMWSLGCMFAGMIFRKEPFFYGHDNHDQL 243
D+WSLG M P + + D
Sbjct: 184 DIWSLGITIYEMATGNPP----YSDVDAF 208
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 8e-18
Identities = 70/295 (23%), Positives = 123/295 (41%), Gaps = 47/295 (15%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGP 93
D E V+ +G+G V++ + T + +K + +K++ RE+K L++ C P
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRS-CESP 59
Query: 94 NVVKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHS 150
VVK S++ EY++ D + + + Y ++LK LDY H+
Sbjct: 60 YVVKCYGAF--YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 151 Q-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVDLQ 208
+ I+HRD+KP N++I+ + ++++ D+G+++ + N V + + PE + +
Sbjct: 118 KRHIIHRDIKPSNLLINSK-GEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERI-QGE 175
Query: 209 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268
Y Y+ D+WSLG K PF EL + P
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPF-----------LPPGQPSFFELMQAICD---GPPP 221
Query: 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
L A SPE DF+ L+ D + R +A E + HP
Sbjct: 222 SLPA-------------------EEFSPEFRDFISACLQKDPKKRPSAAELLQHP 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-17
Identities = 55/210 (26%), Positives = 106/210 (50%), Gaps = 19/210 (9%)
Query: 39 DYEVVRKVGRGKYSEVFEGINVNTNERC------IIKILKPVKKKKIKREIKILQNLCGG 92
++++ +K+GRG++SEV+ + + I +++ ++ +EI +L+ L
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NH 61
Query: 93 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKAL 145
PNV+K LD + + +++ E ++ D FK + + + Y +L A+
Sbjct: 62 PNVIKYLDSFIEDNEL--NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119
Query: 146 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELL 204
++ HS+ +MHRD+KP NV I ++L D GL F+ + V + Y+ PE +
Sbjct: 120 EHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178
Query: 205 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 234
+ Y++ D+WSLGC+ M + PF+
Sbjct: 179 HE-NGYNFKSDIWSLGCLLYEMAALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-17
Identities = 72/298 (24%), Positives = 129/298 (43%), Gaps = 47/298 (15%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK---KKIKREIKILQNLCGGP 93
Q+DYE+++++G G Y +V++ ++ T E IK++K + I++EI +L+ C P
Sbjct: 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKE-CRHP 60
Query: 94 NVVKLLDIVRDQHSKTPSLIFEYV--NSTD--FKVLYPTLTDYDIRYYIYELLKALDYCH 149
N+V + ++ EY S ++V L++ I Y E LK L Y H
Sbjct: 61 NIVAYFGSYLRRD--KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH 118
Query: 150 SQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQ 208
G +HRD+K N+++ E ++L D+G+ A+ + + + Y+ PE+ +
Sbjct: 119 ETGKIHRDIKGANILLT-EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVER 177
Query: 209 --DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266
YD D+W+LG + + P F H + L
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPPMFDLH--------PMRAL---------------- 213
Query: 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 324
L+ + + P ++ SP DF+ K L D + R TA + + HP+
Sbjct: 214 -----FLISKSNFPPPK----LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 3e-17
Identities = 67/305 (21%), Positives = 124/305 (40%), Gaps = 54/305 (17%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI----LKPVKKKKIKREIKILQNLCGGP 93
DD E + ++G G V + ++ T + +K + +K+I RE+ IL C P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHK-CNSP 59
Query: 94 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCH 149
+V + S+ EY++ + + + + +LK L Y H
Sbjct: 60 YIVGFYGAFYNNG--DISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 150 SQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN----VRVASRYFKGPELL 204
+ I+HRDVKP N++++ +++L D+G++ G+ N V + + PE +
Sbjct: 118 EKHKIIHRDVKPSNILVNS-RGQIKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPERI 171
Query: 205 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264
DY D+WSLG + + P+ + + + L +N
Sbjct: 172 QGN-DYSVKSDIWSLGLSLIELATGRFPY----PPENDPPD--GIF--ELLQYIVN---- 218
Query: 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 324
E P+L P KF SP+ DF++ L D ++R + +E + HP+
Sbjct: 219 EPPPRL----------PSGKF---------SPDFQDFVNLCLIKDPRERPSYKELLEHPF 259
Query: 325 FAQVR 329
+
Sbjct: 260 IKKYE 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 3e-17
Identities = 77/302 (25%), Positives = 133/302 (44%), Gaps = 50/302 (16%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIK---ILKPVKKKKIKREIKILQNLCGGPNVV 96
Y K+G+G VF I+V T + IK + K KK+ I EI +++ L PN+V
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL-KNPNIV 79
Query: 97 KLLD--IVRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRYYIYELLKALDYCHSQG 152
LD +V D+ ++ EY+ V + + I E L+AL++ H+
Sbjct: 80 NFLDSFLVGDELF----VVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQ 135
Query: 153 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYD 211
++HRD+K NV++ + ++L D+G P + + + V + Y+ PE +V + Y
Sbjct: 136 VIHRDIKSDNVLLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKAYG 193
Query: 212 YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD 271
+D+WSLG M M+ + P+ ++N + + + GT EL
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPELQ--------------- 236
Query: 272 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331
N +SP DFL++ L D + R +A+E + HP+ +
Sbjct: 237 ------------------NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPL 278
Query: 332 ES 333
S
Sbjct: 279 SS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 3e-17
Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 51/214 (23%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGP 93
DDYE++ +G G + V+ I + NE+ IK + ++++E++ + + C P
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAM-SQCNHP 59
Query: 94 NVVK----------------------LLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTD 131
NVVK LLDI++ S P +
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMK---SSYPRGGLDEAI------------- 103
Query: 132 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPG---- 186
I + E+LK L+Y HS G +HRD+K N+++ E +++ D+G+ A G
Sbjct: 104 --IATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG-EDGSVKIADFGVSASLADGGDRTR 160
Query: 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 220
K V + + PE++ + YD+ D+WS G
Sbjct: 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFG 194
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 4e-17
Identities = 66/298 (22%), Positives = 122/298 (40%), Gaps = 56/298 (18%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGP 93
+ + ++ +G+G + EV++ I+ TN+ IK++ + + I++EI+ L C P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQ-CRSP 59
Query: 94 NVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLYP-TLTDYDIRYYIYELLKALDYCHSQ 151
+ K +I EY + +L P L + I + + E+L L+Y H +
Sbjct: 60 YITKYYGSFLKGSKLW--IIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 152 GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 210
G +HRD+K N+++ E ++L D+G++ + + N V + ++ PE++ Y
Sbjct: 118 GKIHRDIKAANILLSEE-GDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ-SGY 175
Query: 211 DYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266
D D+WSLG + G EP L I K
Sbjct: 176 DEKADIWSLGITAIELAKG-----EPPLSDLHPMRVLFLIPK----------------NN 214
Query: 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 324
P L+ + S DF+ L D ++R +A+E + H +
Sbjct: 215 PPSLEG-------------------NKFSKPFKDFVSLCLNKDPKERPSAKELLKHKF 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 6e-17
Identities = 71/299 (23%), Positives = 120/299 (40%), Gaps = 58/299 (19%)
Query: 46 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKK---------IKREIKILQNLCGGPNVV 96
+G G +S ++ +V T +K + V+ +++EI+++ L P+++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHII 66
Query: 97 KLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGI 153
++L +L E++ L Y + I Y +LL+ L Y H I
Sbjct: 67 RMLGAT--CEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124
Query: 154 MHRDVKPHNVMIDHELRKLRLIDWGLA-----EFYHPGKEYNVRVASRYFKGPELLVDLQ 208
+HRDVK N++ID ++LR+ D+G A + G+ + + F PE+L +
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-E 183
Query: 209 DYDYSLDMWSLGCMFAGMIFRKEPF-FYGHDNHDQLV-KIAKVLGTDELNAYLNKYHLEL 266
Y S D+WS+GC+ M K P+ H NH L+ KIA + +L
Sbjct: 184 QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL------- 236
Query: 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325
SP D + L +DR +RE + HP F
Sbjct: 237 ----------------------------SPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 8e-17
Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 23/225 (10%)
Query: 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIK-----ILKPVKKKKIKREIKILQNLCGGP 93
DYEV+ +G+G + V + + + + K + +K+++ E+ IL+ L P
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHP 59
Query: 94 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIY----ELLKALD 146
N+V+ D + D+ ++T ++ EY D L Y +I+ +LL AL
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 147 YCH-----SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKG 200
CH ++HRD+KP N+ +D ++L D+GLA+ + V + Y+
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178
Query: 201 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 245
PE L YD D+WSLGC+ + P F N QL
Sbjct: 179 PEQLNH-MSYDEKSDIWSLGCLIYELCALSPP-FTAR-NQLQLAS 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 18/200 (9%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNV 95
D +E++ +G+G Y +VF+ +N + +KIL P+ ++I+ E IL+ L PNV
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNV 77
Query: 96 VKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKAL 145
VK + + K L+ E N L + + I Y ++E L L
Sbjct: 78 VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137
Query: 146 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELL 204
+ H +HRDVK +N+++ E ++L+D+G+ A+ N V + ++ PE++
Sbjct: 138 QHLHVNKTIHRDVKGNNILLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 196
Query: 205 VDLQD----YDYSLDMWSLG 220
Q YD D+WSLG
Sbjct: 197 ACEQQLDSTYDARCDVWSLG 216
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-16
Identities = 81/314 (25%), Positives = 130/314 (41%), Gaps = 63/314 (20%)
Query: 33 IFSDQDD---YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK------IKREI 83
+FS D + +R++G G + V+ +V TNE IK + K+ I +E+
Sbjct: 7 LFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEV 66
Query: 84 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV--NSTD-FKVLYPTLTDYDIRYYIYE 140
+ LQ PN ++ +H T L+ EY +++D +V L + +I +
Sbjct: 67 RFLQQ-LRHPNTIEYKGCYLREH--TAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHG 123
Query: 141 LLKALDYCHSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 199
L+ L Y HS +HRD+K N+++ + KL D+G A P N V + Y+
Sbjct: 124 ALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLA--DFGSASLVSPA---NSFVGTPYWM 178
Query: 200 GPE--LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 257
PE L +D YD +D+WSLG + RK P F +NA
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-------------------NMNA 219
Query: 258 YLNKYHLELD--PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT 315
YH+ + P L S WS +F+D L+ QDR +
Sbjct: 220 MSALYHIAQNDSPTL-------SSNDWSD------------YFRNFVDSCLQKIPQDRPS 260
Query: 316 AREAMAHPYFAQVR 329
+ E + H + + R
Sbjct: 261 SEELLKHRFVLRER 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 3e-16
Identities = 61/223 (27%), Positives = 106/223 (47%), Gaps = 34/223 (15%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKK---IKREIKILQNLCG 91
DD+E ++ +G G + V + + + +KIL K VK K+ + E +ILQ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL--YPTLTDYDIRYYIYELLKALDYC 148
P +V L Q L+ EYV + F L + R+Y +++ AL+Y
Sbjct: 61 -PFLVNLYG--SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYL 117
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--------G 200
HS I++RD+KP N+++D + +++ D+G A RV R +
Sbjct: 118 HSLDIVYRDLKPENLLLDSD-GYIKITDFGFA----------KRVKGRTYTLCGTPEYLA 166
Query: 201 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 243
PE+++ + Y ++D W+LG + M+ PFF DN Q+
Sbjct: 167 PEIIL-SKGYGKAVDWWALGILIYEMLAGYPPFF--DDNPIQI 206
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-16
Identities = 67/250 (26%), Positives = 110/250 (44%), Gaps = 54/250 (21%)
Query: 93 PNVVKLLD--IVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDY 147
PN+V++ +V D+ ++ E++ TD V + + + I +LKAL +
Sbjct: 76 PNIVEMYSSYLVGDELW----VVMEFLEGGALTDI-VTHTRMNEEQIATVCLAVLKALSF 130
Query: 148 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELL 204
H+QG++HRD+K ++++ + R ++L D+G KE R V + Y+ PE++
Sbjct: 131 LHAQGVIHRDIKSDSILLTSDGR-VKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPEVI 187
Query: 205 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264
L Y +D+WSLG M M+ + P+F
Sbjct: 188 SRLP-YGTEVDIWSLGIMVIEMVDGEPPYFN----------------------------- 217
Query: 265 ELDPQLDALVG-RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
+P L A+ R + P K N H VSP FLD++L D R TA E + HP
Sbjct: 218 --EPPLQAMKRIRDNLPPKLK-----NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHP 270
Query: 324 YFAQVRAAES 333
+ A+ S
Sbjct: 271 FLAKAGPPSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 4e-16
Identities = 78/305 (25%), Positives = 134/305 (43%), Gaps = 56/305 (18%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIK---ILKPVKKKKIKREIKILQNLCGGPNVV 96
Y K+G+G V+ I+V T + IK + + KK+ I EI +++ PN+V
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN-KHPNIV 79
Query: 97 KLLD--IVRDQHSKTPSLIFEYV---NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 151
LD +V D+ ++ EY+ + TD V + + I E L+AL++ HS
Sbjct: 80 NYLDSYLVGDELW----VVMEYLAGGSLTDV-VTETCMDEGQIAAVCRECLQALEFLHSN 134
Query: 152 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVDLQ 208
++HRD+K N+++ + ++L D+G P E + R V + Y+ PE +V +
Sbjct: 135 QVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPE-VVTRK 190
Query: 209 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268
Y +D+WSLG M M+ + P Y ++N + + + GT EL
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPP--YLNENPLRALYLIATNGTPEL------------Q 236
Query: 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328
+ L S DFL++ L D + R +A+E + HP+
Sbjct: 237 NPEKL---------------------SAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275
Query: 329 RAAES 333
+ S
Sbjct: 276 KPLSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 5e-16
Identities = 78/310 (25%), Positives = 136/310 (43%), Gaps = 64/310 (20%)
Query: 33 IFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK------IKREIKIL 86
+F+D +R++G G + V+ +V TNE IK + K+ I +E+K L
Sbjct: 26 LFTD------LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFL 79
Query: 87 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV--NSTDF-KVLYPTLTDYDIRYYIYELLK 143
Q + PN ++ +H T L+ EY +++D +V L + +I + L+
Sbjct: 80 QRI-KHPNSIEYKGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQ 136
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
L Y HS ++HRD+K N+++ E +++L D+G A P + V + Y+ PE+
Sbjct: 137 GLAYLHSHNMIHRDIKAGNILLT-EPGQVKLADFGSASIASPANSF---VGTPYWMAPEV 192
Query: 204 LVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261
++ + + YD +D+WSLG + RK P F +NA
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-------------------NMNAMSAL 233
Query: 262 YHLELD--PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 319
YH+ + P L + WS + +F+D L+ QDR T+ E
Sbjct: 234 YHIAQNESPTLQS-------NEWSDYFR------------NFVDSCLQKIPQDRPTSEEL 274
Query: 320 MAHPYFAQVR 329
+ H + + R
Sbjct: 275 LKHMFVLRER 284
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 6e-16
Identities = 48/207 (23%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 43 VRKVGRGKYSEV----FEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGPN 94
++++G G + +V ++ + NT E+ +K L + +REI+IL+ L N
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHEN 67
Query: 95 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIR----YYIYELLKALDYCHS 150
+VK + ++ LI EY+ S + D + ++ K +DY S
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 151 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLVD 206
Q +HRD+ N++++ E +++ D+GLA+ K+Y + ++ PE L
Sbjct: 128 QRYIHRDLAARNILVESE-DLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186
Query: 207 LQDYDYSLDMWSLGCMFAGMIFRKEPF 233
+ S D+WS G + +P
Sbjct: 187 SKFSSAS-DVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 9e-16
Identities = 69/294 (23%), Positives = 135/294 (45%), Gaps = 53/294 (18%)
Query: 46 VGRGKYSEVFEGINVNTNE----RCIIK--ILKPVKKKKIKREIKILQNLCGGPNVVKLL 99
+G G + V + N +C+ K I++ +++ I E +IL+ C P +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEE-CNHPFIVKLY 59
Query: 100 DIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHR 156
+D+ K ++ EY + + +L +Y R+YI ++ A +Y H++GI++R
Sbjct: 60 RTFKDK--KYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYR 117
Query: 157 DVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDM 216
D+KP N+++D ++L+D+G A+ G++ + + PE++++ + YD+S+D
Sbjct: 118 DLKPENLLLDSNGY-VKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN-KGYDFSVDY 175
Query: 217 WSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGR 276
WSLG + ++ + PF G D+ D + +L LE
Sbjct: 176 WSLGILLYELLTGRPPF--GEDDEDPMEIYNDILK--------GNGKLE----------- 214
Query: 277 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYF 325
+ +I A D + +LLR + ++RL ++ H +F
Sbjct: 215 -----FPNYI--------DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.9 bits (191), Expect = 1e-15
Identities = 61/246 (24%), Positives = 120/246 (48%), Gaps = 38/246 (15%)
Query: 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNL 89
S ++YEV++K+G G++ EVF + T E K LK +K ++ E+ +++ L
Sbjct: 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL 69
Query: 90 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK-------VLYPTLTDYDIRYYIYELL 142
N+V+ +D ++ ++ ++ E+ ++ D ++ + ++ I +LL
Sbjct: 70 -KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128
Query: 143 KALDYCHS-------QGIMHRDVKPHNVMIDHELRKL----------------RLIDWGL 179
AL YCH+ + ++HRD+KP N+ + +R + ++ D+GL
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188
Query: 180 AEFYHPGKEYNVRVASRYFKGPELLV-DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 238
++ + V + Y+ PELL+ + + YD DMW+LGC+ + K P F+ +
Sbjct: 189 SKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP-FHKAN 247
Query: 239 NHDQLV 244
N QL+
Sbjct: 248 NFSQLI 253
|
Length = 1021 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--------VKKKKIKREIKILQNL 89
D++V VGRG + EV T + +K++K V + +R+I + N
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN- 59
Query: 90 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYD-IRYYIYELLKAL 145
P + +L +D+ + L+ EY D L Y D D ++Y+ EL+ A+
Sbjct: 60 --SPWIPQLQYAFQDKDNLY--LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAI 115
Query: 146 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR--VASRYFKGPEL 203
H G +HRD+KP NV+ID ++L D+G A K N + V + + PE+
Sbjct: 116 HSVHQMGYVHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEV 174
Query: 204 LVDLQD-----YDYSLDMWSLGCMFAGMIFRKEPF 233
L + Y D WSLG + MI+ + PF
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-15
Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 39 DYEVVRKVGRGKYSEVF------EGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGG 92
++ + +K+GRG++SEV+ +G+ V + I ++ + +EI +L+ L
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NH 61
Query: 93 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKAL 145
PNV+K + + +++ E ++ D FK + + + Y +L AL
Sbjct: 62 PNVIKYYASFIEDNEL--NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 146 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELL 204
++ HS+ +MHRD+KP NV I ++L D GL F+ + V + Y+ PE +
Sbjct: 120 EHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178
Query: 205 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 234
+ Y++ D+WSLGC+ M + PF+
Sbjct: 179 HE-NGYNFKSDIWSLGCLLYEMAALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 5e-15
Identities = 61/198 (30%), Positives = 104/198 (52%), Gaps = 15/198 (7%)
Query: 43 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPNVVKL 98
+ K+G+G + EVF+GI+ T + IKI+ + + I++EI +L C P V K
Sbjct: 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDSPYVTKY 67
Query: 99 L-DIVRDQHSKTPSLIFEYVNS-TDFKVLYP-TLTDYDIRYYIYELLKALDYCHSQGIMH 155
++D +I EY+ + +L P L + I + E+LK LDY HS+ +H
Sbjct: 68 YGSYLKDTKL---WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIH 124
Query: 156 RDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 214
RD+K NV++ E +++L D+G+A + + N V + ++ PE ++ YD
Sbjct: 125 RDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDSKA 182
Query: 215 DMWSLGCMFAGMIFRKEP 232
D+WSLG + A + + EP
Sbjct: 183 DIWSLG-ITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 5e-15
Identities = 76/302 (25%), Positives = 134/302 (44%), Gaps = 50/302 (16%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIK---ILKPVKKKKIKREIKILQNLCGGPNVV 96
Y K+G+G V+ I++ T + IK + + KK+ I EI +++ PN+V
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE-NKNPNIV 79
Query: 97 KLLD--IVRDQHSKTPSLIFEYVNSTDFK-VLYPTLTDY-DIRYYIYELLKALDYCHSQG 152
LD +V D+ ++ EY+ V+ T D I E L+ALD+ HS
Sbjct: 80 NYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQ 135
Query: 153 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYD 211
++HRD+K N+++ + ++L D+G P + + + V + Y+ PE +V + Y
Sbjct: 136 VIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKAYG 193
Query: 212 YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD 271
+D+WSLG M M+ + P+ ++N + + + GT EL +P+
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPELQ----------NPERL 241
Query: 272 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331
+ V R DFL++ L D R +A+E + HP+ +
Sbjct: 242 SAVFR-----------------------DFLNRCLEMDVDRRGSAKELLQHPFLKLAKPL 278
Query: 332 ES 333
S
Sbjct: 279 SS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 8e-15
Identities = 58/190 (30%), Positives = 90/190 (47%), Gaps = 42/190 (22%)
Query: 141 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRY 197
+LKAL H+QG++HRD+K ++++ H+ R ++L D+G KE R V + Y
Sbjct: 125 VLKALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCA--QVSKEVPRRKSLVGTPY 181
Query: 198 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 257
+ PEL+ L Y +D+WSLG M M+ + P+F ++ +K K++ +
Sbjct: 182 WMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYF-----NEPPLKAMKMIRDN---- 231
Query: 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 317
L P+L N H VSP FLD+LL D R TA
Sbjct: 232 --------LPPKL------------------KNLHKVSPSLKGFLDRLLVRDPAQRATAA 265
Query: 318 EAMAHPYFAQ 327
E + HP+ A+
Sbjct: 266 ELLKHPFLAK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 9e-15
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 38/205 (18%)
Query: 129 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGK 187
L + I +L+AL Y HSQG++HRD+K ++++ + R ++L D+G A+
Sbjct: 114 LNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVP 172
Query: 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 247
+ V + Y+ PE ++ Y +D+WSLG M M+ + P+F D V+
Sbjct: 173 KRKSLVGTPYWMAPE-VISRTPYGTEVDIWSLGIMVIEMVDGEPPYF-----SDSPVQAM 226
Query: 248 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 307
K L R S P N H +SP DFL+++L
Sbjct: 227 KRL-------------------------RDSPPP-----KLKNAHKISPVLRDFLERMLT 256
Query: 308 YDHQDRLTAREAMAHPYFAQVRAAE 332
+ Q+R TA+E + HP+ Q E
Sbjct: 257 REPQERATAQELLDHPFLLQTGLPE 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 9e-15
Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 21/216 (9%)
Query: 33 IFSDQDDYEV---VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK------KIKREI 83
+F D E+ + ++G G + V+ N +TNE +K + K+ I +E+
Sbjct: 13 LFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEV 72
Query: 84 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV--NSTD-FKVLYPTLTDYDIRYYIYE 140
K LQ L PN ++ +H T L+ EY +++D +V L + +I +
Sbjct: 73 KFLQQL-KHPNTIEYKGCYLKEH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHG 129
Query: 141 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 200
L+ L Y HS ++HRD+K N+++ E +++L D+G A P + V + Y+
Sbjct: 130 ALQGLAYLHSHNMIHRDIKAGNILLT-EPGQVKLADFGSASKSSPANSF---VGTPYWMA 185
Query: 201 PELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFF 234
PE+++ + + YD +D+WSLG + RK P F
Sbjct: 186 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 73/304 (24%), Positives = 138/304 (45%), Gaps = 53/304 (17%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---EIKILQNLCGGPN 94
D +E++ ++G G + +V++ + T KI++ +++++ EI IL C PN
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSE-CKHPN 63
Query: 95 VVKLLDIVRDQHSKTPSLIFEY-----VNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 149
+V L + + ++ E+ ++S ++ LT+ IRY ++L+AL++ H
Sbjct: 64 IVGLYEAY--FYENKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLH 120
Query: 150 SQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV--- 205
S ++HRD+K N+++ + ++L D+G+ A+ ++ + + + Y+ PE++
Sbjct: 121 SHKVIHRDLKAGNILLTLD-GDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACET 179
Query: 206 -DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264
YDY D+WSLG + + P H+ + V + K+L ++
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPP---HHELNPMRV-LLKILKSEP---------- 225
Query: 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 324
P LD K WS N DFL L D DR TA E + HP+
Sbjct: 226 ---PTLDQ-----PSK-WSSSFN------------DFLKSCLVKDPDDRPTAAELLKHPF 264
Query: 325 FAQV 328
+
Sbjct: 265 VSDQ 268
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 1e-14
Identities = 47/205 (22%), Positives = 88/205 (42%), Gaps = 37/205 (18%)
Query: 44 RKVGRGKYSEVFEGI---NVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGPNVV 96
+K+G G + EV++G +K LK ++K +E ++++ L G PNVV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVV 59
Query: 97 KLLDIVRDQHSKTPSLIFEYVNSTDFK------------VLYPTLTDYDIRYYIYELLKA 144
+LL + ++ L+ EY+ D TL+ D+ + ++ K
Sbjct: 60 RLLGVCTEEEP--LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 145 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 200
++Y S+ +HRD+ N ++ +L +++ D+GL+ + Y + G
Sbjct: 118 MEYLASKKFVHRDLAARNCLVGEDLV-VKISDFGLSRDVYDDDYYRKKT-----GGKLPI 171
Query: 201 ----PELLVDLQDYDYSLDMWSLGC 221
PE L D + D+WS G
Sbjct: 172 RWMAPESLKD-GIFTSKSDVWSFGV 195
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-14
Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 18/203 (8%)
Query: 43 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK------IKREIKILQNLCGGPNVV 96
+R++G G + V+ +V +E IK + K+ I +E++ LQ L PN +
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTI 78
Query: 97 KLLDIVRDQHSKTPSLIFEYV--NSTDF-KVLYPTLTDYDIRYYIYELLKALDYCHSQGI 153
+ +H T L+ EY +++D +V L + +I + L+ L Y HS +
Sbjct: 79 QYRGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 154 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YD 211
+HRDVK N+++ E ++L D+G A P + V + Y+ PE+++ + + YD
Sbjct: 137 IHRDVKAGNILLS-EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYD 192
Query: 212 YSLDMWSLGCMFAGMIFRKEPFF 234
+D+WSLG + RK P F
Sbjct: 193 GKVDVWSLGITCIELAERKPPLF 215
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 59/211 (27%), Positives = 103/211 (48%), Gaps = 20/211 (9%)
Query: 44 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI---------KREIKILQNLCGGPN 94
R +GRG Y++V + + N++ I +K VKK+ + + E + + P
Sbjct: 1 RVIGRGSYAKVLL-VRLKKNDQ--IYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPF 57
Query: 95 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQ 151
+V L Q + L+ EYVN D L + R+Y E+ AL++ H +
Sbjct: 58 LVGLHSCF--QTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER 115
Query: 152 GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 210
GI++RD+K NV++D + ++L D+G+ E PG + + + PE+L ++Y
Sbjct: 116 GIIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEY 173
Query: 211 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 241
+S+D W+LG + M+ + PF DN D
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPD 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-14
Identities = 75/309 (24%), Positives = 137/309 (44%), Gaps = 53/309 (17%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---EIKILQNLCGGPNVV 96
+E++ ++G G + +V++ N T K+++ +++++ EI+IL C P +V
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILAT-CNHPYIV 72
Query: 97 KLLDIVRDQHSKTPSLIFEY-----VNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 151
KLL ++ E+ V++ + L LT+ I+ ++L+AL Y HS
Sbjct: 73 KLLGAF--YWDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQVICRQMLEALQYLHSM 129
Query: 152 GIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV--DLQ 208
I+HRD+K NV++ + ++L D+G+ A+ + + + + Y+ PE+++ ++
Sbjct: 130 KIIHRDLKAGNVLLTLD-GDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188
Query: 209 D--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266
D YDY D+WSLG M + EP + + L+KIAK
Sbjct: 189 DTPYDYKADIWSLGITLIEMA-QIEPPHHELNPMRVLLKIAK----------------SE 231
Query: 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 326
P L W S E DFL L + R +A + + HP+ +
Sbjct: 232 PPTLS------QPSKW------------SMEFRDFLKTALDKHPETRPSAAQLLEHPFVS 273
Query: 327 QVRAAESSR 335
V + R
Sbjct: 274 SVTSNRPLR 282
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 4e-14
Identities = 79/307 (25%), Positives = 140/307 (45%), Gaps = 57/307 (18%)
Query: 39 DYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKP---VKKKKI----KREIKILQN 88
++E+++ +G G Y +VF V +T + +K+L+ V+K K + E +L++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 89 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKAL 145
+ P +V L Q LI +YV+ + F LY ++ ++R+Y E++ AL
Sbjct: 61 VRQSPFLVTLHYAF--QTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILAL 118
Query: 146 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVR-VASRYFKGPEL 203
++ H GI++RD+K N+++D E + L D+GL+ EF KE + + PE+
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSE-GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
+ + ++D WSLG + ++ PF + + Q + +++
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--------------SEVSRRI 223
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TARE 318
L+ DP + +G PEA D L KLLR D + RL A E
Sbjct: 224 LKCDPPFPSFIG--------------------PEAQDLLHKLLRKDPKKRLGAGPQGASE 263
Query: 319 AMAHPYF 325
HP+F
Sbjct: 264 IKEHPFF 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-14
Identities = 56/185 (30%), Positives = 96/185 (51%), Gaps = 16/185 (8%)
Query: 45 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPNVVKLLD 100
++G+G + EV++GI+ T E IKI+ + + I++EI +L C P + +
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDSPYITRYYG 69
Query: 101 IVRDQHSKTPSL--IFEYVNS-TDFKVLYP-TLTDYDIRYYIYELLKALDYCHSQGIMHR 156
+ K L I EY+ + +L P L + I + E+LK LDY HS+ +HR
Sbjct: 70 ----SYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHR 125
Query: 157 DVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 215
D+K NV++ E ++L D+G+A + + N V + ++ PE ++ YD+ D
Sbjct: 126 DIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDFKAD 183
Query: 216 MWSLG 220
+WSLG
Sbjct: 184 IWSLG 188
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 5e-14
Identities = 67/219 (30%), Positives = 106/219 (48%), Gaps = 32/219 (14%)
Query: 44 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI---------KREIKILQNLCGGPN 94
R +GRG Y++V + + ER I +K VKK+ + + E + + P
Sbjct: 1 RVIGRGSYAKVLL-VRLKKTER--IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 57
Query: 95 VVKLLDIVRDQHS--KTPSLIF---EYVNSTDFKVLYP---TLTDYDIRYYIYELLKALD 146
+V L HS +T S +F EYVN D L + R+Y E+ AL+
Sbjct: 58 LVGL-------HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 110
Query: 147 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLV 205
Y H +GI++RD+K NV++D E ++L D+G+ E PG + + + PE+L
Sbjct: 111 YLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 169
Query: 206 DLQDYDYSLDMWSLGCMFAGMIFRKEPF--FYGHDNHDQ 242
+DY +S+D W+LG + M+ + PF DN DQ
Sbjct: 170 G-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 207
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 5e-14
Identities = 75/298 (25%), Positives = 128/298 (42%), Gaps = 56/298 (18%)
Query: 46 VGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKR---EIKILQNLCGGPNVVK 97
+G+G + V+ +V+T K ++ P K++ EI++L+NL +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQ 68
Query: 98 LLDIVRDQHSKTPSLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYCHSQGIM 154
+RD+ KT ++ EY+ K Y LT+ R Y ++L+ + Y HS I+
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIV 128
Query: 155 HRDVKPHNVMIDHELRKLRLIDWG----LAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 210
HRD+K N++ D ++L D+G L G + Y+ PE ++ + Y
Sbjct: 129 HRDIKGANILRD-SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE-VISGEGY 186
Query: 211 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 270
D+WSLGC M+ K P+ ++ + I K+ T N PQL
Sbjct: 187 GRKADVWSLGCTVVEMLTEKPPW----AEYEAMAAIFKI-ATQPTN-----------PQL 230
Query: 271 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328
+ + H+R DFL + + + R +A E + HP FAQ+
Sbjct: 231 PSHISEHAR--------------------DFLGCIF-VEARHRPSAEELLRHP-FAQL 266
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 6e-14
Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 30/208 (14%)
Query: 44 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK---------IKREIKILQNLCGGPN 94
R +GRG Y++V + + R I +K +KK+ ++ E + + P
Sbjct: 1 RVIGRGSYAKVLL-VELKKTRR--IYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPF 57
Query: 95 VVKLLDIVRDQHS--KTPSLIF---EYVNSTDFKVLYP---TLTDYDIRYYIYELLKALD 146
+V L HS +T S +F E+V+ D L + R+Y E+ AL+
Sbjct: 58 LVGL-------HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALN 110
Query: 147 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLV 205
+ H +GI++RD+K NV++D E ++L D+G+ E PG + + + PE+L
Sbjct: 111 FLHERGIIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILR 169
Query: 206 DLQDYDYSLDMWSLGCMFAGMIFRKEPF 233
+DY +S+D W+LG + M+ + PF
Sbjct: 170 G-EDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 7e-14
Identities = 80/309 (25%), Positives = 136/309 (44%), Gaps = 62/309 (20%)
Query: 39 DYEVVRKVGRGKYSEVF---EGINVNTNERCIIKILKP---VKKKKI----KREIKILQN 88
++E++R +G G Y +VF + + + +K+LK V+K K + E ++L+
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 89 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYPT--LTDYDIRYYIYELLKAL 145
+ P +V L Q LI +YVN + F LY T+ ++R YI E++ AL
Sbjct: 61 VRRCPFLVTLHYAF--QTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLAL 118
Query: 146 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPEL 203
D+ H GI++RD+K N+++D E + L D+GL++ + +E + + PE+
Sbjct: 119 DHLHQLGIIYRDIKLENILLDSE-GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEV 177
Query: 204 LVDLQD-YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262
+ +D ++D WSLG + ++ PF V G
Sbjct: 178 IRGGSGGHDKAVDWWSLGVLTFELLTGASPF--------------TVDG----------- 212
Query: 263 HLELDPQLDALVGRHSRKPWSKFINADN---QHLVSPEAIDFLDKLLRYDHQDRL---TA 316
++S+ S+ I +S EA DF+ KLL D + RL A
Sbjct: 213 ------------EQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGA 260
Query: 317 REAMAHPYF 325
E HP+F
Sbjct: 261 DEIKNHPFF 269
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 7e-14
Identities = 54/211 (25%), Positives = 103/211 (48%), Gaps = 15/211 (7%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKKIKREIKILQNLCGGPN 94
Q+D+E+++++G G Y +V++ NVNT E IK++K P + + ++ I+ C N
Sbjct: 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 95 VVKLLD--IVRDQHSKTPSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCH 149
+V + RD+ + E+ + +Y L++ I Y E L+ L Y H
Sbjct: 68 IVAYFGSYLRRDKL----WICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 150 SQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQ 208
S+G MHRD+K N+++ ++L D+G+ A+ + + + Y+ PE+ +
Sbjct: 124 SKGKMHRDIKGANILLTDN-GHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVER 182
Query: 209 D--YDYSLDMWSLGCMFAGMIFRKEPFFYGH 237
Y+ D+W++G + + P F H
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPMFDLH 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 8e-14
Identities = 53/200 (26%), Positives = 98/200 (49%), Gaps = 23/200 (11%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVK 97
+E+V VG G Y +V++G +V T + IK++ ++++IK+EI +L+ N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 98 LLDIVRDQHSKTPS-------LIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKAL 145
K P L+ E+ + L TL + I Y E+L+ L
Sbjct: 68 YYGAFI---KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124
Query: 146 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELL 204
+ H ++HRD+K NV++ E +++L+D+G+ A+ N + + Y+ PE++
Sbjct: 125 SHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 183
Query: 205 VDLQD----YDYSLDMWSLG 220
++ YD+ D+WSLG
Sbjct: 184 ACDENPDATYDFKSDLWSLG 203
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 1e-13
Identities = 39/162 (24%), Positives = 75/162 (46%), Gaps = 18/162 (11%)
Query: 44 RKVGRGKYSEVFEGI----NVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNV 95
+K+G G + EV++G +K LK ++ RE +I++ L PNV
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNV 63
Query: 96 VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHS 150
VKLL + ++ ++ EY+ D Y P L+ D+ + ++ + ++Y S
Sbjct: 64 VKLLGVCTEEEP--LYIVMEYMEGGDLL-SYLRKNRPKLSLSDLLSFALQIARGMEYLES 120
Query: 151 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 192
+ +HRD+ N ++ L +++ D+GL+ + Y R
Sbjct: 121 KNFIHRDLAARNCLVGENLV-VKISDFGLSRDLYDDDYYRKR 161
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 75/301 (24%), Positives = 136/301 (45%), Gaps = 53/301 (17%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---EIKILQNLCGGP 93
++ +E++ ++G G + +V++ N T K++ +++++ EI IL + C P
Sbjct: 4 EEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILAS-CDHP 62
Query: 94 NVVKLLDIVRDQHSKTPSLIFEY-----VNSTDFKVLYPTLTDYDIRYYIYELLKALDYC 148
N+VKLLD + ++ E+ V++ ++ P LT+ IR + L+AL+Y
Sbjct: 63 NIVKLLDAF--YYENNLWILIEFCAGGAVDAVMLELERP-LTEPQIRVVCKQTLEALNYL 119
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV-- 205
H I+HRD+K N++ + ++L D+G+ A+ + + + + Y+ PE+++
Sbjct: 120 HENKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 206 --DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
+ YDY D+WSLG M + EP + + L+KIAK
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMA-QIEPPHHELNPMRVLLKIAKS-------------- 223
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
+P A R W S E DFL K L + R T + + HP
Sbjct: 224 ---EPPTLAQPSR-----W------------SSEFKDFLKKCLEKNVDARWTTTQLLQHP 263
Query: 324 Y 324
+
Sbjct: 264 F 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 53/197 (26%), Positives = 98/197 (49%), Gaps = 17/197 (8%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVK 97
+E+V VG G Y +V++G +V T + IK++ + +++IK EI +L+ N+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 98 LLDIVRDQ----HSKTPSLIFEYVNS---TDF--KVLYPTLTDYDIRYYIYELLKALDYC 148
+ H L+ E+ + TD L + I Y E+L+ L +
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDL 207
H+ ++HRD+K NV++ E +++L+D+G+ A+ N + + Y+ PE++
Sbjct: 138 HAHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 196
Query: 208 QD----YDYSLDMWSLG 220
++ YDY D+WSLG
Sbjct: 197 ENPDATYDYRSDIWSLG 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 57/186 (30%), Positives = 95/186 (51%), Gaps = 18/186 (9%)
Query: 45 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPNVVKLLD 100
++G+G + EVF+GI+ T + IKI+ + + I++EI +L C P V K
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDSPYVTKYYG 69
Query: 101 IVRDQHSKTPSL--IFEYV---NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMH 155
+ K L I EY+ ++ D P ++ I + E+LK LDY HS+ +H
Sbjct: 70 ----SYLKGTKLWIIMEYLGGGSALDLLRAGP-FDEFQIATMLKEILKGLDYLHSEKKIH 124
Query: 156 RDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 214
RD+K NV++ E ++L D+G+A + + N V + ++ PE ++ YD
Sbjct: 125 RDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIQQSAYDSKA 182
Query: 215 DMWSLG 220
D+WSLG
Sbjct: 183 DIWSLG 188
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 52/203 (25%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 46 VGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKR---EIKILQNLCGGPNVVK 97
+G+G + V+ + +T +K ++ P K++ EI++L+NL +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH-ERIVQ 68
Query: 98 LLDIVRDQHSKTPSLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYCHSQGIM 154
+RD +T S+ E++ K Y LT+ R Y ++L+ + Y HS I+
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIV 128
Query: 155 HRDVKPHNVMIDHELRKLRLIDWG----LAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 210
HRD+K N++ D + ++L D+G L G + Y+ PE ++ + Y
Sbjct: 129 HRDIKGANILRD-SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE-VISGEGY 186
Query: 211 DYSLDMWSLGCMFAGMIFRKEPF 233
D+WS+GC M+ K P+
Sbjct: 187 GRKADIWSVGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 3e-13
Identities = 72/304 (23%), Positives = 124/304 (40%), Gaps = 65/304 (21%)
Query: 46 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ 105
+GRG + EV+ +T + +K L K+ IK+ Q N +L +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLD-------KKRIKMKQGETLALNERIMLSLVSTG 54
Query: 106 HS----------KTP---SLIFEYVNSTDFKV---LYPTLTDYDIRYYIYELLKALDYCH 149
TP S I + +N D + ++ ++R+Y E++ L++ H
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH 114
Query: 150 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 209
++ +++RD+KP N+++D E +R+ D GLA + K + V + + PE+L
Sbjct: 115 NRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGVA 172
Query: 210 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 269
YD S D +SLGCM ++ P F H D+ +++ L + +
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSP-FRQHKTKDKHE--------------IDRMTLTMAVE 217
Query: 270 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPY 324
L SPE L+ LL+ D RL A+E HP+
Sbjct: 218 LP--------------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPF 257
Query: 325 FAQV 328
F +
Sbjct: 258 FRSL 261
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-13
Identities = 56/222 (25%), Positives = 107/222 (48%), Gaps = 20/222 (9%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGPNV 95
YE+++K+G G + +++ + +E C+IK + PVK+K+ ++ IL PN+
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 96 VKLLDIVRDQHSKTPSLIFEYVNSTDFK--------VLYPTLTDYDIRYYIYELLKALDY 147
V Q + ++ EY + D VL+ ++ I + ++ L +
Sbjct: 62 VTFFASF--QENGRLFIVMEYCDGGDLMKRINRQRGVLF---SEDQILSWFVQISLGLKH 116
Query: 148 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVD 206
H + I+HRD+K N+ + +L D+G+A + E V + Y+ PE+ +
Sbjct: 117 IHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN 176
Query: 207 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 248
+ Y+ D+WSLGC+ + K P F G++ H ++KI +
Sbjct: 177 -RPYNNKTDIWSLGCVLYELCTLKHP-FEGNNLHQLVLKICQ 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 4e-13
Identities = 37/162 (22%), Positives = 75/162 (46%), Gaps = 17/162 (10%)
Query: 44 RKVGRGKYSEVFEGI----NVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNV 95
+K+G G + EV++G +K LK ++ RE +I++ L PN+
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNI 63
Query: 96 VKLLDIVRDQHSKTPSLIFEYVNSTDFK-VL----YPTLTDYDIRYYIYELLKALDYCHS 150
VKLL + ++ ++ EY+ D L L+ D+ + ++ + ++Y S
Sbjct: 64 VKLLGVCTEEEP--LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 151 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 192
+ +HRD+ N ++ L +++ D+GL+ + Y V+
Sbjct: 122 KNFIHRDLAARNCLVGENLV-VKISDFGLSRDLYDDDYYKVK 162
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 5e-13
Identities = 66/216 (30%), Positives = 104/216 (48%), Gaps = 29/216 (13%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR-------EIKILQNLC 90
+DYEVV+ +GRG + EV + +T + +K+L K + IKR E + +
Sbjct: 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS--KFEMIKRSDSAFFWEERDIMAFA 100
Query: 91 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI-----RYYIYELLKAL 145
P VV+L +D + ++ EY+ D L +++YD+ R+Y E++ AL
Sbjct: 101 NSPWVVQLFYAFQD--DRYLYMVMEYMPGGD---LVNLMSNYDVPEKWARFYTAEVVLAL 155
Query: 146 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGP 201
D HS G +HRDVKP N+++D + L+L D+G KE VR V + + P
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISP 212
Query: 202 ELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFF 234
E+L Y D WS+G M+ PF+
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 6e-13
Identities = 86/351 (24%), Positives = 150/351 (42%), Gaps = 84/351 (23%)
Query: 31 YVIFSDQDD-----YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKI 85
YV+ + D ++++ +G G + +V E + E C +KI++ V K R+ KI
Sbjct: 117 YVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK--YTRDAKI 174
Query: 86 LQNLCGGPNVVKLLDIVR--DQHSKTPSLIFE--YVNSTDFKVLY-----PTLTDYDIRY 136
++ ++ VR D + P + + + N T + P L D+ +++
Sbjct: 175 ---------EIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKH 225
Query: 137 ----------YIYELLKALDYCHSQ-GIMHRDVKPHNVM-------IDHELRK------- 171
I++ ALDY H++ +MH D+KP N++ +D +
Sbjct: 226 GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285
Query: 172 -LRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 227
+R+ D G E + R V++R+++ PE+++ L + YS DMWS+GC+ +
Sbjct: 286 RVRICDLGGC-----CDERHSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYEL- 338
Query: 228 FRKEPFFYGHDNHDQLVKIAKVL-----------GTDELNAYLNKY-HLE--LDPQLDAL 273
+ + + HDN + L + K L GT+E N L DP+ A
Sbjct: 339 YTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLAR 398
Query: 274 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 324
+ R +P + I D + LL YD Q RL AR+ HPY
Sbjct: 399 IAR--ARPVREVIR-------DDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440
|
Length = 467 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 8e-13
Identities = 72/294 (24%), Positives = 132/294 (44%), Gaps = 50/294 (17%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIK---ILKPVKKKKIKREIKILQNLCGGPNVV 96
Y K+G+G V+ ++V T + I+ + + KK+ I EI +++ PN+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE-NKNPNIV 80
Query: 97 KLLD--IVRDQHSKTPSLIFEYVNSTDFK-VLYPTLTDY-DIRYYIYELLKALDYCHSQG 152
LD +V D+ ++ EY+ V+ T D I E L+AL++ HS
Sbjct: 81 NYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 153 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYD 211
++HRD+K N+++ + ++L D+G P + + + V + Y+ PE +V + Y
Sbjct: 137 VIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKAYG 194
Query: 212 YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD 271
+D+WSLG M MI + P+ ++N + + + GT EL +P+
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQ----------NPEKL 242
Query: 272 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325
+ + R DFL++ L D + R +A+E + H +
Sbjct: 243 SAIFR-----------------------DFLNRCLDMDVEKRGSAKELLQHQFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 56/213 (26%), Positives = 106/213 (49%), Gaps = 19/213 (8%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK---IKREIKILQNLCGGP 93
Q DYE++++VG G Y +V++ N++T E +KI+K I++EI +++ C
Sbjct: 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKE-CKHC 66
Query: 94 NVVKLLD--IVRDQHSKTPSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYC 148
N+V + R++ + EY + +Y L++ I Y E L+ L Y
Sbjct: 67 NIVAYFGSYLSREKL----WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYL 122
Query: 149 HSQGIMHRDVKPHNVMI-DHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVD 206
HS+G MHRD+K N+++ D+ ++L D+G+ A+ + + + Y+ PE+
Sbjct: 123 HSKGKMHRDIKGANILLTDNG--DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 207 LQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGH 237
++ Y+ D+W++G + + P F H
Sbjct: 181 EKNGGYNQLCDIWAVGITAIELAELQPPMFDLH 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 50/207 (24%)
Query: 130 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE--FYHPGK 187
T+ D+++Y+ EL ALD+ HS GI++RD+KP N+++D E ++L D+GL++ H K
Sbjct: 96 TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKK 154
Query: 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 247
Y+ Y PE +V+ + + S D WS G + M+ P F G D + + I
Sbjct: 155 AYSFCGTVEYM-APE-VVNRRGHTQSADWWSFGVLMFEMLTGSLP-FQGKDRKETMTMIL 211
Query: 248 KV-LGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 306
K LG PQ +SPEA L L
Sbjct: 212 KAKLGM---------------PQ-----------------------FLSPEAQSLLRALF 233
Query: 307 RYDHQDRLTA-----REAMAHPYFAQV 328
+ + +RL A E HP+F+ +
Sbjct: 234 KRNPANRLGAGPDGVEEIKRHPFFSTI 260
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-12
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 36/215 (16%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLL 99
YE +R VGRG + V + IIK + PV++ K E QN C V+KLL
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQI-PVEQMT-KDERLAAQNEC---QVLKLL 56
Query: 100 DIVRDQHSKTPSLIFEYVNSTDFKVL-----YP---TLTDY------------DIRYYIY 139
H P++I Y N + K L Y TL +Y I ++
Sbjct: 57 -----SH---PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV 108
Query: 140 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYF 198
++L AL + H++ I+HRD+K N+++D +++ D+G++ K Y V V + +
Sbjct: 109 QILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV-VGTPCY 167
Query: 199 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 233
PE L + + Y+ D+W+LGC+ + K F
Sbjct: 168 ISPE-LCEGKPYNQKSDIWALGCVLYELASLKRAF 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-12
Identities = 84/308 (27%), Positives = 133/308 (43%), Gaps = 68/308 (22%)
Query: 43 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIK----------ILQNLCGG 92
++ +G+G Y +VF+ V + I +K +KK I R K IL+ +
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KH 59
Query: 93 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI------RYYIYELLKALD 146
P +V L I Q LI EY++ + L+ L I +Y+ E+ AL+
Sbjct: 60 PFIVDL--IYAFQTGGKLYLILEYLSGGE---LFMHLEREGIFMEDTACFYLSEISLALE 114
Query: 147 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLV 205
+ H QGI++RD+KP N+++D + ++L D+GL E H G + + + PE+L+
Sbjct: 115 HLHQQGIIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILM 173
Query: 206 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265
+ ++D WSLG + M+ PF +N + I K+L K L
Sbjct: 174 R-SGHGKAVDWWSLGALMYDMLTGAPPF--TAENRKK--TIDKIL----------KGKLN 218
Query: 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAM 320
L P L +PEA D L KLL+ + RL A E
Sbjct: 219 LPPYL------------------------TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQ 254
Query: 321 AHPYFAQV 328
+HP+F V
Sbjct: 255 SHPFFRHV 262
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-12
Identities = 40/127 (31%), Positives = 64/127 (50%), Gaps = 7/127 (5%)
Query: 112 LIFEYVNSTDFKV-LY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 166
L+ +N D K +Y P + +Y E+L L+ H + ++RD+KP N+++D
Sbjct: 77 LVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD 136
Query: 167 HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGM 226
+ +R+ D GLA G+ RV + + PE+L + Q Y S D W LGC+ M
Sbjct: 137 -DYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEM 194
Query: 227 IFRKEPF 233
I + PF
Sbjct: 195 IEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR-------EIKILQNLC 90
+DY+VV+ +GRG + EV + ++ + +K+L K + IKR E + +
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLS--KFEMIKRSDSAFFWEERDIMAFA 100
Query: 91 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI-----RYYIYELLKAL 145
P VV+L +D K ++ EY+ D L +++YD+ ++Y E++ AL
Sbjct: 101 NSPWVVQLFCAFQDD--KYLYMVMEYMPGGD---LVNLMSNYDVPEKWAKFYTAEVVLAL 155
Query: 146 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEY-NVRVASRYFKGPEL 203
D HS G++HRDVKP N+++D + L+L D+G + G + V + + PE+
Sbjct: 156 DAIHSMGLIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEV 214
Query: 204 LVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFF 234
L Y D WS+G M+ PF+
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (158), Expect = 7e-12
Identities = 47/199 (23%), Positives = 87/199 (43%), Gaps = 34/199 (17%)
Query: 44 RKVGRGKYSEVFEGI----NVNTNERCIIKILKP----VKKKKIKREIKILQNLCGGPNV 95
+K+G G + EV++G T + +K LK ++++ E I++ L PN+
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKL-SHPNI 63
Query: 96 VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHS 150
V+LL + + ++ EY+ D + LT D+ ++ K ++Y S
Sbjct: 64 VRLLGVCT--QGEPLYIVTEYMPGGDLL-DFLRKHGEKLTLKDLLQMALQIAKGMEYLES 120
Query: 151 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---------VASRYFKGP 201
+ +HRD+ N ++ L +++ D+GL+ + Y R +A P
Sbjct: 121 KNFVHRDLAARNCLVTENL-VVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMA------P 173
Query: 202 ELLVDLQDYDYSLDMWSLG 220
E L D + S D+WS G
Sbjct: 174 ESLKDGKFTSKS-DVWSFG 191
|
Length = 258 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 8e-12
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 34/210 (16%)
Query: 44 RKVGRGKYSEVFEGINVNTNERCIIKI------LKPVKKKKIKR---------EIKILQN 88
R +G+G + EV C ++ K ++KK+IK+ E +IL+
Sbjct: 6 RVLGKGGFGEVCA---------CQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK 56
Query: 89 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV-LY----PTLTDYDIRYYIYELLK 143
+ VV L + + L+ +N D K +Y P + +Y E+
Sbjct: 57 V-NSRFVVSLAYAYETKDALC--LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITC 113
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
L+ H + I++RD+KP N+++D + +R+ D GLA G+ RV + + PE
Sbjct: 114 GLEDLHRERIVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPE- 171
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 233
+V + Y +S D W LGC+ MI K PF
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 8e-12
Identities = 41/143 (28%), Positives = 72/143 (50%), Gaps = 22/143 (15%)
Query: 111 SLIFEYVNSTDFKVLYPTLTDYDIRYYIY-------------------ELLKALDYCHSQ 151
SL + + TD ++ + D+RY+IY +++ L++ H +
Sbjct: 57 SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116
Query: 152 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA-SRYFKGPELLVDLQDY 210
I++RD+KP NV++D++ +R+ D GLA G+ A + F PELL ++Y
Sbjct: 117 RIIYRDLKPENVLLDND-GNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG-EEY 174
Query: 211 DYSLDMWSLGCMFAGMIFRKEPF 233
D+S+D ++LG MI + PF
Sbjct: 175 DFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 18/203 (8%)
Query: 46 VGRGKYSEVFEGINVNTNERCIIKIL--KPVKKKKIKR------EIKILQNLCGGPNVVK 97
+GRG + EV+ + +T +K + P ++ K EI++L+NL +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQ 68
Query: 98 LLDIVRDQHSKTPSLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYCHSQGIM 154
+RD K S+ EY+ K Y LT+ R Y ++L+ + Y HS I+
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIV 128
Query: 155 HRDVKPHNVMIDHELRKLRLIDWGLAE----FYHPGKEYNVRVASRYFKGPELLVDLQDY 210
HRD+K N++ D ++L D+G ++ G + Y+ PE ++ + Y
Sbjct: 129 HRDIKGANILRDSA-GNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE-VISGEGY 186
Query: 211 DYSLDMWSLGCMFAGMIFRKEPF 233
D+WS+ C M+ K P+
Sbjct: 187 GRKADVWSVACTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 52/214 (24%), Positives = 96/214 (44%), Gaps = 46/214 (21%)
Query: 46 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---------EIKILQNLCGGPNVV 96
+G+G + EV + V + + K + KK++K+ E +IL+ + P +V
Sbjct: 1 LGKGGFGEVC-AVQVKNTGK--MYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIV 56
Query: 97 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIY-------ELLKALDYC- 148
+L + + + T ++ + D++Y+IY E+ + + Y
Sbjct: 57 --------------NLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102
Query: 149 ---------HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 199
HS I++RD+KP NV++D + RL D GLA GK R + +
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQRAGTNGYM 161
Query: 200 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 233
PE+L + + Y Y +D +++GC M+ + PF
Sbjct: 162 APEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 25/204 (12%)
Query: 46 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ 105
+GRG + EV+ +T + +K L K+ IK+ Q N +L +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLD-------KKRIKMKQGETLALNERIMLSLVSTG 54
Query: 106 HS----------KTPS---LIFEYVNSTDFKV---LYPTLTDYDIRYYIYELLKALDYCH 149
TP I + +N D + ++ ++R+Y E++ L++ H
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH 114
Query: 150 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 209
++ +++RD+KP N+++D E +R+ D GLA + K + V + + PE+L
Sbjct: 115 NRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGTA 172
Query: 210 YDYSLDMWSLGCMFAGMIFRKEPF 233
YD S D +SLGCM ++ PF
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 54/194 (27%), Positives = 92/194 (47%), Gaps = 19/194 (9%)
Query: 43 VRKVGRGKYSEV----FEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPN 94
+R +G G + +V ++ NT E+ +K LKP +K+EI+IL+NL N
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH-EN 67
Query: 95 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY----DIRYYIYELLKALDYCHS 150
+VK I + LI E++ S K P + Y ++ K +DY S
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 151 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPELLVD 206
+ +HRD+ NV+++ E ++++ D+GL + KEY + ++ PE L+
Sbjct: 128 RQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 207 LQDYDYSLDMWSLG 220
+ Y S D+WS G
Sbjct: 187 SKFYIAS-DVWSFG 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 73/295 (24%), Positives = 125/295 (42%), Gaps = 56/295 (18%)
Query: 46 VGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKR---EIKILQNLCGGPNVVK 97
+G+G + V+ +V+T +K + P KK++ EI++L+NL +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQ 68
Query: 98 LLDIVRDQHSKTPSLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYCHSQGIM 154
+RD +T S+ EY+ K Y LT+ R Y ++L+ ++Y HS I+
Sbjct: 69 YYGCLRDD--ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV 126
Query: 155 HRDVKPHNVMIDHELRKLRLIDWG----LAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 210
HRD+K N++ D ++L D+G L G + Y+ PE ++ + Y
Sbjct: 127 HRDIKGANILRDSA-GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE-VISGEGY 184
Query: 211 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 270
D+WS+GC M+ K P+ + + I K+ T N PQL
Sbjct: 185 GRKADVWSVGCTVVEMLTEKPPW----AEFEAMAAIFKI-ATQPTN-----------PQL 228
Query: 271 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325
P VSP+A +FL + + + R +A E + H +
Sbjct: 229 ----------PSH----------VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 37/212 (17%)
Query: 46 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ 105
+G+G + +V++ V + I +K + KK+I + ++ + G N+ +VR
Sbjct: 1 IGKGTFGQVYQ---VRKKDTRRIYAMKVLSKKEIVAKKEVAHTI-GERNI-----LVRTL 51
Query: 106 HSKTPSLI---FEYVNSTDFKVLYPTLTDY-------------------DIRYYIYELLK 143
++P ++ F + +D LY +TDY ++YI EL+
Sbjct: 52 LDESPFIVGLKFSFQTDSD---LY-LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVL 107
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF-YHPGKEYNVRVASRYFKGPE 202
AL++ H I++RD+KP N+++D + L D+GL++ K N + + PE
Sbjct: 108 ALEHLHKYDIVYRDLKPENILLDAT-GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPE 166
Query: 203 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 234
+L+D + Y +D WSLG + M PF+
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFY 198
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 54/236 (22%), Positives = 103/236 (43%), Gaps = 39/236 (16%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IKILK----PVKKKKIKREIKILQN 88
++D + R +G G++ +V++G+ ++ I +K K P ++K +E I++
Sbjct: 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQ 63
Query: 89 LCGGPNVVKLLDIVRDQHSKTPSLI------------FEYVNSTDFKVLYPTLTDYDIRY 136
P++VKL+ ++ + P I + VN + L
Sbjct: 64 F-DHPHIVKLIGVITEN----PVWIVMELAPLGELRSYLQVNKYSLDLASLIL------- 111
Query: 137 YIYELLKALDYCHSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVAS 195
Y Y+L AL Y S+ +HRD+ NV++ + KL D+GL+ + Y
Sbjct: 112 YSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLG--DFGLSRYLEDESYYKASKGK 169
Query: 196 RYFK--GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 248
K PE ++ + + + D+W G CM+ ++ +PF G N+D + +I
Sbjct: 170 LPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMLGVKPFQ-GVKNNDVIGRIEN 223
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 47/160 (29%), Positives = 79/160 (49%), Gaps = 21/160 (13%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKRE----IKILQNLCG-- 91
DD+E ++ +GRG + EV +T +K L+ K + +++E ++ +++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLR--KSEMLEKEQVAHVRAERDILAEA 58
Query: 92 -GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDY 147
P VVKL +D LI EY+ D L T T+ + R+YI E + A+D
Sbjct: 59 DNPWVVKLYYSFQD--ENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDS 116
Query: 148 CHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLAEFYH 184
H G +HRD+KP N+++D H ++L D+GL
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGH----IKLSDFGLCTGLK 152
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-11
Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 46/200 (23%)
Query: 135 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 193
R+Y E++ AL+Y HS+ +++RD+K N+M+D + +++ D+GL E G
Sbjct: 98 RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFC 156
Query: 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 253
+ + PE+L D DY ++D W LG + M+ + PF+ + +H++L ++
Sbjct: 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFEL------- 206
Query: 254 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 313
++ R P + +SPEA L LL+ D + R
Sbjct: 207 -------------------ILMEEIRFPRT----------LSPEAKSLLAGLLKKDPKQR 237
Query: 314 L-----TAREAMAHPYFAQV 328
L A+E M H +F +
Sbjct: 238 LGGGPSDAKEVMEHRFFLSI 257
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 5e-11
Identities = 55/199 (27%), Positives = 83/199 (41%), Gaps = 45/199 (22%)
Query: 135 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 193
R+Y E+ AL Y HS I++RD+KP N+++D + + L D+GL E K +
Sbjct: 99 RFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGIEHSKTTSTFC 157
Query: 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 253
+ + PE+L Q YD ++D W LG + M++ P FY D + I
Sbjct: 158 GTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPP-FYSRDTAEMYDNI------- 208
Query: 254 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 313
LNK L L P +S A L+ LL+ D R
Sbjct: 209 -----LNK-PLRLKPN------------------------ISVSARHLLEGLLQKDRTKR 238
Query: 314 LTAR----EAMAHPYFAQV 328
L A+ E H +F+ +
Sbjct: 239 LGAKDDFLEIKNHVFFSSI 257
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 7e-11
Identities = 54/199 (27%), Positives = 80/199 (40%), Gaps = 45/199 (22%)
Query: 135 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 193
R+Y E+ AL Y HS I++RD+KP N+++D + L D+GL E
Sbjct: 99 RFYAAEIASALGYLHSINIVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFC 157
Query: 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 253
+ + PE++ Q YD ++D W LG + M++ P FY D +
Sbjct: 158 GTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPP-FYCRDVAEM----------- 204
Query: 254 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 313
Y N H L + A S WS L++LL D Q R
Sbjct: 205 ----YDNILHKPLVLRPGA-----SLTAWS-----------------ILEELLEKDRQRR 238
Query: 314 LTAR----EAMAHPYFAQV 328
L A+ E HP+F +
Sbjct: 239 LGAKEDFLEIQEHPFFESL 257
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 7e-11
Identities = 52/237 (21%), Positives = 88/237 (37%), Gaps = 85/237 (35%)
Query: 134 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 193
I+ + ++L ALD HS GI+HRDVKP N++ ++ID G A ++RV
Sbjct: 257 IQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAA--------DLRV 308
Query: 194 ASRY----------FKGPELLV------------------------DLQDYDYSLDMWSL 219
Y + PE + +L D D++S
Sbjct: 309 GINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD---RFDIYSA 365
Query: 220 GCMFAGMIF---RKEPFFYGHDNHDQLVKIAKVLGTDELNAY-LNKYHLELDPQLDALVG 275
G +F M F R + L++ + L + N Y L + ++P+ +
Sbjct: 366 GLIFLQMAFPNLRSD---------SNLIQFNRQL---KRNDYDLVAWRKLVEPRASPDLR 413
Query: 276 R-------HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325
R W + L ++R+ + R++A+ A+AHPYF
Sbjct: 414 RGFEVLDLDGGAGW-----------------ELLKSMMRFKGRQRISAKAALAHPYF 453
|
Length = 566 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 7e-11
Identities = 54/198 (27%), Positives = 85/198 (42%), Gaps = 41/198 (20%)
Query: 136 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS 195
+Y E+ L+ H + I++RD+KP N+++D +R+ D GLA G+ RV +
Sbjct: 106 FYAAEICCGLEDLHQERIVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVGT 164
Query: 196 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL 255
+ PE +V + Y +S D W+LGC+ MI + PF + KI +
Sbjct: 165 VGYMAPE-VVKNERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIKR------- 210
Query: 256 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL- 314
+++ LV + KF SP+A LL D ++RL
Sbjct: 211 ------------EEVERLVKEVQEEYSEKF---------SPDARSLCKMLLCKDPKERLG 249
Query: 315 ----TAREAMAHPYFAQV 328
ARE HP F Q+
Sbjct: 250 CQGGGAREVKEHPLFKQI 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 7e-11
Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 28/212 (13%)
Query: 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------KKKIKREIKILQNLC 90
D++V++K+G+G Y V++ V LK V ++ EI+IL ++
Sbjct: 1 DFKVLKKLGKGSYGSVYK---VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV- 56
Query: 91 GGPNVVK----LLDIVR----DQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELL 142
PN++ LD + +++ L + L P + R +I +LL
Sbjct: 57 NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW--RIFI-QLL 113
Query: 143 KALDYCHSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 201
+ L H Q I+HRD+K N+++ ++L K+ D G+++ + + ++ P
Sbjct: 114 RGLQALHEQKILHRDLKSANILLVANDLVKIG--DLGISKVLKKNMAKTQ-IGTPHYMAP 170
Query: 202 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 233
E+ + Y Y D+WSLGC+ M PF
Sbjct: 171 EVWKG-RPYSYKSDIWSLGCLLYEMATFAPPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 7e-11
Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 22/214 (10%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCG 91
DD+E+++ +GRG + EV +T +KIL K + + E +L N G
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVN--G 58
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY---DI-RYYIYELLKALDY 147
+ L Q L+ +Y D L D D+ R+YI E++ A+
Sbjct: 59 DCQWITTLHYAF-QDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHS 117
Query: 148 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWG--LAEFYHPGKEYNVRVASRYFKGPELLV 205
H +HRD+KP NV++D +RL D+G L + +V V + + PE+L
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ 176
Query: 206 DLQD----YDYSLDMWSLG-CMFAGMIFRKEPFF 234
++D Y D WSLG CM+ M++ + PF+
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYE-MLYGETPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 9e-11
Identities = 71/319 (22%), Positives = 133/319 (41%), Gaps = 76/319 (23%)
Query: 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCGGPN 94
+ E V ++G G V++ I+ T +K++ + +++I REI+IL+++ PN
Sbjct: 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPN 133
Query: 95 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHS 150
VVK D+ H+ ++ E+++ + + L D ++L + Y H
Sbjct: 134 VVKCHDMF--DHNGEIQVLLEFMDGGSLEGTHIADEQFLADVA-----RQILSGIAYLHR 186
Query: 151 QGIMHRDVKPHNVMIDHELRKLRLIDWG----LAEFYHPGKEYNVRVASRYFKGPELL-V 205
+ I+HRD+KP N++I+ + +++ D+G LA+ P N V + + PE +
Sbjct: 187 RHIVHRDIKPSNLLINSA-KNVKIADFGVSRILAQTMDP---CNSSVGTIAYMSPERINT 242
Query: 206 DLQD--YD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262
DL YD Y+ D+WSLG V I L YL ++
Sbjct: 243 DLNHGAYDGYAGDIWSLG-----------------------VSI--------LEFYLGRF 271
Query: 263 HLELDPQLDALVGRHSRKPWSKFINA-------DNQHLVSPEAIDFLDKLLRYDHQDRLT 315
+ Q D W+ + A + S E F+ L+ + R +
Sbjct: 272 PFGVGRQGD----------WASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWS 321
Query: 316 AREAMAHPYFAQVRAAESS 334
A + + HP+ + + +
Sbjct: 322 AMQLLQHPFILRAQPGQGQ 340
|
Length = 353 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 19/206 (9%)
Query: 43 VRKVGRGKYSEV----FEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGPN 94
+R +G G + +V ++ N T E +K LK K+EI IL+ L N
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YHEN 67
Query: 95 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQG 152
+VK +Q K LI EYV + P L + + ++ + + Y HSQ
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH 127
Query: 153 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR-----YFKGPELLVDL 207
+HRD+ NV++D++ R +++ D+GLA+ G EY RV ++ E L +
Sbjct: 128 YIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEY-YRVREDGDSPVFWYAVECLKEN 185
Query: 208 QDYDYSLDMWSLGCMFAGMIFRKEPF 233
+ Y+ D+WS G ++ +
Sbjct: 186 KFS-YASDVWSFGVTLYELLTHCDSK 210
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 46/200 (23%)
Query: 135 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 193
R+Y E++ AL Y HS +++RD+K N+M+D + +++ D+GL E G
Sbjct: 98 RFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFC 156
Query: 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 253
+ + PE+L D DY ++D W LG + M+ + P FY D H++L ++ + +
Sbjct: 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLP-FYNQD-HEKLFELILM---E 210
Query: 254 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 313
E+ R R +SPEA L LL+ D + R
Sbjct: 211 EI--------------------RFPRT-------------LSPEAKSLLAGLLKKDPKQR 237
Query: 314 L-----TAREAMAHPYFAQV 328
L A+E M H +FA +
Sbjct: 238 LGGGPEDAKEIMEHRFFASI 257
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCG 91
+D+E+++ +GRG + EV N ++ +KIL K + + E +L N G
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN--G 58
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY---DI-RYYIYELLKALDY 147
+ L Q L+ +Y D L D D+ R+Y+ E++ A+D
Sbjct: 59 DNQWITTLHYAF-QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDS 117
Query: 148 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWG--LAEFYHPGKEYNVRVASRYFKGPELLV 205
H +HRD+KP N+++D +RL D+G L + +V V + + PE+L
Sbjct: 118 VHQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176
Query: 206 DLQD----YDYSLDMWSLGCMFAGMIFRKEPFF 234
++D Y D WSLG M++ + PF+
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 71/236 (30%), Positives = 108/236 (45%), Gaps = 37/236 (15%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 89
DD+E+++ +GRG + EV NT + +KIL K + +KR E +L N
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILN--KWEMLKRAETACFREERDVLVN- 57
Query: 90 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY---DI-RYYIYELLKAL 145
G + L Q L+ +Y D L D D+ R+Y+ E++ A+
Sbjct: 58 -GDRRWITNLHYAF-QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAI 115
Query: 146 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG--LAEFYHPGKEYNVRVASRYFKGPEL 203
D H G +HRD+KP NV++D +RL D+G L + NV V + + PE+
Sbjct: 116 DSVHQLGYVHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI 174
Query: 204 LVDLQD----YDYSLDMWSLG-CMFAGMIFRKEPFF-------YG----HDNHDQL 243
L ++D Y D WSLG CM+ M++ + PF+ YG H H Q
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYE-MLYGETPFYAESLVETYGKIMNHKEHFQF 229
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 36/134 (26%), Positives = 71/134 (52%), Gaps = 7/134 (5%)
Query: 112 LIFEYVNSTDFKVLYPTLTDYDI---RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 168
+ EY+N D + +D+ +Y E++ L + HS+GI++RD+K N+++D +
Sbjct: 73 FVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD 132
Query: 169 LRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 227
+++ D+G+ + G + + + PE+L+ Q Y+ S+D WS G + M+
Sbjct: 133 -GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEML 190
Query: 228 FRKEPFFYGHDNHD 241
+ P F+GHD +
Sbjct: 191 IGQSP-FHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 40/204 (19%)
Query: 124 VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEF 182
V + + + I +L+AL Y H+QG++HRD+K ++++ + R ++L D+G A+
Sbjct: 110 VTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR-IKLSDFGFCAQV 168
Query: 183 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 242
+ V + Y+ PE++ L Y +D+WSLG M MI + P+F
Sbjct: 169 SKEVPKRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYFN------- 220
Query: 243 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVG-RHSRKPWSKFINADNQHLVSPEAIDF 301
+P L A+ R + P K + H VS F
Sbjct: 221 ------------------------EPPLQAMRRIRDNLPPRVK-----DSHKVSSVLRGF 251
Query: 302 LDKLLRYDHQDRLTAREAMAHPYF 325
LD +L + R TA+E + HP+
Sbjct: 252 LDLMLVREPSQRATAQELLQHPFL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 29/216 (13%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR-------EIKILQNLC 90
+D++V++ +GRG + EV + ++ + +K+L K + IKR E + +
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS--KFEMIKRSDSAFFWEERDIMAHA 100
Query: 91 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI-----RYYIYELLKAL 145
+V+L +D K ++ EY+ D L +++YDI R+Y E++ AL
Sbjct: 101 NSEWIVQLHYAFQDD--KYLYMVMEYMPGGDLVNL---MSNYDIPEKWARFYTAEVVLAL 155
Query: 146 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGP 201
D HS G +HRDVKP N+++D L+L D+G VR V + + P
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTC--MKMDANGMVRCDTAVGTPDYISP 212
Query: 202 ELLVDLQ---DYDYSLDMWSLGCMFAGMIFRKEPFF 234
E+L Y D WS+G M+ PF+
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 32/216 (14%)
Query: 46 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---------EIKILQNLCGGPNVV 96
+G+G + +V T+E IK+LK K I + E +IL P +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLK---KDVILQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 97 KLLDIVRDQHS--KTPSLIF---EYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYC 148
L H +T +F EYVN D +D R+Y E+ AL +
Sbjct: 60 AL-------HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFL 112
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 207
H G+++RD+K N+++D E +L D+G+ E G + + PE+L +
Sbjct: 113 HRHGVIYRDLKLDNILLDAE-GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE- 170
Query: 208 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 243
+Y S+D W+LG + M+ + PF DN D L
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPPF--EADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 75/347 (21%), Positives = 126/347 (36%), Gaps = 100/347 (28%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNLCG 91
+ ++ +G G + EV V+TN +K L+ K + R E IL
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLR--KADVLMRNQAAHVKAERDILAE-AD 59
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYC 148
VVKL +D+ + + +Y+ D L L ++ R+YI EL A++
Sbjct: 60 NEWVVKLYYSFQDKDNLY--FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESV 117
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL---------AEFYHPG------------- 186
H G +HRD+KP N++ID + ++L D+GL +++Y G
Sbjct: 118 HKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176
Query: 187 ------------KEYNVR----------VASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 224
+ R V + + PE+L+ Y D WS+G +
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILY 235
Query: 225 GMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSK 284
M+ + PF + T + W
Sbjct: 236 EMLVGQPPF---LAD--------TPAET-----------------------QLKVINWET 261
Query: 285 FINADNQHLVSPEAIDFLDKLLRYDHQDRL---TAREAMAHPYFAQV 328
++ +Q +S EA D + +L +DRL A E AHP+F +
Sbjct: 262 TLHIPSQAKLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFFKGI 307
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 30/217 (13%)
Query: 44 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNLCGGPNV 95
+ +G+G + +V T+E +K+LK K ++ E ++L P +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLK--KDVILQDDDVECTMTEKRVLALAGKHPFL 58
Query: 96 VKLLDIVRDQHS--KTPSLIF---EYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDY 147
+L HS +T +F EYVN D +D R+Y E++ L +
Sbjct: 59 TQL-------HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQF 111
Query: 148 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVD 206
H +GI++RD+K NV++D E +++ D+G+ E G + + + PE+L
Sbjct: 112 LHERGIIYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY 170
Query: 207 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 243
Q Y ++D W+LG + M+ + PF D+ D+L
Sbjct: 171 -QPYGPAVDWWALGVLLYEMLAGQSPF--EGDDEDEL 204
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 63/241 (26%), Positives = 109/241 (45%), Gaps = 50/241 (20%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKK---IKREIKILQNLCG 91
DD+E ++ +GRG + EV +T +KIL+ ++K++ I+ E IL
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE-AD 59
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYC 148
G VVK+ +D+ + LI E++ D L TL++ ++YI E + A+D
Sbjct: 60 GAWVVKMFYSFQDK--RNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAI 117
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL---------AEFY-----HPGKEYNVR-- 192
H G +HRD+KP N+++D + ++L D+GL EFY +P +++ +
Sbjct: 118 HQLGFIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176
Query: 193 --------------------VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 232
V + + PE+ + Y+ D WSLG + M+ P
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 233 F 233
F
Sbjct: 236 F 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 4e-10
Identities = 64/261 (24%), Positives = 114/261 (43%), Gaps = 51/261 (19%)
Query: 40 YEVVRKVGRGKYSE-------------VFEGINVNTNERCIIKILKPVKKKKIKREIKIL 86
Y +R +G+G + E V++ +N + L +++ EI IL
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVN--------LTRLSEKERRDALNEIVIL 53
Query: 87 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDF--KVLYPTLTDYDIRY---YIYEL 141
L PN++ + D T + EY N K++ ++ Y++++
Sbjct: 54 SLL-QHPNIIAYYNHFMD--DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQI 110
Query: 142 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI---DWGLAEFYHPGKEYNVR---VAS 195
+ A+ Y H GI+HRD+K N+ L K LI D+G+++ G EY++ V +
Sbjct: 111 VSAVSYIHKAGILHRDIKTLNIF----LTKAGLIKLGDFGISKIL--GSEYSMAETVVGT 164
Query: 196 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKVLGTDE 254
Y+ PE L Y++ D+W+LGC+ ++ K F N LV KI + T
Sbjct: 165 PYYMSPE-LCQGVKYNFKSDIWALGCVLYELLTLKRTF--DATNPLNLVVKIVQGNYTPV 221
Query: 255 LNAYLNKYH------LELDPQ 269
++ Y ++ L+ DP+
Sbjct: 222 VSVYSSELISLVHSLLQQDPE 242
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 32/101 (31%), Positives = 56/101 (55%), Gaps = 3/101 (2%)
Query: 135 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 193
R+Y E+ A+ Y HS I++RD+KP N+++D + + L D+GL E P + +
Sbjct: 99 RFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGVEPEETTSTFC 157
Query: 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 234
+ + PE+L + YD ++D W LG + M++ PF+
Sbjct: 158 GTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-10
Identities = 57/227 (25%), Positives = 107/227 (47%), Gaps = 28/227 (12%)
Query: 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNLC 90
D+E++ K+G+G + VF+ + ++R + +K + K+ R E ++L L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVR-KADKR--VYAMKQIDLSKMNRREREEAIDEARVLAKL- 56
Query: 91 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKA 144
+++ + D+ +++ EY + D L P D R++I LL
Sbjct: 57 DSSYIIRYYESFLDK--GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL-G 113
Query: 145 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPEL 203
L + HS+ I+HRD+K N+ +D +++ D G+A+ + N V + Y+ PEL
Sbjct: 114 LAHLHSKKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPEL 172
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 250
D + Y+ D+W+LG + K PF D ++Q I K++
Sbjct: 173 CED-KPYNEKSDVWALGVVLYECCTGKHPF----DANNQGALILKII 214
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 5e-10
Identities = 50/206 (24%), Positives = 102/206 (49%), Gaps = 16/206 (7%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---PVKKKK---IKREIKILQNLCG 91
DD E ++ VG G + V + + +K++ ++ K+ + E ++L+ +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-S 59
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYC 148
P +++L DQ ++ EYV + F L ++ +Y E++ AL+Y
Sbjct: 60 HPFIIRLFWTEHDQRFLY--MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYL 117
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 208
HS+ I++RD+KP N+++D E ++L D+G A+ + + + Y PE++ +
Sbjct: 118 HSKEIVYRDLKPENILLDKE-GHIKLTDFGFAKKLR-DRTWTLCGTPEYL-APEVIQS-K 173
Query: 209 DYDYSLDMWSLGCMFAGMIFRKEPFF 234
++ ++D W+LG + M+ PFF
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFF 199
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 6e-10
Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 47/201 (23%)
Query: 135 RYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVR 192
R+Y E++ ALDY HS+ +++RD+K N+M+D + +++ D+GL E G
Sbjct: 98 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTF 156
Query: 193 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 252
+ + PE+L D DY ++D W LG + M+ + PF+ + +H++L ++
Sbjct: 157 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFEL------ 207
Query: 253 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD 312
++ R P + +SPEA L LL+ D +
Sbjct: 208 --------------------ILMEEIRFPRT----------LSPEAKSLLSGLLKKDPKQ 237
Query: 313 RL-----TAREAMAHPYFAQV 328
RL A+E M H +FA +
Sbjct: 238 RLGGGPDDAKEIMQHKFFAGI 258
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 6e-10
Identities = 74/337 (21%), Positives = 119/337 (35%), Gaps = 86/337 (25%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKR---EIKILQNLCG 91
++ ++ +G+G VF T + +K+L +K+ K+KR E +IL L
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-D 59
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALD 146
P + L Q L+ +Y + L L++ R+Y E+L AL+
Sbjct: 60 HPFLPTLY--ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALE 117
Query: 147 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL---------AEFYHPGKEYNVRVASRY 197
Y H GI++RD+KP N+++ HE + L D+ L K +
Sbjct: 118 YLHLLGIVYRDLKPENILL-HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 198 ---------------FKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 236
F G PE++ + ++D W+LG + M++ PF G
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFK-G 234
Query: 237 HDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSP 296
+ + I K K + VS
Sbjct: 235 SNRDETFSNILK-----------------------------------KEVTFPGSPPVSS 259
Query: 297 EAIDFLDKLLRYDHQDRL----TAREAMAHPYFAQVR 329
A D + KLL D RL A E HP+F V
Sbjct: 260 SARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 7e-10
Identities = 33/101 (32%), Positives = 54/101 (53%), Gaps = 3/101 (2%)
Query: 135 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 193
R+Y E+ AL Y HS I++RD+KP N+++D + + L D+GL E +
Sbjct: 99 RFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNGTTSTFC 157
Query: 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 234
+ + PE+L Q YD ++D W LG + M++ PF+
Sbjct: 158 GTPEYLAPEVL-HKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 2/98 (2%)
Query: 136 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS 195
+Y EL L+ + I++RD+KP N+++D + +R+ D GLA G+ RV +
Sbjct: 106 FYAAELCCGLEDLQRERIVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGT 164
Query: 196 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 233
+ PE++ + + Y +S D W LGC+ MI + PF
Sbjct: 165 VGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 49/191 (25%), Positives = 87/191 (45%), Gaps = 40/191 (20%)
Query: 141 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 199
++KAL+Y HS+ ++HRDVKP NV+I+ +++L D+G++ + + + +
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINRN-GQVKLCDFGISGYLVDSVAKTIDAGCKPYM 170
Query: 200 GPELL---VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 256
PE + ++ + YD D+WSLG + + P+ QL ++ +
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-------- 222
Query: 257 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 316
E PQL P KF SPE DF++K L+ ++++R
Sbjct: 223 --------EPSPQL----------PAEKF---------SPEFQDFVNKCLKKNYKERPNY 255
Query: 317 REAMAHPYFAQ 327
E + HP+F
Sbjct: 256 PELLQHPFFEL 266
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 44/143 (30%), Positives = 72/143 (50%), Gaps = 11/143 (7%)
Query: 108 KTPSLIF---EYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCHSQGIMHRDVKPH 161
+TP +F E+VN D +D R+Y E+ AL + H +GI++RD+K
Sbjct: 66 QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLD 125
Query: 162 NVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 220
NV++DHE +L D+G+ E GK + + + PE+L ++ Y S+D W++G
Sbjct: 126 NVLLDHE-GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML-YGPSVDWWAMG 183
Query: 221 CMFAGMIFRKEPFFYGHDNHDQL 243
+ M+ PF +N D L
Sbjct: 184 VLLYEMLCGHAPF--EAENEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 60/260 (23%), Positives = 108/260 (41%), Gaps = 39/260 (15%)
Query: 73 PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY 132
P +K+I RE++I ++ C P +VK D+ S + + EY +Y +
Sbjct: 40 PDLQKQILRELEINKS-CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKR 98
Query: 133 DIRYYIYEL-------LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYH 184
R L LK L Y HS+ I+HRD+KP N+++ + +++L D+G++ E +
Sbjct: 99 GGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRK-GQVKLCDFGVSGELVN 157
Query: 185 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 244
+ ++ PE + + Y + D+WSLG + + PF + L
Sbjct: 158 SLA--GTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPF--PPEGEPPLG 212
Query: 245 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 304
I + L+ +N + EL + + WS+ DF+ +
Sbjct: 213 PI------ELLSYIVNMPNPELKDEPGNGIK------WSEEFK------------DFIKQ 248
Query: 305 LLRYDHQDRLTAREAMAHPY 324
L D R T + + HP+
Sbjct: 249 CLEKDPTRRPTPWDMLEHPW 268
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 75/316 (23%), Positives = 127/316 (40%), Gaps = 53/316 (16%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLL 99
Y V++ + G VF + ++KI +K E +LQN+ P+V+++
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKI---GQKGTTLIEAMLLQNV-NHPSVIRMK 123
Query: 100 DIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIR---YYIYELLKALDYCHSQGIMHR 156
D + ++ + +S + L I ++L+ L Y H+Q I+HR
Sbjct: 124 DTL--VSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHR 181
Query: 157 DVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---------PELLVDL 207
DVK N+ I+ ++ + D G A+F V + F G PE+L
Sbjct: 182 DVKTENIFINDV-DQVCIGDLGAAQF---------PVVAPAFLGLAGTVETNAPEVLAR- 230
Query: 208 QDYDYSLDMWSLGCMFAGM------IFRKEPFF---YGHDNHDQLVKIAKVLGTDELNAY 258
Y+ D+WS G + M IF P Y H L+KI L
Sbjct: 231 DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLK------- 283
Query: 259 LNKYHLELDPQLDALVG-----RHSRKPWSKFINADNQHLVSPEAIDFL-DKLLRYDHQD 312
++ DP + G R+P++++ Q + P +FL K+L +D
Sbjct: 284 VHPEEFPRDPGSRLVRGFIEYASLERQPYTRY--PCFQRVNLPIDGEFLVHKMLTFDAAM 341
Query: 313 RLTAREAMAHPYFAQV 328
R +A E + +P FAQ+
Sbjct: 342 RPSAEEILNYPMFAQL 357
|
Length = 357 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 38/216 (17%)
Query: 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR------EIKILQNLCGG 92
D+E+ +G G + V + T E IK LK + K+K+ E IL L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH- 77
Query: 93 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL-----YPTLTDYDI-RYYIYELLKAL 145
P +V ++ +D+ + E+V + F L +P D+ ++Y EL+ A
Sbjct: 78 PFIVNMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPN----DVAKFYHAELVLAF 131
Query: 146 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK---GPE 202
+Y HS+ I++RD+KP N+++D++ +++ D+G A+ +V R F PE
Sbjct: 132 EYLHSKDIIYRDLKPENLLLDNK-GHVKVTDFGFAK----------KVPDRTFTLCGTPE 180
Query: 203 LL----VDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 234
L + + + ++D W++G + I PFF
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFF 216
|
Length = 329 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-PVKKKKIK--REIKILQNLCGGPNV 95
Y V+R VG G + +VN++++ +K ++ P ++ R+ +L PN+
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 96 VKLLDIVR-DQHSKTPSLIFEYVNSTDF--KV------LYPTLTDYDIRYYIYELLKALD 146
V + D H ++ EY + D K+ L+P T I + ++ +
Sbjct: 61 VAFKESFEADGHL---YIVMEYCDGGDLMQKIKLQRGKLFPEDT---ILQWFVQMCLGVQ 114
Query: 147 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLV 205
+ H + ++HRD+K N+ + K++L D+G A PG V + Y+ PE+
Sbjct: 115 HIHEKRVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWE 173
Query: 206 DLQDYDYSLDMWSLGCMFAGMIFRKEPF 233
++ Y+ D+WSLGC+ + K PF
Sbjct: 174 NMP-YNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 67/312 (21%), Positives = 135/312 (43%), Gaps = 60/312 (19%)
Query: 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI----------KREIKILQN 88
++E+++ +G G Y +VF V+ ++ + +K +KK I + E ++L++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 89 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKAL 145
+ P +V L Q LI +Y+N + + +++ Y E++ AL
Sbjct: 61 IRQSPFLVTLHYAF--QTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLAL 118
Query: 146 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPE 202
++ H GI++RD+K N+++D + L D+GL++ +H + Y+ Y P+
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM-APD 176
Query: 203 LLVDLQD-YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261
++ +D ++D WS+G + ++ PF V G A +++
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELLTGASPF--------------TVDGEKNSQAEISR 222
Query: 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TA 316
L+ +P P+ + + S A D + +LL D + RL A
Sbjct: 223 RILKSEP------------PYPQEM--------SALAKDIIQRLLMKDPKKRLGCGPSDA 262
Query: 317 REAMAHPYFAQV 328
E HP+F ++
Sbjct: 263 DEIKKHPFFQKI 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-09
Identities = 41/139 (29%), Positives = 73/139 (52%), Gaps = 8/139 (5%)
Query: 112 LIFEYVNSTD--FKVLYPTLTDYD-IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 168
+ EYVN + F + + D R+Y E++ ALDY HS I++RD+K N+M+D +
Sbjct: 72 FVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD 131
Query: 169 LRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 227
+++ D+GL E + + PE+L D DY ++D W LG + M+
Sbjct: 132 -GHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMM 189
Query: 228 FRKEPFFYGHDNHDQLVKI 246
+ PF+ + +H++L ++
Sbjct: 190 CGRLPFY--NQDHEKLFEL 206
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 6e-09
Identities = 43/151 (28%), Positives = 79/151 (52%), Gaps = 11/151 (7%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQN---LCGG 92
+++ +V+ + RG + +V+ G N ++ +K++K K + +++ ++ L
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 93 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCH 149
P +V L + Q + L+ EY+ D K L +D YI E+ ALDY H
Sbjct: 64 PFIVHLYYSL--QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121
Query: 150 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180
GI+HRD+KP N++I +E ++L D+GL+
Sbjct: 122 RHGIIHRDLKPDNMLISNE-GHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 6e-09
Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 26/205 (12%)
Query: 46 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPNVVKLLDI 101
+G+G Y V+ +++T R IK + P + + + EI + L N+V+ L
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEI-PERDSRYVQPLHEEIALHSYLKHR-NIVQYLG- 72
Query: 102 VRDQHSKTPSLIFEYVNSTDFKVLYPT----LTDYD--IRYYIYELLKALDYCHSQGIMH 155
D + + E V L + L D + I +Y ++L+ L Y H I+H
Sbjct: 73 -SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131
Query: 156 RDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELL-VDLQ 208
RD+K NV+++ +++ D+G ++ + + + F G PE++ +
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSK-----RLAGINPCTETFTGTLQYMAPEVIDKGPR 186
Query: 209 DYDYSLDMWSLGCMFAGMIFRKEPF 233
Y D+WSLGC M K PF
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 8e-09
Identities = 36/119 (30%), Positives = 66/119 (55%), Gaps = 5/119 (4%)
Query: 132 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYN 190
Y +Y E++ L + HS+GI++RD+K NVM+D + +++ D+G+ E +
Sbjct: 96 YRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRAS 154
Query: 191 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 249
+ + PE+L L+ Y +S+D WS G + M+ + P F+G D+ D+L + +V
Sbjct: 155 TFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSP-FHG-DDEDELFESIRV 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 53/222 (23%), Positives = 86/222 (38%), Gaps = 38/222 (17%)
Query: 134 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-------LRKLRLID----WGLAEF 182
I + + ++L ALDY HS+G +HR VK ++++ + LR +
Sbjct: 103 IAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162
Query: 183 YHP-GKEYNVRVASRYFKGPELL-VDLQDYDYSLDMWSLG---CMFAGMIFRKEPFFYGH 237
P N+ S PE+L +LQ Y+ D++S+G C A PF
Sbjct: 163 DFPKSSVKNLPWLS-----PEVLQQNLQGYNEKSDIYSVGITACELANGH---VPFK--- 211
Query: 238 DNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLV--- 294
D + + KV GT + Y L D SR N D+
Sbjct: 212 DMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQ------SRSSNEHPNNRDSVDHPYTR 265
Query: 295 --SPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS 334
S F++ L+ D + R +A + + H +F Q + +S
Sbjct: 266 TFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRNTS 307
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 85/361 (23%), Positives = 136/361 (37%), Gaps = 100/361 (27%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKKKK-----IKREIKILQNLCG 91
+D+ V+ +G+G + EV +T + +K +LK KK +K E +L
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE-SD 59
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYC 148
P VV L +D ++ LI E++ D + Y T ++ R+Y+ E + A++
Sbjct: 60 SPWVVSLYYSFQD--AQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAV 117
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP------------GKEYNVRVASR 196
H G +HRD+KP N++ID ++L D+GL+ +H GK R+ +R
Sbjct: 118 HKLGFIHRDIKPDNILIDRG-GHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176
Query: 197 Y------------------------------------FKGPELLVDLQDYDYSLDMWSLG 220
+ PE+ + Q Y D WSLG
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLG 235
Query: 221 C-MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSR 279
MF +I P F ++H+ KI +N P
Sbjct: 236 AIMFECLI--GWPPFCSENSHETYRKI------------INWRETLYFP----------- 270
Query: 280 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQ--DRLTAREAMAHPYFAQVRAAESSRTR 337
D+ HL S EA D + +L+ R A E +HP+F V + R
Sbjct: 271 ---------DDIHL-SVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWDTIRQIR 320
Query: 338 A 338
A
Sbjct: 321 A 321
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 48/203 (23%), Positives = 77/203 (37%), Gaps = 44/203 (21%)
Query: 139 YELLKALDYC-HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 197
++KAL Y G++HRDVKP N+++D ++L D+G++ K
Sbjct: 121 VAIVKALHYLKEKHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAA 179
Query: 198 FKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 253
+ PE + D D YD D+WSLG + + P+ + L KI
Sbjct: 180 YMAPERI-DPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI------- 231
Query: 254 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 313
L+ +P SP+ F+D L DH+ R
Sbjct: 232 ----------LQEEPPS-----------------LPPNEGFSPDFCSFVDLCLTKDHRKR 264
Query: 314 LTAREAMAHPYFAQVRAAESSRT 336
RE + HP+ +R E++
Sbjct: 265 PKYRELLQHPF---IRRYETAEV 284
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 48/197 (24%), Positives = 80/197 (40%), Gaps = 46/197 (23%)
Query: 135 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 193
+Y ++ L Y H I++RD+K N+++D E +++ D+GL E G +
Sbjct: 104 VFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGFGDRTSTFC 162
Query: 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 253
+ F PE+L + Y ++D W LG + M+ + PF G D
Sbjct: 163 GTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPF----------------PGDD 205
Query: 254 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 313
E + D++V R P + L S EAI + +LLR + + R
Sbjct: 206 E------------EEVFDSIVNDEVRYP---------RFL-SREAISIMRRLLRRNPERR 243
Query: 314 L-----TAREAMAHPYF 325
L A + P+F
Sbjct: 244 LGSGEKDAEDVKKQPFF 260
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 3/104 (2%)
Query: 132 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YN 190
R+Y ELL AL+ H +++RD+KP N+++D++ + L D+GL + + N
Sbjct: 93 SRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQ-GHIALCDFGLCKLNMKDDDKTN 151
Query: 191 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 234
+ + PELL+ Y ++D W+LG + M+ PF+
Sbjct: 152 TFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFY 194
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 39/136 (28%), Positives = 70/136 (51%), Gaps = 10/136 (7%)
Query: 113 IFEYVNSTDFKVLYPTLTDYDI---RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL 169
+ EY+N D + +D R+Y E++ L + H +GI++RD+K NV++D +
Sbjct: 74 VMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG 133
Query: 170 RKLRLIDWGLA--EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 227
+++ D+G+ GK + + + PE+L Q Y+ S+D WS G + M+
Sbjct: 134 H-IKIADFGMCKENMNGEGKA-STFCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEML 190
Query: 228 FRKEPFFYGHDNHDQL 243
+ P F+G D D+L
Sbjct: 191 IGQSP-FHGED-EDEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 70/327 (21%), Positives = 125/327 (38%), Gaps = 90/327 (27%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQN--------- 88
+D+E ++ + G Y V+ + T +R +K KI ++ IL+N
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMK--------KINKQNLILRNQIQQVFVER 52
Query: 89 ----LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI---RYYIYEL 141
P VV + + + ++ EYV D L + + R Y E
Sbjct: 53 DILTFAENPFVVSMF--CSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAET 110
Query: 142 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE---------FYHPGKEYNVR 192
+ AL+Y H+ GI+HRD+KP N++I + ++L D+GL++ Y E ++
Sbjct: 111 VLALEYLHNYGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLY----EGHIE 165
Query: 193 VASRYFK-----------GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 241
+R F PE+++ Q Y +D W++G + + PFF D +
Sbjct: 166 KDTREFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFF--GDTPE 222
Query: 242 QLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDF 301
+L +V+ D + + +A D
Sbjct: 223 EL--FGQVISDD-------------------------------IEWPEGDEALPADAQDL 249
Query: 302 LDKLLRYDHQDRL---TAREAMAHPYF 325
+ +LLR + +RL A E H +F
Sbjct: 250 ISRLLRQNPLERLGTGGAFEVKQHRFF 276
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 71/331 (21%), Positives = 123/331 (37%), Gaps = 70/331 (21%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKI-LKPVKKKKIKREIKILQNLCGGP 93
DD+E + ++G G V + ++ + R +I + +KP + +I RE+K+L C P
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHE-CNSP 59
Query: 94 NVVKL---------------------LDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY 132
+V LD V + + P I ++
Sbjct: 60 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKIS-------------- 105
Query: 133 DIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 191
+L+ L Y + IMHRDVKP N++++ +++L D+G++ N
Sbjct: 106 ------IAVLRGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA-NS 157
Query: 192 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 251
V +R + PE L Y D+WSLG M + P D ++ + G
Sbjct: 158 FVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPI----PPPDAK-ELEAMFG 211
Query: 252 TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADN----------QHLVSPEAIDF 301
+ H + S +P + F D S E DF
Sbjct: 212 RPVSEGEAKESHRPVSGH-----PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDF 266
Query: 302 LDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332
+DK L+ + ++R +E HP+ + E
Sbjct: 267 VDKCLKKNPKERADLKELTKHPFIKRAELEE 297
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 4e-08
Identities = 72/309 (23%), Positives = 117/309 (37%), Gaps = 47/309 (15%)
Query: 40 YEVVRKVGRGKYSEVFEGINV--NTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVK 97
Y ++ + G EVF ++ I+K + K REI IL+ + ++
Sbjct: 94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAV--TGGKTPGREIDILKTI-SHRAIIN 150
Query: 98 LLDIVRDQHSKTPSL------IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 151
L+ R + + + +F YV+ + L LL+AL Y H +
Sbjct: 151 LIHAYRWKSTVCMVMPKYKCDLFTYVDRSG------PLPLEQAITIQRRLLEALAYLHGR 204
Query: 152 GIMHRDVKPHNVMIDHELRKLRLIDWGLA-----EFYHPGKEYNVRVASRYFKGPELLVD 206
GI+HRDVK N+ +D E L D+G A P + Y + PELL
Sbjct: 205 GIIHRDVKTENIFLD-EPENAVLGDFGAACKLDAHPDTP-QCYG-WSGTLETNSPELLA- 260
Query: 207 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD--QLVKIAKVLGTDEL------NAY 258
L Y D+WS G + M + F QL I + + L +
Sbjct: 261 LDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320
Query: 259 LNKYHLELDPQLDALVGRHSRKPWS--KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 316
L K+ + L R P++ I H+ I K+L +D + R +A
Sbjct: 321 LCKHFKQYAIVL--------RPPYTIPPVIRKYGMHMDVEYLIA---KMLTFDQEFRPSA 369
Query: 317 REAMAHPYF 325
++ ++ P F
Sbjct: 370 QDILSLPLF 378
|
Length = 392 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-08
Identities = 48/212 (22%), Positives = 103/212 (48%), Gaps = 22/212 (10%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIK-----ILKPVKKKKIKREIKILQNLCGGPN 94
Y V+K+G G + + + ++ +IK + P ++++ ++E+ +L N+ PN
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPN 60
Query: 95 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FK-------VLYPTLTDYDIRYYIYELLKALD 146
+V+ + + + ++ +Y D +K VL+P + I + ++ AL
Sbjct: 61 IVQYQESF--EENGNLYIVMDYCEGGDLYKKINAQRGVLFP---EDQILDWFVQICLALK 115
Query: 147 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLV 205
+ H + I+HRD+K N+ + + ++L D+G+A + E + + Y+ PE +
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVELARTCIGTPYYLSPE-IC 173
Query: 206 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 237
+ + Y+ D+W+LGC+ M K F G+
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 46/151 (30%), Positives = 81/151 (53%), Gaps = 13/151 (8%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKK---IKREIKILQNLCG 91
+D+E ++ +GRG + EV +T +KIL+ ++K++ I+ E IL
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE-AD 59
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYC 148
VVK+ +D+ + LI E++ D L TLT+ + ++YI E + A+D
Sbjct: 60 SLWVVKMFYSFQDKLNLY--LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSI 117
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 179
H G +HRD+KP N+++D + ++L D+GL
Sbjct: 118 HQLGFIHRDIKPDNLLLDSK-GHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 7e-08
Identities = 48/203 (23%), Positives = 91/203 (44%), Gaps = 22/203 (10%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNLCG 91
Y + +++G+G + V+ + +K+LK + ++ +E ++L L
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-D 60
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKA 144
P +VK ++ + +I EY D K TL++ + + +LL
Sbjct: 61 HPAIVKFHASFLERDAFC--IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 145 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPEL 203
+ Y H + I+HRD+K N+ + + L L++ D+G++ + + Y+ PE
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLKNNL--LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEA 176
Query: 204 LVDLQDYDYSLDMWSLGCMFAGM 226
L Q YD D+WSLGC+ M
Sbjct: 177 LKH-QGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 8e-08
Identities = 71/309 (22%), Positives = 128/309 (41%), Gaps = 49/309 (15%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCG 91
+D E + +G G V + ++ T K++ K +K+I RE++I+ C
Sbjct: 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHE-CR 61
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD--FKVLYPTLTDYDIRYYIYELLKALDYCH 149
P +V ++++ + F S D +K P + + +++ L Y +
Sbjct: 62 SPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEI-LGKIAVAVVEGLTYLY 120
Query: 150 S-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN----VRVASRYFKGPELL 204
+ IMHRD+KP N++++ +++L D+G++ G+ N V + + PE
Sbjct: 121 NVHRIMHRDIKPSNILVNSR-GQIKLCDFGVS-----GELINSIADTFVGTSTYMSPE-- 172
Query: 205 VDLQDYDYSL--DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262
+Q Y++ D+WSLG + K PF + + + D +L D L +
Sbjct: 173 -RIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL--DLLQQIVQ-- 227
Query: 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322
E P+L P S F + DF+D L D +R T ++ A
Sbjct: 228 --EPPPRL----------PSSDF---------PEDLRDFVDACLLKDPTERPTPQQLCAM 266
Query: 323 PYFAQVRAA 331
P F Q A
Sbjct: 267 PPFIQALRA 275
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 67/295 (22%), Positives = 116/295 (39%), Gaps = 54/295 (18%)
Query: 46 VGRGKYSEVFEGINVNTNERCIIK--ILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVR 103
+G+G Y V+ G+ N + +K L ++E + LQ +K ++IV+
Sbjct: 8 LGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 104 D----QHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGIMHR 156
T S+ E+V + + L + Y ++L + Y H+ ++HR
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126
Query: 157 DVKPHNVMIDHELRKLRLIDWG----LAEFYHPGKEYNVRVASR---YFKGPELLVDLQD 209
D+K +NVM+ ++LID+G LA G N+ + Y+ PE++ +
Sbjct: 127 DIKGNNVML-MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE-SG 184
Query: 210 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 269
Y D+WS+GC M K P + D+L + + H L P+
Sbjct: 185 YGRKSDIWSIGCTVFEMATGKPPL----ASMDRLAAMFYI-----------GAHRGLMPR 229
Query: 270 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 324
L F S AIDF+ L D +R +A + + H +
Sbjct: 230 LP-----------DSF---------SAAAIDFVTSCLTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 79/356 (22%), Positives = 136/356 (38%), Gaps = 102/356 (28%)
Query: 43 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR----EIKILQNLCGGPN---V 95
++ +G G + EV V+T+ +K L+ KK + R +K +++ + V
Sbjct: 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLR--KKDVLNRNQVAHVKAERDILAEADNEWV 63
Query: 96 VKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQG 152
VKL +D+ + + +Y+ D L + R+YI EL A++ H G
Sbjct: 64 VKLYYSFQDKDNLY--FVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG 121
Query: 153 IMHRDVKPHNVMIDHELRKLRLIDWGL---------AEFYHPGKEY-------------- 189
+HRD+KP N++ID + ++L D+GL +++Y G
Sbjct: 122 FIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 190 -NVRVASRY------------------------FKGPELLVDLQDYDYSLDMWSLGCMFA 224
N R R + PE+L+ + Y D WS+G +
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVILF 239
Query: 225 GMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSK 284
M+ + PF QL KV+ W
Sbjct: 240 EMLVGQPPFLAPTPTETQL----KVIN------------------------------WEN 265
Query: 285 FINADNQHLVSPEAIDFLDKLLRYDHQDRL---TAREAMAHPYFAQVRAAESSRTR 337
++ Q +SPEA+D + KL ++RL A + AHP+F++V + RT+
Sbjct: 266 TLHIPPQVKLSPEAVDLITKLC-CSAEERLGRNGADDIKAHPFFSEVDFSSDIRTQ 320
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 46/167 (27%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 78 KIKREIKILQNLCGGPNVVKL---------LDIVRDQHSKTPSLIFEYVNSTDFKVLYPT 128
I E+ I++ PN+V+ L IV D P + E+ NS K
Sbjct: 54 DIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAP--LGEHFNS--LKEKKQR 109
Query: 129 LTDYDIRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187
T+ I +++ AL Y H + I+HRD+ P+N+M+ E K+ + D+GLA+ P
Sbjct: 110 FTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPES 168
Query: 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 234
+ V + + PE++ + Y D+W+ GC+ M + PF+
Sbjct: 169 KLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFY 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 2e-07
Identities = 52/189 (27%), Positives = 82/189 (43%), Gaps = 39/189 (20%)
Query: 138 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 197
I +L++AL+ H I+H D+K NV+ D ++ L D+GL + Y+ + Y
Sbjct: 115 IRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLD--Y 172
Query: 198 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 257
F PE + +YD S D W++G + ++ K PF D
Sbjct: 173 FS-PEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE------------------ 212
Query: 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA- 316
ELD ++L+ R +K FI VS A DF+ +L+Y+ RLT
Sbjct: 213 -------ELDL--ESLLKRQQKKL--PFIKN-----VSKNANDFVQSMLKYNINYRLTNY 256
Query: 317 REAMAHPYF 325
E + HP+
Sbjct: 257 NEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 136 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVA 194
+Y E+ L + HS+GI++RD+K NVM+D E +++ D+G+ E GK
Sbjct: 105 FYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGGKTTRTFCG 163
Query: 195 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 233
+ + PE ++ Q Y S+D W+ G + M+ + PF
Sbjct: 164 TPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 28/201 (13%)
Query: 141 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV-ASRYF- 198
+L+A+ Y H I+HRD+K N+ I+H + L D+G A + V + A++Y+
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHP-GDVCLGDFGAA-------CFPVDINANKYYG 242
Query: 199 -------KGPELLVDLQDYDYSLDMWSLGCMFAGM------IFRKEPFFYGHDNHDQLVK 245
PELL Y ++D+WS G + M +F K+ D+ Q+
Sbjct: 243 WAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKL 301
Query: 246 IAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLD-K 304
I + GT N + LD L + SRKP S+ + + L P +++L K
Sbjct: 302 IIRRSGTHP-NEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYEL--PIDLEYLICK 358
Query: 305 LLRYDHQDRLTAREAMAHPYF 325
+L +D R +A + F
Sbjct: 359 MLAFDAHHRPSAEALLDFAAF 379
|
Length = 391 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 7e-07
Identities = 33/117 (28%), Positives = 54/117 (46%), Gaps = 19/117 (16%)
Query: 62 TNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS---- 111
T IK+L+ ++ + +RE + L PN+V LLD + P
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARL-YHPNIVALLD-----SGEAPPGLLF 55
Query: 112 LIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 165
+FEYV + + L + + ++L AL H+QGI+HRD+KP N+M+
Sbjct: 56 AVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMV 112
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 8e-07
Identities = 53/228 (23%), Positives = 107/228 (46%), Gaps = 29/228 (12%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPN 94
++ ++V+K+G G++ EV+ G N + + +K LKP + + E +++ L
Sbjct: 5 RESIKLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQAFLEEANLMKTL-QHDK 62
Query: 95 VVKLLDIVRDQHSKTPSLIFEYVNS---TDF-------KVLYPTLTDYDIRYYIYELLKA 144
+V+L +V + + +I EY+ DF KVL P L D+ ++ +
Sbjct: 63 LVRLYAVVTKE--EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA-----QIAEG 115
Query: 145 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGP 201
+ Y + +HRD++ NV++ E ++ D+GLA EY R +++ + P
Sbjct: 116 MAYIERKNYIHRDLRAANVLVS-ESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAP 173
Query: 202 ELLVDLQDYDYSLDMWSLGCMFAGMI-FRKEPFFYGHDNHDQLVKIAK 248
E ++ + D+WS G + ++ + K P + G N D + + +
Sbjct: 174 E-AINFGSFTIKSDVWSFGILLYEIVTYGKIP-YPGMSNSDVMSALQR 219
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 44/214 (20%), Positives = 88/214 (41%), Gaps = 38/214 (17%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGI--NVNTNE---RCIIKILKPV----KKKKIKREIKIL 86
++ ++R++G+G + V+EG+ V E R IK + ++ + E ++
Sbjct: 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVM 63
Query: 87 QNL-CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV-------------LYPTLTDY 132
+ C +VV+LL +V + ++ E + D K T
Sbjct: 64 KEFNC--HHVVRLLGVVSTG--QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 133 DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPG 186
E+ + Y ++ +HRD+ N M+ +L +++ D+G+ ++Y G
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL-TVKIGDFGMTRDIYETDYYRKG 178
Query: 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 220
+ + V R+ PE L D + D+WS G
Sbjct: 179 GKGLLPV--RWM-APESLKD-GVFTTKSDVWSFG 208
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 47/193 (24%), Positives = 82/193 (42%), Gaps = 22/193 (11%)
Query: 45 KVGRGKYSEVFEGINVNTNERCIIK----ILKPVKKKKIKREIKILQNLCGGPNVVKLLD 100
++GRG + EVF G N +K L P K K +E +IL+ PN+V+L+
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIG 60
Query: 101 IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK-------ALDYCHSQGI 153
+ + ++ E V DF L R + EL++ ++Y S+
Sbjct: 61 VCTQKQPIY--IVMELVQGGDFLTF---LRTEGPRLKVKELIQMVENAAAGMEYLESKHC 115
Query: 154 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPELLVDLQDY 210
+HRD+ N ++ E L++ D+G++ G ++ + PE L + Y
Sbjct: 116 IHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEAL-NYGRY 173
Query: 211 DYSLDMWSLGCMF 223
D+WS G +
Sbjct: 174 SSESDVWSFGILL 186
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 54/223 (24%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKI-LKPVKKKKIKREIKILQNLCGGP 93
DD+E + ++G G VF+ + + R +I + +KP + +I RE+++L C P
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE-CNSP 63
Query: 94 NVVKL---------------------LDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY 132
+V LD V + + P I V+
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS-------------- 109
Query: 133 DIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 191
++K L Y + IMHRDVKP N++++ +++L D+G++ N
Sbjct: 110 ------IAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA-NS 161
Query: 192 RVASRYFKGPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEP 232
V +R + PE LQ YS+ D+WS+G M + P
Sbjct: 162 FVGTRSYMSPE---RLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPN 94
Y VR VG+G Y EV + ++ +IK L ++K ++E ++L L PN
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPN 60
Query: 95 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--------PTLTDYDIRYYIYELLKALD 146
+V R+ L++ + + LY L + + + ++ AL
Sbjct: 61 IV----AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ 116
Query: 147 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLV 205
Y H + I+HRD+K NV + +++ D G+A + + + + Y+ PEL
Sbjct: 117 YLHEKHILHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFS 175
Query: 206 DLQDYDYSLDMWSLGCMFAGMIFRKEPF 233
+ + Y+Y D+W+LGC M K F
Sbjct: 176 N-KPYNYKSDVWALGCCVYEMATLKHAF 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 56/229 (24%), Positives = 97/229 (42%), Gaps = 30/229 (13%)
Query: 129 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-------LRK-LRLIDWGL- 179
+++ I Y + +LKALDY H G +HR VK +++I + LR L +I+ G
Sbjct: 98 MSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157
Query: 180 AEFYHPGKEYNVRVASRYFKGPELL-VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 238
H +Y+V+V + PE+L +LQ YD D++S+G + PF D
Sbjct: 158 LRVVHDFPKYSVKVLP--WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF---KD 212
Query: 239 NHDQLVKIAKVLGT------------DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFI 286
+ + K+ GT +EL ++ V
Sbjct: 213 MPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSS 272
Query: 287 NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV--RAAES 333
+ N+ SP F+++ L+ + R +A + H +F Q+ RA+E+
Sbjct: 273 HPYNRTF-SPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEA 320
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 31/106 (29%), Positives = 56/106 (52%), Gaps = 5/106 (4%)
Query: 131 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 190
+Y++ Y+++ ALD HS+ +MHRD+K N+ + ++L D+G ++ Y +
Sbjct: 168 EYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL-MPTGIIKLGDFGFSKQYSDSVSLD 226
Query: 191 VRVA---SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 233
V + + Y+ PEL + + Y DMWSLG + ++ PF
Sbjct: 227 VASSFCGTPYYLAPELW-ERKRYSKKADMWSLGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 39/132 (29%), Positives = 64/132 (48%), Gaps = 18/132 (13%)
Query: 112 LIFEYVNSTDFKVLYPTLTDY---DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 168
+ EYVN D + + +Y E+ L + H +GI++RD+K NVM+D E
Sbjct: 78 FVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSE 137
Query: 169 LRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKG------PELLVDLQDYDYSLDMWSLGC 221
+++ D+G+ KE+ V V +R F G PE++ Q Y S+D W+ G
Sbjct: 138 -GHIKIADFGMC------KEHMVDGVTTRTFCGTPDYIAPEIIA-YQPYGKSVDWWAYGV 189
Query: 222 MFAGMIFRKEPF 233
+ M+ + PF
Sbjct: 190 LLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 59/288 (20%), Positives = 115/288 (39%), Gaps = 44/288 (15%)
Query: 46 VGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCGGPNVVKLLDI 101
+G G V++ ++ T +K++ +K+I E++IL C P ++
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYK-CDSPYIIGFYGA 67
Query: 102 VRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPH 161
++ S+ E+++ V Y + ++ + ++K L Y S I+HRDVKP
Sbjct: 68 FFVENRI--SICTEFMDGGSLDV-YRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPS 124
Query: 162 NVMIDHELRKLRLIDWGLAE--FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 219
N++++ +++L D+G++ K Y V + + PE + Q Y D+WSL
Sbjct: 125 NMLVNTR-GQVKLCDFGVSTQLVNSIAKTY---VGTNAYMAPERISGEQ-YGIHSDVWSL 179
Query: 220 GCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSR 279
G F + + P+ N L+ + L ++ E P L
Sbjct: 180 GISFMELALGRFPYPQIQKNQGSLMPL------QLLQCIVD----EDPPVLPV------- 222
Query: 280 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 327
S + + F+ + +R ++R M HP+ Q
Sbjct: 223 ------------GQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQ 258
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 24/163 (14%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCGGP 93
Y+++R +G+G EV+ + + R +K ++ P+ KK+ RE KI +L P
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH-P 62
Query: 94 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTL-------TDYDIRYYIYELLKALD 146
+V + I D Y+ K L ++ + + + L
Sbjct: 63 GIVPVYSICSD--GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 147 -------YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182
Y HS+G++HRD+KP N+++ ++ ++DWG A F
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLG-LFGEVVILDWGAAIF 162
|
Length = 932 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIK---REIKILQNLCGG 92
D+ + +G+G + +V T+E IKILK ++ ++ E ++L L G
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLA-LSGK 59
Query: 93 PNVVKLLDIVRDQHSKTPSL-----IFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 144
P + L HS ++ + EYVN D + + +Y E+
Sbjct: 60 PPFLTQL------HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG 113
Query: 145 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPEL 203
L + HS+GI++RD+K NVM+D E +++ D+G+ E G + + PE+
Sbjct: 114 LFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEI 172
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 233
+ Q Y S+D W+ G + M+ + PF
Sbjct: 173 IA-YQPYGKSVDWWAFGVLLYEMLAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 7e-06
Identities = 59/245 (24%), Positives = 89/245 (36%), Gaps = 88/245 (35%)
Query: 135 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL---------AEFY-- 183
R+YI EL A++ H G +HRD+KP N++ID + ++L D+GL +++Y
Sbjct: 104 RFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYYQS 162
Query: 184 --HP-----------GKEYNVRVASRY------------------------FKGPELLVD 206
H G N R R + PE+L+
Sbjct: 163 GDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR 222
Query: 207 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266
Y D WS+G + M+ + PF Q+ KV+
Sbjct: 223 -TGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQM----KVIN--------------- 262
Query: 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL---TAREAMAHP 323
W ++ Q +SPEA D + KL R +DRL A E AHP
Sbjct: 263 ---------------WQTSLHIPPQAKLSPEASDLIIKLCR-GPEDRLGKNGADEIKAHP 306
Query: 324 YFAQV 328
+F +
Sbjct: 307 FFKTI 311
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 7e-06
Identities = 49/200 (24%), Positives = 96/200 (48%), Gaps = 32/200 (16%)
Query: 43 VRKVGRGKYSEV----FEGINVNTNERCIIKILKPVKKKKI---KREIKILQNLCGGPNV 95
++++G+G + V ++ + NT E +K L+ + + +REI+IL++L N+
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDNI 67
Query: 96 VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRY-----------YIYELLKA 144
VK + + L+ EY+ Y +L DY ++ Y ++ K
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLP-------YGSLRDYLQKHRERLDHRKLLLYASQICKG 120
Query: 145 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASR---YFKG 200
++Y S+ +HRD+ N++++ E R +++ D+GL + KE Y VR ++
Sbjct: 121 MEYLGSKRYVHRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA 179
Query: 201 PELLVDLQDYDYSLDMWSLG 220
PE L + + + D+WS G
Sbjct: 180 PESLTE-SKFSVASDVWSFG 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 8e-06
Identities = 76/310 (24%), Positives = 119/310 (38%), Gaps = 65/310 (20%)
Query: 60 VNTNERCIIKILKPVKKKKI--KREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 117
ER I K +K + I + EI L L N++K+ +I+R + + +
Sbjct: 189 KPKCERLIAKRVKAGSRAAIQLENEILALGRL-NHENILKIEEILR-----SEANTYMIT 242
Query: 118 NSTDFKVLYPTLTDYDI-----------RYYIYELLKALDYCHSQGIMHRDVKPHNVMID 166
DF LY + D R + +LL A++Y H + ++HRD+K N+ ++
Sbjct: 243 QKYDFD-LYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301
Query: 167 HELRKLRLIDWGLAEFYHPGKEYNVRVASRY-------FKGPELLVDLQDYDYSLDMWSL 219
+ K+ L D+G A + R A Y PE+L Y D+WS
Sbjct: 302 CD-GKIVLGDFGTAMPFE-----KEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSC 354
Query: 220 GCMFAGMIFRKE-PFFYGHDN-HDQLVKIAKVLGT-DE--------LNAYLNKYHLELDP 268
G + M+ P G QL+KI L DE L Y++ ++
Sbjct: 355 GLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAG 414
Query: 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDF-LDKLLRYDHQDRLTAREAMAHPYFAQ 327
HS P + N L P ++ L K+L +D R A E +A P F
Sbjct: 415 --------HSVPPLIR-----NLGL--PADFEYPLVKMLTFDWHLRPGAAELLALPLF-- 457
Query: 328 VRAAESSRTR 337
+AE
Sbjct: 458 --SAEEEEEI 465
|
Length = 501 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 48/226 (21%), Positives = 103/226 (45%), Gaps = 26/226 (11%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPN 94
++ ++++K+G G++ EV+ G N N + +K LKP + + E +I++ L
Sbjct: 5 RESLQLIKKLGNGQFGEVWMGT-WNGNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDK 62
Query: 95 VVKLLDIVRDQHSKTP-SLIFEYVNSTDFKVLYPTLTDYDIRY--------YIYELLKAL 145
+V+L +V S+ P ++ EY++ L L D + R ++ +
Sbjct: 63 LVQLYAVV----SEEPIYIVTEYMSKGS---LLDFLKDGEGRALKLPNLVDMAAQVAAGM 115
Query: 146 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPE 202
Y +HRD++ N+++ L ++ D+GLA EY R +++ + PE
Sbjct: 116 AYIERMNYIHRDLRSANILVGDGL-VCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPE 173
Query: 203 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 248
+ + D+WS G + ++ + + G +N + L ++ +
Sbjct: 174 AAL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER 218
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 47/210 (22%), Positives = 96/210 (45%), Gaps = 30/210 (14%)
Query: 44 RKVGRGKYSEVFEGINVNTNER---CIIKILKPVKK----KKIKREIKILQNLCGGPNVV 96
R +G+G + V+ G ++++ + C +K L + ++ +E I+++ PNV+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVL 59
Query: 97 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHS 150
LL I +P ++ Y+ D + PT+ D + + ++ K ++Y S
Sbjct: 60 SLLGICLPSEG-SPLVVLPYMKHGDLRNFIRSETHNPTVKD--LIGFGLQVAKGMEYLAS 116
Query: 151 QGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKGPELL 204
+ +HRD+ N M+D E +++ D+GLA E+Y ++ ++ L
Sbjct: 117 KKFVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA----L 171
Query: 205 VDLQDYDYSL--DMWSLGCMFAGMIFRKEP 232
LQ ++ D+WS G + ++ R P
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 19/50 (38%), Positives = 31/50 (62%), Gaps = 1/50 (2%)
Query: 134 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183
I+ + ++L L+Y H GI H D+KP N+M+D R +ID+G+A +
Sbjct: 128 IKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY-IIDYGIASHF 176
|
Length = 294 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 48/209 (22%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 38 DDYEVVRKVGRGKYSEV---------FEGINVNTNERCIIKILKPVKKKKIKREIKILQN 88
+D+ +R +G G + V F + + E+ KI+K + + E KIL N
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKS--KIIKQKQVDHVFSERKIL-N 86
Query: 89 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY--DIR-YYIYELLKAL 145
P V L +D+ L+ E+V +F + D+ +Y +++
Sbjct: 87 YINHPFCVNLYGSFKDE--SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIF 144
Query: 146 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 205
+Y S I++RD+KP N+++D + +++ D+G A+ + Y + Y PE+L+
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKD-GFIKMTDFGFAKVVDT-RTYTLCGTPEYI-APEILL 201
Query: 206 DLQDYDYSLDMWSLGCMFAGMIFRKEPFF 234
++ + + D W+LG ++ PF+
Sbjct: 202 NV-GHGKAADWWTLGIFIYEILVGCPPFY 229
|
Length = 340 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 5e-05
Identities = 31/89 (34%), Positives = 45/89 (50%), Gaps = 15/89 (16%)
Query: 140 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF--------YHPGKEYNV 191
+LL A+DY H +GI+HRD+K NV+++ + L D+G A F +H G V
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGP-EDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 192 RVASRYFKGPELLVDLQDYDYSLDMWSLG 220
PE+L Y S+D+WS G
Sbjct: 327 DT-----NAPEVLAG-DPYTPSVDIWSAG 349
|
Length = 461 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 30/109 (27%), Positives = 54/109 (49%), Gaps = 5/109 (4%)
Query: 115 EYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRL 174
EY + D + TLT D+ + Y++ + +++ S+ +HRD+ NV++ + +++
Sbjct: 115 EYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH-VMKI 173
Query: 175 IDWGLAEFYHPGKEYNVRVASRY---FKGPELLVDLQDYDYSLDMWSLG 220
D+GLA H Y R + PE L D + Y + D+WS G
Sbjct: 174 ADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFG 221
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 6e-05
Identities = 46/201 (22%), Positives = 90/201 (44%), Gaps = 21/201 (10%)
Query: 37 QDDYEVVRKVGRGKYSEVFEG-----INVNTNERCIIKILKPV----KKKKIKREIKILQ 87
+++ + +G G + +V E + + +K+LKP +++ + E+KI+
Sbjct: 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMS 93
Query: 88 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDF-----KVLYPTLTDYDIRYYIYELL 142
+L N+V LL +I EY D + LT D+ + Y++
Sbjct: 94 HLGNHENIVNLLGAC--TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151
Query: 143 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FK 199
K + + S+ +HRD+ NV++ H + +++ D+GLA Y V+ +R +
Sbjct: 152 KGMAFLASKNCIHRDLAARNVLLTHG-KIVKICDFGLARDIMNDSNYVVKGNARLPVKWM 210
Query: 200 GPELLVDLQDYDYSLDMWSLG 220
PE + + Y + D+WS G
Sbjct: 211 APESIFNCV-YTFESDVWSYG 230
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 7e-05
Identities = 29/100 (29%), Positives = 51/100 (51%), Gaps = 7/100 (7%)
Query: 128 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-- 185
LT D+ Y++ + ++Y SQ +HRD+ NV++ + +++ D+GLA H
Sbjct: 130 QLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED-NVMKIADFGLARDVHNID 188
Query: 186 --GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 223
K N R+ ++ PE L D + Y + D+WS G +
Sbjct: 189 YYKKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLL 226
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 9e-05
Identities = 30/126 (23%), Positives = 52/126 (41%), Gaps = 4/126 (3%)
Query: 61 NTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS 119
+E ++KI K +RE+ ILQ L V + + + L+ E++
Sbjct: 19 TKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKV-LASGESDGWSYLLMEWIEG 77
Query: 120 TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 179
+ DI + ELL L + H D+ P N+++D + + L +IDW
Sbjct: 78 ETLDEV-SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD-DGKILGIIDWEY 135
Query: 180 AEFYHP 185
A + P
Sbjct: 136 AGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 9e-05
Identities = 51/227 (22%), Positives = 101/227 (44%), Gaps = 33/227 (14%)
Query: 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNV 95
++ + RK+G G + EV+EG+ N R IKILK +K++ ++E++ L+ L ++
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHL 64
Query: 96 VKLLDIVRDQHSKTPSLIF----------EYVNSTDFKVLYPTLTDYDIRYYIYELLKAL 145
+ L + P I ++ S + +VL P + D+ + E +
Sbjct: 65 ISLFAVCS---VGEPVYIITELMEKGSLLAFLRSPEGQVL-PVASLIDMACQVAE---GM 117
Query: 146 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-----EFYHPGKEYNVRVASRYFKG 200
Y Q +HRD+ N+++ +L ++ D+GLA + Y + ++ ++
Sbjct: 118 AYLEEQNSIHRDLAARNILVGEDL-VCKVADFGLARLIKEDVYLS---SDKKIPYKW-TA 172
Query: 201 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 247
PE + D+WS G + M + + G +NH+ +I
Sbjct: 173 PEAA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT 218
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 1e-04
Identities = 46/207 (22%), Positives = 96/207 (46%), Gaps = 30/207 (14%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPN 94
++ ++V+K+G G++ EV+ G N + + IK LK + + E +++ L P
Sbjct: 5 RETLKLVKKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPR 62
Query: 95 VVKLLDIVRDQHSKTPSLIF-EYVNS---TDFKVLYPTLTDYDIRYYIYELL-------K 143
+V+L +V ++ P I EY+ + DF T I+ I +L+ +
Sbjct: 63 LVRLYAVV----TQEPIYIITEYMENGSLVDF-----LKTPEGIKLTINKLIDMAAQIAE 113
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKG 200
+ + + +HRD++ N+++ L ++ D+GLA EY R +++ +
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSETL-CCKIADFGLARLIED-NEYTAREGAKFPIKWTA 171
Query: 201 PELLVDLQDYDYSLDMWSLGCMFAGMI 227
PE ++ + D+WS G + ++
Sbjct: 172 PE-AINYGTFTIKSDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 28/98 (28%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 129 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--- 185
+T D+ Y++ + ++Y SQ +HRD+ NV++ E +++ D+GLA +
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDVNNIDY 192
Query: 186 -GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCM 222
K N R+ ++ PE L D + Y + D+WS G +
Sbjct: 193 YKKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVL 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 48/233 (20%), Positives = 94/233 (40%), Gaps = 32/233 (13%)
Query: 122 FKVLYPT-LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGL 179
K +P +++ I ++ L+ L+Y H G +HR++K +++I + L L GL
Sbjct: 90 LKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLS----GL 145
Query: 180 AEFY---HPGKEYNVRVASRYFK-------GPELL-VDLQDYDYSLDMWSLGCMFAGMIF 228
+ Y G++ V F PELL DL Y+ D++S+G +
Sbjct: 146 SHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELAT 205
Query: 229 RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHS-------RKP 281
+ PF D + + K+ G + + E ++ G S
Sbjct: 206 GRVPF---QDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAG 262
Query: 282 WSKFINADNQH-----LVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329
++ + ++ SP + ++ L+ D + R +A ++H +F QV+
Sbjct: 263 MTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 19/83 (22%), Positives = 40/83 (48%), Gaps = 9/83 (10%)
Query: 101 IVRDQHSKTPSLIFEYVNSTDFK-VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVK 159
++ D + +++ EY+ D K VL + ++ + + H GI+H D+
Sbjct: 402 VIYDVDPEEKTIVMEYIGGKDLKDVLEGNPE------LVRKVGEIVAKLHKAGIVHGDLT 455
Query: 160 PHNVMIDHELRKLRLIDWGLAEF 182
N ++ + +L LID+GL ++
Sbjct: 456 TSNFIVRDD--RLYLIDFGLGKY 476
|
Length = 535 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 54/229 (23%), Positives = 105/229 (45%), Gaps = 29/229 (12%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 93
D+ +++RK+G G++ EV+EG+ NT +K LKP + K E +I++ L P
Sbjct: 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKDFLAEAQIMKKL-RHP 61
Query: 94 NVVKLLDIVRDQHS--------KTPSLIFEYVNSTDFKVL-YPTLTDYDIRYYIYELLKA 144
+++L + + K SL+ EY+ + L P L D ++
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLL-EYLQGGAGRALKLPQLIDMAA-----QVASG 115
Query: 145 LDYCHSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKG 200
+ Y +Q +HRD+ NV++ ++ + K + D+GLA Y R +++ +
Sbjct: 116 MAYLEAQNYIHRDLAARNVLVGENNICK--VADFGLARVIKE-DIYEAREGAKFPIKWTA 172
Query: 201 PELLVDLQDYDYSLDMWSLGCMFAGMI-FRKEPFFYGHDNHDQLVKIAK 248
PE + D+WS G + ++ + + P + G N + L ++ +
Sbjct: 173 PE-AALYNRFSIKSDVWSFGILLTEIVTYGRMP-YPGMTNAEVLQQVDQ 219
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 39/204 (19%), Positives = 94/204 (46%), Gaps = 30/204 (14%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 93
++ D + K+G G+Y EV+EG+ + +K LK ++ ++ +E +++ + P
Sbjct: 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP 62
Query: 94 NVVKLLDIVRDQHSKTPSL-----------IFEYVNSTDFKVLYPTLTDYDIRYYIYELL 142
N+V+LL + ++ P + +Y+ + + + + + Y ++
Sbjct: 63 NLVQLLGVC----TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQIS 114
Query: 143 KALDYCHSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---F 198
A++Y + +HRD+ N ++ ++ L +++ D+GL+ G Y +++ +
Sbjct: 115 SAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMT-GDTYTAHAGAKFPIKW 171
Query: 199 KGPELLVDLQDYDYSLDMWSLGCM 222
PE L + D+W+ G +
Sbjct: 172 TAPESLA-YNKFSIKSDVWAFGVL 194
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 40/209 (19%), Positives = 82/209 (39%), Gaps = 29/209 (13%)
Query: 45 KVGRGKYSEVFEGINVNTNERCI---IKILKPVKKKKIK----REIKILQNLCGGPNVVK 97
K+G G + V G + + I +K LK K I +E I+ +L N+++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIR 60
Query: 98 LLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELL--------KALDYCH 149
L +V ++ E L L + +++ L + Y
Sbjct: 61 LYGVVLTHPLM---MVTEL---APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE 114
Query: 150 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK----GPELLV 205
S+ +HRD+ N+++ + K+++ D+GL +++ V PE L
Sbjct: 115 SKRFIHRDLAARNILLASD-DKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173
Query: 206 DLQDYDYSLDMWSLG-CMFAGMIFRKEPF 233
+ ++ D+W G ++ + +EP+
Sbjct: 174 TRT-FSHASDVWMFGVTLWEMFTYGEEPW 201
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 30/129 (23%), Positives = 60/129 (46%), Gaps = 12/129 (9%)
Query: 98 LLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRD 157
L + +R + P F+ + ++ + L Y++ + ++Y S+ +HRD
Sbjct: 105 LREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC-----AYQVARGMEYLESRRCIHRD 159
Query: 158 VKPHNVMIDHELRKLRLIDWGLAEFYHP----GKEYNVRVASRYFKGPELLVDLQDYDYS 213
+ NV++ + +++ D+GLA H K N R+ ++ PE L D + Y +
Sbjct: 160 LAARNVLVTED-NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWM-APEALFD-RVYTHQ 216
Query: 214 LDMWSLGCM 222
D+WS G +
Sbjct: 217 SDVWSFGIL 225
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 46/190 (24%), Positives = 80/190 (42%), Gaps = 21/190 (11%)
Query: 44 RKVGRGKYSEVFEGINVNTNERCIIKI----LKPVKKKKIKREIKILQNLCGGPNVVKLL 99
K+G+G + +V++G+ + N +K L P K+K +E +IL+ PN+VKL+
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLI 58
Query: 100 DIVRDQHSKTPSLI-FEYVNSTDFKVLYPT----LTDYDIRYYIYELLKALDYCHSQGIM 154
+ K P I E V LT + + ++Y S+ +
Sbjct: 59 GVCVQ---KQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCI 115
Query: 155 HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY----FKGPELLVDLQDY 210
HRD+ N ++ L++ D+G++ G Y V + + PE L + Y
Sbjct: 116 HRDLAARNCLVGEN-NVLKISDFGMSREEEGG-IYTVSDGLKQIPIKWTAPEAL-NYGRY 172
Query: 211 DYSLDMWSLG 220
D+WS G
Sbjct: 173 TSESDVWSYG 182
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 49/216 (22%), Positives = 99/216 (45%), Gaps = 36/216 (16%)
Query: 41 EVVRKVGRGKYSEVFEGINVNTNER-CI---IKILK----PVKKKKIKREIKILQNLCGG 92
E ++ +G G + V++G+ + E+ I IK+L+ P K+I E ++ +
Sbjct: 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMAS-VDH 68
Query: 93 PNVVKLLDIVRDQHSKTPSLIFEYV----------NSTDFKVLYPTLTDYDIRYYIYELL 142
P+VV+LL I S LI + + N D + + + ++
Sbjct: 69 PHVVRLLGICL---SSQVQLITQLMPLGCLLDYVRNHKD------NIGSQYLLNWCVQIA 119
Query: 143 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNV---RVASRYF 198
K + Y + ++HRD+ NV++ + +++ D+GLA+ KEY+ +V ++
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178
Query: 199 KGPELLVDLQDYDYSLDMWSLGC-MFAGMIFRKEPF 233
E ++ + Y + D+WS G ++ M F +P+
Sbjct: 179 -ALESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 4e-04
Identities = 13/53 (24%), Positives = 24/53 (45%)
Query: 133 DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185
++ + L AL ++H D+ P N+++D R +ID+ A P
Sbjct: 147 ELWERLLAALLALLPALPLVLVHGDLHPGNLLVDPGGRVTGVIDFEDAGLGDP 199
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 4e-04
Identities = 26/89 (29%), Positives = 47/89 (52%), Gaps = 7/89 (7%)
Query: 139 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP----GKEYNVRVA 194
Y++ + ++Y S+ +HRD+ NV++ E +++ D+GLA H K N R+
Sbjct: 147 YQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLP 205
Query: 195 SRYFKGPELLVDLQDYDYSLDMWSLGCMF 223
++ PE L D + Y + D+WS G +
Sbjct: 206 VKWM-APEALFD-RIYTHQSDVWSFGVLL 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 7e-04
Identities = 51/227 (22%), Positives = 95/227 (41%), Gaps = 35/227 (15%)
Query: 46 VGRGKYSEVFEG-----INVNTNE-RCIIKILK----PVKKKKIKREIKILQNLCGGPNV 95
+G G + EV+EG + + R +K L+ +KK+ +E ++ N PN+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNI 61
Query: 96 VKLLDIVRDQHSKTPSLIFEYVNSTDF----------KVLYPTLTDYDIRYYIYELLKAL 145
VKLL + + +I E + D + P LT ++ ++ K
Sbjct: 62 VKLLGVCLLNEPQ--YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 146 DYCHSQGIMHRDVKPHNVMIDHEL----RKLRLIDWGLAEFYHPGKEYNVR----VASRY 197
Y +HRD+ N ++ + R +++ D+GLA + Y + R+
Sbjct: 120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 198 FKGPELLVDLQDYDYSLDMWSLGC-MFAGMIFRKEPFFYGHDNHDQL 243
PE L+D + S D+WS G M+ + ++P + +N + L
Sbjct: 180 M-APESLLDGKFTTQS-DVWSFGVLMWEILTLGQQP-YPALNNQEVL 223
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 44/186 (23%), Positives = 74/186 (39%), Gaps = 50/186 (26%)
Query: 71 LKPVKKKKIKREIKILQNLCGGPNVVKL---------------------LDIVRDQHSKT 109
+KP + +I RE+++L C P +V LD V + +
Sbjct: 42 IKPAIRNQIIRELQVLHE-CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRI 100
Query: 110 PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHE 168
P I V+ +L+ L Y + IMHRDVKP N++++
Sbjct: 101 PEEILGKVS--------------------IAVLRGLAYLREKHQIMHRDVKPSNILVNSR 140
Query: 169 LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL--DMWSLGCMFAGM 226
+++L D+G++ N V +R + PE LQ YS+ D+WS+G +
Sbjct: 141 -GEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPE---RLQGTHYSVQSDIWSMGLSLVEL 195
Query: 227 IFRKEP 232
+ P
Sbjct: 196 AIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.001
Identities = 36/151 (23%), Positives = 69/151 (45%), Gaps = 25/151 (16%)
Query: 46 VGRGKYSEVFEGINVNTNERCIIKILKP-----------VKKKKIKREIKIL-QNLCGGP 93
+ RG +E++ G + + +IK P +++++ +RE +I+ + G
Sbjct: 4 IKRGAEAEIYLGDFLG--IKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGV 61
Query: 94 NV--VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 151
NV V +D ++ EY+ K L + ++ E+ + + HS
Sbjct: 62 NVPAVYFVDPENF------IIVMEYIEGEPLKDLINSNGMEELELS-REIGRLVGKLHSA 114
Query: 152 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182
GI+H D+ N+++ K+ LID+GLAEF
Sbjct: 115 GIIHGDLTTSNMILSG--GKIYLIDFGLAEF 143
|
Length = 211 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 44/216 (20%), Positives = 81/216 (37%), Gaps = 44/216 (20%)
Query: 46 VGRGKYSEVFEGINVNTNER-----CIIKILK----PVKKKKIKREIKILQNLCGGPNVV 96
+G G++ +V + R +K+LK + + + E +L+ + P+V+
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NHPHVI 66
Query: 97 KLLDIVRDQHSKTPSLIFEYV---------------------------NSTDFKVLYPTL 129
KL LI EY +S L
Sbjct: 67 KLYGAC--SQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 130 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189
T D+ + +++ + + Y ++HRD+ NV++ E RK+++ D+GL+ + Y
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV-AEGRKMKISDFGLSRDVYEEDSY 183
Query: 190 NVRVASRY---FKGPELLVDLQDYDYSLDMWSLGCM 222
R R + E L D Y D+WS G +
Sbjct: 184 VKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVL 218
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 38.4 bits (90), Expect = 0.002
Identities = 26/104 (25%), Positives = 49/104 (47%), Gaps = 11/104 (10%)
Query: 80 KREIKILQNLC-GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI 138
+ E ++L G N + D+ D +KT ++ EY+ K + D +
Sbjct: 45 RNEARLLSRARKAGVNTPVVYDV--DPDNKT--IVMEYIEGKPLKDVIEEGNDE----LL 96
Query: 139 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182
E+ + + H GI+H D+ N+++ + KL LID+GL ++
Sbjct: 97 REIGRLVGKLHKAGIVHGDLTTSNIIVRDD--KLYLIDFGLGKY 138
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.003
Identities = 44/212 (20%), Positives = 82/212 (38%), Gaps = 50/212 (23%)
Query: 46 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCG---------GPNVV 96
+G+G++ +V G + V K +K + Q PN+V
Sbjct: 14 IGKGEFGDVMLGDYRG----------QKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLV 63
Query: 97 KLLDIVRD--------QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYC 148
+LL +V ++ SL+ +Y+ S V+ T + ++ + ++Y
Sbjct: 64 QLLGVVLQGNPLYIVTEYMAKGSLV-DYLRSRGRAVI----TLAQQLGFALDVCEGMEYL 118
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF----KGPELL 204
+ +HRD+ NV++ +L ++ D+GLA KE + S PE L
Sbjct: 119 EEKNFVHRDLAARNVLVSEDLVA-KVSDFGLA------KEASQGQDSGKLPVKWTAPEAL 171
Query: 205 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 236
+ + D+WS G I E + +G
Sbjct: 172 -REKKFSTKSDVWSFG------ILLWEIYSFG 196
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.003
Identities = 51/224 (22%), Positives = 100/224 (44%), Gaps = 32/224 (14%)
Query: 44 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI----KREIK--ILQNLC----GGP 93
+ +G G++ V EG + I+K+ VK KI + E++ + + +C P
Sbjct: 5 KTLGEGEFGSVMEGQL--NQDDSILKV--AVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 94 NVVKLLDI----VRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRY-------YIYE 140
NV++L+ + V + +P +I ++ D +LY L D ++ +
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 141 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV-RVASRYFK 199
+ ++Y S+ +HRD+ N M++ + + + D+GL++ + G Y R+A K
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENM-NVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179
Query: 200 --GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 241
E L D + Y D+WS G + R + + G +N +
Sbjct: 180 WIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE 222
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.004
Identities = 45/216 (20%), Positives = 93/216 (43%), Gaps = 22/216 (10%)
Query: 45 KVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNVVKLLDIV 102
K+G+G + EV+ G N R IK LKP + + +E ++++ L +V+L +V
Sbjct: 13 KLGQGCFGEVWMG-TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV 70
Query: 103 RDQ------HSKTPSLIFEYVNSTDFKVL-YPTLTDYDIRYYIYELLKALDYCHSQGIMH 155
++ + + +++ K L P L D ++ + Y +H
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM-----AAQIASGMAYVERMNYVH 125
Query: 156 RDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELLVDLQDYDY 212
RD++ N+++ L ++ D+GLA EY R +++ + PE + +
Sbjct: 126 RDLRAANILVGENL-VCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAAL-YGRFTI 182
Query: 213 SLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 248
D+WS G + + + + G N + L ++ +
Sbjct: 183 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 218
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.004
Identities = 38/193 (19%), Positives = 83/193 (43%), Gaps = 24/193 (12%)
Query: 44 RKVGRGKYSEVFEGINVNTNER---CIIKILKPVK----KKKIKREIKILQNLCGGPNVV 96
+++G G + V +G+ + + + +K LK KK+ RE ++ L P +V
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIV 59
Query: 97 KLLDIVRDQHSKTPS--LIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 151
+L+ + K L+ E + + D++ +++ + Y S+
Sbjct: 60 RLIGV-----CKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK 114
Query: 152 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRY---FKGPELLVDL 207
+HRD+ NV++ + + ++ D+G++ G + Y A R+ + PE ++
Sbjct: 115 HFVHRDLAARNVLLVNR-HQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPE-CINY 172
Query: 208 QDYDYSLDMWSLG 220
+ D+WS G
Sbjct: 173 GKFSSKSDVWSYG 185
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.004
Identities = 39/196 (19%), Positives = 85/196 (43%), Gaps = 22/196 (11%)
Query: 44 RKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNVVKLLDI 101
+K+G G++ EV+ N + + +K +KP + + E +++ L +VKL +
Sbjct: 12 KKLGAGQFGEVWMA-TYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAV 69
Query: 102 VRDQHSKTPSLIFEYVNSTDF-------KVLYPTLTDYDIRYYIYELLKALDYCHSQGIM 154
V + + + DF K P L D+ ++ + + + + +
Sbjct: 70 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA-----QIAEGMAFIEQRNYI 124
Query: 155 HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELLVDLQDYD 211
HRD++ N+++ L ++ D+GLA EY R +++ + PE ++ +
Sbjct: 125 HRDLRAANILVSASL-VCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPE-AINFGSFT 181
Query: 212 YSLDMWSLGCMFAGMI 227
D+WS G + ++
Sbjct: 182 IKSDVWSFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.004
Identities = 27/87 (31%), Positives = 42/87 (48%), Gaps = 8/87 (9%)
Query: 139 YELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVAS 195
+KAL+Y + I+HRDVKP N+++D R ++L D+G++
Sbjct: 114 VATVKALNYLKEELKIIHRDVKPSNILLD---RNGNIKLCDFGISGQLVDSIAKTRDAGC 170
Query: 196 RYFKGPELLV--DLQDYDYSLDMWSLG 220
R + PE + YD D+WSLG
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLG 197
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 37.7 bits (88), Expect = 0.004
Identities = 41/168 (24%), Positives = 77/168 (45%), Gaps = 25/168 (14%)
Query: 43 VRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNVVKLLD 100
RK+G G++ EV+ G N + +K LKP + + +E +I++ L +V+L
Sbjct: 11 ERKLGAGQFGEVWMGT-WNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-RHDKLVQLYA 68
Query: 101 IVRDQHSKTPSLIF-EYVNS---TDF-------KVLYPTLTDYDIRYYIYELLKALDYCH 149
+ ++ P I EY++ DF K+ P L D ++ + + Y
Sbjct: 69 VCSEEE---PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA-----QIAEGMAYLE 120
Query: 150 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 197
S+ +HRD+ N+++ E ++ D+GLA EY R +++
Sbjct: 121 SRNYIHRDLAARNILVG-ENLVCKIADFGLARLIED-DEYTAREGAKF 166
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.004
Identities = 42/199 (21%), Positives = 80/199 (40%), Gaps = 44/199 (22%)
Query: 34 FSDQDDYEVV-RKVGRGKYSEVFEGINVNTNERCIIKI-------LKPVKKKK------- 78
+ E + K+G GK S+V+ I+ + +K + VK+ +
Sbjct: 86 LVKRGIVEAIGTKIGVGKESDVYVAIDPKGRK-VAVKFHRLGRTSFRKVKRNRDYLADKE 144
Query: 79 -----------IKREIKILQNLCG-GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 126
+RE + LQ L G V K + R H +++ EY+ + LY
Sbjct: 145 HGSWLYVSRLAAEREFEALQRLYPEGVKVPKPIAWNR--H----AVVMEYI---EGVELY 195
Query: 127 PT-LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYH 184
L + + ++L+ + + +GI+H D+ N+++ + + +IDW A H
Sbjct: 196 RLRLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV-VIDWPQAVPISH 254
Query: 185 PGKEY----NVRVASRYFK 199
P E +V +YF+
Sbjct: 255 PDAEELLERDVENIIKYFR 273
|
Length = 304 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 338 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.81 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.7 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.58 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.5 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.5 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.49 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.44 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.4 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.37 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.35 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.35 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.33 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.32 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.3 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.28 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.21 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.19 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.16 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.1 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.07 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.0 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.87 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.86 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.81 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.71 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.61 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.59 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.57 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.52 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.51 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.48 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.46 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.33 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.26 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.26 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.03 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.03 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.0 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.93 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.9 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.84 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.79 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.78 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.72 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.62 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.59 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.51 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.5 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.49 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.39 | |
| PLN02236 | 344 | choline kinase | 97.32 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.08 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.07 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.97 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.96 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.88 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.87 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.76 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.64 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.6 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.42 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.4 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.09 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.86 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.76 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.14 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.9 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.48 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-58 Score=385.83 Aligned_cols=266 Identities=27% Similarity=0.436 Sum_probs=219.4
Q ss_pred ceeeeeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc----------hHHHHHHHHHHHHhcCCCCeeEe
Q 019642 29 SSYVIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----------KKKIKREIKILQNLCGGPNVVKL 98 (338)
Q Consensus 29 ~~~~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----------~~~~~~E~~~l~~l~~h~~iv~~ 98 (338)
+........+-|.+.+.||+|+||.|-+|..+++++.||||++++.. .....+|+++|++| +||+||++
T Consensus 163 ~~~~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~ 241 (475)
T KOG0615|consen 163 SKVPPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRI 241 (475)
T ss_pred ccCccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEE
Confidence 33444556789999999999999999999999999999999987421 22357999999999 99999999
Q ss_pred eeeeeccCCCccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC--CCceE
Q 019642 99 LDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLR 173 (338)
Q Consensus 99 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~--~~~~~ 173 (338)
+++|.. ....|+||||++||.|-+.+ +.+.+..-+.++.|++.|+.|||++||+||||||+|||+..+ .-.+|
T Consensus 242 ~d~f~~--~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llK 319 (475)
T KOG0615|consen 242 KDFFEV--PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLK 319 (475)
T ss_pred eeeeec--CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEE
Confidence 999955 45679999999999998876 448888889999999999999999999999999999999654 35799
Q ss_pred EEeccccccccCCCcceeeeccccccccccccCc--CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhC
Q 019642 174 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 251 (338)
Q Consensus 174 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~ 251 (338)
|+|||++...+........+|||.|.|||++.+. ..+..++|+|||||+||-+++|.+||..........+++.+.--
T Consensus 320 ItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y 399 (475)
T KOG0615|consen 320 ITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRY 399 (475)
T ss_pred ecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcc
Confidence 9999999988877777888999999999999652 23445889999999999999999999554444434444433221
Q ss_pred CchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 252 TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
......| ..++++..+||++||.+||++|||++|+|+||||+.++-
T Consensus 400 ~f~p~~w---------------------------------~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 400 AFGPLQW---------------------------------DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC 445 (475)
T ss_pred cccChhh---------------------------------hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence 1111111 127999999999999999999999999999999998763
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-57 Score=356.04 Aligned_cols=311 Identities=85% Similarity=1.363 Sum_probs=298.8
Q ss_pred hceeeeeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 28 VSSYVIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 28 ~~~~~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
.+-.+.-+++++|++.+++|+|.++.||.|.+..+.++++||++++...+.+.+|+.++++|+.+|||++++++..++..
T Consensus 28 E~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S 107 (338)
T KOG0668|consen 28 ESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPES 107 (338)
T ss_pred hheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence 34445567889999999999999999999999999999999999999999999999999999889999999999999888
Q ss_pred CccEEEEeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 108 KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
..+.+++||.+..++..+.+.++...++.++.+++.||.|+|+.||+|+|+||.|+++|.....++|+|||++.+..++.
T Consensus 108 ktpaLiFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 108 KTPSLIFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred cCchhHhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 99999999999999999999999999999999999999999999999999999999999988899999999999999999
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
..+.+..+..|..||++...+.++..-|+|||||++..|+..+.||+.+.++.+++..+.+++|+..+......+...++
T Consensus 188 eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ld 267 (338)
T KOG0668|consen 188 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLD 267 (338)
T ss_pred eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCC
Confidence 99999999999999999998899999999999999999999999999999999999999999999999999999999999
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcccccccC
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 338 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~ 338 (338)
+....+.+.+.+.+|..|...++..-++++..+|+.++|..|-++|+||.|++.||||..+.+++.++.|+
T Consensus 268 p~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~~~~~~~ 338 (338)
T KOG0668|consen 268 PQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAESSRMRS 338 (338)
T ss_pred hhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHhhcccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999998887663
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-57 Score=378.36 Aligned_cols=256 Identities=21% Similarity=0.403 Sum_probs=217.4
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEe----cccchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~----~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
++.+.++.||+|..|+||+++++.+++.+|+|++ ++...+++.+|++++++. +|||||.+|+.|..+.. .++++
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~-~isI~ 156 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGE-EISIC 156 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCc-eEEee
Confidence 4788899999999999999999999999999998 345578899999999999 99999999999977543 58999
Q ss_pred EeeecCCccccccCC---CCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEecCCCCceEEEeccccccccCCCcc
Q 019642 114 FEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189 (338)
Q Consensus 114 ~e~~~~~~l~~~~~~---~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~ 189 (338)
||||++|+|+..+.. +++..+.+++.+|+.||.|||+ ++|+||||||+|||++.. |.|||||||.+..+... ..
T Consensus 157 mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNsk-GeVKicDFGVS~~lvnS-~a 234 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSK-GEVKICDFGVSGILVNS-IA 234 (364)
T ss_pred hhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccC-CCEEeccccccHHhhhh-hc
Confidence 999999999999864 9999999999999999999996 899999999999999998 99999999999776654 45
Q ss_pred eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCC-CHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 190 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD-NHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
+...||..|||||.+.+ ..|+.++||||||++++|+++|+.||..... ....++.+......++ +...
T Consensus 235 ~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp-P~lP--------- 303 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP-PRLP--------- 303 (364)
T ss_pred ccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC-CCCC---------
Confidence 67899999999999988 7899999999999999999999999955422 2222332222222111 1110
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
...+|+++++||..||++||.+|||+.|+++|||++....
T Consensus 304 ----------------------~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 304 ----------------------EGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred ----------------------cccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 0027999999999999999999999999999999986543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-55 Score=384.43 Aligned_cols=258 Identities=26% Similarity=0.502 Sum_probs=224.1
Q ss_pred hhceeeeeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEeee
Q 019642 27 NVSSYVIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLD 100 (338)
Q Consensus 27 ~~~~~~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~------~~~~~~~~E~~~l~~l~~h~~iv~~~~ 100 (338)
+++..+......+|...+.||+|+|+.||.+.+..+|+.||+|++.+ ..++.+.+|+++.++| +|||||++++
T Consensus 7 ~ip~~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~ 85 (592)
T KOG0575|consen 7 EIPEVIEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYH 85 (592)
T ss_pred CCCCeeecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeee
Confidence 45666777777899999999999999999999999999999999853 4567789999999999 9999999999
Q ss_pred eeeccCCCccEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEec
Q 019642 101 IVRDQHSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW 177 (338)
Q Consensus 101 ~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~df 177 (338)
+|++ ..++|+|.|+|..++|..+.+ .+++.+++.+++||+.||.|||+++|+|||||..|++++.+ -++||+||
T Consensus 86 ~FED--s~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~-~~VKIgDF 162 (592)
T KOG0575|consen 86 FFED--SNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNEN-MNVKIGDF 162 (592)
T ss_pred Eeec--CCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCc-CcEEeccc
Confidence 9955 678999999999999888874 59999999999999999999999999999999999999999 79999999
Q ss_pred cccccccC-CCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhh
Q 019642 178 GLAEFYHP-GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 256 (338)
Q Consensus 178 g~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (338)
|+|+.... +......+|||.|.|||++.. ...++.+||||+||+||-|+.|++||. ..+-.+....+..
T Consensus 163 GLAt~le~~~Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFe-tk~vkety~~Ik~-------- 232 (592)
T KOG0575|consen 163 GLATQLEYDGERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFE-TKTVKETYNKIKL-------- 232 (592)
T ss_pred ceeeeecCcccccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcc-cchHHHHHHHHHh--------
Confidence 99988863 366677899999999999986 789999999999999999999999993 2222233332221
Q ss_pred hhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcch
Q 019642 257 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 327 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 327 (338)
.++..|..+|.++.+||.++|+.||.+|||+++||.|+||+.
T Consensus 233 -----------------------------~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 233 -----------------------------NEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred -----------------------------cCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 222333458999999999999999999999999999999944
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-55 Score=375.21 Aligned_cols=288 Identities=30% Similarity=0.551 Sum_probs=238.9
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
...++|.++++||.|.||.||+|....++..||||.+++.. .-.-.+|+..|+++..||||+++.+++.+.+. ++
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~-~L 85 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-IL 85 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eE
Confidence 34589999999999999999999999999999999987532 22235799999999559999999999987654 89
Q ss_pred EEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 111 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
++|||||+.+..+.+. ..+++..++.|+.||++||+|+|++|+.|||+||+|||+... ..+||+|||+|+......
T Consensus 86 ~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~-~~iKiaDFGLARev~Skp 164 (538)
T KOG0661|consen 86 YFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGN-DVIKIADFGLAREVRSKP 164 (538)
T ss_pred eeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEeccc-ceeEecccccccccccCC
Confidence 9999999987654443 349999999999999999999999999999999999999976 689999999999988888
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
+.+..+.|.+|+|||+++....|+.+.|+|++||+++|+.+-+. .+.+.+..+++..+.+++|++....|...+.+.-.
T Consensus 165 PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrP-LFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~ 243 (538)
T KOG0661|consen 165 PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRP-LFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA 243 (538)
T ss_pred CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcc-cCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence 88889999999999999988899999999999999999999884 45899999999999999999998888764221110
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
- .--+..-...+...+ . +..+.++.++|.+||++||.+||||.|+|+||||.......
T Consensus 244 m--nf~~P~~~~~~l~~L----~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~~ 301 (538)
T KOG0661|consen 244 M--NFRFPQVKPSPLKDL----L-PNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRASG 301 (538)
T ss_pred h--ccCCCcCCCCChHHh----C-cccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccccc
Confidence 0 000000111111111 1 12689999999999999999999999999999998776553
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-54 Score=352.70 Aligned_cols=283 Identities=31% Similarity=0.547 Sum_probs=233.1
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
+.|+.+.++|+|+||+||+|+++.||+.||||.+.... ++-..+|+++++++ +|+|+|.++++|.. ...+++
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqL-kH~NLVnLiEVFrr--krklhL 78 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQL-KHENLVNLIEVFRR--KRKLHL 78 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhc-ccchHHHHHHHHHh--cceeEE
Confidence 67899999999999999999999999999999986432 45577999999999 99999999999955 457889
Q ss_pred EEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc-CCCc
Q 019642 113 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKE 188 (338)
Q Consensus 113 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~-~~~~ 188 (338)
|+|||+..-|.++- ..++.+.+++++.|++.|+.|+|+++++|+||||+|||++.+ +.+||||||+|+... ++..
T Consensus 79 VFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~-gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 79 VFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQN-GVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred EeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecC-CcEEeccchhhHhhcCCcch
Confidence 99999998776653 459999999999999999999999999999999999999999 899999999998876 6666
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
.+....|.+|+|||.+.+..+|...+||||+||++.||++|. |++++.++.+++..+...+|.-.++...-...-.+..
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~-pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGE-PLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCC-cCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 777889999999999999889999999999999999999998 5558999999999999999985554432211111111
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
.+. ...+...-.-+...+.++.-+.+|+++||+.||.+|++.+|+|.||||.+..+-
T Consensus 237 Gv~------lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er 293 (396)
T KOG0593|consen 237 GVR------LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIER 293 (396)
T ss_pred eee------cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHH
Confidence 000 000000001111223367789999999999999999999999999999877654
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-53 Score=340.43 Aligned_cols=281 Identities=35% Similarity=0.686 Sum_probs=235.4
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
++|...+.||+|.||.||+|++..+++.||||.++... .....+|+..++.+ +|+||+.+++.| .....+.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel-~h~nIi~LiD~F--~~~~~l~l 78 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQEL-KHPNIIELIDVF--PHKSNLSL 78 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHc-cCcchhhhhhhc--cCCCceEE
Confidence 57889999999999999999999999999999987432 44578999999999 899999999999 54667889
Q ss_pred EEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-
Q 019642 113 IFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 187 (338)
Q Consensus 113 v~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~- 187 (338)
|+||+... |+..++ -++..+++.++.+++.||+|||++.|+||||||.|+|++.+ |.+||+|||+++.+....
T Consensus 79 VfEfm~td-Le~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~-g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 79 VFEFMPTD-LEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSD-GQLKIADFGLARFFGSPNR 156 (318)
T ss_pred EEEecccc-HHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCC-CcEEeecccchhccCCCCc
Confidence 99999854 444443 38999999999999999999999999999999999999999 899999999998875433
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
.......|.+|+|||.+.+...|+..+|+||.||++.||+.|. ||+.+.++.+++..+.+.+|++..+.|.+-..+...
T Consensus 157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~-P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRV-PFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccC-CCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 3444588999999999999899999999999999999999765 888999999999999999999999988654333322
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhccc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 333 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 333 (338)
-....... .+....+ +..++++.+|+.+||..||.+|+|+.|+|+|+||++.+.++.
T Consensus 236 ~~~~~~P~----~~~~~lf-----~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~ 292 (318)
T KOG0659|consen 236 VKIQQFPK----PPLNNLF-----PAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTP 292 (318)
T ss_pred HHHhcCCC----Ccccccc-----ccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCC
Confidence 22221111 1111122 226788899999999999999999999999999998776654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-52 Score=349.58 Aligned_cols=256 Identities=31% Similarity=0.546 Sum_probs=220.5
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
...++|++++.||+|+||+|++++.+.+++.+|+|++++. ..+....|..++.++ +||.||.++-.| ++..
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysF--Qt~~ 98 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSF--QTEE 98 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEec--ccCC
Confidence 4468999999999999999999999999999999998742 345678899999998 999999999999 4467
Q ss_pred ccEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc-c
Q 019642 109 TPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-H 184 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~-~ 184 (338)
.+|+|+||+.||.|...++ .+++..++.++.+|+.||.|||++||+||||||+|||+|.+ |+++|+|||+++.. .
T Consensus 99 kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~-GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQ-GHIKLTDFGLCKEDLK 177 (357)
T ss_pred eEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCC-CcEEEeccccchhccc
Confidence 8999999999999998886 59999999999999999999999999999999999999999 99999999999743 4
Q ss_pred CCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccc
Q 019642 185 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264 (338)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
.+......+||+.|+|||++.+ ..++..+|.||||+++|+|++|..|| .+.+.....+.+.+.-
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF-~~~~~~~~~~~I~~~k-------------- 241 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPF-YAEDVKKMYDKILKGK-------------- 241 (357)
T ss_pred CCCccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCC-cCccHHHHHHHHhcCc--------------
Confidence 4556666799999999999998 68999999999999999999999998 3444444444443321
Q ss_pred ccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC----CHHHHhcCCCcchhhhcc
Q 019642 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL----TAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp----t~~ell~hp~~~~~~~~~ 332 (338)
....+..++.+.+++++++|+.||++|. ++.++-+||||.++.+..
T Consensus 242 ----------------------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~ 291 (357)
T KOG0598|consen 242 ----------------------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEK 291 (357)
T ss_pred ----------------------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHH
Confidence 0112222789999999999999999995 789999999999987643
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-52 Score=359.45 Aligned_cols=286 Identities=32% Similarity=0.593 Sum_probs=240.3
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
...+.|+.+++||+|.||.||+|++..+++.||+|.+.-. ......+||.+|++| .||||+++.++..+.....
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-DHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-CCCcccceeeEEEecCCce
Confidence 3457899999999999999999999999999999998632 345678999999999 9999999999998776678
Q ss_pred cEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 110 PSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
+|+|+|||+......... .+++.+++.++.|++.||+|+|++|++|+|||.+|||+|.+ |.+||+|||++++....
T Consensus 193 iYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~-G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 193 IYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNN-GVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCC-CCEEeccccceeeccCC
Confidence 999999999876665554 59999999999999999999999999999999999999999 99999999999976544
Q ss_pred C--cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccc
Q 019642 187 K--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264 (338)
Q Consensus 187 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
. ..+..+.|.+|+|||++++...|+.+.|+||.||||.||++|+.. +++.+.-+++..+.+..|.+....|. ...+
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI-~~G~tEveQl~kIfklcGSP~e~~W~-~~kL 349 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPI-LQGRTEVEQLHKIFKLCGSPTEDYWP-VSKL 349 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCC-cCCccHHHHHHHHHHHhCCCChhccc-cccC
Confidence 3 567788999999999999989999999999999999999999955 58999999999999999999888876 3333
Q ss_pred ccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
........ ..++...+.+. -..++....+|+..||..||.+|.||.++|+|+||...+.+
T Consensus 350 P~~~~~kp------~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~ 409 (560)
T KOG0600|consen 350 PHATIFKP------QQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLP 409 (560)
T ss_pred CcccccCC------CCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCC
Confidence 32211111 11111112111 34478999999999999999999999999999999544433
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-52 Score=342.98 Aligned_cols=290 Identities=30% Similarity=0.520 Sum_probs=240.7
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
.-++|+.+.+|++|.||.||+|+|++|++.||+|.++-.. .-...+|+.++.++ +|||||.+.++....+-+.+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~-~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKA-RHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhc-CCCCeeeeEEEEecccccee
Confidence 3468999999999999999999999999999999987433 23357899999999 89999999999988777889
Q ss_pred EEEEeeecCC--c-cccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC-
Q 019642 111 SLIFEYVNST--D-FKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG- 186 (338)
Q Consensus 111 ~lv~e~~~~~--~-l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~- 186 (338)
|+||||+... + ++..-+++...+++-++.|++.|++|||++.|+|+||||+|+|++.. |.+||+|||+|+.+...
T Consensus 153 y~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~-G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 153 YIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHK-GILKIADFGLAREYGSPL 231 (419)
T ss_pred eeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccC-CcEEecccchhhhhcCCc
Confidence 9999999875 2 33333579999999999999999999999999999999999999998 89999999999877543
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.+......|.+|+|||++.+...|+.+.|+||+||++.+++++. |.+.+....+++..+.+.+|++....|.+......
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~k-Plf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~ 310 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQK-PLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA 310 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcC-CCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence 45667788999999999999889999999999999999999988 55589999999999999999999888876544332
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhccc
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 333 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 333 (338)
... .-+......+....+... .+++...+|++++|..||.+|.||+|.|+|+||.+.+.+.+
T Consensus 311 ~k~--~~f~~~pyn~lr~kF~~~---~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~ 372 (419)
T KOG0663|consen 311 VKK--MTFSEHPYNNLRKKFGAL---SLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPID 372 (419)
T ss_pred hhc--cccCCCCchhhhhhcccc---ccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCC
Confidence 210 111111111222222221 16799999999999999999999999999999999776654
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-52 Score=345.80 Aligned_cols=283 Identities=34% Similarity=0.611 Sum_probs=237.6
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC---ccEEEEe
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK---TPSLIFE 115 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~---~~~lv~e 115 (338)
+|.-.+.+|.|+||.||+|....+++.+|||..-+..+ .-.+|+++|+.+ .|||||++.-+|....+. +..+|||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-~knrEl~im~~l-~HpNIV~L~~~f~~~~~~d~~~lnlVle 102 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-YKNRELQIMRKL-DHPNIVRLLYFFSSSTESDEVYLNLVLE 102 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-cCcHHHHHHHhc-CCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence 68999999999999999999999999999998754332 234799999998 999999999988654433 5668999
Q ss_pred eecCCcccccc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcc
Q 019642 116 YVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189 (338)
Q Consensus 116 ~~~~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~ 189 (338)
|++........ .+++.-.++-++.|++.||.|||+.||+||||||.|+|+|.+.+.+||||||.|+....+.+.
T Consensus 103 ymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn 182 (364)
T KOG0658|consen 103 YMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN 182 (364)
T ss_pred hchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc
Confidence 99876554443 458888999999999999999999999999999999999999999999999999999888888
Q ss_pred eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcc
Q 019642 190 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 269 (338)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
.....|..|+|||.+.+...|+.+.||||.||++.||+.|+.. +.+.+..+++.++.+++|.+..+....-...+....
T Consensus 183 iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~pl-FpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~ 261 (364)
T KOG0658|consen 183 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPL-FPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFK 261 (364)
T ss_pred eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcc-cCCCCHHHHHHHHHHHhCCCCHHHHhhcCccccccc
Confidence 8899999999999999999999999999999999999999855 588999999999999999988776643332222111
Q ss_pred hhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 270 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
.......+|.+ ......++++.+|+.++|+.+|.+|.++.|+++||||.+++.+.
T Consensus 262 ----~p~ik~~~~~~----~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~ 316 (364)
T KOG0658|consen 262 ----FPQIKAHPWHK----VFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPN 316 (364)
T ss_pred ----Cccccccccee----ecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcC
Confidence 11222223322 23344789999999999999999999999999999999998764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-51 Score=356.79 Aligned_cols=254 Identities=31% Similarity=0.535 Sum_probs=220.8
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~------~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
...+|...+.||.|+|++|++|.++.+++.||||++.+ ...+.+..|-++|.+|.+||.|++++-.|++ ...
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD--~~s 148 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD--EES 148 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec--ccc
Confidence 34799999999999999999999999999999999753 3345677899999999999999999999966 568
Q ss_pred cEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 110 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
+|+|+||+.+|+|-.++ +.+.+...+.++.||+.||+|||++||+||||||+|||+|.+ ++++|+|||.+..+.+.
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~d-mhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKD-GHIKITDFGSAKILSPS 227 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCC-CcEEEeeccccccCChh
Confidence 99999999999988887 459999999999999999999999999999999999999999 89999999998776432
Q ss_pred Ccc--------------eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCC
Q 019642 187 KEY--------------NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 252 (338)
Q Consensus 187 ~~~--------------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 252 (338)
... ...+||..|.+||++.. ...++.+|+|+|||++|.|+.|..|| .+.+..-.++.+....
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPF-ra~NeyliFqkI~~l~-- 303 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPF-RAANEYLIFQKIQALD-- 303 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCC-ccccHHHHHHHHHHhc--
Confidence 211 34689999999999987 78999999999999999999999998 5566666666655431
Q ss_pred chhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 253 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
..-++.+++.+++||+++|..||++|+|+.||.+||||.++.+-
T Consensus 304 -----------------------------------y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~ 347 (604)
T KOG0592|consen 304 -----------------------------------YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWE 347 (604)
T ss_pred -----------------------------------ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChh
Confidence 22233478999999999999999999999999999999999764
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=340.84 Aligned_cols=256 Identities=29% Similarity=0.505 Sum_probs=215.3
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
...++|.+.++||+|+||+||+|+++.++..||||.+... ..+.+..|+.+|+.+ +|||||++++.+.. .+.
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~~~~--~~~ 83 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKEL-KHPNIVRLLDCIED--DDF 83 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhc-CCcceeeEEEEEec--CCe
Confidence 4468999999999999999999999999999999998654 345578899999999 89999999999955 568
Q ss_pred cEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC--C---CceEEEeccccc
Q 019642 110 PSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--L---RKLRLIDWGLAE 181 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~--~---~~~~l~dfg~~~ 181 (338)
+++|||||+||+|.+++. .+++..++.++.|++.||++||+++|+|+||||+|||++.. . ..+||+|||+++
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 999999999999999974 59999999999999999999999999999999999999763 2 468999999999
Q ss_pred cccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 182 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
...++......+|++.|||||++.. .+|+.|+|+||+|+++|+|++|+.||. ..+..+-+..+.+.-. ..
T Consensus 164 ~L~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~-a~t~~eL~~~~~k~~~--~~------ 233 (429)
T KOG0595|consen 164 FLQPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFD-AETPKELLLYIKKGNE--IV------ 233 (429)
T ss_pred hCCchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCcc-ccCHHHHHHHHhcccc--cc------
Confidence 9988877788899999999999976 789999999999999999999999983 3333333332211100 00
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
...+..++..+.+++...|+.+|.+|.+..+-+.|+++..-+
T Consensus 234 --------------------------~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 234 --------------------------PVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred --------------------------CchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 011112577788999999999999999999999999987654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-50 Score=349.27 Aligned_cols=261 Identities=31% Similarity=0.493 Sum_probs=216.6
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
...-++|+++..||+|+||.||+|+.+.||..+|+|++++.. ...++.|-.+|... .+|+||+++-.|++ .
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD--~ 213 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQD--K 213 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecC--C
Confidence 456789999999999999999999999999999999998643 34567899999986 99999999999954 6
Q ss_pred CccEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 108 KTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
.++||||||++||++..++. .+++..++.++.+++.|+..+|+.|++|+||||+|+|||.. |++||+|||++....
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~-GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAK-GHIKLSDFGLSTGLD 292 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCC-CCEeeccccccchhh
Confidence 78999999999999888774 49999999999999999999999999999999999999999 999999999983321
Q ss_pred C----------------------CC-c-------------------------ceeeeccccccccccccCcCCCCCcchh
Q 019642 185 P----------------------GK-E-------------------------YNVRVASRYFKGPELLVDLQDYDYSLDM 216 (338)
Q Consensus 185 ~----------------------~~-~-------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 216 (338)
. .. . .....|||.|+|||++.+ ..++..+|.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDw 371 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDW 371 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccH
Confidence 1 00 0 012368999999999999 679999999
Q ss_pred HHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCCh
Q 019642 217 WSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSP 296 (338)
Q Consensus 217 wslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 296 (338)
||||||+|||+.|..|| .+.+..+....+...- ..+.......+++
T Consensus 372 WSLG~ImyEmLvGyPPF-~s~tp~~T~rkI~nwr---------------------------------~~l~fP~~~~~s~ 417 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPF-CSETPQETYRKIVNWR---------------------------------ETLKFPEEVDLSD 417 (550)
T ss_pred HHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHh---------------------------------hhccCCCcCcccH
Confidence 99999999999999998 4455555444443321 1111122223789
Q ss_pred hHHHHHHHhcCCCcCCcC---CHHHHhcCCCcchhhhcccc
Q 019642 297 EAIDFLDKLLRYDHQDRL---TAREAMAHPYFAQVRAAESS 334 (338)
Q Consensus 297 ~l~~li~~~L~~dP~~Rp---t~~ell~hp~~~~~~~~~~~ 334 (338)
+.++||.+||. ||++|. .++||.+||||+++.+...+
T Consensus 418 eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~ 457 (550)
T KOG0605|consen 418 EAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLR 457 (550)
T ss_pred HHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhh
Confidence 99999999999 999998 59999999999999876654
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-50 Score=336.19 Aligned_cols=292 Identities=33% Similarity=0.604 Sum_probs=236.8
Q ss_pred eeeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEeeeeeec--
Q 019642 32 VIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRD-- 104 (338)
Q Consensus 32 ~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~-----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 104 (338)
..+.....|...+.||.|+||.|+.+.++.+++.||||++.. ...++..+|+..++.+ +|+||+.+.+++..
T Consensus 16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~-~HeNIi~l~di~~p~~ 94 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHL-RHENIIGLLDIFRPPS 94 (359)
T ss_pred eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHh-cCCCcceEEeeccccc
Confidence 344556677778999999999999999999999999999862 3456778999999999 79999999999865
Q ss_pred -cCCCccEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccc
Q 019642 105 -QHSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
Q Consensus 105 -~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~ 180 (338)
..-..+|+|+|++ +.+|...++ .+++..++.++.|++.||+|+|+.|++|+||||+|++++.+ ..+||+|||++
T Consensus 95 ~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~-c~lKI~DFGLA 172 (359)
T KOG0660|consen 95 RDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNAD-CDLKICDFGLA 172 (359)
T ss_pred ccccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccC-CCEEeccccce
Confidence 2345789999999 456666653 28999999999999999999999999999999999999999 78999999999
Q ss_pred ccccC---CCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhh
Q 019642 181 EFYHP---GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 257 (338)
Q Consensus 181 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
+.... ....+....|.+|+|||+......++.+.||||+||++.||++|+..| .+.+.-+++..+.+.+|.++...
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplF-pG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLF-PGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCC-CCCchHHHHHHHHHhcCCCCHHH
Confidence 87753 223344678999999999988889999999999999999999998554 89999999999999999986655
Q ss_pred hhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhccc
Q 019642 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 333 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 333 (338)
...-....... .-.......+.++...+. ..++...+|+.+||..||.+|+|++|+|+||||....-+.+
T Consensus 252 l~~i~s~~ar~-yi~slp~~p~~~f~~~fp-----~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~d 321 (359)
T KOG0660|consen 252 LQKIRSEKARP-YIKSLPQIPKQPFSSIFP-----NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPED 321 (359)
T ss_pred HHHhccHHHHH-HHHhCCCCCCCCHHHHcC-----CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCcc
Confidence 43222111111 111122233333333332 47899999999999999999999999999999998765544
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-49 Score=349.37 Aligned_cols=253 Identities=30% Similarity=0.506 Sum_probs=212.7
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
...+.|.+.+.||+|+||+|+.|.+..++..||+|+++.. ..+.+.+|+.+++.+..||||+++++++...
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~- 92 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP- 92 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC-
Confidence 3467999999999999999999999999999999987652 2445678999999994499999999999654
Q ss_pred CCccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 107 SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
..+++||||+.||.|.+++ .++.+..++.+++|++.|+.|+|++||+||||||+|||++.+.+++||+|||++...
T Consensus 93 -~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 93 -TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred -CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 4589999999998887776 459999999999999999999999999999999999999987679999999999877
Q ss_pred -cCCCcceeeeccccccccccccCcC-CCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 184 -HPGKEYNVRVASRYFKGPELLVDLQ-DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 184 -~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
.........+|++.|+|||++.+.. ....++||||+|++||.|++|+.||.. .+.......+.. +.
T Consensus 172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~~ki~~--~~--------- 239 (370)
T KOG0583|consen 172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLYRKIRK--GE--------- 239 (370)
T ss_pred CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHHHHHhc--CC---------
Confidence 4556677789999999999998855 456899999999999999999999943 121111111111 00
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCC-ChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcch
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLV-SPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 327 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 327 (338)
...+..+ |.++.+|+++||..||.+|+|+.++++||||+.
T Consensus 240 --------------------------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 240 --------------------------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred --------------------------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 1122226 899999999999999999999999999999996
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-49 Score=351.29 Aligned_cols=286 Identities=28% Similarity=0.496 Sum_probs=222.4
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc--hHHHHHHHHHHHHhcCC-----CCeeEeeeeeeccCCCccE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGG-----PNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~E~~~l~~l~~h-----~~iv~~~~~~~~~~~~~~~ 111 (338)
+|++.+.||+|+||.|-+|.+.+|++.||||++++.. ..+...|+.+|..+.+| -|+|+++++|.. .++.|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f--r~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF--RNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc--cccee
Confidence 8899999999999999999999999999999998643 45667899999999634 399999999944 67999
Q ss_pred EEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEec-CCCCceEEEeccccccccCC
Q 019642 112 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 112 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~-~~~~~~~l~dfg~~~~~~~~ 186 (338)
||+|.+.-+..+.+. ..++...++.++.||+.||.+||+.||+|+||||+|||+. .+...+||+|||.++.....
T Consensus 265 iVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~ 344 (586)
T KOG0667|consen 265 IVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR 344 (586)
T ss_pred eeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCc
Confidence 999999855443332 2489999999999999999999999999999999999994 45568999999999875533
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
. .....+..|+|||++++ .+++.+.|||||||+++||++| .|++.+.+..+++..+.+++|.++............
T Consensus 345 v--ytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG-~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~k 420 (586)
T KOG0667|consen 345 V--YTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTG-EPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHK 420 (586)
T ss_pred c--eeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcC-ccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccce
Confidence 2 26788999999999999 7999999999999999999999 577899999999999999999876555432222210
Q ss_pred Ccch-hhhh------------------------ccccCCC-CcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHh
Q 019642 267 DPQL-DALV------------------------GRHSRKP-WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 320 (338)
Q Consensus 267 ~~~~-~~~~------------------------~~~~~~~-~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell 320 (338)
...- .... ......+ -..-........-...+.+||++||.+||.+|+|+.|+|
T Consensus 421 ff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal 500 (586)
T KOG0667|consen 421 FFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQAL 500 (586)
T ss_pred ehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHh
Confidence 0000 0000 0000011 001111111112345689999999999999999999999
Q ss_pred cCCCcchhhh
Q 019642 321 AHPYFAQVRA 330 (338)
Q Consensus 321 ~hp~~~~~~~ 330 (338)
+||||.+...
T Consensus 501 ~Hpfl~~~~~ 510 (586)
T KOG0667|consen 501 NHPFLTGTSL 510 (586)
T ss_pred cCcccccccc
Confidence 9999995543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=321.73 Aligned_cols=255 Identities=24% Similarity=0.423 Sum_probs=219.1
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
..-++|+.++.||.|+||.|-+++.+.++..+|+|++++.. .+...+|..+|+.+ .||.++++++.+.+ ..
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-~~PFlv~l~~t~~d--~~ 117 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-SHPFLVKLYGTFKD--NS 117 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-cCceeEEEEEeecc--CC
Confidence 34579999999999999999999999999999999987543 34567899999999 89999999999955 67
Q ss_pred ccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 109 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
.+++||||.+||.|..++ +++++..++.++.||+.||+|||+.+|++||+||+|||+|.+ |.+||+|||++....+
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~-G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQN-GHIKITDFGFAKRVSG 196 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccC-CcEEEEeccceEEecC
Confidence 899999999999887776 469999999999999999999999999999999999999999 9999999999988765
Q ss_pred CCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 186 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
. .-..+|||.|+|||++.. +++..++|-||||+++|||+.|..||+.... ....+.+.+.--
T Consensus 197 r--T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI~~~~v-------------- 258 (355)
T KOG0616|consen 197 R--TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEKILEGKV-------------- 258 (355)
T ss_pred c--EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHHHhCcc--------------
Confidence 4 566799999999999988 7899999999999999999999999954333 444444433111
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCc-----CCHHHHhcCCCcchhhhcccc
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR-----LTAREAMAHPYFAQVRAAESS 334 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R-----pt~~ell~hp~~~~~~~~~~~ 334 (338)
.-|+.++.++++||+++|++|-++| ....+|.+||||+++.+....
T Consensus 259 -----------------------~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~ 309 (355)
T KOG0616|consen 259 -----------------------KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAIL 309 (355)
T ss_pred -----------------------cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHh
Confidence 1223379999999999999999999 367899999999998776543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-50 Score=350.63 Aligned_cols=255 Identities=27% Similarity=0.495 Sum_probs=217.7
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc---cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
......|....+||+|+.|.||.+....+++.||||.+.. ..++.+.+|+.+|+.+ +|+|||.+++.|... ..+
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~-~H~NiVnfl~Sylv~--deL 345 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDL-HHPNIVNFLDSYLVG--DEL 345 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhc-cchHHHHHHHHhccc--cee
Confidence 3455689999999999999999999999999999999763 3456688999999999 999999999988553 678
Q ss_pred EEEEeeecCCccccccCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-
Q 019642 111 SLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 187 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~- 187 (338)
++||||++|++|.+.... +++.++..++++++.||+|||.+||+|+|||.+|||++.+ +.+||+|||++..+....
T Consensus 346 WVVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~-g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 346 WVVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMD-GSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred EEEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccC-CcEEEeeeeeeeccccccC
Confidence 999999999999999864 8999999999999999999999999999999999999999 899999999987765443
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
....-.|||+|||||+... ..|.+++||||||++++||+.|+.||+. .+.-+...+...-|.+.+.
T Consensus 425 KR~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYln--E~PlrAlyLIa~ng~P~lk----------- 490 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLN--ENPLRALYLIATNGTPKLK----------- 490 (550)
T ss_pred ccccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccC--CChHHHHHHHhhcCCCCcC-----------
Confidence 4455689999999999877 7899999999999999999999999964 2222333333333333322
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
.+..+|+.+++|+.+||+.||++|++|.|||+||||+-.
T Consensus 491 ----------------------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 491 ----------------------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred ----------------------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 122389999999999999999999999999999999654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-50 Score=340.01 Aligned_cols=258 Identities=27% Similarity=0.446 Sum_probs=207.6
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
..+|...+.||+|+||+||++.+.+++...|||...... .+.+.+|+.++.++ +|||||++++.........++++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l-~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRL-NHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhC-CCCCEEeeCCccccccCeeeEee
Confidence 467899999999999999999999999999999987554 45589999999999 69999999997433322367899
Q ss_pred EeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC----
Q 019642 114 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP---- 185 (338)
Q Consensus 114 ~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~---- 185 (338)
|||+.+|+|.+++. .+++..++.+.+|+++||+|||++|++|+||||+|||++...+.+||+|||.+.....
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 99999999999874 4899999999999999999999999999999999999999338999999999876553
Q ss_pred CCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 186 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
........||+.|||||++.......+++|||||||++.+|+||..||..- .+....+.........+
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~---~~~~~~~~~ig~~~~~P--------- 242 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF---FEEAEALLLIGREDSLP--------- 242 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh---cchHHHHHHHhccCCCC---------
Confidence 122334689999999999985233446999999999999999999998332 11111111111110000
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
..+..+|++.++||.+||+.||++||||.++|+|||.++...
T Consensus 243 -----------------------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 243 -----------------------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred -----------------------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 123338999999999999999999999999999999977543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-49 Score=335.14 Aligned_cols=267 Identities=24% Similarity=0.403 Sum_probs=216.7
Q ss_pred eeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc----cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 33 IFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 33 i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
...+.+.|++...||.|..++||+|+...+++.||||.++- .+-+.+.+|+..+..+ +||||++++..|.. +.
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~-~HPNIv~~~~sFvv--~~ 97 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI-DHPNIVTYHCSFVV--DS 97 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc-CCCCcceEEEEEEe--cc
Confidence 34667899999999999999999999999999999999873 2347789999999998 99999999999966 45
Q ss_pred ccEEEEeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 109 TPSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
.+++||++|.+|++.+++. .+++..+..+++++++||.|||++|.+|||||+.|||++.+ |.|+|+|||.+..+
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~d-G~VkLadFgvsa~l 176 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSD-GTVKLADFGVSASL 176 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCC-CcEEEcCceeeeee
Confidence 7899999999999988874 49999999999999999999999999999999999999999 99999999976444
Q ss_pred -cCCCcc----eeeeccccccccccc-cCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhh
Q 019642 184 -HPGKEY----NVRVASRYFKGPELL-VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 257 (338)
Q Consensus 184 -~~~~~~----~~~~~~~~y~aPE~~-~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
..+... ....|+++|+|||++ .....|+.|+||||||++..|+++|..||. .....+.+...+...++..
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~----k~pPmkvLl~tLqn~pp~~ 252 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFS----KYPPMKVLLLTLQNDPPTL 252 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcc----cCChHHHHHHHhcCCCCCc
Confidence 222222 334899999999995 444579999999999999999999999993 2222333333333322211
Q ss_pred hhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
..+ ....+....++..++.+|..||..||++||||+++|+|+||+.....
T Consensus 253 ~t~------------------------~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 253 LTS------------------------GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK 302 (516)
T ss_pred ccc------------------------cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence 111 11112223368899999999999999999999999999999987543
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=339.98 Aligned_cols=287 Identities=29% Similarity=0.492 Sum_probs=219.3
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
+..++|++.+.||+|+||+||+|.+..+++.||+|+++... .....+|+.+++.+ +||||+++++++.+ ....
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~ 78 (303)
T cd07869 2 GKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHANIVLLHDIIHT--KETL 78 (303)
T ss_pred CccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhC-CCCCcCeEEEEEec--CCeE
Confidence 45689999999999999999999999999999999986432 34567899999999 99999999999955 4578
Q ss_pred EEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC-
Q 019642 111 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG- 186 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~- 186 (338)
++||||+.++.+.... ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++......
T Consensus 79 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 79 TLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDT-GELKLADFGLARAKSVPS 157 (303)
T ss_pred EEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECCCCcceeccCCC
Confidence 9999999866544433 348899999999999999999999999999999999999987 88999999988643221
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.......+++.|+|||++.+...++.++|+||||+++|+|++|..||....+..+.+..+...++.+....+........
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 22233567889999999876567889999999999999999999999655555566666666666554444332211100
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
.. ...... ...............++.+.+|+.+||+.||++|||+.|+|+||||++++.
T Consensus 238 ~~--~~~~~~---~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 238 FK--PERFTL---YSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP 296 (303)
T ss_pred cc--cccccc---cCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence 00 000000 000111111111225678999999999999999999999999999998854
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-49 Score=350.39 Aligned_cols=256 Identities=27% Similarity=0.470 Sum_probs=222.8
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
-+-|++.+.||.|+.|.|-+|.+..||+.+|||++.+. ....+.+|+-+|+.+ .|||++++++++ ++..++
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydVw--e~~~~l 87 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDVW--ENKQHL 87 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeeee--ccCceE
Confidence 45799999999999999999999999999999998643 356789999999999 999999999999 556789
Q ss_pred EEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 111 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
|+|.||+.||-|.+++ +++++.++.+++.||+.|+.|+|..+|+|+|+||+|+|+|.. +++||+|||+|..-.++.
T Consensus 88 ylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~-~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVK-NNIKIADFGMASLEVPGK 166 (786)
T ss_pred EEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcc-cCEeeeccceeecccCCc
Confidence 9999999999877775 569999999999999999999999999999999999999998 569999999998888888
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
.....+|+|.|.+||++.+..+...++||||.|++||.++||.+||. +++...+..-.+. |.
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd--DdNir~LLlKV~~-G~--------------- 228 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD--DDNIRVLLLKVQR-GV--------------- 228 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC--CccHHHHHHHHHc-Cc---------------
Confidence 88889999999999999998888899999999999999999999994 3444333322111 11
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcccc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS 334 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~ 334 (338)
...+..++.++++||++||.+||++|.|.+||++|||+.+-.....+
T Consensus 229 --------------------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 229 --------------------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred --------------------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence 11223489999999999999999999999999999999987766655
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-49 Score=338.06 Aligned_cols=253 Identities=29% Similarity=0.546 Sum_probs=209.3
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----------------hHHHHHHHHHHHHhcCCCCeeEeee
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------------KKKIKREIKILQNLCGGPNVVKLLD 100 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----------------~~~~~~E~~~l~~l~~h~~iv~~~~ 100 (338)
++|++.+.||+|.||.|-+|++..+++.||||++.+.. .+...+|+.+|+++ .|||||++++
T Consensus 97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-~H~nVV~LiE 175 (576)
T KOG0585|consen 97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-HHPNVVKLIE 175 (576)
T ss_pred hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-CCcCeeEEEE
Confidence 68999999999999999999999999999999986321 24688999999999 9999999999
Q ss_pred eeeccCCCccEEEEeeecCCcccccc--CC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEec
Q 019642 101 IVRDQHSKTPSLIFEYVNSTDFKVLY--PT-LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW 177 (338)
Q Consensus 101 ~~~~~~~~~~~lv~e~~~~~~l~~~~--~~-~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~df 177 (338)
+..+.....+|+|+|||..|.+...- .. +++.++++++++++.||+|||.+||+||||||+|+|++.+ +++||+||
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~-g~VKIsDF 254 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSD-GTVKISDF 254 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCC-CcEEeecc
Confidence 99998889999999999988766553 23 8999999999999999999999999999999999999999 99999999
Q ss_pred cccccccCC------CcceeeeccccccccccccCc---CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHH
Q 019642 178 GLAEFYHPG------KEYNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 248 (338)
Q Consensus 178 g~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~ 248 (338)
|.+..+..+ .......|||.|+|||...+. ...+.+.||||+|++||+|+.|+.||.. ....+....+..
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-~~~~~l~~KIvn 333 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-DFELELFDKIVN 333 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-chHHHHHHHHhc
Confidence 998766322 223447899999999998762 3467899999999999999999999932 222222222211
Q ss_pred HhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 249 VLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
.++ .....+.+.+.++++|++||++||++|.++.+|..|||...-
T Consensus 334 ----~pL-------------------------------~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 334 ----DPL-------------------------------EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred ----Ccc-------------------------------cCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 110 000111267899999999999999999999999999998765
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-51 Score=329.92 Aligned_cols=247 Identities=23% Similarity=0.506 Sum_probs=202.6
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEec-----ccchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~-----~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
.+|+++++||.|.||.||++.+..+|+.+|.|.++ ...++....|+.+|++| +|||||++++.-...+...+++
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL-~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQL-NHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhc-CCchHHHHHHHhhhccchhhHH
Confidence 46999999999999999999999999999999875 23467788999999999 9999999999333344456889
Q ss_pred EEeeecCCccccccC-------CCCHHHHHHHHHHHHHHHHHHHH--CC--ceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 113 IFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHS--QG--IMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 113 v~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~--~~--i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
|||+|++|+|..+++ .+++..+|+++.|++.||.++|. .+ ++|+||||.||+++.+ |.+||+|||+++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~-gvvKLGDfGL~r 176 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTAN-GVVKLGDFGLGR 176 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCC-CceeeccchhHh
Confidence 999999999998873 39999999999999999999999 45 9999999999999998 899999999998
Q ss_pred cccCCCc-ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhh
Q 019642 182 FYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 260 (338)
Q Consensus 182 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.+..... .....|||.||+||.+.+ .++++++||||+||++|+|+..+.||+-. +. .++.+.+...+....+
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~--n~---~~L~~KI~qgd~~~~p- 249 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGD--NL---LSLCKKIEQGDYPPLP- 249 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccc--cH---HHHHHHHHcCCCCCCc-
Confidence 8765443 234689999999999988 79999999999999999999999999432 22 2222222221111111
Q ss_pred ccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
...+|.++..+|..|+.+||+.||+. +|++.++
T Consensus 250 ------------------------------~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di 282 (375)
T KOG0591|consen 250 ------------------------------DEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDI 282 (375)
T ss_pred ------------------------------HHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHH
Confidence 01268999999999999999999986 4555444
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=320.65 Aligned_cols=256 Identities=28% Similarity=0.502 Sum_probs=215.8
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEec-----ccchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~-----~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
.++|++.+.||+|+|+.|+++.+..+|+.+++|+++ ..+-+.+.+|+.+-+.| +||||+++.+.+ ......+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~L-qHP~IvrL~~ti--~~~~~~y 86 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSI--QEESFHY 86 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhc-CCCcEeehhhhh--cccceeE
Confidence 578999999999999999999999999999999875 34567899999999999 999999999998 4456789
Q ss_pred EEEeeecCCcccc-ccCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecC--CCCceEEEeccccccccCC
Q 019642 112 LIFEYVNSTDFKV-LYPT--LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 112 lv~e~~~~~~l~~-~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~--~~~~~~l~dfg~~~~~~~~ 186 (338)
+|+|.+.|+.+-. ..++ .++..+-..++||+++|.|+|.+||+|+|+||+|+++.+ ...-+||+|||++....++
T Consensus 87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g 166 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG 166 (355)
T ss_pred EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence 9999999997643 3343 788888999999999999999999999999999999943 2356999999999888877
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.......|+|.|+|||++.. .+++..+|||+.|++||-++.|+.||+ +.+..+..+++.+..-.-+.+
T Consensus 167 ~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~-~~~~~rlye~I~~g~yd~~~~---------- 234 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFW-DEDQHRLYEQIKAGAYDYPSP---------- 234 (355)
T ss_pred cccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCC-CccHHHHHHHHhccccCCCCc----------
Confidence 66777899999999999987 789999999999999999999999994 344455555554432211111
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
..+.++++.++||++||..||.+|.|+.|+|+|||+.+-..
T Consensus 235 -----------------------~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~ 275 (355)
T KOG0033|consen 235 -----------------------EWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRER 275 (355)
T ss_pred -----------------------ccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHH
Confidence 12238999999999999999999999999999999987644
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-48 Score=344.69 Aligned_cols=258 Identities=27% Similarity=0.468 Sum_probs=224.0
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
....++|.+++.||+|.||+|+++..+.+++.+|||++++. +.+....|-.++....+||.++.++..| +..
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f--QT~ 441 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF--QTK 441 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc--ccC
Confidence 45568999999999999999999999999999999999853 3566788999999887899999999999 556
Q ss_pred CccEEEEeeecCCccccccC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc-
Q 019642 108 KTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH- 184 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~- 184 (338)
.++++||||+.||++..+.. .+++..++.++..|+.||.|||++||+|||||.+|||+|.+ |.+||+|||+++...
T Consensus 442 ~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~e-Gh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTE-GHVKIADFGLCKEGMG 520 (694)
T ss_pred CeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEccc-CcEEecccccccccCC
Confidence 79999999999999766654 59999999999999999999999999999999999999999 999999999997643
Q ss_pred CCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccc
Q 019642 185 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264 (338)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
.+......+|||.|+|||++.+ ..|+.++|-||||++||+|+.|..|| .+++..+.+..+...
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF-~gddEee~FdsI~~d--------------- 583 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPF-PGDDEEEVFDSIVND--------------- 583 (694)
T ss_pred CCCccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHhcC---------------
Confidence 4556677899999999999988 78999999999999999999999998 566666666655331
Q ss_pred ccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCC-----HHHHhcCCCcchhhhccc
Q 019642 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAAES 333 (338)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt-----~~ell~hp~~~~~~~~~~ 333 (338)
+-..|..+|.+..++++++|.+||++|.. +++|.+||||+++.+..-
T Consensus 584 ----------------------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L 635 (694)
T KOG0694|consen 584 ----------------------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDL 635 (694)
T ss_pred ----------------------CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHH
Confidence 01122237999999999999999999994 589999999999986543
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=332.36 Aligned_cols=277 Identities=29% Similarity=0.578 Sum_probs=216.1
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
...++|++.+.||.|+||+||+|.+..+++.||+|.++.. ....+.+|+.+++++ +||||+++++++.. ....
T Consensus 2 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~ 78 (288)
T cd07871 2 GKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL-KHANIVTLHDIIHT--ERCL 78 (288)
T ss_pred CccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhC-CCCCEeeEEEEEcC--CCeE
Confidence 3467899999999999999999999999999999998632 234577899999999 99999999999854 4578
Q ss_pred EEEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 111 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
++||||+.+ ++...+ ..+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++......
T Consensus 79 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 79 TLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEK-GELKLADFGLARAKSVP 156 (288)
T ss_pred EEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEECcCcceeeccCC
Confidence 899999987 554443 237889999999999999999999999999999999999988 89999999998654322
Q ss_pred C-cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 187 K-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 187 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
. ......+++.|+|||.+.+...++.++|+||+|+++|+|++|..|| .+.+..+.+..+.+..+.+....+.......
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF-PGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 2 2233567889999999876567899999999999999999999998 4556666777777777766655543211100
Q ss_pred cCcchhhh-hccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 266 LDPQLDAL-VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 266 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
..... .......+ .......++.++.+||++||+.||.+|||++|+|+||||
T Consensus 236 ---~~~~~~~~~~~~~~-----~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 236 ---EFRSYLFPQYRAQP-----LINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ---hhhccccCccCCCc-----hHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 00000 00000000 011123468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-48 Score=351.41 Aligned_cols=287 Identities=30% Similarity=0.518 Sum_probs=220.6
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeecc------CC
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ------HS 107 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~------~~ 107 (338)
....++|++.+.||+|+||.||+|.+..+++.||+|.+... .....+|+.+++.+ +||||+++++++... ..
T Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~-~~~~~~Ei~il~~l-~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-PQYKNRELLIMKNL-NHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC-cchHHHHHHHHHhc-CCCCCcceeeeEeecccccCCCc
Confidence 34567899999999999999999999999999999987543 23345799999999 999999999876432 12
Q ss_pred CccEEEEeeecCCccccc------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 108 KTPSLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
..+++||||+.++..... ...+++..++.++.|++.||.|||+.||+|+||||+|||++.+.+.+||+|||++.
T Consensus 140 ~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 140 IFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred eEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 246789999997543322 13589999999999999999999999999999999999999775679999999998
Q ss_pred cccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 182 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
............+++.|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+.+..+.+.++.+....+...
T Consensus 220 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf-~~~~~~~~~~~i~~~~~~p~~~~~~~~ 298 (440)
T PTZ00036 220 NLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF-SGQSSVDQLVRIIQVLGTPTEDQLKEM 298 (440)
T ss_pred hccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 7654444445678999999999877567899999999999999999999887 556667778888888777655443221
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
........ +....... .....+...++++.+||.+||+.||.+|||+.|+|+||||.++...
T Consensus 299 ~~~~~~~~----~~~~~~~~----l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~ 360 (440)
T PTZ00036 299 NPNYADIK----FPDVKPKD----LKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP 360 (440)
T ss_pred chhhhccc----CCccCchh----HHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcc
Confidence 10000000 00000000 0111223367899999999999999999999999999999987653
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-48 Score=322.55 Aligned_cols=285 Identities=33% Similarity=0.591 Sum_probs=229.7
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCC-eeEeeeeeeccC----
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPN-VVKLLDIVRDQH---- 106 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~-iv~~~~~~~~~~---- 106 (338)
...|+.+++||+|+||+||+|+++.+|+.||+|.+... ......+|+.+++++ +|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L-~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRL-SHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHh-CCCcceEEEEeeeeecccccc
Confidence 35677888999999999999999999999999998743 245578999999999 8998 999999986643
Q ss_pred CCccEEEEeeecCCcccccc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccc
Q 019642 107 SKTPSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~ 179 (338)
....++|+||++... ..++ ..++...++.++.|++.||.|||++||+||||||+||++++. |.+||+|||+
T Consensus 89 ~~~l~lvfe~~d~DL-~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~-G~lKlaDFGl 166 (323)
T KOG0594|consen 89 IGKLYLVFEFLDRDL-KKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSS-GVLKLADFGL 166 (323)
T ss_pred cceEEEEEEeecccH-HHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCC-CcEeeeccch
Confidence 236789999997543 2222 247778999999999999999999999999999999999997 9999999999
Q ss_pred ccccc-CCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhh
Q 019642 180 AEFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 258 (338)
Q Consensus 180 ~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
+.... +........+|.+|+|||++.+...|+...||||+||++++|++++ |.+.+....+++..+.+.+|++....|
T Consensus 167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~-~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRR-PLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCC-CCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 97665 4445677889999999999999878999999999999999999977 445888889999999999999998888
Q ss_pred hhccccccCcchhhhhcccc-CCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhccc
Q 019642 259 LNKYHLELDPQLDALVGRHS-RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 333 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 333 (338)
...-....... .+.... ...... ..+..+++..+++.+||+.+|.+|.||..+|+||||.+.+....
T Consensus 246 p~v~~~~~~k~---~f~~~~~~~~l~~-----~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~ 313 (323)
T KOG0594|consen 246 PGVSSLPDYKA---PFPKWPGPKDLSS-----ILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSS 313 (323)
T ss_pred CCccccccccc---cCcCCCCccchHH-----hccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchh
Confidence 65443222111 000000 111111 11113468999999999999999999999999999999866543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-49 Score=342.93 Aligned_cols=248 Identities=28% Similarity=0.556 Sum_probs=212.7
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHH-----HHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+..+.. +.+|+++++.+ +||||+.++++| +...+.++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l-kHpniv~m~esf--Et~~~~~v 78 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSL-KHPNIVEMLESF--ETSAHLWV 78 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhc-CCcchhhHHHhh--cccceEEE
Confidence 68999999999999999999999999999999998765544 88999999999 999999999999 55778999
Q ss_pred EEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-c
Q 019642 113 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E 188 (338)
Q Consensus 113 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-~ 188 (338)
|.||+.| +|..++ ..++++.+..++.+++.||.|||+.+|.|+|+||.|||++.+ +.+|+||||+++.+..+. .
T Consensus 79 Vte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~-~~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 79 VTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKG-GTLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred Eehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCC-CceeechhhhhhhcccCcee
Confidence 9999998 666665 469999999999999999999999999999999999999999 899999999998776543 3
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
.....|||.|||||+..+ .+++..+|+|||||++|++++|+.||+ ...+.++.+.+-.++..
T Consensus 157 ltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~-----a~si~~Lv~~I~~d~v~------------ 218 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFY-----ARSITQLVKSILKDPVK------------ 218 (808)
T ss_pred eeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCch-----HHHHHHHHHHHhcCCCC------------
Confidence 444579999999999987 899999999999999999999999994 22333333322221110
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
.+..++..+.+|+.++|.+||.+|.|..+++.|||.++.-
T Consensus 219 ---------------------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 219 ---------------------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred ---------------------CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence 1112789999999999999999999999999999988753
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-47 Score=328.71 Aligned_cols=277 Identities=32% Similarity=0.573 Sum_probs=210.5
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
++|++.+.||+|+||.||++.+..+++.+++|.++.. ....+.+|+.+++.+ +||||+++++.+.. ....++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 77 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQENIVELKEAFRR--RGKLYL 77 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhC-CCccccchhhhEec--CCEEEE
Confidence 4799999999999999999999999999999998642 235577899999999 99999999999854 567899
Q ss_pred EEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC--
Q 019642 113 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-- 187 (338)
Q Consensus 113 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-- 187 (338)
||||+.++++..+. ..+++..++.++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 78 VFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHN-DVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEEeeccCcccccccccc
Confidence 99999998776654 358999999999999999999999999999999999999988 899999999987654322
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......+++.|+|||++.+ ..++.++|+||||+++|+|++|+.||. +.+..+....+....+..+...+..... .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 231 (287)
T cd07848 157 NYTEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFP-GESEIDQLFTIQKVLGPLPAEQMKLFYS---N 231 (287)
T ss_pred cccccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhhCCCCHHHHHhhhc---c
Confidence 2223467889999999877 568999999999999999999998884 4444455555555544433222211000 0
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
+....... ..... ...........++.++.+||++||++||++|||++|+|+||||
T Consensus 232 ~~~~~~~~-~~~~~-~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 232 PRFHGLRF-PAVNH-PQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred chhccccc-CcccC-cccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00000000 00000 0000011122368899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=336.19 Aligned_cols=284 Identities=26% Similarity=0.479 Sum_probs=215.5
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC----
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---- 107 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~---- 107 (338)
.++|++.+.||+|+||.||++.+..+++.||+|.+... ....+.+|+.+++.+ +||||+++++++.....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCCcccc
Confidence 58999999999999999999999999999999998632 245567899999999 99999999998854321
Q ss_pred CccEEEEeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 108 KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
...+++|||+.++.+......+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~-~~~kl~Dfg~a~~~~~~~ 177 (359)
T cd07876 99 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTACTNF 177 (359)
T ss_pred ceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEecCCCccccccCc
Confidence 3578999999987666665678999999999999999999999999999999999999988 899999999987554433
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||. +.+..+....+.+.++.+.........
T Consensus 178 ~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 250 (359)
T cd07876 178 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQ-GTDHIDQWNKVIEQLGTPSAEFMNRLQ----- 250 (359)
T ss_pred cCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCCcHHHHHHHH-----
Confidence 3444578899999999977 678999999999999999999999984 444455555555555543322111000
Q ss_pred cchhhhhccccC----------CCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 268 PQLDALVGRHSR----------KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 268 ~~~~~~~~~~~~----------~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
............ ..+............++++.+||.+||+.||++|||+.|+|+||||+.+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 322 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY 322 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhc
Confidence 000000000000 00000001111223577899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-47 Score=333.23 Aligned_cols=261 Identities=30% Similarity=0.550 Sum_probs=219.9
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
...+.|++.+.||+|.||.||++.++.+|+.+|+|.+.+.. ...+.+|+.+|+++..||||+.+++.|.+ ..
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~--~~ 109 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED--PD 109 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc--CC
Confidence 44568999999999999999999999999999999987532 35789999999999559999999999965 45
Q ss_pred ccEEEEeeecCCccccccCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC---CCceEEEeccccccc
Q 019642 109 TPSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE---LRKLRLIDWGLAEFY 183 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~---~~~~~l~dfg~~~~~ 183 (338)
..++|||++.|+.|.+.+.. +++..+..++.|++.++.|||+.|++|+|+||+|+|+... .+.++++|||++...
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred eEEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 78899999999988877644 9999999999999999999999999999999999999554 247999999999988
Q ss_pred cCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccc
Q 019642 184 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263 (338)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
..+......+||+.|+|||++.. ..++..+|+||+|+++|.|++|..||+ +.+.......+...--
T Consensus 190 ~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~-~~~~~~~~~~i~~~~~------------ 255 (382)
T KOG0032|consen 190 KPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFW-GETEFEIFLAILRGDF------------ 255 (382)
T ss_pred cCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCc-CCChhHHHHHHHcCCC------------
Confidence 77667777899999999999987 689999999999999999999999994 3333333332222110
Q ss_pred cccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
.+.....+.++..+.+||++||..||..|+|+.++|+|||+++...++
T Consensus 256 ---------------------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~ 303 (382)
T KOG0032|consen 256 ---------------------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEAT 303 (382)
T ss_pred ---------------------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcccc
Confidence 122223334799999999999999999999999999999999875544
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=325.61 Aligned_cols=254 Identities=24% Similarity=0.399 Sum_probs=206.1
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
.|++.+.||+|+||.||++.+..+++.||+|.+.... ...+.+|+.+++++ +|++++++++.+.+ ....++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~--~~~~~l 77 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYET--KDALCL 77 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEcc--CCeEEE
Confidence 4889999999999999999999999999999876321 23467899999999 99999999999854 457899
Q ss_pred EEeeecCCcccccc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 113 IFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 113 v~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
+|||+.+++|...+ ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 78 v~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~-~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 78 VLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDR-GHIRISDLGLAVQIPEGE 156 (285)
T ss_pred EEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC-CCEEEeeCCCcEEcCCCC
Confidence 99999999987654 248899999999999999999999999999999999999987 789999999987654444
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......|+..|+|||++.+ ..++.++||||||+++|+|++|..||...... .....+........
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~------------- 221 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER-VKREEVDRRVKEDQ------------- 221 (285)
T ss_pred eecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcc-hhHHHHHHHhhccc-------------
Confidence 4444578999999999987 67899999999999999999999999543221 11111111110000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCC-----HHHHhcCCCcchhhhc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAA 331 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt-----~~ell~hp~~~~~~~~ 331 (338)
...+..++.++.+|+++||+.||++||+ ++++++||||.+++..
T Consensus 222 --------------------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05631 222 --------------------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFK 270 (285)
T ss_pred --------------------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHH
Confidence 0011236889999999999999999997 8999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=332.59 Aligned_cols=285 Identities=32% Similarity=0.578 Sum_probs=212.6
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC---Ccc
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---KTP 110 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~---~~~ 110 (338)
+|++.+.||+|+||.||+|.+..+++.||+|.++.. ....+.+|+.+++.+ +||||+++++++..... ...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhC-CCCCEeeecceEeccCCCCCceE
Confidence 699999999999999999999999999999987632 234577899999999 99999999998754322 357
Q ss_pred EEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 111 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
++||||+.+ +|...+ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 80 ~lv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 80 YVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFNDT 157 (338)
T ss_pred EEEEecCCC-CHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CcEEEccCcccccccccc
Confidence 899999975 555544 248999999999999999999999999999999999999988 899999999986542211
Q ss_pred c----ceeeeccccccccccccCc-CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcc
Q 019642 188 E----YNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262 (338)
Q Consensus 188 ~----~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
. .....+++.|+|||++.+. ..++.++||||||+++|+|++|+.|| .+.+....+..+....+.+.......-.
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF-PGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCC-CCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 1 1234688999999997642 46889999999999999999999888 3444455555555555554433222111
Q ss_pred ccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhccc
Q 019642 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 333 (338)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 333 (338)
............. ....+... ..+.+++++.++|.+||+.||++|||++|+|+||||+++.....
T Consensus 237 ~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~ 301 (338)
T cd07859 237 NEKARRYLSSMRK-KQPVPFSQ-----KFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVER 301 (338)
T ss_pred hhhHHHHHHhhcc-cCCCchHH-----hcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcccc
Confidence 1000000110000 00000000 11235788999999999999999999999999999998876543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-47 Score=328.42 Aligned_cols=249 Identities=24% Similarity=0.412 Sum_probs=205.6
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
++|++.+.||+|+||.||+|.+..+++.||+|.+... ..+.+.+|+.+++++ +||||+++++.+.+ ....+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~ 77 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTEHD--QRFLY 77 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhhcc--CCeEE
Confidence 5799999999999999999999999999999998632 234577899999999 99999999998854 56789
Q ss_pred EEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 112 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 112 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
+||||+.+++|.+++ ..+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~-~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKE-GHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEEEecCcchhccCC--
Confidence 999999999988776 348999999999999999999999999999999999999987 89999999998765432
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
.....|++.|+|||++.+ ..++.++||||||+++|+|++|..||... +..+....+... ..
T Consensus 155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~-~~~~~~~~i~~~--~~--------------- 215 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDD-NPFGIYEKILAG--KL--------------- 215 (291)
T ss_pred cccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhC--Cc---------------
Confidence 223468999999999877 67889999999999999999999998432 222222221110 00
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCC-----HHHHhcCCCcchhhhc
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAA 331 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt-----~~ell~hp~~~~~~~~ 331 (338)
..+..++..+.++|++||+.||.+||+ ++++++||||+.+...
T Consensus 216 --------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 263 (291)
T cd05612 216 --------------------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD 263 (291)
T ss_pred --------------------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence 011225789999999999999999995 9999999999876554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-48 Score=309.93 Aligned_cols=258 Identities=24% Similarity=0.477 Sum_probs=215.4
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----------chHHHHHHHHHHHHhcCCCCeeEeeeeeecc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ 105 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 105 (338)
.+.|.-.+.||.|..++|-++.++.+++.+++|++... -.+...+|+.+++++..||+|+++.+++ +
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y--e 93 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY--E 93 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec--c
Confidence 35788899999999999999999999999999997521 1244567999999999999999999999 4
Q ss_pred CCCccEEEEeeecCCccccccCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccc
Q 019642 106 HSKTPSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
Q Consensus 106 ~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~ 182 (338)
.....++|+|.+..|.|.+++.. +++...+.+++|+++|++|||.++|||+||||+|||++.+ .+++|+|||+++.
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn-~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDN-MNIKISDFGFACQ 172 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccc-cceEEeccceeec
Confidence 46688899999999999888864 9999999999999999999999999999999999999999 7999999999999
Q ss_pred ccCCCcceeeeccccccccccccC-----cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhh
Q 019642 183 YHPGKEYNVRVASRYFKGPELLVD-----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 257 (338)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
..++......+|||+|.|||.+.. .+.|+..+|+|++|++||-++.|..||+. ..++.. .+.+.....
T Consensus 173 l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH----RkQmlM-LR~ImeGky-- 245 (411)
T KOG0599|consen 173 LEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH----RKQMLM-LRMIMEGKY-- 245 (411)
T ss_pred cCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH----HHHHHH-HHHHHhccc--
Confidence 999999999999999999999853 34688999999999999999999999942 122221 111111110
Q ss_pred hhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
-+......++|.+..+||++||++||++|.|++|+|+||||..+-.-
T Consensus 246 ---------------------------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~ 292 (411)
T KOG0599|consen 246 ---------------------------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQ 292 (411)
T ss_pred ---------------------------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHh
Confidence 01111223379999999999999999999999999999999766433
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=332.20 Aligned_cols=249 Identities=24% Similarity=0.422 Sum_probs=205.8
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
..++|++.+.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++.+.+ ...
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~ 92 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQD--ENR 92 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEc--CCE
Confidence 357899999999999999999999999999999998642 234578899999999 99999999999955 467
Q ss_pred cEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 110 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
.+++|||+.+++|...+ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++......
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNK-GHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCC-CCEEEeeccCceEcCCC
Confidence 89999999999987776 348999999999999999999999999999999999999988 89999999998765432
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.....|++.|+|||++.+ ..++.++|+||||+++|+|++|..||... +.......+.. +..
T Consensus 172 --~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~--~~~------------- 232 (329)
T PTZ00263 172 --TFTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDD-TPFRIYEKILA--GRL------------- 232 (329)
T ss_pred --cceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCC-CHHHHHHHHhc--CCc-------------
Confidence 233578999999999877 67889999999999999999999998432 22222211111 000
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCC-----HHHHhcCCCcchhh
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVR 329 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt-----~~ell~hp~~~~~~ 329 (338)
..+..++..+.+||++||+.||++||+ ++++++||||.+..
T Consensus 233 ----------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~ 278 (329)
T PTZ00263 233 ----------------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGAN 278 (329)
T ss_pred ----------------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCC
Confidence 001126788999999999999999997 79999999998753
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=336.75 Aligned_cols=288 Identities=23% Similarity=0.323 Sum_probs=211.7
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
...++|++.+.||+|+||.||++.+..+++.||+|... ...+.+|+.+++++ +||||+++++++.. ....++++
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~~lv~ 162 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---RGGTATEAHILRAI-NHPSIIQLKGTFTY--NKFTCLIL 162 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---hhhhHHHHHHHHhC-CCCCCCCEeEEEEE--CCeeEEEE
Confidence 34578999999999999999999999999999999754 34567899999999 99999999999955 45788999
Q ss_pred eeecCCcccccc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC--Ccce
Q 019642 115 EYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG--KEYN 190 (338)
Q Consensus 115 e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~--~~~~ 190 (338)
|++.+..+..+. ..++...++.++.|++.||.|||++||+|+||||+||+++.. +.++|+|||++...... ....
T Consensus 163 e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~-~~vkL~DFG~a~~~~~~~~~~~~ 241 (391)
T PHA03212 163 PRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHP-GDVCLGDFGAACFPVDINANKYY 241 (391)
T ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCC-CCEEEEeCCcccccccccccccc
Confidence 999754433332 358999999999999999999999999999999999999988 88999999998643221 1223
Q ss_pred eeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCC------CCHHHHHHHHHHhCCchhhhhhhcccc
Q 019642 191 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH------DNHDQLVKIAKVLGTDELNAYLNKYHL 264 (338)
Q Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
...||+.|+|||++.+ ..++.++||||||+++|+|++|..||+... +....+..+....+..+.. +......
T Consensus 242 ~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~-~~~~~~~ 319 (391)
T PHA03212 242 GWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE-FPIDAQA 319 (391)
T ss_pred cccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh-cCcchhH
Confidence 3578999999999877 678999999999999999999999886533 2234555555555543211 0000000
Q ss_pred ccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
................+... ........++.++.+||.+||+.||++|||+.|+|+||||.+++.+-
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~ 386 (391)
T PHA03212 320 NLDEIYIGLAKKSSRKPGSR-PLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDPY 386 (391)
T ss_pred HHHHHHHHHHhccCCCCCCC-CCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCCC
Confidence 00000000000111110000 00001112567899999999999999999999999999999986553
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-46 Score=330.68 Aligned_cols=285 Identities=26% Similarity=0.477 Sum_probs=214.9
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccC----
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---- 106 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~---- 106 (338)
..++|++.+.||+|+||.||++.+..+++.+++|.+... ....+.+|+.+++.+ +||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHh-CCCchhceeeeeeccccccc
Confidence 357999999999999999999999999999999998642 234567899999999 9999999999885432
Q ss_pred CCccEEEEeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 107 SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
....+++|||++++........++...++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++......
T Consensus 94 ~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~-~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 94 FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTS 172 (355)
T ss_pred cceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCC-CCEEEeeCcccccCCCc
Confidence 23578999999987666665678999999999999999999999999999999999999988 89999999999765544
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||. +.+..+......+.++.+....+...
T Consensus 173 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~----- 245 (355)
T cd07874 173 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFP-GRDYIDQWNKVIEQLGTPCPEFMKKL----- 245 (355)
T ss_pred cccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHhCCCCHHHHHhh-----
Confidence 44445678999999999877 678999999999999999999999984 44444555555555544322211100
Q ss_pred CcchhhhhccccC---CCC-----ccc--ccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 267 DPQLDALVGRHSR---KPW-----SKF--INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 267 ~~~~~~~~~~~~~---~~~-----~~~--~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
.+........... ... ... .........+.++.+||.+||+.||++|||+.|+|+||||....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~ 318 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY 318 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence 0000000000000 000 000 01111223467889999999999999999999999999997553
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=320.70 Aligned_cols=274 Identities=30% Similarity=0.566 Sum_probs=208.0
Q ss_pred CcEEEEEeeeecCceeEEEEEEcC-CCceEEEEEeccc-----chHHHHHHHHHHHHhc--CCCCeeEeeeeeec---cC
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVN-TNERCIIKILKPV-----KKKKIKREIKILQNLC--GGPNVVKLLDIVRD---QH 106 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~--~h~~iv~~~~~~~~---~~ 106 (338)
++|++.+.||+|+||.||+|.+.. +++.+|+|.++.. ......+|+.+++.+. .||||+++++++.. ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999854 5688999987632 1234567888877763 59999999998752 23
Q ss_pred CCccEEEEeeecCCcccccc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 107 SKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
....+++|||+.+ ++..++ ..+++..++.++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++.
T Consensus 81 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~-~~~kl~Dfg~~~ 158 (290)
T cd07862 81 ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLAR 158 (290)
T ss_pred CCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCC-CCEEEccccceE
Confidence 4568899999986 444443 237899999999999999999999999999999999999988 899999999987
Q ss_pred cccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 182 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
............+++.|+|||.+.+ ..++.++|+||||+++|+|++|..|| .+.+..+.+..+....+.+....+...
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f-~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 159 IYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred eccCCcccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCc-CCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 6554444445678899999999876 67889999999999999999999887 445556666666666665544433222
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
..... ..+......+... ..+.++..+.+++.+||+.||++|||+.++|+||||
T Consensus 237 ~~~~~-----~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 237 VALPR-----QAFHSKSAQPIEK-----FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hcccc-----hhccCCCCCCHHH-----HccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 11100 0000001111111 112368889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=323.28 Aligned_cols=284 Identities=28% Similarity=0.552 Sum_probs=218.3
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
...++|++.+.||+|+||.||+|.+..+++.+|+|.++.. ......+|+.+++++ +||||+++++++.. ....
T Consensus 3 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~ 79 (309)
T cd07872 3 GKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIVHT--DKSL 79 (309)
T ss_pred CCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhC-CCCCcceEEEEEee--CCeE
Confidence 3458899999999999999999999999999999998632 234567899999999 99999999999855 4578
Q ss_pred EEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 111 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
++||||+.+..+.... ..++...++.++.|++.||.+||++|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 80 TLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINER-GELKLADFGLARAKSVPT 158 (309)
T ss_pred EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECccccceecCCCc
Confidence 9999999875443332 237889999999999999999999999999999999999988 899999999986543222
Q ss_pred -cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 188 -EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 188 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
......+++.|+|||.+.+...++.++|+||||+++|+|++|..|| ...+..+.+..+.+.++.+....+........
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF-PGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 2233467889999999876567899999999999999999999998 44555667777777777666554432111100
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
............+ . ......++.++.++|.+||+.||.+|||+.|+|+||||+.+..
T Consensus 238 --~~~~~~~~~~~~~---~--~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 294 (309)
T cd07872 238 --FKNYNFPKYKPQP---L--INHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT 294 (309)
T ss_pred --hhhhhcCccCCCc---h--hhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence 0000000000000 0 0111237889999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=331.30 Aligned_cols=286 Identities=26% Similarity=0.472 Sum_probs=215.8
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccC----
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---- 106 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~---- 106 (338)
..++|++.+.||+|+||.||++.+..+++.||+|.+... ....+.+|+.+++.+ +||||+++++++....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhc-CCCCccccceeecccccccc
Confidence 357999999999999999999999999999999998642 234577899999999 9999999999875432
Q ss_pred CCccEEEEeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 107 SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
....++||||+.++........++...++.++.|++.||.+||++|++|+||||+||+++.+ +.++|+|||++......
T Consensus 101 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 101 FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTS 179 (364)
T ss_pred cCeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCC-CcEEEEeCCCccccCCC
Confidence 23578999999887666555668999999999999999999999999999999999999988 89999999999765444
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.......++..|+|||++.+ ..++.++||||||+++|+|++|..|| .+.+..+....+.+.++.+....... ..
T Consensus 180 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--- 253 (364)
T cd07875 180 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLF-PGTDHIDQWNKVIEQLGTPCPEFMKK-LQ--- 253 (364)
T ss_pred CcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCCHHHHHh-hh---
Confidence 33445578899999999977 67899999999999999999999998 44455555666655555433221110 00
Q ss_pred Ccchhhhhcccc---CCCCccc-------ccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 267 DPQLDALVGRHS---RKPWSKF-------INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 267 ~~~~~~~~~~~~---~~~~~~~-------~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
+.......... ...+... .........++++++||.+||+.||++|||+.|+|+||||..+..
T Consensus 254 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 326 (364)
T cd07875 254 -PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 326 (364)
T ss_pred -HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccC
Confidence 00000000000 0000000 000111124678999999999999999999999999999986433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=330.92 Aligned_cols=257 Identities=29% Similarity=0.476 Sum_probs=208.3
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+..|+.++..+ +||||+++++.+.+ ....+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~--~~~~~ 77 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-KSEWLVKLLYAFQD--DEYLY 77 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-CCCCCccEEEEEEc--CCEEE
Confidence 4799999999999999999999999999999998642 234577899999999 89999999999854 56789
Q ss_pred EEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 112 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 112 lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
+||||+.+++|..++. .+++..++.++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||++..... .
T Consensus 78 lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kL~Dfg~a~~~~~--~ 154 (333)
T cd05600 78 LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDAS-GHIKLTDFGLSKGIVT--Y 154 (333)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CCEEEEeCcCCccccc--c
Confidence 9999999999988873 48999999999999999999999999999999999999988 8999999999875443 2
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
.....|++.|+|||++.+ ..++.++||||||+++|+|++|..||.. .+..+....+..........
T Consensus 155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~------------ 220 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWENLKYWKETLQRP------------ 220 (333)
T ss_pred cCCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCCC-CCHHHHHHHHHhccccccCC------------
Confidence 334578999999999987 5889999999999999999999999842 22222222221110000000
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
. .......+++++.++|.+||..+|.+||++.++++||||+++...
T Consensus 221 ------------~-----~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~ 266 (333)
T cd05600 221 ------------V-----YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWN 266 (333)
T ss_pred ------------C-----CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHH
Confidence 0 000002268999999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-46 Score=332.42 Aligned_cols=255 Identities=26% Similarity=0.424 Sum_probs=202.7
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
++|++.+.||+|+||+||++.+..+++.||+|+++.. ....+..|+.++..+ +||+|+++++.+.+ ....+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~--~~~~~ 77 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQD--KLNLY 77 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEec--CCeEE
Confidence 5899999999999999999999999999999998642 224567899999999 99999999999955 56789
Q ss_pred EEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 112 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 112 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
+||||+.+++|..++ ..+++..++.++.|++.||.|||++|++|+||||+|||++.+ +.++|+|||++........
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~-~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSK-GHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred EEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC-CCEEEeeccCccccccccc
Confidence 999999999988776 358999999999999999999999999999999999999988 8999999999864421100
Q ss_pred ------------------------------------ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCC
Q 019642 189 ------------------------------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 232 (338)
Q Consensus 189 ------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~p 232 (338)
.....||+.|+|||++.+ ..++.++|+||||+++|+|++|..|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCC
Confidence 112468999999999977 6789999999999999999999999
Q ss_pred CcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcC-
Q 019642 233 FFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQ- 311 (338)
Q Consensus 233 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~- 311 (338)
|. +.+..+....+......... .....+++++.++|.+|+. +|.
T Consensus 236 f~-~~~~~~~~~~i~~~~~~~~~---------------------------------p~~~~~s~~~~~li~~l~~-~~~~ 280 (363)
T cd05628 236 FC-SETPQETYKKVMNWKETLIF---------------------------------PPEVPISEKAKDLILRFCC-EWEH 280 (363)
T ss_pred CC-CCCHHHHHHHHHcCcCcccC---------------------------------CCcCCCCHHHHHHHHHHcC-Chhh
Confidence 94 22323333222211000000 0011268899999999875 444
Q ss_pred --CcCCHHHHhcCCCcchhhhcc
Q 019642 312 --DRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 312 --~Rpt~~ell~hp~~~~~~~~~ 332 (338)
.||+++|+++||||+++....
T Consensus 281 r~~r~~~~ei~~hp~f~~~~~~~ 303 (363)
T cd05628 281 RIGAPGVEEIKTNPFFEGVDWEH 303 (363)
T ss_pred cCCCCCHHHHhCCCCCCCCCHHH
Confidence 468999999999999875443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=325.71 Aligned_cols=254 Identities=24% Similarity=0.436 Sum_probs=225.0
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
+=|.+.+.||+|-|++|-++++.-+|..||||++.+.. ...+.+|++-|+.+ +|||||++|++... ...+|+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLV-QHpNiVRLYEViDT--QTKlyL 94 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV-QHPNIVRLYEVIDT--QTKLYL 94 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHh-cCcCeeeeeehhcc--cceEEE
Confidence 35889999999999999999999999999999997643 45688999999998 99999999999844 457899
Q ss_pred EEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 113 IFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 113 v~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
|.|..++|+|.+++. .+.+...++++.||+.|+.|+|+..+||+||||+|+.+....|-+||+|||++..+.++..
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 999999999999873 4999999999999999999999999999999999999988779999999999999999999
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
....+|+..|.|||++.+.....+++||||||++||.++.|+.||.. .++.+.+..+..+.-
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqe-ANDSETLTmImDCKY----------------- 236 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQE-ANDSETLTMIMDCKY----------------- 236 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccc-ccchhhhhhhhcccc-----------------
Confidence 99999999999999999988888999999999999999999999954 444555555544322
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
..+..++.++++||..||..||.+|.++++|..++|++.+.+..
T Consensus 237 --------------------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 237 --------------------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL 280 (864)
T ss_pred --------------------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence 23344799999999999999999999999999999999887653
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=333.77 Aligned_cols=256 Identities=32% Similarity=0.552 Sum_probs=208.2
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
++|++.+.||+|+||+||+|.+..+++.||+|+++.. ....+..|+.++..+ +||||+++++.+.+ ....+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~ 77 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSFQD--EEHLY 77 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhheec--CCeEE
Confidence 5799999999999999999999999999999998642 234577899999999 89999999999854 56789
Q ss_pred EEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-
Q 019642 112 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 187 (338)
Q Consensus 112 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~- 187 (338)
+||||+.+++|..++ ..+++..++.++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDAD-GHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEeecCCCCccCcccCc
Confidence 999999999988776 358999999999999999999999999999999999999988 899999999987654322
Q ss_pred -----------------------------cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCC
Q 019642 188 -----------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 238 (338)
Q Consensus 188 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~ 238 (338)
......|++.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~- 234 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT- 234 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCCC-
Confidence 2233568899999999987 588999999999999999999999994332
Q ss_pred CHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCC-HH
Q 019642 239 NHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-AR 317 (338)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt-~~ 317 (338)
..+....+...... ........+++++.+||.+||+ ||.+||+ ++
T Consensus 235 ~~~~~~~i~~~~~~---------------------------------~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~ 280 (350)
T cd05573 235 LQETYNKIINWKES---------------------------------LRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFE 280 (350)
T ss_pred HHHHHHHHhccCCc---------------------------------ccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHH
Confidence 22222222110000 0000111168999999999997 9999999 99
Q ss_pred HHhcCCCcchhhhccc
Q 019642 318 EAMAHPYFAQVRAAES 333 (338)
Q Consensus 318 ell~hp~~~~~~~~~~ 333 (338)
++++||||+++.....
T Consensus 281 ~ll~hp~~~~~~~~~~ 296 (350)
T cd05573 281 EIKSHPFFKGIDWENL 296 (350)
T ss_pred HHhcCCCcCCCCHHHH
Confidence 9999999998765443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=327.89 Aligned_cols=244 Identities=27% Similarity=0.444 Sum_probs=199.0
Q ss_pred EeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeee
Q 019642 44 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 117 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~ 117 (338)
+.||+|+||.||++.+..+++.||+|+++.. ....+..|+.+++++ +||||+++++.+.. ....++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~--~~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSFQT--HDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEc--CCEEEEEEeCC
Confidence 3699999999999999999999999998742 224467899999999 99999999999854 56789999999
Q ss_pred cCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc-CCCcceeee
Q 019642 118 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRV 193 (338)
Q Consensus 118 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~-~~~~~~~~~ 193 (338)
.+++|...+ ..+++..++.++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++.... .........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~-~~~kl~DfG~a~~~~~~~~~~~~~~ 156 (323)
T cd05571 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC-CCEEEeeCCCCcccccCCCccccee
Confidence 999987765 348999999999999999999999999999999999999988 889999999986432 222233456
Q ss_pred ccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhh
Q 019642 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL 273 (338)
Q Consensus 194 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (338)
|++.|+|||++.+ ..++.++|+||||+++|+|++|..||... +.......+.. +..
T Consensus 157 gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~-~~~~~~~~~~~--~~~-------------------- 212 (323)
T cd05571 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKLFELILM--EEI-------------------- 212 (323)
T ss_pred cCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCC-CHHHHHHHHHc--CCC--------------------
Confidence 8999999999877 67899999999999999999999999432 21111111100 000
Q ss_pred hccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC-----CHHHHhcCCCcchhhh
Q 019642 274 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRA 330 (338)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~ 330 (338)
..+..+++++.+||++||+.||++|| ++.++++||||.++..
T Consensus 213 ---------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~ 259 (323)
T cd05571 213 ---------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINW 259 (323)
T ss_pred ---------------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 01123689999999999999999999 8999999999988643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=330.99 Aligned_cols=283 Identities=30% Similarity=0.536 Sum_probs=216.5
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC---Ccc
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---KTP 110 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~---~~~ 110 (338)
+|++.+.||+|+||.||++.+..+++.||+|.+... ..+.+.+|+.+++.+ +||||+++++++..... ...
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-KHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhC-CCCCcCCHhheecCCCccccceE
Confidence 578999999999999999999999999999988642 234678899999999 99999999999865431 267
Q ss_pred EEEEeeecCCcccccc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-
Q 019642 111 SLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 187 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~- 187 (338)
++||||+.+....... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 80 YVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN-CVLKICDFGLARVEEPDES 158 (372)
T ss_pred EEEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCC-CCEEeccccceeecccCcc
Confidence 8999999865443332 348999999999999999999999999999999999999988 899999999987543221
Q ss_pred -cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 188 -EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 188 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
......+++.|+|||.+.+...++.++||||+|+++|+|++|+.|| .+.+..+++..+.+.++.+....+.....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~g~~~~~~~~~~~~--- 234 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILF-QAQSPIQQLDLITDLLGTPSLEAMRSACE--- 234 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHHcCCCCHHHHHHhhH---
Confidence 2223457889999999887556889999999999999999999998 45566677777888777766554432211
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
............+.............++++.+||.+||+.||++|||+.|+|+||||.+..
T Consensus 235 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 235 --GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred --HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 0011110000000000000112233588999999999999999999999999999998853
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=333.15 Aligned_cols=254 Identities=30% Similarity=0.496 Sum_probs=203.8
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
++|++.+.||+|+||+||+|.+..+++.||+|+++.. ....+.+|+.+++.+ +||||+++++.+.+ ....+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~--~~~~~ 77 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSFQD--ENYLY 77 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEc--CCeEE
Confidence 5799999999999999999999999999999998642 223467899999999 89999999999955 56889
Q ss_pred EEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 112 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 112 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
+||||+.+++|..++ ..+++..++.++.|++.||.|||+.|++|+||||+|||++.+ +.++|+|||++........
T Consensus 78 lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAK-GHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred EEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEeecccceecccccc
Confidence 999999999998776 348999999999999999999999999999999999999988 8999999998865421110
Q ss_pred ---------------------------------------ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhc
Q 019642 189 ---------------------------------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR 229 (338)
Q Consensus 189 ---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg 229 (338)
.....||+.|+|||++.+ ..++.++|+|||||++|+|++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcC
Confidence 011358999999999877 6789999999999999999999
Q ss_pred CCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCC
Q 019642 230 KEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYD 309 (338)
Q Consensus 230 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~d 309 (338)
..||... +..+....+...... ........+++++.++|.+||. +
T Consensus 236 ~~Pf~~~-~~~~~~~~i~~~~~~---------------------------------~~~~~~~~~s~~~~~li~~ll~-~ 280 (364)
T cd05599 236 YPPFCSD-NPQETYRKIINWKET---------------------------------LQFPDEVPLSPEAKDLIKRLCC-E 280 (364)
T ss_pred CCCCCCC-CHHHHHHHHHcCCCc---------------------------------cCCCCCCCCCHHHHHHHHHHcc-C
Confidence 9999432 222222211110000 0000111268899999999997 9
Q ss_pred cCCcCC---HHHHhcCCCcchhhhc
Q 019642 310 HQDRLT---AREAMAHPYFAQVRAA 331 (338)
Q Consensus 310 P~~Rpt---~~ell~hp~~~~~~~~ 331 (338)
|.+|++ +.++++||||++....
T Consensus 281 p~~R~~~~~~~~ll~h~~~~~~~~~ 305 (364)
T cd05599 281 AERRLGNNGVNEIKSHPFFKGVDWE 305 (364)
T ss_pred HhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 999998 9999999999887543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=317.63 Aligned_cols=273 Identities=27% Similarity=0.546 Sum_probs=208.0
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhc--CCCCeeEeeeeeecc---CCC
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLC--GGPNVVKLLDIVRDQ---HSK 108 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~--~h~~iv~~~~~~~~~---~~~ 108 (338)
+|++.+.||+|+||+||+|.+..+++.|++|.++.. ......+|+.+++.+. +||||+++++++... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 589999999999999999999999999999988642 1234567888877663 699999999988542 234
Q ss_pred ccEEEEeeecCCcccccc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 109 TPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
..+++||++.+. +..++ ..+++..++.++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++...
T Consensus 81 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~-~~~kl~dfg~~~~~ 158 (288)
T cd07863 81 KVTLVFEHVDQD-LRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-GQVKLADFGLARIY 158 (288)
T ss_pred eEEEEEcccccC-HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECccCccccc
Confidence 578999999864 44333 238999999999999999999999999999999999999988 88999999998765
Q ss_pred cCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccc
Q 019642 184 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263 (338)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
..........++..|+|||++.+ ..++.++|+||+|+++|+|++|..|| ......+.+..+....+.+....+.....
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07863 159 SCQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLF-CGNSEADQLGKIFDLIGLPPEDDWPRDVT 236 (288)
T ss_pred cCcccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCc-CCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence 54444444567889999999877 67899999999999999999998877 44455556666666665544433322111
Q ss_pred cccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
..... .......+. ....+.+++.+.++|.+||+.||++|||+.|+++||||
T Consensus 237 ~~~~~-----~~~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 237 LPRGA-----FSPRGPRPV-----QSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccc-----cCCCCCCch-----HHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00000 000000000 11112367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=327.75 Aligned_cols=252 Identities=21% Similarity=0.382 Sum_probs=205.7
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCC-ceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTN-ERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
...++|++.+.||+|+||.||+|.+..++ ..||+|.+... ..+.+.+|+.+++.+ +||||+++++++.+ .
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~--~ 103 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSFKD--E 103 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCCcceEEEEEe--C
Confidence 34578999999999999999999876655 68999987532 234577899999999 99999999999955 4
Q ss_pred CccEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 108 KTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
...++||||+.+++|..++. .+++..+..++.|++.||.|||+.|++|+||||+|||++.+ +.++|+|||++....
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~-~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKD-GFIKMTDFGFAKVVD 182 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC-CCEEEecCCCCeecC
Confidence 67899999999999887763 48999999999999999999999999999999999999987 899999999987653
Q ss_pred CCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccc
Q 019642 185 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264 (338)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
.. .....|++.|+|||++.+ ..++.++|+||||+++|+|++|..||... +.......+... .
T Consensus 183 ~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~-~~~~~~~~i~~~--~------------ 244 (340)
T PTZ00426 183 TR--TYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYAN-EPLLIYQKILEG--I------------ 244 (340)
T ss_pred CC--cceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCC-CHHHHHHHHhcC--C------------
Confidence 22 234578999999999977 67889999999999999999999999432 222222221110 0
Q ss_pred ccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC-----CHHHHhcCCCcchhhhc
Q 019642 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAA 331 (338)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~~ 331 (338)
...+..+++.+.++|++||+.||++|+ +++++++||||+++...
T Consensus 245 -----------------------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~ 293 (340)
T PTZ00426 245 -----------------------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV 293 (340)
T ss_pred -----------------------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 001223688999999999999999995 89999999999987543
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-46 Score=333.14 Aligned_cols=253 Identities=27% Similarity=0.466 Sum_probs=201.3
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
++|++.+.||+|+||.||++.+..+++.||+|++... ..+.+.+|+++++.+ +||||+++++.+.+ ....+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~--~~~~~ 77 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQD--AQYLY 77 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEc--CCeeE
Confidence 5799999999999999999999999999999987532 234567899999999 99999999999955 56789
Q ss_pred EEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 112 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 112 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
+||||+.+++|..++ ..+++..++.++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||+++.......
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~-~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRG-GHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC-CCEEEeecccccccccccc
Confidence 999999999998776 348899999999999999999999999999999999999988 8999999998853211000
Q ss_pred ------------------------------------------------ceeeeccccccccccccCcCCCCCcchhHHHH
Q 019642 189 ------------------------------------------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 220 (338)
Q Consensus 189 ------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG 220 (338)
.....||+.|+|||++.+ ..++.++|+||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG 235 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLG 235 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecc
Confidence 001358899999999877 6789999999999
Q ss_pred HHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHH
Q 019642 221 CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAID 300 (338)
Q Consensus 221 ~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ 300 (338)
|++|+|++|..||.. .+..+....+....... .......++.++.+
T Consensus 236 vil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~---------------------------------~~p~~~~~s~~~~d 281 (377)
T cd05629 236 AIMFECLIGWPPFCS-ENSHETYRKIINWRETL---------------------------------YFPDDIHLSVEAED 281 (377)
T ss_pred hhhhhhhcCCCCCCC-CCHHHHHHHHHccCCcc---------------------------------CCCCCCCCCHHHHH
Confidence 999999999999843 22223222221100000 00011126889999
Q ss_pred HHHHhcCCCcCCc---CCHHHHhcCCCcchhhh
Q 019642 301 FLDKLLRYDHQDR---LTAREAMAHPYFAQVRA 330 (338)
Q Consensus 301 li~~~L~~dP~~R---pt~~ell~hp~~~~~~~ 330 (338)
||.+||. +|.+| +|+.++++||||+++..
T Consensus 282 li~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 282 LIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred HHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 9999997 77765 59999999999997654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=321.03 Aligned_cols=281 Identities=25% Similarity=0.505 Sum_probs=205.3
Q ss_pred EEeeeecCceeEEEEEEc--CCCceEEEEEecccc-hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeecC
Q 019642 43 VRKVGRGKYSEVFEGINV--NTNERCIIKILKPVK-KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS 119 (338)
Q Consensus 43 ~~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~-~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 119 (338)
..+||+|+||+||+|.+. .+++.+++|.+.... ...+.+|+.+++++ +||||+++++.+........+++|||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhc-CCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 358999999999999865 467889999987533 45578899999999 99999999999876666778999999876
Q ss_pred Ccccccc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEec---CCCCceEEEeccccccccC
Q 019642 120 TDFKVLY-----------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 120 ~~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~---~~~~~~~l~dfg~~~~~~~ 185 (338)
....... ..+++..++.++.|++.||.|||++|++|+||||+|||++ ...+.+||+|||++.....
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~ 164 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCC
Confidence 5332211 1488999999999999999999999999999999999994 2336899999999876543
Q ss_pred CC----cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCC--------CHHHHHHHHHHhCCc
Q 019642 186 GK----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--------NHDQLVKIAKVLGTD 253 (338)
Q Consensus 186 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~--------~~~~~~~~~~~~~~~ 253 (338)
.. ......+|+.|+|||++.+...++.++|+||+|+++|+|++|..||..... ..+++..+...++.+
T Consensus 165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (317)
T cd07868 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 244 (317)
T ss_pred CCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCC
Confidence 22 223356789999999987756789999999999999999999999854322 234566666666665
Q ss_pred hhhhhhhccccccCcchhhhhccccC--CCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 254 ELNAYLNKYHLELDPQLDALVGRHSR--KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
....+..................... ....... .......+.++.+||.+||+.||.+|||++|+|+||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 245 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYM-EKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred ChHHhHHHhhccchhhhhhhhhccccCcccccchH-HhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 55444332221111111110000000 0000000 01112245678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=315.69 Aligned_cols=258 Identities=26% Similarity=0.418 Sum_probs=215.7
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
.-+.|++++.||.|.-|+||++....++..+|+|++.+.. ..+...|-++|+.+ .||.++.+|..| +....
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~f--et~~~ 151 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASF--ETDKY 151 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhhee--eccce
Confidence 3468899999999999999999999999999999997532 34567799999999 999999999999 44678
Q ss_pred cEEEEeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 110 PSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
.|++||||.||+|..+.+ .+++..++.++.+|+.||+|||-.|||+|||||+|||+..+ |++.|+||.++....
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvred-GHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVRED-GHIMLSDFDLSLRCP 230 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecC-CcEEeeeccccccCC
Confidence 999999999999988874 39999999999999999999999999999999999999999 999999999862221
Q ss_pred C-----------------------------------C----------------------CcceeeeccccccccccccCc
Q 019642 185 P-----------------------------------G----------------------KEYNVRVASRYFKGPELLVDL 207 (338)
Q Consensus 185 ~-----------------------------------~----------------------~~~~~~~~~~~y~aPE~~~~~ 207 (338)
- . ......+||..|.|||++.+
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G- 309 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG- 309 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-
Confidence 0 0 01122467888999999998
Q ss_pred CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCccccc
Q 019642 208 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFIN 287 (338)
Q Consensus 208 ~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (338)
...+.++|-|+||+.+|||+.|..|| .+.++.+.+..+...-.. .
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPF-KG~~~~~Tl~NIv~~~l~--F-------------------------------- 354 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPF-KGSNNKETLRNIVGQPLK--F-------------------------------- 354 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCc-CCCCchhhHHHHhcCCCc--C--------------------------------
Confidence 78899999999999999999999998 667766666654321100 0
Q ss_pred ccCCCCCChhHHHHHHHhcCCCcCCcCC----HHHHhcCCCcchhhhcccc
Q 019642 288 ADNQHLVSPEAIDFLDKLLRYDHQDRLT----AREAMAHPYFAQVRAAESS 334 (338)
Q Consensus 288 ~~~~~~~s~~l~~li~~~L~~dP~~Rpt----~~ell~hp~~~~~~~~~~~ 334 (338)
...+.++..+++||+++|.+||++|.. |.||.+||||+++.++=.+
T Consensus 355 -p~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir 404 (459)
T KOG0610|consen 355 -PEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIR 404 (459)
T ss_pred -CCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhhee
Confidence 011137889999999999999999998 9999999999999987444
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=330.10 Aligned_cols=255 Identities=27% Similarity=0.456 Sum_probs=200.9
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
..|++++.||+|+||+||+|.+..+++.||+|++... ....+.+|+.+++.+ +||||+++++.+.+ ....+
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~--~~~~~ 77 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSFQD--KDNLY 77 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEEec--CCEEE
Confidence 3689999999999999999999999999999998642 234577899999999 99999999999965 46789
Q ss_pred EEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-
Q 019642 112 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 187 (338)
Q Consensus 112 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~- 187 (338)
+||||+.+++|..++ ..+++..++.++.|++.||.|||+.||+|+||||+|||++.+ +.++|+|||++.......
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~-~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 78 FVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCC-CCEEEeeCcCCcccccccc
Confidence 999999999988776 348899999999999999999999999999999999999987 899999999864321000
Q ss_pred -----------------------------------------------cceeeeccccccccccccCcCCCCCcchhHHHH
Q 019642 188 -----------------------------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 220 (338)
Q Consensus 188 -----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG 220 (338)
......||+.|+|||++.+ ..++.++||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG 235 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVG 235 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehh
Confidence 0012368899999999877 6789999999999
Q ss_pred HHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHH
Q 019642 221 CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAID 300 (338)
Q Consensus 221 ~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ 300 (338)
|++|+|++|..||..... .+....+....... .......+++++.+
T Consensus 236 ~il~elltG~~Pf~~~~~-~~~~~~i~~~~~~~---------------------------------~~~~~~~~s~~~~d 281 (381)
T cd05626 236 VILFEMLVGQPPFLAPTP-TETQLKVINWENTL---------------------------------HIPPQVKLSPEAVD 281 (381)
T ss_pred hHHHHHHhCCCCCcCCCH-HHHHHHHHcccccc---------------------------------CCCCCCCCCHHHHH
Confidence 999999999999954322 22111111100000 00011126899999
Q ss_pred HHHHhc--CCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 301 FLDKLL--RYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 301 li~~~L--~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
||.+|+ ..+|..|++++++++||||.++...
T Consensus 282 li~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~ 314 (381)
T cd05626 282 LITKLCCSAEERLGRNGADDIKAHPFFSEVDFS 314 (381)
T ss_pred HHHHHccCcccccCCCCHHHHhcCcccCCCChh
Confidence 999965 4555569999999999999986543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=320.97 Aligned_cols=280 Identities=19% Similarity=0.318 Sum_probs=209.2
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
.++|++.+.||+|+||.||++.+..++..+++|.+... ....+.+|+++++++ +||||+++++++.. ....++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYS--DGEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEE--CCEEEE
Confidence 58999999999999999999999999999999998643 235688999999999 99999999999855 457899
Q ss_pred EEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 113 IFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 113 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
||||+.+++|.+++. .+++..+..++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||++...... .
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~-~ 158 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-M 158 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCC-CcEEEccCccccccccc-c
Confidence 999999999988873 489999999999999999999986 69999999999999988 88999999998655332 2
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhh------cc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN------KY 262 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 262 (338)
.....+++.|+|||++.+ ..++.++|+||||+++|+|++|+.||.... ...+.. .++......... ..
T Consensus 159 ~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~--~~~~~~---~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 159 ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPD--AKELEA---IFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred cccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCC--HHHHHH---HhcccccccccCCccccCcc
Confidence 233468899999999877 678999999999999999999999994222 122221 122111000000 00
Q ss_pred ccccCc-------------chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 263 HLELDP-------------QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 263 ~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
...... ............. ........+++++.+||.+||+.||++|||+.++++||||+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEP----PPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCC----CcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 000000 0000000000000 00111123688999999999999999999999999999998765
Q ss_pred hc
Q 019642 330 AA 331 (338)
Q Consensus 330 ~~ 331 (338)
..
T Consensus 309 ~~ 310 (331)
T cd06649 309 VE 310 (331)
T ss_pred cc
Confidence 43
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-45 Score=314.90 Aligned_cols=254 Identities=26% Similarity=0.398 Sum_probs=205.6
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
.|++.+.||+|+||.||++.+..+++.||+|.+.... ...+.+|+.+++.+ +||||+++++.+.. ....++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 77 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYET--KDALCL 77 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecC--CCeEEE
Confidence 4899999999999999999999999999999986422 23456799999999 99999999999854 457899
Q ss_pred EEeeecCCcccccc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 113 IFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 113 v~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
+|||+.+++|...+ ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 78 VLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDY-GHIRISDLGLAVEIPEGE 156 (285)
T ss_pred EEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCC-CCEEEeeCCCceecCCCC
Confidence 99999999987664 248999999999999999999999999999999999999988 889999999987654443
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......++..|+|||++.+ ..++.++|+||+|+++|+|++|..||... +.......+...+....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~-~~~~~~~~~~~~~~~~~------------- 221 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQR-KEKVKREEVERRVKEDQ------------- 221 (285)
T ss_pred ccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCC-chhhHHHHHHHHhhhcc-------------
Confidence 3344578899999999876 67889999999999999999999998432 22222222211111000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC-----CHHHHhcCCCcchhhhc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAA 331 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~~ 331 (338)
...+..++..+.+||.+||..||++|| +++++++||||+.....
T Consensus 222 --------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05605 222 --------------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK 270 (285)
T ss_pred --------------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence 001122688999999999999999999 99999999999985444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=328.48 Aligned_cols=257 Identities=25% Similarity=0.400 Sum_probs=206.6
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
...++|++.+.||+|+||.||++.+..+++.||+|.++.. ....+..|+.+++.+ +||||+++++.+.+ ..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~--~~ 116 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQD--DK 116 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEec--CC
Confidence 3467999999999999999999999999999999998632 233467899999999 99999999999854 56
Q ss_pred ccEEEEeeecCCccccccC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 109 TPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
..++||||+.+++|..++. .+++..+..++.|++.||.|||+.|++|+||||+|||++.+ +.++|+|||++......
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~-~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCC-CCEEEEeccceeeccCC
Confidence 7899999999999988874 48889999999999999999999999999999999999988 89999999998765332
Q ss_pred C--cceeeeccccccccccccCc---CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 187 K--EYNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 187 ~--~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
. ......|++.|+|||++.+. ..++.++|+||||+++|+|++|..||... +.......+.......
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-~~~~~~~~i~~~~~~~-------- 266 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD-SLVGTYSKIMDHKNSL-------- 266 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC-CHHHHHHHHHcCCCcC--------
Confidence 2 22345689999999998652 24789999999999999999999999432 2222222221100000
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCC--cCCHHHHhcCCCcchhh
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD--RLTAREAMAHPYFAQVR 329 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~--Rpt~~ell~hp~~~~~~ 329 (338)
.......++.++.+||.+||+.+|.+ |+|++++++||||++..
T Consensus 267 -------------------------~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~ 311 (370)
T cd05596 267 -------------------------TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ 311 (370)
T ss_pred -------------------------CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence 00011126899999999999999987 99999999999998754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=326.57 Aligned_cols=255 Identities=27% Similarity=0.458 Sum_probs=205.4
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
++|++.+.||+|+||+||++.+..+++.||+|+++.. ..+.+.+|+.+++.+ +||||+++++.+.+ ....+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~--~~~~~ 77 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQD--KDNLY 77 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEec--CCeEE
Confidence 4799999999999999999999999999999998743 234577889999988 99999999999854 46789
Q ss_pred EEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 112 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 112 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
+||||+.+++|..++ ..+++..++.++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRT-GHIKLADFGSAARLTANK 156 (330)
T ss_pred EEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCC-CCEEeccCCCCeECCCCC
Confidence 999999999998876 358999999999999999999999999999999999999988 899999999987654332
Q ss_pred cc--eeeeccccccccccccC-----cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhh
Q 019642 188 EY--NVRVASRYFKGPELLVD-----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 260 (338)
Q Consensus 188 ~~--~~~~~~~~y~aPE~~~~-----~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.. ....+++.|+|||++.. ...++.++||||||+++|+|++|..||... +.......+.....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~-~~~~~~~~i~~~~~--------- 226 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG-TSAKTYNNIMNFQR--------- 226 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC-CHHHHHHHHHcCCC---------
Confidence 21 22368899999999863 246788999999999999999999998432 22222222211100
Q ss_pred ccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
.........+++++.+||.+||+ +|.+|||++++++||||..+...
T Consensus 227 ------------------------~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~ 272 (330)
T cd05601 227 ------------------------FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWN 272 (330)
T ss_pred ------------------------ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHH
Confidence 00000112368899999999998 99999999999999999986544
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=330.37 Aligned_cols=254 Identities=27% Similarity=0.451 Sum_probs=201.9
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
.+|++++.||+|+||.||+|.+..+++.+|+|++.... ...+.+|+.+++.+ +||||+++++.+.+ ....+
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~--~~~~~ 77 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQD--KDNLY 77 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEe--CCEEE
Confidence 36999999999999999999999999999999986432 34577899999999 99999999999955 56789
Q ss_pred EEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC--
Q 019642 112 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-- 186 (338)
Q Consensus 112 lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~-- 186 (338)
+||||+.+++|..++. .+++..++.++.|++.||.|||+.||+|+||||+|||++.+ +.++|+|||++......
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~-g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 78 FVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEEeECCCCcccccccc
Confidence 9999999998877763 48899999999999999999999999999999999999988 89999999986432100
Q ss_pred ----------------------------------------------CcceeeeccccccccccccCcCCCCCcchhHHHH
Q 019642 187 ----------------------------------------------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 220 (338)
Q Consensus 187 ----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG 220 (338)
.......||+.|+|||++.+ ..++.++|+||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG 235 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVG 235 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEech
Confidence 00012358899999999877 6789999999999
Q ss_pred HHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHH
Q 019642 221 CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAID 300 (338)
Q Consensus 221 ~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ 300 (338)
|++|+|++|..||... +..+....+...... ........+++++.+
T Consensus 236 vil~elltG~~Pf~~~-~~~~~~~~i~~~~~~---------------------------------~~~p~~~~~s~~~~~ 281 (382)
T cd05625 236 VILYEMLVGQPPFLAQ-TPLETQMKVINWQTS---------------------------------LHIPPQAKLSPEASD 281 (382)
T ss_pred HHHHHHHhCCCCCCCC-CHHHHHHHHHccCCC---------------------------------cCCCCcccCCHHHHH
Confidence 9999999999999432 222222211110000 000011236899999
Q ss_pred HHHHhcCCCcCCcCC---HHHHhcCCCcchhhhc
Q 019642 301 FLDKLLRYDHQDRLT---AREAMAHPYFAQVRAA 331 (338)
Q Consensus 301 li~~~L~~dP~~Rpt---~~ell~hp~~~~~~~~ 331 (338)
+|.+|+ .+|++|++ ++++++||||+++...
T Consensus 282 li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~ 314 (382)
T cd05625 282 LIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDFS 314 (382)
T ss_pred HHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcChH
Confidence 999986 59999997 9999999999987543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=331.01 Aligned_cols=254 Identities=28% Similarity=0.454 Sum_probs=202.2
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
++|++.+.||+|+||.||++.+..+++.||+|++... ....+.+|+.+++.+ +||||+++++.+.+ ...++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~--~~~~~ 77 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSFQD--KDNLY 77 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEEc--CCEEE
Confidence 4799999999999999999999999999999998642 234577899999999 99999999999955 56889
Q ss_pred EEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC--
Q 019642 112 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-- 186 (338)
Q Consensus 112 lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~-- 186 (338)
+||||+.+++|.+++. .+++..++.++.|++.||.|||++||+|+||||+||+++.+ +.++|+|||++......
T Consensus 78 lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~-~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 78 FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCC-CCEEEEeCCCCcccccccc
Confidence 9999999999988763 47889999999999999999999999999999999999988 89999999987422100
Q ss_pred ------------------------------------------CcceeeeccccccccccccCcCCCCCcchhHHHHHHHH
Q 019642 187 ------------------------------------------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 224 (338)
Q Consensus 187 ------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~ 224 (338)
.......||+.|+|||++.+ ..++.++|||||||++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvily 235 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILY 235 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceee
Confidence 00012368899999999877 67899999999999999
Q ss_pred HHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHH
Q 019642 225 GMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 304 (338)
Q Consensus 225 ~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~ 304 (338)
+|++|..||.... ..+....+...... ........++.++.++|.+
T Consensus 236 ell~G~~Pf~~~~-~~~~~~~i~~~~~~---------------------------------~~~~~~~~~s~~~~~li~~ 281 (376)
T cd05598 236 EMLVGQPPFLADT-PAETQLKVINWETT---------------------------------LHIPSQAKLSREASDLILR 281 (376)
T ss_pred ehhhCCCCCCCCC-HHHHHHHHhccCcc---------------------------------ccCCCCCCCCHHHHHHHHH
Confidence 9999999994322 22221111110000 0000112268899999999
Q ss_pred hcCCCcCCcC---CHHHHhcCCCcchhhhc
Q 019642 305 LLRYDHQDRL---TAREAMAHPYFAQVRAA 331 (338)
Q Consensus 305 ~L~~dP~~Rp---t~~ell~hp~~~~~~~~ 331 (338)
|+ .+|++|+ |+.++++||||+++...
T Consensus 282 l~-~~p~~R~~~~t~~ell~h~~~~~~~~~ 310 (376)
T cd05598 282 LC-CGAEDRLGKNGADEIKAHPFFKGIDFA 310 (376)
T ss_pred Hh-cCHhhcCCCCCHHHHhCCCCcCCCCHH
Confidence 87 5999999 99999999999986543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=320.86 Aligned_cols=250 Identities=25% Similarity=0.397 Sum_probs=201.9
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
+|++.+.||+|+||.||+|.+..+++.||+|+++.. ..+.+..|..++..+.+|++++++++.+.+ ....++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCEEEE
Confidence 589999999999999999999999999999998642 234567788999988555678899998854 457899
Q ss_pred EEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc-CCCc
Q 019642 113 IFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKE 188 (338)
Q Consensus 113 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~-~~~~ 188 (338)
||||+.+++|...+. .+++..+..++.|++.||.|||++|++|+||||+|||++.+ +.++|+|||++.... ....
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCC-CCEEEeecCcceecCCCCCc
Confidence 999999999977763 48999999999999999999999999999999999999988 899999999886432 1222
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
.....|++.|+|||++.+ ..++.++|+||+|+++|+|++|..||.. .+..+....+... .
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~--~---------------- 217 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQSIMEH--N---------------- 217 (324)
T ss_pred eeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHcC--C----------------
Confidence 334568999999999987 6789999999999999999999999842 2222222222110 0
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCH-----HHHhcCCCcchhhh
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA-----REAMAHPYFAQVRA 330 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~-----~ell~hp~~~~~~~ 330 (338)
...+..++.++.+++++||..||++|++. .++++||||.++..
T Consensus 218 -------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 218 -------------------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred -------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 00112268899999999999999999976 89999999988654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=322.43 Aligned_cols=244 Identities=27% Similarity=0.457 Sum_probs=198.5
Q ss_pred EeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeee
Q 019642 44 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 117 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~ 117 (338)
+.||+|+||.||++.+..+++.||+|+++.. ....+..|+.+++.+ +||||+++++.+.. ....++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~--~~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQT--HDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEEec--CCEEEEEEeCC
Confidence 3689999999999999999999999998642 223456799999999 99999999999855 45789999999
Q ss_pred cCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC-CCcceeee
Q 019642 118 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV 193 (338)
Q Consensus 118 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~-~~~~~~~~ 193 (338)
.+++|...+ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++..... ........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~ 156 (323)
T cd05595 78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCC-CCEEecccHHhccccCCCCcccccc
Confidence 999987665 348999999999999999999999999999999999999988 8999999998865322 22223356
Q ss_pred ccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhh
Q 019642 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL 273 (338)
Q Consensus 194 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (338)
|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||... +.......+.. ..
T Consensus 157 gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~-~~~~~~~~~~~--~~--------------------- 211 (323)
T cd05595 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHERLFELILM--EE--------------------- 211 (323)
T ss_pred CCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCC-CHHHHHHHHhc--CC---------------------
Confidence 8899999999877 67899999999999999999999998432 22222221110 00
Q ss_pred hccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC-----CHHHHhcCCCcchhhh
Q 019642 274 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRA 330 (338)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~ 330 (338)
...+..+++++.++|.+||+.||++|+ ++.++++||||.+...
T Consensus 212 --------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~ 259 (323)
T cd05595 212 --------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 259 (323)
T ss_pred --------------CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 001123789999999999999999998 9999999999988653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-45 Score=314.52 Aligned_cols=275 Identities=31% Similarity=0.560 Sum_probs=213.9
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
+|++.+.||+|++|.||+|.+..+++.+++|.++.. ....+.+|+.+++++ +|||++++++++.+ ....+++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 77 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLYDVLHS--DKKLTLV 77 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhc-CCCCeeeHHHHhcc--CCceEEE
Confidence 589999999999999999999999999999998632 234567899999999 99999999999955 4578999
Q ss_pred EeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-cc
Q 019642 114 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EY 189 (338)
Q Consensus 114 ~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-~~ 189 (338)
+||+.++.+..+. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||++....... ..
T Consensus 78 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~ 156 (284)
T cd07839 78 FEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVRCY 156 (284)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCC-CcEEECccchhhccCCCCCCc
Confidence 9999875444332 348999999999999999999999999999999999999988 899999999987543222 22
Q ss_pred eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcc
Q 019642 190 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 269 (338)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
....++..|+|||.+.+...++.++|+||||+++|+|++|..|++...+..+.+..+.+..+......+...........
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 23456788999999877556789999999999999999999998877777777777777666554443322111100000
Q ss_pred hhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 270 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
... ...... .......+++++.++|.+||+.||.+|||++++++||||
T Consensus 237 ~~~---~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 237 YPM---YPATTS-----LVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cCC---CCCcch-----hhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 000 000000 011123478999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=315.44 Aligned_cols=249 Identities=21% Similarity=0.472 Sum_probs=214.6
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
....+|++.+.||+|.||.|-++.+...|+.||||.+++.. .-.+.+|+++|..| +||||+++|++| ++..
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVF--ENkd 126 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVF--ENKD 126 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhh--cCCc
Confidence 34578999999999999999999999999999999987532 23478999999999 999999999999 5566
Q ss_pred ccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 109 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
.+.+||||..+|.|.+++ +.+++.+++.+++||..|+.|+|+++++|+|||.+|||+|.+ +++||+|||++..+..
T Consensus 127 KIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N-~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 127 KIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQN-NNIKIADFGLSNLYAD 205 (668)
T ss_pred eEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCC-CCeeeeccchhhhhcc
Confidence 789999999999999998 469999999999999999999999999999999999999999 8999999999998888
Q ss_pred CCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 186 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
.......+|++.|.+||+..+...-.+.+|-||||++||-++.|..|| .+.+....+.++... .+.+
T Consensus 206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPF-DG~Dhk~lvrQIs~G----aYrE-------- 272 (668)
T KOG0611|consen 206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPF-DGRDHKRLVRQISRG----AYRE-------- 272 (668)
T ss_pred ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhccccc-CCchHHHHHHHhhcc----cccC--------
Confidence 888888999999999999999777789999999999999999999998 344433333333221 1100
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcc
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 326 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~ 326 (338)
+.-+....-||++||-+||++|.|++++-.|=|++
T Consensus 273 --------------------------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 273 --------------------------PETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred --------------------------CCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 01356788999999999999999999999997754
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=321.22 Aligned_cols=254 Identities=25% Similarity=0.460 Sum_probs=201.7
Q ss_pred cEEEEEeeeecCceeEEEEEEc---CCCceEEEEEeccc-------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 39 DYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~-------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
+|++.+.||+|+||+||++.+. .+++.||+|++... ..+.+..|+.+++.+.+||+|+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT--EA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec--CC
Confidence 5899999999999999998864 47889999998642 124467899999999779999999999854 45
Q ss_pred ccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 109 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
..++||||+.+++|...+ ..+++..++.++.|++.||.|||++|++|+||||+|||++.+ +.++|+|||++.....
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~-~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSE-GHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCC-CCEEEeeCcCCccccc
Confidence 788999999999987765 358999999999999999999999999999999999999988 8999999999875432
Q ss_pred CC--cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccc
Q 019642 186 GK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263 (338)
Q Consensus 186 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
.. ......|++.|+|||++.+...++.++||||||+++|+|++|..||......... ..+.......
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~~~~---------- 226 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ-SEVSRRILKC---------- 226 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH-HHHHHHHhcC----------
Confidence 22 2223468999999999877456889999999999999999999999432211111 1111100000
Q ss_pred cccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC-----CHHHHhcCCCcchhh
Q 019642 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVR 329 (338)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~ 329 (338)
....+..++..+.++|.+||+.||++|| +++++++||||++..
T Consensus 227 -----------------------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 227 -----------------------DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred -----------------------CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 0001123688999999999999999999 888999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=314.02 Aligned_cols=282 Identities=28% Similarity=0.555 Sum_probs=213.5
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
..++|++.+.||.|+||.||+|.+..+++.|++|.++.. ....+.+|+..++++ +||||+++++++.. ....+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~--~~~~~ 80 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHT--EKSLT 80 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhc-CCCCcceEEEEEec--CCeEE
Confidence 457899999999999999999999999999999998632 234567899999999 99999999999954 45789
Q ss_pred EEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 112 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 112 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
+||||+.+ ++...+ ..+++..++.++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 81 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 81 LVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINER-GELKLADFGLARAKSIPT 158 (301)
T ss_pred EEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCC-CcEEECcCcchhccCCCC
Confidence 99999986 444433 348899999999999999999999999999999999999988 799999999886543221
Q ss_pred -cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 188 -EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 188 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
......+++.|+|||.+.+...++.++||||||+++|+|++|..||. ..+..+....+...++.+....|........
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFP-GSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 22234568899999998765668899999999999999999999984 4444555555655555544333321100000
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
.. ..................+++.+.+||.+||+.||.+|||++|+|+||||....+
T Consensus 238 ~~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~ 294 (301)
T cd07873 238 FK-------SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294 (301)
T ss_pred cc-------ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 00 0000000000001112347889999999999999999999999999999987753
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=321.85 Aligned_cols=245 Identities=24% Similarity=0.410 Sum_probs=198.6
Q ss_pred EeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeee
Q 019642 44 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 117 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~ 117 (338)
+.||+|+||+||+|.+..+++.||+|+++.. .......|..++..+.+||||+++++.+.. ....++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEEEEEcCC
Confidence 3689999999999999999999999998642 234456788888877689999999999854 46789999999
Q ss_pred cCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC-CCcceeee
Q 019642 118 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV 193 (338)
Q Consensus 118 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~-~~~~~~~~ 193 (338)
.+++|...+ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++..... ........
T Consensus 79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~-~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC-CcEEEeeCCCCeecCcCCCcccccc
Confidence 999987765 358999999999999999999999999999999999999988 8999999998765322 22233456
Q ss_pred ccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhh
Q 019642 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL 273 (338)
Q Consensus 194 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (338)
|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.. .+..+....+.. ..
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~-~~~~~~~~~i~~---~~-------------------- 212 (320)
T cd05590 158 GTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILN---DE-------------------- 212 (320)
T ss_pred cCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhc---CC--------------------
Confidence 8999999999876 6788999999999999999999999842 222222222211 00
Q ss_pred hccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCH------HHHhcCCCcchhhh
Q 019642 274 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA------REAMAHPYFAQVRA 330 (338)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~------~ell~hp~~~~~~~ 330 (338)
...+..++.++.++|++||+.||++||++ +++++||||.++..
T Consensus 213 --------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~ 261 (320)
T cd05590 213 --------------VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW 261 (320)
T ss_pred --------------CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence 00112268899999999999999999998 99999999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=319.86 Aligned_cols=248 Identities=24% Similarity=0.440 Sum_probs=200.0
Q ss_pred EEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHH---HhcCCCCeeEeeeeeeccCCCcc
Q 019642 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQ---NLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 40 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~---~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
|++.+.||+|+||.||+|.+..+++.||+|+++.. ..+.+..|..++. .+ +||||+++++++.. ....
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l-~hp~i~~~~~~~~~--~~~~ 77 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE-RHPFLVNLFACFQT--EDHV 77 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcccc-CCCChhceeeEEEc--CCEE
Confidence 78899999999999999999999999999998642 2244666766654 44 79999999999854 5678
Q ss_pred EEEEeeecCCccccccC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC-CC
Q 019642 111 SLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GK 187 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~-~~ 187 (338)
++||||+.+++|...+. .+++..++.++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++..... ..
T Consensus 78 ~lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 78 CFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EEEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC-CcEEeCcccCCccCCCCCC
Confidence 99999999999877763 48999999999999999999999999999999999999998 8999999998764322 22
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||. ..+..+....+... .
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~-~~~~~~~~~~i~~~--~--------------- 217 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFP-GDDEEEVFDSIVND--E--------------- 217 (324)
T ss_pred cccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhC--C---------------
Confidence 2334568999999999877 678899999999999999999999983 22222222221110 0
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC-----CHHHHhcCCCcchhhh
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRA 330 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~ 330 (338)
...+..++..+.++|.+||+.||++|| ++.++++||||+++..
T Consensus 218 --------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~ 265 (324)
T cd05589 218 --------------------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW 265 (324)
T ss_pred --------------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence 001123688999999999999999999 7999999999988643
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=332.82 Aligned_cols=290 Identities=23% Similarity=0.401 Sum_probs=207.0
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhc-----CCCCeeEeeeeeeccCC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLC-----GGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~-----~h~~iv~~~~~~~~~~~ 107 (338)
...++|++.+.||+|+||+||+|.+..+++.||||+++.. .......|+.+++.+. .|.+++++++++... .
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~-~ 204 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE-T 204 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC-C
Confidence 3457899999999999999999999999999999998642 2344567888888772 234588898888654 3
Q ss_pred CccEEEEeeecCCcccccc--CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEecCCC---------------
Q 019642 108 KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEL--------------- 169 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~~~--------------- 169 (338)
.+.++||+++++..+..+. ..+++..++.++.|++.||.|||+ .||+|+||||+|||++.+.
T Consensus 205 ~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 205 GHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred ceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 5788999998665544443 358999999999999999999998 5999999999999997652
Q ss_pred CceEEEeccccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHH
Q 019642 170 RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 249 (338)
Q Consensus 170 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~ 249 (338)
..+||+|||.+.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.|| ...+..+.+..+.+.
T Consensus 285 ~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf-~~~~~~~~~~~i~~~ 360 (467)
T PTZ00284 285 CRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLY-DTHDNLEHLHLMEKT 360 (467)
T ss_pred ceEEECCCCccccCc--cccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHH
Confidence 159999999875422 22334578999999999987 67999999999999999999999998 455556666667776
Q ss_pred hCCchhhhhhhccccccCcchhhhhc----cccCCCCcccccc--cCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCC
Q 019642 250 LGTDELNAYLNKYHLELDPQLDALVG----RHSRKPWSKFINA--DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323 (338)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~--~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp 323 (338)
++..+.. +...........+..... .........+... ......++.+.+||.+||++||++|||++|+|+||
T Consensus 361 ~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp 439 (467)
T PTZ00284 361 LGRLPSE-WAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHP 439 (467)
T ss_pred cCCCCHH-HHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCc
Confidence 6654322 211110000000000000 0000000000000 00001246788999999999999999999999999
Q ss_pred Ccchhhh
Q 019642 324 YFAQVRA 330 (338)
Q Consensus 324 ~~~~~~~ 330 (338)
||.....
T Consensus 440 ~~~~~~~ 446 (467)
T PTZ00284 440 YVLKYYP 446 (467)
T ss_pred cccccCC
Confidence 9998644
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=319.58 Aligned_cols=241 Identities=24% Similarity=0.424 Sum_probs=196.4
Q ss_pred eeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeecC
Q 019642 46 VGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS 119 (338)
Q Consensus 46 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 119 (338)
||+|+||.||++.+..+++.||+|.++.. ....+..|+.+++++ +||||+++++.+.. ....++||||+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQS--PEKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEec--CCeEEEEEcCCCC
Confidence 69999999999999999999999998632 234567899999999 99999999999854 4678999999999
Q ss_pred CccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC-Ccceeeecc
Q 019642 120 TDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRVAS 195 (338)
Q Consensus 120 ~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~ 195 (338)
++|...+. .+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++...... .......|+
T Consensus 78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt 156 (312)
T cd05585 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQ-GHIALCDFGLCKLNMKDDDKTNTFCGT 156 (312)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCC-CcEEEEECcccccCccCCCccccccCC
Confidence 99977763 48999999999999999999999999999999999999988 89999999998653222 222335689
Q ss_pred ccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhc
Q 019642 196 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVG 275 (338)
Q Consensus 196 ~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (338)
+.|+|||++.+ ..++.++||||||+++|+|++|..||... +..+....+.. . .
T Consensus 157 ~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~-~~~~~~~~~~~---~-~--------------------- 209 (312)
T cd05585 157 PEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDE-NVNEMYRKILQ---E-P--------------------- 209 (312)
T ss_pred cccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCC-CHHHHHHHHHc---C-C---------------------
Confidence 99999999987 67899999999999999999999999432 21111111110 0 0
Q ss_pred cccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC---CHHHHhcCCCcchhh
Q 019642 276 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL---TAREAMAHPYFAQVR 329 (338)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp---t~~ell~hp~~~~~~ 329 (338)
...+..+++++.++|.+||+.||++|| ++.++++||||.+..
T Consensus 210 ------------~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~ 254 (312)
T cd05585 210 ------------LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS 254 (312)
T ss_pred ------------CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence 001123688999999999999999997 589999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=322.56 Aligned_cols=283 Identities=30% Similarity=0.566 Sum_probs=211.9
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccC----C
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----S 107 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~----~ 107 (338)
.++|++.+.||+|+||+||+|.+..+++.||+|.+... ....+.+|+.+++.+ +||||+++++++.... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-KHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhc-CCCchhhhhhhhccccccccc
Confidence 57899999999999999999999999999999998642 234566899999999 9999999999875321 2
Q ss_pred CccEEEEeeecCCccccccC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 108 KTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
...+++++++ ++++..++. .+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++.....
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNED-CELRILDFGLARQADD 170 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCC-CCEEEcCCccceecCC
Confidence 3467889887 556665553 59999999999999999999999999999999999999988 8999999999876543
Q ss_pred CCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 186 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
. .....+++.|+|||++.+...++.++||||||+++|+|++|..|| ...+..+.+..+....+.+.......-...
T Consensus 171 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 246 (343)
T cd07878 171 E--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF-PGNDYIDQLKRIMEVVGTPSPEVLKKISSE- 246 (343)
T ss_pred C--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHhcchh-
Confidence 2 233468899999999877567889999999999999999999998 344445556666555554433222110000
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
............+...+ .......++.+.+||.+||..||++|||+.|+|+||||......
T Consensus 247 ---~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~ 307 (343)
T cd07878 247 ---HARKYIQSLPHMPQQDL--KKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP 307 (343)
T ss_pred ---hHHHHhhccccccchhH--HHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCC
Confidence 00000000000000000 00011256788999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=325.37 Aligned_cols=256 Identities=25% Similarity=0.402 Sum_probs=204.0
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
...++|++.+.||+|+||.||++.+..+++.+|+|++... ....+.+|+.+++.+ +||||+++++.+.+ ..
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~--~~ 116 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQD--DK 116 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEc--CC
Confidence 3457999999999999999999999999999999998631 234467899999998 99999999999954 56
Q ss_pred ccEEEEeeecCCccccccC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 109 TPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
..++||||+.+++|..++. .+++..+..++.|++.||.|||++|++|+||||+|||++.+ +.+||+|||++......
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~-~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKH-GHLKLADFGTCMKMDET 195 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC-CCEEEEecccceecccC
Confidence 7899999999999988774 47899999999999999999999999999999999999988 89999999998765322
Q ss_pred C--cceeeeccccccccccccCc---CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 187 K--EYNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 187 ~--~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
. ......||+.|+|||++.+. ..++.++|+||||+++|+|++|..||... +.......+........
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~-~~~~~~~~i~~~~~~~~------- 267 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD-SLVGTYSKIMDHKNSLN------- 267 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCcccC-------
Confidence 2 12345689999999998652 23788999999999999999999999432 22222222211100000
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCC--cCCHHHHhcCCCcchh
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD--RLTAREAMAHPYFAQV 328 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~--Rpt~~ell~hp~~~~~ 328 (338)
......++..+.+++.+||+.+|.. |+|+.|+++||||++.
T Consensus 268 --------------------------~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 268 --------------------------FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred --------------------------CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 0011126889999999999865543 8999999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=321.37 Aligned_cols=244 Identities=26% Similarity=0.441 Sum_probs=198.0
Q ss_pred EeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeee
Q 019642 44 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 117 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~ 117 (338)
+.||+|+||.||++.+..+++.||+|++... ....+.+|+.+++.+ +||||+++++.+.. ....++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSFQT--KDRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEc--CCEEEEEEeCC
Confidence 3689999999999999999999999998642 234567899999999 99999999999854 56789999999
Q ss_pred cCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC-Ccceeee
Q 019642 118 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRV 193 (338)
Q Consensus 118 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~-~~~~~~~ 193 (338)
.+++|...+ ..+++..++.++.|++.||.|||++|++|+||||+|||++.+ +.++|+|||++...... .......
T Consensus 78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~~~ 156 (328)
T cd05593 78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD-GHIKITDFGLCKEGITDAATMKTFC 156 (328)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCC-CcEEEecCcCCccCCCccccccccc
Confidence 999987665 348999999999999999999999999999999999999988 89999999998653221 2223346
Q ss_pred ccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhh
Q 019642 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL 273 (338)
Q Consensus 194 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (338)
|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||... +.......+. ...
T Consensus 157 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~-~~~~~~~~~~----~~~------------------- 211 (328)
T cd05593 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKLFELIL----MED------------------- 211 (328)
T ss_pred CCcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCC-CHHHHHHHhc----cCC-------------------
Confidence 8999999999877 67899999999999999999999999432 2111111110 000
Q ss_pred hccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC-----CHHHHhcCCCcchhhh
Q 019642 274 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRA 330 (338)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~ 330 (338)
...+..++.++.+||++||+.||++|+ ++.++++||||.+...
T Consensus 212 --------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 259 (328)
T cd05593 212 --------------IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW 259 (328)
T ss_pred --------------ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 001123688999999999999999997 8999999999987643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=326.35 Aligned_cols=255 Identities=27% Similarity=0.454 Sum_probs=203.3
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
++|++.+.||+|+||.||++.+..+++.||+|+++.. ....+..|+.++..+ +||+|+++++.+.+ ....+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~--~~~~~ 77 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQD--KRNLY 77 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEc--CCEEE
Confidence 5799999999999999999999999999999998632 234577899999999 99999999999854 56789
Q ss_pred EEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-
Q 019642 112 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 187 (338)
Q Consensus 112 lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~- 187 (338)
+||||+.+++|..++. .+++..++.++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~-~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred EEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC-CCEEEeeccCCcccccccc
Confidence 9999999999988763 48999999999999999999999999999999999999988 899999999876432110
Q ss_pred -----------------------------------cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCC
Q 019642 188 -----------------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 232 (338)
Q Consensus 188 -----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~p 232 (338)
......||+.|+|||++.+ ..++.++|+|||||++|+|++|..|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCC
Confidence 0112368899999999877 6789999999999999999999999
Q ss_pred CcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCC
Q 019642 233 FFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD 312 (338)
Q Consensus 233 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 312 (338)
|.. .+..+....+....... .......+++++.++|.+|+ .||.+
T Consensus 236 f~~-~~~~~~~~~i~~~~~~~---------------------------------~~p~~~~~s~~~~~li~~l~-~~p~~ 280 (360)
T cd05627 236 FCS-ETPQETYRKVMNWKETL---------------------------------VFPPEVPISEKAKDLILRFC-TDSEN 280 (360)
T ss_pred CCC-CCHHHHHHHHHcCCCce---------------------------------ecCCCCCCCHHHHHHHHHhc-cChhh
Confidence 843 22222222221100000 00001126889999999987 49999
Q ss_pred cC---CHHHHhcCCCcchhhhcc
Q 019642 313 RL---TAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 313 Rp---t~~ell~hp~~~~~~~~~ 332 (338)
|+ +++++++||||+++....
T Consensus 281 R~~~~~~~ei~~hp~f~~~~~~~ 303 (360)
T cd05627 281 RIGSNGVEEIKSHPFFEGVDWGH 303 (360)
T ss_pred cCCCCCHHHHhcCCCCCCCCHHH
Confidence 98 589999999999875443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=319.11 Aligned_cols=252 Identities=24% Similarity=0.375 Sum_probs=203.4
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
+|++.+.||+|+||.||+|.+..+++.||+|+++... ......|..++..+.+|++++++++.+.+ ....++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--MDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--CCEEEE
Confidence 5899999999999999999999999999999986421 23456677888877678999999999854 457899
Q ss_pred EEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC-CCc
Q 019642 113 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKE 188 (338)
Q Consensus 113 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~-~~~ 188 (338)
||||+.+++|...+ ..+++..+..++.|++.||.|||+.|++|+||||+|||++.+ +.++|+|||++..... ...
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~-~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCC-CcEEEccCCCceecCCCCCc
Confidence 99999999987765 358999999999999999999999999999999999999998 8999999999865332 222
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
.....|++.|+|||++.+ ..++.++|+||||+++|+|++|..||.. .+.......+... .
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~--~---------------- 217 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEH--N---------------- 217 (323)
T ss_pred cccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCC-CCHHHHHHHHHhC--C----------------
Confidence 234568999999999987 6789999999999999999999999842 2222222222110 0
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCH-----HHHhcCCCcchhhhcc
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA-----REAMAHPYFAQVRAAE 332 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~-----~ell~hp~~~~~~~~~ 332 (338)
...+..++.++.+++.+||+.||++|++. .++++||||+.+...+
T Consensus 218 -------------------~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~ 267 (323)
T cd05616 218 -------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 267 (323)
T ss_pred -------------------CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 00112268999999999999999999984 8999999999876443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=323.22 Aligned_cols=279 Identities=22% Similarity=0.338 Sum_probs=202.6
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEee
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 116 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~ 116 (338)
..+|++.+.||+|+||.||+|.+..+++.|++|+... .....|+.+++++ +||||+++++++.. ....++|||+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK---GTTLIEAMLLQNV-NHPSVIRMKDTLVS--GAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc---cccHHHHHHHHhC-CCCCCcChhheEEe--CCeeEEEEEc
Confidence 4579999999999999999999999999999998543 2345699999999 99999999999865 4567899999
Q ss_pred ecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcceeee
Q 019642 117 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 193 (338)
Q Consensus 117 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 193 (338)
+.+..+..+. ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++.............
T Consensus 139 ~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~~~~~ 217 (357)
T PHA03209 139 YSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDV-DQVCIGDLGAAQFPVVAPAFLGLA 217 (357)
T ss_pred cCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEecCccccccccCccccccc
Confidence 9875544433 348999999999999999999999999999999999999988 789999999986543333333456
Q ss_pred ccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCH---------HHHHHHHHHhCCchhhhhhhcccc
Q 019642 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH---------DQLVKIAKVLGTDELNAYLNKYHL 264 (338)
Q Consensus 194 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
|+..|+|||++.+ ..++.++|+||||+++|+|+++..+++...... ..+..+...++..+. .+......
T Consensus 218 gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~~~~ 295 (357)
T PHA03209 218 GTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE-EFPRDPGS 295 (357)
T ss_pred ccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh-hcCCCCcc
Confidence 8899999999977 678999999999999999999776665432221 122222222222111 00000000
Q ss_pred ccCcchhhhhc--cccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 265 ELDPQLDALVG--RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 265 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
........ .....++..+ .......++.++.+||.+||+.||++|||+.|+|+||||+++
T Consensus 296 ---~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 296 ---RLVRGFIEYASLERQPYTRY-PCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred ---HHHHHHHhhcccCCCccccc-HHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 00000000 0000011110 011112367788999999999999999999999999999864
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=315.71 Aligned_cols=248 Identities=20% Similarity=0.314 Sum_probs=200.0
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCCCce-EEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNER-CIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~-~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
..+.++..+.+.||+|+||+||+|... |+. ||+|.+.... .+.+.+|+.++.++ +|||||++++++.++..
T Consensus 37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 37 EIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRL-RHPNIVQFYGACTSPPG 113 (362)
T ss_pred ecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCC
Confidence 344456677777999999999999774 445 9999987543 45899999999999 99999999999966432
Q ss_pred CccEEEEeeecCCcccccc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 108 KTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
..++||||+.+|+|..++ ..++...+..++.||+.|+.|||+++ |+|+||||+|||++.+..++||+|||+++
T Consensus 114 -~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr 192 (362)
T KOG0192|consen 114 -SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSR 192 (362)
T ss_pred -ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccce
Confidence 678999999999999887 34899999999999999999999999 99999999999999983399999999997
Q ss_pred cccCC-CcceeeeccccccccccccC-cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhh
Q 019642 182 FYHPG-KEYNVRVASRYFKGPELLVD-LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259 (338)
Q Consensus 182 ~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
..... .......||..|||||++.+ ...++.++||||||+++|+|+||..||..... .............+.
T Consensus 193 ~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~Rp~----- 266 (362)
T KOG0192|consen 193 EKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGLRPP----- 266 (362)
T ss_pred eeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCCCCC-----
Confidence 65543 23334689999999999985 26899999999999999999999999943333 222222211111111
Q ss_pred hccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
.+...++.+..++..||..||+.||+..+++.
T Consensus 267 ------------------------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 267 ------------------------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred ------------------------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 11125789999999999999999999999875
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=307.20 Aligned_cols=251 Identities=31% Similarity=0.560 Sum_probs=204.5
Q ss_pred EEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHH-----HHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 40 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
|++.+.||+|+||+||++.+..+++.+|+|.+....... ...|+.+++++ +||||+++++++.+ ....+++|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~~v~ 77 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-RHPNIVQILDVFQD--DNYLYIVM 77 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-TBTTBCHEEEEEEE--SSEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-cccccccccccccc--cccccccc
Confidence 899999999999999999999999999999997654322 34589999999 99999999999966 56788999
Q ss_pred eeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc-cCCCcce
Q 019642 115 EYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYN 190 (338)
Q Consensus 115 e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~-~~~~~~~ 190 (338)
|++.+++|..++ ..++...++.++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||.+... .......
T Consensus 78 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~-~~~~l~Dfg~~~~~~~~~~~~~ 156 (260)
T PF00069_consen 78 EYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDEN-GEVKLIDFGSSVKLSENNENFN 156 (260)
T ss_dssp EEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTT-SEEEESSGTTTEESTSTTSEBS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccc
Confidence 999999888765 458999999999999999999999999999999999999977 89999999998753 2233445
Q ss_pred eeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcch
Q 019642 191 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 270 (338)
Q Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (338)
...++..|+|||+.......+.++|+||||+++++|++|..||... ........+.+.............
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~--------- 226 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES-NSDDQLEIIEKILKRPLPSSSQQS--------- 226 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS-SHHHHHHHHHHHHHTHHHHHTTSH---------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccc-cchhhhhhhhhccccccccccccc---------
Confidence 5678899999999873378999999999999999999999998533 223333333333332222111000
Q ss_pred hhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 271 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
...+.++.++|.+||+.||++|||+.++++||||
T Consensus 227 ---------------------~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 227 ---------------------REKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp ---------------------TTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ---------------------chhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 0013789999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=322.44 Aligned_cols=255 Identities=22% Similarity=0.397 Sum_probs=202.0
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
..++|+..+.||+|+||.||++.+..+++.|++|++.... ...+.+|+.+++.+ +|+||+++++++.. ....+
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~ 148 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPNVVKCHDMFDH--NGEIQ 148 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhC-CCCCcceeeeEecc--CCeEE
Confidence 3468899999999999999999999999999999985432 35678899999999 99999999999844 56788
Q ss_pred EEEeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-cce
Q 019642 112 LIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYN 190 (338)
Q Consensus 112 lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-~~~ 190 (338)
+||||+.+++|.... ..++..+..++.|++.||.|||++|++|+||||+|||++.+ +.++|+|||++....... ...
T Consensus 149 lv~e~~~~~~L~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~ 226 (353)
T PLN00034 149 VLLEFMDGGSLEGTH-IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSA-KNVKIADFGVSRILAQTMDPCN 226 (353)
T ss_pred EEEecCCCCcccccc-cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC-CCEEEcccccceeccccccccc
Confidence 999999999887543 35677888999999999999999999999999999999988 899999999987654322 223
Q ss_pred eeeccccccccccccCc----CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 191 VRVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 191 ~~~~~~~y~aPE~~~~~----~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
...|+..|+|||.+... ...+.++||||||+++|+|++|+.||....... ............
T Consensus 227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~------------ 292 (353)
T PLN00034 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASLMCAICMSQ------------ 292 (353)
T ss_pred ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHhccC------------
Confidence 45789999999987431 235578999999999999999999995222111 111100000000
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
....+..++.++.+||.+||+.||++|||+.|+|+||||.+..
T Consensus 293 --------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 293 --------------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred --------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 0001123688999999999999999999999999999999864
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=319.07 Aligned_cols=250 Identities=25% Similarity=0.431 Sum_probs=198.5
Q ss_pred EeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeee
Q 019642 44 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 117 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~ 117 (338)
+.||+|+||.||++.+..+++.||+|+++.. ..+.+..|..++..+.+||||+++++.+.+ ....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEEEEeCC
Confidence 3689999999999999999999999998742 224467899999988789999999999855 45789999999
Q ss_pred cCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc-cCCCcceeee
Q 019642 118 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRV 193 (338)
Q Consensus 118 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~-~~~~~~~~~~ 193 (338)
.+++|..++ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++... ..........
T Consensus 79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEECcCccccccccCCCcccccc
Confidence 999987665 359999999999999999999999999999999999999988 89999999988642 2222333457
Q ss_pred ccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCH---H-HHHHHHHHhCCchhhhhhhccccccCcc
Q 019642 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH---D-QLVKIAKVLGTDELNAYLNKYHLELDPQ 269 (338)
Q Consensus 194 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~---~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
|++.|+|||++.+ ..++.++|+||||+++|+|++|..||....... . ......+....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~----------------- 219 (329)
T cd05588 158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE----------------- 219 (329)
T ss_pred CCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc-----------------
Confidence 8999999999987 678899999999999999999999994211100 0 00000000000
Q ss_pred hhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCC------HHHHhcCCCcchhhh
Q 019642 270 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT------AREAMAHPYFAQVRA 330 (338)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt------~~ell~hp~~~~~~~ 330 (338)
.. ...+..++.++.++|++||+.||++|+| ++++++||||..+..
T Consensus 220 ------~~----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 220 ------KQ----------IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred ------CC----------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 00 0012236889999999999999999997 789999999987644
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=317.23 Aligned_cols=253 Identities=25% Similarity=0.427 Sum_probs=209.3
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc----cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
.....|...+.||+|+||.||+|.+..+++.||+|++.- .....+.+|+.++.++ .++||.++|+.+.. +..+
T Consensus 10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~-~~~~it~yygsyl~--g~~L 86 (467)
T KOG0201|consen 10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQC-DSPNITEYYGSYLK--GTKL 86 (467)
T ss_pred CcccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhc-CcchHHhhhhheee--cccH
Confidence 345678889999999999999999999999999999873 2345688999999999 89999999999855 5678
Q ss_pred EEEEeeecCCccccccCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC-
Q 019642 111 SLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG- 186 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~- 186 (338)
+++|||+.||++.+.++. +.+..+.-++++++.||.|||.++.+|+|||+.||++... +.+||+|||.+......
T Consensus 87 wiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~-g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSES-GDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEecc-CcEEEEecceeeeeechh
Confidence 899999999999888853 4788888899999999999999999999999999999999 99999999988655433
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.......||+.|||||++.+ ..|+.++||||||+++++|++|..|+-..+. ...+.
T Consensus 166 ~rr~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hP-mrvlf---------------------- 221 (467)
T KOG0201|consen 166 KRRKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHP-MRVLF---------------------- 221 (467)
T ss_pred hccccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCc-ceEEE----------------------
Confidence 23366789999999999986 7899999999999999999999999832221 00000
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
-.+...+ .. ....+|+.+++||..||++||+.||+|.++|+|+|++...
T Consensus 222 --------lIpk~~P-P~-----L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 222 --------LIPKSAP-PR-----LDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred --------eccCCCC-Cc-----cccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 0000000 00 1113789999999999999999999999999999998843
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=312.54 Aligned_cols=280 Identities=25% Similarity=0.512 Sum_probs=203.3
Q ss_pred EeeeecCceeEEEEEEcC--CCceEEEEEecccc-hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeecCC
Q 019642 44 RKVGRGKYSEVFEGINVN--TNERCIIKILKPVK-KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST 120 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~-~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~ 120 (338)
.+||+|+||.||+|.+.. ++..+++|.++... ...+.+|+.+++.+ +|||++++++++........+++|||+.++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLREL-KHPNVIALQKVFLSHSDRKVWLLFDYAEHD 85 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhC-CCCCeeeEEEEEeccCCCeEEEEEeeeCCc
Confidence 579999999999998654 56789999887543 34577899999999 999999999998766667789999999875
Q ss_pred cccccc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEec---CCCCceEEEeccccccccCC
Q 019642 121 DFKVLY-----------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 121 ~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~---~~~~~~~l~dfg~~~~~~~~ 186 (338)
.+.... ..+++..++.++.|++.||.|||+.|++|+||||+||++. ...+.++|+|||++......
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~ 165 (317)
T cd07867 86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165 (317)
T ss_pred HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCC
Confidence 433221 1378889999999999999999999999999999999994 23368999999998765432
Q ss_pred C----cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCC--------CHHHHHHHHHHhCCch
Q 019642 187 K----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--------NHDQLVKIAKVLGTDE 254 (338)
Q Consensus 187 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~--------~~~~~~~~~~~~~~~~ 254 (338)
. ......+++.|+|||.+.+...++.++||||||+++|+|+||..||..... ...++..+...++.+.
T Consensus 166 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (317)
T cd07867 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPA 245 (317)
T ss_pred cccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCC
Confidence 2 123346788999999987756689999999999999999999999854322 1234555566666554
Q ss_pred hhhhhhccccccCcchhhhhccccC--CCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 255 LNAYLNKYHLELDPQLDALVGRHSR--KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
...|.........+........... ...... ........+..+.++|.+||+.||.+|||+.|+|+||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 246 DKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKY-MEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hhhhhhhhhcccchhhhhhhcccccCCchhhhh-hhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 4444332221111111111110000 000000 011112246779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=318.95 Aligned_cols=245 Identities=24% Similarity=0.386 Sum_probs=198.2
Q ss_pred EeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeee
Q 019642 44 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 117 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~ 117 (338)
+.||+|+||.||+|.+..+++.||+|+++.. .......|..++..+.+||+|+++++.+.. ....++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEEEEEeCC
Confidence 3689999999999999999999999998642 223456788888877689999999999955 45789999999
Q ss_pred cCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC-CCcceeee
Q 019642 118 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV 193 (338)
Q Consensus 118 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~-~~~~~~~~ 193 (338)
.+++|...+ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++..... ........
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE-GHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEeecccceecccCCccccccc
Confidence 999987665 358899999999999999999999999999999999999988 8999999998865322 22223346
Q ss_pred ccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhh
Q 019642 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL 273 (338)
Q Consensus 194 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (338)
|++.|+|||++.+ ..++.++|+||||+++|+|++|..||. ..+..+....+... .
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~-~~~~~~~~~~i~~~--~--------------------- 212 (321)
T cd05591 158 GTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFE-ADNEDDLFESILHD--D--------------------- 212 (321)
T ss_pred cCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCC-CCCHHHHHHHHHcC--C---------------------
Confidence 8899999999876 678999999999999999999999984 22222222222110 0
Q ss_pred hccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC-------CHHHHhcCCCcchhhh
Q 019642 274 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-------TAREAMAHPYFAQVRA 330 (338)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-------t~~ell~hp~~~~~~~ 330 (338)
...+..++.++.++|++||+.||++|| ++.++++||||.++..
T Consensus 213 --------------~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~ 262 (321)
T cd05591 213 --------------VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDW 262 (321)
T ss_pred --------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCH
Confidence 001112688999999999999999999 9999999999987643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=290.43 Aligned_cols=249 Identities=27% Similarity=0.457 Sum_probs=212.9
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~------~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
.-++|++.+.||+|.||.||+|+.++++--||+|++.+ ....++.+|+++...| .||||.++|++|.+ ...
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~~fhd--~~r 96 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYGYFHD--SKR 96 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhhheec--cce
Confidence 45789999999999999999999999999999999753 3457789999999999 99999999999976 567
Q ss_pred cEEEEeeecCCcccccc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 110 PSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
+|+++||..++.+...+ .++++...+.++.|++.||.|+|..+++||||||+|+|++.. +.+|++|||.+...+
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~-~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAP 175 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCC-CCeeccCCCceeecC
Confidence 89999999988765554 358999999999999999999999999999999999999998 899999999987655
Q ss_pred CCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccc
Q 019642 185 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264 (338)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
.......+||..|.+||...+ ...+..+|+|++|++.|+++.|..||.. ....+....+.+.--
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes-~~~~etYkrI~k~~~------------- 239 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFES-QSHSETYKRIRKVDL------------- 239 (281)
T ss_pred -CCCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhh-hhhHHHHHHHHHccc-------------
Confidence 334455689999999999887 7899999999999999999999999943 334444554444211
Q ss_pred ccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
..+..++..+.++|.+||.++|.+|.+..|+++|||....
T Consensus 240 ------------------------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 240 ------------------------KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred ------------------------cCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 1123389999999999999999999999999999998653
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=310.05 Aligned_cols=246 Identities=24% Similarity=0.397 Sum_probs=196.5
Q ss_pred eeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeecC
Q 019642 46 VGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS 119 (338)
Q Consensus 46 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 119 (338)
||+|+||+||++.+..+++.+++|.+.... ...+..|+.+++.+ +||||+++.+.+.. ....+++|||+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQT--KTDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcC--CCeEEEEEeCCCC
Confidence 699999999999999999999999986321 23456799999999 99999999998854 4578999999999
Q ss_pred Ccccccc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc-cee
Q 019642 120 TDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNV 191 (338)
Q Consensus 120 ~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~-~~~ 191 (338)
++|...+ ..+++..++.++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||.+........ ...
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~ 156 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDND-GNVRISDLGLAVELKDGQSKTKG 156 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEeeCccceecCCCCccccc
Confidence 9987554 248999999999999999999999999999999999999987 8899999999865543322 223
Q ss_pred eeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchh
Q 019642 192 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD 271 (338)
Q Consensus 192 ~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (338)
..+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||......... ...........
T Consensus 157 ~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~----------------- 217 (280)
T cd05608 157 YAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-KELKQRILNDS----------------- 217 (280)
T ss_pred cCCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH-HHHHHhhcccC-----------------
Confidence 467889999999987 67889999999999999999999999533221111 11111100000
Q ss_pred hhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC-----CHHHHhcCCCcchhhh
Q 019642 272 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRA 330 (338)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~ 330 (338)
...+..++.++.+++.+||+.||++|| |++++++||||++...
T Consensus 218 ----------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~ 265 (280)
T cd05608 218 ----------------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNW 265 (280)
T ss_pred ----------------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCH
Confidence 001123788999999999999999999 8899999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=308.97 Aligned_cols=249 Identities=24% Similarity=0.358 Sum_probs=197.9
Q ss_pred eeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeecC
Q 019642 46 VGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS 119 (338)
Q Consensus 46 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 119 (338)
||+|+||.||++.+..+++.+++|.+... .......|+++++++ +||||+++++.+.. ....+++|||+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~--~~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFES--KTHLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEec--CCeEEEEEecCCC
Confidence 69999999999999999999999988632 123456699999999 99999999999854 5678999999999
Q ss_pred CccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcceeeec
Q 019642 120 TDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 194 (338)
Q Consensus 120 ~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 194 (338)
++|...+. .++...+..++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||++.............+
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQ-GNCRLSDLGLAVELKDGKTITQRAG 156 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCC-CCEEEeeceeeeecCCCceeeccCC
Confidence 99876652 37888899999999999999999999999999999999988 7899999999876654444444578
Q ss_pred cccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhh
Q 019642 195 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALV 274 (338)
Q Consensus 195 ~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (338)
+..|+|||++.+ ..++.++|+||+|+++|+|++|..||......... ...........
T Consensus 157 ~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~-------------------- 214 (277)
T cd05607 157 TNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK-EELKRRTLEDE-------------------- 214 (277)
T ss_pred CCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH-HHHHHHhhccc--------------------
Confidence 899999999877 56999999999999999999999998432221111 11111000000
Q ss_pred ccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCH----HHHhcCCCcchhhhcc
Q 019642 275 GRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA----REAMAHPYFAQVRAAE 332 (338)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~----~ell~hp~~~~~~~~~ 332 (338)
. ......+++++.++|++||+.||++||++ +++++||||+++....
T Consensus 215 -------~-----~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~ 264 (277)
T cd05607 215 -------V-----KFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPR 264 (277)
T ss_pred -------c-----ccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHH
Confidence 0 00011268899999999999999999999 6788999999876443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=318.64 Aligned_cols=251 Identities=26% Similarity=0.481 Sum_probs=216.6
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~-----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
.++|..++.+|+|+||.+++++++.+++.+++|.+.- ..++...+|+.+++++ .|||||.+.+.|... +...+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~-~hP~iv~y~ds~~~~-~~~l~ 80 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKL-LHPNIVEYKDSFEED-GQLLC 80 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhc-cCCCeeeeccchhcC-CceEE
Confidence 5789999999999999999999999999999999863 2345678999999998 999999999999654 23489
Q ss_pred EEEeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 112 LIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 112 lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
|+|+|++||++.+.+. .++++.+..++.|++.|+.|||+++|+|+|||+.||+++.+ +.|+|+|||+++...+.
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~-~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKD-KKVKLGDFGLAKILNPE 159 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcccc-CceeecchhhhhhcCCc
Confidence 9999999999998874 39999999999999999999999999999999999999999 77899999999988776
Q ss_pred C-cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 187 K-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 187 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
. ......||+.|++||.+.+ .++..++|+|||||.+|+|++-+.+| .+.+...-...+.+....+
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF-~a~~m~~Li~ki~~~~~~P------------ 225 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAF-KASNMSELILKINRGLYSP------------ 225 (426)
T ss_pred hhhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhccccc-CccchHHHHHHHhhccCCC------------
Confidence 6 4555789999999999988 89999999999999999999999888 4455445555554433221
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
.+...+.+++.+|+.||+.+|+.||++.++|.+|.+...
T Consensus 226 ------------------------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 226 ------------------------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred ------------------------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 122378999999999999999999999999999988754
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=315.96 Aligned_cols=246 Identities=23% Similarity=0.420 Sum_probs=197.1
Q ss_pred EeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeee
Q 019642 44 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 117 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~ 117 (338)
+.||+|+||.||+|.+..+++.||+|.++.. .......|..++....+||+|+++++.+.+ ....++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEEEECCC
Confidence 4699999999999999999999999998642 234456677787765589999999999954 56889999999
Q ss_pred cCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC-CCcceeee
Q 019642 118 NSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV 193 (338)
Q Consensus 118 ~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~-~~~~~~~~ 193 (338)
.+++|...+. .+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++..... ........
T Consensus 79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD-GHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEeCccCCCeecccCCCceeccC
Confidence 9999877653 58999999999999999999999999999999999999988 7999999998864321 12233456
Q ss_pred ccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhh
Q 019642 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL 273 (338)
Q Consensus 194 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (338)
|++.|+|||++.+ ..++.++|+||||+++|+|++|..||... +.......+.. ...
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~-~~~~~~~~~~~--~~~-------------------- 213 (316)
T cd05620 158 GTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGD-DEDELFESIRV--DTP-------------------- 213 (316)
T ss_pred CCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCC-CHHHHHHHHHh--CCC--------------------
Confidence 8999999999987 67899999999999999999999999422 22222221110 000
Q ss_pred hccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCH-HHHhcCCCcchhhhc
Q 019642 274 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA-REAMAHPYFAQVRAA 331 (338)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~-~ell~hp~~~~~~~~ 331 (338)
..+..++.++.++|++||+.||++||++ +++++||||+++...
T Consensus 214 ---------------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~~ 257 (316)
T cd05620 214 ---------------HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWT 257 (316)
T ss_pred ---------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCHH
Confidence 0111268899999999999999999998 589999999887543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=315.92 Aligned_cols=245 Identities=25% Similarity=0.432 Sum_probs=196.1
Q ss_pred EeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeee
Q 019642 44 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 117 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~ 117 (338)
+.||+|+||.||+|.+..+++.||+|+++.. ..+....|..++....+||||+++++.+.. ....++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 3699999999999999999999999998642 223445677777665589999999999854 46789999999
Q ss_pred cCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC-Ccceeee
Q 019642 118 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRV 193 (338)
Q Consensus 118 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~-~~~~~~~ 193 (338)
.+++|...+ ..+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++...... .......
T Consensus 79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~-~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD-GHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCC-CCEEEccCcCCeECCCCCCcccccc
Confidence 999998776 358999999999999999999999999999999999999988 89999999998654322 2233456
Q ss_pred ccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhh
Q 019642 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL 273 (338)
Q Consensus 194 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (338)
|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.. .+..+....+.. ..
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~---~~-------------------- 212 (316)
T cd05592 158 GTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHG-EDEDELFDSILN---DR-------------------- 212 (316)
T ss_pred CCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHc---CC--------------------
Confidence 8999999999877 5789999999999999999999999842 222222221110 00
Q ss_pred hccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCH-HHHhcCCCcchhhh
Q 019642 274 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA-REAMAHPYFAQVRA 330 (338)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~-~ell~hp~~~~~~~ 330 (338)
...+..++.++.++|.+||+.||++||++ .++++||||..+..
T Consensus 213 --------------~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 213 --------------PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW 256 (316)
T ss_pred --------------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence 00112268899999999999999999986 48889999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=316.43 Aligned_cols=250 Identities=26% Similarity=0.443 Sum_probs=198.1
Q ss_pred EeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeee
Q 019642 44 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 117 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~ 117 (338)
+.||+|+||.||++.+..+++.+|+|+++.. ....+..|+.++.++.+||||+++++.+.. ....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEeCC
Confidence 4699999999999999999999999998742 123466788888877689999999999855 46789999999
Q ss_pred cCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc-CCCcceeee
Q 019642 118 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRV 193 (338)
Q Consensus 118 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~-~~~~~~~~~ 193 (338)
.+++|...+ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++.... .........
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~-~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC-CCEEEeeCCccccccCCCCcccccc
Confidence 999987665 358999999999999999999999999999999999999988 899999999986432 222233457
Q ss_pred ccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCC----HHHHHHHHHHhCCchhhhhhhccccccCcc
Q 019642 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN----HDQLVKIAKVLGTDELNAYLNKYHLELDPQ 269 (338)
Q Consensus 194 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
|++.|+|||++.+ ..++.++|+||||+++|+|++|..||...... ......+.+....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~----------------- 219 (329)
T cd05618 158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE----------------- 219 (329)
T ss_pred CCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc-----------------
Confidence 8999999999987 67889999999999999999999999421110 0000001110000
Q ss_pred hhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCC------HHHHhcCCCcchhhh
Q 019642 270 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT------AREAMAHPYFAQVRA 330 (338)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt------~~ell~hp~~~~~~~ 330 (338)
. ....+..++.++.++|++||+.||++||| +.++++||||+++..
T Consensus 220 ------~----------~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 220 ------K----------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred ------C----------CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 0 00112236889999999999999999998 579999999988654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=315.80 Aligned_cols=245 Identities=24% Similarity=0.420 Sum_probs=198.6
Q ss_pred EeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeee
Q 019642 44 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 117 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~ 117 (338)
+.||+|+||+||++.+..+++.||+|+++.. ....+..|..+++.+.+||||+++++.+.. ....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 4699999999999999999999999998742 234466788888888679999999999855 45789999999
Q ss_pred cCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc-CCCcceeee
Q 019642 118 NSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRV 193 (338)
Q Consensus 118 ~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~-~~~~~~~~~ 193 (338)
.+++|...+. .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++.... .........
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCC-CcEEecccCCCeecCcCCCccccee
Confidence 9999877653 58999999999999999999999999999999999999988 899999999886432 222233346
Q ss_pred ccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhh
Q 019642 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL 273 (338)
Q Consensus 194 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (338)
+++.|+|||++.+ ..++.++|+||||+++|+|++|..||.. .+.......+.. . .
T Consensus 158 g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~-~~~~~~~~~i~~---~-~------------------- 212 (318)
T cd05570 158 GTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEG-DDEDELFQSILE---D-E------------------- 212 (318)
T ss_pred cCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCC-CCHHHHHHHHHc---C-C-------------------
Confidence 8899999999977 6789999999999999999999999842 222211111110 0 0
Q ss_pred hccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCH-----HHHhcCCCcchhhh
Q 019642 274 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA-----REAMAHPYFAQVRA 330 (338)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~-----~ell~hp~~~~~~~ 330 (338)
...+..+++++.+||++||+.||++|||+ .++++||||+.+..
T Consensus 213 --------------~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 213 --------------VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred --------------CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 00112268899999999999999999999 99999999988654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=307.93 Aligned_cols=252 Identities=26% Similarity=0.435 Sum_probs=204.6
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
.|++.+.||+|+||.||++.+..+++.+++|.+.... ...+..|+.+++++ +|++++++++.+.+ ....++
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~--~~~~~l 77 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYET--KDALCL 77 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEec--CCEEEE
Confidence 4788899999999999999999999999999876421 23466799999999 99999999999855 457899
Q ss_pred EEeeecCCcccccc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 113 IFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 113 v~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
+|||+.+++|...+ ..+++..+..++.|++.||.|||+.|++|+||||+||+++.. +.++|+|||++.......
T Consensus 78 v~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 78 VLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC-CCEEEeeccceeecCCCc
Confidence 99999999997765 248899999999999999999999999999999999999987 789999999987654433
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCH--HHHHHHHHHhCCchhhhhhhccccc
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
......++..|+|||++.+ ..++.++|+||+|+++|+|++|..||....... +..........
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~-------------- 221 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ-------------- 221 (285)
T ss_pred cccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh--------------
Confidence 3334578899999999877 678999999999999999999999995432211 11111100000
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCC-----HHHHhcCCCcchhhhc
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAA 331 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt-----~~ell~hp~~~~~~~~ 331 (338)
......+++++.+|+++||+.||++||| ++|+++||||+++...
T Consensus 222 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05630 222 ----------------------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK 270 (285)
T ss_pred ----------------------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHH
Confidence 0011226888999999999999999999 9999999999987554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=319.47 Aligned_cols=244 Identities=27% Similarity=0.454 Sum_probs=197.3
Q ss_pred EeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeee
Q 019642 44 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 117 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~ 117 (338)
+.||+|+||.||++.+..+++.||+|+++.. ....+..|+.+++.+ .||||+++++.+.. ....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~~~--~~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQT--HDRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEEEc--CCEEEEEEeCC
Confidence 3689999999999999999999999998642 224456789999998 99999999999854 46789999999
Q ss_pred cCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEecCCCCceEEEeccccccccC-CCcceee
Q 019642 118 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVR 192 (338)
Q Consensus 118 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~-~~~~~~~ 192 (338)
.+++|...+ ..+++..++.++.|++.||.|||+ .|++|+||||+||+++.+ +.++|+|||++..... .......
T Consensus 78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (325)
T cd05594 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTF 156 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCC-CCEEEecCCCCeecCCCCcccccc
Confidence 999987765 348999999999999999999998 799999999999999988 8999999999864322 2222335
Q ss_pred eccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhh
Q 019642 193 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA 272 (338)
Q Consensus 193 ~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (338)
.|++.|+|||++.+ ..++.++|+||||+++|+|++|..||... +.......+.. ..
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~-~~~~~~~~i~~--~~-------------------- 212 (325)
T cd05594 157 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKLFELILM--EE-------------------- 212 (325)
T ss_pred cCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCC-CHHHHHHHHhc--CC--------------------
Confidence 68999999999877 67899999999999999999999999432 21111111100 00
Q ss_pred hhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC-----CHHHHhcCCCcchhhh
Q 019642 273 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRA 330 (338)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~ 330 (338)
...+..+++++.++|.+||+.||++|+ ++.++++||||.++..
T Consensus 213 ---------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 260 (325)
T cd05594 213 ---------------IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVW 260 (325)
T ss_pred ---------------CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence 001122688999999999999999997 9999999999997643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=305.77 Aligned_cols=289 Identities=25% Similarity=0.457 Sum_probs=218.8
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc--hHHHHHHHHHHHHhcCCC-----CeeEeeeeeeccCCC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGP-----NVVKLLDIVRDQHSK 108 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~E~~~l~~l~~h~-----~iv~~~~~~~~~~~~ 108 (338)
..++|+++..+|+|.||.|-.+.+..++..||+|+++... ++...-|+++++++.++. -++++.++| +-.+
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF--dyrg 164 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF--DYRG 164 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh--hccC
Confidence 3679999999999999999999999999999999998643 456677999999995332 477888888 4467
Q ss_pred ccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC----------------
Q 019642 109 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE---------------- 168 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~---------------- 168 (338)
++|+|+|.++......+-. +++...++.++.|+++++++||+.+++|.||||+|||+.+.
T Consensus 165 hiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r 244 (415)
T KOG0671|consen 165 HICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIR 244 (415)
T ss_pred ceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceec
Confidence 8999999997555444332 49999999999999999999999999999999999998311
Q ss_pred ---CCceEEEeccccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHH
Q 019642 169 ---LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 245 (338)
Q Consensus 169 ---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~ 245 (338)
...++++|||.++...... .....|..|+|||++++ -.|+.++||||+||||+|+.||...| +.+++.+.+..
T Consensus 245 ~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LF-qtHen~EHLaM 320 (415)
T KOG0671|consen 245 PLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLF-QTHENLEHLAM 320 (415)
T ss_pred cCCCcceEEEecCCcceeccCc--ceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceec-ccCCcHHHHHH
Confidence 2468999999998754333 55688999999999999 78999999999999999999999887 66778898988
Q ss_pred HHHHhCCchhhhhhhcc--------ccccCcchhhhhccccCCCCcccccccCC-CCCChhHHHHHHHhcCCCcCCcCCH
Q 019642 246 IAKVLGTDELNAYLNKY--------HLELDPQLDALVGRHSRKPWSKFINADNQ-HLVSPEAIDFLDKLLRYDHQDRLTA 316 (338)
Q Consensus 246 ~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~~li~~~L~~dP~~Rpt~ 316 (338)
+.+.+|..+........ ...++..-..--.+....+.......... ...-.++++||++||..||.+|+|+
T Consensus 321 MerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl 400 (415)
T KOG0671|consen 321 MERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITL 400 (415)
T ss_pred HHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccH
Confidence 88999965554443321 11111100000000011111111111111 1123469999999999999999999
Q ss_pred HHHhcCCCcchhhh
Q 019642 317 REAMAHPYFAQVRA 330 (338)
Q Consensus 317 ~ell~hp~~~~~~~ 330 (338)
.|+|.||||+..+.
T Consensus 401 ~EAL~HpFF~~~~~ 414 (415)
T KOG0671|consen 401 REALSHPFFARLTP 414 (415)
T ss_pred HHHhcCHHhhcCCC
Confidence 99999999998754
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=314.88 Aligned_cols=256 Identities=27% Similarity=0.422 Sum_probs=201.3
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
++|++.+.||+|+||.||++.+..+++.||+|++... ..+.+.+|..+++.+ +|+||+++++.+.+ ....+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~ 77 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQD--ENNLY 77 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEec--CCeEE
Confidence 5899999999999999999999999999999998632 234477899999998 99999999999854 56889
Q ss_pred EEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 112 LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 112 lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
+||||+.+++|..++. .+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADG 156 (331)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCC-CCEEEEECCceeecCCCC
Confidence 9999999999987763 48999999999999999999999999999999999999888 899999999986554322
Q ss_pred c--ceeeeccccccccccccC----cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 188 E--YNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 188 ~--~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
. .....|++.|+|||++.+ ...++.++|+||+|+++|+|++|+.||... +..+....+.......
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~-~~~~~~~~i~~~~~~~-------- 227 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE-SLVETYGKIMNHKEHF-------- 227 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC-CHHHHHHHHHcCCCcc--------
Confidence 2 223468999999999863 245788999999999999999999998422 2222222211100000
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCC--cCCHHHHhcCCCcchhhh
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD--RLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~--Rpt~~ell~hp~~~~~~~ 330 (338)
.. ......+++++.++|++||..+++. |+++.++++||||.+...
T Consensus 228 -------------------~~-----~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~ 274 (331)
T cd05597 228 -------------------QF-----PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW 274 (331)
T ss_pred -------------------cC-----CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence 00 0001126889999999998754443 789999999999988654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=313.13 Aligned_cols=246 Identities=24% Similarity=0.421 Sum_probs=197.7
Q ss_pred EeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeee
Q 019642 44 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 117 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~ 117 (338)
+.||+|+||.||+|.+..+++.||+|.++.. .......|..++....+||||+++++.+.+ ....++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEEEEeCC
Confidence 4699999999999999999999999998643 233455677777765589999999999855 45789999999
Q ss_pred cCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC-CCcceeee
Q 019642 118 NSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV 193 (338)
Q Consensus 118 ~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~-~~~~~~~~ 193 (338)
.+++|...+. .+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++..... ........
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD-GHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC-CCEEEccCCcceECCCCCCceeeec
Confidence 9999987763 48899999999999999999999999999999999999988 7899999999864322 22233456
Q ss_pred ccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhh
Q 019642 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL 273 (338)
Q Consensus 194 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (338)
|++.|+|||++.+ ..++.++|+||+|+++|+|++|..||.. .+..+....+ ... ...
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~i-~~~-~~~------------------- 214 (316)
T cd05619 158 GTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHG-HDEEELFQSI-RMD-NPC------------------- 214 (316)
T ss_pred CCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCC-CCHHHHHHHH-HhC-CCC-------------------
Confidence 8999999999877 6789999999999999999999999843 2222222211 100 000
Q ss_pred hccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHH-HHhcCCCcchhhhc
Q 019642 274 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR-EAMAHPYFAQVRAA 331 (338)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~-ell~hp~~~~~~~~ 331 (338)
.+..++.++.++|.+||+.||++||++. ++++||||+++...
T Consensus 215 ----------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05619 215 ----------------YPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWS 257 (316)
T ss_pred ----------------CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHH
Confidence 0112688999999999999999999996 89999999987643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=320.14 Aligned_cols=257 Identities=26% Similarity=0.400 Sum_probs=203.7
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
...++|++.+.||+|+||.||++.+..+++.+|+|++... ....+.+|+.+++.+ +||||+++++.+.+ ..
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~--~~ 116 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQD--DR 116 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEc--CC
Confidence 4458999999999999999999999999999999998632 233466889999988 99999999999854 56
Q ss_pred ccEEEEeeecCCccccccC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 109 TPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
..++||||+.+++|..++. .+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++......
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~-~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCC-CCEEEEeCCceeEcCcC
Confidence 7899999999999988764 48889999999999999999999999999999999999988 89999999998765432
Q ss_pred C--cceeeeccccccccccccCc---CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 187 K--EYNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 187 ~--~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
. ......||+.|+|||++.+. ..++.++|+||||+++|+|++|..||.. .+.......+........
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~------- 267 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLT------- 267 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCccc-------
Confidence 2 22345689999999998652 2378899999999999999999999942 222222222211100000
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCC--cCCHHHHhcCCCcchhh
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD--RLTAREAMAHPYFAQVR 329 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~--Rpt~~ell~hp~~~~~~ 329 (338)
......++.++.++|..||..++.+ |++++++++||||++..
T Consensus 268 --------------------------~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 268 --------------------------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred --------------------------CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 0011237899999999999844433 78999999999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=315.41 Aligned_cols=282 Identities=21% Similarity=0.321 Sum_probs=207.5
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
..++|++.+.||+|+||.||++.+..++..+++|.++.. ....+.+|+++++.+ +||||+++++++.+ ....+
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~ 79 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYS--DGEIS 79 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCcccceeEEEEE--CCEEE
Confidence 358999999999999999999999999999999987643 235678999999999 89999999999965 45789
Q ss_pred EEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 112 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 112 lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
+||||+.+++|.+++. .+++..+..++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCC-CCEEEeeCCcchhhhhh-
Confidence 9999999999988763 488899999999999999999985 79999999999999987 78999999998654322
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHh--CCchhhhhhhccccc
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL--GTDELNAYLNKYHLE 265 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 265 (338)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..... .......... +....... ......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~ 233 (333)
T cd06650 158 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDA--KELELMFGCPVEGDPAESET-SPRPRP 233 (333)
T ss_pred ccccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcch--hHHHHHhcCcccCCcccccc-CcccCC
Confidence 2233468889999999877 6788999999999999999999999943221 1111111100 00000000 000000
Q ss_pred cCcch-------------hhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 266 LDPQL-------------DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 266 ~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
..... ........... ........++.++.+||.+||+.||++|||+.|+++||||+....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~ 307 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEP----PPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEA 307 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCC----CccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCcc
Confidence 00000 00000000000 000111225788999999999999999999999999999987643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=305.84 Aligned_cols=273 Identities=32% Similarity=0.617 Sum_probs=204.8
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
+|++.+.||+|++|.||+|.+..+++.|++|.++.. ....+.+|+.+++++ .|||++++++++.+ ....++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v 77 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-QHPNIVCLQDVLMQ--ESRLYLI 77 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhc-CCCCEeeeEEEEee--CCeEEEE
Confidence 589999999999999999999999999999998632 235678899999999 89999999999955 4578999
Q ss_pred EeeecCCcccccc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 114 FEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 114 ~e~~~~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
|||+.+ ++..++ ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 78 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 78 FEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNK-GVIKLADFGLARAFGIPV 155 (285)
T ss_pred EecCCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCC-CcEEECcccceeecCCCc
Confidence 999985 444333 348899999999999999999999999999999999999988 899999999986543221
Q ss_pred -cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 188 -EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 188 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
......+++.|+|||.+.+...++.++|+||||+++|+|++|+.||. +....+......+..+......|......
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 232 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH-GDSEIDQLFRIFRILGTPTEDVWPGVTSL-- 232 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHHHhCCCChhhhhcchhh--
Confidence 12234567889999998765567899999999999999999998884 33334444444444433222222110000
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
+....... .+...........+++++.++|++||+.||++|||+.++++||||
T Consensus 233 -~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 233 -PDYKNTFP-----KWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred -HHHHhhcc-----ccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00000000 000001111122378999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=315.27 Aligned_cols=243 Identities=28% Similarity=0.485 Sum_probs=195.9
Q ss_pred EeeeecCceeEEEEEEc---CCCceEEEEEeccc-------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 44 RKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~-------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
+.||+|+||.||++.+. .+++.||+|+++.. ....+..|+.+++.+ +||||+++++.+.. ....+++
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~--~~~~~lv 78 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAFQT--GGKLYLI 78 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEEec--CCeEEEE
Confidence 67999999999999864 46889999998642 123467899999999 99999999999855 4578999
Q ss_pred EeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC-Ccc
Q 019642 114 FEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEY 189 (338)
Q Consensus 114 ~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~-~~~ 189 (338)
|||+.+++|...+. .+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++...... ...
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 79 LEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred EeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEeeCcCCeecccCCCcc
Confidence 99999999877763 47888999999999999999999999999999999999988 89999999998643222 222
Q ss_pred eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcc
Q 019642 190 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 269 (338)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
....|++.|+|||.+.+ ..++.++||||||+++|+|++|..||.. .+.......+... .
T Consensus 158 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~-~~~~~~~~~~~~~--~----------------- 216 (323)
T cd05584 158 HTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTA-ENRKKTIDKILKG--K----------------- 216 (323)
T ss_pred cccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCC-CCHHHHHHHHHcC--C-----------------
Confidence 33468999999999877 5788999999999999999999999842 2222222221110 0
Q ss_pred hhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC-----CHHHHhcCCCcchhh
Q 019642 270 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVR 329 (338)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~ 329 (338)
...+..+++++.+||++||+.||++|| +++++++||||....
T Consensus 217 ------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~ 263 (323)
T cd05584 217 ------------------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVN 263 (323)
T ss_pred ------------------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence 001223688999999999999999999 899999999998754
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=309.32 Aligned_cols=287 Identities=26% Similarity=0.500 Sum_probs=217.6
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
..++|++.+.||.|+||.||+|.+..+++.|++|.++... .....+|+.+++++ +|+|++++++++.+......
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-RHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhC-CCCCCcceEEEEecCCCCeE
Confidence 4679999999999999999999999999999999986322 22456799999999 99999999999876655678
Q ss_pred EEEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 111 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
++||||+.+. +..++ ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 84 ~lv~e~~~~~-l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 84 FLVMEYCEQD-LASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDK-GCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEEecCCCC-HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECccceeeecCCc
Confidence 9999999864 43332 348999999999999999999999999999999999999988 89999999998765432
Q ss_pred C-cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 187 K-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 187 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
. ......++..|+|||.+.+...++.++|+||||+++|+|++|..|| ...+..+.+..+.+.++.+....+.......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLL-PGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 2 2223345778999999876567889999999999999999999888 4455566666666666655433332111100
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhccc
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 333 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 333 (338)
...... ....+...+. .....+++++.++|.+||+.||++|||+.++++||||++...+..
T Consensus 241 ~~~~~~-----~~~~~~~~~~--~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~ 301 (309)
T cd07845 241 LVGKFT-----LPKQPYNNLK--HKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCE 301 (309)
T ss_pred cccccc-----ccCCCCCchH--HhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCC
Confidence 000000 0000000000 011225788999999999999999999999999999998776643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=312.93 Aligned_cols=251 Identities=25% Similarity=0.439 Sum_probs=199.9
Q ss_pred EeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeee
Q 019642 44 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 117 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~ 117 (338)
+.||+|+||.||++.+..+++.+|+|+++.. ..+.+..|..++.++.+||+|+++++.+.. ....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEEEEeCC
Confidence 4699999999999999999999999998742 224467899999988789999999999855 45789999999
Q ss_pred cCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc-CCCcceeee
Q 019642 118 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRV 193 (338)
Q Consensus 118 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~-~~~~~~~~~ 193 (338)
.+++|...+ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++.... .........
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCC-CCEEEeccccceeccCCCCceeccc
Confidence 999987665 359999999999999999999999999999999999999988 789999999886432 222334457
Q ss_pred ccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHH--HHHHHHHHhCCchhhhhhhccccccCcchh
Q 019642 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD--QLVKIAKVLGTDELNAYLNKYHLELDPQLD 271 (338)
Q Consensus 194 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (338)
|++.|+|||++.+ ..++.++|+||||+++|+|++|..||....+... ......+......
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------------- 219 (327)
T cd05617 158 GTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP----------------- 219 (327)
T ss_pred CCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC-----------------
Confidence 8999999999877 6789999999999999999999999953221110 0011111100000
Q ss_pred hhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCC------HHHHhcCCCcchhhhc
Q 019642 272 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT------AREAMAHPYFAQVRAA 331 (338)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt------~~ell~hp~~~~~~~~ 331 (338)
...+..++..+.+++++||..||++|++ ++++++||||..+.+.
T Consensus 220 ----------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~ 269 (327)
T cd05617 220 ----------------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD 269 (327)
T ss_pred ----------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence 0012236889999999999999999998 5799999999987643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=339.40 Aligned_cols=258 Identities=25% Similarity=0.426 Sum_probs=207.7
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
..++|++++.||+|+||+||++.+..++..+++|++... ....+..|+.+++.+ +||||+++++.|.+.....+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L-~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-KHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEecCCCEE
Confidence 357999999999999999999999999999999998632 245678899999999 99999999999876666678
Q ss_pred EEEEeeecCCcccccc-------CCCCHHHHHHHHHHHHHHHHHHHHC-------CceeccCCCCCeEecCC--------
Q 019642 111 SLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQ-------GIMHRDVKPHNVMIDHE-------- 168 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~-------~i~H~dikp~NIli~~~-------- 168 (338)
++||||+.+++|..++ ..+++..++.++.||+.||.|||+. +|+|+||||+|||++..
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 9999999999998765 3489999999999999999999985 49999999999999642
Q ss_pred --------CCceEEEeccccccccCCCcceeeeccccccccccccCc-CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCC
Q 019642 169 --------LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 239 (338)
Q Consensus 169 --------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~ 239 (338)
.+.++|+|||++.............+++.|+|||++.+. ..++.++|||||||+||+|++|..||....+
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~- 248 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN- 248 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc-
Confidence 235899999998765443333445789999999998642 4588999999999999999999999954332
Q ss_pred HHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHH
Q 019642 240 HDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 319 (338)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~el 319 (338)
...+...... .+. ......+.++.+||..||..+|.+||++.|+
T Consensus 249 ~~qli~~lk~--~p~----------------------------------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~Ql 292 (1021)
T PTZ00266 249 FSQLISELKR--GPD----------------------------------LPIKGKSKELNILIKNLLNLSAKERPSALQC 292 (1021)
T ss_pred HHHHHHHHhc--CCC----------------------------------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHH
Confidence 2222111110 000 0001157899999999999999999999999
Q ss_pred hcCCCcchhhhc
Q 019642 320 MAHPYFAQVRAA 331 (338)
Q Consensus 320 l~hp~~~~~~~~ 331 (338)
|.|||++.+..+
T Consensus 293 L~h~~ik~i~~p 304 (1021)
T PTZ00266 293 LGYQIIKNVGPP 304 (1021)
T ss_pred hccHHHhhcCCC
Confidence 999999877543
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=312.09 Aligned_cols=250 Identities=23% Similarity=0.373 Sum_probs=201.6
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
+|+..+.||+|+||+||+|.+..+++.||+|+++.. ....+..|..++..+.+|++++++++.+.. ....++
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--VDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec--CCEEEE
Confidence 478899999999999999999999999999998642 223466788888888567888899998855 457899
Q ss_pred EEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC-Cc
Q 019642 113 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KE 188 (338)
Q Consensus 113 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~-~~ 188 (338)
||||+.+++|..++ ..+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++...... ..
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~-~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSE-GHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEeccccccccCCCCcc
Confidence 99999999988776 358999999999999999999999999999999999999988 89999999988653222 12
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
.....|++.|+|||++.+ ..++.++|+||+|+++|+|++|..||.. .+.......+... .
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~--~---------------- 217 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEH--N---------------- 217 (323)
T ss_pred ccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhC--C----------------
Confidence 233468899999999877 6789999999999999999999999842 2222222222110 0
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCC-----HHHHhcCCCcchhhh
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRA 330 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt-----~~ell~hp~~~~~~~ 330 (338)
...+..++.++.+++.+||+.+|++|++ ..++++||||..+..
T Consensus 218 -------------------~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~ 265 (323)
T cd05615 218 -------------------VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW 265 (323)
T ss_pred -------------------CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence 0011226889999999999999999997 579999999998754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=313.09 Aligned_cols=285 Identities=26% Similarity=0.482 Sum_probs=213.0
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccC----C
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----S 107 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~----~ 107 (338)
.++|++.+.||+|+||.||++.+..+++.+++|.+... ....+.+|+.+++++ +|||++++++.+.... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV-NHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhc-CCCCCcceeeeeccCCCcccc
Confidence 47899999999999999999999999999999998532 234566899999999 9999999999885432 2
Q ss_pred CccEEEEeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 108 KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
...++||||+.+.........++...+..++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~ 172 (353)
T cd07850 94 QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSF 172 (353)
T ss_pred CcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEccCccceeCCCCC
Confidence 3578999999875444444458999999999999999999999999999999999999998 789999999987654433
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||. ..+.......+...++.+...- ......
T Consensus 173 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--- 246 (353)
T cd07850 173 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFP-GTDHIDQWNKIIEQLGTPSDEF-MSRLQP--- 246 (353)
T ss_pred CCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCC-CCCHHHHHHHHHHhcCCCCHHH-HHHhhh---
Confidence 3334567889999999877 678999999999999999999999984 4444555555655555543211 111000
Q ss_pred cchhhhhccccC---CCCcccc--------cccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 268 PQLDALVGRHSR---KPWSKFI--------NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 268 ~~~~~~~~~~~~---~~~~~~~--------~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
........... .++.... ........++.+.++|.+||+.||++|||+.|+|+||||+.+-.
T Consensus 247 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 247 -TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD 319 (353)
T ss_pred -hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence 00000000000 0000000 00012234677899999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=307.00 Aligned_cols=280 Identities=34% Similarity=0.588 Sum_probs=214.7
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc--------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
+|++.+.||+|++|.||+|.+..+++.|++|.++... ...+..|+.+++++ +|+|++++++++.+ ....
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~ 77 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPNIIGLLDVFGH--KSNI 77 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-CCCCChhhhheeec--CCEE
Confidence 5889999999999999999999999999999986432 23466799999999 89999999999965 5678
Q ss_pred EEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 111 SLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
++||||+ +++|..++. .+++..+..++.|+++||.+||++|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 78 ~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 78 NLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASD-GVLKLADFGLARSFGSP 155 (298)
T ss_pred EEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCC-CCEEEccceeeeeccCC
Confidence 9999999 778877763 48899999999999999999999999999999999999988 89999999998765432
Q ss_pred -CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 187 -KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 187 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
.......++..|+|||.+.+...++.++|+||||+++++|++|..+| ...+..+.+..+....+.+....+.......
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFL-PGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccc-cCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 22233456778999999866567889999999999999999996554 5555556666665555544433332211110
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhccc
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 333 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 333 (338)
.. . .. ......+. .......+.++.++|.+||++||++|||+.|+++||||++.+.++.
T Consensus 235 ~~--~-~~-~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 235 DY--V-EF-KPFPPTPL-----KQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred cc--c-cc-cccCCcch-----hhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 00 0 00 00000000 1111235789999999999999999999999999999999876653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=295.47 Aligned_cols=263 Identities=26% Similarity=0.435 Sum_probs=211.0
Q ss_pred CCcEEEE-EeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeecc--CCCccEEE
Q 019642 37 QDDYEVV-RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSKTPSLI 113 (338)
Q Consensus 37 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~~~lv 113 (338)
.++|.+- +.||-|-.|.|-.+.++.+++.+|+|++. +....++|++..-....|||||.++++|.+. +...+.+|
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~--Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiV 137 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL--DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIV 137 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHh--cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEee
Confidence 4566553 67999999999999999999999999987 4455678999988888999999999998653 34577889
Q ss_pred EeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC--CCceEEEeccccccccCC
Q 019642 114 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 114 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~--~~~~~l~dfg~~~~~~~~ 186 (338)
||.+.||.|...++ .+++.++..|++||..|+.|||+.+|+|+||||+|+|.... +..+||+|||+++.....
T Consensus 138 mE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~ 217 (400)
T KOG0604|consen 138 MECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP 217 (400)
T ss_pred eecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCC
Confidence 99999998877763 39999999999999999999999999999999999999543 357899999999876655
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
......+.||.|.|||++.. ..++...|+||+|+++|-|+.|..|||..+... .-..+...+....
T Consensus 218 ~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-ispgMk~rI~~gq------------ 283 (400)
T KOG0604|consen 218 GDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-ISPGMKRRIRTGQ------------ 283 (400)
T ss_pred ccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCcc-CChhHHhHhhccC------------
Confidence 55566788999999999876 789999999999999999999999997654421 1111111110000
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
.-+.......+|++.+++|+++|+.+|++|.|+.++++|||+++-+.-+
T Consensus 284 -----------------y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp 332 (400)
T KOG0604|consen 284 -----------------YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVP 332 (400)
T ss_pred -----------------ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCC
Confidence 0011222234799999999999999999999999999999998765443
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=319.54 Aligned_cols=286 Identities=22% Similarity=0.292 Sum_probs=209.3
Q ss_pred CCcEEEEEeeeecCceeEEEEEEc--CCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINV--NTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
..+|++++.||.|+||.||++... .+++.|++|.+... ....+|+.+++.+ +||||+++++.+.. ....+++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--~~~~~E~~il~~l-~h~~iv~~~~~~~~--~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--KTPGREIDILKTI-SHRAIINLIHAYRW--KSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--ccHHHHHHHHHhc-CCCCccceeeeEee--CCEEEEEe
Confidence 457999999999999999999754 35678999987643 3456899999999 99999999999854 45789999
Q ss_pred eeecCCcccccc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc---c
Q 019642 115 EYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---Y 189 (338)
Q Consensus 115 e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~---~ 189 (338)
|++.+..+.... ..+++..++.++.|++.||.|||+.|++|+||||+|||++.. +.++|+|||++........ .
T Consensus 166 e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~-~~~~l~DfG~a~~~~~~~~~~~~ 244 (392)
T PHA03207 166 PKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEP-ENAVLGDFGAACKLDAHPDTPQC 244 (392)
T ss_pred hhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC-CCEEEccCccccccCcccccccc
Confidence 999865444332 358999999999999999999999999999999999999988 8999999999866543322 2
Q ss_pred eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCC--CCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 190 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH--DNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
....|++.|+|||++.+ ..++.++||||||+++|+|++|..||+... .....+..+.+.++.....-. ........
T Consensus 245 ~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~-~~~~~~~~ 322 (392)
T PHA03207 245 YGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP-QNGSTNLC 322 (392)
T ss_pred cccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC-CccchhHH
Confidence 23468999999999877 678999999999999999999999996543 234555555555543322110 00000000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
........ ..+.++ ..........++.++.++|++||..||++|||+.++|+||||+..+...
T Consensus 323 ~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~ 385 (392)
T PHA03207 323 KHFKQYAI-VLRPPY-TIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINL 385 (392)
T ss_pred HHHHhhcc-cccCCc-cccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhh
Confidence 00000000 000000 0000111123577899999999999999999999999999999876543
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=302.20 Aligned_cols=282 Identities=28% Similarity=0.507 Sum_probs=209.2
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
+..++|++.+.||+|+||.||+|.+..++..+++|.+.... ...+.+|+.+++.+ +|+||+++++++.. ....
T Consensus 2 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~--~~~~ 78 (291)
T cd07870 2 GAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL-KHANIVLLHDIIHT--KETL 78 (291)
T ss_pred CccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhc-CCCCEeEEEEEEec--CCeE
Confidence 34689999999999999999999999999999999986432 23567899999999 99999999999854 4578
Q ss_pred EEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC-
Q 019642 111 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG- 186 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~- 186 (338)
++||||+.++.+.... ..+++..+..++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||++......
T Consensus 79 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 79 TFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYL-GELKLADFGLARAKSIPS 157 (291)
T ss_pred EEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCC-CcEEEeccccccccCCCC
Confidence 8999999865554443 237888899999999999999999999999999999999987 89999999988654221
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.......++..|+|||.+.+...++.++|+||||+++++|++|..||....+..+.+.......+.+....+......
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 235 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL-- 235 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc--
Confidence 122334568889999998764567889999999999999999999996555555566665555554332222111000
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
..................... ....+.++.+++.+||..||++|||+.|++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWK---RLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ccccchhccccCCcchhhhcc---ccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 000000000000000000000 01136789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=321.13 Aligned_cols=277 Identities=22% Similarity=0.328 Sum_probs=202.9
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEe
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 115 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e 115 (338)
....|.+.+.||+|+||.||++.+..+++.|++|... .....+|+.+++++ +|+||+++++++.. ....+++||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---~~~~~~E~~iL~~L-~HpnIv~l~~~~~~--~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---YASSVHEARLLRRL-SHPAVLALLDVRVV--GGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---ccCHHHHHHHHHHC-CCCCCCcEEEEEEE--CCEEEEEEE
Confidence 3568999999999999999999999999999999643 23456899999999 99999999998854 457789999
Q ss_pred eecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc---c
Q 019642 116 YVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---Y 189 (338)
Q Consensus 116 ~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~---~ 189 (338)
++.+..+..+. ..+++..++.++.|++.||.|||++||+|+||||+|||++.+ +.++|+|||++........ .
T Consensus 241 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~-~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 241 KYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGP-EDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred ccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCC-CCEEEcccCCceecccccccccc
Confidence 99765444432 248999999999999999999999999999999999999988 7899999999876533221 1
Q ss_pred eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCC------HHHHHHHHHHhCCchhhhhhhccc
Q 019642 190 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN------HDQLVKIAKVLGTDELNAYLNKYH 263 (338)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
....||..|+|||++.+ ..++.++|||||||++|+|++|..+++..... ...+..+.+..+... ..+.....
T Consensus 320 ~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~-~~~~~~~~ 397 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHV-DEFPQHAG 397 (461)
T ss_pred cccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccc-ccCCCCcc
Confidence 22458999999999977 67899999999999999999998877553321 233333333322210 00000000
Q ss_pred cccCcchhhhhcc-----ccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcch
Q 019642 264 LELDPQLDALVGR-----HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 327 (338)
Q Consensus 264 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 327 (338)
..+.......... .....|.. ...++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTR------YYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhh------hccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0000000000000 00011111 1125678999999999999999999999999999974
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=303.91 Aligned_cols=275 Identities=25% Similarity=0.381 Sum_probs=228.8
Q ss_pred HHHHHHHHHhhhceeeeeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc------cchHHHHHHHHHHHHhc
Q 019642 17 MVYSYCLCFWNVSSYVIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLC 90 (338)
Q Consensus 17 ~~~~~~~~~~~~~~~~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~------~~~~~~~~E~~~l~~l~ 90 (338)
..+..-.|+|++-.. +.-..+.|..-+.||+|+||.|+-++-..||+-||.|.+.+ .......+|-.++.++
T Consensus 165 S~yf~rFlQWK~lE~-qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV- 242 (591)
T KOG0986|consen 165 SDYFTRFLQWKWLEL-QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV- 242 (591)
T ss_pred HHHHHHHHHHHHHHh-hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-
Confidence 345556788887776 55667899999999999999999999999999999998753 2234567899999999
Q ss_pred CCCCeeEeeeeeeccCCCccEEEEeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEe
Q 019642 91 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 165 (338)
Q Consensus 91 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli 165 (338)
+.+.||.+--.|.. ...+|+|+..|+||+|..++. .+++..+..++.+|+.||++||..+||++|+||+|||+
T Consensus 243 ~s~FiVslaYAfeT--kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL 320 (591)
T KOG0986|consen 243 SSPFIVSLAYAFET--KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL 320 (591)
T ss_pred ccCcEEEEeeeecC--CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee
Confidence 89999998888844 567899999999999998873 49999999999999999999999999999999999999
Q ss_pred cCCCCceEEEeccccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHH
Q 019642 166 DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 245 (338)
Q Consensus 166 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~ 245 (338)
|.. |+++|+|+|++..+..+.+...+.||.+|||||++.+ ..|+...|-|||||++|+|+.|+.||...... ..-++
T Consensus 321 Dd~-GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK-vk~eE 397 (591)
T KOG0986|consen 321 DDH-GHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK-VKREE 397 (591)
T ss_pred ccC-CCeEeeccceEEecCCCCccccccCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCchhhhhhh-hhHHH
Confidence 999 9999999999999998888888899999999999988 56999999999999999999999999432211 11111
Q ss_pred HHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC-----CHHHHh
Q 019642 246 IAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAM 320 (338)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----t~~ell 320 (338)
+.+..-. .+...+..+|++++++++.+|++||++|. +++++.
T Consensus 398 vdrr~~~---------------------------------~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk 444 (591)
T KOG0986|consen 398 VDRRTLE---------------------------------DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVK 444 (591)
T ss_pred HHHHHhc---------------------------------chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhh
Confidence 1111111 01122234899999999999999999998 678999
Q ss_pred cCCCcchhhhc
Q 019642 321 AHPYFAQVRAA 331 (338)
Q Consensus 321 ~hp~~~~~~~~ 331 (338)
+||||+++++-
T Consensus 445 ~HpfFk~lnw~ 455 (591)
T KOG0986|consen 445 EHPFFKDLNWR 455 (591)
T ss_pred hCcccccCCHh
Confidence 99999998653
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=325.14 Aligned_cols=258 Identities=26% Similarity=0.449 Sum_probs=211.2
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchH---HHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK---KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
..+-|+|+..||.|+||.||++.++.++...|.|++...... .+.-|+++|..+ .||+|+++++.|.. ++.+++
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~C-dHP~ivkLl~ayy~--enkLwi 106 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAEC-DHPVIVKLLSAYYF--ENKLWI 106 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcC-CChHHHHHHHHHhc--cCceEE
Confidence 345789999999999999999999999999999999865544 455699999998 89999999998754 457889
Q ss_pred EEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc-cCCC
Q 019642 113 IFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGK 187 (338)
Q Consensus 113 v~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~-~~~~ 187 (338)
+.|+|+||.....+ ..+++.++..++.|++.||.|||+++|+|+|||+.|||++.+ |.++|+|||.+.+. ....
T Consensus 107 liEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tld-GdirLADFGVSAKn~~t~q 185 (1187)
T KOG0579|consen 107 LIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLD-GDIRLADFGVSAKNKSTRQ 185 (1187)
T ss_pred EEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEec-CcEeeecccccccchhHHh
Confidence 99999999887765 459999999999999999999999999999999999999999 89999999987543 2334
Q ss_pred cceeeeccccccccccccC----cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccc
Q 019642 188 EYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
..+...|||+|||||+... ..+|+.++||||||++|.+|..+.+|- ..-+....+..+.+. .++
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPH-helnpMRVllKiaKS----ePP------- 253 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPH-HELNPMRVLLKIAKS----EPP------- 253 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCc-cccchHHHHHHHhhc----CCC-------
Confidence 4566899999999999854 357999999999999999999998774 222333333322221 000
Q ss_pred cccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
+...+...+..+.+|+++||.+||..||++.++|+|||+.+++..+
T Consensus 254 -----------------------TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK 299 (1187)
T KOG0579|consen 254 -----------------------TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSNK 299 (1187)
T ss_pred -----------------------cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcch
Confidence 1112333588999999999999999999999999999999887653
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=303.89 Aligned_cols=258 Identities=20% Similarity=0.368 Sum_probs=205.3
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
++|++.+.||+|+||.||+|.+..+++.+++|.+... ....+.+|+.+++++ +|||++++++.+.. ....+++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKC-DSPYIIGFYGAFFV--ENRISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEE--CCEEEEE
Confidence 4789999999999999999999999999999998532 234577899999999 99999999999965 4567899
Q ss_pred EeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcceeee
Q 019642 114 FEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 193 (338)
Q Consensus 114 ~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 193 (338)
|||+.++++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++...... ......
T Consensus 78 ~e~~~~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~-~~~~l~dfg~~~~~~~~-~~~~~~ 154 (279)
T cd06619 78 TEFMDGGSLDVY-RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTR-GQVKLCDFGVSTQLVNS-IAKTYV 154 (279)
T ss_pred EecCCCCChHHh-hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCC-CCEEEeeCCcceecccc-cccCCC
Confidence 999999988654 457889999999999999999999999999999999999988 89999999998655332 223346
Q ss_pred ccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHH--HHHHHHhCCchhhhhhhccccccCcchh
Q 019642 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL--VKIAKVLGTDELNAYLNKYHLELDPQLD 271 (338)
Q Consensus 194 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (338)
++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.......... ....+.......
T Consensus 155 ~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------------- 217 (279)
T cd06619 155 GTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP---------------- 217 (279)
T ss_pred CChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC----------------
Confidence 8889999999877 678999999999999999999999995422211110 011111100000
Q ss_pred hhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhccc
Q 019642 272 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 333 (338)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 333 (338)
........+.++.++|.+||+.+|++||+++++++||||........
T Consensus 218 ---------------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~~ 264 (279)
T cd06619 218 ---------------PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNA 264 (279)
T ss_pred ---------------CCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccCccH
Confidence 00011225788999999999999999999999999999998755444
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=303.10 Aligned_cols=274 Identities=33% Similarity=0.606 Sum_probs=213.2
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
+|++.+.||+|++|.||+|.+..+++.+++|.+.... ...+.+|+.+++++ +|||++++++++.. ....++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~~v 77 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHPYVVKLLDVFPH--GSGFVLV 77 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhC-CCCCCcceeeEEec--CCeeEEE
Confidence 5899999999999999999999999999999986432 35678899999999 89999999999955 5678999
Q ss_pred EeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC--
Q 019642 114 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-- 187 (338)
Q Consensus 114 ~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-- 187 (338)
+||+ +++|...+ ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISAD-GVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCC-CcEEEeeeeecccccCCCCC
Confidence 9999 88887765 348999999999999999999999999999999999999987 889999999987654332
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......++..|+|||.+.+....+.++||||+|+++++|++|..+| .+.+....+..+....+.+....+.......
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 232 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLF-PGENDIEQLAIVFRTLGTPNEETWPGLTSLP-- 232 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCc-CCCCHHHHHHHHHHHcCCCChHHHhhccCcc--
Confidence 1334567889999999876556789999999999999999996554 5556666666666666655444433211110
Q ss_pred cchhhhhc-cccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcc
Q 019642 268 PQLDALVG-RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 326 (338)
Q Consensus 268 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~ 326 (338)
....... .....++. ...+..+.++.++|.+||+.||++|||++++|+||||.
T Consensus 233 -~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 233 -DYNKITFPESKPIPLE-----EIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred -hhhcccCCCCCcchHH-----HhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0000000 00000000 11123578999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=299.96 Aligned_cols=247 Identities=26% Similarity=0.437 Sum_probs=200.2
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc--------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
++|++.+.||+|++|.||.+.+..+++.+++|.+.... .+.+.+|+.+++++ +||||+++++++.+ ...
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~ 78 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRD--DET 78 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEcc--CCe
Confidence 57999999999999999999999999999999875321 24577899999999 99999999999955 458
Q ss_pred cEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 110 PSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
.++++||+.++++.+.+. .+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 79 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~-~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 79 LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeecccceecccc
Confidence 899999999999887763 47889999999999999999999999999999999999987 89999999998654322
Q ss_pred Ccc----eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcc
Q 019642 187 KEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262 (338)
Q Consensus 187 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
... ....++..|+|||.+.+ ...+.++|+||||+++|++++|..||... +.......... ...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~-~~~~~~~~~~~---~~~-------- 224 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEF-EAMAAIFKIAT---QPT-------- 224 (263)
T ss_pred ccccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCcccc-chHHHHHHHhc---cCC--------
Confidence 111 22356788999999987 56889999999999999999999998432 22211111110 000
Q ss_pred ccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
....+..++..+.++|.+||..+|.+|||+.++++||||
T Consensus 225 ------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 225 ------------------------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred ------------------------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 001112368899999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=313.02 Aligned_cols=244 Identities=26% Similarity=0.446 Sum_probs=193.7
Q ss_pred EeeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHH-HHHHhcCCCCeeEeeeeeeccCCCccEEEEee
Q 019642 44 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIK-ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 116 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~-~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~ 116 (338)
+.||+|+||+||+|.+..+++.||+|++.... ...+..|.. +++.+ +||||+++++.+.+ ....++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~--~~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQT--ADKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEe--CCEEEEEEcC
Confidence 36999999999999999999999999986421 233444544 45667 99999999999854 5678999999
Q ss_pred ecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC-CCcceee
Q 019642 117 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVR 192 (338)
Q Consensus 117 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~-~~~~~~~ 192 (338)
+.+++|...+ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++..... .......
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (323)
T cd05575 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGIEHSKTTSTF 156 (323)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC-CcEEEeccCCCcccccCCCccccc
Confidence 9999987765 348999999999999999999999999999999999999988 8999999998864322 2222334
Q ss_pred eccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhh
Q 019642 193 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA 272 (338)
Q Consensus 193 ~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (338)
.|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.. .+..+....+.. . .
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~---~-~------------------ 212 (323)
T cd05575 157 CGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDTAEMYDNILN---K-P------------------ 212 (323)
T ss_pred cCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCC-CCHHHHHHHHHc---C-C------------------
Confidence 68999999999877 6789999999999999999999999843 222222221111 0 0
Q ss_pred hhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCH----HHHhcCCCcchhhh
Q 019642 273 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA----REAMAHPYFAQVRA 330 (338)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~----~ell~hp~~~~~~~ 330 (338)
...+..++.++.++|++||+.||++||++ .++++||||..+..
T Consensus 213 ---------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~ 259 (323)
T cd05575 213 ---------------LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW 259 (323)
T ss_pred ---------------CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 00112268899999999999999999988 69999999987653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=300.37 Aligned_cols=277 Identities=31% Similarity=0.560 Sum_probs=208.4
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
++|++.+.||+|++|.||++.+..+++.+++|.+... ..+.+.+|+.+++.+ +|||++++++.+.. ....++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~~ 77 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-KHPNLVNLIEVFRR--KRKLHL 77 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhC-CCCCEeeeeeEEee--CCEEEE
Confidence 5799999999999999999999999999999987532 234567899999999 89999999999855 457889
Q ss_pred EEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-c
Q 019642 113 IFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E 188 (338)
Q Consensus 113 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-~ 188 (338)
+|||++++++..+.. .+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||++....... .
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQ-GQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCC-CcEEECccccceecCCCccc
Confidence 999999998887653 48999999999999999999999999999999999999988 789999999987654332 2
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
.....++..|+|||.+.+...++.++|+||||+++++|++|..||. +.+..+....+....+........ ... ...
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~-~~~--~~~ 232 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWP-GKSDVDQLYLIRKTLGDLIPRHQQ-IFS--TNQ 232 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCChHHhh-hcc--ccc
Confidence 2234567889999998765568899999999999999999998984 344445555544444332211000 000 000
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
..... .......... .......++..+.+||.+||+.+|++|||+.|+++||||
T Consensus 233 ~~~~~-~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 233 FFKGL-SIPEPETREP--LESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccccc-cCCCcccccC--HHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 00000 0000000000 000112368899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=303.73 Aligned_cols=280 Identities=31% Similarity=0.560 Sum_probs=212.5
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
.++|++.+.||+|++|.||+|.+..+++.+++|.++... ...+.+|+.+++++ .|||++++++++........+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhc-CCCCEEEEEEEEEecCCCcEE
Confidence 468999999999999999999999999999999986432 22456899999999 899999999998766557899
Q ss_pred EEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC-
Q 019642 112 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG- 186 (338)
Q Consensus 112 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~- 186 (338)
++|||+.+ +|..++ ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNR-GILKICDFGLAREYGSPL 160 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC-CcEEEeecCceeeccCCc
Confidence 99999986 554443 248999999999999999999999999999999999999988 89999999988765433
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.......++..|+|||.+.+....+.++|+||||+++++|++|..||. ..+..+....+....+.+....|........
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP-GKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 223334577889999998764557899999999999999999998884 4444555555555555554444432211111
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
... ...................+++.+.++|++||+.||++|||+.|+|+||||
T Consensus 240 ~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 240 AKK-----KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hcc-----cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 100 000000111111111111158889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=302.55 Aligned_cols=278 Identities=32% Similarity=0.583 Sum_probs=209.9
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
..++|++.+.||+|++|.||+|.+..+++.|++|.+.... ...+.+|+.+++++ +||||+++++++.+ ....+
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~ 79 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL-KHANIVTLHDIIHT--KKTLT 79 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhC-CCcceeeEEEEEec--CCeEE
Confidence 4589999999999999999999999899999999986322 24467899999999 99999999999854 56889
Q ss_pred EEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC-
Q 019642 112 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG- 186 (338)
Q Consensus 112 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~- 186 (338)
+||||+.+ +|..++ ..+++..++.++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 80 lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 80 LVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISER-GELKLADFGLARAKSVPS 157 (291)
T ss_pred EEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCC-CCEEECccccccccCCCC
Confidence 99999986 565544 247889999999999999999999999999999999999988 78999999988643211
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.......++..|+|||.+.+...++.++|+||+|+++|+|++|..||.......+.+..+.+.++.+....+........
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 11122346778999999876556889999999999999999999998655545566666666666544443322211100
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCC--hhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVS--PEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s--~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
..... .......+ .. .....++ .++.+++.+||+.+|++|||+.++++||||
T Consensus 238 ~~~~~--~~~~~~~~---~~--~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 238 FKPYS--FPFYPPRP---LI--NHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccc--ccccCChh---HH--HhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00000 00000000 00 0001133 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=301.76 Aligned_cols=254 Identities=26% Similarity=0.385 Sum_probs=205.0
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
.|+..+.||+|+||+||++.+..+++.+|+|.+.... ...+.+|+.+++.+ +|++++++.+.+.. ....++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~--~~~~~l 77 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYET--KDALCL 77 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEec--CCEEEE
Confidence 4788899999999999999999999999999986421 23467899999999 99999999998854 457899
Q ss_pred EEeeecCCcccccc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 113 IFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 113 v~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
+|||+.+++|...+ ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 78 VLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDY-GHIRISDLGLAVKIPEGE 156 (285)
T ss_pred EEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCC-CCEEEecCCcceecCCCC
Confidence 99999999887654 248999999999999999999999999999999999999988 789999999886654333
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......++..|+|||.+.+ ..++.++|+||||+++|++++|..||... ........+.........
T Consensus 157 ~~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~-~~~~~~~~~~~~~~~~~~------------ 222 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGR-KEKVKREEVDRRVLETEE------------ 222 (285)
T ss_pred cccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHhhhcccc------------
Confidence 3344578899999999877 67889999999999999999999998432 222222222111111000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCC-----HHHHhcCCCcchhhhc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAA 331 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt-----~~ell~hp~~~~~~~~ 331 (338)
.....++.++.+|+.+||+.||++||+ +.++++||||++....
T Consensus 223 ---------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05632 223 ---------------------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK 270 (285)
T ss_pred ---------------------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence 011226788999999999999999999 8999999999987554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=306.18 Aligned_cols=282 Identities=27% Similarity=0.522 Sum_probs=208.3
Q ss_pred cEEEEEeeeecCceeEEEEEEcC--CCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVN--TNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
+|++.+.||+|++|.||+|.+.. +++.||+|.+... ....+.+|+.+++.+ +|||++++++++.+......
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-CCCCccceEEEEeCCCCceE
Confidence 58899999999999999999988 8999999998752 235677899999999 99999999999977655789
Q ss_pred EEEEeeecCCcccccc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecC----CCCceEEEeccc
Q 019642 111 SLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH----ELRKLRLIDWGL 179 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~----~~~~~~l~dfg~ 179 (338)
++||||++++++.... ..+++..++.++.|++.||.|||+.|++|+||||+||+++. . +.++|+|||+
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~-~~~kl~Dfg~ 158 (316)
T cd07842 80 YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPER-GVVKIGDLGL 158 (316)
T ss_pred EEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCcc-ceEEECCCcc
Confidence 9999999875543221 25789999999999999999999999999999999999988 6 8899999999
Q ss_pred cccccCCCc----ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCC--------HHHHHHHH
Q 019642 180 AEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--------HDQLVKIA 247 (338)
Q Consensus 180 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~--------~~~~~~~~ 247 (338)
+........ .....++..|+|||.+.+...++.++|+||||+++++|++|+.||...... ...+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 876533221 223456788999999877566889999999999999999999998543322 12344455
Q ss_pred HHhCCchhhhhhhccccccCcchhhhhccccCCCCc--cc-ccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCC
Q 019642 248 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWS--KF-INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 324 (338)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 324 (338)
..++.+....+............. ......... .. .........+.++.+++.+||+.||++|||+.|+++|||
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~ 315 (316)
T cd07842 239 EVLGTPTEKDWPDIKKMPEYDTLM---KDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315 (316)
T ss_pred HHhCCCchhHHHHHhhcccchhhh---hhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence 555544333332111111100000 000000000 00 000000236788999999999999999999999999999
Q ss_pred c
Q 019642 325 F 325 (338)
Q Consensus 325 ~ 325 (338)
|
T Consensus 316 f 316 (316)
T cd07842 316 F 316 (316)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=309.62 Aligned_cols=256 Identities=25% Similarity=0.417 Sum_probs=201.0
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
++|++.+.||+|+||.||++.+..+++.+++|++... ....+..|+.++..+ +|++|+++++.+.+ ....+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~ 77 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQD--ENNLY 77 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEec--CCEEE
Confidence 5899999999999999999999999999999998632 223467788899988 99999999999854 46789
Q ss_pred EEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 112 LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 112 lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
+||||+.+++|..++. .+++..++.++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~-~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC-CCEEEeecchheecccCC
Confidence 9999999999988763 48899999999999999999999999999999999999987 899999999986543222
Q ss_pred c--ceeeeccccccccccccC----cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 188 E--YNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 188 ~--~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
. .....|++.|+|||++.+ ...++.++|+||||+++|+|++|+.||... +..+....+.. ...
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~-~~~~~~~~i~~---~~~------- 225 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE-SLVETYGKIMN---HKE------- 225 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC-CHHHHHHHHhC---CCc-------
Confidence 1 223468999999999852 246789999999999999999999999432 22222222111 000
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCC--cCCHHHHhcCCCcchhhh
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD--RLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~--Rpt~~ell~hp~~~~~~~ 330 (338)
..+.. .....+++++.+||++||..+|.. |++++++++||||.++..
T Consensus 226 -----------------~~~~p-----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~ 274 (332)
T cd05623 226 -----------------RFQFP-----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW 274 (332)
T ss_pred -----------------cccCC-----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence 00000 001226899999999999765544 789999999999998653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=314.25 Aligned_cols=243 Identities=28% Similarity=0.479 Sum_probs=196.8
Q ss_pred EeeeecCceeEEEEEEc---CCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEe
Q 019642 44 RKVGRGKYSEVFEGINV---NTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 115 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e 115 (338)
+.||+|+||.||++.+. .+++.+|+|+++.. .......|+++++++ +||||+++++.+.+ ....++|||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~~lv~e 78 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPFIVKLHYAFQT--EGKLYLILD 78 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-CCCCcccEEEEEEc--CCEEEEEEc
Confidence 57999999999998763 57899999998642 234467799999999 99999999999955 567899999
Q ss_pred eecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC-Cccee
Q 019642 116 YVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNV 191 (338)
Q Consensus 116 ~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~-~~~~~ 191 (338)
|+.+++|...+. .+++..++.++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++...... .....
T Consensus 79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~~~~ 157 (318)
T cd05582 79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYS 157 (318)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCC-CcEEEeeccCCcccCCCCCceec
Confidence 999999877753 48999999999999999999999999999999999999988 79999999998654333 22334
Q ss_pred eeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchh
Q 019642 192 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD 271 (338)
Q Consensus 192 ~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (338)
..|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.. .+..+....+.+. .
T Consensus 158 ~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~-~~~~~~~~~i~~~--~------------------- 214 (318)
T cd05582 158 FCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQG-KDRKETMTMILKA--K------------------- 214 (318)
T ss_pred ccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCC-CCHHHHHHHHHcC--C-------------------
Confidence 568899999999877 6788999999999999999999999842 2222222221110 0
Q ss_pred hhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCC-----HHHHhcCCCcchhh
Q 019642 272 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVR 329 (338)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt-----~~ell~hp~~~~~~ 329 (338)
...+..+++.+.++|++||+.||++||+ +.++++||||..+.
T Consensus 215 ----------------~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 215 ----------------LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred ----------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence 0011226889999999999999999999 77899999998764
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=323.75 Aligned_cols=257 Identities=21% Similarity=0.327 Sum_probs=205.7
Q ss_pred eeeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 32 VIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 32 ~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
.+....++|++.+.||+|+||+||++.+..+++.||+|.+... ....+.+|+..+..+ .|+|++++++.+....
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKD 104 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC-CCCcEEEeecceeccc
Confidence 4455678999999999999999999999999999999998642 234567899999998 9999999998775322
Q ss_pred C------CccEEEEeeecCCccccccC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceE
Q 019642 107 S------KTPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR 173 (338)
Q Consensus 107 ~------~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~ 173 (338)
. ..+++||||+.+++|.+.+. .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~-~~vk 183 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSN-GLVK 183 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCC-CCEE
Confidence 1 13679999999999987652 48899999999999999999999999999999999999988 8999
Q ss_pred EEeccccccccCCC---cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHh
Q 019642 174 LIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 250 (338)
Q Consensus 174 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~ 250 (338)
|+|||++....... ......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||.. .+..+........
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~-~~~~~~~~~~~~~- 260 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDG-ENMEEVMHKTLAG- 260 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcC-
Confidence 99999986543221 1233568999999999977 6789999999999999999999999832 2222221111100
Q ss_pred CCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 251 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
. . ...+..+++++.+++.+||+.||.+||++.++++|||++..
T Consensus 261 -~-----------------------------~-----~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 261 -R-----------------------------Y-----DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred -C-----------------------------C-----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 0 0 00122368899999999999999999999999999998754
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=300.50 Aligned_cols=275 Identities=31% Similarity=0.567 Sum_probs=207.1
Q ss_pred EEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEe
Q 019642 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 115 (338)
Q Consensus 40 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e 115 (338)
|++.+.||+|+||.||++.+..+++.+++|.++... ......|+..+.++.+|+|++++++++.+......++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 678999999999999999999999999999886431 2233568889998866999999999997764468899999
Q ss_pred eecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcceee
Q 019642 116 YVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 192 (338)
Q Consensus 116 ~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~~~ 192 (338)
|+.++.+..... .+++..+..++.|++.||.+||+.|++|+||+|+||+++. +.++|+|||.+............
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~~~~~~~ 158 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD--DILKLADFGSCRGIYSKPPYTEY 158 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC--CCeEEEecccccccccCCCcCCC
Confidence 998765554432 4899999999999999999999999999999999999998 79999999998766544443445
Q ss_pred eccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhh
Q 019642 193 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA 272 (338)
Q Consensus 193 ~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (338)
.++..|+|||.+......+.++|+||||+++|+|++|..|| .+.+..+....+....+....... ......... ..
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~-~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~ 234 (282)
T cd07831 159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLF-PGTNELDQIAKIHDVLGTPDAEVL-KKFRKSRHM--NY 234 (282)
T ss_pred CCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCC-CCCCHHHHHHHHHHHcCCCCHHHH-Hhhcccccc--cc
Confidence 67889999998765456789999999999999999999887 444555555555555554332221 100000000 00
Q ss_pred hhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 273 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
.......... ......++.++.++|.+||+.+|++|||++++++||||
T Consensus 235 ~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 235 NFPSKKGTGL-----RKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cCcccccccH-----HHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0000000000 00112368999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=310.68 Aligned_cols=247 Identities=20% Similarity=0.338 Sum_probs=191.4
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEc-----CCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
..++|++.+.||+|+||.||+|.+. .+++.||+|.++... ...+.+|+.++..+.+||||+++++.+...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP- 83 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence 3689999999999999999999752 345679999986432 345788999999997899999999988543
Q ss_pred CCccEEEEeeecCCccccccC-----------------------------------------------------------
Q 019642 107 SKTPSLIFEYVNSTDFKVLYP----------------------------------------------------------- 127 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~~----------------------------------------------------------- 127 (338)
....+++|||+.+++|.+++.
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 345789999999999876542
Q ss_pred ------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc---ceeeeccccc
Q 019642 128 ------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYF 198 (338)
Q Consensus 128 ------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y 198 (338)
.++...+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++........ .....++..|
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCC-CcEEEeecccccccccCcchhcccCCCCCccc
Confidence 26677888899999999999999999999999999999987 7999999999875432211 1122345789
Q ss_pred cccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccc
Q 019642 199 KGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRH 277 (338)
Q Consensus 199 ~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (338)
+|||++.+ ..++.++||||||+++|+|++ |..||....... .+..... ...
T Consensus 243 ~aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~~~~~---~~~----------------------- 294 (338)
T cd05102 243 MAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFCQRLK---DGT----------------------- 294 (338)
T ss_pred cCcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHHHh---cCC-----------------------
Confidence 99999877 678999999999999999997 888984322222 1111110 000
Q ss_pred cCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 278 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 278 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
. ...+..+++++.+++.+||+.||++|||+.++++
T Consensus 295 -~--------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 295 -R--------MRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred -C--------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0 0011226789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=322.53 Aligned_cols=248 Identities=23% Similarity=0.372 Sum_probs=201.2
Q ss_pred cEEEEEeeeecCceeEEEEEEcCC-CceEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNT-NERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~-~~~~aiK~~~~~~---~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
.|.+.+.||+|++|.||+|.+..+ +..|++|.+.... ...+..|+.+++.+ +||||+++++.+.. ....++||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~--~~~~~lv~ 144 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAAC-DHFGIVKHFDDFKS--DDKLLLIM 144 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEE--CCEEEEEE
Confidence 499999999999999999998877 7888898765332 33467799999999 99999999999955 46789999
Q ss_pred eeecCCccccccC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 115 EYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 115 e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
||+.+++|...+. .+++..+..++.|++.||.|||+.|++|+||||+|||++.+ +.++|+|||++.......
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~-~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT-GIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCC-CcEEEEeCcCceecCCcc
Confidence 9999999976542 37899999999999999999999999999999999999988 899999999987654332
Q ss_pred c---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccc
Q 019642 188 E---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264 (338)
Q Consensus 188 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
. .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.. .+..+....+.. +...
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~-~~~~~~~~~~~~--~~~~---------- 289 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKG-PSQREIMQQVLY--GKYD---------- 289 (478)
T ss_pred ccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHh--CCCC----------
Confidence 1 233468999999999877 6789999999999999999999999832 222222222111 0000
Q ss_pred ccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
..+..++.++.++|.+||..||++||++.++++|||++..
T Consensus 290 ------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 290 ------------------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred ------------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 0112268899999999999999999999999999998754
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=300.38 Aligned_cols=282 Identities=33% Similarity=0.596 Sum_probs=209.8
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
++|++.+.||+|++|+||+|.+..+++.+++|.+... ..+.+.+|+.+++++ +|||++++++++.+ ....++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 78 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHS--EKRLYL 78 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhc-cCCCEeeEEEEEec--CCeEEE
Confidence 6899999999999999999999999999999987532 234577899999999 99999999999954 468899
Q ss_pred EEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-
Q 019642 113 IFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 187 (338)
Q Consensus 113 v~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~- 187 (338)
||||+++........ .+++..++.++.|++.||.+||++|++|+||+|+||+++...+.++|+|||++.......
T Consensus 79 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 79 VFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred EEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 999997644333322 257788899999999999999999999999999999998765789999999986543221
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......+++.|+|||.+.+...++.++|+||+|+++|+|++|..||.. .+..+....+....+.+....|......
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 234 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG-DSEIDELFKIFRILGTPNEETWPGVTSL--- 234 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHhCCCChhhccccccc---
Confidence 122335678899999987655688999999999999999999999843 3334444444444444332222110000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
+....... .+...........+++++.++|.+||+.+|++||++.++++||||.++.+.
T Consensus 235 ~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~~ 293 (294)
T PLN00009 235 PDYKSAFP-----KWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDA 293 (294)
T ss_pred hhhhhhcc-----cCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhcC
Confidence 00000000 000000111123368899999999999999999999999999999998764
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=314.08 Aligned_cols=244 Identities=27% Similarity=0.438 Sum_probs=192.7
Q ss_pred eeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHHHHHHhc--CCCCeeEeeeeeeccCCCccEEEEeee
Q 019642 46 VGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLC--GGPNVVKLLDIVRDQHSKTPSLIFEYV 117 (338)
Q Consensus 46 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~~l~~l~--~h~~iv~~~~~~~~~~~~~~~lv~e~~ 117 (338)
||+|+||+||+|.+..+++.||+|++.... ......|..++.... .||+|+++++.+.. ....++||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEEEEcCC
Confidence 699999999999999999999999986321 122345666666654 79999999999855 46789999999
Q ss_pred cCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC-CCcceeee
Q 019642 118 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV 193 (338)
Q Consensus 118 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~-~~~~~~~~ 193 (338)
.+++|...+ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++..... ........
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDAT-GHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEecCCcCcCCCCCCCCccCcc
Confidence 999887665 348999999999999999999999999999999999999988 7999999999865322 22233456
Q ss_pred ccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhh
Q 019642 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL 273 (338)
Q Consensus 194 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (338)
|+..|+|||++.+...++.++||||||+++|+|++|..||... +..+....+.. +...
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~-~~~~~~~~i~~--~~~~------------------- 215 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE-DTQQMYRNIAF--GKVR------------------- 215 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC-CHHHHHHHHHc--CCCC-------------------
Confidence 8999999999876556899999999999999999999998432 21111111110 0000
Q ss_pred hccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC----CHHHHhcCCCcchhh
Q 019642 274 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL----TAREAMAHPYFAQVR 329 (338)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp----t~~ell~hp~~~~~~ 329 (338)
.....+++++.+||++||+.||.+|| ++.++++||||++..
T Consensus 216 ---------------~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 216 ---------------FPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred ---------------CCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 00112688999999999999999998 799999999998754
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=308.04 Aligned_cols=256 Identities=25% Similarity=0.392 Sum_probs=200.9
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
++|++.+.||+|+||.||++.+..+++.||+|++... ....+.+|..++..+ +|++|+++++.+.+ ....+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~--~~~~~ 77 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQD--ENYLY 77 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEc--CCEEE
Confidence 5899999999999999999999999999999998642 123467788999888 99999999999954 56789
Q ss_pred EEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 112 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 112 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
+||||+.+++|..++ ..+++..+..++.|++.||.+||++|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 78 lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCC-CCEEEEeccceeeccCCC
Confidence 999999999998776 347899999999999999999999999999999999999987 889999999986654322
Q ss_pred c--ceeeeccccccccccccCc----CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 188 E--YNVRVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 188 ~--~~~~~~~~~y~aPE~~~~~----~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
. .....|++.|+|||++.+. ..++.++|+||||+++|+|++|+.||... +..+....+......
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~-~~~~~~~~i~~~~~~--------- 226 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE-SLVETYGKIMNHEER--------- 226 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC-CHHHHHHHHHcCCCc---------
Confidence 2 1224689999999998642 35788999999999999999999999432 222222221110000
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCC--cCCHHHHhcCCCcchhhh
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD--RLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~--Rpt~~ell~hp~~~~~~~ 330 (338)
.+... ....++.++.++|.+||..++.+ |++++++++||||.++..
T Consensus 227 ------------------~~~p~-----~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~ 274 (331)
T cd05624 227 ------------------FQFPS-----HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDW 274 (331)
T ss_pred ------------------ccCCC-----ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCH
Confidence 00000 00126889999999999876654 569999999999988653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=280.93 Aligned_cols=257 Identities=21% Similarity=0.310 Sum_probs=201.6
Q ss_pred eeeeeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc---cchHHHHHHHHHHHHhcCCCCeeEeeeeeecc-
Q 019642 30 SYVIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ- 105 (338)
Q Consensus 30 ~~~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 105 (338)
...+..+.++|++.+.||+|||+.||++.+..++..||+|.+.- .+.+...+|++..+++ +|||+++++++...+
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~ 91 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKF-NSPNVLRLVDHQLREE 91 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhh
Confidence 45566778999999999999999999999999999999998863 3456678999999999 999999999876432
Q ss_pred --CCCccEEEEeeecCCccccccC-------CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCeEecCCCCceEE
Q 019642 106 --HSKTPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRL 174 (338)
Q Consensus 106 --~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~~~~~~l 174 (338)
.....|++++|+..|+|.+.+. -+++.++..++.+++.||++||+.. ++|+||||.||++... +.++|
T Consensus 92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~-~~~vl 170 (302)
T KOG2345|consen 92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDS-GLPVL 170 (302)
T ss_pred ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCC-CceEE
Confidence 2235889999999998877763 3899999999999999999999998 9999999999999987 89999
Q ss_pred EeccccccccCCCc----------ceeeeccccccccccccCc--CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHH
Q 019642 175 IDWGLAEFYHPGKE----------YNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 242 (338)
Q Consensus 175 ~dfg~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~ 242 (338)
.|||.++...-... ......|..|+|||.+.-. ...+.++|||||||++|.|+.|..||.........
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS 250 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS 250 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence 99999876532211 1223467889999998542 35778999999999999999999999321110000
Q ss_pred HHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 243 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
+ .+. ...+. ........+|+.+.++|+.||++||.+||++.+++++
T Consensus 251 l----------aLA--------------------v~n~q----~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 251 L----------ALA--------------------VQNAQ----ISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred E----------EEe--------------------eeccc----cccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 0 000 00000 1111222279999999999999999999999999864
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=301.08 Aligned_cols=251 Identities=26% Similarity=0.471 Sum_probs=207.0
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
++|++.+.||+|++|.||++.+..+++.+++|++... ..+.+.+|+++++++ +||||+++++.+.+ ....+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~ 77 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLVNLYGSFQD--DSNLY 77 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCccceeeEEEc--CCeEE
Confidence 5799999999999999999999999999999998642 235577899999999 89999999999854 56789
Q ss_pred EEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 112 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 112 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
++|||+.+++|..++ ..+++..+..++.|++.||.+||+.|++|+||+|.||+++.+ +.++|+|||++......
T Consensus 78 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 78 LVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSD-GYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC-CCEEEeeCCCccccCCC--
Confidence 999999999988776 358999999999999999999999999999999999999988 88999999998765433
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
.....+++.|+|||.+.+ ...+.++|+||||+++|+|++|..||.... .......+.. +..
T Consensus 155 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~--~~~--------------- 215 (290)
T cd05580 155 TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDN-PIQIYEKILE--GKV--------------- 215 (290)
T ss_pred CCCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhc--CCc---------------
Confidence 233467889999999876 578899999999999999999999984322 1111111110 000
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC-----CHHHHhcCCCcchhhhccc
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAES 333 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~~~~ 333 (338)
..+..++..+.++|.+||..||.+|+ +++++++||||..+.....
T Consensus 216 --------------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~ 265 (290)
T cd05580 216 --------------------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIAL 265 (290)
T ss_pred --------------------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHH
Confidence 01112578999999999999999999 9999999999998875543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=307.12 Aligned_cols=287 Identities=30% Similarity=0.585 Sum_probs=212.1
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccC---CC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---SK 108 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~---~~ 108 (338)
-.++|++.+.||+|++|.||+|.+..+++.|++|.++.. ....+.+|+.+++++ +||||+++++++.... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-KHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhC-CCCCcCchhheeecccccccc
Confidence 357999999999999999999999999999999998642 234567899999999 8999999999875432 23
Q ss_pred ccEEEEeeecCCcccccc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 109 TPSLIFEYVNSTDFKVLY-PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
..++++||+.+....... ..+++..++.++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 82 DVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTN-CDLKICDFGLARIADPEH 160 (336)
T ss_pred eEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC-CCEEECcccceeeccccc
Confidence 578999999864433332 358999999999999999999999999999999999999988 899999999886543221
Q ss_pred c----ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccc
Q 019642 188 E----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263 (338)
Q Consensus 188 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
. .....++..|+|||.+.+...++.++|+||+|+++|+|++|+.||. +.+.......+...++.+....+.....
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFP-GKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 1 1223578889999987664578899999999999999999999983 4444455555555555544333211110
Q ss_pred cccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
.......... ......++.. ..+.+++++.++|.+||+.+|++|||+.++++||||+....+
T Consensus 240 ~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 240 LRARNYIKSL-PFKPKVPWNK-----LFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred hhhhhHHhhc-CcCCcccHHH-----HhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 0000000000 0000000000 012257889999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=301.51 Aligned_cols=255 Identities=28% Similarity=0.502 Sum_probs=207.4
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
...+|++.+.||.|++|.||++.+..+++.+++|.+... ..+.+.+|+..++.+ +|||++++++.+.. ....++
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 93 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL-KNPNIVNFLDSFLV--GDELFV 93 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhc-CCCceeeeeeeEec--CceEEE
Confidence 456899999999999999999999999999999987532 345677899999999 99999999999854 567899
Q ss_pred EEeeecCCccccccC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc-c
Q 019642 113 IFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-Y 189 (338)
Q Consensus 113 v~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~-~ 189 (338)
|+||+.+++|..++. .+++.++..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||++........ .
T Consensus 94 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~-~~~kl~dfg~~~~~~~~~~~~ 172 (296)
T cd06655 94 VMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMD-GSVKLTDFGFCAQITPEQSKR 172 (296)
T ss_pred EEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEccCccchhcccccccC
Confidence 999999999988764 48999999999999999999999999999999999999987 8999999998865543322 2
Q ss_pred eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcc
Q 019642 190 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 269 (338)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
....++..|+|||.+.+ ..++.++|+||||+++|++++|..||..... ......+.. .....
T Consensus 173 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~-~~~~~~~~~-~~~~~--------------- 234 (296)
T cd06655 173 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-LRALYLIAT-NGTPE--------------- 234 (296)
T ss_pred CCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHh-cCCcc---------------
Confidence 23467788999999876 6788999999999999999999999843322 121111111 00000
Q ss_pred hhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 270 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
...+..+++.+.++|++||..||++|||+.++++||||+....
T Consensus 235 ------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 235 ------------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred ------------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 0011226889999999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=299.48 Aligned_cols=278 Identities=32% Similarity=0.596 Sum_probs=205.7
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC---Cc
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---KT 109 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~---~~ 109 (338)
++|++.+.||+|+||.||+|.+..+++.|++|..+.. ....+.+|+.+++.+.+|||++++++.+..... ..
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 5799999999999999999999999999999987632 234577899999999667999999998855322 23
Q ss_pred cEEEEeeecCCcccccc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 110 PSLIFEYVNSTDFKVLY--------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
.+++|||+.++ +..++ ..+++..++.++.||+.||.|||++|++|+||+|+||+++.+.+.++|+|||.+.
T Consensus 81 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDSD-LKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCcC-HHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 78999999974 44332 2378999999999999999999999999999999999999844899999999886
Q ss_pred cccCC-CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhh
Q 019642 182 FYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 260 (338)
Q Consensus 182 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
..... .......+++.|+|||.+.+...++.++|+||||+++|+|++|..||. +.+.......+.+.++.+....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFP-GDSELQQLLHIFKLLGTPTEQVWPG 238 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHHHhCCCChhhCcc
Confidence 54322 122234567889999998764568899999999999999999998884 3444444444444444333222211
Q ss_pred ccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcc
Q 019642 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 326 (338)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~ 326 (338)
........ ....+.........+.++.++.+||.+||..||++|||+.|+++||||+
T Consensus 239 ~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 239 VSKLRDWH---------EFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhhccchh---------hcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 10000000 0000000000011123788999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=302.74 Aligned_cols=259 Identities=26% Similarity=0.450 Sum_probs=208.6
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
.....+|++.+.||+|++|.||++.+..+++.+++|.+... ....+.+|+.+++.+ .|||++++++.+.. ....
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~--~~~~ 92 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLV--GDEL 92 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhC-CCCCEeeEEEEEEe--CCEE
Confidence 35567999999999999999999999999999999988642 245677899999998 99999999999855 4578
Q ss_pred EEEEeeecCCccccccC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-
Q 019642 111 SLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 187 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~- 187 (338)
++||||+.+++|..++. .++..++..++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||.+.......
T Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~-~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred EEeecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCEEECccccchhcccccc
Confidence 99999999999988874 37889999999999999999999999999999999999887 799999999886543322
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||..... ......... .+.+.
T Consensus 172 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~-~~~~~~~~~-~~~~~------------- 235 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-LRALYLIAT-NGTPE------------- 235 (296)
T ss_pred ccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCH-HHhHHHHhc-CCCCC-------------
Confidence 1233467889999999876 6788999999999999999999999943322 111111100 00000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
...+..++..+.+++.+||..+|++|||+.++++||||.......
T Consensus 236 --------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~ 280 (296)
T cd06654 236 --------------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLS 280 (296)
T ss_pred --------------------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCCcc
Confidence 001122678899999999999999999999999999998765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=302.47 Aligned_cols=259 Identities=24% Similarity=0.403 Sum_probs=206.3
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
..+.|++++.||+|+||.||+|.+..+++.+++|.+.... ...+.+|+.+++.+ +|||++++++.+.. ....++
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 86 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC-NHPYIVKLLGAFYW--DGKLWI 86 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCcEeeeEEEEEe--CCeEEE
Confidence 4578999999999999999999999999999999987544 34567899999999 89999999999854 457899
Q ss_pred EEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC-C
Q 019642 113 IFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-K 187 (338)
Q Consensus 113 v~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~-~ 187 (338)
||||+.++++...+ ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.+ +.++|+|||.+...... .
T Consensus 87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLD-GDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCC-CCEEEccCccceecccccc
Confidence 99999999987654 348999999999999999999999999999999999999887 89999999987653222 2
Q ss_pred cceeeeccccccccccccC----cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccc
Q 019642 188 EYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
......++..|+|||.+.+ ...++.++|+||||+++|+|++|..||.... .......+ ..... .
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-~~~~~~~~---~~~~~-~------- 233 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-PMRVLLKI---AKSEP-P------- 233 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc-HHHHHHHH---hcCCC-c-------
Confidence 2234567889999999852 2357889999999999999999999984322 11111111 11000 0
Q ss_pred cccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhccc
Q 019642 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 333 (338)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 333 (338)
....+..++.++.++|++||..||++||+++++++||||..+...+.
T Consensus 234 -----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~ 280 (292)
T cd06644 234 -----------------------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRP 280 (292)
T ss_pred -----------------------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccchh
Confidence 00011226788999999999999999999999999999998876653
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=310.67 Aligned_cols=243 Identities=26% Similarity=0.445 Sum_probs=192.9
Q ss_pred EeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHH-HHHhcCCCCeeEeeeeeeccCCCccEEEEee
Q 019642 44 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKI-LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 116 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~-l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~ 116 (338)
+.||+|+||+||++.+..+++.+|+|++... ....+..|... ++.+ +||||+++++.+.. ....++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~--~~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQT--TEKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEec--CCEEEEEEcC
Confidence 3689999999999999999999999998642 12334455544 5566 99999999999855 4678999999
Q ss_pred ecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC-CCcceee
Q 019642 117 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVR 192 (338)
Q Consensus 117 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~-~~~~~~~ 192 (338)
+.+++|...+ ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++..... .......
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~~ 156 (325)
T cd05604 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQ-GHVVLTDFGLCKEGIAQSDTTTTF 156 (325)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEEeecCCcccCCCCCCCcccc
Confidence 9999887665 358999999999999999999999999999999999999988 8999999999864322 2223345
Q ss_pred eccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhh
Q 019642 193 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA 272 (338)
Q Consensus 193 ~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (338)
.|++.|+|||++.+ ..++.++|+||||+++|+|++|..||.. .+..+....+.. . .
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~~~~---~-~------------------ 212 (325)
T cd05604 157 CGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYC-RDVAEMYDNILH---K-P------------------ 212 (325)
T ss_pred cCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCC-CCHHHHHHHHHc---C-C------------------
Confidence 68999999999877 6788999999999999999999999843 222222222111 0 0
Q ss_pred hhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCH----HHHhcCCCcchhh
Q 019642 273 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA----REAMAHPYFAQVR 329 (338)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~----~ell~hp~~~~~~ 329 (338)
....+.++..+.++|++||+.+|++||++ .++++||||.+..
T Consensus 213 ---------------~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 213 ---------------LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred ---------------ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence 00111268889999999999999999977 5999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=305.12 Aligned_cols=256 Identities=26% Similarity=0.410 Sum_probs=206.0
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
++|++.+.||+|++|+||+|.+..+++.+++|.+.... .+.+..|+++++.+ +||||+++++.+.+ ....+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~ 77 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYASFQT--ETYLC 77 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-CCCCchhheeeeec--CCEEE
Confidence 47999999999999999999999999999999986432 34577899999999 89999999999854 56789
Q ss_pred EEEeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 112 LIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 112 lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
++|||+.+++|..++. .+++..++.++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHES-GHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCC-CCEEEeecchhhccccc
Confidence 9999999999988763 48899999999999999999999999999999999999987 89999999987544221
Q ss_pred Cc------------------------------ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCC
Q 019642 187 KE------------------------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 236 (338)
Q Consensus 187 ~~------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~ 236 (338)
.. .....|+..|+|||.+.+ ..++.++|+||||+++|++++|..||..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~- 234 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKG- 234 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCC-
Confidence 10 112356788999999877 5788999999999999999999999842
Q ss_pred CCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCC-
Q 019642 237 HDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT- 315 (338)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt- 315 (338)
.+....+..+.. ... . ......+++++.++|.+||..||++|||
T Consensus 235 ~~~~~~~~~~~~---~~~--------------------------~------~~~~~~~~~~~~~li~~~l~~~p~~R~s~ 279 (316)
T cd05574 235 SNRDETFSNILK---KEV--------------------------T------FPGSPPVSSSARDLIRKLLVKDPSKRLGS 279 (316)
T ss_pred CchHHHHHHHhc---CCc--------------------------c------CCCccccCHHHHHHHHHHccCCHhHCCCc
Confidence 222222222110 000 0 0001115889999999999999999999
Q ss_pred ---HHHHhcCCCcchhhhcccc
Q 019642 316 ---AREAMAHPYFAQVRAAESS 334 (338)
Q Consensus 316 ---~~ell~hp~~~~~~~~~~~ 334 (338)
++++|+||||++...+..+
T Consensus 280 ~~~~~~ll~~~~~~~~~~~~~~ 301 (316)
T cd05574 280 KRGAAEIKQHPFFRGVNWALIR 301 (316)
T ss_pred hhhHHHHHcCchhhcCChhhcc
Confidence 9999999999998765544
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=298.25 Aligned_cols=273 Identities=32% Similarity=0.643 Sum_probs=206.3
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
+|++.+.||.|++|.||+|.+..+++.+++|.++.. ....+.+|+++++++ +|||++++++++.+ ....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v 77 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHT--ENKLYLV 77 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhc-CCCCCcchhhhccc--CCcEEEE
Confidence 589999999999999999999999999999988632 234678899999999 99999999999854 5678999
Q ss_pred EeeecCCcccccc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-
Q 019642 114 FEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 187 (338)
Q Consensus 114 ~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~- 187 (338)
|||+.+ ++..++ ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 78 ~e~~~~-~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~-~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 78 FEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVR 155 (284)
T ss_pred eecccc-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEeeccchhhcccCcc
Confidence 999975 454443 347899999999999999999999999999999999999988 799999999886543222
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......++..|+|||.+.+...++.++|+||||+++|+|+||..||. ..+..+......+..+.+....+......
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 231 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP-GDSEIDQLFRIFRTLGTPDEVVWPGVTSL--- 231 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHHHhCCCChhhhhhhhHH---
Confidence 22233567889999998765557889999999999999999999984 34444555555555554432222110000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
+.....+........ ......++.++.++|.+||+.||++|||++++++||||
T Consensus 232 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 232 PDYKPSFPKWARQDF-----SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHHhhcccccccCH-----HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 000000000000000 00112368899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=298.97 Aligned_cols=253 Identities=24% Similarity=0.412 Sum_probs=198.0
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
++|++.+.||+|+||.||++.+..+++.||+|.++... ...+..|+..+.+..+|||++++++.+.. ....+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~--~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR--EGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec--CCcEEEE
Confidence 57999999999999999999999999999999886432 23455666664444499999999999854 4568999
Q ss_pred EeeecCCcccccc-------CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 114 FEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 114 ~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
|||+++. +..++ ..+++..++.++.|++.||.|||++ +++|+||||+||+++.+ +.++|+|||.+.....
T Consensus 79 ~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~-~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 79 MEVMDTS-LDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRN-GQVKLCDFGISGYLVD 156 (283)
T ss_pred hhhhccc-HHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCC-CCEEEeeccccccccc
Confidence 9999854 32222 2489999999999999999999998 99999999999999988 8999999999876543
Q ss_pred CCcceeeeccccccccccccCc---CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcc
Q 019642 186 GKEYNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262 (338)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
........++..|+|||.+.+. ..++.++|+||||+++|+|++|..||.......+...........
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 226 (283)
T cd06617 157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSP---------- 226 (283)
T ss_pred ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCC----------
Confidence 3333335678889999988542 346889999999999999999999985433333333222110000
Q ss_pred ccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
......++.++.++|.+||..+|.+|||+.++++||||....
T Consensus 227 -------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 227 -------------------------QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred -------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 000112688999999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=303.62 Aligned_cols=258 Identities=26% Similarity=0.466 Sum_probs=208.1
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
....+|++.+.||+|++|.||++.+..+++.|++|.+... ..+.+.+|+.+++.+ +|||++++++.+.. ....+
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~ 92 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLV--GDELW 92 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhC-CCCCEeeEEEEEec--CCEEE
Confidence 4458999999999999999999999999999999998632 245577899999998 99999999999954 45789
Q ss_pred EEEeeecCCccccccC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc-
Q 019642 112 LIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE- 188 (338)
Q Consensus 112 lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~- 188 (338)
+||||+.+++|..++. .+++.++..++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||.+........
T Consensus 93 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~-~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 93 VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred EeecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEECcCccceEccCCccC
Confidence 9999999999988864 47889999999999999999999999999999999999987 8999999998865533222
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
.....+++.|+|||.+.+ ..++.++|+||||+++|++++|..||...... ........ .+.+
T Consensus 172 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~-~~~~~~~~-~~~~--------------- 233 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-RALYLIAT-NGTP--------------- 233 (297)
T ss_pred cCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc-hheeeecc-CCCC---------------
Confidence 223467888999999877 67889999999999999999999999432211 11000000 0000
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
....+..++..+.+|+.+||..+|++||++.++++||||...+...
T Consensus 234 ------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 279 (297)
T cd06656 234 ------------------ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLS 279 (297)
T ss_pred ------------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccccc
Confidence 0001223678899999999999999999999999999998776544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=300.22 Aligned_cols=254 Identities=25% Similarity=0.422 Sum_probs=202.0
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEeeeeeeccC----CC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----SK 108 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~----~~ 108 (338)
...+.|++.+.||+|+||.||+|.+..+++.+++|.+... ....+..|+.+++++.+|||++++++.+.... ..
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 3467899999999999999999999999999999998643 34567889999999867999999999986532 24
Q ss_pred ccEEEEeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 109 TPSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
..+++|||+.+++|..++. .+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++...
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~-~~~~l~Dfg~~~~~ 161 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQL 161 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCC-CCEEEccCCCceec
Confidence 5789999999998887653 37899999999999999999999999999999999999988 78999999998654
Q ss_pred cCCC-cceeeeccccccccccccC----cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhh
Q 019642 184 HPGK-EYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 258 (338)
Q Consensus 184 ~~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
.... ......++..|+|||++.+ ...++.++|+||+|+++|+|++|..||....... ..... ...
T Consensus 162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-~~~~~---~~~------ 231 (272)
T cd06637 162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-ALFLI---PRN------ 231 (272)
T ss_pred ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-HHHHH---hcC------
Confidence 3221 2233467889999999853 2357889999999999999999999984322111 11000 000
Q ss_pred hhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
.........++.++.+|+.+||..||++|||+.++++||||
T Consensus 232 --------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 232 --------------------------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred --------------------------CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 00001112267899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=307.09 Aligned_cols=285 Identities=19% Similarity=0.233 Sum_probs=198.3
Q ss_pred EEEeeeec--CceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 42 VVRKVGRG--KYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 42 ~~~~lg~G--~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
+++.||+| +|++||++.+..+++.||+|.++... ...+.+|+.+++.+ +||||+++++++.. ....++||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~--~~~~~lv~ 78 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-NHPNIVPYRATFIA--DNELWVVT 78 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEE--CCEEEEEE
Confidence 56789999 78999999999999999999987431 24567899999999 99999999999965 45788999
Q ss_pred eeecCCcccccc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC--
Q 019642 115 EYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-- 187 (338)
Q Consensus 115 e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-- 187 (338)
||+.++++.+++ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++++||+.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~-~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD-GKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecC-CcEEEcccchhhcccccccc
Confidence 999999988776 238899999999999999999999999999999999999988 789999998653321110
Q ss_pred ------cceeeeccccccccccccCc-CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCc------h
Q 019642 188 ------EYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD------E 254 (338)
Q Consensus 188 ------~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~------~ 254 (338)
......++..|+|||++.+. ..++.++||||||+++|+|++|..||.................... .
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 01123456779999998653 3588999999999999999999999953322221111111000000 0
Q ss_pred hhhh-hhccccccCcchhhhhcc-ccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 255 LNAY-LNKYHLELDPQLDALVGR-HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 255 ~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
.... ........+......... .................+++++.+||++||+.||++|||++|+++||||+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~ 315 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR 315 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcch
Confidence 0000 000000000000000000 000000000011122236789999999999999999999999999999988653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=303.51 Aligned_cols=282 Identities=21% Similarity=0.321 Sum_probs=206.2
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
++|++.+.||+|+||.||++.+..++..+++|.++... ...+.+|+++++++ +||||+++++.+.. ....+++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYS--DGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEee--CCEEEEE
Confidence 47999999999999999999999999999999886432 34577899999999 99999999999955 4678999
Q ss_pred EeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEecCCCCceEEEeccccccccCCCcc
Q 019642 114 FEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189 (338)
Q Consensus 114 ~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~ 189 (338)
|||+.+++|..++. .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.+ +.++|+|||.+...... ..
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~-~~ 155 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MA 155 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecC-CcEEEccCCCccccccc-cc
Confidence 99999999988863 48899999999999999999998 599999999999999987 78999999988654322 22
Q ss_pred eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCC-chhhhh---hhccccc
Q 019642 190 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT-DELNAY---LNKYHLE 265 (338)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~ 265 (338)
....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.... ............. ...... .......
T Consensus 156 ~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 156 NSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred ccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCccccccccCCcccccCCCCC
Confidence 33467889999999866 568899999999999999999999984322 1111111110000 000000 0000000
Q ss_pred cCc--chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 266 LDP--QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 266 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
... .............. .......++.++.+|+.+||..||++|||+.++++||||.+....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 296 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPP----PKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELE 296 (308)
T ss_pred ccchhhHHHHHHHHhcCCC----ccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccc
Confidence 000 00000000000000 001111267889999999999999999999999999999986544
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=297.66 Aligned_cols=258 Identities=26% Similarity=0.449 Sum_probs=204.1
Q ss_pred eeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEeeeeeeccC---C
Q 019642 33 IFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---S 107 (338)
Q Consensus 33 i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~---~ 107 (338)
+....++|++.+.||+|+||.||++.+..+++.+++|.+... ....+..|+.+++++.+|||++++++++...+ .
T Consensus 17 ~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 344578999999999999999999999999999999998653 34567789999999878999999999986432 2
Q ss_pred CccEEEEeeecCCcccccc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccc
Q 019642 108 KTPSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~ 180 (338)
...++||||+.+++|.+++ ..+++..++.++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||++
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~-~~~kl~dfg~~ 175 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTE-GGVKLVDFGVS 175 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC-CCEEEeecccc
Confidence 4689999999999987654 348999999999999999999999999999999999999988 78999999998
Q ss_pred ccccCCC-cceeeeccccccccccccCcC----CCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchh
Q 019642 181 EFYHPGK-EYNVRVASRYFKGPELLVDLQ----DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL 255 (338)
Q Consensus 181 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~----~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (338)
....... ......++..|+|||.+.... .++.++|+||||+++|+|++|+.||.... ....+..+.+ ...
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~-~~~~~~~~~~---~~~- 250 (291)
T cd06639 176 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH-PVKTLFKIPR---NPP- 250 (291)
T ss_pred hhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc-HHHHHHHHhc---CCC-
Confidence 7554322 222346788899999975422 36789999999999999999999984322 1112211110 000
Q ss_pred hhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcc
Q 019642 256 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 326 (338)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~ 326 (338)
. ....+..++..+.++|.+||+.+|++||++.++++||||+
T Consensus 251 ~------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 251 P------------------------------TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred C------------------------------CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 0 0001122567899999999999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=299.61 Aligned_cols=283 Identities=31% Similarity=0.496 Sum_probs=204.9
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccC---
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH--- 106 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--- 106 (338)
...++|++.+.||+|+||.||+|.+..+++.|++|.+.... .....+|+.+++++ +||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPY 87 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhC-CCCCccceEEEEecccccc
Confidence 44578999999999999999999999999999999875321 23456799999999 9999999999875432
Q ss_pred ---CCccEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccc
Q 019642 107 ---SKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
Q Consensus 107 ---~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~ 180 (338)
....+++|||+.+.....+.. .+++..++.++.|++.||.+||++|++|+||+|+||+++.+ +.++|+|||.+
T Consensus 88 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~ 166 (310)
T cd07865 88 NRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKD-GILKLADFGLA 166 (310)
T ss_pred cCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCC-CcEEECcCCCc
Confidence 235689999998744333322 48999999999999999999999999999999999999988 89999999998
Q ss_pred ccccCCCc-----ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchh
Q 019642 181 EFYHPGKE-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL 255 (338)
Q Consensus 181 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (338)
........ .....++..|+|||.+.+...++.++|+||||+++|+|++|..|| ...+.......+.+..+....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~-~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIM-QGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCh
Confidence 65533221 122356778999999876455788999999999999999999887 344444445555554443222
Q ss_pred hhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 256 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
..+......... .... ..............+...++.+.+||.+||..||++|||++++|+||||
T Consensus 246 ~~~~~~~~~~~~---~~~~--~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 246 EVWPGVDKLELF---KKME--LPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhcccccchhhh---hhcc--CCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 221111000000 0000 0000000000111111246788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=297.72 Aligned_cols=255 Identities=27% Similarity=0.454 Sum_probs=201.9
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc--hHHHHHHHHHHHHhcCCCCeeEeeeeeec---cCCCc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRD---QHSKT 109 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~E~~~l~~l~~h~~iv~~~~~~~~---~~~~~ 109 (338)
...++|++.+.||+|+||.||++.+..+++.+++|+++... ...+..|+.+++++.+|||++++++.+.. .....
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 94 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ 94 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence 46789999999999999999999999999999999986532 35678899999999679999999998743 23457
Q ss_pred cEEEEeeecCCcccccc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccc
Q 019642 110 PSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~ 182 (338)
.+++|||+++++|..++ ..+++..++.++.|++.||.+||+.+++|+||||+||+++.+ +.++|+|||++..
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~-~~~kl~dfg~~~~ 173 (286)
T cd06638 95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTE-GGVKLVDFGVSAQ 173 (286)
T ss_pred EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCC-CCEEEccCCceee
Confidence 89999999999987653 347888999999999999999999999999999999999988 7899999999865
Q ss_pred ccCCC-cceeeeccccccccccccCc----CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhh
Q 019642 183 YHPGK-EYNVRVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 257 (338)
Q Consensus 183 ~~~~~-~~~~~~~~~~y~aPE~~~~~----~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
..... ......++..|+|||++... ..++.++|+||+|+++|+|++|..||..... ........ ....
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~-~~~~~~~~---~~~~--- 246 (286)
T cd06638 174 LTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-MRALFKIP---RNPP--- 246 (286)
T ss_pred cccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch-hHHHhhcc---ccCC---
Confidence 54322 22334688899999997531 3478899999999999999999999843221 11111100 0000
Q ss_pred hhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
.....+..++..+.++|.+||+.||++|||+.|+++|+||
T Consensus 247 ----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 247 ----------------------------PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred ----------------------------CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 0000112257789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=304.83 Aligned_cols=286 Identities=32% Similarity=0.590 Sum_probs=213.9
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC---C
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---K 108 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~---~ 108 (338)
.++|++.+.||+|+||+||++.+..+++.|++|.+... ....+.+|+.+++.+ +||||+++++++..... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhc-CCCCccchHHheecccccccC
Confidence 46899999999999999999999999999999987642 234567899999999 99999999998864322 3
Q ss_pred ccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 109 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
..++++||+.+ +|...+ ..+++..++.++.|++.||.+||++|++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 83 ~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 83 DVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFGLARTTSE 160 (337)
T ss_pred cEEEEEeCCCC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEECcCccccccCC
Confidence 57999999975 454443 358999999999999999999999999999999999999988 8999999999876543
Q ss_pred C-CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccc
Q 019642 186 G-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264 (338)
Q Consensus 186 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
. .......++..|+|||.+.+...++.++|+||||+++|+|++|..|| ...+.......+....+.+....+..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~---- 235 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLF-PGKDYVHQLKLITELLGSPSEEDLGF---- 235 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCC-CCCChHHHHHHHHHHhCCCChHHhhh----
Confidence 2 12233457888999999876456889999999999999999999988 34444455555555555443332210
Q ss_pred ccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
................+...+ ....+.+++++.++|++||+.+|++|||+.++++||||..+....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~ 301 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSF--ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS 301 (337)
T ss_pred cCchhhhHHHHhcCcccccCH--HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence 000111111110000000000 011223789999999999999999999999999999998876544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=307.23 Aligned_cols=243 Identities=24% Similarity=0.445 Sum_probs=192.8
Q ss_pred EeeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHH-HHHHhcCCCCeeEeeeeeeccCCCccEEEEee
Q 019642 44 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIK-ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 116 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~-~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~ 116 (338)
+.||+|+||+||++.+..+++.||+|++.... ...+..|.. +++.+ .||||+++++.+.. ....++||||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~--~~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQT--ADKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEc--CCeEEEEEeC
Confidence 36999999999999999999999999986421 123334443 45666 99999999999855 4578999999
Q ss_pred ecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC-CCcceee
Q 019642 117 VNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVR 192 (338)
Q Consensus 117 ~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~-~~~~~~~ 192 (338)
+.+++|...+. .+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++..... .......
T Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~-~~~kl~DfG~a~~~~~~~~~~~~~ 156 (325)
T cd05602 78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNGTTSTF 156 (325)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEEccCCCCcccccCCCCcccc
Confidence 99999987763 48889999999999999999999999999999999999988 8999999999864322 2223345
Q ss_pred eccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhh
Q 019642 193 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA 272 (338)
Q Consensus 193 ~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (338)
.|++.|+|||++.+ ..++.++||||||+++|+|++|..||.. .+..+....+... .
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~--~-------------------- 212 (325)
T cd05602 157 CGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNK--P-------------------- 212 (325)
T ss_pred cCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCC-CCHHHHHHHHHhC--C--------------------
Confidence 68999999999877 6788999999999999999999999942 2222222222110 0
Q ss_pred hhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHH----HHhcCCCcchhh
Q 019642 273 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR----EAMAHPYFAQVR 329 (338)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~----ell~hp~~~~~~ 329 (338)
....+.+++.+.++|.+||+.||.+|+++. ++++|+||....
T Consensus 213 ---------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~ 258 (325)
T cd05602 213 ---------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPIN 258 (325)
T ss_pred ---------------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCC
Confidence 001123788999999999999999999876 899999997653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=284.81 Aligned_cols=257 Identities=20% Similarity=0.346 Sum_probs=210.9
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
++.+.+..||+|..|+||++....++...|||.+.... .+++...++++..-..+|+||+++++|.... ..++.
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~--dV~Ic 169 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT--DVFIC 169 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc--hHHHH
Confidence 34467889999999999999999999999999986543 4567777888777646999999999997654 45577
Q ss_pred Eeeec---CCccccccCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEecCCCCceEEEeccccccccCCCcc
Q 019642 114 FEYVN---STDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189 (338)
Q Consensus 114 ~e~~~---~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~ 189 (338)
||.+. ...|....+++|+..+-++...++.||.||.++ |++|+|+||+|||+|.. |++||||||.+-.+.+....
T Consensus 170 MelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~-GniKlCDFGIsGrlvdSkAh 248 (391)
T KOG0983|consen 170 MELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER-GNIKLCDFGISGRLVDSKAH 248 (391)
T ss_pred HHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccC-CCEEeecccccceeeccccc
Confidence 77764 345555667799999999999999999999975 89999999999999998 99999999999888877888
Q ss_pred eeeeccccccccccccCc--CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 190 NVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
....|.+.|||||.+... ..|+.++||||||++++++.||+.||.....+.+.+..+.+... +...
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP----P~L~-------- 316 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP----PLLP-------- 316 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC----CCCC--------
Confidence 888999999999998542 46888999999999999999999999766666666665544111 1100
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
....+|+.+.+|+..||++|+.+||...++|+|||+.....+
T Consensus 317 ----------------------~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a 358 (391)
T KOG0983|consen 317 ----------------------GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETA 358 (391)
T ss_pred ----------------------cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchh
Confidence 111279999999999999999999999999999998766544
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=292.45 Aligned_cols=246 Identities=23% Similarity=0.377 Sum_probs=202.1
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
+|++.+.||+|++|.||++.+..+++.+++|.+... ....+.+|+++++++ +|||++++++.+.. ....++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL-SHPNIIEYYENFLE--DKALMIV 77 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhC-CCCchhheeeeEec--CCEEEEE
Confidence 589999999999999999999999999999987642 245678899999999 99999999998854 5678999
Q ss_pred EeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 114 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 114 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
|||+.+++|.+++. .+++..+..++.|++.+|.+||++|++|+||+|+||+++.+.+.++|+|||.+........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999887763 3788999999999999999999999999999999999987656789999999876654444
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
.....++..|+|||.+.+ ..++.++|+||||+++++|++|..||.. .+.......+......
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~-~~~~~~~~~~~~~~~~---------------- 219 (256)
T cd08220 158 AYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEA-ANLPALVLKIMSGTFA---------------- 219 (256)
T ss_pred ccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCccc-CchHHHHHHHHhcCCC----------------
Confidence 444567889999999876 5688999999999999999999999833 2222222221110000
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
..+..++.++.+++.+||+.+|++|||+.|+++||||
T Consensus 220 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 220 --------------------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred --------------------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 0011268899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=297.46 Aligned_cols=252 Identities=24% Similarity=0.426 Sum_probs=205.5
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
++|++.+.||.|++|.||+|.+..+++.+++|.+.... ...+.+|+.+++.+ +|||++++++.+.+ ....+++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC-RSPYITKYYGSFLK--GSKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHc-CCCCeeeeeEEEEE--CCeEEEE
Confidence 57899999999999999999999999999999986432 34578899999999 89999999999855 4678999
Q ss_pred EeeecCCccccccC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC-Ccce
Q 019642 114 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYN 190 (338)
Q Consensus 114 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~-~~~~ 190 (338)
+||+.+++|..++. .+++..++.++.|++.||.+||+.+++|+||+|+||+++.+ +.++|+|||.+...... ....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~~~~ 156 (274)
T cd06609 78 MEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEE-GDVKLADFGVSGQLTSTMSKRN 156 (274)
T ss_pred EEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEcccccceeecccccccc
Confidence 99999999988875 48999999999999999999999999999999999999998 89999999998766533 2223
Q ss_pred eeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcch
Q 019642 191 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 270 (338)
Q Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (338)
...+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.... .......+.... .
T Consensus 157 ~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~~-~~~~~~~~~~~~-~------------------ 215 (274)
T cd06609 157 TFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLH-PMRVLFLIPKNN-P------------------ 215 (274)
T ss_pred cccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCc-hHHHHHHhhhcC-C------------------
Confidence 3467788999999887 569999999999999999999999984322 111111111000 0
Q ss_pred hhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 271 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
.......++.++.+++.+||..+|++|||++++++||||++...
T Consensus 216 ----------------~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 259 (274)
T cd06609 216 ----------------PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKK 259 (274)
T ss_pred ----------------CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence 00000115788999999999999999999999999999988643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=306.61 Aligned_cols=244 Identities=25% Similarity=0.415 Sum_probs=192.2
Q ss_pred EeeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHH-HHHHhcCCCCeeEeeeeeeccCCCccEEEEee
Q 019642 44 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIK-ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 116 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~-~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~ 116 (338)
+.||+|+||.||+|.+..+++.|++|++.... ...+..|.. +++.+ +||||+++++.+.+ ....++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~--~~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQT--AEKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEc--CCEEEEEEcC
Confidence 36999999999999999999999999986421 233444544 56677 99999999999854 4678999999
Q ss_pred ecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC-CCcceee
Q 019642 117 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVR 192 (338)
Q Consensus 117 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~-~~~~~~~ 192 (338)
+.+++|...+ ..+++..++.++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++..... .......
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05603 78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGVEPEETTSTF 156 (321)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEccCCCCccCCCCCCccccc
Confidence 9999987665 348899999999999999999999999999999999999988 8999999998864322 2222335
Q ss_pred eccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhh
Q 019642 193 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA 272 (338)
Q Consensus 193 ~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (338)
.+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||... +.......+.. . .
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~i~~---~-~------------------ 212 (321)
T cd05603 157 CGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSR-DVSQMYDNILH---K-P------------------ 212 (321)
T ss_pred cCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCC-CHHHHHHHHhc---C-C------------------
Confidence 68899999999877 67899999999999999999999998432 21111111110 0 0
Q ss_pred hhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCH----HHHhcCCCcchhhh
Q 019642 273 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA----REAMAHPYFAQVRA 330 (338)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~----~ell~hp~~~~~~~ 330 (338)
...+...+.++.++|.+||+.||.+||++ .++++||||..+..
T Consensus 213 ---------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~ 259 (321)
T cd05603 213 ---------------LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW 259 (321)
T ss_pred ---------------CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence 00112257889999999999999999976 49999999986543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=291.13 Aligned_cols=246 Identities=24% Similarity=0.414 Sum_probs=198.6
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
+|++.+.||.|++|.||++.+..+++.+++|.+... ..+.+.+|+.+++++ +|+|++++++.+... ....+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVAYRESWEGE-DGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecCC-CCEEEEE
Confidence 589999999999999999999999999999998532 234577899999999 999999999987432 3457899
Q ss_pred EeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-
Q 019642 114 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 187 (338)
Q Consensus 114 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~- 187 (338)
|||+.++++.+++. .+++.+++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecC-CcEEEecccceEEecccCC
Confidence 99999998877652 38999999999999999999999999999999999999987 899999999986653222
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......+++.|+|||...+ ..++.++|+||||++++++++|..||.. .+.......+... ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~-~~~~~~~~~~~~~--~~-------------- 219 (257)
T cd08223 158 MASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNA-KDMNSLVYRIIEG--KL-------------- 219 (257)
T ss_pred ccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhc--CC--------------
Confidence 2223457889999999877 6788999999999999999999999842 2212221111110 00
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
...+..+++++.+++.+||+.||++|||+.++++||||
T Consensus 220 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 220 --------------------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred --------------------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00112268899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=304.80 Aligned_cols=286 Identities=32% Similarity=0.612 Sum_probs=215.5
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeecc--CCCc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSKT 109 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~ 109 (338)
.++|++.+.||+|++|.||+|.+..+++.|++|.+... ....+.+|+.+++.+ +||||+++++++... ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhc-CCCCccCHHHhccccCCCCce
Confidence 48999999999999999999999999999999998642 235567899999999 899999999987543 2346
Q ss_pred cEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 110 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
.++||||+.+ ++..++ ..+++..++.++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||.+......
T Consensus 83 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 83 VYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNED-CELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEEehhhh-hHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEecccccceeeccc
Confidence 8899999975 555554 348999999999999999999999999999999999999988 89999999998654322
Q ss_pred Cc-----ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 187 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 187 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
.. .....++..|+|||.+.+...++.++|+||||+++|+|++|+.|| .+.+....+..+....+.+....+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf-~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLF-PGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCcc-CCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 11 122367888999999866556889999999999999999999998 445555566666666665443322111
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
.......... ........++.. ..+.+++++.++|++||+.+|++|||+.++++||||.+.+...
T Consensus 240 ~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~ 304 (334)
T cd07855 240 GSDRVRKYIQ-NLPRKQPVPWSK-----IFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD 304 (334)
T ss_pred chhhHHHHHh-hcccCCCCCHHH-----HcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence 1000000000 000000011110 1122588999999999999999999999999999998876554
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=296.19 Aligned_cols=255 Identities=24% Similarity=0.413 Sum_probs=203.3
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEeeeeeeccC----CC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----SK 108 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~----~~ 108 (338)
...++|++.+.||+|++|.||+|.+..+++.+++|++... ..+.+.+|+.+++++..|+|++++++.+.... ..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4578999999999999999999999989999999998743 34568899999999977999999999986533 45
Q ss_pred ccEEEEeeecCCcccccc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 109 TPSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
..+++|||+.+++|.+++ ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+.
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~-~~~~l~d~~~~~ 161 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKN-AEVKLVDFGVSA 161 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccC-CeEEECCCccce
Confidence 688999999999887664 248899999999999999999999999999999999999988 889999999886
Q ss_pred cccCCC-cceeeeccccccccccccC----cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhh
Q 019642 182 FYHPGK-EYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 256 (338)
Q Consensus 182 ~~~~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (338)
...... ......++..|+|||.+.. ...++.++|+||||+++|+|++|..||... ........+... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~---~~-- 235 (275)
T cd06608 162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM-HPMRALFKIPRN---PP-- 235 (275)
T ss_pred ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc-chHHHHHHhhcc---CC--
Confidence 543222 2233467888999998743 234778999999999999999999998432 222222211110 00
Q ss_pred hhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 257 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
. .......+++++.++|.+||..||++|||+.++++|||+
T Consensus 236 --------------------------~---~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 236 --------------------------P---TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred --------------------------C---CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 0 000111257889999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=292.58 Aligned_cols=250 Identities=27% Similarity=0.492 Sum_probs=201.5
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
.++|++.+.||.|++|.||+|.+..+++.+++|++... ..+.+.+|+.+++++ +|||++++++.+.+ ....+++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC-RHPNIVAYFGSYLR--RDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhC-CCCChhceEEEEEe--CCEEEEE
Confidence 57999999999999999999999999999999998743 346688999999999 99999999999855 4578999
Q ss_pred EeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-c
Q 019642 114 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E 188 (338)
Q Consensus 114 ~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-~ 188 (338)
|||+.++++..++ ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+....... .
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTED-GDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCC-CCEEECccccchhhhhhhhc
Confidence 9999999988775 358999999999999999999999999999999999999987 889999999886654322 2
Q ss_pred ceeeeccccccccccccCc--CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHH-hCCchhhhhhhccccc
Q 019642 189 YNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV-LGTDELNAYLNKYHLE 265 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 265 (338)
.....++..|+|||.+.+. ..++.++|+||||+++|+|++|..||..... .......... .....
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~-~~~~~~~~~~~~~~~~----------- 225 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP-MRALFLISKSNFPPPK----------- 225 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccCCCcc-----------
Confidence 2334577889999998652 2678899999999999999999999853322 1111111110 00000
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCC
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 324 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 324 (338)
......++.++.+++++||..+|.+|||+.++++|||
T Consensus 226 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 226 ----------------------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ----------------------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 0001125678999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=294.36 Aligned_cols=249 Identities=26% Similarity=0.469 Sum_probs=203.4
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEe
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 115 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e 115 (338)
.++|++.+.||+|++|.||++.+..+++.+++|.+.... .+.+.+|+++++++ +|||++++++.+.+ ....++++|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~l~~e 78 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQC-DSPYIVKYYGSYFK--NTDLWIVME 78 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhC-CCCcEeeeeeeeec--CCcEEEEEe
Confidence 478999999999999999999998889999999987543 56788999999999 99999999999855 467899999
Q ss_pred eecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-cce
Q 019642 116 YVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYN 190 (338)
Q Consensus 116 ~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-~~~ 190 (338)
|+.+++|.+++ ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+....... ...
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~-~~~~l~dfg~~~~~~~~~~~~~ 157 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEE-GQAKLADFGVSGQLTDTMAKRN 157 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCC-CcEEEcccccchhcccCccccc
Confidence 99999998775 348999999999999999999999999999999999999988 789999999987654332 223
Q ss_pred eeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcch
Q 019642 191 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 270 (338)
Q Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (338)
...++..|+|||.+.+ ..++.++|+||||+++++|++|..||..... ......+ ... .
T Consensus 158 ~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~-~~~~~~~---~~~-~---------------- 215 (256)
T cd06612 158 TVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHP-MRAIFMI---PNK-P---------------- 215 (256)
T ss_pred cccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcch-hhhhhhh---ccC-C----------------
Confidence 3457889999999877 5788999999999999999999999843211 1111000 000 0
Q ss_pred hhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 271 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
. .....+..++.++.++|.+||+.||++|||+.|+|+||||
T Consensus 216 --------~------~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 216 --------P------PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred --------C------CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 0 0000112267889999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=298.08 Aligned_cols=254 Identities=25% Similarity=0.430 Sum_probs=201.6
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEeeeeeecc----CCC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----HSK 108 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~----~~~ 108 (338)
...+.|++.+.||+|+||.||+|.+..+++.+++|.+... ....+..|+.+++++.+|||++++++.+... ...
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 4568999999999999999999999999999999997643 3456778999999987799999999988532 245
Q ss_pred ccEEEEeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 109 TPSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
..+++|||+.++++..++. .+++..++.++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++...
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~-~~~~l~dfg~~~~~ 171 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQL 171 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEeeCcchhhh
Confidence 7899999999998877663 37888899999999999999999999999999999999988 78999999988654
Q ss_pred cCC-CcceeeeccccccccccccC----cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhh
Q 019642 184 HPG-KEYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 258 (338)
Q Consensus 184 ~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
... .......++..|+|||.+.. ...++.++|+||||+++|+|++|..||..... ......... ..
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~-~~~~~~~~~---~~----- 242 (282)
T cd06636 172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP-MRALFLIPR---NP----- 242 (282)
T ss_pred hccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH-HhhhhhHhh---CC-----
Confidence 321 12233467889999998753 24578899999999999999999999843221 111111000 00
Q ss_pred hhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
........++.++.+||++||..||.+|||+.|+|+||||
T Consensus 243 ---------------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 243 ---------------------------PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ---------------------------CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 0000112268899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=300.18 Aligned_cols=257 Identities=25% Similarity=0.433 Sum_probs=206.0
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
..++|++.+.||.|++|.||++.+..+++.+++|.+.... .+.+..|+.+++++ +|||++++++.+.. ....++
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 79 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC-KHPNIVGLYEAYFY--ENKLWI 79 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEec--CCeEEE
Confidence 3578999999999999999999998899999999986543 34567899999999 89999999999854 457899
Q ss_pred EEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC-C
Q 019642 113 IFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-K 187 (338)
Q Consensus 113 v~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~-~ 187 (338)
||||+.+++|..++. .+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+...... .
T Consensus 80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLD-GDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCC-CCEEEccCccchhhccccc
Confidence 999999999987763 48999999999999999999999999999999999999988 89999999987654322 2
Q ss_pred cceeeeccccccccccccC----cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccc
Q 019642 188 EYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
......+++.|+|||.+.. ...++.++|+||||+++|+|++|..||... +.......+.. ...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~---~~~--------- 225 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILK---SEP--------- 225 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC-CHHHHHHHHhc---CCC---------
Confidence 2234568889999999742 245778999999999999999999998432 22221111110 000
Q ss_pred cccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
.....+..++.++.++|.+||+.+|.+||++.++++||||.+....
T Consensus 226 ----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 271 (280)
T cd06611 226 ----------------------PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDN 271 (280)
T ss_pred ----------------------CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccchh
Confidence 0000112368899999999999999999999999999999987544
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=295.28 Aligned_cols=278 Identities=34% Similarity=0.558 Sum_probs=210.5
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
++|++.+.||+|++|.||+|.+..+++.|++|.++.. ..+.+.+|+++++++ +|+|++++++.+.. ....++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~i 77 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHENIVNLKEAFRR--KGRLYL 77 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhc-CCCCeeehhheEEE--CCEEEE
Confidence 4799999999999999999999999999999987632 245688999999999 89999999999955 557899
Q ss_pred EEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC--
Q 019642 113 IFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-- 187 (338)
Q Consensus 113 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-- 187 (338)
+|||+.++++..+.. .+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~-~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 78 VFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSES-GVLKLCDFGFARALRARPAS 156 (288)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEEeeecccccCCCccc
Confidence 999999988776543 48899999999999999999999999999999999999987 899999999987654433
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......++..|+|||.+.+...++.++|+||||+++|+|++|..||. ..+..+.+..+....+..............
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 233 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFP-GDSDIDQLYLIQKCLGPLPPSHQELFSSNP-- 233 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHhCCCCHHHhhhcccCc--
Confidence 22334567889999999874478899999999999999999998874 334444444444444432222111100000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
..... ...............+..++.++.+||++||..+|++|||++++++||||
T Consensus 234 -~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 234 -RFAGV--AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred -ccccc--ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00000 00000000001111223358899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=293.66 Aligned_cols=249 Identities=25% Similarity=0.412 Sum_probs=197.6
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
.+|++.+.||+|+||.||++.+..++..+++|.+... ....+.+|+.+++.+ +|||++++++.+.......
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-CCCCeeeEEEEEEcCCCCE
Confidence 4789999999999999999999999999999987532 123577899999999 8999999999987655567
Q ss_pred cEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 110 PSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
.++++||+.+++|...+. .+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~-~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEccCCCccccccc
Confidence 889999999999887763 48889999999999999999999999999999999999987 78999999988654321
Q ss_pred C----cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcc
Q 019642 187 K----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262 (338)
Q Consensus 187 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
. ......++..|+|||.+.+ ..++.++|+||+|+++|++++|+.||... +... .+.+.......
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~-~~~~---~~~~~~~~~~~------- 227 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEY-EAMA---AIFKIATQPTN------- 227 (266)
T ss_pred cccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCcccc-chHH---HHHHHhcCCCC-------
Confidence 1 1122346788999999877 67889999999999999999999998432 1111 11111110000
Q ss_pred ccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcc
Q 019642 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 326 (338)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~ 326 (338)
...+..+++.+.+++ +||..+|++|||++|+++||||+
T Consensus 228 -------------------------~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 228 -------------------------PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred -------------------------CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 000112577888998 57778999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=295.05 Aligned_cols=263 Identities=21% Similarity=0.328 Sum_probs=204.6
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
++|+..+.||.|++|.||++.+..+++.+++|.+... ....+.+|+++++++ +||||+++++++.+......+++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC-KSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEccCCCeEEEE
Confidence 5799999999999999999999999999999998643 235678899999999 89999999999876666678999
Q ss_pred EeeecCCcccccc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 114 FEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 114 ~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
|||+.+++|.+++ ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRK-GQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecC-CeEEEeecccccccccc
Confidence 9999999987654 237888999999999999999999999999999999999987 78999999997654322
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.. ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+....+.........
T Consensus 159 ~~-~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 229 (287)
T cd06621 159 LA-GTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELK------- 229 (287)
T ss_pred cc-ccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhc-------
Confidence 21 23456778999999876 6788999999999999999999999854322100111111111110000000
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
.........++.+.+||.+||+.+|++|||+.|+++||||+....
T Consensus 230 -------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 274 (287)
T cd06621 230 -------------------DEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274 (287)
T ss_pred -------------------cCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence 000000114678999999999999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=296.81 Aligned_cols=253 Identities=25% Similarity=0.422 Sum_probs=200.1
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
...++|++.+.||+|+||.||+|.+..+++.+++|++... ....+.+|+.+++.+ +|||++++++.+.. ....+
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~-~h~~ii~~~~~~~~--~~~~~ 82 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC-KHCNIVAYFGSYLS--REKLW 82 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhc-CCCCeeeeeEEEEe--CCEEE
Confidence 4467899999999999999999999999999999998643 234577899999999 99999999999855 45788
Q ss_pred EEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-
Q 019642 112 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 187 (338)
Q Consensus 112 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~- 187 (338)
+||||+.+++|.+++ ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDN-GDVKLADFGVAAKITATIA 161 (267)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CCEEECcCccceeeccccc
Confidence 999999999998775 358999999999999999999999999999999999999887 789999999987653222
Q ss_pred cceeeeccccccccccccC--cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 188 EYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
......++..|+|||.+.. ...++.++|+||+|+++|+|++|..||........ ...+.. ..
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~~~----~~----------- 225 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMSK----SN----------- 225 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heeeec----CC-----------
Confidence 2233467789999998742 24577899999999999999999999843221110 000000 00
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCC
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 324 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 324 (338)
... .. ......++..+.+||++||+.+|++|||++++|+|+|
T Consensus 226 ------------~~~--~~---~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 226 ------------FQP--PK---LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ------------CCC--CC---CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 000 00 0001226789999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=306.51 Aligned_cols=261 Identities=25% Similarity=0.448 Sum_probs=199.0
Q ss_pred eeeeeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEec-----ccchHHHHHHHHHHHHhcCCCCeeEeeeeeec
Q 019642 30 SYVIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPNVVKLLDIVRD 104 (338)
Q Consensus 30 ~~~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~-----~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 104 (338)
..+|..++..|++++.||+||.+.||++.....+ .|++|.+. ....+.+.+|+..|.+|.+|.+|++++++-..
T Consensus 353 ~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~ 431 (677)
T KOG0596|consen 353 NEIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT 431 (677)
T ss_pred CeeEEECcchhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc
Confidence 3677788899999999999999999999865444 45555432 23346688999999999999999999999744
Q ss_pred cCCCccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccc
Q 019642 105 QHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
Q Consensus 105 ~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~ 180 (338)
+..+|+||||.+ .+|..++. ..+...++.+..|++.|+.++|++||||.||||.|+|+-.+ .+||+|||.+
T Consensus 432 --d~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG--~LKLIDFGIA 506 (677)
T KOG0596|consen 432 --DGYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKG--RLKLIDFGIA 506 (677)
T ss_pred --CceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEee--eEEeeeechh
Confidence 678999999865 45555553 25555899999999999999999999999999999999875 8999999999
Q ss_pred ccccCCC---cceeeeccccccccccccCcC----------CCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHH
Q 019642 181 EFYHPGK---EYNVRVASRYFKGPELLVDLQ----------DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 247 (338)
Q Consensus 181 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~----------~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~ 247 (338)
..+.... .....+||..||+||++.... ++++++|||||||+||+|+.|+.||. .....+.
T Consensus 507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~------~~~n~~a 580 (677)
T KOG0596|consen 507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG------QIINQIA 580 (677)
T ss_pred cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH------HHHHHHH
Confidence 7765443 234468999999999984311 37789999999999999999999992 2222222
Q ss_pred HHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcch
Q 019642 248 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 327 (338)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 327 (338)
+.....++.. +.-+.+.. -..++.++++.||+.||.+|||+.++|+|||++-
T Consensus 581 Kl~aI~~P~~-------------------------~Iefp~~~---~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 581 KLHAITDPNH-------------------------EIEFPDIP---ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred HHHhhcCCCc-------------------------cccccCCC---CchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 2222211110 00000000 1234899999999999999999999999999987
Q ss_pred hhh
Q 019642 328 VRA 330 (338)
Q Consensus 328 ~~~ 330 (338)
.+.
T Consensus 633 ~~i 635 (677)
T KOG0596|consen 633 QPI 635 (677)
T ss_pred ccc
Confidence 543
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=296.69 Aligned_cols=277 Identities=29% Similarity=0.505 Sum_probs=207.4
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
++|++.+.||+|++|.||+|.+..+++.+++|.+... ..+.+.+|+++++.+ +|||++++++++.+ ....++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 77 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHENLVNLIEVFRR--KKRLYL 77 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhc-CCcchhhHHHhccc--CCeEEE
Confidence 5799999999999999999999989999999987532 234577899999999 99999999999954 567899
Q ss_pred EEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC-Cc
Q 019642 113 IFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KE 188 (338)
Q Consensus 113 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~-~~ 188 (338)
++||+.++++..+.. .+++..++.++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++...... ..
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 78 VFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CcEEEEeeeeeeeccCCccc
Confidence 999999998877653 48899999999999999999999999999999999999988 89999999998655332 22
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
.....++..|+|||.+.+...++.++|+||||+++++|++|..||. .....+....+....+........... ..+
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 232 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFP-GDSDIDQLYHIIKCLGNLIPRHQEIFQ---KNP 232 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCC-CCchHHHHHHHHHHhCCCchhhHHHhc---cch
Confidence 2234577889999998765567889999999999999999997773 334444444444443332111000000 000
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
..... ...............+.++..+.+|+.+||..+|++||++.++++||||
T Consensus 233 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 233 LFAGM---RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred Hhhcc---ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 00000 0000000000001123478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=290.71 Aligned_cols=247 Identities=27% Similarity=0.461 Sum_probs=202.2
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
+|++.+.||.|+||.||++.+..+++.+++|.++.. ..+.+..|+.+++.+ +|||++++++.+........+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhc-CCCccceeeeeeecCCCCEEEEE
Confidence 589999999999999999999999999999987532 234577899999999 99999999998866556678999
Q ss_pred EeeecCCcccccc-------CCCCHHHHHHHHHHHHHHHHHHH-----HCCceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 114 FEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCH-----SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 114 ~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lH-----~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
|||+.+++|..++ ..+++..++.++.|++.||.+|| +.+++|+||+|+||+++.+ +.++|+|||++.
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~-~~~kl~d~g~~~ 158 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN-NNVKLGDFGLAK 158 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecC-CCEEEecccccc
Confidence 9999999987775 34788999999999999999999 8999999999999999987 899999999987
Q ss_pred cccCCCc-ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhh
Q 019642 182 FYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 260 (338)
Q Consensus 182 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
....... .....+++.|+|||.+.+ ..++.++|+||||+++++|++|..||.... ....... ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~---~~~~~~----- 227 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLASK---IKEGKF----- 227 (265)
T ss_pred cccCCcccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHHH---HhcCCC-----
Confidence 6654332 333467889999999877 568899999999999999999999984322 2221111 111000
Q ss_pred ccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
...+..++..+.+++.+||+.+|++|||+.++++|||+
T Consensus 228 ---------------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 228 ---------------------------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ---------------------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 00112267899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=286.21 Aligned_cols=294 Identities=30% Similarity=0.547 Sum_probs=229.9
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCc----eEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeecc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQ 105 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 105 (338)
.....|++.+.||+|.||.||+|..+++.. .+|+|.++... ....-+|+..++.+ +|||++.+..+|...
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl-~h~nvi~Lv~Vfl~~ 99 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLREL-KHPNVISLVKVFLSH 99 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh-cCCcchhHHHHHhcc
Confidence 345689999999999999999997655433 68999987542 34567899999999 999999999998654
Q ss_pred CCCccEEEEeeecCCcccccc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecC---CCCceEEE
Q 019642 106 HSKTPSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH---ELRKLRLI 175 (338)
Q Consensus 106 ~~~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~---~~~~~~l~ 175 (338)
+..+++++||.+...+.-.. +.++...++.++.||+.|+.|||++=++|+||||.|||+.. +.|.|||+
T Consensus 100 -d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 100 -DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred -CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence 57889999999877664332 34899999999999999999999999999999999999954 35899999
Q ss_pred eccccccccCCC----cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCC--------CCHHHH
Q 019642 176 DWGLAEFYHPGK----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH--------DNHDQL 243 (338)
Q Consensus 176 dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~--------~~~~~~ 243 (338)
|+|+++.+.... ..+.-..|.+|+|||++.+...++++.|+|+.||++.||+|....|.... -..+++
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 999998775432 23445778999999999998899999999999999999999887774321 135789
Q ss_pred HHHHHHhCCchhhhhhhccccccCcchhhhhccccCCC--CcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 244 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKP--WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
..+.+++|.+....|..-...+....+-+.+..+...+ ...+... ...-++...+|+.+||..||-+|.|++++|+
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~--~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHK--HKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHH--hcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 99999999999999877665554422222222222222 1111111 1112455889999999999999999999999
Q ss_pred CCCcchhhhcc
Q 019642 322 HPYFAQVRAAE 332 (338)
Q Consensus 322 hp~~~~~~~~~ 332 (338)
|+||.+-+-++
T Consensus 337 h~yF~~d~lpp 347 (438)
T KOG0666|consen 337 HPYFTEDPLPP 347 (438)
T ss_pred ccccccCCCCC
Confidence 99999886553
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=297.39 Aligned_cols=251 Identities=24% Similarity=0.422 Sum_probs=199.7
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
.++|++.+.||+|+||.||+|.+..+++.+++|+++... ...+.+|+.+++.+ +|||++++++.+.. ....+++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~--~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC-KHSNIVAYFGSYLR--RDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCeeeEEEEEEe--CCEEEEE
Confidence 468999999999999999999999999999999987443 23467899999999 99999999999855 4578999
Q ss_pred EeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-cc
Q 019642 114 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EY 189 (338)
Q Consensus 114 ~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-~~ 189 (338)
|||+.+++|.+++ ..+++..++.++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||.+....... ..
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~-~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDN-GHVKLADFGVSAQITATIAKR 163 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECcceeeeEccCccccc
Confidence 9999999998875 358999999999999999999999999999999999999987 789999999986543222 12
Q ss_pred eeeeccccccccccccC--cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 190 NVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 190 ~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
....++..|+|||.+.. ...++.++|+||||+++|+|++|..||......... ..... ....
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~-~~~~~--~~~~------------- 227 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLMTK--SNFQ------------- 227 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH-Hhhhc--cCCC-------------
Confidence 33467889999998742 245788999999999999999999998543321111 11100 0000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCC
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 324 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 324 (338)
... . .....++..+.++|.+||+.+|++|||++++++|||
T Consensus 228 -----------~~~---~---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 228 -----------PPK---L---KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred -----------CCc---c---cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 000 0 001125788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=292.93 Aligned_cols=251 Identities=25% Similarity=0.454 Sum_probs=200.6
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc---------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
+|+..+.||+|++|.||++.+..+++.+++|++.... .+.+..|+.+++.+ +|||++++++++.+ ...
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~ 77 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLGATCE--DSH 77 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-CCCceehhhceecc--CCe
Confidence 5888999999999999999999999999999986422 35678899999999 99999999999854 567
Q ss_pred cEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 110 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
.++++||+.+++|..++ ..+++..+..++.|++.||.+||++|++|+||+|+||+++.+...++|+|||.+......
T Consensus 78 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 78 FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 88999999999998876 348889999999999999999999999999999999999877457999999998665432
Q ss_pred Cc-----ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 187 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 187 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
.. .....++..|+|||.+.+ ..++.++|+||+|++++++++|..||..... ......+.+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~-------- 227 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKH-SNHLALIFKIASAT-------- 227 (268)
T ss_pred cccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCC-cchHHHHHHHhccC--------
Confidence 11 122356788999999876 6788999999999999999999999843221 11111111110000
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcc
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 326 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~ 326 (338)
.....+..+++++.+++.+||..+|.+|||+.++++||||+
T Consensus 228 ------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 228 ------------------------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ------------------------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 00011122678999999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=293.30 Aligned_cols=247 Identities=27% Similarity=0.471 Sum_probs=203.9
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
+|++.+.||.|+||.||++.+..+++.+++|.+... ..+.+.+|+++++++ +|||++++++.+.+ ....++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 77 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQD--EENMYL 77 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcC--CCeEEE
Confidence 589999999999999999999999999999998632 245678899999999 99999999999844 567899
Q ss_pred EEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcc
Q 019642 113 IFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189 (338)
Q Consensus 113 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~ 189 (338)
++||+.+++|...+. .+++..+..++.|+++||.+||+.|++|+||+|+||+++.+ +.++|+|||.+.........
T Consensus 78 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 78 VVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ-GHVHITDFNIATKVTPDTLT 156 (258)
T ss_pred EEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCC-CCEEEeecccccccCCCccc
Confidence 999999999987763 58999999999999999999999999999999999999988 89999999998766544334
Q ss_pred eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcc
Q 019642 190 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 269 (338)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...... ......+.....
T Consensus 157 ~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~---------------- 217 (258)
T cd05578 157 TSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQETA---------------- 217 (258)
T ss_pred cccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhccc----------------
Confidence 44567888999999877 56899999999999999999999998543321 111111111100
Q ss_pred hhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCH--HHHhcCCCc
Q 019642 270 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA--REAMAHPYF 325 (338)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~--~ell~hp~~ 325 (338)
....+..++.++.++|.+||+.||.+||++ .|+++||||
T Consensus 218 -----------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 218 -----------------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred -----------------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 001112267899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=302.37 Aligned_cols=286 Identities=29% Similarity=0.514 Sum_probs=207.6
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC-----
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS----- 107 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~----- 107 (338)
..++|++.+.||.|+||.||+|.+..+++.|++|.+... ..+.+.+|+++++++ +|||++++++.+.....
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhc-CCCcchhhHhhhcccccccccc
Confidence 358999999999999999999999999999999987643 245578899999999 99999999987754322
Q ss_pred -------CccEEEEeeecCCcccccc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecc
Q 019642 108 -------KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG 178 (338)
Q Consensus 108 -------~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg 178 (338)
...+++|||+.+ ++...+ ..+++..++.++.|+++||.+||+.|++|+||||+||+++...+.++|+|||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 82 VGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred cccccccceEEEEeecccc-cHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence 246899999985 565554 3589999999999999999999999999999999999998765789999999
Q ss_pred ccccccCCC----cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCch
Q 019642 179 LAEFYHPGK----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 254 (338)
Q Consensus 179 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (338)
.+....... ......++..|+|||.+.+...++.++|+||||+++|+|++|+.||... +..+.............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~-~~~~~~~~~~~~~~~~~ 239 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA-HELEQMQLILESVPVVR 239 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHhcCCCC
Confidence 986543211 1122356788999998766467889999999999999999999999433 33333333333322211
Q ss_pred hhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 255 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
....... ........... ......+... ....++.++.+||.+||+.||++|||+.++++||||+...-+
T Consensus 240 ~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~ 309 (342)
T cd07854 240 EEDRNEL-LNVIPSFVRND-GGEPRRPLRD-----LLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCP 309 (342)
T ss_pred hHHhhhh-hhhhhhhhhhc-ccccCCCHHH-----HccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCC
Confidence 1111000 00000000000 0000000000 112368899999999999999999999999999999865433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=293.59 Aligned_cols=276 Identities=35% Similarity=0.638 Sum_probs=209.2
Q ss_pred EEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 40 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
|++.+.||+|++|.||+|.+..+++.+++|.+... ....+.+|+.+++.+ +|||++++++.+.+......++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-RHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCeeeheeeEecCCCCcEEEEe
Confidence 68899999999999999999999999999998754 234577899999999 899999999998664336789999
Q ss_pred eeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC--c
Q 019642 115 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--E 188 (338)
Q Consensus 115 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~--~ 188 (338)
||+.+ ++..++ ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+....... .
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~-~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINND-GVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCC-CCEEEccccceeeccCCCccc
Confidence 99986 454443 248999999999999999999999999999999999999998 899999999987654332 1
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
.....++..|+|||.+.+...++.++|+||||+++++|++|..||. ..+.......+....+.+....+..........
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ-GSTELEQLEKIFELCGSPTDENWPGVSKLPWFE 236 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence 2334567889999988765568899999999999999999999984 444555555565555544433332211110000
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
.. .................++.++.+++++||+.+|++||++.++++||||
T Consensus 237 ~~------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 237 NL------KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hc------cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00 0000000011111111148899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=297.25 Aligned_cols=253 Identities=23% Similarity=0.401 Sum_probs=204.5
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
++|++.+.||+|++|.||++.+..+++.+++|.+... ....+.+|+++++++ .||||+++++.+.. ....+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC-NSPYIVGFYGAFYN--NGDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHC-CCCchhhhheeeec--CCEEEEE
Confidence 4788899999999999999999999999999987643 235578899999999 79999999999855 4678999
Q ss_pred EeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 114 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 114 ~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
+|++.+++|..++ ..+++..+..++.|++.||.+||+ .|++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSR-GQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCC-CCEEEeecccchhhHHHHh
Confidence 9999999988876 357899999999999999999999 999999999999999997 8899999998865532222
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHH-hCCchhhhhhhccccccC
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV-LGTDELNAYLNKYHLELD 267 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 267 (338)
. ...++..|+|||.+.+ ..++.++|+||||++++++++|..||.......+......+. ......
T Consensus 157 ~-~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------------ 222 (265)
T cd06605 157 K-TFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP------------ 222 (265)
T ss_pred h-cccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCC------------
Confidence 2 2667889999999877 578999999999999999999999996543222222221111 111000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
......++.++.++|.+||..||++|||+.++++||||++.
T Consensus 223 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 223 --------------------RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred --------------------CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 00001157889999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=301.49 Aligned_cols=239 Identities=20% Similarity=0.375 Sum_probs=198.1
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc--cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEe
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 115 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e 115 (338)
+.++++++||+|-||.||.|... ....|++|.++. ...+.+.+|+++|++| +|++||++++++.. ++.++||||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L-~H~~lV~l~gV~~~--~~piyIVtE 281 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMSPEAFLREAQIMKKL-RHEKLVKLYGVCTK--QEPIYIVTE 281 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccChhHHHHHHHHHHhC-cccCeEEEEEEEec--CCceEEEEE
Confidence 34566789999999999999874 344799999875 3457788999999999 99999999999955 447899999
Q ss_pred eecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcce
Q 019642 116 YVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 190 (338)
Q Consensus 116 ~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~ 190 (338)
|+..|+|.++++ .+...+...++.||++|++||+++++|||||.+.||||+.+ ..+||+|||+++...+. ...
T Consensus 282 ~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~-~~vKIsDFGLAr~~~d~-~Y~ 359 (468)
T KOG0197|consen 282 YMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDED-LVVKISDFGLARLIGDD-EYT 359 (468)
T ss_pred ecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccC-ceEEEcccccccccCCC-cee
Confidence 999999988875 38889999999999999999999999999999999999999 79999999999844332 222
Q ss_pred eeec---cccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 191 VRVA---SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 191 ~~~~---~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
...+ ..-|.|||++.. ..++.+|||||||++|+|++| |+.|| ...++.+.++.+.+....+
T Consensus 360 ~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py-~~msn~ev~~~le~GyRlp------------- 424 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPY-PGMSNEEVLELLERGYRLP------------- 424 (468)
T ss_pred ecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCC-CCCCHHHHHHHHhccCcCC-------------
Confidence 2222 346999999987 789999999999999999998 56554 6667777777665533322
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHh
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 320 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell 320 (338)
.|..+++++-+++..|+..+|++|||++.+.
T Consensus 425 -----------------------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 425 -----------------------RPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred -----------------------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 2333799999999999999999999999665
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=290.56 Aligned_cols=249 Identities=23% Similarity=0.397 Sum_probs=199.1
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
.+|++.+.||+|+||.||.+.+..++..|++|.+... ....+.+|+.+++++ .||||+++++.+.+.....
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEeccCCCce
Confidence 5799999999999999999999999999999987421 123577899999999 9999999999886655567
Q ss_pred cEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 110 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
++++|||+.+++|.+++ ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSV-GNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCC-CCEEECcCccccccccc
Confidence 88999999999998776 347888999999999999999999999999999999999987 89999999988654321
Q ss_pred C----cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcc
Q 019642 187 K----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262 (338)
Q Consensus 187 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
. ......++..|+|||.+.+ ..++.++|+||||+++|++++|+.||... +..... .+......
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~---~~~~~~~~-------- 226 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEF-EAMAAI---FKIATQPT-------- 226 (265)
T ss_pred cccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCcc-chHHHH---HHHhcCCC--------
Confidence 1 1122357788999999877 67889999999999999999999998422 111111 11111100
Q ss_pred ccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcc
Q 019642 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 326 (338)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~ 326 (338)
....+..++..+.++|++|+ .+|++||+++++++|||+.
T Consensus 227 ------------------------~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 227 ------------------------NPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRHTFVH 265 (265)
T ss_pred ------------------------CCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhcCcccC
Confidence 00011226788999999999 4999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=292.17 Aligned_cols=245 Identities=28% Similarity=0.532 Sum_probs=197.2
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc------------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------------KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
+|.+...||+|++|.||+|.+..+++.+++|.+.... .+.+.+|+.+++++ +||||+++++.+..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-- 77 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQYLGSSLD-- 77 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEe--
Confidence 4778899999999999999999899999999875321 13577899999999 99999999999855
Q ss_pred CCccEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 107 SKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
....+++|||+.+++|..++. .+++..+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+...
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~-~~~~l~dfg~~~~~ 156 (267)
T cd06628 78 ADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNK-GGIKISDFGISKKL 156 (267)
T ss_pred CCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCC-CCEEecccCCCccc
Confidence 457889999999999887763 48889999999999999999999999999999999999887 78999999988655
Q ss_pred cCCCc-------ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhh
Q 019642 184 HPGKE-------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 256 (338)
Q Consensus 184 ~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (338)
..... .....++..|+|||.+.+ ..++.++|+||||+++|++++|..||..... ......... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~---~---- 227 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-LQAIFKIGE---N---- 227 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccH-HHHHHHHhc---c----
Confidence 42111 112346788999999876 5688999999999999999999999843221 111111100 0
Q ss_pred hhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 257 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
.....+..++..+.++|++||+.||.+||++.++++||||
T Consensus 228 -----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 228 -----------------------------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred -----------------------------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 0000112268899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=288.29 Aligned_cols=245 Identities=22% Similarity=0.429 Sum_probs=199.9
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~-----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
+|++.+.||+|++|.||++.+..+++.|++|.+.. .....+.+|+.+++.+ +|||++++++.+.. ....+++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-DSSYIIRYYESFLD--KGKLNIV 77 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhc-CCCCeehheeeecc--CCEEEEE
Confidence 58899999999999999999999999999998753 2345677899999999 99999999999854 4678999
Q ss_pred EeeecCCcccccc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 114 FEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 114 ~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
|||+.+++|..++ ..++...++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~-~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAY-DNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCC-CCEEEcccccceeccCccc
Confidence 9999999988775 347888999999999999999999999999999999999988 7899999998876543322
Q ss_pred -ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 189 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 189 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
.....+++.|+|||...+ ..++.++|+||||+++++|++|..||.... .......+.+. ...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~----~~~----------- 219 (256)
T cd08529 157 FANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANN-QGALILKIIRG----VFP----------- 219 (256)
T ss_pred hhhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcC----CCC-----------
Confidence 223457788999999877 568899999999999999999999984322 21111111110 000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
..+..++.++.+++.+||+.+|++||++.++++|||+
T Consensus 220 ---------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 220 ---------------------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ---------------------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 0011267899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=297.76 Aligned_cols=279 Identities=32% Similarity=0.561 Sum_probs=207.3
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccC-----
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----- 106 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~----- 106 (338)
.++|++.+.||+|++|.||+|.+..+++.+++|.+... ......+|+++++++ +||||+++++.+.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-KHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhc-CCCCccchhhheecccccccc
Confidence 58999999999999999999999999999999987532 123567899999999 9999999999875433
Q ss_pred -CCccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccc
Q 019642 107 -SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
Q Consensus 107 -~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~ 182 (338)
....+++|||+.+..+.... ..+++..++.++.|+++||.+||+.|++|+||||+||+++.+ +.++|+|||++..
T Consensus 86 ~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~ 164 (311)
T cd07866 86 KRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQ-GILKIADFGLARP 164 (311)
T ss_pred cCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECcCccchh
Confidence 23578999999876544433 258999999999999999999999999999999999999998 8999999998865
Q ss_pred ccCCCc------------ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHh
Q 019642 183 YHPGKE------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 250 (338)
Q Consensus 183 ~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~ 250 (338)
...... .....+++.|+|||.+.+...++.++|+||||+++|+|++|..|| .+.+.......+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~-~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL-QGKSDIDQLHLIFKLC 243 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHh
Confidence 432211 112245778999999876556889999999999999999999887 4455555555555555
Q ss_pred CCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 251 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
+......+............... ........ .....++..+.+||.+||+.||++|||+.++++||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSF--TNYPRTLE-----ERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCCChhhchhhhhcccccccccC--CCCCccHH-----HHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 54433333221111110000000 00000000 0111256789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=292.25 Aligned_cols=273 Identities=30% Similarity=0.606 Sum_probs=205.5
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
+|++.+.||.|++|.||+|.+..+++.|++|.++.. ....+.+|+.+++++ +|||++++++.+.+ ....++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-KHENIVRLHDVIHT--ENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhh-cCCCEeeeeeeEee--CCcEEEEE
Confidence 589999999999999999999999999999988643 245677899999999 99999999999965 45778999
Q ss_pred eeecCCcccccc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-
Q 019642 115 EYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 187 (338)
Q Consensus 115 e~~~~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~- 187 (338)
||+.+ ++..++ ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~-~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKR-GELKLADFGLARAFGIPVN 155 (284)
T ss_pred ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC-CcEEEeecchhhhhcCCcc
Confidence 99997 444432 247999999999999999999999999999999999999987 899999999886543221
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......++..|++||.+.+...++.++|+||||+++|++++|..||. +.+..+....+.+....+....+..-.. .
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 231 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFP-GTNNEDQLLKIFRIMGTPTESTWPGISQ---L 231 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCcHHHHHHHHHHhCCCChhhHHHHhc---C
Confidence 12234567889999998765567899999999999999999999984 3445555555555444333222211100 0
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
+.............. ....+.++..+.+++.+||+.||.+||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 232 PEYKPTFPRYPPQDL-----QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred chhcccccCCChHHH-----HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 000000000000000 00112257889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=291.44 Aligned_cols=252 Identities=23% Similarity=0.420 Sum_probs=202.3
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
++|++.+.||.|++|+||+|....++..+++|++... ..+.+.+|+..++.+ +|+|++++++.+.. ....+++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC-NHPNVVKYYTSFVV--GDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhc-CCCCEEEEEEEEee--CCEEEEE
Confidence 5799999999999999999999889999999998632 345678899999999 99999999998854 4678899
Q ss_pred EeeecCCccccccC------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 114 FEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 114 ~e~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
||++.++++...+. .+++..+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~-~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGED-GSVKIADFGVSASLADGG 156 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC-CCEEEcccchHHHhccCc
Confidence 99999999887763 37888999999999999999999999999999999999987 789999999886654332
Q ss_pred cc-----eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcc
Q 019642 188 EY-----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262 (338)
Q Consensus 188 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
.. ....++..|+|||.+......+.++|+||||+++++|++|..||..... ........+ ...
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-~~~~~~~~~---~~~-------- 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP-MKVLMLTLQ---NDP-------- 224 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh-hhhHHHHhc---CCC--------
Confidence 21 2335788899999987744789999999999999999999999843222 111111111 000
Q ss_pred ccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
...........+++.+.+++.+||..||++|||+.++++||||
T Consensus 225 --------------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 225 --------------------PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred --------------------CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 0000000112368899999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=300.77 Aligned_cols=286 Identities=36% Similarity=0.633 Sum_probs=218.3
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccC---CCcc
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---SKTP 110 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~---~~~~ 110 (338)
+|++.+.||+|++|.||+|.+..+++.+++|.+... ..+.+.+|+.+++.+ +|||++++++++.... ....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhc-CCcchhhhhhhhcccCcccccce
Confidence 589999999999999999999989999999988643 245678899999999 8999999999886542 2367
Q ss_pred EEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 111 SLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
+++|||+.+ ++...+. .+++..++.++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||.+.......
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~-~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN-CDLKICDFGLARGVDPDE 157 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEcccCceEeecccc
Confidence 899999985 4554442 48999999999999999999999999999999999999998 899999999987654432
Q ss_pred ----cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccc
Q 019642 188 ----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263 (338)
Q Consensus 188 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
......++..|+|||.+.+...++.++|+||||+++|+|++|..|| .+.+..+....+....+.+....+.....
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLF-PGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCc-CCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 1233467888999999987448899999999999999999999998 44455566666666666554433321110
Q ss_pred cccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcccc
Q 019642 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS 334 (338)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~ 334 (338)
......... .......++. ...+.++.++.++|.+||+++|++|||++++++||||+++...+..
T Consensus 237 ~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~ 301 (330)
T cd07834 237 EKARNYLKS-LPKKPKKPLS-----KLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDE 301 (330)
T ss_pred cchhhHHhh-cccCCcchhH-----HhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccC
Confidence 000000000 0000000111 1122268899999999999999999999999999999998776544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=295.85 Aligned_cols=255 Identities=23% Similarity=0.408 Sum_probs=203.1
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
++|++.+.||+|+||.||++.+..+++.+++|.++.. ....+.+|+.+++++ +|||++++++.+.. ....+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKA-VSPYIVDFYGAFFI--EGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhc-CCCcHHhhhhheec--CCeEEEE
Confidence 5799999999999999999999999999999987642 134677899999999 99999999998855 4678999
Q ss_pred EeeecCCccccccC------CCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 114 FEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 114 ~e~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
|||+.+++|..++. .+++..+..++.|++.||.|||+ .|++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVAS 156 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCC-CCEEEeecCCcccccCC
Confidence 99999999877652 58899999999999999999997 599999999999999987 89999999998655322
Q ss_pred CcceeeeccccccccccccCc-----CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 187 KEYNVRVASRYFKGPELLVDL-----QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
. .....++..|+|||.+.+. ..++.++|+||||+++|+|++|..||.... .......+........
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~------- 227 (286)
T cd06622 157 L-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET-YANIFAQLSAIVDGDP------- 227 (286)
T ss_pred c-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc-hhhHHHHHHHHhhcCC-------
Confidence 2 2234577889999998542 235789999999999999999999984321 1111221111111000
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
...+..+++++.+||.+||..+|++||++.++++||||......
T Consensus 228 --------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 228 --------------------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred --------------------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 00112268899999999999999999999999999999887654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=295.60 Aligned_cols=255 Identities=24% Similarity=0.418 Sum_probs=202.6
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
++|++.+.||+|+||.||++.+..+++.|++|.+.... ...+.+|+++++.+ +||||+++++.+.. ....+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~ 77 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSFET--KRHLC 77 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEec--CCEEE
Confidence 47999999999999999999999999999999986432 34567899999999 99999999999854 45789
Q ss_pred EEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-
Q 019642 112 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 187 (338)
Q Consensus 112 lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~- 187 (338)
++|||+.+++|..++. .+++..+..++.|++.||.+||+.|++|+||+|+||+++.. +.++|+|||.+.......
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~-~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 78 MVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSM-GHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCC-CCEEEeeCCCccccCcCcc
Confidence 9999999999988863 48899999999999999999999999999999999999987 899999999875311000
Q ss_pred ---------------cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCC
Q 019642 188 ---------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 252 (338)
Q Consensus 188 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 252 (338)
......++..|+|||.+.+ ..++.++|+||||+++|++++|..||.. .+..+........ .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~-~~~~~~~~~~~~~--~ 232 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISD--D 232 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhc--c
Confidence 0011246778999999877 6789999999999999999999999842 2222222211110 0
Q ss_pred chhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCC---HHHHhcCCCcchhh
Q 019642 253 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT---AREAMAHPYFAQVR 329 (338)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt---~~ell~hp~~~~~~ 329 (338)
.... .....++.++.++|.+||+.||++||+ +.++|+||||...+
T Consensus 233 ~~~~--------------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~ 280 (305)
T cd05609 233 IEWP--------------------------------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280 (305)
T ss_pred cCCC--------------------------------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence 0000 000126889999999999999999997 79999999998776
Q ss_pred hcc
Q 019642 330 AAE 332 (338)
Q Consensus 330 ~~~ 332 (338)
.++
T Consensus 281 ~~~ 283 (305)
T cd05609 281 WNG 283 (305)
T ss_pred HHH
Confidence 655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=261.31 Aligned_cols=279 Identities=31% Similarity=0.576 Sum_probs=227.4
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
..|.-.++||+|.+|+||++++..+++.||+|.++-.+ .....+|+-+++.+ +|.|||++++.... ++.+-+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkel-khknivrl~dvlhs--dkkltl 78 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHS--DKKLTL 78 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHh-hhcceeehhhhhcc--CceeEE
Confidence 45667789999999999999999999999999886432 46688999999999 99999999999855 456779
Q ss_pred EEeeecCCcc---ccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-c
Q 019642 113 IFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E 188 (338)
Q Consensus 113 v~e~~~~~~l---~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-~ 188 (338)
|+|+|....- ....+.+..+.++.++.|++.||.++|++++.|+|+||.|.+++.+ |.+|++|||+++-+.-.- -
T Consensus 79 vfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~n-gelkladfglarafgipvrc 157 (292)
T KOG0662|consen 79 VFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRN-GELKLADFGLARAFGIPVRC 157 (292)
T ss_pred eHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccC-CcEEecccchhhhcCCceEe
Confidence 9999975432 2223458999999999999999999999999999999999999999 999999999997664332 3
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
......|.+|++|.++.+.+-++...|+||.||++.++.....|.+.+.+-.+++..+...+|.+....|.+--......
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 44567889999999999988899999999999999999987778889999999999999999998887776533322111
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
.. ..-+....|.+. .+.++..-+++++++|.-+|.+|.+|+++|+||||.+.
T Consensus 238 ~y---p~ypattswsqi-----vp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 238 PY---PIYPATTSWSQI-----VPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred cc---CCccccchHHHH-----hhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 10 001111122221 12356778999999999999999999999999999875
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=293.69 Aligned_cols=253 Identities=26% Similarity=0.427 Sum_probs=201.5
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
+-|++.+.||+|+||.||++.+..++..+++|.+.... ...+.+|+.+++.+ .|||++++++.+.. ....++++
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~--~~~~~~v~ 81 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYY--ENNLWILI 81 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHC-CCCCeeeEEEEEee--CCEEEEEE
Confidence 45788999999999999999999999999999986433 34567899999999 99999999999855 45788999
Q ss_pred eeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC-Ccc
Q 019642 115 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEY 189 (338)
Q Consensus 115 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~-~~~ 189 (338)
||+.++++...+ ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||++...... ...
T Consensus 82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~-~~~kl~dfg~~~~~~~~~~~~ 160 (282)
T cd06643 82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRR 160 (282)
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccC-CCEEEcccccccccccccccc
Confidence 999999987764 348999999999999999999999999999999999999988 78999999988654322 122
Q ss_pred eeeeccccccccccccC----cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 190 NVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 190 ~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
....++..|+|||++.. ...++.++|+||+|+++|+|++|..||.. .+..+....+......
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~-~~~~~~~~~~~~~~~~------------- 226 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE-LNPMRVLLKIAKSEPP------------- 226 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccc-cCHHHHHHHHhhcCCC-------------
Confidence 33467889999999742 24577899999999999999999999842 2222222222111000
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
....+..++.++.+||.+||+.||++|||++++++||||+...
T Consensus 227 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 227 ---------------------TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred ---------------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 0001122678999999999999999999999999999998654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=290.06 Aligned_cols=246 Identities=24% Similarity=0.423 Sum_probs=196.3
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc---------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
+|++.+.||+|+||.||+|.+ .+++.+++|.++... ...+.+|+++++.+ +|+||+++++++.+ ...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~ 76 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQYLGTCLD--DNT 76 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-CCCCEeeEeeEeec--CCe
Confidence 588999999999999999986 478889999876321 24577899999999 89999999999955 467
Q ss_pred cEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 110 PSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
.++++||+.+++|..++. .+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 77 ISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWV 155 (265)
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCC-CeEEeccchhhHhhhhc
Confidence 899999999999988863 48899999999999999999999999999999999999987 89999999988654211
Q ss_pred -------CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhh
Q 019642 187 -------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259 (338)
Q Consensus 187 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
.......++..|+|||.+.+ ..++.++|+||||+++|++++|..||..... ......+....+. .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-~~~~~~~~~~~~~--~---- 227 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDR-LAAMFYIGAHRGL--M---- 227 (265)
T ss_pred cccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCCh-HHHHHHhhhccCC--C----
Confidence 11123457788999999876 5688999999999999999999999943221 1111111100000 0
Q ss_pred hccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
...+..++.++.++|++||+.+|++|||+.++++||||
T Consensus 228 ----------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 228 ----------------------------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred ----------------------------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00112268899999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=300.54 Aligned_cols=280 Identities=28% Similarity=0.497 Sum_probs=209.5
Q ss_pred CCcEEE-EEeeeecCceeEEEEEEcCCCceEEEEEecccch-----------------HHHHHHHHHHHHhcCCCCeeEe
Q 019642 37 QDDYEV-VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-----------------KKIKREIKILQNLCGGPNVVKL 98 (338)
Q Consensus 37 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----------------~~~~~E~~~l~~l~~h~~iv~~ 98 (338)
.++|.. .+.||+|+||+||+|.+..+++.|++|.++.... ..+.+|+.+++.+ +||||+++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~ 85 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-KHENIMGL 85 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-CCcceeee
Confidence 467764 5779999999999999999999999998864321 1467899999999 99999999
Q ss_pred eeeeeccCCCccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEE
Q 019642 99 LDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI 175 (338)
Q Consensus 99 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~ 175 (338)
++++.. ....+++|||+.+ ++...+ ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+
T Consensus 86 ~~~~~~--~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~-~~~kl~ 161 (335)
T PTZ00024 86 VDVYVE--GDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSK-GICKIA 161 (335)
T ss_pred eEEEec--CCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCC-CCEEEC
Confidence 999854 4678999999985 555544 248999999999999999999999999999999999999988 899999
Q ss_pred eccccccccCC---------------CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCH
Q 019642 176 DWGLAEFYHPG---------------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH 240 (338)
Q Consensus 176 dfg~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~ 240 (338)
|||.+...... .......++..|+|||.+.+...++.++|+||||+++|+|++|..||. ..+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~-~~~~~ 240 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP-GENEI 240 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCHH
Confidence 99988654311 111223457789999998775567899999999999999999998873 44445
Q ss_pred HHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHh
Q 019642 241 DQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 320 (338)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell 320 (338)
+.+..+....+.+....+.............. ...... .......++++.++|.+||+.+|++|||++|+|
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 311 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTP-------RKPKDL--KTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCc-------CCcccH--HHhCcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence 55556666555544333322111000000000 000000 001123578899999999999999999999999
Q ss_pred cCCCcchhhhc
Q 019642 321 AHPYFAQVRAA 331 (338)
Q Consensus 321 ~hp~~~~~~~~ 331 (338)
.||||++.+..
T Consensus 312 ~~~~~~~~~~~ 322 (335)
T PTZ00024 312 KHEYFKSDPLP 322 (335)
T ss_pred cCcccCCCCCC
Confidence 99999987544
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=298.47 Aligned_cols=282 Identities=33% Similarity=0.600 Sum_probs=208.4
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC----C
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS----K 108 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~----~ 108 (338)
++|.+...||+|++|.||+|.+..+++.+++|.++.. ....+.+|+.+++.+ .||||+++++++..... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-QHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhc-CCCCccchhheecccccCCCCc
Confidence 6899999999999999999999999999999988632 234577899999999 99999999998854321 3
Q ss_pred ccEEEEeeecCCccccccC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 109 TPSLIFEYVNSTDFKVLYP-TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
..++++||+.. ++..... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~-~~~kL~dfg~~~~~~~-- 169 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNED-CELKILDFGLARHADA-- 169 (342)
T ss_pred eEEEEeccccc-CHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEeeCCCCcCCCC--
Confidence 46899999875 4554443 68999999999999999999999999999999999999988 8999999999865432
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......++..|+|||.+.+...++.++|+||||+++|+|++|+.||. +.+....+..+....+.+...... .......
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 247 (342)
T cd07879 170 EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK-GKDYLDQLTQILKVTGVPGPEFVQ-KLEDKAA 247 (342)
T ss_pred CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCCCHHHHH-Hhcccch
Confidence 22234567889999998764568899999999999999999999984 333344455554444433221111 0000000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
................ ...+.++.++.+||.+||+.||++||++.++++||||.+....
T Consensus 248 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 248 KSYIKSLPKYPRKDFS-----TLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred HHHHhhcCCcccchHH-----HHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 0000000000000000 0112367889999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=284.99 Aligned_cols=257 Identities=23% Similarity=0.417 Sum_probs=203.8
Q ss_pred EeeeecCceeEEEEEEcCCCceEEEEEecc---cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeecCC
Q 019642 44 RKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST 120 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~ 120 (338)
+.||+|+++.|--+....+++.||||++.+ +.+.++.+|++++...+.|+||++++++|.+ +...|+|||.+.||
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd--d~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED--DTRFYLVFEKMRGG 161 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc--cceEEEEEecccCc
Confidence 578999999999999999999999999875 4678899999999999999999999999954 56889999999999
Q ss_pred ccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC--CCceEEEeccccccccCC--------C
Q 019642 121 DFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG--------K 187 (338)
Q Consensus 121 ~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~--~~~~~l~dfg~~~~~~~~--------~ 187 (338)
.+-..+. .+++.++..+.++|+.||.+||++||+|+|+||+|||-... ..-+|||||.+....... .
T Consensus 162 plLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP 241 (463)
T KOG0607|consen 162 PLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTP 241 (463)
T ss_pred hHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCc
Confidence 8877764 39999999999999999999999999999999999998543 245899999987544221 1
Q ss_pred cceeeecccccccccccc----CcCCCCCcchhHHHHHHHHHHHhcCCCCcC----------CCCCHHHHHHHHHHhCCc
Q 019642 188 EYNVRVASRYFKGPELLV----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFY----------GHDNHDQLVKIAKVLGTD 253 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~----~~~~~~~~~DvwslG~~l~~lltg~~pf~~----------~~~~~~~~~~~~~~~~~~ 253 (338)
.....+|+..|||||+.. ....|+.+.|.||||+++|-|+.|+.||.- +......-+.+.+.+..
T Consensus 242 ~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQE- 320 (463)
T KOG0607|consen 242 ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQE- 320 (463)
T ss_pred cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhc-
Confidence 223356788899999973 224688999999999999999999999932 11112222222222221
Q ss_pred hhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 254 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
+.++ +.......+|.+..++|+.+|..|+.+|.++.++++|||++.....
T Consensus 321 --------------------------GkYe--FPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 321 --------------------------GKYE--FPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred --------------------------cCCc--CChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 1111 1112223389999999999999999999999999999999987554
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=288.80 Aligned_cols=251 Identities=26% Similarity=0.459 Sum_probs=206.7
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
++|++.+.||+|++|.||++.+..+++.+++|.+.... ...+..|+..+.++ +|+|++++++.+.. ....+++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv 77 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESPYVVKCYGAFYK--EGEISIV 77 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEcc--CCeEEEE
Confidence 47999999999999999999999999999999987543 46788999999999 89999999999855 4678999
Q ss_pred EeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEecCCCCceEEEeccccccccCCCcc
Q 019642 114 FEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189 (338)
Q Consensus 114 ~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~ 189 (338)
|||+.+++|..++. .+++..++.++.|++.|+.+||+ .|++|+||+|+||+++.+ +.++|+|||.+.........
T Consensus 78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~-~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSK-GEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCC-CCEEEccCccceecccCCCc
Confidence 99999999988874 48999999999999999999999 999999999999999998 89999999998765433322
Q ss_pred -eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCC-CH-HHHHHHHHHhCCchhhhhhhcccccc
Q 019642 190 -NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD-NH-DQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 190 -~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..... .. +....+. .....
T Consensus 157 ~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----~~~~~---------- 221 (264)
T cd06623 157 CNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----DGPPP---------- 221 (264)
T ss_pred ccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----cCCCC----------
Confidence 24467888999999877 5788999999999999999999999844331 11 1111111 00000
Q ss_pred CcchhhhhccccCCCCcccccccCCCC-CChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHL-VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
..+.. ++..+.++|.+||..+|++|||+.++++|||+++..
T Consensus 222 ----------------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~ 263 (264)
T cd06623 222 ----------------------SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD 263 (264)
T ss_pred ----------------------CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence 00111 578899999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=301.36 Aligned_cols=287 Identities=31% Similarity=0.588 Sum_probs=214.0
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC--
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS-- 107 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~-- 107 (338)
...++|++.+.||+|++|.||+|.+..+++.|++|.+... ....+.+|+.+++.+ .|||++++++.+.....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhcccccc
Confidence 3467899999999999999999999999999999997632 234566799999999 99999999998754322
Q ss_pred --CccEEEEeeecCCcccccc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 108 --KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 108 --~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
...++|+||++ ++|..++ ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+...
T Consensus 91 ~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~-~~~kL~dfg~~~~~ 168 (343)
T cd07851 91 DFQDVYLVTHLMG-ADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARHT 168 (343)
T ss_pred ccccEEEEEecCC-CCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEccccccccc
Confidence 34789999985 4666655 358999999999999999999999999999999999999988 88999999998755
Q ss_pred cCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccc
Q 019642 184 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263 (338)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
... .....++..|+|||...+...++.++|+||||+++|++++|+.||. ..+....+..+.+..+.+....+ ....
T Consensus 169 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~-~~~~~~~~~~i~~~~~~~~~~~~-~~~~ 244 (343)
T cd07851 169 DDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP-GSDHIDQLKRIMNLVGTPDEELL-QKIS 244 (343)
T ss_pred ccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHhcCCCCHHHH-hhcc
Confidence 322 2234567889999998664568899999999999999999999984 34445555555555544332211 1111
Q ss_pred cccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhccc
Q 019642 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 333 (338)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 333 (338)
. .................+. .....+++++.+||.+||+.||++|||+.+|++||||.+....++
T Consensus 245 ~---~~~~~~~~~~~~~~~~~~~--~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~ 309 (343)
T cd07851 245 S---ESARNYIQSLPQMPKKDFK--EVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPED 309 (343)
T ss_pred c---hhHHHHHHhccccCCCCHH--HHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcc
Confidence 0 0011111110000000000 011225889999999999999999999999999999998766544
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=300.60 Aligned_cols=286 Identities=33% Similarity=0.612 Sum_probs=213.4
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~-----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
.++|++.+.||+|+||.||+|.+..+++.+++|.+.. .....+..|+.+++++.+||||+++++++...+....+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 4789999999999999999999998999999998743 22345667999999997899999999998665556789
Q ss_pred EEEeeecCCccccccC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC--
Q 019642 112 LIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-- 187 (338)
Q Consensus 112 lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-- 187 (338)
+||||+.+ +|..++. .+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 86 lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~-~~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 86 LVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSD-CRVKLADFGLARSLSELEEN 163 (337)
T ss_pred EEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEEeeccchhcccccccc
Confidence 99999986 6655543 47888889999999999999999999999999999999988 899999999886553221
Q ss_pred ----cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccc
Q 019642 188 ----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263 (338)
Q Consensus 188 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
......++..|+|||.+.+....+.++|+||||+++|+|++|+.||. .....+....+....+......+.. ..
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 241 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFP-GTSTLNQLEKIIEVIGPPSAEDIES-IK 241 (337)
T ss_pred ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCCHHHHHH-HH
Confidence 12224578889999998765678899999999999999999999983 4444555555555544332221110 00
Q ss_pred cccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
... ............... .... ...++.++.++|.+||+.||++|||+.++++||||+....+
T Consensus 242 ~~~---~~~~~~~~~~~~~~~-~~~~-~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~ 304 (337)
T cd07852 242 SPF---AATMLDSLPSRPRKP-LDEL-LPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP 304 (337)
T ss_pred hhh---HHHhhhhcccccccc-hhhh-ccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence 000 000111000000000 1111 11268899999999999999999999999999999887544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=289.68 Aligned_cols=248 Identities=27% Similarity=0.417 Sum_probs=193.3
Q ss_pred CcEEEEEee--eecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEe
Q 019642 38 DDYEVVRKV--GRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 115 (338)
Q Consensus 38 ~~y~~~~~l--g~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e 115 (338)
++|++.+.+ |+|+||.||++.+..++..+++|.+........ |+.....+.+|||++++++.+... ...++|||
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--e~~~~~~~~~h~~iv~~~~~~~~~--~~~~iv~e 89 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--EPMVHQLMKDNPNFIKLYYSVTTL--KGHVLIMD 89 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--hHHHHHHhhcCCCEEEEEEEEecC--CeeEEEEE
Confidence 456666665 999999999999999999999999875432222 343444344799999999999654 57899999
Q ss_pred eecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcceee
Q 019642 116 YVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 192 (338)
Q Consensus 116 ~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~~~ 192 (338)
|+.+++|..++. .+++..++.++.|++.||.+||+.|++|+||+|+||+++.+.+.++|+|||.+...... ...
T Consensus 90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---~~~ 166 (267)
T PHA03390 90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---SCY 166 (267)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---ccC
Confidence 999999987763 48999999999999999999999999999999999999988448999999988654322 223
Q ss_pred eccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhh
Q 019642 193 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA 272 (338)
Q Consensus 193 ~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (338)
.++..|+|||++.+ ..++.++|+||+|+++|+|++|..||............+...... .
T Consensus 167 ~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~------------------ 226 (267)
T PHA03390 167 DGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK-K------------------ 226 (267)
T ss_pred CCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc-c------------------
Confidence 57889999999877 568899999999999999999999995332221111211111100 0
Q ss_pred hhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCC-HHHHhcCCCcch
Q 019642 273 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-AREAMAHPYFAQ 327 (338)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt-~~ell~hp~~~~ 327 (338)
......+++.+.+||.+||+.+|.+||+ ++++|+||||++
T Consensus 227 ---------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 227 ---------------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred ---------------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 0001126899999999999999999996 699999999974
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=291.24 Aligned_cols=247 Identities=25% Similarity=0.420 Sum_probs=192.2
Q ss_pred eeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHHHHHHh--cCCCCeeEeeeeeeccCCCccEEEEee
Q 019642 45 KVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNL--CGGPNVVKLLDIVRDQHSKTPSLIFEY 116 (338)
Q Consensus 45 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~~l~~l--~~h~~iv~~~~~~~~~~~~~~~lv~e~ 116 (338)
.||+|+||.||++.+..+++.+++|.+.... .....+|..+++.+ ..||+++.+++.+.. ....++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEEEEEec
Confidence 4899999999999999999999999875421 12234454444433 268999999999855 4578899999
Q ss_pred ecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcceeee
Q 019642 117 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 193 (338)
Q Consensus 117 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 193 (338)
+.+++|..++ ..+++..+..++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||++....... .....
T Consensus 79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~-~~~~l~dfg~~~~~~~~~-~~~~~ 156 (279)
T cd05633 79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKKK-PHASV 156 (279)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCC-CCEEEccCCcceeccccC-ccCcC
Confidence 9999998765 348999999999999999999999999999999999999988 799999999886543222 23346
Q ss_pred ccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCC-HHHHHHHHHHhCCchhhhhhhccccccCcchhh
Q 019642 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN-HDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA 272 (338)
Q Consensus 194 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (338)
++..|+|||.+.+...++.++|+||+|+++|+|++|..||...... ........ ..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~~-------------------- 213 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LT-------------------- 213 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh---hc--------------------
Confidence 8899999999865456889999999999999999999999543221 11111110 00
Q ss_pred hhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC-----CHHHHhcCCCcchhhhc
Q 019642 273 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAA 331 (338)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~~ 331 (338)
.....+..++.++.++|.+||+.||++|| |+.++++||||+++...
T Consensus 214 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~ 264 (279)
T cd05633 214 -------------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQ 264 (279)
T ss_pred -------------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHh
Confidence 00011223688999999999999999999 69999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=289.50 Aligned_cols=245 Identities=24% Similarity=0.489 Sum_probs=198.4
Q ss_pred eeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeecC
Q 019642 46 VGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS 119 (338)
Q Consensus 46 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 119 (338)
||.|++|.||++.+..+++.+++|.+... ..+.+.+|+.+++.+ +||||+++++.+.+ ....++++||+.+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKD--KKYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEc--CCccEEEEecCCC
Confidence 68999999999999999999999998642 235688899999999 99999999999854 4678999999999
Q ss_pred CccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcceeeeccc
Q 019642 120 TDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR 196 (338)
Q Consensus 120 ~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 196 (338)
++|.+++. .+++..+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+.............+++
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~ 156 (262)
T cd05572 78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSN-GYVKLVDFGFAKKLKSGQKTWTFCGTP 156 (262)
T ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCC-CCEEEeeCCcccccCcccccccccCCc
Confidence 99988763 47899999999999999999999999999999999999988 899999999987665443333346788
Q ss_pred cccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhcc
Q 019642 197 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGR 276 (338)
Q Consensus 197 ~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (338)
.|++||.+.+ ..++.++|+||+|+++|++++|..||.....+..... .......
T Consensus 157 ~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--~~~~~~~----------------------- 210 (262)
T cd05572 157 EYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIY--NDILKGN----------------------- 210 (262)
T ss_pred CccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHH--HHHhccC-----------------------
Confidence 9999999876 5688999999999999999999999954432111111 1111000
Q ss_pred ccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCC-----HHHHhcCCCcchhh
Q 019642 277 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVR 329 (338)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt-----~~ell~hp~~~~~~ 329 (338)
.. ...+...++++.++|.+||+.+|++||+ +.|+++||||++..
T Consensus 211 -~~--------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 211 -GK--------LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred -CC--------CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence 00 0011124788999999999999999999 99999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=308.01 Aligned_cols=260 Identities=24% Similarity=0.442 Sum_probs=217.1
Q ss_pred ceeeeeccCCcE-EEEEeeeecCceeEEEEEEcCCCceEE---EEEec----ccchHHHHHHHHHHHHhcCCCCeeEeee
Q 019642 29 SSYVIFSDQDDY-EVVRKVGRGKYSEVFEGINVNTNERCI---IKILK----PVKKKKIKREIKILQNLCGGPNVVKLLD 100 (338)
Q Consensus 29 ~~~~i~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~a---iK~~~----~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 100 (338)
+..+-....++| +....||+|+|-+||+|.|..+|..|| +|.-+ +...+++..|+.+|+.| +||||+++|+
T Consensus 30 ~~~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-~H~NIirfy~ 108 (632)
T KOG0584|consen 30 SEFVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-KHPNIIRFYD 108 (632)
T ss_pred ccccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-CCCceeeeee
Confidence 444555666777 677899999999999999999998877 33221 22347788999999999 9999999999
Q ss_pred eeeccCCCccEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCeEecCCCCceEEE
Q 019642 101 IVRDQHSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLI 175 (338)
Q Consensus 101 ~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~~~~~~l~ 175 (338)
++.+.....+-+|+|.+..|+|..+.+ +.....++.|++||+.||.|||++. |+|+|||.+||+|+.+.|.|||+
T Consensus 109 SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIG 188 (632)
T KOG0584|consen 109 SWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIG 188 (632)
T ss_pred heecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeec
Confidence 999887778889999999999999874 5899999999999999999999985 99999999999999999999999
Q ss_pred eccccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchh
Q 019642 176 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL 255 (338)
Q Consensus 176 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (338)
|+|+|+........ ...|||.|||||.+.. .|+..+||||||+-+.+|+|+..||-.+.+...+.........+..+
T Consensus 189 DLGLAtl~r~s~ak-svIGTPEFMAPEmYEE--~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl 265 (632)
T KOG0584|consen 189 DLGLATLLRKSHAK-SVIGTPEFMAPEMYEE--NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAAL 265 (632)
T ss_pred chhHHHHhhccccc-eeccCccccChHHHhh--hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHh
Confidence 99999876544332 2689999999999874 79999999999999999999999997666665555544443333222
Q ss_pred hhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 256 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
... -.+++++||.+||.. .++|||+.|+|+||||..-
T Consensus 266 ~kV-----------------------------------~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 266 SKV-----------------------------------KDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred hcc-----------------------------------CCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 211 257899999999999 9999999999999999875
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=287.42 Aligned_cols=245 Identities=20% Similarity=0.444 Sum_probs=199.3
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
+|++.+.||+|+||.+|.+.+..+++.+++|.+... ....+.+|+.+++++ +|||++++++.+.. ....+++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPNIVQYQESFEE--NGNLYIV 77 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhC-CCCCeeeeEeeecC--CCeEEEE
Confidence 589999999999999999999999999999987532 234678899999999 99999999999854 5678999
Q ss_pred EeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 114 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 114 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
+||+.++++...+. .+++..+..++.|++.||.+||++|++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~-~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEEeeccceeecCcchh
Confidence 99999988877652 37888999999999999999999999999999999999987 7899999998875543221
Q ss_pred -ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 189 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 189 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
.....+++.|+|||.+.+ ...+.++|+||||++++++++|..||... +..+....+.. +..
T Consensus 157 ~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-~~~~~~~~~~~--~~~-------------- 218 (256)
T cd08218 157 LARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAG-NMKNLVLKIIR--GSY-------------- 218 (256)
T ss_pred hhhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCC-CHHHHHHHHhc--CCC--------------
Confidence 122357788999999877 67889999999999999999999998432 22222221111 000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
...+..++.++.++|.+||+.+|++||++.++++||||
T Consensus 219 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 219 --------------------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred --------------------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 00112268899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=286.23 Aligned_cols=249 Identities=31% Similarity=0.526 Sum_probs=205.1
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
+|++.+.||+|++|.||+|.+..+++.+++|++.... .+.+.+|+..++++ +|||++++++.+.+......+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHc-CCCCEeeEEEEEecCCCCeEEEE
Confidence 5889999999999999999999899999999987544 56788999999999 89999999999866433678899
Q ss_pred EeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc--
Q 019642 114 FEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-- 188 (338)
Q Consensus 114 ~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~-- 188 (338)
+|++.+++|.+++. .+++..++.++.|++.+|.+||+.|++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD-GVVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC-CCEEEcccccEEecccccccc
Confidence 99999999888763 58999999999999999999999999999999999999987 8999999999876654432
Q ss_pred -ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 189 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 189 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
.....++..|+|||...+ ...+.++|+||||++++++++|..||....+.......+.. ...
T Consensus 159 ~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~------------- 221 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS---SGE------------- 221 (260)
T ss_pred cccCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc---cCC-------------
Confidence 344567889999999877 56899999999999999999999998543322211111100 000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
....+..++..+.++|.+||..||++||++.++++||||
T Consensus 222 -------------------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 222 -------------------PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred -------------------CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 001122257899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=297.66 Aligned_cols=284 Identities=32% Similarity=0.583 Sum_probs=209.3
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC---
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS--- 107 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~--- 107 (338)
..++|++.+.||+|++|.||++.+..+++.||+|.+... ....+.+|+.+++.+ +||||+++++.+.....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCccceeeeecCCccccc
Confidence 367899999999999999999999999999999987532 134577899999999 99999999998854321
Q ss_pred -CccEEEEeeecCCcccccc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 108 -KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 108 -~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
...++|||++ ++++..++ ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+....
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~-~~~kl~dfg~~~~~~ 169 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNED-CELKILDFGLARQTD 169 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeecccccccc
Confidence 2458999998 55666665 358999999999999999999999999999999999999987 789999999987543
Q ss_pred CCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccc
Q 019642 185 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264 (338)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
.. .....+++.|+|||.+.+...++.++|+||||+++|++++|..||.. .+.......+........ ..+......
T Consensus 170 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 245 (343)
T cd07880 170 SE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG-HDHLDQLMEIMKVTGTPS-KEFVQKLQS 245 (343)
T ss_pred cC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHhcCCCC-HHHHHhhcc
Confidence 22 22345678899999987645688999999999999999999999843 333334444333322221 111111110
Q ss_pred ccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
.................. ......++.++.++|.+||+.||++|||+.++++||||+.....
T Consensus 246 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 246 EDAKNYVKKLPRFRKKDF-----RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307 (343)
T ss_pred hhHHHHHHhccccCcchH-----HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence 000000000000000000 01122368889999999999999999999999999999987554
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=288.08 Aligned_cols=251 Identities=22% Similarity=0.386 Sum_probs=197.1
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
.++......||+|+||.||+|.+..++..+++|.+.... .+.+.+|+.+++.+ +|+||+++++.+.. ....+++
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv 83 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL-KHRNIVQYLGSDSE--NGFFKIF 83 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhc-CCCCeeeeeeeecc--CCEEEEE
Confidence 445555678999999999999999999999999886543 34678999999999 99999999999855 4678999
Q ss_pred EeeecCCccccccC----CC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 114 FEYVNSTDFKVLYP----TL--TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 114 ~e~~~~~~l~~~~~----~~--~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
+||+.+++|..++. .+ ++..+..++.|++.||.+||+.|++|+||||+||+++...+.++|+|||.+.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 99999999988763 24 7788889999999999999999999999999999998755789999999886543222
Q ss_pred -cceeeeccccccccccccCc-CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 188 -EYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 188 -~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
......++..|+|||.+.+. ..++.++|+||+|+++|++++|..||............. .....
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~-~~~~~------------- 229 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV-GMFKI------------- 229 (268)
T ss_pred CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh-hhhcc-------------
Confidence 22234578899999998552 247889999999999999999999984322211111100 00000
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
....+..+++++.+++++||+.+|++|||+.++++||||
T Consensus 230 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 230 ---------------------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred ---------------------CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 000112267899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=316.04 Aligned_cols=282 Identities=21% Similarity=0.263 Sum_probs=193.8
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCC-ceEEEE------------------Eecc--cchHHHHHHHHHHHHhcCCCCee
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTN-ERCIIK------------------ILKP--VKKKKIKREIKILQNLCGGPNVV 96 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~aiK------------------~~~~--~~~~~~~~E~~~l~~l~~h~~iv 96 (338)
++|++++.||+|+||+||++...... ...+.| .... .....+.+|+.+++++ +||||+
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l-~HpnIv 226 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-NHENIL 226 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC-CCCCcC
Confidence 68999999999999999998754322 112222 1111 1234577899999999 999999
Q ss_pred EeeeeeeccCCCccEEEEeeecCCccccccC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCC
Q 019642 97 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL 169 (338)
Q Consensus 97 ~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 169 (338)
++++++.. ....+++++++.+..+..... ......++.++.|++.||.|||++||+|+||||+|||++.+
T Consensus 227 ~l~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~- 303 (501)
T PHA03210 227 KIEEILRS--EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD- 303 (501)
T ss_pred cEeEEEEE--CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-
Confidence 99999965 456789999987665544322 23456788899999999999999999999999999999988
Q ss_pred CceEEEeccccccccCCCc--ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCC--CCHHHHHH
Q 019642 170 RKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH--DNHDQLVK 245 (338)
Q Consensus 170 ~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~--~~~~~~~~ 245 (338)
+.+||+|||++........ .....|+..|+|||++.+ ..++.++|||||||++|+|++|..+++... .....+..
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 8999999999976543322 223468999999999987 678999999999999999999886554322 22334444
Q ss_pred HHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 246 IAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
+...++.... .+... .....+.+....................++.++.++|.+||+.||++|||+.|+|+||||
T Consensus 383 ~~~~~~~~~~-~~p~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f 457 (501)
T PHA03210 383 IIDSLSVCDE-EFPDP----PCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF 457 (501)
T ss_pred HHHhcccChh-hcCCc----HHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence 4443332111 01000 000000000000000000000111112257788999999999999999999999999999
Q ss_pred chhh
Q 019642 326 AQVR 329 (338)
Q Consensus 326 ~~~~ 329 (338)
.+..
T Consensus 458 ~~~~ 461 (501)
T PHA03210 458 SAEE 461 (501)
T ss_pred hcCC
Confidence 8754
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=296.20 Aligned_cols=286 Identities=29% Similarity=0.539 Sum_probs=210.8
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccC----
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH---- 106 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~---- 106 (338)
..++|++.+.||+|+||.||++.+..+++.|++|.++... ...+.+|+.+++++ +||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHc-CCCcccceeeeeeecccccc
Confidence 3589999999999999999999999999999999986421 34567899999999 9999999999885421
Q ss_pred CCccEEEEeeecCCcccccc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 107 SKTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
....+++++++ ++++..++ ..+++..++.++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||++....
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kl~dfg~~~~~~ 171 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-CELKILDFGLARHTD 171 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCC-CCEEEeccccccccc
Confidence 23467788776 55666554 348999999999999999999999999999999999999988 789999999986543
Q ss_pred CCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccc
Q 019642 185 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264 (338)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
. ......++..|+|||.+.+...++.++|+||||+++|+|++|..||. ..+....+..+.+..+......... ...
T Consensus 172 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 247 (345)
T cd07877 172 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP-GTDHIDQLKLILRLVGTPGAELLKK-ISS 247 (345)
T ss_pred c--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHhCCCCHHHHhh-ccc
Confidence 2 22334678889999998765568899999999999999999999983 3444445555555444433222111 100
Q ss_pred ccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhccc
Q 019642 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 333 (338)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 333 (338)
......-............. .....++++.++|.+||+.||.+|||+.++++||||++...+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~ 311 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFAN-----VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 311 (345)
T ss_pred HhHHHHHHHhcccCCcchhh-----hcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCc
Confidence 00000000000000000000 01125788999999999999999999999999999998765443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=292.17 Aligned_cols=279 Identities=27% Similarity=0.557 Sum_probs=208.6
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccC-----
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----- 106 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~----- 106 (338)
.++|++.+.||+|++|.||+|.+..+++.|++|.++.. ....+.+|+.+++.+ +|||++++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-NHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhC-CCCCeeeeeheecCcchhhhc
Confidence 57899999999999999999999999999999998632 234567899999999 9999999999886543
Q ss_pred ---CCccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccc
Q 019642 107 ---SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
Q Consensus 107 ---~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~ 180 (338)
....++++||++++.+.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+
T Consensus 85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~-~~~kl~dfg~~ 163 (302)
T cd07864 85 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNK-GQIKLADFGLA 163 (302)
T ss_pred cccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CcEEeCccccc
Confidence 23788999999985444333 258999999999999999999999999999999999999988 89999999998
Q ss_pred ccccCCC--cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhh
Q 019642 181 EFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 258 (338)
Q Consensus 181 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
....... ......++..|+|||.+.+....+.++|+||||+++++|++|+.||. ..+..+.+..+.+..+.+....+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 242 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQ-ANQELAQLELISRLCGSPCPAVW 242 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCChhhc
Confidence 7654322 12223457789999988664567899999999999999999998884 34455555555555554433322
Q ss_pred hhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
............+. ... ... ........++..+.+++.+||+.||++|||+.++++||||
T Consensus 243 ~~~~~~~~~~~~~~-----~~~-~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 243 PDVIKLPYFNTMKP-----KKQ-YRR-RLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccc-----ccc-ccc-chhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 11110000000000 000 000 0001112368899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=286.90 Aligned_cols=249 Identities=29% Similarity=0.514 Sum_probs=200.6
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
+|++.+.||+|++|.||++.+..+++.+++|.++.. ..+.+.+|+.+++.+ +|+||+++++.+.. ....+++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~lv 77 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKYYGVEVH--REKVYIF 77 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhC-CCCChhheeeeEec--CCEEEEE
Confidence 689999999999999999999989999999998643 245678999999999 99999999998744 4678899
Q ss_pred EeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcc-
Q 019642 114 FEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY- 189 (338)
Q Consensus 114 ~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~- 189 (338)
+||+.+++|.+++. .+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+.........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~-~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred EecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEcccccccccCCCCCcc
Confidence 99999999988873 37888999999999999999999999999999999999987 89999999998765433221
Q ss_pred ----eeeeccccccccccccCcC--CCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccc
Q 019642 190 ----NVRVASRYFKGPELLVDLQ--DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263 (338)
Q Consensus 190 ----~~~~~~~~y~aPE~~~~~~--~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
....++..|+|||.+.+.. ..+.++|+||||++++++++|..||....+.......+.. +... .
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~--~------ 226 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA--GHKP--P------ 226 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc--CCCC--C------
Confidence 1235678899999987632 3789999999999999999999999543322222211111 0000 0
Q ss_pred cccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
......++..+.++|.+||+.+|++|||+.++++|||+
T Consensus 227 ------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 227 ------------------------IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ------------------------CCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00011157889999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=313.29 Aligned_cols=251 Identities=19% Similarity=0.302 Sum_probs=198.2
Q ss_pred eeeeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEeeee-eec--
Q 019642 31 YVIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDI-VRD-- 104 (338)
Q Consensus 31 ~~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~E~~~l~~l~~h~~iv~~~~~-~~~-- 104 (338)
.++-....+++|.+.|++|||+.||+|.+...+..||+|.+-.. ..+.+.+|+++|++|..|+|||.+++. ...
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence 44455668999999999999999999999988899999986433 345678999999999889999999993 221
Q ss_pred -cC-CCccEEEEeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCeEecCCCCceEEE
Q 019642 105 -QH-SKTPSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLI 175 (338)
Q Consensus 105 -~~-~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~~~~~~l~ 175 (338)
.+ .....|+||||.|+.|-+++. +|++.++.+|+.|+++|+.+||..+ |+|||||-+|||++.+ ++.|||
T Consensus 110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~-g~~KLC 188 (738)
T KOG1989|consen 110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSAD-GNYKLC 188 (738)
T ss_pred CCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCC-CCEEeC
Confidence 12 245778999999888877763 4999999999999999999999997 9999999999999999 899999
Q ss_pred eccccccccCCCc----------ceeeecccccccccccc--CcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHH
Q 019642 176 DWGLAEFYHPGKE----------YNVRVASRYFKGPELLV--DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 243 (338)
Q Consensus 176 dfg~~~~~~~~~~----------~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~ 243 (338)
|||.++-...... .-....|+.|+|||.+. ...+.+.|+|||+|||+||.++....||..... -.++
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-laIl 267 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-LAIL 267 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-eeEE
Confidence 9998854322111 11235689999999973 236789999999999999999999999942211 0000
Q ss_pred HHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 244 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
. . -+.....+.+++.+.+||+.||+.||.+||++.|++.+
T Consensus 268 n-------------------------------g--------~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 268 N-------------------------------G--------NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred e-------------------------------c--------cccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 0 0 01111113378999999999999999999999999865
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=305.56 Aligned_cols=250 Identities=28% Similarity=0.402 Sum_probs=207.2
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEe
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 115 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e 115 (338)
..++|.+...+|.|+|+.|-.+.+..+++..++|++... .....+|+.++....+||||++.++.+. +..+.++|||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~--~~~~~~~v~e 396 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYE--DGKEIYLVME 396 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc-ccccccccchhhhhcCCCcceeecceec--CCceeeeeeh
Confidence 468999999999999999999999999999999999865 3344578888888889999999999994 4678999999
Q ss_pred eecCCccccccCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcceeee
Q 019642 116 YVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 193 (338)
Q Consensus 116 ~~~~~~l~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 193 (338)
.++|+.+.+.+.. .....+..|+.+|+.|+.|||++|++|||+||+|||++.+.++++|+|||.+...... ....+
T Consensus 397 ~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~tp~ 474 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CDTPA 474 (612)
T ss_pred hccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--hcccc
Confidence 9999977766643 2225667799999999999999999999999999999644489999999998765543 34456
Q ss_pred ccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhh
Q 019642 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL 273 (338)
Q Consensus 194 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (338)
-|..|.|||+... ..+++++|+||||++||+|++|+.||....+. .++...++.+...
T Consensus 475 ~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~ei~~~i~~~~~s----------------- 532 (612)
T KOG0603|consen 475 LTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----IEIHTRIQMPKFS----------------- 532 (612)
T ss_pred hhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCch----HHHHHhhcCCccc-----------------
Confidence 7888999999985 78999999999999999999999999655544 3333333333222
Q ss_pred hccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 274 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
..+|+++++||++||++||.+||++.+++.||||.+.+.
T Consensus 533 ------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~~t 571 (612)
T KOG0603|consen 533 ------------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLSHPT 571 (612)
T ss_pred ------------------cccCHHHHHHHHHhccCChhhCcChhhhccCcchhcCCC
Confidence 128999999999999999999999999999999944433
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=290.63 Aligned_cols=272 Identities=33% Similarity=0.641 Sum_probs=203.9
Q ss_pred EEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 40 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
|++.+.||.|++|.||+|.+..+++.|++|.+... ....+.+|+++++.+ +|||++++++++.+ ....+++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~iv~~~~~~~~--~~~~~iv~ 77 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL-NHPNIVRLLDVVHS--ENKLYLVF 77 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhc-CCCCccCHhheecc--CCeEEEEE
Confidence 67889999999999999999999999999988632 234577899999999 89999999999854 46789999
Q ss_pred eeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-c
Q 019642 115 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E 188 (338)
Q Consensus 115 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-~ 188 (338)
||+++ ++..++. .+++..+..++.|++.||.+||+.+++|+||+|+||+++.+ +.++|+|||.+....... .
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 78 EFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDRE-GALKLADFGLARAFGVPVRT 155 (283)
T ss_pred eccCc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC-CcEEEeecccccccCCCccc
Confidence 99964 5655542 47899999999999999999999999999999999999987 899999999986543221 1
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
.....++..|+|||.+.+...++.++|+||||+++|+|++|..||.. .+.......+.+..+.+....+...... +
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 231 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPG-DSEIDQLFRIFRTLGTPDEDVWPGVTSL---P 231 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHhCCCChHHhhhhhhc---h
Confidence 22335578899999887645678999999999999999999999843 3334444444444444332222111000 0
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
............ ........++.++.++|.+||+.||++|||+.|+++||||
T Consensus 232 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 232 DYKPTFPKWARQ-----DLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhhhccccccc-----chhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 000000000000 0011123478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=286.92 Aligned_cols=247 Identities=27% Similarity=0.454 Sum_probs=199.8
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
+|+..+.||+|++|.||+|.+..+++.+++|.+... ..+.+.+|+.+++.+ +|+|++++++.+.+ ....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~ 77 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTERE--EDNL 77 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEec--CCeE
Confidence 477889999999999999999889999999987532 234578899999999 99999999998854 4678
Q ss_pred EEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 111 SLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
++++||+.+++|..++. .+++..+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~-~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 78 YIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEccCccceeccccc
Confidence 89999999999987763 37899999999999999999999999999999999999987 799999999887654333
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......++..|++||.+.....++.++|+||||+++|++++|..||.... ..............
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~--------------- 220 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-GVAAVFKIGRSKEL--------------- 220 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc-HHHHHHHHHhcccC---------------
Confidence 33445678889999998763348899999999999999999999984332 11111111100000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
...+..+++.+.+++++||+.+|++|||+.++++|||+
T Consensus 221 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 221 --------------------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred --------------------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 00112267899999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=303.86 Aligned_cols=250 Identities=25% Similarity=0.470 Sum_probs=213.8
Q ss_pred EEeeeecCceeEEEEEEcCCCceEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeee
Q 019642 43 VRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 117 (338)
Q Consensus 43 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~-----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~ 117 (338)
.+.||+|-||+||-|.+.++|+.||||++.+ ...+++++|+.+++++ .||.||.+--+|+ ..+.+++|||.+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l-~HPGiV~le~M~E--T~ervFVVMEKl 645 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNL-HHPGIVNLECMFE--TPERVFVVMEKL 645 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhc-CCCCeeEEEEeec--CCceEEEEehhh
Confidence 5789999999999999999999999999863 3467899999999999 9999999999994 456789999999
Q ss_pred cCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecC--CCCceEEEeccccccccCCCccee
Q 019642 118 NSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNV 191 (338)
Q Consensus 118 ~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~--~~~~~~l~dfg~~~~~~~~~~~~~ 191 (338)
.|.-|+-.+ .++++...+.+..||+.||.|||.+||+|+||||+|||+.. +..++||||||+++.+....-...
T Consensus 646 ~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrs 725 (888)
T KOG4236|consen 646 HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRS 725 (888)
T ss_pred cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhh
Confidence 999888776 46999999999999999999999999999999999999954 357999999999998887666667
Q ss_pred eeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchh
Q 019642 192 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD 271 (338)
Q Consensus 192 ~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (338)
-.|||.|.|||++.+ +.+...-|+||.|+++|--++|..||..+.+..++++...=.
T Consensus 726 VVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFM---------------------- 782 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFM---------------------- 782 (888)
T ss_pred hcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCccchhHHhhccccc----------------------
Confidence 799999999999988 789999999999999999999999996555544444322111
Q ss_pred hhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 272 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
....+ ...++.+..+||+.+|++.=.+|-|.+..|.|||+++...+-
T Consensus 783 -----yPp~P---------W~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w~ 829 (888)
T KOG4236|consen 783 -----YPPNP---------WSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWL 829 (888)
T ss_pred -----cCCCc---------hhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchHHH
Confidence 11111 223799999999999999999999999999999999865443
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=309.61 Aligned_cols=247 Identities=22% Similarity=0.388 Sum_probs=205.2
Q ss_pred EeeeecCceeEEEEEEcCCCceEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeecCC
Q 019642 44 RKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST 120 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~ 120 (338)
-.||+|.||+||-|+|..+....|||-+... ..+.+..|+...+.| .|.|||++++.+ ..+++.-|.||.+.||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~L-rHkNIVrYLGs~--senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTL-RHKNIVRYLGSV--SENGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHH-hhHhHHHHhhcc--CCCCeEEEEeecCCCC
Confidence 4699999999999999999999999998643 345688999999999 999999999998 4456788999999999
Q ss_pred ccccccC----CC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-cceeee
Q 019642 121 DFKVLYP----TL--TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRV 193 (338)
Q Consensus 121 ~l~~~~~----~~--~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 193 (338)
+|..++. ++ .+..+..+.+||++||+|||++.|||+|||-+|+|++...|.+||+|||-++....-. -.....
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT 737 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT 737 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence 9998874 34 6777888999999999999999999999999999999988999999999987765433 345578
Q ss_pred ccccccccccccCc-CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhh
Q 019642 194 ASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA 272 (338)
Q Consensus 194 ~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (338)
||..|||||++..+ ..|..++|||||||++.+|.||+.||..-.++.......-.....+
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP------------------- 798 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHP------------------- 798 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCC-------------------
Confidence 99999999999543 4699999999999999999999999965444433322211100011
Q ss_pred hhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 273 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
..+..+|.+.+.||.+|+.+||.+||+|.++|++||++.-
T Consensus 799 ----------------~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 799 ----------------PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred ----------------CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 1222368899999999999999999999999999999876
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=295.63 Aligned_cols=255 Identities=22% Similarity=0.412 Sum_probs=204.6
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
+.|.....||+|+||.||++.+..++..+++|.+... ..+.+.+|+..++.+ +|||++++++.+.. ....+++|
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~--~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDY-HHENVVDMYNSYLV--GDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhC-CCCcHHHHHHheec--CCeEEEEE
Confidence 5666678899999999999999999999999998643 234577899999999 99999999999854 46789999
Q ss_pred eeecCCcccccc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-ccee
Q 019642 115 EYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNV 191 (338)
Q Consensus 115 e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-~~~~ 191 (338)
||+.++++..++ ..+++..+..++.|++.||.+||++|++|+||+|+||+++.+ +.++|+|||++....... ....
T Consensus 99 e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~~~kL~dfg~~~~~~~~~~~~~~ 177 (292)
T cd06658 99 EFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD-GRIKLSDFGFCAQVSKEVPKRKS 177 (292)
T ss_pred eCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC-CCEEEccCcchhhcccccccCce
Confidence 999999998876 358899999999999999999999999999999999999988 799999999886543222 2233
Q ss_pred eeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchh
Q 019642 192 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD 271 (338)
Q Consensus 192 ~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (338)
..++..|+|||.+.+ ..++.++|+||||+++|++++|..||... +.......+........
T Consensus 178 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~----------------- 238 (292)
T cd06658 178 LVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNE-PPLQAMRRIRDNLPPRV----------------- 238 (292)
T ss_pred eecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCcc-----------------
Confidence 567889999999876 57889999999999999999999998532 22222221111100000
Q ss_pred hhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 272 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
.....++..+.+++.+||..||++|||++++++||||.....++
T Consensus 239 -----------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~ 282 (292)
T cd06658 239 -----------------KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS 282 (292)
T ss_pred -----------------ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence 00112678899999999999999999999999999999775443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=284.21 Aligned_cols=245 Identities=24% Similarity=0.457 Sum_probs=200.8
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
+|++.+.||.|+||.||.+.+..+++.+++|.+... ....+.+|+.+++++ +|+|++++++.+.+ ....+++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~~~ 77 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPNIIAYYNHFMD--DNTLLIE 77 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC-CCCCeeEEEeEEec--CCeEEEE
Confidence 589999999999999999999999999999986532 235577899999999 99999999999955 4678999
Q ss_pred EeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-
Q 019642 114 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 187 (338)
Q Consensus 114 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~- 187 (338)
|||+.+++|.+++. .+++..+..++.|++.+|.+||+.|++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~-~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA-GLIKLGDFGISKILGSEYS 156 (256)
T ss_pred EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCC-CCEEECcCcceEEcccccc
Confidence 99999999987763 37889999999999999999999999999999999999988 789999999987653332
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......+++.|.|||...+ ..++.++|+||||+++++|++|..||.. .+..+....+.. +. ..
T Consensus 157 ~~~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~--~~--~~----------- 219 (256)
T cd08221 157 MAETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDA-TNPLNLVVKIVQ--GN--YT----------- 219 (256)
T ss_pred cccccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHc--CC--CC-----------
Confidence 2233567889999999877 5688999999999999999999999832 222222222211 00 00
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
..+..++.++.+++.+||..+|.+||++.++++|||+
T Consensus 220 ---------------------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 220 ---------------------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred ---------------------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 0012268899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=287.90 Aligned_cols=251 Identities=27% Similarity=0.487 Sum_probs=197.1
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-------------hHHHHHHHHHHHHhcCCCCeeEeeeeeecc
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-------------KKKIKREIKILQNLCGGPNVVKLLDIVRDQ 105 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 105 (338)
+|.+.+.||+|++|.||+|.+..+++.+++|.++... .+.+..|+.+++.+ +|||++++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIVQYLGFETT- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcceEEEEecc-
Confidence 5889999999999999999999899999999875210 13467899999999 99999999999854
Q ss_pred CCCccEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccc
Q 019642 106 HSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
Q Consensus 106 ~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~ 182 (338)
....++||||+.+++|...+. .++...+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+..
T Consensus 80 -~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~-~~~~l~d~~~~~~ 157 (272)
T cd06629 80 -EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDAD-GICKISDFGISKK 157 (272)
T ss_pred -CCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCC-CeEEEeecccccc
Confidence 467889999999999987763 48889999999999999999999999999999999999987 8999999998865
Q ss_pred ccCCC---cceeeeccccccccccccCcC-CCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhh
Q 019642 183 YHPGK---EYNVRVASRYFKGPELLVDLQ-DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 258 (338)
Q Consensus 183 ~~~~~---~~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
..... ......++..|+|||.+.... .++.++|+||||++++++++|..||..... ..... +.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~---~~~~~~----- 228 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-IAAMF---KLGNKR----- 228 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-HHHHH---Hhhccc-----
Confidence 43211 122235678899999987633 478999999999999999999999832211 11111 110000
Q ss_pred hhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
.... ........++.++.++|.+||..+|++|||++++|+||||
T Consensus 229 -------------------~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 229 -------------------SAPP----IPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred -------------------cCCc----CCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 0000 0001112368899999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=295.20 Aligned_cols=257 Identities=20% Similarity=0.360 Sum_probs=199.7
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
++|+..+.||+|+||.||++.+..+++.+++|.+... ....+.+|+..+.++..||||+++++++.. ....+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~--~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR--EGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--CCcEEEE
Confidence 5677888999999999999999999999999988643 234577899999999559999999998854 4567899
Q ss_pred EeeecCCc--cccc-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 114 FEYVNSTD--FKVL-----YPTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 114 ~e~~~~~~--l~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
||++.... +... ...+++..+..++.|++.||+|||+. |++|+||||+||+++.+ +.++|+|||++.....
T Consensus 82 ~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRN-GNIKLCDFGISGQLVD 160 (288)
T ss_pred EecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccC-CcEEEeecchhHHhcc
Confidence 99987532 2211 13589999999999999999999985 99999999999999987 7899999999876544
Q ss_pred CCcceeeeccccccccccccCc--CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccc
Q 019642 186 GKEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263 (338)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
........++..|+|||.+.+. ..++.++|+||+|+++|+|++|..||.... .....+.+........
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~~~~~~~~~~~------- 230 (288)
T cd06616 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN---SVFDQLTQVVKGDPPI------- 230 (288)
T ss_pred CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc---hHHHHHhhhcCCCCCc-------
Confidence 3333445678889999998764 368899999999999999999999984332 1112221211110000
Q ss_pred cccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
........++.++.+||.+||+.||++|||++++++||||....
T Consensus 231 ----------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 231 ----------------------LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred ----------------------CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 00001122688999999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=290.57 Aligned_cols=248 Identities=26% Similarity=0.411 Sum_probs=197.8
Q ss_pred eeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeecC
Q 019642 46 VGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS 119 (338)
Q Consensus 46 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 119 (338)
||+|+||+||++.+..+++.+++|.+... ....+..|+++++.+ +|||++++++.+.. ....++||||+.+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAFET--KDDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-CCCCEeeeeeEEec--CCeEEEEEecCCC
Confidence 68999999999999999999999998532 133456799999999 89999999999854 4578999999999
Q ss_pred Ccccccc---C--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcceeeec
Q 019642 120 TDFKVLY---P--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 194 (338)
Q Consensus 120 ~~l~~~~---~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 194 (338)
++|.+++ . .+++..+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+.............+
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDH-GNVRISDLGLAVELKGGKKIKGRAG 156 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEccCcchhhhccCCccccccC
Confidence 9998765 2 48899999999999999999999999999999999999988 7899999998876544333344567
Q ss_pred cccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhh
Q 019642 195 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALV 274 (338)
Q Consensus 195 ~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (338)
+..|+|||.+.+ ..++.++|+||||+++|+|++|..||....... ....+.+....
T Consensus 157 ~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~---------------------- 212 (277)
T cd05577 157 TPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-EKEELKRRTLE---------------------- 212 (277)
T ss_pred CCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-cHHHHHhcccc----------------------
Confidence 788999999877 558899999999999999999999984322211 11111110000
Q ss_pred ccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC-----CHHHHhcCCCcchhhhcc
Q 019642 275 GRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~~~ 332 (338)
.....+..+++.+.++|.+||+.||++|| ++.++++||||.++....
T Consensus 213 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~ 264 (277)
T cd05577 213 -----------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRR 264 (277)
T ss_pred -----------ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhh
Confidence 00011223688999999999999999999 999999999998876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=289.63 Aligned_cols=292 Identities=25% Similarity=0.413 Sum_probs=222.5
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc--cchHHHHHHHHHHHHhcCC-------CCeeEeeeeeec--c
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGG-------PNVVKLLDIVRD--Q 105 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~--~~~~~~~~E~~~l~~l~~h-------~~iv~~~~~~~~--~ 105 (338)
..+|.+.++||-|-|++||++.|..+.+.||+|+.+. +-.+....||.+|+++..+ .+||++++.|.. .
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 4799999999999999999999999999999999985 3456678999999998633 389999999964 5
Q ss_pred CCCccEEEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEec--------------
Q 019642 106 HSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMID-------------- 166 (338)
Q Consensus 106 ~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~NIli~-------------- 166 (338)
++.++|+|+|+++...|.... +.++...++.|++||+.||.|||.. ||+|.||||+|||+.
T Consensus 157 NG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~ 236 (590)
T KOG1290|consen 157 NGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAG 236 (590)
T ss_pred CCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhc
Confidence 677999999999998887665 4599999999999999999999986 999999999999984
Q ss_pred --------------------------------------------------------------------------------
Q 019642 167 -------------------------------------------------------------------------------- 166 (338)
Q Consensus 167 -------------------------------------------------------------------------------- 166 (338)
T Consensus 237 e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v 316 (590)
T KOG1290|consen 237 EATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTV 316 (590)
T ss_pred cccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccch
Confidence
Q ss_pred --------------------CC---------------------------------------------------CCceEEE
Q 019642 167 --------------------HE---------------------------------------------------LRKLRLI 175 (338)
Q Consensus 167 --------------------~~---------------------------------------------------~~~~~l~ 175 (338)
.. .-++||+
T Consensus 317 ~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIa 396 (590)
T KOG1290|consen 317 ERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIA 396 (590)
T ss_pred hhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEe
Confidence 00 0136888
Q ss_pred eccccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCC-----CCHHHHHHHHHHh
Q 019642 176 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH-----DNHDQLVKIAKVL 250 (338)
Q Consensus 176 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~-----~~~~~~~~~~~~~ 250 (338)
|||.++... ........|..|+|||++.+ ..|+..+||||++|++|+|+||...|.+.. .+.+.+..+.+.+
T Consensus 397 DlGNACW~~--khFT~DIQTRQYRapEVllG-sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELL 473 (590)
T KOG1290|consen 397 DLGNACWVH--KHFTEDIQTRQYRAPEVLLG-SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELL 473 (590)
T ss_pred eccchhhhh--hhhchhhhhhhccCcceeec-CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHH
Confidence 888876543 23344578889999999999 789999999999999999999999996543 2456788888888
Q ss_pred CCchhhhhhhccccccCcchhhhhccc-cCCCCccccc----ccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 251 GTDELNAYLNKYHLELDPQLDALVGRH-SRKPWSKFIN----ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
|..+..-...........+-.-.+..+ .-++|.-... +.-+..-..++.+|+.-||+.+|++||||.++|+|||+
T Consensus 474 G~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwL 553 (590)
T KOG1290|consen 474 GKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWL 553 (590)
T ss_pred hhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccc
Confidence 875544433322222111111111111 1223322110 11111123568999999999999999999999999999
Q ss_pred chhhhc
Q 019642 326 AQVRAA 331 (338)
Q Consensus 326 ~~~~~~ 331 (338)
+.+..+
T Consensus 554 n~~~~~ 559 (590)
T KOG1290|consen 554 NPVAGP 559 (590)
T ss_pred cCCCCC
Confidence 987654
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=289.90 Aligned_cols=274 Identities=36% Similarity=0.669 Sum_probs=206.9
Q ss_pred EEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 40 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
|++.+.||+|++|.||++.+..+++.+++|.++... ...+..|+.+++++ +|+|++++++.+.+ ....++++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v~ 77 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPNIIKLLDVFRH--KGDLYLVF 77 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHh-cCCCcchHHHhhcc--CCCEEEEE
Confidence 677899999999999999999999999999886432 34677899999999 89999999999855 46788999
Q ss_pred eeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-cce
Q 019642 115 EYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYN 190 (338)
Q Consensus 115 e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-~~~ 190 (338)
||+.+.....+.. .+++..+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+....... ...
T Consensus 78 e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~df~~~~~~~~~~~~~~ 156 (283)
T cd05118 78 EFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE-GVLKLADFGLARSFGSPVRPYT 156 (283)
T ss_pred eccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCC-CcEEEeeeeeeEecCCCccccc
Confidence 9998744433332 58899999999999999999999999999999999999987 889999999987654433 222
Q ss_pred eeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcch
Q 019642 191 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 270 (338)
Q Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (338)
...++..|+|||.+.+...++.++|+||||+++|++++|+.|| ...+..+....+...++.+....+........ ..
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 233 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLF-PGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR--NY 233 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCchHhcccchhhhh--hh
Confidence 3457788999999877447899999999999999999999887 44455555555555555443322211111000 00
Q ss_pred hhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 271 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
............ ....+.++.++.+||.+||+.||.+||++.++++||||
T Consensus 234 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 234 KFSFPKKAGMPL-----PKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhccccccCH-----HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 000000000000 11112368899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=290.76 Aligned_cols=257 Identities=23% Similarity=0.382 Sum_probs=211.2
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc-cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
..+-|.++++||+|+||.||++.++.+|+.+|||.+.. .+.+++..|+.+++++ .+|++|++|+.+.- ...+++||
T Consensus 31 PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC-~S~yVVKYYGSYFK--~sDLWIVM 107 (502)
T KOG0574|consen 31 PEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQC-KSKYVVKYYGSYFK--HSDLWIVM 107 (502)
T ss_pred hHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHc-CCchhhhhhhhhcc--CCceEeeh
Confidence 34567889999999999999999999999999998874 4678899999999998 99999999997743 34689999
Q ss_pred eeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-cc
Q 019642 115 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EY 189 (338)
Q Consensus 115 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-~~ 189 (338)
|||+.|+..+.+ +.+++.++..+++..+.||.|||...=+|+|||+.|||++.+ |..||+|||.+-.+.+.. ..
T Consensus 108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~-G~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTD-GIAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEccc-chhhhhhccccchhhhhHHhh
Confidence 999999988876 469999999999999999999999999999999999999999 899999999986554333 34
Q ss_pred eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcc
Q 019642 190 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 269 (338)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
+...|||-|+|||++.. -.|..++||||||++..+|..|+.||..-+.-..
T Consensus 187 NTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---------------------------- 237 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---------------------------- 237 (502)
T ss_pred CccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccccce----------------------------
Confidence 45689999999999977 6788999999999999999999999832221110
Q ss_pred hhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 270 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
++-. ...+...| ..++..|+++.+||++||-++|++|-||.++++|||.++.+.+.
T Consensus 238 ---IFMI-PT~PPPTF---~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~ 293 (502)
T KOG0574|consen 238 ---IFMI-PTKPPPTF---KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCD 293 (502)
T ss_pred ---eEec-cCCCCCCC---CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCccc
Confidence 0000 00011111 11223689999999999999999999999999999999887553
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=301.22 Aligned_cols=246 Identities=23% Similarity=0.348 Sum_probs=190.6
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCC-----CceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
..++|++.+.||+|+||.||+|.+... +..||+|.++... ...+.+|+.+++.+.+|+||+++++.+..
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~-- 113 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH-- 113 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC--
Confidence 346899999999999999999986443 3579999986432 34577899999998789999999999854
Q ss_pred CCccEEEEeeecCCccccccC-----------------------------------------------------------
Q 019642 107 SKTPSLIFEYVNSTDFKVLYP----------------------------------------------------------- 127 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~~----------------------------------------------------------- 127 (338)
....++||||+.+++|.+++.
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 457899999999998876541
Q ss_pred --------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcce---
Q 019642 128 --------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN--- 190 (338)
Q Consensus 128 --------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~--- 190 (338)
.++...+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++..........
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~-~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDG-RVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCC-CeEEEeeceeeeeccCCcceeecc
Confidence 25777889999999999999999999999999999999987 789999999986543322111
Q ss_pred eeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcc
Q 019642 191 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 269 (338)
Q Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
...++..|+|||++.+ ..++.++||||||+++|+|++ |..||....... ........ +.
T Consensus 273 ~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~-~~----------------- 332 (374)
T cd05106 273 NARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKR-GY----------------- 332 (374)
T ss_pred CCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHc-cc-----------------
Confidence 1123457999999876 678999999999999999997 999984332221 11111110 00
Q ss_pred hhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 270 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
....+..+++++.+++.+||+.||++|||+.++++
T Consensus 333 -----------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 333 -----------------QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred -----------------CccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00011125789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=293.39 Aligned_cols=258 Identities=26% Similarity=0.457 Sum_probs=206.7
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
....++|++.+.||+|+||.||++.+..+++.+++|.+... ..+.+.+|+.+++++ +|||++++++.+.. ....
T Consensus 15 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~--~~~~ 91 (293)
T cd06647 15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN-KHPNIVNYLDSYLV--GDEL 91 (293)
T ss_pred cCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhc-CCCCeeehhheeee--CCcE
Confidence 45568999999999999999999999889999999997532 245678899999999 89999999999855 4578
Q ss_pred EEEEeeecCCccccccC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 111 SLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
++|+||+.+++|..++. .++...+..++.|++.||.+||++|++|+||+|+||+++.+ +.++|+|||++........
T Consensus 92 ~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~-~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 92 WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred EEEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCC-CCEEEccCcceeccccccc
Confidence 89999999999988874 47889999999999999999999999999999999999987 7899999998765433221
Q ss_pred -ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 189 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 189 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
.....+++.|+|||.+.+ ..++.++|+||||+++|++++|..||..... ......+.. .+.
T Consensus 171 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~-~~~~~~~~~-~~~--------------- 232 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-LRALYLIAT-NGT--------------- 232 (293)
T ss_pred ccccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-hhheeehhc-CCC---------------
Confidence 223357788999999876 5788999999999999999999999943211 111110000 000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
. ....+..++..+.++|++||..+|++||++.++++||||+..+..
T Consensus 233 ------------~------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~ 278 (293)
T cd06647 233 ------------P------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPL 278 (293)
T ss_pred ------------C------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCccc
Confidence 0 000112267889999999999999999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=290.49 Aligned_cols=252 Identities=26% Similarity=0.426 Sum_probs=203.4
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
..|+..+.||.|+||.||+|.+..++..+++|.++... ...+.+|+.+++.+ .|||++++++.+.+ ....++|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLK--GTKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE--CCEEEEE
Confidence 56888999999999999999999999999999986432 34577899999999 99999999999855 4578999
Q ss_pred EeeecCCccccccC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-cce
Q 019642 114 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYN 190 (338)
Q Consensus 114 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-~~~ 190 (338)
|||+.+++|.+++. .+++..+..++.|++.||.+||+.+++|+||+|+||+++.+ +.++|+|||++....... ...
T Consensus 81 ~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06640 81 MEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCC-CCEEEcccccceeccCCccccc
Confidence 99999999888764 48889999999999999999999999999999999999987 789999999986554322 222
Q ss_pred eeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcch
Q 019642 191 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 270 (338)
Q Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (338)
...++..|+|||.+.+ ...+.++|+||||+++|+|++|..||.... .......+ .....
T Consensus 160 ~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~-~~~~~~~~----~~~~~--------------- 218 (277)
T cd06640 160 TFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMH-PMRVLFLI----PKNNP--------------- 218 (277)
T ss_pred cccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcC-hHhHhhhh----hcCCC---------------
Confidence 3356778999999876 578999999999999999999999984221 11111100 00000
Q ss_pred hhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 271 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
......++..+.+++.+||+.+|++||++.++++||||......
T Consensus 219 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06640 219 -----------------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKK 262 (277)
T ss_pred -----------------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcchh
Confidence 00011257789999999999999999999999999999887653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=301.59 Aligned_cols=246 Identities=21% Similarity=0.351 Sum_probs=190.3
Q ss_pred CCcEEEEEeeeecCceeEEEEEE-----cCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGIN-----VNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
.++|++.+.||+|+||+||+|.+ ..++..||+|+++.. ..+.+.+|+.+++.+.+||||+++++++.+ .
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~--~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV--G 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc--C
Confidence 45899999999999999999964 345678999998743 234577899999999789999999999955 4
Q ss_pred CccEEEEeeecCCccccccC------------------------------------------------------------
Q 019642 108 KTPSLIFEYVNSTDFKVLYP------------------------------------------------------------ 127 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------ 127 (338)
...++||||+.+++|..++.
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 57889999999998865542
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcc
Q 019642 128 ------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189 (338)
Q Consensus 128 ------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~ 189 (338)
.++...+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++.........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHG-RITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECC-CcEEEecCccceeccCcccc
Confidence 25677888999999999999999999999999999999987 78999999998755432211
Q ss_pred ---eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 190 ---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 190 ---~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...... .........- .
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~~~~~-~------------- 334 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMIKEG-Y------------- 334 (375)
T ss_pred cccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHHHHhC-c-------------
Confidence 11223457999999877 678999999999999999998 78887432222 1111111100 0
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
. ...+...+.++.+++.+||+.||++|||+.++++.
T Consensus 335 -------------~--------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 335 -------------R--------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred -------------c--------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 0 00111257889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=283.05 Aligned_cols=252 Identities=27% Similarity=0.478 Sum_probs=212.1
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
.++|..++.||+|.||.|-+++.+.+++.||+|++++. .......|-+++++. .||.+..+.-.| +....+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-~HPFLt~LKYsF--Qt~drl 243 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-RHPFLTSLKYSF--QTQDRL 243 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-cCcHHHHhhhhh--ccCceE
Confidence 47889999999999999999999999999999998753 233456789999998 999999888888 446789
Q ss_pred EEEEeeecCCccccccCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc-cCC
Q 019642 111 SLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPG 186 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~-~~~ 186 (338)
|+||||.+||.|...+.+ +++...+.+-..|+.||.|||+++|+++|+|.+|.|+|.+ |++||+|||++..- ..+
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkD-GHIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKD-GHIKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccC-CceEeeecccchhccccc
Confidence 999999999998887753 9999999999999999999999999999999999999999 99999999998643 344
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
......+|||.|.|||++.. ..+..++|-|.+|+++|+|+.|+.||+..+ .+.+.++.-.-.
T Consensus 323 ~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~d--h~kLFeLIl~ed--------------- 384 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKD--HEKLFELILMED--------------- 384 (516)
T ss_pred ceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccc--hhHHHHHHHhhh---------------
Confidence 55666899999999999977 789999999999999999999999996432 222222211100
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC-----CHHHHhcCCCcchhhhc
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAA 331 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~~ 331 (338)
..-+..++++.+.|+.++|.+||.+|. .|.|+.+|+||.++.+.
T Consensus 385 ---------------------~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~ 433 (516)
T KOG0690|consen 385 ---------------------LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWE 433 (516)
T ss_pred ---------------------ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHH
Confidence 011223799999999999999999998 68999999999998753
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=292.78 Aligned_cols=283 Identities=31% Similarity=0.558 Sum_probs=210.4
Q ss_pred cEEEEEeeeecCceeEEEEEEcCC--CceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeec--cCCCc
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNT--NERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRD--QHSKT 109 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~ 109 (338)
+|++.+.||+|+||.||++.+..+ +..+|+|.+... ..+.+.+|+.+++++.+||||+++++.... .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999888 889999987632 234567899999999679999999987532 22345
Q ss_pred cEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 110 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
.+++++++++ +|...+ ..+++..++.++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||.+......
T Consensus 81 ~~~~~e~~~~-~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~-~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 81 LYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNAD-CELKICDFGLARGFSEN 158 (332)
T ss_pred EEEEEecccC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCC-CCEEeCcCCCceecccc
Confidence 7788888875 455444 358999999999999999999999999999999999999988 78999999998754322
Q ss_pred Cc-----ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 187 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 187 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
.. .....++..|+|||...+...++.++|+||+|+++|++++|..|| ...+....+..+...++.+....+..-
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF-KGKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCC-CCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 11 122357888999998866457889999999999999999999887 445556677777777776543322111
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
.. +............+...+. .....++..+.+|+.+||+.||++|||+.++++||||+.+..
T Consensus 238 ~~----~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~ 300 (332)
T cd07857 238 GS----PKAQNYIRSLPNIPKKPFE--SIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD 300 (332)
T ss_pred hh----hhHHHHHHhccccCCcchH--hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence 00 0000000000000000000 011225788999999999999999999999999999987753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=306.62 Aligned_cols=250 Identities=26% Similarity=0.411 Sum_probs=204.9
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
..|.-++.||.|+||.||-+++..+.+.||||.+.-. ..+.+..|+..++++ .|||++.+.+.|.. +...+
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-~HPntieYkgCyLr--e~TaW 102 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-RHPNTIEYKGCYLR--EHTAW 102 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-cCCCcccccceeec--cchHH
Confidence 3577789999999999999999999999999997632 245688999999999 99999999998854 34567
Q ss_pred EEEeeecCC---ccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 112 LIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 112 lv~e~~~~~---~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
+|||||-|. .+....+++.+-++..|+.+.+.||.|||+.+.+|+|||+.|||++.. |.|||+|||.+.... +
T Consensus 103 LVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~-g~VKLaDFGSAsi~~---P 178 (948)
T KOG0577|consen 103 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEP-GLVKLADFGSASIMA---P 178 (948)
T ss_pred HHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCC-CeeeeccccchhhcC---c
Confidence 999999875 344455679999999999999999999999999999999999999998 899999999987653 3
Q ss_pred ceeeecccccccccccc--CcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 189 YNVRVASRYFKGPELLV--DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
-+..+|||.|||||++. ..+.|+-++||||||++-.++...++|++. .+.-..+.-+.+.-.+.-
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn-MNAMSALYHIAQNesPtL------------ 245 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQNESPTL------------ 245 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC-chHHHHHHHHHhcCCCCC------------
Confidence 46679999999999984 336799999999999999999999999853 222222333322211100
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
.....|+.+++||..||++-|.+|||.+++|.|+|...-+.
T Consensus 246 -----------------------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp 286 (948)
T KOG0577|consen 246 -----------------------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERP 286 (948)
T ss_pred -----------------------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCC
Confidence 01125889999999999999999999999999999876543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=289.73 Aligned_cols=251 Identities=18% Similarity=0.333 Sum_probs=189.8
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcC----------------CCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCe
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVN----------------TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNV 95 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~i 95 (338)
..++|++.++||+|+||.||+|.+.. ++..||+|.+.... ...+.+|+.++.++ +||||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 81 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRL-KDPNI 81 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhc-CCCCe
Confidence 35789999999999999999997532 34479999987532 34578899999999 99999
Q ss_pred eEeeeeeeccCCCccEEEEeeecCCccccccC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCc
Q 019642 96 VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----------------------TLTDYDIRYYIYELLKALDYCHSQGI 153 (338)
Q Consensus 96 v~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----------------------~~~~~~~~~i~~qi~~~l~~lH~~~i 153 (338)
+++++++.+ ....+++|||+.+++|..++. .++...+..++.|++.||.|||+.|+
T Consensus 82 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 159 (304)
T cd05096 82 IRLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF 159 (304)
T ss_pred eEEEEEEec--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence 999999965 456899999999998876652 25667889999999999999999999
Q ss_pred eeccCCCCCeEecCCCCceEEEeccccccccCCCcc---eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh--
Q 019642 154 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-- 228 (338)
Q Consensus 154 ~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-- 228 (338)
+|+||||+||+++.+ +.++|+|||++......... ....++..|+|||++.+ ..++.++|+||||+++|+|++
T Consensus 160 vH~dlkp~Nill~~~-~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 160 VHRDLATRNCLVGEN-LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred cccCcchhheEEcCC-ccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHcc
Confidence 999999999999988 89999999998765433221 12234678999999876 678999999999999999987
Q ss_pred cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCC
Q 019642 229 RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRY 308 (338)
Q Consensus 229 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~ 308 (338)
+..||... +..+............... .....++.++..+.+++.+||+.
T Consensus 238 ~~~p~~~~-~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~li~~cl~~ 287 (304)
T cd05096 238 KEQPYGEL-TDEQVIENAGEFFRDQGRQ-----------------------------VYLFRPPPCPQGLYELMLQCWSR 287 (304)
T ss_pred CCCCCCcC-CHHHHHHHHHHHhhhcccc-----------------------------ccccCCCCCCHHHHHHHHHHccC
Confidence 45566322 2222222221111000000 00001123678999999999999
Q ss_pred CcCCcCCHHHHhc
Q 019642 309 DHQDRLTAREAMA 321 (338)
Q Consensus 309 dP~~Rpt~~ell~ 321 (338)
||++|||+.+|.+
T Consensus 288 ~p~~RPs~~~i~~ 300 (304)
T cd05096 288 DCRERPSFSDIHA 300 (304)
T ss_pred CchhCcCHHHHHH
Confidence 9999999999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=290.00 Aligned_cols=285 Identities=32% Similarity=0.569 Sum_probs=211.0
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~-----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
...++|++.+.||.|+||.||++.+..+++.+++|.+.. .....+..|+.+++.+ .|||++++++++... ...
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~-~~~ 84 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHENIISLSDIFISP-LED 84 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhc-CCCCeeeEeeeEecC-CCc
Confidence 346889999999999999999999999999999998643 2245677899999999 999999999988543 346
Q ss_pred cEEEEeeecCCccccccC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 110 PSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
.++++||+++ ++...+. .+++..+..++.|+++||.+||+.|++|+||+|+||+++.+ +.++|+|||.+.....
T Consensus 85 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~-~~~~l~dfg~~~~~~~-- 160 (328)
T cd07856 85 IYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINEN-CDLKICDFGLARIQDP-- 160 (328)
T ss_pred EEEEeehhcc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCC-CCEEeCccccccccCC--
Confidence 7899999854 5665553 47888899999999999999999999999999999999987 8999999999865432
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......++..|+|||.+.+...++.++|+||||+++|+|++|..||. ..+.......+.+.++.+..............
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFP-GKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 22234567789999987664578999999999999999999998883 33334444445555554332211110000000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
+.... .......+.. ...+.+++++.++|++||+.+|++|||+++++.||||.......
T Consensus 240 ~~~~~-~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~ 298 (328)
T cd07856 240 RFVQS-LPKREPVPFS-----EKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPT 298 (328)
T ss_pred HHHhh-ccccCCCcHH-----HHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCc
Confidence 00000 0000000000 11123678999999999999999999999999999998765553
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=289.73 Aligned_cols=254 Identities=24% Similarity=0.420 Sum_probs=202.8
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhc--CCCCeeEeeeeeeccCCCccEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLC--GGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~--~h~~iv~~~~~~~~~~~~~~~l 112 (338)
.|++.+.||+|+||.||+|.+..+++.+++|.++.. ....+.+|+.+++++. .|||++++++.+.+ ....++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEEE
Confidence 578899999999999999999999999999987632 2356778999999994 39999999999854 457899
Q ss_pred EEeeecCCccccccC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc-c
Q 019642 113 IFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-Y 189 (338)
Q Consensus 113 v~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~-~ 189 (338)
+|||+.+++|.+++. .+++..+..++.|++.||.+||+.|++|+||+|+||+++.. +.++|+|||.+........ .
T Consensus 80 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 80 IMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNT-GNVKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred EEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCC-CCEEEccCCceeecCCCcccc
Confidence 999999999887763 47889999999999999999999999999999999999987 8999999999876543322 2
Q ss_pred eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcc
Q 019642 190 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 269 (338)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
....++..|+|||.+.+...++.++|+||||+++|+|++|..||..... ..... ......
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~----~~~~~~--------------- 218 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-FRAMM----LIPKSK--------------- 218 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-hhhhh----ccccCC---------------
Confidence 3346788899999987645678999999999999999999999832211 10000 000000
Q ss_pred hhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 270 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
.. ......++.++.+++.+||+.||++||++.++++||||++....
T Consensus 219 ------------~~----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~~ 264 (277)
T cd06917 219 ------------PP----RLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKT 264 (277)
T ss_pred ------------CC----CCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccccC
Confidence 00 00011157889999999999999999999999999999887643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=284.75 Aligned_cols=246 Identities=23% Similarity=0.469 Sum_probs=199.2
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
+|++.+.||+|+||.||++.+..++..+++|.+... ..+.+.+|+.+++.+ +|+|++++++.+.. ....+++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~-~h~~i~~~~~~~~~--~~~~~lv 77 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHPNIVTFFASFQE--NGRLFIV 77 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhC-CCCChhhhhheecc--CCeEEEE
Confidence 589999999999999999999999999999998632 345678999999999 99999999999844 5678999
Q ss_pred EeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 114 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 114 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
+||+.+++|.+++. .+++..+..++.|++.||.+||+.+++|+||+|+||+++.+...++|+|||.+........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999887763 3688999999999999999999999999999999999988745679999998876543322
Q ss_pred -ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 189 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 189 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
.....+++.|+|||.+.+ ..++.++|+||||++++++++|..||... +..+....... . . .
T Consensus 158 ~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~---~-~-----------~- 219 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVLKICQ---G-Y-----------F- 219 (257)
T ss_pred cccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHhc---c-c-----------C-
Confidence 222457888999999876 56889999999999999999999998322 21221111110 0 0 0
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
......++.++.++|.+||..+|++|||+.++++||||
T Consensus 220 --------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 220 --------------------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred --------------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 00012267899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=292.90 Aligned_cols=252 Identities=23% Similarity=0.435 Sum_probs=202.8
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc---cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
..|.....||+|+||.||++.+..+++.|++|.+.. .....+.+|+..++.+ .|||++++++.+.. ....++++
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~--~~~~~iv~ 97 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHQNVVEMYKSYLV--GEELWVLM 97 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhC-CCCchhhhhhheee--CCeEEEEE
Confidence 445566689999999999999998999999999853 2345677899999999 89999999999855 46789999
Q ss_pred eeecCCccccccC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-ccee
Q 019642 115 EYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNV 191 (338)
Q Consensus 115 e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-~~~~ 191 (338)
||+.++++..+.. .+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||++....... ....
T Consensus 98 e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~-~~~kL~dfg~~~~~~~~~~~~~~ 176 (297)
T cd06659 98 EFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKS 176 (297)
T ss_pred ecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccC-CcEEEeechhHhhcccccccccc
Confidence 9999999987764 48899999999999999999999999999999999999988 899999999886543322 2233
Q ss_pred eeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchh
Q 019642 192 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD 271 (338)
Q Consensus 192 ~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (338)
..++..|+|||.+.+ ..++.++|+||||+++++|++|..||... +..+....+.. . ....
T Consensus 177 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~---~-~~~~-------------- 236 (297)
T cd06659 177 LVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSD-SPVQAMKRLRD---S-PPPK-------------- 236 (297)
T ss_pred eecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhc---c-CCCC--------------
Confidence 567889999999877 57899999999999999999999998532 22222211110 0 0000
Q ss_pred hhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 272 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
......++..+.++|++||+.+|++||++.++++||||....
T Consensus 237 ----------------~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 237 ----------------LKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred ----------------ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 001112678899999999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=286.42 Aligned_cols=274 Identities=32% Similarity=0.591 Sum_probs=207.9
Q ss_pred EEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEe
Q 019642 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 115 (338)
Q Consensus 40 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e 115 (338)
|++.+.||+|++|+||+|.+..+++.+++|.+... ......+|+..++++..|||++++++.+.+ ....++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEEe
Confidence 67899999999999999999889999999987643 223345789999999339999999999855 567899999
Q ss_pred eecCCcccccc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcce
Q 019642 116 YVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 190 (338)
Q Consensus 116 ~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~ 190 (338)
|+. +++...+ ..+++..+..++.|++.+|.+||++|++|+||+|+||+++.+ +.++|+|||.+..........
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~ 156 (283)
T cd07830 79 YME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGP-EVVKIADFGLAREIRSRPPYT 156 (283)
T ss_pred cCC-CCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC-CCEEEeecccceeccCCCCcC
Confidence 994 5554433 247999999999999999999999999999999999999987 899999999987665444444
Q ss_pred eeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcch
Q 019642 191 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 270 (338)
Q Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (338)
...++..|+|||.+.....++.++|+||||++++++++|..|| ......+........++.+....+......... .
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 233 (283)
T cd07830 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLF-PGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK--L 233 (283)
T ss_pred CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCcc-CCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc--c
Confidence 4567889999999866567899999999999999999999887 444556666666666665544433322111100 0
Q ss_pred hhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 271 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
........... .. ......+..+.++|++||+.||++|||+.|+++||||
T Consensus 234 ~~~~~~~~~~~----~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 234 GFRFPQFAPTS----LH-QLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccc----HH-HHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00000000000 00 0011136789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=285.10 Aligned_cols=246 Identities=24% Similarity=0.440 Sum_probs=197.2
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
++|++.+.||+|+||.||+|.+..+++.|++|.++.. ....+.+|+.+++.+ +|||++++++.+.+ ....+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~ 78 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYLDSFIE--DNELN 78 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCcceeeeeeeEEE--CCeEE
Confidence 6899999999999999999999999999999986531 134577899999999 99999999999865 45778
Q ss_pred EEEeeecCCccccccC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 112 LIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 112 lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
+++||+.+++|..++. .+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||.+....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~-~~~~l~d~g~~~~~~ 157 (267)
T cd08228 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFS 157 (267)
T ss_pred EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCC-CCEEECccccceecc
Confidence 9999999999876652 37889999999999999999999999999999999999987 789999999887654
Q ss_pred CCCc-ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccc
Q 019642 185 PGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263 (338)
Q Consensus 185 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
.... .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...................+.
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------- 227 (267)
T cd08228 158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP--------- 227 (267)
T ss_pred chhHHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC---------
Confidence 3221 122357788999999877 56889999999999999999999998654333222222111111100
Q ss_pred cccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
.....++..+.+++.+||+.+|++||++.++++.
T Consensus 228 -------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 228 -------------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred -------------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 0011257889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=290.47 Aligned_cols=259 Identities=21% Similarity=0.361 Sum_probs=204.5
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
.++|++.+.||+|++|+||++.+..+++.+++|++... ....+.+|+++++.+ +|||++++++.+.. ....++
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 80 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC-RSPYIVSFYGAFLN--ENNICM 80 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHc-CCCCcceEeeeEec--CCEEEE
Confidence 47899999999999999999999999999999987532 245678899999999 99999999999955 467899
Q ss_pred EEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 113 IFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 113 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
||||+.+++|..++. .++...+..++.+++.+|.|||+ .|++|+||+|+||+++.+ +.++|+|||++...... .
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~-~~~~l~d~gl~~~~~~~-~ 158 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSR-GQIKLCDFGVSGELINS-I 158 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCC-CcEEEccCCcccchhhh-c
Confidence 999999999987763 48899999999999999999997 599999999999999987 88999999987644222 1
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHH------HHHHHHHHhCCchhhhhhhcc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD------QLVKIAKVLGTDELNAYLNKY 262 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~ 262 (338)
.....++..|+|||.+.+ ..++.++|+||||+++|++++|..||.......+ .+....+..-...
T Consensus 159 ~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 229 (284)
T cd06620 159 ADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-------- 229 (284)
T ss_pred cCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc--------
Confidence 223467889999999876 5788999999999999999999999954322111 0001101000000
Q ss_pred ccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
... .....++.++.+|+.+||+.||++|||+.|+++||||.+.....
T Consensus 230 -------------------~~~----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~~ 276 (284)
T cd06620 230 -------------------PPR----LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRAS 276 (284)
T ss_pred -------------------CCC----CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccccc
Confidence 000 00011577899999999999999999999999999997765443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=293.69 Aligned_cols=253 Identities=25% Similarity=0.418 Sum_probs=202.4
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
+.|+..+.||+|+||.||+|.+..+++.+++|.++... .+.+.+|+.+++++ +|||++++++.+.. ....++|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 80 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYITRYYGSYLK--GTKLWII 80 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC-CCCccHhhhccccc--CCceEEE
Confidence 35667788999999999999999999999999986332 34578899999999 89999999999854 4578999
Q ss_pred EeeecCCccccccC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-cce
Q 019642 114 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYN 190 (338)
Q Consensus 114 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-~~~ 190 (338)
|||+.++++...+. .+++..+..++.|++.|+.+||++|++|+||+|+||+++.+ +.++|+|||++....... ...
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06642 81 MEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred EEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCC-CCEEEccccccccccCcchhhh
Confidence 99999999887764 47899999999999999999999999999999999999987 889999999986554322 122
Q ss_pred eeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcch
Q 019642 191 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 270 (338)
Q Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (338)
...++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..... ......+ ....
T Consensus 160 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~~----~~~~---------------- 217 (277)
T cd06642 160 TFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHP-MRVLFLI----PKNS---------------- 217 (277)
T ss_pred cccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccch-hhHHhhh----hcCC----------------
Confidence 3357788999999877 5788999999999999999999999842211 1111100 0000
Q ss_pred hhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 271 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
.. .....++.++.++|.+||+.+|++|||+.++++||||......+
T Consensus 218 -----------~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 263 (277)
T cd06642 218 -----------PP-----TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKT 263 (277)
T ss_pred -----------CC-----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhhhH
Confidence 00 00112578899999999999999999999999999998766543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=285.76 Aligned_cols=251 Identities=26% Similarity=0.419 Sum_probs=201.9
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
+-|++.+.||+|+||.||+|.+..++..+++|.+.... .+.+.+|+..++++ .|||++++++.+.. ....++|
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv 80 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLK--DTKLWII 80 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEe--CCeEEEE
Confidence 45788999999999999999998899999999876322 34577899999999 99999999999855 4578999
Q ss_pred EeeecCCccccccC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-cce
Q 019642 114 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYN 190 (338)
Q Consensus 114 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-~~~ 190 (338)
|||+.++++..++. .++...+..++.|++.++.+||+.|++|+||+|+||+++.+ +.++|+|||++....... ...
T Consensus 81 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~-~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06641 81 MEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred EEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCC-CCEEEeecccceecccchhhhc
Confidence 99999999888764 48899999999999999999999999999999999999988 889999999886543322 122
Q ss_pred eeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcch
Q 019642 191 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 270 (338)
Q Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (338)
...++..|+|||.+.+ ...+.++|+||||+++|++++|..||.. .........+ .....
T Consensus 160 ~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~-~~~~~~~~~~----~~~~~--------------- 218 (277)
T cd06641 160 TFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSE-LHPMKVLFLI----PKNNP--------------- 218 (277)
T ss_pred cccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCc-cchHHHHHHH----hcCCC---------------
Confidence 3457788999999876 5778899999999999999999999832 1111111111 00000
Q ss_pred hhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 271 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
......++.++.+++.+||+.+|.+||++.++++||||.+...
T Consensus 219 -----------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~ 261 (277)
T cd06641 219 -----------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAK 261 (277)
T ss_pred -----------------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhhh
Confidence 0011126788999999999999999999999999999987644
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=286.80 Aligned_cols=242 Identities=18% Similarity=0.208 Sum_probs=191.2
Q ss_pred CcEEEE--EeeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEeeeeeec--cCC
Q 019642 38 DDYEVV--RKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRD--QHS 107 (338)
Q Consensus 38 ~~y~~~--~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~ 107 (338)
++++.. ..||+|++|.||+|.. +++.||+|.++... .+.+.+|+.+++++ +||||+++++++.+ ...
T Consensus 18 ~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 18 DDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIVDDL 94 (283)
T ss_pred HHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-CCCCEEEEeeeEEecccCC
Confidence 344444 6789999999999987 78899999987432 24566999999999 99999999999866 434
Q ss_pred CccEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 108 KTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
...+++|||+.+++|..++. .++......++.|++.||.+||+. +++|+||||+||+++.+ +.+||+|||++...
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~-~~~kl~dfg~~~~~ 173 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTEN-YKLKIICHGLEKIL 173 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCC-CcEEEcccchHhhh
Confidence 56789999999999988874 488888999999999999999985 99999999999999988 89999999998754
Q ss_pred cCCCcceeeeccccccccccccCc-CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcc
Q 019642 184 HPGKEYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262 (338)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
... .....++..|+|||++.+. ..++.++||||||+++|+|++|..||.. .+..+....+.......
T Consensus 174 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~--------- 241 (283)
T PHA02988 174 SSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN-LTTKEIYDLIINKNNSL--------- 241 (283)
T ss_pred ccc--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcCCCC---------
Confidence 322 2234678899999998652 4689999999999999999999999942 22222222211100000
Q ss_pred ccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
..+...++++.+++.+||+.||++|||+.++++
T Consensus 242 --------------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 242 --------------------------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred --------------------------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 001126789999999999999999999999985
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=279.70 Aligned_cols=246 Identities=34% Similarity=0.553 Sum_probs=201.4
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEe
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 115 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e 115 (338)
+|++.+.||+|++|.||++.+..+++.+++|.+... ..+.+.+|+..++++ +|++++++++.+.. ....++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKC-KHPNIVKYYGSYLK--KDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEEec--CCeEEEEEe
Confidence 588999999999999999999989999999998754 346788999999999 89999999999855 467889999
Q ss_pred eecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCccee
Q 019642 116 YVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 191 (338)
Q Consensus 116 ~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~~ 191 (338)
|+.+++|.+.+ ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.+ +.++|+|||.+...........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~~ 156 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSD-GEVKLIDFGLSAQLSDTKARNT 156 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccC-CeEEEeeccccccccccccccc
Confidence 99999998876 357999999999999999999999999999999999999987 8999999999876654432345
Q ss_pred eeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchh
Q 019642 192 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD 271 (338)
Q Consensus 192 ~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (338)
..++..|+|||.+.+ ...+.++|+||||+++++|++|..||..... ......... .....
T Consensus 157 ~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~-~~~~~----------------- 216 (253)
T cd05122 157 MVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPP-MKALFKIAT-NGPPG----------------- 216 (253)
T ss_pred eecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCch-HHHHHHHHh-cCCCC-----------------
Confidence 577889999999876 5688999999999999999999999843221 111111111 00000
Q ss_pred hhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCC
Q 019642 272 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 324 (338)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 324 (338)
......++..+.++|.+||+.||++|||+.++++|||
T Consensus 217 ----------------~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 217 ----------------LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ----------------cCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 0001114788999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=284.66 Aligned_cols=244 Identities=14% Similarity=0.261 Sum_probs=191.6
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEc---CCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
+.++|++.+.||+|+||.||+|.+. ..+..+++|.++... ...+.+|+..++++ +|||++++++.+.. ..
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~ 79 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-DHSNIVRLEGVITR--GN 79 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEec--CC
Confidence 4578999999999999999999765 456689999987432 24577899999999 99999999999854 56
Q ss_pred ccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 109 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
..++||||+++++|..++. .+++..++.++.|++.||.+||+.|++|+||||+||+++.+ +.++++|||.+....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~-~~~~l~dfg~~~~~~ 158 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSD-LVCKISGFRRLQEDK 158 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCC-CcEEECCCccccccc
Confidence 7899999999999987753 47899999999999999999999999999999999999988 799999999865432
Q ss_pred CCCcce--eeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 185 PGKEYN--VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 185 ~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
...... ...++..|+|||.+.+ ..++.++||||||+++|++++ |..||.. .+..+....+.+...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~-~~~~~~~~~~~~~~~---------- 226 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWD-MSGQDVIKAVEDGFR---------- 226 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCc-CCHHHHHHHHHCCCC----------
Confidence 221111 1233567999999876 678999999999999999775 9989842 222222221111000
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
...+..++..+.+++..||+.+|++|||++++++
T Consensus 227 --------------------------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 227 --------------------------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred --------------------------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 0012236788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=285.46 Aligned_cols=255 Identities=23% Similarity=0.429 Sum_probs=204.0
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
.+|...+.||+|++|.||++.+..+++.+++|.++.. ..+.+.+|+.+++.+ +|||++++++.+.. ....++++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~--~~~~~~v~ 95 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDY-QHPNIVEMYSSYLV--GDELWVVM 95 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHc-CCCChheEEEEEEc--CCeEEEEE
Confidence 4677788999999999999999999999999987532 244578899999999 99999999999854 45789999
Q ss_pred eeecCCccccccC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc-cee
Q 019642 115 EYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNV 191 (338)
Q Consensus 115 e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~-~~~ 191 (338)
||+.+++|.+.+. +++...+..++.|++.||.+||++|++|+||+|+||+++.+ +.++|+|||.+........ ...
T Consensus 96 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~d~g~~~~~~~~~~~~~~ 174 (285)
T cd06648 96 EFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKEVPRRKS 174 (285)
T ss_pred eccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCC-CcEEEcccccchhhccCCccccc
Confidence 9999999988764 48889999999999999999999999999999999999988 8999999998765433221 222
Q ss_pred eeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchh
Q 019642 192 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD 271 (338)
Q Consensus 192 ~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (338)
..++..|+|||...+ ..++.++|+||||+++++|++|..||.... .......+... ..+.
T Consensus 175 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~-~~~~~~~~~~~-~~~~----------------- 234 (285)
T cd06648 175 LVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEP-PLQAMKRIRDN-LPPK----------------- 234 (285)
T ss_pred ccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCC-HHHHHHHHHhc-CCCC-----------------
Confidence 457889999999876 568899999999999999999999985321 11111111110 0000
Q ss_pred hhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 272 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
......++..+.++|.+||+.+|++|||+.++++||||+..+.++
T Consensus 235 ----------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~ 279 (285)
T cd06648 235 ----------------LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPS 279 (285)
T ss_pred ----------------CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCcc
Confidence 000112678999999999999999999999999999998876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=290.19 Aligned_cols=245 Identities=17% Similarity=0.284 Sum_probs=190.3
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCce--EEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNER--CIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
.++|++.+.||+|+||.||+|.+..++.. +++|..+.. ....+.+|+.++.++.+|||++++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--~~~~ 83 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYL 83 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC--CCCc
Confidence 46899999999999999999998777654 567766532 234577899999999789999999999844 5678
Q ss_pred EEEEeeecCCccccccC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCc
Q 019642 111 SLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK 171 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 171 (338)
+++|||+.+++|..++. .++...++.++.|++.||.+||++|++|+||||+||+++.+ +.
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~-~~ 162 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YV 162 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC-Cc
Confidence 99999999998877652 36888999999999999999999999999999999999988 78
Q ss_pred eEEEeccccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHh
Q 019642 172 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVL 250 (338)
Q Consensus 172 ~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~ 250 (338)
++|+|||++..............+..|+|||...+ ..++.++||||||+++|+|+| |..||.. .+..+.......
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~-- 238 (303)
T cd05088 163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQ-- 238 (303)
T ss_pred EEeCccccCcccchhhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCccc-CChHHHHHHHhc--
Confidence 99999998853221111122233567999998866 568899999999999999998 9989842 222221111100
Q ss_pred CCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 251 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
.. ....+..++.++.+++.+||+.+|++||++++++++
T Consensus 239 -~~---------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 239 -GY---------------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred -CC---------------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 000111257889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=284.95 Aligned_cols=249 Identities=25% Similarity=0.413 Sum_probs=193.1
Q ss_pred eeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHHHHHHh--cCCCCeeEeeeeeeccCCCccEEEEee
Q 019642 45 KVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNL--CGGPNVVKLLDIVRDQHSKTPSLIFEY 116 (338)
Q Consensus 45 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~~l~~l--~~h~~iv~~~~~~~~~~~~~~~lv~e~ 116 (338)
.||+|+||.||++.+..+++.||+|.+.... ......|..+++.+ ..||+++++++.+.. ....++||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEEEec
Confidence 4799999999999999999999999875421 11233444433332 278999999999854 4578899999
Q ss_pred ecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcceeee
Q 019642 117 VNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 193 (338)
Q Consensus 117 ~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 193 (338)
+.+++|..++. .+++..++.++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++....... .....
T Consensus 79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~-~~~kl~dfg~~~~~~~~~-~~~~~ 156 (278)
T cd05606 79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKKK-PHASV 156 (278)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCC-CCEEEccCcCccccCccC-CcCcC
Confidence 99999987763 48999999999999999999999999999999999999988 789999999986543222 23346
Q ss_pred ccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCH-HHHHHHHHHhCCchhhhhhhccccccCcchhh
Q 019642 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH-DQLVKIAKVLGTDELNAYLNKYHLELDPQLDA 272 (338)
Q Consensus 194 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (338)
++..|+|||.+.+...++.++|+||+|+++|+|++|..||....... ........ ..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~-------------------- 214 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TM-------------------- 214 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh--cc--------------------
Confidence 88999999998764568899999999999999999999995432211 11111000 00
Q ss_pred hhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC-----CHHHHhcCCCcchhhhccc
Q 019642 273 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAES 333 (338)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~~~~ 333 (338)
....+..++.++.+++.+||..+|++|| ++.++++||||++......
T Consensus 215 --------------~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~ 266 (278)
T cd05606 215 --------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMV 266 (278)
T ss_pred --------------CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHh
Confidence 0001122588999999999999999999 9999999999999875544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=284.90 Aligned_cols=272 Identities=35% Similarity=0.658 Sum_probs=209.8
Q ss_pred EEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 40 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
|++.+.||+|++|.||+|.+..+++.+++|.+.... .+.+..|+.+++.+ +|+|++++++++.+ ....++++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~~v~ 77 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPNIVKLLDVIHT--ERKLYLVF 77 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhc-CCCCHHHHHhhhhc--CCceEEEe
Confidence 677899999999999999999999999999987532 34567899999999 89999999999855 46789999
Q ss_pred eeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-cc
Q 019642 115 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EY 189 (338)
Q Consensus 115 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-~~ 189 (338)
|++++ +|..++ ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+....... ..
T Consensus 78 e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~~~ 155 (282)
T cd07829 78 EYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLRTY 155 (282)
T ss_pred cCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCC-CCEEEecCCcccccCCCcccc
Confidence 99985 666665 258999999999999999999999999999999999999997 899999999886654322 22
Q ss_pred eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcc
Q 019642 190 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 269 (338)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
....++..|+|||.+.+...++.++|+||||++++++++|..|| ...+..+.+..+.+..+.+....+..-.... .
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 231 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLF-PGDSEIDQLFKIFQILGTPTEESWPGVTKLP---D 231 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCC-CCccHHHHHHHHHHHhCCCcHHHHHhhcccc---c
Confidence 33455678999999877457899999999999999999998777 4555556666666666655544443221111 0
Q ss_pred hhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 270 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
............. ....+.++..+.++|++||..||++||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 232 YKPTFPKFPPKDL-----EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccccccCccch-----HHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0000000000000 11112247889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=284.42 Aligned_cols=272 Identities=30% Similarity=0.585 Sum_probs=203.0
Q ss_pred EEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhc--CCCCeeEeeeeeeccCC---Cc
Q 019642 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLC--GGPNVVKLLDIVRDQHS---KT 109 (338)
Q Consensus 40 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~--~h~~iv~~~~~~~~~~~---~~ 109 (338)
|++.+.||+|++|.||+|.+..+++.+++|.++... ...+.+|+.+++++. .|||++++++.+..... ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 688999999999999999998889999999986321 234567888887773 59999999999865432 23
Q ss_pred cEEEEeeecCCcccccc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 110 PSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
.+++||++.+ ++..++ ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+....
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~-~~~~l~dfg~~~~~~ 158 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSD-GQVKIADFGLARIYS 158 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccC-CCEEEeccCcceecc
Confidence 8899999986 454443 248999999999999999999999999999999999999998 899999999987664
Q ss_pred CCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccc
Q 019642 185 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264 (338)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
.........++..|+|||.+.+ ..++.++|+||||+++|+|++|..|| ......+....+.+..+......+......
T Consensus 159 ~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07838 159 FEMALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLF-RGTSEADQLDKIFDVIGLPSEEEWPRNVSL 236 (287)
T ss_pred CCcccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcc-cCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence 4433344457888999999877 67889999999999999999998776 445555555555554443322222111000
Q ss_pred ccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
. ............ ......++..+.++|.+||+.||++||++.++++||||
T Consensus 237 ~-----~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 237 P-----RSSFPSYTPRSF-----KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred c-----hhhcccccccch-----hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 000000000000 01111256888999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=287.44 Aligned_cols=244 Identities=17% Similarity=0.343 Sum_probs=193.5
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCC-----ceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
.++|++.+.||+|+||.||+|.+...+ ..+++|.++... ...+.+|+..++.+ +||||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~--~ 80 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPNIVCLLGVCTK--E 80 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhc-CCcccceEEEEEcC--C
Confidence 458999999999999999999876554 679999886432 34578899999999 99999999999854 4
Q ss_pred CccEEEEeeecCCcccccc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC
Q 019642 108 KTPSLIFEYVNSTDFKVLY-------------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 168 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~ 168 (338)
...+++|||+.+++|.+++ ..++...+..++.|++.||.+||++|++|+||||+||+++.+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 5688999999999887765 236778899999999999999999999999999999999988
Q ss_pred CCceEEEeccccccccCCC---cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHH
Q 019642 169 LRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLV 244 (338)
Q Consensus 169 ~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~ 244 (338)
+.++|+|||++....... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||+. .+..+...
T Consensus 161 -~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~-~~~~~~~~ 237 (283)
T cd05048 161 -LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYG-FSNQEVIE 237 (283)
T ss_pred -CcEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHH
Confidence 789999999986543222 1223345678999999876 578999999999999999998 9989843 22222222
Q ss_pred HHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 245 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
.+.. ... ...+..+++++.+++.+||+.||.+||++.+++++
T Consensus 238 ~i~~----~~~--------------------------------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 238 MIRS----RQL--------------------------------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHc----CCc--------------------------------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1111 000 00122368999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=298.29 Aligned_cols=255 Identities=23% Similarity=0.443 Sum_probs=216.5
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
.....|.+...||+|.|++|.++.+..++..||+|.+.+.. .+.+.+|+++|+.+ +|||||+++++... ...
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-~HPnIvkl~~v~~t--~~~ 129 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-NHPNIVKLFSVIET--EAT 129 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-CCcceeeeeeeeee--cce
Confidence 34568999999999999999999999999999999997543 34578999999999 99999999999844 568
Q ss_pred cEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 110 PSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
+|+||||+.++.+.+++. +..+..+..++.|+..|++|||+++|+|+|||++||+++.+ -++||+|||++..+..+
T Consensus 130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~-mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDEN-MNIKIADFGFSTFFDYG 208 (596)
T ss_pred eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccc-cceeeeccccceeeccc
Confidence 999999999999888873 46778899999999999999999999999999999999999 67999999999999888
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
......+|++.|.|||++.+.....+.+|+||+|+++|.++.|.+||.- .+-.+- .. +....
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG-~~lk~L--------r~---rvl~g------ 270 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG-QNLKEL--------RP---RVLRG------ 270 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC-cccccc--------cc---hheee------
Confidence 8888899999999999999988888999999999999999999999931 110000 00 00000
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
..-.+..++.++.++|+++|-.+|.+|++.+++..|.|.....+.
T Consensus 271 --------------------k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 271 --------------------KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred --------------------eecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 011122278899999999999999999999999999999877655
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=282.45 Aligned_cols=244 Identities=18% Similarity=0.345 Sum_probs=195.1
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc--hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
..+|.+.+.||+|++|.||+|.+..+++.+++|.++... ...+.+|++.++.+ +|||++++++.+.. ....+++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 81 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--EPPFYIIT 81 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhC-CCCChhheEEEEcC--CCCcEEEE
Confidence 467999999999999999999999999999999987543 34678899999999 99999999999854 45788999
Q ss_pred eeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcc
Q 019642 115 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189 (338)
Q Consensus 115 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~ 189 (338)
||+.+++|.+++. .+++..+..++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||.+.........
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC-CcEEeCCCccccccccceee
Confidence 9999999887753 37888999999999999999999999999999999999887 88999999998765432211
Q ss_pred e--eeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 190 N--VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 190 ~--~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
. ....+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||. +.+..+....+....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~-~~~~~~~~~~~~~~~---------------- 222 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYP-GIDLSQVYELLEKGY---------------- 222 (263)
T ss_pred ccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCC-CCCHHHHHHHHHCCC----------------
Confidence 1 1223557999998876 678899999999999999998 888873 222222111111000
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
....+..++.++.+++.+||+.||++|||+.++++.
T Consensus 223 --------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 223 --------------------RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred --------------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 001112368899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=294.81 Aligned_cols=247 Identities=20% Similarity=0.338 Sum_probs=191.8
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcC-----CCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
.++|++.+.||+|+||.||+|.+.. +++.|++|.++... .+.+..|+.+++++.+|+||+++++.+... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-~ 84 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP-G 84 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-C
Confidence 5799999999999999999997543 45789999986422 245678999999997899999999987543 3
Q ss_pred CccEEEEeeecCCccccccC------------------------------------------------------------
Q 019642 108 KTPSLIFEYVNSTDFKVLYP------------------------------------------------------------ 127 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------ 127 (338)
..++++|||+.+++|..++.
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 56789999999998876541
Q ss_pred ----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc---ceeeeccccccc
Q 019642 128 ----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKG 200 (338)
Q Consensus 128 ----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~a 200 (338)
.++...+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++........ .....++..|+|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~-~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCC-CcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 46788899999999999999999999999999999999987 7899999999876532221 112234567999
Q ss_pred cccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccC
Q 019642 201 PELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSR 279 (338)
Q Consensus 201 PE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (338)
||.+.+ ..++.++|||||||++|+|++ |..||...... +.+..... ...
T Consensus 244 PE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-~~~~~~~~---~~~------------------------- 293 (337)
T cd05054 244 PESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-EEFCRRLK---EGT------------------------- 293 (337)
T ss_pred cHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-HHHHHHHh---ccC-------------------------
Confidence 999877 679999999999999999998 98888432211 11111110 000
Q ss_pred CCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 280 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 280 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
....+...++++.+++.+||+.+|++||++.++++|
T Consensus 294 -------~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 294 -------RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred -------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 000112257889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=279.86 Aligned_cols=245 Identities=24% Similarity=0.491 Sum_probs=200.6
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
+|++.+.||.|++|.||++.+..++..+++|.+... ....+..|++.++.+ +|||++++.+.+.. ....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~--~~~~~lv 77 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHPNIIKYYESFEE--KGKLCIV 77 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhc-CCCChhheEEEEec--CCEEEEE
Confidence 589999999999999999999999999999998643 345678899999999 89999999999855 4678999
Q ss_pred EeeecCCcccccc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 114 FEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 114 ~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
+|++.+++|...+ ..++...+..++.+++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSST 156 (258)
T ss_pred EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCC-CcEEECCccceeecccC
Confidence 9999999887765 348899999999999999999999999999999999999987 89999999998765433
Q ss_pred C-cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 187 K-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 187 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
. ......+++.|+|||...+ ...+.++|+||+|+++++|++|..||.... .......... ....
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-~~~~~~~~~~----~~~~--------- 221 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELALKILK----GQYP--------- 221 (258)
T ss_pred cceecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCc-HHHHHHHHhc----CCCC---------
Confidence 2 2233467888999999876 568899999999999999999999983222 1111111110 0000
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
..+..++..+.+++.+||..+|++|||+.++|+||||
T Consensus 222 -----------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 222 -----------------------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred -----------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 0011268899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=286.89 Aligned_cols=261 Identities=23% Similarity=0.381 Sum_probs=201.7
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
....++|++.+.||+|++|.||+|.+..+++.+++|.++... ...+..|+.++.+...||||+++++++.+ ...
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~ 88 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT--DSD 88 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec--CCe
Confidence 456689999999999999999999999889999999986432 23456677777777569999999999955 457
Q ss_pred cEEEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 110 PSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
.+++|||+.+ ++.... ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.+ +.++|+|||.+....
T Consensus 89 ~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~-~~~kL~dfg~~~~~~ 166 (296)
T cd06618 89 VFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDAS-GNVKLCDFGISGRLV 166 (296)
T ss_pred EEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCC-CCEEECccccchhcc
Confidence 8999999865 333332 348899999999999999999997 599999999999999987 899999999987654
Q ss_pred CCCcceeeeccccccccccccCc---CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 185 PGKEYNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
.........++..|+|||.+.+. ..++.++|+||||+++|+|++|..||.......+.+... ..... .
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~-~----- 237 (296)
T cd06618 167 DSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI---LQEEP-P----- 237 (296)
T ss_pred CCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHH---hcCCC-C-----
Confidence 33333344577889999998653 247889999999999999999999984332222222211 11100 0
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
.. .....++.++.+|+.+||..||++|||++++++||||.......
T Consensus 238 -----------------~~--------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 283 (296)
T cd06618 238 -----------------SL--------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE 283 (296)
T ss_pred -----------------CC--------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchhH
Confidence 00 00012678899999999999999999999999999999865544
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=294.90 Aligned_cols=282 Identities=17% Similarity=0.258 Sum_probs=195.9
Q ss_pred Eeeeec--CceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEee
Q 019642 44 RKVGRG--KYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 116 (338)
Q Consensus 44 ~~lg~G--~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~ 116 (338)
..||.| +||+||++.+..+++.|++|+..... .+.+.+|+.+++.+ +||||+++++++.. ....++++||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~--~~~~~~v~e~ 80 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF-RHPNIMTSWTVFTT--GSWLWVISPF 80 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcceEeeeEec--CCceEEEEec
Confidence 456766 99999999999999999999986422 25577899999888 99999999999965 4578999999
Q ss_pred ecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc---
Q 019642 117 VNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--- 188 (338)
Q Consensus 117 ~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~--- 188 (338)
+.++++..++. .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++++||+.+........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~-~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCC-CcEEEechHHHhhhhccCcccc
Confidence 99998877763 37889999999999999999999999999999999999988 7899999985432211100
Q ss_pred -----ceeeeccccccccccccCc-CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc-
Q 019642 189 -----YNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK- 261 (338)
Q Consensus 189 -----~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 261 (338)
.....++..|+|||++.+. ..++.++|+||+|+++|+|++|..||..... ..... ..+.......+...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~-~~~~~---~~~~~~~~~~~~~~~ 235 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLR-TQMLL---QKLKGPPYSPLDITT 235 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcCh-HHHHH---HHhcCCCCCCccccc
Confidence 0112345569999998653 3478999999999999999999999843322 22211 11111111000000
Q ss_pred ccc----------ccCc-chhhhhccccC-CCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 262 YHL----------ELDP-QLDALVGRHSR-KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 262 ~~~----------~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
... .... ........... ..............+++.+.+|+++||+.||++|||+.|+|+||||.++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 000 0000 00000000000 00000001111223678899999999999999999999999999999987
Q ss_pred hccc
Q 019642 330 AAES 333 (338)
Q Consensus 330 ~~~~ 333 (338)
....
T Consensus 316 ~~~~ 319 (328)
T cd08226 316 EQTQ 319 (328)
T ss_pred Hhcc
Confidence 7543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=281.79 Aligned_cols=245 Identities=28% Similarity=0.461 Sum_probs=191.0
Q ss_pred EeeeecCceeEEEEEEcCCCceEEEEEecccch------HHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeee
Q 019642 44 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKK------KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 117 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~ 117 (338)
+.||+|++|.||+|.+..+++.+++|.+..... .....|..++....+|+|++++++.+.. ....++++||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEecc
Confidence 568999999999999999999999999864321 2234455554444489999999999954 56789999999
Q ss_pred cCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcceeeec
Q 019642 118 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 194 (338)
Q Consensus 118 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 194 (338)
++++|..++ ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||++..... .....+
T Consensus 80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~---~~~~~~ 155 (260)
T cd05611 80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQT-GHLKLTDFGLSRNGLE---NKKFVG 155 (260)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CcEEEeecccceeccc---cccCCC
Confidence 999998876 358999999999999999999999999999999999999987 7899999998865332 223357
Q ss_pred cccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhh
Q 019642 195 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALV 274 (338)
Q Consensus 195 ~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (338)
+..|+|||.+.+ ..++.++|+||||+++|++++|..||.. .+.......+... ...
T Consensus 156 ~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~--~~~-------------------- 211 (260)
T cd05611 156 TPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFHA-ETPDAVFDNILSR--RIN-------------------- 211 (260)
T ss_pred CcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhc--ccC--------------------
Confidence 788999999877 4588999999999999999999999832 2222222111110 000
Q ss_pred ccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCC---HHHHhcCCCcchhh
Q 019642 275 GRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT---AREAMAHPYFAQVR 329 (338)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt---~~ell~hp~~~~~~ 329 (338)
........+++.+.++|.+||+.+|++||+ ++|+++||||+++.
T Consensus 212 -----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 212 -----------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred -----------CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence 000011126889999999999999999995 57999999998764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=280.59 Aligned_cols=242 Identities=20% Similarity=0.411 Sum_probs=195.0
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
+|++.+.||.|+||.||++.+..+++.+++|.++.. ..+.+..|+.+++.+ +|||++++++.+.+ ...++++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-KHPNIVAFKESFEA--DGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEE--CCEEEEEE
Confidence 589999999999999999999999999999987532 235677899999999 99999999999855 46789999
Q ss_pred eeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc-
Q 019642 115 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE- 188 (338)
Q Consensus 115 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~- 188 (338)
||+.++++...+. .+++..+..++.|++.||.+||++|++|+||+|+||+++.+ +.++++|||.+........
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN-GKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCC-CcEEEcccCcceeecccccc
Confidence 9999998876542 37899999999999999999999999999999999999887 7899999999865543221
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
.....++..|+|||++.+ ..++.++|+||||+++|+|++|..||... +.......+.. + ...
T Consensus 157 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~-~~~~~~~~~~~--~--~~~------------ 218 (255)
T cd08219 157 ACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQAN-SWKNLILKVCQ--G--SYK------------ 218 (255)
T ss_pred cccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCC-CHHHHHHHHhc--C--CCC------------
Confidence 223467888999999877 57899999999999999999999998422 21111111110 0 000
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
..+..++..+.++|.+||+.||++|||+.++++-
T Consensus 219 --------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 --------------------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --------------------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0111267889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=286.75 Aligned_cols=244 Identities=17% Similarity=0.285 Sum_probs=189.6
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCc--eEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNE--RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
++|++.+.||+|+||.||+|.+..++. .+++|.++.. ..+.+.+|+.++.++.+||||+++++.+.. ....+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN--RGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc--CCcce
Confidence 689999999999999999999877664 4688877642 234577899999999779999999999854 45688
Q ss_pred EEEeeecCCccccccC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCce
Q 019642 112 LIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKL 172 (338)
Q Consensus 112 lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~ 172 (338)
+++||+.+++|.+++. .++...+..++.|++.||++||++|++|+||||+||+++.+ +.+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~ 158 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN-LAS 158 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC-CeE
Confidence 9999999998877652 37788999999999999999999999999999999999987 789
Q ss_pred EEEeccccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhC
Q 019642 173 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLG 251 (338)
Q Consensus 173 ~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~ 251 (338)
+|+|||++..............+..|+|||...+ ..++.++||||||+++|+|++ |..||.. ....+....+.+..
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~-~~~~~~~~~~~~~~- 235 (297)
T cd05089 159 KIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGY- 235 (297)
T ss_pred EECCcCCCccccceeccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCC-
Confidence 9999998854321111111223456999999876 678999999999999999997 9999832 22222221111000
Q ss_pred CchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 252 TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
....+..++.++.+|+.+||+.+|.+|||++++++.
T Consensus 236 -----------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 -----------------------------------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred -----------------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000112268899999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=285.54 Aligned_cols=246 Identities=33% Similarity=0.577 Sum_probs=199.9
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
++|++.+.||+|++|.||++.+..+++.+++|++... ..+.+..|..+++++.+||||+++++.+.+ ....+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD--EENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--CceEE
Confidence 5799999999999999999999999999999998642 235577899999999339999999999844 56789
Q ss_pred EEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 112 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 112 lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
++||++.+++|...+. .+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||++........
T Consensus 79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~-~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEecCCccccccCCccc
Confidence 9999999999887763 48999999999999999999999999999999999999987 7899999998865533221
Q ss_pred ---------------------ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHH
Q 019642 189 ---------------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 247 (338)
Q Consensus 189 ---------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~ 247 (338)
.....++..|+|||...+ ..++.++|+||||++++++++|..||.... ....+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~ 235 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSN-EYLTFQKIL 235 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHH
Confidence 122346788999999876 568899999999999999999999984322 111111111
Q ss_pred HHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCH----HHHhcCC
Q 019642 248 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA----REAMAHP 323 (338)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~----~ell~hp 323 (338)
.. ....+..+++.+.+||.+||+.+|++|||+ +++++||
T Consensus 236 ~~-------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~ 278 (280)
T cd05581 236 KL-------------------------------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHP 278 (280)
T ss_pred hc-------------------------------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCC
Confidence 00 000112257889999999999999999999 9999999
Q ss_pred Cc
Q 019642 324 YF 325 (338)
Q Consensus 324 ~~ 325 (338)
||
T Consensus 279 ~~ 280 (280)
T cd05581 279 FF 280 (280)
T ss_pred CC
Confidence 97
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=279.66 Aligned_cols=248 Identities=25% Similarity=0.410 Sum_probs=199.1
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
.+|++.+.||+|++|.||++.+..+++.+++|.+... ....+.+|+.+++++ +|||++++++.+.+.....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-CCCCcceEEEEEEcCCCCE
Confidence 5799999999999999999999999999999986421 124577899999999 9999999999987665567
Q ss_pred cEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 110 PSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
.++++||+.+++|...+. .+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEECccccccccccc
Confidence 889999999998887753 47889999999999999999999999999999999999987 78999999998754321
Q ss_pred C----cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcc
Q 019642 187 K----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262 (338)
Q Consensus 187 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
. ......++..|+|||.+.+ ...+.++|+||||+++|++++|..||... ..... +.+....+..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~---~~~~~~~~~~------- 227 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEY-EAMAA---IFKIATQPTK------- 227 (264)
T ss_pred cccCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCcc-CHHHH---HHHHHcCCCC-------
Confidence 1 1122357788999999877 56889999999999999999999998422 11211 1111111100
Q ss_pred ccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
...+..+++++.++|.+||. +|..|||+.++++|||.
T Consensus 228 -------------------------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 228 -------------------------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred -------------------------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 01122378899999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=286.95 Aligned_cols=250 Identities=28% Similarity=0.435 Sum_probs=197.8
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
...|++.+.||+|+||+||+|.+..+++.|++|.+.... .+.+.+|+.+++.+ +|||++++++.+.+ ....
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~--~~~~ 90 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIEYKGCYLR--EHTA 90 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEEe--CCeE
Confidence 467999999999999999999999899999999875321 24577899999999 99999999999965 4567
Q ss_pred EEEEeeecCCccccc---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 111 SLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
++|+||+.+..+... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 91 ~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~-~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 91 WLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEP-GTVKLADFGSASLVSPA- 168 (307)
T ss_pred EEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCC-CCEEEeecCcceecCCC-
Confidence 899999986544333 2358999999999999999999999999999999999999988 89999999988654322
Q ss_pred cceeeeccccccccccccC--cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 188 EYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
....++..|+|||.+.+ ...++.++||||||+++|+|++|..||.... .......+.. ...
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~-~~~~~~~~~~---~~~----------- 231 (307)
T cd06607 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQ---NDS----------- 231 (307)
T ss_pred --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc-HHHHHHHHhc---CCC-----------
Confidence 23467788999998742 2468889999999999999999999984321 1111111100 000
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
.......++.++.++|.+||+.+|++||++.+++.||||..-.
T Consensus 232 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 232 ---------------------PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred ---------------------CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 0000111578899999999999999999999999999997754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=283.96 Aligned_cols=244 Identities=19% Similarity=0.338 Sum_probs=192.8
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEc-----CCCceEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~---~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
++++|.+.+.||+|+||.||++.+. .++..+++|.+.... ...+.+|+.+++++ +|||++++++++.. .
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~ 79 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVE--G 79 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec--C
Confidence 5689999999999999999999853 345668999886433 34578899999999 89999999999854 5
Q ss_pred CccEEEEeeecCCccccccC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCc
Q 019642 108 KTPSLIFEYVNSTDFKVLYP----------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK 171 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 171 (338)
...+++|||+.+++|..++. .+++..+..++.|++.||.+||++|++|+||||+||+++.+ +.
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~-~~ 158 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN-LL 158 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC-Cc
Confidence 67899999999999877652 37999999999999999999999999999999999999988 89
Q ss_pred eEEEeccccccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHH
Q 019642 172 LRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIA 247 (338)
Q Consensus 172 ~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~ 247 (338)
++|+|||.+........ .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||... ...+....+.
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~-~~~~~~~~i~ 236 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQL-SNNEVIECIT 236 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHH
Confidence 99999999875532221 122334668999999877 678999999999999999998 88887432 2222222211
Q ss_pred HHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 248 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
.. . . ...+..++.++.+++.+||+.||.+|||+.++++
T Consensus 237 ~~--~--~--------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 237 QG--R--V--------------------------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cC--C--c--------------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 10 0 0 0001126789999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=278.18 Aligned_cols=242 Identities=16% Similarity=0.285 Sum_probs=191.7
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
.++|++.+.||+|+||.||++... ++..+++|.+... ....+.+|+.+++++ +|||++++++++.. ....+++|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~iv~ 78 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKL-SHPKLVQLYGVCTQ--QKPLYIVT 78 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHC-CCCCceeEEEEEcc--CCCEEEEE
Confidence 468999999999999999999764 4567999987643 346788899999999 99999999999854 45789999
Q ss_pred eeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcce
Q 019642 115 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 190 (338)
Q Consensus 115 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~ 190 (338)
||+.+++|.+++. .++...+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||.+..........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSST-GVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCC-CeEEECCCCCccccCCCceec
Confidence 9999998887763 37889999999999999999999999999999999999987 789999999887543222211
Q ss_pred --eeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 191 --VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 191 --~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
...++..|+|||.+.+ ..++.++|+||||+++|++++ |+.||. ..+..+....+.+...
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~-~~~~~~~~~~i~~~~~---------------- 219 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFE-KKSNYEVVEMISRGFR---------------- 219 (256)
T ss_pred cCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCC-CCCHHHHHHHHHCCCC----------------
Confidence 1234457999999876 678899999999999999999 888873 2222222222211000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
...+...+.++.+++.+||+.+|++|||+.++++
T Consensus 220 --------------------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 220 --------------------LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred --------------------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0011124678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=285.03 Aligned_cols=243 Identities=21% Similarity=0.387 Sum_probs=193.7
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcC-----CCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
.++|.+.+.||+|+||.||+|.+.. ++..+++|.++... .+.+.+|+++++.+ +|||++++++++.. .
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~ 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-QHENIVKFYGVCTE--G 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhc-CCCCchheeeEEec--C
Confidence 5689999999999999999998743 36789999987532 35688899999999 99999999999855 4
Q ss_pred CccEEEEeeecCCccccccC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCC
Q 019642 108 KTPSLIFEYVNSTDFKVLYP-----------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR 170 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~-----------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~ 170 (338)
...+++|||+.+++|..++. .+++..+..++.|++.||.+||++|++|+||||+||+++.+ +
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~-~ 159 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD-L 159 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCC-C
Confidence 67899999999999887652 26788899999999999999999999999999999999988 8
Q ss_pred ceEEEeccccccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHH
Q 019642 171 KLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKI 246 (338)
Q Consensus 171 ~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~ 246 (338)
.++|+|||.+........ .....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||.... ..+....+
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~-~~~~~~~~ 237 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLS-NEEVIECI 237 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHH
Confidence 999999999865432221 122344678999999877 678999999999999999998 999985332 22222211
Q ss_pred HHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 247 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
.. +. . ...+..++..+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~--~~--~--------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 238 TQ--GR--L--------------------------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred Hc--CC--c--------------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 10 00 0 0011126889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=279.80 Aligned_cols=243 Identities=18% Similarity=0.314 Sum_probs=192.5
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
..++|++.++||+|++|.||+|.+. ++..+++|.+... ..+.+.+|+.+++.+ +|+|++++++.+.+ ....+++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 79 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTL-QHDKLVRLYAVVTK--EEPIYII 79 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhC-CCCCeeeEEEEEcC--CCCcEEE
Confidence 4579999999999999999999864 5667999987643 346788899999999 99999999999854 4568899
Q ss_pred EeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 114 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 114 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
|||+.+++|.+++. .++...+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSES-LMCKIADFGLARVIEDNEY 158 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCC-CcEEECCCccceecCCCce
Confidence 99999999887762 37888899999999999999999999999999999999988 8899999999876543221
Q ss_pred c--eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 189 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 189 ~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
. ....++..|+|||...+ ..++.++|+||||+++|+|++ |..||.. ....+....+.....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~-------------- 222 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPG-MSNSDVMSALQRGYR-------------- 222 (261)
T ss_pred eccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCC-CCHHHHHHHHHcCCC--------------
Confidence 1 12234567999999876 578899999999999999998 8888832 222222222111000
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
......++.++.+++.+||..+|++|||++++++
T Consensus 223 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 223 ----------------------MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0011126789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=281.67 Aligned_cols=252 Identities=21% Similarity=0.369 Sum_probs=195.0
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcC-----CCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
+.++|++.+.||+|+||.||+|.... .+..|++|.++... ...+.+|+..++.+ +|||++++++.+.+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-- 80 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF-TCHHVVRLLGVVSK-- 80 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcC--
Confidence 35799999999999999999997542 34579999876432 23467899999999 89999999999854
Q ss_pred CCccEEEEeeecCCccccccCC-------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceE
Q 019642 107 SKTPSLIFEYVNSTDFKVLYPT-------------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR 173 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~~~-------------~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~ 173 (338)
....+++|||+.+++|..++.. .+...+..++.|++.||.|||++|++|+||||+||+++.+ +.++
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~-~~~~ 159 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD-FTVK 159 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCC-CcEE
Confidence 4578999999999999888632 3456788899999999999999999999999999999987 8999
Q ss_pred EEeccccccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHH
Q 019642 174 LIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKV 249 (338)
Q Consensus 174 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~ 249 (338)
|+|||++........ .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||. ..+..+....+...
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~-~~~~~~~~~~~~~~ 237 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQ-GLSNEQVLKFVMDG 237 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHcC
Confidence 999998865432221 111234567999999876 678899999999999999998 677873 22222211111000
Q ss_pred hCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc------CC
Q 019642 250 LGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA------HP 323 (338)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~------hp 323 (338)
+.. ..+...++.+.+++.+||+.||++|||+.++++ ||
T Consensus 238 -~~~-----------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 238 -GYL-----------------------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred -CCC-----------------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 000 001125788999999999999999999999987 99
Q ss_pred Ccchhh
Q 019642 324 YFAQVR 329 (338)
Q Consensus 324 ~~~~~~ 329 (338)
||.++.
T Consensus 282 ~~~~~~ 287 (288)
T cd05061 282 SFPEVS 287 (288)
T ss_pred CCCCCC
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=276.74 Aligned_cols=245 Identities=25% Similarity=0.470 Sum_probs=196.2
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~------~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
++|++.+.||+|++|.||+|.+..+++.+++|.++. ...+.+.+|+++++++ +|++++++++.+.. ....+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~--~~~~~ 78 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIE--NNELN 78 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeec--CCeEE
Confidence 689999999999999999999998999999998753 1245678999999999 99999999999955 45778
Q ss_pred EEEeeecCCccccccC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 112 LIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 112 lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
++|||+.+++|..++. .+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+....
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~-~~~~l~d~~~~~~~~ 157 (267)
T cd08224 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITAT-GVVKLGDLGLGRFFS 157 (267)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCC-CcEEEeccceeeecc
Confidence 9999999999876652 37889999999999999999999999999999999999987 789999999886543
Q ss_pred CCC-cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccc
Q 019642 185 PGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263 (338)
Q Consensus 185 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
... ......++..|.|||.+.+ ..++.++|+||||+++|+|++|..||........... +.......
T Consensus 158 ~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~-------- 225 (267)
T cd08224 158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC---KKIEKCDY-------- 225 (267)
T ss_pred CCCcccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHH---hhhhcCCC--------
Confidence 322 1233467888999999876 6788999999999999999999999854332211111 11000000
Q ss_pred cccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
.......++..+.++|.+||..+|++|||+.++++
T Consensus 226 -----------------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 226 -----------------------PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred -----------------------CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00001126788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=288.49 Aligned_cols=276 Identities=20% Similarity=0.243 Sum_probs=193.6
Q ss_pred CceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeecCCcccc
Q 019642 50 KYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 124 (338)
Q Consensus 50 ~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~ 124 (338)
++|.||.+.+..+++.||+|.++.. ..+.+.+|+..++.+ +||||+++++.+.+ ....+++|||+.++++..
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~--~~~~~~~~e~~~~~~l~~ 88 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL-QHPNILPYVTSFIV--DSELYVVSPLMAYGSCED 88 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhc-CCcchhhhhheeec--CCeEEEEEeccCCCCHHH
Confidence 4456666666779999999998643 235688999999999 89999999999855 456789999999999887
Q ss_pred ccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC--------ccee
Q 019642 125 LYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--------EYNV 191 (338)
Q Consensus 125 ~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~--------~~~~ 191 (338)
++. .+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+||+.+....... ....
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~-~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~ 167 (314)
T cd08216 89 LLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGKRQRVVHDFPKS 167 (314)
T ss_pred HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecC-CceEEecCccceeecccccccccccccccc
Confidence 763 37899999999999999999999999999999999999987 899999999875442211 1122
Q ss_pred eeccccccccccccCc-CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC-cc
Q 019642 192 RVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD-PQ 269 (338)
Q Consensus 192 ~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 269 (338)
..++..|+|||.+.+. ..++.++|+||+|+++++|++|..||............. .+... ........... ..
T Consensus 168 ~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~---~~~~~--~~~~~~~~~~~~~~ 242 (314)
T cd08216 168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKV---RGTVP--CLLDKSTYPLYEDS 242 (314)
T ss_pred ccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hccCc--cccccCchhhhcCC
Confidence 3456789999998653 357889999999999999999999995433322222211 11100 00000000000 00
Q ss_pred hhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcccc
Q 019642 270 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS 334 (338)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~ 334 (338)
........................++.++.+|+..||..||++|||+.++|+||||+.+.+++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~~~~ 307 (314)
T cd08216 243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRNTS 307 (314)
T ss_pred cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcccchh
Confidence 00000000000000111111222356789999999999999999999999999999999866653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=277.48 Aligned_cols=243 Identities=17% Similarity=0.304 Sum_probs=191.3
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
.++|++.+.||+|++|+||.+.+.. +..+++|.++.. ..+.+.+|+.+++++ +||||+++++++.. ....+++|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKL-SHEKLVQLYGVCTK--QRPIYIVT 78 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcC-CCCCeeeEEEEEcc--CCCcEEEE
Confidence 5689999999999999999997643 456999987743 245688999999999 89999999999854 45678999
Q ss_pred eeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcce
Q 019642 115 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 190 (338)
Q Consensus 115 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~ 190 (338)
||+.+++|.+++. .+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+..........
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~-~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQ-GCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC-CCEEECCCccceecCCCceee
Confidence 9999998887763 48999999999999999999999999999999999999987 789999999886553322111
Q ss_pred --eeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 191 --VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 191 --~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
...++..|+|||...+ ..++.++|+||||+++|+|++ |..||... +..+....+.+....
T Consensus 158 ~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~--------------- 220 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERF-NNSETVEKVSQGLRL--------------- 220 (256)
T ss_pred cCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHhcCCCC---------------
Confidence 1234467999999876 568899999999999999998 88888322 222222211110000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
..+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 221 ---------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 221 ---------------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ---------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 0011257899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=293.67 Aligned_cols=246 Identities=22% Similarity=0.323 Sum_probs=189.8
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCC-----CceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
..++|++.+.||+|+||.||+|.+... +..||+|.++... .+.+.+|+.+++++..||||+++++++..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~-- 112 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK-- 112 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc--
Confidence 357899999999999999999987433 3469999986432 35678899999999559999999999954
Q ss_pred CCccEEEEeeecCCccccccC-----------------------------------------------------------
Q 019642 107 SKTPSLIFEYVNSTDFKVLYP----------------------------------------------------------- 127 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~~----------------------------------------------------------- 127 (338)
....++||||+.+++|.+++.
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 567899999999998865431
Q ss_pred ----------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecC
Q 019642 128 ----------------------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 167 (338)
Q Consensus 128 ----------------------------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~ 167 (338)
.++...+..++.|++.||.|||+.|++|+||||+||+++.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence 2566778899999999999999999999999999999998
Q ss_pred CCCceEEEeccccccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHH
Q 019642 168 ELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQL 243 (338)
Q Consensus 168 ~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~ 243 (338)
+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||..........
T Consensus 273 ~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 273 G-KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred C-CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 8 7899999999875432221 122345678999999877 678999999999999999997 888884322211111
Q ss_pred HHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 244 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
..+... . ....+..++.++.+++.+||+.||++|||+.++.+
T Consensus 351 ~~~~~~--~----------------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 351 NKIKSG--Y----------------------------------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHhcC--C----------------------------------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 111000 0 00011226889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=284.18 Aligned_cols=255 Identities=29% Similarity=0.489 Sum_probs=206.7
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc--hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
....+.|++...||+|++|.||++.+..++..+++|++.... ...+.+|++.++.+ +|+|++++++.+... ...+
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~ 91 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDC-KHPNIVDYYDSYLVG--DELW 91 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHC-CCCCeeEEEEEEEEC--CEEE
Confidence 345678999999999999999999999889999999987554 56688999999999 999999999998654 6789
Q ss_pred EEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 112 LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 112 lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
+++||+.+++|.+++. .++...+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKD-GSVKLADFGFAAQLTKEK 170 (286)
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCC-CCEEECccchhhhhccch
Confidence 9999999999988863 58999999999999999999999999999999999999987 899999999876543222
Q ss_pred -cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 188 -EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 188 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.. .+.......+.. .....
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~-~~~~~~~~~~~~-~~~~~------------ 235 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLR-EPPLRALFLITT-KGIPP------------ 235 (286)
T ss_pred hhhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHh-cCCCC------------
Confidence 1122346788999999876 5789999999999999999999999832 222221111111 00000
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
......++..+.++|.+||+.+|.+|||+.++++||||++.
T Consensus 236 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 236 ---------------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred ---------------------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 00111257889999999999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=283.68 Aligned_cols=294 Identities=29% Similarity=0.538 Sum_probs=238.6
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcC---CCceEEEEEecc-cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVN---TNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
.+.|.++.+||.|.|++||++.+.. ..++||+|.+.. .....+.+|++++..+..+.||+++.+.+.. .....+
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rn--nd~v~i 112 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRN--NDQVAI 112 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhcc--CCeeEE
Confidence 4789999999999999999999877 788999998764 5678899999999999999999999999944 567889
Q ss_pred EEeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc---------
Q 019642 113 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY--------- 183 (338)
Q Consensus 113 v~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~--------- 183 (338)
|+||++.....++...++..+++.+++.++.||.++|++||+|+||||+|++.+...+.-.|+|||++...
T Consensus 113 vlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s 192 (418)
T KOG1167|consen 113 VLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHS 192 (418)
T ss_pred EecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhh
Confidence 99999999999999999999999999999999999999999999999999999998889999999998511
Q ss_pred --------cC--C--------------------------CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHH
Q 019642 184 --------HP--G--------------------------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 227 (338)
Q Consensus 184 --------~~--~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll 227 (338)
.+ + .....+.||++|+|||++...+..+.+.||||.|+++..++
T Consensus 193 ~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lsll 272 (418)
T KOG1167|consen 193 RSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLL 272 (418)
T ss_pred hhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhh
Confidence 00 0 00112468999999999998889999999999999999999
Q ss_pred hcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccc--ccC-------cchhhhhccc---cCCCCcc--cccccCCCC
Q 019642 228 FRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL--ELD-------PQLDALVGRH---SRKPWSK--FINADNQHL 293 (338)
Q Consensus 228 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-------~~~~~~~~~~---~~~~~~~--~~~~~~~~~ 293 (338)
++..||+...++.+.+.++....|...+++..-.... .+. +.+...+... ...+..+ .......+.
T Consensus 273 s~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~ 352 (418)
T KOG1167|consen 273 SRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDV 352 (418)
T ss_pred ccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecccccc
Confidence 9999999999999999999999998887775433222 111 1000000000 0011111 222333344
Q ss_pred CChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 294 VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 294 ~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
++..+.+|+.+||..||.+|.||+++|+||||.+..+..
T Consensus 353 ~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~~ 391 (418)
T KOG1167|consen 353 FPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRTE 391 (418)
T ss_pred ccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhhh
Confidence 667899999999999999999999999999999776543
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=283.19 Aligned_cols=258 Identities=24% Similarity=0.333 Sum_probs=194.5
Q ss_pred CcE-EEEEeeeecCceeEEEEE----EcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 38 DDY-EVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 38 ~~y-~~~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
++| ++.+.||+|+||+||++. ...++..+++|.++.. ....+.+|+++++++ +|||++++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCc
Confidence 455 999999999999998765 3456788999998743 235577899999999 999999999988665556
Q ss_pred ccEEEEeeecCCccccccC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 109 TPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
..+++|||+.+++|.+++. .+++..+..++.|++.||.+||++|++|+||||+||+++.+ +.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEG 160 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCC-CcEEEeecccccccCCc
Confidence 7889999999999988764 58999999999999999999999999999999999999988 78999999998765432
Q ss_pred Cc----ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhC-Cchhhhhhhc
Q 019642 187 KE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG-TDELNAYLNK 261 (338)
Q Consensus 187 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 261 (338)
.. .....++..|+|||...+ ..++.++|+||||+++|+|++|..||....... ........ ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~---~~~~~~~~~~~~------- 229 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF---EEMIGPKQGQMT------- 229 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcchh---hhhhcccccccc-------
Confidence 21 111234566999999876 578899999999999999999999984332211 11110000 000
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
............. ...+..++.++.+++..||+.+|++|||+.++++
T Consensus 230 -----~~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 230 -----VVRLIELLERGMR--------LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred -----hhhhhhhhhcCCC--------CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000000000000 0112336889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=277.28 Aligned_cols=244 Identities=22% Similarity=0.429 Sum_probs=199.2
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
+|++.+.||.|++|.||++.+..+++.+++|.+... ....+.+|+..++.+ +|+||+++++.+.+ ....+++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v 77 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-NHPNIISYKEAFLD--GNKLCIV 77 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhC-CCCCchhhhhhhcc--CCEEEEE
Confidence 589999999999999999999999999999997642 234567899999999 89999999999855 4678999
Q ss_pred EeeecCCcccccc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 114 FEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 114 ~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
+||+.+++|..++ ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~-~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAN-DLVKIGDLGISKVLKKN 156 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecC-CcEEEeeccchhhhccC
Confidence 9999999988775 248889999999999999999999999999999999999987 88999999998766544
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
......++..|+|||.+.+ ..++.++|+||||++++++++|..||.. .+..+..... ......
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~-~~~~~~~~~~----~~~~~~---------- 219 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEA-RSMQDLRYKV----QRGKYP---------- 219 (256)
T ss_pred -CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHH----hcCCCC----------
Confidence 2333567889999999876 6788899999999999999999999832 2221111111 000000
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
..+..++.++.+++.+||..+|++|||+.++++||++
T Consensus 220 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 220 ----------------------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred ----------------------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 0011267889999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=275.61 Aligned_cols=245 Identities=27% Similarity=0.538 Sum_probs=201.0
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
+|++.+.||+|++|.||++.+..+++.+++|.+.... .+.+.+|++++.++ .|||++++++++.+ ....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v 77 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHPNIVKYIGSIET--SDSLYII 77 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhC-CCCCccEEEEEEEe--CCEEEEE
Confidence 5899999999999999999999999999999986543 35678899999999 89999999999855 4678899
Q ss_pred EeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc-c
Q 019642 114 FEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-Y 189 (338)
Q Consensus 114 ~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~-~ 189 (338)
||++.+++|.+++. .+++..++.++.|++.+|.+||+.|++|+||+|+||+++.+ +.++|+|||.+........ .
T Consensus 78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~ 156 (254)
T cd06627 78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKDD 156 (254)
T ss_pred EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCC-CCEEEeccccceecCCCcccc
Confidence 99999999988763 48999999999999999999999999999999999999987 8999999999876644332 2
Q ss_pred eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcc
Q 019642 190 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 269 (338)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
....++..|+|||...+ ...+.++|+||+|++++++++|..||..... ..... +.... .
T Consensus 157 ~~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-~~~~~---~~~~~-~--------------- 215 (254)
T cd06627 157 ASVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLNP-MAALF---RIVQD-D--------------- 215 (254)
T ss_pred cccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCccH-HHHHH---HHhcc-C---------------
Confidence 23467888999999876 4588999999999999999999999843221 11111 10000 0
Q ss_pred hhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 270 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
....+..+++.+.+++.+||..+|++|||+.+++.||||
T Consensus 216 -----------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 216 -----------------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred -----------------CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 000112368899999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=282.15 Aligned_cols=243 Identities=33% Similarity=0.555 Sum_probs=195.1
Q ss_pred eeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeecC
Q 019642 46 VGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS 119 (338)
Q Consensus 46 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 119 (338)
||.|+||.||++.+..+++.+++|.+... ....+.+|++.++++ +|||++++++.+.. ....++++||+.+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLYYSFQG--KKNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-CCcchhHHHHheec--CcEEEEEEecCCC
Confidence 68999999999999989999999998643 234678899999999 89999999998844 5678999999999
Q ss_pred CccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC---------
Q 019642 120 TDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--------- 187 (338)
Q Consensus 120 ~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~--------- 187 (338)
++|..++. .+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCC-CCEEEEecccchhcccCcccccccccc
Confidence 99887763 58999999999999999999999999999999999999998 899999999886543221
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......++..|+|||...+ ...+.++|+||||++++++++|..||.... ..+....+.. +..
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-~~~~~~~~~~--~~~-------------- 218 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGET-PEEIFQNILN--GKI-------------- 218 (265)
T ss_pred cccCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhc--CCc--------------
Confidence 1223456788999999877 558899999999999999999999984322 1211111111 000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCH---HHHhcCCCcchhh
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA---REAMAHPYFAQVR 329 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~---~ell~hp~~~~~~ 329 (338)
.+. ....++..+.+++.+||+.+|.+|||+ .++|+||||+++.
T Consensus 219 -------------~~~------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 219 -------------EWP------EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred -------------CCC------ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence 000 000147899999999999999999999 9999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=280.85 Aligned_cols=244 Identities=17% Similarity=0.327 Sum_probs=191.5
Q ss_pred CCcEEEEEeeeecCceeEEEEEEc----CCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINV----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
-++|++.+.||+|+||+||+|.+. .++..+++|.+.... ...+.+|+.+++.+ +|||++++++.+.. ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~ 80 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-HHPNIVCLLGVVTQ--EQ 80 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEec--CC
Confidence 368999999999999999999853 456789999987432 24577899999999 99999999999855 45
Q ss_pred ccEEEEeeecCCccccccC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC
Q 019642 109 TPSLIFEYVNSTDFKVLYP--------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 168 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~--------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~ 168 (338)
..+++|||+.+++|..++. .+++..+..++.|++.||.|||++|++|+||||+||+++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 6889999999998877651 36788889999999999999999999999999999999987
Q ss_pred CCceEEEeccccccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHH
Q 019642 169 LRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLV 244 (338)
Q Consensus 169 ~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~ 244 (338)
+.++|+|||++........ .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.. .+..+...
T Consensus 161 -~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~-~~~~~~~~ 237 (283)
T cd05090 161 -LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYG-FSNQEVIE 237 (283)
T ss_pred -CcEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHH
Confidence 7899999999876533221 122334567999999876 578999999999999999998 8888732 22222222
Q ss_pred HHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 245 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
.+.. .... ..+..+++.+.+++.+||+.||++||++.+++++
T Consensus 238 ~~~~-~~~~-----------------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 238 MVRK-RQLL-----------------------------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHc-CCcC-----------------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 2111 0000 0112267899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=285.42 Aligned_cols=243 Identities=18% Similarity=0.315 Sum_probs=191.1
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCce----EEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNER----CIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
..+|++.+.||+|+||+||+|.+..+++. |++|.++... .+.+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~~--- 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS--- 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcCC---
Confidence 46899999999999999999987666554 8999986432 35677899999999 999999999988543
Q ss_pred ccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 109 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
..++++||+.++++.+.+. .++...+..++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++....
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~-~~~kl~DfG~a~~~~ 160 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTP-QHVKITDFGLAKLLG 160 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCC-CcEEEcccccccccc
Confidence 4679999999998877763 37888899999999999999999999999999999999988 789999999997654
Q ss_pred CCCccee---eeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhh
Q 019642 185 PGKEYNV---RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 260 (338)
Q Consensus 185 ~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
....... ...+..|+|||.+.+ ..++.++|+||||+++|++++ |..||.. . ....+..+.......
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~-~-~~~~~~~~~~~~~~~------- 230 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDG-I-PASEISSILEKGERL------- 230 (316)
T ss_pred CCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCC-C-CHHHHHHHHhCCCCC-------
Confidence 3322111 223567999999877 678999999999999999997 8888732 1 222222211100000
Q ss_pred ccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
..+...+.++.+++.+||..+|++|||+.+++++
T Consensus 231 ----------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 231 ----------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred ----------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0011257789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=280.91 Aligned_cols=245 Identities=19% Similarity=0.332 Sum_probs=189.7
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcC-----CCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
..++|++.+.||+|++|.||+|.+.. ++..+++|.++... ...+.+|+.+++.+ +||||+++++++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~-- 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ-- 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcC--
Confidence 35789999999999999999998642 35679999876422 34577899999999 99999999999844
Q ss_pred CCccEEEEeeecCCccccccCC-------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceE
Q 019642 107 SKTPSLIFEYVNSTDFKVLYPT-------------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR 173 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~~~-------------~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~ 173 (338)
....++||||+.+++|.+++.. ++...+..++.|++.||.|||+.|++|+||||+||+++.+ +.++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~-~~~~ 159 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVK 159 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCC-CCEE
Confidence 4678999999999998877532 3566788899999999999999999999999999999987 8899
Q ss_pred EEeccccccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHH
Q 019642 174 LIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKV 249 (338)
Q Consensus 174 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~ 249 (338)
|+|||++........ .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||. ..+..+.......
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~-~~~~~~~~~~~~~- 236 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQ-GMSNEQVLRFVME- 236 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCC-CCCHHHHHHHHHc-
Confidence 999999865432221 111234667999999876 678999999999999999999 677773 2222222211111
Q ss_pred hCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 250 LGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
.... ..+...++.+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~-----------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 237 GGLL-----------------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCcC-----------------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0000 0011257889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=317.30 Aligned_cols=261 Identities=27% Similarity=0.448 Sum_probs=211.2
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~------~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
....++|.+++.||+|+||.|.+++++.+++.||+|++++ ....-+..|-.+|..- +++.|++++-.|++ +
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD--~ 147 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQD--E 147 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcC--c
Confidence 4567899999999999999999999999999999999875 2345577788888876 89999999999944 6
Q ss_pred CccEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 108 KTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
.++|+||||+.||+|-.++. .+|+..++.++..|..||..+|+.|+|||||||+|||+|.. |++||+|||.+-.+.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~-GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKS-GHIKLADFGSCLKMD 226 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEeccc-CcEeeccchhHHhcC
Confidence 79999999999998877764 48999999999999999999999999999999999999999 999999999887765
Q ss_pred C-CC-cceeeeccccccccccccC---c-CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhh
Q 019642 185 P-GK-EYNVRVASRYFKGPELLVD---L-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 258 (338)
Q Consensus 185 ~-~~-~~~~~~~~~~y~aPE~~~~---~-~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
. +. .....+|||-|.+||++.. + +.|++.+|-||+|+.+|+|+.|..|||... -.+..-.|......
T Consensus 227 ~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads-lveTY~KIm~hk~~------ 299 (1317)
T KOG0612|consen 227 ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS-LVETYGKIMNHKES------ 299 (1317)
T ss_pred CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH-HHHHHHHHhchhhh------
Confidence 3 22 3455789999999999832 2 468899999999999999999999996322 11222111111000
Q ss_pred hhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCC---HHHHhcCCCcchhhhccc
Q 019642 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT---AREAMAHPYFAQVRAAES 333 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt---~~ell~hp~~~~~~~~~~ 333 (338)
+.-.....+|.+.++||.+++ -+|+.|.. ++++-+||||.++.+...
T Consensus 300 ---------------------------l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W~~i 349 (1317)
T KOG0612|consen 300 ---------------------------LSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDWDNI 349 (1317)
T ss_pred ---------------------------cCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCChhhh
Confidence 000011228999999999998 57888887 999999999999988543
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=308.67 Aligned_cols=244 Identities=22% Similarity=0.360 Sum_probs=191.0
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
++|++.+.||+|+||.||+|.+..+++.||+|.+... ..+.+.+|+.+++++ +|||++++++.+.+ ....+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-~HPNIVkl~~v~~d--~~~ly 78 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVYSICSD--GDPVY 78 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-CCcCcCeEEEEEee--CCEEE
Confidence 6899999999999999999999999999999998642 134678899999999 99999999999854 45789
Q ss_pred EEEeeecCCccccccC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEec
Q 019642 112 LIFEYVNSTDFKVLYP--------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW 177 (338)
Q Consensus 112 lv~e~~~~~~l~~~~~--------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~df 177 (338)
++|||+.|++|..++. ..+...+..++.|++.||.+||+.|++|+||||+||+++.+ +.++|+||
T Consensus 79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~d-g~vKLiDF 157 (932)
T PRK13184 79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLF-GEVVILDW 157 (932)
T ss_pred EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCC-CCEEEEec
Confidence 9999999999877652 24456778899999999999999999999999999999988 88999999
Q ss_pred cccccccCCC-------------------cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCC
Q 019642 178 GLAEFYHPGK-------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 238 (338)
Q Consensus 178 g~~~~~~~~~-------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~ 238 (338)
|++....... ......||+.|+|||...+ ..++.++|+||||+++|+|++|..||.....
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~~ 236 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKKG 236 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence 9986541110 0112358999999999877 6789999999999999999999999843211
Q ss_pred CHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHH
Q 019642 239 NHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 318 (338)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~e 318 (338)
...... .....+. . ......+++.+.+++.+||+.||++|++..+
T Consensus 237 -~ki~~~--~~i~~P~--~------------------------------~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~e 281 (932)
T PRK13184 237 -RKISYR--DVILSPI--E------------------------------VAPYREIPPFLSQIAMKALAVDPAERYSSVQ 281 (932)
T ss_pred -hhhhhh--hhccChh--h------------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 111100 0000000 0 0001126889999999999999999987665
Q ss_pred Hhc
Q 019642 319 AMA 321 (338)
Q Consensus 319 ll~ 321 (338)
.+.
T Consensus 282 eLl 284 (932)
T PRK13184 282 ELK 284 (932)
T ss_pred HHH
Confidence 553
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=279.55 Aligned_cols=246 Identities=19% Similarity=0.343 Sum_probs=192.1
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcC-----CCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
..++|++.+.||+|++|.||+|.+.. ++..|++|...... ...+..|+.+++.+ +|+||+++++++.+
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-- 80 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-NHQNIVRLIGVSFE-- 80 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcc--
Confidence 35789999999999999999999877 77889999876432 34577899999999 99999999998855
Q ss_pred CCccEEEEeeecCCccccccC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC--CCceEE
Q 019642 107 SKTPSLIFEYVNSTDFKVLYP----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRL 174 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~--~~~~~l 174 (338)
....+++|||+.+++|..++. .+++..+..++.|++.||.|||++|++|+||||+||+++.+ ...++|
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 356789999999999987752 37888999999999999999999999999999999999764 236899
Q ss_pred EeccccccccCCCcc---eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHh
Q 019642 175 IDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVL 250 (338)
Q Consensus 175 ~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~ 250 (338)
+|||++......... .....+..|+|||.+.+ ..++.++||||||+++|+|++ |..||. ..+..+....+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~-~~~~~~~~~~~~--- 235 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYP-GRTNQEVMEFVT--- 235 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCC-CCCHHHHHHHHH---
Confidence 999998765322111 11223457999999876 578999999999999999997 888883 222222211110
Q ss_pred CCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 251 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
.... ...+..++.++.+++.+||+.+|++|||+.++++|
T Consensus 236 ~~~~---------------------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 236 GGGR---------------------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred cCCc---------------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0000 00112267899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=282.12 Aligned_cols=251 Identities=25% Similarity=0.426 Sum_probs=200.4
Q ss_pred EEEeeeecCceeEEEEEEcCCCceEEEEEecc---cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeec
Q 019642 42 VVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN 118 (338)
Q Consensus 42 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 118 (338)
....||+|+||.||++.+..+++.+++|.+.. .....+.+|+.+++.+ +|+|++++++.+.. ....+++|||+.
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e~~~ 100 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLV--GDELWVVMEFLE 100 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhc-CCcchhheeeEEEe--CCEEEEEEecCC
Confidence 34579999999999999999999999998753 2344577899999999 89999999999855 567899999999
Q ss_pred CCcccccc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-cceeeecc
Q 019642 119 STDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVAS 195 (338)
Q Consensus 119 ~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~ 195 (338)
++++..+. ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.+ +.++|+|||.+....... ......++
T Consensus 101 ~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~ 179 (292)
T cd06657 101 GGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRKSLVGT 179 (292)
T ss_pred CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEcccccceecccccccccccccC
Confidence 99998876 347889999999999999999999999999999999999988 789999999876543222 12234578
Q ss_pred ccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhc
Q 019642 196 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVG 275 (338)
Q Consensus 196 ~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (338)
..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.. .+..+....+...... .
T Consensus 180 ~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~-~~~~~~~~~~~~~~~~-~--------------------- 235 (292)
T cd06657 180 PYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPP-K--------------------- 235 (292)
T ss_pred ccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhhCCc-c---------------------
Confidence 88999998866 5678999999999999999999999842 2222222211111000 0
Q ss_pred cccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 276 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
......++..+.+++.+||+.+|.+||++.++++||||.....++
T Consensus 236 ------------~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~ 280 (292)
T cd06657 236 ------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPS 280 (292)
T ss_pred ------------cCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCCc
Confidence 000112578899999999999999999999999999999887543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=271.71 Aligned_cols=292 Identities=29% Similarity=0.470 Sum_probs=230.5
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEec-----ccchHHHHHHHHHHHHhcCCCCeeEeeeeeecc-----
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----- 105 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~-----~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~----- 105 (338)
..+.|+-..+||+|.||.||+|+..++++.|++|+.- .-......+|+.+++.+ +|+|++.+++++...
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~l-kHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPTN 93 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHh-cchhHHHHHHHHhhccCCcc
Confidence 4567888899999999999999999999999988642 22345567899999999 999999999887531
Q ss_pred -CCCccEEEEeeecCCc---cccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 106 -HSKTPSLIFEYVNSTD---FKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 106 -~~~~~~lv~e~~~~~~---l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
.....++|+.+|.... |.+...+++...+++++.+++.||.|+|...|+|+|+||.|+|++.+ +.++|+|||+++
T Consensus 94 r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~d-gilklADFGlar 172 (376)
T KOG0669|consen 94 RDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKD-GILKLADFGLAR 172 (376)
T ss_pred cccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCC-ceEEeecccccc
Confidence 1234789999998754 45555679999999999999999999999999999999999999998 899999999996
Q ss_pred cccCC-----CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhh
Q 019642 182 FYHPG-----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 256 (338)
Q Consensus 182 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (338)
.+... .....+..|.+|++||.+.+...++++.|+|..||++.+|+|+.+. .++..+..++..+....|.....
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspi-mqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPI-MQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcc-ccCChHHHHHHHHHHHhccCCcc
Confidence 55432 2345567799999999999999999999999999999999998855 57888888999999999998888
Q ss_pred hhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 257 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
.|++-...++-....... -..+...+..+...+-.-.++..+|+.++|..||.+|++++++|+|.||..-+.+.
T Consensus 252 vWP~~d~lpL~~sie~eP--l~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~pq 325 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEP--LPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMPQ 325 (376)
T ss_pred cCCCcccchHHHhccCCC--CCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcch
Confidence 887665554433221110 11111111111111111256889999999999999999999999999998776653
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=275.91 Aligned_cols=242 Identities=19% Similarity=0.309 Sum_probs=190.6
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
..++|++.++||+|++|.||+|.+..+ ..+++|.++.. ..+.+.+|+.+++.+ +||||+++++.+.. ...+++
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~---~~~~lv 78 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIV 78 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhC-CCCCcceEEEEECC---CCcEEE
Confidence 357899999999999999999987655 45999998743 345688999999999 89999999998732 357899
Q ss_pred EeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 114 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 114 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
|||+.+++|.+++. .++...+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~-~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEY 157 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCC-CcEEeccCCceeecccccc
Confidence 99999999887764 37888999999999999999999999999999999999987 7899999999875543322
Q ss_pred c--eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 189 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 189 ~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
. ....++..|+|||...+ ..++.++|+||||+++|++++ |..||. .....+....+......
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~-~~~~~~~~~~~~~~~~~------------- 222 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYP-GMVNREVLDQVERGYRM------------- 222 (262)
T ss_pred ccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCC-CCChHHHHHHHhcCCCC-------------
Confidence 1 12234567999998866 578999999999999999999 777773 22222222211100000
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
.....++..+.+++.+|++.||++|||+.++++
T Consensus 223 -----------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 223 -----------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred -----------------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 001126788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=294.68 Aligned_cols=246 Identities=15% Similarity=0.330 Sum_probs=195.7
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
....++..+...||+|.||+||+|.+.. .||||+++-. ..+.+++|+.++++- .|.||+-+.+++... .
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkT-RH~NIlLFMG~~~~p--~ 461 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKT-RHENILLFMGACMNP--P 461 (678)
T ss_pred ccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhc-chhhheeeehhhcCC--c
Confidence 3445778899999999999999998754 5999998732 346789999999998 999999999999553 3
Q ss_pred ccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccc--
Q 019642 109 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF-- 182 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~-- 182 (338)
. .||.-+|+|.+|..++. ++.......|++|+++|+.|||.++|+|+|||..||++..+ +.|||+|||+++.
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~-~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHED-LKVKIGDFGLATVKT 539 (678)
T ss_pred e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccC-CcEEEecccceeeee
Confidence 3 89999999999988874 48888999999999999999999999999999999999998 8999999999843
Q ss_pred -ccCCCcceeeeccccccccccccC--cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHH-HHHHHHHhCCchhhhh
Q 019642 183 -YHPGKEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ-LVKIAKVLGTDELNAY 258 (338)
Q Consensus 183 -~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~ 258 (338)
+..........+...|+|||++.. ..++++.+||||||+++|||++|..||- .++.++ +...-+....++.-
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys--i~~~dqIifmVGrG~l~pd~s-- 615 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS--IQNRDQIIFMVGRGYLMPDLS-- 615 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC--CCChhheEEEecccccCccch--
Confidence 233334444567788999999854 2479999999999999999999999993 333322 11111111111110
Q ss_pred hhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
....+.++++++|+..|+..+|++||.+.+||.
T Consensus 616 ------------------------------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 616 ------------------------------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ------------------------------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 011125679999999999999999999999987
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=280.07 Aligned_cols=245 Identities=24% Similarity=0.449 Sum_probs=194.7
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
++|++.+.||+|++|.||++.+..++..+++|.+... ....+.+|+.+++.+ +|||++++++.+.. ....+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~ 78 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIE--DNELN 78 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEe--CCeEE
Confidence 5789999999999999999999999999999987532 234677899999999 99999999999855 45788
Q ss_pred EEEeeecCCccccccC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 112 LIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 112 lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
++|||+.+++|..++. .+++..++.++.|++.||.+||++|++|+||+|+||+++.+ +.++|+|||.+....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~ 157 (267)
T cd08229 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFS 157 (267)
T ss_pred EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CCEEECcchhhhccc
Confidence 9999999999887652 37889999999999999999999999999999999999987 789999999886554
Q ss_pred CCCc-ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccc
Q 019642 185 PGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263 (338)
Q Consensus 185 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
.... .....++..|+|||.+.+ ...+.++|+||||+++|+|++|..||............ .......
T Consensus 158 ~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~-------- 225 (267)
T cd08229 158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK---KIEQCDY-------- 225 (267)
T ss_pred cCCcccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh---hhhcCCC--------
Confidence 3222 223467888999999876 67889999999999999999999998533222111111 1000000
Q ss_pred cccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
.......++.++.+++.+||+.||++|||+.+|++
T Consensus 226 -----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 226 -----------------------PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred -----------------------CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 00011126789999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=275.06 Aligned_cols=242 Identities=19% Similarity=0.317 Sum_probs=191.8
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
.++|++.+.||+|++|.||+|.+. +++.|++|.++.. ..+.+.+|+.+++++ +|||++++++++.. ....+++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 80 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKL-RHPKLIQLYAVCTL--EEPIYIVT 80 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHC-CCCCccceeEEEec--CCCeeeee
Confidence 578999999999999999999865 4567999998753 346688999999999 89999999999854 45688999
Q ss_pred eeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcc
Q 019642 115 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189 (338)
Q Consensus 115 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~ 189 (338)
||+.+++|.+++. .++...+..++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||++.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGEN-NICKVADFGLARVIKEDIYE 159 (261)
T ss_pred ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCC-CCEEECCcceEEEccCCccc
Confidence 9999999987763 37899999999999999999999999999999999999988 78999999998765422211
Q ss_pred e--eeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 190 N--VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 190 ~--~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
. ....+..|+|||...+ ..++.++|+||||++++++++ |+.||. +.+.......+.....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~-~~~~~~~~~~~~~~~~--------------- 222 (261)
T cd05068 160 AREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYP-GMTNAEVLQQVDQGYR--------------- 222 (261)
T ss_pred ccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCC-CCCHHHHHHHHHcCCC---------------
Confidence 1 1122347999999876 678999999999999999999 888873 2222222221111000
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
...+...+..+.+++.+||+.+|++||++.++++
T Consensus 223 ---------------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 223 ---------------------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred ---------------------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 0011125789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=283.22 Aligned_cols=250 Identities=26% Similarity=0.399 Sum_probs=196.6
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
+.|...++||+|+||+||+|.+..+++.+++|.+.... ...+.+|+.+++.+ +|||++++++++.+ ....+
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~ 97 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEYKGCYLK--EHTAW 97 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEe--CCEEE
Confidence 34777888999999999999999999999999976321 24577899999999 89999999999855 45788
Q ss_pred EEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 112 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 112 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
++|||+.+..+.... ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.+ +.++|+|||++.... .
T Consensus 98 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~-~~~kL~dfg~~~~~~---~ 173 (313)
T cd06633 98 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP-GQVKLADFGSASKSS---P 173 (313)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCC-CCEEEeecCCCcccC---C
Confidence 999999765444332 348899999999999999999999999999999999999987 789999999875432 2
Q ss_pred ceeeeccccccccccccC--cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 189 YNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.....++..|+|||.+.. ...++.++|+||||+++|+|++|..||..... .......... ..+
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-~~~~~~~~~~-~~~------------- 238 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQN-DSP------------- 238 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhc-CCC-------------
Confidence 233467888999999742 24688899999999999999999999843322 2222111110 000
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
......++..+.+|+.+||+.+|++||++.++++||||...+.
T Consensus 239 ---------------------~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~ 281 (313)
T cd06633 239 ---------------------TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRP 281 (313)
T ss_pred ---------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCch
Confidence 0001125778999999999999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=277.94 Aligned_cols=244 Identities=19% Similarity=0.339 Sum_probs=192.6
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCC-----ceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
..++|++.+.||+|+||.||++.+...+ ..+++|.+.... ...+.+|+.+++.+ +|||++++++++..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~-- 80 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-NCHHVVRLLGVVST-- 80 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEcC--
Confidence 4679999999999999999999876443 789999976432 34577899999999 99999999999854
Q ss_pred CCccEEEEeeecCCccccccC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceE
Q 019642 107 SKTPSLIFEYVNSTDFKVLYP-------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR 173 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~~-------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~ 173 (338)
....+++|||+.+++|..++. .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~-~~~k 159 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAED-LTVK 159 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCC-CCEE
Confidence 467899999999999887763 25677889999999999999999999999999999999998 8999
Q ss_pred EEeccccccccCCC---cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHH
Q 019642 174 LIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKV 249 (338)
Q Consensus 174 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~ 249 (338)
|+|||++....... ......++..|+|||.+.+ ..++.++|+||||+++|++++ |..||. ..+..+....+ ..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~-~~~~~~~~~~~-~~ 236 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQ-GLSNEEVLKFV-ID 236 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCc-cCCHHHHHHHH-hc
Confidence 99999986543322 1122345678999999876 578999999999999999998 888873 22222222211 10
Q ss_pred hCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 250 LGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
... ...+..++.++.+++.+||+.+|++|||+.++++
T Consensus 237 ~~~-----------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 237 GGH-----------------------------------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCC-----------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000 0011225789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=281.10 Aligned_cols=247 Identities=18% Similarity=0.341 Sum_probs=192.4
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCC-----ceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeecc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQ 105 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 105 (338)
...++|++.+.||+|+||.||++.+...+ ..+++|.+.... ...+.+|+.+++++.+||||+++++++..
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~- 87 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ- 87 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC-
Confidence 34578999999999999999999876443 679999886432 23477899999998779999999999854
Q ss_pred CCCccEEEEeeecCCcccccc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEec
Q 019642 106 HSKTPSLIFEYVNSTDFKVLY-------------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 166 (338)
Q Consensus 106 ~~~~~~lv~e~~~~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~ 166 (338)
....+++|||+.+++|..++ ..+++..+..++.|++.||.|||+.|++|+||||+||+++
T Consensus 88 -~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 88 -EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166 (293)
T ss_pred -CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence 45789999999999887665 2378889999999999999999999999999999999999
Q ss_pred CCCCceEEEeccccccccCCCcc---eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHH
Q 019642 167 HELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQ 242 (338)
Q Consensus 167 ~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~ 242 (338)
.+ +.++|+|||.+......... ....++..|+|||.+.+ ..++.++|+||||+++|++++ |..||.. ....+.
T Consensus 167 ~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~ 243 (293)
T cd05053 167 ED-HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPVEEL 243 (293)
T ss_pred CC-CeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCC-CCHHHH
Confidence 87 89999999998765432211 11223457999999876 678999999999999999997 8888732 222221
Q ss_pred HHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 243 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
...+... . . ...+...+.++.+|+.+||+.||++|||+.+++++
T Consensus 244 ~~~~~~~----~------------------------~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 244 FKLLKEG----Y------------------------R--------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHcC----C------------------------c--------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 1111100 0 0 00112257899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=282.28 Aligned_cols=246 Identities=21% Similarity=0.351 Sum_probs=192.2
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEc-----CCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
..++|.+.+.||+|+||.||++.+. .++..+++|.++... .+.+.+|+.+++++.+||||+++++.+..
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 110 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI-- 110 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec--
Confidence 3568999999999999999999752 345679999886432 34578899999999679999999999855
Q ss_pred CCccEEEEeeecCCccccccCC-----CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 107 SKTPSLIFEYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
....+++|||+.+++|..++.. +++.++..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||.+.
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~~l~dfg~~~ 189 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHG-KIVKICDFGLAR 189 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCC-CeEEECCCcccc
Confidence 4568999999999998877632 7899999999999999999999999999999999999887 789999999987
Q ss_pred cccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhh
Q 019642 182 FYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNA 257 (338)
Q Consensus 182 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
....... .....++..|+|||.+.+ ..++.++||||+|+++|++++ |..||..... .+.+...... +.
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~-~~~~~~~~~~-~~----- 261 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPV-DSKFYKLIKE-GY----- 261 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc-hHHHHHHHHc-CC-----
Confidence 5533221 111234567999999877 568899999999999999998 8888843222 2211111110 00
Q ss_pred hhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
....+...++++.+++.+||..+|++|||+.|+++
T Consensus 262 -----------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 262 -----------------------------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred -----------------------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 00011125789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=276.42 Aligned_cols=244 Identities=16% Similarity=0.287 Sum_probs=192.5
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCC---CceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
.++|++.+.||+|+||+||+|.+..+ ...+++|.++... ...+..|+..++++ +||||+++++.+.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 79 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-DHPNIIRLEGVVTK--SRP 79 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCcceEeEEEec--CCc
Confidence 47899999999999999999988644 4579999876432 34577899999999 99999999999854 457
Q ss_pred cEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 110 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
.+++|||+.+++|..++. .++...+..++.|++.||.+||++|++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~-~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSRRLED 158 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-CCEEECccchhhcccc
Confidence 889999999999988763 48899999999999999999999999999999999999988 7899999999876642
Q ss_pred CCcc-e--eeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 186 GKEY-N--VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 186 ~~~~-~--~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
.... . ...++..|+|||.+.+ ..++.++|+||||+++|++++ |..||.... ..+....+.+....
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~-~~~~~~~~~~~~~~--------- 227 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMS-NQDVIKAVEDGYRL--------- 227 (266)
T ss_pred cccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHHcCCCC---------
Confidence 2111 1 1233467999999876 678899999999999999998 998984322 11111111110000
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
..+...++.+.+++.+||+.+|++||++.+++++
T Consensus 228 ---------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 228 ---------------------------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ---------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0011267899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=278.79 Aligned_cols=255 Identities=23% Similarity=0.439 Sum_probs=200.6
Q ss_pred cEEEEEeeeecCceeEEEEEEc---CCCceEEEEEeccc-------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 39 DYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~-------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
+|++.+.||.|+||.||.+.+. .+++.|++|.++.. ..+.+.+|+.+++.+.+|++|+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--DT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec--CC
Confidence 5899999999999999999874 47889999998642 235577899999999779999999999854 45
Q ss_pred ccEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 109 TPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
..++||||+.+++|.+++. .+++..+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFHE 157 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCC-CCEEEeeCccceeccc
Confidence 7889999999999887763 48899999999999999999999999999999999999988 8999999998865533
Q ss_pred CC--cceeeeccccccccccccCc-CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcc
Q 019642 186 GK--EYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262 (338)
Q Consensus 186 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
.. ......++..|+|||.+.+. ..++.++|+||||+++|++++|..||..... ......+.+......
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~-------- 228 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILKSE-------- 228 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhccC--------
Confidence 22 11234578889999998652 3467899999999999999999999842211 111111111110000
Q ss_pred ccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC-----CHHHHhcCCCcchhhh
Q 019642 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRA 330 (338)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~ 330 (338)
. ..+..++..+.+++++||+.||++|| +++++++||||..+..
T Consensus 229 -----------------~--------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 276 (290)
T cd05613 229 -----------------P--------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276 (290)
T ss_pred -----------------C--------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence 0 01122678899999999999999997 8999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=278.19 Aligned_cols=242 Identities=19% Similarity=0.337 Sum_probs=194.7
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
..+|++.+.||.|+||.||+|.+.. +..+++|.+.... ...+..|+.+++.+ +|||++++++++.+ ....+++
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHLISLFAVCSV--GEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcC-CCcchhheeeeEec--CCCeEEE
Confidence 4689999999999999999999877 8889999987543 45688899999999 99999999999854 4578899
Q ss_pred EeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 114 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 114 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
|||+.+++|.+++. .++...+..++.|++.||.+||++|++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~-~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGED-LVCKVADFGLARLIKEDVY 159 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCC-ceEEEccccchhhcCCccc
Confidence 99999999988864 37889999999999999999999999999999999999988 8999999999865532211
Q ss_pred -ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 189 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 189 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.....++..|+|||...+ ..++.++|+||||+++|+|++ |..||.. .+..+.+..+......
T Consensus 160 ~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-------------- 223 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPG-MNNHEVYDQITAGYRM-------------- 223 (261)
T ss_pred cccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHHhCCcC--------------
Confidence 112234567999999876 678899999999999999998 7888832 2222222222110000
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
..+..+++.+.+++.+||+.||++|||+.++++
T Consensus 224 ----------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 224 ----------------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred ----------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 011226889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=287.92 Aligned_cols=247 Identities=21% Similarity=0.337 Sum_probs=189.9
Q ss_pred CCcEEEEEeeeecCceeEEEEEE-----cCCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGIN-----VNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
.++|++.+.||+|+||.||+|.+ ..+++.||+|.++... ...+.+|+.++.++.+|||++++++.+... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-C
Confidence 47899999999999999999985 3467889999986422 345778999999997789999999987544 3
Q ss_pred CccEEEEeeecCCccccccC------------------------------------------------------------
Q 019642 108 KTPSLIFEYVNSTDFKVLYP------------------------------------------------------------ 127 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------ 127 (338)
...+++|||+.+++|.+++.
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 46789999999998876542
Q ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc---ceeeec
Q 019642 128 ----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVA 194 (338)
Q Consensus 128 ----------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~ 194 (338)
.++...+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++........ .....+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCC-CcEEEEecccccccccCcchhhcCCCCC
Confidence 25667788899999999999999999999999999999987 7999999999865432211 111234
Q ss_pred cccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhh
Q 019642 195 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL 273 (338)
Q Consensus 195 ~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (338)
+..|+|||.+.+ ..++.++|+||||+++|++++ |..||............+... .
T Consensus 244 ~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~--------------------- 299 (343)
T cd05103 244 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG--T--------------------- 299 (343)
T ss_pred CcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhcc--C---------------------
Confidence 567999999876 678999999999999999997 888874322221111111000 0
Q ss_pred hccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 274 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
. ...+...++++.+++..||+.||++|||+.++++|
T Consensus 300 -----~--------~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 300 -----R--------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred -----C--------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0 00011257789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=277.41 Aligned_cols=261 Identities=20% Similarity=0.366 Sum_probs=194.3
Q ss_pred CCcEEEEEeeeecCceeEEEEE----EcCCCceEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~---~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
..+|++.+.||+|+||.||++. +..++..|++|.++... .+.+.+|+.+++.+ +|||++++++++.......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEccCCCCc
Confidence 4689999999999999999997 44678899999987543 34577899999999 9999999999876555567
Q ss_pred cEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 110 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
.+++|||+.+++|..++. .+++..+..++.|++.||.+||++|++|+||||+||+++.+ +.++|+|||++.....
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~-~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESE-NRVKIGDFGLTKVLPQ 160 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCC-CeEEECCCcccccccC
Confidence 899999999999988763 37899999999999999999999999999999999999988 7899999999876543
Q ss_pred CCcc----eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 186 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 186 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
.... ....++..|+|||...+ ..++.++|+||||+++++|++|..++..... . ..+..+......
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~----~~~~~~~~~~~~---- 229 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPA--E----FMRMMGNDKQGQ---- 229 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcch--h----hhhhcccccccc----
Confidence 2221 11123345999999876 6788999999999999999998776522111 1 111111110000
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
.....+......... ...+..++.++.+++.+||+.+|++|||+.++++
T Consensus 230 ---~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 230 ---MIVYHLIELLKNNGR--------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred ---cchHHHHHHHhcCCc--------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 000000000000000 0112336889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=289.77 Aligned_cols=235 Identities=18% Similarity=0.298 Sum_probs=193.6
Q ss_pred EEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeecCC
Q 019642 41 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST 120 (338)
Q Consensus 41 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~ 120 (338)
.-++=||+|+.|.||+|+. .++.||||+++ +.-+.+|.-|++| +||||+.+.++|.. ...+|||||||..|
T Consensus 127 sELeWlGSGaQGAVF~Grl--~netVAVKKV~----elkETdIKHLRkL-kH~NII~FkGVCtq--sPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRL--HNETVAVKKVR----ELKETDIKHLRKL-KHPNIITFKGVCTQ--SPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhhccCcccceeeeec--cCceehhHHHh----hhhhhhHHHHHhc-cCcceeeEeeeecC--CceeEEeeeccccc
Confidence 3467799999999999975 56789999765 2234578999999 99999999999944 56789999999999
Q ss_pred ccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcceeeecccc
Q 019642 121 DFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 197 (338)
Q Consensus 121 ~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 197 (338)
.|...++ .++......+..+|+.|+.|||.+.|+|+|||..||||+.+ ..|||+|||-+.........-...||..
T Consensus 198 qL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~-d~VKIsDFGTS~e~~~~STkMSFaGTVa 276 (904)
T KOG4721|consen 198 QLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYD-DVVKISDFGTSKELSDKSTKMSFAGTVA 276 (904)
T ss_pred cHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeecc-ceEEeccccchHhhhhhhhhhhhhhhHh
Confidence 9988874 48889999999999999999999999999999999999998 7899999999877766555566899999
Q ss_pred ccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccc
Q 019642 198 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRH 277 (338)
Q Consensus 198 y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (338)
|||||++.+ .+++.|+||||||++||+|+||..||-.-.. ...+. ..|..
T Consensus 277 WMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sAIIw-GVGsN------------------------ 326 (904)
T KOG4721|consen 277 WMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SAIIW-GVGSN------------------------ 326 (904)
T ss_pred hhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccch----heeEE-eccCC------------------------
Confidence 999999998 8999999999999999999999999821111 00000 00100
Q ss_pred cCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 278 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 278 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
-+....+...++-+.=||+.||+-.|.+||++.++|.|
T Consensus 327 -------sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 327 -------SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred -------cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 01122333468889999999999999999999999998
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=274.16 Aligned_cols=242 Identities=17% Similarity=0.330 Sum_probs=192.2
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
..++|++.++||+|+||.||+|... +++.+++|.+... ....+.+|+.+++++ +|||++++++.+.. ...+++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~~~~v 78 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPRLVRLYAVVTQ---EPIYII 78 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhc-CCcCeeeEEEEEcc---CCcEEE
Confidence 3578999999999999999999854 5678999988743 346788999999999 99999999998733 457899
Q ss_pred EeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 114 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 114 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
||++.+++|.+++. .++...+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSET-LCCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCC-CCEEEccCcceeecCCCCc
Confidence 99999999887752 47888999999999999999999999999999999999988 7899999999865542221
Q ss_pred --ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 189 --YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 189 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
.....++..|+|||.+.. ..++.++|+||||+++|++++ |..||. +.+..+....+......
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~-~~~~~~~~~~~~~~~~~------------- 222 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYP-GMTNPEVIQNLERGYRM------------- 222 (260)
T ss_pred ccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCC-CCChHHHHHHHHcCCCC-------------
Confidence 112234567999999876 578899999999999999998 998884 22322222222110000
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
..+...+.++.+++.+||+.+|++|||++++++
T Consensus 223 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 223 -----------------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred -----------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 011225789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=275.47 Aligned_cols=243 Identities=17% Similarity=0.304 Sum_probs=191.5
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
..+|++.+.||+|+||.||++.+. ++..+++|.+... ....+.+|+.+++.+ +|||++++++++.. ....+++|
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKL-SHPNLVQLYGVCTK--QRPIFIVT 78 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEEEEEEEEcC--CCceEEEE
Confidence 357899999999999999999875 4667999988643 345678899999999 99999999999844 45789999
Q ss_pred eeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcce
Q 019642 115 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 190 (338)
Q Consensus 115 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~ 190 (338)
||+.+++|.+++. .+++..+..++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||.+..........
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGED-NVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCC-CcEEECCcccceecccccccc
Confidence 9999999887753 37889999999999999999999999999999999999988 889999999886543222111
Q ss_pred --eeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 191 --VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 191 --~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
...++..|+|||.+.+ ..++.++|+||||+++|++++ |..||.. .+..+....+.....
T Consensus 158 ~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~---------------- 219 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYER-FSNSEVVESVSAGYR---------------- 219 (256)
T ss_pred cCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHHHcCCc----------------
Confidence 1123347999999877 678899999999999999999 7888742 222222221111000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
...+...+.++.+++.+||..+|++|||+.++++.
T Consensus 220 --------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 220 --------------------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred --------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 00112268899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=285.41 Aligned_cols=267 Identities=20% Similarity=0.325 Sum_probs=201.6
Q ss_pred ceeeeeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEeeeeeecc
Q 019642 29 SSYVIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQ 105 (338)
Q Consensus 29 ~~~~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 105 (338)
+...+...+++|.-...||+|+||+||+|.... +..||||.+.... ..++.+|+.++.++ +|||+|+++++|.+.
T Consensus 66 s~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l-~H~Nlv~LlGyC~e~ 143 (361)
T KOG1187|consen 66 SYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRL-RHPNLVKLLGYCLEG 143 (361)
T ss_pred eHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcC-CCcCcccEEEEEecC
Confidence 444556677999999999999999999998654 4899999887543 46799999999999 799999999999664
Q ss_pred CCCccEEEEeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCCeEecCCCCceEEEec
Q 019642 106 HSKTPSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDW 177 (338)
Q Consensus 106 ~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~~~l~df 177 (338)
.. ..++|+||+..|+|.+++. .+++....+|+.+++.||+|||+.. |+|+||||+|||+|.+ .+.||+||
T Consensus 144 ~~-~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~-~~aKlsDF 221 (361)
T KOG1187|consen 144 GE-HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED-FNAKLSDF 221 (361)
T ss_pred Cc-eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC-CCEEccCc
Confidence 32 5889999999999988863 5789999999999999999999864 9999999999999988 79999999
Q ss_pred cccccccC-CCcceee-eccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCC-CHHHHHHHH-HHhCCc
Q 019642 178 GLAEFYHP-GKEYNVR-VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD-NHDQLVKIA-KVLGTD 253 (338)
Q Consensus 178 g~~~~~~~-~~~~~~~-~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~-~~~~~~~~~-~~~~~~ 253 (338)
|++...+. ....... .||.+|+|||.... ...+.++||||||++|.+++||+.+...... ....+..+. ..+...
T Consensus 222 GLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~ 300 (361)
T KOG1187|consen 222 GLAKLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG 300 (361)
T ss_pred cCcccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence 99965543 2222222 79999999999877 7899999999999999999999988754331 111122222 222221
Q ss_pred hhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 254 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
....+.+ +.+.. ..... ...-..+..+...|++.+|.+||++.|+++
T Consensus 301 ~~~eiiD-------~~l~~-------~~~~~-------~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 301 KLREIVD-------PRLKE-------GEYPD-------EKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred chhheeC-------CCccC-------CCCCh-------HHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1111111 11100 00000 001234678889999999999999999754
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=279.49 Aligned_cols=243 Identities=20% Similarity=0.347 Sum_probs=191.8
Q ss_pred CCcEEEEEeeeecCceeEEEEEEc-----CCCceEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~---~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
..+|.+.+.||+|+||.||++.+. .++..+++|.++... .+.+.+|+..++++ +||||+++++.+.. ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHIVKFYGVCGD--GD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcC-CCCCcceEEEEEcc--CC
Confidence 467999999999999999999854 345568889876543 35688999999999 99999999999854 56
Q ss_pred ccEEEEeeecCCccccccC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCC
Q 019642 109 TPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL 169 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 169 (338)
..++||||+.+++|.+++. .+++..++.++.|++.||.+||++|++|+||||+||+++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~- 159 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN- 159 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC-
Confidence 7899999999999887752 26888999999999999999999999999999999999988
Q ss_pred CceEEEeccccccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHH
Q 019642 170 RKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVK 245 (338)
Q Consensus 170 ~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~ 245 (338)
+.++|+|||++........ .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||... +..+....
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~-~~~~~~~~ 237 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQL-SNTEVIEC 237 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHH
Confidence 7999999999865433221 122345678999999877 678899999999999999998 89887432 22222111
Q ss_pred HHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 246 IAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
+.. ... . ..+..++..+.+++.+||+.||++|||+.++++
T Consensus 238 ~~~----~~~---------------------------~-----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 238 ITQ----GRV---------------------------L-----ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HhC----CCC---------------------------C-----CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 100 000 0 001125788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=278.75 Aligned_cols=258 Identities=27% Similarity=0.450 Sum_probs=199.4
Q ss_pred cEEEEEeeeecCceeEEEEEEc---CCCceEEEEEeccc-------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 39 DYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~-------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
+|++.+.||+|++|.||++.+. .+++.+++|.++.. ..+.+..|+.++.++.+||+++++++.+.. ..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~--~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT--DT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec--CC
Confidence 5899999999999999999864 46788999988632 234567899999999779999999998844 56
Q ss_pred ccEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 109 TPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
..++||||+.+++|...+. .+++..++.++.|++.+|.+||+.|++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSE-GHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEEECcccccccc
Confidence 7889999999998877653 47889999999999999999999999999999999999988 7899999998865433
Q ss_pred CCc--ceeeeccccccccccccCcC-CCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcc
Q 019642 186 GKE--YNVRVASRYFKGPELLVDLQ-DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262 (338)
Q Consensus 186 ~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
... .....++..|+|||...+.. ..+.++|+||||+++++|++|..||..... ......+.+.....
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~--------- 227 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSEISRRILKS--------- 227 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc-cchHHHHHHHHHcc---------
Confidence 221 11235788899999986532 378899999999999999999999842211 11111111110000
Q ss_pred ccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCC---HHHHhcCCCcchhhhccc
Q 019642 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT---AREAMAHPYFAQVRAAES 333 (338)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt---~~ell~hp~~~~~~~~~~ 333 (338)
. ...+..++..+.+++.+||+.||++||| +.++|+||||+++..+..
T Consensus 228 --------------~----------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~ 277 (288)
T cd05583 228 --------------K----------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDL 277 (288)
T ss_pred --------------C----------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHH
Confidence 0 0011226788999999999999999998 567899999999876543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=272.98 Aligned_cols=236 Identities=20% Similarity=0.354 Sum_probs=184.8
Q ss_pred EeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeecC
Q 019642 44 RKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS 119 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 119 (338)
+.||+|+||.||+|.+..+++.+++|.+... ....+.+|+++++.+ +||||+++++++.. ....++||||+.+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQ--KQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcC--CCCeEEEEeeccC
Confidence 3689999999999999999999999987533 235678899999999 99999999999855 4578899999999
Q ss_pred CccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcce---ee
Q 019642 120 TDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN---VR 192 (338)
Q Consensus 120 ~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~---~~ 192 (338)
++|..++. .+++..++.++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||.+.......... ..
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEK-NVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCC-CcEEECccccCcccccccccccCCCC
Confidence 99987763 37899999999999999999999999999999999999987 789999999986543221111 11
Q ss_pred eccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchh
Q 019642 193 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD 271 (338)
Q Consensus 193 ~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (338)
..+..|+|||.+.+ ..++.++|+||||+++|++++ |..||... ........+.. ...
T Consensus 157 ~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~-~~~~~~~~~~~-~~~------------------- 214 (252)
T cd05084 157 QIPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANL-SNQQTREAIEQ-GVR------------------- 214 (252)
T ss_pred CCceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccc-CHHHHHHHHHc-CCC-------------------
Confidence 22346999999876 568899999999999999997 77777321 11111111100 000
Q ss_pred hhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 272 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
...+...+..+.+++.+||+.+|++|||+.++++
T Consensus 215 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 215 ----------------LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred ----------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0011125789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=273.61 Aligned_cols=241 Identities=17% Similarity=0.334 Sum_probs=190.7
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
.++|++.+.||+|++|.||+|.+. ++..+++|.+... ..+.+.+|+.+++++ +|++++++++.+.. ...+++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~---~~~~lv~ 79 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDKLVQLYAVVSE---EPIYIVT 79 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhc-CCCceEEEEeEECC---CCcEEEE
Confidence 468999999999999999999765 5667999988743 346788999999999 99999999998732 3578999
Q ss_pred eeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcc
Q 019642 115 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189 (338)
Q Consensus 115 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~ 189 (338)
||+.+++|.+++. .+++..++.++.|++.||.+||++|++|+||+|+||+++.+ +.++|+|||.+.........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~-~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDG-LVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCC-ceEEeCCceeeeeccCcccc
Confidence 9999999887763 37889999999999999999999999999999999999987 79999999998765432211
Q ss_pred e--eeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 190 N--VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 190 ~--~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
. ...++..|+|||...+ ..++.++|+||||+++|++++ |..||. ..+..+....+......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~-~~~~~~~~~~~~~~~~~-------------- 222 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYP-GMNNREVLEQVERGYRM-------------- 222 (260)
T ss_pred cccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCC-CCCHHHHHHHHHcCCCC--------------
Confidence 1 1233457999999866 678899999999999999999 788873 33333322222110000
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
..+...+..+.+++.+||+.+|++|||+.++++
T Consensus 223 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 223 ----------------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred ----------------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 011225788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=278.01 Aligned_cols=244 Identities=17% Similarity=0.319 Sum_probs=191.1
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEc-----CCCceEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~---~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
+..+|.+.++||+|+||.||++... .++..+++|.+.... ...+.+|++.++.+ +|+||+++++++.+ .
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~ 79 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL-QHQHIVRFYGVCTE--G 79 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcC-CCCCCceEEEEEec--C
Confidence 4578999999999999999999643 356678899876433 35688899999999 99999999999855 4
Q ss_pred CccEEEEeeecCCccccccC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCC
Q 019642 108 KTPSLIFEYVNSTDFKVLYP------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL 169 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 169 (338)
...+++|||+.+++|..++. .+++..+..++.|++.||.|||+.|++|+||||+||+++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~- 158 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG- 158 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC-
Confidence 56789999999998877652 36788999999999999999999999999999999999987
Q ss_pred CceEEEeccccccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHH
Q 019642 170 RKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVK 245 (338)
Q Consensus 170 ~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~ 245 (338)
+.++|+|||++........ .....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||... ...+....
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~~~ 236 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQL-SNTEAIEC 236 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCccC-CHHHHHHH
Confidence 8999999999865432221 112234578999999877 678999999999999999998 88887432 22222211
Q ss_pred HHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 246 IAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
...... ...+..+++.+.+++.+||+.||++||++.++++
T Consensus 237 ~~~~~~------------------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 237 ITQGRE------------------------------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHcCcc------------------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 111000 0011226889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=275.53 Aligned_cols=243 Identities=19% Similarity=0.334 Sum_probs=188.4
Q ss_pred EEEEEeeeecCceeEEEEEEcCC---CceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC----
Q 019642 40 YEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---- 107 (338)
Q Consensus 40 y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~---- 107 (338)
|++.+.||+|+||.||+|....+ +..+++|.++... ...+.+|+..++.+ +|||++++++.+.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCccccC
Confidence 57889999999999999987543 4789999987432 24577899999999 99999999998754322
Q ss_pred CccEEEEeeecCCcccccc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecc
Q 019642 108 KTPSLIFEYVNSTDFKVLY---------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG 178 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg 178 (338)
...+++|||+.+++|...+ ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~dfg 158 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRED-MTVCVADFG 158 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCC-CeEEECCcc
Confidence 3478999999999887664 248899999999999999999999999999999999999988 799999999
Q ss_pred ccccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCch
Q 019642 179 LAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDE 254 (338)
Q Consensus 179 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (338)
++........ ......+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||. ..+..+....+... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~-~~~~~~~~~~~~~~---~~ 233 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYP-GVENHEIYDYLRHG---NR 233 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHcC---CC
Confidence 9876543221 111234567999999866 678999999999999999999 777773 33322222211110 00
Q ss_pred hhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 255 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
...+..++.++.+++.+||+.||++|||+.+++++
T Consensus 234 ---------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 234 ---------------------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ---------------------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00112268899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=280.72 Aligned_cols=245 Identities=19% Similarity=0.334 Sum_probs=190.3
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcC-------CCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeecc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVN-------TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQ 105 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 105 (338)
.++|.+.+.||+|+||.||++.+.. +...+++|.++... ...+..|+.+++.+.+|||++++++.+..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~- 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-
Confidence 4789999999999999999998643 23469999987432 24577899999999779999999999855
Q ss_pred CCCccEEEEeeecCCccccccC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEec
Q 019642 106 HSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 166 (338)
Q Consensus 106 ~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~ 166 (338)
....+++|||+.+++|..++. .++...+..++.|++.||.+||+.|++|+||||+||+++
T Consensus 96 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 96 -DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 174 (307)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence 457889999999998877763 267788999999999999999999999999999999999
Q ss_pred CCCCceEEEeccccccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHH
Q 019642 167 HELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQ 242 (338)
Q Consensus 167 ~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~ 242 (338)
.+ +.++|+|||.+........ .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||. .. +.+.
T Consensus 175 ~~-~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~-~~-~~~~ 250 (307)
T cd05098 175 ED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYP-GV-PVEE 250 (307)
T ss_pred CC-CcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCC-cC-CHHH
Confidence 88 7999999999865432211 111223467999999877 678899999999999999998 777773 22 2222
Q ss_pred HHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 243 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
+..... ... ....+..++.++.+++.+||..+|++|||+.+++++
T Consensus 251 ~~~~~~---~~~--------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 251 LFKLLK---EGH--------------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHH---cCC--------------------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 221111 000 000112267899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=272.13 Aligned_cols=243 Identities=18% Similarity=0.332 Sum_probs=194.2
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc--cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
..++|++.+.||+|++|+||++.+. +++.+++|.+.. ...+.+.+|+..++++ +|||++++++.+.. ....+++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v 79 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-RHDKLVQLYAVCSE--EEPIYIV 79 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhC-CCCCEeeeeeeeec--CCceEEE
Confidence 4689999999999999999999875 457799999874 3456788999999999 89999999999854 4568999
Q ss_pred EeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 114 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 114 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
||++.+++|..++. .++...+..++.|++.|+.+||++|++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGEN-LVCKIADFGLARLIEDDEY 158 (261)
T ss_pred EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCC-CCEEECccccceeccchhh
Confidence 99999999887763 47889999999999999999999999999999999999988 8999999999876543211
Q ss_pred --ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 189 --YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 189 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
......+..|+|||.+.+ ...+.++|+||+|++++++++ |+.||. +.+.......+......
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~-~~~~~~~~~~~~~~~~~------------- 223 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYP-GMTNREVLEQVERGYRM------------- 223 (261)
T ss_pred hhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHcCCCC-------------
Confidence 112234467999999876 678899999999999999998 888873 33333333322111000
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
..+...+.++.+++.+||+.+|++||+++++++
T Consensus 224 -----------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 224 -----------------------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred -----------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 011125788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=280.62 Aligned_cols=244 Identities=18% Similarity=0.318 Sum_probs=190.4
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCC-----CceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
..+|++.+.||+|+||.||+|.+..+ ++.+++|.++... ...+..|+.++..+ +||||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~--~ 80 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-QHPNIVCLLGVVTK--E 80 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC--C
Confidence 45688899999999999999987543 5789999987433 24577899999999 99999999999855 3
Q ss_pred CccEEEEeeecCCccccccC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC
Q 019642 108 KTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 168 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~ 168 (338)
...++++||+.+++|..++. .++...+..++.|++.||.+||++|++|+||||+||+++.+
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 56789999999988876651 36788899999999999999999999999999999999987
Q ss_pred CCceEEEeccccccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHH
Q 019642 169 LRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLV 244 (338)
Q Consensus 169 ~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~ 244 (338)
+.++|+|||++........ .....+++.|+|||...+ ..++.++|+||||+++|+|++ |..|| .+....+...
T Consensus 161 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~-~~~~~~~~~~ 237 (283)
T cd05091 161 -LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPY-CGYSNQDVIE 237 (283)
T ss_pred -CceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCC-CCCCHHHHHH
Confidence 7899999998865433221 122334678999999876 568899999999999999998 76676 3333222222
Q ss_pred HHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 245 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
.+... ... ..+..++..+.+++.+||+.+|.+||++.++++.
T Consensus 238 ~i~~~----~~~--------------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 238 MIRNR----QVL--------------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHcC----CcC--------------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 22110 000 0112368899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=278.32 Aligned_cols=241 Identities=20% Similarity=0.355 Sum_probs=187.2
Q ss_pred cEEEEEeeeecCceeEEEEEEcC-----CCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
+|++.+.||+|+||.||+|.+.. ....+++|.+.... ...+.+|+.+++.+ +||||+++++.+.. ...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NHPHVIKLYGACSQ--DGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCCEeeEEEEEec--CCC
Confidence 57899999999999999998753 23568888876432 34577899999999 99999999999854 456
Q ss_pred cEEEEeeecCCccccccC---------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCC
Q 019642 110 PSLIFEYVNSTDFKVLYP---------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHN 162 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~~---------------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~N 162 (338)
.++++||+.+++|..++. .++...+..++.|++.||.+||+.|++|+||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 789999999998877642 26788899999999999999999999999999999
Q ss_pred eEecCCCCceEEEeccccccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCC
Q 019642 163 VMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHD 238 (338)
Q Consensus 163 Ili~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~ 238 (338)
|+++.+ +.++|+|||++........ .....++..|+|||...+ ..++.++||||||+++++|++ |..||. +..
T Consensus 158 ill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~-~~~ 234 (290)
T cd05045 158 VLVAEG-RKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYP-GIA 234 (290)
T ss_pred EEEcCC-CcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCC-CCC
Confidence 999887 7999999999865432221 112234567999999866 678899999999999999998 888873 222
Q ss_pred CHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHH
Q 019642 239 NHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 318 (338)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~e 318 (338)
...+..... .. .....+..++.++.+++.+||+.+|++||++.+
T Consensus 235 -~~~~~~~~~---~~--------------------------------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~ 278 (290)
T cd05045 235 -PERLFNLLK---TG--------------------------------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFAD 278 (290)
T ss_pred -HHHHHHHHh---CC--------------------------------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 222111111 00 000111236789999999999999999999999
Q ss_pred Hhc
Q 019642 319 AMA 321 (338)
Q Consensus 319 ll~ 321 (338)
+++
T Consensus 279 i~~ 281 (290)
T cd05045 279 ISK 281 (290)
T ss_pred HHH
Confidence 975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=276.14 Aligned_cols=242 Identities=17% Similarity=0.323 Sum_probs=186.5
Q ss_pred EEEEeeeecCceeEEEEEEcCCCc--eEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeecc----CCCc
Q 019642 41 EVVRKVGRGKYSEVFEGINVNTNE--RCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----HSKT 109 (338)
Q Consensus 41 ~~~~~lg~G~~g~V~~~~~~~~~~--~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~----~~~~ 109 (338)
.+.+.||+|+||.||+|.+..++. .+++|.++.. ..+.+..|+..++.+ +||||+++++.+... ....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCCCC
Confidence 467899999999999999877665 6899987632 235577899999999 999999999976432 1235
Q ss_pred cEEEEeeecCCcccccc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccc
Q 019642 110 PSLIFEYVNSTDFKVLY---------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~ 180 (338)
.+++|||+.+++|..++ ..+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~ 159 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNEN-MNVCVADFGLS 159 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCC-CCEEECCCCcc
Confidence 78999999999887654 237889999999999999999999999999999999999887 78999999998
Q ss_pred ccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhh
Q 019642 181 EFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELN 256 (338)
Q Consensus 181 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (338)
........ .....+++.|++||...+ ..++.++|+||||+++|+|++ |..||. .....+....+.. ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~-~~~~~~~~~~~~~---~~~-- 232 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYP-GVENSEIYDYLRQ---GNR-- 232 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCC-CCCHHHHHHHHHc---CCC--
Confidence 76543221 112235567999999877 678999999999999999999 777773 2222222221111 000
Q ss_pred hhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 257 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
...+..+++.+.++|.+||+.||++|||+.+++++
T Consensus 233 -------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 233 -------------------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred -------------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00112267889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=272.08 Aligned_cols=241 Identities=17% Similarity=0.289 Sum_probs=189.4
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
.++|++.+.||+|++|.||++.+..+ ..+++|.+... ..+.+.+|+.+++.+ +|||++++++.+.. ...+++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~~~~v~ 79 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKL-RHDKLVPLYAVVSE---EPIYIVT 79 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhC-CCCCeeeEEEEEcC---CCcEEEE
Confidence 46799999999999999999987655 45899987643 345678899999999 99999999998732 4578999
Q ss_pred eeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcc
Q 019642 115 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189 (338)
Q Consensus 115 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~ 189 (338)
||+.+++|.+++. .++...+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||.+.........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~-~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDN-LVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC-CeEEECCCccceEccCCccc
Confidence 9999998877763 26888899999999999999999999999999999999988 78999999998655332211
Q ss_pred --eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 190 --NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 190 --~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
....++..|+|||...+ ...+.++|+||||+++|++++ |..||.. ....+....+......
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-------------- 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPG-MVNREVLEQVERGYRM-------------- 222 (260)
T ss_pred ccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC--------------
Confidence 12234567999998876 678899999999999999999 8888732 2222222221110000
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
..+..++..+.+++++||..||++||+++++++
T Consensus 223 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 223 ----------------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred ----------------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 011125788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=274.89 Aligned_cols=244 Identities=23% Similarity=0.419 Sum_probs=192.4
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
+|.+.+.||+|+||.||++.+..++..+++|+.+.. ....+..|+.+++.+ +|||++++++.+.+ ....
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~ 77 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-DHPAIVKFHASFLE--RDAF 77 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-CCCcHHHHHHHHhc--CCce
Confidence 589999999999999999998877777777765531 223456789999999 99999999999854 4568
Q ss_pred EEEEeeecCCcccccc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 111 SLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
++++||+.++++...+ ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ .++|+|||.+...
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~--~~~l~d~g~~~~~ 155 (260)
T cd08222 78 CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN--LLKIGDFGVSRLL 155 (260)
T ss_pred EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC--CEeecccCceeec
Confidence 8999999999987654 348999999999999999999999999999999999999864 6999999988665
Q ss_pred cCCC-cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcc
Q 019642 184 HPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262 (338)
Q Consensus 184 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
.... ......++..|+|||.+.+ ..++.++|+||||++++++++|..||.. .........+ ... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~-~~~~~~~~~~---~~~-~~~------ 223 (260)
T cd08222 156 MGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEG-QNFLSVVLRI---VEG-PTP------ 223 (260)
T ss_pred CCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC-ccHHHHHHHH---HcC-CCC------
Confidence 3322 2223457788999999866 5678899999999999999999999832 2211111111 100 000
Q ss_pred ccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
..+..++.++.++|.+||+.+|++||++.++++||||
T Consensus 224 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 224 --------------------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred --------------------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 0011267899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=277.93 Aligned_cols=261 Identities=23% Similarity=0.359 Sum_probs=194.4
Q ss_pred CCcEEEEEeeeecCceeEEEEEE----cCCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGIN----VNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~----~~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
+.-|++.+.||+|+||.||++.. ..++..|++|.++... ...+.+|+.+++.+ +|||++++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCC
Confidence 45679999999999999999974 4568889999987432 35678899999999 999999999998765456
Q ss_pred ccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 109 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
..+++|||+.+++|..++. .++...+..++.|++.||.+||++|++|+||||+||+++.+ +.++|+|||++....
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~-~~~~l~dfg~~~~~~ 160 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIE 160 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCC-CCEEECCCccccccc
Confidence 7899999999999988763 37889999999999999999999999999999999999887 789999999987654
Q ss_pred CCCcc----eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhh
Q 019642 185 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 260 (338)
Q Consensus 185 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
..... ....++..|+|||.+.+ ..++.++|+||||+++|+++++..|....... . .+..+.........
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~~---~---~~~~~~~~~~~~~~ 233 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMTL---F---LKMIGPTHGQMTVT 233 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccch---h---hhhcccccccccHH
Confidence 32211 12345567999999876 57889999999999999999987665321110 0 00101000000000
Q ss_pred ccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
..... ...... ...+..++..+.+|+.+||+.||++|||+.++++.
T Consensus 234 -------~~~~~-~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 234 -------RLVRV-LEEGKR--------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred -------HHHHH-HHcCcc--------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 00000 000000 01122368899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=278.43 Aligned_cols=250 Identities=18% Similarity=0.353 Sum_probs=189.4
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCC--------------CceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEe
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNT--------------NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKL 98 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------------~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~ 98 (338)
.++|++.+.||+|+||.||++.+..+ ...|++|.++... ...+.+|+++++++ +|||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRL-KNPNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCcCeE
Confidence 57999999999999999999987543 2358999886532 34577899999999 99999999
Q ss_pred eeeeeccCCCccEEEEeeecCCccccccC---------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCe
Q 019642 99 LDIVRDQHSKTPSLIFEYVNSTDFKVLYP---------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNV 163 (338)
Q Consensus 99 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NI 163 (338)
++++.. ....++||||+.+++|..++. .++...+..++.|++.||.|||+.|++|+||||+||
T Consensus 83 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 83 LGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred EEEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 999854 457899999999998877652 257788899999999999999999999999999999
Q ss_pred EecCCCCceEEEeccccccccCCCcc---eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh--cCCCCcCCCC
Q 019642 164 MIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF--RKEPFFYGHD 238 (338)
Q Consensus 164 li~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt--g~~pf~~~~~ 238 (338)
+++.+ +.++|+|||++......... ....++..|+|||...+ ..++.++|+||||+++++|++ +..||.. .+
T Consensus 161 ll~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~~-~~ 237 (295)
T cd05097 161 LVGNH-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYSL-LS 237 (295)
T ss_pred EEcCC-CcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCcc-cC
Confidence 99987 78999999998654332211 11234568999999876 678999999999999999998 5566632 22
Q ss_pred CHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHH
Q 019642 239 NHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 318 (338)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~e 318 (338)
.........+........ .....+..+++.+.+|+.+||+.||++|||+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~ 288 (295)
T cd05097 238 DEQVIENTGEFFRNQGRQ-----------------------------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNK 288 (295)
T ss_pred hHHHHHHHHHhhhhcccc-----------------------------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 222222211111000000 000011225789999999999999999999999
Q ss_pred Hhc
Q 019642 319 AMA 321 (338)
Q Consensus 319 ll~ 321 (338)
+++
T Consensus 289 i~~ 291 (295)
T cd05097 289 IHH 291 (295)
T ss_pred HHH
Confidence 975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=274.37 Aligned_cols=243 Identities=18% Similarity=0.308 Sum_probs=190.2
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCc----eEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
..++|++.+.||+|+||+||+|.+..++. .|++|+++... ...+.+|+..++.+ +||||+++++++..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--- 80 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV-GSPYVCRLLGICLT--- 80 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc-CCCCCceEEEEEcC---
Confidence 35799999999999999999998776665 47899876432 34577899999998 99999999998854
Q ss_pred CccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 108 KTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
...+++++++.++++.+.+. .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++...
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~-~~~kL~dfG~~~~~ 159 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSP-NHVKITDFGLARLL 159 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC-CcEEECCCCceeec
Confidence 34679999999998877763 37999999999999999999999999999999999999887 78999999998765
Q ss_pred cCCCcc---eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhh
Q 019642 184 HPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259 (338)
Q Consensus 184 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
...... ....++..|+|||...+ ..++.++||||||+++|++++ |..||.. .. ..............
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~-~~~~~~~~~~~~~~------ 230 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDG-IP-AREIPDLLEKGERL------ 230 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC-CC-HHHHHHHHHCCCcC------
Confidence 432221 11234567999999876 678899999999999999998 8888732 11 11121111110000
Q ss_pred hccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
..+...+.++.+++.+||..||++||++.+++.
T Consensus 231 -----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 231 -----------------------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred -----------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011226788999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=272.48 Aligned_cols=237 Identities=30% Similarity=0.519 Sum_probs=193.6
Q ss_pred eeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeecC
Q 019642 46 VGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS 119 (338)
Q Consensus 46 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 119 (338)
||.|++|.||++.+..+++.+++|.+... ....+..|+.+++++ +|||++++++.+.. ....+++||++.+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLHYAFQT--EEKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-CCCcHHHHHHHeec--CCeeEEEEecCCC
Confidence 68999999999999888999999998643 234678899999999 89999999999844 5678999999998
Q ss_pred CccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC-Ccceeeecc
Q 019642 120 TDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRVAS 195 (338)
Q Consensus 120 ~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~ 195 (338)
++|.+++. .+++..+..++.|++.||.+||+.+++|+||+|+||+++.+ +.++|+|||.+...... .......++
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05123 78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDAD-GHIKLTDFGLAKELSSEGSRTNTFCGT 156 (250)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCC-CcEEEeecCcceecccCCCcccCCcCC
Confidence 88887763 47999999999999999999999999999999999999988 78999999998765433 223345678
Q ss_pred ccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhc
Q 019642 196 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVG 275 (338)
Q Consensus 196 ~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (338)
..|+|||...+ ...+.++|+||||+++|++++|..||.... .......+.+ ..
T Consensus 157 ~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~-~~~~~~~~~~--~~----------------------- 209 (250)
T cd05123 157 PEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAED-RKEIYEKILK--DP----------------------- 209 (250)
T ss_pred ccccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHhc--CC-----------------------
Confidence 88999999877 568899999999999999999999984322 1111111111 00
Q ss_pred cccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCH---HHHhcCCCc
Q 019642 276 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA---REAMAHPYF 325 (338)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~---~ell~hp~~ 325 (338)
...+..+++.+.+++++||..||++|||+ +++++||||
T Consensus 210 ------------~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 210 ------------LRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ------------CCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 00112257899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=279.62 Aligned_cols=250 Identities=28% Similarity=0.424 Sum_probs=196.9
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
...|...+.||+|+||.||++.+..++..+++|.+.... ...+.+|+.+++.+ +|||++++++++.+ ....
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~ 100 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIEYKGCYLR--EHTA 100 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee--CCeE
Confidence 356889999999999999999999999999999976321 23577899999999 89999999999855 4567
Q ss_pred EEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 111 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
+++|||+.+..+.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 101 ~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~-~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 101 WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP-GQVKLADFGSASIASP-- 177 (317)
T ss_pred EEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCC-CCEEEecCCCccccCC--
Confidence 8999999875433332 348899999999999999999999999999999999999887 8899999998765432
Q ss_pred cceeeeccccccccccccC--cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 188 EYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
.....++..|+|||.+.. ....+.++|+||||+++|+|++|..||... +.......+......
T Consensus 178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~~------------- 242 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESP------------- 242 (317)
T ss_pred -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHHhccCC-------------
Confidence 223467888999999742 246889999999999999999999998532 211222211110000
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
......+++.+.+++.+||+.+|.+||++.++++|+|+....
T Consensus 243 ----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 243 ----------------------TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred ----------------------CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 001112578899999999999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=269.93 Aligned_cols=240 Identities=18% Similarity=0.337 Sum_probs=192.7
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc--hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
+.++|++.+.||.|++|.||++.. .++.+++|.++... .+.+.+|+.+++++ +|+|++++++.+.+ ....+++
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v 78 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTL-RHPNLVQLLGVVLQ--GNPLYIV 78 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhc-CCcceeeeEEEEcC--CCCeEEE
Confidence 467999999999999999999976 47889999987543 45688899999999 89999999999855 5678899
Q ss_pred EeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 114 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 114 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
|||+.+++|.+++. .+++..++.++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||.+.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~-~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSED-LVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCC-CCEEEccccccccccccc-
Confidence 99999999888763 48899999999999999999999999999999999999988 889999999987653221
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
.....+..|+|||.+.. ..++.++|+||||++++++++ |..||... ....+..... ...
T Consensus 157 -~~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~---~~~------------- 216 (256)
T cd05039 157 -DSGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPHVE---KGY------------- 216 (256)
T ss_pred -ccCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHh---cCC-------------
Confidence 12334567999999876 578889999999999999997 88888322 1221111110 000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
....+..+++++.++|.+||..+|++|||+.++++
T Consensus 217 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 217 -------------------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred -------------------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 00011226889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=275.21 Aligned_cols=236 Identities=17% Similarity=0.299 Sum_probs=182.2
Q ss_pred eeeecCceeEEEEEEcCCCc--eEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeec
Q 019642 45 KVGRGKYSEVFEGINVNTNE--RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN 118 (338)
Q Consensus 45 ~lg~G~~g~V~~~~~~~~~~--~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 118 (338)
.||+|+||.||+|.+..++. .+++|..+.. ....+.+|+.+++++.+|||++++++.+.. ....+++|||+.
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCceEEEEeCC
Confidence 58999999999999887765 4688887642 234577899999999789999999999854 456899999999
Q ss_pred CCccccccC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccc
Q 019642 119 STDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
Q Consensus 119 ~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~ 179 (338)
+++|..++. .++...+..++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||+
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~-~~~kl~dfgl 158 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIADFGL 158 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCC-CeEEECCCCC
Confidence 998877652 36788999999999999999999999999999999999988 8999999998
Q ss_pred cccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhh
Q 019642 180 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAY 258 (338)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
+..............+..|+|||.+.. ..++.++|+||||+++|+|++ |..||.. .+..+....+.. .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~-~~~~~~~~~~~~---~------ 227 (270)
T cd05047 159 SRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQ---G------ 227 (270)
T ss_pred ccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccc-cCHHHHHHHHhC---C------
Confidence 753221111111223456999999866 678999999999999999997 9989832 221111111100 0
Q ss_pred hhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
. ....+..++.++.+++.+|++.||.+|||+.++++
T Consensus 228 ---~------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 228 ---Y------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred ---C------------------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 0 00011125788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=273.07 Aligned_cols=243 Identities=17% Similarity=0.315 Sum_probs=191.2
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCC---ceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
.++|++.+.||+|+||.||+|.+..++ ..+++|.++.. ....+.+|+.+++.+ +||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 79 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTK--SKP 79 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec--CCc
Confidence 468999999999999999999876544 36899987642 234678899999999 99999999999854 457
Q ss_pred cEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 110 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
.+++|||+.+++|..++. .++...+..++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||.+.....
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~-~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSN-LVCKVSDFGLSRVLED 158 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCC-CeEEeCCCCccccccc
Confidence 899999999999988763 37888999999999999999999999999999999999987 7999999999876543
Q ss_pred CCccee----eeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhh
Q 019642 186 GKEYNV----RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 260 (338)
Q Consensus 186 ~~~~~~----~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
...... ..++..|+|||.+.+ ..++.++|+||||+++|++++ |..||... +..+....+.+....
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~-~~~~~~~~~~~~~~~-------- 228 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEM-SNQDVIKAIEEGYRL-------- 228 (267)
T ss_pred ccceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccC-CHHHHHHHHhCCCcC--------
Confidence 221111 122457999999876 678999999999999999886 99998432 222222222110000
Q ss_pred ccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
.....+++.+.+++.+||+.+|++||++.++++
T Consensus 229 ----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 229 ----------------------------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred ----------------------------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 001125788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=271.36 Aligned_cols=241 Identities=17% Similarity=0.333 Sum_probs=190.1
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
+.++|++.+.||+|+||.||++.. .+..+++|..+.. ..+.+.+|+.+++++ +|++++++++.+... ....+++|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~~~~~lv~ 79 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEE-KGGLYIVT 79 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhC-CCCCeeeEEEEEEcC-CCceEEEE
Confidence 456899999999999999999965 4778999988754 345688999999999 999999999976443 34678999
Q ss_pred eeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcc
Q 019642 115 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189 (338)
Q Consensus 115 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~ 189 (338)
||+.+++|..++. .+++..+..++.|++.||.+||++|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCC-CcEEecCCccceeccccC--
Confidence 9999999887753 27888999999999999999999999999999999999988 899999999886543222
Q ss_pred eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 190 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
.....+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.. .+..+....+.+. .
T Consensus 157 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~----~-------------- 216 (256)
T cd05082 157 DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKG----Y-------------- 216 (256)
T ss_pred CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcC----C--------------
Confidence 22234567999999876 678899999999999999997 8888732 1111111111000 0
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
....+..+++.+.+++.+||+.+|++|||+.++++
T Consensus 217 ------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 217 ------------------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred ------------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00011236889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=293.14 Aligned_cols=203 Identities=26% Similarity=0.471 Sum_probs=180.5
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc----cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccC----
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---- 106 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~---- 106 (338)
+...-|...+.||+|+||.||+++++.+|+.||||.+++ ...+..-+|+++++++ +|+|||+..++-....
T Consensus 10 ~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKL-nh~NIVk~f~iee~~~~~~~ 88 (732)
T KOG4250|consen 10 GENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKL-NHPNIVKLFDIEETKFLGLV 88 (732)
T ss_pred CCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHc-CchhhhhhcccCCccccCcc
Confidence 445677889999999999999999999999999999875 3456678899999999 7999999999876555
Q ss_pred CCccEEEEeeecCCccccccC------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC---CCceEEEec
Q 019642 107 SKTPSLIFEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE---LRKLRLIDW 177 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~---~~~~~l~df 177 (338)
.....++||||.||+|...+. .+++.++..++.++..||.|||++||+||||||.||++-.+ ....||+||
T Consensus 89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 567889999999999999885 39999999999999999999999999999999999998443 246799999
Q ss_pred cccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCC
Q 019642 178 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 238 (338)
Q Consensus 178 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~ 238 (338)
|.|+...++.......||..|.+||.+...+.++..+|.||||+++|+++||..||.....
T Consensus 169 G~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 169 GAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred cccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 9999999888889999999999999998557899999999999999999999999955433
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=269.82 Aligned_cols=226 Identities=21% Similarity=0.311 Sum_probs=180.8
Q ss_pred cCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeecCCcccccc--
Q 019642 49 GKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-- 126 (338)
Q Consensus 49 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-- 126 (338)
|.+|.||++++..+++.+++|.+.... ....|...+... .|||++++++.+.+ ....+++|||+.+++|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--~~~~~~~~~~~~-~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--EYSRERLTIIPH-CVPNMVCLHKYIVS--EDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--hhhhHHHHHHhc-CCCceeehhhheec--CCeEEEEEecCCCCCHHHHHHH
Confidence 889999999999999999999987543 233455555555 79999999999855 46789999999999987765
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcceeeecccccccccccc
Q 019642 127 -PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 205 (338)
Q Consensus 127 -~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~ 205 (338)
..+++..+..++.|++.||.+||+.|++|+||||+||+++.+ +.++++|||.+...... .....++..|+|||...
T Consensus 79 ~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~ 155 (237)
T cd05576 79 FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR-GHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGG 155 (237)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC-CCEEEecccchhccccc--cccCCcCccccCCcccC
Confidence 348999999999999999999999999999999999999988 78999999987554332 22334567799999986
Q ss_pred CcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCccc
Q 019642 206 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF 285 (338)
Q Consensus 206 ~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (338)
+ ..++.++|+||+|+++|+|++|..|+....... . ..
T Consensus 156 ~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---~---------------------------------------~~ 192 (237)
T cd05576 156 I-SEETEACDWWSLGAILFELLTGKTLVECHPSGI---N---------------------------------------TH 192 (237)
T ss_pred C-CCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---c---------------------------------------cc
Confidence 6 568899999999999999999998762111000 0 00
Q ss_pred ccccCCCCCChhHHHHHHHhcCCCcCCcCCH-----HHHhcCCCc
Q 019642 286 INADNQHLVSPEAIDFLDKLLRYDHQDRLTA-----REAMAHPYF 325 (338)
Q Consensus 286 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~-----~ell~hp~~ 325 (338)
.....+..+++.+.++|.+||+.||++||++ +++++||||
T Consensus 193 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 193 TTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred cccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 0001122368899999999999999999986 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=278.76 Aligned_cols=244 Identities=18% Similarity=0.312 Sum_probs=189.4
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcC-------CCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeecc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVN-------TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQ 105 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 105 (338)
.++|.+.+.||+|+||.||++.+.. ....+++|.++... ...+..|+.+++.+.+||||+++++++.+
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ- 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc-
Confidence 4799999999999999999997632 34568999877432 24567899999998669999999999854
Q ss_pred CCCccEEEEeeecCCccccccC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEec
Q 019642 106 HSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 166 (338)
Q Consensus 106 ~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~ 166 (338)
....+++|||+.+++|..++. .++...+..++.|++.||.|||++|++|+||||+||+++
T Consensus 90 -~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 90 -EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT 168 (314)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence 456889999999999877652 267788899999999999999999999999999999999
Q ss_pred CCCCceEEEeccccccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHH
Q 019642 167 HELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQ 242 (338)
Q Consensus 167 ~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~ 242 (338)
.+ +.++|+|||.+........ .....++..|+|||.+.+ ..++.++|+||||+++|++++ |..||. ..+..+.
T Consensus 169 ~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~-~~~~~~~ 245 (314)
T cd05099 169 ED-NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYP-GIPVEEL 245 (314)
T ss_pred CC-CcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCC-CCCHHHH
Confidence 87 7899999999875532211 111223457999999876 678999999999999999999 788873 2222222
Q ss_pred HHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 243 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
...+... . ....+..++.++.+++.+||..+|++|||+.++++
T Consensus 246 ~~~~~~~----~--------------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 246 FKLLREG----H--------------------------------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHcC----C--------------------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 2211100 0 00011226789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=271.74 Aligned_cols=243 Identities=18% Similarity=0.335 Sum_probs=191.4
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCc---eEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
.++|+..+.||+|++|.||+|.+..++. .+++|.++... .+.+..|+.+++.+ +|||++++.+++.+ ...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 80 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF-SHHNIIRLEGVVTK--FKP 80 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEcc--CCC
Confidence 4689999999999999999999876654 68999876432 34578899999999 99999999999854 467
Q ss_pred cEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 110 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
.+++|||+++++|..++. .++...+..++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSN-LECKVSDFGLSRVLED 159 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCC-CcEEECCCccceeccc
Confidence 899999999999987763 47889999999999999999999999999999999999987 7899999999865543
Q ss_pred CCccee----eeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhh
Q 019642 186 GKEYNV----RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 260 (338)
Q Consensus 186 ~~~~~~----~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
...... ...+..|+|||.+.+ ..++.++|+||||+++|++++ |..||... +..+....+......
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~-~~~~~~~~i~~~~~~-------- 229 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDM-SNHEVMKAINDGFRL-------- 229 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcC-CHHHHHHHHhcCCCC--------
Confidence 221111 112346999999876 578899999999999999997 99998432 222222222110000
Q ss_pred ccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
......+.++.+++.+|++.+|++||++.++++
T Consensus 230 ----------------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 230 ----------------------------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred ----------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 001125788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=276.10 Aligned_cols=251 Identities=19% Similarity=0.342 Sum_probs=192.4
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCC----------------ceEEEEEecccc----hHHHHHHHHHHHHhcCCCCe
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTN----------------ERCIIKILKPVK----KKKIKREIKILQNLCGGPNV 95 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~i 95 (338)
+.++|++.+.||+|+||.||++.+...+ ..+++|.+.... .+.+.+|+.+++++ +|||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i 81 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRL-SDPNI 81 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhc-CCCCE
Confidence 3578999999999999999999876543 457899886432 45677899999999 99999
Q ss_pred eEeeeeeeccCCCccEEEEeeecCCccccccC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 019642 96 VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPH 161 (338)
Q Consensus 96 v~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~ 161 (338)
+++++++.. ....+++||++.+++|..++. .+++..++.++.|++.||.+||+.|++|+||||+
T Consensus 82 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~ 159 (296)
T cd05051 82 ARLLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR 159 (296)
T ss_pred eEEEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence 999999855 467899999999998887652 4788999999999999999999999999999999
Q ss_pred CeEecCCCCceEEEeccccccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh--cCCCCcCC
Q 019642 162 NVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF--RKEPFFYG 236 (338)
Q Consensus 162 NIli~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt--g~~pf~~~ 236 (338)
||+++.+ +.++|+|||.+........ .....++..|+|||.+.+ ..++.++||||||+++|++++ +..||..
T Consensus 160 Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~- 236 (296)
T cd05051 160 NCLVGKN-YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYEH- 236 (296)
T ss_pred ceeecCC-CceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCCC-
Confidence 9999998 8999999999865433221 112334668999999876 578999999999999999998 6667632
Q ss_pred CCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCH
Q 019642 237 HDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 316 (338)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~ 316 (338)
.+..+.+............. .....+..++.++.+++.+||+.||++|||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~ 287 (296)
T cd05051 237 LTDQQVIENAGHFFRDDGRQ-----------------------------IYLPRPPNCPKDIYELMLECWRRDEEDRPTF 287 (296)
T ss_pred cChHHHHHHHHhcccccccc-----------------------------ccCCCccCCCHHHHHHHHHHhccChhcCCCH
Confidence 22222222221111000000 0000112257899999999999999999999
Q ss_pred HHHhc
Q 019642 317 REAMA 321 (338)
Q Consensus 317 ~ell~ 321 (338)
.++++
T Consensus 288 ~el~~ 292 (296)
T cd05051 288 REIHL 292 (296)
T ss_pred HHHHH
Confidence 99964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=271.06 Aligned_cols=237 Identities=23% Similarity=0.403 Sum_probs=191.4
Q ss_pred EeeeecCceeEEEEEEcCC---CceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEee
Q 019642 44 RKVGRGKYSEVFEGINVNT---NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 116 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~ 116 (338)
+.||+|+||.||++.+... +..+++|.++... .+.+.+|+..++.+ +|+|++++++++.. ....+++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVVRLLGVCTE--EEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhc-CCCChheeeeeecC--CCceEEEEEe
Confidence 4689999999999999866 8899999987543 45788899999999 79999999999855 5678999999
Q ss_pred ecCCccccccC------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 117 VNSTDFKVLYP------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 117 ~~~~~l~~~~~------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
+.+++|..++. .+++..++.++.|++.||.+||++|++|+||+|+||+++.+ +.++|+|||.+....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~-~~~~l~dfg~~~~~~ 156 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGED-LVVKISDFGLSRDVY 156 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCC-CcEEEcccccccccc
Confidence 99999887753 37899999999999999999999999999999999999998 899999999987665
Q ss_pred CCC---cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhh
Q 019642 185 PGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 260 (338)
Q Consensus 185 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
... ......++..|+|||.+.. ..++.++|+||||+++|+|++ |..||... +..+....+.. +
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~--~--------- 223 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYPGL-SNEEVLEYLRK--G--------- 223 (262)
T ss_pred cccccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHc--C---------
Confidence 432 1233456778999999877 578999999999999999999 58887432 22222211111 0
Q ss_pred ccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
.....+..++.++.+++.+||+.+|++|||+.+++++
T Consensus 224 -------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 224 -------------------------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred -------------------------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0001122268899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=272.13 Aligned_cols=259 Identities=20% Similarity=0.335 Sum_probs=207.3
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc----cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
.++.+-+..||.|+||+|++..++.+++..|||.++. ...+++..|.+...+-.++||||++|+....+ +.-++
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E--GdcWi 140 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE--GDCWI 140 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC--Cceee
Confidence 4667788999999999999999999999999999874 23466788888888777999999999987553 34468
Q ss_pred EEeeecCCcccccc--------CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 113 IFEYVNSTDFKVLY--------PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 113 v~e~~~~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
.||.++-. +..+. ..+++..+-.+....+.||.||.+. +|+|+|+||+|||++.. |.+||||||.+-..
T Consensus 141 CMELMd~S-lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~-G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 141 CMELMDIS-LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRH-GDVKLCDFGICGQL 218 (361)
T ss_pred eHHHHhhh-HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecC-CCEeeecccchHhH
Confidence 89988744 33332 2489998889999999999999975 89999999999999999 89999999999777
Q ss_pred cCCCcceeeeccccccccccccCcCC-CCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcc
Q 019642 184 HPGKEYNVRVASRYFKGPELLVDLQD-YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262 (338)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
..........|...|+|||.+..... ++.++|+||||++|||+.||..|+..+.+. ++++.++....++
T Consensus 219 v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv---feql~~Vv~gdpp------- 288 (361)
T KOG1006|consen 219 VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV---FEQLCQVVIGDPP------- 288 (361)
T ss_pred HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH---HHHHHHHHcCCCC-------
Confidence 66666677789999999999966444 899999999999999999999999665553 4444443322111
Q ss_pred ccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
..........++..+..||..||.+|.++||...+++++||++....
T Consensus 289 ---------------------~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~ 335 (361)
T KOG1006|consen 289 ---------------------ILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV 335 (361)
T ss_pred ---------------------eecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence 11111111236889999999999999999999999999999976543
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=271.99 Aligned_cols=243 Identities=16% Similarity=0.302 Sum_probs=190.7
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCc---eEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
.++|++.+.||+|+||.||+|.+..+++ .|++|.++.. ....+..|+..++.+ +||||+++++.+.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~--~~~ 79 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTK--SRP 79 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCcCcceEEEEECC--CCc
Confidence 3579999999999999999999877665 5999998643 234678899999999 99999999999844 567
Q ss_pred cEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 110 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
.+++|||+.+++|..++. .++...+..++.|++.||.+||++|++|+||+|+||+++.+ +.++|+|||.+.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSRFLED 158 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCC-CcEEECCCcccccccc
Confidence 889999999999987763 37889999999999999999999999999999999999987 7899999998865433
Q ss_pred CCcc---eeee---ccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhh
Q 019642 186 GKEY---NVRV---ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAY 258 (338)
Q Consensus 186 ~~~~---~~~~---~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
.... .... .+..|+|||.+.+ ..++.++|+||||+++|++++ |..||... +..+....+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~-~~~~~~~~i~~~~~------- 229 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDM-SNQDVINAIEQDYR------- 229 (269)
T ss_pred CccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCC-CHHHHHHHHHcCCc-------
Confidence 2211 1111 1346999999876 678999999999999999886 99898432 22222221111000
Q ss_pred hhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
...+..++..+.+++.+||+.+|.+||++.++++
T Consensus 230 -----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 230 -----------------------------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred -----------------------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0011125788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=271.03 Aligned_cols=234 Identities=18% Similarity=0.342 Sum_probs=183.6
Q ss_pred eeeecCceeEEEEEE--cCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeee
Q 019642 45 KVGRGKYSEVFEGIN--VNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 117 (338)
Q Consensus 45 ~lg~G~~g~V~~~~~--~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~ 117 (338)
+||+|+||.||+|.+ ..++..+++|+++... .+.+..|+.+++.+ +||||+++++.+.. ...+++|||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---~~~~lv~e~~ 77 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-DNPYIVRMIGICEA---ESWMLVMELA 77 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcC---CCcEEEEecC
Confidence 689999999999964 4567889999986432 34678899999999 99999999998733 3568999999
Q ss_pred cCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcc----e
Q 019642 118 NSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----N 190 (338)
Q Consensus 118 ~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~----~ 190 (338)
.+++|..++. .+++..+..++.|++.||.+||++|++|+||||.||+++.+ +.++|+|||.+......... .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 78 ELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCC-CeEEECCCccccccCCCCCeeeecC
Confidence 9999887763 48999999999999999999999999999999999999987 78999999998765433221 1
Q ss_pred eeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcc
Q 019642 191 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 269 (338)
Q Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
...++..|+|||.+.. ..++.++|+||||+++|+|++ |..||.. .+..+....+.+. ..
T Consensus 157 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~i~~~-~~----------------- 216 (257)
T cd05116 157 HGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKG-MKGNEVTQMIESG-ER----------------- 216 (257)
T ss_pred CCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHCC-CC-----------------
Confidence 1223468999998865 678899999999999999998 8888832 2222222211100 00
Q ss_pred hhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 270 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
...+..+++++.++|.+||+.||++||++.+|.+
T Consensus 217 ------------------~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 217 ------------------MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred ------------------CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 0011226889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=295.00 Aligned_cols=276 Identities=22% Similarity=0.318 Sum_probs=181.2
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCC----CceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeee----ccCC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNT----NERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVR----DQHS 107 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~----~~~~ 107 (338)
..++|++.+.||+|+||.||+|.+..+ +..|++|.++.........+. .+... .+.++..+...+. ....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e-~l~~~-~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE-RVRRA-CPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH-HHHhh-chhhHHHHHHhhhcccccccC
Confidence 567999999999999999999999988 899999987644322221111 11222 2222222222111 1334
Q ss_pred CccEEEEeeecCCccccccCC-----------------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeE
Q 019642 108 KTPSLIFEYVNSTDFKVLYPT-----------------------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 164 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~~-----------------------~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIl 164 (338)
...++|+||+.+++|.+++.. .....+..++.|++.||.|||+.||+|+||||+|||
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NIL 287 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNII 287 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEE
Confidence 578899999999988776532 113346789999999999999999999999999999
Q ss_pred ecCCCCceEEEeccccccccCCC--cceeeeccccccccccccCcC---------------------CCCCcchhHHHHH
Q 019642 165 IDHELRKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQ---------------------DYDYSLDMWSLGC 221 (338)
Q Consensus 165 i~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~DvwslG~ 221 (338)
++.+.+.+||+|||++....... ......+++.|+|||.+.... .++.++||||+||
T Consensus 288 l~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv 367 (566)
T PLN03225 288 FSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 367 (566)
T ss_pred EeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence 98755789999999997543221 223356789999999763311 1334569999999
Q ss_pred HHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHH
Q 019642 222 MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDF 301 (338)
Q Consensus 222 ~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~l 301 (338)
++|+|+++..++ .+....+.......+.. ...|.........+.... .+. .........++|
T Consensus 368 iL~el~~~~~~~---~~~~~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~------------~~~--~~d~~~~~~~dL 429 (566)
T PLN03225 368 IFLQMAFPNLRS---DSNLIQFNRQLKRNDYD-LVAWRKLVEPRASPDLRR------------GFE--VLDLDGGAGWEL 429 (566)
T ss_pred HHHHHHhCcCCC---chHHHHHHHHHHhcCCc-HHHHHHhhccccchhhhh------------hhh--hccccchHHHHH
Confidence 999999876554 22233333333322221 122211111000000000 000 001124467799
Q ss_pred HHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 302 LDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 302 i~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
|.+||+.||++|||+.|+|+||||.+....
T Consensus 430 i~~mL~~dP~kR~ta~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 430 LKSMMRFKGRQRISAKAALAHPYFDREGLL 459 (566)
T ss_pred HHHHccCCcccCCCHHHHhCCcCcCCCCcc
Confidence 999999999999999999999999876543
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=273.24 Aligned_cols=239 Identities=23% Similarity=0.432 Sum_probs=183.4
Q ss_pred EEEEeeeecCceeEEEEEEc----CCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 41 EVVRKVGRGKYSEVFEGINV----NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 41 ~~~~~lg~G~~g~V~~~~~~----~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
++.+.||.|.||.||+|... ..+..|+||.++.. ..+.+.+|++.++++ +||||+++++++.. ....++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~--~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIE--NEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEES--SSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc-cccccccccccccc--cccccc
Confidence 57899999999999999887 44677999999643 246788999999999 99999999999973 445889
Q ss_pred EEeeecCCcccccc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 113 IFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 113 v~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
|+||+.+++|.+++ ..++...+..++.|++.||.|||+++++|++|+++||+++.+ +.+||+|||++.......
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~-~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSN-GQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETT-TEEEEESTTTGEETTTSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccc
Confidence 99999999998765 248999999999999999999999999999999999999998 799999999987653222
Q ss_pred cc---eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccc
Q 019642 188 EY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263 (338)
Q Consensus 188 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
.. ........|+|||.+.+ ..++.++||||||++++++++ |..||. ..+..+....+.+...
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~~-~~~~~~~~~~~~~~~~------------ 223 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPFS-DYDNEEIIEKLKQGQR------------ 223 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTTT-TSCHHHHHHHHHTTEE------------
T ss_pred cccccccccccccccccccccc-cccccccccccccccccccccccccccc-cccccccccccccccc------------
Confidence 11 22345667999999877 568999999999999999999 677873 2233333333211100
Q ss_pred cccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
...+..++..+.++|..||+.||++|||+.++++
T Consensus 224 ------------------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 224 ------------------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ------------------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ------------------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0011226889999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=275.72 Aligned_cols=244 Identities=18% Similarity=0.316 Sum_probs=190.6
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcC-----CCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
+.++|++.+.||+|+||.||++.+.. ++..+++|.+.... .+.+.+|+.+++.+ .|||++++++++.+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~-- 79 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DHPNIVKLLGVCAV-- 79 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc-CCCchheEEEEEcC--
Confidence 35789999999999999999998743 67889999886432 35578899999999 99999999999854
Q ss_pred CCccEEEEeeecCCccccccC-------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 019642 107 SKTPSLIFEYVNSTDFKVLYP-------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPH 161 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~~-------------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~ 161 (338)
....+++|||+.+++|..++. .++...++.++.|++.||.+||++|++|+||+|+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ 159 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR 159 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence 457899999999998877753 2677888999999999999999999999999999
Q ss_pred CeEecCCCCceEEEeccccccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCC
Q 019642 162 NVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGH 237 (338)
Q Consensus 162 NIli~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~ 237 (338)
||+++.+ +.++|+|||.+........ ......+..|+|||...+ ..++.++|+||||+++|+|++ |..||...
T Consensus 160 nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~~- 236 (288)
T cd05050 160 NCLVGEN-MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYGM- 236 (288)
T ss_pred heEecCC-CceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-
Confidence 9999887 8999999998865432211 112234567999999876 678999999999999999997 77787422
Q ss_pred CCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHH
Q 019642 238 DNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 317 (338)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ 317 (338)
+..+....+ ..... ...+..++.++.+|+.+||+.+|++|||+.
T Consensus 237 ~~~~~~~~~----~~~~~--------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 280 (288)
T cd05050 237 AHEEVIYYV----RDGNV--------------------------------LSCPDNCPLELYNLMRLCWSKLPSDRPSFA 280 (288)
T ss_pred CHHHHHHHH----hcCCC--------------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHH
Confidence 212111111 00000 001122678999999999999999999999
Q ss_pred HHhc
Q 019642 318 EAMA 321 (338)
Q Consensus 318 ell~ 321 (338)
|+++
T Consensus 281 el~~ 284 (288)
T cd05050 281 SINR 284 (288)
T ss_pred HHHH
Confidence 9874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=272.72 Aligned_cols=246 Identities=17% Similarity=0.336 Sum_probs=193.0
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcC----CCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVN----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
.+.++|++.+.||+|+||.||+|.+.. ++..+++|.+.... ...+.+|+.+++++ +|||++++++++...
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~- 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-SHQNILPILHVCIED- 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecC-
Confidence 457899999999999999999999875 35789999876432 34577899999999 999999999987554
Q ss_pred CCccEEEEeeecCCccccccC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEE
Q 019642 107 SKTPSLIFEYVNSTDFKVLYP-----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI 175 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~~-----------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~ 175 (338)
....+++++|+.+++|..++. .++...++.++.|++.||.|||+.+++|+||||+||+++.+ +.++|+
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~-~~~kl~ 159 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE-LQVKIT 159 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCC-CcEEEC
Confidence 356789999999988877752 37889999999999999999999999999999999999887 899999
Q ss_pred eccccccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhC
Q 019642 176 DWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLG 251 (338)
Q Consensus 176 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~ 251 (338)
|||+++....... .....++..|+|||.+.+ ..++.++||||||+++|++++ |..||... +..+....+..
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~--- 234 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEI-DPFEMAAYLKD--- 234 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcC-CHHHHHHHHHc---
Confidence 9999875533221 112234567999999876 678999999999999999998 99998432 22221111110
Q ss_pred CchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 252 TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
... ......+++++.+++.+||..||++|||+.++++
T Consensus 235 ~~~---------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 235 GYR---------------------------------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCC---------------------------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000 0001125788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=279.34 Aligned_cols=251 Identities=27% Similarity=0.415 Sum_probs=196.6
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
....|...+.||+|++|.||+|.+..++..+++|.+... ....+.+|+.+++.+ +|+|++++++++.. ...
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 89 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLR--EHT 89 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCcccEEEEEEc--CCe
Confidence 345688899999999999999999999999999987532 123567899999999 99999999999865 456
Q ss_pred cEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 110 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
.++||||+.+....... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 90 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 90 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPA 168 (308)
T ss_pred eEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCC-CcEEECCcccceeecCc
Confidence 78999999864433222 348899999999999999999999999999999999999987 89999999988654322
Q ss_pred CcceeeeccccccccccccC--cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccc
Q 019642 187 KEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
....++..|+|||.+.+ ....+.++||||||+++|+|++|..||.... ..+....+.+...
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~------------- 231 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNES------------- 231 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc-HHHHHHHHhhcCC-------------
Confidence 23457788999999742 2457889999999999999999999984321 1111111111000
Q ss_pred ccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
.......++..+.++|++||+.+|++||++.++++|||+....
T Consensus 232 ----------------------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~ 274 (308)
T cd06634 232 ----------------------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (308)
T ss_pred ----------------------CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence 0000112678899999999999999999999999999988753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=271.92 Aligned_cols=244 Identities=21% Similarity=0.390 Sum_probs=191.8
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCC---CceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
..++|.+.+.||+|+||.||+|.+... ...+++|...... .+.+.+|+.+++++ +|||++++++++.+ .
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~---~ 79 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF-DHPHIVKLIGVITE---N 79 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCchhceeEEEcC---C
Confidence 457899999999999999999987544 4568899876432 34678899999999 89999999998854 3
Q ss_pred ccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 109 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
..+++|||+.+++|..++. .++...+..++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||++....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~ 158 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSP-DCVKLGDFGLSRYLE 158 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecC-CCeEEccCceeeecc
Confidence 4689999999999988863 37899999999999999999999999999999999999987 799999999987654
Q ss_pred CCCcce--eeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 185 PGKEYN--VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 185 ~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
...... ...++..|+|||.+.. ..++.++|+||||+++|++++ |..||... +..+....+.....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~-~~~~~~~~~~~~~~---------- 226 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGV-KNNDVIGRIENGER---------- 226 (270)
T ss_pred cccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHcCCc----------
Confidence 332211 1223457999999866 578899999999999999986 99998322 22222222111000
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
...+..++.++.++|.+|+..+|.+|||+.++++.
T Consensus 227 --------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 227 --------------------------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred --------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00112368899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=268.42 Aligned_cols=243 Identities=16% Similarity=0.344 Sum_probs=191.9
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
..+|++.+.||+|+||.||++.+. .+..+++|.+... ....+.+|+++++.+ +||+++++++.+.. ....+++|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v~ 78 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKL-SHPKLVQLYGVCTE--RSPICLVF 78 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhC-CCCCeeeEEEEEcc--CCceEEEE
Confidence 468999999999999999999875 4668999987643 346788999999999 99999999999844 45788999
Q ss_pred eeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc--
Q 019642 115 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-- 188 (338)
Q Consensus 115 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~-- 188 (338)
||+.+++|.+++. .++++.++.++.|++.++.+||+.|++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGEN-QVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCC-CeEEECCCcceeecccCcccc
Confidence 9999999887763 37889999999999999999999999999999999999987 7899999998865432211
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
.....++..|+|||...+ ..++.++|+||||+++|++++ |..||.. .........+.+.
T Consensus 158 ~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~------------------ 217 (256)
T cd05112 158 STGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYEN-RSNSEVVETINAG------------------ 217 (256)
T ss_pred cCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHhCC------------------
Confidence 112234567999999876 678899999999999999998 8888832 2212222211100
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
.....+...++.+.+++.+||+.+|++|||+.++++.
T Consensus 218 ------------------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 218 ------------------FRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred ------------------CCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 0000111257889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=308.42 Aligned_cols=252 Identities=27% Similarity=0.436 Sum_probs=191.9
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccC------
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH------ 106 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~------ 106 (338)
-.+|+....||+||||.||+++++-+|+.||||.+... ....+.+|+..+.+| +|||+|+++..+.+..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCCccccc
Confidence 35788899999999999999999999999999998643 345688999999999 9999999995332111
Q ss_pred --------------------------------------------------------------------------------
Q 019642 107 -------------------------------------------------------------------------------- 106 (338)
Q Consensus 107 -------------------------------------------------------------------------------- 106 (338)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred -----------------------C--------CccEEEEeeecCCccccccCC--C--CHHHHHHHHHHHHHHHHHHHHC
Q 019642 107 -----------------------S--------KTPSLIFEYVNSTDFKVLYPT--L--TDYDIRYYIYELLKALDYCHSQ 151 (338)
Q Consensus 107 -----------------------~--------~~~~lv~e~~~~~~l~~~~~~--~--~~~~~~~i~~qi~~~l~~lH~~ 151 (338)
+ ..+||-||||...++.+++.. + .....|+++++|++||.|+|+.
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 0 235677888888887777643 3 3677899999999999999999
Q ss_pred CceeccCCCCCeEecCCCCceEEEecccccccc------------------CCC-cceeeeccccccccccccCcC--CC
Q 019642 152 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH------------------PGK-EYNVRVASRYFKGPELLVDLQ--DY 210 (338)
Q Consensus 152 ~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~------------------~~~-~~~~~~~~~~y~aPE~~~~~~--~~ 210 (338)
|++||||||.||+++.. +.|||+|||+++... ++. ..+...||..|+|||++.+.. .+
T Consensus 717 giIHRDLKP~NIFLd~~-~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 717 GIIHRDLKPRNIFLDSR-NSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred ceeeccCCcceeEEcCC-CCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 99999999999999987 899999999987621 011 234457899999999997755 69
Q ss_pred CCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccC
Q 019642 211 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADN 290 (338)
Q Consensus 211 ~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (338)
+.|+|+||||+++|||+ .||.+...-...+..+. ...++.. ..++
T Consensus 796 n~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR----~g~iP~~------------------------~~f~---- 840 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEML---YPFGTSMERASILTNLR----KGSIPEP------------------------ADFF---- 840 (1351)
T ss_pred cchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcc----cCCCCCC------------------------cccc----
Confidence 99999999999999998 46733322222222221 1111100 0000
Q ss_pred CCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcc
Q 019642 291 QHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 326 (338)
Q Consensus 291 ~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~ 326 (338)
.+ --+.-..+|++||+.||++||||.|+|++.||-
T Consensus 841 ~~-~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 841 DP-EHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred cc-cchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 00 123457899999999999999999999999986
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=271.99 Aligned_cols=242 Identities=16% Similarity=0.277 Sum_probs=187.4
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCc----eEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
.++|++.+.||+|+||+||+|.+..+++ .+++|.+.... ...+..|+..+.++ .||||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~~---~ 81 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL-DHAYIVRLLGICPG---A 81 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC-CCCCcceEEEEECC---C
Confidence 4789999999999999999999877666 47777765322 24456677788888 99999999998733 3
Q ss_pred ccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 109 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
..++++||+.+++|.+++. .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||.+....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~-~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSD-SIVQIADFGVADLLY 160 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC-CcEEEcCCccceecc
Confidence 4678999999999887763 47899999999999999999999999999999999999987 899999999987653
Q ss_pred CCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhh
Q 019642 185 PGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 260 (338)
Q Consensus 185 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.... .....++..|+|||.+.+ ..++.++|+||||+++|++++ |..||... . ......+.+......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~-~-~~~~~~~~~~~~~~~------ 231 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGM-R-PHEVPDLLEKGERLA------ 231 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCC-C-HHHHHHHHHCCCcCC------
Confidence 3221 122345568999999876 578999999999999999998 98888322 1 122222111000000
Q ss_pred ccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
.+...+.++.+++.+|+..||++|||+.|+++
T Consensus 232 -----------------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 232 -----------------------------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred -----------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 01114678899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=279.58 Aligned_cols=245 Identities=18% Similarity=0.320 Sum_probs=189.4
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCC-------CceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeecc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNT-------NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQ 105 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 105 (338)
..+|++.+.||+|+||.||++.+... +..+++|.++... .+.+.+|+.+++++.+||||+++++.+..
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 89 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc-
Confidence 35899999999999999999986432 2368999876422 35678899999999779999999999854
Q ss_pred CCCccEEEEeeecCCccccccC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEec
Q 019642 106 HSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 166 (338)
Q Consensus 106 ~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~ 166 (338)
....++++||+.+++|..++. .++...+..++.|++.||.|||++|++|+||||+||+++
T Consensus 90 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~ 168 (334)
T cd05100 90 -DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT 168 (334)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence 457889999999998877652 266778889999999999999999999999999999999
Q ss_pred CCCCceEEEeccccccccCCCcc---eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHH
Q 019642 167 HELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQ 242 (338)
Q Consensus 167 ~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~ 242 (338)
.+ +.++|+|||++......... ....++..|+|||++.+ ..++.++|+||||+++|+|++ |..||. ..+..+.
T Consensus 169 ~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~-~~~~~~~ 245 (334)
T cd05100 169 ED-NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYP-GIPVEEL 245 (334)
T ss_pred CC-CcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCC-CCCHHHH
Confidence 88 79999999998654332211 11223457999999877 678899999999999999998 777773 2222222
Q ss_pred HHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 243 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
...+.. .. ....+...+.++.+++.+||+.+|++|||+.+++++
T Consensus 246 ~~~~~~----~~--------------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 246 FKLLKE----GH--------------------------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHc----CC--------------------------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 111110 00 000112257899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=283.99 Aligned_cols=247 Identities=21% Similarity=0.326 Sum_probs=190.2
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEc-----CCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
..++|.+.+.||+|+||.||+|.+. .+++.||+|+++... .+.+.+|+.++.++..||||+++++.+..
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~-- 112 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK-- 112 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--
Confidence 3467899999999999999999853 345689999987432 23577899999999449999999999855
Q ss_pred CCccEEEEeeecCCccccccC-----------------------------------------------------------
Q 019642 107 SKTPSLIFEYVNSTDFKVLYP----------------------------------------------------------- 127 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~~----------------------------------------------------------- 127 (338)
....++||||+.+++|.+++.
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 457899999999998866542
Q ss_pred ------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEe
Q 019642 128 ------------------------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 165 (338)
Q Consensus 128 ------------------------------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli 165 (338)
.++...+..++.|++.||.|||+.|++|+||||+||++
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl 272 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI 272 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence 14556678899999999999999999999999999999
Q ss_pred cCCCCceEEEeccccccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHH
Q 019642 166 DHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHD 241 (338)
Q Consensus 166 ~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~ 241 (338)
+.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.... ..+
T Consensus 273 ~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~-~~~ 349 (401)
T cd05107 273 CEG-KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELP-MNE 349 (401)
T ss_pred eCC-CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC-chH
Confidence 987 7899999999875432211 122345678999999877 578899999999999999998 888873322 222
Q ss_pred HHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 242 QLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
........ +. + ...+..++.++.+++.+||..+|++||++.+|++
T Consensus 350 ~~~~~~~~-~~--------------------------~--------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 350 QFYNAIKR-GY--------------------------R--------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred HHHHHHHc-CC--------------------------C--------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 21111100 00 0 0011226889999999999999999999999986
Q ss_pred C
Q 019642 322 H 322 (338)
Q Consensus 322 h 322 (338)
.
T Consensus 395 ~ 395 (401)
T cd05107 395 L 395 (401)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=274.14 Aligned_cols=250 Identities=17% Similarity=0.340 Sum_probs=187.8
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcC----------------CCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCee
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVN----------------TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVV 96 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv 96 (338)
.++|++.+.||+|+||.||++.+.. ++..+++|.++... ...+.+|+.+++.+ +|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRL-KDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcc
Confidence 4689999999999999999986432 34568999987432 35678899999999 999999
Q ss_pred EeeeeeeccCCCccEEEEeeecCCccccccC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCC
Q 019642 97 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHN 162 (338)
Q Consensus 97 ~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~N 162 (338)
++++++.. ....+++|||+.+++|..++. .++...+..++.|++.||.+||+.|++|+||||+|
T Consensus 83 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 83 RLLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred eEEEEEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 99999855 456789999999999877753 25567899999999999999999999999999999
Q ss_pred eEecCCCCceEEEeccccccccCCCcc---eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh--cCCCCcCCC
Q 019642 163 VMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF--RKEPFFYGH 237 (338)
Q Consensus 163 Ili~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt--g~~pf~~~~ 237 (338)
|+++.+ +.++|+|||++......... .....+..|++||...+ ..++.++|+||||+++|+|++ |..||...
T Consensus 161 ili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~- 237 (296)
T cd05095 161 CLVGKN-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQL- 237 (296)
T ss_pred EEEcCC-CCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCcccc-
Confidence 999887 78999999998755332211 11223567999998766 578999999999999999998 66777322
Q ss_pred CCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHH
Q 019642 238 DNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 317 (338)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ 317 (338)
+..+.............. . .....+..+++.+.+|+..||+.||++|||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~--------------------~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ 288 (296)
T cd05095 238 SDEQVIENTGEFFRDQGR--------------------Q---------VYLPKPALCPDSLYKLMLSCWRRNAKERPSFQ 288 (296)
T ss_pred ChHHHHHHHHHHHhhccc--------------------c---------ccCCCCCCCCHHHHHHHHHHcCCCcccCCCHH
Confidence 222211111110000000 0 00001122578899999999999999999999
Q ss_pred HHhc
Q 019642 318 EAMA 321 (338)
Q Consensus 318 ell~ 321 (338)
++++
T Consensus 289 ~i~~ 292 (296)
T cd05095 289 EIHA 292 (296)
T ss_pred HHHH
Confidence 9874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=276.12 Aligned_cols=247 Identities=18% Similarity=0.294 Sum_probs=191.1
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEc-------CCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeee
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINV-------NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVR 103 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 103 (338)
...++|.+.+.||+|+||.||++.+. .++..+++|..+.. ..+.+.+|+.+++.+.+||||+++++.+.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 44689999999999999999999752 23457999987642 23567889999999878999999999985
Q ss_pred ccCCCccEEEEeeecCCccccccC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeE
Q 019642 104 DQHSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 164 (338)
Q Consensus 104 ~~~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIl 164 (338)
. ....+++|||+.+++|..++. .++...+..++.|++.||.|||++|++|+||||+||+
T Consensus 92 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 169 (304)
T cd05101 92 Q--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL 169 (304)
T ss_pred c--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence 5 457889999999998877652 2567788999999999999999999999999999999
Q ss_pred ecCCCCceEEEeccccccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCH
Q 019642 165 IDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNH 240 (338)
Q Consensus 165 i~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~ 240 (338)
++.+ +.++|+|||.+........ .....++..|+|||++.+ ..++.++||||||+++|++++ |..||. ..+..
T Consensus 170 i~~~-~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~-~~~~~ 246 (304)
T cd05101 170 VTEN-NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYP-GIPVE 246 (304)
T ss_pred EcCC-CcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcc-cCCHH
Confidence 9987 8999999999876543221 112234567999999876 678899999999999999998 677762 22222
Q ss_pred HHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHh
Q 019642 241 DQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 320 (338)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell 320 (338)
+....+ ..... ...+..++.++.+++.+||+.+|++|||+.+++
T Consensus 247 ~~~~~~----~~~~~--------------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l 290 (304)
T cd05101 247 ELFKLL----KEGHR--------------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLV 290 (304)
T ss_pred HHHHHH----HcCCc--------------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHH
Confidence 211111 00000 001122678999999999999999999999998
Q ss_pred cC
Q 019642 321 AH 322 (338)
Q Consensus 321 ~h 322 (338)
+.
T Consensus 291 ~~ 292 (304)
T cd05101 291 ED 292 (304)
T ss_pred HH
Confidence 74
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=315.47 Aligned_cols=251 Identities=25% Similarity=0.422 Sum_probs=207.0
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
-+++-...||.|.||.||.|.+..+|...|+|-++-+ .-..+.+|..++..+ +|||+|+++++-.+ .+..+|
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvH--Rekv~I 1311 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVH--REKVYI 1311 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhc-cCccccccCceeec--HHHHHH
Confidence 4677788999999999999999999999999987632 235578899999999 99999999998755 345679
Q ss_pred EEeeecCCccccccCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC--
Q 019642 113 IFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-- 187 (338)
Q Consensus 113 v~e~~~~~~l~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-- 187 (338)
.||||.+|+|.+..+. .++.....+..|++.|+.|||++||||+||||.||+++.+ |.+|++|||.+.+.....
T Consensus 1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~-g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFN-GLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecC-CcEEeecccceeEecCchhc
Confidence 9999999999998753 6666777889999999999999999999999999999999 899999999998776543
Q ss_pred ---cceeeeccccccccccccCcC--CCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcc
Q 019642 188 ---EYNVRVASRYFKGPELLVDLQ--DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262 (338)
Q Consensus 188 ---~~~~~~~~~~y~aPE~~~~~~--~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
......||+.|||||++.+.. ....+.|||||||++.||+||+.||..-++++.+.......- .+.
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh-~Pq-------- 1461 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGH-KPQ-------- 1461 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccC-CCC--------
Confidence 223458999999999997643 466799999999999999999999966555555444322211 111
Q ss_pred ccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
.|..+|++.++||..||..||++|.++.|+|+|-|=+.-
T Consensus 1462 ---------------------------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1462 ---------------------------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred ---------------------------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 112279999999999999999999999999999986554
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=268.35 Aligned_cols=240 Identities=23% Similarity=0.407 Sum_probs=191.8
Q ss_pred EEEEEeeeecCceeEEEEEEcCCC----ceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 40 YEVVRKVGRGKYSEVFEGINVNTN----ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 40 y~~~~~lg~G~~g~V~~~~~~~~~----~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
+++.+.||.|+||.||++.+..++ ..+++|.++... .+.+..|+..++.+ +|+|++++++.+.+. ...+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEE--EPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCC--CeeE
Confidence 357889999999999999998766 889999987543 45788899999999 999999999998553 5788
Q ss_pred EEEeeecCCccccccCC-----CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 112 LIFEYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 112 lv~e~~~~~~l~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
++||++.++++..++.. +++..+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGEN-LVVKISDFGLSRDLYDD 156 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccC-CeEEEcccCCceecccc
Confidence 99999999998877632 8999999999999999999999999999999999999988 79999999998765443
Q ss_pred Cccee--eeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccc
Q 019642 187 KEYNV--RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263 (338)
Q Consensus 187 ~~~~~--~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
..... ..++..|+|||...+ ..++.++|+||||+++++|++ |..||. ..+............ .
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~-~~~~~~~~~~~~~~~-~----------- 222 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYP-GMSNEEVLEYLKKGY-R----------- 222 (258)
T ss_pred cccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHhcCC-C-----------
Confidence 22221 235678999999855 678999999999999999998 677763 222222222111100 0
Q ss_pred cccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
...+...+.++.+++.+||+.||++|||+.|+++
T Consensus 223 ------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 223 ------------------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred ------------------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 0011126889999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=267.13 Aligned_cols=242 Identities=15% Similarity=0.293 Sum_probs=190.1
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc--hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
..++|++.+.||+|+||.||++.+. .+..+++|.+.... .+.+.+|+.+++.+ +|+|++++++.+.. ...+++
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~---~~~~~v 78 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVTK---EPIYII 78 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhc-CCCCcceEEEEEcC---CCeEEE
Confidence 3579999999999999999999754 45669999876533 45678899999999 89999999999854 467899
Q ss_pred EeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 114 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 114 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
|||+.+++|.+++. .++...+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS-LVCKIADFGLARVIEDNEY 157 (260)
T ss_pred EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC-CcEEECCCcceeeccCCCc
Confidence 99999999887763 26778899999999999999999999999999999999988 8999999998865543221
Q ss_pred c--eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 189 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 189 ~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
. ....++..|+|||.+.. ..++.++|+||||+++|++++ |..||. ..+..+....+.....
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~-~~~~~~~~~~~~~~~~-------------- 221 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYP-GMSNPEVIRALERGYR-------------- 221 (260)
T ss_pred ccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCC-CCCHHHHHHHHhCCCC--------------
Confidence 1 12234567999999876 678899999999999999998 888873 2222222211111000
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
.......+.++.+++.+||+.+|++||++.++++
T Consensus 222 ----------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 222 ----------------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred ----------------------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0011226789999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=267.87 Aligned_cols=235 Identities=18% Similarity=0.326 Sum_probs=184.2
Q ss_pred EeeeecCceeEEEEEEcCCC---ceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEee
Q 019642 44 RKVGRGKYSEVFEGINVNTN---ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 116 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~ 116 (338)
++||+|+||.||+|.+..++ ..+++|.+.... .+.+..|+.+++.+ .|||++++++++.. ...+++|||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIVRLIGVCKG---EPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEcC---CceEEEEEe
Confidence 47999999999999876554 789999987433 34677899999999 99999999998743 357899999
Q ss_pred ecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcce---
Q 019642 117 VNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN--- 190 (338)
Q Consensus 117 ~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~--- 190 (338)
+.+++|.+++. .+++..+..++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||.+..........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~-~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR-HQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCC-CcEEeccccccceeecCCcccccc
Confidence 99999888774 48899999999999999999999999999999999999988 899999999987653332211
Q ss_pred -eeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 191 -VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 191 -~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
...++..|+|||.+.+ ..++.++|+||||+++|++++ |..||... +..+....+... .
T Consensus 156 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~-~~~~~~~~~~~~-~----------------- 215 (257)
T cd05060 156 TAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEM-KGAEVIAMLESG-E----------------- 215 (257)
T ss_pred cCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccC-CHHHHHHHHHcC-C-----------------
Confidence 1122357999999876 678999999999999999998 88888322 222221111110 0
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
....+..++..+.++|.+||..+|++|||+.++++
T Consensus 216 ------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 216 ------------------RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ------------------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00111226789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=295.00 Aligned_cols=248 Identities=20% Similarity=0.367 Sum_probs=204.5
Q ss_pred eeeeccCCcEEEEEeeeecCceeEEEEEEcC-----CCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeee
Q 019642 31 YVIFSDQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDI 101 (338)
Q Consensus 31 ~~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~ 101 (338)
.+.-....+.+..++||+|+||.||+|+... ....||||.++... +.++++|++++..+ +|||||+++++
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l-~H~nIVrLlGV 557 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAEL-QHPNIVRLLGV 557 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhc-cCCCeEEEEEE
Confidence 3344455788899999999999999998643 45679999998543 56799999999999 99999999999
Q ss_pred eeccCCCccEEEEeeecCCccccccC-------------C----CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeE
Q 019642 102 VRDQHSKTPSLIFEYVNSTDFKVLYP-------------T----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 164 (338)
Q Consensus 102 ~~~~~~~~~~lv~e~~~~~~l~~~~~-------------~----~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIl 164 (338)
+.. ++..++|+||+..|+|.+++. . ++..+...|+.||+.|+.||-++.+||+||...|+|
T Consensus 558 C~~--~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCL 635 (774)
T KOG1026|consen 558 CRE--GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCL 635 (774)
T ss_pred Ecc--CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhce
Confidence 955 567899999999999998872 2 788899999999999999999999999999999999
Q ss_pred ecCCCCceEEEeccccccccCCCcce---eeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCH
Q 019642 165 IDHELRKLRLIDWGLAEFYHPGKEYN---VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNH 240 (338)
Q Consensus 165 i~~~~~~~~l~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~ 240 (338)
|..+ -.|||+|||+++.....+.+. ...-...|||||.+.. .++|.+|||||+|++|||+++ |..|| .+..+.
T Consensus 636 Vge~-l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy-~glSn~ 712 (774)
T KOG1026|consen 636 VGEN-LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPY-YGLSNQ 712 (774)
T ss_pred eccc-eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcc-cccchH
Confidence 9999 799999999997665443322 2334567999999988 789999999999999999997 78887 455666
Q ss_pred HHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHh
Q 019642 241 DQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 320 (338)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell 320 (338)
+.++.+.+.-- ...++..+.++.+|+..||+.+|++||++.||=
T Consensus 713 EVIe~i~~g~l------------------------------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 713 EVIECIRAGQL------------------------------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HHHHHHHcCCc------------------------------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 66655433211 112334799999999999999999999999873
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=270.84 Aligned_cols=245 Identities=18% Similarity=0.357 Sum_probs=191.5
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcC-----CCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
.++|++.+.||+|+||.||+|.... +.+.+++|...... .+.+.+|+++++++ +|||++++++++.+ .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~ 80 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-SHKNVVRLLGLCRE--A 80 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhc-CCcceeeeEEEECC--C
Confidence 4789999999999999999998654 35679999876433 34688899999999 99999999999844 4
Q ss_pred CccEEEEeeecCCccccccC------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEE
Q 019642 108 KTPSLIFEYVNSTDFKVLYP------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI 175 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~ 175 (338)
...+++|||+.+++|..++. .+++..+..++.|++.||.|||+.|++|+||||+||+++.. +.++++
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~-~~~~l~ 159 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQ-REVKVS 159 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCC-CcEEEc
Confidence 57789999999999987752 47899999999999999999999999999999999999987 789999
Q ss_pred eccccccccCCC--cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCC
Q 019642 176 DWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGT 252 (338)
Q Consensus 176 dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~ 252 (338)
|||++....... ......++..|+|||.+.+ ...+.++|+||||+++|++++ |..||... ........... +.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~~~-~~~~~~~~~~~--~~ 235 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGL-SDEEVLNRLQA--GK 235 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCcccc-chHHHHHHHHc--CC
Confidence 999875432211 1223345677999998876 567899999999999999998 77787321 11111111100 00
Q ss_pred chhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 253 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
.. ...+..++..+.+++.+||+.+|++|||+.++++.
T Consensus 236 ---------------------------~~------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 236 ---------------------------LE------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred ---------------------------cC------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 00 00112368899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=273.05 Aligned_cols=260 Identities=21% Similarity=0.366 Sum_probs=195.9
Q ss_pred CCcEEEEEeeeecCceeEEEEEEc----CCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINV----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
.++|++.+.||+|+||.||++... .+++.+++|.++... ...+.+|+..++.+ +|||++++++++......
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l-~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhC-CCCChheEEeeeecCCCC
Confidence 468899999999999999999864 347889999987543 35688999999999 999999999998665566
Q ss_pred ccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 109 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
..+++|||+.+++|..++. .++...+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~ 160 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESE-DLVKISDFGLAKVLP 160 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC-CCEEEcccccccccc
Confidence 7899999999999988874 38889999999999999999999999999999999999988 899999999987665
Q ss_pred CCCcc----eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhh
Q 019642 185 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 260 (338)
Q Consensus 185 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
..... ....++..|+|||...+ ..++.++|+||||+++++|++|..|+......... ..+......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~------~~~~~~~~~--- 230 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR------MIGIAQGQM--- 230 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhcc------ccccccccc---
Confidence 32211 11233456999999876 57889999999999999999999998432221100 000000000
Q ss_pred ccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
..+........... ...+..++.++.+++.+||+.+|++|||+.++++
T Consensus 231 -----~~~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 231 -----IVTRLLELLKEGER--------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred -----cHHHHHHHHHcCCc--------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00000000000000 0011225788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=266.71 Aligned_cols=234 Identities=18% Similarity=0.333 Sum_probs=181.9
Q ss_pred eeeecCceeEEEEEEc--CCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeec
Q 019642 45 KVGRGKYSEVFEGINV--NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN 118 (338)
Q Consensus 45 ~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 118 (338)
.||+|+||.||+|.+. .++..+++|+..... .+.+.+|+.+++++ +||||+++++.+.. ...++||||+.
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~---~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL-DNPYIVRMIGVCEA---EALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEcC---CCeEEEEEeCC
Confidence 4899999999999765 445679999886432 34577899999999 99999999998732 36789999999
Q ss_pred CCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcc----e
Q 019642 119 STDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----N 190 (338)
Q Consensus 119 ~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~----~ 190 (338)
+++|.+++. .+++..++.++.|++.||.+||++|++|+||||+||+++.+ +.++|+|||++......... .
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQ-HYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCC-CcEEeccCCccccccCCccceeccC
Confidence 999987763 48999999999999999999999999999999999999988 78999999998654322211 1
Q ss_pred eeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcc
Q 019642 191 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 269 (338)
Q Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
...++..|+|||.+.. ..++.++|+||||+++|++++ |..||... ...+....+.+. ..
T Consensus 157 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~-~~----------------- 216 (257)
T cd05115 157 AGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKM-KGPEVMSFIEQG-KR----------------- 216 (257)
T ss_pred CCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHHCC-CC-----------------
Confidence 1122467999999876 578899999999999999996 89898432 222211111100 00
Q ss_pred hhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 270 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
...+...++++.++|.+||..+|++||++.++.+
T Consensus 217 ------------------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 217 ------------------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred ------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0011225789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=271.76 Aligned_cols=235 Identities=16% Similarity=0.264 Sum_probs=180.9
Q ss_pred EeeeecCceeEEEEEEcCCCc-------eEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 44 RKVGRGKYSEVFEGINVNTNE-------RCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~~~-------~~aiK~~~~~~---~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
+.||+|+||.||+|.+...+. .+++|...... .+.+.+|+.+++.+ +|||++++++.+.. ....++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~--~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL-SHKHLVLNYGVCVC--GDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhC-CCCChhheeeEEEe--CCCcEEE
Confidence 368999999999998865543 37888775432 34577899999998 99999999999865 4567899
Q ss_pred EeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCC-------ceEEEecccccc
Q 019642 114 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR-------KLRLIDWGLAEF 182 (338)
Q Consensus 114 ~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~-------~~~l~dfg~~~~ 182 (338)
|||+.+++|..++. .+++..+..++.|++.||.|||+.|++|+||||+||+++.+.. .++++|||.+..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999988763 3788999999999999999999999999999999999976622 379999998765
Q ss_pred ccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcc
Q 019642 183 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262 (338)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
... .....++..|+|||.+.+...++.++|+||||+++|++++|..+++...+...... ... ...
T Consensus 158 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~--~~~--------- 222 (258)
T cd05078 158 VLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYE--DRH--------- 222 (258)
T ss_pred cCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHH--ccc---------
Confidence 432 22345778899999987645688999999999999999999544433222221111 000 000
Q ss_pred ccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
..+...+.++.+++.+||+.||++|||++++++.
T Consensus 223 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 223 --------------------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred --------------------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 0111246789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=268.41 Aligned_cols=234 Identities=18% Similarity=0.255 Sum_probs=177.4
Q ss_pred EeeeecCceeEEEEEEcC------------CCceEEEEEecccch---HHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 44 RKVGRGKYSEVFEGINVN------------TNERCIIKILKPVKK---KKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~------------~~~~~aiK~~~~~~~---~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
+.||+|+||.||+|.... ....+++|++..... ..+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l-~hp~iv~~~~~~~~--~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV-SHKHIVLLYGVCVR--DV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhC-CCCCEeeEEEEEec--CC
Confidence 368999999999997432 233588898765432 3567788999999 99999999999855 34
Q ss_pred ccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCC------CceEEEecc
Q 019642 109 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL------RKLRLIDWG 178 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~------~~~~l~dfg 178 (338)
..+++|||+.++++..++. .+++..++.++.|++.||.|||++|++|+||||+||+++.+. ..++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 6789999999998877653 389999999999999999999999999999999999997652 138999999
Q ss_pred ccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHH-hcCCCCcCCCCCHHHHHHHHHHhCCchhhh
Q 019642 179 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI-FRKEPFFYGHDNHDQLVKIAKVLGTDELNA 257 (338)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
.+...... ....++..|+|||.+.....++.++||||||+++|+|+ +|..||.. ....+ ...... . ..
T Consensus 158 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~-~~~~~-~~~~~~---~-~~-- 226 (262)
T cd05077 158 IPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD-KTLAE-KERFYE---G-QC-- 226 (262)
T ss_pred CCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-cchhH-HHHHHh---c-Cc--
Confidence 88644321 23456778999999875467899999999999999998 57777632 11111 111000 0 00
Q ss_pred hhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
......++++.++|.+||+.||++||++.+|+++
T Consensus 227 -------------------------------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 227 -------------------------------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred -------------------------------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 0001135789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=299.70 Aligned_cols=141 Identities=29% Similarity=0.533 Sum_probs=126.3
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
.++|++.+.||+|+||+||+|.+..+++.||+|+++... ...+..|+.++..+ +||||+++++.+.. ....
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~--~~~~ 79 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYSLQS--ANNV 79 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEEEEE--CCEE
Confidence 478999999999999999999999999999999986432 35678899999998 99999999998854 4578
Q ss_pred EEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 111 SLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
++||||+.+++|..++. .+++..++.++.||+.||.|||+.||+|+||||+|||++.+ +.++|+|||++.
T Consensus 80 ~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~-g~vkL~DFGls~ 152 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNE-GHIKLTDFGLSK 152 (669)
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCC-CCEEEEeCCCCc
Confidence 99999999999987763 47899999999999999999999999999999999999987 899999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=268.45 Aligned_cols=243 Identities=18% Similarity=0.306 Sum_probs=191.1
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCc----eEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
..++|++.+.||+|+||+||+|.+..++. .+++|...... ...+.+|+..++++ +|||++++++++..
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--- 80 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV-DHPHVVRLLGICLS--- 80 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec---
Confidence 35789999999999999999999876654 58888876432 34577899999999 99999999999855
Q ss_pred CccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 108 KTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
...+++|||+.+++|.+.+. .+++..+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+...
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~-~~~kL~dfg~~~~~ 159 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTP-QHVKITDFGLAKLL 159 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCC-CeEEECCCcccccc
Confidence 46789999999999887763 48899999999999999999999999999999999999887 78999999998765
Q ss_pred cCCCccee---eeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhh
Q 019642 184 HPGKEYNV---RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259 (338)
Q Consensus 184 ~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
........ ..++..|+|||.+.. ..++.++|+||||+++|++++ |..||... . ...+.........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~-~~~~~~~~~~~~~------- 229 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGI-P-AVEIPDLLEKGER------- 229 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCC-C-HHHHHHHHhCCCC-------
Confidence 43322111 123457999999865 678899999999999999998 99898322 2 2222211110000
Q ss_pred hccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
...+...+.++.+++.+||..||++|||+.++++
T Consensus 230 ----------------------------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 230 ----------------------------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred ----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0011125678999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=267.02 Aligned_cols=238 Identities=15% Similarity=0.291 Sum_probs=188.5
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEe
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 115 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e 115 (338)
.++|++.+.||+|+||.||++. .+++.+++|.++.. ....+.+|+.+++.+ +|||++++++.+.. ...+++||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~---~~~~~v~e 78 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKL-HHKNLVRLLGVILH---NGLYIVME 78 (254)
T ss_pred HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcchHHHHHHHHHHHHhC-CCCCcCeEEEEEcC---CCcEEEEE
Confidence 3679999999999999999985 47788999998643 445688999999999 99999999999854 24689999
Q ss_pred eecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcce
Q 019642 116 YVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 190 (338)
Q Consensus 116 ~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~ 190 (338)
|+.+++|..++. .++...+..++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||.+...... ..
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~-~~~kl~Dfg~~~~~~~~--~~ 155 (254)
T cd05083 79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSED-GVAKVSDFGLARVGSMG--VD 155 (254)
T ss_pred CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC-CcEEECCCccceecccc--CC
Confidence 999999887763 37888899999999999999999999999999999999988 78999999988653321 12
Q ss_pred eeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcc
Q 019642 191 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 269 (338)
Q Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
....+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||... +..+....+.+. .
T Consensus 156 ~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~--~----------------- 214 (254)
T cd05083 156 NSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKM-SLKEVKECVEKG--Y----------------- 214 (254)
T ss_pred CCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccC-CHHHHHHHHhCC--C-----------------
Confidence 2234567999999876 678899999999999999997 88887322 211111111000 0
Q ss_pred hhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 270 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
.......++..+.+++.+||+.+|++||++.++++
T Consensus 215 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 215 -----------------RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred -----------------CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00011226889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=264.67 Aligned_cols=235 Identities=20% Similarity=0.355 Sum_probs=184.5
Q ss_pred EeeeecCceeEEEEEEcCCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeecC
Q 019642 44 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS 119 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 119 (338)
+.||+|++|.||++.+.. ++.|++|.+.... ...+.+|+++++++ +||||+++++++.+ ....+++|||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLIGVCVQ--KQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeEEEEEEEec--CCCeEEEEEcCCC
Confidence 468999999999999877 9999999876432 34678899999999 99999999999854 4578999999999
Q ss_pred CccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcc---eee
Q 019642 120 TDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVR 192 (338)
Q Consensus 120 ~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~---~~~ 192 (338)
+++..++. .++...+..++.+++.+|.+||++|++|+||+|+||+++.+ +.++|+|||.+......... ...
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGEN-NVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCC-CcEEEeeccccccccCCcceeccccC
Confidence 98887752 37888999999999999999999999999999999999988 89999999998654321111 112
Q ss_pred eccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchh
Q 019642 193 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD 271 (338)
Q Consensus 193 ~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (338)
..+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||... ........+... .
T Consensus 156 ~~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~-~~~~~~~~~~~~-~-------------------- 212 (251)
T cd05041 156 QIPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGM-SNQQTRERIESG-Y-------------------- 212 (251)
T ss_pred cceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccC-CHHHHHHHHhcC-C--------------------
Confidence 23456999999876 678999999999999999999 77777322 211111111000 0
Q ss_pred hhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 272 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
....+..++.++.+++.+||..+|.+|||+.|+++
T Consensus 213 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 213 ---------------RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred ---------------CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 00011226789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=271.31 Aligned_cols=257 Identities=25% Similarity=0.406 Sum_probs=212.7
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
..+|..+..||+|+||.|-++..+.+.+.+|||++++. +.+-...|-++|....+-|.+++++..|+. -..+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT--mDRL 425 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT--MDRL 425 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh--hhhe
Confidence 35788999999999999999999999999999998753 223344577777766567788999998844 5678
Q ss_pred EEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc-cCC
Q 019642 111 SLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPG 186 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~-~~~ 186 (338)
|+||||++||+|-+.++ ++.+..+..++.+|+-||-+||++||+++|||.+||++|.+ |++||+|||++..- -++
T Consensus 426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~e-GHiKi~DFGmcKEni~~~ 504 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENIFDG 504 (683)
T ss_pred eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccC-CceEeeecccccccccCC
Confidence 99999999999988874 58889999999999999999999999999999999999999 99999999998543 233
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
......+|||.|+|||++.- ++|+..+|-||+|++||+|+.|+.|| .+.+..+.+..+.+....
T Consensus 505 ~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPF-dGeDE~elF~aI~ehnvs-------------- 568 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPF-DGEDEDELFQAIMEHNVS-------------- 568 (683)
T ss_pred cceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHccCc--------------
Confidence 44556799999999999877 89999999999999999999999998 455555555555442111
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCH-----HHHhcCCCcchhhhccccc
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA-----REAMAHPYFAQVRAAESSR 335 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~-----~ell~hp~~~~~~~~~~~~ 335 (338)
.+..+|.+..++++..|.+.|.+|... .++-+||||+.+.+.+..+
T Consensus 569 -----------------------yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~ 619 (683)
T KOG0696|consen 569 -----------------------YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLER 619 (683)
T ss_pred -----------------------CcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhh
Confidence 223379999999999999999999843 5888999999998766543
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=266.72 Aligned_cols=238 Identities=21% Similarity=0.341 Sum_probs=181.1
Q ss_pred EeeeecCceeEEEEEEcC---CCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEee
Q 019642 44 RKVGRGKYSEVFEGINVN---TNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 116 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~ 116 (338)
+.||+|+||.||+|.+.. ....+++|.+... ..+.+.+|+.+++.+ +|||++++++++... ....+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPS-EGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccC-CCCCcceEEEEeecC-CCCcEEEEec
Confidence 368999999999998653 3457999987532 234667899999999 999999999976433 3457899999
Q ss_pred ecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc----
Q 019642 117 VNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---- 188 (338)
Q Consensus 117 ~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~---- 188 (338)
+.+++|..++. ..+...+..++.|++.||.|||+.+++|+||||+||+++.+ +.++|+|||++........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDES-FTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC-CcEEECCccccccccCCcceeec
Confidence 99999988863 35677788899999999999999999999999999999988 7899999999865432111
Q ss_pred -ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 189 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 189 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|..|++...+..+....... ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~---~~~------------- 220 (262)
T cd05058 158 NHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ---GRR------------- 220 (262)
T ss_pred ccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc---CCC-------------
Confidence 112234567999999876 67899999999999999999966555443333222211110 000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
...+..+++.+.+++.+||..+|++||++.++++
T Consensus 221 --------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 221 --------------------LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred --------------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0001225788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=263.81 Aligned_cols=236 Identities=20% Similarity=0.339 Sum_probs=183.8
Q ss_pred EeeeecCceeEEEEEEcCCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeecC
Q 019642 44 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS 119 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 119 (338)
+.||+|+||.||+|.. .++..+++|.++... ...+.+|+++++.+ +|||++++++.+.. ....+++|||+.+
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQY-DHPNIVKLIGVCTQ--RQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEec--CCccEEEEECCCC
Confidence 3689999999999985 467889999876433 23577899999999 99999999999855 4578899999999
Q ss_pred CccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcc--eeee
Q 019642 120 TDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY--NVRV 193 (338)
Q Consensus 120 ~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~--~~~~ 193 (338)
++|..++. .+++..+..++.|++.+|.+||++|++|+||+|+||+++.+ +.++|+|||++......... ....
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGEN-NVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCC-CeEEECCCccceeccccccccCCCCC
Confidence 99887753 37889999999999999999999999999999999999887 78999999988644322211 1123
Q ss_pred ccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhh
Q 019642 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA 272 (338)
Q Consensus 194 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (338)
++..|+|||.+.+ ..++.++|+||||+++|++++ |..||... ........+.. ..
T Consensus 156 ~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~-~~~~~~~~~~~---~~------------------- 211 (250)
T cd05085 156 IPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGM-TNQQAREQVEK---GY------------------- 211 (250)
T ss_pred CcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHHc---CC-------------------
Confidence 3457999999876 678899999999999999998 88888322 22111111110 00
Q ss_pred hhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 273 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
....+..++..+.+++.+||..+|++|||+.++++.
T Consensus 212 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 212 --------------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred --------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 000112267899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=264.47 Aligned_cols=236 Identities=19% Similarity=0.286 Sum_probs=185.6
Q ss_pred EeeeecCceeEEEEEEcC-CCc--eEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEee
Q 019642 44 RKVGRGKYSEVFEGINVN-TNE--RCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 116 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~-~~~--~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~ 116 (338)
+.||+|++|.||+|.+.. .++ .+++|.+.... .+.+.+|+..++++ +|||++++++.+.+ ...+++|||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIRLYGVVLT---HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhc-CCCCccceeEEEcC---CeEEEEEEe
Confidence 368999999999998765 333 58999987543 34678899999999 99999999999855 578899999
Q ss_pred ecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc---
Q 019642 117 VNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--- 188 (338)
Q Consensus 117 ~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~--- 188 (338)
+.+++|...+. .+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||++........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASD-DKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecC-CEEEecccccccccccccccee
Confidence 99998887752 37889999999999999999999999999999999999998 8999999999876543221
Q ss_pred -ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 189 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 189 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.....++..|+|||...+ ..++.++|+||||+++++|++ |..||.. .+..+....+... ..
T Consensus 156 ~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~-~~-------------- 218 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAG-LSGSQILKKIDKE-GE-------------- 218 (257)
T ss_pred cccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHhc-CC--------------
Confidence 112345678999999876 678899999999999999998 9999832 2222222222110 00
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
....+..++..+.+++.+||+.+|++|||+.++++
T Consensus 219 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 219 --------------------RLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred --------------------cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 00001125789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=268.55 Aligned_cols=255 Identities=16% Similarity=0.185 Sum_probs=179.8
Q ss_pred eeccCCcEEEEEeeeecCceeEEEEEEcCC---CceEEEEEecccchH--------------HHHHHHHHHHHhcCCCCe
Q 019642 33 IFSDQDDYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPVKKK--------------KIKREIKILQNLCGGPNV 95 (338)
Q Consensus 33 i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~--------------~~~~E~~~l~~l~~h~~i 95 (338)
+....++|++.+.||+|+||+||+|.+..+ +..+++|+....... ....+...+..+ .|+++
T Consensus 7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i 85 (294)
T PHA02882 7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGI 85 (294)
T ss_pred eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCC
Confidence 345568999999999999999999998777 667777764321110 011222334445 79999
Q ss_pred eEeeeeeeccCC--CccEEEEeeecCCcc--ccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCc
Q 019642 96 VKLLDIVRDQHS--KTPSLIFEYVNSTDF--KVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK 171 (338)
Q Consensus 96 v~~~~~~~~~~~--~~~~lv~e~~~~~~l--~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 171 (338)
+++++....... ...+++++++..... .......++..++.++.|++.||.|||+.+++|+||||+|||++.+ +.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~-~~ 164 (294)
T PHA02882 86 PKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGN-NR 164 (294)
T ss_pred CcEEEeeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-Cc
Confidence 999986543322 234567777654322 2222346788899999999999999999999999999999999987 78
Q ss_pred eEEEeccccccccCCC--------cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHH
Q 019642 172 LRLIDWGLAEFYHPGK--------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 243 (338)
Q Consensus 172 ~~l~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~ 243 (338)
++|+|||++....... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||..........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 9999999987653211 1122468999999999877 678999999999999999999999995432322222
Q ss_pred HHHHH-HhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 244 VKIAK-VLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 244 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
..... ........ .......++++.+++..|++.+|++||++.++++
T Consensus 244 ~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 244 HAAKCDFIKRLHEG-------------------------------KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHhHHHHHHHhhhh-------------------------------hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 11110 00000000 0001125788999999999999999999999875
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=267.25 Aligned_cols=244 Identities=21% Similarity=0.414 Sum_probs=191.3
Q ss_pred cEEEEEeeeecCceeEEEEEEcC-CCceEEEEEeccc-------------chHHHHHHHHHHHHhcCCCCeeEeeeeeec
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVN-TNERCIIKILKPV-------------KKKKIKREIKILQNLCGGPNVVKLLDIVRD 104 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~-------------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 104 (338)
.|++.+.||+|+||.||++.+.. +++.+++|.+... ....+..|+.++.+..+|||++++++.+..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999887 6788999987521 123356688877764489999999999854
Q ss_pred cCCCccEEEEeeecCCcccccc-------CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEecCCCCceEEEe
Q 019642 105 QHSKTPSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLID 176 (338)
Q Consensus 105 ~~~~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~~~~~~~l~d 176 (338)
....+++|||+.++++..++ ..+++..++.++.|++.+|.+||+ .|++|+||+|.||+++.+ +.++|+|
T Consensus 81 --~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~-~~~~l~d 157 (269)
T cd08528 81 --NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGED-DKVTITD 157 (269)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCC-CcEEEec
Confidence 56789999999999887654 248899999999999999999996 689999999999999988 7899999
Q ss_pred ccccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhh
Q 019642 177 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 256 (338)
Q Consensus 177 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (338)
||.+.............++..|+|||.+.+ ..++.++|+||||+++|++++|..||... +.......+......
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~-~~~~~~~~~~~~~~~---- 231 (269)
T cd08528 158 FGLAKQKQPESKLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYST-NMLSLATKIVEAVYE---- 231 (269)
T ss_pred ccceeecccccccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCccccc-CHHHHHHHHhhccCC----
Confidence 999876554433344567889999999977 56899999999999999999999998422 111111111110000
Q ss_pred hhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 257 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
+ .....+++++.++|.+||+.||++||++.|+.++
T Consensus 232 ------------------------~-------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 232 ------------------------P-------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred ------------------------c-------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 0 0011257899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=268.30 Aligned_cols=233 Identities=15% Similarity=0.210 Sum_probs=177.5
Q ss_pred eeeecCceeEEEEEEcC------------------------CCceEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeE
Q 019642 45 KVGRGKYSEVFEGINVN------------------------TNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVK 97 (338)
Q Consensus 45 ~lg~G~~g~V~~~~~~~------------------------~~~~~aiK~~~~~~---~~~~~~E~~~l~~l~~h~~iv~ 97 (338)
.||+|+||.||+|.... ....+++|.+.... ...+.+|+.+++.+ +||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l-~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQV-SHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcC-CCCCeee
Confidence 58999999999997432 12458888876433 23566788889988 9999999
Q ss_pred eeeeeeccCCCccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC-----
Q 019642 98 LLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----- 168 (338)
Q Consensus 98 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~----- 168 (338)
+++++.. ....++||||+.+++|..++. .+++..+..++.|++.||.|||++|++|+||||+||+++..
T Consensus 81 ~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 81 VHGVCVR--GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEEe--CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999855 456789999999999887762 47899999999999999999999999999999999999753
Q ss_pred -CCceEEEeccccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHH-hcCCCCcCCCCCHHHHHHH
Q 019642 169 -LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI-FRKEPFFYGHDNHDQLVKI 246 (338)
Q Consensus 169 -~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll-tg~~pf~~~~~~~~~~~~~ 246 (338)
.+.++++|||.+...... ....++..|+|||.+.+...++.++|+||||+++|+++ +|..||... ...+. ...
T Consensus 159 ~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-~~~~~-~~~ 233 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER-TPSEK-ERF 233 (274)
T ss_pred ccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc-ChHHH-HHH
Confidence 124899999987543221 22356778999998876567899999999999999985 688887422 11111 111
Q ss_pred HHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 247 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
..... ..+...++.+.++|.+||+.+|++|||+.++|++
T Consensus 234 ~~~~~-------------------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 234 YEKKH-------------------------------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHhcc-------------------------------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 10000 0001135679999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=270.36 Aligned_cols=244 Identities=17% Similarity=0.278 Sum_probs=190.0
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCc----eEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
..++|++.+.||+|+||.||++.+..++. .+++|.+.... ...+.+|+.+++.+ +||||+++++.+...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~-- 81 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHLVRLLGVCLSP-- 81 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcCC--
Confidence 35789999999999999999999877775 46888776432 23567899999999 999999999988542
Q ss_pred CccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 108 KTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
..++++||+.++++.+++. .+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++...
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~-~~~kL~Dfg~~~~~ 159 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSP-NHVKITDFGLARLL 159 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCC-CceEEccccccccc
Confidence 3568999999998877753 47888999999999999999999999999999999999887 78999999998765
Q ss_pred cCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhh
Q 019642 184 HPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259 (338)
Q Consensus 184 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
..... .....++..|+|||.+.+ ..++.++||||||+++|++++ |..||... .......+.+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~--~~~~~~~~~~~~~~~------ 230 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGI--PTREIPDLLEKGERL------ 230 (303)
T ss_pred cCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHCCCCC------
Confidence 43222 112234568999999876 678999999999999999997 88888321 122222221110000
Q ss_pred hccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
..+...+..+.+++..|+..+|++||++.++++.
T Consensus 231 -----------------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 231 -----------------------------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred -----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0011256789999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=279.55 Aligned_cols=264 Identities=27% Similarity=0.486 Sum_probs=215.0
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
.++.-|..++.||-|+||.|.++....|...||.|.+.+.+ ....+.|-++|... .++.+|++|-.|++ ..
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQD--kd 702 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQD--KD 702 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEecc--CC
Confidence 45678999999999999999999999999999999876432 34467799999988 99999999999955 56
Q ss_pred ccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc-
Q 019642 109 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH- 184 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~- 184 (338)
.+|+||+|..||++-.++ +-++++.++.++.++..|+++.|+.|++|+||||+|||||.+ |++||+|||+++.+.
T Consensus 703 nLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrd-GHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 703 NLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRW 781 (1034)
T ss_pred ceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccC-Cceeeeecccccccee
Confidence 899999999999877665 348899999999999999999999999999999999999999 999999999985431
Q ss_pred --------CCC-----------------c-----------------ceeeeccccccccccccCcCCCCCcchhHHHHHH
Q 019642 185 --------PGK-----------------E-----------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCM 222 (338)
Q Consensus 185 --------~~~-----------------~-----------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~ 222 (338)
.+. . --...||+.|+|||++.. ..++..+|.||.|++
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVI 860 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHH
Confidence 000 0 001368899999999987 689999999999999
Q ss_pred HHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHH
Q 019642 223 FAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFL 302 (338)
Q Consensus 223 l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li 302 (338)
||+|+.|+.||........+ ..-.+|..++......++|.++.++|
T Consensus 861 l~em~~g~~pf~~~tp~~tq----------------------------------~kv~nw~~~l~~~~~~~ls~e~~~li 906 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQ----------------------------------YKVINWRNFLHIPYQGNLSKEALDLI 906 (1034)
T ss_pred HHHHhhCCCCccCCCCCcce----------------------------------eeeeehhhccccccccccCHHHHHHH
Confidence 99999999999433222111 11234555566666666999999999
Q ss_pred HHhcCCCcCCcC---CHHHHhcCCCcchhhhcccccccC
Q 019642 303 DKLLRYDHQDRL---TAREAMAHPYFAQVRAAESSRTRA 338 (338)
Q Consensus 303 ~~~L~~dP~~Rp---t~~ell~hp~~~~~~~~~~~~~~~ 338 (338)
.++. .+++.|. .++||.+||||+++....-++-||
T Consensus 907 ~kLc-~sad~RLGkng~d~vKaHpfFkgIDfsslRkq~A 944 (1034)
T KOG0608|consen 907 QKLC-CSADSRLGKNGADQVKAHPFFKGIDFSSLRKQRA 944 (1034)
T ss_pred HHHh-cChhhhhcccchhhhhcCccccccchHhhhhccC
Confidence 9875 5677777 677899999999999988777654
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=264.57 Aligned_cols=241 Identities=17% Similarity=0.228 Sum_probs=178.2
Q ss_pred EeeeecCceeEEEEEEc--CCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeee
Q 019642 44 RKVGRGKYSEVFEGINV--NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 117 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~ 117 (338)
+.||+|+||.||+|... .++..+++|.++... ...+.+|+.+++.+ +|||++++++.+.+ ....++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-QHSNLLQCLGQCTE--VTPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcC--CCCcEEEEECC
Confidence 36899999999999754 345678999876432 24577899999999 99999999999854 45678999999
Q ss_pred cCCccccccC--------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc-
Q 019642 118 NSTDFKVLYP--------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE- 188 (338)
Q Consensus 118 ~~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~- 188 (338)
.+++|.+++. ..+...+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||.+........
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~-~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTAD-LTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC-CcEEECCccccccccCccee
Confidence 9999987763 24566778899999999999999999999999999999987 8999999998864332211
Q ss_pred --ceeeeccccccccccccCc------CCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhh
Q 019642 189 --YNVRVASRYFKGPELLVDL------QDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259 (338)
Q Consensus 189 --~~~~~~~~~y~aPE~~~~~------~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
.....++..|+|||++.+. ..++.++|+||||+++|+|++ |..||..... .+....... +...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-~~~~~~~~~--~~~~----- 228 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD-EQVLTYTVR--EQQL----- 228 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh-HHHHHHHhh--cccC-----
Confidence 1223456789999998542 135789999999999999996 9999843222 221111100 0000
Q ss_pred hccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
...........++.+.+++..|+ .+|++|||+++|+.
T Consensus 229 ------------------------~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 229 ------------------------KLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ------------------------CCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 00000001125778999999998 68999999999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=278.90 Aligned_cols=256 Identities=24% Similarity=0.422 Sum_probs=220.8
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~------~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
-.+.+++..||-|+||.|=++........+|+|.+++ ...+.+..|-.+|... .+|.||++|..|.+ .+.+
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-~s~fIvrLYrTfrd--~kyv 495 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-RSDFIVRLYRTFRD--SKYV 495 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-CchHHHHHHHHhcc--chhh
Confidence 4578889999999999999988766665688888764 2345577899999998 79999999999955 6789
Q ss_pred EEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 111 SLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
|++||-|-||.++..+. .+.+...+.++..+++|++|||.+||+++||||+|.+++.+ |-+||.|||++.++..+.
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~-Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNR-GYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccC-CceEEeehhhHHHhccCC
Confidence 99999999998888773 59999999999999999999999999999999999999999 899999999999999888
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
..-..+|||.|.|||++.+ +..+.++|.||||+++|++++|..|| .+.++......+.+.+.....+
T Consensus 575 KTwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPF-s~~dpmktYn~ILkGid~i~~P----------- 641 (732)
T KOG0614|consen 575 KTWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPF-SGVDPMKTYNLILKGIDKIEFP----------- 641 (732)
T ss_pred ceeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCC-CCCchHHHHHHHHhhhhhhhcc-----------
Confidence 8888999999999999998 78899999999999999999999998 5666666666666655443322
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCC-----HHHHhcCCCcchhhhccc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAAES 333 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt-----~~ell~hp~~~~~~~~~~ 333 (338)
..++....++|+++.+.+|.+|.. +.+|-.|.||.+..+..-
T Consensus 642 ------------------------r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwegl 688 (732)
T KOG0614|consen 642 ------------------------RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGL 688 (732)
T ss_pred ------------------------cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhh
Confidence 227888999999999999999985 899999999998776543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=259.52 Aligned_cols=285 Identities=28% Similarity=0.516 Sum_probs=223.8
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC---C
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---K 108 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~-----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~---~ 108 (338)
..+.+-.+.||.|+||.||.+.|..+++.|++|++.+ ...+.+.+|+.++.-+ +|.|++..+++.+-.+. .
T Consensus 52 q~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfF-kHdNVLSaLDILQPph~dfFq 130 (449)
T KOG0664|consen 52 QQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSF-RHDNVLSLLDILQPANPSFFQ 130 (449)
T ss_pred cccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhh-ccccHHHHHHhcCCCCchHHH
Confidence 3466777899999999999999999999999998764 3457788999999999 99999999887743322 1
Q ss_pred ccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 109 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
.+|++.|.+... |...+ +.++...++-++.||+.||+|||+.||.|+||||.|.|++++ -.+||||||+++....
T Consensus 131 EiYV~TELmQSD-LHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSN-CvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 131 ELYVLTELMQSD-LHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSN-CILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHHHHHhh-hhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccC-ceEEecccccccccch
Confidence 356777777643 44443 348899999999999999999999999999999999999999 8899999999987654
Q ss_pred CCc--ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccc
Q 019642 186 GKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263 (338)
Q Consensus 186 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
... ......|..|+|||++.+...++.+.||||.||++.+++..+.. ++..++..+++.+.+.+|++..+.+.....
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrIL-FQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKIL-FQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhh-hhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 432 33456788999999999988999999999999999999965555 588899999999999999999888754332
Q ss_pred cccCcchhhhhc-cccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 264 LELDPQLDALVG-RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 264 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
-- ....+. .........+.+.-.+..-..+...++..+|.+||.+|.+.++.+.|+++.+.+
T Consensus 288 GA----k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 288 GA----KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred hh----HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 11 111111 111222222233333333456788999999999999999999999999987754
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=266.19 Aligned_cols=237 Identities=21% Similarity=0.342 Sum_probs=182.9
Q ss_pred EeeeecCceeEEEEEEcCCC------ceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 44 RKVGRGKYSEVFEGINVNTN------ERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~~------~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
+.||+|+||.||+|.+.... +.+++|.+... ....+.+|+..++.+ +||||+++++++.. ....+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNIVKLLGVCLL--NEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhc-CCCCeeeEeeeecC--CCCeEEE
Confidence 36899999999999876443 67899987532 345678899999999 99999999999854 4568899
Q ss_pred EeeecCCccccccC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCC----CceEEEeccc
Q 019642 114 FEYVNSTDFKVLYP----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL----RKLRLIDWGL 179 (338)
Q Consensus 114 ~e~~~~~~l~~~~~----------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~----~~~~l~dfg~ 179 (338)
|||+.+++|..++. .++...+..++.|++.||.|||+.+++|+||+|+||+++.+. ..++|+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999877652 267788999999999999999999999999999999998762 2799999999
Q ss_pred cccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchh
Q 019642 180 AEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDEL 255 (338)
Q Consensus 180 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (338)
+........ ......+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.. .+..+....+.. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~----~~- 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPA-LNNQEVLQHVTA----GG- 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcc-cCHHHHHHHHhc----CC-
Confidence 865432221 112244578999999876 678999999999999999998 8988832 222221111100 00
Q ss_pred hhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 256 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
....+..++..+.++|.+||+.+|++||++.++++
T Consensus 231 -------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 231 -------------------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred -------------------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00011226788999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=262.72 Aligned_cols=232 Identities=17% Similarity=0.246 Sum_probs=180.8
Q ss_pred EeeeecCceeEEEEEEcCCC----------ceEEEEEecccc--hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 44 RKVGRGKYSEVFEGINVNTN----------ERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~~----------~~~aiK~~~~~~--~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
+.||+|+||.||+|.+..++ ..+++|.+.... ...+.+|+.+++.+ +|||++++++.+.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQL-SHKHLVKLYGVCVR---DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcC-CCcchhheeeEEec---CCcE
Confidence 46899999999999998776 357788766433 46778899999999 99999999998855 3568
Q ss_pred EEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCC------CceEEEeccccc
Q 019642 112 LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL------RKLRLIDWGLAE 181 (338)
Q Consensus 112 lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~------~~~~l~dfg~~~ 181 (338)
++|||+.+++|..++. .++...+..++.|++.||.|||++|++|+||||+||+++.+. ..++|+|||++.
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 9999999999987763 478899999999999999999999999999999999998762 169999999987
Q ss_pred cccCCCcceeeeccccccccccccCc-CCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhh
Q 019642 182 FYHPGKEYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259 (338)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
.... .....++..|+|||.+.+. ..++.++|+||||++++++++ |..||.... ..+... .... . .
T Consensus 157 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~~~-~~~~--~-~----- 223 (259)
T cd05037 157 TVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKER-FYQD--Q-H----- 223 (259)
T ss_pred cccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhHHH-HHhc--C-C-----
Confidence 6443 2234566789999998763 378899999999999999999 466663221 111111 0000 0 0
Q ss_pred hccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
. .+......+.++|.+||..+|++|||+.++++
T Consensus 224 -------------------~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 224 -------------------R----------LPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -------------------C----------CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0 00002368899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=282.17 Aligned_cols=259 Identities=26% Similarity=0.450 Sum_probs=211.9
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc--cchHHHHHHHHHHHHhcCCCCeeEeeeeeec---cCCCc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNVVKLLDIVRD---QHSKT 109 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~---~~~~~ 109 (338)
...+-|++.+.||.|.+|.||++.+.++++..|+|+... ....+++.|.++++.++.|||++.++++|.- ..++.
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 457899999999999999999999999999999998764 4467788999999999999999999998853 34568
Q ss_pred cEEEEeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 110 PSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
+++|||+|++|+..++.+ ++.++.+..|++.++.|+.+||.+.++|+|||-.|||++.+ +.|||+|||.+....
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e-~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLD 174 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEecc-CcEEEeeeeeeeeee
Confidence 999999999999998875 48899999999999999999999999999999999999999 899999999875543
Q ss_pred -CCCcceeeeccccccccccccCcC----CCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhh
Q 019642 185 -PGKEYNVRVASRYFKGPELLVDLQ----DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259 (338)
Q Consensus 185 -~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
.....+...||+.|||||++...+ .++..+|+||||++..+|.-|.+|+..-+.-.
T Consensus 175 sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr------------------- 235 (953)
T KOG0587|consen 175 STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR------------------- 235 (953)
T ss_pred cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh-------------------
Confidence 334456678999999999996543 36778999999999999999999983221111
Q ss_pred hccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
.++. +.+.|..++. -+...++++.+||..||.+|-++||+..++|+|||+++-+
T Consensus 236 ------------aLF~-IpRNPPPkLk---rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 236 ------------ALFL-IPRNPPPKLK---RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP 289 (953)
T ss_pred ------------hhcc-CCCCCCcccc---chhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence 1111 1111111111 1122488999999999999999999999999999998554
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=278.06 Aligned_cols=243 Identities=23% Similarity=0.375 Sum_probs=189.7
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCc---e-EEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNE---R-CIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~-~aiK~~~~------~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
++-.+.++||+|+||.||+|.....+. . ||+|..+. ....++.+|.++|+++ +|||||+++|+... .
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yGVa~~--~ 233 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYGVAVL--E 233 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcC--C
Confidence 345556999999999999998765422 3 89998773 2346688999999999 99999999999855 4
Q ss_pred CccEEEEeeecCCccccccCC----CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 108 KTPSLIFEYVNSTDFKVLYPT----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
..+++|||+|.||+|.+++++ ++..+...++.+.+.||+|||+++++||||-+.|+|++.+ +.+||+|||++...
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~-~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKK-GVVKISDFGLSRAG 312 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCC-CeEEeCccccccCC
Confidence 578999999999999999854 8899999999999999999999999999999999999998 67899999998654
Q ss_pred cCCCcce-eeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 184 HPGKEYN-VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 184 ~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
....... ...-...|+|||.+.. ..+++++||||||+++||+.+ |..||. +....+....+... +.
T Consensus 313 ~~~~~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~-g~~~~~v~~kI~~~-~~--------- 380 (474)
T KOG0194|consen 313 SQYVMKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYP-GMKNYEVKAKIVKN-GY--------- 380 (474)
T ss_pred cceeeccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCC-CCCHHHHHHHHHhc-Cc---------
Confidence 3111111 1234567999999988 589999999999999999998 788873 33333222222110 00
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
+. ..+..-+.++..++..|+..+|++|||+.++.+
T Consensus 381 -----------------r~--------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 381 -----------------RM--------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred -----------------cC--------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 00 011124778999999999999999999998864
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=255.91 Aligned_cols=255 Identities=25% Similarity=0.477 Sum_probs=211.4
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
.-++|.+++.||+|+|+.|-+++.+++.+.||+|++++. +.+-.+.|-.+.....+||.+|-++..|+. +..
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt--esr 325 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT--ESR 325 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc--cce
Confidence 357899999999999999999999999999999998742 234456788888888899999999999944 567
Q ss_pred cEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccc-ccC
Q 019642 110 PSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF-YHP 185 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~-~~~ 185 (338)
+++|.||++|++|-..++ ++|++.++.+...|+.||.|||++||+++|+|.+|+|+|.+ |++||+|+|.++. +.+
T Consensus 326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldae-ghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccC-CceeecccchhhcCCCC
Confidence 899999999999987764 59999999999999999999999999999999999999999 9999999998854 455
Q ss_pred CCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcC-CCC-----CHHHHHHHHHHhCCchhhhhh
Q 019642 186 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY-GHD-----NHDQLVKIAKVLGTDELNAYL 259 (338)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~-~~~-----~~~~~~~~~~~~~~~~~~~~~ 259 (338)
+......+|||.|.|||++.+ ..|.+.+|-|+||+++++|+.|+.||.. +.+ ..+.+.++ +-..
T Consensus 405 gd~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv---ilek------ 474 (593)
T KOG0695|consen 405 GDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV---ILEK------ 474 (593)
T ss_pred CcccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH---Hhhh------
Confidence 667777899999999999998 7899999999999999999999999953 222 22223222 1110
Q ss_pred hccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC------CHHHHhcCCCcchhhh
Q 019642 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL------TAREAMAHPYFAQVRA 330 (338)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp------t~~ell~hp~~~~~~~ 330 (338)
+.-.+..+|-....++++-|.+||.+|. ...++..|+||+.+.+
T Consensus 475 ---------------------------qiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idw 524 (593)
T KOG0695|consen 475 ---------------------------QIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW 524 (593)
T ss_pred ---------------------------cccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence 0111222566778899999999999997 5789999999998765
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=263.25 Aligned_cols=241 Identities=19% Similarity=0.277 Sum_probs=177.4
Q ss_pred EeeeecCceeEEEEEEcC--CCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeee
Q 019642 44 RKVGRGKYSEVFEGINVN--TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 117 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~ 117 (338)
++||+|+||.||+|.... ....+++|.+.... ...+.+|+..++.+ +||||+++++.+.. ....+++|||+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~--~~~~~lv~e~~ 77 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIE--SIPYLLVLEFC 77 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC-CCCCcceEEEEECC--CCceEEEEEeC
Confidence 368999999999996533 34568888765332 23567899999998 99999999999854 45789999999
Q ss_pred cCCccccccCC--------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc-
Q 019642 118 NSTDFKVLYPT--------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE- 188 (338)
Q Consensus 118 ~~~~l~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~- 188 (338)
.+++|.+++.. .++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++........
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTAD-LSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCC-CcEEEeccccccccccchhe
Confidence 99999887632 3567788999999999999999999999999999999988 8999999998854322211
Q ss_pred --ceeeeccccccccccccC------cCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhh
Q 019642 189 --YNVRVASRYFKGPELLVD------LQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259 (338)
Q Consensus 189 --~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
.....++..|+|||+... ...++.++|+||||+++|+|++ |..||. ...+.+.+..........
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~-~~~~~~~~~~~~~~~~~~------ 229 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYP-DLSDEQVLKQVVREQDIK------ 229 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCC-cCCHHHHHHHHhhccCcc------
Confidence 112234567999998743 2357889999999999999999 677763 222222222221110000
Q ss_pred hccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
+.....+..++..+.+++..|+ .||++|||+++|++
T Consensus 230 -------------------------~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 230 -------------------------LPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred -------------------------CCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 0000111236788899999998 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=274.06 Aligned_cols=285 Identities=27% Similarity=0.470 Sum_probs=213.8
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc--hHHHHHHHHHHHHhcC-----CCCeeEeeeeeeccCCCc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCG-----GPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~E~~~l~~l~~-----h~~iv~~~~~~~~~~~~~ 109 (338)
..+|.+....|+|-||+|.+|.+...+..||||++.... .+.-..|+++|++|.. .-|+++++..| ....+
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F--~hknH 508 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF--KHKNH 508 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh--hhcce
Confidence 468999999999999999999999999999999998543 4556789999999952 23899999988 44679
Q ss_pred cEEEEeeecCCcccccc---C--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 110 PSLIFEYVNSTDFKVLY---P--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~---~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
+|+|+|.+.-+.-+.+. . .+....+..++.|++.||..|.+.|++|.||||+|||++.....+||||||.|..+.
T Consensus 509 LClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ 588 (752)
T KOG0670|consen 509 LCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFAS 588 (752)
T ss_pred eEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccccc
Confidence 99999988755433222 1 378889999999999999999999999999999999999988899999999998776
Q ss_pred CCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccc
Q 019642 185 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264 (338)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
.+.. .+...+.-|+|||++.+ .+|+..-|+||.||+||++.||+..| ++..+-..+....++.|..+-.... ...+
T Consensus 589 enei-tPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlF-pG~TNN~MLrl~me~KGk~p~KmlR-KgqF 664 (752)
T KOG0670|consen 589 ENEI-TPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILF-PGRTNNQMLRLFMELKGKFPNKMLR-KGQF 664 (752)
T ss_pred cccc-cHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceec-CCCCcHHHHHHHHHhcCCCcHHHhh-hcch
Confidence 5443 44566778999999999 78999999999999999999999887 6777777777777766654322221 1100
Q ss_pred c---cCcch-------hhhhcccc------CCCCccccc--------ccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHh
Q 019642 265 E---LDPQL-------DALVGRHS------RKPWSKFIN--------ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 320 (338)
Q Consensus 265 ~---~~~~~-------~~~~~~~~------~~~~~~~~~--------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell 320 (338)
. ++..+ +....... -.|-..+-. ...+..+-.++++|+.+||..||++|.|..|+|
T Consensus 665 ~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL 744 (752)
T KOG0670|consen 665 KDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQAL 744 (752)
T ss_pred hhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHh
Confidence 0 01000 00000000 001000000 001111335689999999999999999999999
Q ss_pred cCCCcch
Q 019642 321 AHPYFAQ 327 (338)
Q Consensus 321 ~hp~~~~ 327 (338)
+||||++
T Consensus 745 ~HpFi~~ 751 (752)
T KOG0670|consen 745 KHPFITE 751 (752)
T ss_pred cCCcccC
Confidence 9999975
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=262.52 Aligned_cols=243 Identities=18% Similarity=0.332 Sum_probs=185.5
Q ss_pred EEEEEeeeecCceeEEEEEEc---CCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC----
Q 019642 40 YEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---- 107 (338)
Q Consensus 40 y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~---- 107 (338)
|.+.+.||+|+||.||+|.+. .+++.+++|.+... ..+.+.+|+.+++.+ +|||++++++++.....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-DHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCCCCcc
Confidence 577889999999999999864 35788999988643 234577899999999 99999999998754322
Q ss_pred CccEEEEeeecCCcccccc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecc
Q 019642 108 KTPSLIFEYVNSTDFKVLY---------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG 178 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg 178 (338)
...+++++|+.++++..++ ..++...+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~-~~~kl~dfg 158 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNEN-MTVCVADFG 158 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCC-CCEEECccc
Confidence 2347889999999886553 137888999999999999999999999999999999999887 789999999
Q ss_pred ccccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCch
Q 019642 179 LAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDE 254 (338)
Q Consensus 179 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (338)
.+........ .....+++.|++||...+ ...+.++|+||||+++|++++ |..||. ..+..+....+.. ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~-~~~~~~~~~~~~~---~~~ 233 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYA-GVENSEIYNYLIK---GNR 233 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCC-CCCHHHHHHHHHc---CCc
Confidence 9876533221 112234567999999876 578889999999999999999 777773 2222221111110 000
Q ss_pred hhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 255 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
...+...++.+.+++.+||+.+|++|||+.++++.
T Consensus 234 ---------------------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 234 ---------------------------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred ---------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00011257899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=258.70 Aligned_cols=241 Identities=16% Similarity=0.257 Sum_probs=176.1
Q ss_pred EeeeecCceeEEEEEEcCC--CceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeee
Q 019642 44 RKVGRGKYSEVFEGINVNT--NERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 117 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~--~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~ 117 (338)
++||+|+||.||++..... ...+++|..+.. ....+.+|+..++.+ +|||++++++.+.. ....+++|||+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~--~~~~~lv~e~~ 77 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVE--AIPYLLVFEYC 77 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhcc-CCcchhheEEEecC--CCccEEEEecC
Confidence 3699999999999975433 334667765532 235678899999999 99999999999854 45789999999
Q ss_pred cCCccccccC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC---
Q 019642 118 NSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--- 187 (338)
Q Consensus 118 ~~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~--- 187 (338)
.+++|..++. ..+...++.++.|++.||.|||+.+++|+||||+||+++.+ +.++|+|||++.......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~-~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSD-LTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCC-ccEEecccccccccCcchhhh
Confidence 9999987653 25666788999999999999999999999999999999987 789999999875322111
Q ss_pred cceeeeccccccccccccCc------CCCCCcchhHHHHHHHHHHHhc-CCCCcCCCCCHHHHHHHHHHhCCchhhhhhh
Q 019642 188 EYNVRVASRYFKGPELLVDL------QDYDYSLDMWSLGCMFAGMIFR-KEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 260 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~------~~~~~~~DvwslG~~l~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
......++..|+|||+.... ...+.++|+||||+++|+|+++ ..|| ...+..+............
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~-~~~~~~~~~~~~~~~~~~~------- 228 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPY-SHLSDREVLNHVIKDQQVK------- 228 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHhhcccc-------
Confidence 11234567889999997431 2457899999999999999975 5565 3333333333221110000
Q ss_pred ccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
.........+++.+.+++..|+ .+|.+||++.++++
T Consensus 229 ------------------------~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 229 ------------------------LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ------------------------cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 0000011126788999999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=253.49 Aligned_cols=288 Identities=26% Similarity=0.449 Sum_probs=221.4
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccC--
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH-- 106 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~-----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-- 106 (338)
++...+|.-++.+|.|+- .|..+.|.-+++.|++|.... ...++..+|...+..+ +|+||++++..|.-..
T Consensus 13 ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~~l 90 (369)
T KOG0665|consen 13 FTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQKTL 90 (369)
T ss_pred eeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhh-cccceeeeeeccCccccH
Confidence 344578999999999998 778888988999999998642 2345567899999999 9999999999985321
Q ss_pred --CCccEEEEeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 107 --SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 107 --~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
....|+|||++..+.-....-.+..+.+..++.|++.|+++||+.||+||||||+||++..+ ..+||.|||++....
T Consensus 91 ~~~~e~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~-~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 91 EEFQEVYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSD-CTLKILDFGLARTED 169 (369)
T ss_pred HHHHhHHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecch-hheeeccchhhcccC
Confidence 23578999999887666556678889999999999999999999999999999999999998 899999999998766
Q ss_pred CCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhh--cc
Q 019642 185 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN--KY 262 (338)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 262 (338)
.....+....+..|+|||++.+ ..+...+||||+||++.+|++|...| .+.+..++...+.+.+|.++..-... .-
T Consensus 170 ~~~~mtpyVvtRyyrapevil~-~~~ke~vdiwSvGci~gEli~~~Vlf-~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~ 247 (369)
T KOG0665|consen 170 TDFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELILGTVLF-PGKDHIDQWNKIIEQLGTPDPSFMKQLQPT 247 (369)
T ss_pred cccccCchhheeeccCchheec-cCCcccchhhhhhhHHHHHhhceEEe-cCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence 5555666788999999999999 45999999999999999999999887 68888899999999999866443211 00
Q ss_pred ccccCcchhhhhcc--ccCCCCcccccccCCC-CCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcc
Q 019642 263 HLELDPQLDALVGR--HSRKPWSKFINADNQH-LVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 326 (338)
Q Consensus 263 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~-~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~ 326 (338)
...+..+..+..+. ...-+-..|......+ .-...+++++.+||..||++|.+++++|+|||++
T Consensus 248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 00000011111110 0001111111111111 2345789999999999999999999999999997
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=287.47 Aligned_cols=245 Identities=22% Similarity=0.415 Sum_probs=201.5
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCC-----ceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeecc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ 105 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 105 (338)
.+..+-++.+.||+|.||.||.|...... ..|++|.++.. ....+.+|..+|.++ +||||+++++++.+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~- 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLD- 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecC-
Confidence 45678999999999999999999875433 34999988753 356688999999999 99999999999966
Q ss_pred CCCccEEEEeeecCCccccccC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEE
Q 019642 106 HSKTPSLIFEYVNSTDFKVLYP----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI 175 (338)
Q Consensus 106 ~~~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~ 175 (338)
....++++|||.+|+|..+++ .++..++..++.||+.|++||++++.+|+||.+.|+|++.. ..+||+
T Consensus 767 -~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~-r~VKIa 844 (1025)
T KOG1095|consen 767 -SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER-RVVKIA 844 (1025)
T ss_pred -CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc-CcEEEc
Confidence 567889999999999988873 28899999999999999999999999999999999999998 899999
Q ss_pred eccccccccCCCcceee---eccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhC
Q 019642 176 DWGLAEFYHPGKEYNVR---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLG 251 (338)
Q Consensus 176 dfg~~~~~~~~~~~~~~---~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~ 251 (338)
|||+++.+......... .-...|||||.+.. ..++.++||||||+++||++| |..|| ...++.+.+....+.-
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY-~~~~n~~v~~~~~~gg- 921 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPY-PSRSNFEVLLDVLEGG- 921 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCC-CCcchHHHHHHHHhCC-
Confidence 99999855444332221 22356999999988 789999999999999999998 66665 5555555555332211
Q ss_pred CchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 252 TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
....+..+++.+.++|..||+.+|++||++..|++
T Consensus 922 -----------------------------------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 922 -----------------------------------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred -----------------------------------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 11233448899999999999999999999999987
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=266.99 Aligned_cols=258 Identities=24% Similarity=0.460 Sum_probs=206.9
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEec--ccc--------hHHHHHHHHHHHHhcCCCCeeEeeeeeecc
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVK--------KKKIKREIKILQNLCGGPNVVKLLDIVRDQ 105 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~--~~~--------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 105 (338)
..++|-++..||+|+|+.||++.|....++||+|+-. +.. .+..-+|.++.+.| .||.||++|++|.-.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYFSLD 539 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeeeeec
Confidence 3578889999999999999999999999999999853 211 23355799999999 999999999999654
Q ss_pred CCCccEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCCCCeEecCC--CCceEEEecc
Q 019642 106 HSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQ--GIMHRDVKPHNVMIDHE--LRKLRLIDWG 178 (338)
Q Consensus 106 ~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dikp~NIli~~~--~~~~~l~dfg 178 (338)
. ...|.|.|||.|++|..+++ .+++.+++.|+.||+.||.||.+. -|+|-||||.|||+-.+ -|.+||+|||
T Consensus 540 t-dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 540 T-DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred c-ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 3 46789999999999999985 389999999999999999999987 49999999999999543 3789999999
Q ss_pred ccccccCCCc--------ceeeeccccccccccccC---cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHH
Q 019642 179 LAEFYHPGKE--------YNVRVASRYFKGPELLVD---LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 247 (338)
Q Consensus 179 ~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~ 247 (338)
++..+.+... .....||.+|.+||.+.- .+..+.++||||+|+++|.++.|+.||.......+.+....
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 9987754321 233578999999999843 34688899999999999999999999965544444444321
Q ss_pred HHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcch
Q 019642 248 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 327 (338)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 327 (338)
-.... . ..-...+.++++..+||++||+...++|....++-.||+|.-
T Consensus 699 IlkAt-E-------------------------------VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 699 ILKAT-E-------------------------------VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred hhcce-e-------------------------------ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 11000 0 011122337999999999999999999999999999999864
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=269.77 Aligned_cols=266 Identities=19% Similarity=0.304 Sum_probs=180.4
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEc----------------CCCceEEEEEecccch-----------------HHHHH
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINV----------------NTNERCIIKILKPVKK-----------------KKIKR 81 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~~aiK~~~~~~~-----------------~~~~~ 81 (338)
...++|++.++||+|+||+||+|... ..++.||||.++.... +....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 45789999999999999999999752 2346799999763221 12234
Q ss_pred HHHHHHHhcCCCC-----eeEeeeeeecc------CCCccEEEEeeecCCccccccC-----------------------
Q 019642 82 EIKILQNLCGGPN-----VVKLLDIVRDQ------HSKTPSLIFEYVNSTDFKVLYP----------------------- 127 (338)
Q Consensus 82 E~~~l~~l~~h~~-----iv~~~~~~~~~------~~~~~~lv~e~~~~~~l~~~~~----------------------- 127 (338)
|+.++.++ +|.+ ++++++++... .....++||||+.+++|.+++.
T Consensus 222 E~~~l~~l-~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 222 EAYMCAKI-KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHh-hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 67777777 4443 35666666432 1245789999999998876652
Q ss_pred ----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCccee--eecccccccc
Q 019642 128 ----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKGP 201 (338)
Q Consensus 128 ----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~~--~~~~~~y~aP 201 (338)
.++...++.++.|++.+|.|||+.+++|+||||+||+++.+ +.++|+|||++........... ..+++.|+||
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD-GQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCC-CcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 13456688899999999999999999999999999999988 7899999999865433222222 2347899999
Q ss_pred ccccCcCC---------------------CCCcchhHHHHHHHHHHHhcCC-CCcCCCCCHHHHHHHHHHhCCchhhhhh
Q 019642 202 ELLVDLQD---------------------YDYSLDMWSLGCMFAGMIFRKE-PFFYGHDNHDQLVKIAKVLGTDELNAYL 259 (338)
Q Consensus 202 E~~~~~~~---------------------~~~~~DvwslG~~l~~lltg~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
|.+..... ...+.|+||+||++++|++|.. |+.... .+....+.. ......|.
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~----~f~~~~~~~-~~~~~~~r 454 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIR----LFNTELRQY-DNDLNRWR 454 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchh----hhhhHHhhc-cchHHHHH
Confidence 99754211 1124799999999999999876 552111 111100000 01111111
Q ss_pred hccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCc---CCcCCHHHHhcCCCcch
Q 019642 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH---QDRLTAREAMAHPYFAQ 327 (338)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP---~~Rpt~~ell~hp~~~~ 327 (338)
... ...+ ........++..++|+.+||..+| .+|+|+.|+|+||||..
T Consensus 455 ~~~----------------~~~~----~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 455 MYK----------------GQKY----DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred hhc----------------ccCC----CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 000 0000 001122268899999999999876 68999999999999964
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=250.51 Aligned_cols=237 Identities=35% Similarity=0.621 Sum_probs=192.4
Q ss_pred CceeEEEEEEcCCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeecCCccccc
Q 019642 50 KYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL 125 (338)
Q Consensus 50 ~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 125 (338)
+||.||+|.+..+++.+++|++.... .+.+.+|+..++++ +|++++++++.+.. ....++++|++.+++|..+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL-KHPNIVRLYDVFED--EDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC-CCCcHHHHHhheee--CCEEEEEEeCCCCCCHHHH
Confidence 58999999998889999999987543 47788999999999 99999999999854 4578899999999988887
Q ss_pred cCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcceeeeccccccccc
Q 019642 126 YPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 202 (338)
Q Consensus 126 ~~~---~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE 202 (338)
+.. ++...++.++.+++.++.+||+.|++|+||+|.||+++.+ +.++|+|||.+.............++..|++||
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE 156 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDED-GHVKLADFGLARQLDPGGLLTTFVGTPEYMAPE 156 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCC-CcEEEccccceeeeccccccccccCCcCCCCHH
Confidence 643 7889999999999999999999999999999999999998 899999999987765443444566788999999
Q ss_pred cccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCC
Q 019642 203 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPW 282 (338)
Q Consensus 203 ~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (338)
...+ ...+.++|+||+|++++++++|..||....+......... ......
T Consensus 157 ~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~----~~~~~~------------------------- 206 (244)
T smart00220 157 VLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG----KPKPPF------------------------- 206 (244)
T ss_pred HHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh----ccCCCC-------------------------
Confidence 9876 5778899999999999999999999844322222222111 100000
Q ss_pred cccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 283 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 283 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
......++.++.+++.+||..+|++||++.++++||||
T Consensus 207 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 207 -----PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred -----ccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 00000157889999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=292.03 Aligned_cols=253 Identities=20% Similarity=0.299 Sum_probs=187.1
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeec
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN 118 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 118 (338)
.+.....||+|+||.||+|.+..++..||+|.++.... ....|+..++++ +||||+++++++.+ ....++||||+.
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~l~~l-~HpnIv~~~~~~~~--~~~~~lv~Ey~~ 766 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-IPSSEIADMGKL-QHPNIVKLIGLCRS--EKGAYLIHEYIE 766 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-ccHHHHHHHhhC-CCCCcceEEEEEEc--CCCCEEEEeCCC
Confidence 45566789999999999999989999999999864332 224578999999 99999999999965 456789999999
Q ss_pred CCccccccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcceeeecc
Q 019642 119 STDFKVLYPTLTDYDIRYYIYELLKALDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS 195 (338)
Q Consensus 119 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 195 (338)
+++|.+++..+++..+..++.|++.||.||| +.+++|+||||+||+++.+ ...++. ++....... .....++
T Consensus 767 ~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~-~~~~~~-~~~~~~~~~---~~~~~~t 841 (968)
T PLN00113 767 GKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK-DEPHLR-LSLPGLLCT---DTKCFIS 841 (968)
T ss_pred CCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC-CceEEE-ecccccccc---CCCcccc
Confidence 9999999999999999999999999999999 6699999999999999887 555554 554332211 1223678
Q ss_pred ccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhC-CchhhhhhhccccccCcchhhhh
Q 019642 196 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG-TDELNAYLNKYHLELDPQLDALV 274 (338)
Q Consensus 196 ~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 274 (338)
+.|+|||++.+ ..++.++||||||+++|+|++|+.||............+.+... ......+. ++.+
T Consensus 842 ~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~---- 909 (968)
T PLN00113 842 SAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWI-------DPSI---- 909 (968)
T ss_pred ccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhee-------Cccc----
Confidence 89999999877 67999999999999999999999998543332222222221110 00000000 0000
Q ss_pred ccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 275 GRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
.... ........++.+++.+|++.||++|||+.|+++.
T Consensus 910 ----~~~~------~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 910 ----RGDV------SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred ----cCCC------CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0000 0000012467889999999999999999999875
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=271.47 Aligned_cols=245 Identities=18% Similarity=0.323 Sum_probs=206.9
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCC---ceEEEEEecc----cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
+-....|.+.||.|.||.|++|+.+..+ ..||||.++. ..+..+..|..+|-++ +||||+++.++. +..+
T Consensus 627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF-dHPNIIrLEGVV--Tks~ 703 (996)
T KOG0196|consen 627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIRLEGVV--TKSK 703 (996)
T ss_pred ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC-CCCcEEEEEEEE--ecCc
Confidence 3456789999999999999999987655 4699999884 3466789999999999 999999999998 5567
Q ss_pred ccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 109 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
..+||.|||..++|+.+++ .++..++..+++.|+.|++||-+.|+|||||.+.|||++.+ ..+|++|||+++...
T Consensus 704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsn-LvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVLE 782 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccc-eEEEeccccceeecc
Confidence 8899999999999999984 48889999999999999999999999999999999999999 899999999998775
Q ss_pred CCCcc-eeeec---cccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhh
Q 019642 185 PGKEY-NVRVA---SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259 (338)
Q Consensus 185 ~~~~~-~~~~~---~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
+.... ....| ...|.|||++.. .+.+.++||||+|++|||.++ |..||+ .-.+.+.+..+.+....+++
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYW-dmSNQdVIkaIe~gyRLPpP---- 856 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYW-DMSNQDVIKAIEQGYRLPPP---- 856 (996)
T ss_pred cCCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCccc-ccchHHHHHHHHhccCCCCC----
Confidence 54421 11222 356999999977 789999999999999999886 888974 45667777777665554432
Q ss_pred hccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
.+.+..+.+|+..||++|-.+||++.||+++
T Consensus 857 --------------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 857 --------------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred --------------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 2378899999999999999999999999863
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=271.89 Aligned_cols=245 Identities=26% Similarity=0.365 Sum_probs=186.1
Q ss_pred EEEEEeeeecCcee-EEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeec
Q 019642 40 YEVVRKVGRGKYSE-VFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN 118 (338)
Q Consensus 40 y~~~~~lg~G~~g~-V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 118 (338)
|.-.+.+|.|+.|+ ||+|.. .++.||||.+-....+...+|+..++.-..||||+++++.- .+....||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E--~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE--QDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec--cCCceEEEEehHhh
Confidence 44456788999975 599976 67799999988777888899999999988999999999987 44678899999987
Q ss_pred CCccccccCC-------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecC----CCCceEEEeccccccccCCC
Q 019642 119 STDFKVLYPT-------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH----ELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 119 ~~~l~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~----~~~~~~l~dfg~~~~~~~~~ 187 (338)
. +|++++.. ......+.++.|+++||++||+.+|+||||||.||||+. ....++|+|||++.++..+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 4 44555432 121345778999999999999999999999999999976 33579999999999887654
Q ss_pred c----ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhc-CCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcc
Q 019642 188 E----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR-KEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262 (338)
Q Consensus 188 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
. .....||.+|+|||.+.. ...+.++||+||||++|+.++| .+||.. .-..+.+ +.. +...+.
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~-~~~~~avDiFslGCvfyYvltgG~HpFGd--~~~R~~N-Il~--~~~~L~------ 733 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLRE-DRKTQAVDIFSLGCVFYYVLTGGSHPFGD--SLERQAN-ILT--GNYTLV------ 733 (903)
T ss_pred chhhcccCCCCcccccCHHHHhc-cccCcccchhhcCceEEEEecCCccCCCc--hHHhhhh-hhc--Ccccee------
Confidence 3 233468899999999987 5567799999999999999996 889931 1111111 110 000000
Q ss_pred ccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcch
Q 019642 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 327 (338)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 327 (338)
... . .-..+..+||.+|+.++|..||+|.++|.||+|=.
T Consensus 734 ---------------------~L~---~--~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 734 ---------------------HLE---P--LPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred ---------------------eec---c--CchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 000 0 01127899999999999999999999999999943
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=261.83 Aligned_cols=249 Identities=20% Similarity=0.310 Sum_probs=199.7
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCC---CceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
+..++..+.++||+|.||.|++|.++.. ...||||.++.. ..+.+.+|+.+|.+| +|||++++|++..++
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L-~H~hliRLyGvVl~q-- 183 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKL-QHPHLIRLYGVVLDQ-- 183 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhc-cCcceeEEeeeeccc--
Confidence 3345677889999999999999987642 345899998743 357799999999999 999999999998663
Q ss_pred CccEEEEeeecCCccccccCC-----CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccc
Q 019642 108 KTPSLIFEYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~ 182 (338)
...+|+|.+.+|+|.+.+.. +....+..++.||+.|+.||..+++||+||...|+++... ..|||+|||+.+.
T Consensus 184 -p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasp-rtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 184 -PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASP-RTVKICDFGLMRA 261 (1039)
T ss_pred -hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheeccc-ceeeeecccceec
Confidence 46799999999999887743 7788899999999999999999999999999999999886 7999999999987
Q ss_pred ccCCCccee----eeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhh
Q 019642 183 YHPGKEYNV----RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNA 257 (338)
Q Consensus 183 ~~~~~~~~~----~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
+..+..... ......|.|||.+.. ..++.++|+|++|+++|||+| |+.|| .+-....+++.+.+.
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW-~G~~g~qIL~~iD~~-------- 331 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPW-VGCRGIQILKNIDAG-------- 331 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCC-CCCCHHHHHHhcccc--------
Confidence 765544322 122346999999987 789999999999999999998 67787 444444444443211
Q ss_pred hhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcc
Q 019642 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 326 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~ 326 (338)
.....++.+++.+.++++.||..+|++|||+..|.+.-++.
T Consensus 332 ----------------------------erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 332 ----------------------------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred ----------------------------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 01112334789999999999999999999999997655543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=225.39 Aligned_cols=209 Identities=20% Similarity=0.394 Sum_probs=174.5
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc----cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
..++......||+|++|.|-+.++..+|+..|+|.+.. ...+++.+|+++..+...+|.+|.+++...+ +...+
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r--egdvw 121 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR--EGDVW 121 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc--cccEE
Confidence 34566667899999999999999999999999998763 3345677888888877789999999997744 45678
Q ss_pred EEEeeecCCcccccc-------CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 112 LIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 112 lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
+.||.++.. +..+. ..+++..+-+++..++.||.|||++ .++|+|+||+|||++.. |++|+||||.+-.+
T Consensus 122 IcME~M~tS-ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~-GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 122 ICMELMDTS-LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYD-GQVKICDFGISGYL 199 (282)
T ss_pred EeHHHhhhh-HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccC-CcEEEcccccceee
Confidence 999998754 33332 3489999999999999999999987 89999999999999999 99999999999777
Q ss_pred cCCCcceeeeccccccccccccCc---CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHH
Q 019642 184 HPGKEYNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 248 (338)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~ 248 (338)
.+....+...|...|+|||.+... ..|+.++||||||++++||.+++.||..+..+.+++.+..+
T Consensus 200 ~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 200 VDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred hhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 666555556788899999998542 36899999999999999999999999888777777766544
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=245.13 Aligned_cols=271 Identities=17% Similarity=0.215 Sum_probs=207.6
Q ss_pred HHHHHhhhceeeeeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHh-cCCCCeeEee
Q 019642 21 YCLCFWNVSSYVIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNL-CGGPNVVKLL 99 (338)
Q Consensus 21 ~~~~~~~~~~~~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l-~~h~~iv~~~ 99 (338)
.+......+..+..+-..+..+.+.||+|.||.||+|.+ .|+.||||++...+.+.+.+|.++++.. -.|+||+.++
T Consensus 194 tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFI 271 (513)
T KOG2052|consen 194 TSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFI 271 (513)
T ss_pred cCCCCCCchhHhHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhh
Confidence 334445666777788889999999999999999999976 6889999999999999999999998854 3899999998
Q ss_pred eeee--ccCCCccEEEEeeecCCccccccCC--CCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCCeEecC
Q 019642 100 DIVR--DQHSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQ--------GIMHRDVKPHNVMIDH 167 (338)
Q Consensus 100 ~~~~--~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~--------~i~H~dikp~NIli~~ 167 (338)
+.=. ......+++|.+|.+.|+|.+++.+ ++.+...+++..++.||++||.. .|+|||||..|||+.+
T Consensus 272 aaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk 351 (513)
T KOG2052|consen 272 AADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 351 (513)
T ss_pred hccccCCCceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc
Confidence 7421 2223478999999999999999864 88899999999999999999943 4999999999999999
Q ss_pred CCCceEEEeccccccccCC-----CcceeeeccccccccccccCcCC-----CCCcchhHHHHHHHHHHHh---------
Q 019642 168 ELRKLRLIDWGLAEFYHPG-----KEYNVRVASRYFKGPELLVDLQD-----YDYSLDMWSLGCMFAGMIF--------- 228 (338)
Q Consensus 168 ~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~-----~~~~~DvwslG~~l~~llt--------- 228 (338)
+ +.+-|+|+|++...... .+.+.+.||..|||||++.+..+ .-..+||||||+++||++.
T Consensus 352 n-~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~e 430 (513)
T KOG2052|consen 352 N-GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVE 430 (513)
T ss_pred C-CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEeh
Confidence 9 89999999999665433 24567899999999999966322 1246999999999999873
Q ss_pred -cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcC
Q 019642 229 -RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 307 (338)
Q Consensus 229 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~ 307 (338)
...||+..-+....++++.++.-...++.-. ...|. ....-..+..+++.||.
T Consensus 431 ey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~i----------------------pnrW~----s~~~l~~m~klMkeCW~ 484 (513)
T KOG2052|consen 431 EYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNI----------------------PNRWK----SDPALRVMAKLMKECWY 484 (513)
T ss_pred hhcCCcccCCCCCCCHHHHhcceeecccCCCC----------------------Ccccc----cCHHHHHHHHHHHHhhc
Confidence 2457766555555555555544332221110 00110 00012346788999999
Q ss_pred CCcCCcCCHHHHh
Q 019642 308 YDHQDRLTAREAM 320 (338)
Q Consensus 308 ~dP~~Rpt~~ell 320 (338)
.||.-|.||--+.
T Consensus 485 ~Np~aRltALriK 497 (513)
T KOG2052|consen 485 ANPAARLTALRIK 497 (513)
T ss_pred CCchhhhHHHHHH
Confidence 9999999986654
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=256.02 Aligned_cols=240 Identities=20% Similarity=0.372 Sum_probs=191.3
Q ss_pred cEEEEEeeeecCceeEEEEEEcCC----CceEEEEEecc----cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNT----NERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~----~~~~aiK~~~~----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
...+.+.||.|-||.||.|....- .-.||||.-+. .+.+.+..|..+|+++ .||||+++++++.++ ..
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf-dHphIikLIGv~~e~---P~ 465 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF-DHPHIIKLIGVCVEQ---PM 465 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC-CCcchhheeeeeecc---ce
Confidence 345567899999999999987432 33588888664 3467789999999999 999999999999654 57
Q ss_pred EEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 111 SLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
++|||.+.-|.|..+++ .++...+..++.|++.||.|||+.+.||+||...|||+.+. ..+||+|||+++...+.
T Consensus 466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp-~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSP-QCVKLADFGLSRYLEDD 544 (974)
T ss_pred eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCc-ceeeecccchhhhcccc
Confidence 89999999999988875 48888899999999999999999999999999999999998 79999999999887765
Q ss_pred Ccceeee--ccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccc
Q 019642 187 KEYNVRV--ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263 (338)
Q Consensus 187 ~~~~~~~--~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
....... -...|||||.+.- ..++.++|||.||+-+|+++. |..||..-.+ .+.+..+
T Consensus 545 ~yYkaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN-sDVI~~i----------------- 605 (974)
T KOG4257|consen 545 AYYKASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKN-SDVIGHI----------------- 605 (974)
T ss_pred chhhccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCccccccc-cceEEEe-----------------
Confidence 5433332 2456999999866 689999999999999999886 8889842222 1111111
Q ss_pred cccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
+.-.....++.+++.+..++.+||+.+|.+||++.++.+
T Consensus 606 -------------------EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 606 -------------------ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred -------------------cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 011112234458899999999999999999999887754
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=251.50 Aligned_cols=251 Identities=19% Similarity=0.331 Sum_probs=195.8
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
...+...++++||+|-||.|.++.- ..+.+||+|.+++.. +..+.+|+.+|.+| +||||+.++++|.. ++.+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL-khPNIveLvGVC~~--DePi 610 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRL-KHPNIVELLGVCVQ--DDPL 610 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhcc-CCCCeeEEEeeeec--CCch
Confidence 3456788999999999999999975 347899999998543 56788999999999 99999999999955 4578
Q ss_pred EEEEeeecCCccccccCC-----CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 111 SLIFEYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
++++||+..|+|.+++.. ...+....++.||+.|++||.+.++||+||.+.|+|++.+ .++||+|||.++....
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e-~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGE-FTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCc-ccEEecCccccccccc
Confidence 899999999999988743 2445567799999999999999999999999999999999 8999999999986654
Q ss_pred CCccee---eeccccccccccccCcCCCCCcchhHHHHHHHHHHHh--cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhh
Q 019642 186 GKEYNV---RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF--RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 260 (338)
Q Consensus 186 ~~~~~~---~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
++.... ..-...|||||.+.- ++.+.++|+|+||+++||+++ ...||... .+....+..-..+..+.....+
T Consensus 690 g~yy~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~l-t~e~vven~~~~~~~~~~~~~l- 766 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQL-TDEQVVENAGEFFRDQGRQVVL- 766 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhh-hHHHHHHhhhhhcCCCCcceec-
Confidence 443222 234568999999987 689999999999999999865 56687322 2222222222222222111110
Q ss_pred ccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
..+..++..+.+++.+|+..+-++||+++++-.
T Consensus 767 ----------------------------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 767 ----------------------------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred ----------------------------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 112337889999999999999999999999853
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=250.78 Aligned_cols=241 Identities=20% Similarity=0.383 Sum_probs=195.3
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEe
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 115 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e 115 (338)
.+....++||-|-||.||.|.+++-.-.||||.++.. ...++..|..+|+.+ +|||+|+++++|.. +...|||.|
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKei-kHpNLVqLLGVCT~--EpPFYIiTE 343 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTH--EPPFYIITE 343 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhh-cCccHHHHhhhhcc--CCCeEEEEe
Confidence 4667889999999999999999999999999999854 467899999999999 99999999999944 557889999
Q ss_pred eecCCccccccCC-----CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcce
Q 019642 116 YVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 190 (338)
Q Consensus 116 ~~~~~~l~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~ 190 (338)
||..|+|-+++.. ++.-.+..++.||..|++||.+++++|+||.+.|+|+..+ ..+|++|||+++.+.... +.
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEn-hiVKvADFGLsRlMtgDT-YT 421 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HIVKVADFGLSRLMTGDT-YT 421 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccccc-ceEEeeccchhhhhcCCc-ee
Confidence 9988888777643 6666778999999999999999999999999999999998 789999999998775432 22
Q ss_pred eeec---cccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 191 VRVA---SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 191 ~~~~---~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
...| ...|.|||-+.- ..++.++|||+||++||++.| |-.|| .+-+-. +...+.+
T Consensus 422 AHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPY-PGidlS-qVY~LLE------------------ 480 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLS-QVYGLLE------------------ 480 (1157)
T ss_pred cccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCC-CCccHH-HHHHHHh------------------
Confidence 2222 456999999866 689999999999999999998 55565 333322 2222211
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
+-+..+.+..+++.+.+|++.||+++|++||++.|+-+
T Consensus 481 -----------------kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 481 -----------------KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred -----------------ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 11222334458999999999999999999999998743
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=260.85 Aligned_cols=258 Identities=25% Similarity=0.428 Sum_probs=207.4
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc---cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
...+++|++++++|+|.+|.||+++++.+++..|+|+++- .+-+.+.+|+-+++.. .||||+.+++.+.. ....
T Consensus 11 rnP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc-~h~nivay~gsylr--~dkl 87 (829)
T KOG0576|consen 11 RNPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDC-RHPNIVAYFGSYLR--RDKL 87 (829)
T ss_pred cCCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecC-CCcChHHHHhhhhh--hcCc
Confidence 3678899999999999999999999999999999999873 4456678899999998 99999999998844 4568
Q ss_pred EEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 111 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
++.||||+|++|++.. ..+++.++..++++.+.||+|||+.|=+|||||-.||+++.. +.+|+.|||.+..+....
T Consensus 88 wicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~-gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDE-GDVKLADFGVSAQITATI 166 (829)
T ss_pred EEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeeccc-CceeecccCchhhhhhhh
Confidence 8999999999999887 459999999999999999999999999999999999999998 899999999875544332
Q ss_pred -cceeeecccccccccccc--CcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccc
Q 019642 188 -EYNVRVASRYFKGPELLV--DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264 (338)
Q Consensus 188 -~~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
+.....||+.|+|||+.. ....+...+|+|++|++..++-..+.|.+..+.-.. ..+....+..+
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~--l~LmTkS~~qp---------- 234 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA--LFLMTKSGFQP---------- 234 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH--HHHhhccCCCC----------
Confidence 334468999999999972 224688999999999999999888877643222111 11111111110
Q ss_pred ccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
... ......++.+-+|++.+|.++|.+|||++-+|+|||....
T Consensus 235 ------------p~l---------kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 235 ------------PTL---------KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred ------------Ccc---------cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 000 0111247889999999999999999999999999997654
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=239.98 Aligned_cols=264 Identities=19% Similarity=0.259 Sum_probs=193.3
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHh-cCCCCeeEeeeeeeccC--CCccEEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNL-CGGPNVVKLLDIVRDQH--SKTPSLI 113 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l-~~h~~iv~~~~~~~~~~--~~~~~lv 113 (338)
....++.+.+|+|.||.||+|.. +++.||||++....++.+.+|-+++... .+|+||+++++.-.... ...+++|
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 45678899999999999999975 5599999999998899999888887743 28999999998764322 3468899
Q ss_pred EeeecCCccccccCC--CCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCCeEecCCCCceEEEecccccc
Q 019642 114 FEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQ---------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
Q Consensus 114 ~e~~~~~~l~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~---------~i~H~dikp~NIli~~~~~~~~l~dfg~~~~ 182 (338)
++|...|+|.+++.. ++.....+++..++.||+|||+. .|+|||||..|||+..+ .+..|+|||++-+
T Consensus 287 t~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D-lTccIaDFGLAl~ 365 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND-LTCCIADFGLALR 365 (534)
T ss_pred eeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC-CcEEeeccceeEE
Confidence 999999999999864 89999999999999999999954 49999999999999999 8999999999987
Q ss_pred ccCCCcc---eeeeccccccccccccCcCCCC-----CcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCC-c
Q 019642 183 YHPGKEY---NVRVASRYFKGPELLVDLQDYD-----YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT-D 253 (338)
Q Consensus 183 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~-----~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~-~ 253 (338)
+.+.... -...||..|||||++.+.-... .+.||||+|.+|||+++...-++.+..+.-++. ....+|. +
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlp-fe~evG~hP 444 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLP-FEAEVGNHP 444 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCc-hhHHhcCCC
Confidence 7654432 2368999999999997643333 469999999999999986654432222111111 1111111 1
Q ss_pred hhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHH
Q 019642 254 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 318 (338)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~e 318 (338)
.+.. .......+..+..+...+... .--..+.+.+..|++.||+-|.||.=
T Consensus 445 t~e~-----------mq~~VV~kK~RP~~p~~W~~h---~~~~~l~et~EeCWDhDaeARLTA~C 495 (534)
T KOG3653|consen 445 TLEE-----------MQELVVRKKQRPKIPDAWRKH---AGMAVLCETIEECWDHDAEARLTAGC 495 (534)
T ss_pred CHHH-----------HHHHHHhhccCCCChhhhhcC---ccHHHHHHHHHHHcCCchhhhhhhHH
Confidence 1111 111111122222222222111 12457899999999999999999863
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=246.59 Aligned_cols=198 Identities=26% Similarity=0.494 Sum_probs=172.6
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----------hHHHHHHHHHHHHhc--CCCCeeEeee
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLC--GGPNVVKLLD 100 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----------~~~~~~E~~~l~~l~--~h~~iv~~~~ 100 (338)
.....+|...+.+|+|+||.|++|.++.+...|++|.+.+.. -..+..|+.+|..+. .|+||+++++
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 455678999999999999999999999999999999986432 233667999999993 3999999999
Q ss_pred eeeccCCCccEEEEeeecCC-cccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEe
Q 019642 101 IVRDQHSKTPSLIFEYVNST-DFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLID 176 (338)
Q Consensus 101 ~~~~~~~~~~~lv~e~~~~~-~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~d 176 (338)
+|++ .+++|++||..+.+ +|.+++ +++++.+++.|++||..|+++||+.||+|||||-+|+.++.+ |-+||+|
T Consensus 637 fFEd--dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~-g~~klid 713 (772)
T KOG1152|consen 637 FFED--DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSN-GFVKLID 713 (772)
T ss_pred eeec--CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecC-CeEEEee
Confidence 9955 56889999987554 666665 569999999999999999999999999999999999999999 9999999
Q ss_pred ccccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcC
Q 019642 177 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 235 (338)
Q Consensus 177 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~ 235 (338)
||.+.... ..+.....||..|.|||++.+.+.....-|||+||++||-++....|||.
T Consensus 714 fgsaa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 714 FGSAAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ccchhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99987554 44667889999999999999978888999999999999999999999863
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-33 Score=224.85 Aligned_cols=247 Identities=19% Similarity=0.319 Sum_probs=188.6
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc--cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
...+.|.|.+.||+|.||.+-++++..+.+.+++|.+.. ...+.+.+|...---|..|.||+.-|+..-.. .+.+++
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt-~d~YvF 99 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT-SDAYVF 99 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhc-CceEEE
Confidence 345899999999999999999999999999999999864 34567788877766777899999988854333 446788
Q ss_pred EEeeecCCccccccC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEe-cCCCCceEEEeccccccccCCCcc
Q 019642 113 IFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEY 189 (338)
Q Consensus 113 v~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli-~~~~~~~~l~dfg~~~~~~~~~~~ 189 (338)
++||+..++|..-+. .+.+...+.++.|+++||.|||++++||+|||.+|||+ +.+...+||||||....... .-
T Consensus 100 ~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~--tV 177 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT--TV 177 (378)
T ss_pred eeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc--ee
Confidence 999999999988875 48888999999999999999999999999999999998 55667999999999875432 11
Q ss_pred eeeeccccccccccccCc----CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 190 NVRVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~----~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
......-.|.+||+.... -...+.+|+|.||+++|+++||..||...........+..+..+.-.. .
T Consensus 178 ~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~---------~ 248 (378)
T KOG1345|consen 178 KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP---------A 248 (378)
T ss_pred hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc---------c
Confidence 122345568899987432 246788999999999999999999996433222223333332222111 0
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 314 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 314 (338)
. .+. -..+++.+..+.++-|..+|++|-
T Consensus 249 ~---------------P~~------F~~fs~~a~r~Fkk~lt~~~~drc 276 (378)
T KOG1345|consen 249 L---------------PKK------FNPFSEKALRLFKKSLTPRFKDRC 276 (378)
T ss_pred C---------------chh------hcccCHHHHHHHHHhcCCcccccc
Confidence 0 000 011689999999999999999993
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=247.09 Aligned_cols=243 Identities=23% Similarity=0.416 Sum_probs=190.7
Q ss_pred CcEEEEEeeeecCceeEEEEEEcC-------CCceEEEEEecc----cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVN-------TNERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
++.++.+.||+|.||.|++|.-.. ....||||..+. ...+.+..|+++++.+..|+|++.+++.+..
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~-- 373 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ-- 373 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc--
Confidence 344667799999999999997431 145699999864 2356788999999999899999999999955
Q ss_pred CCccEEEEeeecCCccccccC--C-----------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecC
Q 019642 107 SKTPSLIFEYVNSTDFKVLYP--T-----------------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 167 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~~--~-----------------~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~ 167 (338)
...+++|+||+..|+|..++. + ++..++..++.||+.|++||++.+++||||-+.|||+..
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITK 453 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecC
Confidence 567899999999998877652 3 788899999999999999999999999999999999999
Q ss_pred CCCceEEEeccccccccCCCcceee--e--ccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCC-CHH
Q 019642 168 ELRKLRLIDWGLAEFYHPGKEYNVR--V--ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHD-NHD 241 (338)
Q Consensus 168 ~~~~~~l~dfg~~~~~~~~~~~~~~--~--~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~-~~~ 241 (338)
+ ..+||+|||+++........... . -...|+|||.+.. ..++.++||||+|++|||+++ |..|| .+-. ..+
T Consensus 454 ~-~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PY-p~~~~~~~ 530 (609)
T KOG0200|consen 454 N-KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPY-PGIPPTEE 530 (609)
T ss_pred C-CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCC-CCCCcHHH
Confidence 9 79999999999865544333221 1 2334999999988 789999999999999999998 66676 3322 222
Q ss_pred HHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 242 QLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
....+.+ | .....+...++++.++++.|++.+|++||+..++.+
T Consensus 531 l~~~l~~--G----------------------------------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 531 LLEFLKE--G----------------------------------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHhc--C----------------------------------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 2221111 0 011122336899999999999999999999998874
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=214.23 Aligned_cols=205 Identities=33% Similarity=0.616 Sum_probs=178.4
Q ss_pred eeecCceeEEEEEEcCCCceEEEEEecccch----HHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeecCCc
Q 019642 46 VGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD 121 (338)
Q Consensus 46 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~ 121 (338)
||+|++|.||++.+..+++.+++|.+..... +.+.+|+..++.+ +|++++++++++.. ....++++|++.+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGVFED--ENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhc-CCCCeeeEeeeeec--CCeEEEEEecCCCCc
Confidence 6899999999999988899999999986654 6789999999999 89999999999855 367889999999999
Q ss_pred cccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecC-CCCceEEEeccccccccCCC-cceeeecc
Q 019642 122 FKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-ELRKLRLIDWGLAEFYHPGK-EYNVRVAS 195 (338)
Q Consensus 122 l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~-~~~~~~l~dfg~~~~~~~~~-~~~~~~~~ 195 (338)
|..++. .++...++.++.+++.++.+||+.|++|+||+|.||+++. + +.++|+|||.+....... ......+.
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDN-GKVKLADFGLSKLLTSDKSLLKTIVGT 156 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCC-CcEEEecCCceEEccCCcchhhcccCC
Confidence 888874 4799999999999999999999999999999999999998 5 789999999987654332 12335577
Q ss_pred ccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhc
Q 019642 196 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVG 275 (338)
Q Consensus 196 ~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (338)
..|.+||........+.++|+|++|++++++
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------- 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------- 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence 8899999987633788999999999999999
Q ss_pred cccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCC
Q 019642 276 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323 (338)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp 323 (338)
..+.+++.+|++.||++||++.++++++
T Consensus 188 --------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1367899999999999999999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=239.03 Aligned_cols=240 Identities=20% Similarity=0.323 Sum_probs=188.7
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCc----eEEEEEecc----cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
+.+..+.||+|+||+||+|.+.-.++ +|++|++.. ....++.+|+..|.++ .|||++++++++... .+
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s---~~ 772 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASL-DHPNLLRLLGVCMLS---TL 772 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcC-CCchHHHHhhhcccc---hH
Confidence 45567899999999999998865554 578887653 3457789999999999 999999999998553 27
Q ss_pred EEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 111 SLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
.||++|+..|.|.++.+ ++.......++.||++|+.|||+++++||||-+.|+|+... ..+|+.|||++....+.
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP-~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSP-NHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCC-CeEEEEecchhhccCcc
Confidence 79999999999988863 58888999999999999999999999999999999999988 79999999999876544
Q ss_pred Ccceee---eccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcc
Q 019642 187 KEYNVR---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262 (338)
Q Consensus 187 ~~~~~~---~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
...... ...+.|+|-|.+.. ..++.++||||+|+++||++| |..|++ +....+....+... +
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~-gi~~~eI~dlle~g----e-------- 917 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYD-GIPAEEIPDLLEKG----E-------- 917 (1177)
T ss_pred cccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccC-CCCHHHhhHHHhcc----c--------
Confidence 332221 22356888888877 689999999999999999997 888873 22222222211110 0
Q ss_pred ccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
....++..+.++.-++.+||-.|+..||+++++-+
T Consensus 918 ------------------------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 918 ------------------------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred ------------------------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 01122336889999999999999999999998764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=207.49 Aligned_cols=192 Identities=33% Similarity=0.650 Sum_probs=166.0
Q ss_pred EEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEe
Q 019642 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 115 (338)
Q Consensus 40 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e 115 (338)
|.+.+.||+|++|.||++.+..+++.+++|.+... ..+.+.+|++.++++ +|+|++++++.+.. ....++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~--~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKL-KHPNIVKLYGVFED--PEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCChhhheeeeec--CCceEEEEe
Confidence 56789999999999999999888999999998754 356788899999999 99999999998854 456789999
Q ss_pred eecCCccccccCC----CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC--cc
Q 019642 116 YVNSTDFKVLYPT----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--EY 189 (338)
Q Consensus 116 ~~~~~~l~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~--~~ 189 (338)
++.+++|..++.. +++..+..++.+++.++.+||+.+++|+|++|.||+++.+ +.++|+|||.+....... ..
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~-~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD-GLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeeCceeeEecCcccccc
Confidence 9999888888642 7889999999999999999999999999999999999998 899999999887665432 23
Q ss_pred eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcC
Q 019642 190 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 235 (338)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~ 235 (338)
....++..|++||.+.....++.++|+|+||++++++++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 4456778899999984336778899999999999999999999943
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=213.95 Aligned_cols=244 Identities=17% Similarity=0.284 Sum_probs=191.8
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCC-----CceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
.+++++.-.+-+|.||.||.|.+... .+.+.+|.++.+. ...+..|.-++..+ .|||+.++.++.... .
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~-sH~nll~V~~V~ie~-~ 360 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGA-SHPNLLSVLGVSIED-Y 360 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcC-cCCCccceeEEEeec-c
Confidence 46788888899999999999976543 3446677666432 34567888888888 899999999987664 4
Q ss_pred CccEEEEeeecCCccccccC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEe
Q 019642 108 KTPSLIFEYVNSTDFKVLYP-----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLID 176 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~-----------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~d 176 (338)
..+++++++.+-++|..++. .++..++..++.|++.|++|||++|++|.||.+.|.++|.. -++||+|
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~-LqVkltD 439 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ-LQVKLTD 439 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh-eeEEecc
Confidence 56788999999999988873 37778899999999999999999999999999999999998 8999999
Q ss_pred ccccccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCC
Q 019642 177 WGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGT 252 (338)
Q Consensus 177 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~ 252 (338)
=.+++..-+.+. .+.......||+||.+.+ ..++.++|+||||++||||+| |+.|+ -.-++.+....+.+....
T Consensus 440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~Py-aeIDPfEm~~ylkdGyRl 517 (563)
T KOG1024|consen 440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPY-AEIDPFEMEHYLKDGYRL 517 (563)
T ss_pred chhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCc-cccCHHHHHHHHhcccee
Confidence 998876543321 222334557999999988 789999999999999999998 77786 333444443333222111
Q ss_pred chhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 253 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
-.+-+.++++..++-.||+.+|++||+.+|+..
T Consensus 518 ------------------------------------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 518 ------------------------------------AQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ------------------------------------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 122337999999999999999999999999874
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=248.69 Aligned_cols=195 Identities=13% Similarity=0.178 Sum_probs=134.8
Q ss_pred CCeeEeeeeeec-----cCCCccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCe
Q 019642 93 PNVVKLLDIVRD-----QHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNV 163 (338)
Q Consensus 93 ~~iv~~~~~~~~-----~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NI 163 (338)
+||+.++++|.. .....++.++|++. .+|.+++. .+++..++.++.||+.||.|||++||+|+||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 456666665521 11235567788764 47777763 389999999999999999999999999999999999
Q ss_pred EecCC------------------CCceEEEeccccccccCCC-----------------cceeeeccccccccccccCcC
Q 019642 164 MIDHE------------------LRKLRLIDWGLAEFYHPGK-----------------EYNVRVASRYFKGPELLVDLQ 208 (338)
Q Consensus 164 li~~~------------------~~~~~l~dfg~~~~~~~~~-----------------~~~~~~~~~~y~aPE~~~~~~ 208 (338)
|++.. .+.+|++|||++....... ......+|+.|+|||++.+ .
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~ 190 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNG-S 190 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhcc-C
Confidence 99643 2456666666654321000 0011347888999999887 6
Q ss_pred CCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccc
Q 019642 209 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINA 288 (338)
Q Consensus 209 ~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (338)
.++.++|||||||+||+|++|..|+.. .......+...... +..
T Consensus 191 ~~~~~sDVwSlGviL~ELl~~~~~~~~---~~~~~~~~~~~~~~---------------~~~------------------ 234 (793)
T PLN00181 191 SSNCASDVYRLGVLLFELFCPVSSREE---KSRTMSSLRHRVLP---------------PQI------------------ 234 (793)
T ss_pred CCCchhhhhhHHHHHHHHhhCCCchhh---HHHHHHHHHHhhcC---------------hhh------------------
Confidence 789999999999999999998877621 11111111110000 000
Q ss_pred cCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 289 DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 289 ~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
..-.....+++.+||+++|.+||++.|+|+||||.+.
T Consensus 235 ---~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 235 ---LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred ---hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 0013456789999999999999999999999999875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=196.13 Aligned_cols=158 Identities=23% Similarity=0.272 Sum_probs=119.4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcceeeeccccccccccccCc
Q 019642 128 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 207 (338)
Q Consensus 128 ~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 207 (338)
.+++..++.++.|++.||.|||+.+ ||+||+++.+ +.+++ ||.+...... ...+++.|+|||++.+
T Consensus 13 ~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~-~~~~~--fG~~~~~~~~----~~~g~~~y~aPE~~~~- 78 (176)
T smart00750 13 PLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWD-GLLKL--DGSVAFKTPE----QSRVDPYFMAPEVIQG- 78 (176)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCc-cceee--ccceEeeccc----cCCCcccccChHHhcC-
Confidence 4899999999999999999999998 9999999988 78888 9988654332 2367899999999987
Q ss_pred CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCccccc
Q 019642 208 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFIN 287 (338)
Q Consensus 208 ~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (338)
..++.++||||||+++|+|++|..||.........+..+........... ..
T Consensus 79 ~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~~------------------- 130 (176)
T smart00750 79 QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRD---------RS------------------- 130 (176)
T ss_pred CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccc---------cc-------------------
Confidence 67899999999999999999999998543332233333222211110000 00
Q ss_pred ccCCCCCCh--hHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 288 ADNQHLVSP--EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 288 ~~~~~~~s~--~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
....+++ ++.++|.+||..||.+|||+.++++|+|+....
T Consensus 131 --~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 131 --NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred --cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 0001233 699999999999999999999999999987543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.6e-28 Score=224.41 Aligned_cols=258 Identities=23% Similarity=0.361 Sum_probs=189.6
Q ss_pred EEEEeeeecCceeEEEEEEcCCCceEEEEEec----ccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 41 EVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 41 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~----~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
.....+|.|++|.|+.+......+.+..|.+. +.. ...+..|+-+-..+ .|||++.....+.+... ..
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-~h~~~~e~l~~~~~~~~--~~ 397 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-SHPNIIETLDIVQEIDG--IL 397 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-cCCchhhhHHHHhhccc--ch
Confidence 56788999999988888776666655555443 111 11144566666677 89999888887754332 22
Q ss_pred EEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-
Q 019642 112 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 187 (338)
Q Consensus 112 lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~- 187 (338)
-.|||+.+ +|..++. .++..++..++.|++.|+.|||+.|+.|+|+|++|+++..+ +.+||+|||.+....-..
T Consensus 398 ~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~-g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 398 QSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTEN-GILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecC-CceEEeecCcceeeccCcc
Confidence 34999999 7766653 48899999999999999999999999999999999999999 899999999886553221
Q ss_pred ----cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccc
Q 019642 188 ----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263 (338)
Q Consensus 188 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
......|+..|.|||++.+........||||.|+++..|++|+.||-.......++.... .....
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~---~~~~~-------- 544 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN---YSDQR-------- 544 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc---ccccc--------
Confidence 234467899999999998866677789999999999999999999954433332220000 00000
Q ss_pred cccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
....++. .....++...+.+|.+||++||.+|.|+++|++.+||+++..+.
T Consensus 545 ------------~~~~~~~------~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~ 595 (601)
T KOG0590|consen 545 ------------NIFEGPN------RLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCH 595 (601)
T ss_pred ------------ccccChH------HHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceEE
Confidence 0000000 00111677889999999999999999999999999999998765
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-25 Score=193.45 Aligned_cols=163 Identities=19% Similarity=0.249 Sum_probs=126.7
Q ss_pred eeeccCCcEEEEEeeeecCceeEEEEEEcC-CCceEEEEEeccc--------chHHHHHHHHHHHHhcCCCCeeE-eeee
Q 019642 32 VIFSDQDDYEVVRKVGRGKYSEVFEGINVN-TNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVK-LLDI 101 (338)
Q Consensus 32 ~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~--------~~~~~~~E~~~l~~l~~h~~iv~-~~~~ 101 (338)
-+....++|.+.+.||+|+||+||+|.+.. +++.+|+|.+... ....+.+|+++++++ +|+++++ +++.
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-~h~~iv~~l~~~ 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-RGIGVVPQLLAT 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-cCCCCCcEEEEc
Confidence 344556889999999999999999998876 6777899986422 134588999999999 8999885 4432
Q ss_pred eeccCCCccEEEEeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCCeEecCCCCceEEEecccc
Q 019642 102 VRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDV-KPHNVMIDHELRKLRLIDWGLA 180 (338)
Q Consensus 102 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di-kp~NIli~~~~~~~~l~dfg~~ 180 (338)
...++||||+.|++|.... ... ...++.|++.+|.+||++|++|+|| ||+|||++.+ +.++|+|||++
T Consensus 91 ------~~~~LVmE~~~G~~L~~~~-~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~-~~ikLiDFGlA 159 (365)
T PRK09188 91 ------GKDGLVRGWTEGVPLHLAR-PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPD-GEAAVIDFQLA 159 (365)
T ss_pred ------CCcEEEEEccCCCCHHHhC-ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCC-CCEEEEECccc
Confidence 2468999999999887432 111 2467899999999999999999999 9999999877 78999999999
Q ss_pred ccccCCCc---------ceeeeccccccccccccC
Q 019642 181 EFYHPGKE---------YNVRVASRYFKGPELLVD 206 (338)
Q Consensus 181 ~~~~~~~~---------~~~~~~~~~y~aPE~~~~ 206 (338)
........ .....++..|.|||.+..
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 76543221 122356677899998754
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.3e-24 Score=185.94 Aligned_cols=194 Identities=23% Similarity=0.324 Sum_probs=156.7
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCC-ceEEEEEecccc---hHHHHHHHHHHHHhc---CCCCeeEeeeeeeccCCCccE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTN-ERCIIKILKPVK---KKKIKREIKILQNLC---GGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~~aiK~~~~~~---~~~~~~E~~~l~~l~---~h~~iv~~~~~~~~~~~~~~~ 111 (338)
+|++.+.||+|+||.||.+.+..++ ..+|+|+..... ...+..|..++..+. ..++++.+++... ......+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCceeE
Confidence 8999999999999999999988775 678888865432 226889999999995 2468999998874 2345678
Q ss_pred EEEeeecCCcccccc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCC----CceEEEeccccc-
Q 019642 112 LIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL----RKLRLIDWGLAE- 181 (338)
Q Consensus 112 lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~----~~~~l~dfg~~~- 181 (338)
+||+.++.+ |.++. +.++...+..++.|++.+|++||+.|++||||||+|+++.... ..+.|.|||+++
T Consensus 98 iVM~l~G~s-L~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 98 IVMSLLGPS-LEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred EEEeccCcc-HHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 998877654 44333 4689999999999999999999999999999999999997652 469999999998
Q ss_pred -cccCCC--------c-ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcC
Q 019642 182 -FYHPGK--------E-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 235 (338)
Q Consensus 182 -~~~~~~--------~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~ 235 (338)
...... . .....||..|.++.+..+ ...+.+.|+||++.++.++..|..||..
T Consensus 177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~ 239 (322)
T KOG1164|consen 177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEA 239 (322)
T ss_pred ccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCcc
Confidence 321111 1 122348999999999888 7889999999999999999999999843
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=170.69 Aligned_cols=195 Identities=23% Similarity=0.389 Sum_probs=161.8
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
..+.|.++++||+|+||.+|.|....+|..||||+-... ...++..|..+.+.|+....|+.+..+..+ ..+-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e--~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTE--KDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccc--cccceeee
Confidence 357899999999999999999999999999999997644 345678899999999777888888887743 45667999
Q ss_pred eeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC--CCceEEEeccccccccCCC-
Q 019642 115 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPGK- 187 (338)
Q Consensus 115 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~--~~~~~l~dfg~~~~~~~~~- 187 (338)
+.++. +|+++. ..++...+.-++-|++.-++|+|.++.+|+||||+|.|+.-+ -.++.++|||++.+.-+..
T Consensus 91 dLLGP-sLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t 169 (341)
T KOG1163|consen 91 DLLGP-SLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT 169 (341)
T ss_pred eccCc-cHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence 98864 444443 569999999999999999999999999999999999998433 3579999999997764321
Q ss_pred -------cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCc
Q 019642 188 -------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 234 (338)
Q Consensus 188 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~ 234 (338)
......||..|.+-.+..+ ..-+...|+-|+|.+|.++..|..||.
T Consensus 170 ~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQ 222 (341)
T KOG1163|consen 170 RQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQ 222 (341)
T ss_pred cccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCccc
Confidence 2233578889998877776 567889999999999999999999994
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-24 Score=176.81 Aligned_cols=224 Identities=19% Similarity=0.346 Sum_probs=179.6
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEec-ccchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
..+-.|++.++||.|+||.++.|.+.-+++.||||.-. +...-++..|...++.|...+.|+..|-+. +.+.+-.+|
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG--qeG~~NiLV 102 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG--QEGKYNILV 102 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec--cccchhhhh
Confidence 34568999999999999999999999999999999864 445667899999999998899999988776 456677799
Q ss_pred EeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecC----CCCceEEEeccccccccC
Q 019642 114 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH----ELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 114 ~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~----~~~~~~l~dfg~~~~~~~ 185 (338)
+|.++. +|+++. .+++...+..++.|++.-++++|++.++++||||+|+||.. +...+.++|||++....+
T Consensus 103 idLLGP-SLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 103 IDLLGP-SLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred hhhhCc-CHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 998864 444443 46999999999999999999999999999999999999943 234799999999976643
Q ss_pred CC--------cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcC--CCCCHHHHHHHHHHhCCchh
Q 019642 186 GK--------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY--GHDNHDQLVKIAKVLGTDEL 255 (338)
Q Consensus 186 ~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~--~~~~~~~~~~~~~~~~~~~~ 255 (338)
.. ......||..||+-...++ ..-+...|+-|||.++++++.|.+||.- ..++.+..+.+-+.....++
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i 260 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPI 260 (449)
T ss_pred ccccccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCH
Confidence 22 1223578999999988888 6778999999999999999999999943 34555555555555555555
Q ss_pred hhhhhcc
Q 019642 256 NAYLNKY 262 (338)
Q Consensus 256 ~~~~~~~ 262 (338)
......+
T Consensus 261 ~~Lc~g~ 267 (449)
T KOG1165|consen 261 EVLCEGF 267 (449)
T ss_pred HHHHhcC
Confidence 5554443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-22 Score=178.38 Aligned_cols=258 Identities=32% Similarity=0.543 Sum_probs=196.1
Q ss_pred EEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCC-CeeEeeeeeeccCCCccEE
Q 019642 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGP-NVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 40 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~-~iv~~~~~~~~~~~~~~~l 112 (338)
|.+.+.||.|+||.||.+.+. ..+++|.+... ....+.+|+..+..+ .|+ +++++.+.+.. ....++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~-~~~~~i~~~~~~~~~--~~~~~~ 75 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASL-NHPPNIVKLYDFFQD--EGSLYL 75 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHc-cCCcceeeEEEEEec--CCEEEE
Confidence 789999999999999999887 77888987642 245678899999999 666 79999999933 344789
Q ss_pred EEeeecCCccccccC------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 113 IFEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 113 v~e~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
+++++.++++..... .++......++.|++.++.++|+.|++|+|+||+||+++.....++++|||.+......
T Consensus 76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 999999998886653 58889999999999999999999999999999999999998337999999998654433
Q ss_pred C-------cceeeeccccccccccccCc--CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCC--HHHHHHHHHHhCCc-h
Q 019642 187 K-------EYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKVLGTD-E 254 (338)
Q Consensus 187 ~-------~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~--~~~~~~~~~~~~~~-~ 254 (338)
. ......++..|++||...+. ...+...|+||+|++++++++|..||...... .............+ .
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence 2 23556889999999999774 47889999999999999999999996433321 22222222222211 0
Q ss_pred hhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 255 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
.... ... ........+.+++..++..+|..|.+..+...+++.......
T Consensus 236 ~~~~------------------------~~~----~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~ 284 (384)
T COG0515 236 ASPL------------------------SPS----NPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLK 284 (384)
T ss_pred cccc------------------------Ccc----ccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcccc
Confidence 0000 000 001123578999999999999999999999988766554433
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=171.21 Aligned_cols=169 Identities=13% Similarity=0.190 Sum_probs=129.9
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc---hH---------HHHHHHHHHHHhcCCCCeeEeeeeeec
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KK---------KIKREIKILQNLCGGPNVVKLLDIVRD 104 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~---------~~~~E~~~l~~l~~h~~iv~~~~~~~~ 104 (338)
.++|++.+.||.|+||.||++.+ ++..+++|++.+.. .. .+.+|+..+.++ .|++|..+.+++..
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-~~~GI~~~~d~~~~ 106 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-RSEGLASLNDFYLL 106 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-HHCCCCcceEeeee
Confidence 68999999999999999999654 46689999987432 11 157899999999 99999999998754
Q ss_pred cC------CCccEEEEeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecc
Q 019642 105 QH------SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG 178 (338)
Q Consensus 105 ~~------~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg 178 (338)
.. ....+++|||++|.+|.+.. .+++ ....+++.++..+|+.|++|+|++|+||+++.+ + ++|+|||
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~-~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~-g-i~liDfg 179 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP-EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKN-G-LRIIDLS 179 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh-hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCC-C-EEEEECC
Confidence 32 23578999999999998773 2333 346699999999999999999999999999987 6 9999999
Q ss_pred ccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHH
Q 019642 179 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 227 (338)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll 227 (338)
............. .... ..+..++|+||||+++..+.
T Consensus 180 ~~~~~~e~~a~d~-----------~vle-r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 180 GKRCTAQRKAKDR-----------IDLE-RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CcccccchhhHHH-----------HHHH-hHhcccccccceeEeehHHH
Confidence 8764422111110 2223 34557999999999877654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.4e-25 Score=195.58 Aligned_cols=237 Identities=26% Similarity=0.386 Sum_probs=188.8
Q ss_pred eeeecCceeEEEEEE---cCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEee
Q 019642 45 KVGRGKYSEVFEGIN---VNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 116 (338)
Q Consensus 45 ~lg~G~~g~V~~~~~---~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~ 116 (338)
.+|+|++|.|++++. ...+..++.|+.++. .......|-.++...++||.+++++..++. ....++++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt--~~kl~l~ld~ 78 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT--DGKLYLILDF 78 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc--ccchhHhhhh
Confidence 378999999998753 235667888887532 122345678888888679999999999854 4567799999
Q ss_pred ecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcceeee
Q 019642 117 VNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 193 (338)
Q Consensus 117 ~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 193 (338)
..|+.+..... .+.+.....+...++.+++++|+.+++|+|+|++||+++.+ |++++.|||.++..-..... +
T Consensus 79 ~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~-Ghi~~tdfglske~v~~~~~---c 154 (612)
T KOG0603|consen 79 LRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLE-GHIKLTDFGLSKEAVKEKIA---C 154 (612)
T ss_pred cccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeeccc-CccccCCchhhhHhHhhhhc---c
Confidence 99988776654 37778888899999999999999999999999999999999 99999999998765443332 8
Q ss_pred ccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhh
Q 019642 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL 273 (338)
Q Consensus 194 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (338)
|+..|||||+.. .....+|-||+|+++++|+||..||.. +....+.+.--
T Consensus 155 gt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~~---------------------- 204 (612)
T KOG0603|consen 155 GTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAEL---------------------- 204 (612)
T ss_pred cchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhcc----------------------
Confidence 899999999987 366799999999999999999999943 34443333100
Q ss_pred hccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCC-----HHHHhcCCCcchhhhcc
Q 019642 274 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAAE 332 (338)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt-----~~ell~hp~~~~~~~~~ 332 (338)
..+..++..+++++..++..+|.+|.- +.++++|+||..+.+.+
T Consensus 205 ---------------~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~ 253 (612)
T KOG0603|consen 205 ---------------EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNE 253 (612)
T ss_pred ---------------CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhh
Confidence 111226788999999999999999984 47999999999998773
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=176.28 Aligned_cols=230 Identities=21% Similarity=0.278 Sum_probs=140.7
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcC---------CCCeeEeeeee
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCG---------GPNVVKLLDIV 102 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~---------h~~iv~~~~~~ 102 (338)
..+...+.||.|+++.||.+.+..|++.+++|++... ..+.+++|.-....+.. |-.++..++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 4678889999999999999999999999999997421 22334444433333211 22333333333
Q ss_pred ecc---------C---CC---ccEEEEeeecCCccccccC------C----CCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 019642 103 RDQ---------H---SK---TPSLIFEYVNSTDFKVLYP------T----LTDYDIRYYIYELLKALDYCHSQGIMHRD 157 (338)
Q Consensus 103 ~~~---------~---~~---~~~lv~e~~~~~~l~~~~~------~----~~~~~~~~i~~qi~~~l~~lH~~~i~H~d 157 (338)
..+ . .. +.+++|+-+.+ +|..+.. . +.......+..|++..+++||..|++|+|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgd 170 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGD 170 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecc
Confidence 211 0 11 33567776643 4444431 1 22233455668999999999999999999
Q ss_pred CCCCCeEecCCCCceEEEeccccccccCCCcceeeeccccccccccccCc-------CCCCCcchhHHHHHHHHHHHhcC
Q 019642 158 VKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL-------QDYDYSLDMWSLGCMFAGMIFRK 230 (338)
Q Consensus 158 ikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~DvwslG~~l~~lltg~ 230 (338)
|+|+|++++.+ |.+.|+||+........... ...+..|.+||..... -.++.+.|.|+||+++|.++++.
T Consensus 171 i~~~nfll~~~-G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 171 IKPENFLLDQD-GGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp -SGGGEEE-TT-S-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred cceeeEEEcCC-CCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 99999999999 99999999877654322211 3445678999986442 24788999999999999999999
Q ss_pred CCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCc
Q 019642 231 EPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 310 (338)
Q Consensus 231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP 310 (338)
.||........... + +. ... ++++.++.||.++|+.||
T Consensus 248 lPf~~~~~~~~~~~---------~---------------------------f~-----~C~-~~Pe~v~~LI~~lL~~~~ 285 (288)
T PF14531_consen 248 LPFGLSSPEADPEW---------D---------------------------FS-----RCR-DMPEPVQFLIRGLLQRNP 285 (288)
T ss_dssp -STCCCGGGSTSGG---------G---------------------------GT-----TSS----HHHHHHHHHHT-SSG
T ss_pred CCCCCCCccccccc---------c---------------------------ch-----hcC-CcCHHHHHHHHHHccCCc
Confidence 99932111000000 0 00 011 278999999999999999
Q ss_pred CCc
Q 019642 311 QDR 313 (338)
Q Consensus 311 ~~R 313 (338)
++|
T Consensus 286 ~~R 288 (288)
T PF14531_consen 286 EDR 288 (288)
T ss_dssp GGS
T ss_pred ccC
Confidence 988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.6e-22 Score=158.69 Aligned_cols=182 Identities=17% Similarity=0.148 Sum_probs=137.5
Q ss_pred EEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 41 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 41 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
-+...|++|+||+|+.+.. .+.+++.+.+.... ...+.+|++++++|.+++++++++++. ..+++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------~~~lv 76 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD------GRHLD 76 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------CEEEE
Confidence 4578899999999997754 67778777665332 225788999999997678899998862 35899
Q ss_pred EeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCCeEecCCCCceEEEeccccccccCCCcc---
Q 019642 114 FEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDV-KPHNVMIDHELRKLRLIDWGLAEFYHPGKEY--- 189 (338)
Q Consensus 114 ~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di-kp~NIli~~~~~~~~l~dfg~~~~~~~~~~~--- 189 (338)
|+|+.|.+|...... . ...++.|++.+|.++|++|++|+|| ||+||+++.+ +.++|+|||++.........
T Consensus 77 meyI~G~~L~~~~~~---~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~-g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 77 RSYLAGAAMYQRPPR---G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQED-GSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred EeeecCccHHhhhhh---h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCC-CCEEEEECCCceecCCcchHHHH
Confidence 999999998654322 1 2357889999999999999999999 7999999977 78999999999755433210
Q ss_pred -----------eeeeccccccccccccCcCCCC-CcchhHHHHHHHHHHHhcCCCCcC
Q 019642 190 -----------NVRVASRYFKGPELLVDLQDYD-YSLDMWSLGCMFAGMIFRKEPFFY 235 (338)
Q Consensus 190 -----------~~~~~~~~y~aPE~~~~~~~~~-~~~DvwslG~~l~~lltg~~pf~~ 235 (338)
-....++.+++|+...-....+ ...+.++.|..+|.++|+..+.+.
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0123466777777654333344 567778899999999999988743
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=162.07 Aligned_cols=133 Identities=17% Similarity=0.250 Sum_probs=104.7
Q ss_pred EEeeeecCceeEEEEEEcCCCceEEEEEecccch-----------------------------HHHHHHHHHHHHhcCCC
Q 019642 43 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-----------------------------KKIKREIKILQNLCGGP 93 (338)
Q Consensus 43 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----------------------------~~~~~E~~~l~~l~~h~ 93 (338)
...||+|++|.||+|.+. +|+.||+|++++... .....|+..+.++ .++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL-VTA 79 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH-HHC
Confidence 467999999999999986 899999999864311 1123499999999 666
Q ss_pred CeeEeeeeeeccCCCccEEEEeeecCCccccc-c--CCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCCeEecCCC
Q 019642 94 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-Y--PTLTDYDIRYYIYELLKALDYC-HSQGIMHRDVKPHNVMIDHEL 169 (338)
Q Consensus 94 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~-~--~~~~~~~~~~i~~qi~~~l~~l-H~~~i~H~dikp~NIli~~~~ 169 (338)
++........ . ..++||||++|+++... . ..++...+..++.|++.+|.++ |+.|++|+||||+||+++.
T Consensus 80 ~v~~p~~~~~-~---~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-- 153 (190)
T cd05147 80 GIPCPEPILL-K---SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-- 153 (190)
T ss_pred CCCCCcEEEe-c---CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC--
Confidence 6643333221 1 23799999999876543 2 3588899999999999999999 7999999999999999984
Q ss_pred CceEEEeccccccc
Q 019642 170 RKLRLIDWGLAEFY 183 (338)
Q Consensus 170 ~~~~l~dfg~~~~~ 183 (338)
+.++|+|||++...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 57999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.6e-22 Score=167.86 Aligned_cols=191 Identities=21% Similarity=0.313 Sum_probs=130.2
Q ss_pred CCCCeeEeeeeeeccC-------------------------CCccEEEEeeecCCcccccc-CCCCHHHHHHHHHHHHHH
Q 019642 91 GGPNVVKLLDIVRDQH-------------------------SKTPSLIFEYVNSTDFKVLY-PTLTDYDIRYYIYELLKA 144 (338)
Q Consensus 91 ~h~~iv~~~~~~~~~~-------------------------~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~i~~qi~~~ 144 (338)
.|||||++...|.+.- ...+|+||..+.....+... ...+.....-++.|+++|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~~s~r~~~~~laQlLEa 353 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRHRSYRTGRVILAQLLEA 353 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCCCchHHHHHHHHHHHHH
Confidence 6999999998775421 23467777666644333332 336666677789999999
Q ss_pred HHHHHHCCceeccCCCCCeEec---CCCCceEEEeccccccccC-------CCcceeeeccccccccccccCcCC-----
Q 019642 145 LDYCHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLAEFYHP-------GKEYNVRVASRYFKGPELLVDLQD----- 209 (338)
Q Consensus 145 l~~lH~~~i~H~dikp~NIli~---~~~~~~~l~dfg~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~----- 209 (338)
+.|||++|+.|+|+|.+|||+. .+-..+.++|||++--... ........|....+|||+......
T Consensus 354 v~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avv 433 (598)
T KOG4158|consen 354 VTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVV 433 (598)
T ss_pred HHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceee
Confidence 9999999999999999999993 2335789999998632111 111223467778999999854322
Q ss_pred CCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCccccccc
Q 019642 210 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINAD 289 (338)
Q Consensus 210 ~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (338)
.-.++|.|+.|.+.||++....|||.... ...+... .....++ .
T Consensus 434 ny~kAD~WA~GalaYEIfg~~NPFY~rGe---m~L~~r~-Yqe~qLP--------------------------------a 477 (598)
T KOG4158|consen 434 NYEKADTWAAGALAYEIFGRSNPFYKRGE---MLLDTRT-YQESQLP--------------------------------A 477 (598)
T ss_pred ccchhhhhhhhhhHHHHhccCCcccccch---heechhh-hhhhhCC--------------------------------C
Confidence 22589999999999999999999975110 0000000 0000000 0
Q ss_pred CCCCCChhHHHHHHHhcCCCcCCcCCHH
Q 019642 290 NQHLVSPEAIDFLDKLLRYDHQDRLTAR 317 (338)
Q Consensus 290 ~~~~~s~~l~~li~~~L~~dP~~Rpt~~ 317 (338)
.++.+++.+++++..+|+.||++|+++.
T Consensus 478 lp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 478 LPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred CcccCChHHHHHHHHHhcCCccccCCcc
Confidence 1222788999999999999999999754
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.5e-21 Score=156.31 Aligned_cols=134 Identities=17% Similarity=0.205 Sum_probs=106.3
Q ss_pred EEeeeecCceeEEEEEEcCCCceEEEEEecccch-----------------------------HHHHHHHHHHHHhcCCC
Q 019642 43 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-----------------------------KKIKREIKILQNLCGGP 93 (338)
Q Consensus 43 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----------------------------~~~~~E~~~l~~l~~h~ 93 (338)
.+.||+|++|.||+|.+. +|+.||+|++++... .....|...+.++ .++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~ 79 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL-YEA 79 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH-HhC
Confidence 568999999999999987 899999999874311 1135788999999 788
Q ss_pred CeeEeeeeeeccCCCccEEEEeeecCCccccc-c--CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEecCCC
Q 019642 94 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-Y--PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEL 169 (338)
Q Consensus 94 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~-~--~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~~~ 169 (338)
++.....+... ..++||||++|+++... + ..++......++.|++.++.++|+ .|++|+||||+||+++ +
T Consensus 80 ~i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~- 153 (190)
T cd05145 80 GVPVPEPILLK----KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D- 153 (190)
T ss_pred CCCCceEEEec----CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C-
Confidence 77544443322 23799999998754322 2 247788899999999999999999 9999999999999998 4
Q ss_pred CceEEEecccccccc
Q 019642 170 RKLRLIDWGLAEFYH 184 (338)
Q Consensus 170 ~~~~l~dfg~~~~~~ 184 (338)
+.++|+|||++....
T Consensus 154 ~~~~liDFG~a~~~~ 168 (190)
T cd05145 154 GKPYIIDVSQAVELD 168 (190)
T ss_pred CCEEEEEcccceecC
Confidence 789999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.2e-22 Score=187.14 Aligned_cols=225 Identities=24% Similarity=0.402 Sum_probs=162.1
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEe
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 115 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e 115 (338)
-.++|..++.+..|++|.||.++++.+.+.+|+|+-+ . .. ++++ | ..| .+.++.|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q--~l------ilRn------i----lt~----a~npfvv-- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-Q--NL------ILRN------I----LTF----AGNPFVV-- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcccc-c--ch------hhhc------c----ccc----cCCccee--
Confidence 3468999999999999999999999999999995422 1 11 1111 1 111 1222333
Q ss_pred eecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC---------
Q 019642 116 YVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG--------- 186 (338)
Q Consensus 116 ~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~--------- 186 (338)
.+..++...++.++... +.+++|+|+.||+|+|+||+|.+|+.- |++|++|||+++.....
T Consensus 136 -gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~m-GhiKlTDfgLsk~GLms~atnl~eg~ 205 (1205)
T KOG0606|consen 136 -GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSM-GHIKLTDFGLSKKGLMSLATNLKEGH 205 (1205)
T ss_pred -chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeec-ccccccchhhhhhhhhhccchhhhcc
Confidence 23334444444566544 778999999999999999999999998 89999999987543111
Q ss_pred C------cce-eeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhh
Q 019642 187 K------EYN-VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259 (338)
Q Consensus 187 ~------~~~-~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
. ... ..+||+.|.|||++.. +.|...+|-|++|+++|+++-|..||+ ++..++-+...........
T Consensus 206 I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpff-Gdtpeelfg~visd~i~wp----- 278 (1205)
T KOG0606|consen 206 IEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFF-GDTPEELFGQVISDDIEWP----- 278 (1205)
T ss_pred hHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeecc-CCCHHHHHhhhhhhhcccc-----
Confidence 0 111 2378999999999987 689999999999999999999999994 3333444443322111100
Q ss_pred hccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC---CHHHHhcCCCcchhhhc
Q 019642 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL---TAREAMAHPYFAQVRAA 331 (338)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp---t~~ell~hp~~~~~~~~ 331 (338)
+ ....+.++++++|..+|+.+|..|. .+-++.+|+||+.+.+.
T Consensus 279 ----------------------------E-~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 279 ----------------------------E-EDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred ----------------------------c-cCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 0 1223788999999999999999997 67788999999998765
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.2e-22 Score=187.53 Aligned_cols=242 Identities=19% Similarity=0.356 Sum_probs=164.7
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc----hHHHHHHHHHHH-HhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQ-NLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~E~~~l~-~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
+|..++.||++.|=+|.+|.+. .|. |+||++-+.+ -+.+.++++-.+ .+.++||++++.-+... .+..|+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t--~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVT--DKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHh--hHHHHHH
Confidence 7899999999999999999764 343 8899875433 233433333332 33489999998877533 4455677
Q ss_pred EeeecCCccccccCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc--cCCCc-
Q 019642 114 FEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY--HPGKE- 188 (338)
Q Consensus 114 ~e~~~~~~l~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~--~~~~~- 188 (338)
-+|...+....+..+ +..-+.+-++.|++.||..+|+.||+|||||.+|||++.= .=+.|+||..-+.. +...+
T Consensus 100 RqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSW-NW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 100 RQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSW-NWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeee-chhhhhcccccCCccCCCCCcc
Confidence 777775544433322 6777788899999999999999999999999999999886 35789999865332 21111
Q ss_pred -c----eeeeccccccccccccCcC---------C-CCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCC
Q 019642 189 -Y----NVRVASRYFKGPELLVDLQ---------D-YDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGT 252 (338)
Q Consensus 189 -~----~~~~~~~~y~aPE~~~~~~---------~-~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~ 252 (338)
. +......+|.|||.+.... . .+++=||||+||+++|+++ |+.|| .-.++......- .
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF-----~LSQL~aYr~~~-~ 252 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLF-----TLSQLLAYRSGN-A 252 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcc-----cHHHHHhHhccC-c
Confidence 1 1122345799999985421 1 5678999999999999987 56666 122222111110 0
Q ss_pred chhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 253 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
.+.+.. +..+ -+..++++|..|++.||++|.+|++.|+-
T Consensus 253 ~~~e~~---------------Le~I----------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 253 DDPEQL---------------LEKI----------------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cCHHHH---------------HHhC----------------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 010100 0000 14578999999999999999999999975
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=185.90 Aligned_cols=195 Identities=20% Similarity=0.381 Sum_probs=155.5
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhc--CCCCeeEeeeeeeccCCCccE
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLC--GGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~--~h~~iv~~~~~~~~~~~~~~~ 111 (338)
.-.++.|.|.+.||+|+||+||.|.+.+ ++.||+|+-++....++---.+++.+|. --+.|..+...+...+ ..+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~--~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQN--ASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCC--cce
Confidence 3446799999999999999999999876 9999999988766554443444555551 1123444444443333 456
Q ss_pred EEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecC------CCCceEEEecccccc
Q 019642 112 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH------ELRKLRLIDWGLAEF 182 (338)
Q Consensus 112 lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~------~~~~~~l~dfg~~~~ 182 (338)
+|++|.+-|+|-+++. .+++..+..++.|++..+++||..+|+||||||+|.|+.. +..-++|+|||.+..
T Consensus 771 lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD 850 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID 850 (974)
T ss_pred eeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence 9999999999888874 3888899999999999999999999999999999999942 234689999998744
Q ss_pred c---cCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCC
Q 019642 183 Y---HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 232 (338)
Q Consensus 183 ~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~p 232 (338)
+ .++.......+|..+-.+|...| .+|++..|.|.|+.+++.|+.|+..
T Consensus 851 m~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 851 MKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred eeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHHHH
Confidence 3 45556677788999999999988 7999999999999999999999743
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6e-21 Score=154.45 Aligned_cols=239 Identities=16% Similarity=0.183 Sum_probs=175.9
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~-----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
..+..+..+..+|.....|..|+|++.. ..+++|+++- ...+.+..|.-.++-+ .||||..+++.+.. ..
T Consensus 186 gid~~~lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrif-shpnilpvlgacns--pp 260 (448)
T KOG0195|consen 186 GIDVSSLNLITKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIF-SHPNILPVLGACNS--PP 260 (448)
T ss_pred CcchhhhhhhhhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeee-cCCchhhhhhhccC--CC
Confidence 3445667788899999999999998754 4466676542 3346688899999998 99999999999954 45
Q ss_pred ccEEEEeeecCCccccccCC-----CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCeEecCCCCceEE--Eeccc
Q 019642 109 TPSLIFEYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRL--IDWGL 179 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~~~~~~l--~dfg~ 179 (338)
++.++..|+.-++|...+.. ....++.+++.+++.|+.|||+.. |----++...+++|.+ -+.+| +|-.+
T Consensus 261 nlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmided-ltarismad~kf 339 (448)
T KOG0195|consen 261 NLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDED-LTARISMADTKF 339 (448)
T ss_pred CceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecch-hhhheeccccee
Confidence 78899999999999888753 677889999999999999999975 4445688899999887 44443 34333
Q ss_pred cccccCCCcceeeeccccccccccccCcC--CCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhh
Q 019642 180 AEFYHPGKEYNVRVASRYFKGPELLVDLQ--DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 257 (338)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
+. ....+..+|.|++||.+...+ ..-.++|+|||++++|++.|...||-...+-+-......+.
T Consensus 340 sf------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeg-------- 405 (448)
T KOG0195|consen 340 SF------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEG-------- 405 (448)
T ss_pred ee------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcc--------
Confidence 31 122345678999999986522 23367999999999999999999994333222111111111
Q ss_pred hhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHh
Q 019642 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 320 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell 320 (338)
..-..++.++.....+++-|+..||.+||.++.++
T Consensus 406 ----------------------------lrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 406 ----------------------------LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ----------------------------ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 11123444789999999999999999999988764
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=148.32 Aligned_cols=134 Identities=19% Similarity=0.266 Sum_probs=104.0
Q ss_pred EEEeeeecCceeEEEEEEcCCCceEEEEEeccc---chHHHHHHHHHHHHhc----CCCCeeEeeeeeeccCC-CccE-E
Q 019642 42 VVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLC----GGPNVVKLLDIVRDQHS-KTPS-L 112 (338)
Q Consensus 42 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~E~~~l~~l~----~h~~iv~~~~~~~~~~~-~~~~-l 112 (338)
-.+.||+|++|.||. ++.++.. +||++... ..+.+.+|+.+++.+. .||||+++++++....+ ...+ +
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 357899999999995 7777766 68887643 4567899999999994 37999999999976542 2323 6
Q ss_pred EEeee--cCCccccccCC--CCHHHHHHHHHHHHHHH-HHHHHCCceeccCCCCCeEecCC---CCceEEEe-cccc
Q 019642 113 IFEYV--NSTDFKVLYPT--LTDYDIRYYIYELLKAL-DYCHSQGIMHRDVKPHNVMIDHE---LRKLRLID-WGLA 180 (338)
Q Consensus 113 v~e~~--~~~~l~~~~~~--~~~~~~~~i~~qi~~~l-~~lH~~~i~H~dikp~NIli~~~---~~~~~l~d-fg~~ 180 (338)
|+||. .+++|.+++.. +++. ..++.|++.++ +|||+++|+|+||||+||+++.. ...++|+| ||..
T Consensus 83 I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred EecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 89994 47899888753 4444 35678888777 99999999999999999999743 24799999 4443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.6e-19 Score=148.18 Aligned_cols=137 Identities=15% Similarity=0.201 Sum_probs=108.9
Q ss_pred CCcEEEEEeeeecCceeEEEEE-EcCCCceEEEEEecccc---------------------------hHHHHHHHHHHHH
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGI-NVNTNERCIIKILKPVK---------------------------KKKIKREIKILQN 88 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~~aiK~~~~~~---------------------------~~~~~~E~~~l~~ 88 (338)
+.-|.+.+.||+|++|.||+|. +..+++.||+|+++... ...+..|+..+.+
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 4568899999999999999998 67789999999986421 0224679999999
Q ss_pred hcCC--CCeeEeeeeeeccCCCccEEEEeeecCCcccccc-C--CCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCC
Q 019642 89 LCGG--PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-P--TLTDYDIRYYIYELLKALDYCHSQG-IMHRDVKPHN 162 (338)
Q Consensus 89 l~~h--~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~--~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dikp~N 162 (338)
+ .+ ..++++++. . ..++||||+++.++.... . ......+..++.|++.++.+||+.| ++|+||||+|
T Consensus 107 L-~~~~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~N 179 (237)
T smart00090 107 L-YEAGVPVPKPIAW---R---RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYN 179 (237)
T ss_pred H-HhcCCCCCeeeEe---c---CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhh
Confidence 9 44 334444442 1 247999999998876553 2 3555567889999999999999999 9999999999
Q ss_pred eEecCCCCceEEEecccccc
Q 019642 163 VMIDHELRKLRLIDWGLAEF 182 (338)
Q Consensus 163 Ili~~~~~~~~l~dfg~~~~ 182 (338)
|+++ + +.++|+|||.+..
T Consensus 180 Ili~-~-~~i~LiDFg~a~~ 197 (237)
T smart00090 180 ILVH-D-GKVVIIDVSQSVE 197 (237)
T ss_pred EEEE-C-CCEEEEEChhhhc
Confidence 9999 4 7899999998864
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.7e-18 Score=141.33 Aligned_cols=131 Identities=25% Similarity=0.380 Sum_probs=107.7
Q ss_pred EeeeecCceeEEEEEEcCCCceEEEEEecccc-----------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 44 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
+.||+|++|.||+|.+ .+..+++|+..... .....+|+..+..+ .+++++....++.+. ...++
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~--~~~~l 76 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA-RKAGVNVPAVYFVDP--ENFII 76 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHH-HHCCCCCCeEEEEeC--CCCEE
Confidence 5789999999999986 67788999765321 23467899999999 788887666665433 45679
Q ss_pred EEeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccc
Q 019642 113 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
Q Consensus 113 v~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~ 182 (338)
+|||++|.+|.+.+..... ....++.+++.+|.++|+.|++|+|++|.||+++ + +.++++|||.+..
T Consensus 77 v~e~~~G~~L~~~~~~~~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~-~~~~liDf~~a~~ 143 (211)
T PRK14879 77 VMEYIEGEPLKDLINSNGM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-G-GKIYLIDFGLAEF 143 (211)
T ss_pred EEEEeCCcCHHHHHHhccH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-C-CCEEEEECCcccC
Confidence 9999999999888765444 7788999999999999999999999999999999 4 6899999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=1e-17 Score=137.06 Aligned_cols=134 Identities=20% Similarity=0.337 Sum_probs=105.9
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-------------------------hHHHHHHHHHHHHhcCC
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-------------------------KKKIKREIKILQNLCGG 92 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------------------------~~~~~~E~~~l~~l~~h 92 (338)
..|.+.+.||+|+||.||++.+. +++.+++|++.... ......|+..+..+ .+
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~ 92 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL-YE 92 (198)
T ss_pred chhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH-HH
Confidence 34888899999999999999874 79999999865321 11256788888888 66
Q ss_pred C--CeeEeeeeeeccCCCccEEEEeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCC
Q 019642 93 P--NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR 170 (338)
Q Consensus 93 ~--~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~ 170 (338)
+ .++..++. ...+++|||+.|.++...... .....++.+++.++.++|+.|++|+||+|+||+++.+ +
T Consensus 93 ~~i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~~---~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~-~ 162 (198)
T cd05144 93 EGFPVPKPIDW------NRHAVVMEYIDGVELYRVRVL---EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDD-E 162 (198)
T ss_pred cCCCCCceeec------CCceEEEEEeCCcchhhcccc---ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCC-C
Confidence 5 34444432 234799999999988766432 3456788999999999999999999999999999987 7
Q ss_pred ceEEEeccccccc
Q 019642 171 KLRLIDWGLAEFY 183 (338)
Q Consensus 171 ~~~l~dfg~~~~~ 183 (338)
.++|+|||.+...
T Consensus 163 ~~~liDfg~~~~~ 175 (198)
T cd05144 163 KIYIIDWPQMVST 175 (198)
T ss_pred cEEEEECCccccC
Confidence 9999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.3e-19 Score=157.97 Aligned_cols=173 Identities=20% Similarity=0.364 Sum_probs=129.9
Q ss_pred CccEEEEeeecCCccccccC------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 108 KTPSLIFEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
.++++.|++|...+|.+++. ..+....+.++.|+..+++| +|.+|+|+||.||+...+ .+++|.|||+.+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d-~q~kIgDFgl~t 404 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDD-DQLKIGDFGLVT 404 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccc-hhhhhhhhhhee
Confidence 36889999999999999984 26667788999999999999 999999999999999887 689999999987
Q ss_pred cccCCC-------cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCc
Q 019642 182 FYHPGK-------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTD 253 (338)
Q Consensus 182 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (338)
...... ......||..||+||.+.+ ..++.++||||||++|++++. -...+ .....+..+... .
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~f~T~~----er~~t~~d~r~g--~- 476 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQFSTQF----ERIATLTDIRDG--I- 476 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHHhccHH----HHHHhhhhhhcC--C-
Confidence 665443 4455689999999999998 789999999999999999996 12222 111111111100 0
Q ss_pred hhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 254 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
-++. +. . =-++-..|+.+||...|.+||++.+.--|+|.
T Consensus 477 ip~~---------------------------~~-~-----d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 477 IPPE---------------------------FL-Q-----DYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred CChH---------------------------Hh-h-----cCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 0000 00 0 01345689999999999999988777777775
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.3e-18 Score=151.95 Aligned_cols=201 Identities=21% Similarity=0.321 Sum_probs=149.0
Q ss_pred HHhcCCCCeeEeeeeeeccCCCccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCc-eeccCCCC
Q 019642 87 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGI-MHRDVKPH 161 (338)
Q Consensus 87 ~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i-~H~dikp~ 161 (338)
+.+ .|.|+.++++...+. ...++|.+||..++|.+.+. .++......++++++.||.|+|...+ .|+.+++.
T Consensus 2 ~~l-~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 2 RQL-DHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred ccc-chhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 456 899999999999765 67789999999999999875 37777888899999999999999865 99999999
Q ss_pred CeEecCCCCceEEEeccccccccCC---CcceeeeccccccccccccCcC------CCCCcchhHHHHHHHHHHHhcCCC
Q 019642 162 NVMIDHELRKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPELLVDLQ------DYDYSLDMWSLGCMFAGMIFRKEP 232 (338)
Q Consensus 162 NIli~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~------~~~~~~DvwslG~~l~~lltg~~p 232 (338)
|.++|.. ..+||+|||+....... ...........|.|||.+.+.. ..+.+.|+||+|++++++++...|
T Consensus 79 nClvd~~-w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 79 NCLVDSR-WVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred cceeeee-EEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999998 89999999998665321 1111122345699999986631 156789999999999999999999
Q ss_pred CcCCCCCHHHHHHHHHHhC--CchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCc
Q 019642 233 FFYGHDNHDQLVKIAKVLG--TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 310 (338)
Q Consensus 233 f~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP 310 (338)
|.......+..+.+.+... ....... ... .. .+.+++..+++.|+..+|
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~-----------i~~-------------~~-----e~~~~l~~l~~~cw~e~P 208 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPS-----------IEL-------------LN-----ELPPELLLLVARCWEEIP 208 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcc-----------hhh-------------hh-----hcchHHHHHHHHhcccCh
Confidence 9765544443222222111 1111100 000 00 145689999999999999
Q ss_pred CCcCCHHHHh
Q 019642 311 QDRLTAREAM 320 (338)
Q Consensus 311 ~~Rpt~~ell 320 (338)
++||+++++-
T Consensus 209 ~~rPs~~~i~ 218 (484)
T KOG1023|consen 209 EKRPSIEQIR 218 (484)
T ss_pred hhCccHHHHH
Confidence 9999999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.7e-20 Score=171.38 Aligned_cols=255 Identities=22% Similarity=0.364 Sum_probs=194.6
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCC-CceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNT-NERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
...|.+.+.||+|+|+.|-......+ ...++.|.+.... ...+..|..+-..+.+|+|++.+++...+ ....
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~--~~~~ 96 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS--PRSY 96 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC--Cccc
Confidence 57899999999999999988876433 3446666554321 23345578888888559999999998844 5567
Q ss_pred EEEEeeecCCcccccc-C----CCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCCeEecCCCC-ceEEEeccccccc
Q 019642 111 SLIFEYVNSTDFKVLY-P----TLTDYDIRYYIYELLKALDYCH-SQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFY 183 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~-~----~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dikp~NIli~~~~~-~~~l~dfg~~~~~ 183 (338)
++++++..|+++...+ . ..+......++.|+..++.|+| ..++.|+|+||+|.+++.. + .+++.|||+++..
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s-~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDES-GSALKIADFGLATAY 175 (601)
T ss_pred ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccC-CCcccCCCchhhccc
Confidence 7899999888887776 2 3567778889999999999999 9999999999999999988 5 8999999999776
Q ss_pred cC-CC---cceeeec-cccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhh
Q 019642 184 HP-GK---EYNVRVA-SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 258 (338)
Q Consensus 184 ~~-~~---~~~~~~~-~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
.. .. ......| ++.|.|||...+.....+..|+||.|+++..+++|..|+............+...
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~--------- 246 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSN--------- 246 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccc---------
Confidence 54 21 2333567 9999999999875567789999999999999999999985433322111100000
Q ss_pred hhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcch
Q 019642 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 327 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 327 (338)
...+.......++....+++.+++..+|+.|.+.+++..+||+..
T Consensus 247 ------------------------~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 247 ------------------------KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ------------------------ccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 001112222336888999999999999999999999999999988
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.9e-17 Score=133.85 Aligned_cols=127 Identities=21% Similarity=0.391 Sum_probs=98.3
Q ss_pred eeeecCceeEEEEEEcCCCceEEEEEecccc-----------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 45 KVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 45 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
.||+|++|.||++.. ++..+++|...... ...+.+|+.+++.+ .++++.....++.. ....+++
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~--~~~~~lv 75 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRA-RKAGVNTPVVYDVD--PDNKTIV 75 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHH-HHCCCCCCEEEEEE--CCCCEEE
Confidence 379999999999974 56789999854211 24466899999999 66654433333322 2345799
Q ss_pred EeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccc
Q 019642 114 FEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
Q Consensus 114 ~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~ 182 (338)
|||+.|.++.+....... .++.+++.+|.+||+.|++|+|++|.||+++ + +.++++|||++..
T Consensus 76 ~e~~~g~~l~~~~~~~~~----~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~-~~~~liDfg~a~~ 138 (199)
T TIGR03724 76 MEYIEGKPLKDVIEEGND----ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D-DKLYLIDFGLGKY 138 (199)
T ss_pred EEEECCccHHHHHhhcHH----HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-C-CcEEEEECCCCcC
Confidence 999999998877543221 7899999999999999999999999999999 4 7899999998854
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.2e-17 Score=151.02 Aligned_cols=132 Identities=20% Similarity=0.362 Sum_probs=103.7
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEe--ccc---------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL--KPV---------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~--~~~---------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
.|...+.||+|+||+||++.+.... +++|.. +.. ..+.+.+|+++++.+ +|++++....+..+.
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~-- 408 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEA-RRAGVPTPVIYDVDP-- 408 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh-cccCCCeeEEEEEeC--
Confidence 4456889999999999999765443 333332 111 124577899999999 899988776665443
Q ss_pred CccEEEEeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccc
Q 019642 108 KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~ 182 (338)
...++||||+.+++|.+.+. ....++.+++.+|.+||+.|++|+|+||+||+++ + +.++|+|||++..
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~-----~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~-~~~~liDFGla~~ 476 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE-----GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-D-DRLYLIDFGLGKY 476 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH-----HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-C-CcEEEEeCccccc
Confidence 35679999999999987754 4567899999999999999999999999999994 3 6899999999864
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=2e-16 Score=128.31 Aligned_cols=132 Identities=20% Similarity=0.326 Sum_probs=95.5
Q ss_pred EEeeeecCceeEEEEEEcCCCceEEEEEecccch-----HH----------------------HHHHHHHHHHhcCC-CC
Q 019642 43 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-----KK----------------------IKREIKILQNLCGG-PN 94 (338)
Q Consensus 43 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~----------------------~~~E~~~l~~l~~h-~~ 94 (338)
.+.||+|+||+||+|.+. +++.|++|++++... .. ...|...+..+..+ -.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999876 789999999764221 11 13455566665222 12
Q ss_pred eeEeeeeeeccCCCccEEEEeeecCCcccc-ccCCCCH-HHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEecCCCCc
Q 019642 95 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKV-LYPTLTD-YDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRK 171 (338)
Q Consensus 95 iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~-~~~~~~~-~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~~~~~ 171 (338)
+++.++. ...+++|||+.++.+.. .+..... ..+..++.+++.++.++|. .|++|+||+|+||+++ + +.
T Consensus 81 ~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~-~~ 152 (187)
T cd05119 81 VPKPIDL------NRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D-GK 152 (187)
T ss_pred CCceEec------CCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C-Cc
Confidence 4444443 13579999999854321 1222222 6778899999999999999 9999999999999999 4 78
Q ss_pred eEEEeccccccc
Q 019642 172 LRLIDWGLAEFY 183 (338)
Q Consensus 172 ~~l~dfg~~~~~ 183 (338)
++|+|||.+...
T Consensus 153 ~~liDfg~a~~~ 164 (187)
T cd05119 153 VYIIDVPQAVEI 164 (187)
T ss_pred EEEEECcccccc
Confidence 999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.5e-15 Score=118.63 Aligned_cols=132 Identities=22% Similarity=0.327 Sum_probs=109.8
Q ss_pred EEEeeeecCceeEEEEEEcCCCceEEEEEecccc-hHHHHHHHHHHHHhcCC-CCeeEeeeeeeccCCCccEEEEeeecC
Q 019642 42 VVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-KKKIKREIKILQNLCGG-PNVVKLLDIVRDQHSKTPSLIFEYVNS 119 (338)
Q Consensus 42 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~E~~~l~~l~~h-~~iv~~~~~~~~~~~~~~~lv~e~~~~ 119 (338)
+++.||+|.++.||++.... ..+++|...... ...+..|+..++.+.++ .++++++..... ....+++|||+.+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGES--DGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccEEEEEecCC
Confidence 46789999999999998744 679999986543 35688999999999444 688898887744 3568899999999
Q ss_pred CccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCCeEecCCCCceEEEecccccc
Q 019642 120 TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
Q Consensus 120 ~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~~~l~dfg~~~~ 182 (338)
..+... +......++.+++.++..+|.. +++|+|++|.||+++.. +.++++||+.+..
T Consensus 78 ~~~~~~----~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~-~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV----SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG-KILGIIDWEYAGY 138 (155)
T ss_pred eecccC----CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC-cEEEEEecccccC
Confidence 877655 5667778899999999999985 69999999999999986 7899999998853
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.3e-15 Score=127.61 Aligned_cols=131 Identities=18% Similarity=0.323 Sum_probs=98.1
Q ss_pred Eeee-ecCceeEEEEEEcCCCceEEEEEecc----------------cchHHHHHHHHHHHHhcCCCCe--eEeeeeeec
Q 019642 44 RKVG-RGKYSEVFEGINVNTNERCIIKILKP----------------VKKKKIKREIKILQNLCGGPNV--VKLLDIVRD 104 (338)
Q Consensus 44 ~~lg-~G~~g~V~~~~~~~~~~~~aiK~~~~----------------~~~~~~~~E~~~l~~l~~h~~i--v~~~~~~~~ 104 (338)
..|| .|+.|+||.+.. .+..+++|.+.. .......+|+.++..+ .++++ +..++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L-~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQL-YEAGLPVPRPIAARVV 113 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHH-HhCCCCCceeEeeeee
Confidence 4566 788888988865 367788887642 1124567899999999 77664 666665433
Q ss_pred cCCC--ccEEEEeeecC-CccccccCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccc
Q 019642 105 QHSK--TPSLIFEYVNS-TDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
Q Consensus 105 ~~~~--~~~lv~e~~~~-~~l~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~ 179 (338)
.... ..++|||++.| .+|.+++.. +++. .+.+++.+|.+||++||+|+||||.|||++.+ +.++|+|||.
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~-~~v~LIDfg~ 188 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEAPLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPD-GKFWLIDFDR 188 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcCCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCC-CCEEEEECCC
Confidence 2221 23599999997 678777643 3433 36789999999999999999999999999987 6899999998
Q ss_pred ccc
Q 019642 180 AEF 182 (338)
Q Consensus 180 ~~~ 182 (338)
+..
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1e-15 Score=137.46 Aligned_cols=249 Identities=20% Similarity=0.197 Sum_probs=188.0
Q ss_pred CCcEEEEEeeee--cCceeEEEEEE--cCCCceEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 37 QDDYEVVRKVGR--GKYSEVFEGIN--VNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 37 ~~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~~aiK~~~~-----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
...+.+.+.+|. |.+|.||.+.. ..++..+++|.-+. .....-.+|+....++..|++.++.+..+.+ .
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~--~ 190 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG--S 190 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc--C
Confidence 456788899999 99999999988 78889999998431 2233345788888888889999998887744 5
Q ss_pred CccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHH----HHHHHHHCCceeccCCCCCeEecCCCCceEEEecccc
Q 019642 108 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLK----ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~----~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~ 180 (338)
...++-.|+++........ .-++...++..+.+... ||.++|+.+++|.|++|.||+...+....+++|||+.
T Consensus 191 ~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 191 GILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred CcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 5677888888744333332 23888999999999999 9999999999999999999999887568899999998
Q ss_pred ccccCCCc-ceee-----eccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCC-CHHHHHHHHHHhCCc
Q 019642 181 EFYHPGKE-YNVR-----VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD-NHDQLVKIAKVLGTD 253 (338)
Q Consensus 181 ~~~~~~~~-~~~~-----~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~-~~~~~~~~~~~~~~~ 253 (338)
..+..+.. .... .+...|++||+..+ -++...|++++|.++.+..++..+...+.. .+.++....
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~------ 342 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY------ 342 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc------
Confidence 87765542 1112 56778999999876 688999999999999999988777633321 121111110
Q ss_pred hhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcch
Q 019642 254 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 327 (338)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 327 (338)
.+.+.-...+..+...+..|++.+|-.|+++..+++|++...
T Consensus 343 --------------------------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 343 --------------------------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred --------------------------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 000000114667778999999999999999999999999764
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.1e-13 Score=107.75 Aligned_cols=126 Identities=20% Similarity=0.264 Sum_probs=95.7
Q ss_pred EEeeeecCceeEEEEEEcCCCceEEEEEecccc--hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeecCC
Q 019642 43 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST 120 (338)
Q Consensus 43 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~ 120 (338)
++.|+.|.++.||++.. .+..+++|...... ......|+.+++.+.+...+++++... . ...++|||+++|.
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~--~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--P--ETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--C--CCCeEEEEecCCC
Confidence 56789999999999975 37789999976543 234678999999984443345565543 2 2346999999998
Q ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eeccCCCCCeEecCCCCceEEEeccccc
Q 019642 121 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGI-----MHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 121 ~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i-----~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
++... . ......+.+++.+|..||+.++ +|+|++|.||+++ + +.++++||+.+.
T Consensus 77 ~l~~~--~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~-~~~~liDf~~a~ 135 (170)
T cd05151 77 ELLTE--D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D-GRLWLIDWEYAG 135 (170)
T ss_pred ccccc--c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C-CeEEEEeccccc
Confidence 87654 1 1123456789999999999985 9999999999999 3 579999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.8e-13 Score=124.46 Aligned_cols=138 Identities=17% Similarity=0.272 Sum_probs=93.8
Q ss_pred EEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHH------------------------------------------
Q 019642 43 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK------------------------------------------ 80 (338)
Q Consensus 43 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~------------------------------------------ 80 (338)
.+.||+|++|.||+|.. .+|+.||||+.++...+.+.
T Consensus 122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 36799999999999986 47899999998764333322
Q ss_pred -HHHHHHHHhc---CCCCeeEeeeeeeccCCCccEEEEeeecCCccccccCC--CCHHHHHHHHHHHHH-HHHHHHHCCc
Q 019642 81 -REIKILQNLC---GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELLK-ALDYCHSQGI 153 (338)
Q Consensus 81 -~E~~~l~~l~---~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~i~~qi~~-~l~~lH~~~i 153 (338)
+|...+.++. ++.+-+.+-..+.+. ....+++|||+.|.++.+.... ... ....++.+++. .+..+|..|+
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~-~~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGL-DRKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCC-CHHHHHHHHHHHHHHHHHhCCc
Confidence 3333333332 122223333333221 2245799999999998776421 111 23445566655 4688999999
Q ss_pred eeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 154 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 154 ~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
+|+|++|.||+++.+ +.++++|||++....
T Consensus 279 ~H~D~hPgNilv~~~-g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKD-GKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCC-CcEEEEeCCCeeECC
Confidence 999999999999887 899999999986554
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.49 E-value=7.2e-13 Score=106.31 Aligned_cols=133 Identities=17% Similarity=0.261 Sum_probs=98.2
Q ss_pred EEeeeecCceeEEEEEEcC------CCceEEEEEecccc-------------------------hHH----HHHHHHHHH
Q 019642 43 VRKVGRGKYSEVFEGINVN------TNERCIIKILKPVK-------------------------KKK----IKREIKILQ 87 (338)
Q Consensus 43 ~~~lg~G~~g~V~~~~~~~------~~~~~aiK~~~~~~-------------------------~~~----~~~E~~~l~ 87 (338)
...||.|.-+.||.|.... .+..+|+|+++... ... .+.|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998653 35789999874210 112 237999999
Q ss_pred HhcCC-CCeeEeeeeeeccCCCccEEEEeeecCCcccc-ccC--CCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCC
Q 019642 88 NLCGG-PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV-LYP--TLTDYDIRYYIYELLKALDYC-HSQGIMHRDVKPHN 162 (338)
Q Consensus 88 ~l~~h-~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~-~~~--~~~~~~~~~i~~qi~~~l~~l-H~~~i~H~dikp~N 162 (338)
++... -+++++++.. .-++||||++++.+.. .+. .++......+..+++.+|..| |+.|++||||++.|
T Consensus 82 rl~~~Gv~vP~pi~~~------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 82 RMQKAGIPCPEVVVLK------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHHcCCCCCeEEEec------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 98533 4666777642 3469999998753321 111 345566778889999999988 89999999999999
Q ss_pred eEecCCCCceEEEeccccccc
Q 019642 163 VMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 163 Ili~~~~~~~~l~dfg~~~~~ 183 (338)
|+++. +.+.|+|||.+...
T Consensus 156 IL~~~--~~v~iIDF~qav~~ 174 (197)
T cd05146 156 MLWHD--GKVWFIDVSQSVEP 174 (197)
T ss_pred EEEEC--CcEEEEECCCceeC
Confidence 99975 47999999988543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1e-13 Score=115.77 Aligned_cols=204 Identities=20% Similarity=0.203 Sum_probs=141.2
Q ss_pred HHHHhcCCCCeeEeeeeeeccC---CCccEEEEeeecCCccccccC-------CCCHHHHHHHHHHHHHHHHHHHHCC--
Q 019642 85 ILQNLCGGPNVVKLLDIVRDQH---SKTPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQG-- 152 (338)
Q Consensus 85 ~l~~l~~h~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~-- 152 (338)
-+..+ -|.|+++++.++.+.. .....++.||+..+++..+++ .+.....++++.||+.||.|||+..
T Consensus 120 nllql-vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 120 NLLQL-VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHH-HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 34445 6889999999886542 234667889999999988874 3788888999999999999999985
Q ss_pred ceeccCCCCCeEecCCCCceEEEecccccccc-----CCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHH
Q 019642 153 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-----PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 227 (338)
Q Consensus 153 i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll 227 (338)
++|+++..+.|++..+ +-+|+.--....... .........+-++|.+||.=.. ...+.++|||++|.-..+|.
T Consensus 199 iihgnlTc~tifiq~n-gLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHN-GLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred cccCCcchhheeecCC-ceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHHHHH
Confidence 9999999999999977 777765332211110 0011223455678999986333 46778999999999999998
Q ss_pred hcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcC
Q 019642 228 FRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 307 (338)
Q Consensus 228 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~ 307 (338)
.+..--..+....+.-+.+..+.-. . -.+.-++++.+||+
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~i~~-------------------------------------l---en~lqr~~i~kcl~ 316 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANVIIG-------------------------------------L---ENGLQRGSITKCLE 316 (458)
T ss_pred HheeccCCCcceeehhhhhhhheee-------------------------------------c---cCccccCcCccccc
Confidence 7765432222211111111111000 0 01223578999999
Q ss_pred CCcCCcCCHHHHhcCCCcchhhhc
Q 019642 308 YDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 308 ~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
..|+.||++.+++.||.+-++...
T Consensus 317 ~eP~~rp~ar~llfHpllfeVhsl 340 (458)
T KOG1266|consen 317 GEPNGRPDARLLLFHPLLFEVHSL 340 (458)
T ss_pred CCCCCCcchhhhhcCceeeecchH
Confidence 999999999999999998777543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.40 E-value=4.4e-12 Score=115.63 Aligned_cols=167 Identities=20% Similarity=0.344 Sum_probs=127.9
Q ss_pred EE-EEEEcCCCceEEEEEecccch---HHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeecCCccccccCCC
Q 019642 54 VF-EGINVNTNERCIIKILKPVKK---KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTL 129 (338)
Q Consensus 54 V~-~~~~~~~~~~~aiK~~~~~~~---~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~ 129 (338)
+| .|..+.++.+|.|.+++.... ..+.+-+..++.+ +||+|+++++.+.. ....|+|+|.+.. |...++.+
T Consensus 27 ~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtl-RHP~Il~yL~t~e~--~~~~ylvTErV~P--l~~~lk~l 101 (690)
T KOG1243|consen 27 LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTL-RHPNILSYLDTTEE--EGTLYLVTERVRP--LETVLKEL 101 (690)
T ss_pred cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhc-cCchhhhhhhhhcc--cCceEEEeecccc--HHHHHHHh
Confidence 34 456677888999998875544 5567788899999 99999999999844 5688999998854 45555566
Q ss_pred CHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc-ceeeeccccccccccccCc
Q 019642 130 TDYDIRYYIYELLKALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDL 207 (338)
Q Consensus 130 ~~~~~~~i~~qi~~~l~~lH-~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~ 207 (338)
+...+...+.||+.||.+|| +.+++|++|.-+.|+++.. |..||++|.++........ .....--..|..|+....
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~-GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~- 179 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNES-GEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP- 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCC-CcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc-
Confidence 78888889999999999998 5689999999999999999 9999999998865543222 111112224566665433
Q ss_pred CCCCCcchhHHHHHHHHHHHhc
Q 019642 208 QDYDYSLDMWSLGCMFAGMIFR 229 (338)
Q Consensus 208 ~~~~~~~DvwslG~~l~~lltg 229 (338)
-....|.|.||+++++++.|
T Consensus 180 --s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 180 --SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cccchhhhhHHHHHHHHhCc
Confidence 22567999999999999988
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.6e-13 Score=130.20 Aligned_cols=260 Identities=22% Similarity=0.311 Sum_probs=181.6
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~------~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
...+.+.+.+.+-+|.++.++.+.-..++....+|+... ...+.+..+-.+.-.. .+|.++.....+ ....
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~--~~rs 877 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSF--PCRS 877 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCC--CCCC
Confidence 356788899999999999999987777776666665432 1222222232222222 345555544443 3345
Q ss_pred ccEEEEeeecCCccccccCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc-
Q 019642 109 TPSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH- 184 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~- 184 (338)
..+++++|++++++...+.. .+.+..+.....+..++++||...+.|+|++|.|.+.... +..++.||+......
T Consensus 878 P~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~-gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYD-GHRPLTDFGTLSKVGL 956 (1205)
T ss_pred CcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhccc-CCcccCcccccccccc
Confidence 67899999999888777643 5566677788889999999999999999999999999888 788899987321110
Q ss_pred -----C---------------C-----------CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCC
Q 019642 185 -----P---------------G-----------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 233 (338)
Q Consensus 185 -----~---------------~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf 233 (338)
+ . .......+++.|.+||...+ ......+|.|+.|+.+++.++|..||
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0 0 00112357888999999988 67788999999999999999999998
Q ss_pred cCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCc
Q 019642 234 FYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 313 (338)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 313 (338)
........+ +.+...... ....+...+.+..+++...|..+|.+|
T Consensus 1036 -na~tpq~~f----~ni~~~~~~------------------------------~p~g~~~~s~~aq~~~~~ll~~~~~qr 1080 (1205)
T KOG0606|consen 1036 -NAETPQQIF----ENILNRDIP------------------------------WPEGPEEGSYEAQDLINRLLTEEPTQR 1080 (1205)
T ss_pred -CCcchhhhh----hccccCCCC------------------------------CCCCccccChhhhhhhhhhhccCchhc
Confidence 222222222 222111111 111222368899999999999999999
Q ss_pred CCHH---HHhcCCCcchhhhcccc
Q 019642 314 LTAR---EAMAHPYFAQVRAAESS 334 (338)
Q Consensus 314 pt~~---ell~hp~~~~~~~~~~~ 334 (338)
..+. ++-.||||+.+.+....
T Consensus 1081 ~~a~~~~e~k~~~~~~~~~~~~l~ 1104 (1205)
T KOG0606|consen 1081 LGAKGAAEVKGHPFFQDVDWENLA 1104 (1205)
T ss_pred cCcccccccccCCccCCCCccccc
Confidence 9888 89999999998876543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.35 E-value=3.7e-12 Score=117.39 Aligned_cols=138 Identities=14% Similarity=0.309 Sum_probs=89.9
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHH---------------------------------------
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK--------------------------------------- 78 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--------------------------------------- 78 (338)
.+|.. +.||+|++|.||+|..+.+|+.||||+.++...+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 79999999999999988889999999987542111
Q ss_pred ----HHHHHHHHHHhc---CCCCeeEeeeeeeccCCCccEEEEeeecCCcccccc--C--C-----CCHHHHHHHHHHHH
Q 019642 79 ----IKREIKILQNLC---GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--P--T-----LTDYDIRYYIYELL 142 (338)
Q Consensus 79 ----~~~E~~~l~~l~---~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~--~-----~~~~~~~~i~~qi~ 142 (338)
+.+|...+.++. .+...+.+-.++.+- ....++||||+.|..+.+.. . . +.+..+..++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~---- 273 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF---- 273 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH----
Confidence 222333333331 123333333333221 23457999999999886532 1 1 2222223333
Q ss_pred HHHHHHHHCCceeccCCCCCeEecCCC---CceEEEecccccccc
Q 019642 143 KALDYCHSQGIMHRDVKPHNVMIDHEL---RKLRLIDWGLAEFYH 184 (338)
Q Consensus 143 ~~l~~lH~~~i~H~dikp~NIli~~~~---~~~~l~dfg~~~~~~ 184 (338)
..+...|++|+|++|.||+++.+. ++++++|||++....
T Consensus 274 ---~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 274 ---TQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ---HHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 344569999999999999998872 289999999986554
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.35 E-value=4.5e-11 Score=106.06 Aligned_cols=208 Identities=15% Similarity=0.241 Sum_probs=150.7
Q ss_pred ceeEEEEEEcCCCceEEEEEecc---cchHHHHHHHHHHHHhcCCCCeeEeeeeeecc--CCCccEEEEeeecCC-cccc
Q 019642 51 YSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSKTPSLIFEYVNST-DFKV 124 (338)
Q Consensus 51 ~g~V~~~~~~~~~~~~aiK~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~~~lv~e~~~~~-~l~~ 124 (338)
..+.|++....+|..|++|.++. ........-+++++++ .|+|+|++.++|... ....+++|++|+.+. +|.+
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl-~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKL-CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHh-ccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 36889999999999999999832 2233344568999999 999999999998632 234678899998654 4433
Q ss_pred cc------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 125 LY------------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 125 ~~------------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
.. ...+++.+|.++.|+..||.++|+.|+.-.-|.|.+|+++.+ .+++|...|........
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~-~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGK-MRIRISGCGIMDVLQED 446 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCc-ceEEEecccceeeecCC
Confidence 32 137889999999999999999999999999999999999988 58888877776544322
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHH-HHHHHHHhCCchhhhhhhccccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ-LVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
. . |.+.+ -.+-|.-.||.+++.+.||...-......... +..+..
T Consensus 447 ~-----------~--~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~~----------------- 492 (655)
T KOG3741|consen 447 P-----------T--EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRITT----------------- 492 (655)
T ss_pred C-----------C--cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhhh-----------------
Confidence 2 0 11111 13569999999999999996543222221111 222211
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
.++.+++++|.-+...++++ -++.+++.+
T Consensus 493 ---------------------------~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 493 ---------------------------TYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ---------------------------hhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 16788889999888888887 588888764
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2e-11 Score=94.80 Aligned_cols=127 Identities=20% Similarity=0.320 Sum_probs=91.6
Q ss_pred eeeecCceeEEEEEEcCCCceEEEEEeccc-----------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 45 KVGRGKYSEVFEGINVNTNERCIIKILKPV-----------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 45 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
.+++|+-+.++.+.. -+..+++|.--+. ......+|..++.++. .-.+....-+..+++ ...++
T Consensus 3 ~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~-~~GV~~P~v~dvD~~--~~~I~ 77 (204)
T COG3642 3 LIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAR-EAGVPVPIVYDVDPD--NGLIV 77 (204)
T ss_pred hhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHH-HcCCCCCeEEEEcCC--CCEEE
Confidence 578899999999854 3444777763221 1345678999998873 323333333333343 34599
Q ss_pred EeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccc
Q 019642 114 FEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
Q Consensus 114 ~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~ 182 (338)
|||.+|..+.+.+.... -.++..+-.-+.-||..||+||||.++||++... .+.++|||++..
T Consensus 78 me~I~G~~lkd~l~~~~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~--~i~~IDfGLg~~ 140 (204)
T COG3642 78 MEYIEGELLKDALEEAR----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG--RIYFIDFGLGEF 140 (204)
T ss_pred EEEeCChhHHHHHHhcc----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC--cEEEEECCcccc
Confidence 99999999987765442 4466777777888999999999999999999986 599999999863
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.32 E-value=3.4e-11 Score=93.13 Aligned_cols=136 Identities=19% Similarity=0.288 Sum_probs=98.5
Q ss_pred EEEeeeecCceeEEEEEEcCCCceEEEEEecc-----------cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 42 VVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 42 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~-----------~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
....+-+|+-+.|+++.+ .|+.++||.-.+ -.+.+..+|+..+.++. --.|.-..-++.+... -
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~D~~~--~ 85 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFIDTYG--G 85 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEEecCC--C
Confidence 677888999999999965 678888886421 12456778999999883 3344444444544433 3
Q ss_pred EEEEeeecCC-cccccc----CC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCce--EEEecccccc
Q 019642 111 SLIFEYVNST-DFKVLY----PT-LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKL--RLIDWGLAEF 182 (338)
Q Consensus 111 ~lv~e~~~~~-~l~~~~----~~-~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~--~l~dfg~~~~ 182 (338)
.++||++.|. ++.+++ .. -..+....++..+-+.+.-||.++++||||..+||++.+...++ .++|||++..
T Consensus 86 ~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 86 QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 5999999883 444443 22 33333467888999999999999999999999999997664544 8999999854
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.1e-12 Score=118.20 Aligned_cols=248 Identities=19% Similarity=0.115 Sum_probs=176.4
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEc-CCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINV-NTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
...+|..+..||.|.|+.|+..... .++..|++|-..+. ....-..|+.+...+..|.+++..+..+.. ..+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~--~r~ 340 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ--LRQ 340 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc--ccc
Confidence 4568999999999999999987643 56777888865432 222235688888888789999988887744 334
Q ss_pred cEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 110 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
.++=-||+.+++..... ..+.+...+.+..|++.++.++|+..++|.|++|+||++..+....++.||+..+...-.
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence 55778999988776655 347888899999999999999999999999999999999875467789999987642211
Q ss_pred Ccceeeecccccc-ccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 187 KEYNVRVASRYFK-GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 187 ~~~~~~~~~~~y~-aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
.....+...+. ..|++.....+..+.|++|||..+.+.+++...-.......... ...
T Consensus 421 --~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~--------~~~----------- 479 (524)
T KOG0601|consen 421 --SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIR--------SGD----------- 479 (524)
T ss_pred --cccccccccccccchhhccccccccccccccccccccccccCcccCcccccceeee--------ccc-----------
Confidence 11122233344 35666655678899999999999999998874331111100000 000
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
.........++..+.+.+...++..||.+.++..|+-|...
T Consensus 480 ----------------------~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 480 ----------------------TPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred ----------------------ccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence 00011134677888899999999999999999998876554
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.9e-10 Score=99.88 Aligned_cols=189 Identities=16% Similarity=0.209 Sum_probs=130.2
Q ss_pred EEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeee----eecc-CCCccEEEEe
Q 019642 41 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDI----VRDQ-HSKTPSLIFE 115 (338)
Q Consensus 41 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~----~~~~-~~~~~~lv~e 115 (338)
...+.||+|+.+.+|-.-. -...+.|++..-....-.+-+.+|.+...||-+..-+.+ .... ..+.+.++|+
T Consensus 14 ~~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CCCccccCCccceeeecch---hhchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 3467899999999986532 223457777644333333445555555466644331111 1111 2233678888
Q ss_pred eecCCc-ccccc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 116 YVNSTD-FKVLY---------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 116 ~~~~~~-l~~~~---------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
.+.|.- ...++ .......+.+.++.++.+...||..|.+-||++++|+|++.. +.+.|+|-..-.....
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~-~~V~LVdsDsfqi~~n 169 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDD-SKVVLVDSDSFQINAN 169 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecC-ceEEEEcccceeeccC
Confidence 877652 22222 236778899999999999999999999999999999999988 7899998654433334
Q ss_pred CCcceeeeccccccccccccC----cCCCCCcchhHHHHHHHHHHHhc-CCCC
Q 019642 186 GKEYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFR-KEPF 233 (338)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~lltg-~~pf 233 (338)
+.......|...|.+||...- .-.-+..+|.|.||+++|+++.| ++||
T Consensus 170 g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPy 222 (637)
T COG4248 170 GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPY 222 (637)
T ss_pred CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCC
Confidence 444555678899999998641 12456789999999999999987 8998
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.7e-10 Score=93.99 Aligned_cols=138 Identities=25% Similarity=0.397 Sum_probs=103.6
Q ss_pred EEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCC-CCeeEeeeeeeccC-CCccEEEEee
Q 019642 43 VRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGG-PNVVKLLDIVRDQH-SKTPSLIFEY 116 (338)
Q Consensus 43 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h-~~iv~~~~~~~~~~-~~~~~lv~e~ 116 (338)
.+.|+.|..+.||++... +++.+++|..... ....+..|..+++.+..+ ..+++++.+..... ....+++||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred ceecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 367899999999999764 3578999987643 245688999999999432 34566666653321 1256899999
Q ss_pred ecCCcccccc--CCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 019642 117 VNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHS-------------------------------------------- 150 (338)
Q Consensus 117 ~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~-------------------------------------------- 150 (338)
+.|.++.... ..++..+...++.+++.+|..||+
T Consensus 82 i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 82 VDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred eCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 9999888765 357777777778888888888873
Q ss_pred ------------CCceeccCCCCCeEecCC-CCceEEEeccccc
Q 019642 151 ------------QGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAE 181 (338)
Q Consensus 151 ------------~~i~H~dikp~NIli~~~-~~~~~l~dfg~~~ 181 (338)
..++|+|+.|.||+++.+ .+.+.|+||+.+.
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 236899999999999883 2568999999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=7.3e-12 Score=114.64 Aligned_cols=158 Identities=16% Similarity=0.244 Sum_probs=113.9
Q ss_pred HHHHHHHHHHHHHC-CceeccCCCCCeEecCCCCceEEEeccccccccCCCc-----cee-----eeccccccccccccC
Q 019642 138 IYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-----YNV-----RVASRYFKGPELLVD 206 (338)
Q Consensus 138 ~~qi~~~l~~lH~~-~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~-----~~~-----~~~~~~y~aPE~~~~ 206 (338)
+.++..|+.++|.. ++||+.|.|++|.++.+ +..||+.|+++....+... .+. ......|.|||.+.+
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~-~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNAN-GDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccC-cceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34455899999975 89999999999999999 8999999998765543211 111 123456999999988
Q ss_pred cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccc
Q 019642 207 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFI 286 (338)
Q Consensus 207 ~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (338)
...+.++|++|+|+++|.+..|..+.....+.......-....+. -
T Consensus 184 -~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~---------------------------------~ 229 (700)
T KOG2137|consen 184 -TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNA---------------------------------G 229 (700)
T ss_pred -ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccc---------------------------------c
Confidence 788999999999999999985555543333222211111000000 0
Q ss_pred cccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 287 NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 287 ~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
.......+++++++-+.+++..++..||++.+++..|||.+...
T Consensus 230 ~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~ 273 (700)
T KOG2137|consen 230 AFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGL 273 (700)
T ss_pred cccccccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCchh
Confidence 01111348999999999999999999999999999999998754
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.16 E-value=5.3e-10 Score=89.52 Aligned_cols=121 Identities=25% Similarity=0.407 Sum_probs=80.5
Q ss_pred eEEEEEEcCCCceEEEEEecccc-----------------------------hHHHHHHHHHHHHhcCC-CCeeEeeeee
Q 019642 53 EVFEGINVNTNERCIIKILKPVK-----------------------------KKKIKREIKILQNLCGG-PNVVKLLDIV 102 (338)
Q Consensus 53 ~V~~~~~~~~~~~~aiK~~~~~~-----------------------------~~~~~~E~~~l~~l~~h-~~iv~~~~~~ 102 (338)
.||.|.. .++..+|+|+.+... .....+|.+.|.++... -++++++++-
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3788876 457789999864210 13367899999999433 2577777653
Q ss_pred eccCCCccEEEEeeec--CCccccccCC-CCHHHHHHHHHHHHHHHHH-HHHCCceeccCCCCCeEecCCCCceEEEecc
Q 019642 103 RDQHSKTPSLIFEYVN--STDFKVLYPT-LTDYDIRYYIYELLKALDY-CHSQGIMHRDVKPHNVMIDHELRKLRLIDWG 178 (338)
Q Consensus 103 ~~~~~~~~~lv~e~~~--~~~l~~~~~~-~~~~~~~~i~~qi~~~l~~-lH~~~i~H~dikp~NIli~~~~~~~~l~dfg 178 (338)
.-++||||++ |..+..+... ++......++.+++..+.. +|+.|++|||+++.||+++.+ .+.++|||
T Consensus 80 ------~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~--~~~iIDf~ 151 (188)
T PF01163_consen 80 ------RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG--KVYIIDFG 151 (188)
T ss_dssp ------TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT--CEEE--GT
T ss_pred ------CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc--eEEEEecC
Confidence 2359999999 6666554332 2345567778888885544 689999999999999999987 79999999
Q ss_pred cccc
Q 019642 179 LAEF 182 (338)
Q Consensus 179 ~~~~ 182 (338)
.+..
T Consensus 152 qav~ 155 (188)
T PF01163_consen 152 QAVD 155 (188)
T ss_dssp TEEE
T ss_pred ccee
Confidence 8864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.5e-09 Score=89.57 Aligned_cols=132 Identities=23% Similarity=0.382 Sum_probs=99.5
Q ss_pred EEEEEeeeecCceeEEEEEEcCCCceEEEEEecc-------------------------cchHHHHHHHHHHHHhcCC-C
Q 019642 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-------------------------VKKKKIKREIKILQNLCGG-P 93 (338)
Q Consensus 40 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~-------------------------~~~~~~~~E~~~l~~l~~h-~ 93 (338)
+.+...||-|.-|.||.|.+. .|.++++|.-+. ..+...++|.++|++|... -
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456789999999999999876 688899997421 0123467899999999322 2
Q ss_pred CeeEeeeeeeccCCCccEEEEeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceE
Q 019642 94 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR 173 (338)
Q Consensus 94 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~ 173 (338)
.+++.+++- .-.+|||+..|..|.... +..+....++..|++-+..+-..|++|||+++-||+++.+ +.+.
T Consensus 172 ~VP~P~~~n------RHaVvMe~ieG~eL~~~r--~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~d-g~~~ 242 (304)
T COG0478 172 KVPKPIAWN------RHAVVMEYIEGVELYRLR--LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTED-GDIV 242 (304)
T ss_pred CCCCccccc------cceeeeehcccceeeccc--CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecC-CCEE
Confidence 566666642 346999999998776653 2345555566667766666668999999999999999998 8899
Q ss_pred EEeccccc
Q 019642 174 LIDWGLAE 181 (338)
Q Consensus 174 l~dfg~~~ 181 (338)
++||-.+.
T Consensus 243 vIDwPQ~v 250 (304)
T COG0478 243 VIDWPQAV 250 (304)
T ss_pred EEeCcccc
Confidence 99997664
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=7.9e-09 Score=87.76 Aligned_cols=119 Identities=19% Similarity=0.179 Sum_probs=85.2
Q ss_pred CCceEEEEEecccch--------------HHHHHHHHHHHHhcCCCCe--eEeeeeeeccC---CCccEEEEeeecCC-c
Q 019642 62 TNERCIIKILKPVKK--------------KKIKREIKILQNLCGGPNV--VKLLDIVRDQH---SKTPSLIFEYVNST-D 121 (338)
Q Consensus 62 ~~~~~aiK~~~~~~~--------------~~~~~E~~~l~~l~~h~~i--v~~~~~~~~~~---~~~~~lv~e~~~~~-~ 121 (338)
.|+.+.||....... ....+|...+.++. .-.| ++++.+..... ....++|+|++++. +
T Consensus 44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~s 122 (268)
T PRK15123 44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLH-EVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTIS 122 (268)
T ss_pred CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHH-HcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCcc
Confidence 456778886543221 13678999988883 2233 33333432211 23467999999986 7
Q ss_pred cccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecC------CCCceEEEeccccc
Q 019642 122 FKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH------ELRKLRLIDWGLAE 181 (338)
Q Consensus 122 l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~------~~~~~~l~dfg~~~ 181 (338)
+.++.. ..+......++.+++..+..||+.|++|+|+++.|||++. +...+.++||+.+.
T Consensus 123 L~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 123 LEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 777652 3456677889999999999999999999999999999975 23689999999875
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.6e-08 Score=81.44 Aligned_cols=132 Identities=17% Similarity=0.158 Sum_probs=95.0
Q ss_pred eeecCceeEEEEEEcCCCceEEEEEec---------ccchHHHHHHHHHHHHhcCC-CCeeEeeeee---eccCCCccEE
Q 019642 46 VGRGKYSEVFEGINVNTNERCIIKILK---------PVKKKKIKREIKILQNLCGG-PNVVKLLDIV---RDQHSKTPSL 112 (338)
Q Consensus 46 lg~G~~g~V~~~~~~~~~~~~aiK~~~---------~~~~~~~~~E~~~l~~l~~h-~~iv~~~~~~---~~~~~~~~~l 112 (338)
-|.||.+.|+.... .|+.+-+|... +.....+.+|+..++++... -.++++. ++ ........+|
T Consensus 26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 35688888888754 33367788654 34467789999999988421 1133333 22 1222345678
Q ss_pred EEeeecCC-ccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCc--eEEEeccccc
Q 019642 113 IFEYVNST-DFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAE 181 (338)
Q Consensus 113 v~e~~~~~-~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~--~~l~dfg~~~ 181 (338)
|+|-+++. +|.+++. +.+......++.+++.++.-||+.|+.|+|+.+.||+++.+ +. +.++||..+.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~-g~~~v~lIDlEk~r 178 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTE-GKAEAGFLDLEKSR 178 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCC-CCeeEEEEEhhccc
Confidence 99977654 7766642 35777778999999999999999999999999999999855 34 9999998764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.87 E-value=7.6e-08 Score=79.03 Aligned_cols=107 Identities=25% Similarity=0.355 Sum_probs=80.6
Q ss_pred hHHHHHHHHHHHHhcC-CCCeeEeeeeeeccC--CCccEEEEeeecCC-ccccccCC---CCHHHHHHHHHHHHHHHHHH
Q 019642 76 KKKIKREIKILQNLCG-GPNVVKLLDIVRDQH--SKTPSLIFEYVNST-DFKVLYPT---LTDYDIRYYIYELLKALDYC 148 (338)
Q Consensus 76 ~~~~~~E~~~l~~l~~-h~~iv~~~~~~~~~~--~~~~~lv~e~~~~~-~l~~~~~~---~~~~~~~~i~~qi~~~l~~l 148 (338)
.....+|...+..+.. .=..++++.+..... ....++|+|++++. +|.++... .+......++.+++..+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 4567788888887732 112344444443221 23457899999885 78887754 66777889999999999999
Q ss_pred HHCCceeccCCCCCeEecCCC--CceEEEecccccc
Q 019642 149 HSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEF 182 (338)
Q Consensus 149 H~~~i~H~dikp~NIli~~~~--~~~~l~dfg~~~~ 182 (338)
|++|++|+|+++.|||++.+. ..+.++||+.+..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999998872 3799999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.1e-07 Score=77.82 Aligned_cols=134 Identities=16% Similarity=0.250 Sum_probs=95.5
Q ss_pred EEEEeeeecCceeEEEEEEcCCCceEEEEEecccc----------------------h-----HHHHHHHHHHHHhc-CC
Q 019642 41 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----------------------K-----KKIKREIKILQNLC-GG 92 (338)
Q Consensus 41 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----------------------~-----~~~~~E~~~l~~l~-~h 92 (338)
.+...|++|..+.||+|.. .++..+|+|+++... . .-...|+.-|+++. .+
T Consensus 51 ~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAG 129 (268)
T COG1718 51 ELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAG 129 (268)
T ss_pred eeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcC
Confidence 4456888999999999974 568899999986321 0 11345777777773 23
Q ss_pred CCeeEeeeeeeccCCCccEEEEeeecCCcccc-ccC--CCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEecCC
Q 019642 93 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV-LYP--TLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHE 168 (338)
Q Consensus 93 ~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~-~~~--~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~~ 168 (338)
-.+++.+... .-.+|||+++...... .+. .+...+...+..+++..+.-|=. .|+||+||+.-|||+..
T Consensus 130 VrvP~Pi~~~------~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~- 202 (268)
T COG1718 130 VRVPEPIAFR------NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHD- 202 (268)
T ss_pred CCCCCceeec------CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEEC-
Confidence 4556666654 2359999998762111 111 13333677888899998888776 89999999999999994
Q ss_pred CCceEEEeccccccc
Q 019642 169 LRKLRLIDWGLAEFY 183 (338)
Q Consensus 169 ~~~~~l~dfg~~~~~ 183 (338)
+.+.++|++.+...
T Consensus 203 -~~p~iID~~QaV~~ 216 (268)
T COG1718 203 -GEPYIIDVSQAVTI 216 (268)
T ss_pred -CeEEEEECcccccc
Confidence 58999999988643
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.81 E-value=2e-07 Score=75.56 Aligned_cols=136 Identities=15% Similarity=0.259 Sum_probs=89.1
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccch------------HHHHHHHHHHHHhc--CCCCeeEeeeee
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK------------KKIKREIKILQNLC--GGPNVVKLLDIV 102 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------------~~~~~E~~~l~~l~--~h~~iv~~~~~~ 102 (338)
..+|.+.+.+-......|.+.. -+++.+++|..++..+ ....+++..+.++. .......++-..
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 5789999999888877777664 4678899998764321 11223333333331 222222222221
Q ss_pred ec---cCCCccEEEEeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccc
Q 019642 103 RD---QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
Q Consensus 103 ~~---~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~ 179 (338)
.- .-....+++|||++|..+.+... +++ .+...+.+++..+|+.|++|||++|.|++++.+ .++++|++.
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~--~i~iID~~~ 180 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN--GIRIIDTQG 180 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC--cEEEEECcc
Confidence 11 11123458999999998876632 332 244567788999999999999999999999976 599999976
Q ss_pred cc
Q 019642 180 AE 181 (338)
Q Consensus 180 ~~ 181 (338)
..
T Consensus 181 k~ 182 (229)
T PF06176_consen 181 KR 182 (229)
T ss_pred cc
Confidence 53
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.3e-07 Score=73.29 Aligned_cols=130 Identities=18% Similarity=0.276 Sum_probs=95.9
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeee
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 117 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~ 117 (338)
.-++.+.||+|.+|.||++.. .+..+++|+-+.. .+..+..|.++++.+....--++++.+-. ..+.|||.
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~------~~i~me~i 94 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGE------DFIRMEYI 94 (201)
T ss_pred hhhhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEech------hhhhhhhh
Confidence 446778999999999999976 4558999987754 46678999999999954444456666531 23569999
Q ss_pred cCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC-CCCeEecCCCCceEEEeccccc
Q 019642 118 NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVK-PHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 118 ~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dik-p~NIli~~~~~~~~l~dfg~~~ 181 (338)
.|..|.......+.. ....+++.-.-|-..||-|+.|+ |...++-.. +.+.|+||..++
T Consensus 95 ~G~~L~~~~~~~~rk----~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~-~~~~iIDFd~At 154 (201)
T COG2112 95 DGRPLGKLEIGGDRK----HLLRVLEKAYKLDRLGIEHGELSRPWKNVLVND-RDVYIIDFDSAT 154 (201)
T ss_pred cCcchhhhhhcccHH----HHHHHHHHHHHHHHhccchhhhcCCceeEEecC-CcEEEEEccchh
Confidence 998887775444333 34456676667888899999998 555555544 489999999986
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.1e-06 Score=73.07 Aligned_cols=130 Identities=18% Similarity=0.257 Sum_probs=80.3
Q ss_pred EeeeecCceeEEEEEEcCCCceEEEEEeccc-chHHHHHHHHHHHHhcCCC-CeeEeeeeeeccCCCccEEEEeeecCCc
Q 019642 44 RKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGP-NVVKLLDIVRDQHSKTPSLIFEYVNSTD 121 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~E~~~l~~l~~h~-~iv~~~~~~~~~~~~~~~lv~e~~~~~~ 121 (338)
..||+|..+.||+. .+..+++|..... ....+.+|.++++.+.... .+++.+.+..+ .....++||++.|..
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~--~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVED--GGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEec--CCeeeeeeeecCCcc
Confidence 57899999999984 2446788987653 3556789999999985332 25666776533 334568999999963
Q ss_pred -cccccC---------------------C-----CCHHH-HHHHHH----------HHHHH-HHHHHH----CCceeccC
Q 019642 122 -FKVLYP---------------------T-----LTDYD-IRYYIY----------ELLKA-LDYCHS----QGIMHRDV 158 (338)
Q Consensus 122 -l~~~~~---------------------~-----~~~~~-~~~i~~----------qi~~~-l~~lH~----~~i~H~di 158 (338)
+..... . .+... ...+.. .+... ..+|.. ..++|+|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 211110 0 01000 000100 01111 122221 14789999
Q ss_pred CCCCeEecCCCCceEEEeccccc
Q 019642 159 KPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 159 kp~NIli~~~~~~~~l~dfg~~~ 181 (338)
.|.||+++.+ + +.++||+.+.
T Consensus 161 ~~~Nii~~~~-~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGK-G-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCC-C-cEEEechhcC
Confidence 9999999987 5 8999999874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.59 E-value=7e-07 Score=82.33 Aligned_cols=135 Identities=16% Similarity=0.359 Sum_probs=88.1
Q ss_pred EeeeecCceeEEEEEEcCCCceEEEEEecccchHH-------------------------------------------HH
Q 019642 44 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-------------------------------------------IK 80 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-------------------------------------------~~ 80 (338)
..|+.++-|.||+|..+ +|+.||||+.++.-.+. +.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 78999999999999865 49999999986543222 23
Q ss_pred HHHHHHHHhc----CCCCeeEeeeeeeccCCCccEEEEeeecCCcccccc--C--CCCHHHHHHHHHHHHHH-HHHHHHC
Q 019642 81 REIKILQNLC----GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--P--TLTDYDIRYYIYELLKA-LDYCHSQ 151 (338)
Q Consensus 81 ~E~~~l~~l~----~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~--~~~~~~~~~i~~qi~~~-l~~lH~~ 151 (338)
.|...+.++. +.|++ ++-.++.+- ...-.++|||+.|..+.+.. + ..+... ++..++.+ +..+=..
T Consensus 210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~-t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~~d 284 (517)
T COG0661 210 REAANAERFRENFKDDPDV-YVPKVYWEY-TTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCCe-Eeceeehhc-cCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHHhc
Confidence 3444444332 22322 222222111 12346999999999887773 2 244333 33333332 2344458
Q ss_pred CceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 152 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 152 ~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
|+.|+|.+|.||+++.+ +.+.+.|||......+
T Consensus 285 gffHaDpHpGNi~v~~~-g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 GFFHADPHPGNILVRSD-GRIVLLDFGIVGRLDP 317 (517)
T ss_pred CccccCCCccceEEecC-CcEEEEcCcceecCCH
Confidence 99999999999999999 8999999999866543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.3e-06 Score=73.18 Aligned_cols=80 Identities=20% Similarity=0.397 Sum_probs=57.7
Q ss_pred EEeeeecCceeEEEEEEcCCCceEEEEEeccc-chHHHHHHHHHHHHhcCC-CCeeEeeeeeecc-CCCccEEEEeeecC
Q 019642 43 VRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGG-PNVVKLLDIVRDQ-HSKTPSLIFEYVNS 119 (338)
Q Consensus 43 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~E~~~l~~l~~h-~~iv~~~~~~~~~-~~~~~~lv~e~~~~ 119 (338)
++.|+.|..+.||++.... ..+++|..... ....+..|..+++.+.++ ..+++++...... .....+++|+++.|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 5789999999999997654 48899998765 556788999999988544 2356666643222 23346899999999
Q ss_pred Ccccc
Q 019642 120 TDFKV 124 (338)
Q Consensus 120 ~~l~~ 124 (338)
..+..
T Consensus 80 ~~~~~ 84 (239)
T PF01636_consen 80 RPLDD 84 (239)
T ss_dssp EEHHH
T ss_pred ccccc
Confidence 87777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.2e-06 Score=80.55 Aligned_cols=134 Identities=22% Similarity=0.302 Sum_probs=88.5
Q ss_pred EEeeeecCceeEEEEEEcCCCceEEEEEecccch----------------------------------HHHHH------H
Q 019642 43 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----------------------------------KKIKR------E 82 (338)
Q Consensus 43 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----------------------------------~~~~~------E 82 (338)
.+.||..+.|.|++|+.+. |+.||||+.++.-. +.+.. |
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 5789999999999998765 99999999765321 11222 3
Q ss_pred HHHHHHhc---CCCC------eeEeeeeeeccCCCccEEEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHH-HHH
Q 019642 83 IKILQNLC---GGPN------VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKAL-DYC 148 (338)
Q Consensus 83 ~~~l~~l~---~h~~------iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l-~~l 148 (338)
.+-..++. .|-+ |++++..+ .....++|||++|..+.+.- ..++...+ +..+.++. ..+
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~----st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i---~~~l~~~~~~qI 317 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDL----STKRVLTMEYVDGIKINDLDAIDKRGISPHDI---LNKLVEAYLEQI 317 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhc----CcceEEEEEecCCccCCCHHHHHHcCCCHHHH---HHHHHHHHHHHH
Confidence 22222221 2333 44554444 12457999999998776663 23565543 33333332 345
Q ss_pred HHCCceeccCCCCCeEecC---CCCceEEEecccccccc
Q 019642 149 HSQGIMHRDVKPHNVMIDH---ELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 149 H~~~i~H~dikp~NIli~~---~~~~~~l~dfg~~~~~~ 184 (338)
=..|.+|+|-.|.||++++ ....+.+.|+|+.....
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 5679999999999999984 34789999999986554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=4.2e-08 Score=89.71 Aligned_cols=242 Identities=16% Similarity=0.135 Sum_probs=162.8
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCC-eeEeeeeeeccCCCccEEEEee
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPN-VVKLLDIVRDQHSKTPSLIFEY 116 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~-iv~~~~~~~~~~~~~~~lv~e~ 116 (338)
.-+...+.+++|+++++++.+...++..+ .+++... -...-++++|.++ +||| .+..++.+ +.+....+.|++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--l~~rl~~eLLdK~-n~P~~~v~~~~d~--~~E~~~~i~~~i 315 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--LSRRLAIELLDKV-NNPNPVVRYLEDY--DGEDYLWIPMRI 315 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--hhhHHHHHHHHHc-cCCCCcccccccC--Ccccccchhhhh
Confidence 34566677889999999999877766655 6665544 3345689999999 9999 44544444 556678899999
Q ss_pred ecCC-ccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCccee
Q 019642 117 VNST-DFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 191 (338)
Q Consensus 117 ~~~~-~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~~ 191 (338)
+.++ +-..... .+..-+...+.+.-+.+++++|+..=+|+| ||+...+ ..+..||+.............
T Consensus 316 ~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~--~~~~~~~~v~~~L~~~~~~~t 389 (829)
T KOG0576|consen 316 CSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEE--EVKLLDFAVPPQLTRTMKPRT 389 (829)
T ss_pred hcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccccc--ccccccccCCcccCccccccc
Confidence 9887 2222211 144445566677778899999998777888 8877764 689999998876665555566
Q ss_pred eeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchh
Q 019642 192 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD 271 (338)
Q Consensus 192 ~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (338)
..+++.++|||+..+ ..+....|.|++|.-..++.-|-.|-- . +..... ..+.
T Consensus 390 ~~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~-~--P~~~~~----~~g~------------------- 442 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRS-S--PPAVLP----MIGN------------------- 442 (829)
T ss_pred CCCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCC-C--CccccC----CCCC-------------------
Confidence 788999999998876 678889999999987777776665531 1 000000 0000
Q ss_pred hhhccccCCCCcccccccCCCCCChhH-HHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 272 ALVGRHSRKPWSKFINADNQHLVSPEA-IDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~s~~l-~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
..+......... -+... .++...|+...|..|+....++.|.+|.+-
T Consensus 443 -------~p~s~~L~~~~a---w~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 443 -------GPNSPMLTDKSA---WSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred -------CCCccccchhhh---cCcccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 000000000000 11111 247788999999999999999999998864
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.8e-06 Score=71.83 Aligned_cols=77 Identities=22% Similarity=0.226 Sum_probs=54.5
Q ss_pred eeeecCc-eeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeecCCccc
Q 019642 45 KVGRGKY-SEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK 123 (338)
Q Consensus 45 ~lg~G~~-g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~ 123 (338)
.|..|.. +.||+... .+..+++|.........+..|+.+++.+.++-.+++++..... ....++|||++.|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSD--DGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEec--CCccEEEEEeeCCccHh
Confidence 4455555 78898854 3467888887654445678899999999656556677776643 24568999999998765
Q ss_pred cc
Q 019642 124 VL 125 (338)
Q Consensus 124 ~~ 125 (338)
..
T Consensus 81 ~~ 82 (244)
T cd05150 81 AL 82 (244)
T ss_pred Hh
Confidence 43
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.46 E-value=5.3e-07 Score=87.94 Aligned_cols=206 Identities=19% Similarity=0.235 Sum_probs=136.4
Q ss_pred HHHHHHHHHHhcCCCCeeEeeeeeeccCCCc--cEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 019642 79 IKREIKILQNLCGGPNVVKLLDIVRDQHSKT--PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGI 153 (338)
Q Consensus 79 ~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~--~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i 153 (338)
.+.|+..+.+. .|+|++.++.+-....... ..+..+++...++...+ ...+.+..+.+..+.++||.++|+...
T Consensus 229 ~E~e~~~l~k~-~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l 307 (1351)
T KOG1035|consen 229 TEIELESLSKI-AHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSL 307 (1351)
T ss_pred HHHHHHHHHhh-ccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence 45678888888 9999999988764332221 22344677766666555 358888999999999999999999966
Q ss_pred eeccCCCC---CeEecCCCCceEEE--eccccccccCCCcceeeeccccccccccccCc-CCCCCcchhHHHHHHHHHHH
Q 019642 154 MHRDVKPH---NVMIDHELRKLRLI--DWGLAEFYHPGKEYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMI 227 (338)
Q Consensus 154 ~H~dikp~---NIli~~~~~~~~l~--dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~ll 227 (338)
.|.-+..+ +--.+.+ +.+.++ ||+...................+-+||..... .......|+|++|.....+.
T Consensus 308 ~~v~L~~s~~~~~~~~~e-~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~ 386 (1351)
T KOG1035|consen 308 EHVVLSASSSKESTVDGE-GVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLS 386 (1351)
T ss_pred ceeEEecccccccccCcc-ceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhh
Confidence 66555544 2223333 445555 78777665554444444555567777776541 12334479999999999998
Q ss_pred hcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcC
Q 019642 228 FRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 307 (338)
Q Consensus 228 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~ 307 (338)
.|..+-..... .. ..+.. ....+..+.+.+|+.
T Consensus 387 ~~~~i~~~~~~----~~---~~l~~----------------------------------------~~~~~~~d~~~~~~~ 419 (1351)
T KOG1035|consen 387 QGEDISEKSAV----PV---SLLDV----------------------------------------LSTSELLDALPKCLD 419 (1351)
T ss_pred hcCcccccccc----hh---hhhcc----------------------------------------ccchhhhhhhhhhcc
Confidence 87655311000 00 00000 012267789999999
Q ss_pred CCcCCcCCHHHHhcCCCcchhhhccc
Q 019642 308 YDHQDRLTAREAMAHPYFAQVRAAES 333 (338)
Q Consensus 308 ~dP~~Rpt~~ell~hp~~~~~~~~~~ 333 (338)
-++++|+++.+++.|||.+.-....+
T Consensus 420 ~~~~~Rl~~~~ll~~~f~~~~~~~~~ 445 (1351)
T KOG1035|consen 420 EDSEERLSALELLTHPFLRFPTDNES 445 (1351)
T ss_pred hhhhhccchhhhhhchhccccccccc
Confidence 99999999999999999876654443
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.9e-05 Score=78.25 Aligned_cols=81 Identities=23% Similarity=0.328 Sum_probs=56.4
Q ss_pred EEEeeeecCceeEEEEEEcCCC--ceEEEEEeccc----chHHHHHHHHHHHHhcCCCCe--eEeeeeeeccC-CCccEE
Q 019642 42 VVRKVGRGKYSEVFEGINVNTN--ERCIIKILKPV----KKKKIKREIKILQNLCGGPNV--VKLLDIVRDQH-SKTPSL 112 (338)
Q Consensus 42 ~~~~lg~G~~g~V~~~~~~~~~--~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~i--v~~~~~~~~~~-~~~~~l 112 (338)
.++.++.|.++.+|+......+ ..+++|..... ....+.+|..+++.+..|+++ ++++.++.+.. ....++
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 3677899999999998654432 35677765431 235688999999999545554 77777764421 245789
Q ss_pred EEeeecCCcc
Q 019642 113 IFEYVNSTDF 122 (338)
Q Consensus 113 v~e~~~~~~l 122 (338)
|||++.|..+
T Consensus 122 VME~v~G~~~ 131 (822)
T PLN02876 122 IMEYLEGRIF 131 (822)
T ss_pred EEEecCCccc
Confidence 9999998754
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.6e-05 Score=66.84 Aligned_cols=77 Identities=12% Similarity=0.184 Sum_probs=48.5
Q ss_pred EEeeeecCce-eEEEEEEcCCCceEEEEEeccc-chHHHHHHHHHHHHhcCCC--CeeEeeeeeeccCC-CccEEEEeee
Q 019642 43 VRKVGRGKYS-EVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGP--NVVKLLDIVRDQHS-KTPSLIFEYV 117 (338)
Q Consensus 43 ~~~lg~G~~g-~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~E~~~l~~l~~h~--~iv~~~~~~~~~~~-~~~~lv~e~~ 117 (338)
++.++.|+.. .||+. +..+++|..+.. ....+..|..+++.+..+- .+++++......+. ...+++|+++
T Consensus 2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred ceeccCCCcccceEEc-----CCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 3567777776 48875 134778886653 3457889999999884331 34444443322111 2457899999
Q ss_pred cCCcccc
Q 019642 118 NSTDFKV 124 (338)
Q Consensus 118 ~~~~l~~ 124 (338)
.|.++..
T Consensus 77 ~G~~l~~ 83 (235)
T cd05155 77 EGETATA 83 (235)
T ss_pred cCCCCCc
Confidence 9987643
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.26 E-value=2.8e-05 Score=62.94 Aligned_cols=128 Identities=20% Similarity=0.378 Sum_probs=88.6
Q ss_pred EEeeeecCceeEEEEEEcCCCceEEEEEecccc-------------------hHHHHHHHHHHHHhc-----CCCCeeEe
Q 019642 43 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-------------------KKKIKREIKILQNLC-----GGPNVVKL 98 (338)
Q Consensus 43 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------------------~~~~~~E~~~l~~l~-----~h~~iv~~ 98 (338)
...||+|+.=.||.- +. ....+||+..+.. .++..+|+.....+. .+.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H--P~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC--CC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 356899999999864 33 3456799887665 577788988888883 26789999
Q ss_pred eeeeeccCCCccEEEEeeecCC------ccccccCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCC-
Q 019642 99 LDIVRDQHSKTPSLIFEYVNST------DFKVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL- 169 (338)
Q Consensus 99 ~~~~~~~~~~~~~lv~e~~~~~------~l~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~- 169 (338)
+++... ...+.+|+|...+. +|.+++.. ++. . +...+-+-..+|-+.+|+.+|++|.||++....
T Consensus 83 ~G~veT--~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 83 YGFVET--NLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred eEEEec--CCceEEEEEEEECCCCCcCccHHHHHHcCCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 999844 45667999987443 44455432 343 2 333344445678899999999999999995431
Q ss_pred -C-ceEEEe-ccc
Q 019642 170 -R-KLRLID-WGL 179 (338)
Q Consensus 170 -~-~~~l~d-fg~ 179 (338)
. .+.|+| ||.
T Consensus 157 ~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 157 GEFRLVLIDGLGE 169 (199)
T ss_pred CceEEEEEeCCCC
Confidence 2 577777 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.03 E-value=0.00012 Score=61.51 Aligned_cols=75 Identities=16% Similarity=0.297 Sum_probs=49.9
Q ss_pred EEeeeecCceeEEEEEEcC-CCceEEEEEecccch--HHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeecC
Q 019642 43 VRKVGRGKYSEVFEGINVN-TNERCIIKILKPVKK--KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS 119 (338)
Q Consensus 43 ~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~--~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 119 (338)
++.|..|-...+|++.... .++.+++|+...... -...+|..+++.+..+.-.++++... . . .++|||+.|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~--~--~~l~e~i~G 76 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF--Q--N--GLIYEFIPG 76 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe--C--C--cEEEEeeCC
Confidence 4677788888999986433 356788998764322 12347899999885444455655543 2 1 379999998
Q ss_pred Cccc
Q 019642 120 TDFK 123 (338)
Q Consensus 120 ~~l~ 123 (338)
.++.
T Consensus 77 ~~l~ 80 (235)
T cd05157 77 RTLE 80 (235)
T ss_pred CcCC
Confidence 7663
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.03 E-value=0.00024 Score=57.12 Aligned_cols=126 Identities=22% Similarity=0.272 Sum_probs=89.6
Q ss_pred CCcEEEEEeeeecCc-eeEEEEEEcCCCceEEEEEecc------------------------cchHHHHHHHHHHHHhcC
Q 019642 37 QDDYEVVRKVGRGKY-SEVFEGINVNTNERCIIKILKP------------------------VKKKKIKREIKILQNLCG 91 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~-g~V~~~~~~~~~~~~aiK~~~~------------------------~~~~~~~~E~~~l~~l~~ 91 (338)
..+++.++.||.|.. |.||++.. +|+.||+|+++. ...+.+..|.+...+|+.
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 489999999999999 99999965 678999999321 011336678888888753
Q ss_pred --CCCe--eEeeeeeecc----------------CCCccEEEEeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHC
Q 019642 92 --GPNV--VKLLDIVRDQ----------------HSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 151 (338)
Q Consensus 92 --h~~i--v~~~~~~~~~----------------~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 151 (338)
+.++ ++++++..-. ......||-|+..... .+... -+.+|+.-+..+|+.
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------~~~~~----~~~~~~~dl~~~~k~ 183 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------PLQIR----DIPQMLRDLKILHKL 183 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------ccchh----HHHHHHHHHHHHHHC
Confidence 3344 8999987321 0112346667665443 22332 356677888889999
Q ss_pred CceeccCCCCCeEecCCCCceEEEecccc
Q 019642 152 GIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
Q Consensus 152 ~i~H~dikp~NIli~~~~~~~~l~dfg~~ 180 (338)
||+-+|+++.|.. .-+|+|||.+
T Consensus 184 gI~~~Dv~~~ny~------~G~lvDfs~~ 206 (207)
T PF13095_consen 184 GIVPRDVKPRNYR------GGKLVDFSSS 206 (207)
T ss_pred CeeeccCcccccc------CCEEEecccC
Confidence 9999999999995 3489999864
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.00 E-value=5e-05 Score=61.14 Aligned_cols=95 Identities=23% Similarity=0.209 Sum_probs=77.8
Q ss_pred HHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeecCCccc-------cccCCCCHHHHHHHHHHHHHHHHHHHH--
Q 019642 80 KREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK-------VLYPTLTDYDIRYYIYELLKALDYCHS-- 150 (338)
Q Consensus 80 ~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~-------~~~~~~~~~~~~~i~~qi~~~l~~lH~-- 150 (338)
..|.-+++.+...+++++++|++ . ..++.||.+.+++. .+ -..++..+.+++.++++.+.+++.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C--G----~~~v~E~~~~~~~~~~~~~l~~~-~~~~w~~R~~iA~~lL~~l~~l~~~~ 79 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC--G----RFYVVEYVGAGSLYGIYRPLSQF-LQSPWEQRAKIALQLLELLEELDHGP 79 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC--C----CEEEEEeecCccccccccccccc-cccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 35888999996667999999998 2 25789999976543 22 246888999999999999999997
Q ss_pred -CCceeccCCCCCeEecCCCCceEEEecccccc
Q 019642 151 -QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
Q Consensus 151 -~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~ 182 (338)
..+.-.|++|+|+-++.+ +++|++|...+..
T Consensus 80 ~~~~~lcDv~~~nfgv~~~-~~lk~iDld~v~~ 111 (188)
T PF12260_consen 80 LGFFYLCDVSPDNFGVNDD-GRLKLIDLDDVFV 111 (188)
T ss_pred CCcEEEeecchHHeEEeCC-CcEEEEechhcch
Confidence 347888999999999987 8899999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00012 Score=62.30 Aligned_cols=127 Identities=22% Similarity=0.282 Sum_probs=76.0
Q ss_pred eeeecCceeEEEEEEcCCCceEEEEEecccchH---HHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeecCCc
Q 019642 45 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKK---KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD 121 (338)
Q Consensus 45 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~ 121 (338)
.+..|-.+.+|+.. .++..+++|........ ....|..+++.+..+.-.++++... . -++||||+.|..
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~----~~~v~e~i~G~~ 74 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E----HWLLVEWLEGEV 74 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C----CEEEEEeccCcc
Confidence 35567778899885 45667888876533211 3477999999985443334444433 2 258999999876
Q ss_pred ccccc-----------------CC-------CCH-HHHHHHHHHH---------HHHHHHHHHC--------CceeccCC
Q 019642 122 FKVLY-----------------PT-------LTD-YDIRYYIYEL---------LKALDYCHSQ--------GIMHRDVK 159 (338)
Q Consensus 122 l~~~~-----------------~~-------~~~-~~~~~i~~qi---------~~~l~~lH~~--------~i~H~dik 159 (338)
+.... .. ++. ..+..+..++ ...+..+... .++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 64320 00 111 1111211111 1112222221 48999999
Q ss_pred CCCeEecCCCCceEEEeccccc
Q 019642 160 PHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 160 p~NIli~~~~~~~~l~dfg~~~ 181 (338)
|.||+++.+ + +.++||..+.
T Consensus 155 ~~Nil~~~~-~-~~lIDwE~a~ 174 (256)
T TIGR02721 155 AYNLVVTPQ-G-LKLIDWEYAS 174 (256)
T ss_pred cCcEEEeCC-C-CEEEeccccC
Confidence 999999887 4 7899999875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00019 Score=62.54 Aligned_cols=137 Identities=15% Similarity=0.208 Sum_probs=85.3
Q ss_pred EEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCC-CeeEeeeeeec----cCCCccEEEEee
Q 019642 42 VVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGP-NVVKLLDIVRD----QHSKTPSLIFEY 116 (338)
Q Consensus 42 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~-~iv~~~~~~~~----~~~~~~~lv~e~ 116 (338)
-.+.+..|....+|+... .+..+++|+........+..|+.+++.+.++- .+++++....+ ...+..+.++++
T Consensus 18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred heecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 366787888889999854 33468899887655667888999999884332 24555442111 112346789999
Q ss_pred ecCCcccccc------------------CCCCH--------HHHHH------------HHHHHHHHHHHHHH-------C
Q 019642 117 VNSTDFKVLY------------------PTLTD--------YDIRY------------YIYELLKALDYCHS-------Q 151 (338)
Q Consensus 117 ~~~~~l~~~~------------------~~~~~--------~~~~~------------i~~qi~~~l~~lH~-------~ 151 (338)
++|..+.... ..+.. ..... ....+..++.++.+ .
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 9988764311 00000 00000 01112233444443 3
Q ss_pred CceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 152 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 152 ~i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
+++|+|+.|.||+++.+ +.+.|+||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~~-~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDGD-ELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeCC-ceEEEeehhhhc
Confidence 69999999999999986 556899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00028 Score=61.48 Aligned_cols=134 Identities=18% Similarity=0.262 Sum_probs=94.5
Q ss_pred EEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc------------------------h-----HHHHHHHHHHHHhc
Q 019642 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------------------------K-----KKIKREIKILQNLC 90 (338)
Q Consensus 40 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------------------------~-----~~~~~E~~~l~~l~ 90 (338)
-.+-.+|..|.-+.||.+. ..+|..+|||+++... + --...|++-|.++
T Consensus 146 ~~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl- 223 (520)
T KOG2270|consen 146 VEINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRL- 223 (520)
T ss_pred eecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHH-
Confidence 4567889999999999986 4567779999986321 1 1145688888888
Q ss_pred CCCCeeEeeeeeeccCCCccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCCeEec
Q 019642 91 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYC-HSQGIMHRDVKPHNVMID 166 (338)
Q Consensus 91 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~l-H~~~i~H~dikp~NIli~ 166 (338)
..-.|+-.-.+.. ..-.|||+++++..+..-. ..++...+..+-.|++.-+.-| |..++||.||.--|+|+.
T Consensus 224 ~~aGIP~PePIlL----k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 224 NNAGIPCPEPILL----KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH 299 (520)
T ss_pred HhcCCCCCCceee----ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE
Confidence 4444443333321 2346999999866543332 2366667777777777766554 566999999999999998
Q ss_pred CCCCceEEEeccccc
Q 019642 167 HELRKLRLIDWGLAE 181 (338)
Q Consensus 167 ~~~~~~~l~dfg~~~ 181 (338)
.+ .+.++|.+.+.
T Consensus 300 dG--~lyiIDVSQSV 312 (520)
T KOG2270|consen 300 DG--KLYIIDVSQSV 312 (520)
T ss_pred CC--EEEEEEccccc
Confidence 75 89999998764
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00045 Score=60.89 Aligned_cols=136 Identities=13% Similarity=0.208 Sum_probs=78.2
Q ss_pred EEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCC-CCeeEeeeeee----ccCCCccEEEEeee
Q 019642 43 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGG-PNVVKLLDIVR----DQHSKTPSLIFEYV 117 (338)
Q Consensus 43 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h-~~iv~~~~~~~----~~~~~~~~lv~e~~ 117 (338)
.+.++.|....+|+.... ++ .+++|++.....+.+..|..+++.|..+ -.+++++.... ....+..+++++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT-QG-EYVLTLFERLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred cchhccccccceEEEEeC-CC-cEEEEEeccCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 556777888899988643 33 6888987644456667778888777422 12334443210 01133468999999
Q ss_pred cCCcccccc------------------CCCC--------H---HH-HHH-----------HHHHHH-HHHHHHH------
Q 019642 118 NSTDFKVLY------------------PTLT--------D---YD-IRY-----------YIYELL-KALDYCH------ 149 (338)
Q Consensus 118 ~~~~l~~~~------------------~~~~--------~---~~-~~~-----------i~~qi~-~~l~~lH------ 149 (338)
+|..+.... ..++ . .. ... .+.+.+ ..+..+.
T Consensus 105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 184 (319)
T PRK05231 105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA 184 (319)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence 887542110 0010 0 00 000 111111 1122222
Q ss_pred -HCCceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 150 -SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 150 -~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
..+++|+|+.|.||+++.+ ....++||+.+.
T Consensus 185 lp~~liHgD~~~~Nil~~~~-~~~~iIDf~~~~ 216 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGD-RLSGFIDFYFAC 216 (319)
T ss_pred CCcccCCCCCCCCcEEEECC-ceEEEEeccccc
Confidence 2379999999999999865 445899999875
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00031 Score=63.13 Aligned_cols=78 Identities=17% Similarity=0.201 Sum_probs=54.5
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc----------cchHHHHHHHHHHHHhcCC--CCeeEeeeeeecc
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----------VKKKKIKREIKILQNLCGG--PNVVKLLDIVRDQ 105 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~----------~~~~~~~~E~~~l~~l~~h--~~iv~~~~~~~~~ 105 (338)
+..+ .+.||.|.+..||++.+...++.++||.-.+ ...+....|.+.|+.+... .++++++.+-
T Consensus 27 ~~~~-~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--- 102 (401)
T PRK09550 27 ALLT-AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--- 102 (401)
T ss_pred ccce-eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC---
Confidence 4444 5789999999999998865446899997432 1345567788888876433 3567777763
Q ss_pred CCCccEEEEeeecCC
Q 019642 106 HSKTPSLIFEYVNST 120 (338)
Q Consensus 106 ~~~~~~lv~e~~~~~ 120 (338)
....++|||++++.
T Consensus 103 -~~~~~lVME~L~~~ 116 (401)
T PRK09550 103 -EELAVTVMEDLSDH 116 (401)
T ss_pred -CCCCEEEEecCCCc
Confidence 23467999998763
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00057 Score=59.71 Aligned_cols=75 Identities=17% Similarity=0.232 Sum_probs=49.3
Q ss_pred EEeeeecCceeEEEEEEcC------CCceEEEEEecccc--hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 43 VRKVGRGKYSEVFEGINVN------TNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 43 ~~~lg~G~~g~V~~~~~~~------~~~~~aiK~~~~~~--~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
++.+..|-...+|+..... .++.+++|+..... .....+|..+++.+..+.-.++++..+. + ..|+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~----~~v~ 76 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP--N----GRIE 76 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC--C----Cchh
Confidence 4556667777888886533 25788999976532 2345789999998855444456666552 1 2578
Q ss_pred eeecCCccc
Q 019642 115 EYVNSTDFK 123 (338)
Q Consensus 115 e~~~~~~l~ 123 (338)
+++.|..+.
T Consensus 77 e~i~G~~l~ 85 (302)
T cd05156 77 EFIPSRTLT 85 (302)
T ss_pred heeCCCcCC
Confidence 998887654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00012 Score=62.76 Aligned_cols=132 Identities=19% Similarity=0.290 Sum_probs=94.4
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEec-------cc--c----------------hHHHHHHHHHHHHhcCCC
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-------PV--K----------------KKKIKREIKILQNLCGGP 93 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~-------~~--~----------------~~~~~~E~~~l~~l~~h~ 93 (338)
-+.+...||-|.-+.||.+.+. .|+..++|.-. .. . +=...+|...|+.|..|.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 4567889999999999999864 57788888632 00 0 112457888888885432
Q ss_pred -CeeEeeeeeeccCCCccEEEEeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCce
Q 019642 94 -NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKL 172 (338)
Q Consensus 94 -~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~ 172 (338)
.+++.++.. .-++|||.+.|-.|.....-..... +...+..-+.-|..+|++|||.+--||+++.+ +.+
T Consensus 172 fpVPkpiD~~------RH~Vvmelv~g~Pl~~v~~v~d~~~---ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd-~~i 241 (465)
T KOG2268|consen 172 FPVPKPIDHN------RHCVVMELVDGYPLRQVRHVEDPPT---LYDDLMGLIVRLANHGLIHGDFNEFNIMVKDD-DKI 241 (465)
T ss_pred CCCCCccccc------ceeeHHHhhcccceeeeeecCChHH---HHHHHHHHHHHHHHcCceecccchheeEEecC-CCE
Confidence 344444432 3478999999988877754444444 44455556677889999999999999999977 789
Q ss_pred EEEeccccc
Q 019642 173 RLIDWGLAE 181 (338)
Q Consensus 173 ~l~dfg~~~ 181 (338)
+++||-.+.
T Consensus 242 ~vIDFPQmv 250 (465)
T KOG2268|consen 242 VVIDFPQMV 250 (465)
T ss_pred EEeechHhh
Confidence 999997553
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.0012 Score=57.92 Aligned_cols=141 Identities=18% Similarity=0.267 Sum_probs=84.1
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-chHHHHHHHHHHHHhcCCC-CeeEeeeeeec----cCCCccE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGP-NVVKLLDIVRD----QHSKTPS 111 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~E~~~l~~l~~h~-~iv~~~~~~~~----~~~~~~~ 111 (338)
+.....+.++.|....+|+... .++ .+++|+.... ..+.+..|..++..|.++- .+++++..... ...+..+
T Consensus 22 ~~~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 22 GELLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred CCceeccccCCccccceEEEEe-CCC-cEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 3455577788888889998854 333 5778887653 3456778888888884221 24444442211 1134567
Q ss_pred EEEeeecCCcccccc------------------CCCCH-------HHHH----------------HHHHHHHHHHHHHHH
Q 019642 112 LIFEYVNSTDFKVLY------------------PTLTD-------YDIR----------------YYIYELLKALDYCHS 150 (338)
Q Consensus 112 lv~e~~~~~~l~~~~------------------~~~~~-------~~~~----------------~i~~qi~~~l~~lH~ 150 (338)
++++|++|..+.... ..++. ...+ .....+...+.++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 899999886543110 01100 0000 001112233444432
Q ss_pred -------CCceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 151 -------QGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 151 -------~~i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
.+++|+|+.+.|++++.+ +.+.++||+.+.
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~~~-~~~~vIDfd~~~ 216 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFDGD-SVKGVIDFYFAC 216 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEECC-ceEEEeeccccc
Confidence 579999999999999987 566899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0028 Score=55.05 Aligned_cols=140 Identities=20% Similarity=0.309 Sum_probs=82.5
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc-----cchHHHHHHHHHHHHhcCC-CCeeEeeeeeeccCCCccEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGG-PNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~-----~~~~~~~~E~~~l~~l~~h-~~iv~~~~~~~~~~~~~~~l 112 (338)
...+++.+..|....+|...+. ++.++++ ... .......+|..+++.+... -.+...++.+.+..-..++.
T Consensus 26 ~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~ 102 (321)
T COG3173 26 GLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY 102 (321)
T ss_pred CCceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence 4455555644544555665443 7778888 221 2234466789999988432 23344455553332236789
Q ss_pred EEeeecCCccccccCCCCHHHHHHHH-HHHHHHHHHHH------------------------------------------
Q 019642 113 IFEYVNSTDFKVLYPTLTDYDIRYYI-YELLKALDYCH------------------------------------------ 149 (338)
Q Consensus 113 v~e~~~~~~l~~~~~~~~~~~~~~i~-~qi~~~l~~lH------------------------------------------ 149 (338)
||+++.|..........+.. .+++ ..+...|..||
T Consensus 103 v~~~veGe~~~~~~~~~~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 103 VMEWVEGEVVWSALPPESLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred EEEEecceeccCcCCcccch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 99999986444333221111 1111 13333333333
Q ss_pred --------HC--------CceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 150 --------SQ--------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 150 --------~~--------~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
.+ .++|||+.+.|++++.+. .+-+.||+.+....
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~-~~gVlDwe~~~lGD 230 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGR-PTGVLDWELATLGD 230 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCC-eeEEEeccccccCC
Confidence 22 278999999999999984 49999999986543
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00027 Score=64.14 Aligned_cols=175 Identities=21% Similarity=0.189 Sum_probs=100.3
Q ss_pred hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 019642 76 KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMH 155 (338)
Q Consensus 76 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H 155 (338)
..++.-...+++.+ +|+|..++++.-....+ ...+|||+++..+-.....+. . ...+ .+ +|
T Consensus 26 s~~ilgr~~~lktl-~~~~l~~yl~~~r~~~~-r~IVV~e~~~~Sled~~~~~~-l-~~~s----~~-----------~~ 86 (725)
T KOG1093|consen 26 SIQILGRFQYLKSL-QHDNLCQYLDFSRGKHE-RVIVVMEHYTMSLEDILKTGN-L-KDES----LL-----------AH 86 (725)
T ss_pred HHHHhhhhHHHHhh-cCccceeeEeeecCccc-eEEEEehhhccchHHHHHhcc-c-chhh----hc-----------cc
Confidence 34566778899999 99999999998766544 377899998754432222111 0 0000 00 22
Q ss_pred ccCCCCCeEecCCCCceEEEeccccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcC
Q 019642 156 RDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 235 (338)
Q Consensus 156 ~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~ 235 (338)
+ +.+-| .++.+| .+.+. | | ....+++||||+|.++.++..|...+ .
T Consensus 87 ~-~~~~~--------~~~~td-~~~t~---------------~--~------~~~~pKsdVwsl~~i~~el~L~~~l~-~ 132 (725)
T KOG1093|consen 87 G-VLHLN--------IIYITD-HFLTK---------------Y--P------SPIGPKSDVWSLGFIILELYLGISLE-A 132 (725)
T ss_pred c-cceeh--------hhhccc-ccccc---------------C--C------CCCCcchhhhhHHHHHHHHHHhhHHH-H
Confidence 2 11112 223333 11100 0 1 11125999999999999999887665 2
Q ss_pred CCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCC
Q 019642 236 GHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT 315 (338)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt 315 (338)
.....+++..+.+..-.+.-........ .- .-..+..+.++.++|+-..|..||.
T Consensus 133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e~------~~-------------------~~~~d~~~~~~~~~c~~~~~~ir~l 187 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYTDDQELLSTAMEH------LI-------------------QLLADKKRLPLLKKCLWLEPIIRPL 187 (725)
T ss_pred HHHHHHHHHHHHHhccCchhHHHHHHHH------HH-------------------HHhhhHhHHHHhccCCccccccccc
Confidence 3333344443333322111111100000 00 0014677889999999999999999
Q ss_pred HHHHhcCCCcchh
Q 019642 316 AREAMAHPYFAQV 328 (338)
Q Consensus 316 ~~ell~hp~~~~~ 328 (338)
..++.+++-|.++
T Consensus 188 ~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 188 PMELSKRCSFTEV 200 (725)
T ss_pred hhHHhcCccHHHH
Confidence 9999999999887
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0018 Score=56.40 Aligned_cols=109 Identities=9% Similarity=0.092 Sum_probs=79.7
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-chHHHHHHHHHHHHhcCC--CCeeEeeeeeecc-CCCccEEEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGG--PNVVKLLDIVRDQ-HSKTPSLIF 114 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~E~~~l~~l~~h--~~iv~~~~~~~~~-~~~~~~lv~ 114 (338)
.-.-.+.||.|..+.||..... ++ .+.+|..+.. ....+..|...++.+..+ -.++++++.+... ..+..++||
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDS-QG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hhheeeecCCccceeEEEEEcC-CC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 4455789999999999998532 23 4677886652 456889999999999654 3678888876442 234578999
Q ss_pred eeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHC
Q 019642 115 EYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 151 (338)
Q Consensus 115 e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 151 (338)
|++.|.++.+. ..+......+..+++.+|..||+.
T Consensus 93 E~i~G~~~~~~--~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 93 ERLRGVSVEAP--ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred eccCCEecCCC--CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 99999887763 234445566777888999999975
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0025 Score=56.35 Aligned_cols=137 Identities=16% Similarity=0.252 Sum_probs=79.4
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCC---CceEEEEEecccchH--HHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPVKKK--KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~--~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
+..++ +.|..|-...+|++..... +..|++|+....... .-.+|..+++.+..+.--++++.++ .+ . +
T Consensus 15 ~~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~--~~--G--~ 87 (330)
T PLN02421 15 SDFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVF--GN--G--M 87 (330)
T ss_pred CceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEe--CC--c--E
Confidence 45554 4454577788998864432 347889987643221 1247889999885554445666665 22 2 5
Q ss_pred EEeeecCCccccc-------c----------C--CC-----C--HHHHHHHHHHH----------------------HHH
Q 019642 113 IFEYVNSTDFKVL-------Y----------P--TL-----T--DYDIRYYIYEL----------------------LKA 144 (338)
Q Consensus 113 v~e~~~~~~l~~~-------~----------~--~~-----~--~~~~~~i~~qi----------------------~~~ 144 (338)
|.+|+.+..+... . . .+ + ...+..+..++ ..-
T Consensus 88 i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 167 (330)
T PLN02421 88 IQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDE 167 (330)
T ss_pred eehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHH
Confidence 7888877655321 0 0 00 0 11122222111 111
Q ss_pred HHHHHH----CC----ceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 145 LDYCHS----QG----IMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 145 l~~lH~----~~----i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
+..+.+ .+ .+|+|+.+.||+++.+.+.++++||..+.
T Consensus 168 ~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 168 IVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 222221 12 79999999999997654689999999874
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0051 Score=54.71 Aligned_cols=137 Identities=18% Similarity=0.276 Sum_probs=82.4
Q ss_pred CcEEEEEeeeecCceeEEEEEEcC----CCceEEEEEecccchH--HHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVN----TNERCIIKILKPVKKK--KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~aiK~~~~~~~~--~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
+... +..|..|-...+|++.... .++.+++|+....... .-.+|..+++.+..+.--+++++.+ .++
T Consensus 37 ~~~~-i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~--~~g---- 109 (344)
T PLN02236 37 EALQ-VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRF--PNG---- 109 (344)
T ss_pred CcEE-EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEE--CCc----
Confidence 4444 4456568888999986432 2467899987643211 1257999999886655556777766 222
Q ss_pred EEEeeecCCccccc--c---------------CC--------C-CHHHHHHHHHH-----------------HHHHHHHH
Q 019642 112 LIFEYVNSTDFKVL--Y---------------PT--------L-TDYDIRYYIYE-----------------LLKALDYC 148 (338)
Q Consensus 112 lv~e~~~~~~l~~~--~---------------~~--------~-~~~~~~~i~~q-----------------i~~~l~~l 148 (338)
.|.+|+.+.++... . .. . ....+..+..+ +...+..|
T Consensus 110 ~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L 189 (344)
T PLN02236 110 RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLL 189 (344)
T ss_pred eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHH
Confidence 57899887765421 0 00 0 01122222211 11112222
Q ss_pred H--------HCCceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 149 H--------SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 149 H--------~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
. ...++|+|+++.||+++...+.+.++||..+.
T Consensus 190 ~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 190 EKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 12489999999999998754689999999875
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.014 Score=50.44 Aligned_cols=78 Identities=14% Similarity=0.190 Sum_probs=49.8
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhc--CCCCeeEeeeeeeccCCCccEEEEee
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLC--GGPNVVKLLDIVRDQHSKTPSLIFEY 116 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~--~h~~iv~~~~~~~~~~~~~~~lv~e~ 116 (338)
..+-.+.++.|..+.+|+.. .+++.+.+|+-.......+..|..-|+.|. ..-.+++++.+.... ...+++||+
T Consensus 18 ~i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~--~~~fLlle~ 93 (288)
T PF03881_consen 18 KITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD--DDAFLLLEF 93 (288)
T ss_dssp ---EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S--SCCEEEEE-
T ss_pred ceeeeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec--CCceEEEEe
Confidence 35667888889999999875 677889999987666778899999999983 233567777776443 345899999
Q ss_pred ecCC
Q 019642 117 VNST 120 (338)
Q Consensus 117 ~~~~ 120 (338)
++.+
T Consensus 94 l~~~ 97 (288)
T PF03881_consen 94 LEMG 97 (288)
T ss_dssp ----
T ss_pred ecCC
Confidence 8766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0092 Score=51.31 Aligned_cols=30 Identities=37% Similarity=0.716 Sum_probs=24.7
Q ss_pred CceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 152 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 152 ~i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
.++|+|++|.||+++.+....-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 389999999999999742345799999885
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.016 Score=52.27 Aligned_cols=79 Identities=16% Similarity=0.183 Sum_probs=49.5
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCC-c-----eEEEEEecccch--HHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTN-E-----RCIIKILKPVKK--KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~-~-----~~aiK~~~~~~~--~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
++.+ .+.|..|-...+|++...... . .|.++....... -.-.+|+.+++.+..+..-+++++.+ .+
T Consensus 51 ~~i~-i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f--~~--- 124 (383)
T PTZ00384 51 EFIE-IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRF--GD--- 124 (383)
T ss_pred ccEE-EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEec--CC---
Confidence 4455 445656888899998654321 2 244444322111 11246899999996666777888877 21
Q ss_pred cEEEEeeecCCccc
Q 019642 110 PSLIFEYVNSTDFK 123 (338)
Q Consensus 110 ~~lv~e~~~~~~l~ 123 (338)
+++.||+.|..+.
T Consensus 125 -g~l~efIeGr~l~ 137 (383)
T PTZ00384 125 -FTIQEWVEGNTMG 137 (383)
T ss_pred -EEEEEEeccccCC
Confidence 4899999988664
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0088 Score=52.85 Aligned_cols=71 Identities=18% Similarity=0.272 Sum_probs=46.3
Q ss_pred eeeecCceeEEEEEEcCCCceEEEEEecc----------cchHHHHHHHHHHHHhcC-CC-CeeEeeeeeeccCCCccEE
Q 019642 45 KVGRGKYSEVFEGINVNTNERCIIKILKP----------VKKKKIKREIKILQNLCG-GP-NVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 45 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~----------~~~~~~~~E~~~l~~l~~-h~-~iv~~~~~~~~~~~~~~~l 112 (338)
+||.|....||++.+...++.++||.-.+ ...++..-|...|+...+ .| .+++++.+= .....+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D----~e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD----TEMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc----ccccee
Confidence 67999999999999764446799996431 223455678888876633 23 355555542 234458
Q ss_pred EEeeecC
Q 019642 113 IFEYVNS 119 (338)
Q Consensus 113 v~e~~~~ 119 (338)
+||+++.
T Consensus 78 vMEdL~~ 84 (370)
T TIGR01767 78 VMEDLSH 84 (370)
T ss_pred hHhhCcc
Confidence 9999854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.013 Score=51.44 Aligned_cols=136 Identities=25% Similarity=0.309 Sum_probs=80.7
Q ss_pred EEeeeecCceeEEEEEEcCCCceEEEEEeccc-chHHHHHHHHHHHHhcCCCCee-Eee----eeeeccCC--CccEEEE
Q 019642 43 VRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVV-KLL----DIVRDQHS--KTPSLIF 114 (338)
Q Consensus 43 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~E~~~l~~l~~h~~iv-~~~----~~~~~~~~--~~~~lv~ 114 (338)
...|.+ .-..+|+.... ++. +++|+..+. ...++..|+..++.|.++.--| ..+ +-....-. ...+-+.
T Consensus 31 ~~~l~s-~eN~~f~~~~~-~g~-~iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf 107 (331)
T COG2334 31 LRGLNS-EENSNFRVQTE-DGR-YILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF 107 (331)
T ss_pred cccccc-ccCceEEEEec-CCC-eEEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence 344444 45678888643 333 499999875 7788899999999885432111 111 11111112 2567788
Q ss_pred eeecCCcccc-cc------------------CCCC-----------HH----H---------HHHHHHHHHHHHHHHHH-
Q 019642 115 EYVNSTDFKV-LY------------------PTLT-----------DY----D---------IRYYIYELLKALDYCHS- 150 (338)
Q Consensus 115 e~~~~~~l~~-~~------------------~~~~-----------~~----~---------~~~i~~qi~~~l~~lH~- 150 (338)
+|++|..+.. .. +.++ .. . -.....++...+..+.+
T Consensus 108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~ 187 (331)
T COG2334 108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR 187 (331)
T ss_pred EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence 9999988873 22 0011 00 0 00122233333444332
Q ss_pred -------CC--ceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 151 -------QG--IMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 151 -------~~--i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
-+ ++|+|+.|.||+++.+...+.++||+.+.
T Consensus 188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 23 99999999999999983348999999874
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0044 Score=51.06 Aligned_cols=55 Identities=13% Similarity=0.146 Sum_probs=33.6
Q ss_pred CceEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeecCCccc
Q 019642 63 NERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK 123 (338)
Q Consensus 63 ~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~ 123 (338)
.+.|++|+.... ..-.-..|..+++.+..+..-+++++.+.+ . .|.+|+.+..+.
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g--~v~e~i~g~~l~ 58 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFEN----G--RVEEFIEGRTLS 58 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----E--EEEE--SSEE--
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----C--cEEEEecccccC
Confidence 356788887654 223345788999988666666778887622 2 677999777653
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.00021 Score=72.45 Aligned_cols=193 Identities=11% Similarity=-0.037 Sum_probs=123.9
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCc-eEEEEEecccc--------hHHHHHHHHHHHHhcCCCCeeEeeeeeecc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNE-RCIIKILKPVK--------KKKIKREIKILQNLCGGPNVVKLLDIVRDQ 105 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~aiK~~~~~~--------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 105 (338)
++...+++.--++.|..+ ++...+... .+.+|+.+..+ ++....|.+.++.. .|+++.....-....
T Consensus 1226 s~~e~~EV~l~i~~~~~~---R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~-~h~~~~~~p~rI~ps 1301 (2724)
T KOG1826|consen 1226 SAMEHSEVNLGISNHFHF---RNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREA-KHYLTEVDPLRIPPS 1301 (2724)
T ss_pred HHhhhhheeeecccceee---ccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhh-hceeeecccccCCCC
Confidence 445666666666655433 333322222 24566665433 22233455555555 788887777655444
Q ss_pred CCCccEEEEeeecCCccccccCC-------CCHHHHHHHHHHHHHHHHHHHHC-C----ceeccCCCCCeEecCCCCceE
Q 019642 106 HSKTPSLIFEYVNSTDFKVLYPT-------LTDYDIRYYIYELLKALDYCHSQ-G----IMHRDVKPHNVMIDHELRKLR 173 (338)
Q Consensus 106 ~~~~~~lv~e~~~~~~l~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~-~----i~H~dikp~NIli~~~~~~~~ 173 (338)
.....+..++++.+|.+...+-+ +....+-....+.+.+..-+|.. + -+|.++|+-|.++..+ ..++
T Consensus 1302 ~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtn-y~v~ 1380 (2724)
T KOG1826|consen 1302 ESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTN-YNVK 1380 (2724)
T ss_pred CChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecC-Cccc
Confidence 44556688899988877666521 23333333334435666665644 2 6889999999999888 6899
Q ss_pred EEecccccc-ccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCC
Q 019642 174 LIDWGLAEF-YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 233 (338)
Q Consensus 174 l~dfg~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf 233 (338)
++++|+.+. -+.........+++.|+.|++... -..+.++|+|..|+.+|....|..+|
T Consensus 1381 ~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1381 LGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred ccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 999999983 222233344567788999988766 56777899999999999988777666
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.06 Score=48.62 Aligned_cols=72 Identities=18% Similarity=0.260 Sum_probs=49.9
Q ss_pred EEEeeeecCceeEEEEEEcCCCceEEEEEecc----------cchHHHHHHHHHHHHhcCC--CCeeEeeeeeeccCCCc
Q 019642 42 VVRKVGRGKYSEVFEGINVNTNERCIIKILKP----------VKKKKIKREIKILQNLCGG--PNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 42 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~----------~~~~~~~~E~~~l~~l~~h--~~iv~~~~~~~~~~~~~ 109 (338)
..+.||.|....||+..+. +..++||.-.+ ....+...|...|+.+.+. .++++++.+.. ..
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de----d~ 109 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR----TM 109 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC----CC
Confidence 4888999999999998763 44688887431 2334455667777766322 37778888763 33
Q ss_pred cEEEEeeecC
Q 019642 110 PSLIFEYVNS 119 (338)
Q Consensus 110 ~~lv~e~~~~ 119 (338)
.+++||++++
T Consensus 110 ~vlvME~L~~ 119 (418)
T PLN02756 110 ALIGMRYLEP 119 (418)
T ss_pred CEEEEeecCC
Confidence 5689999977
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.0078 Score=53.51 Aligned_cols=125 Identities=20% Similarity=0.210 Sum_probs=75.1
Q ss_pred EeeeecCceeEEEEEE---------------cCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeec----
Q 019642 44 RKVGRGKYSEVFEGIN---------------VNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRD---- 104 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~---------------~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~---- 104 (338)
..||+|+-+.||+|.- +...+.+|+|+.++...+.+...+.++.....-+|+++-..+..-
T Consensus 195 ~PIGsG~IAQVY~atl~~a~lekd~~~~~~~~~~tq~~AiKv~Hp~V~~~ir~Dl~Il~f~Akl~~~vP~l~wL~l~~~v 274 (565)
T KOG1236|consen 195 EPIGSGCIAQVYRATLKTAYLEKDSGKEYVQKLGTQSCAIKVLHPNVEKQIRLDLGILGFGAKLINNVPDLSWLSLPLEV 274 (565)
T ss_pred cccccchhhhhhhhhhhHHHhhcccchhhhcCCccceeeeeccCccHHHHHHHHHHHHhhhhhhhhhcCccccccCcchH
Confidence 4689999999998752 122456899999877766666665555544322222222111100
Q ss_pred ----------------------------------------cCCCccEEEEeeecCCccccccC--CCCHHHHHHHHHHHH
Q 019642 105 ----------------------------------------QHSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELL 142 (338)
Q Consensus 105 ----------------------------------------~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~ 142 (338)
+-.....++-+|..|-++..++. +.+++..+.++.-..
T Consensus 275 kqF~v~ln~QvdL~~EA~hL~rF~~NF~~s~~V~fP~P~~~~~~~~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~ 354 (565)
T KOG1236|consen 275 KQFSVGLNAQVDLRQEALHLPRFTNNFSGSKKVLFPKPIAPLHTDLVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGV 354 (565)
T ss_pred HHHHHHHHhhcchhhhhhhhHHHHHhcccceeecCCcccccccccceeeeeccccccHHhhhhcccChHHHHHHHHHHHH
Confidence 00011223445566666666654 356656667666666
Q ss_pred HHHHH-HHHCCceeccCCCCCeEecCC
Q 019642 143 KALDY-CHSQGIMHRDVKPHNVMIDHE 168 (338)
Q Consensus 143 ~~l~~-lH~~~i~H~dikp~NIli~~~ 168 (338)
.|+-. +--.+.+|.|+.|.||++..+
T Consensus 355 ~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 355 NALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred HHHHHHHHhhcceecccCCCcEEEEec
Confidence 66543 445689999999999999655
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.023 Score=49.82 Aligned_cols=30 Identities=20% Similarity=0.338 Sum_probs=26.7
Q ss_pred CceeccCCCCCeEecCCCCceEEEecccccc
Q 019642 152 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
Q Consensus 152 ~i~H~dikp~NIli~~~~~~~~l~dfg~~~~ 182 (338)
+++|+|+.+.|++++.+ +.+.++||..++.
T Consensus 197 ~lcHgD~~~~Nvl~~~~-~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDET-RGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCC-CCEEEEEhhhccc
Confidence 69999999999999887 6789999998753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.011 Score=53.05 Aligned_cols=78 Identities=21% Similarity=0.252 Sum_probs=50.9
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEec---------ccchHHHHHHHHHHHHhcC-CC-CeeEeeeeeecc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---------PVKKKKIKREIKILQNLCG-GP-NVVKLLDIVRDQ 105 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~---------~~~~~~~~~E~~~l~~l~~-h~-~iv~~~~~~~~~ 105 (338)
.+.+. .+.||.|.-..||++.+...++.++||.-. +-..++..-|.+.|+.+.+ .| ++++++.+=
T Consensus 29 ~~~~~-~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D--- 104 (409)
T PRK12396 29 AKGLQ-CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD--- 104 (409)
T ss_pred cccce-eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC---
Confidence 34555 788999999999999885445678998642 1234556678888887643 23 455555542
Q ss_pred CCCccEEEEeeecC
Q 019642 106 HSKTPSLIFEYVNS 119 (338)
Q Consensus 106 ~~~~~~lv~e~~~~ 119 (338)
.....+|||+++.
T Consensus 105 -~e~~~~vMEdL~~ 117 (409)
T PRK12396 105 -SVMNCCVMEDLSD 117 (409)
T ss_pred -cHHhhHHHHhCcc
Confidence 2334578888753
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.19 Score=44.40 Aligned_cols=72 Identities=17% Similarity=0.183 Sum_probs=42.9
Q ss_pred cCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCC-CeeEeee----eeeccCCCccEEEEeeecCCc
Q 019642 49 GKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGP-NVVKLLD----IVRDQHSKTPSLIFEYVNSTD 121 (338)
Q Consensus 49 G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~-~iv~~~~----~~~~~~~~~~~lv~e~~~~~~ 121 (338)
+.-..||+... .++..+++|+.++. ....+..|+..+..|..+. .++.... .+. ..+...+.++++++|..
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~-~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLH-EHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEE-EECCEEEEEEeeeCCCC
Confidence 34457888753 45667999988643 4567788999988884321 1222211 011 11235677889988764
Q ss_pred c
Q 019642 122 F 122 (338)
Q Consensus 122 l 122 (338)
.
T Consensus 114 ~ 114 (325)
T PRK11768 114 P 114 (325)
T ss_pred C
Confidence 3
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.24 Score=45.60 Aligned_cols=80 Identities=16% Similarity=0.207 Sum_probs=51.1
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCC--------CceEEEEEecccchH--HHHHHHHHHHHhcCCCCeeEeeeeeecc
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNT--------NERCIIKILKPVKKK--KIKREIKILQNLCGGPNVVKLLDIVRDQ 105 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~aiK~~~~~~~~--~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 105 (338)
..++. -++.|..|=.-.+|++..... ++.|++++....... .-..|..+++.+..+.--+++++.+ .
T Consensus 104 ~~~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f--~ 180 (442)
T PTZ00296 104 TEDDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTF--S 180 (442)
T ss_pred CcccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEe--C
Confidence 33455 677777777788898864421 567889987543221 1246888888885554445667665 2
Q ss_pred CCCccEEEEeeecCCcc
Q 019642 106 HSKTPSLIFEYVNSTDF 122 (338)
Q Consensus 106 ~~~~~~lv~e~~~~~~l 122 (338)
+ ..+.+|+.|..+
T Consensus 181 --g--g~I~efi~g~~l 193 (442)
T PTZ00296 181 --G--GRIEEWLYGDPL 193 (442)
T ss_pred --C--CEEEEeeCCccC
Confidence 1 267889887644
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.2 Score=51.31 Aligned_cols=137 Identities=19% Similarity=0.297 Sum_probs=76.3
Q ss_pred EeeeecCceeEEEEEEcCCCceEEEEEeccc-chHHHHHHHHHHHHhcCC-CC--eeEeeeee--------eccCC-Ccc
Q 019642 44 RKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGG-PN--VVKLLDIV--------RDQHS-KTP 110 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~E~~~l~~l~~h-~~--iv~~~~~~--------~~~~~-~~~ 110 (338)
+.|+ |..-.+|+... .++..+++|+.++. ....+..|...+..|.++ +. +++++... ....+ ...
T Consensus 31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~ 108 (1013)
T PRK06148 31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSEPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL 108 (1013)
T ss_pred eecC-CcCCceEEEEe-CCCCeEEEEEcCCccchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence 4564 34567788753 45668999998854 334555666777666432 22 33333211 11111 145
Q ss_pred EEEEeeecCCcccccc---------------------CCCC--------------------------HHHHHHHHHHHHH
Q 019642 111 SLIFEYVNSTDFKVLY---------------------PTLT--------------------------DYDIRYYIYELLK 143 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~---------------------~~~~--------------------------~~~~~~i~~qi~~ 143 (338)
+.+++|+.|..+.... +.++ ....+.++.+++.
T Consensus 109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~ 188 (1013)
T PRK06148 109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA 188 (1013)
T ss_pred EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence 6789999997765411 0000 0111222233333
Q ss_pred HHHH-----HHH--CCceeccCCCCCeEecCCC--CceEEEecccccc
Q 019642 144 ALDY-----CHS--QGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEF 182 (338)
Q Consensus 144 ~l~~-----lH~--~~i~H~dikp~NIli~~~~--~~~~l~dfg~~~~ 182 (338)
.... +.+ .+++|+|+++.||+++.+. ...-|+|||.+..
T Consensus 189 ~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 189 RFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 2221 211 4799999999999998762 2345999998753
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.14 E-value=0.16 Score=41.61 Aligned_cols=112 Identities=18% Similarity=0.262 Sum_probs=68.8
Q ss_pred cCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeecCCcccc
Q 019642 49 GKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 124 (338)
Q Consensus 49 G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~ 124 (338)
++.++.-.+... -|. ..+|++... ...-+..+..++.++ . .|+++.. .+.....++.|+|......
T Consensus 73 ~gNsTl~~~kt~-iG~-L~lKKi~slp~~~~~~~y~nky~v~Arm-h--GilrL~N----Dn~~~yGvIlE~Cy~~~i~- 142 (308)
T PF07387_consen 73 NGNSTLLIGKTK-IGP-LFLKKIRSLPCCINDALYFNKYRVFARM-H--GILRLKN----DNNYKYGVILERCYKIKIN- 142 (308)
T ss_pred CCceEEEEeccc-cch-hhhhhccCCCcccchhhhhhhhhHHHHh-h--heeEeec----CCCceeEEEEeeccCcccc-
Confidence 344454444322 233 445555432 234467788888887 2 4676662 3445567888988643211
Q ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCCCCeEecCCCCceEEEecccc
Q 019642 125 LYPTLTDYDIRYYIYELLKALDYCHSQ--GIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
Q Consensus 125 ~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dikp~NIli~~~~~~~~l~dfg~~ 180 (338)
+. .++..=+.+|.-.|+. +..|||..|+||+-|.. |.+||.|-+..
T Consensus 143 -----~~----N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~-G~lKlVDP~~L 190 (308)
T PF07387_consen 143 -----FS----NFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKF-GYLKLVDPVCL 190 (308)
T ss_pred -----hh----HHHHHhHHHHHHhhccCCCeecCCCChhheeecCC-CCEEecChhhh
Confidence 11 1111124567778854 79999999999999999 89999997743
|
The function of this family is unknown. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.90 E-value=0.15 Score=45.03 Aligned_cols=102 Identities=19% Similarity=0.293 Sum_probs=66.3
Q ss_pred CccEEEEeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 108 KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
.+.|++|++.++.. . .+.....+++..++.+.+..+.-+.+. ..-|+++.-.||+++ + |++.|+||.+++.-.++
T Consensus 299 ~y~yl~~kdhgt~i-s-~ik~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~-GnvtLIDfklsRl~~~q 374 (488)
T COG5072 299 LYLYLHFKDHGTPI-S-IIKADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-E-GNVTLIDFKLSRLSYSQ 374 (488)
T ss_pred eEEEEEEecCCcee-e-eeecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-c-CceEEEEeeeeecccCC
Confidence 34556666654432 2 223345677888899999888888876 689999999999999 5 79999999999743222
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHH
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 219 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl 219 (338)
..... ...--|-.+.| ..+.+-+||-+
T Consensus 375 ~~isy----~rldhp~lF~G--~dd~QFeIYrl 401 (488)
T COG5072 375 GIISY----NRLDHPDLFNG--VDDYQFEIYRL 401 (488)
T ss_pred ceeec----cccCchhhhcC--ccceeeeHHHH
Confidence 21111 11223444444 33667777765
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.48 E-value=0.31 Score=40.29 Aligned_cols=81 Identities=15% Similarity=0.203 Sum_probs=52.5
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCC--CCeeEeeeeeeccCCCccEEEEee
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGG--PNVVKLLDIVRDQHSKTPSLIFEY 116 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h--~~iv~~~~~~~~~~~~~~~lv~e~ 116 (338)
+.+..+++.-|.--..|...+ ....+.+|+-.......+..|+.-|..+... -.+++++..- ....+.++||||
T Consensus 17 ~i~er~~v~gG~inea~~v~d--g~~~~FvK~n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G--~~~~~sylVle~ 92 (286)
T COG3001 17 EIKEREEVSGGDINEAWRLRD--GTDPFFVKCNQREQLSMFTAEADGLELLARSNTITVPKVIAVG--ASRDHSYLVLEY 92 (286)
T ss_pred hhhcccccCCccccceeEeec--CCcceEEEecchhhHHHHHHHHHHHHHHHhcCCccccceEEec--CCCCeeEEEEee
Confidence 444455565555556666643 4456888876655567778888888777432 3455666554 446788999999
Q ss_pred ecCCccc
Q 019642 117 VNSTDFK 123 (338)
Q Consensus 117 ~~~~~l~ 123 (338)
+..+.+.
T Consensus 93 L~~~~~d 99 (286)
T COG3001 93 LPTGPLD 99 (286)
T ss_pred ccCCCCC
Confidence 9876554
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 338 | ||||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-159 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-159 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-159 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-158 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-158 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-157 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-156 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-156 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-155 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-155 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-128 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-127 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-127 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-127 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-127 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-127 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-127 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-127 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-127 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-127 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-127 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-127 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-127 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-127 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-126 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-124 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-123 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-36 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-36 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-35 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-34 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-32 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-32 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-32 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-32 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-32 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-32 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-32 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-32 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-32 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-32 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-32 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-32 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-32 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-32 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-32 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-32 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-32 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-32 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-32 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-32 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-32 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-32 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-32 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-31 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-31 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-31 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-31 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-31 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-31 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-31 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-31 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-31 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-31 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-31 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-31 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-31 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-31 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-31 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-31 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-31 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-31 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-31 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-31 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-31 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-31 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-31 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-31 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-31 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-31 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-31 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-31 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-31 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-31 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-31 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-31 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-31 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-31 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-31 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-31 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-30 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-30 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-30 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-30 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-28 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-28 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-28 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-28 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-28 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-28 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-28 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-28 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-27 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-27 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-27 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-27 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-27 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-27 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-27 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-27 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-27 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-27 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-27 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-27 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-27 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-27 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-27 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-27 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-27 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-27 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-27 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-27 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-27 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-27 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-27 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-27 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-27 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-27 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-27 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-26 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-26 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-26 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-26 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-26 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-26 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-26 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-26 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-26 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-26 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-26 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-26 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-26 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-26 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-26 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-26 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-26 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-26 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-26 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-26 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-26 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-26 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-26 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-26 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-26 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-26 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-26 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-26 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-26 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-26 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-26 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-26 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-26 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-26 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-26 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-26 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-26 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-26 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-26 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-26 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-26 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-26 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-26 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-26 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-26 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-26 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-26 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-26 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-26 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-26 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-26 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-26 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-26 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-26 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-26 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-25 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-25 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-25 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-25 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-25 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-25 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-25 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-25 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-24 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-23 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-23 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-23 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-23 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-23 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-23 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-23 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-23 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-22 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-22 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-22 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-22 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-22 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-21 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-21 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-21 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-21 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-21 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-21 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-21 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-21 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-21 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-21 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-21 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-21 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-21 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-21 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-21 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-21 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-21 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-21 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-21 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-21 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-21 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-21 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-21 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-21 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-21 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-21 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-21 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-21 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-21 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-21 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-20 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-20 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-20 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-20 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-20 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-20 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-18 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-17 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-17 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 8e-17 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-16 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-16 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-16 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-16 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-16 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-16 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-15 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-15 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-14 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-14 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-14 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 4e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-14 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-13 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-13 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-13 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-13 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-12 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-12 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-12 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-12 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-11 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-11 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-11 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-11 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-11 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-11 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-11 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 6e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-11 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 7e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-11 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 7e-11 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-11 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-11 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 9e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-08 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-08 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-07 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-06 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-06 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-05 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-05 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-05 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-05 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-05 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-05 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-05 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-05 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-05 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-05 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-05 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-05 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-05 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-05 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 6e-05 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 7e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 8e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-04 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-04 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 1e-04 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-04 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-04 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-04 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-04 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 2e-04 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-04 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-04 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-04 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-04 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 3e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-04 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-04 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-04 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-04 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-04 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-04 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-04 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-04 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-04 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-04 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-04 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-04 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-04 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-04 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-04 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-04 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-04 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-04 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-04 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-04 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-04 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-04 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-04 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-04 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-04 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-04 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-04 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-04 |
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 521 bits (1345), Expect = 0.0
Identities = 229/309 (74%), Positives = 275/309 (88%), Gaps = 1/309 (0%)
Query: 25 FWNVSSYVI-FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREI 83
+W+ S+V+ + +QDDY++VRK+GRGKYSEVFE IN+ NE+ ++KILKPVKKKKIKREI
Sbjct: 22 YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREI 81
Query: 84 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 143
KIL+NL GGPN++ L DIV+D S+TP+L+FE+VN+TDFK LY TLTDYDIR+Y+YE+LK
Sbjct: 82 KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK 141
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
ALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG+EYNVRVASRYFKGPEL
Sbjct: 142 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 201
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
LVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV+IAKVLGT++L Y++KY+
Sbjct: 202 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
+ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDKLLRYDHQ RLTAREAM HP
Sbjct: 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 321
Query: 324 YFAQVRAAE 332
YF V +
Sbjct: 322 YFYTVVKDQ 330
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 1e-78
Identities = 96/309 (31%), Positives = 151/309 (48%), Gaps = 27/309 (8%)
Query: 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGP 93
+ Y + +G G + V++ ++ E IK + K+ K RE++I++ L
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-RELQIMRKL-DHC 107
Query: 94 NVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVLYP------TLTDYDIRYYIYELLK 143
N+V+L K L+ +YV T ++V TL ++ Y+Y+L +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
+L Y HS GI HRD+KP N+++D + L+L D+G A+ G+ + SRY++ PEL
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 227
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLN 260
+ DY S+D+WS GC+ A ++ + P F G DQLV+I KVLGT +++
Sbjct: 228 IFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 286
Query: 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 320
Y PQ+ PW+K PEAI +LL Y RLT EA
Sbjct: 287 NYTEFKFPQI-------KAHPWTKVFRPR----TPPEAIALCSRLLEYTPTARLTPLEAC 335
Query: 321 AHPYFAQVR 329
AH +F ++R
Sbjct: 336 AHSFFDELR 344
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 5e-77
Identities = 101/309 (32%), Positives = 158/309 (51%), Gaps = 28/309 (9%)
Query: 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGP 93
+ Y + +G G + VF+ V ++E I K+L+ K+ RE++I++ + P
Sbjct: 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD--KRFKNRELQIMRIV-KHP 92
Query: 94 NVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVL--YP----TLTDYDIRYYIYELLK 143
NVV L K L+ EYV T ++ Y T+ I+ Y+Y+LL+
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
+L Y HS GI HRD+KP N+++D L+LID+G A+ G+ + SRY++ PEL
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPEL 212
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLN 260
+ +Y ++D+WS GC+ A ++ + P F G DQLV+I KVLGT +++
Sbjct: 213 IFGATNYTTNIDIWSTGCVMAELMQGQ-PLFPGESGIDQLVEIIKVLGTPSREQIKTMNP 271
Query: 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 320
Y PQ+ P+SK P+AID + +LL Y RLTA EA+
Sbjct: 272 NYMEHKFPQI-------RPHPFSKVFRPR----TPPDAIDLISRLLEYTPSARLTAIEAL 320
Query: 321 AHPYFAQVR 329
HP+F ++R
Sbjct: 321 CHPFFDELR 329
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 3e-75
Identities = 84/314 (26%), Positives = 146/314 (46%), Gaps = 28/314 (8%)
Query: 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK--ILKPVKKKKIKREIKILQNLCG 91
+ D ++V R G+G + V G +T IK I P + + + ++ L L
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-H 77
Query: 92 GPNVVKLLDIVRDQHSKTPS-----LIFEYVNSTDFKVL--YP----TLTDYDIRYYIYE 140
PN+V+L + ++ EYV T + Y I+ ++++
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 141 LLKALDYCH--SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF 198
L++++ H S + HRD+KPHNV+++ L+L D+G A+ P + + SRY+
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYY 197
Query: 199 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DEL 255
+ PEL+ Q Y ++D+WS+GC+FA M+ + P F G ++ QL +I +VLG + L
Sbjct: 198 RAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE-PIFRGDNSAGQLHEIVRVLGCPSREVL 256
Query: 256 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT 315
+ PWS + + + EA D L LL+Y ++R+
Sbjct: 257 RKLNPSHTDVDLYNS-------KGIPWSNVFSDHSLKD-AKEAYDLLSALLQYLPEERMK 308
Query: 316 AREAMAHPYFAQVR 329
EA+ HPYF ++
Sbjct: 309 PYEALCHPYFDELH 322
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 5e-72
Identities = 94/336 (27%), Positives = 156/336 (46%), Gaps = 61/336 (18%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLL 99
Y + + +G G + V E ++ + +R +K + + K RE+ I++ L N++KL+
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN-RELDIMKVLDH-VNIIKLV 66
Query: 100 DIVRDQHSKTPS------------------------------------LIFEYVNSTDFK 123
D + P +I EYV T K
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126
Query: 124 VLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW 177
VL ++ I YIY+L +A+ + HS GI HRD+KP N++++ + L+L D+
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDF 186
Query: 178 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 237
G A+ P + + SR+++ PEL++ +Y S+D+WS+GC+F +I K P F G
Sbjct: 187 GSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK-PLFSGE 245
Query: 238 DNHDQLVKIAKVLGT---DELNAYLNKYHLELDPQLDALVGRHSRKPWSK-FINADNQHL 293
+ DQLV+I +++GT +++ Y P L K W K
Sbjct: 246 TSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTL-------KAKDWRKILPEGTP--- 295
Query: 294 VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329
AID L+++LRY+ R+ EAMAHP+F +R
Sbjct: 296 --SLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLR 329
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 5e-69
Identities = 91/312 (29%), Positives = 145/312 (46%), Gaps = 36/312 (11%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIK 84
+ YE + K+G G Y VF+ N +T + IK K REI+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK--------KFLESEDDPVIKKIALREIR 54
Query: 85 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPT-LTDYDIRYYIYEL 141
+L+ L PN+V LL++ R + L+FEY + T L Y + ++ ++ ++
Sbjct: 55 MLKQLKH-PNLVNLLEVFR--RKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQT 111
Query: 142 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKG 200
L+A+++CH +HRDVKP N++I ++L D+G A P Y+ VA+R+++
Sbjct: 112 LQAVNFCHKHNCIHRDVKPENILITKH-SVIKLCDFGFARLLTGPSDYYDDEVATRWYRS 170
Query: 201 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 260
PELLV Y +D+W++GC+FA ++ P + G + DQL I K LG L
Sbjct: 171 PELLVGDTQYGPPVDVWAIGCVFAELL-SGVPLWPGKSDVDQLYLIRKTLGD------LI 223
Query: 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 320
H ++ G P +S A+ L L D +RLT + +
Sbjct: 224 PRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283
Query: 321 AHPYFAQVRAAE 332
HPYF +R E
Sbjct: 284 HHPYFENIREIE 295
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 3e-67
Identities = 91/313 (29%), Positives = 144/313 (46%), Gaps = 30/313 (9%)
Query: 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-IK----REIKILQN 88
F + YE + VG G Y V + N +T IK K +K REIK+L+
Sbjct: 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80
Query: 89 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPT-LTDYDIRYYIYELLKAL 145
L N+V LL++ + K L+FE+V+ T L +P L ++ Y+++++ +
Sbjct: 81 LRH-ENLVNLLEVCK--KKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI 137
Query: 146 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELL 204
+CHS I+HRD+KP N+++ ++L D+G A PG+ Y+ VA+R+++ PELL
Sbjct: 138 GFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELL 196
Query: 205 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT-DELN----AYL 259
V Y ++D+W++GC+ M F EP F G + DQL I LG +
Sbjct: 197 VGDVKYGKAVDVWAIGCLVTEM-FMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255
Query: 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 319
+ P+ R+P + +S ID K L D R E
Sbjct: 256 PVFAGVRLPE------IKEREPLERRYPK-----LSEVVIDLAKKCLHIDPDKRPFCAEL 304
Query: 320 MAHPYFAQVRAAE 332
+ H +F AE
Sbjct: 305 LHHDFFQMDGFAE 317
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 1e-65
Identities = 90/320 (28%), Positives = 156/320 (48%), Gaps = 51/320 (15%)
Query: 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------R 81
+ D Y + K+G G Y EV++ I+ TNE V K+I+ R
Sbjct: 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNET--------VAIKRIRLEHEEEGVPGTAIR 82
Query: 82 EIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYI 138
E+ +L+ L N+++L ++ H LIFEY D K P ++ I+ ++
Sbjct: 83 EVSLLKELQH-RNIIELKSVIHHNHRLH--LIFEYA-ENDLKKYMDKNPDVSMRVIKSFL 138
Query: 139 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRK----LRLIDWGLAEFYH-PGKEYNVRV 193
Y+L+ +++CHS+ +HRD+KP N+++ L++ D+GLA + P +++ +
Sbjct: 139 YQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEI 198
Query: 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT- 252
+ +++ PE+L+ + Y S+D+WS+ C++A M+ K P F G DQL KI +VLG
Sbjct: 199 ITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML-MKTPLFPGDSEIDQLFKIFEVLGLP 257
Query: 253 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLV----SPEAIDFLDKLLRY 308
D+ P + AL P KF + ++ E +D L +L
Sbjct: 258 DD----------TTWPGVTALPDWKQSFP--KFRGKTLKRVLGALLDDEGLDLLTAMLEM 305
Query: 309 DHQDRLTAREAMAHPYFAQV 328
D R++A+ A+ HPYF+
Sbjct: 306 DPVKRISAKNALEHPYFSHN 325
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 2e-65
Identities = 91/311 (29%), Positives = 152/311 (48%), Gaps = 43/311 (13%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIK 84
YE + K+G G Y VF+ N T+E V K+++ REI
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEI--------VALKRVRLDDDDEGVPSSALREIC 53
Query: 85 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYE 140
+L+ L N+V+L D++ T L+FE+ D K L ++ ++++
Sbjct: 54 LLKELKH-KNIVRLHDVLHSDKKLT--LVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQ 109
Query: 141 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFK 199
LLK L +CHS+ ++HRD+KP N++I+ +L+L ++GLA + P + Y+ V + +++
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYR 168
Query: 200 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT-DELNAY 258
P++L + Y S+DMWS GC+FA + P F G+D DQL +I ++LGT E
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE---- 224
Query: 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQ-HLVSPEAIDFLDKLLRYDHQDRLTAR 317
E P + L + + N ++ D L LL+ + R++A
Sbjct: 225 ------EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAE 278
Query: 318 EAMAHPYFAQV 328
EA+ HPYF+
Sbjct: 279 EALQHPYFSDF 289
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 5e-65
Identities = 85/320 (26%), Positives = 161/320 (50%), Gaps = 47/320 (14%)
Query: 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK------------RE 82
S ++ + K+G G Y+ V++G+N T V K++K RE
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVY--------VALKEVKLDSEEGTPSTAIRE 53
Query: 83 IKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV--------NSTDFKVLYPTLTDYDI 134
I +++ L N+V+L D++ ++ T L+FE++ +S L +
Sbjct: 54 ISLMKELKH-ENIVRLYDVIHTENKLT--LVFEFMDNDLKKYMDSRTVGNTPRGLELNLV 110
Query: 135 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRV 193
+Y+ ++LL+ L +CH I+HRD+KP N++I+ + L+L D+GLA + P ++ V
Sbjct: 111 KYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ-LKLGDFGLARAFGIPVNTFSSEV 169
Query: 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT- 252
+ +++ P++L+ + Y S+D+WS GC+ A MI +P F G ++ +QL I ++GT
Sbjct: 170 VTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI-TGKPLFPGTNDEEQLKLIFDIMGTP 228
Query: 253 DELN----AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRY 308
+E L KY+ + + + + + + + +DFL LL+
Sbjct: 229 NESLWPSVTKLPKYNPNIQQR--------PPRDLRQVLQPHTKEPLDGNLMDFLHGLLQL 280
Query: 309 DHQDRLTAREAMAHPYFAQV 328
+ RL+A++A+ HP+FA+
Sbjct: 281 NPDMRLSAKQALHHPWFAEY 300
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 9e-65
Identities = 81/318 (25%), Positives = 146/318 (45%), Gaps = 37/318 (11%)
Query: 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLC 90
F Y ++ +G G VF ++ + ++R IK + P K REIKI++ L
Sbjct: 7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL- 65
Query: 91 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP-------------TLTDYDIRYY 137
N+VK+ +I+ S+ + ++ L + R +
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLF 125
Query: 138 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----V 193
+Y+LL+ L Y HS ++HRD+KP N+ I+ E L++ D+GLA P + +
Sbjct: 126 MYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185
Query: 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT- 252
+++++ P LL+ +Y ++DMW+ GC+FA M+ K F G +Q+ I + +
Sbjct: 186 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-TLFAGAHELEQMQLILESIPVV 244
Query: 253 --DELNAYLNKYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYD 309
++ L+ + + KP ++ EA+DFL+++L +
Sbjct: 245 HEEDRQELLSVIPVYIRND-----MTEPHKPLTQLLPGIS------REAVDFLEQILTFS 293
Query: 310 HQDRLTAREAMAHPYFAQ 327
DRLTA EA++HPY +
Sbjct: 294 PMDRLTAEEALSHPYMSI 311
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 3e-64
Identities = 90/306 (29%), Positives = 156/306 (50%), Gaps = 30/306 (9%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK----KKIKREIKILQNLCGG 92
Y VG G Y V I+ + E+ IK + +P + K+ RE+ +L+++
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH- 82
Query: 93 PNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYC 148
NV+ LLD+ S L+ ++ + K++ ++ I+Y +Y++LK L Y
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYI 142
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDL 207
HS G++HRD+KP N+ ++ + +L+++D+GLA Y V +R+++ PE+++
Sbjct: 143 HSAGVVHRDLKPGNLAVNEDC-ELKILDFGLARHADAEMTGY---VVTRWYRAPEVILSW 198
Query: 208 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKYHL 264
Y+ ++D+WS+GC+ A M+ K F G D DQL +I KV G + + +K
Sbjct: 199 MHYNQTVDIWSVGCIMAEMLTGK-TLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 257
Query: 265 ELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
L + RK +++ F A P+A D L+K+L D RLTA +A+ HP
Sbjct: 258 SYIQSL----PQTPRKDFTQLFPRAS------PQAADLLEKMLELDVDKRLTAAQALTHP 307
Query: 324 YFAQVR 329
+F R
Sbjct: 308 FFEPFR 313
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 203 bits (520), Expect = 6e-64
Identities = 81/327 (24%), Positives = 140/327 (42%), Gaps = 60/327 (18%)
Query: 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK------------- 80
YE V ++G G Y V++ + ++ V K ++
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHF--------VALKSVRVPNGGGGGGGLPI 56
Query: 81 ---REIKILQNLCGG--PNVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVL-----YP 127
RE+ +L+ L PNVV+L+D+ + L+FE+V D + P
Sbjct: 57 STVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPP 115
Query: 128 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187
L I+ + + L+ LD+ H+ I+HRD+KP N+++ ++L D+GLA Y
Sbjct: 116 GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-GTVKLADFGLARIYSYQM 174
Query: 188 EYNVRVASRYFKGPELLVDLQD-YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 246
V + +++ PE+L LQ Y +DMWS+GC+FA M FR++P F G+ DQL KI
Sbjct: 175 ALTPVVVTLWYRAPEVL--LQSTYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKI 231
Query: 247 AKVLGT-DELN----AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDF 301
++G E + L + +P + +
Sbjct: 232 FDLIGLPPEDDWPRDVSLPRGAFP----------PRGPRPVQSVVPE-----MEESGAQL 276
Query: 302 LDKLLRYDHQDRLTAREAMAHPYFAQV 328
L ++L ++ R++A A+ H Y +
Sbjct: 277 LLEMLTFNPHKRISAFRALQHSYLHKD 303
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 8e-64
Identities = 86/313 (27%), Positives = 157/313 (50%), Gaps = 48/313 (15%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK------------REIKI 85
+ Y + K+G G Y+ V++G + T+ V K+I+ RE+ +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNL--------VALKEIRLEHEEGAPCTAIREVSL 53
Query: 86 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYEL 141
L++L N+V L DI+ + S T L+FEY++ D K + ++++ ++++L
Sbjct: 54 LKDLKH-ANIVTLHDIIHTEKSLT--LVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQL 109
Query: 142 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKG 200
L+ L YCH Q ++HRD+KP N++I+ +L+L D+GLA P K Y+ V + +++
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINER-GELKLADFGLARAKSIPTKTYDNEVVTLWYRP 168
Query: 201 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT-DELN--- 256
P++L+ DY +DMW +GC+F M + P F G +QL I ++LGT E
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGR-PLFPGSTVEEQLHFIFRILGTPTEETWPG 227
Query: 257 -AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT 315
++ P+ + + + + D L KLL+++ ++R++
Sbjct: 228 ILSNEEFKTYNYPK-------YRAEALLSHAPR-----LDSDGADLLTKLLQFEGRNRIS 275
Query: 316 AREAMAHPYFAQV 328
A +AM HP+F +
Sbjct: 276 AEDAMKHPFFLSL 288
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 1e-63
Identities = 94/306 (30%), Positives = 156/306 (50%), Gaps = 32/306 (10%)
Query: 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKIL 86
S YE + +G G+++ V++ + NTN+ IK +K + + K REIK+L
Sbjct: 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLL 66
Query: 87 QNLCGGPNVVKLLDIVRDQHSKTP-SLIFEYVNSTDFKVL----YPTLTDYDIRYYIYEL 141
Q L PN++ LLD K+ SL+F+++ TD +V+ LT I+ Y+
Sbjct: 67 QELSH-PNIIGLLDAF---GHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 142 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKG 200
L+ L+Y H I+HRD+KP+N+++D L+L D+GLA F P + Y +V +R+++
Sbjct: 122 LQGLEYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRA 180
Query: 201 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT-DELNAYL 259
PELL + Y +DMW++GC+ A ++ R PF G + DQL +I + LGT E
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGTPTE----- 234
Query: 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 319
E P + +L + K + + +D + L ++ R+TA +A
Sbjct: 235 -----EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 289
Query: 320 MAHPYF 325
+ YF
Sbjct: 290 LKMKYF 295
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 2e-63
Identities = 91/314 (28%), Positives = 154/314 (49%), Gaps = 51/314 (16%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIK 84
+ Y + K+G G Y V++ N N E KKI+ REI
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGET--------FALKKIRLEKEDEGIPSTTIREIS 52
Query: 85 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYE 140
IL+ L N+VKL D++ + L+FE++ D K L L + ++ +
Sbjct: 53 ILKELKH-SNIVKLYDVIHTKKRLV--LVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 141 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFK 199
LL + YCH + ++HRD+KP N++I+ E +L++ D+GLA + P ++Y + + +++
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYR 167
Query: 200 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT-DELN-- 256
P++L+ + Y ++D+WS+GC+FA M+ P F G DQL++I ++LGT + N
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMV-NGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226
Query: 257 --AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 314
L KY + PW F+ + ID L K+L+ D R+
Sbjct: 227 NVTELPKYDPNFT--------VYEPLPWESFLKG-----LDESGIDLLSKMLKLDPNQRI 273
Query: 315 TAREAMAHPYFAQV 328
TA++A+ H YF +
Sbjct: 274 TAKQALEHAYFKEN 287
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 2e-63
Identities = 87/326 (26%), Positives = 156/326 (47%), Gaps = 37/326 (11%)
Query: 28 VSSYVIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREI 83
+ ++++ D+++ +G G Y V + T E IK ++P K + REI
Sbjct: 1 MPKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREI 60
Query: 84 KILQNLCGGPNVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLYP-TLTDYDIRYYIY 139
KIL++ N++ + +I R + + +I E + + +V+ L+D I+Y+IY
Sbjct: 61 KILKHF-KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY 119
Query: 140 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR------- 192
+ L+A+ H ++HRD+KP N++I+ L++ D+GLA N
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 193 ----VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 248
VA+R+++ PE+++ Y ++D+WS GC+ A + R+ P F G D QL+ I
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PIFPGRDYRHQLLLIFG 237
Query: 249 VLGT----DELNAYLNKYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLD 303
++GT ++L + E L + P K F + P+ ID L
Sbjct: 238 IIGTPHSDNDLRCIESPRAREYIKSL----PMYPAAPLEKMFPRVN------PKGIDLLQ 287
Query: 304 KLLRYDHQDRLTAREAMAHPYFAQVR 329
++L +D R+TA+EA+ HPY
Sbjct: 288 RMLVFDPAKRITAKEALEHPYLQTYH 313
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 2e-63
Identities = 89/307 (28%), Positives = 160/307 (52%), Gaps = 31/307 (10%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK----KKIKREIKILQNLCGG 92
Y ++ VG G Y V ++ T + IK + +P + K+ RE+++L+++
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH- 83
Query: 93 PNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVLYP-TLTDYDIRYYIYELLKALDY 147
NV+ LLD+ + L+ ++ + K++ L + I++ +Y++LK L Y
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 143
Query: 148 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVD 206
H+ GI+HRD+KP N+ ++ + +L+++D+GLA Y V +R+++ PE++++
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQADSEMTGY---VVTRWYRAPEVILN 199
Query: 207 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKYH 263
Y ++D+WS+GC+ A MI K F G D+ DQL +I KV GT + + +
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITGK-TLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 258
Query: 264 LELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322
L +K ++ NA SP A++ L+K+L D + R+TA EA+AH
Sbjct: 259 KNYMKGL----PELEKKDFASILTNA------SPLAVNLLEKMLVLDAEQRVTAGEALAH 308
Query: 323 PYFAQVR 329
PYF +
Sbjct: 309 PYFESLH 315
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 9e-63
Identities = 98/317 (30%), Positives = 157/317 (49%), Gaps = 50/317 (15%)
Query: 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------R 81
+ Y+ + KVG G Y V++ + + V K+I+ R
Sbjct: 18 GLMEKYQKLEKVGEGTYGVVYKAKD-SQGRI--------VALKRIRLDAEDEGIPSTAIR 68
Query: 82 EIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYY 137
EI +L+ L PN+V L+D++ + T L+FE++ D K + L D I+ Y
Sbjct: 69 EISLLKELHH-PNIVSLIDVIHSERCLT--LVFEFM-EKDLKKVLDENKTGLQDSQIKIY 124
Query: 138 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASR 196
+Y+LL+ + +CH I+HRD+KP N++I+ + L+L D+GLA + P + Y V +
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA-LKLADFGLARAFGIPVRSYTHEVVTL 183
Query: 197 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT-DEL 255
+++ P++L+ + Y S+D+WS+GC+FA MI K P F G + DQL KI +LGT +
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIFSILGTPNPR 242
Query: 256 N----AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQ 311
L + +KPWS I E ID L +L +D
Sbjct: 243 EWPQVQELPLWKQRTFQV-------FEKKPWSSIIPG-----FCQEGIDLLSNMLCFDPN 290
Query: 312 DRLTAREAMAHPYFAQV 328
R++AR+AM HPYF +
Sbjct: 291 KRISARDAMNHPYFKDL 307
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-62
Identities = 88/312 (28%), Positives = 161/312 (51%), Gaps = 31/312 (9%)
Query: 33 IFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-----KPVKKKKIKREIKILQ 87
I+ + Y+ + VG G Y V + T R +K L + K+ RE+++L+
Sbjct: 24 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 88 NLCGGPNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVLYP-TLTDYDIRYYIYELL 142
++ NV+ LLD+ S L+ + + ++ LTD +++ IY++L
Sbjct: 84 HMKH-ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 142
Query: 143 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGP 201
+ L Y HS I+HRD+KP N+ ++ + +L+++D+GLA Y VA+R+++ P
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTADEMTGY---VATRWYRAP 198
Query: 202 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAY 258
E++++ Y+ ++D+WS+GC+ A ++ + F G D+ DQL I +++GT + L
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR-TLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 259 LNKYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 317
++ L + + ++ FI A+ P A+D L+K+L D R+TA
Sbjct: 258 SSESARNYIQSL----TQMPKMNFANVFIGAN------PLAVDLLEKMLVLDSDKRITAA 307
Query: 318 EAMAHPYFAQVR 329
+A+AH YFAQ
Sbjct: 308 QALAHAYFAQYH 319
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 1e-62
Identities = 89/313 (28%), Positives = 160/313 (51%), Gaps = 29/313 (9%)
Query: 33 IFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQN 88
+F Y + +G G Y V + R IK + P + ++ REIKIL
Sbjct: 22 VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLR 81
Query: 89 LCGGPNVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLY-PTLTDYDIRYYIYELLKA 144
N++ + DI+R + ++ + + + +K+L L++ I Y++Y++L+
Sbjct: 82 F-RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 140
Query: 145 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKG 200
L Y HS ++HRD+KP N++++ L++ D+GLA P ++ VA+R+++
Sbjct: 141 LKYIHSANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 201 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNA 257
PE++++ + Y S+D+WS+GC+ A M+ + P F G DQL I +LG+ ++LN
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 258 YLNKYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 316
+N L ++ PW++ F NAD +A+D LDK+L ++ R+
Sbjct: 259 IINLKARNYLLSL----PHKNKVPWNRLFPNAD------SKALDLLDKMLTFNPHKRIEV 308
Query: 317 REAMAHPYFAQVR 329
+A+AHPY Q
Sbjct: 309 EQALAHPYLEQYY 321
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 2e-62
Identities = 92/322 (28%), Positives = 152/322 (47%), Gaps = 60/322 (18%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIK 84
YE V ++G G Y +VF+ ++ R V K+++ RE+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRF-------VALKRVRVQTGEEGMPLSTIREVA 63
Query: 85 ILQNLCGG--PNVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVL-----YPTLTDYDI 134
+L++L PNVV+L D+ + + L+FE+V D P + I
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETI 122
Query: 135 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 194
+ +++LL+ LD+ HS ++HRD+KP N+++ +++L D+GLA Y V
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVV 181
Query: 195 SRYFKGPELLVDLQD-YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT- 252
+ +++ PE+L LQ Y +D+WS+GC+FA M FR++P F G + DQL KI V+G
Sbjct: 182 TLWYRAPEVL--LQSSYATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVIGLP 238
Query: 253 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHL------VSPEAIDFLDKLL 306
E E P+ AL P F + Q + + D L K L
Sbjct: 239 GE----------EDWPRDVAL-------PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCL 281
Query: 307 RYDHQDRLTAREAMAHPYFAQV 328
++ R++A A++HPYF +
Sbjct: 282 TFNPAKRISAYSALSHPYFQDL 303
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 4e-62
Identities = 87/336 (25%), Positives = 164/336 (48%), Gaps = 40/336 (11%)
Query: 32 VIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK----KKIKREIKIL 86
V YE+V+K+G+G Y V++ I+ T E +K I + ++ REI IL
Sbjct: 3 VDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMIL 62
Query: 87 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-PTLTDYDIRYYIYELLKAL 145
L G N+V LL+++R + + L+F+Y+ + V+ L +Y +Y+L+K +
Sbjct: 63 TELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVI 122
Query: 146 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR------------- 192
Y HS G++HRD+KP N++++ E +++ D+GL+ + +
Sbjct: 123 KYLHSGGLLHRDMKPSNILLNAEC-HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 193 ---------VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 243
VA+R+++ PE+L+ Y +DMWSLGC+ ++ K P F G +QL
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK-PIFPGSSTMNQL 240
Query: 244 VKIAKVLGT---DELNAYLNKY------HLELDPQLDALVGRHSRKPWSK-FINADNQHL 293
+I V+ +++ + + + L+ ++ R W + + +
Sbjct: 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKAD 300
Query: 294 VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329
+ EA+D LDKLL+++ R++A +A+ HP+ +
Sbjct: 301 CNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFH 336
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 8e-62
Identities = 79/321 (24%), Positives = 146/321 (45%), Gaps = 37/321 (11%)
Query: 33 IFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK-------------KK 78
+ + Q Y V R + G Y V G++ + IK + V K+
Sbjct: 17 LHAMQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 79 IKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLY---PTLTDY 132
+ REI++L + PN++ L DI L+ E + + +V++ ++
Sbjct: 76 VLREIRLLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQ 134
Query: 133 DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 192
I+Y++Y +L L H G++HRD+ P N+++ + + D+ LA
Sbjct: 135 HIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN-DITICDFNLAREDTADANKTHY 193
Query: 193 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 252
V R+++ PEL++ + + +DMWS GC+ A M RK F G ++QL KI +V+GT
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK-ALFRGSTFYNQLNKIVEVVGT 252
Query: 253 ---DELNAYLNKYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRY 308
+++ + + + L + + W+ AD P A+D + K+L +
Sbjct: 253 PKIEDVVMFSSPSARDY---LRNSLSNVPARAWTAVVPTAD------PVALDLIAKMLEF 303
Query: 309 DHQDRLTAREAMAHPYFAQVR 329
+ Q R++ +A+ HPYF +
Sbjct: 304 NPQRRISTEQALRHPYFESLF 324
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 5e-61
Identities = 89/324 (27%), Positives = 144/324 (44%), Gaps = 55/324 (16%)
Query: 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------R 81
+ YE + K+G+G + EVF+ + T ++ V KK+ R
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQK--------VALKKVLMENEKEGFPITALR 65
Query: 82 EIKILQNLCGGPNVVKLLDIVRDQHSKTPS------LIFEYVNSTDFKVL----YPTLTD 131
EIKILQ L NVV L++I R + S L+F++ D L T
Sbjct: 66 EIKILQLL-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTL 123
Query: 132 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-----PG 186
+I+ + LL L Y H I+HRD+K NV+I + L+L D+GLA +
Sbjct: 124 SEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQP 182
Query: 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 246
Y RV + +++ PELL+ +DY +D+W GC+ A M + + P G+ QL I
Sbjct: 183 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLALI 241
Query: 247 AKVLGT-DELNAYLNKYHLELDPQLDALVGRHSRKPW----SKFINADNQHLVSPEAIDF 301
+++ G+ E+ P +D + K + ++ P A+D
Sbjct: 242 SQLCGSITP----------EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDL 291
Query: 302 LDKLLRYDHQDRLTAREAMAHPYF 325
+DKLL D R+ + +A+ H +F
Sbjct: 292 IDKLLVLDPAQRIDSDDALNHDFF 315
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 3e-59
Identities = 75/311 (24%), Positives = 145/311 (46%), Gaps = 32/311 (10%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK----KKIKREIKILQNLCGG 92
Y+ ++ +G G V + + IK + +P + K+ RE+ +++ +
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NH 120
Query: 93 PNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYC 148
N++ LL++ Q + L+ E +++ +V+ L + Y +Y++L + +
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 180
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLV 205
HS GI+HRD+KP N+++ + L+++D+GLA Y V +RY++ PE+++
Sbjct: 181 HSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVIL 236
Query: 206 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT--DELNAYLNKYH 263
Y ++D+WS+GC+ M+ K F G D DQ K+ + LGT E L
Sbjct: 237 G-MGYKENVDIWSVGCIMGEMVRHK-ILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294
Query: 264 LELDPQLDALVGRHSRKPWSK-FINAD------NQHLVSPEAIDFLDKLLRYDHQDRLTA 316
+++ + K F ++ + L + +A D L K+L D R++
Sbjct: 295 RNYVENR----PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 350
Query: 317 REAMAHPYFAQ 327
+A+ HPY
Sbjct: 351 DDALQHPYINV 361
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 8e-59
Identities = 75/308 (24%), Positives = 141/308 (45%), Gaps = 26/308 (8%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK----KKIKREIKILQNLCGG 92
Y+ ++ +G G V + IK + +P + K+ RE+ +++ +
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NH 83
Query: 93 PNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYC 148
N++ LL++ Q S ++ E +++ +V+ L + Y +Y++L + +
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 143
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 208
HS GI+HRD+KP N+++ + L+++D+GLA V +RY++ PE+++
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-M 201
Query: 209 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT--DELNAYLNKYHLEL 266
Y ++D+WS+GC+ MI F G D+ DQ K+ + LGT E L
Sbjct: 202 GYKENVDIWSVGCIMGEMIKGG-VLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 260
Query: 267 DPQLDALVGRHSRKPWSK-FINADN------QHLVSPEAIDFLDKLLRYDHQDRLTAREA 319
+++ + K F + L + +A D L K+L D R++ EA
Sbjct: 261 VENR----PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316
Query: 320 MAHPYFAQ 327
+ HPY
Sbjct: 317 LQHPYINV 324
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 4e-57
Identities = 92/369 (24%), Positives = 158/369 (42%), Gaps = 86/369 (23%)
Query: 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK----KKIKREIKILQN 88
+ D YE+ +G G Y V E + IK IL+ + K+I REI IL
Sbjct: 49 WQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNR 108
Query: 89 LCGGPNVVKLLDIVRDQHSKTPS---LIFEYVNSTDF-KVLY--PTLTDYDIRYYIYELL 142
L +VVK+LDIV + + ++ E + +DF K+ LT+ I+ +Y LL
Sbjct: 109 L-NHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLL 166
Query: 143 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---------- 192
+ Y HS GI+HRD+KP N +++ + +++ D+GLA + N +
Sbjct: 167 VGVKYVHSAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 193 ------------------VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI------- 227
V +R+++ PEL++ ++Y ++D+WS+GC+FA ++
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285
Query: 228 ---FRKEPFFYGHD--------------------NHDQLVKIAKVLGT---DELNAYLNK 261
+ P F G N DQL I +LGT +++ A +
Sbjct: 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKE 345
Query: 262 YHLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 320
+ ++ F + +AI L ++L ++ R+T E +
Sbjct: 346 DAKRYIRIF----PKREGTDLAERFPASS------ADAIHLLKRMLVFNPNKRITINECL 395
Query: 321 AHPYFAQVR 329
AHP+F +VR
Sbjct: 396 AHPFFKEVR 404
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 8e-55
Identities = 83/361 (22%), Positives = 153/361 (42%), Gaps = 78/361 (21%)
Query: 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK----KKIKREIKILQN 88
D+Y + +GRG Y V+ + NT + IK + + + K+I REI IL
Sbjct: 22 VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNR 81
Query: 89 LCGGPNVVKLLDIVRDQHSKTPS---LIFEYVNSTDF-KVLYP--TLTDYDIRYYIYELL 142
L +++L D++ ++ E + +D K+ LT+ I+ +Y LL
Sbjct: 82 L-KSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLL 139
Query: 143 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---------- 192
++ H GI+HRD+KP N +++ + +++ D+GLA + K+ N+
Sbjct: 140 LGENFIHESGIIHRDLKPANCLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 193 -------------VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI----------FR 229
V +R+++ PEL++ ++Y S+D+WS GC+FA ++
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258
Query: 230 KEPFFYG-----------------HDNHDQLVKIAKVLGT---DELNAYLNKYHLELDPQ 269
+ P F G N DQL I ++GT D+L ++
Sbjct: 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKL 318
Query: 270 LDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328
+ + + S + I+ L+ +L+++ R+T +A+ HPY V
Sbjct: 319 F----PHRKPINLKQKYPSI------SDDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368
Query: 329 R 329
R
Sbjct: 369 R 369
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 1e-54
Identities = 80/333 (24%), Positives = 145/333 (43%), Gaps = 54/333 (16%)
Query: 37 QDDYEVVR-KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK---------REIKIL 86
+D +E KVGRG Y V++ + + + K+I+ REI +L
Sbjct: 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYAL------KQIEGTGISMSACREIALL 72
Query: 87 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL------------YPTLTDYDI 134
+ L PNV+ L + + L+F+Y D + L +
Sbjct: 73 RELKH-PNVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMV 130
Query: 135 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK---LRLIDWGLA-EFYHPGKEY- 189
+ +Y++L + Y H+ ++HRD+KP N+++ E + +++ D G A F P K
Sbjct: 131 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 190
Query: 190 --NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--------- 238
+ V + +++ PELL+ + Y ++D+W++GC+FA ++ EP F+
Sbjct: 191 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPY 249
Query: 239 NHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLV---- 294
+HDQL +I V+G + + + P+ L+ R ++
Sbjct: 250 HHDQLDRIFNVMGFPADKDWEDIKKM---PEHSTLMKDFRRNTYTNCSLIKYMEKHKVKP 306
Query: 295 SPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 327
+A L KLL D R+T+ +AM PYF +
Sbjct: 307 DSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLE 339
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-48
Identities = 74/308 (24%), Positives = 139/308 (45%), Gaps = 49/308 (15%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCG 91
+ Y+ V+K+G G Y EV + T+ IKI + K+ E+ +L+ L
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-D 94
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYC 148
PN++KL D D+ + L+ E D + + D I ++L + Y
Sbjct: 95 HPNIMKLYDFFEDKRNY--YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYL 152
Query: 149 HSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 206
H I+HRD+KP N++++ + ++++D+GL+ + K+ R+ + Y+ PE+L
Sbjct: 153 HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-- 210
Query: 207 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266
+ YD D+WS+G + ++ P F G + + L K+ K KY +
Sbjct: 211 RKKYDEKCDVWSIGVILFILLAGYPP-FGGQTDQEILRKVEK-----------GKYTFD- 257
Query: 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 326
W VS A D + ++L++D Q R++A++A+ HP+
Sbjct: 258 ------------SPEWKN---------VSEGAKDLIKQMLQFDSQRRISAQQALEHPWIK 296
Query: 327 QVRAAESS 334
++ + + S
Sbjct: 297 EMCSKKES 304
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 4e-48
Identities = 65/308 (21%), Positives = 113/308 (36%), Gaps = 61/308 (19%)
Query: 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGG- 92
Y +++++G G S+VF+ +N + IK + EI L L
Sbjct: 29 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 93 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYDIRYYIYELLKALDYCHS 150
+++L D + ++ E N L ++ ++ + Y +L+A+ H
Sbjct: 88 DKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 151 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVDL 207
GI+H D+KP N +I L+LID+G+A P V+ V + + PE + D+
Sbjct: 146 HGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 208 ----------QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 257
D+WSLGC+ M + K PF + +L I
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID--------- 254
Query: 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 317
+ +E + D L L+ D + R++
Sbjct: 255 --PNHEIEFPDI------------------------PEKDLQDVLKCCLKRDPKQRISIP 288
Query: 318 EAMAHPYF 325
E +AHPY
Sbjct: 289 ELLAHPYV 296
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 7e-48
Identities = 65/308 (21%), Positives = 112/308 (36%), Gaps = 61/308 (19%)
Query: 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGG- 92
Y +++++G G S+VF+ +N + IK + EI L L
Sbjct: 10 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 93 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYDIRYYIYELLKALDYCHS 150
+++L D + ++ E N L ++ ++ + Y +L+A+ H
Sbjct: 69 DKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 151 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVD- 206
GI+H D+KP N +I L+LID+G+A P V+ V + + PE + D
Sbjct: 127 HGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 207 ---------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 257
D+WSLGC+ M + K PF + +L I
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID--------- 235
Query: 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 317
+ +E + D L L+ D + R++
Sbjct: 236 --PNHEIEFPDI------------------------PEKDLQDVLKCCLKRDPKQRISIP 269
Query: 318 EAMAHPYF 325
E +AHPY
Sbjct: 270 ELLAHPYV 277
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 7e-48
Identities = 70/312 (22%), Positives = 123/312 (39%), Gaps = 53/312 (16%)
Query: 35 SDQDDYEVVRKV-GRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGP 93
+ DDY+V +V G G +V + N T E+ +K+L+ K +RE+++ P
Sbjct: 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCP 115
Query: 94 NVVKLLDIVRDQHSKTPS--LIFEYVNSTD-----FKVLYPTLTDYDIRYYIYELLKALD 146
++V+++D+ + ++ ++ E ++ + T+ + + + +A+
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 147 YCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 204
Y HS I HRDVKP N++ L+L D+G A+ + Y+ PE+L
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 235
Query: 205 VDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKI-AKVLGTDELNAYL 259
+ YD S DMWSLG + G P FY + + ++
Sbjct: 236 -GPEKYDKSCDMWSLGVIMYILLCGY-----PPFYSNHGLAISPGMKTRIR--------- 280
Query: 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 319
E WS+ VS E + LL+ + R+T E
Sbjct: 281 -MGQYEFP-----------NPEWSE---------VSEEVKMLIRNLLKTEPTQRMTITEF 319
Query: 320 MAHPYFAQVRAA 331
M HP+ Q
Sbjct: 320 MNHPWIMQSTKV 331
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 9e-48
Identities = 60/308 (19%), Positives = 123/308 (39%), Gaps = 61/308 (19%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGG 92
D + RK+G G + +V ++ +IK + V ++I+ EI++L++L
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DH 79
Query: 93 PNVVKLLDIVRDQHSKTPSLIFEYVNS-------TDFKVLYPTLTDYDIRYYIYELLKAL 145
PN++K+ ++ D H+ ++ E + L++ + + +++ AL
Sbjct: 80 PNIIKIFEVFEDYHNM--YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137
Query: 146 DYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
Y HSQ ++H+D+KP N++ +++ID+GLAE + + + + PE+
Sbjct: 138 AYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV 197
Query: 204 LVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259
+D + D+WS G + G F G + K
Sbjct: 198 F--KRDVTFKCDIWSAGVVMYFLLTGC-----LPFTGTSLEEVQQKATYK---------- 240
Query: 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 319
+ ++P+A+D L ++L D + R +A +
Sbjct: 241 ---EPNYAVE-----------CRP----------LTPQAVDLLKQMLTKDPERRPSAAQV 276
Query: 320 MAHPYFAQ 327
+ H +F Q
Sbjct: 277 LHHEWFKQ 284
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-47
Identities = 72/309 (23%), Positives = 123/309 (39%), Gaps = 52/309 (16%)
Query: 37 QDDYEVVRKV-GRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNV 95
DDY++ ++V G G +V E + T ++C +K+L K ++E+ GGP++
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY--DSPKARQEVDHHWQASGGPHI 84
Query: 96 VKLLDIVRDQHSKTPS--LIFEYVNSTD-----FKVLYPTLTDYDIRYYIYELLKALDYC 148
V +LD+ + H +I E + + + T+ + + ++ A+ +
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL 144
Query: 149 HSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 206
HS I HRDVKP N++ + L+L D+G A+ + Y+ PE+L
Sbjct: 145 HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVL-G 202
Query: 207 LQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262
+ YD S DMWSLG + G P FY + + + +
Sbjct: 203 PEKYDKSCDMWSLGVIMYILLCGF-----PPFYSNTGQAISPGMKRRIR---------LG 248
Query: 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322
WS+ VS +A + LL+ D +RLT + M H
Sbjct: 249 QYGFP-----------NPEWSE---------VSEDAKQLIRLLLKTDPTERLTITQFMNH 288
Query: 323 PYFAQVRAA 331
P+ Q
Sbjct: 289 PWINQSMVV 297
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-47
Identities = 65/315 (20%), Positives = 130/315 (41%), Gaps = 63/315 (20%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL--KPVKKKKIKREIKILQNLCGGPN 94
+ Y + +GRG++ V + ++ + + K + K + +K+EI IL N
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRN 62
Query: 95 VVKLLDIVRDQHSKTPSLIFEYVN---------STDFKVLYPTLTDYDIRYYIYELLKAL 145
++ L + +IFE+++ ++ F+ L + +I Y++++ +AL
Sbjct: 63 ILHLHESFESMEELV--MIFEFISGLDIFERINTSAFE-----LNEREIVSYVHQVCEAL 115
Query: 146 DYCHSQGIMHRDVKPHNVM-IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 204
+ HS I H D++P N++ +++I++G A PG + + + + PE+
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH 175
Query: 205 VDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 260
+ DMWSLG + +G+ F N + I
Sbjct: 176 -QHDVVSTATDMWSLGTLVYVLLSGI-----NPFLAETNQQIIENIMNA----------- 218
Query: 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 320
D + + + +S EA+DF+D+LL + + R+TA EA+
Sbjct: 219 --EYTFDEE-----------AFKE---------ISIEAMDFVDRLLVKERKSRMTASEAL 256
Query: 321 AHPYFAQVRAAESSR 335
HP+ Q S++
Sbjct: 257 QHPWLKQKIERVSTK 271
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 1e-47
Identities = 74/316 (23%), Positives = 136/316 (43%), Gaps = 64/316 (20%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERC---IIKILKPVKKKKIKREIKILQNLCGGP 93
D Y+++ ++G G + V + T I P+ K +K EI I+ L P
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH-P 108
Query: 94 NVVKLLDIVRDQHSKTPSLIFEYVN---------STDFKVLYPTLTDYDIRYYIYELLKA 144
++ L D D++ LI E+++ + D+K +++ ++ Y+ + +
Sbjct: 109 KLINLHDAFEDKYEMV--LILEFLSGGELFDRIAAEDYK-----MSEAEVINYMRQACEG 161
Query: 145 LDYCHSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
L + H I+H D+KP N+M + +++ID+GLA +P + V A+ F PE+
Sbjct: 162 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI 221
Query: 204 LVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259
+ D + + DMW++G + +G+ F G D+ + L + +
Sbjct: 222 V-DREPVGFYTDMWAIGVLGYVLLSGL-----SPFAGEDDLETLQNVKRC---------- 265
Query: 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 319
E D +S VSPEA DF+ LL+ + + RLT +A
Sbjct: 266 ---DWEFDED-----------AFSS---------VSPEAKDFIKNLLQKEPRKRLTVHDA 302
Query: 320 MAHPYFAQVRAAESSR 335
+ HP+ + +SR
Sbjct: 303 LEHPWLKGDHSNLTSR 318
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-47
Identities = 73/309 (23%), Positives = 133/309 (43%), Gaps = 50/309 (16%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLC 90
D Y+ R +G+G + EV + T + C +K++ K+ + RE+++L+ L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL- 83
Query: 91 GGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDY 147
PN++KL + D+ L+ E D + ++ D I ++L + Y
Sbjct: 84 DHPNIMKLYEFFEDKGYF--YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITY 141
Query: 148 CHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 205
H I+HRD+KP N++++ + +R+ID+GL+ + K+ ++ + Y+ PE+L
Sbjct: 142 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL- 200
Query: 206 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265
YD D+WS G + ++ P F G + +D L K+ K
Sbjct: 201 -HGTYDEKCDVWSTGVILYILLSGCPP-FNGANEYDILKKV-------------EKGKYT 245
Query: 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325
+ W K VS A D + K+L Y R++AR+A+ H +
Sbjct: 246 FE-----------LPQWKK---------VSESAKDLIRKMLTYVPSMRISARDALDHEWI 285
Query: 326 AQVRAAESS 334
+ S
Sbjct: 286 QTYTKEQIS 294
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 3e-47
Identities = 64/316 (20%), Positives = 119/316 (37%), Gaps = 64/316 (20%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERC---IIKILKPVKKKKIKREIKILQNLCGGP 93
D Y++ ++G G + V T + K+ +++EI+ + L P
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHP 214
Query: 94 NVVKLLDIVRDQHSKTPSLIFEYVN---------STDFKVLYPTLTDYDIRYYIYELLKA 144
+V L D D + +I+E+++ K +++ + Y+ ++ K
Sbjct: 215 TLVNLHDAFEDDNEMV--MIYEFMSGGELFEKVADEHNK-----MSEDEAVEYMRQVCKG 267
Query: 145 LDYCHSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
L + H +H D+KP N+M +L+LID+GL P + V + F PE+
Sbjct: 268 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 327
Query: 204 LVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259
+ + Y DMWS+G + +G+ F G ++ + L +
Sbjct: 328 A-EGKPVGYYTDMWSVGVLSYILLSGL-----SPFGGENDDETLRNVKSC---------- 371
Query: 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 319
+D +S +S + DF+ KLL D R+T +A
Sbjct: 372 ---DWNMD-----------DSAFSG---------ISEDGKDFIRKLLLADPNTRMTIHQA 408
Query: 320 MAHPYFAQVRAAESSR 335
+ HP+ A
Sbjct: 409 LEHPWLTPGNAPGRDS 424
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 3e-47
Identities = 58/301 (19%), Positives = 112/301 (37%), Gaps = 52/301 (17%)
Query: 39 DYEVVRKVGRGKYSE-VFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVK 97
+ +G G V+ G+ N +K + P RE+++L+ PNV++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR 82
Query: 98 LLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGIM 154
+D+ + + E +T + + + + + L + HS I+
Sbjct: 83 YFCTEKDRQFQ--YIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIV 140
Query: 155 HRDVKPHNVMIDHE----LRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPELLVD 206
HRD+KPHN++I K + D+GL + G+ R + + PE+L +
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200
Query: 207 L--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264
++ Y++D++S GC+F +I F + +
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGA---------------- 244
Query: 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 324
LD L P A + ++K++ D Q R +A+ + HP+
Sbjct: 245 ---CSLDCL------HPEKH---------EDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286
Query: 325 F 325
F
Sbjct: 287 F 287
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 5e-47
Identities = 64/316 (20%), Positives = 126/316 (39%), Gaps = 58/316 (18%)
Query: 37 QDDYEVVRKV-GRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLC 90
+ Y + K GRGK++ V + I+ +T + K + +I EI +L+
Sbjct: 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86
Query: 91 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-F----KVLYPTLTDYDIRYYIYELLKAL 145
P V+ L ++ + LI EY + F L +++ D+ I ++L+ +
Sbjct: 87 SCPRVINLHEVYENTSEII--LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGV 144
Query: 146 DYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
Y H I+H D+KP N+++ + L ++++D+G++ E + + + PE+
Sbjct: 145 YYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEI 204
Query: 204 LVDLQDYDYSLDMWSLG----CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259
L + + DMW++G + F G DN + + I++V
Sbjct: 205 L-NYDPITTATDMWNIGIIAYMLLTHT-----SPFVGEDNQETYLNISQV---------- 248
Query: 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 319
+++ + +S VS A DF+ LL + + R TA
Sbjct: 249 ---NVDYS-----------EETFSS---------VSQLATDFIQSLLVKNPEKRPTAEIC 285
Query: 320 MAHPYFAQVRAAESSR 335
++H + Q
Sbjct: 286 LSHSWLQQWDFENLFH 301
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 6e-47
Identities = 76/321 (23%), Positives = 139/321 (43%), Gaps = 61/321 (19%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---------PVKKKKIKREIKILQ 87
+D Y++ ++G G+++ V + +T K +K V +++I+RE+ IL+
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 88 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKA 144
+ NV+ L D+ ++ LI E V+ DF +L++ + +I ++L
Sbjct: 71 QV-LHHNVITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 145 LDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 201
++Y H++ I H D+KP N+M+ + + ++LID+GLA G E+ + F P
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 202 ELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 257
E++ + + DMWS+G + +G F G + L I V
Sbjct: 188 EIV-NYEPLGLEADMWSIGVITYILLSGA-----SPFLGDTKQETLANITSV-------- 233
Query: 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 317
+ D + +S S A DF+ KLL + + RLT +
Sbjct: 234 -----SYDFDEE-----------FFSH---------TSELAKDFIRKLLVKETRKRLTIQ 268
Query: 318 EAMAHPYFAQVRAAESSRTRA 338
EA+ HP+ V ++ R
Sbjct: 269 EALRHPWITPVDNQQAMVRRE 289
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 7e-47
Identities = 69/315 (21%), Positives = 135/315 (42%), Gaps = 63/315 (20%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCG 91
+ Y +V +G+G + EV + + T + +K+ K I RE+++L+ L
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-D 79
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 145
PN++KL +I+ D S ++ E + L+ +++D I ++ +
Sbjct: 80 HPNIMKLFEILEDSSSF--YIVGELYTGGE---LFDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 146 DYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
Y H I+HRD+KP N++++ + +++ID+GL+ + + R+ + Y+ PE+
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194
Query: 204 LVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259
L YD D+WS G + +G P FYG + +D L ++
Sbjct: 195 L--RGTYDEKCDVWSAGVILYILLSG-----TPPFYGKNEYDILKRVET----------- 236
Query: 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 319
KY + W +S +A D + K+L + R+TA +
Sbjct: 237 GKYAFD-------------LPQWRT---------ISDDAKDLIRKMLTFHPSLRITATQC 274
Query: 320 MAHPYFAQVRAAESS 334
+ HP+ + + +
Sbjct: 275 LEHPWIQKYSSETPT 289
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 9e-47
Identities = 65/308 (21%), Positives = 112/308 (36%), Gaps = 61/308 (19%)
Query: 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCG-G 92
Y +++++G G S+VF+ +N + IK + EI L L
Sbjct: 57 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 93 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYDIRYYIYELLKALDYCHS 150
+++L D + ++ E N L ++ ++ + Y +L+A+ H
Sbjct: 116 DKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 151 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVD- 206
GI+H D+KP N +I L+LID+G+A P V+ V + + PE + D
Sbjct: 174 HGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 207 ---------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 257
D+WSLGC+ M + K PF + +L I
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID--------- 282
Query: 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 317
+ +E + D L L+ D + R++
Sbjct: 283 --PNHEIEFPDI------------------------PEKDLQDVLKCCLKRDPKQRISIP 316
Query: 318 EAMAHPYF 325
E +AHPY
Sbjct: 317 ELLAHPYV 324
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 6e-46
Identities = 72/320 (22%), Positives = 123/320 (38%), Gaps = 65/320 (20%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------------PVKKKKIKREIK 84
++YE +GRG S V I+ T + +KI+ ++ +E+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 85 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYEL 141
IL+ + G PN+++L D L+F+ + D+ TL++ + R + L
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFF--FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133
Query: 142 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 201
L+ + H I+HRD+KP N+++D ++ ++L D+G + PG++ + + P
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 192
Query: 202 ELL-----VDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 252
E++ + Y +DMWS G + AG P F+ L I
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS-----PPFWHRKQMLMLRMIMS---- 243
Query: 253 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD 312
Y W S D + + L Q
Sbjct: 244 -------GNYQFG-------------SPEWDD---------YSDTVKDLVSRFLVVQPQK 274
Query: 313 RLTAREAMAHPYFAQVRAAE 332
R TA EA+AHP+F Q E
Sbjct: 275 RYTAEEALAHPFFQQYVVEE 294
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 6e-46
Identities = 70/303 (23%), Positives = 120/303 (39%), Gaps = 55/303 (18%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGGP 93
Y + +GRG + EV + T R K + + K+EI+I+++L P
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHP 66
Query: 94 NVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 150
N+++L + D L+ E + V + D + ++L A+ YCH
Sbjct: 67 NIIRLYETFEDNTDI--YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK 124
Query: 151 QGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 208
+ HRD+KP N + L+LID+GLA + PGK +V + Y+ P++L
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL--EG 182
Query: 209 DYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264
Y D WS G + G P F + + ++KI + +
Sbjct: 183 LYGPECDEWSAGVMMYVLLCGY-----PPFSAPTDSEVMLKIRE-----------GTFTF 226
Query: 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 324
K W VSP+A + +LL + R+T+ +A+ H +
Sbjct: 227 P-------------EKDWLN---------VSPQAESLIRRLLTKSPKQRITSLQALEHEW 264
Query: 325 FAQ 327
F +
Sbjct: 265 FEK 267
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 8e-46
Identities = 70/310 (22%), Positives = 134/310 (43%), Gaps = 57/310 (18%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCG 91
+ Y +V +G+G + EV + + T + +K+ K I RE+++L+ L
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-D 79
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYC 148
PN++KL +I+ D S ++ E D + +++D I ++ + Y
Sbjct: 80 HPNIMKLFEILEDSSSF--YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 149 HSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 206
H I+HRD+KP N++++ + +++ID+GL+ + + R+ + Y+ PE+L
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-- 195
Query: 207 LQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262
YD D+WS G + +G P FYG + +D L ++ KY
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGT-----PPFYGKNEYDILKRVET-----------GKY 239
Query: 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322
+ W +S +A D + K+L + R+TA + + H
Sbjct: 240 AFD-------------LPQWRT---------ISDDAKDLIRKMLTFHPSLRITATQCLEH 277
Query: 323 PYFAQVRAAE 332
P+ + + E
Sbjct: 278 PWIQKYSSEE 287
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-45
Identities = 72/311 (23%), Positives = 134/311 (43%), Gaps = 60/311 (19%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----------------PVKKKKIKR 81
+ Y VRK+G G Y EV N + IK++K ++I
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 82 EIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYI 138
EI +L++L PN++KL D+ D+ L+ E+ + + + D +
Sbjct: 96 EISLLKSL-DHPNIIKLFDVFEDKKYF--YLVTEFYEGGELFEQIINRHKFDECDAANIM 152
Query: 139 YELLKALDYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASR 196
++L + Y H I+HRD+KP N++++ + L ++++D+GL+ F+ + R+ +
Sbjct: 153 KQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTA 212
Query: 197 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 256
Y+ PE+L + Y+ D+WS G + ++ P F G ++ D + K+ K
Sbjct: 213 YYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPP-FGGQNDQDIIKKVEK-------- 261
Query: 257 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 316
KY+ + W +S EA + + +L YD+ R TA
Sbjct: 262 ---GKYYFD-------------FNDWKN---------ISDEAKELIKLMLTYDYNKRCTA 296
Query: 317 REAMAHPYFAQ 327
EA+ + +
Sbjct: 297 EEALNSRWIKK 307
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-45
Identities = 54/311 (17%), Positives = 111/311 (35%), Gaps = 30/311 (9%)
Query: 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLC 90
+ + + +G+G + VF G + T + IK+ + + RE ++L+ L
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 91 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL-----YPTLTDYDIRYYIYELLKA 144
N+VKL I + ++ LI E+ + VL L + + + +++
Sbjct: 66 H-KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 145 LDYCHSQGIMHRDVKPHNVMIDHELRK---LRLIDWGLAEFYHPGKEYNVRVASRYFKGP 201
+++ GI+HR++KP N+M +L D+G A +++ + + P
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 202 ELL-------VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 254
++ + Y ++D+WS+G F PF + K++
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 255 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 314
A E P + P S ++ + L +L D +
Sbjct: 245 SGAISGVQKAENGP-----IDWSGDMPVSCSLSRG----LQVLLTPVLANILEADQEKCW 295
Query: 315 TAREAMAHPYF 325
+ A
Sbjct: 296 GFDQFFAETSD 306
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-45
Identities = 62/299 (20%), Positives = 101/299 (33%), Gaps = 52/299 (17%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCG 91
Q ++ + ++G G Y EVF+ + +K P + + E+ + +
Sbjct: 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYC 148
P V+L + L E + + +L + + Y+ + L AL +
Sbjct: 116 HPCCVRLEQ--AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHL 173
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 208
HSQG++H DVKP N+ + R +L D+GL V+ + PELL
Sbjct: 174 HSQGLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-- 230
Query: 209 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268
Y + D++SLG + E G QL + E
Sbjct: 231 SYGTAADVFSLGLTILEVACNMELPHGGEGWQ-QLRQ--------------GYLPPEFTA 275
Query: 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 327
L S E L +L D + R TA +A P Q
Sbjct: 276 GL------------------------SSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-45
Identities = 76/320 (23%), Positives = 141/320 (44%), Gaps = 61/320 (19%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---------PVKKKKIKREIKILQ 87
+D Y++ ++G G+++ V + +T K +K V +++I+RE+ IL+
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 88 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKA 144
+ PN++ L D+ ++ LI E V+ DF +L++ + +I ++L
Sbjct: 71 QV-LHPNIITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 145 LDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 201
++Y H++ I H D+KP N+M+ + + ++LID+GLA G E+ + F P
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 202 ELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 257
E++ + + DMWS+G + +G F G + L I V
Sbjct: 188 EIV-NYEPLGLEADMWSIGVITYILLSGA-----SPFLGDTKQETLANITAV-------- 233
Query: 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 317
+ D + +S+ S A DF+ KLL + + RLT +
Sbjct: 234 -----SYDFDEE-----------FFSQ---------TSELAKDFIRKLLVKETRKRLTIQ 268
Query: 318 EAMAHPYFAQVRAAESSRTR 337
EA+ HP+ V ++ R
Sbjct: 269 EALRHPWITPVDTQQAMVRR 288
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-45
Identities = 73/316 (23%), Positives = 137/316 (43%), Gaps = 65/316 (20%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---------PVKKKKIKREIKILQ 87
+D YE+ ++G G+++ V + T + K +K V +++I+RE+ IL+
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 88 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST-----DFKVLYPTLTDYDIRYYIYELL 142
+ PN++ L DI ++ LI E V + DF +LT+ + ++ ++L
Sbjct: 64 EI-RHPNIITLHDIFENKTDVV--LILELV--SGGELFDFLAEKESLTEDEATQFLKQIL 118
Query: 143 KALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 199
+ Y HS+ I H D+KP N+M+ + +++LID+G+A G E+ + F
Sbjct: 119 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFV 178
Query: 200 GPELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL 255
PE++ + + DMWS+G + +G F G + L I+ V
Sbjct: 179 APEIV-NYEPLGLEADMWSIGVITYILLSGA-----SPFLGETKQETLTNISAV------ 226
Query: 256 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT 315
+ + D + +S S A DF+ +LL D + R+T
Sbjct: 227 -------NYDFDEE-----------YFSN---------TSELAKDFIRRLLVKDPKRRMT 259
Query: 316 AREAMAHPYFAQVRAA 331
+++ H + +R
Sbjct: 260 IAQSLEHSWIKAIRRR 275
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-45
Identities = 70/316 (22%), Positives = 135/316 (42%), Gaps = 61/316 (19%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---------PVKKKKIKREIKILQ 87
D Y+ ++G G+++ V + +T + K +K V ++ I+RE+ IL+
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 88 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKA 144
+ PNV+ L ++ ++ LI E V DF +LT+ + ++ ++L
Sbjct: 70 EI-QHPNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 145 LDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 201
+ Y HS I H D+KP N+M+ + ++++ID+GLA G E+ + F P
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 202 ELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 257
E++ + + DMWS+G + +G F G + L ++ V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGA-----SPFLGDTKQETLANVSAV-------- 232
Query: 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 317
+ E + + +S S A DF+ +LL D + R+T +
Sbjct: 233 -----NYEFEDE-----------YFSN---------TSALAKDFIRRLLVKDPKKRMTIQ 267
Query: 318 EAMAHPYFAQVRAAES 333
+++ HP+ ++
Sbjct: 268 DSLQHPWIKPKDTQQA 283
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-45
Identities = 71/311 (22%), Positives = 134/311 (43%), Gaps = 56/311 (18%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCG 91
D+Y+V ++G+G +S V ++ T KI L +K++RE +I + L
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYC 148
PN+V+L D ++++ L+F+ V + V ++ D + I ++L+++ YC
Sbjct: 88 -PNIVRLHDSIQEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 144
Query: 149 HSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 206
HS GI+HR++KP N+++ + + ++L D+GLA + + ++ + + PE+L
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL-K 203
Query: 207 LQDYDYSLDMWSLGCMF----AGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262
Y +D+W+ G + G P F+ D H +I Y
Sbjct: 204 KDPYSKPVDIWACGVILYILLVGY-----PPFWDEDQHRLYAQIKA-----------GAY 247
Query: 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322
W V+PEA +D +L + + R+TA +A+
Sbjct: 248 DYP-------------SPEWDT---------VTPEAKSLIDSMLTVNPKKRITADQALKV 285
Query: 323 PYFAQVRAAES 333
P+ S
Sbjct: 286 PWICNRERVAS 296
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 8e-45
Identities = 74/338 (21%), Positives = 154/338 (45%), Gaps = 50/338 (14%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLC-----GG 92
YEV++ +G+G + +V + + ++ +K+++ K+ ++ EI+IL++L
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 93 PNVVKLLD---------IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 143
NV+ +L+ + + S +L +E + F+ L +R + + +L+
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLS--MNL-YELIKKNKFQGFSLPL----VRKFAHSILQ 211
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 202
LD H I+H D+KP N+++ + R +++ID+G + + H + Y + SR+++ PE
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH-QRVYTY-IQSRFYRAPE 269
Query: 203 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG----------- 251
+++ Y +DMWSLGC+ A + P G D DQL + ++LG
Sbjct: 270 VILGA-RYGMPIDMWSLGCILAEL-LTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK 327
Query: 252 --TDELNAYLNKYHLELDPQLDALVGRHSRK---------PWSKFINADNQHLVSPEAID 300
+ +++ + + D V + + P S+ + P +D
Sbjct: 328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLD 387
Query: 301 FLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 338
FL + L +D R+T +A+ HP+ + + +
Sbjct: 388 FLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEKT 425
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-44
Identities = 65/321 (20%), Positives = 111/321 (34%), Gaps = 70/321 (21%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKKIKREIKILQNLCGGPN 94
D+E + +G+G + +V + N + IK ++ K I E+ +L +L
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQY 63
Query: 95 VVKLLDIVRDQHSKTPS-----------LIFEYVNS---TDFKVLYPTLTDYD-IRYYIY 139
VV+ ++ + + EY + D D
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 140 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 199
++L+AL Y HSQGI+HRD+KP N+ ID R +++ D+GLA+ H + +
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDES-RNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 200 G---------------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 244
E+L Y+ +DM+SLG +F MI+ PF G ++
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-ERVNIL 238
Query: 245 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 304
K L +E P +
Sbjct: 239 KK------------LRSVSIEFPPDF-----------DDNK---------MKVEKKIIRL 266
Query: 305 LLRYDHQDRLTAREAMAHPYF 325
L+ +D R AR + +
Sbjct: 267 LIDHDPNKRPGARTLLNSGWL 287
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-44
Identities = 71/311 (22%), Positives = 134/311 (43%), Gaps = 56/311 (18%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCG 91
D+Y+V ++G+G +S V ++ T KI L +K++RE +I + L
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYC 148
PN+V+L D ++++ L+F+ V + V ++ D + I ++L+++ YC
Sbjct: 65 -PNIVRLHDSIQEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 149 HSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 206
HS GI+HR++KP N+++ + + ++L D+GLA + + ++ + + PE+L
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL-K 180
Query: 207 LQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262
Y +D+W+ G + G P F+ D H +I Y
Sbjct: 181 KDPYSKPVDIWACGVILYILLVGY-----PPFWDEDQHRLYAQIKA-----------GAY 224
Query: 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322
W V+PEA +D +L + + R+TA +A+
Sbjct: 225 DYP-------------SPEWDT---------VTPEAKSLIDSMLTVNPKKRITADQALKV 262
Query: 323 PYFAQVRAAES 333
P+ S
Sbjct: 263 PWICNRERVAS 273
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-44
Identities = 68/313 (21%), Positives = 126/313 (40%), Gaps = 64/313 (20%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK-----------KIKREIKIL 86
Y+ +GRG S V ++ T +KI++ ++ +RE IL
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 87 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLK 143
+ + G P+++ L+D L+F+ + D+ L++ + R + LL+
Sbjct: 154 RQVAGHPHIITLIDSYESSSFM--FLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLE 211
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
A+ + H+ I+HRD+KP N+++D + ++RL D+G + PG++ + + PE+
Sbjct: 212 AVSFLHANNIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEI 270
Query: 204 L-----VDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 254
L Y +D+W+ G + AG P F+ L I +
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAGS-----PPFWHRRQILMLRMIME------ 319
Query: 255 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 314
+Y W S D + +LL+ D + RL
Sbjct: 320 -----GQYQFS-------------SPEWDD---------RSSTVKDLISRLLQVDPEARL 352
Query: 315 TAREAMAHPYFAQ 327
TA +A+ HP+F +
Sbjct: 353 TAEQALQHPFFER 365
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-44
Identities = 66/318 (20%), Positives = 135/318 (42%), Gaps = 62/318 (19%)
Query: 37 QDDYEVVRK--VGRGKYSEVFEGINVNTNERC---IIKILKPVKKKKIKREIKILQNLCG 91
Y V + +G G++ +V + T + IIK K+++K EI ++ L
Sbjct: 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-D 144
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNS-------TDFKVLYPTLTDYDIRYYIYELLKA 144
N+++L D ++ L+ EYV+ D T+ D ++ ++ +
Sbjct: 145 HANLIQLYDAFESKNDIV--LVMEYVDGGELFDRIIDESYNL---TELDTILFMKQICEG 199
Query: 145 LDYCHSQGIMHRDVKPHNVM-IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
+ + H I+H D+KP N++ ++ + +++++ID+GLA Y P ++ V + F PE+
Sbjct: 200 IRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEV 259
Query: 204 LVDLQDYDYSLDMWSLG----CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259
+ + + DMWS+G + +G+ F G ++ + L I
Sbjct: 260 V-NYDFVSFPTDMWSVGVIAYMLLSGL-----SPFLGDNDAETLNNILAC---------- 303
Query: 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 319
+L+ + + +S EA +F+ KLL + R++A EA
Sbjct: 304 ---RWDLEDE-----------EFQD---------ISEEAKEFISKLLIKEKSWRISASEA 340
Query: 320 MAHPYFAQVRAAESSRTR 337
+ HP+ + + +
Sbjct: 341 LKHPWLSDHKLHSRLSAQ 358
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 4e-44
Identities = 49/336 (14%), Positives = 87/336 (25%), Gaps = 71/336 (21%)
Query: 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNL--- 89
++V + G S VF +V E +K+ + +++ L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 90 --------------------CGGPNVVKLLDIVRDQHSKTPSLIFEYVNST--------- 120
P +L D L+ +
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 121 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180
V + +L++ S+G++H P N+ I + R L L D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR-LMLGDVSAL 241
Query: 181 EFYHPGKEYNVRVASRYFKGPELL-VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 239
+ G + E L + ++L+ W LG + PF
Sbjct: 242 --WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299
Query: 240 HDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAI 299
K + R F + +
Sbjct: 300 IKGSWKRPSL--------------------------RVPGTDSLAFGSCTP---LPDFVK 330
Query: 300 DFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSR 335
+ + L +D + RL EAM P F Q++ SS
Sbjct: 331 TLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISSS 366
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 6e-44
Identities = 55/322 (17%), Positives = 111/322 (34%), Gaps = 69/322 (21%)
Query: 37 QDDYEVVRKVGRGKYSEV-FEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNV 95
++ + +G G V F+G +K + EIK+L PNV
Sbjct: 14 KNLVVSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNV 71
Query: 96 VKLLDIVRDQHSKTPSLIFEYVNST---------DFKVLYPTLTDYDIRYYIYELLKALD 146
++ + E N +Y+ + ++ +
Sbjct: 72 IRYYCSETTDRFL--YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 147 YCHSQGIMHRDVKPHNVMID------------HELRKLRLIDWGLAEFYHPGKEY----- 189
+ HS I+HRD+KP N+++ E ++ + D+GL + G+
Sbjct: 130 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 190 NVRVASRYFKGPELLVDLQD------YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 243
N + ++ PELL + + S+D++S+GC+F ++ + + F D + +
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG--DKYSRE 247
Query: 244 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLD 303
I + + L+ + EA D +
Sbjct: 248 SNIIR-----------GIFSLDEMK----------CLHDRS---------LIAEATDLIS 277
Query: 304 KLLRYDHQDRLTAREAMAHPYF 325
+++ +D R TA + + HP F
Sbjct: 278 QMIDHDPLKRPTAMKVLRHPLF 299
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-43
Identities = 71/349 (20%), Positives = 124/349 (35%), Gaps = 95/349 (27%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--------PVKKKKIKREIKILQN 88
Q Y + +G+G Y V I T IKI+ P ++IK E+++++
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 89 LCGGPNVVKLLDIVRDQHSKTPSLIFEYV------------------------------- 117
L PN+ +L ++ D+ L+ E
Sbjct: 85 LHH-PNIARLYEVYEDEQYI--CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141
Query: 118 ------------NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 165
+ L + I + ++ AL Y H+QGI HRD+KP N +
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF 201
Query: 166 DH-ELRKLRLIDWGLAEFYHPGKE-----YNVRVASRYFKGPELL-VDLQDYDYSLDMWS 218
+ +++L+D+GL++ ++ + + YF PE+L + Y D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 219 LGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHS 278
G + ++ PF N I++VL L +
Sbjct: 262 AGVLLHLLLMGAVPFP--GVNDADT--ISQVL----------NKKLCFE----------- 296
Query: 279 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 327
++ +SP A D L LL + +R A A+ HP+ +Q
Sbjct: 297 NPNYNV---------LSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-43
Identities = 69/315 (21%), Positives = 128/315 (40%), Gaps = 53/315 (16%)
Query: 37 QDDYEV---VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGP 93
Y++ + +G G +S + ++ +N+ +KI+ + ++EI L+ G P
Sbjct: 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHP 66
Query: 94 NVVKLLDIVRDQHSKTPSLIFEYVNSTD-F-----KVLYPTLTDYDIRYYIYELLKALDY 147
N+VKL ++ DQ L+ E +N + F K + ++ + Y + +L+ A+ +
Sbjct: 67 NIVKLHEVFHDQLHT--FLVMELLNGGELFERIKKKKHF---SETEASYIMRKLVSAVSH 121
Query: 148 CHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELL 204
H G++HRD+KP N++ + ++++ID+G A P + + ++ PELL
Sbjct: 122 MHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL 181
Query: 205 VDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 260
+ YD S D+WSLG M +G F HD +++ +
Sbjct: 182 -NQNGYDESCDLWSLGVILYTMLSGQ-----VPFQSHDRSLTCTSAVEIM------KKIK 229
Query: 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 320
K + + W VS EA D + LL D RL
Sbjct: 230 KGDFSFEG-----------EAWKN---------VSQEAKDLIQGLLTVDPNKRLKMSGLR 269
Query: 321 AHPYFAQVRAAESSR 335
+ + S+
Sbjct: 270 YNEWLQDGSQLSSNP 284
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 4e-43
Identities = 75/306 (24%), Positives = 121/306 (39%), Gaps = 55/306 (17%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKKKKIKREIKILQNLCGGPNV 95
D +EV ++GRG S V+ T + +K + K V KK ++ EI +L L PN+
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSH-PNI 110
Query: 96 VKLLDIVRDQHSKTPSLIFEYVNST-----DFKVLYPTLTDYDIRYYIYELLKALDYCHS 150
+KL +I SL+ E V T D V ++ D + ++L+A+ Y H
Sbjct: 111 IKLKEIFETPTEI--SLVLELV--TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE 166
Query: 151 QGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 208
GI+HRD+KP N++ L++ D+GL++ + + PE+L
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRG-C 225
Query: 209 DYDYSLDMWSLGCMF----AGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264
Y +DMWS+G + G FY + ++L
Sbjct: 226 AYGPEVDMWSVGIITYILLCGF-----EPFYDERGDQFM--FRRIL----------NCEY 268
Query: 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 324
W + VS A D + KL+ D + RLT +A+ HP+
Sbjct: 269 YFIS-----------PWWDE---------VSLNAKDLVRKLIVLDPKKRLTTFQALQHPW 308
Query: 325 FAQVRA 330
A
Sbjct: 309 VTGKAA 314
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 5e-43
Identities = 71/319 (22%), Positives = 135/319 (42%), Gaps = 65/319 (20%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--------PVKKKKIKREIKILQN 88
+D YE+ +G+G +S V IN T ++ +KI+ + + +KRE I
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 89 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS-------TDFKVLYPTLTDYDIRYYIYEL 141
L P++V+LL+ ++FE+++ ++ +Y+ ++
Sbjct: 83 L-KHPHIVELLETYSSDGML--YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI 139
Query: 142 LKALDYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLA-EFYHPGKEYNVRVASRYF 198
L+AL YCH I+HRDVKPH V++ ++L +G+A + G RV + +F
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199
Query: 199 KGPELLVDLQDYDYSLDMWSLG----CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 254
PE++ + Y +D+W G + +G PF + ++L + ++
Sbjct: 200 MAPEVV-KREPYGKPVDVWGCGVILFILLSGC----LPF---YGTKERLFE--GII---- 245
Query: 255 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 314
K +++P + WS +S A D + ++L D +R+
Sbjct: 246 ------KGKYKMNP-----------RQWSH---------ISESAKDLVRRMLMLDPAERI 279
Query: 315 TAREAMAHPYFAQVRAAES 333
T EA+ HP+ +
Sbjct: 280 TVYEALNHPWLKERDRYAY 298
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-42
Identities = 69/319 (21%), Positives = 125/319 (39%), Gaps = 63/319 (19%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-----------KPVKKKKIKREIKI 85
+D+Y + + +G G EV T ++ I+I+ + ++ EI+I
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 86 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELL 142
L+ L P ++K+ + + ++ E + D V L + + Y Y++L
Sbjct: 194 LKKL-NHPCIIKIKNFFDAEDY---YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249
Query: 143 KALDYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 200
A+ Y H GI+HRD+KP NV++ E +++ D+G ++ + +
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 309
Query: 201 PELLVDLQD--YDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 254
PE+LV + Y+ ++D WSLG +G PF +I
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGY----PPFSEHRTQVSLKDQITS------ 359
Query: 255 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 314
KY+ + W++ VS +A+D + KLL D + R
Sbjct: 360 -----GKYNFIPE-------------VWAE---------VSEKALDLVKKLLVVDPKARF 392
Query: 315 TAREAMAHPYFAQVRAAES 333
T EA+ HP+
Sbjct: 393 TTEEALRHPWLQDEDMKRK 411
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-42
Identities = 71/305 (23%), Positives = 116/305 (38%), Gaps = 50/305 (16%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVK 97
D YEV +G G YS I+ TN +KI+ K+ EI+IL PN++
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID-KSKRDPTEEIEILLRYGQHPNIIT 80
Query: 98 LLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIM 154
L D+ D ++ E + D + ++ + ++ + K ++Y H+QG++
Sbjct: 81 LKDVYDDGKYV--YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVV 138
Query: 155 HRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDY 210
HRD+KP N++ +R+ D+G A+ + F PE+L + Q Y
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL-ERQGY 197
Query: 211 DYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266
D + D+WSLG M G F + +A++ L
Sbjct: 198 DAACDIWSLGVLLYTMLTGY-----TPFANGPDDTPEEILARIG----------SGKFSL 242
Query: 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 326
W+ VS A D + K+L D RLTA + HP+
Sbjct: 243 S-----------GGYWNS---------VSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV 282
Query: 327 QVRAA 331
Sbjct: 283 HWDQL 287
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 8e-42
Identities = 70/311 (22%), Positives = 119/311 (38%), Gaps = 59/311 (18%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGGP 93
+ + + +G G +SEVF T + +K + + ++ EI +L+ +
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH-E 66
Query: 94 NVVKLLDIVRDQHSKTPSLIFEYVNST-----DFKVLYPTLTDYDIRYYIYELLKALDYC 148
N+V L DI L+ + V + D + T+ D I ++L A+ Y
Sbjct: 67 NIVTLEDIYESTTHY--YLVMQLV--SGGELFDRILERGVYTEKDASLVIQQVLSAVKYL 122
Query: 149 HSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 206
H GI+HRD+KP N++ E K+ + D+GL++ G + + + PE+L
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-MSTACGTPGYVAPEVLAQ 181
Query: 207 LQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262
+ Y ++D WS+G + G P FY KI + Y
Sbjct: 182 -KPYSKAVDCWSIGVITYILLCGY-----PPFYEETESKLFEKIKE-----------GYY 224
Query: 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322
E W +S A DF+ LL D +R T +A++H
Sbjct: 225 EFE-------------SPFWDD---------ISESAKDFICHLLEKDPNERYTCEKALSH 262
Query: 323 PYFAQVRAAES 333
P+ A
Sbjct: 263 PWIDGNTALHR 273
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 9e-42
Identities = 54/310 (17%), Positives = 108/310 (34%), Gaps = 34/310 (10%)
Query: 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLC 90
+ + + +G+G + VF G + T + IK+ + RE ++L+ L
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 91 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL-----YPTLTDYDIRYYIYELLKA 144
N+VKL I + ++ LI E+ + VL L + + + +++
Sbjct: 66 H-KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 145 LDYCHSQGIMHRDVKPHNVMIDHELRK---LRLIDWGLAEFYHPGKEYNVRVASRYFKGP 201
+++ GI+HR++KP N+M +L D+G A +++ + + P
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 202 ELL-------VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 254
++ + Y ++D+WS+G F PF + K++
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 255 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQ--HLVSPEAIDFLDKLLRYDHQD 312
A E P WS + + L +L D +
Sbjct: 245 SGAISGVQKAENGP-----------IDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293
Query: 313 RLTAREAMAH 322
+ A
Sbjct: 294 CWGFDQFFAE 303
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 9e-42
Identities = 66/321 (20%), Positives = 132/321 (41%), Gaps = 60/321 (18%)
Query: 37 QDDYEVVRKV-GRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGG 92
+D Y++ V G G ++ V IN+ T++ +KI+ + ++ RE+++L G
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 93 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-F-----KVLYPTLTDYDIRYYIYELLKALD 146
NV++L++ ++ L+FE + + + + + + ++ ALD
Sbjct: 71 RNVLELIEFFEEEDRF--YLVFEKMRGGSILSHIHKRRHF---NELEASVVVQDVASALD 125
Query: 147 YCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNV--------RVASR 196
+ H++GI HRD+KP N++ +H ++ +++ D+ L + + S
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 197 YFKGPELL----VDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAK 248
+ PE++ + YD D+WSLG + +G P F G D +
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY-----PPFVGRCGSDCGWDRGE 240
Query: 249 VLGTDELNAYLN--KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 306
+ + + + E K W+ +S A D + KLL
Sbjct: 241 ACPACQNMLFESIQEGKYEFP-----------DKDWAH---------ISCAAKDLISKLL 280
Query: 307 RYDHQDRLTAREAMAHPYFAQ 327
D + RL+A + + HP+
Sbjct: 281 VRDAKQRLSAAQVLQHPWVQG 301
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-41
Identities = 71/313 (22%), Positives = 125/313 (39%), Gaps = 63/313 (20%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKI 85
+D+Y + + +G G EV T ++ IKI+ K ++ EI+I
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 86 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELL 142
L+ L P ++K+ + + ++ E + D V L + + Y Y++L
Sbjct: 69 LKKL-NHPCIIKIKNFFDAEDY---YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 143 KALDYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 200
A+ Y H GI+HRD+KP NV++ E +++ D+G ++ + +
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184
Query: 201 PELLVDLQD--YDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 254
PE+LV + Y+ ++D WSLG +G PF +I
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGY----PPFSEHRTQVSLKDQITS------ 234
Query: 255 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 314
KY+ + W++ VS +A+D + KLL D + R
Sbjct: 235 -----GKYNFIPE-------------VWAE---------VSEKALDLVKKLLVVDPKARF 267
Query: 315 TAREAMAHPYFAQ 327
T EA+ HP+
Sbjct: 268 TTEEALRHPWLQD 280
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-41
Identities = 72/313 (23%), Positives = 134/313 (42%), Gaps = 61/313 (19%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGG 92
++Y++ ++G+G +S V + V + I L +K++RE +I + L
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KH 69
Query: 93 PNVVKLLDIVRDQHSKTPSLIFEYVNST-----DFKVLYPTLTDYDIRYYIYELLKALDY 147
PN+V+L D + ++ LIF+ V T + V ++ D + I ++L+A+ +
Sbjct: 70 PNIVRLHDSISEEGHH--YLIFDLV--TGGELFEDIVAREYYSEADASHCIQQILEAVLH 125
Query: 148 CHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELL 204
CH G++HR++KP N+++ +L+ ++L D+GLA + + + + PE+L
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185
Query: 205 VDLQDYDYSLDMWSLGCMF----AGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 260
Y +D+W+ G + G P F+ D H +I
Sbjct: 186 -RKDPYGKPVDLWACGVILYILLVGY-----PPFWDEDQHRLYQQIKA-----------G 228
Query: 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 320
Y W V+PEA D ++K+L + R+TA EA+
Sbjct: 229 AYDFP-------------SPEWDT---------VTPEAKDLINKMLTINPSKRITAAEAL 266
Query: 321 AHPYFAQVRAAES 333
HP+ + S
Sbjct: 267 KHPWISHRSTVAS 279
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-41
Identities = 67/312 (21%), Positives = 116/312 (37%), Gaps = 74/312 (23%)
Query: 35 SDQDDYEVVRKV-GRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGP 93
+ DDY+V +V G G +V + N T E+ +K+L+ K +RE+++ P
Sbjct: 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCP 71
Query: 94 NVVKLLDIVRDQHSKTPS--LIFEYVNSTD-----FKVLYPTLTDYDIRYYIYELLKALD 146
++V+++D+ + ++ ++ E ++ + T+ + + + +A+
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 147 YCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 204
Y HS I HRDVKP N++ L+L D+G A E
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA--------------------KETT 171
Query: 205 VDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKI-AKVLGTDELNAYL 259
+ YD S DMWSLG + G P FY + + ++
Sbjct: 172 --GEKYDKSCDMWSLGVIMYILLCGY-----PPFYSNHGLAISPGMKTRIR--------- 215
Query: 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 319
E WS+ VS E + LL+ + R+T E
Sbjct: 216 -MGQYEFP-----------NPEWSE---------VSEEVKMLIRNLLKTEPTQRMTITEF 254
Query: 320 MAHPYFAQVRAA 331
M HP+ Q
Sbjct: 255 MNHPWIMQSTKV 266
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 6e-41
Identities = 71/332 (21%), Positives = 138/332 (41%), Gaps = 39/332 (11%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLC------- 90
Y +VRK+G G +S V+ ++ N +KI++ K + + EIK+LQ +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 91 ---GGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYEL 141
G +++KLLD + + ++FE + ++ + + ++ +L
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 142 LKALDYCHSQ-GIMHRDVKPHNVMIDHELR-----KLRLIDWGLAEFYHPGKEYNVRVAS 195
L LDY H + GI+H D+KP NV+++ ++++ D G A +Y + Y + +
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSIQT 198
Query: 196 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD------NHDQLVKIAKV 249
R ++ PE+L+ + D+WS C+ +I F + + D + +I ++
Sbjct: 199 REYRSPEVLLGAP-WGCGADIWSTACLIFELITGD-FLFEPDEGHSYTKDDDHIAQIIEL 256
Query: 250 LG--TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEA---IDFLDK 304
LG L + + + + + + EA DFL
Sbjct: 257 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 316
Query: 305 LLRYDHQDRLTAREAMAHPYFAQVRAAESSRT 336
+L+ D + R A + HP+ E R
Sbjct: 317 MLQLDPRKRADAGGLVNHPWLKDTLGMEEIRV 348
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 7e-41
Identities = 77/347 (22%), Positives = 150/347 (43%), Gaps = 61/347 (17%)
Query: 40 YEVVRKVGRGKYSEVFEGI-NVNTNERCIIKILKPVKK--KKIKREIKILQNLC-----G 91
YE+V +G G + +V E + + + +KI++ V K + + EI +L+ +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 92 GPNVVKLLD---------IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELL 142
V + D I + + FE++ +F+ +R+ Y+L
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFELLG--KNT-FEFLKENNFQPYPLPH----VRHMAYQLC 133
Query: 143 KALDYCHSQGIMHRDVKPHNVMIDHELRK------------------LRLIDWGLAEFYH 184
AL + H + H D+KP N++ + + +R+ D+G A F H
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193
Query: 185 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 244
+ VA+R+++ PE++++L + D+WS+GC+ +R F H+N + LV
Sbjct: 194 E-HHTTI-VATRHYRPPEVILELG-WAQPCDVWSIGCILFEY-YRGFTLFQTHENREHLV 249
Query: 245 KIAKVLGT--DEL--NAYLNKYHLE-----LDPQLDALVGRHSRKPWSKFINADNQHLVS 295
+ K+LG + KY + + D + + KP ++ D+
Sbjct: 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEH-- 307
Query: 296 PEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV----RAAESSRTRA 338
+ D + ++L +D R+T EA+ HP+FA + R+ +SR +
Sbjct: 308 VQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNPS 354
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-40
Identities = 74/334 (22%), Positives = 145/334 (43%), Gaps = 57/334 (17%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTN-ERCIIKILKPVKK--KKIKREIKILQNLC-----G 91
YE+V +G G + +V E I+ +KI+K V + + + EI++L++L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 92 GPNVVKLLD---------IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELL 142
V++L+ IV + S ++++ F IR Y++
Sbjct: 76 TFRCVQMLEWFEHHGHICIVFELLG--LST-YDFIKENGFLPFRLDH----IRKMAYQIC 128
Query: 143 KALDYCHSQGIMHRDVKPHNVMIDHELR------------------KLRLIDWGLAEFYH 184
K++++ HS + H D+KP N++ ++++D+G A +
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188
Query: 185 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 244
+ V++R+++ PE+++ L + D+WS+GC+ + F HD+ + L
Sbjct: 189 E-HHSTL-VSTRHYRAPEVILALG-WSQPCDVWSIGCILIEY-YLGFTVFPTHDSKEHLA 244
Query: 245 KIAKVLGT--DEL--NAYLNKYH--LELDPQLDALVGRHSR---KPWSKFINADNQHLVS 295
+ ++LG + KY LD + GR+ KP +F+ + +
Sbjct: 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEH-- 302
Query: 296 PEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329
D + K+L YD R+T REA+ HP+F ++
Sbjct: 303 ERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-40
Identities = 71/334 (21%), Positives = 144/334 (43%), Gaps = 57/334 (17%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLC-----GG 92
YE+ +G+G + +V + + E IKI+K K + + E+++L+ +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 93 PNVVKLLD---------IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 143
+V L +V + S +L ++ + +T+F+ + L R + ++
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLS--YNL-YDLLRNTNFRGVSLNL----TRKFAQQMCT 168
Query: 144 ALDYCHSQ--GIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKG 200
AL + + I+H D+KP N+++ + R ++++D+G + + + SR+++
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG--QRIYQYIQSRFYRS 226
Query: 201 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG--------- 251
PE+L+ + YD ++DMWSLGC+ M EP F G + DQ+ KI +VLG
Sbjct: 227 PEVLLGM-PYDLAIDMWSLGCILVEM-HTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQ 284
Query: 252 -----------------TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLV 294
+ +Y +L ++G + P + +
Sbjct: 285 APKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVA 344
Query: 295 SPEA-IDFLDKLLRYDHQDRLTAREAMAHPYFAQ 327
D + ++L YD + R+ A+ H +F +
Sbjct: 345 DYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 378
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 8e-40
Identities = 53/322 (16%), Positives = 105/322 (32%), Gaps = 67/322 (20%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVV 96
D++ + +G G + +VF+ + + +IK +K +K +RE+K L L N+V
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK-YNNEKAEREVKALAKLDH-VNIV 67
Query: 97 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--------------------PTLTDYDIRY 136
+ S K L+ L
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKT-KCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 137 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR 196
++ K +DY HS+ +++RD+KP N+ + +++++ D+GL + +
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDT-KQVKIGDFGLVTSLKNDGKRTRSKGTL 185
Query: 197 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 256
+ PE + QDY +D+++LG + A ++ + F L
Sbjct: 186 RYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG---------- 234
Query: 257 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 316
+ + L KLL +DR
Sbjct: 235 --------IISDI------------------------FDKKEKTLLQKLLSKKPEDRPNT 262
Query: 317 REAMAHPYFAQVRAAESSRTRA 338
E + + ++ R A
Sbjct: 263 SEILRTLTVWKKSPEKNERHTA 284
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 8e-40
Identities = 68/334 (20%), Positives = 137/334 (41%), Gaps = 59/334 (17%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNL----CGGP 93
+ V+RK+G G + V +++ + +K+++ +KK + K E IL+ +
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 94 NVVKLLD---------IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKA 144
N+VK ++ + PSL +E + ++ + I+ Y E+LKA
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPLG--PSL-YEIITRNNYNGFHIED----IKLYCIEILKA 149
Query: 145 LDYCHSQGIMHRDVKPHNVMIDHELRK------------------------LRLIDWGLA 180
L+Y + H D+KP N+++D + ++LID+G A
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209
Query: 181 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH 240
F ++ + +R ++ PE++++L +D S DMWS GC+ A + + F H++
Sbjct: 210 TFKSD-YHGSI-INTRQYRAPEVILNLG-WDVSSDMWSFGCVLAEL-YTGSLLFRTHEHM 265
Query: 241 DQLVKIAKVLGT--DEL-----NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHL 293
+ L + ++ + +KY + + +L S +
Sbjct: 266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYK 325
Query: 294 VS--PEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325
+ DFL +L+ D R + E + H +
Sbjct: 326 IIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 68/307 (22%), Positives = 120/307 (39%), Gaps = 32/307 (10%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGP 93
+E+ ++G G + V I+ +T E+ IK + P +++ EI+I++ L P
Sbjct: 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHP 72
Query: 94 NVVKLLDIVRDQHSKTPS----LIFEYVNSTD-FKVL-----YPTLTDYDIRYYIYELLK 143
NVV ++ P+ L EY D K L L + IR + ++
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 144 ALDYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 201
AL Y H I+HRD+KP N+++ + ++ID G A+ G+ V + + P
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 192
Query: 202 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261
ELL + + Y ++D WS G + I P F + Q + + + Y
Sbjct: 193 ELL-EQKKYTVTVDYWSFGTLAFECITGFRP-FLPNWQPVQWHGKVREKSNEHIVVY--- 247
Query: 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321
L V S P ++ + +L +L + + R T +
Sbjct: 248 ------DDLTGAVKFSSVLPTPNHLSGILAGKLER----WLQCMLMWHQRQRGTDPQNPN 297
Query: 322 HPYFAQV 328
F +
Sbjct: 298 VGCFQAL 304
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-37
Identities = 53/321 (16%), Positives = 100/321 (31%), Gaps = 71/321 (22%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCG 91
++ + K+G G++ VF+ + IK K V ++ RE+ L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 92 GPNVVKLLDIVRDQHSKTPSLIF-EYVNS-------TDFKVLYPTLTDYDIRYYIYELLK 143
+VV+ + LI EY N ++ + + +++ + ++ +
Sbjct: 70 HSHVVRYFSAWAEDDH---MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-------------- 189
L Y HS ++H D+KP N+ I + G + + K
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 190 -NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 248
V F E+L + + D+++L + G H +I +
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH----EIRQ 242
Query: 249 VLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRY 308
GR R P Q L S E + L ++
Sbjct: 243 --------------------------GRLPRIP---------QVL-SQEFTELLKVMIHP 266
Query: 309 DHQDRLTAREAMAHPYFAQVR 329
D + R +A + H
Sbjct: 267 DPERRPSAMALVKHSVLLSAS 287
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 2e-37
Identities = 59/304 (19%), Positives = 101/304 (33%), Gaps = 58/304 (19%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNV 95
+ +VGRG + EV + T +C +K ++ + E+ L P +
Sbjct: 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--LEVFRVEELVACAGLSS-PRI 112
Query: 96 VKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQG 152
V L VR+ ++ E + L + YY+ + L+ L+Y H++
Sbjct: 113 VPLYGAVREGP--WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR 170
Query: 153 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELLVD 206
I+H DVK NV++ + + L D+G A P + Y G PE +V
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-VVM 229
Query: 207 LQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262
+ D +D+WS C M G + + +KIA
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNG-----CHPWTQYFRGPLCLKIAS-------------- 270
Query: 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322
P + +P + + LR + R +A E
Sbjct: 271 ---------------EPPP-----IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRK 310
Query: 323 PYFA 326
A
Sbjct: 311 VGKA 314
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-37
Identities = 61/311 (19%), Positives = 117/311 (37%), Gaps = 58/311 (18%)
Query: 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNL 89
S +DYEV+ +G G Y + + + + K + +K+ + E+ +L+ L
Sbjct: 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 90 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELL 142
PN+V+ D + D+ + T ++ EY D L + + + +L
Sbjct: 63 K-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 143 KALDYCHSQG-----IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASR 196
AL CH + ++HRD+KP NV +D + + ++L D+GLA + + V +
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTP 180
Query: 197 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 256
Y+ PE + Y+ D+WSLGC+ + PF + +L
Sbjct: 181 YYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFT--AFSQKELAG----------- 226
Query: 257 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 316
+ + S E + + ++L R +
Sbjct: 227 ----------------KIREGKFRRIPYRY--------SDELNEIITRMLNLKDYHRPSV 262
Query: 317 REAMAHPYFAQ 327
E + +P +
Sbjct: 263 EEILENPLILE 273
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-37
Identities = 67/308 (21%), Positives = 130/308 (42%), Gaps = 75/308 (24%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK--------KIKREIKILQNL 89
+D+E+ R +G+GK+ V+ + +K+L K + +++RE++I +L
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF--KAQLEKAGVEHQLRREVEIQSHL 66
Query: 90 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYPT--LTDYDIRYYIYELLKALD 146
PN+++L D + LI EY ++ L + YI EL AL
Sbjct: 67 RH-PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 147 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--------EYNVRVASRYF 198
YCHS+ ++HRD+KP N+++ L++ D+G + + +Y +
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGE-LKIADFGWSVHAPSSRRTDLCGTLDY---LP---- 175
Query: 199 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKVLGTDELNA 257
PE++ + +D +D+WSLG + + K PF + + + +I++V
Sbjct: 176 --PEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFE--ANTYQETYKRISRV-------- 222
Query: 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 317
++ P + V+ A D + +LL+++ R R
Sbjct: 223 ---EFTF---P------------DF-----------VTEGARDLISRLLKHNPSQRPMLR 253
Query: 318 EAMAHPYF 325
E + HP+
Sbjct: 254 EVLEHPWI 261
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 4e-37
Identities = 54/337 (16%), Positives = 113/337 (33%), Gaps = 79/337 (23%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGP 93
D+E ++ +GRG + VFE N + IK ++ + ++K+ RE+K L L P
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH-P 63
Query: 94 NVVKLLDIVRDQHSKTPS----------LIFEYVNSTDFKVL------YPTLTDYDIRYY 137
+V+ + ++++ + + + K +
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 138 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-------EFYHPGKEYN 190
++ +A+++ HS+G+MHRD+KP N+ + +++ D+GL E
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 191 VRVASRYFKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 244
G PE + Y + +D++SLG + +++ PF + L
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238
Query: 245 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 304
+ + K P +
Sbjct: 239 DVRN--------------------------LKFPPLFTQK----------YPCEYVMVQD 262
Query: 305 LLRYDHQDRLTAREAMAHPYFAQV----RAAESSRTR 337
+L +R A + + F + + R+R
Sbjct: 263 MLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSR 299
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-36
Identities = 53/314 (16%), Positives = 111/314 (35%), Gaps = 63/314 (20%)
Query: 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGGPNV 95
Y ++K+G G +S V ++ +K + + +++ +RE + + PN+
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNI 88
Query: 96 VKLLDIVRDQHSKTPS--LIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKALD 146
++L+ + L+ + K LT+ I + + + + L+
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 147 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR---------- 196
H++G HRD+KP N+++ E + L+D G E + + +
Sbjct: 149 AIHAKGYAHRDLKPTNILLGDE-GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 197 YFKGPELLVDLQDY---DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 253
++ PE L +Q + D D+WSLGC+ M+F + P+ D + +
Sbjct: 208 SYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ----- 261
Query: 254 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 313
N+ + P+ S L+ ++ D R
Sbjct: 262 ------NQLSIPQSPR------------------------HSSALWQLLNSMMTVDPHQR 291
Query: 314 LTAREAMAHPYFAQ 327
++ Q
Sbjct: 292 PHIPLLLSQLEALQ 305
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-36
Identities = 66/308 (21%), Positives = 125/308 (40%), Gaps = 73/308 (23%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCG 91
Y R +G+G +++ FE + +T E KI+ KP +++K+ EI I ++L
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYC 148
+VV D + ++ E + LT+ + RYY+ +++ Y
Sbjct: 101 -QHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 157
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE----------YNVRVASRYF 198
H ++HRD+K N+ ++ +L +++ D+GLA E Y +A
Sbjct: 158 HRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKVLCGTPNY---IA---- 209
Query: 199 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL-VKIAKVLGTDELNA 257
PE+L + + + +D+WS+GC+ ++ K PF + ++I K
Sbjct: 210 --PEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFE--TSCLKETYLRIKK--------- 255
Query: 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 317
N+Y + P ++P A + K+L+ D R T
Sbjct: 256 --NEYSI---P------------KH-----------INPVAASLIQKMLQTDPTARPTIN 287
Query: 318 EAMAHPYF 325
E + +F
Sbjct: 288 ELLNDEFF 295
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 129 bits (328), Expect = 1e-35
Identities = 64/311 (20%), Positives = 134/311 (43%), Gaps = 74/311 (23%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCG 91
+D++V +G+G ++ V+ +++T IK++ K ++++ E+KI L
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP---TLTDYDIRYYIYELLKALDY 147
P++++L + D S L+ E ++ + + L ++ + R+++++++ + Y
Sbjct: 71 -PSILELYNYFED--SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLY 127
Query: 148 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE----------YNVRVASRY 197
HS GI+HRD+ N+++ + +++ D+GLA E Y ++
Sbjct: 128 LHSHGILHRDLTLSNLLLTRNMN-IKIADFGLATQLKMPHEKHYTLCGTPNY---IS--- 180
Query: 198 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKVLGTDELN 256
PE+ + D+WSLGCMF ++ + PF D + K+
Sbjct: 181 ---PEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFD--TDTVKNTLNKVVL-------- 226
Query: 257 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 316
Y + P + +S EA D + +LLR + DRL+
Sbjct: 227 ---ADYEM---P------------SF-----------LSIEAKDLIHQLLRRNPADRLSL 257
Query: 317 REAMAHPYFAQ 327
+ HP+ ++
Sbjct: 258 SSVLDHPFMSR 268
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-35
Identities = 69/309 (22%), Positives = 115/309 (37%), Gaps = 69/309 (22%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---------KPVKKKKIKREIKILQN 88
Y+V +G G + V+ GI V+ N IK + + ++ E+ +L+
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 89 LC-GGPNVVKLLDIVRDQHSKTPS---LIFEYVNST----DFKVLYPTLTDYDIRYYIYE 140
+ G V++LLD + P LI E DF L + R + ++
Sbjct: 103 VSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 157
Query: 141 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 200
+L+A+ +CH+ G++HRD+K N++ID +L+LID+G Y +R +
Sbjct: 158 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSP 216
Query: 201 PELLVDLQDYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259
PE + Y S +WSLG + M+ PF + +I +
Sbjct: 217 PEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPF---EHDE----EIIR----------- 257
Query: 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 319
G+ + VS E + L DR T E
Sbjct: 258 ---------------GQVFFRQR-----------VSSECQHLIRWCLALRPSDRPTFEEI 291
Query: 320 MAHPYFAQV 328
HP+ V
Sbjct: 292 QNHPWMQDV 300
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-35
Identities = 66/308 (21%), Positives = 125/308 (40%), Gaps = 73/308 (23%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCG 91
Y R +G+G +++ FE + +T E KI+ KP +++K+ EI I ++L
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYC 148
+VV D + ++ E + LT+ + RYY+ +++ Y
Sbjct: 75 -QHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 131
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE----------YNVRVASRYF 198
H ++HRD+K N+ ++ +L +++ D+GLA E Y +A
Sbjct: 132 HRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKVLCGTPNY---IA---- 183
Query: 199 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL-VKIAKVLGTDELNA 257
PE+L + + + +D+WS+GC+ ++ K PF + ++I K
Sbjct: 184 --PEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFE--TSCLKETYLRIKK--------- 229
Query: 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 317
N+Y + P ++P A + K+L+ D R T
Sbjct: 230 --NEYSI---P------------KH-----------INPVAASLIQKMLQTDPTARPTIN 261
Query: 318 EAMAHPYF 325
E + +F
Sbjct: 262 ELLNDEFF 269
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-35
Identities = 56/306 (18%), Positives = 122/306 (39%), Gaps = 55/306 (17%)
Query: 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQN 88
F + Y ++K+G G + + + + +IK + ++++ +RE+ +L N
Sbjct: 20 FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLAN 79
Query: 89 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL----YPTLTDYDIRYYIYELLK 143
+ PN+V+ + + + + ++ +Y D FK + + I + ++
Sbjct: 80 MKH-PNIVQYRESFEE--NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICL 136
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPE 202
AL + H + I+HRD+K N+ + + ++L D+G+A + E + + Y+ PE
Sbjct: 137 ALKHVHDRKILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELARACIGTPYYLSPE 195
Query: 203 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKVLGTDELNAYLNK 261
+ + + Y+ D+W+LGC+ + K F + LV KI
Sbjct: 196 ICEN-KPYNNKSDIWALGCVLYELCTLKHAFE--AGSMKNLVLKIIS------------- 239
Query: 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321
G P S S + + +L + + +DR + +
Sbjct: 240 -------------GSF--PPVSLHY--------SYDLRSLVSQLFKRNPRDRPSVNSILE 276
Query: 322 HPYFAQ 327
+ A+
Sbjct: 277 KGFIAK 282
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-35
Identities = 56/295 (18%), Positives = 113/295 (38%), Gaps = 51/295 (17%)
Query: 45 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGGPNVVKLL 99
++GRG + V++G++ T L+ K K K E ++L+ L PN+V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PNIVRFY 91
Query: 100 DIVRDQHSKTPSLIF--EYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQG-- 152
D ++ E + S + + + +R + ++LK L + H++
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 151
Query: 153 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 212
I+HRD+K N+ I +++ D GLA V + + F PE+ + YD
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFMAPEMY--EEKYDE 208
Query: 213 SLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA 272
S+D+++ G M + P + N Q+ +
Sbjct: 209 SVDVYAFGMCMLEMATSEYP-YSECQNAAQIYRRVT------------------------ 243
Query: 273 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 327
S A + PE + ++ +R + +R + ++ + H +F +
Sbjct: 244 ----------SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-35
Identities = 65/307 (21%), Positives = 127/307 (41%), Gaps = 73/307 (23%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCG 91
DD+++ R +G+GK+ V+ +K+L + + +++REI+I +L
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL--YPTLTDYDIRYYIYELLKALDYC 148
PN++++ + D K L+ E+ + +K L + + ++ EL AL YC
Sbjct: 74 -PNILRMYNYFHD--RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYC 130
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---------EYNVRVASRYFK 199
H + ++HRD+KP N+++ ++ L++ D+G + + P +Y +
Sbjct: 131 HERKVIHRDIKPENLLMGYKGE-LKIADFGWS-VHAPSLRRRTMCGTLDY---LP----- 180
Query: 200 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKVLGTDELNAY 258
PE++ + +D +D+W G + + PF +H + +I V
Sbjct: 181 -PEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFD--SPSHTETHRRIVNV--------- 227
Query: 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 318
P P+ +S + D + KLLRY RL +
Sbjct: 228 --DLKF---P------------PF-----------LSDGSKDLISKLLRYHPPQRLPLKG 259
Query: 319 AMAHPYF 325
M HP+
Sbjct: 260 VMEHPWV 266
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-35
Identities = 65/313 (20%), Positives = 119/313 (38%), Gaps = 55/313 (17%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIK------ILKPVKKKKIKREIKILQNLCG 91
++ + +K+GRG++SEV+ + +K ++ + +EI +L+ L
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKA 144
PNV+K + + +++ E ++ D FK + + + Y +L A
Sbjct: 92 -PNVIKYYASFIEDN--ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 145 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPEL 203
L++ HS+ +MHRD+KP NV I ++L D GL F+ + V + Y+ PE
Sbjct: 149 LEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 207
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKVLGTDELNAYLNKY 262
+ + Y++ D+WSLGC+ M + PF+ N L KI +
Sbjct: 208 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-------------- 252
Query: 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322
+ P + S E ++ + D + R
Sbjct: 253 ------------CDYPPLPSDHY---------SEELRQLVNMCINPDPEKRPDVTYVYDV 291
Query: 323 PYFAQVRAAESSR 335
A S
Sbjct: 292 AKRMHACTASSLE 304
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-35
Identities = 47/348 (13%), Positives = 99/348 (28%), Gaps = 95/348 (27%)
Query: 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK------KKIKREIKILQNL--- 89
+G+ E + T E + + ++ K++K E+ L+ L
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 90 ---------------------CGGPNVVKLLDIVRDQHSKTPSLIFEYVNST-------- 120
++++ RD + ++ + S
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 121 -DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 179
+ +L + ++++ L H G++H ++P ++++D + L +
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG-VFLTGFEH 252
Query: 180 AEFYHPGKEYNVRVASRYFKGPELLVDLQD----------YDYSLDMWSLGCMFAGMIFR 229
V SR F+ PEL +S D W+LG + +
Sbjct: 253 L---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
Query: 230 KEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINAD 289
P T + +++
Sbjct: 310 DLPI------------------TKDAALGGSEWIFRSCKN-------------------- 331
Query: 290 NQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTR 337
+ L+ LRY +DRL +AM P + Q+R S+
Sbjct: 332 ----IPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALP 375
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-34
Identities = 64/312 (20%), Positives = 116/312 (37%), Gaps = 67/312 (21%)
Query: 46 VGRGKYSEVFEGINVNTNERCIIKILKPVKK---KKIKREIKILQNLCGGPNVVKLLDIV 102
+G+G Y V+ G +++ R IK + + + EI + ++L N+V+ L
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH-KNIVQYLGSF 88
Query: 103 RDQHSKTPSLIFEYVN----STDFKVLYPTLTDYD--IRYYIYELLKALDYCHSQGIMHR 156
+ + E V S + + L D + I +Y ++L+ L Y H I+HR
Sbjct: 89 SENG--FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 157 DVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PE-LLVDLQD 209
D+K NV+I+ L++ D+G + + + + F G PE + +
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTS-----KRLAGINPCTETFTGTLQYMAPEIIDKGPRG 201
Query: 210 YDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265
Y + D+WSLGC M G K PF+ + + K+ K H E
Sbjct: 202 YGKAADIWSLGCTIIEMATG----KPPFYELGEPQAAMFKVGM-----------FKVHPE 246
Query: 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325
+ + S EA F+ K D R A + + +
Sbjct: 247 IPESM------------------------SAEAKAFILKCFEPDPDKRACANDLLVDEFL 282
Query: 326 AQVRAAESSRTR 337
+ ++ +
Sbjct: 283 KVSSKKKKTQPK 294
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-33
Identities = 68/325 (20%), Positives = 125/325 (38%), Gaps = 60/325 (18%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--------------------PVKKK 77
+DY ++R + +GK++++ N+ +K + K
Sbjct: 31 NDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 78 KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-----------NSTDFKVLY 126
K E++I+ ++ + I+ + +I+EY+ K
Sbjct: 89 DFKNELQIITDIKN-EYCLTCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145
Query: 127 PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185
+ I+ I +L + Y H++ I HRDVKP N+++D R ++L D+G +E Y
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR-VKLSDFGESE-YMV 203
Query: 186 GKEYNVRVASRYFKGPELLVDLQDYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 244
K+ + F PE + Y+ +D+WSLG M + PF + +L
Sbjct: 204 DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF-SLKISLVELF 262
Query: 245 -KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLD 303
I LD H P + + + + +S E IDFL
Sbjct: 263 NNIRTK-----------NIEYPLDRN-------HFLYPLTNKKSTCSNNFLSNEDIDFLK 304
Query: 304 KLLRYDHQDRLTAREAMAHPYFAQV 328
LR + +R+T+ +A+ H + A
Sbjct: 305 LFLRKNPAERITSEDALKHEWLADT 329
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-33
Identities = 61/312 (19%), Positives = 107/312 (34%), Gaps = 79/312 (25%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---------KPVKKKKIKREIKILQN 88
+Y + +G+G + VF G + + IK++ E+ +L
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 89 LCGG---PNVVKLLDIVRDQHSKTPS---LIFEYVNST----DFKVLYPTLTDYDIRYYI 138
+ G P V++LLD +T L+ E D+ L + R +
Sbjct: 91 VGAGGGHPGVIRLLDWF-----ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF 145
Query: 139 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF 198
+++ A+ +CHS+G++HRD+K N++ID +LID+G H Y +R +
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP-YTDFDGTRVY 204
Query: 199 KGPELLVDLQDYD-YSLDMWSLG----CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 253
PE + Y +WSLG M G I PF ++ +I +
Sbjct: 205 SPPEWISR-HQYHALPATVWSLGILLYDMVCGDI----PF-------ERDQEILE----- 247
Query: 254 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 313
VSP+ + + L R
Sbjct: 248 ---------------------AELHFPAH-----------VSPDCCALIRRCLAPKPSSR 275
Query: 314 LTAREAMAHPYF 325
+ E + P+
Sbjct: 276 PSLEEILLDPWM 287
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 69/305 (22%), Positives = 121/305 (39%), Gaps = 65/305 (21%)
Query: 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----------PVKKKKIKREIKILQ 87
Y + +G G + V+ ++ N+ ++K +K K K+ EI IL
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 88 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELLK 143
+ N++K+LDI +Q L+ E S F +P L + Y +L+
Sbjct: 85 RVEH-ANIIKVLDIFENQ--GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS 141
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
A+ Y + I+HRD+K N++I + ++LID+G A + GK + + + PE+
Sbjct: 142 AVGYLRLKDIIHRDIKDENIVIAEDFT-IKLIDFGSAAYLERGKLFYTFCGTIEYCAPEV 200
Query: 204 LVDLQDYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262
L+ Y L+MWSLG ++F + PF +L + +
Sbjct: 201 LMG-NPYRGPELEMWSLGVTLYTLVFEENPF-------CELEETVE-----------AAI 241
Query: 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322
H P +LVS E + + LL+ + R T + +
Sbjct: 242 HP---P-----------------------YLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275
Query: 323 PYFAQ 327
P+ Q
Sbjct: 276 PWVTQ 280
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 5e-33
Identities = 60/316 (18%), Positives = 119/316 (37%), Gaps = 74/316 (23%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGGPNVV 96
V R + G ++ V+E +V + +K L + K + I +E+ ++ L G PN+V
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 97 KLLD--IVRDQHSKTPSLIF----EYVNSTDFKVLYPT-----LTDYDIRYYIYELLKAL 145
+ + + S T F E + L L+ + Y+ +A+
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 146 DYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR------- 196
+ H Q I+HRD+K N+++ ++ ++L D+G A +Y+ R
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 197 ------YFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 247
++ PE ++DL D+W+LGC+ + FR+ PF ++ +L +I
Sbjct: 209 TRNTTPMYRTPE-IIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF----EDGAKL-RIV 262
Query: 248 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 307
G++S P + +L+
Sbjct: 263 N--------------------------GKYSIPPHDTQ---------YTVFHSLIRAMLQ 287
Query: 308 YDHQDRLTAREAMAHP 323
+ ++RL+ E +
Sbjct: 288 VNPEERLSIAEVVHQL 303
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 65/299 (21%), Positives = 134/299 (44%), Gaps = 58/299 (19%)
Query: 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGGP 93
+Y +++ +G+G +++V ++ T IKI L P +K+ RE++I++ L P
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH-P 74
Query: 94 NVVKLLDIVRDQHSKTPS---LIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDY 147
N+VKL +++ +T LI EY + D+ V + + + + R +++ A+ Y
Sbjct: 75 NIVKLFEVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQY 129
Query: 148 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 207
CH + I+HRD+K N+++D ++ +++ D+G + + G + + + + PEL
Sbjct: 130 CHQKRIVHRDLKAENLLLDADM-NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQG- 187
Query: 208 QDYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266
+ YD +D+WSLG + ++ PF N +L + +VL
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPF--DGQNLKELRE--RVLR--------------- 228
Query: 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325
G++ + +S + + L + L + R T + M +
Sbjct: 229 --------GKYRIPFY-----------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI 268
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-31
Identities = 64/306 (20%), Positives = 119/306 (38%), Gaps = 65/306 (21%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQNLCGGP 93
+D+++V+ +G G Y EV +N T E +KI+ + + IK+EI I + L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-E 65
Query: 94 NVVKLLDIVRDQHSKTPSLIF---EYVNST---DFKVLYPTLTDYDIRYYIYELLKALDY 147
NVVK + ++ + EY + D + + D + + ++L+ + Y
Sbjct: 66 NVVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 148 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELL 204
H GI HRD+KP N+++D L++ D+GLA + + + + PELL
Sbjct: 121 LHGIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 205 VDLQDYD-YSLDMWSLG----CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259
+++ +D+WS G M AG + P+ D+ + +
Sbjct: 180 KR-REFHAEPVDVWSCGIVLTAMLAGEL----PWDQPSDSCQEYSDWKE----------- 223
Query: 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 319
+ PW K + L K+L + R+T +
Sbjct: 224 ---------------KKTYLNPWKKI---------DSAPLALLHKILVENPSARITIPDI 259
Query: 320 MAHPYF 325
++
Sbjct: 260 KKDRWY 265
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-31
Identities = 70/301 (23%), Positives = 121/301 (40%), Gaps = 55/301 (18%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-------PVKKKKIKREIKILQNLCGG 92
Y + +G G Y +V E ++ T R +KILK P + +K+EI++L+ L
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH- 65
Query: 93 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF----KVLYPTLTDYDIRYYIYELLKALDYC 148
NV++L+D++ ++ + ++ EY V Y +L+ L+Y
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYL 125
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELLV 205
HSQGI+H+D+KP N+++ L++ G+AE HP + S F+ PE+
Sbjct: 126 HSQGIVHKDIKPGNLLLTTGGT-LKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184
Query: 206 DLQDYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264
L + + +D+WS G + PF DN +L + + Y +
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPFE--GDNIYKLFE--NIGKGS--------YAI 232
Query: 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 324
P P D L +L Y+ R + R+ H +
Sbjct: 233 ---P------------GD-----------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266
Query: 325 F 325
F
Sbjct: 267 F 267
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 5e-31
Identities = 43/280 (15%), Positives = 96/280 (34%), Gaps = 38/280 (13%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCIIKILKPVKKKKIKREIKILQNLC 90
V +G G +++V+E + N ++ ++K+ KP + ++++ L
Sbjct: 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLK 122
Query: 91 GG--PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF--------KVLYPTLTDYDIRYYIYE 140
+K Q+ L+ E + + + +
Sbjct: 123 PSMQHMFMKFYSAHLFQNGS--VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 141 LLKALDYCHSQGIMHRDVKPHNVMIDHELR----------KLRLIDWGLA---EFYHPGK 187
+L ++ H I+H D+KP N ++ + L LID G + + + G
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 247
+ + + F+ E+L + + ++Y +D + + M+F + +
Sbjct: 241 IFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF 299
Query: 248 KV-----LGTDELNAYLNKYHLELDPQLDALVGRHSRKPW 282
+ + + + LN P LD L R K
Sbjct: 300 RRLPHLDMWNEFFHVMLNIPDCHHLPSLDLL--RQKLKKV 337
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 8e-31
Identities = 71/322 (22%), Positives = 127/322 (39%), Gaps = 65/322 (20%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI--LKPVKKKKIKREIKILQNLCGGPN 94
+E+V VG G Y +V++G +V T + IK+ + ++++IK+EI +L+ N
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 95 VVKLLDIVRDQHSKTPS----LIFEY---------VNSTDFKVLYPTLTDYDIRYYIYEL 141
+ ++ L+ E+ + +T TL + I Y E+
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN----TLKEEWIAYICREI 138
Query: 142 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKG 200
L+ L + H ++HRD+K NV++ +++L+D+G+ A+ N + + Y+
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 197
Query: 201 PELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTDE 254
PE++ ++ YD+ D+WSLG M P D H L I +
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC---DMHPMRALFLIPR------ 248
Query: 255 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 314
N P+L + K WSK F++ L +H R
Sbjct: 249 -----NP-----APRLKS-------KKWSKKFQ------------SFIESCLVKNHSQRP 279
Query: 315 TAREAMAHPYFAQVRAAESSRT 336
+ M HP+ R
Sbjct: 280 ATEQLMKHPFIRDQPNERQVRI 301
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-30
Identities = 64/306 (20%), Positives = 119/306 (38%), Gaps = 65/306 (21%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQNLCGGP 93
+D+++V+ +G G Y EV +N T E +KI+ + + IK+EI I + L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-E 65
Query: 94 NVVKLLDIVRDQHSKTPSLIF---EYVNST---DFKVLYPTLTDYDIRYYIYELLKALDY 147
NVVK + ++ + EY + D + + D + + ++L+ + Y
Sbjct: 66 NVVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 148 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELL 204
H GI HRD+KP N+++D L++ D+GLA + + + + PELL
Sbjct: 121 LHGIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 205 VDLQDYD-YSLDMWSLG----CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259
+++ +D+WS G M AG + P+ D+ + +
Sbjct: 180 KR-REFHAEPVDVWSCGIVLTAMLAGEL----PWDQPSDSCQEYSDWKE----------- 223
Query: 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 319
+ PW K + L K+L + R+T +
Sbjct: 224 ---------------KKTYLNPWKKI---------DSAPLALLHKILVENPSARITIPDI 259
Query: 320 MAHPYF 325
++
Sbjct: 260 KKDRWY 265
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-30
Identities = 63/335 (18%), Positives = 117/335 (34%), Gaps = 47/335 (14%)
Query: 36 DQDDYEVVRKVGRG--KYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQN 88
+ YE++ +G+G V T E ++ + ++ E+ + +
Sbjct: 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSK- 81
Query: 89 LCGGPNVVKLLD--IVRDQHSKTPSL--IFEYVNS---TDF-KVLYP-TLTDYDIRYYIY 139
L PN+V I ++ L + ++ D + + + I Y +
Sbjct: 82 LFNHPNIVPYRATFIADNE------LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ 135
Query: 140 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE--FYHPGKEYNVRVASRY 197
+LKALDY H G +HR VK +++I + K+ L H ++ V +Y
Sbjct: 136 GVLKALDYIHHMGYVHRSVKASHILISVD-GKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194
Query: 198 FKG------PELLV-DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ--LVKIAK 248
PE+L +LQ YD D++S+G + PF D L++
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF---KDMPATQMLLEKLN 251
Query: 249 ---------VLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAI 299
E + D+L R + SP
Sbjct: 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH 311
Query: 300 DFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS 334
F+++ L+ + R +A + H +F Q++ S
Sbjct: 312 HFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASE 346
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-29
Identities = 64/332 (19%), Positives = 118/332 (35%), Gaps = 79/332 (23%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCG 91
++DDYE+ +G G + V E+ IK + ++ +EI+ + C
Sbjct: 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMS-QCH 71
Query: 92 GPNVVK----------------------LLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTL 129
PN+V +LDI++ +K L
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHK-------------SGVL 118
Query: 130 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189
+ I + E+L+ L+Y H G +HRDVK N+++ + +++ D+G++ F G +
Sbjct: 119 DESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG-SVQIADFGVSAFLATGGDI 177
Query: 190 NVRVASRYFKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--D 241
+ F G PE++ ++ YD+ D+WS G + P+ H
Sbjct: 178 TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY---HKYPPMK 234
Query: 242 QLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDF 301
L+ + P L+ V K+
Sbjct: 235 VLMLTLQ----------------NDPPSLETGVQDKEML--KKY---------GKSFRKM 267
Query: 302 LDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 333
+ L+ D + R TA E + H +F + + E
Sbjct: 268 ISLCLQKDPEKRPTAAELLRHKFFQKAKNKEF 299
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-29
Identities = 47/346 (13%), Positives = 99/346 (28%), Gaps = 92/346 (26%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK------KKIKREIKILQNLCGGP 93
+G+ E + T E + + ++ K++K E+ L+ L G
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 94 NVVKLLDIVRD-------QHSKTPSLIFEYVNSTDFKVLY-------------------- 126
N + +R + + +I ++ D VL
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 127 ------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180
+L + ++++ L H G++H ++P ++++D + L +
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG-VFLTGFEHL 258
Query: 181 EFYHPGKEYNVRVASRY----FKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEP 232
G + + +L Q ++ D W+LG + P
Sbjct: 259 V--RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
Query: 233 FFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQH 292
TD+ +++
Sbjct: 317 N------------------TDDAALGGSEWIFRSCKN----------------------- 335
Query: 293 LVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 338
+ L+ LRY +DRL +AM P + Q+R S+
Sbjct: 336 -IPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPL 380
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 64/298 (21%), Positives = 119/298 (39%), Gaps = 49/298 (16%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL--KPVKKKKIKREIKILQNLCGGPNV 95
D Y+ V+ +G G + + T E +K + + ++REI ++L PN+
Sbjct: 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRH-PNI 78
Query: 96 VKLLDIVRDQHSKTPSLIF---EYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 149
V+ +++ TP+ + EY + + ++ + R++ +LL + YCH
Sbjct: 79 VRFKEVI-----LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH 133
Query: 150 SQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 208
S I HRD+K N ++D +L++ D+G ++ + V + + PE+L+ Q
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR-Q 192
Query: 209 DYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267
+YD D+WS G M+ PF + D I ++L Y +
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK--------YSI--- 241
Query: 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325
P I SPE + ++ D R++ E H +F
Sbjct: 242 -------------PDDIRI--------SPECCHLISRIFVADPATRISIPEIKTHSWF 278
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 68/299 (22%), Positives = 123/299 (41%), Gaps = 59/299 (19%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGP 93
Y + +G G + +V G + T + +KIL K KIKREI+ L+ P
Sbjct: 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH-P 71
Query: 94 NVVKLLDIVRDQHSKTPSLIF---EYVNST---DFKVLYPTLTDYDIRYYIYELLKALDY 147
+++KL ++ TP+ F EYV+ D+ + + + + R ++L A+DY
Sbjct: 72 HIIKLYQVI-----STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126
Query: 148 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 207
CH ++HRD+KP NV++D + ++ D+GL+ G+ S + PE++
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG- 184
Query: 208 QDYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266
+ Y +D+WS G + ++ PF ++ L K K+ G
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPF--DDEHVPTLFK--KIRG--------------- 225
Query: 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325
G + ++ L +L+ D R T ++ H +F
Sbjct: 226 --------GVFYIPEY-----------LNRSVATLLMHMLQVDPLKRATIKDIREHEWF 265
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-28
Identities = 66/322 (20%), Positives = 131/322 (40%), Gaps = 76/322 (23%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKK------------------- 77
Y + ++G+G Y V N N N +K+L K +++
Sbjct: 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 78 -------KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYPT- 128
++ +EI IL+ PNVVKL++++ D + ++FE VN +V
Sbjct: 75 QPRGPIEQVYQEIAILK-KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133
Query: 129 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188
L++ R+Y +L+K ++Y H Q I+HRD+KP N+++ + +++ D+G++ +
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH-IKIADFGVSNEFKGSDA 192
Query: 189 Y-NVRVASRYFKGPELLVDL-QDYD-YSLDMWSLGC-MFAGMIFRKEPFFYGHDNHDQL- 243
+ V + F PE L + + + +LD+W++G ++ +F + PF + L
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC-FVFGQCPFM--DERIMCLH 249
Query: 244 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLD 303
KI P + + + D +
Sbjct: 250 SKIKS-----------QALEFPDQPDI------------------------AEDLKDLIT 274
Query: 304 KLLRYDHQDRLTAREAMAHPYF 325
++L + + R+ E HP+
Sbjct: 275 RMLDKNPESRIVVPEIKLHPWV 296
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 69/307 (22%), Positives = 124/307 (40%), Gaps = 54/307 (17%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-KKIKREIKILQNLCGGPNV 95
++ ++V+ K+G G Y V++ I+ T + IK + ++I +EI I+Q C P+V
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQ-CDSPHV 86
Query: 96 VKLLDIVRDQHSKTPSL--IFEYVNS---TD-FKVLYPTLTDYDIRYYIYELLKALDYCH 149
VK + K L + EY + +D ++ TLT+ +I + LK L+Y H
Sbjct: 87 VKYYG----SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 150 SQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQ 208
+HRD+K N++++ E +L D+G+ + + N + + ++ PE++ +
Sbjct: 143 FMRKIHRDIKAGNILLNTE-GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-I 200
Query: 209 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTDELNAYLNKYHLEL 266
Y+ D+WSLG M K P+ D H + I
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPPYA---DIHPMRAIFMIPT----------------NP 241
Query: 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 326
P L S DF+ + L + R TA + + HP+
Sbjct: 242 PPTF------------------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR 283
Query: 327 QVRAAES 333
+
Sbjct: 284 SAKGVSI 290
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-28
Identities = 69/310 (22%), Positives = 133/310 (42%), Gaps = 60/310 (19%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGGP 93
+ + K+G G V ++ + +K++ K +++ + E+ I+++
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD-YQHF 102
Query: 94 NVVKLLD--IVRDQHSKTPSL--IFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALD 146
NVV++ +V ++ L + E++ TD V L + I +L+AL
Sbjct: 103 NVVEMYKSYLVGEE------LWVLMEFLQGGALTDI-VSQVRLNEEQIATVCEAVLQALA 155
Query: 147 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV 205
Y H+QG++HRD+K ++++ + +++L D+G A+ + V + Y+ PE++
Sbjct: 156 YLHAQGVIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS 214
Query: 206 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTDELNAYLNKYH 263
Y +D+WSLG M M+ + P+F + + ++
Sbjct: 215 R-SLYATEVDIWSLGIMVIEMVDGEPPYF---SDSPVQAMKRLRD--------------- 255
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
P+L N H VSP DFL+++L D Q+R TA+E + HP
Sbjct: 256 -SPPPKL------------------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296
Query: 324 YFAQVRAAES 333
+ Q E
Sbjct: 297 FLLQTGLPEC 306
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 9e-28
Identities = 75/315 (23%), Positives = 130/315 (41%), Gaps = 59/315 (18%)
Query: 33 IFSDQD---DYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKIL 86
I S D Y K+G+G V+ ++V T + I+ + + KK+ I EI ++
Sbjct: 12 IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 71
Query: 87 QNLCGGPNVVKLLDIVRDQHSKTPSL--IFEYVNS---TDFKVLYPTLTDYDIRYYIYEL 141
+ PN+V LD + L + EY+ TD V + + I E
Sbjct: 72 RE-NKNPNIVNYLD----SYLVGDELWVVMEYLAGGSLTDV-VTETCMDEGQIAAVCREC 125
Query: 142 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKG 200
L+AL++ HS ++HRD+K N+++ + ++L D+G A+ + + V + Y+
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184
Query: 201 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTDELNAY 258
PE +V + Y +D+WSLG M MI + P+ + + L IA
Sbjct: 185 PE-VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL---NENPLRALYLIAT---------- 230
Query: 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 318
P+L N +S DFL++ L D + R +A+E
Sbjct: 231 ------NGTPEL------------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKE 266
Query: 319 AMAHPYFAQVRAAES 333
+ H + + S
Sbjct: 267 LLQHQFLKIAKPLSS 281
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 65/298 (21%), Positives = 124/298 (41%), Gaps = 58/298 (19%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCGGP 93
Y + +G G + +V + T ++ +K + K +++REI L+ L P
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH-P 69
Query: 94 NVVKLLDIVRDQHSKTPSLIF---EYVNST--DFKVLYPTLTDYDIRYYIYELLKALDYC 148
+++KL D++ TP+ I EY D+ V +T+ + R + +++ A++YC
Sbjct: 70 HIIKLYDVI-----TTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 208
H I+HRD+KP N+++D L +++ D+GL+ G S + PE++ +
Sbjct: 125 HRHKIVHRDLKPENLLLDDNL-NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVING-K 182
Query: 209 DYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267
Y +D+WS G + M+ + PF D+ KV
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLPF----DDEFIPNLFKKVNS---------------- 222
Query: 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325
+ + +SP A + +++ D R+T +E P+F
Sbjct: 223 -------CVYVMPDF-----------LSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 74/320 (23%), Positives = 135/320 (42%), Gaps = 62/320 (19%)
Query: 33 IFSDQD---DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKIL 86
+ D D +E+V ++G G + +V++ N T K+++ + + EI+IL
Sbjct: 11 VRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEIL 70
Query: 87 QNLCGGPNVVKLLDIVRDQHSKTPSL--IFEYVNS---TD-FKVLYPTLTDYDIRYYIYE 140
C P +VKLL + L + E+ L LT+ I+ +
Sbjct: 71 AT-CDHPYIVKLLG----AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQ 125
Query: 141 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFK 199
+L+AL++ HS+ I+HRD+K NV++ E +RL D+G+ A+ ++ + + + Y+
Sbjct: 126 MLEALNFLHSKRIIHRDLKAGNVLMTLE-GDIRLADFGVSAKNLKTLQKRDSFIGTPYWM 184
Query: 200 GPELLVDLQ----DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTD 253
PE+++ YDY D+WSLG M + P + + L+KIAK
Sbjct: 185 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH---ELNPMRVLLKIAK----- 236
Query: 254 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 313
+ P L S E DFL L + + R
Sbjct: 237 ------SD-----PPTL------------------LTPSKWSVEFRDFLKIALDKNPETR 267
Query: 314 LTAREAMAHPYFAQVRAAES 333
+A + + HP+ + + + ++
Sbjct: 268 PSAAQLLEHPFVSSITSNKA 287
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 73/302 (24%), Positives = 127/302 (42%), Gaps = 57/302 (18%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGG 92
++ + + K+G+G + EVF+GI+ T + IKI+ + + I++EI +L C
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDS 79
Query: 93 PNVVKLLDIVRDQHSKTPSL--IFEYVN--STDFKVLYPTLTDYDIRYYIYELLKALDYC 148
P V K + K L I EY+ S + L + I + E+LK LDY
Sbjct: 80 PYVTKYYG----SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYL 135
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDL 207
HS+ +HRD+K NV++ +++L D+G+ + + N V + ++ PE++
Sbjct: 136 HSEKKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ- 193
Query: 208 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTDELNAYLNKYHLE 265
YD D+WSLG + + P + H L I K N
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPPHS---ELHPMKVLFLIPK-----------NN---- 235
Query: 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325
P L+ +SK + +F++ L + R TA+E + H +
Sbjct: 236 -PPTLE--------GNYSKPLK------------EFVEACLNKEPSFRPTAKELLKHKFI 274
Query: 326 AQ 327
+
Sbjct: 275 LR 276
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 70/319 (21%), Positives = 127/319 (39%), Gaps = 65/319 (20%)
Query: 33 IFSDQD---DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK------IKREI 83
+F D + +R++G G + V+ +V +E IK + K+ I +E+
Sbjct: 46 LFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEV 105
Query: 84 KILQNLCGGPNVVKLLDIVRDQHSKTPSL--IFEYVN---STDFKVLYPTLTDYDIRYYI 138
+ LQ PN ++ + + + + EY S +V L + +I
Sbjct: 106 RFLQK-LRHPNTIQYRG----CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVT 160
Query: 139 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF 198
+ L+ L Y HS ++HRDVK N+++ ++L D+G A P + V + Y+
Sbjct: 161 HGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPANSF---VGTPYW 216
Query: 199 KGPELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTDE 254
PE+++ + + YD +D+WSLG + RK P F + + L IA+
Sbjct: 217 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYHIAQ------ 267
Query: 255 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 314
N+ P L + + S +F+D L+ QDR
Sbjct: 268 -----NE-----SPALQS----------GHW---------SEYFRNFVDSCLQKIPQDRP 298
Query: 315 TAREAMAHPYFAQVRAAES 333
T+ + H + + R
Sbjct: 299 TSEVLLKHRFVLRERPPTV 317
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 71/299 (23%), Positives = 123/299 (41%), Gaps = 59/299 (19%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGP 93
Y + +G G + +V G + T + +KIL K KI+REI+ L+ P
Sbjct: 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH-P 76
Query: 94 NVVKLLDIVRDQHSKTPSLIF---EYVNST---DFKVLYPTLTDYDIRYYIYELLKALDY 147
+++KL ++ TPS IF EYV+ D+ L + + R ++L +DY
Sbjct: 77 HIIKLYQVI-----STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDY 131
Query: 148 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 207
CH ++HRD+KP NV++D + ++ D+GL+ G+ S + PE++
Sbjct: 132 CHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG- 189
Query: 208 QDYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266
+ Y +D+WS G + ++ PF D+ L K K+
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLPF--DDDHVPTLFK--KICD--------------- 230
Query: 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325
G + ++P I L +L+ D R T ++ H +F
Sbjct: 231 --------GIFYTPQY-----------LNPSVISLLKHMLQVDPMKRATIKDIREHEWF 270
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-26
Identities = 56/370 (15%), Positives = 117/370 (31%), Gaps = 120/370 (32%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCGG 92
D+E ++ +GRG + VFE N + IK + + + ++K+ RE+K L L
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EH 63
Query: 93 PNVVKLLD----------------------------------------IVRDQHSKTPSL 112
P +V+ + I R T +
Sbjct: 64 PGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNT 123
Query: 113 IFEYVNSTDFKVLY--------PTLTDY-------------DIRYYIYELLKALDYCHSQ 151
+ + S+ LY L D+ + ++ +A+++ HS+
Sbjct: 124 VGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183
Query: 152 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----------- 200
G+MHRD+KP N+ + +++ D+GL +E +
Sbjct: 184 GLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 201 --PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 258
PE + +Y + +D++SLG + +++ F + + +
Sbjct: 243 MSPEQIHG-NNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRN---------- 288
Query: 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 318
+ K P+ + +L +R A +
Sbjct: 289 ----------------LKFPLLFTQK----------YPQEHMMVQDMLSPSPTERPEATD 322
Query: 319 AMAHPYFAQV 328
+ + F +
Sbjct: 323 IIENAIFENL 332
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 69/315 (21%), Positives = 122/315 (38%), Gaps = 71/315 (22%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---------EIKILQN 88
+ + R +G+G + EV T + K L+ KK+IK+ E +IL+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLE---KKRIKKRKGEAMALNEKQILE- 239
Query: 89 LCGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-----FKVLYPTLTDYDIRYYI 138
VV L +T L+ +N D + + + +Y
Sbjct: 240 KVNSRFVVSL-------AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA 292
Query: 139 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF 198
E+ L+ H + I++RD+KP N+++D +R+ D GLA G+ RV + +
Sbjct: 293 AEICCGLEDLHRERIVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVGTVGY 351
Query: 199 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 258
PE++ + + Y +S D W+LGC+ MI + P F + ++ +++
Sbjct: 352 MAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSP-FQQRKKKIKREEVERLVKEVPE--- 406
Query: 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL---- 314
+Y SP+A +LL D +RL
Sbjct: 407 --EYSERF----------------------------SPQARSLCSQLLCKDPAERLGCRG 436
Query: 315 -TAREAMAHPYFAQV 328
+ARE HP F ++
Sbjct: 437 GSAREVKEHPLFKKL 451
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 54/309 (17%), Positives = 110/309 (35%), Gaps = 49/309 (15%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCG 91
+ +D E + ++G G +V++ T +K + + K+I ++ ++
Sbjct: 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHD 82
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVN--STDFKVLYP-TLTDYDIRYYIYELLKALDYC 148
P +V+ + E + + K + + + ++KAL Y
Sbjct: 83 CPYIVQCFGTFITNTDV--FIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYL 140
Query: 149 HSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE----L 203
+ G++HRDVKP N+++D +++L D+G++ K + + PE
Sbjct: 141 KEKHGVIHRDVKPSNILLDER-GQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPP 199
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
DYD D+WSLG + + P+ + + L K+ +
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--------------- 244
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
E P L + S + F+ L DH+ R + + H
Sbjct: 245 -EEPPLLP------GHMGF------------SGDFQSFVKDCLTKDHRKRPKYNKLLEHS 285
Query: 324 YFAQVRAAE 332
+ + E
Sbjct: 286 FIKRYETLE 294
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 74/315 (23%), Positives = 122/315 (38%), Gaps = 71/315 (22%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---------EIKILQ- 87
+D+ V R +GRG + EV+ +T + +K L KK+IK E +L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIKMKQGETLALNERIMLSL 245
Query: 88 -NLCGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYI 138
+ P +V + TP I + +N D L ++ D+R+Y
Sbjct: 246 VSTGDCPFIVCM-------SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYA 298
Query: 139 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF 198
E++ L++ H++ +++RD+KP N+++D +R+ D GLA K+ + V + +
Sbjct: 299 AEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLAC-DFSKKKPHASVGTHGY 356
Query: 199 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 258
PE+L YD S D +SLGCM ++ P F H D+ L
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP-FRQHKTKDKHEIDRMTL-------- 407
Query: 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL---- 314
SPE L+ LL+ D RL
Sbjct: 408 ------------------TMAVELPDSF--------SPELRSLLEGLLQRDVNRRLGCLG 441
Query: 315 -TAREAMAHPYFAQV 328
A+E P+F +
Sbjct: 442 RGAQEVKESPFFRSL 456
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-25
Identities = 63/314 (20%), Positives = 119/314 (37%), Gaps = 30/314 (9%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI----LKPVKKKKIKREIKILQNLCGGP 93
DD+E + ++G G VF+ + + K+ +KP + +I RE+++L C P
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE-CNSP 91
Query: 94 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCHS 150
+V S+ E+++ + + ++K L Y
Sbjct: 92 YIVGFYGAF--YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 151 QG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK----EYNVRVASRYFKGPELLV 205
+ IMHRDVKP N++++ +++L D+G++ G+ N V +R + PE L
Sbjct: 150 KHKIMHRDVKPSNILVNSR-GEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERL- 202
Query: 206 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265
Y D+WS+G M + P D + + + D
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPIP-PPDAKELELMFGCQVEGDAAETPPRPRTPG 261
Query: 266 LDPQLDALVGRHSRKPWS--KFINADN-----QHLVSPEAIDFLDKLLRYDHQDRLTARE 318
+ R + +I + + S E DF++K L + +R ++
Sbjct: 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
Query: 319 AMAHPYFAQVRAAE 332
M H + + A E
Sbjct: 322 LMVHAFIKRSDAEE 335
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 7e-25
Identities = 73/362 (20%), Positives = 136/362 (37%), Gaps = 81/362 (22%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLC------- 90
Y V+RK+G G +S V+ ++ + +K++K + + EI++L+++
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98
Query: 91 GGPNVVKLLDI--VRDQHSKTPSLIFEY--VNSTDFKVLYPT--LTDYDIRYYIYELLKA 144
VV+LLD + + ++FE + + + L ++ I ++L+
Sbjct: 99 NREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG 158
Query: 145 LDYCHSQ-GIMHRDVKPHNVMI-------------------------------------- 165
LDY H++ I+H D+KP N+++
Sbjct: 159 LDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 166 ----------DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 215
+ E K+++ D G A K + + +R ++ E+L+ Y+ D
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNA--CWVHKHFTEDIQTRQYRSLEVLIGS-GYNTPAD 275
Query: 216 MWSLGCMFAGMIFRKEPFFYGHDNH------DQLVKIAKVLGT--DELNAYLNKYHLELD 267
+WS CM + + F H D + I ++LG +L
Sbjct: 276 IWSTACMAFE-LATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFT 334
Query: 268 PQLDALVGRHSRKPWSKFINADNQHLVSPE----AIDFLDKLLRYDHQDRLTAREAMAHP 323
+ D L KPW F ++ S E DFL +L + R TA E + HP
Sbjct: 335 KKGD-LKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHP 393
Query: 324 YF 325
+
Sbjct: 394 WL 395
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 71/318 (22%), Positives = 123/318 (38%), Gaps = 74/318 (23%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---------EIKILQN 88
D + R +GRG + EVF T + K L KK++K+ E KIL
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLN---KKRLKKRKGYQGAMVEKKILA- 240
Query: 89 LCGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTDFKV-LYPTLTDYDI------RY 136
+V L +T + L+ +N D + +Y D +
Sbjct: 241 KVHSRFIVSL-------AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 137 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVAS 195
Y +++ L++ H + I++RD+KP NV++D + +R+ D GLA E + +
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDD-GNVRISDLGLAVELKAGQTKTKGYAGT 352
Query: 196 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL 255
F PELL+ ++YD+S+D ++LG MI + P F + ++ + + +
Sbjct: 353 PGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGP-FRARGEKVENKELKQRVLEQAV 410
Query: 256 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL- 314
Y + SP + DF + LL+ D + RL
Sbjct: 411 -----TYPDKF----------------------------SPASKDFCEALLQKDPEKRLG 437
Query: 315 ----TAREAMAHPYFAQV 328
+ HP F +
Sbjct: 438 FRDGSCDGLRTHPLFRDI 455
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-24
Identities = 58/330 (17%), Positives = 115/330 (34%), Gaps = 90/330 (27%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCGGP 93
+D + + ++GRG Y V + ++ + + +K + ++K++ ++ ++ P
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 94 NVVK---------------------LLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY 132
+V+ + +S +I E +
Sbjct: 82 YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEI--------------- 126
Query: 133 DIRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 191
+ +KAL++ I+HRD+KP N+++D ++L D+G++ +
Sbjct: 127 -LGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS-GNIKLCDFGIS------GQLVD 178
Query: 192 RVASRYFKG------PELL---VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 242
+A G PE + Q YD D+WSLG + + P+ + DQ
Sbjct: 179 SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ 238
Query: 243 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFL 302
L ++ K PQL +F SP I+F+
Sbjct: 239 LTQVVK----------------GDPPQLSN-------SEEREF---------SPSFINFV 266
Query: 303 DKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332
+ L D R +E + HP+
Sbjct: 267 NLCLTKDESKRPKYKELLKHPFILMYEERA 296
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 5e-24
Identities = 75/317 (23%), Positives = 129/317 (40%), Gaps = 77/317 (24%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKI---KREIKILQNLCG 91
+D++ + +G G +S V + T+ IKIL+ +K+ K+ RE ++ L
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-D 88
Query: 92 GPNVVKLLDIVRDQHS-KTPS---LIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKA 144
P VKL + + Y + + K + + + R+Y E++ A
Sbjct: 89 HPFFVKLY------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 142
Query: 145 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 200
L+Y H +GI+HRD+KP N++++ ++ +++ D+G A+ + R S F G
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAK-VLSPESKQARANS--FVGTAQY 198
Query: 201 --PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKVLGTDELNA 257
PELL + + S D+W+LGC+ ++ PF N + KI K
Sbjct: 199 VSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFR--AGNEYLIFQKIIK--------- 246
Query: 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-- 315
+Y P+ P+A D ++KLL D RL
Sbjct: 247 --LEYDF---PE-----------------------KFFPKARDLVEKLLVLDATKRLGCE 278
Query: 316 ----AREAMAHPYFAQV 328
AHP+F V
Sbjct: 279 EMEGYGPLKAHPFFESV 295
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-22
Identities = 72/324 (22%), Positives = 119/324 (36%), Gaps = 83/324 (25%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 89
DD+E+++ +GRG +SEV T + +KI+ K +KR E +L N
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMN--KWDMLKRGEVSCFREERDVLVN- 117
Query: 90 CGGPNVVKLLDIVRDQHS-KTPS---LIFEYVNSTD-FKVLY---PTLTDYDIRYYIYEL 141
+ +L + + + L+ EY D +L + R+Y+ E+
Sbjct: 118 GDRRWITQL------HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEI 171
Query: 142 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV--RVASRYFK 199
+ A+D H G +HRD+KP N+++D +RL D+G + V S
Sbjct: 172 VMAIDSVHRLGYVHRDIKPDNILLDRC-GHIRLADFGSC------LKLRADGTVRSLVAV 224
Query: 200 G------PELL------VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 247
G PE+L Y D W+LG M + + PF+ D+ +
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY--ADSTAET--YG 280
Query: 248 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 307
K++ E V EA DF+ +LL
Sbjct: 281 KIVHYKE-----------------------------HLSLPLVDEGVPEEARDFIQRLLC 311
Query: 308 YDHQDRLT---AREAMAHPYFAQV 328
+ RL A + HP+F +
Sbjct: 312 -PPETRLGRGGAGDFRTHPFFFGL 334
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 9e-22
Identities = 54/314 (17%), Positives = 110/314 (35%), Gaps = 73/314 (23%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKK----IKREIKILQNLCG 91
D +E++R +G+G + +V +T + +K + ++ + +E++I+Q L
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-E 73
Query: 92 GPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLK 143
P +V L + ++ + + D L + ++ +I EL+
Sbjct: 74 HPFLVNL-------WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVM 126
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG--- 200
ALDY +Q I+HRD+KP N+++D + + D+ +A G
Sbjct: 127 ALDYLQNQRIIHRDMKPDNILLDEH-GHVHITDFNIA------AMLPRETQITTMAGTKP 179
Query: 201 ---PELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL 255
PE+ Y +++D WSLG ++ + P ++ + +
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP-YHIRSSTSSKEIVHTFE----- 233
Query: 256 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL- 314
+ + S E + L KLL + R
Sbjct: 234 ---------------------TTVVTYPSAW--------SQEMVSLLKKLLEPNPDQRFS 264
Query: 315 TAREAMAHPYFAQV 328
+ PY +
Sbjct: 265 QLSDVQNFPYMNDI 278
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 69/323 (21%), Positives = 126/323 (39%), Gaps = 83/323 (25%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 89
+D+E+++ +GRG + EV N ++ +KIL K + +KR E +L N
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN--KWEMLKRAETACFREERDVLVN- 130
Query: 90 CGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY---PTLTDYDIRYYIYE 140
+ L H + + L+ +Y D +L L + R+Y+ E
Sbjct: 131 GDSKWITTL-------HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE 183
Query: 141 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--YNVRVASRYF 198
++ A+D H +HRD+KP N+++D +RL D+G + + V S
Sbjct: 184 MVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSC------LKLMEDGTVQSSVA 236
Query: 199 KG------PELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 248
G PE+L ++ Y D WSLG M++ + PF+ ++ + K
Sbjct: 237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY--AESLVET--YGK 292
Query: 249 VLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRY 308
++ +K + Q+ VS A D + +L+
Sbjct: 293 IMN--------HKERFQFPTQVTD---------------------VSENAKDLIRRLIC- 322
Query: 309 DHQDRLT---AREAMAHPYFAQV 328
+ RL + HP+F+ +
Sbjct: 323 SREHRLGQNGIEDFKKHPFFSGI 345
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 4e-21
Identities = 75/321 (23%), Positives = 124/321 (38%), Gaps = 83/321 (25%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKR---EIKILQNLCG 91
+DYEVV+ +GRG + EV + +T + +K+L +K+ E I+
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 92 GPNVVKLLDIVRDQHS-KTPS---LIFEYVNSTDFKVLYPTLTDYDI-----RYYIYELL 142
P VV+L ++ + ++ EY+ D L +++YD+ R+Y E++
Sbjct: 129 -PWVVQL------FYAFQDDRYLYMVMEYMPGGD---LVNLMSNYDVPEKWARFYTAEVV 178
Query: 143 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKG 200
ALD HS G +HRDVKP N+++D L+L D+G + N V G
Sbjct: 179 LALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTC------MKMNKEGMVRCDTAVG 231
Query: 201 ------PELLVD---LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL- 250
PE+L Y D WS+G M+ PF+ D+ +K++
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY--ADSLVGT--YSKIMN 287
Query: 251 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 310
+ L + + D +S EA + + L D
Sbjct: 288 HKNSL-----TFPDDND--------------------------ISKEAKNLICAFLT-DR 315
Query: 311 QDRLT---AREAMAHPYFAQV 328
+ RL E H +F
Sbjct: 316 EVRLGRNGVEEIKRHLFFKND 336
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 5e-21
Identities = 57/309 (18%), Positives = 105/309 (33%), Gaps = 41/309 (13%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCI-IKILKPVK----KKKIKREIKILQNLCGGPN 94
YEV + G ++ ++ N N R + +K L + E + L + P+
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPS 140
Query: 95 VVKLLDIVRDQHSKTPSLIF---EYVNSTDFK-VLYPTLTDYDIRYYIYELLKALDYCHS 150
+V++ + V + + EYV K L + Y+ E+L AL Y HS
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHS 200
Query: 151 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 210
G+++ D+KP N+M+ E +L+LID G + + F+ PE++
Sbjct: 201 IGLVYNDLKPENIMLTEE--QLKLIDLGAV---SRINSFGYLYGTPGFQAPEIVRTGPT- 254
Query: 211 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 270
+ D++++G A + + + L+
Sbjct: 255 VAT-DIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPV----------------LKTYDSY 297
Query: 271 DALVGRHSRK-PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329
L+ R P +F A+ E L +LR F+ R
Sbjct: 298 GRLLRRAIDPDPRQRFTTAE-------EMSAQLTGVLREVVAQDTGVPRPGLSTIFSPSR 350
Query: 330 AAESSRTRA 338
+
Sbjct: 351 STFGVDLLV 359
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 7e-21
Identities = 73/322 (22%), Positives = 123/322 (38%), Gaps = 90/322 (27%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 89
D+ ++ +G+G + +V + +K+L+ KK +K+ E +L
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQ--KKAILKKKEEKHIMSERNVLLKN 95
Query: 90 CGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYEL 141
P +V L H +T + +Y+N + F L + R+Y E+
Sbjct: 96 VKHPFLVGL-------HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI 148
Query: 142 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EYNV 191
AL Y HS I++RD+KP N+++D + + L D+GL E EY
Sbjct: 149 ASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNSTTSTFCGTPEY-- 205
Query: 192 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKVL 250
+A PE+L Q YD ++D W LG + M++ PF+ N ++ I
Sbjct: 206 -LA------PEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFY--SRNTAEMYDNI---- 251
Query: 251 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 310
L QL KP ++ A L+ LL+ D
Sbjct: 252 -------------LNKPLQL---------KPN-----------ITNSARHLLEGLLQKDR 278
Query: 311 QDRL----TAREAMAHPYFAQV 328
RL E +H +F+ +
Sbjct: 279 TKRLGAKDDFMEIKSHVFFSLI 300
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-20
Identities = 78/321 (24%), Positives = 132/321 (41%), Gaps = 77/321 (23%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKK----IKREIKILQNLCG 91
D++++R +GRG Y++V T+ +K++K V + ++ E + +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 92 GPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLK 143
P +V L HS +T S + EYVN D + L + R+Y E+
Sbjct: 69 HPFLVGL-------HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL 121
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EYNVRV 193
AL+Y H +GI++RD+K NV++D E ++L D+G+ E PG Y +
Sbjct: 122 ALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNY---I 177
Query: 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 253
A PE+L +DY +S+D W+LG + M+ + PF D
Sbjct: 178 A------PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPF-------------------D 211
Query: 254 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 313
+ + N D ++ + R P +S +A L L D ++R
Sbjct: 212 IVGSSDNPDQNTEDYLFQVILEKQIRIP----------RSLSVKAASVLKSFLNKDPKER 261
Query: 314 L------TAREAMAHPYFAQV 328
L + HP+F V
Sbjct: 262 LGCHPQTGFADIQGHPFFRNV 282
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-20
Identities = 67/314 (21%), Positives = 119/314 (37%), Gaps = 77/314 (24%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKK----IKREIKILQNLCG 91
D ++ ++ +G G + V + + +KIL V K K E +ILQ
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 92 GPNVVKLLDIVRDQHSKTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLKAL 145
P +VKL + K S ++ EYV + F L ++ R+Y +++
Sbjct: 100 FPFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 146 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----- 200
+Y HS +++RD+KP N++ID + +++ D+G A K R + G
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFA------KRVKGRTWT--LCGTPEAL 205
Query: 201 -PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259
PE+++ + Y+ ++D W+LG + M PFF D Q+
Sbjct: 206 APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF--ADQPIQI---------------- 246
Query: 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL----- 314
Y + ++ + S + D L LL+ D R
Sbjct: 247 --YEKIVSGKVR----------FPSHF--------SSDLKDLLRNLLQVDLTKRFGNLKN 286
Query: 315 TAREAMAHPYFAQV 328
+ H +FA
Sbjct: 287 GVNDIKNHKWFATT 300
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-20
Identities = 78/321 (24%), Positives = 137/321 (42%), Gaps = 88/321 (27%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 89
+D++ ++ +G+G + +V T +KIL+ K+ I + E ++LQN
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILR--KEVIIAKDEVAHTVTESRVLQN- 61
Query: 90 CGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYEL 141
P + L +T + EY N + F L T+ R+Y E+
Sbjct: 62 TRHPFLTAL-------KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI 114
Query: 142 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYF 198
+ AL+Y HS+ +++RD+K N+M+D + +++ D+GL KE + + F
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLC------KEGISDGATMKT--F 165
Query: 199 KG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 252
G PE+L D DY ++D W LG + M+ + PF+ + +H++L + +L
Sbjct: 166 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFE--LIL-M 219
Query: 253 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD 312
+E+ R P +SPEA L LL+ D +
Sbjct: 220 EEI-----------------------RFP----------RTLSPEAKSLLAGLLKKDPKQ 246
Query: 313 RL-----TAREAMAHPYFAQV 328
RL A+E M H +F +
Sbjct: 247 RLGGGPSDAKEVMEHRFFLSI 267
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-20
Identities = 67/323 (20%), Positives = 119/323 (36%), Gaps = 91/323 (28%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI---------KREIKILQN 88
D+ + +G+G + +V T+E +KILK K + E ++L
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK---KDVVIQDDDVECTMVEKRVLAL 76
Query: 89 LCGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLYPT--LTDYDIRYYIYE 140
P + +L HS +T + EYVN D + + +Y E
Sbjct: 77 PGKPPFLTQL-------HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE 129
Query: 141 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EYN 190
+ L + S+GI++RD+K NVM+D E +++ D+G+ E G +Y
Sbjct: 130 IAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWDGVTTKTFCGTPDY- 187
Query: 191 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 250
+A PE++ Q Y S+D W+ G + M+ + P F G ++ D+L
Sbjct: 188 --IA------PEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAP-FEG-EDEDEL------- 229
Query: 251 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 310
+++ + P +S EA+ L+
Sbjct: 230 -------------------FQSIMEHNVAYP----------KSMSKEAVAICKGLMTKHP 260
Query: 311 QDRL-----TAREAMAHPYFAQV 328
RL R+ H +F +
Sbjct: 261 GKRLGCGPEGERDIKEHAFFRYI 283
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 4e-20
Identities = 77/321 (23%), Positives = 132/321 (41%), Gaps = 77/321 (23%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKK----IKREIKILQNLCG 91
D++++R +GRG Y++V T+ ++++K V + ++ E + +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 92 GPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLK 143
P +V L HS +T S + EYVN D + L + R+Y E+
Sbjct: 112 HPFLVGL-------HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL 164
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EYNVRV 193
AL+Y H +GI++RD+K NV++D E ++L D+G+ E PG Y +
Sbjct: 165 ALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNY---I 220
Query: 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 253
A PE+L +DY +S+D W+LG + M+ + PF D
Sbjct: 221 A------PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPF-------------------D 254
Query: 254 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 313
+ + N D ++ + R P +S +A L L D ++R
Sbjct: 255 IVGSSDNPDQNTEDYLFQVILEKQIRIP----------RSLSVKAASVLKSFLNKDPKER 304
Query: 314 L------TAREAMAHPYFAQV 328
L + HP+F V
Sbjct: 305 LGCHPQTGFADIQGHPFFRNV 325
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-20
Identities = 65/311 (20%), Positives = 126/311 (40%), Gaps = 56/311 (18%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI----LKPVKKKKIKREIKILQNLCGGP 93
DD E + ++GRG Y V + +V + + +K + ++K++ ++ I P
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 94 NVVKLLDIVRDQHSKTPSLIFEYVN-STD-----FKVLYPTLTDYDIRYYIYELLKALDY 147
V + + + E ++ S D T+ + + ++KAL++
Sbjct: 67 FTVTFYGALFREG--DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 148 CHSQG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE---L 203
HS+ ++HRDVKP NV+I+ ++++ D+G++ + ++ + + PE
Sbjct: 125 LHSKLSVIHRDVKPSNVLINAL-GQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINP 183
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTDELNAYLNK 261
++ + Y D+WSLG + + P Y QL ++ +
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILRFP--YDSWGTPFQQLKQVVE------------- 228
Query: 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321
E PQL P KF S E +DF + L+ + ++R T E M
Sbjct: 229 ---EPSPQL----------PADKF---------SAEFVDFTSQCLKKNSKERPTYPELMQ 266
Query: 322 HPYFAQVRAAE 332
HP+F +
Sbjct: 267 HPFFTLHESKG 277
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 5e-20
Identities = 69/324 (21%), Positives = 120/324 (37%), Gaps = 92/324 (28%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI---------KREIKILQN 88
D++E +R +G+G + +V T + +K+LK K I E +IL
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLK---KDVILQDDDVECTMTEKRILSL 79
Query: 89 LCGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLYPT--LTDYDIRYYIYE 140
P + +L +TP + E+VN D + + + R+Y E
Sbjct: 80 ARNHPFLTQL-------FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE 132
Query: 141 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EYN 190
++ AL + H +GI++RD+K NV++DHE +L D+G+ E G +Y
Sbjct: 133 IISALMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMCKEGICNGVTTATFCGTPDY- 190
Query: 191 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 250
+A PE+L + Y ++D W++G + M+ P F + D I
Sbjct: 191 --IA------PEILQE-MLYGPAVDWWAMGVLLYEMLCGHAP-FEAENEDDLFEAILN-- 238
Query: 251 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 310
DE+ Y L +A L + +
Sbjct: 239 --DEV-----VYPTWL----------------------------HEDATGILKSFMTKNP 263
Query: 311 QDRL------TAREAMAHPYFAQV 328
RL + HP+F ++
Sbjct: 264 TMRLGSLTQGGEHAILRHPFFKEI 287
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 89.7 bits (222), Expect = 6e-20
Identities = 69/321 (21%), Positives = 116/321 (36%), Gaps = 87/321 (27%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 89
D+ + +G+G + +V T+E +KILK K I+ E ++L
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK--KDVVIQDDDVECTMVEKRVLALP 398
Query: 90 CGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLYPT--LTDYDIRYYIYEL 141
P + +L HS +T + EYVN D + + +Y E+
Sbjct: 399 GKPPFLTQL-------HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI 451
Query: 142 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYF 198
L + S+GI++RD+K NVM+D E +++ D+G+ KE V + F
Sbjct: 452 AIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMC------KENIWDGVTTKT--F 502
Query: 199 KG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 252
G PE++ Q Y S+D W+ G + M+ + P F G D + I +
Sbjct: 503 CGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAP-FEGEDEDELFQSIME---- 556
Query: 253 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD 312
+ P +S EA+ L+
Sbjct: 557 HNV-----------------------AYP----------KSMSKEAVAICKGLMTKHPGK 583
Query: 313 RL-----TAREAMAHPYFAQV 328
RL R+ H +F +
Sbjct: 584 RLGCGPEGERDIKEHAFFRYI 604
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-20
Identities = 72/329 (21%), Positives = 138/329 (41%), Gaps = 92/329 (27%)
Query: 38 DDYEVVRKVGRGKYSEVF---EGINVNTNERCIIKILKP---VKKKK----IKREIKILQ 87
+++E+++ +G G Y +VF + +T + +K+LK V+K K + E ++L+
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 88 NLCGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIY 139
++ P +V L H +T + LI +Y+N + F L T+++++ Y+
Sbjct: 114 HIRQSPFLVTL-------HYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG 166
Query: 140 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE----YNVRVAS 195
E++ AL++ H GI++RD+K N+++D + L D+GL+ KE R
Sbjct: 167 EIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLS------KEFVADETERAYD 219
Query: 196 RYFKG------PELLVDL-QDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLV 244
F G P+++ +D ++D WSLG + G F +
Sbjct: 220 --FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA-----SPFTVDGEKNSQA 272
Query: 245 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 304
+I++ + E P+ + + S A D + +
Sbjct: 273 EISRRILKSEP-------------------------PYPQEM--------SALAKDLIQR 299
Query: 305 LLRYDHQDRL-----TAREAMAHPYFAQV 328
LL D + RL A E H +F ++
Sbjct: 300 LLMKDPKKRLGCGPRDADEIKEHLFFQKI 328
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 8e-20
Identities = 77/325 (23%), Positives = 131/325 (40%), Gaps = 94/325 (28%)
Query: 38 DDYEVVRKVGRGKYSEVF---EGINVNTNERCIIKILKPVKKKKIKR--------EIKIL 86
+E+++ +G+G + +VF + + + +K+LK K +K E IL
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK---KATLKVRDRVRTKMERDIL 80
Query: 87 QNLCGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYI 138
P +VKL H +T LI +++ D F L T+ D+++Y+
Sbjct: 81 VE-VNHPFIVKL-------HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 132
Query: 139 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------E 188
EL ALD+ HS GI++RD+KP N+++D E ++L D+GL+ E K E
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYSFCGTVE 191
Query: 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 248
Y +A PE++ + + S D WS G + M+ P F G D + + I
Sbjct: 192 Y---MA------PEVVNR-RGHTQSADWWSFGVLMFEMLTGTLP-FQGKDRKETMTMI-- 238
Query: 249 VLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRY 308
L+ + + +SPEA L L +
Sbjct: 239 ---------------LKAKLGM---------PQF-----------LSPEAQSLLRMLFKR 263
Query: 309 DHQDRL-----TAREAMAHPYFAQV 328
+ +RL E H +F+ +
Sbjct: 264 NPANRLGAGPDGVEEIKRHSFFSTI 288
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 9e-20
Identities = 65/316 (20%), Positives = 121/316 (38%), Gaps = 81/316 (25%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKK----IKREIKILQNLCG 91
+D+ + + +G+G + +VF TN+ IK LK V E ++L
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 92 GPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLK 143
P + + +T + EY+N D + +Y E++
Sbjct: 77 HPFLTHM-------FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL 129
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EYNVRV 193
L + HS+GI++RD+K N+++D + +++ D+G+ E +Y +
Sbjct: 130 GLQFLHSKGIVYRDLKLDNILLDKD-GHIKIADFGMCKENMLGDAKTNTFCGTPDY---I 185
Query: 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 253
A PE+L+ Q Y++S+D WS G + M+ + P F+G + ++L
Sbjct: 186 A------PEILLG-QKYNHSVDWWSFGVLLYEMLIGQSP-FHG-QDEEEL---------- 226
Query: 254 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 313
++ + P + EA D L KL + + R
Sbjct: 227 ----------------FHSIRMDNPFYP----------RWLEKEAKDLLVKLFVREPEKR 260
Query: 314 LTAREA-MAHPYFAQV 328
L R HP F ++
Sbjct: 261 LGVRGDIRQHPLFREI 276
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 1e-19
Identities = 85/328 (25%), Positives = 136/328 (41%), Gaps = 98/328 (29%)
Query: 38 DDYEVVRKVGRGKYSEVF---EGINVNTNERCIIKILKP---VKKKK----IKREIKILQ 87
+ +E++R +G+G Y +VF + NT + +K+LK V+ K K E IL+
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 88 NLCGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIY 139
P +V L +T LI EY++ + F L + +Y+
Sbjct: 77 E-VKHPFIVDL-------IYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA 128
Query: 140 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EY 189
E+ AL + H +GI++RD+KP N+M++H+ ++L D+GL E H G EY
Sbjct: 129 EISMALGHLHQKGIIYRDLKPENIMLNHQ-GHVKLTDFGLCKESIHDGTVTHTFCGTIEY 187
Query: 190 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVK 245
+A PE+L+ ++ ++D WSLG M G P F G + + K
Sbjct: 188 ---MA------PEILMR-SGHNRAVDWWSLGALMYDMLTG-----APPFTGENRKKTIDK 232
Query: 246 IAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKL 305
I K +L P+ ++ EA D L KL
Sbjct: 233 ILK----CKL-----NL-----------------PPY-----------LTQEARDLLKKL 255
Query: 306 LRYDHQDRL-----TAREAMAHPYFAQV 328
L+ + RL A E AHP+F +
Sbjct: 256 LKRNAASRLGAGPGDAGEVQAHPFFRHI 283
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 76/314 (24%), Positives = 135/314 (42%), Gaps = 73/314 (23%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 89
+++E ++ +G+G + +V T +KILK K+ + + E ++LQN
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILK--KEVIVAKDEVAHTLTENRVLQN- 204
Query: 90 CGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYEL 141
P + L +T + EY N + F L ++ R+Y E+
Sbjct: 205 SRHPFLTAL-------KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 257
Query: 142 LKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFK 199
+ ALDY HS+ +++RD+K N+M+D + +++ D+GL E G + +
Sbjct: 258 VSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTPEYL 316
Query: 200 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259
PE+L D DY ++D W LG + M+ + PF+ + +H++L + +L +E+
Sbjct: 317 APEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFE--LIL-MEEI---- 366
Query: 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL----- 314
R P + PEA L LL+ D + RL
Sbjct: 367 -------------------RFP----------RTLGPEAKSLLSGLLKKDPKQRLGGGSE 397
Query: 315 TAREAMAHPYFAQV 328
A+E M H +FA +
Sbjct: 398 DAKEIMQHRFFAGI 411
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 4e-19
Identities = 61/316 (19%), Positives = 122/316 (38%), Gaps = 81/316 (25%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKK----IKREIKILQNLCG 91
D++++R +G G + V + + +K+LK V + K E +L +
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-T 64
Query: 92 GPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLK 143
P ++++ + +I +Y+ + F +L + ++Y E+
Sbjct: 65 HPFIIRM-------WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL 117
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG--- 200
AL+Y HS+ I++RD+KP N+++D +++ D+G A K + G
Sbjct: 118 ALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFA------KYVPDVTYT--LCGTPD 168
Query: 201 ---PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 257
PE++ + Y+ S+D WS G + M+ PF+ N + + K+L
Sbjct: 169 YIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFY--DSNTMKTYE--KIL------- 216
Query: 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL--- 314
++ + F + + D L +L+ D RL
Sbjct: 217 -------------------NAELRFPPFF--------NEDVKDLLSRLITRDLSQRLGNL 249
Query: 315 --TAREAMAHPYFAQV 328
+ HP+F +V
Sbjct: 250 QNGTEDVKNHPWFKEV 265
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-17
Identities = 36/150 (24%), Positives = 68/150 (45%), Gaps = 13/150 (8%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCGGP 93
Y++V K+G G S V+ + N + IK + K+ +RE+ L
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQ 71
Query: 94 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHS 150
N+V ++D+ + L+ EY+ + L+ + ++L + + H
Sbjct: 72 NIVSMIDVDEEDD--CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 151 QGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180
I+HRD+KP N++ID L++ D+G+A
Sbjct: 130 MRIVHRDIKPQNILIDSNKT-LKIFDFGIA 158
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 7e-17
Identities = 37/156 (23%), Positives = 71/156 (45%), Gaps = 18/156 (11%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-PVKKKKIKREIKILQNLCGGPNVVKL 98
+ V +K+G G + E+ G N+ TNE IK+ + ++ E + + L G + ++
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70
Query: 99 LDIVRDQHSKT-------PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 151
PSL E + F + T + + +L+ ++Y HS+
Sbjct: 71 YYFGPCGKYNAMVLELLGPSL--EDL----FDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124
Query: 152 GIMHRDVKPHNVMI----DHELRKLRLIDWGLAEFY 183
+++RDVKP N +I + + + +ID+ LA+ Y
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 50/224 (22%), Positives = 90/224 (40%), Gaps = 40/224 (17%)
Query: 29 SSYVIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-KKKIKREIKILQ 87
S ++I D + EV VGRG + V + + IK ++ +K E++ L
Sbjct: 1 SLHMI--DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLS 56
Query: 88 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLY-----PTLTDYDIRYYIYEL 141
+ PN+VKL L+ EY + + VL+ P T + +
Sbjct: 57 RVNH-PNIVKLYGACL----NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC 111
Query: 142 LKALDYCHS---QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF 198
+ + Y HS + ++HRD+KP N+++ L++ D+G A +
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----------CDIQTHM 160
Query: 199 KG---------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 233
PE+ +Y D++S G + +I R++PF
Sbjct: 161 TNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPF 203
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-16
Identities = 36/154 (23%), Positives = 69/154 (44%), Gaps = 16/154 (10%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKL 98
Y + RK+G G + +++ G ++ E IK+ K ++ E KI + + GG + +
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70
Query: 99 LDIVRDQHSKT-------PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 151
+ PSL E + F + + +++ ++Y HS+
Sbjct: 71 RWCGAEGDYNVMVMELLGPSL--EDL----FNFCSRKFSLKTVLLLADQMISRIEYIHSK 124
Query: 152 GIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFY 183
+HRDVKP N ++ + + +ID+GLA+ Y
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-16
Identities = 38/153 (24%), Positives = 67/153 (43%), Gaps = 19/153 (12%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKI---LQNLC 90
Y + R VGRG +V+E + +K++ PV + +++RE + LQ
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE-- 93
Query: 91 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDY 147
P+VV + D + + +N D + L + ++ ALD
Sbjct: 94 --PHVVPIHD--FGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDA 149
Query: 148 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180
H+ G HRDVKP N+++ + L+D+G+A
Sbjct: 150 AHAAGATHRDVKPENILVSAD-DFAYLVDFGIA 181
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 5e-16
Identities = 27/169 (15%), Positives = 63/169 (37%), Gaps = 21/169 (12%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKKIKREIKILQNLCGGPNVVK 97
+ + +K+G G + ++ N E+ ++K + + E+K Q + + K
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98
Query: 98 LLDIVRDQHSKTPSLIF---EYVNSTDFKV-----LYPTLTDYDIRYYIY---------- 139
++ + + P ++ L L + +
Sbjct: 99 WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGI 158
Query: 140 ELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGK 187
+L L+Y H +H D+K N+++ ++ ++ L D+GL+ Y P
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-16
Identities = 31/156 (19%), Positives = 67/156 (42%), Gaps = 18/156 (11%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKL 98
Y+V R++G G + +FEG N+ N++ IK +++ E + + L G + +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 99 LDIVRDQHSKT-------PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 151
++ PSL E + + + + ++L + H +
Sbjct: 72 YYFGQEGLHNVLVIDLLGPSL--EDL----LDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125
Query: 152 GIMHRDVKPHNVMI----DHELRKLRLIDWGLAEFY 183
+++RD+KP N +I + ++D+G+ +FY
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 8e-16
Identities = 28/244 (11%), Positives = 72/244 (29%), Gaps = 41/244 (16%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGP 93
Y ++ G + ++ ++ + + + + P ++ L + P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKP 91
Query: 94 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFK-VLYPTLTDYDIRYYIYELLKALDYCHSQG 152
V ++LD+V + ++ E++ + V + + + L A D H G
Sbjct: 92 GVARVLDVVHTRA--GGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAG 149
Query: 153 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 212
+ P V + + G +V +A +
Sbjct: 150 VALSIDHPSRVRVSID---------G-----------DVVLAYPATMPDA--------NP 181
Query: 213 SLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA 272
D+ +G ++ + P + A+ + ++ Q+ A
Sbjct: 182 QDDIRGIGASLYALLVNRWPL--PEAGVRSGLAPAERDTAGQPIE-PADIDRDIPFQISA 238
Query: 273 LVGR 276
+ R
Sbjct: 239 VAAR 242
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 39/154 (25%), Positives = 72/154 (46%), Gaps = 16/154 (10%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKL 98
+ + RK+G G + E++ G N+ TNE IK+ K ++ E KI + L GG + +
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68
Query: 99 LDIVRDQHSKT-------PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 151
+ PSL E + F L+ + +++ +++ HS+
Sbjct: 69 RWFGVEGDYNVLVMDLLGPSL--EDL----FNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
Query: 152 GIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFY 183
+HRD+KP N ++ ++ +ID+GLA+ Y
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-15
Identities = 47/225 (20%), Positives = 88/225 (39%), Gaps = 33/225 (14%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGG 92
D +G+G + + + + T E ++K L ++ +E+K+++ L
Sbjct: 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH- 66
Query: 93 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK-ALD----- 146
PNV+K + ++ K + I EY+ L + D +Y + + A D
Sbjct: 67 PNVLKFIGVLY--KDKRLNFITEYIKGGT---LRGIIKSMDSQYPWSQRVSFAKDIASGM 121
Query: 147 -YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF---------YHPGKEYNVRVASR 196
Y HS I+HRD+ HN ++ + + D+GLA + R
Sbjct: 122 AYLHSMNIIHRDLNSHNCLVRENKN-VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 197 YFKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 235
G PE++ + YD +D++S G + +I R
Sbjct: 181 TVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-15
Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 13/152 (8%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCGGP 93
YE+ +G G SEV ++ + +K+L+ P + +RE + L P
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHP 72
Query: 94 NVVKLLDI--VRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYC 148
+V + D P ++ EYV+ + + +T I + +AL++
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180
H GI+HRDVKP N+MI ++++D+G+A
Sbjct: 133 HQNGIIHRDVKPANIMISATNA-VKVMDFGIA 163
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-15
Identities = 49/231 (21%), Positives = 90/231 (38%), Gaps = 52/231 (22%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----------KKKKIKREIKI 85
++ E +++G+G + V +G V IK L K ++ +RE+ I
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 86 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK-A 144
+ NL PN+VKL ++ + P ++ E+V D LY L D L+
Sbjct: 77 MSNLN-HPNIVKLYGLMHNP----PRMVMEFVPCGD---LYHRLLDKAHPIKWSVKLRLM 128
Query: 145 LD------YCHSQG--IMHRDVKPHNVMIDHELRK----LRLIDWGLAEFYHPGKEYNVR 192
LD Y +Q I+HRD++ N+ + ++ D+GL+ +
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-----------Q 177
Query: 193 VASRYFKG---------PELLVDLQD-YDYSLDMWSLGCMFAGMIFRKEPF 233
+ G PE + ++ Y D +S + ++ + PF
Sbjct: 178 QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-14
Identities = 40/201 (19%), Positives = 76/201 (37%), Gaps = 26/201 (12%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLC 90
D + K+ E+++G + ++K+LK K + E L+
Sbjct: 8 DFKQLNFLTKLNENHSGELWKGRWQGND--IVVKVLKVRDWSTRKSRDFNEECPRLRIFS 65
Query: 91 GGPNVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLY---PTLTDYDIRYYI-YELLKAL 145
PNV+ +L + + P+LI ++ + + VL+ + D ++ + +
Sbjct: 66 H-PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124
Query: 146 DYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVR-VASRYFKGP 201
+ H+ I + +VMID ++ R+ + F PG+ Y VA P
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMT-ARISMADVKFSFQSPGRMYAPAWVA------P 177
Query: 202 ELLVDLQDYDYSL--DMWSLG 220
E L + DMWS
Sbjct: 178 EALQKKPEDTNRRSADMWSFA 198
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.1 bits (168), Expect = 2e-13
Identities = 49/339 (14%), Positives = 97/339 (28%), Gaps = 75/339 (22%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-----------KPVKKKKIKREIKIL 86
+ + K+G G + EVF+ I + IKI+ ++I EI I
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTI--ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 87 QNLCG--------GPNVVKLLDIVRDQHSKTPSLI------------------------- 113
+ L + L + Q S P L+
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 114 -----FEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDH 167
FE+ ++ + + +++L +L + HRD+ NV++
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK- 196
Query: 168 ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 227
+ Y + S L V + DY S +F +
Sbjct: 197 -------------KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDV- 242
Query: 228 FRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGR-HSRKPWSKFI 286
E F G D I +++ + N + + L L + + +
Sbjct: 243 SMDEDLFTGD--GDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKC 300
Query: 287 NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325
N + + +F +L + +A + +
Sbjct: 301 NTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-13
Identities = 29/173 (16%), Positives = 69/173 (39%), Gaps = 26/173 (15%)
Query: 40 YEVVRKVGRGKYSEVFEGI-----NVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPN 94
++V +G+G + ++ +V ++ C++K+ +P + E+K Q
Sbjct: 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKV-EPSDNGPLFTELKFYQRAAKPEQ 95
Query: 95 VVKLLDIVRDQHSKTPSLIF---EYVNSTDFKVLYPTLTDYDIRYYI------------- 138
+ K + + ++ P N ++ + D++
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVL 155
Query: 139 ---YELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGK 187
+L L+Y H +H D+K N++++++ ++ L+D+GLA Y P
Sbjct: 156 QLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-13
Identities = 46/223 (20%), Positives = 88/223 (39%), Gaps = 35/223 (15%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLC 90
+ E+ +G+G++ +V+ G + I+++ + K KRE+ +
Sbjct: 31 PFEQLEIGELIGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTR 87
Query: 91 GGPNVVKLLDIVRDQHSKTPSL--IFEYV-NSTDFKVLYPTLTDYDIRYYI---YELLKA 144
NVV + P L I T + V+ D+ E++K
Sbjct: 88 H-ENVVLFMGAC----MSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKG 142
Query: 145 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 200
+ Y H++GI+H+D+K NV D+ K+ + D+GL + R G
Sbjct: 143 MGYLHAKGILHKDLKSKNVFYDN--GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200
Query: 201 --PELL--------VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 233
PE++ D + D+++LG ++ + R+ PF
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 41/230 (17%), Positives = 96/230 (41%), Gaps = 37/230 (16%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLC 90
V +++G G + V++G + +K+L P + + K E+ +L+
Sbjct: 22 PDGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78
Query: 91 GGPNVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLYPTLTDYDIRYYIYELLK-ALD-- 146
N++ + +++ ++ S+ LY L + ++ + +L+ A
Sbjct: 79 H-VNILLFMGYSTAPQ---LAIVTQWCEGSS----LYHHLHASETKFEMKKLIDIARQTA 130
Query: 147 ----YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG-- 200
Y H++ I+HRD+K +N+ + + +++ D+GLA + G
Sbjct: 131 RGMDYLHAKSIIHRDLKSNNIFLHEDN-TVKIGDFGLATEKSRWSGSHQFEQL---SGSI 186
Query: 201 ----PELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 244
PE++ YS D+++ G + ++ + P+ +N DQ++
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQII 235
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 7e-12
Identities = 43/204 (21%), Positives = 92/204 (45%), Gaps = 31/204 (15%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLC 90
D + K+G G + V ++ +KIL + RE+ I++ L
Sbjct: 35 PWCDLNIKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERVNEFLREVAIMKRLR 92
Query: 91 GGPNVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLY-----PTLTDYDIRYYIYELLKA 144
PN+V + V S++ EY+ + +++L+ L + Y++ K
Sbjct: 93 H-PNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 145 LDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG-- 200
++Y H++ I+HR++K N+++D + +++ D+GL+ + + ++S+ G
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVDKKYT-VKVCDFGLSRL-----KASTFLSSKSAAGTP 203
Query: 201 ----PELLVDLQDYDYSLDMWSLG 220
PE+L D + + D++S G
Sbjct: 204 EWMAPEVLRD-EPSNEKSDVYSFG 226
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 35/210 (16%), Positives = 81/210 (38%), Gaps = 30/210 (14%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI-IKILKPVKKKKIKREIKILQ-NLCGGP 93
+ +G+G++ EV+ G + +KI +++ RE +I Q +
Sbjct: 40 IARTIVLQESIGKGRFGEVWRGK---WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHE 96
Query: 94 NVVKLLDIVRDQHSKTP--SLIFEYV-NSTDFKVLYPTLTDYDIRYYI-YELLKALDYCH 149
N++ + + L+ +Y + + F L + + L + H
Sbjct: 97 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH 156
Query: 150 SQ--------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG- 200
+ I HRD+K N+++ + D GLA + + + +A + G
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDT-IDIAPNHRVGT 214
Query: 201 -----PELL---VDLQDYDYSL--DMWSLG 220
PE+L ++++ ++ D++++G
Sbjct: 215 KRYMAPEVLDDSINMKHFESFKRADIYAMG 244
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 44/209 (21%), Positives = 82/209 (39%), Gaps = 28/209 (13%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQ-NLCGGPN 94
++V+++G+G+Y EV+ G E+ +K+ ++ RE +I Q L N
Sbjct: 35 IAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHEN 92
Query: 95 VVKLLDIVRDQHSKTP--SLIFEYV-NSTDFKVLYPTLTDYDIRYYI-YELLKALDYCHS 150
++ + LI +Y N + + L T D + Y + L + H+
Sbjct: 93 ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 151 Q--------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG-- 200
+ I HRD+K N+++ + D GLA + V + G
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVKFISDTN-EVDIPPNTRVGTK 210
Query: 201 ----PELL---VDLQDYDYSL--DMWSLG 220
PE+L ++ + + DM+S G
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFG 239
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 46/204 (22%), Positives = 78/204 (38%), Gaps = 28/204 (13%)
Query: 41 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQ-NLCGGPNVVKLL 99
++ VG+G+Y EV+ G N +KI +K RE ++ + N++ +
Sbjct: 11 TLLECVGKGRYGEVWRGSWQGEN--VAVKIFSSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 100 --DIVRDQHSKTPSLIFEYV-NSTDFKVLYPTLTDYDIRYYI-YELLKALDYCHSQ---- 151
D+ S LI Y + + L T D I + L + H +
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 152 ----GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------P 201
I HRD+K N+++ + + D GLA + + V + G P
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQ-CCIADLGLAVMHSQSTNQ-LDVGNNPRVGTKRYMAP 186
Query: 202 ELL-----VDLQDYDYSLDMWSLG 220
E+L VD D +D+W+ G
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFG 210
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 7e-11
Identities = 28/176 (15%), Positives = 58/176 (32%), Gaps = 30/176 (17%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNT--------NERCIIKILKPVKKKKIKREIKILQNLCG 91
+++ R ++E +T ++ +K+ K ++ E Q
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDA--KDGRLFNEQNFFQRAAK 101
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV-----LYPTLTDYDIRYY--------- 137
V K + P+ + V+ ++ L +L +
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSA-LDVSPKHVLSERS 160
Query: 138 ----IYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKE 188
LL AL++ H +H +V N+ +D E ++ L +G A Y P +
Sbjct: 161 VLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 8e-11
Identities = 41/223 (18%), Positives = 88/223 (39%), Gaps = 38/223 (17%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-------KKKIKREIKILQN 88
D + + +G G + +V+ + +K + + +++E K+
Sbjct: 5 DFAELTLEEIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 89 LCGGPNVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLYPTLTDYDIRYYI-YELLKALD 146
L PN++ L + + L+ E+ +VL DI ++ + ++
Sbjct: 63 LKH-PNIIALRGVCLKE--PNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMN 119
Query: 147 YCHSQG---IMHRDVKPHNVMIDHELRK-------LRLIDWGLAEFYHPGKEYNVRVASR 196
Y H + I+HRD+K N++I ++ L++ D+GLA +H + +
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS------ 173
Query: 197 YFKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 233
G PE++ + D+WS G + ++ + PF
Sbjct: 174 -AAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPF 214
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 6e-10
Identities = 42/220 (19%), Positives = 87/220 (39%), Gaps = 43/220 (19%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI-IKILKPVKKKKIKREIKI-----LQNL 89
D D+ +++ +GRG+Y V++G +ER + +K+ ++ E I +++
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGS---LDERPVAVKVFSFANRQNFINEKNIYRVPLMEH- 66
Query: 90 CGGPNVVKLL--DIVRDQHSKTP-SLIFEYV-NSTDFKVLYPTLTDYDIRYYI-YELLKA 144
N+ + + D + L+ EY N + K L +D+ + + + +
Sbjct: 67 ---DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRG 123
Query: 145 LDYCHSQ---------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS 195
L Y H++ I HRD+ NV++ ++ + D+GL+ +
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT-CVISDFGLSMRLTGNRLVRPGEED 182
Query: 196 RYFKG---------PELL------VDLQDYDYSLDMWSLG 220
PE+L D + +DM++LG
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALG 222
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-09
Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKP----VKKKKIKREIKILQ 87
++ + +R +G G + +V NT E+ +K LKP +K+EI+IL+
Sbjct: 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILR 78
Query: 88 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELL 142
NL N+VK I + LI E++ S K Y + Y ++
Sbjct: 79 NLYH-ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE-YLPKNKNKINLKQQLKYAVQIC 136
Query: 143 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189
K +DY S+ +HRD+ NV+++ E + +++ D+GL + KEY
Sbjct: 137 KGMDYLGSRQYVHRDLAARNVLVESEHQ-VKIGDFGLTKAIETDKEY 182
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 47/192 (24%), Positives = 88/192 (45%), Gaps = 17/192 (8%)
Query: 43 VRKVGRGKYSEVFEGI----NVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGPN 94
+R +G G + +V N T E +K LK P + K+EI IL+ L +
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYH-EH 94
Query: 95 VVKLLDIVRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRYYIYELLKALDYCHSQG 152
++K D + + L+ EYV + + ++ + + ++ + + Y H+Q
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQH 154
Query: 153 IMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRY-FK--GPELLVDLQ 208
+HRD+ NV++D++ +++ D+GLA + Y VR PE L + +
Sbjct: 155 YIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 213
Query: 209 DYDYSLDMWSLG 220
+ Y+ D+WS G
Sbjct: 214 -FYYASDVWSFG 224
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 5e-09
Identities = 49/236 (20%), Positives = 96/236 (40%), Gaps = 26/236 (11%)
Query: 25 FWNVSSYVIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IKILKPV----KKK 77
V VI +GRG + V+ G ++ + + I +K L + +
Sbjct: 12 VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS 71
Query: 78 KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDY 132
+ E I+++ PNV+ LL I +P ++ Y+ D + + T
Sbjct: 72 QFLTEGIIMKDFS-HPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRN-FIRNETHNPTVK 128
Query: 133 DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPG 186
D+ + ++ K + Y S+ +HRD+ N M+D + +++ D+GLA E+Y
Sbjct: 129 DLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVH 187
Query: 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHD 241
+ ++ ++ E L Q + D+WS G ++ M P + + D
Sbjct: 188 NKTGAKLPVKWM-ALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFD 240
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 6e-09
Identities = 47/238 (19%), Positives = 92/238 (38%), Gaps = 30/238 (12%)
Query: 25 FWNVSSYVIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IKILKPV----KKK 77
V VI +GRG + V+ G ++ + + I +K L + +
Sbjct: 76 VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS 135
Query: 78 KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDY 132
+ E I+++ PNV+ LL I P ++ Y+ D + + T
Sbjct: 136 QFLTEGIIMKDFS-HPNVLSLLGICLRSEGS-PLVVLPYMKHGDLRN-FIRNETHNPTVK 192
Query: 133 DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 192
D+ + ++ K + + S+ +HRD+ N M+D + +++ D+GLA + + +V
Sbjct: 193 DLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVH 251
Query: 193 VASRYFKG--------PELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHD 241
+ E L Q + D+WS G ++ M P + + D
Sbjct: 252 NKT---GAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFD 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 6e-09
Identities = 41/209 (19%), Positives = 80/209 (38%), Gaps = 29/209 (13%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK--KIKREIKILQNLCGGP 93
+++ RG++ V++ NE +KI K+ + + E+ L +
Sbjct: 22 QSMPLQLLEVKARGRFGCVWKA--QLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKH-E 78
Query: 94 NVVKLL--DIVRDQHSKTPSLIFEYV-NSTDFKVLYPTLTDYDIRYYI-YELLKALDYCH 149
N+++ + + LI + + L + ++ +I + + L Y H
Sbjct: 79 NILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLH 138
Query: 150 SQ----------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS---- 195
I HRD+K NV++ + L + D+GLA + GK
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLT-ACIADFGLALKFEAGKSAGDTHGQVGTR 197
Query: 196 RYFKGPELLVD----LQDYDYSLDMWSLG 220
RY PE+L +D +DM+++G
Sbjct: 198 RYM-APEVLEGAINFQRDAFLRIDMYAMG 225
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 50/230 (21%), Positives = 89/230 (38%), Gaps = 28/230 (12%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCG 91
+ +D + ++GRG + EVF G N +K + K K +E +IL+
Sbjct: 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS- 170
Query: 92 GPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKAL 145
PN+V+L+ + + P I E V DF + L + + + +
Sbjct: 171 HPNIVRLIGVCTQKQ---PIYIVMELVQGGDFLT-FLRTEGARLRVKTLLQMVGDAAAGM 226
Query: 146 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF----KGP 201
+Y S+ +HRD+ N ++ + L++ D+G++ G Y R P
Sbjct: 227 EYLESKCCIHRDLAARNCLVTEKNV-LKISDFGMSREEADG-VYAASGGLRQVPVKWTAP 284
Query: 202 ELLVDLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 248
E L + YS D+WS G ++ P + N + K
Sbjct: 285 EALNYGR---YSSESDVWSFGILLWETFSLGASP-YPNLSNQQTREFVEK 330
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 43/225 (19%), Positives = 99/225 (44%), Gaps = 20/225 (8%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 93
++ D + K+G G+Y EV+EG+ + +K LK ++ ++ +E +++ + P
Sbjct: 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HP 276
Query: 94 NVVKLLDIVRDQHSKTPSLI-FEYVNS---TDF--KVLYPTLTDYDIRYYIYELLKALDY 147
N+V+LL + + P I E++ D+ + ++ + Y ++ A++Y
Sbjct: 277 NLVQLLGVCTREP---PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 333
Query: 148 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELL 204
+ +HR++ N ++ +++ D+GL+ G Y +++ + PE L
Sbjct: 334 LEKKNFIHRNLAARNCLVGENH-LVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESL 391
Query: 205 VDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 248
+ D+W+ G ++ + P + G D + K
Sbjct: 392 AY-NKFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELLEK 434
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 38/165 (23%), Positives = 79/165 (47%), Gaps = 13/165 (7%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILK---PVKKKKIKREIKILQN 88
++ + + ++G+G + V NT +K L+ P +++ +REI+IL+
Sbjct: 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKA 80
Query: 89 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS---TDF-KVLYPTLTDYDIRYYIYELLKA 144
L +VK + ++ L+ EY+ S DF + L + Y ++ K
Sbjct: 81 L-HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139
Query: 145 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189
++Y S+ +HRD+ N++++ E +++ D+GLA+ K+Y
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAH-VKIADFGLAKLLPLDKDY 183
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 6e-08
Identities = 47/235 (20%), Positives = 90/235 (38%), Gaps = 28/235 (11%)
Query: 27 NVSSYVIFSDQDDYEVVRKVGRGKYSEVFEGI---NVNTNERCIIKILKPV----KKKKI 79
V +I ++ R +G+G + V+ G +C IK L + + +
Sbjct: 10 EVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAF 69
Query: 80 KREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK----VLYPTLTDYDIR 135
RE +++ L PNV+ L+ I+ P ++ Y+ D T D+
Sbjct: 70 LREGLLMRGLN-HPNVLALIGIMLPPEG-LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLI 127
Query: 136 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS 195
+ ++ + ++Y Q +HRD+ N M+D +++ D+GLA + Y+V+
Sbjct: 128 SFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF-TVKVADFGLARDILDREYYSVQQHR 186
Query: 196 RYFKG--------PELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHD 241
E L + D+WS G ++ + P + D D
Sbjct: 187 ---HARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPP-YRHIDPFD 236
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 7e-08
Identities = 50/241 (20%), Positives = 107/241 (44%), Gaps = 33/241 (13%)
Query: 34 FSDQDDYEV-------VRKVGRGKYSEVFEG----INVNTNERCIIKILKPVKKKKIK-- 80
F D+D + ++++G+G + V + NT E +K L+ ++ ++
Sbjct: 30 FEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 89
Query: 81 -REIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS---TDF-KVLYPTLTDYDIR 135
REI+IL++L N+VK + + LI EY+ D+ + + +
Sbjct: 90 EREIEILKSLQH-DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 148
Query: 136 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVA 194
Y ++ K ++Y ++ +HRD+ N+++++E R +++ D+GL + Y V+
Sbjct: 149 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENR-VKIGDFGLTKVLPQDKEYYKVKEP 207
Query: 195 SRY-FK--GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 250
PE L + + + + D+WS G ++ E F Y + + +++
Sbjct: 208 GESPIFWYAPESLTESK-FSVASDVWSFGVVLY-------ELFTYIEKSKSPPAEFMRMI 259
Query: 251 G 251
G
Sbjct: 260 G 260
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 46/232 (19%), Positives = 105/232 (45%), Gaps = 26/232 (11%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEG----INVNTNERCIIKILKPVKKKKIK---REIKILQN 88
++ + ++++G+G + V + NT E +K L+ ++ ++ REI+IL++
Sbjct: 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS 67
Query: 89 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS---TDF-KVLYPTLTDYDIRYYIYELLKA 144
L N+VK + + LI EY+ D+ + + + Y ++ K
Sbjct: 68 LQH-DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 145 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRY-FK--G 200
++Y ++ +HRD+ N+++++E R +++ D+GL + + V+
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENR-VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185
Query: 201 PELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 251
PE L + + + + D+WS G ++ E F Y + + +++G
Sbjct: 186 PESLTESK-FSVASDVWSFGVVLY-------ELFTYIEKSKSPPAEFMRMIG 229
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 48/225 (21%), Positives = 94/225 (41%), Gaps = 22/225 (9%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 93
++ + K+G+G + EV+ G N R IK LKP + + +E ++++ L
Sbjct: 265 PRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HE 322
Query: 94 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDF-----KVLYPTLTDYDIRYYIYELLKALDY 147
+V+L +V S+ P I EY++ L + ++ + Y
Sbjct: 323 KLVQLYAVV----SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 378
Query: 148 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPELL 204
+HRD++ N+++ L ++ D+GLA EY R +++ K PE
Sbjct: 379 VERMNYVHRDLRAANILVGENL-VCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 436
Query: 205 VDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 248
+ + D+WS G + + P + G N + L ++ +
Sbjct: 437 LY-GRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVER 479
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-07
Identities = 40/165 (24%), Positives = 75/165 (45%), Gaps = 25/165 (15%)
Query: 35 SDQDDYEV-------VRKVGRGKYSEVFEGINVNTNERCI---IKILKP----VKKKKIK 80
S DYE+ R +G G++ +V +GI ++ + IK K ++K
Sbjct: 5 SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 64
Query: 81 REIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIR 135
+E ++ P++VKL+ ++ ++ P I E + +V +L +
Sbjct: 65 QEALTMRQFD-HPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLI 119
Query: 136 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180
Y Y+L AL Y S+ +HRD+ NV++ ++L D+GL+
Sbjct: 120 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLS 163
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 53/233 (22%), Positives = 102/233 (43%), Gaps = 32/233 (13%)
Query: 37 QDDYEV-------VRKVGRGKYSEVFEGINVNTNERCI---IKILKP----VKKKKIKRE 82
DYE+ R +G G++ +V +GI ++ + IK K ++K +E
Sbjct: 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQE 441
Query: 83 IKILQNLCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDFKVLY-----PTLTDYDIRY 136
++ P++VKL+ ++ ++ P I E + + + +L +
Sbjct: 442 ALTMRQFDH-PHIVKLIGVI----TENPVWIIMELCTLGELRS-FLQVRKFSLDLASLIL 495
Query: 137 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR 196
Y Y+L AL Y S+ +HRD+ NV++ ++L D+GL+ + Y
Sbjct: 496 YAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKL 554
Query: 197 YFKG--PELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 246
K PE + + + + D+W G CM+ ++ +P F G N+D + +I
Sbjct: 555 PIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 605
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 3e-07
Identities = 40/163 (24%), Positives = 71/163 (43%), Gaps = 25/163 (15%)
Query: 37 QDDYEV-------VRKVGRGKYSEVFEGINVNTNERCI---IKILKP----VKKKKIKRE 82
Y + R +G G + EV+EG+ N I +K K K+K E
Sbjct: 4 GPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSE 63
Query: 83 IKILQNLCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYY 137
I++NL P++VKL+ I+ + P+ I E + + +L + Y
Sbjct: 64 AVIMKNLD-HPHIVKLIGII----EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY 118
Query: 138 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180
++ KA+ Y S +HRD+ N+++ ++L D+GL+
Sbjct: 119 SLQICKAMAYLESINCVHRDIAVRNILVASPE-CVKLGDFGLS 160
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 47/225 (20%), Positives = 94/225 (41%), Gaps = 22/225 (9%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 93
++ + K+G+G + EV+ G N R IK LKP + + +E ++++ L
Sbjct: 182 PRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HE 239
Query: 94 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDF-----KVLYPTLTDYDIRYYIYELLKALDY 147
+V+L +V S+ P I EY++ L + ++ + Y
Sbjct: 240 KLVQLYAVV----SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 148 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELL 204
+HRD++ N+++ L ++ D+GLA EY R +++ + PE
Sbjct: 296 VERMNYVHRDLRAANILVGENL-VCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 353
Query: 205 VDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 248
+ + D+WS G + + P + G N + L ++ +
Sbjct: 354 LY-GRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVER 396
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 1e-06
Identities = 31/238 (13%), Positives = 78/238 (32%), Gaps = 39/238 (16%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI-------IKILKPV---KKKKIKREIKI 85
+D +G+G ++++F+G+ + +K+L + +
Sbjct: 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASM 65
Query: 86 LQNLCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDFKVLY-----PTLTDYDIRYYIY 139
+ L ++V + +++ E+V Y +
Sbjct: 66 MSKLS-HKHLVLNYGVCVCGD---ENILVQEFVKFGSLD-TYLKKNKNCINILWKLEVAK 120
Query: 140 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI-------DWGLAEFYHPGKEYNVR 192
+L A+ + ++H +V N+++ E + D G++ P R
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER 180
Query: 193 V---ASRYFKGPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 246
+ PE + + ++ + + D WS G ++ +P D+ +L
Sbjct: 181 IPWVP------PECIENPKNLNLATDKWSFGTTLWEICSGGDKP-LSALDSQRKLQFY 231
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 46/236 (19%), Positives = 92/236 (38%), Gaps = 36/236 (15%)
Query: 38 DDYEV-------VRKVGRGKYSEVFEGINVNTNERCI---IKILKP-----VKKKKIKRE 82
+D + R +G+G++ V E + + +K+LK ++ RE
Sbjct: 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 83 IKILQNLCGGPNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFK---------VLYPTL 129
++ P+V KL+ + +K +I ++ D L
Sbjct: 76 AACMKEFD-HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 130 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189
+ ++ ++ ++Y S+ +HRD+ N M+ + + + D+GL+ + G Y
Sbjct: 135 PLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED-MTVCVADFGLSRKIYSGDYY 193
Query: 190 NVRVASRY-FK--GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHD 241
AS+ K E L D Y D+W+ G M+ M + P + G +N +
Sbjct: 194 RQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTP-YAGIENAE 247
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 46/228 (20%), Positives = 100/228 (43%), Gaps = 26/228 (11%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 93
++ D + K+G G+Y EV+EG+ + +K LK ++ ++ +E +++ + P
Sbjct: 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HP 69
Query: 94 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALD 146
N+V+LL + + P I E++ + Y ++ + Y ++ A++
Sbjct: 70 NLVQLLGVCTREP---PFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAME 125
Query: 147 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPEL 203
Y + +HRD+ N ++ +++ D+GL+ G Y +++ K PE
Sbjct: 126 YLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 183
Query: 204 LVDLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 248
L +S+ D+W+ G ++ + P + G D + K
Sbjct: 184 ---LAYNKFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELLEK 227
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 37/213 (17%), Positives = 86/213 (40%), Gaps = 33/213 (15%)
Query: 38 DDYEV-------VRKVGRGKYSEVFEGINVNTNERCI---IKILKP-----VKKKKIKRE 82
+D + + +G G++ V EG + + +K +K + ++ E
Sbjct: 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86
Query: 83 IKILQNLCGGPNVVKLLDIVRD---QHSKTPSLIFEYVNSTDFK---------VLYPTLT 130
+++ PNV++LL + + Q P +I ++ D +
Sbjct: 87 AACMKDFS-HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP 145
Query: 131 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 190
+ ++ ++ ++Y ++ +HRD+ N M+ ++ + + D+GL++ + G Y
Sbjct: 146 LQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM-TVCVADFGLSKKIYSGDYYR 204
Query: 191 VRVASRY-FK--GPELLVDLQDYDYSLDMWSLG 220
++ K E L D + Y D+W+ G
Sbjct: 205 QGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFG 236
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 46/223 (20%), Positives = 88/223 (39%), Gaps = 41/223 (18%)
Query: 36 DQDDYEV-------VRKVGRGKYSEVFEGI-----NVNTNERCIIKILKP----VKKKKI 79
D +E + +GRG + +V E T +K+LK + + +
Sbjct: 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 77
Query: 80 KREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-------------------NST 120
E+KIL ++ NVV LL + +I E+
Sbjct: 78 MSELKILIHIGHHLNVVNLLGAC-TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 121 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180
+ LT + Y +++ K +++ S+ +HRD+ N+++ + +++ D+GLA
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLA 195
Query: 181 EFYHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDMWSLG 220
+ +Y + +R K PE + D + Y D+WS G
Sbjct: 196 RDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFG 237
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 23/147 (15%), Positives = 59/147 (40%), Gaps = 17/147 (11%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGI-NVNTNERCI---IKILKP----VKKKKIKREIKILQ 87
+ +G G++ EV++G+ ++ ++ + IK LK ++ E I+
Sbjct: 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 101
Query: 88 NLCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYYIYELL 142
N+++L ++ P +I EY+ + + + + + +
Sbjct: 102 QFS-HHNIIRLEGVISKYK---PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 157
Query: 143 KALDYCHSQGIMHRDVKPHNVMIDHEL 169
+ Y + +HRD+ N++++ L
Sbjct: 158 AGMKYLANMNYVHRDLAARNILVNSNL 184
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 31/146 (21%), Positives = 60/146 (41%), Gaps = 16/146 (10%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IKILKP----VKKKKIKREIKILQN 88
D + + + VG G++ EV G +++ I IK LK +++ E I+
Sbjct: 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 89 LCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYYIYELLK 143
PN+++L +V P +I EY+ + + T + + +
Sbjct: 103 FD-HPNIIRLEGVVTKSK---PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHEL 169
+ Y G +HRD+ N++I+ L
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNL 184
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.5 bits (112), Expect = 5e-06
Identities = 47/373 (12%), Positives = 112/373 (30%), Gaps = 99/373 (26%)
Query: 9 IRSFFSEIMVYSYCLCF----WNVSSYVIFSDQ-------DDYEVVRKVGRGKYSEVF-- 55
+R Y CL N ++ F+ +V + + +
Sbjct: 234 LRRLLKS-KPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLD 292
Query: 56 ---EGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLL------------- 99
+ + + ++K L + + + RE+ P + ++
Sbjct: 293 HHSMTLTPDEVKSLLLKYLD-CRPQDLPREVLT-----TNPRRLSIIAESIRDGLATWDN 346
Query: 100 --DIVRDQHSKTPSLIFEYVNSTDFKVLYPTLT----DYDIRYYIYELL----------K 143
+ D+ + + +++ ++ L+ I + L+
Sbjct: 347 WKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMV 406
Query: 144 ALDYCHSQGIMHRDVKP-----HNVMID--------HELRKLRLIDWGLAEFYHPGKEYN 190
++ H ++ + K ++ ++ + L + ++D YN
Sbjct: 407 VVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHR-SIVD-----------HYN 454
Query: 191 VRVASRYFKGPELLVDLQD-YDYS--------LDMWSLGCMFAGMIFRKEPFFYGHDNHD 241
+ + F +L+ D Y YS ++ +F M+F F HD
Sbjct: 455 IP---KTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFR-MVFLDFRFLEQKIRHD 510
Query: 242 QLVKIAKVLGTD---ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEA 298
A + +L Y Y + DP+ + LV F+ ++L+ +
Sbjct: 511 STAWNASGSILNTLQQLKFY-KPYICDNDPKYERLV-----NAILDFLPKIEENLICSKY 564
Query: 299 IDFLDKLLRYDHQ 311
D L L + +
Sbjct: 565 TDLLRIALMAEDE 577
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 5e-05
Identities = 48/356 (13%), Positives = 97/356 (27%), Gaps = 119/356 (33%)
Query: 39 DYEVVRKVGRGKYS-----EVF-EGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGG 92
D+E G +Y VF + N + + + + K + K+ EI ++
Sbjct: 8 DFET----GEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKE---EID---HIIMS 57
Query: 93 PNVV----KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTL-TDYDIRYYIYELLKALDY 147
+ V +L + + + E V ++K L + T+ + + Y
Sbjct: 58 KDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRM-----Y 112
Query: 148 CHSQGIMHRDV---KPHNVMIDHELRKLR-----------LIDWGLAEFYHPGKEYNVRV 193
+ ++ D +NV KLR ++ G+ GK
Sbjct: 113 IEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGS---GK--TWVA 167
Query: 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 253
Y + C IF + + +
Sbjct: 168 LDV----------CLSYK-------VQCKMDFKIF--------------WLNLKNCNSPE 196
Query: 254 ELNAYLNKYHLELDPQLDALVGR--------HSRKPWSKFINADNQH----LV-----SP 296
+ L K ++DP + HS + + + + LV +
Sbjct: 197 TVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNA 256
Query: 297 EAIDFLD---KLL---RY------------------DHQDRLTAREAMAHPYFAQV 328
+A + + K+L R+ H LT E + +
Sbjct: 257 KAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKS--LLLKY 310
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 5e-06
Identities = 44/231 (19%), Positives = 100/231 (43%), Gaps = 23/231 (9%)
Query: 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCI----IKILK----PVKKKKIKREIKI 85
+ +++ ++ +G G + V++G+ + E+ IK L+ P K+I E +
Sbjct: 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 86 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV---NSTDF-KVLYPTLTDYDIRYYIYEL 141
+ ++ P+V +LL I T LI + + D+ + + + + ++
Sbjct: 71 MASVD-NPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 142 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK- 199
K ++Y + ++HRD+ NV++ +++ D+GLA+ ++ + K
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 200 -GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 248
E ++ Y + D+WS G ++ M F +P+ G + + K
Sbjct: 186 MALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEK 234
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 5e-06
Identities = 29/172 (16%), Positives = 67/172 (38%), Gaps = 33/172 (19%)
Query: 38 DDYEV-------VRKVGRGKYSEVFEGINVNTNE-----RCIIKILKP----VKKKKIKR 81
D++EV R++G+G + V+EG+ + R IK + ++ +
Sbjct: 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 82 EIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-------------NSTDFKVLYPT 128
E +++ +VV+LL +V +I E + + +
Sbjct: 78 EASVMKEF-NCHHVVRLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134
Query: 129 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180
+ + E+ + Y ++ +HRD+ N M+ + +++ D+G+
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKIGDFGMT 185
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 9e-06
Identities = 29/146 (19%), Positives = 56/146 (38%), Gaps = 16/146 (10%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IKILKP----VKKKKIKREIKILQN 88
+ + + +G G EV G +R + IK LK +++ E I+
Sbjct: 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQ 106
Query: 89 LCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYYIYELLK 143
PN+++L +V ++I EY+ + + T + + +
Sbjct: 107 FDH-PNIIRLEGVVTRGR---LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGA 162
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHEL 169
+ Y G +HRD+ NV++D L
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVDSNL 188
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 9e-06
Identities = 38/231 (16%), Positives = 95/231 (41%), Gaps = 27/231 (11%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILK----PVKKKKIKREIKILQ 87
+ + ++ +G G + V +G+ + IK+++ + + + +
Sbjct: 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG 70
Query: 88 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYV---NSTDF-KVLYPTLTDYDIRYYIYELLK 143
+L ++V+LL + + L+ +Y+ + D + L + + ++ K
Sbjct: 71 SLD-HAHIVRLLGLCPGS---SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAK 126
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--G 200
+ Y G++HR++ NV++ ++++ D+G+A+ P + + ++ K
Sbjct: 127 GMYYLEEHGMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185
Query: 201 PELLVDLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 248
E + Y+ D+WS G ++ M F EP+ G + + K
Sbjct: 186 LE---SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA-GLRLAEVPDLLEK 232
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 1e-05
Identities = 40/199 (20%), Positives = 88/199 (44%), Gaps = 26/199 (13%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 93
++ ++V ++G G++ EV+ G N + + +K LK + E +++ L
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQ 68
Query: 94 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALD 146
+V+L +V ++ P I EY+ + + LT + ++ + +
Sbjct: 69 RLVRLYAVV----TQEPIYIITEYMENGSLVD-FLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 147 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPEL 203
+ + +HRD++ N+++ L ++ D+GLA EY R +++ K PE
Sbjct: 124 FIEERNYIHRDLRAANILVSDTL-SCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEA 181
Query: 204 LVDLQDYDYSL--DMWSLG 220
+ +++ D+WS G
Sbjct: 182 INYGT---FTIKSDVWSFG 197
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 1e-05
Identities = 27/153 (17%), Positives = 69/153 (45%), Gaps = 15/153 (9%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 93
+++ +++++G G++ V G +K++K + + + +E + + L P
Sbjct: 6 KREEITLLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLS-HP 63
Query: 94 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDY 147
+VK + ++ P I EY+++ Y L + Y++ + + +
Sbjct: 64 KLVKFYGVCSKEY---PIYIVTEYISNGCLLN-YLRSHGKGLEPSQLLEMCYDVCEGMAF 119
Query: 148 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180
S +HRD+ N ++D +L +++ D+G+
Sbjct: 120 LESHQFIHRDLAARNCLVDRDL-CVKVSDFGMT 151
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 1e-05
Identities = 30/152 (19%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 93
D D ++++G G++ V G IK++K + + + E K++ NL
Sbjct: 22 DPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HE 79
Query: 94 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYYIYELLKALDYC 148
+V+L + Q P I EY+ + + + + ++ +A++Y
Sbjct: 80 KLVQLYGVCTKQR---PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180
S+ +HRD+ N +++ + +++ D+GL+
Sbjct: 137 ESKQFLHRDLAARNCLVNDQG-VVKVSDFGLS 167
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 34/204 (16%), Positives = 69/204 (33%), Gaps = 40/204 (19%)
Query: 30 SYVIFSDQDDYEV-------VRKVGRGKYSEVFEGI-------NVNTNERCIIKILKP-- 73
S + +E + +G G + +V +K+LK
Sbjct: 20 SEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA 79
Query: 74 --VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-------------- 117
+ E+++++ + N++ LL +I EY
Sbjct: 80 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRP 137
Query: 118 -----NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKL 172
+ +V +T D+ Y+L + ++Y SQ +HRD+ NV++ +
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVM 196
Query: 173 RLIDWGLAEFYHPGKEYNVRVASR 196
++ D+GLA + Y R
Sbjct: 197 KIADFGLARDINNIDYYKKTTNGR 220
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 44/231 (19%), Positives = 100/231 (43%), Gaps = 23/231 (9%)
Query: 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCI----IKILK----PVKKKKIKREIKI 85
+ +++ ++ +G G + V++G+ + E+ IK L+ P K+I E +
Sbjct: 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 86 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV---NSTDF-KVLYPTLTDYDIRYYIYEL 141
+ ++ P+V +LL I T LI + + D+ + + + + ++
Sbjct: 71 MASVD-NPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 142 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK- 199
K ++Y + ++HRD+ NV++ +++ D+GLA+ ++ + K
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 200 -GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 248
E ++ Y + D+WS G ++ M F +P+ G + + K
Sbjct: 186 MALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEK 234
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 16/82 (19%), Positives = 33/82 (40%), Gaps = 8/82 (9%)
Query: 101 IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKP 160
+ D ++ Y+N K + D Y++ + + H ++H D+
Sbjct: 405 YIFDVDLDNKRIMMSYINGKLAKDVIEDNLDI-----AYKIGEIVGKLHKNDVIHNDLTT 459
Query: 161 HNVMIDHELRKLRLIDWGLAEF 182
N + D + L +ID+GL +
Sbjct: 460 SNFIFD---KDLYIIDFGLGKI 478
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 4e-05
Identities = 46/221 (20%), Positives = 84/221 (38%), Gaps = 40/221 (18%)
Query: 38 DDYEV-------VRKVGRGKYSEVFEG-----INVNTNERCIIKILKP----VKKKKIKR 81
+E + +G G + +V E I + +K+LKP +++ +
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 75
Query: 82 EIKILQNLCGGPNVVKLLDIVRDQH-------------------SKTPSLIFEYVNSTDF 122
E+K+L L N+V LL K S I +
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 123 KVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182
+ L D+ + Y++ K + + S+ +HRD+ N+++ R ++ D+GLA
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGLARD 194
Query: 183 YHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDMWSLG 220
Y V+ +R K PE + + Y + D+WS G
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYG 234
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 43/227 (18%), Positives = 101/227 (44%), Gaps = 26/227 (11%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 93
++ ++ +K+G G++ EV+ N + + +K +KP + + E +++ L
Sbjct: 186 PRESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQ-HD 243
Query: 94 NVVKLLDIVRDQHSKTPSLI-FEYV---NSTDF--KVLYPTLTDYDIRYYIYELLKALDY 147
+VKL +V +K P I E++ + DF + + ++ + + +
Sbjct: 244 KLVKLHAVV----TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 299
Query: 148 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPELL 204
+ +HRD++ N+++ L ++ D+GLA EY R +++ K PE +
Sbjct: 300 IEQRNYIHRDLRAANILVSASL-VCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAI 357
Query: 205 VDLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 248
+++ D+WS G + + + + P + G N + + + +
Sbjct: 358 NFGS---FTIKSDVWSFGILLMEIVTYGRIP-YPGMSNPEVIRALER 400
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 6e-05
Identities = 46/212 (21%), Positives = 87/212 (41%), Gaps = 33/212 (15%)
Query: 38 DDYEVVRKVGRGKYSEVFEGI-----NVNTNERCIIKILKP----VKKKKIKREIKILQN 88
++ + + +G G + +V E + + +K+LK +K+ + E+KI+ +
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 89 LCGGPNVVKLLDIVRDQHSKTPSLIFEYV-----------------NSTDFKVLYPTLTD 131
L N+V LL H +I EY F + T +
Sbjct: 106 LGQHENIVNLLGAC--THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 132 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 191
D+ ++ ++ + + + S+ +HRDV NV++ + ++ D+GLA Y V
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG-HVAKIGDFGLARDIMNDSNYIV 222
Query: 192 RVASRY-FK--GPELLVDLQDYDYSLDMWSLG 220
+ +R K PE + D Y D+WS G
Sbjct: 223 KGNARLPVKWMAPESIFD-CVYTVQSDVWSYG 253
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 6e-05
Identities = 39/226 (17%), Positives = 89/226 (39%), Gaps = 24/226 (10%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 93
D + V+++G G++ V G ++ IK ++ + ++ E +++ L P
Sbjct: 6 DPSELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HP 63
Query: 94 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYYIYELLKALDYC 148
+V+L + +Q P + E++ + + ++ + + Y
Sbjct: 64 KLVQLYGVCLEQA---PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPELLV 205
++HRD+ N ++ +++ D+G+ F +Y +++ K PE+
Sbjct: 121 EEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEV-- 176
Query: 206 DLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 248
YS D+WS G M+ K P + N + + I+
Sbjct: 177 -FSFSRYSSKSDVWSFGVLMWEVFSEGKIP-YENRSNSEVVEDIST 220
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 7e-05
Identities = 27/153 (17%), Positives = 69/153 (45%), Gaps = 15/153 (9%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPN 94
+ + ++++ +G+G++ +V G + +K +K + E ++ L N
Sbjct: 19 NMKELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQAFLAEASVMTQLR-HSN 75
Query: 95 VVKLLDIVRDQHSKTPSL--IFEYV---NSTDF--KVLYPTLTDYDIRYYIYELLKALDY 147
+V+LL ++ ++ L + EY+ + D+ L + + ++ +A++Y
Sbjct: 76 LVQLLGVIVEEK---GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132
Query: 148 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180
+HRD+ NV++ + ++ D+GL
Sbjct: 133 LEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLT 164
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 8e-05
Identities = 32/188 (17%), Positives = 66/188 (35%), Gaps = 40/188 (21%)
Query: 30 SYVIFSDQDDYEV-------VRKVGRGKYSEVFEGI-------NVNTNERCIIKILKP-- 73
S + +E + +G G + +V +K+LK
Sbjct: 66 SEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA 125
Query: 74 --VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-------------- 117
+ E+++++ + N++ LL +I EY
Sbjct: 126 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRP 183
Query: 118 -----NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKL 172
+ +V +T D+ Y+L + ++Y SQ +HRD+ NV++ +
Sbjct: 184 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVM 242
Query: 173 RLIDWGLA 180
++ D+GLA
Sbjct: 243 KIADFGLA 250
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 9e-05
Identities = 37/179 (20%), Positives = 69/179 (38%), Gaps = 27/179 (15%)
Query: 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCI-IKILKPVKKKKIKR-------EIKI 85
F ++ K+G G + V++G N + +K L + + EIK+
Sbjct: 27 FDERPISVGGNKMGEGGFGVVYKGY---VNNTTVAVKKLAAMVDITTEELKQQFDQEIKV 83
Query: 86 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV--NSTDF----KVLYPTLTDYDIRYYI- 138
+ N+V+LL D L++ Y+ S P L + +R I
Sbjct: 84 MAKCQH-ENLVELLGFSSDGDDLC--LVYVYMPNGSLLDRLSCLDGTPPL-SWHMRCKIA 139
Query: 139 YELLKALDYCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNV--RVA 194
+++ H +HRD+K N+++D K+ D+GLA + + R+
Sbjct: 140 QGAANGINFLHENHHIHRDIKSANILLDEAFTAKIS--DFGLARASEKFAQTVMTSRIV 196
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 9e-05
Identities = 46/239 (19%), Positives = 90/239 (37%), Gaps = 41/239 (17%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IKILKP------VKKKKIKREIKIL 86
+ D ++ K+G G + V G + + + +K LKP RE+ +
Sbjct: 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 75
Query: 87 QNLCGGPNVVKLLDIVRDQHSKTPSLI----------FEYVNSTDFKVLYPTLTDYDIRY 136
+L N+++L +V P + + + L TL+
Sbjct: 76 HSLD-HRNLIRLYGVV----LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR----- 125
Query: 137 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVAS 195
Y ++ + + Y S+ +HRD+ N+++ +++ D+GL Y ++
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHYVMQEHR 184
Query: 196 RY-FK--GPELLVDLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 248
+ F PE L +S D W G ++ + +EP + G + L KI K
Sbjct: 185 KVPFAWCAPESLKTRT---FSHASDTWMFGVTLWEMFTYGQEP-WIGLNGSQILHKIDK 239
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 29/170 (17%), Positives = 61/170 (35%), Gaps = 28/170 (16%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGI--NVNTNERCIIKILKP----VKKKKIKREIKILQNL 89
D +D + +G G + +V + IK +K + E+++L L
Sbjct: 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 82
Query: 90 CGGPNVVKLLDIVRDQHSKTPSLIFEYV-------------------NSTDFKVLYPTLT 130
PN++ LL + L EY TL+
Sbjct: 83 GHHPNIINLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140
Query: 131 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180
+ ++ ++ + +DY + +HRD+ N+++ ++ D+GL+
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFGLS 189
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 33/199 (16%), Positives = 72/199 (36%), Gaps = 41/199 (20%)
Query: 19 YSYCLCFWNVSSYVIFSDQDDYEV-------VRKVGRGKYSEVFEGI-------NVNTNE 64
+ VS Y + D +E+ + +G G + +V N
Sbjct: 44 LYFQGMLAGVSEYELPED-PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVT 102
Query: 65 RCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV--- 117
+ +K+LK + E+++++ + N++ LL +I EY
Sbjct: 103 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKG 160
Query: 118 ----------------NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPH 161
+ L+ D+ Y++ + ++Y S+ +HRD+
Sbjct: 161 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 220
Query: 162 NVMIDHELRKLRLIDWGLA 180
NV++ + +++ D+GLA
Sbjct: 221 NVLVTED-NVMKIADFGLA 238
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 3e-04
Identities = 27/169 (15%), Positives = 59/169 (34%), Gaps = 36/169 (21%)
Query: 34 FSDQDDYEV-------VRKVGRGKYSEVFEGI--NVNTNERCI---IKILKPVKKKKIK- 80
FSD + + ++G G + +VF N+ + + +K LK + +
Sbjct: 30 FSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD 89
Query: 81 --REIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV------------------NST 120
RE ++L L ++V+ + + + ++FEY+ +
Sbjct: 90 FQREAELLTMLQ-HQHIVRFFGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAG 146
Query: 121 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL 169
V L + ++ + Y +HRD+ N ++ L
Sbjct: 147 GEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL 195
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 27/162 (16%), Positives = 72/162 (44%), Gaps = 15/162 (9%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPN 94
+ + ++++ +G+G++ +V G + +K +K + E ++ L N
Sbjct: 191 NMKELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQAFLAEASVMTQLR-HSN 247
Query: 95 VVKLLDIVRDQHSKTPSL--IFEYV---NSTDF--KVLYPTLTDYDIRYYIYELLKALDY 147
+V+LL ++ ++ L + EY+ + D+ L + + ++ +A++Y
Sbjct: 248 LVQLLGVIVEEK---GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 304
Query: 148 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189
+HRD+ NV++ + ++ D+GL + ++
Sbjct: 305 LEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQDT 345
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 6e-04
Identities = 46/221 (20%), Positives = 86/221 (38%), Gaps = 42/221 (19%)
Query: 38 DDYEVVRKVGRGKYSEVFEGI-----NVNTNERCIIKILKP----VKKKKIKREIKILQN 88
++ E + +G G + +V + + +K+LK +++ + E+K++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 89 LCGGPNVVKLLDIVRDQHSKTPSLIFEYV--------------------------NSTDF 122
L N+V LL LIFEY +
Sbjct: 105 LGSHENIVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 123 KVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182
+ LT D+ + Y++ K +++ + +HRD+ NV++ + +++ D+GLA
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT-HGKVVKICDFGLARD 221
Query: 183 YHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDMWSLG 220
Y VR +R K PE L + Y D+WS G
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYG 261
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 39.5 bits (92), Expect = 8e-04
Identities = 28/168 (16%), Positives = 64/168 (38%), Gaps = 36/168 (21%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---------------------VKKKK 78
+ + +G GK S VF + C++K K + +
Sbjct: 92 DAIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 150
Query: 79 IKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI 138
+ E + LQ L G V K+ + +++ E +++ + + + +
Sbjct: 151 ARNEFRALQKLQGLA-VPKVYAWEGN------AVLMELIDAKEL----YRVRVENPDEVL 199
Query: 139 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHP 185
+L+ + + +GI+H D+ +NV++ E + +ID+ + E
Sbjct: 200 DMILEEVAKFYHRGIVHGDLSQYNVLVSEE--GIWIIDFPQSVEVGEE 245
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 39.5 bits (93), Expect = 8e-04
Identities = 39/240 (16%), Positives = 95/240 (39%), Gaps = 46/240 (19%)
Query: 38 DDYEVVR--------KVGRGKYSEVFEGI-NVNTNERCI-IKILKP----VKKKKIKREI 83
+ R ++G G + V +G+ + + + IK+LK +++ RE
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 61
Query: 84 KILQNLCGGPNVVKLLDIVRDQHSKTPSLI----------FEYVNSTDFKVLYPTLTDYD 133
+I+ L P +V+L+ + ++ +++ ++ + +
Sbjct: 62 QIMHQLD-NPYIVRLIGVC----QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE-- 114
Query: 134 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVR 192
++++ + Y + +HRD+ NV++ + ++ D+GL+ Y R
Sbjct: 115 ---LLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTAR 170
Query: 193 VASRY-FK--GPELLVDLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 246
A ++ K PE + +S D+WS G M+ + + ++P + + + I
Sbjct: 171 SAGKWPLKWYAPE---CINFRKFSSRSDVWSYGVTMWEALSYGQKP-YKKMKGPEVMAFI 226
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 39.5 bits (93), Expect = 8e-04
Identities = 43/224 (19%), Positives = 89/224 (39%), Gaps = 30/224 (13%)
Query: 44 RKVGRGKYSEVFEGINVNTNERCI---IKILK-----PVKKKKIKREIKILQNLCGGPNV 95
+++G G + V +G + +KILK P K ++ E ++Q L P +
Sbjct: 23 KELGSGNFGTVKKGY-YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYI 80
Query: 96 VKLLDIVRDQHSKTPS-LIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 151
V+++ I L+ E + + D +I ++++ + Y
Sbjct: 81 VRMIGIC----EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 136
Query: 152 GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRY-FK--GPELLVDL 207
+HRD+ NV++ + ++ D+GL+ Y + ++ K PE +
Sbjct: 137 NFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC---I 192
Query: 208 QDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 248
Y +S D+WS G M+ + ++P + G + + K
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKP-YRGMKGSEVTAMLEK 235
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 39.9 bits (93), Expect = 8e-04
Identities = 26/121 (21%), Positives = 53/121 (43%), Gaps = 5/121 (4%)
Query: 103 RDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHN 162
+ SL + LT + Y +++ K +++ S+ +HRD+ N
Sbjct: 164 SSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 223
Query: 163 VMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDMWSL 219
+++ + +++ D+GLA + +Y + +R K PE + D + Y D+WS
Sbjct: 224 ILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSF 281
Query: 220 G 220
G
Sbjct: 282 G 282
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 338 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.75 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.46 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.24 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.13 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.96 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.78 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.73 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.54 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.49 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.43 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.24 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.02 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.98 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.93 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.84 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.78 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.67 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.66 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.62 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.56 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.53 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.44 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.33 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.31 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.89 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.8 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.5 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.0 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 85.3 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.36 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 84.34 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-61 Score=421.41 Aligned_cols=254 Identities=24% Similarity=0.422 Sum_probs=214.7
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc---cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
.+.|++.++||+|+||+||+|.+..+++.||||+++. ...+.+.+|+.+++++ +|||||+++++|.+ ...+|+|
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~--~~~~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLV--GDELWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEEEE
Confidence 3579999999999999999999999999999999863 3456688999999999 99999999999965 4678999
Q ss_pred EeeecCCcccccc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC-Ccce
Q 019642 114 FEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYN 190 (338)
Q Consensus 114 ~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~-~~~~ 190 (338)
|||+.|++|.+++ ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++...... ....
T Consensus 150 mEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~~~~~~~ 228 (346)
T 4fih_A 150 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRK 228 (346)
T ss_dssp ECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSSSCCBC
T ss_pred EeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCC-CCEEEecCcCceecCCCCCccc
Confidence 9999999998886 469999999999999999999999999999999999999988 89999999999876443 3345
Q ss_pred eeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcch
Q 019642 191 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 270 (338)
Q Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (338)
..+||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+..... +.
T Consensus 229 ~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~-~~~~~~~~~~i~~~~~-~~---------------- 289 (346)
T 4fih_A 229 SLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYF-NEPPLKAMKMIRDNLP-PR---------------- 289 (346)
T ss_dssp CCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHSSC-CC----------------
T ss_pred ccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CcCHHHHHHHHHcCCC-CC----------------
Confidence 5689999999999877 678999999999999999999999994 3333333333322110 00
Q ss_pred hhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 271 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
......+|+++.+||.+||+.||++|||++|+|+||||++...
T Consensus 290 -----------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 290 -----------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp -----------------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred -----------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence 0011227999999999999999999999999999999987543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-61 Score=416.59 Aligned_cols=254 Identities=28% Similarity=0.493 Sum_probs=215.8
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~------~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
.++|++.+.||+|+||+||+|++..+++.||+|++++ ...+.+.+|+++++++ +||||++++++|.+ ...+
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~--~~~~ 107 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQD--DEKL 107 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe--CCEE
Confidence 4689999999999999999999999999999999863 2346688999999999 99999999999955 5688
Q ss_pred EEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 111 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
|+||||+.||+|.+++ +.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus 108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~-g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED-MHIQITDFGTAKVLSPES 186 (311)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECCTTT
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCC-CCEEEEEcCCceecCCCC
Confidence 9999999999998886 469999999999999999999999999999999999999988 899999999998764322
Q ss_pred ---cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccc
Q 019642 188 ---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264 (338)
Q Consensus 188 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
.....+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||. +.+..+.+..+.+. ..
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~-~~~~~~~~~~i~~~--~~----------- 251 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFR-AGNEGLIFAKIIKL--EY----------- 251 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHT--CC-----------
T ss_pred CcccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHcC--CC-----------
Confidence 2345689999999999987 678999999999999999999999994 33333333333221 00
Q ss_pred ccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHH------HhcCCCcchhhhccc
Q 019642 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE------AMAHPYFAQVRAAES 333 (338)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~e------ll~hp~~~~~~~~~~ 333 (338)
..+..+|+++++||.+||++||++|||++| +++||||+++.+..-
T Consensus 252 ------------------------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l 302 (311)
T 4aw0_A 252 ------------------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302 (311)
T ss_dssp ------------------------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred ------------------------CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence 012237999999999999999999999998 589999999876543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-61 Score=408.01 Aligned_cols=247 Identities=23% Similarity=0.498 Sum_probs=193.4
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
++|++.+.||+|+||+||+|.+..+++.||+|++++. ....+.+|+.+++++ +||||+++++++.+ ...++
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~--~~~~~ 89 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKS--KDEII 89 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEE--CCEEE
Confidence 6899999999999999999999999999999998632 245688999999999 99999999999955 56789
Q ss_pred EEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 112 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 112 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
+||||++| +|.+.+ ..+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.......
T Consensus 90 ivmEy~~g-~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 90 MVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEH-LNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp EEEECCCE-EHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT-CCEEECCSSCC--------
T ss_pred EEEeCCCC-CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCC-CCEEEeecCCCeecCCCCc
Confidence 99999954 555443 469999999999999999999999999999999999999988 8999999999987665555
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
.....||+.|+|||++.+....+.++|||||||++|+|++|+.||. +.+.......+... ..
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~-~~~~~~~~~~i~~~--~~--------------- 229 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD-DESIPVLFKNISNG--VY--------------- 229 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHT--CC---------------
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHcC--CC---------------
Confidence 5567899999999999884456789999999999999999999993 22222222222110 00
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcch
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 327 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 327 (338)
..+..+|+++.+||.+||+.||++|||++|+|+||||+.
T Consensus 230 --------------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 230 --------------------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp --------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred --------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 011237899999999999999999999999999999963
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-60 Score=406.30 Aligned_cols=253 Identities=21% Similarity=0.416 Sum_probs=206.4
Q ss_pred cCCcE-EEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeecc--CC
Q 019642 36 DQDDY-EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HS 107 (338)
Q Consensus 36 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~ 107 (338)
..++| ++.++||+|+||+||+|.+..++..||+|.+... ..+.+.+|+.+++++ +|||||++++++.+. ..
T Consensus 23 ~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~ 101 (290)
T 3fpq_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp TTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETTE
T ss_pred CCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCCC
Confidence 34455 7888999999999999999999999999998632 245688999999999 999999999998653 23
Q ss_pred CccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCeEecCCCCceEEEecccccc
Q 019642 108 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~~~~~~l~dfg~~~~ 182 (338)
..+++||||+.|++|.+++ ..+++..++.++.||+.||.|||++| |+||||||+|||++...+.+||+|||+++.
T Consensus 102 ~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred cEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 5689999999999999887 45999999999999999999999998 999999999999986448999999999975
Q ss_pred ccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcc
Q 019642 183 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262 (338)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
... .......||+.|+|||++.+ .++.++|||||||++|+|+||+.||....+ ...+... +.....+
T Consensus 182 ~~~-~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~-~~~~~~~---i~~~~~~------ 248 (290)
T 3fpq_A 182 KRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQN-AAQIYRR---VTSGVKP------ 248 (290)
T ss_dssp CCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-HHHHHHH---HTTTCCC------
T ss_pred CCC-CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-HHHHHHH---HHcCCCC------
Confidence 433 33455689999999999865 599999999999999999999999943332 2222211 1110000
Q ss_pred ccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcch
Q 019642 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 327 (338)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 327 (338)
...+...++++.+||.+||+.||++|||++|+|+||||++
T Consensus 249 -------------------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 249 -------------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -------------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -------------------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 0011126889999999999999999999999999999986
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-61 Score=420.18 Aligned_cols=253 Identities=19% Similarity=0.390 Sum_probs=206.8
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
+...++|++++.||+|+||+||+|++..+++.||||+++.. ..+.+.+|+.+++++ +|||||++++++.+ ..
T Consensus 20 f~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~--~~ 96 (350)
T 4b9d_A 20 FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHPNIVQYRESFEE--NG 96 (350)
T ss_dssp CSCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TT
T ss_pred CCcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEE--CC
Confidence 34568999999999999999999999999999999998643 245688999999999 99999999999965 56
Q ss_pred ccEEEEeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 109 TPSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
.+|+||||+.|++|.+++. .+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 97 ~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-g~vKl~DFGla~~~ 175 (350)
T 4b9d_A 97 SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD-GTVQLGDFGIARVL 175 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTT-CCEEECSTTEESCC
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC-CCEEEcccccceee
Confidence 7899999999999988862 36899999999999999999999999999999999999988 89999999999765
Q ss_pred cCCC-cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcc
Q 019642 184 HPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262 (338)
Q Consensus 184 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+....- +
T Consensus 176 ~~~~~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~-~~~~~~~~~~i~~~~~-~--------- 243 (350)
T 4b9d_A 176 NSTVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFE-AGSMKNLVLKIISGSF-P--------- 243 (350)
T ss_dssp CHHHHHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHTCC-C---------
T ss_pred cCCcccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CcCHHHHHHHHHcCCC-C---------
Confidence 4322 2234579999999999987 679999999999999999999999993 3333333333322100 0
Q ss_pred ccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
..+..+|+++.+||.+||++||++|||++|+|+||||++-
T Consensus 244 --------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 244 --------------------------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp --------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred --------------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 0112379999999999999999999999999999999753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-60 Score=422.21 Aligned_cols=253 Identities=24% Similarity=0.425 Sum_probs=214.6
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc---cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
.+.|++.++||+|+||+||+|.+..+++.||||+++. ...+.+.+|+.+|+++ +|||||+++++|.+ ...+|+|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~--~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLV--GDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCCCceEEEEEE--CCEEEEE
Confidence 4679999999999999999999999999999999863 3456788999999999 99999999999965 4678999
Q ss_pred EeeecCCcccccc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC-Ccce
Q 019642 114 FEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYN 190 (338)
Q Consensus 114 ~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~-~~~~ 190 (338)
||||.|++|.+++ ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++...... ....
T Consensus 227 mEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~-g~vKl~DFGla~~~~~~~~~~~ 305 (423)
T 4fie_A 227 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRK 305 (423)
T ss_dssp EECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTT-CCEEECCCTTCEECCSSCCCBC
T ss_pred EeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC-CCEEEecCccceECCCCCcccc
Confidence 9999999998887 469999999999999999999999999999999999999988 89999999999876433 3345
Q ss_pred eeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcch
Q 019642 191 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 270 (338)
Q Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (338)
..+||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+.... ...
T Consensus 306 ~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~-~~~~~~~~~~i~~~~-~~~---------------- 366 (423)
T 4fie_A 306 SLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYF-NEPPLKAMKMIRDNL-PPR---------------- 366 (423)
T ss_dssp CCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHSC-CCC----------------
T ss_pred ccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CcCHHHHHHHHHcCC-CCC----------------
Confidence 5689999999999877 679999999999999999999999994 333333333332210 000
Q ss_pred hhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 271 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
......+|+++.+||.+||+.||++|||+.|+|+||||++..
T Consensus 367 -----------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 367 -----------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp -----------------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred -----------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 011123799999999999999999999999999999998754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-60 Score=420.05 Aligned_cols=291 Identities=29% Similarity=0.480 Sum_probs=229.8
Q ss_pred CCcEEEEEeeeecCceeEEEEEEc---CCCceEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~-~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
.++|++.+.||+|+||+||+|.++ .+++.||+|.+.+. ....+.+|+++++.+.+||||++++++|.+ ..++++
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~--~~~~~l 97 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRK--NDHVVI 97 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE--TTEEEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEE--CCEEEE
Confidence 478999999999999999999875 46788999987643 456688999999999789999999999965 568899
Q ss_pred EEeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-----
Q 019642 113 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK----- 187 (338)
Q Consensus 113 v~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~----- 187 (338)
||||+.+++|.+.++.+++.+++.++.|++.||.|||++||+||||||+|||++.+.+.+||+|||+++......
T Consensus 98 vmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~ 177 (361)
T 4f9c_A 98 AMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLK 177 (361)
T ss_dssp EEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGG
T ss_pred EEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccc
Confidence 999999999999999999999999999999999999999999999999999998876899999999996543221
Q ss_pred ------------------------cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHH
Q 019642 188 ------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 243 (338)
Q Consensus 188 ------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~ 243 (338)
.....+||+.|+|||++.+...++.++||||+||++|+|++|+.||+.+.+..+++
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l 257 (361)
T 4f9c_A 178 FVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTAL 257 (361)
T ss_dssp GC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH
T ss_pred cccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHH
Confidence 12234799999999999876679999999999999999999999999999999999
Q ss_pred HHHHHHhCCchhhhhhhccccccCc-------chhhhhccc----------cCCCCcccccccCCCCCChhHHHHHHHhc
Q 019642 244 VKIAKVLGTDELNAYLNKYHLELDP-------QLDALVGRH----------SRKPWSKFINADNQHLVSPEAIDFLDKLL 306 (338)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~----------~~~~~~~~~~~~~~~~~s~~l~~li~~~L 306 (338)
..+...+|.+............... ......... ................+|+++.+||++||
T Consensus 258 ~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL 337 (361)
T 4f9c_A 258 AQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLL 337 (361)
T ss_dssp HHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHT
T ss_pred HHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHC
Confidence 9999988876554433222111100 000000000 00000011112233458999999999999
Q ss_pred CCCcCCcCCHHHHhcCCCcchhh
Q 019642 307 RYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 307 ~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
+.||++|||++|+|+||||++++
T Consensus 338 ~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 338 DLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp CSCTTTSCCHHHHHTSGGGTTC-
T ss_pred cCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-60 Score=406.88 Aligned_cols=253 Identities=27% Similarity=0.469 Sum_probs=205.7
Q ss_pred CCcEEEEEeeeecCceeEEEEEEc---CCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
.++|++++.||+|+||+||+|++. .+++.||+|+++.. ....+.+|+.+++++ +||||+++++++.+ ..
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~--~~ 99 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFIVKLHYAFQT--EG 99 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-CCTTEECEEEEEEE--TT
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEE--CC
Confidence 468999999999999999999874 46789999998642 234678899999999 99999999999965 56
Q ss_pred ccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 109 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
.+|+||||+.|++|.+++ ..+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESID 178 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT-SCEEEESSEEEEC---
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCC-CCEEecccccceeccC
Confidence 789999999999998887 459999999999999999999999999999999999999998 8999999999976533
Q ss_pred C-CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccc
Q 019642 186 G-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264 (338)
Q Consensus 186 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+.+. ..
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~-~~~~~~~~~~i~~~--~~----------- 243 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQ-GKDRKETMTMILKA--KL----------- 243 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHC--CC-----------
T ss_pred CCccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCC-CcCHHHHHHHHHcC--CC-----------
Confidence 2 33445689999999999987 689999999999999999999999993 33333333333221 00
Q ss_pred ccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCC-----HHHHhcCCCcchhhhcc
Q 019642 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAAE 332 (338)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt-----~~ell~hp~~~~~~~~~ 332 (338)
..+..+|+++.+||++||++||++||| ++|+++||||+++.+..
T Consensus 244 ------------------------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~ 292 (304)
T 3ubd_A 244 ------------------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNK 292 (304)
T ss_dssp ------------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred ------------------------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHH
Confidence 012237999999999999999999998 47999999999986543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-58 Score=413.33 Aligned_cols=285 Identities=28% Similarity=0.556 Sum_probs=225.1
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeecc----CC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----HS 107 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~----~~ 107 (338)
.++|++++.||+|+||+||+|.+..+++.||||+++.. ..+.+.+|+.+|+.+ +||||+++++++... ..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSCTTTC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-CCCCcceEeeeeecccccccC
Confidence 47899999999999999999999999999999998643 234577899999999 999999999988543 33
Q ss_pred CccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 108 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
..+|+||||++|+ |..++ +.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 132 ~~~~ivmE~~~g~-L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~-~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 132 KSVYVVLDLMESD-LHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNEN-CELKIGDFGMARGLC 209 (398)
T ss_dssp CCEEEEEECCSEE-HHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-CCEEECCCTTCBCC-
T ss_pred CEEEEEEeCCCCC-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCC-CCEEEeecceeeecc
Confidence 5789999999765 54444 359999999999999999999999999999999999999988 899999999997653
Q ss_pred CC-----CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhh
Q 019642 185 PG-----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259 (338)
Q Consensus 185 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
.. ......+||+.|+|||++.+...++.++||||+||++|+|++|..|| .+.+..+++..+.+..+.+....+.
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF-~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLF-PGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSS-CCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCC-CCCCHHHHHHHHHHhcCCCChHHhh
Confidence 22 22334689999999999988667899999999999999999999998 5677788888898888877655442
Q ss_pred hccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
............. .......++.. ..+.+++++.+||.+||..||++|||++|+|+||||++...+
T Consensus 289 ~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p 354 (398)
T 4b99_A 289 AVGAERVRAYIQS-LPPRQPVPWET-----VYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDP 354 (398)
T ss_dssp -----CHHHHHHS-SCCCCCCCHHH-----HSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCG
T ss_pred hhhhhhhhhhhhc-CCCcCCCCHHH-----hCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCC
Confidence 2111111000000 00011111111 122378999999999999999999999999999999987543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-59 Score=406.26 Aligned_cols=258 Identities=22% Similarity=0.336 Sum_probs=210.3
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEe
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 115 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e 115 (338)
..+.|++.++||+|+||+||+|++..+++.||||+++.... ..+|+.+++++ +|||||++++++.+ ...+|+|||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--~~~E~~il~~l-~HpnIV~l~~~~~~--~~~~~ivmE 130 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--RVEELVACAGL-SSPRIVPLYGAVRE--GPWVNIFME 130 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CTHHHHTTTTC-CCTTBCCEEEEEEE--TTEEEEEEC
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--HHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEEEEEe
Confidence 34679999999999999999999999999999999975432 24799999999 99999999999965 467899999
Q ss_pred eecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc----
Q 019642 116 YVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---- 188 (338)
Q Consensus 116 ~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~---- 188 (338)
|+.|++|.+++ ..+++..++.++.||+.||.|||++||+||||||+|||++.+...+||+|||++........
T Consensus 131 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~ 210 (336)
T 4g3f_A 131 LLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210 (336)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence 99999999887 45999999999999999999999999999999999999998734799999999976643221
Q ss_pred --ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 189 --YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 189 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||... +..+....+.. +....
T Consensus 211 ~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~-~~~~~~~~i~~--~~~~~----------- 275 (336)
T 4g3f_A 211 LTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQY-FRGPLCLKIAS--EPPPI----------- 275 (336)
T ss_dssp ---CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTT-CCSCCHHHHHH--SCCGG-----------
T ss_pred ecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCC-CHHHHHHHHHc--CCCCc-----------
Confidence 122469999999999988 78999999999999999999999999432 22222222211 00000
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHH-------------hcCCCcchhhhccc
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA-------------MAHPYFAQVRAAES 333 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~el-------------l~hp~~~~~~~~~~ 333 (338)
...++.+++++.+||.+||++||++|||+.|+ |+|||+.+..++..
T Consensus 276 ---------------------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr~ 334 (336)
T 4g3f_A 276 ---------------------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPRG 334 (336)
T ss_dssp ---------------------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCCC
T ss_pred ---------------------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCCC
Confidence 01123479999999999999999999999997 68999998877655
Q ss_pred c
Q 019642 334 S 334 (338)
Q Consensus 334 ~ 334 (338)
+
T Consensus 335 n 335 (336)
T 4g3f_A 335 N 335 (336)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-57 Score=393.19 Aligned_cols=253 Identities=20% Similarity=0.377 Sum_probs=193.5
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC------
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS------ 107 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~------ 107 (338)
++|++++.||+|+||+||+|++..+++.||+|+++... .+.+.+|+.+++++ +|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCccccccc
Confidence 46999999999999999999999999999999986422 35678999999999 99999999999865432
Q ss_pred ----CccEEEEeeecCCccccccCC------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEec
Q 019642 108 ----KTPSLIFEYVNSTDFKVLYPT------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW 177 (338)
Q Consensus 108 ----~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~df 177 (338)
..+|+||||+.+++|.+++.. .+...++.++.|++.||.|||++||+||||||+|||++.+ +.+||+||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~-~~vKl~DF 162 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKVGDF 162 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCC-CcEEEccC
Confidence 247899999999999888642 4556688999999999999999999999999999999988 89999999
Q ss_pred cccccccCCCc-------------ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHH
Q 019642 178 GLAEFYHPGKE-------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 244 (338)
Q Consensus 178 g~~~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~ 244 (338)
|+++....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++ ||. +..+...
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~---~~~~~~~ 235 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFS---TQMERVR 235 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCS---SHHHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCC---CccHHHH
Confidence 99976543221 123469999999999987 689999999999999999995 773 2222222
Q ss_pred HHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCC
Q 019642 245 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 324 (338)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 324 (338)
.+.........+.+ . ..++.+.+||++||+.||++|||+.|+|+|||
T Consensus 236 ~~~~~~~~~~p~~~------------~---------------------~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~ 282 (299)
T 4g31_A 236 TLTDVRNLKFPPLF------------T---------------------QKYPCEYVMVQDMLSPSPMERPEAINIIENAV 282 (299)
T ss_dssp HHHHHHTTCCCHHH------------H---------------------HHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHhcCCCCCCC------------c---------------------ccCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 22222111110000 0 03667889999999999999999999999999
Q ss_pred cchhhhcc
Q 019642 325 FAQVRAAE 332 (338)
Q Consensus 325 ~~~~~~~~ 332 (338)
|+++..+.
T Consensus 283 ~~~~~~p~ 290 (299)
T 4g31_A 283 FEDLDFPG 290 (299)
T ss_dssp GCCC----
T ss_pred hCCCCCCC
Confidence 99987643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-55 Score=387.08 Aligned_cols=303 Identities=75% Similarity=1.268 Sum_probs=274.8
Q ss_pred hceeeeeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 28 VSSYVIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 28 ~~~~~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
.+..+...+.++|++.+.||+|+||+||+|.+..+++.||+|+++....+.+.+|+.+++++.+||||+++++++.+...
T Consensus 26 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 105 (330)
T 3nsz_A 26 ESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVS 105 (330)
T ss_dssp GGCCCCCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred hhhhhcccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC
Confidence 34455567789999999999999999999999999999999999988888999999999999559999999999977667
Q ss_pred CccEEEEeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 108 KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
...++||||+.+++|..++..+++..++.++.|++.||.|||++|++|+||||+||+++.+...++|+|||++.......
T Consensus 106 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 106 RTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp CCEEEEEECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred CceEEEEeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 78899999999999999999999999999999999999999999999999999999999874589999999998766555
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......+++.|+|||++.+...++.++||||||+++|+|++|..||+...+..+.+..+.+.++................
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 265 (330)
T 3nsz_A 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265 (330)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence 55667889999999999776679999999999999999999999998888888999999999998888888888888888
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
+.............+..+........+++++.+||.+||+.||++|||++|+|+||||+++..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence 888888888888888888777777789999999999999999999999999999999998754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=381.07 Aligned_cols=253 Identities=18% Similarity=0.318 Sum_probs=204.7
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEc-----CCCceEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~---~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
...++|.+.++||+|+||+||+|.+. .+++.||||.++... .+.+.+|+.+++++ +|||||++++++.+
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~-- 86 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVE-- 86 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhC-CCCCCccEEEEEee--
Confidence 45679999999999999999999865 357889999997543 45688999999999 99999999999955
Q ss_pred CCccEEEEeeecCCccccccC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCC
Q 019642 107 SKTPSLIFEYVNSTDFKVLYP----------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR 170 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~ 170 (338)
....++||||+.+|+|.+++. .+++..+..++.|++.||.|||+++|+||||||+|||++.+ +
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~-~ 165 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN-L 165 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-G
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC-C
Confidence 567899999999999988762 48999999999999999999999999999999999999988 8
Q ss_pred ceEEEeccccccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHH
Q 019642 171 KLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKI 246 (338)
Q Consensus 171 ~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~ 246 (338)
.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|+| |+.||. +.+..+....+
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~-~~~~~~~~~~i 243 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWY-QLSNNEVIECI 243 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTT-TSCHHHHHHHH
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCC-CCCHHHHHHHH
Confidence 999999999976543322 122468999999999987 689999999999999999998 899984 33333333332
Q ss_pred HHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcc
Q 019642 247 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 326 (338)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~ 326 (338)
.+... ...+..+++++.+||.+||+.||++|||+.|+ ++||.
T Consensus 244 ~~~~~------------------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~ 285 (299)
T 4asz_A 244 TQGRV------------------------------------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQ 285 (299)
T ss_dssp HHTCC------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHH
T ss_pred HcCCC------------------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHH
Confidence 22100 00122378999999999999999999999999 56787
Q ss_pred hhhhc
Q 019642 327 QVRAA 331 (338)
Q Consensus 327 ~~~~~ 331 (338)
++...
T Consensus 286 ~~~~~ 290 (299)
T 4asz_A 286 NLAKA 290 (299)
T ss_dssp HHHHH
T ss_pred HHHhc
Confidence 76554
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-55 Score=408.21 Aligned_cols=256 Identities=24% Similarity=0.437 Sum_probs=216.6
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
++|++.+.||+|+||.||+|.++.+++.||+|++... ..+.+.+|+.+|+.+ +||||++++++|.+ ...+++||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~--~~~~~iv~ 233 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFED--DNEMVMIY 233 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEC--SSEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhC-CCCCCCeEEEEEEE--CCEEEEEE
Confidence 6899999999999999999999999999999998643 345688999999999 99999999999955 56889999
Q ss_pred eeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC-CCceEEEeccccccccCCCcc
Q 019642 115 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEY 189 (338)
Q Consensus 115 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~-~~~~~l~dfg~~~~~~~~~~~ 189 (338)
||+.|++|.+++ ..+++..++.++.||+.||.|||++||+|+||||+|||++.+ .+.+||+|||++.........
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~ 313 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCce
Confidence 999999987765 248999999999999999999999999999999999999753 378999999999888776666
Q ss_pred eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcc
Q 019642 190 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 269 (338)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+........
T Consensus 314 ~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~-~~~~~~~~~~i~~~~~~~~--------------- 376 (573)
T 3uto_A 314 KVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFG-GENDDETLRNVKSCDWNMD--------------- 376 (573)
T ss_dssp EEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHHHTTCCCCC---------------
T ss_pred eeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CcCHHHHHHHHHhCCCCCC---------------
Confidence 77789999999999988 678999999999999999999999983 3343444433322111100
Q ss_pred hhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 270 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
......+|+++.+||++||+.||++|||+.|+|+||||+....+
T Consensus 377 ------------------~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~ 420 (573)
T 3uto_A 377 ------------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420 (573)
T ss_dssp ------------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred ------------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence 01112379999999999999999999999999999999976543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=404.61 Aligned_cols=268 Identities=25% Similarity=0.420 Sum_probs=213.4
Q ss_pred HHhhhceeeeeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHH---HHHHHhcCCCC
Q 019642 24 CFWNVSSYVIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREI---KILQNLCGGPN 94 (338)
Q Consensus 24 ~~~~~~~~~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~---~~l~~l~~h~~ 94 (338)
+.|+.-..-.....++|++.+.||+|+||+||+|++..+++.||+|++++. ......+|. .+++.+ +|||
T Consensus 175 ~q~k~~e~~~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~ 253 (689)
T 3v5w_A 175 CQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPF 253 (689)
T ss_dssp HHHHHHHTTCCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTT
T ss_pred HhccccccCCCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCC
Confidence 344433322233457899999999999999999999999999999998632 223344554 444455 8999
Q ss_pred eeEeeeeeeccCCCccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCc
Q 019642 95 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK 171 (338)
Q Consensus 95 iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 171 (338)
||+++++|.+ ...+|+||||+.||+|..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.
T Consensus 254 IV~l~~~f~~--~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~-G~ 330 (689)
T 3v5w_A 254 IVCMSYAFHT--PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GH 330 (689)
T ss_dssp BCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT-SC
T ss_pred EeEEEEEEEE--CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCC-CC
Confidence 9999999955 56899999999999998887 459999999999999999999999999999999999999998 89
Q ss_pred eEEEeccccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCC-CHHHHHHHHHHh
Q 019642 172 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD-NHDQLVKIAKVL 250 (338)
Q Consensus 172 ~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~-~~~~~~~~~~~~ 250 (338)
+||+|||++....... ....+||+.|+|||++.+...++.++|+|||||++|+|++|..||..... ....+......
T Consensus 331 vKL~DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~- 408 (689)
T 3v5w_A 331 VRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT- 408 (689)
T ss_dssp EEECCCTTCEECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH-
T ss_pred EEecccceeeecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC-
Confidence 9999999998765433 34568999999999997546799999999999999999999999953221 11111111000
Q ss_pred CCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCC-----HHHHhcCCCc
Q 019642 251 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYF 325 (338)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt-----~~ell~hp~~ 325 (338)
.. ...+..+|+++.+||.+||+.||++|++ ++||++||||
T Consensus 409 ~~-----------------------------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF 453 (689)
T 3v5w_A 409 MA-----------------------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453 (689)
T ss_dssp CC-----------------------------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGG
T ss_pred CC-----------------------------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccc
Confidence 00 0112337999999999999999999998 7999999999
Q ss_pred chhhhcc
Q 019642 326 AQVRAAE 332 (338)
Q Consensus 326 ~~~~~~~ 332 (338)
+++.+..
T Consensus 454 ~~idW~~ 460 (689)
T 3v5w_A 454 RSLDWQM 460 (689)
T ss_dssp TTCCHHH
T ss_pred cCCCHHH
Confidence 9987654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-54 Score=375.66 Aligned_cols=252 Identities=16% Similarity=0.303 Sum_probs=198.0
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEc-----CCCceEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~---~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
...+++.+.++||+|+||+||+|.+. .+++.||||+++... .+.+.+|+.+++++ +|||||++++++.+
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~-- 114 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QHQHIVRFFGVCTE-- 114 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--
Confidence 34578999999999999999999864 368899999997543 45688999999999 99999999999954
Q ss_pred CCccEEEEeeecCCccccccC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC
Q 019642 107 SKTPSLIFEYVNSTDFKVLYP------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 168 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~~------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~ 168 (338)
....++||||+.+++|.+++. .+++.++..++.|++.||.|||+++|+||||||+|||++.+
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG 194 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC
Confidence 567899999999999988752 38899999999999999999999999999999999999998
Q ss_pred CCceEEEeccccccccCCC---cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHH
Q 019642 169 LRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLV 244 (338)
Q Consensus 169 ~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~ 244 (338)
+.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|+| |+.||.. .+..+.+.
T Consensus 195 -~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~-~~~~~~~~ 271 (329)
T 4aoj_A 195 -LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQ-LSNTEAID 271 (329)
T ss_dssp -TEEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCS-SCHHHHHH
T ss_pred -CcEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCC-CCHHHHHH
Confidence 899999999997654332 2233568999999999987 789999999999999999999 8999843 23333333
Q ss_pred HHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCC
Q 019642 245 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 324 (338)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 324 (338)
.+.+... ...+..+++++.+|+.+||+.||++|||+.||+++
T Consensus 272 ~i~~g~~------------------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~-- 313 (329)
T 4aoj_A 272 CITQGRE------------------------------------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR-- 313 (329)
T ss_dssp HHHHTCC------------------------------------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH--
T ss_pred HHHcCCC------------------------------------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH--
Confidence 2222100 01122378999999999999999999999999864
Q ss_pred cchhhh
Q 019642 325 FAQVRA 330 (338)
Q Consensus 325 ~~~~~~ 330 (338)
+..+.+
T Consensus 314 L~~l~~ 319 (329)
T 4aoj_A 314 LQALAQ 319 (329)
T ss_dssp HHHHHH
T ss_pred HHHHhh
Confidence 444433
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-54 Score=373.46 Aligned_cols=245 Identities=15% Similarity=0.325 Sum_probs=193.3
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
+.+++++.++||+|+||+||+|... ..||||+++.. ..+.+.+|+.+++++ +|||||++++++.+ ..+
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~---~~~ 106 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKT-RHVNILLFMGYMTK---DNL 106 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS---SSC
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEC---CeE
Confidence 4578999999999999999999754 35899998632 235688999999999 99999999998743 357
Q ss_pred EEEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 111 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
++||||+.+++|.+++ ..+++..+..++.|++.||.|||+++|+||||||+|||++.+ +.+||+|||++......
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~-~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEG-LTVKIGDFGLATVKSRW 185 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETT-EEEEECCCSSCBC----
T ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCC-CcEEEeeccCceecccC
Confidence 9999999999998876 349999999999999999999999999999999999999988 89999999999765322
Q ss_pred ---CcceeeeccccccccccccCc--CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHH-hCCchhhhhhh
Q 019642 187 ---KEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV-LGTDELNAYLN 260 (338)
Q Consensus 187 ---~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 260 (338)
.......||+.|+|||++.+. ..++.++|||||||++|+|+||+.||.. .+....+...... ...+..
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~-~~~~~~~~~~~~~~~~~p~~----- 259 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSH-INNRDQIIFMVGRGYASPDL----- 259 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT-CCCHHHHHHHHHTTCCCCCS-----
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCC-CChHHHHHHHHhcCCCCCCc-----
Confidence 223345799999999998642 3589999999999999999999999943 3333333322211 000000
Q ss_pred ccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
...+..+++++.+||.+||+.||++|||+.|+++
T Consensus 260 ---------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 260 ---------------------------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp ---------------------------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred ---------------------------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 0112237899999999999999999999998754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-54 Score=371.35 Aligned_cols=245 Identities=18% Similarity=0.308 Sum_probs=199.8
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEc-----CCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
..+++++.++||+|+||+||+|... .+++.||||.++.. ..+.+.+|+.+++++ +|||||++++++.+
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~-- 100 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-QHPNVVCLLGVVTK-- 100 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHC-CCTTBCCEEEEECS--
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhC-CCCCCCCcceEEEE--
Confidence 4568999999999999999999853 46788999998643 346789999999999 99999999999954
Q ss_pred CCccEEEEeeecCCcccccc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecC
Q 019642 107 SKTPSLIFEYVNSTDFKVLY-------------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 167 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~ 167 (338)
....++||||+.+|+|.+++ ..+++..+..++.||+.||.|||+++++||||||+|||++.
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 56789999999999998876 23889999999999999999999999999999999999998
Q ss_pred CCCceEEEeccccccccCCC---cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHH
Q 019642 168 ELRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQL 243 (338)
Q Consensus 168 ~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~ 243 (338)
+ +.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|||+| |..||. +.+..+..
T Consensus 181 ~-~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~-~~~~~~~~ 257 (308)
T 4gt4_A 181 K-LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYC-GYSNQDVV 257 (308)
T ss_dssp G-GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTT-TCCHHHHH
T ss_pred C-CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCCC-CCCHHHHH
Confidence 8 899999999987653322 2334578999999999987 689999999999999999998 888983 33333333
Q ss_pred HHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 244 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
..+... . . ...+..+++++.+|+.+||+.||++|||+.||+++
T Consensus 258 ~~i~~~--~--------------------------~--------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 258 EMIRNR--Q--------------------------V--------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHTT--C--------------------------C--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcC--C--------------------------C--------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 222110 0 0 00123378999999999999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-53 Score=372.77 Aligned_cols=247 Identities=19% Similarity=0.316 Sum_probs=201.2
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCC-----CceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
.++|++.+.||+|+||+||+|.+..+ ++.||||.++... .+.+.+|+.++.++.+|||||++++++... .
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~-~ 141 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G 141 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-T
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-C
Confidence 47999999999999999999987654 3579999987532 356889999999996669999999998543 3
Q ss_pred CccEEEEeeecCCccccccC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC
Q 019642 108 KTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 168 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~ 168 (338)
..+++||||+.+|+|.+++. .+++..+..++.||+.||.|||+++++||||||+|||++.+
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 221 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 221 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCC
Confidence 46789999999999988762 27899999999999999999999999999999999999988
Q ss_pred CCceEEEeccccccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHH
Q 019642 169 LRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLV 244 (338)
Q Consensus 169 ~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~ 244 (338)
+.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||+| |..||...........
T Consensus 222 -~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~ 299 (353)
T 4ase_A 222 -NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299 (353)
T ss_dssp -GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred -CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 8999999999976643332 223468899999999987 689999999999999999998 8999854333333222
Q ss_pred HHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 245 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
.+.+.... ..+..+++++.++|.+||+.||++|||+.||++|
T Consensus 300 ~i~~g~~~------------------------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 300 RLKEGTRM------------------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHTCCC------------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCC------------------------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 22211000 1122378999999999999999999999999987
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-52 Score=358.56 Aligned_cols=280 Identities=30% Similarity=0.546 Sum_probs=227.0
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
++|++.+.||+|+||+||+|.+..+++.||+|+++... ...+.+|+.+++++ +||||+++++++.+ ....++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 78 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHS--DKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC-CCCCEeeEEeEEEe--CCEEEE
Confidence 68999999999999999999999999999999986322 35677899999999 99999999999955 567899
Q ss_pred EEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC-Cc
Q 019642 113 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KE 188 (338)
Q Consensus 113 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~-~~ 188 (338)
||||+.++.+..+. ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++...... ..
T Consensus 79 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCSCCSC
T ss_pred EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeecccceecCCcccc
Confidence 99999987666553 469999999999999999999999999999999999999988 89999999999765432 23
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
.....+|+.|+|||++.+...++.++||||||+++|+|++|..||+...+..+.+..+.+..+.+....+..........
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence 34457899999999998755689999999999999999999999988888888888888888876655443322111100
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
.. ...............+++++.+||.+||+.||++|||++|+|+||||++..
T Consensus 238 ~~--------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 238 PY--------PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CC--------CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred cc--------ccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 00 000000011122234789999999999999999999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=360.54 Aligned_cols=252 Identities=22% Similarity=0.448 Sum_probs=212.0
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+.+++.+ +||||+++++++.. ....+
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~--~~~~~ 90 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHPNIVKLFEVIET--EKTLY 90 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE--CCEEE
Confidence 47899999999999999999999999999999998643 234577899999999 89999999999954 56789
Q ss_pred EEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 112 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 112 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
+||||+.+++|.+++ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++........
T Consensus 91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~ 169 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDAD-MNIKIADFGFSNEFTVGGK 169 (328)
T ss_dssp EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECSTTCCGGGSSSCG
T ss_pred EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCC-CCEEEeeccCceecCCCCc
Confidence 999999999988876 569999999999999999999999999999999999999988 8999999999987665555
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
.....||+.|+|||++.+....+.++||||||+++|+|++|..||. +.+..+....+... ..
T Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~-~~~~~~~~~~i~~~--~~--------------- 231 (328)
T 3fe3_A 170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-GQNLKELRERVLRG--KY--------------- 231 (328)
T ss_dssp GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHC--CC---------------
T ss_pred cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHHhC--CC---------------
Confidence 5667899999999999884445689999999999999999999983 22222222222110 00
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
..+..+++++.+||++||+.||++|||++|+++||||+....
T Consensus 232 --------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 232 --------------------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp --------------------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred --------------------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence 011226899999999999999999999999999999987643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-51 Score=363.66 Aligned_cols=256 Identities=27% Similarity=0.464 Sum_probs=213.4
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc---------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
-.++|++.+.||+|+||+||+|.+..+++.||+|+++... .+.+.+|+.+++++ +||||+++++++.+
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~-- 86 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVYEN-- 86 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEEEEe--
Confidence 3578999999999999999999999999999999986432 36688999999999 89999999999954
Q ss_pred CCccEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCC---ceEEEecccc
Q 019642 107 SKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR---KLRLIDWGLA 180 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~---~~~l~dfg~~ 180 (338)
....++||||+.+++|.+++. .+++..++.++.|++.||.|||+.|++|+||||+||+++.+.. .++|+|||++
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 567899999999999988864 4899999999999999999999999999999999999987632 7999999999
Q ss_pred ccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhh
Q 019642 181 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 260 (338)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.............||+.|+|||++.+ ..++.++|+||||+++|+|++|..||. +.+..+.+..+..........
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~-~~~~~~~~~~i~~~~~~~~~~---- 240 (361)
T 2yab_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITAVSYDFDEE---- 240 (361)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHHHTTCCCCCHH----
T ss_pred eEcCCCCccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhcCCCCCch----
Confidence 87765555556789999999999877 678999999999999999999999984 333333333322211100000
Q ss_pred ccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
....+++++.+||.+||..||++|||+.|+|+||||++..
T Consensus 241 -----------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 241 -----------------------------FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp -----------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred -----------------------------hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 0112689999999999999999999999999999999654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-51 Score=374.71 Aligned_cols=285 Identities=26% Similarity=0.467 Sum_probs=221.6
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccC----
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---- 106 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~---- 106 (338)
..++|++.+.||+|+||+||+|.+..+++.||+|++... ..+.+.+|+.+++.+ +||||+++++++....
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCcccc
Confidence 357899999999999999999999999999999998642 245677899999999 9999999999986532
Q ss_pred CCccEEEEeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 107 SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
....++||||++++.+......+++..++.++.|++.||.|||++||+|+||||+|||++.+ +.+||+|||++......
T Consensus 139 ~~~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~ 217 (464)
T 3ttj_A 139 FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTS 217 (464)
T ss_dssp CCEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCCCC-----C
T ss_pred CCeEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCC-CCEEEEEEEeeeecCCC
Confidence 24579999999998877777789999999999999999999999999999999999999998 89999999999876655
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.|| .+.+..+++..+.+.++.+....+....
T Consensus 218 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF-~g~~~~~~~~~i~~~lg~p~~~~~~~~~---- 291 (464)
T 3ttj_A 218 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPCPEFMKKLQ---- 291 (464)
T ss_dssp CCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCSCCHHHHTTSC----
T ss_pred cccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCCHHHHHHcc----
Confidence 55566789999999999988 68999999999999999999999998 5677778888888888876554432211
Q ss_pred CcchhhhhccccC---CCCcccccccC-------CCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 267 DPQLDALVGRHSR---KPWSKFINADN-------QHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 267 ~~~~~~~~~~~~~---~~~~~~~~~~~-------~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
+........... ..+...+.... ....++++.+||.+||+.||++|||++|+|+||||+.+.
T Consensus 292 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 363 (464)
T 3ttj_A 292 -PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 363 (464)
T ss_dssp -HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred -hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence 111111110000 00000000000 000156799999999999999999999999999998654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=353.68 Aligned_cols=284 Identities=32% Similarity=0.597 Sum_probs=220.4
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
-.-.++|++.+.||+|+||+||+|.+. +++.||+|.++... ...+.+|+.+++++ +||||+++++++.+ ..
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~ 92 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-HHPNIVSLIDVIHS--ER 92 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHC-CCTTBCCEEEEECC--SS
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHc-CCCCEeeeeeEEcc--CC
Confidence 345689999999999999999999985 58899999986432 35678999999999 99999999999954 56
Q ss_pred ccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 109 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
..++||||+.++.+..+. ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++.....
T Consensus 93 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 93 CLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD-GALKLADFGLARAFGI 171 (311)
T ss_dssp CEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEETTS
T ss_pred EEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCC-CCEEEccCcCceecCC
Confidence 789999999975444443 238999999999999999999999999999999999999988 8999999999976542
Q ss_pred C-CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccc
Q 019642 186 G-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264 (338)
Q Consensus 186 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
. .......+++.|+|||++.+...++.++||||||+++|+|++|..|| .+.+..+.+..+...++.+....+......
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF-PGVTDDDQLPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence 2 23344578999999999877567899999999999999999999998 455566677777777777665544322111
Q ss_pred ccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
.. .... ..............+.+++++.+||.+||+.||++|||++|+|+||||++++.
T Consensus 251 ~~------~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 309 (311)
T 3niz_A 251 PL------WKQR-TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309 (311)
T ss_dssp HH------HHSC-CCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred ch------hhhc-ccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence 00 0000 00000000011112337889999999999999999999999999999998753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=364.83 Aligned_cols=291 Identities=28% Similarity=0.552 Sum_probs=216.1
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ......+|+.+++.+.+||||+++++++...+....+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 47899999999999999999999999999999988532 3455778999999995599999999999776666789
Q ss_pred EEEeeecCCcccccc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC---
Q 019642 112 LIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG--- 186 (338)
Q Consensus 112 lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~--- 186 (338)
+||||+.+ +|...+ ..+++..++.++.|++.||.|||+.|++|+||||+|||++.+ +.+||+|||++......
T Consensus 88 lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 88 LVFDYMET-DLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAE-CHVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp EEEECCSE-EHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEESSSCCCC
T ss_pred EEecccCc-CHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCC-CCEEecCCcccccccccccc
Confidence 99999986 555554 358999999999999999999999999999999999999998 89999999998754321
Q ss_pred -------------------CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHH
Q 019642 187 -------------------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 247 (338)
Q Consensus 187 -------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~ 247 (338)
.......||+.|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+++..+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~i~ 244 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF-PGSSTMNQLERII 244 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHH
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHH
Confidence 11233478999999999987668999999999999999999999998 5667778888888
Q ss_pred HHhCCchhhhhhhccccccCcchhhhhccc--cCCCCcccc--------cccCCCCCChhHHHHHHHhcCCCcCCcCCHH
Q 019642 248 KVLGTDELNAYLNKYHLELDPQLDALVGRH--SRKPWSKFI--------NADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 317 (338)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~--------~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ 317 (338)
..++.+....+................... ........+ .......+++++.+||.+||+.||++|||++
T Consensus 245 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~ 324 (388)
T 3oz6_A 245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAN 324 (388)
T ss_dssp HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHH
Confidence 888877655442211100000000000000 000000000 0111224789999999999999999999999
Q ss_pred HHhcCCCcchhhh
Q 019642 318 EAMAHPYFAQVRA 330 (338)
Q Consensus 318 ell~hp~~~~~~~ 330 (338)
|+|+||||+....
T Consensus 325 e~l~Hp~~~~~~~ 337 (388)
T 3oz6_A 325 DALKHPFVSIFHN 337 (388)
T ss_dssp HHTTSTTTTTTCC
T ss_pred HHhCCHHHHHhcC
Confidence 9999999987643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=356.35 Aligned_cols=256 Identities=25% Similarity=0.457 Sum_probs=214.6
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
.++|++.+.||+|+||+||+|.+..+++.+++|.++.. ....+.+|+.+++.+ +||||+++++++.+ ....++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFES--MEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEE--TTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhC-CCCCCCeEeEEEec--CCEEEEEE
Confidence 57999999999999999999999999999999998744 345578999999999 99999999999955 45789999
Q ss_pred eeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC-CCceEEEeccccccccCCCcc
Q 019642 115 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEY 189 (338)
Q Consensus 115 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~-~~~~~l~dfg~~~~~~~~~~~ 189 (338)
||+.+++|.+.+. .+++..++.++.|++.||.|||++|++|+||||+||+++.+ .+.++|+|||++.........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~ 160 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence 9999999887763 48999999999999999999999999999999999999862 379999999999877666666
Q ss_pred eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcc
Q 019642 190 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 269 (338)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
....+++.|+|||++.+ ..++.++||||||+++|+|++|..||.. .+..+....+...........
T Consensus 161 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~------------ 226 (321)
T 1tki_A 161 RLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEA------------ 226 (321)
T ss_dssp EEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHH------------
T ss_pred ccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHcCCCCCChhh------------
Confidence 66789999999999977 5688999999999999999999999843 333333333322111111100
Q ss_pred hhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 270 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
...+++++.+||.+||..||++|||+.|+|+||||++...
T Consensus 227 ---------------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 266 (321)
T 1tki_A 227 ---------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp ---------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred ---------------------hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence 1127899999999999999999999999999999987644
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=354.36 Aligned_cols=287 Identities=28% Similarity=0.574 Sum_probs=209.1
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
.++|++.+.||+|+||+||+|.+..+++.||+|.++.. ..+.+.+|+.+++++ +||||+++++++.+ ....++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-KHENIVRLYDVIHT--ENKLTL 80 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTC-CBTTBCCEEEEECC--TTEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhc-CCCCcceEEEEEEE--CCeEEE
Confidence 57999999999999999999999999999999998642 246688999999999 99999999999954 567899
Q ss_pred EEeeecCCcccccc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 113 IFEYVNSTDFKVLY---------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 113 v~e~~~~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
||||+.+ +|.+++ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++...
T Consensus 81 v~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 81 VFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKR-GQLKLGDFGLARAF 158 (317)
T ss_dssp EEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCSSCEET
T ss_pred EEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCC-CCEEECcCccceec
Confidence 9999996 555443 248999999999999999999999999999999999999988 89999999998765
Q ss_pred cCC-CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcc
Q 019642 184 HPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262 (338)
Q Consensus 184 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
... .......+|+.|+|||++.+...++.++||||||+++|+|++|..|| .+.+..+.+..+.+..+.+....+....
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF-PGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 432 23344578999999999977567899999999999999999999998 4555566777777777765443332211
Q ss_pred ccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
... .........................+++++.+||.+||+.||++|||+.|+|+||||++.....
T Consensus 238 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 304 (317)
T 2pmi_A 238 KLP---KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHA 304 (317)
T ss_dssp GCT---TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC--
T ss_pred hhh---hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchh
Confidence 110 0000000001111111122223345789999999999999999999999999999999876544
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=351.55 Aligned_cols=259 Identities=26% Similarity=0.454 Sum_probs=214.4
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc---cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
....++|++.+.||+|+||+||+|.+..+++.||+|.+.. ...+.+.+|+.+++.+ +||||+++++++.. ....
T Consensus 16 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~ 92 (297)
T 3fxz_A 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLV--GDEL 92 (297)
T ss_dssp SCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEE
T ss_pred CChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcC-CCCCCCeEeEEEEE--CCEE
Confidence 3456799999999999999999999999999999999853 3456688999999999 99999999999965 4578
Q ss_pred EEEEeeecCCccccccC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-
Q 019642 111 SLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 187 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~- 187 (338)
++||||+.+++|.+++. .+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp EEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSTTC
T ss_pred EEEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCC-CCEEEeeCCCceecCCccc
Confidence 99999999999988874 48999999999999999999999999999999999999988 899999999987654332
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......|++.|+|||++.+ ..++.++||||||+++|+|++|..||.. .+.......+... +...
T Consensus 172 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~~~~~-~~~~------------- 235 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATN-GTPE------------- 235 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHH-CSCC-------------
T ss_pred ccCCccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhC-CCCC-------------
Confidence 3344578999999999987 6789999999999999999999999843 2222222222111 1100
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
...+..+++.+.+||.+||+.||++|||+.|+|+||||+......
T Consensus 236 --------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~ 280 (297)
T 3fxz_A 236 --------------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLS 280 (297)
T ss_dssp --------------------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGG
T ss_pred --------------------CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCccc
Confidence 001122789999999999999999999999999999999875543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=359.39 Aligned_cols=255 Identities=23% Similarity=0.410 Sum_probs=208.5
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
..++|++.+.||+|+||+||+|.+..+++.||+|+++.. ....+..|..+++.+.+||||+++++++.+ ...
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~ 98 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT--PDR 98 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe--CCE
Confidence 357899999999999999999999999999999998642 345577899999988789999999999955 567
Q ss_pred cEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc-C
Q 019642 110 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-P 185 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~-~ 185 (338)
.++||||+.+++|..++ ..+++..++.++.|++.||.|||++||+|+||||+|||++.+ +.+||+|||++.... .
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~-g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCC-CCEEEccccceeecccC
Confidence 89999999999998776 469999999999999999999999999999999999999988 899999999987533 2
Q ss_pred CCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 186 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
........||+.|+|||++.+ ..++.++|+||||+++|+|++|..||. ..+..+....+... ..
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~-~~~~~~~~~~i~~~--~~------------ 241 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFE-AENEDDLFEAILND--EV------------ 241 (353)
T ss_dssp --------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHC--CC------------
T ss_pred CccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCC-CCCHHHHHHHHHcC--CC------------
Confidence 233445679999999999877 678999999999999999999999984 33333333333221 00
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCH------HHHhcCCCcchhhhcc
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA------REAMAHPYFAQVRAAE 332 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~------~ell~hp~~~~~~~~~ 332 (338)
..+..+++++.+||++||+.||++||++ +|+++||||+++.+..
T Consensus 242 -----------------------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~ 291 (353)
T 3txo_A 242 -----------------------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQ 291 (353)
T ss_dssp -----------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHH
T ss_pred -----------------------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHH
Confidence 0112268999999999999999999999 8999999999876543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=350.48 Aligned_cols=280 Identities=27% Similarity=0.512 Sum_probs=218.2
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc--------hHHHHHHHHHHHHhc--CCCCeeEeeeeeeccC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------KKKIKREIKILQNLC--GGPNVVKLLDIVRDQH 106 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------~~~~~~E~~~l~~l~--~h~~iv~~~~~~~~~~ 106 (338)
.++|++.+.||+|+||+||+|.+..+++.||+|+++... .....+|+.+++.+. +||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 579999999999999999999999999999999986322 346778888888773 4999999999986543
Q ss_pred CC---ccEEEEeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecc
Q 019642 107 SK---TPSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG 178 (338)
Q Consensus 107 ~~---~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg 178 (338)
.. ..+++||++.+ +|..++. .+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||
T Consensus 88 ~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg 165 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-GTVKLADFG 165 (308)
T ss_dssp SSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTT-SCEEECSCS
T ss_pred CCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCEEEeeCc
Confidence 22 57899999986 6655542 28999999999999999999999999999999999999988 899999999
Q ss_pred ccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhh
Q 019642 179 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 258 (338)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
++.............+|+.|+|||++.+ ..++.++||||||+++|+|++|..|| ...+..+....+.+..+.+....+
T Consensus 166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~ 243 (308)
T 3g33_A 166 LARIYSYQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLF-CGNSEADQLGKIFDLIGLPPEDDW 243 (308)
T ss_dssp CTTTSTTCCCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSC-CCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccccCCCcccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChhhc
Confidence 9987665555566788999999999987 67899999999999999999999998 455666777777777777665544
Q ss_pred hhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
........ ..+......+ .....+.+++++.+||.+||+.||++|||+.|+|+||||++...
T Consensus 244 ~~~~~~~~-----~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~ 305 (308)
T 3g33_A 244 PRDVSLPR-----GAFPPRGPRP-----VQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG 305 (308)
T ss_dssp CSSCSSCG-----GGSCCCCCCC-----HHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-----
T ss_pred cchhhccc-----cccCCCCCCc-----HHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCC
Confidence 33221110 0000000000 01112347899999999999999999999999999999998654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-50 Score=345.88 Aligned_cols=276 Identities=32% Similarity=0.628 Sum_probs=213.3
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
++|++.+.||+|+||+||+|.+ .+++.||+|.+.... .+.+.+|+.+++++ +||||+++++++.+ ....++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 77 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHT--KKRLVL 77 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEEC--SSCEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhc-CCCCEeeeeeEEcc--CCeEEE
Confidence 6899999999999999999998 678999999986432 35678999999999 99999999999955 467899
Q ss_pred EEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC-C
Q 019642 113 IFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-K 187 (338)
Q Consensus 113 v~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~-~ 187 (338)
||||+.+ ++...+ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++...... .
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 78 VFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC---
T ss_pred EEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CCEEEeECccccccCcccc
Confidence 9999997 554443 458999999999999999999999999999999999999988 89999999998765432 2
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......+|+.|+|||++.+...++.++||||||+++|+|++|..|| .+.+..+.+..+.+..+.+....+.......
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 232 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF-PGVSEADQLMRIFRILGTPNSKNWPNVTELP-- 232 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTTSTTGGGST--
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHHCCCChhhchhhhccc--
Confidence 2344578999999999977567899999999999999999999998 4445566677777776665544433211110
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
............++. .....+++++.+||.+||+.||++|||+.|+|+||||++.
T Consensus 233 -~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 233 -KYDPNFTVYEPLPWE-----SFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp -TCCTTCCCCCCCCGG-----GTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred -ccccccccccCccHH-----HHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 000000011111111 1123478999999999999999999999999999999874
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-50 Score=351.90 Aligned_cols=252 Identities=26% Similarity=0.459 Sum_probs=211.3
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
.++|++.+.||+|+||+||+|.+..+++.||+|++++. ....+.+|+.+++.+ +||||+++++.+.+ ....
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~--~~~~ 80 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQT--HDRL 80 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEEC--SSEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEe--CCEE
Confidence 57999999999999999999999999999999998642 345678899999999 99999999999955 5678
Q ss_pred EEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc-CC
Q 019642 111 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PG 186 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~-~~ 186 (338)
++||||+.+++|..++ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++.... ..
T Consensus 81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCSCCTT
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCC-CCEEEeeccchhhcccCC
Confidence 9999999999998776 358999999999999999999999999999999999999988 899999999987532 23
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.......||+.|+|||++.+ ..++.++|+||||+++|+|++|..||.. .+.......+.. +..
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~--~~~------------- 222 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILM--EEI------------- 222 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHH--CCC-------------
T ss_pred CcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCC-CCHHHHHHHHHc--CCC-------------
Confidence 33445689999999999877 6789999999999999999999999943 222222222211 000
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC-----CHHHHhcCCCcchhhhc
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAA 331 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~~ 331 (338)
..+..+++++.+||.+||+.||++|| +++|+++||||+++.+.
T Consensus 223 ----------------------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~ 270 (337)
T 1o6l_A 223 ----------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred ----------------------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence 01123789999999999999999999 99999999999987643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-50 Score=352.06 Aligned_cols=254 Identities=24% Similarity=0.396 Sum_probs=208.6
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
.++|++.+.||+|+||+||+|.+..+++.||+|++.... .+.+.+|+.+++.+ +||||+++++++.+ ....++
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--~~~~~l 82 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRRE--GNIQYL 82 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhC-CCCCCCeEEEEEec--CCeEEE
Confidence 579999999999999999999999999999999986432 35678999999999 99999999999954 567899
Q ss_pred EEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC--
Q 019642 113 IFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-- 187 (338)
Q Consensus 113 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-- 187 (338)
||||+.+++|.+++. .+++..++.++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECEETTEE
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCC-CCEEEEEeeccceeccCCcc
Confidence 999999999988875 48999999999999999999999999999999999999988 799999999987543221
Q ss_pred -cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 188 -EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 188 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
......|++.|+|||++.+....+.++||||||+++|+|++|..||....................
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------------- 228 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL------------- 228 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS-------------
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC-------------
Confidence 223457899999999998755567899999999999999999999954433322222211100000
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
.....+++++.+||.+||+.||++|||+.|+++||||+...
T Consensus 229 ----------------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 229 ----------------------NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp ----------------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred ----------------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 00112689999999999999999999999999999998754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-50 Score=351.78 Aligned_cols=256 Identities=26% Similarity=0.447 Sum_probs=212.3
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc---------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ .
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~ 86 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYEN--K 86 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--S
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--C
Confidence 46899999999999999999999999999999998642 246688999999999 89999999999955 5
Q ss_pred CccEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCC---CceEEEeccccc
Q 019642 108 KTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL---RKLRLIDWGLAE 181 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~---~~~~l~dfg~~~ 181 (338)
...++||||+.+++|.+++. .+++..++.++.|++.||.|||+.|++|+||||+||+++.+. ..++|+|||++.
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 67899999999999988864 489999999999999999999999999999999999998762 279999999998
Q ss_pred cccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 182 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
............+|+.|+|||++.+ ..++.++||||||+++|+|++|..||. +.+..+.+..+..........
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~~~~~~~~~~~~----- 239 (326)
T 2y0a_A 167 KIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAVNYEFEDE----- 239 (326)
T ss_dssp ECCTTSCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHHHHTCCCCCHH-----
T ss_pred ECCCCCccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCC-CCCHHHHHHHHHhcCCCcCcc-----
Confidence 7655555555679999999999876 678999999999999999999999984 233333333322211110000
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
....+++.+.+||++||+.||++|||+.|+|+||||++...
T Consensus 240 ----------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 280 (326)
T 2y0a_A 240 ----------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 280 (326)
T ss_dssp ----------------------------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSH
T ss_pred ----------------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcc
Confidence 01126889999999999999999999999999999987643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=357.36 Aligned_cols=257 Identities=26% Similarity=0.461 Sum_probs=211.9
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
...++|++.+.||+|+||+||+|++..+++.||+|++++. ..+.+..|..++.++.+||||+++++++.+ ..
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~ 126 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ES 126 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC--SS
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE--CC
Confidence 3457999999999999999999999999999999998643 234577899999988789999999999955 56
Q ss_pred ccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc-c
Q 019642 109 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-H 184 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~-~ 184 (338)
..++||||+.+++|..++ ..+++..++.++.||+.||.|||++||+|+||||+|||++.+ +.+||+|||++... .
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~-g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCC
T ss_pred EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCC-CCEEEeecceeeeccc
Confidence 789999999999998776 469999999999999999999999999999999999999998 89999999999753 3
Q ss_pred CCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCC-------HHHHHHHHHHhCCchhhh
Q 019642 185 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN-------HDQLVKIAKVLGTDELNA 257 (338)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~ 257 (338)
.........||+.|+|||++.+ ..++.++|+||||+++|+|++|..||...... .+.+...... .
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~-~------ 277 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-K------ 277 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH-C------
T ss_pred CCCccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc-c------
Confidence 3344455689999999999987 67899999999999999999999999532111 1111111100 0
Q ss_pred hhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCH------HHHhcCCCcchhhhc
Q 019642 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA------REAMAHPYFAQVRAA 331 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~------~ell~hp~~~~~~~~ 331 (338)
....+..++.++.+||++||+.||++||++ +|+++||||+++.+.
T Consensus 278 -----------------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~ 328 (396)
T 4dc2_A 278 -----------------------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 328 (396)
T ss_dssp -----------------------------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHH
T ss_pred -----------------------------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHH
Confidence 001122378999999999999999999985 799999999988654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-50 Score=347.54 Aligned_cols=253 Identities=26% Similarity=0.496 Sum_probs=204.9
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----------------------------hHHHHHHHHHHH
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------------------------KKKIKREIKILQ 87 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----------------------------~~~~~~E~~~l~ 87 (338)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 478999999999999999999999999999999986432 245788999999
Q ss_pred HhcCCCCeeEeeeeeeccCCCccEEEEeeecCCccccccC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEe
Q 019642 88 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 165 (338)
Q Consensus 88 ~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli 165 (338)
++ +||||+++++++.+......++||||+.+++|.++.. .+++..++.++.|++.||.|||++|++|+||||+||++
T Consensus 92 ~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 92 KL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170 (298)
T ss_dssp TC-CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred hC-CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 99 9999999999997766678899999999999988764 49999999999999999999999999999999999999
Q ss_pred cCCCCceEEEeccccccccCCC-cceeeeccccccccccccCcCC--CCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHH
Q 019642 166 DHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 242 (338)
Q Consensus 166 ~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~--~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~ 242 (338)
+.+ +.++|+|||++....... ......+++.|+|||++.+... .+.++||||||+++|+|++|..||... +....
T Consensus 171 ~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~ 248 (298)
T 2zv2_A 171 GED-GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE-RIMCL 248 (298)
T ss_dssp CTT-SCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHH
T ss_pred CCC-CCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc-cHHHH
Confidence 988 899999999997654332 2334578999999999876332 477899999999999999999998422 11111
Q ss_pred HHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 243 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
...+.. .. ........+++++.++|.+||+.||++|||+.|+++|
T Consensus 249 ~~~~~~--~~---------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 249 HSKIKS--QA---------------------------------LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHHHHH--CC---------------------------------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHHHhc--cc---------------------------------CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 111110 00 0000112378999999999999999999999999999
Q ss_pred CCcch
Q 019642 323 PYFAQ 327 (338)
Q Consensus 323 p~~~~ 327 (338)
|||++
T Consensus 294 p~~~~ 298 (298)
T 2zv2_A 294 PWVTR 298 (298)
T ss_dssp HHHHC
T ss_pred ccccC
Confidence 99863
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=354.99 Aligned_cols=254 Identities=26% Similarity=0.469 Sum_probs=209.6
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
++|++.+.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ....++
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~~l 105 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQE--ESFHYL 105 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe--CCEEEE
Confidence 5899999999999999999999999999999998643 235678899999999 99999999999955 567899
Q ss_pred EEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC--CCceEEEeccccccccCCC
Q 019642 113 IFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 113 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~--~~~~~l~dfg~~~~~~~~~ 187 (338)
||||+.+++|.+.+. .+++..++.++.|++.||.|||++|++|+||||+||+++.+ .+.+||+|||++.......
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~ 185 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185 (362)
T ss_dssp EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence 999999999876653 48999999999999999999999999999999999999764 2469999999998766555
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.. .+..+....+..........
T Consensus 186 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~----------- 252 (362)
T 2bdw_A 186 AWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSP----------- 252 (362)
T ss_dssp SCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTT-----------
T ss_pred ccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCcc-----------
Confidence 4555689999999999877 6789999999999999999999999843 22222232222211000000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
....+++++.+||.+||+.||++|||+.|+|+||||....
T Consensus 253 ----------------------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 292 (362)
T 2bdw_A 253 ----------------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 292 (362)
T ss_dssp ----------------------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTHH
T ss_pred ----------------------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCCc
Confidence 0112689999999999999999999999999999998653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=355.13 Aligned_cols=256 Identities=21% Similarity=0.446 Sum_probs=214.4
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
..++|++.+.||+|+||.||++.+..+++.||+|++... ....+.+|+.+++.+ +||||+++++++.+ ...
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~--~~~ 89 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQD--EED 89 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--CCE
Confidence 357899999999999999999999999999999998632 345678999999999 99999999999955 467
Q ss_pred cEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 110 PSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
.++||||+.+++|..++. .+++..++.++.|++.||.|||++||+|+||||+||+++.+ +.++|+|||++......
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEH-GHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCTT
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCC-CCEEEeccceeeeccCC
Confidence 899999999999988763 58999999999999999999999999999999999999988 89999999999877665
Q ss_pred CcceeeeccccccccccccCc--CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCC-HHHHHHHHHHhCCchhhhhhhccc
Q 019642 187 KEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN-HDQLVKIAKVLGTDELNAYLNKYH 263 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
.......||+.|+|||++.+. ..++.++|+||||+++|+|++|..||...... ............
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~------------ 236 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV------------ 236 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC------------
T ss_pred CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc------------
Confidence 566667899999999998642 35889999999999999999999999543222 111111111000
Q ss_pred cccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCC-HHHHhcCCCcchhhhc
Q 019642 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-AREAMAHPYFAQVRAA 331 (338)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt-~~ell~hp~~~~~~~~ 331 (338)
...+..+++++.+||.+||+.||++||+ ++++++||||+++.+.
T Consensus 237 ------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~ 281 (384)
T 4fr4_A 237 ------------------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWD 281 (384)
T ss_dssp ------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHH
T ss_pred ------------------------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHH
Confidence 0011236899999999999999999998 8999999999988654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=361.82 Aligned_cols=256 Identities=25% Similarity=0.453 Sum_probs=208.8
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
.++|++.+.||+|+||+||+|.+..+++.+|+|++.... .+.+.+|+.+++.+ +||||+++++++.+ ....+
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~--~~~~~ 86 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHPNIVRLHDSISE--EGHHY 86 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEEC--SSEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEE--CCEEE
Confidence 478999999999999999999999999999999986432 35578999999999 99999999999954 56789
Q ss_pred EEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecC--CCCceEEEeccccccccCC
Q 019642 112 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 112 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~--~~~~~~l~dfg~~~~~~~~ 186 (338)
+||||+.+++|.+.+ ..+++..+..++.|++.||.|||++|++|+||||+||+++. +.+.+||+|||++......
T Consensus 87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 999999999987765 45999999999999999999999999999999999999984 2378999999999766433
Q ss_pred C-cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 187 K-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 187 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
. ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||. ..+..+....+.........
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~-~~~~~~~~~~i~~~~~~~~~---------- 234 (444)
T 3soa_A 167 QQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFW-DEDQHRLYQQIKAGAYDFPS---------- 234 (444)
T ss_dssp CCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHTCCCCCT----------
T ss_pred CceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCC-CccHHHHHHHHHhCCCCCCc----------
Confidence 2 2344679999999999877 678999999999999999999999984 23333333333221111000
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
.....+++++.+||.+||+.||++|||+.|+|+||||++...
T Consensus 235 -----------------------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~ 276 (444)
T 3soa_A 235 -----------------------PEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRST 276 (444)
T ss_dssp -----------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHH
T ss_pred -----------------------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCCcc
Confidence 011237899999999999999999999999999999987643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=360.76 Aligned_cols=284 Identities=30% Similarity=0.544 Sum_probs=225.2
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeecc---------
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--------- 105 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--------- 105 (338)
...++|++.+.||+|+||+||+|.+..+++.||+|.+... .....+|+.+++.+ +||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-PRYKNRELDIMKVL-DHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECC-TTSCCHHHHHHTTC-CCTTBCCEEEEEEEC---------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecC-cchHHHHHHHHHHc-CCCCccchhheeeecCcccccccc
Confidence 3468999999999999999999999999999999988643 23335799999999 999999999988542
Q ss_pred ---------------------------CCCccEEEEeeecCCcccccc-------CCCCHHHHHHHHHHHHHHHHHHHHC
Q 019642 106 ---------------------------HSKTPSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQ 151 (338)
Q Consensus 106 ---------------------------~~~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~ 151 (338)
.....++||||+.++ |...+ ..+++..++.++.|++.||.|||+.
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 160 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT-LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL 160 (383)
T ss_dssp ----------------------------CCEEEEEECCCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCCcc-HHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 223478999999964 33322 4599999999999999999999999
Q ss_pred CceeccCCCCCeEecCCCCceEEEeccccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCC
Q 019642 152 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 231 (338)
Q Consensus 152 ~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~ 231 (338)
|++|+||||+||+++...+.+||+|||++.............+++.|+|||++.+...++.++||||+|+++|+|++|..
T Consensus 161 gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 240 (383)
T 3eb0_A 161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240 (383)
T ss_dssp TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence 99999999999999865489999999999877666666667889999999998875679999999999999999999999
Q ss_pred CCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcC
Q 019642 232 PFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQ 311 (338)
Q Consensus 232 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~ 311 (338)
|| .+.+..+.+..+.+.++.+....+............ ..... ..+....+..+++++.+||.+||+.||+
T Consensus 241 pf-~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~----~~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 241 LF-SGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRF----PTLKA----KDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp SS-CCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCC----CCCCC----CCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred CC-CCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccC----CccCc----ccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 98 566777888889898888776655432211110000 00000 1111223344789999999999999999
Q ss_pred CcCCHHHHhcCCCcchhhh
Q 019642 312 DRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 312 ~Rpt~~ell~hp~~~~~~~ 330 (338)
+|||+.|+|+||||+++..
T Consensus 312 ~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 312 LRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp GSCCHHHHHTSGGGHHHHH
T ss_pred hCCCHHHHhcCHHHHHHHh
Confidence 9999999999999998764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=350.85 Aligned_cols=255 Identities=18% Similarity=0.211 Sum_probs=189.7
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHH--HHHHhcCCCCeeEeeeeeeccCC--CccEEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIK--ILQNLCGGPNVVKLLDIVRDQHS--KTPSLI 113 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~--~l~~l~~h~~iv~~~~~~~~~~~--~~~~lv 113 (338)
.+|.+.++||+|+||+||+|.+ +++.||||+++....+....|.+ .+.++ +||||+++++++.+.+. ..+++|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcC-CCCCCCcEEEEEEecCCCceEEEEE
Confidence 4799999999999999999986 68899999998766655555544 44567 89999999999976533 357899
Q ss_pred EeeecCCcccccc--CCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 114 FEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQ--------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 114 ~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~--------~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
|||+.+++|.+++ ..++++.+..++.|++.||.|||++ +|+||||||+|||++.+ +.+||+|||++...
T Consensus 80 ~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~-~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT-SCEEECCCTTCEEE
T ss_pred ecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC-CCEEEEeCCCCccc
Confidence 9999999999887 4589999999999999999999987 99999999999999998 89999999998766
Q ss_pred cCCCc-----ceeeeccccccccccccCcC-----CCCCcchhHHHHHHHHHHHhcCCCCcCCCCCH----------HHH
Q 019642 184 HPGKE-----YNVRVASRYFKGPELLVDLQ-----DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH----------DQL 243 (338)
Q Consensus 184 ~~~~~-----~~~~~~~~~y~aPE~~~~~~-----~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~----------~~~ 243 (338)
..... .....||+.|+|||++.+.. .++.++|||||||++|+|+||..||....+.. ...
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 43322 22347999999999986521 36678999999999999999987763221110 011
Q ss_pred HHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 244 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
..+.+..... ..+.+... .......++.+.+|+.+||+.||++|||+.||++.
T Consensus 239 ~~~~~~~~~~-----------------------~~rp~~p~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 239 EEMRKVVCEQ-----------------------KLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHHHHHHTTS-----------------------CCCCCCCG---GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcc-----------------------cCCCCCCc---cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1111111100 00000000 00011134578899999999999999999999874
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=351.41 Aligned_cols=256 Identities=24% Similarity=0.416 Sum_probs=212.3
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
....++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+..|..++..+.+||||+++++++.+ .
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~--~ 90 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--K 90 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--S
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe--C
Confidence 34568999999999999999999999999999999998642 345577899999887689999999999955 5
Q ss_pred CccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 108 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
...++||||+.+++|..++ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++....
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD-GHIKIADFGMCKENM 169 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCC-CCEEEeEChhhhhcc
Confidence 6789999999999998876 469999999999999999999999999999999999999988 899999999987543
Q ss_pred C-CCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccc
Q 019642 185 P-GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263 (338)
Q Consensus 185 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
. ........||+.|+|||++.+ ..++.++|+||||+++|+|++|..||. +.+..+....+.. +..
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~-~~~~~~~~~~i~~--~~~---------- 235 (345)
T 1xjd_A 170 LGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFH-GQDEEELFHSIRM--DNP---------- 235 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHH--CCC----------
T ss_pred cCCCcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCC-CCCHHHHHHHHHh--CCC----------
Confidence 2 233445679999999999987 678999999999999999999999984 2332232222211 000
Q ss_pred cccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHH-HHhcCCCcchhhhc
Q 019642 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR-EAMAHPYFAQVRAA 331 (338)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~-ell~hp~~~~~~~~ 331 (338)
..+..+++++.+||.+||+.||++||++. ++++||||+++.+.
T Consensus 236 -------------------------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~ 279 (345)
T 1xjd_A 236 -------------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE 279 (345)
T ss_dssp -------------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred -------------------------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHH
Confidence 01122689999999999999999999998 99999999988654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=352.98 Aligned_cols=281 Identities=28% Similarity=0.569 Sum_probs=215.9
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccch----HHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
++|++.+.||+|+||+||+|.+..+++.||+|+++.... ..+.+|+.+++++ +||||+++++++.+ ....++|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHT--EKSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCC-CCTTBCCEEEEEEC--SSCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhc-CCCCCCeeeeEEee--CCEEEEE
Confidence 689999999999999999999999999999999864332 2345799999999 89999999999954 5678999
Q ss_pred EeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC-Cc
Q 019642 114 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KE 188 (338)
Q Consensus 114 ~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~-~~ 188 (338)
|||+.++ +..++ ..+++..++.++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++...... ..
T Consensus 79 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~ 156 (324)
T 3mtl_A 79 FEYLDKD-LKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINER-GELKLADFGLARAKSIPTKT 156 (324)
T ss_dssp EECCSEE-HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTT-CCEEECSSSEEECC------
T ss_pred ecccccC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCC-CCEEEccCcccccccCCccc
Confidence 9999974 44433 348999999999999999999999999999999999999988 89999999998754322 22
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
.....+++.|+|||++.+...++.++||||||+++|+|++|..|| .+.+..+....+.+.++.+....+........
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-- 233 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF-PGSTVEEQLHFIFRILGTPTEETWPGILSNEE-- 233 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH--
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChHhchhhhcchh--
Confidence 334578999999999877667899999999999999999999998 45666777888888888766555433221100
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
.. ..................+++++.+||.+||+.||++|||++|+|+||||.++.+.
T Consensus 234 -~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 234 -FK----TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp -HH----HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred -hc----ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 00 00000000001111223478999999999999999999999999999999998654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=362.58 Aligned_cols=288 Identities=29% Similarity=0.561 Sum_probs=220.9
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC---
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS--- 107 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~--- 107 (338)
-.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+.+++.+ +||||+++++++.....
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-CCCCcceEEEEEecCCCCcC
Confidence 357999999999999999999999999999999998642 235678999999999 89999999999865422
Q ss_pred CccEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 108 KTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
...++|||++++ +|...+. .+++..++.++.||+.||.|||++|++|+||||+|||++.+ +.+||+|||++....
T Consensus 103 ~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~-~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 103 DELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQD-CSVKVCDFGLARTIN 180 (432)
T ss_dssp CCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEEC-
T ss_pred CeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCC-CCEEEccCCCccccc
Confidence 568999999886 6655553 38999999999999999999999999999999999999988 899999999997654
Q ss_pred CCC-----------------------cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhc----------CC
Q 019642 185 PGK-----------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR----------KE 231 (338)
Q Consensus 185 ~~~-----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg----------~~ 231 (338)
... ......+|+.|+|||++.....++.++|||||||++|+|++| ..
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 260 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence 322 124457899999999976657899999999999999999975 44
Q ss_pred CCcCCCC-----------------CHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCC
Q 019642 232 PFFYGHD-----------------NHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLV 294 (338)
Q Consensus 232 pf~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (338)
|++.+.+ ..+++..+.+.+|.+....+........ ..............+ ....+.+
T Consensus 261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~--~~~~~~~ 334 (432)
T 3n9x_A 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEV----IKYIKLFPHRKPINL--KQKYPSI 334 (432)
T ss_dssp CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHH----HHHHHTSCCCCCCCH--HHHSTTS
T ss_pred ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHH----HHHHHhCCCCCCCCH--HHHCCCC
Confidence 4444433 2567788888888877655433211111 111111110000000 0111237
Q ss_pred ChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 295 SPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 295 s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
++++.+||.+||+.||++|||++|+|+||||+++....
T Consensus 335 s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 372 (432)
T 3n9x_A 335 SDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372 (432)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence 89999999999999999999999999999999986544
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=344.33 Aligned_cols=286 Identities=30% Similarity=0.509 Sum_probs=214.2
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
.++|++.+.||+|+||+||+|.+..+++.||+|++.... .+.+.+|+.+++++ +||||+++++++.+ ....+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~ 78 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-KHPNLVNLLEVFRR--KRRLH 78 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCCccchhheeec--CCeEE
Confidence 378999999999999999999999999999999886432 34567899999999 89999999999955 46788
Q ss_pred EEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC-C
Q 019642 112 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-K 187 (338)
Q Consensus 112 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~-~ 187 (338)
+||||+.++++..+. ..+++..++.++.|++.||.+||++|++|+||||+||+++.+ +.++|+|||.+...... .
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 79 LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKH-SVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp EEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECC----
T ss_pred EEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCC-CCEEEeeCCCchhccCccc
Confidence 999999999888775 459999999999999999999999999999999999999988 89999999999765432 2
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......+++.|+|||++.+...++.++|+||||+++|+|++|..|| .+.+..+....+.+.++................
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLW-PGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 3344578999999999977567899999999999999999999998 445555666666666554332221100000000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhccc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 333 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 333 (338)
. ......+..........+.+++++.+||.+||+.||++|||++|+|+||||+++.+.+.
T Consensus 237 ---~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 296 (311)
T 4agu_A 237 ---S---GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIED 296 (311)
T ss_dssp ---T---TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC----
T ss_pred ---c---cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHHH
Confidence 0 00000000000000111347899999999999999999999999999999999876654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=355.77 Aligned_cols=255 Identities=25% Similarity=0.475 Sum_probs=212.5
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
.++|++.+.||+|+||.||+|.+..+++.+|+|++... ....+.+|+.+++.+ +||||+++++++.+ ....++|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFED--KYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEEC--SSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC-CCcCCCeEEEEEEe--CCEEEEE
Confidence 46899999999999999999999999999999998754 345678999999999 99999999999955 5678999
Q ss_pred EeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC-CCceEEEeccccccccCCCc
Q 019642 114 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 114 ~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~-~~~~~l~dfg~~~~~~~~~~ 188 (338)
|||+.+++|.+++. .+++..++.++.|++.||.|||++|++|+||||+||+++.+ .+.++|+|||++........
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 99999999988763 48999999999999999999999999999999999999753 36899999999987765555
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
.....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.. .+..+.+..+......
T Consensus 207 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~i~~~~~~---------------- 268 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWE---------------- 268 (387)
T ss_dssp EEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHCCCC----------------
T ss_pred eeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC----------------
Confidence 566789999999999977 6789999999999999999999999842 2322333222211000
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
........+++++.+||.+||+.||++|||+.|+|+||||++..
T Consensus 269 -----------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 269 -----------------FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp -----------------CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred -----------------CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 00011123789999999999999999999999999999998754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=355.56 Aligned_cols=261 Identities=23% Similarity=0.413 Sum_probs=200.8
Q ss_pred eeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 33 IFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 33 i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
+....++|++.+.||+|+||+||++.+..+++.||+|++... ....+.+|+.+++.+ +||||+++++++.+ ....
T Consensus 15 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~ 91 (361)
T 3uc3_A 15 IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL-RHPNIVRFKEVILT--PTHL 91 (361)
T ss_dssp CCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEE
T ss_pred CCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhC-CCCCCCcEEEEEee--CCEE
Confidence 445678999999999999999999999999999999998743 356788999999999 99999999999955 5678
Q ss_pred EEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC-CCceEEEeccccccccCC
Q 019642 111 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~-~~~~~l~dfg~~~~~~~~ 186 (338)
++||||+.+++|..++ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ .+.+||+|||++......
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 9999999999998776 469999999999999999999999999999999999999865 235999999998755444
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.......||+.|+|||++.+....+.++||||||+++|+|++|..||............+........
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~------------ 239 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY------------ 239 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC------------
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC------------
Confidence 44455679999999999987444445599999999999999999999543332222222211111100
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
.......+++++.+||.+||+.||++|||+.|+++||||...
T Consensus 240 --------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 240 --------------------SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp --------------------CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred --------------------CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 000111268999999999999999999999999999999654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=350.67 Aligned_cols=251 Identities=22% Similarity=0.439 Sum_probs=206.6
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
..++|++.+.||+|+||+||+|.+..+++.||+|++... ....+.+|+.+++.+ +||||+++++++.. ...
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~--~~~ 83 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVITT--PTD 83 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe--CCE
Confidence 347899999999999999999999999999999998632 245688999999999 99999999999955 457
Q ss_pred cEEEEeeecCCcccccc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 110 PSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
.++||||++|..+..+. ..+++..++.++.|++.||.|||+.|++|+||||+||+++.+ +.+||+|||++.......
T Consensus 84 ~~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 84 IVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTT-CCEEECCSSCTBTTTTSB
T ss_pred EEEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCC-CCEEEEEeccceeccCCc
Confidence 89999999544443332 469999999999999999999999999999999999999988 899999999998776655
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......||+.|+|||++.+....+.++||||||+++|+|++|..||......
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---------------------------- 214 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP---------------------------- 214 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST----------------------------
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH----------------------------
Confidence 5566789999999999987444578999999999999999999999321110
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
........ .....+..+++++.+||++||+.||.+|||++|+++||||+..
T Consensus 215 ----~~~~~i~~------~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 215 ----NLFKKVNS------CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp ----TCBCCCCS------SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred ----HHHHHHHc------CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 00000000 0111233478999999999999999999999999999999853
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=361.29 Aligned_cols=283 Identities=31% Similarity=0.544 Sum_probs=223.5
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeecc----CCCccEEEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----HSKTPSLIF 114 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~----~~~~~~lv~ 114 (338)
+|++.+.||+|+||.||+|.+..+++.||||.+.... ....+|+++++.+ +||||+++++++... ....+++||
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~~~~~~~lv~ 132 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVL 132 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-TSCCHHHHHHHTC-CCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-hhHHHHHHHHHHc-CCCCccceeeEEeccCCCCcceeEEeeh
Confidence 7999999999999999999999999999999986432 3345799999999 999999999988542 223467899
Q ss_pred eeecCCccccc------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 115 EYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 115 e~~~~~~l~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
||+.++.+... ...+++..++.++.|++.||.|||++||+|+||||+|||++.+.+.+||+|||++........
T Consensus 133 e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~ 212 (420)
T 1j1b_A 133 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212 (420)
T ss_dssp ECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC
T ss_pred hcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC
Confidence 99997644332 245999999999999999999999999999999999999997657899999999987655555
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
.....+|+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.++.+....+..........
T Consensus 213 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf-~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~ 291 (420)
T 1j1b_A 213 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF-PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 291 (420)
T ss_dssp CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCC
T ss_pred ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhh
Confidence 555688999999999977567999999999999999999999998 4566677888888888887665543321110000
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
. +......+|. ...+..+++++.+||.+||+.||++|||+.|+++||||+++....
T Consensus 292 ~----~p~~~~~~~~----~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 347 (420)
T 1j1b_A 292 K----FPQIKAHPWT----KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 347 (420)
T ss_dssp C----CCCCCCCCHH----HHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred c----cCccCCCCHH----HhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccccc
Confidence 0 0000111111 112234689999999999999999999999999999999876543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=364.23 Aligned_cols=287 Identities=33% Similarity=0.568 Sum_probs=206.4
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccC---CC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---SK 108 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~---~~ 108 (338)
.++|++.+.||+|+||+||+|.+..+++.||+|++... ..+.+.+|+.+++.+ +||||+++++++.... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCcccCc
Confidence 47899999999999999999999999999999998642 235678999999999 9999999999985432 25
Q ss_pred ccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 109 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
..++|||++++ +|...+ ..+++..++.++.||+.||.|||++||+|+||||+|||++.+ +.+||+|||++.....
T Consensus 131 ~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~-~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 131 ELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQD-CSVKVCDFGLARTVDY 208 (458)
T ss_dssp CEEEEECCCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-CCEEECCCTTCBCTTS
T ss_pred eEEEEEecccc-chhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCC-CCEeecccccchhccC
Confidence 68999999875 454443 249999999999999999999999999999999999999998 8999999999976532
Q ss_pred CC----------------------------cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh---------
Q 019642 186 GK----------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF--------- 228 (338)
Q Consensus 186 ~~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt--------- 228 (338)
.. ......||+.|+|||++.....++.++|||||||++|+|++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~ 288 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence 11 12334679999999987655779999999999999999998
Q ss_pred --cCCCCcCCCC--------------------CHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccc
Q 019642 229 --RKEPFFYGHD--------------------NHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFI 286 (338)
Q Consensus 229 --g~~pf~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (338)
|..+| .+.+ ..+++..+.+.++.+....+...... ................+
T Consensus 289 ~~~~p~f-~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~- 362 (458)
T 3rp9_A 289 ADRGPLF-PGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKE----DAKRYIRIFPKREGTDL- 362 (458)
T ss_dssp GGCCCSC-C--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCH----HHHHHHTTSCCCCCCCG-
T ss_pred ccccccC-CCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCH----HHHHHHHhcCCCCCCCH-
Confidence 44343 3322 24667777777887665544321111 00111110000000001
Q ss_pred cccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhccc
Q 019642 287 NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 333 (338)
Q Consensus 287 ~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 333 (338)
....+.+++++.+||++||..||++|||++|+|+||||+++.....
T Consensus 363 -~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~ 408 (458)
T 3rp9_A 363 -AERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEV 408 (458)
T ss_dssp -GGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGG
T ss_pred -HHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCcc
Confidence 1112336899999999999999999999999999999999865543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=352.88 Aligned_cols=255 Identities=26% Similarity=0.443 Sum_probs=208.1
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
.++|++.+.||+|+||+||+|.+..+++.||+|+++.. ..+.+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--~~ 99 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSS--DG 99 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TT
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--CC
Confidence 36899999999999999999999999999999998531 356788999999999 99999999999955 46
Q ss_pred ccEEEEeeecCCccccccC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC--CCceEEEeccc
Q 019642 109 TPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGL 179 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~--~~~~~l~dfg~ 179 (338)
..++||||+.+++|.+.+. .+++..++.++.|++.||.|||++|++|+||||+||+++.+ ...++|+|||+
T Consensus 100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 7899999999999866542 38999999999999999999999999999999999999765 23499999999
Q ss_pred cccccCCCc-ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhh
Q 019642 180 AEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 258 (338)
Q Consensus 180 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
+........ .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||... ..+....+...........
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~i~~~~~~~~~~~- 255 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGT--KERLFEGIIKGKYKMNPRQ- 255 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSS--HHHHHHHHHHTCCCCCHHH-
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCc--HHHHHHHHHcCCCCCCccc-
Confidence 976654332 344579999999999977 67899999999999999999999999432 1222222211110000000
Q ss_pred hhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
...+++++.+||.+||+.||++|||+.|+|+||||++...
T Consensus 256 --------------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~ 295 (351)
T 3c0i_A 256 --------------------------------WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDR 295 (351)
T ss_dssp --------------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHHH
T ss_pred --------------------------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCcc
Confidence 0126899999999999999999999999999999987643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=352.12 Aligned_cols=257 Identities=28% Similarity=0.407 Sum_probs=196.3
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEe
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 115 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e 115 (338)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ....++|||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~~lv~e 128 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRL-SHPNIIKLKEIFET--PTEISLVLE 128 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHC-CCTTBCCEEEEEEC--SSEEEEEEC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhC-CCCCCcceeeeEec--CCeEEEEEE
Confidence 46799999999999999999999999999999998754 445678899999999 99999999999955 467899999
Q ss_pred eecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecC--CCCceEEEeccccccccCCCcce
Q 019642 116 YVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYN 190 (338)
Q Consensus 116 ~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~--~~~~~~l~dfg~~~~~~~~~~~~ 190 (338)
|+.+++|.+.+. .+++..++.++.|++.||.|||+.|++|+||||+||+++. ..+.++|+|||++..........
T Consensus 129 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 208 (349)
T 2w4o_A 129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208 (349)
T ss_dssp CCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccc
Confidence 999999987764 3899999999999999999999999999999999999975 23789999999987665444445
Q ss_pred eeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcch
Q 019642 191 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 270 (338)
Q Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (338)
...|++.|+|||++.+ ..++.++||||||+++|+|++|..||............+.......
T Consensus 209 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~----------------- 270 (349)
T 2w4o_A 209 TVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYF----------------- 270 (349)
T ss_dssp ----CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCC-----------------
T ss_pred cccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCcc-----------------
Confidence 5678999999999987 6789999999999999999999999954443322322221110000
Q ss_pred hhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 271 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
.......++.++.+||.+||+.||++|||+.|+|+||||.+...
T Consensus 271 ----------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 271 ----------------ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA 314 (349)
T ss_dssp ----------------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred ----------------CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence 00011236899999999999999999999999999999987654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=351.14 Aligned_cols=286 Identities=31% Similarity=0.554 Sum_probs=217.9
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC--
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS-- 107 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~-- 107 (338)
.-.++|++.+.||+|+||.||+|.+..+++.||+|.+... ..+.+.+|+.+++.+ +||||+++++++.....
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTT
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCcCCCCceeeEecCCccc
Confidence 3457899999999999999999999999999999998532 235577899999999 89999999999865421
Q ss_pred --CccEEEEeeecCCcccccc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 108 --KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 108 --~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
...++||||+ +++|..++ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++...
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 101 DFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED-CELKILDFGLARQA 178 (367)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEEC
T ss_pred cCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCC-CCEEEEeeeccccc
Confidence 3569999999 67777766 469999999999999999999999999999999999999988 89999999999765
Q ss_pred cCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccc
Q 019642 184 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263 (338)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
.. ......+|+.|+|||++.+...++.++||||+||++|+|++|+.|| .+.+..+++..+.+..+.+....+..-..
T Consensus 179 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 179 DS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF-KGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp CS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred cc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 42 2334578999999999887667999999999999999999999998 55666778888888888765443221110
Q ss_pred cccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
........ .........+.. ....+++++.+||.+||+.||++|||++|+|+||||++.....
T Consensus 256 ~~~~~~~~-~~~~~~~~~~~~-----~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~ 318 (367)
T 1cm8_A 256 DEAKNYMK-GLPELEKKDFAS-----ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 318 (367)
T ss_dssp HHHHHHHH-HSCCCCCCCGGG-----TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred HHHHHHHH-hCCCCCCCCHHH-----HCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCc
Confidence 00000000 001111111111 1233789999999999999999999999999999999876543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=359.51 Aligned_cols=259 Identities=26% Similarity=0.382 Sum_probs=212.9
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~------~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
....++|++.+.||+|+||+||+|.+..+++.||+|++++ .....+.+|..+++.+ +||||+++++++.+ .
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~--~ 141 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQD--D 141 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEEC--S
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEE--C
Confidence 3456899999999999999999999999999999999864 2334578899999999 99999999999955 5
Q ss_pred CccEEEEeeecCCcccccc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 108 KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
...++||||+.|++|..++ ..+++..++.++.|++.||.|||++||+|+||||+|||++.+ +.+||+|||++.....
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~-g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNK 220 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCT
T ss_pred CEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCC-CCEEEeccceeEeecc
Confidence 6789999999999998876 358999999999999999999999999999999999999988 8999999999976544
Q ss_pred CCc--ceeeeccccccccccccCcC---CCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhh
Q 019642 186 GKE--YNVRVASRYFKGPELLVDLQ---DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 260 (338)
Q Consensus 186 ~~~--~~~~~~~~~y~aPE~~~~~~---~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
... .....||+.|+|||++.+.. .++.++|+||||+++|+|++|..||. +.+..+....+........
T Consensus 221 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~-~~~~~~~~~~i~~~~~~~~------ 293 (410)
T 3v8s_A 221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY-ADSLVGTYSKIMNHKNSLT------ 293 (410)
T ss_dssp TSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTHHHHCC------
T ss_pred CCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCC-CCChhhHHHHHHhcccccc------
Confidence 332 23467999999999997632 27889999999999999999999994 3333333333322100000
Q ss_pred ccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCC--cCCHHHHhcCCCcchhhh
Q 019642 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD--RLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~--Rpt~~ell~hp~~~~~~~ 330 (338)
......+++++.+||++||+.+|.+ ||+++|+++||||+++.+
T Consensus 294 ---------------------------~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w 338 (410)
T 3v8s_A 294 ---------------------------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 338 (410)
T ss_dssp ---------------------------CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSC
T ss_pred ---------------------------CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCH
Confidence 0011127899999999999999988 999999999999998754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=345.45 Aligned_cols=250 Identities=22% Similarity=0.446 Sum_probs=210.9
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|..+++.+ +||||+++++++.+ ....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~--~~~~ 81 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQD--AQQI 81 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEEC--SSEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEe--CCEE
Confidence 47899999999999999999999999999999998642 345677899999999 99999999999955 5678
Q ss_pred EEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 111 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
++||||+.+++|..++ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++.....
T Consensus 82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFAKYVPD-- 158 (318)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT-SCEEECCCSSCEECSS--
T ss_pred EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCC-CCEEEeecCcceecCC--
Confidence 9999999999998876 458999999999999999999999999999999999999988 8999999999976543
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......||+.|+|||++.+ ..++.++|+||||+++|+|++|..||.. .+..+....+... ..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~--~~-------------- 220 (318)
T 1fot_A 159 VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNA--EL-------------- 220 (318)
T ss_dssp CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHC--CC--------------
T ss_pred ccccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhC--CC--------------
Confidence 2334578999999999877 6789999999999999999999999943 2222223222210 00
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC-----CHHHHhcCCCcchhhhc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAA 331 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~~ 331 (338)
..+..+++++.++|.+||+.||++|| +++++++||||+++.+.
T Consensus 221 ---------------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~ 268 (318)
T 1fot_A 221 ---------------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 268 (318)
T ss_dssp ---------------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred ---------------------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence 01123689999999999999999999 99999999999987644
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-49 Score=338.57 Aligned_cols=262 Identities=26% Similarity=0.464 Sum_probs=214.2
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
.++|++.+.||+|+||.||+|.+..+++.|++|++.... .+.+.+|+.+++++ +||||+++++++.. ....+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~ 81 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQE--ESFHY 81 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEc--CCEEE
Confidence 589999999999999999999999999999999986432 35577899999999 99999999999954 56788
Q ss_pred EEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC--CCceEEEeccccccccCC
Q 019642 112 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 112 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~--~~~~~l~dfg~~~~~~~~ 186 (338)
++|||+.+++|...+ ..+++..++.++.|++.||.+||++|++|+||||+||+++.+ .+.++|+|||.+......
T Consensus 82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 999999999886665 458999999999999999999999999999999999999765 234999999999776655
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.. .+.......+........
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~------------ 227 (284)
T 3kk8_A 162 EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYP------------ 227 (284)
T ss_dssp CBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCC------------
T ss_pred ccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCC-CchhHHHHHHHhccccCC------------
Confidence 55555678999999999977 6789999999999999999999999843 222222222221111000
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcccccc
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRT 336 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~ 336 (338)
......+++++.+||.+||+.||++|||+.|+|+||||++.......-.
T Consensus 228 ---------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~~~ 276 (284)
T 3kk8_A 228 ---------------------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIH 276 (284)
T ss_dssp ---------------------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGSCC
T ss_pred ---------------------chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHhHhh
Confidence 0011226899999999999999999999999999999998766655443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=346.37 Aligned_cols=256 Identities=26% Similarity=0.465 Sum_probs=210.0
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
..++|++.+.||+|+||.||+|.+..+++.||+|+++... .+.+..|..+++++.+||||+++++++.+ ...
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~ 84 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESR 84 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe--CCE
Confidence 3578999999999999999999999999999999987431 34467899999987689999999999955 567
Q ss_pred cEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc-C
Q 019642 110 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-P 185 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~-~ 185 (338)
.++||||+.+++|..++ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++.... .
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCGGGCBCSCCT
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC-CCEEEEeccccccccCC
Confidence 89999999999998776 459999999999999999999999999999999999999988 899999999987532 2
Q ss_pred CCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCC-------HHHHHHHHHHhCCchhhhh
Q 019642 186 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN-------HDQLVKIAKVLGTDELNAY 258 (338)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~ 258 (338)
........||+.|+|||++.+ ..++.++|+||||+++|+|++|..||...... ...+......
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~--------- 233 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--------- 233 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH---------
T ss_pred CCcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc---------
Confidence 333445689999999999987 67899999999999999999999999532111 1111110000
Q ss_pred hhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCH------HHHhcCCCcchhhhc
Q 019642 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA------REAMAHPYFAQVRAA 331 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~------~ell~hp~~~~~~~~ 331 (338)
.. ...+..++.++.+||++||+.||++||++ +|+++||||+++.+.
T Consensus 234 -----------------~~----------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~ 285 (345)
T 3a8x_A 234 -----------------KQ----------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 285 (345)
T ss_dssp -----------------CC----------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHH
T ss_pred -----------------CC----------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHH
Confidence 00 00122378999999999999999999995 899999999987643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=349.72 Aligned_cols=291 Identities=30% Similarity=0.484 Sum_probs=221.5
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccC---
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH--- 106 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--- 106 (338)
...++|++.+.||+|+||+||+|.+..+++.||+|++... ....+.+|+.+++.+ +||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 92 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPY 92 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC----
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCcccHhheeecccccc
Confidence 3458999999999999999999999999999999987532 244678999999999 8999999999986543
Q ss_pred ---CCccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccc
Q 019642 107 ---SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
Q Consensus 107 ---~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~ 180 (338)
....++||||+.++.+..+. ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++
T Consensus 93 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~a 171 (351)
T 3mi9_A 93 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLA 171 (351)
T ss_dssp ----CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTC
T ss_pred ccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC-CCEEEccchhc
Confidence 34688999999975544443 459999999999999999999999999999999999999988 89999999998
Q ss_pred ccccCC-----CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchh
Q 019642 181 EFYHPG-----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL 255 (338)
Q Consensus 181 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (338)
...... .......+|+.|+|||++.+...++.++||||||+++|+|++|..|| .+.+..+....+.+..+....
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM-QGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCh
Confidence 765421 22234567999999999977567899999999999999999999887 455566667777777666554
Q ss_pred hhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhccc
Q 019642 256 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 333 (338)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 333 (338)
..+............... ................++++.+||.+||+.||++|||++|+|+||||.+.+.+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 323 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELV-----KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD 323 (351)
T ss_dssp TTSTTGGGCGGGTSSCCC-----SSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCC
T ss_pred hhccccccchhhcccccc-----cccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCccc
Confidence 433222111111000000 0000000000000013678999999999999999999999999999998766554
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=348.32 Aligned_cols=284 Identities=29% Similarity=0.569 Sum_probs=214.3
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
...++|++.+.||+|+||+||+|.+..+++.||+|+++... ...+.+|+.+++++ +||||+++++++.+ ...
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~ 107 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-QHRNIIELKSVIHH--NHR 107 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-CCTTBCCEEEEEEE--TTE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-CCCCcceEEEEEec--CCE
Confidence 44679999999999999999999999999999999986432 34467899999999 99999999999955 467
Q ss_pred cEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC----CCceEEEecccccc
Q 019642 110 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----LRKLRLIDWGLAEF 182 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~----~~~~~l~dfg~~~~ 182 (338)
.++||||+.+ +|..++ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ .+.++|+|||++..
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 8999999996 555554 359999999999999999999999999999999999999532 25699999999976
Q ss_pred ccCC-CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 183 YHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 183 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
.... .......+++.|+|||++.+...++.++||||||+++|+|++|..|| ...+..+.+..+.+..+.+....+...
T Consensus 187 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (329)
T 3gbz_A 187 FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF-PGDSEIDQLFKIFEVLGLPDDTTWPGV 265 (329)
T ss_dssp HC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred cCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCc-CCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence 5422 23344577999999999987566899999999999999999999998 455556677777777776554443221
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
..... .......... ..........+++++.+||.+||+.||++|||+.|+|+||||++...
T Consensus 266 ~~~~~---~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 266 TALPD---WKQSFPKFRG----KTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp GGSTT---CCTTCCCCCC----CCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhh---hhhhhhhhcc----ccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 11100 0000000000 00111112236889999999999999999999999999999998764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=349.12 Aligned_cols=255 Identities=23% Similarity=0.378 Sum_probs=212.0
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
..++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+..|..++..+.+||+|+++++.+.+ ...
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~ 95 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDR 95 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC--SSE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc--CCE
Confidence 458999999999999999999999999999999998642 345577899999887689999999999955 567
Q ss_pred cEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc-C
Q 019642 110 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-P 185 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~-~ 185 (338)
.++||||+.|++|..++ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++.... .
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCT
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCC-CcEEEEeCCcccccccC
Confidence 89999999999998876 469999999999999999999999999999999999999988 899999999987532 2
Q ss_pred CCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 186 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
........||+.|+|||++.+ ..++.++|+||||+++|+|++|..||. +.+..+....+... ..
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~-~~~~~~~~~~i~~~--~~------------ 238 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFE-GEDEDELFQSIMEH--NV------------ 238 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHC--CC------------
T ss_pred CcccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCC-CCCHHHHHHHHHhC--CC------------
Confidence 233445679999999999977 678999999999999999999999984 33333333332220 00
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC-----CHHHHhcCCCcchhhhcc
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~~~ 332 (338)
..+..+++++.+||++||+.||++|| +++++++||||+++.+..
T Consensus 239 -----------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~ 287 (353)
T 2i0e_A 239 -----------------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 287 (353)
T ss_dssp -----------------------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHH
T ss_pred -----------------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHH
Confidence 01123789999999999999999999 469999999999876543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=355.95 Aligned_cols=284 Identities=33% Similarity=0.566 Sum_probs=223.5
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeeccC----CCccEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----SKTPSL 112 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~----~~~~~l 112 (338)
..+|++.+.||+|+||+||+|.+..+++ +++|.+... .....+|+.+++.+ +||||+++++++.... ....++
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~-~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQD-KRFKNRELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECC-TTSCCHHHHHHHTC-CCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecC-cchHHHHHHHHHhC-CCCCcceEEEEEEecCCCCCceEEEE
Confidence 3479999999999999999999887776 777766432 22234799999999 9999999999986532 224789
Q ss_pred EEeeecCCcccccc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 113 IFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 113 v~e~~~~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
||||+.++.+.... ..+++..++.++.|++.||.|||++|++|+||||+||+++...+.+||+|||++......
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 99999987654432 469999999999999999999999999999999999999954489999999999876655
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.......+|+.|+|||++.+...++.++||||||+++|+|++|..|| .+.+..+.+..+.+.++.+....+........
T Consensus 196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 274 (394)
T 4e7w_A 196 EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF-PGESGIDQLVEIIKVLGTPSREQIKTMNPNYM 274 (394)
T ss_dssp CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGS
T ss_pred CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence 55556788999999999977567999999999999999999999998 56667788888888888877665533221111
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
... +......+ +....+..+++++.+||.+||+.||++|||+.|+++||||+++....
T Consensus 275 ~~~----~~~~~~~~----~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 332 (394)
T 4e7w_A 275 EHK----FPQIRPHP----FSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGE 332 (394)
T ss_dssp SSC----CCCCCCCC----HHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSC
T ss_pred hhc----cccccCCc----HHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcccc
Confidence 100 00000111 11122334789999999999999999999999999999999886544
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=343.92 Aligned_cols=259 Identities=25% Similarity=0.424 Sum_probs=209.0
Q ss_pred ccCCcEEEE-EeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 35 SDQDDYEVV-RKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 35 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
.-.++|.+. +.||+|+||+||+|.+..+++.||+|+++.. ....+.+|+.+++.+.+||||+++++++.+ ..
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~--~~ 102 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN--TS 102 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SS
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe--CC
Confidence 345678888 8999999999999999999999999998642 346788999999999778999999999954 56
Q ss_pred ccEEEEeeecCCcccccc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecC--CCCceEEEeccccc
Q 019642 109 TPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAE 181 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~--~~~~~~l~dfg~~~ 181 (338)
..++||||+.+++|..++ ..+++..++.++.|++.||.+||++|++|+||||+||+++. ..+.++|+|||++.
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~ 182 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence 789999999999998876 34899999999999999999999999999999999999987 23789999999998
Q ss_pred cccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 182 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
............+++.|+|||++.+ ..++.++||||||+++|+|++|..||. ..+..+....+.+......
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~~------- 253 (327)
T 3lm5_A 183 KIGHACELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFV-GEDNQETYLNISQVNVDYS------- 253 (327)
T ss_dssp EC---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCCCC-------
T ss_pred ccCCccccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCchHHHHHHHhcccccC-------
Confidence 7665545555679999999999977 678999999999999999999999983 3333333333322111100
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
......+++.+.+||.+||+.||++|||++++|+||||+++..
T Consensus 254 --------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 254 --------------------------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp --------------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred --------------------------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 0111236899999999999999999999999999999998754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=336.21 Aligned_cols=257 Identities=26% Similarity=0.475 Sum_probs=213.3
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc---cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
.++|++.+.||+|+||.||+|.+..++..+++|.+.. ...+.+.+|+.+++++ +||||+++++++.+ ....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 84 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHPNIIRLYETFED--NTDIYLV 84 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhC-CCCCEeeEEEEEec--CCeEEEE
Confidence 4689999999999999999999999999999999864 3456788999999999 99999999999954 5678999
Q ss_pred EeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEe---cCCCCceEEEeccccccccCCC
Q 019642 114 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 114 ~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli---~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
|||+.+++|.+.+ ..+++..++.++.|++.||.+||++|++|+||||+||++ +.+ +.++|+|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~-~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPD-SPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTT-CCEEECCCTTCEECCTTS
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCC-CcEEEEecccceeccCcc
Confidence 9999999987765 458999999999999999999999999999999999999 555 789999999998776655
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......+++.|+|||++.+ .++.++||||||+++|+|++|..||.. .+..+....+.+.........+
T Consensus 164 ~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~--------- 231 (277)
T 3f3z_A 164 MMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSA-PTDSEVMLKIREGTFTFPEKDW--------- 231 (277)
T ss_dssp CBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCHHHH---------
T ss_pred chhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCchhh---------
Confidence 5566789999999999865 489999999999999999999999843 2333333333221111111000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhccc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 333 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 333 (338)
..+++++.++|.+||+.||++|||+.++|+||||++......
T Consensus 232 ------------------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~~ 273 (277)
T 3f3z_A 232 ------------------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSP 273 (277)
T ss_dssp ------------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCCSG
T ss_pred ------------------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccccccc
Confidence 126899999999999999999999999999999988755443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-49 Score=350.50 Aligned_cols=290 Identities=26% Similarity=0.451 Sum_probs=215.8
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc--------------hHHHHHHHHHHHHhcCCCCeeEeee
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------------KKKIKREIKILQNLCGGPNVVKLLD 100 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------------~~~~~~E~~~l~~l~~h~~iv~~~~ 100 (338)
...++|++.+.||+|+||.||+|.+.. ++.||+|.+.... .+.+.+|+.+++++ +||||+++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~ 96 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRD 96 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCccceee
Confidence 346899999999999999999999755 8999999885321 26688999999999 8999999999
Q ss_pred eeecc---CCCccEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEE
Q 019642 101 IVRDQ---HSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRL 174 (338)
Q Consensus 101 ~~~~~---~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l 174 (338)
++... .....++||||+.++.+..+.. .+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl 175 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN-NDITI 175 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEE
T ss_pred eEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCC-CCEEE
Confidence 98542 2346799999999755554433 48999999999999999999999999999999999999988 79999
Q ss_pred EeccccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCch
Q 019642 175 IDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 254 (338)
Q Consensus 175 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (338)
+|||++.............+++.|+|||++.+...++.++||||||+++|+|++|..|| .+.+..+....+.+..+.+.
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~ 254 (362)
T 3pg1_A 176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF-RGSTFYNQLNKIVEVVGTPK 254 (362)
T ss_dssp CCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCC
T ss_pred EecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCC
Confidence 99999976555555555678999999999877667999999999999999999999998 45556677777877777766
Q ss_pred hhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhccc
Q 019642 255 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 333 (338)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 333 (338)
.......... ............ ..........+.+++.+.+||.+||+.||++|||+.|+|+||||+++.....
T Consensus 255 ~~~~~~~~~~----~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 328 (362)
T 3pg1_A 255 IEDVVMFSSP----SARDYLRNSLSN-VPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLD 328 (362)
T ss_dssp HHHHHHTSCH----HHHHHTTTCCCC-CCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGG
T ss_pred hHHhhhccch----hhhHHHHhhccc-CChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccc
Confidence 5544321111 011111000000 0000111122346889999999999999999999999999999998855443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=354.00 Aligned_cols=296 Identities=19% Similarity=0.248 Sum_probs=209.6
Q ss_pred eeeeccCCcEEEEEeeeec--CceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeee
Q 019642 31 YVIFSDQDDYEVVRKVGRG--KYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVR 103 (338)
Q Consensus 31 ~~i~~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 103 (338)
..+....++|++.+.||+| +||+||+|.+..+++.||+|+++... .+.+.+|+.+++.+ +||||+++++++.
T Consensus 18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 96 (389)
T 3gni_B 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-NHPNIVPYRATFI 96 (389)
T ss_dssp CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEE
T ss_pred hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCCCcEeEEEE
Confidence 3455677899999999999 99999999999999999999986432 35577899999999 9999999999996
Q ss_pred ccCCCccEEEEeeecCCcccccc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecc
Q 019642 104 DQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG 178 (338)
Q Consensus 104 ~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg 178 (338)
+ ....++||||+.+++|.+++ ..+++..++.++.|++.||.|||++|++|+||||+|||++.+ +.++|+|||
T Consensus 97 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~-~~~kl~dfg 173 (389)
T 3gni_B 97 A--DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD-GKVYLSGLR 173 (389)
T ss_dssp E--TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCGG
T ss_pred E--CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEcccc
Confidence 5 45789999999999998876 458999999999999999999999999999999999999988 899999999
Q ss_pred ccccccCC--------CcceeeeccccccccccccCc-CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHH-
Q 019642 179 LAEFYHPG--------KEYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK- 248 (338)
Q Consensus 179 ~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~- 248 (338)
.+...... .......+++.|+|||++.+. ..++.++||||||+++|+|++|..||...... ........
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~ 252 (389)
T 3gni_B 174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT-QMLLEKLNG 252 (389)
T ss_dssp GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCST-THHHHC---
T ss_pred cceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHhcC
Confidence 87543211 111224678899999998763 46899999999999999999999999543332 22222111
Q ss_pred HhCCc----hhhh---hhhccccccCcchh-hhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHh
Q 019642 249 VLGTD----ELNA---YLNKYHLELDPQLD-ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 320 (338)
Q Consensus 249 ~~~~~----~~~~---~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell 320 (338)
..... .... .............. ...................+..+++++.+||++||+.||++|||+.|+|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell 332 (389)
T 3gni_B 253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL 332 (389)
T ss_dssp -----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 00000 0000 00000000000000 0000000001111111223344789999999999999999999999999
Q ss_pred cCCCcchhhhc
Q 019642 321 AHPYFAQVRAA 331 (338)
Q Consensus 321 ~hp~~~~~~~~ 331 (338)
+||||+++...
T Consensus 333 ~hp~f~~~~~~ 343 (389)
T 3gni_B 333 NHSFFKQIKRR 343 (389)
T ss_dssp TSGGGGGC---
T ss_pred cCHHHHHHhhc
Confidence 99999987643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=337.75 Aligned_cols=258 Identities=23% Similarity=0.435 Sum_probs=203.7
Q ss_pred eeeeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 31 YVIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 31 ~~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
.....-.++|++.+.||+|+||+||++.+..+++.+++|.+... ..+.+.+|+.+++++ +||||+++++++.+
T Consensus 15 ~~~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-- 91 (285)
T 3is5_A 15 YFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DHPNIIKIFEVFED-- 91 (285)
T ss_dssp EESSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--
T ss_pred CCCCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhC-CCchHHhHHHheec--
Confidence 33344567999999999999999999999999999999998643 346788999999999 99999999999954
Q ss_pred CCccEEEEeeecCCcccccc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC--CCceEEEec
Q 019642 107 SKTPSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDW 177 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~--~~~~~l~df 177 (338)
....++||||+.+++|.+.+ ..+++..++.++.|++.||.+||+.|++|+||||+||+++.+ .+.++|+||
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Df 171 (285)
T 3is5_A 92 YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDF 171 (285)
T ss_dssp SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEee
Confidence 56789999999999887766 469999999999999999999999999999999999999532 268999999
Q ss_pred cccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhh
Q 019642 178 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 257 (338)
Q Consensus 178 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
|++.............+++.|+|||++.+ .++.++||||||+++|+|++|..||.. .+ ............. ..
T Consensus 172 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~-~~-~~~~~~~~~~~~~-~~-- 244 (285)
T 3is5_A 172 GLAELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTG-TS-LEEVQQKATYKEP-NY-- 244 (285)
T ss_dssp CCCCC----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCC-SS-HHHHHHHHHHCCC-CC--
T ss_pred ecceecCCcccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCC-CC-HHHHHhhhccCCc-cc--
Confidence 99976655555556678999999999854 688999999999999999999999842 22 2222111111000 00
Q ss_pred hhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
......+++++.+||.+||+.||++|||+.|+|+||||++.
T Consensus 245 ------------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~a 285 (285)
T 3is5_A 245 ------------------------------AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285 (285)
T ss_dssp ------------------------------CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC-
T ss_pred ------------------------------ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhcC
Confidence 00011268899999999999999999999999999999863
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=344.13 Aligned_cols=256 Identities=27% Similarity=0.443 Sum_probs=211.9
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc---------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~ 87 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDVYEN--R 87 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--S
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEEEec--C
Confidence 46899999999999999999999999999999998642 246688999999999 89999999999954 5
Q ss_pred CccEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCC---ceEEEeccccc
Q 019642 108 KTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR---KLRLIDWGLAE 181 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~---~~~l~dfg~~~ 181 (338)
...++||||+.+++|.+++. .+++..++.++.|++.||.+||+.|++|+||||+||+++.+.. .++|+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 67899999999999988763 4899999999999999999999999999999999999987732 79999999998
Q ss_pred cccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 182 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
............+++.|+|||++.+ ..++.++|+||||+++|+|++|..||.. .+..+....+.........
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~------ 239 (321)
T 2a2a_A 168 EIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITSVSYDFDE------ 239 (321)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCH------
T ss_pred ecCccccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcccccCh------
Confidence 7665555555678999999999877 6789999999999999999999999842 2223333222211100000
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
.....+++.+.+||.+||+.||++|||+.|+++||||+++..
T Consensus 240 ---------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~ 281 (321)
T 2a2a_A 240 ---------------------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN 281 (321)
T ss_dssp ---------------------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSH
T ss_pred ---------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCc
Confidence 001126889999999999999999999999999999987654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=349.03 Aligned_cols=286 Identities=30% Similarity=0.552 Sum_probs=209.3
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeecc----
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ---- 105 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~---- 105 (338)
...++|++.+.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+.+++.+ +||||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCccc
Confidence 3358999999999999999999999999999999998642 245677899999999 899999999998543
Q ss_pred CCCccEEEEeeecCCccccccC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 106 HSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 106 ~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
.....++++|++ +++|..++. .+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++...
T Consensus 105 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 105 EFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-CELKILDFGLARHT 182 (367)
T ss_dssp GCCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECC-------
T ss_pred cCCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCC-CCEEEeeccccccc
Confidence 125678999998 567777664 59999999999999999999999999999999999999988 89999999998764
Q ss_pred cCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccc
Q 019642 184 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263 (338)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
.. ......+|+.|+|||++.+...++.++||||||+++|+|++|..|| .+.+..+++..+.+.++.+....+..-..
T Consensus 183 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 183 AD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred cc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 42 2344578999999999877668999999999999999999999998 55666778888888888765443322111
Q ss_pred cccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
. ............+...+ .......++++.+||.+||+.||++|||+.|+|+||||++...+.
T Consensus 260 ~----~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~ 322 (367)
T 2fst_X 260 E----SARNYIQSLTQMPKMNF--ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322 (367)
T ss_dssp H----HHHHHHHTSCCCCCCCH--HHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred H----HHHHHHhccCCCCCCCH--HHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCC
Confidence 0 00111100000000000 001123688999999999999999999999999999999876544
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=346.43 Aligned_cols=252 Identities=23% Similarity=0.391 Sum_probs=212.2
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
...++|++.+.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~ 114 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKD--NS 114 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SS
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEc--CC
Confidence 3457999999999999999999999999999999998642 345678899999999 99999999999955 56
Q ss_pred ccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 109 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
..++||||+.+++|..++ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++.....
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECSS
T ss_pred EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCC-CCEEEcccccceeccC
Confidence 789999999999998876 459999999999999999999999999999999999999988 8999999999976543
Q ss_pred CCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 186 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
. .....||+.|+|||++.+ ..++.++|+||||+++|+|++|..||.. .+..+....+... ..
T Consensus 194 ~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~--~~------------ 255 (350)
T 1rdq_E 194 R--TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSG--KV------------ 255 (350)
T ss_dssp C--BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHC--CC------------
T ss_pred C--cccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCC-CCHHHHHHHHHcC--CC------------
Confidence 2 234578999999999987 6789999999999999999999999842 2222222222210 00
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCC-----HHHHhcCCCcchhhhc
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAA 331 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt-----~~ell~hp~~~~~~~~ 331 (338)
..+..+++++.++|.+||+.||++||+ ++++++||||+++.+.
T Consensus 256 -----------------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~ 303 (350)
T 1rdq_E 256 -----------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp -----------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred -----------------------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHH
Confidence 011237899999999999999999998 9999999999987653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=347.11 Aligned_cols=261 Identities=25% Similarity=0.443 Sum_probs=191.8
Q ss_pred CcEEEE---EeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 38 DDYEVV---RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 38 ~~y~~~---~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
++|++. +.||+|+||+||+|.+..+++.||+|++.........+|+.+++.+.+||||+++++++.+ ....++||
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~--~~~~~lv~ 85 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHD--QLHTFLVM 85 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEc--CCEEEEEE
Confidence 467775 7899999999999999999999999999887778889999999999569999999999954 56789999
Q ss_pred eeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCC--CceEEEeccccccccCC-Cc
Q 019642 115 EYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEFYHPG-KE 188 (338)
Q Consensus 115 e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~--~~~~l~dfg~~~~~~~~-~~ 188 (338)
||+.+++|.+++ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+. ..++|+|||++...... ..
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 165 (325)
T 3kn6_A 86 ELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165 (325)
T ss_dssp CCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred EccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence 999999988776 3589999999999999999999999999999999999997652 27999999999765432 23
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCH--HHHHHHHHHhCCchhhhhhhcccccc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||....... .....+.+.+..... .
T Consensus 166 ~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~---------~- 234 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF---------S- 234 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC---------C-
T ss_pred ccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC---------C-
Confidence 344567999999999877 678999999999999999999999994322110 001111111111000 0
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
........+++++.+||.+||+.||++|||+.|+++||||++...
T Consensus 235 -------------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 235 -------------------FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp -------------------CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred -------------------CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 000001126899999999999999999999999999999987643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=349.57 Aligned_cols=259 Identities=29% Similarity=0.470 Sum_probs=208.4
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEee
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 116 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~ 116 (338)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.... ...+|++++.++.+||||+++++++.+ ....++||||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~ 97 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-DPTEEIEILLRYGQHPNIITLKDVYDD--GKYVYVVTEL 97 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-CCHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEEEECC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-ChHHHHHHHHHhcCCCCcCeEEEEEEc--CCEEEEEEeC
Confidence 4689999999999999999999999999999999875433 345789999988789999999999954 5688999999
Q ss_pred ecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCC---CceEEEeccccccccCC-Ccc
Q 019642 117 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL---RKLRLIDWGLAEFYHPG-KEY 189 (338)
Q Consensus 117 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~---~~~~l~dfg~~~~~~~~-~~~ 189 (338)
+.+++|.+.+ ..+++..++.++.|++.||.|||++|++|+||||+||++.... +.+||+|||++...... ...
T Consensus 98 ~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 177 (342)
T 2qr7_A 98 MKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177 (342)
T ss_dssp CCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCB
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCce
Confidence 9999887765 3489999999999999999999999999999999999985432 35999999999765433 233
Q ss_pred eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCC-CHH-HHHHHHHHhCCchhhhhhhccccccC
Q 019642 190 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD-NHD-QLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
....+|+.|+|||++.+ ..++.++|+||||+++|+|++|..||..... ... ....+.. +...
T Consensus 178 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~--~~~~------------- 241 (342)
T 2qr7_A 178 MTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS--GKFS------------- 241 (342)
T ss_dssp CCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH--CCCC-------------
T ss_pred eccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc--CCcc-------------
Confidence 44578999999999876 5688899999999999999999999954322 222 2222111 0000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
........+++++.+||++||+.||++|||+.++++||||.++...+
T Consensus 242 ------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~~ 288 (342)
T 2qr7_A 242 ------------------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLP 288 (342)
T ss_dssp ------------------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGGSC
T ss_pred ------------------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccccc
Confidence 00011123789999999999999999999999999999998876544
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=357.56 Aligned_cols=262 Identities=24% Similarity=0.388 Sum_probs=213.3
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
....++|++.+.||+|+||+||+|.+..+++.||+|++++. ....+.+|..++..+ +||||+++++++.+ .
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~--~ 146 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQD--D 146 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEEC--S
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee--C
Confidence 34568999999999999999999999999999999998642 233478899999999 99999999999955 5
Q ss_pred CccEEEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 108 KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
...++||||+.+++|..++ ..+++..++.++.|++.||.|||+.||+|+||||+|||++.+ +.+||+|||++...
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~-g~vkL~DFGla~~~ 225 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKL 225 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEEC
T ss_pred CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCC-CCEEEcchhhhhhc
Confidence 6789999999999998876 358999999999999999999999999999999999999988 89999999999765
Q ss_pred cCCCc--ceeeecccccccccccc----CcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhh
Q 019642 184 HPGKE--YNVRVASRYFKGPELLV----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 257 (338)
Q Consensus 184 ~~~~~--~~~~~~~~~y~aPE~~~----~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
..... .....||+.|+|||++. +...++.++|+||||+++|+|++|..||. +.+..+....+........
T Consensus 226 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~-~~~~~~~~~~i~~~~~~~~--- 301 (437)
T 4aw2_A 226 MEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHKERFQ--- 301 (437)
T ss_dssp CTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTHHHHCC---
T ss_pred ccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCC-CCChhHHHHhhhhcccccc---
Confidence 43332 22357999999999986 23568999999999999999999999994 3333333333322100000
Q ss_pred hhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCC--cCCHHHHhcCCCcchhhhcc
Q 019642 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD--RLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~--Rpt~~ell~hp~~~~~~~~~ 332 (338)
+ . .....+++++.+||++||+.+|++ ||+++|+++||||+++.+..
T Consensus 302 --------~----------------p-----~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~ 349 (437)
T 4aw2_A 302 --------F----------------P-----TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDN 349 (437)
T ss_dssp --------C----------------C-----SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTT
T ss_pred --------C----------------C-----cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHH
Confidence 0 0 001227899999999999999888 99999999999999886544
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-49 Score=351.44 Aligned_cols=284 Identities=26% Similarity=0.471 Sum_probs=206.7
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccC----C
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----S 107 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~----~ 107 (338)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+.+++.+ +||||+++++++.... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-CCCCccceEEeeccccccccc
Confidence 47999999999999999999999999999999998642 234577899999999 9999999999986543 2
Q ss_pred CccEEEEeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 108 KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
...++||||+.++........+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++.......
T Consensus 103 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~a~~~~~~~ 181 (371)
T 2xrw_A 103 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSF 181 (371)
T ss_dssp CEEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCCCC--------
T ss_pred cceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC-CCEEEEEeeccccccccc
Confidence 3679999999987666555679999999999999999999999999999999999999988 899999999997665444
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......+|+.|+|||++.+ ..++.++||||||+++|+|++|..|| .+.+..+....+.+.++.+....+..- .
T Consensus 182 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~-----~ 254 (371)
T 2xrw_A 182 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLF-PGTDHIDQWNKVIEQLGTPCPEFMKKL-----Q 254 (371)
T ss_dssp --------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHC-CCCCCHHHHTTS-----C
T ss_pred ccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHHh-----h
Confidence 4455678999999999987 67899999999999999999999998 444555566666655554433222110 0
Q ss_pred cchhhhhccccC---CCCccccccc-------CCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 268 PQLDALVGRHSR---KPWSKFINAD-------NQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 268 ~~~~~~~~~~~~---~~~~~~~~~~-------~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
+........... ..+....... .....++++.+||.+||+.||++|||++|+|+||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 326 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 326 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence 000000000000 0000000000 0001256799999999999999999999999999998653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=354.09 Aligned_cols=257 Identities=25% Similarity=0.412 Sum_probs=200.3
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----------hHHHHHHHHHHHHhcCCCCeeEeeeeeecc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLCGGPNVVKLLDIVRDQ 105 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 105 (338)
.++|++.+.||+|+||+||+|.+..+++.||+|++.... ...+.+|+.+++++ +||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDA- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEEES-
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEEec-
Confidence 478999999999999999999999999999999986421 12477899999999 99999999999843
Q ss_pred CCCccEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC--CCceEEEecccc
Q 019642 106 HSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLA 180 (338)
Q Consensus 106 ~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~--~~~~~l~dfg~~ 180 (338)
...++||||+.+++|.+.+. .+++..++.++.|++.||.|||++|++|+||||+|||++.+ ...+||+|||++
T Consensus 212 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 212 --EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp --SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred --CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 34689999999999987763 58999999999999999999999999999999999999754 245999999999
Q ss_pred ccccCCCcceeeeccccccccccccC--cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhh
Q 019642 181 EFYHPGKEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 258 (338)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
.............||+.|+|||++.+ ...++.++||||||+++|+|++|..||............+..........
T Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~-- 367 (419)
T 3i6u_A 290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE-- 367 (419)
T ss_dssp TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHH--
T ss_pred eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCch--
Confidence 87655544555679999999999853 35678899999999999999999999954333222222221110000000
Q ss_pred hhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
....+++++.+||.+||+.||++|||++|+|+||||++...
T Consensus 368 -------------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 408 (419)
T 3i6u_A 368 -------------------------------VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 408 (419)
T ss_dssp -------------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHH
T ss_pred -------------------------------hhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhH
Confidence 01126899999999999999999999999999999988654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=345.59 Aligned_cols=283 Identities=30% Similarity=0.549 Sum_probs=215.8
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc--------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
...++|++.+.||+|+||.||+|.+..+++.||+|.++... ...+.+|+.+++.+ +||||+++++++.+
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~-- 83 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGH-- 83 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECC--
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEEee--
Confidence 44689999999999999999999999999999999986421 24577899999999 99999999999954
Q ss_pred CCccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccc
Q 019642 107 SKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~ 182 (338)
....++||||+.+ ++...+. .+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++..
T Consensus 84 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 84 KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKS 161 (346)
T ss_dssp TTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCCGGGST
T ss_pred CCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCC-CCEEEEeccccee
Confidence 5678999999997 4444432 38899999999999999999999999999999999999988 8999999999976
Q ss_pred ccCC-CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 183 YHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 183 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
.... .......+|+.|+|||++.+...++.++||||||+++|+|++|..|| .+.+..+.+..+.+..+.+....|...
T Consensus 162 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~-~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 162 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL-PGDSDLDQLTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred ccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCC-CCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence 5432 23344678999999999977566899999999999999999998776 556666777777777776655444322
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
......... ......+ .......+++++.+||.+||+.||++|||+.|+|+||||++.+.+.
T Consensus 241 ~~~~~~~~~----~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~ 302 (346)
T 1ua2_A 241 CSLPDYVTF----KSFPGIP-----LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT 302 (346)
T ss_dssp TSSTTCCCC----CCCCCCC-----HHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred ccCcccccc----cccCCCC-----hHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCC
Confidence 111000000 0000000 0001133689999999999999999999999999999999865443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=344.87 Aligned_cols=249 Identities=20% Similarity=0.357 Sum_probs=199.5
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC------
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS------ 107 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~------ 107 (338)
++|++.+.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccchhhhh
Confidence 6899999999999999999999999999999998632 346688999999999 99999999998855332
Q ss_pred -------------------------------------------------CccEEEEeeecCCccccccCC------CCHH
Q 019642 108 -------------------------------------------------KTPSLIFEYVNSTDFKVLYPT------LTDY 132 (338)
Q Consensus 108 -------------------------------------------------~~~~lv~e~~~~~~l~~~~~~------~~~~ 132 (338)
...+++|||+.+++|.+++.. .+..
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 137899999999999888642 5666
Q ss_pred HHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-------------cceeeecccccc
Q 019642 133 DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-------------EYNVRVASRYFK 199 (338)
Q Consensus 133 ~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-------------~~~~~~~~~~y~ 199 (338)
.++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++....... ......+|+.|+
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCC-CCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 789999999999999999999999999999999988 899999999987665432 122346899999
Q ss_pred ccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccC
Q 019642 200 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSR 279 (338)
Q Consensus 200 aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (338)
|||++.+ ..++.++||||||+++|+|++|..|+ .+.................
T Consensus 244 aPE~~~~-~~~~~~~Di~slG~il~el~~~~~~~------~~~~~~~~~~~~~~~~~~~--------------------- 295 (332)
T 3qd2_B 244 SPEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQ------MERVRIITDVRNLKFPLLF--------------------- 295 (332)
T ss_dssp CHHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCH------HHHHHHHHHHHTTCCCHHH---------------------
T ss_pred ChHHhcC-CCCcchhhHHHHHHHHHHHHHcCCCh------hHHHHHHHHhhccCCCccc---------------------
Confidence 9999987 67899999999999999999987664 1111111111111000000
Q ss_pred CCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 280 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 280 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
...++++.+||.+||+.||++|||+.|+|+||||+++
T Consensus 296 ------------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 296 ------------TQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp ------------HHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred ------------ccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 0146788999999999999999999999999999874
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=358.18 Aligned_cols=250 Identities=24% Similarity=0.444 Sum_probs=211.6
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
.++|.+.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++.. ....
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~--~~~~ 91 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVIST--PSDI 91 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEE
Confidence 47899999999999999999999999999999998643 235688999999999 99999999999955 4678
Q ss_pred EEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 111 SLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
++||||+.+++|.+++. .+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++.......
T Consensus 92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~-~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTT-CCEEECCCSSCEECCTTC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecC-CCeEEEeccchhhccccc
Confidence 99999999999988874 48999999999999999999999999999999999999988 899999999998766555
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......|++.|+|||++.+....+.++||||||+++|+|++|..||. ..+.......+....
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~-~~~~~~~~~~i~~~~----------------- 232 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD-DDHVPTLFKKICDGI----------------- 232 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSC-CSSSHHHHHHHHTTC-----------------
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCC-CCCHHHHHHHHhcCC-----------------
Confidence 55567899999999999874455789999999999999999999984 233333322221100
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
...+..+++++.+||++||+.||++|||+.|+++||||++.
T Consensus 233 --------------------~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 233 --------------------FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp --------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred --------------------cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 00112368999999999999999999999999999999863
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-49 Score=351.64 Aligned_cols=254 Identities=25% Similarity=0.456 Sum_probs=204.6
Q ss_pred EEEEeeeecCceeEEEEEEcCCCceEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeee
Q 019642 41 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 117 (338)
Q Consensus 41 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~ 117 (338)
...+.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ....++||||+
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--~~~~~lv~E~~ 168 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLYDAFES--KNDIVLVMEYV 168 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEEEEEEECC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC-CCCCCCeEEEEEEE--CCEEEEEEeCC
Confidence 3367899999999999999999999999998753 356688999999999 99999999999955 46789999999
Q ss_pred cCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEec-CCCCceEEEeccccccccCCCcceee
Q 019642 118 NSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVR 192 (338)
Q Consensus 118 ~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~-~~~~~~~l~dfg~~~~~~~~~~~~~~ 192 (338)
.+++|.+.+ ..+++..++.++.|++.||.|||+.|++|+||||+||+++ .+.+.++|+|||++............
T Consensus 169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~ 248 (373)
T 2x4f_A 169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN 248 (373)
T ss_dssp TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccc
Confidence 999887665 2489999999999999999999999999999999999994 23378999999999877655555566
Q ss_pred eccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhh
Q 019642 193 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA 272 (338)
Q Consensus 193 ~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (338)
.||+.|+|||++.+ ..++.++||||||+++|+|++|..||. +.+..+.+..+........
T Consensus 249 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~-~~~~~~~~~~i~~~~~~~~------------------ 308 (373)
T 2x4f_A 249 FGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFL-GDNDAETLNNILACRWDLE------------------ 308 (373)
T ss_dssp CSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHHTCCCSC------------------
T ss_pred cCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhccCCCC------------------
Confidence 79999999999876 678999999999999999999999984 3333334443332111000
Q ss_pred hhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 273 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
......+++++.+||.+||+.||++|||+.|+|+||||.+.+...
T Consensus 309 ---------------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~~~~ 353 (373)
T 2x4f_A 309 ---------------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHS 353 (373)
T ss_dssp ---------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHHHHH
T ss_pred ---------------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCchhh
Confidence 001122789999999999999999999999999999999886543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=345.53 Aligned_cols=292 Identities=28% Similarity=0.552 Sum_probs=226.0
Q ss_pred eeeeeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeecc
Q 019642 30 SYVIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQ 105 (338)
Q Consensus 30 ~~~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 105 (338)
...++...++|++.+.||+|+||.||+|.+..+++.||+|++.... .+.+.+|+.+++++ +||||+++++++...
T Consensus 19 ~g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 97 (364)
T 3qyz_A 19 RGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAP 97 (364)
T ss_dssp C-CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCS
T ss_pred ccEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCccceeEEecC
Confidence 3344556689999999999999999999999999999999987432 35677899999999 999999999998643
Q ss_pred C---CCccEEEEeeecCCcccccc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccc
Q 019642 106 H---SKTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
Q Consensus 106 ~---~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~ 180 (338)
. ....++|||++.+ +|..++ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++
T Consensus 98 ~~~~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a 175 (364)
T 3qyz_A 98 TIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-CDLKICDFGLA 175 (364)
T ss_dssp STTTCCCEEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTC
T ss_pred CccccceEEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCC-CCEEEEeCcce
Confidence 2 2467899999996 555544 459999999999999999999999999999999999999988 89999999998
Q ss_pred ccccCCCc----ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhh
Q 019642 181 EFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 256 (338)
Q Consensus 181 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (338)
........ .....+|+.|+|||++.+...++.++||||||+++|+|++|..|| .+.+..+.+..+...++.+...
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF-PGKHYLDQLNHILGILGSPSQE 254 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSS-CCSSGGGHHHHHHHHHCSCCHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCC-CCCChHHHHHHHHHHhCCCCHH
Confidence 76543221 233578999999999876567899999999999999999999998 5566677788888877776655
Q ss_pred hhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 257 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
.+.............. .......++ ......+++++.+||.+||+.||++|||+.|+|+||||++....
T Consensus 255 ~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~ 323 (364)
T 3qyz_A 255 DLNCIINLKARNYLLS-LPHKNKVPW-----NRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323 (364)
T ss_dssp HHHTCCCHHHHHHHHT-SCCCCCCCH-----HHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred HHHHhhhhhHHHHHHh-cCCccCCCH-----HHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCc
Confidence 4422111100000000 000000111 11112368999999999999999999999999999999987443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=352.27 Aligned_cols=257 Identities=26% Similarity=0.437 Sum_probs=201.0
Q ss_pred CCcEEEE-EeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeec--cCCCccEEE
Q 019642 37 QDDYEVV-RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRD--QHSKTPSLI 113 (338)
Q Consensus 37 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~~~lv 113 (338)
.++|.+. +.||+|+||+||++.+..+++.||+|+++. .....+|+.++.++.+||||+++++++.. .....+++|
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~--~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv 137 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 137 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc--chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEE
Confidence 4578877 789999999999999999999999999873 45677899998777699999999998854 224578999
Q ss_pred EeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC--CCceEEEeccccccccCC
Q 019642 114 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 114 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~--~~~~~l~dfg~~~~~~~~ 186 (338)
|||+.+++|.+++. .+++..++.++.|++.||.|||+.||+|+||||+|||++.. .+.+||+|||++......
T Consensus 138 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~ 217 (400)
T 1nxk_A 138 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217 (400)
T ss_dssp EECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred EEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence 99999999988763 38999999999999999999999999999999999999873 378999999999866544
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCH---HHHHHHHHHhCCchhhhhhhccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH---DQLVKIAKVLGTDELNAYLNKYH 263 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
.......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||....... .....+.. +..
T Consensus 218 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~--~~~---------- 284 (400)
T 1nxk_A 218 NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM--GQY---------- 284 (400)
T ss_dssp ---------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH--TCC----------
T ss_pred CccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc--Ccc----------
Confidence 44556678999999999876 678999999999999999999999995433211 01111110 000
Q ss_pred cccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
. ........+++++.+||++||+.||++|||+.|+++||||.+..
T Consensus 285 ---------------~------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 285 ---------------E------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp ---------------C------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred ---------------c------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 0 00001123789999999999999999999999999999998653
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=361.44 Aligned_cols=258 Identities=24% Similarity=0.503 Sum_probs=212.0
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~-----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
.-.++|++.+.||+|+||+||+|.+..+++.||+|++.. .....+.+|+.+++++ +||||+++++++.+ ...
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~ 95 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILED--SSS 95 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-CCCCcCeEEEEEEc--CCE
Confidence 445789999999999999999999999999999999853 3456788999999999 99999999999955 567
Q ss_pred cEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC--CCceEEEecccccccc
Q 019642 110 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYH 184 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~--~~~~~l~dfg~~~~~~ 184 (338)
.++||||+.+++|.+.+ ..+++..++.++.|++.||.|||++||+|+||||+||+++.. .+.+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 89999999999987765 469999999999999999999999999999999999999643 2579999999998776
Q ss_pred CCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccc
Q 019642 185 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264 (338)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
.........||+.|+|||++.+ .++.++||||||+++|+|++|..||. +.+..+.+..+.........+.
T Consensus 176 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~------- 245 (486)
T 3mwu_A 176 QNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFY-GKNEYDILKRVETGKYAFDLPQ------- 245 (486)
T ss_dssp CC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCCSCSGG-------
T ss_pred CCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCCCCCCcc-------
Confidence 5555566789999999999876 58999999999999999999999984 3333333333322111111110
Q ss_pred ccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
...+++++.+||++||+.||++|||+.|+|+||||++....
T Consensus 246 --------------------------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~ 286 (486)
T 3mwu_A 246 --------------------------WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE 286 (486)
T ss_dssp --------------------------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCC
T ss_pred --------------------------cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCccc
Confidence 11278999999999999999999999999999999876543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=338.96 Aligned_cols=245 Identities=22% Similarity=0.270 Sum_probs=195.0
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
++|++.+.||+|+||+||+|.+..+++.||+|++.... ......|+..+.++.+||||+++++++.+ ....++
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~--~~~~~l 134 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE--GGILYL 134 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe--CCEEEE
Confidence 67999999999999999999999999999999876421 23345566666666689999999999954 567899
Q ss_pred EEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 113 IFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 113 v~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
||||+++ +|...+ ..+++..++.++.|++.||.|||+.|++|+||||+||+++.+ +.+||+|||++........
T Consensus 135 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kl~DFG~a~~~~~~~~ 212 (311)
T 3p1a_A 135 QTELCGP-SLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPR-GRCKLGDFGLLVELGTAGA 212 (311)
T ss_dssp EEECCCC-BHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGG-GCEEECCCTTCEECC----
T ss_pred EEeccCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC-CCEEEccceeeeecccCCC
Confidence 9999965 444443 359999999999999999999999999999999999999988 8999999999877655544
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
.....||+.|+|||++.+ .++.++||||||+++|+|++|..|++. ......+.+.....
T Consensus 213 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~----~~~~~~~~~~~~~~--------------- 271 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHG----GEGWQQLRQGYLPP--------------- 271 (311)
T ss_dssp --CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSS----HHHHHHHTTTCCCH---------------
T ss_pred CcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCC----ccHHHHHhccCCCc---------------
Confidence 555678999999999875 689999999999999999999777632 11111111100000
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcch
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 327 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 327 (338)
.....+++++.+||.+||+.||++|||+.|+|+||||++
T Consensus 272 --------------------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 272 --------------------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp --------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred --------------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 001126899999999999999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=334.00 Aligned_cols=263 Identities=25% Similarity=0.415 Sum_probs=212.1
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc------------hHHHHHHHHHHHHhcCCCCeeEeeeee
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------------KKKIKREIKILQNLCGGPNVVKLLDIV 102 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------------~~~~~~E~~~l~~l~~h~~iv~~~~~~ 102 (338)
...++|++.+.||+|+||.||+|.+..+++.||+|+++... .+.+.+|+.+++++.+||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 44689999999999999999999999999999999986432 345778999999995699999999999
Q ss_pred eccCCCccEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccc
Q 019642 103 RDQHSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
Q Consensus 103 ~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~ 179 (338)
.. ....++||||+.+++|.+++. .+++..++.++.|++.||.+||++|++|+||+|+||+++.+ +.++|+|||.
T Consensus 94 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~ 170 (298)
T 1phk_A 94 ET--NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD-MNIKLTDFGF 170 (298)
T ss_dssp EC--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTT
T ss_pred cc--CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCC-CcEEEecccc
Confidence 54 567899999999999988763 58999999999999999999999999999999999999988 8999999999
Q ss_pred cccccCCCcceeeecccccccccccc-----CcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCch
Q 019642 180 AEFYHPGKEYNVRVASRYFKGPELLV-----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 254 (338)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (338)
+.............+++.|+|||++. ....++.++|+||||+++|+|++|..||.. .+.......+........
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~ 249 (298)
T 1phk_A 171 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFG 249 (298)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCC
T ss_pred hhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC-ccHHHHHHHHhcCCcccC
Confidence 98766555555567899999999985 224678999999999999999999999843 222222222211100000
Q ss_pred hhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcccc
Q 019642 255 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS 334 (338)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~ 334 (338)
......+++++.++|.+||+.||++|||+.|+|+||||++....+-+
T Consensus 250 ---------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~ 296 (298)
T 1phk_A 250 ---------------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVR 296 (298)
T ss_dssp ---------------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-----
T ss_pred ---------------------------------cccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchhhc
Confidence 00011268899999999999999999999999999999988765543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=361.34 Aligned_cols=255 Identities=25% Similarity=0.429 Sum_probs=214.1
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~------~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
...++|++.+.||+|+||.||+|.+..+++.||+|++.. .....+.+|+.+++.+ +||||+++++.+.+ ..
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~--~~ 257 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYET--KD 257 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SS
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEee--CC
Confidence 346789999999999999999999999999999999863 2345578899999999 99999999999955 56
Q ss_pred ccEEEEeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 109 TPSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
..++||||+.|++|..++. .+++..++.++.||+.||.|||++||+|+||||+|||++.+ +.+||+|||++...
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~-g~vKL~DFGla~~~ 336 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDH-GHIRISDLGLAVHV 336 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCTTCEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCC-CCeEEEecccceec
Confidence 7899999999999987652 38999999999999999999999999999999999999988 89999999999877
Q ss_pred cCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCC--CHHHHHHHHHHhCCchhhhhhhc
Q 019642 184 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--NHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
..........||+.|+|||++.+ ..++.++|+||||+++|+|++|..||..... ....+.........
T Consensus 337 ~~~~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~--------- 406 (576)
T 2acx_A 337 PEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE--------- 406 (576)
T ss_dssp CTTCCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC---------
T ss_pred ccCccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc---------
Confidence 65555555689999999999987 6789999999999999999999999954322 12222221111000
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC-----CHHHHhcCCCcchhhh
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRA 330 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~ 330 (338)
..+..+++++.+||++||+.||++|| +++|+++||||+++.+
T Consensus 407 ---------------------------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w 453 (576)
T 2acx_A 407 ---------------------------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF 453 (576)
T ss_dssp ---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred ---------------------------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence 01123789999999999999999999 8999999999998754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=361.01 Aligned_cols=255 Identities=27% Similarity=0.508 Sum_probs=210.9
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----------------chHHHHHHHHHHHHhcCCCCeeEeee
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----------------KKKKIKREIKILQNLCGGPNVVKLLD 100 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----------------~~~~~~~E~~~l~~l~~h~~iv~~~~ 100 (338)
.++|++.+.||+|+||+||+|.+..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~ 113 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLFD 113 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTTBCCEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCCCCeEEE
Confidence 57899999999999999999999999999999998642 245688999999999 9999999999
Q ss_pred eeeccCCCccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCC--CceEEE
Q 019642 101 IVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRLI 175 (338)
Q Consensus 101 ~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~--~~~~l~ 175 (338)
++.+ ....++||||+.+++|.+.+ ..+++..++.++.|++.||.|||+.|++|+||||+||+++.+. ..++|+
T Consensus 114 ~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 114 VFED--KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EEEC--SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEEc--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 9954 56789999999999987765 4699999999999999999999999999999999999998763 269999
Q ss_pred eccccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchh
Q 019642 176 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL 255 (338)
Q Consensus 176 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (338)
|||++.............||+.|+|||++.+ .++.++||||||+++|+|++|..||. +.+..+.+..+.........
T Consensus 192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~~~ 268 (504)
T 3q5i_A 192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFG-GQNDQDIIKKVEKGKYYFDF 268 (504)
T ss_dssp CCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCCCCCH
T ss_pred ECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHcCCCCCCc
Confidence 9999987766555566789999999999864 58999999999999999999999983 33333333333321111111
Q ss_pred hhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 256 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
..+ ..+++++.+||++||+.||++|||++|+|+||||++...
T Consensus 269 ~~~---------------------------------~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 269 NDW---------------------------------KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp HHH---------------------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred ccc---------------------------------CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 111 127899999999999999999999999999999987643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=340.99 Aligned_cols=252 Identities=29% Similarity=0.498 Sum_probs=201.4
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEc---CCCceEEEEEeccc-------chHHHHHHHHHHHHhcCCCCeeEeeeeeecc
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ 105 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~-------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 105 (338)
..++|++.+.||+|+||.||++.+. .+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++..
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~- 92 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYAFQT- 92 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCEEEEEEC-
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEEEEc-
Confidence 4579999999999999999999985 68999999998743 234567899999999 89999999999955
Q ss_pred CCCccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccc
Q 019642 106 HSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
Q Consensus 106 ~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~ 182 (338)
....++||||+.+++|..++ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++..
T Consensus 93 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 93 -GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQ-GHVKLTDFGLCKE 170 (327)
T ss_dssp -SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT-SCEEECCCSCC--
T ss_pred -CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCC-CcEEEEeCCcccc
Confidence 56789999999999988776 358999999999999999999999999999999999999988 8999999999865
Q ss_pred ccC-CCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 183 YHP-GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 183 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
... ........|++.|+|||++.+ ..++.++|+||||+++|+|++|..||. ..+..+....+.....
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~-~~~~~~~~~~i~~~~~---------- 238 (327)
T 3a62_A 171 SIHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFT-GENRKKTIDKILKCKL---------- 238 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHTCC----------
T ss_pred cccCCccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhCCC----------
Confidence 432 222334578999999999977 678999999999999999999999984 2232333332222100
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC-----CHHHHhcCCCcchhhh
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRA 330 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~ 330 (338)
..+..+++++.+||.+||+.||++|| ++.|+++||||+++..
T Consensus 239 ---------------------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~ 285 (327)
T 3a62_A 239 ---------------------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW 285 (327)
T ss_dssp ---------------------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred ---------------------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence 01123689999999999999999999 8999999999998754
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=346.35 Aligned_cols=293 Identities=28% Similarity=0.491 Sum_probs=215.3
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC-----
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS----- 107 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~----- 107 (338)
...++|++.+.||+|+||+||+|.+..+++.||+|.+... ......+++..+..+ +||||+++++++.....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-HHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSSCTTC
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhc-CCCCcccHHHhhhccccccccc
Confidence 3457999999999999999999999999999999987542 344566788888888 99999999999865322
Q ss_pred CccEEEEeeecCCcccccc------CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCCeEecCCCCceEEEeccc
Q 019642 108 KTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCH--SQGIMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~NIli~~~~~~~~l~dfg~ 179 (338)
...++||||+.++.+.... ..+++..++.++.|++.||.+|| +.|++|+||||+||+++...+.++|+|||+
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 99 IYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 2378999999987543322 35899999999999999999999 999999999999999997448999999999
Q ss_pred cccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhh
Q 019642 180 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259 (338)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
+.............+|+.|+|||++.+...++.++||||||+++|+|++|..|| ...+....+..+.+..+.+....+.
T Consensus 179 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3e3p_A 179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF-RGDNSAGQLHEIVRVLGCPSREVLR 257 (360)
T ss_dssp CBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCc-CCCChHHHHHHHHHHcCCCCHHHHH
Confidence 987765555555678999999999877566899999999999999999999998 4556667777777777776554433
Q ss_pred hccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcccc
Q 019642 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS 334 (338)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~ 334 (338)
........... ......++...+. ......++++.+||.+||+.||++|||+.|+|+||||+++......
T Consensus 258 ~~~~~~~~~~~----~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~ 327 (360)
T 3e3p_A 258 KLNPSHTDVDL----YNSKGIPWSNVFS-DHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATK 327 (360)
T ss_dssp HHCTTCCCGGG----GCCCCCCHHHHTT-TCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCC
T ss_pred hcccchhhccc----cccccCCcccccc-hhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcccc
Confidence 22111110000 0000011111110 1112256889999999999999999999999999999998765543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-48 Score=344.60 Aligned_cols=286 Identities=31% Similarity=0.554 Sum_probs=218.2
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC--
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK-- 108 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~-- 108 (338)
..++|.+.+.||+|+||+||+|.+..+++.||+|++.... .+.+.+|+.+++.+ +||||+++++++......
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSSTT
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc-CCCCchhhhhheeccCCccc
Confidence 3479999999999999999999999999999999987422 35677899999999 899999999999654322
Q ss_pred --ccEEEEeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 109 --TPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 109 --~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
..++||||+.+.........+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++.....
T Consensus 119 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a~~~~~- 196 (371)
T 4exu_A 119 FYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED-CELKILDFGLARHADA- 196 (371)
T ss_dssp CCCCEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECSTTCC------
T ss_pred ceeEEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCC-CCEEEEecCccccccc-
Confidence 248999999964444444569999999999999999999999999999999999999988 8999999999975432
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
......+|+.|+|||++.+...++.++||||||+++|+|++|..|| .+.+..+.+..+.+..+.+..........
T Consensus 197 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--- 271 (371)
T 4exu_A 197 -EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF-KGKDYLDQLTQILKVTGVPGTEFVQKLND--- 271 (371)
T ss_dssp ----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCHHHHTTCSC---
T ss_pred -CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCcHHHHHHhhh---
Confidence 2334567999999999977668999999999999999999999998 45556677777777776654433221110
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
.............+...+. .....+++++.+||.+||+.||++|||+.|+|+||||++.....
T Consensus 272 -~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 334 (371)
T 4exu_A 272 -KAAKSYIQSLPQTPRKDFT--QLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPE 334 (371)
T ss_dssp -HHHHHHHHHSCCCCCCCHH--HHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred -hhhhhhhhccCCCcchhHH--HhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcc
Confidence 0001111111111111110 11223689999999999999999999999999999999876544
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-48 Score=343.91 Aligned_cols=253 Identities=25% Similarity=0.458 Sum_probs=209.2
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
++|++.+.||+|+||.||+|.+..+++.||||++.... .+.+.+|+.+++++.+||||+++++++..
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 171 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-- 171 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB--
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee--
Confidence 57999999999999999999999999999999986432 34577899999999779999999999854
Q ss_pred CCccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 107 SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
....++||||+.+++|.+++ ..+++..++.++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++...
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~-~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDN-MQIRLSDFGFSCHL 250 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEEC
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEEEecCccccc
Confidence 56789999999999998876 369999999999999999999999999999999999999988 89999999999877
Q ss_pred cCCCcceeeeccccccccccccCc-----CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhh
Q 019642 184 HPGKEYNVRVASRYFKGPELLVDL-----QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 258 (338)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
..........||+.|+|||++.+. ..++.++||||||+++|+|++|..||.. .+.......+...........
T Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~- 328 (365)
T 2y7j_A 251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH-RRQILMLRMIMEGQYQFSSPE- 328 (365)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCHHH-
T ss_pred CCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCCcc-
Confidence 655555667899999999998631 3578899999999999999999999843 222222222221111100000
Q ss_pred hhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcch
Q 019642 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 327 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 327 (338)
...++.++.++|.+||+.||++|||+.++|+||||++
T Consensus 329 --------------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 329 --------------------------------WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp --------------------------------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred --------------------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 0126889999999999999999999999999999973
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=331.81 Aligned_cols=256 Identities=24% Similarity=0.390 Sum_probs=209.1
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
++|++.+.||+|+||.||+|.+..+++.|++|+++.. ..+.+.+|+.+++.+ +||||+++++++.+ ....++|
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 83 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRRE--GNIQYLF 83 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-CCTTBCCEEEEEEE--TTEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc-CCCCceeeeeEEEc--CCEEEEE
Confidence 6899999999999999999999999999999998643 246688999999999 99999999999855 4678899
Q ss_pred EeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC---
Q 019642 114 FEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--- 187 (338)
Q Consensus 114 ~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~--- 187 (338)
|||+.+++|.+++. .+++..++.++.|++.||.+||++|++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECEETTEEC
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccC-CCEEEeeCCCccccCCCcchh
Confidence 99999999988875 48999999999999999999999999999999999999988 899999999987543221
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......+++.|+|||++.+....+.++|+||||+++|+|++|..||............+......
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 227 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--------------- 227 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT---------------
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc---------------
Confidence 22345688999999999774445789999999999999999999995544332222221110000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
......+++.+.++|.+||+.||++|||+.|+++||||++.....
T Consensus 228 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 272 (276)
T 2yex_A 228 --------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKG 272 (276)
T ss_dssp --------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC--
T ss_pred --------------------cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhhcc
Confidence 000112689999999999999999999999999999999875443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=344.85 Aligned_cols=281 Identities=23% Similarity=0.394 Sum_probs=212.6
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhc----CCCCeeEeeeeeeccCCCc
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLC----GGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~----~h~~iv~~~~~~~~~~~~~ 109 (338)
..++|++.+.||+|+||+||+|.+..+++.||+|+++.. .......|+.+++.+. .||||+++++++.. ...
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~--~~~ 110 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY--YDH 110 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE--TTE
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE--CCe
Confidence 357999999999999999999999999999999998743 3455678999999994 39999999999965 457
Q ss_pred cEEEEeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecC-----------------
Q 019642 110 PSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH----------------- 167 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~----------------- 167 (338)
.++||||+ +++|.+++. .+++..++.++.|++.||.|||++|++|+||||+|||++.
T Consensus 111 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~ 189 (360)
T 3llt_A 111 MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189 (360)
T ss_dssp EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred eEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccc
Confidence 89999999 777766652 3899999999999999999999999999999999999974
Q ss_pred -------CCCceEEEeccccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCH
Q 019642 168 -------ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH 240 (338)
Q Consensus 168 -------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~ 240 (338)
..+.++|+|||++..... ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||. ..+..
T Consensus 190 ~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~-~~~~~ 265 (360)
T 3llt_A 190 KIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLFR-THEHM 265 (360)
T ss_dssp EEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSCC-CSSHH
T ss_pred cccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCCC-CCcHH
Confidence 237899999999976432 2334578999999999987 679999999999999999999999984 44555
Q ss_pred HHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccc------------cccCCCCCChhHHHHHHHhcCC
Q 019642 241 DQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFI------------NADNQHLVSPEAIDFLDKLLRY 308 (338)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~s~~l~~li~~~L~~ 308 (338)
+.+..+....+..+..................... ...+.... ........++.+.+||.+||+.
T Consensus 266 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 342 (360)
T 3llt_A 266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDEL---KLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQI 342 (360)
T ss_dssp HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTT---EECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCS
T ss_pred HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccc---eecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcC
Confidence 66666666655544333222111100000000000 00000000 0000111357888999999999
Q ss_pred CcCCcCCHHHHhcCCCcc
Q 019642 309 DHQDRLTAREAMAHPYFA 326 (338)
Q Consensus 309 dP~~Rpt~~ell~hp~~~ 326 (338)
||++|||+.|+|+||||+
T Consensus 343 dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 343 DPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp SGGGSCCHHHHTTSGGGC
T ss_pred ChhhCCCHHHHhcCcccC
Confidence 999999999999999995
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=351.36 Aligned_cols=261 Identities=26% Similarity=0.402 Sum_probs=211.7
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
...++|++.+.||+|+||.||++.+..+++.||+|++++. ..+.+.+|..++..+ +||||+++++++.+ ..
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~--~~ 134 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQD--EN 134 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEEC--SS
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEee--CC
Confidence 4468999999999999999999999999999999998642 234478899999998 99999999999955 56
Q ss_pred ccEEEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 109 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
..++||||+.+++|..++ ..+++..++.++.|++.||.|||++||+|+||||+|||++.+ +.+||+|||++....
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~-g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRC-GHIRLADFGSCLKLR 213 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCC-CCEEEeechhheecc
Confidence 789999999999998886 359999999999999999999999999999999999999988 899999999997664
Q ss_pred CCCc--ceeeeccccccccccccC------cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhh
Q 019642 185 PGKE--YNVRVASRYFKGPELLVD------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 256 (338)
Q Consensus 185 ~~~~--~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (338)
.... .....||+.|+|||++.. ...++.++|+||||+++|+|++|..||.. .+..+....+.........
T Consensus 214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~- 291 (412)
T 2vd5_A 214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA-DSTAETYGKIVHYKEHLSL- 291 (412)
T ss_dssp TTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCC-
T ss_pred CCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccCcCC-
Confidence 4332 223579999999999863 24689999999999999999999999943 3333333333221000000
Q ss_pred hhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCc---CCHHHHhcCCCcchhhhccc
Q 019642 257 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR---LTAREAMAHPYFAQVRAAES 333 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R---pt~~ell~hp~~~~~~~~~~ 333 (338)
+ .....+++++.+||++||+ +|++| |+++|+++||||+++.+..-
T Consensus 292 -----------p--------------------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l 339 (412)
T 2vd5_A 292 -----------P--------------------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL 339 (412)
T ss_dssp -----------C------------------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred -----------C--------------------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 0 0012279999999999999 99998 59999999999999876543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=333.62 Aligned_cols=258 Identities=26% Similarity=0.464 Sum_probs=208.4
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc---------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
++|++.+.||+|+||.||++.+..+++.|++|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~ 81 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIFEN--KT 81 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SS
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhheecC--CC
Confidence 6799999999999999999999999999999998642 256788999999999 89999999999955 45
Q ss_pred ccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCC---CceEEEecccccc
Q 019642 109 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL---RKLRLIDWGLAEF 182 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~---~~~~l~dfg~~~~ 182 (338)
..++||||+.+++|.+++ ..+++..++.++.|++.||.+||+.|++|+||||+||+++.+. ..++|+|||.+..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 789999999999998876 3599999999999999999999999999999999999998762 2799999999977
Q ss_pred ccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcc
Q 019642 183 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262 (338)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
...........+++.|+|||++.+ ..++.++|+||||+++|+|++|..||.. .+..+....+........
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~-------- 231 (283)
T 3bhy_A 162 IEAGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLG-ETKQETLTNISAVNYDFD-------- 231 (283)
T ss_dssp CC--------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCCCCC--------
T ss_pred ccCCCcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCC-cchHHHHHHhHhcccCCc--------
Confidence 655444455678999999999876 6789999999999999999999999842 222222222211100000
Q ss_pred ccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhccc
Q 019642 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 333 (338)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 333 (338)
......+++.+.++|.+||+.||++|||+.++++||||+++.....
T Consensus 232 -------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~ 277 (283)
T 3bhy_A 232 -------------------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277 (283)
T ss_dssp -------------------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCCC
T ss_pred -------------------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHhh
Confidence 0001126889999999999999999999999999999999866544
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=353.68 Aligned_cols=294 Identities=24% Similarity=0.480 Sum_probs=210.3
Q ss_pred CCcEEEE-EeeeecCceeEEEEEEc--CCCceEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 37 QDDYEVV-RKVGRGKYSEVFEGINV--NTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 37 ~~~y~~~-~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~-~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
.+.|++. ++||+|+||+||+|.+. .+++.||+|.+... ....+.+|+.+++++ +||||+++++++........++
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHC-CCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhc-CCCCeeeEeeEEecCCCCeEEE
Confidence 3567774 47999999999999965 57889999998754 355788999999999 8999999999997766778999
Q ss_pred EEeeecCCcccccc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEe----cCCCCceEEEec
Q 019642 113 IFEYVNSTDFKVLY-----------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHELRKLRLIDW 177 (338)
Q Consensus 113 v~e~~~~~~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli----~~~~~~~~l~df 177 (338)
||||+.++.+..+. ..+++..++.++.|++.||.|||++||+|+||||+|||+ +.. +.+||+||
T Consensus 98 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~-~~~kl~Df 176 (405)
T 3rgf_A 98 LFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER-GRVKIADM 176 (405)
T ss_dssp EEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT-TCEEECCT
T ss_pred EEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC-CcEEEEEC
Confidence 99999875443332 138999999999999999999999999999999999999 444 79999999
Q ss_pred cccccccCC----CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCC--------CHHHHHH
Q 019642 178 GLAEFYHPG----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--------NHDQLVK 245 (338)
Q Consensus 178 g~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~--------~~~~~~~ 245 (338)
|++...... .......||+.|+|||++.+...++.++|||||||++|+|++|..||..... ..+++..
T Consensus 177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~ 256 (405)
T 3rgf_A 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256 (405)
T ss_dssp TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHH
T ss_pred CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHH
Confidence 999765432 2233457899999999998756799999999999999999999999954332 2577888
Q ss_pred HHHHhCCchhhhhhhccccccCcchhhhhccccCCCCc-ccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCC
Q 019642 246 IAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWS-KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 324 (338)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 324 (338)
+...++.+....|......................... ...........++.+.+||.+||+.||++|||++|+|+|||
T Consensus 257 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~ 336 (405)
T 3rgf_A 257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 336 (405)
T ss_dssp HHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 88888877665554332221111111100000000000 00000111124778999999999999999999999999999
Q ss_pred cchhhhcc
Q 019642 325 FAQVRAAE 332 (338)
Q Consensus 325 ~~~~~~~~ 332 (338)
|++.+.+.
T Consensus 337 f~~~~~~~ 344 (405)
T 3rgf_A 337 FLEDPLPT 344 (405)
T ss_dssp GTSSSCCC
T ss_pred hccCCCCc
Confidence 99876543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=361.46 Aligned_cols=255 Identities=28% Similarity=0.498 Sum_probs=212.6
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~------~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
.++|++.+.||+|+||+||+|.+..+++.||+|++.. .....+.+|+.+++++ +||||+++++++.+ ....
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~ 101 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFED--KGYF 101 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--CCEE
Confidence 3689999999999999999999999999999999853 2456788999999999 99999999999955 5678
Q ss_pred EEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecC--CCCceEEEeccccccccC
Q 019642 111 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~--~~~~~~l~dfg~~~~~~~ 185 (338)
++||||+.+++|.+.+ ..+++..++.++.|++.||.|||++|++|+||||+||+++. ..+.++|+|||++.....
T Consensus 102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 9999999999987765 45999999999999999999999999999999999999952 237899999999987766
Q ss_pred CCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 186 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
........||+.|+|||++.+ .++.++||||||+++|+|++|..||. +.+..+.+..+.........+
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~~~~--------- 249 (484)
T 3nyv_A 182 SKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFN-GANEYDILKKVEKGKYTFELP--------- 249 (484)
T ss_dssp CCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCCCCCSG---------
T ss_pred ccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHcCCCCCCCc---------
Confidence 555556789999999999876 58999999999999999999999983 333333333332211111100
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
....+++++.+||++||+.||++|||+.|+|+||||+....
T Consensus 250 ------------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 250 ------------------------QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp ------------------------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred ------------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 01127899999999999999999999999999999987654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=360.09 Aligned_cols=254 Identities=28% Similarity=0.510 Sum_probs=208.0
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~-----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
++|++.+.||+|+||+||+|.+..++..||+|++.. .....+.+|+.+++.+ +||||+++++++.+ ....++
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~~l 113 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-DHPNIMKLYDFFED--KRNYYL 113 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe--CCEEEE
Confidence 379999999999999999999999999999999864 2356788999999999 99999999999954 567899
Q ss_pred EEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC--CCceEEEeccccccccCCC
Q 019642 113 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 113 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~--~~~~~l~dfg~~~~~~~~~ 187 (338)
||||+.+++|.+.+ ..+++..++.++.|++.||.|||++|++|+||||+||+++.. .+.+||+|||++.......
T Consensus 114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 99999999887665 469999999999999999999999999999999999999764 2469999999998776555
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......||+.|+|||++.+ .++.++||||||+++|+|++|..||. +.+..+....+..........
T Consensus 194 ~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~~~~----------- 259 (494)
T 3lij_A 194 KMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFG-GQTDQEILRKVEKGKYTFDSP----------- 259 (494)
T ss_dssp CBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCCCCSG-----------
T ss_pred cccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCCCCCch-----------
Confidence 5566789999999999864 68999999999999999999999983 333333333332211111000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
....+++++.+||++||+.||++|||+.|+|+||||++...
T Consensus 260 ----------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 300 (494)
T 3lij_A 260 ----------------------EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCS 300 (494)
T ss_dssp ----------------------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHH
T ss_pred ----------------------hcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCcc
Confidence 01227899999999999999999999999999999988643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=336.24 Aligned_cols=253 Identities=23% Similarity=0.426 Sum_probs=208.8
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEe
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 115 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e 115 (338)
.|...+.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+.+++++ +||||+++++++.. ....++|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHFNVVEMYKSYLV--GEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEE--CCEEEEEEe
Confidence 588999999999999999999999999999998643 346688999999999 99999999999965 457899999
Q ss_pred eecCCccccccC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-cceee
Q 019642 116 YVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVR 192 (338)
Q Consensus 116 ~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-~~~~~ 192 (338)
|+.+++|.+++. .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++....... .....
T Consensus 123 ~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~ 201 (321)
T 2c30_A 123 FLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSL 201 (321)
T ss_dssp CCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSSSCCBCCC
T ss_pred cCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CcEEEeeeeeeeecccCccccccc
Confidence 999999988875 48999999999999999999999999999999999999988 799999999987654332 23445
Q ss_pred eccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhh
Q 019642 193 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA 272 (338)
Q Consensus 193 ~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (338)
.||+.|+|||++.+ ..++.++||||||+++|+|++|..||... +.......+... ..+.
T Consensus 202 ~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~-~~~~~~~~~~~~-~~~~------------------ 260 (321)
T 2c30_A 202 VGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSD-SPVQAMKRLRDS-PPPK------------------ 260 (321)
T ss_dssp CSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHS-SCCC------------------
T ss_pred cCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcC-CCCC------------------
Confidence 78999999999977 67899999999999999999999998432 222222222110 0000
Q ss_pred hhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 273 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
......+++++.++|.+||+.||++|||+.|+++||||.+...+
T Consensus 261 ---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 304 (321)
T 2c30_A 261 ---------------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLP 304 (321)
T ss_dssp ---------------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCCG
T ss_pred ---------------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCCc
Confidence 00011268899999999999999999999999999999876543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=331.16 Aligned_cols=256 Identities=21% Similarity=0.390 Sum_probs=207.5
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeecc--C
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--H 106 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~ 106 (338)
..+...|++.+.||+|+||+||+|.+..++..|++|.+... ..+.+.+|+.+++++ +||||+++++++... .
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 100 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSS
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCC
Confidence 35566799999999999999999999999999999998632 245678899999999 999999999988643 2
Q ss_pred CCccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 107 SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
....++||||+.+++|.+++ ..+++..++.++.|++.||.|||+.| ++|+||||+||+++...+.++|+|||++.
T Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred CceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 45688999999999998887 45999999999999999999999999 99999999999998544899999999996
Q ss_pred cccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 182 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
..... ......+++.|+|||++.+ .++.++||||||+++|+|++|..||....+.......+.......
T Consensus 181 ~~~~~-~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-------- 249 (290)
T 1t4h_A 181 LKRAS-FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA-------- 249 (290)
T ss_dssp GCCTT-SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG--------
T ss_pred ccccc-ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCcc--------
Confidence 54432 3344578999999998865 589999999999999999999999954333222222211100000
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
..+...++++.++|.+||+.||++|||+.++|+||||++.
T Consensus 250 ---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 250 ---------------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp ---------------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred ---------------------------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 0111257899999999999999999999999999999874
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=344.30 Aligned_cols=261 Identities=26% Similarity=0.466 Sum_probs=207.1
Q ss_pred eeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc--------cchHHHHHHHHHHHHhcCCCCeeEeeeeeec
Q 019642 33 IFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--------VKKKKIKREIKILQNLCGGPNVVKLLDIVRD 104 (338)
Q Consensus 33 i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~--------~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 104 (338)
+....++|++.+.||+|+||+||+|.+..+++.||+|++.. ...+.+.+|+.+++++ +||||+++++++.+
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 99 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYED 99 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhhcc
Confidence 33445789999999999999999999999999999999853 2346688999999999 89999999999955
Q ss_pred cCCCccEEEEeeecCCccccccC-------------------------------------------CCCHHHHHHHHHHH
Q 019642 105 QHSKTPSLIFEYVNSTDFKVLYP-------------------------------------------TLTDYDIRYYIYEL 141 (338)
Q Consensus 105 ~~~~~~~lv~e~~~~~~l~~~~~-------------------------------------------~~~~~~~~~i~~qi 141 (338)
....++||||+.+++|.+++. .+++..++.++.|+
T Consensus 100 --~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 100 --EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp --SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred --CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 567899999999999987763 13577788999999
Q ss_pred HHHHHHHHHCCceeccCCCCCeEecCCC-CceEEEeccccccccCCC-----cceeeeccccccccccccCc-CCCCCcc
Q 019642 142 LKALDYCHSQGIMHRDVKPHNVMIDHEL-RKLRLIDWGLAEFYHPGK-----EYNVRVASRYFKGPELLVDL-QDYDYSL 214 (338)
Q Consensus 142 ~~~l~~lH~~~i~H~dikp~NIli~~~~-~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~~ 214 (338)
+.||.|||+.|++|+||||+||+++.+. ..++|+|||++....... ......+++.|+|||++.+. ..++.++
T Consensus 178 ~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 178 FSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999999999999999999998652 389999999987543211 23445789999999998642 5688999
Q ss_pred hhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCC
Q 019642 215 DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLV 294 (338)
Q Consensus 215 DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (338)
||||||+++|+|++|..||. ..+..+....+......... .....+
T Consensus 258 DiwslG~il~el~~g~~pf~-~~~~~~~~~~~~~~~~~~~~---------------------------------~~~~~~ 303 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFP-GVNDADTISQVLNKKLCFEN---------------------------------PNYNVL 303 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCCCTTS---------------------------------GGGGGS
T ss_pred HHHHHHHHHHHHHHCCCCCC-CCChHHHHHHHHhcccccCC---------------------------------cccccC
Confidence 99999999999999999983 33333333333221111000 001126
Q ss_pred ChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 295 SPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 295 s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
++++.+||.+||+.||++|||+.++|+||||++...
T Consensus 304 ~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 304 SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp CHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence 899999999999999999999999999999998754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=340.25 Aligned_cols=289 Identities=28% Similarity=0.447 Sum_probs=218.3
Q ss_pred eeeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 32 VIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 32 ~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
+.+...++|++.+.||+|+||.||+|.+..+++.||+|++.... .+.+.+|+.+++++ +||||+++++++.+
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~-- 95 (331)
T 4aaa_A 19 LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKK-- 95 (331)
T ss_dssp CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--
T ss_pred hhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhC-CCCCEeeEEEEeec--
Confidence 44566789999999999999999999999999999999875432 34467899999999 89999999999955
Q ss_pred CCccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 107 SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
....++||||+.++++..+. ..+++..++.++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||++...
T Consensus 96 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 96 KKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFARTL 174 (331)
T ss_dssp TTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCTTC---
T ss_pred CCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCC-CcEEEEeCCCceee
Confidence 56789999999999888764 469999999999999999999999999999999999999988 79999999998765
Q ss_pred cCC-CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcc
Q 019642 184 HPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262 (338)
Q Consensus 184 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
... .......+++.|+|||++.+...++.++||||||+++|+|++|..|| ...+..+....+....+...........
T Consensus 175 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (331)
T 4aaa_A 175 AAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF-PGDSDIDQLYHIMMCLGNLIPRHQELFN 253 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred cCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCChhhhhHhh
Confidence 332 23344578999999999987557899999999999999999999998 4445556666666655543322211000
Q ss_pred ccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
..... .. ................+.+++++.+||.+||+.||++|||+.|+|+||||+.....
T Consensus 254 ~~~~~---~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 316 (331)
T 4aaa_A 254 KNPVF---AG---VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316 (331)
T ss_dssp HCGGG---TT---CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGGHH
T ss_pred hcccc---cc---ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCChh
Confidence 00000 00 00000000000011122478999999999999999999999999999999876543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=344.27 Aligned_cols=244 Identities=26% Similarity=0.447 Sum_probs=206.6
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----------chHHHHHHHHHHHHhcCCCCeeEeeeeeecc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ 105 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 105 (338)
.++|++.+.||+|+||+||+|.+..+++.||+|+++.. ....+.+|+.+++++ +||||+++++++.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~- 100 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIFEN- 100 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEEEC-
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEee-
Confidence 47899999999999999999999999999999998643 233567899999999 99999999999954
Q ss_pred CCCccEEEEeeecCC-ccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 106 HSKTPSLIFEYVNST-DFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 106 ~~~~~~lv~e~~~~~-~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
....++||||+.++ +|..++. .+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++.
T Consensus 101 -~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~a~ 178 (335)
T 3dls_A 101 -QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAED-FTIKLIDFGSAA 178 (335)
T ss_dssp -SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCE
T ss_pred -CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCC-CcEEEeecccce
Confidence 56788999998766 7777653 58999999999999999999999999999999999999988 899999999998
Q ss_pred cccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 182 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
............||+.|+|||++.+....+.++||||||+++|+|++|..||..... .
T Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------------------~--- 236 (335)
T 3dls_A 179 YLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------------------T--- 236 (335)
T ss_dssp ECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------------------G---
T ss_pred ECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------------------H---
Confidence 776655556678999999999998744458899999999999999999999932000 0
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
.. .....+..+++++.+||.+||+.||++|||+.++++||||++.
T Consensus 237 ------------~~----------~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 237 ------------VE----------AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp ------------TT----------TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred ------------Hh----------hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 00 0001122378999999999999999999999999999999764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=337.85 Aligned_cols=284 Identities=31% Similarity=0.575 Sum_probs=216.2
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC----
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---- 107 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~---- 107 (338)
.++|.+.+.||+|+||.||+|.+..+++.||+|.+.... .+.+.+|+.+++.+ +||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCcccHhheEecccccccc
Confidence 478999999999999999999999999999999986422 35577899999999 89999999999865432
Q ss_pred CccEEEEeeecCCcccccc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 108 KTPSLIFEYVNSTDFKVLY-PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
...+++|||+.+ +|...+ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++.....
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~- 178 (353)
T 3coi_A 102 YDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED-CELKILDFGLARHADA- 178 (353)
T ss_dssp CCCEEEEECCSE-EGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT-CCEEECSTTCTTC----
T ss_pred eeEEEEeccccC-CHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCC-CcEEEeecccccCCCC-
Confidence 235899999986 555554 469999999999999999999999999999999999999988 8999999999875432
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
......+++.|+|||++.+...++.++||||||+++|+|++|..||. +.+..+.+..+.+..+.+....+..-..
T Consensus 179 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~--- 253 (353)
T 3coi_A 179 -EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK-GKDYLDQLTQILKVTGVPGTEFVQKLND--- 253 (353)
T ss_dssp ------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSB-SSCHHHHHHHHHHHHCBCCHHHHTTCSC---
T ss_pred -CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHhCCCCHHHHHHHhh---
Confidence 23345789999999998775678999999999999999999999984 4455566777777666544322211000
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
.............+...+ ......+++++.+||.+||+.||++|||+.|+|+||||+....+.
T Consensus 254 -~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~ 316 (353)
T 3coi_A 254 -KAAKSYIQSLPQTPRKDF--TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPE 316 (353)
T ss_dssp -HHHHHHHHTSCBCSSCCT--TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred -HHHHHHHHhCcCCCCccH--HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCcc
Confidence 000011111111111111 011234789999999999999999999999999999999876543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=332.58 Aligned_cols=255 Identities=25% Similarity=0.472 Sum_probs=208.8
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
..++|++.+.||+|+||+||+|.+..+++.|++|++... ....+.+|+.+++++ +||||+++++++.+ ...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 83 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHD--ATR 83 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhheEec--CCE
Confidence 457999999999999999999999999999999998532 245688899999999 89999999999955 467
Q ss_pred cEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 110 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
.++||||+.+++|...+ ..+++..++.++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||++......
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~-~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTT-SCEEECSCCEESCC---
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCC-CCEEEEeccccccCCcc
Confidence 89999999999987776 458999999999999999999999999999999999999988 89999999988654332
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||. ..+..+....+... ..
T Consensus 163 -~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~-~~-------------- 224 (279)
T 3fdn_A 163 -RRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV-EF-------------- 224 (279)
T ss_dssp ------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHHT-CC--------------
T ss_pred -cccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCC-CCcHHHHHHHHHhC-CC--------------
Confidence 2344578999999999877 678899999999999999999999983 22222222222110 00
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcccc
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS 334 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~ 334 (338)
..+..+++.+.+||.+||+.||++|||+.|+++||||++....+.+
T Consensus 225 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~~ 270 (279)
T 3fdn_A 225 ----------------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 270 (279)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSSCCC
T ss_pred ----------------------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCccCccc
Confidence 0112268899999999999999999999999999999988765543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=340.62 Aligned_cols=292 Identities=28% Similarity=0.542 Sum_probs=219.3
Q ss_pred eeeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeecc--
Q 019642 32 VIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQ-- 105 (338)
Q Consensus 32 ~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-- 105 (338)
+...-.++|++.+.||+|+||.||+|.+..+++.||+|.++... ...+.+|+.+++++ +||||+++++++...
T Consensus 5 ~~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 83 (353)
T 2b9h_A 5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-KHENIITIFNIQRPDSF 83 (353)
T ss_dssp CCCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCS
T ss_pred cccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhC-cCCCcCCeeeeeccccc
Confidence 44556789999999999999999999999999999999987433 34567899999999 999999999987543
Q ss_pred -CCCccEEEEeeecCCcccccc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccc
Q 019642 106 -HSKTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
Q Consensus 106 -~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~ 182 (338)
.....+++|||+.+ +|...+ ..+++..++.++.|++.||.+||++|++|+||||+||+++.+ +.++|+|||++..
T Consensus 84 ~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 84 ENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSN-CDLKVCDFGLARI 161 (353)
T ss_dssp TTCCCEEEEECCCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEE
T ss_pred CccceEEEEEeccCc-cHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCC-CcEEEEecccccc
Confidence 23568999999985 565554 459999999999999999999999999999999999999988 8999999999876
Q ss_pred ccCCCc-----------ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhC
Q 019642 183 YHPGKE-----------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 251 (338)
Q Consensus 183 ~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~ 251 (338)
...... .....|++.|+|||++.+...++.++||||||+++|+|++|..|| .+.+..+.+..+....+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF-PGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhC
Confidence 542211 122367899999999876567899999999999999999999998 44455556666666665
Q ss_pred CchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 252 TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
.+......... ...............+... .......+++++.+||.+||+.||++|||+.|+|+||||+....+
T Consensus 241 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 315 (353)
T 2b9h_A 241 TPHSDNDLRCI---ESPRAREYIKSLPMYPAAP--LEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDP 315 (353)
T ss_dssp CCCSTTTTTTC---CCHHHHHHHHTSCCCCCCC--HHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred CCchhcccccc---ccchhhHHhhcccCCCCcc--hhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCc
Confidence 54322111100 0000011110000000000 001112478999999999999999999999999999999987655
Q ss_pred c
Q 019642 332 E 332 (338)
Q Consensus 332 ~ 332 (338)
.
T Consensus 316 ~ 316 (353)
T 2b9h_A 316 N 316 (353)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=339.60 Aligned_cols=279 Identities=18% Similarity=0.309 Sum_probs=211.6
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
...++|++.+.||+|+||+||+|.+..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++........
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCcceEEEEeecCCCceE
Confidence 3468999999999999999999999999999999998742 346678999999999 89999999999977666688
Q ss_pred EEEEeeecCCccccccCC------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEe----cCCCCceEEEecccc
Q 019642 111 SLIFEYVNSTDFKVLYPT------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHELRKLRLIDWGLA 180 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli----~~~~~~~~l~dfg~~ 180 (338)
++||||+.+++|.+++.. +++..++.++.|++.||.|||+.|++|+||||+||++ +.. +.+||+|||++
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~-~~~kL~Dfg~a 163 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQ-SVYKLTDFGAA 163 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSC-EEEEECCCTTC
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCC-ceEEEccCCCc
Confidence 999999999999888743 8999999999999999999999999999999999998 555 68999999999
Q ss_pred ccccCCCcceeeeccccccccccccC-------cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCc
Q 019642 181 EFYHPGKEYNVRVASRYFKGPELLVD-------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 253 (338)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 253 (338)
.............+++.|+|||++.. ...++.++||||||+++|+|++|..||............+.+.+...
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (319)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred eecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence 87765555556679999999999852 25788999999999999999999999964433332222222222111
Q ss_pred hhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCC
Q 019642 254 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 324 (338)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 324 (338)
....+...... ...... . ....+ ........+++.+.++|.+||+.||++|||++|+|+||=
T Consensus 244 p~~~~~~~~~~-~~~~~~-~---~~~~~----~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 244 PSGAISGVQKA-ENGPID-W---SGDMP----VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp CTTCCEEEECS-TTCCEE-E---ESSCC----TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred Ccccchhhhcc-cCCccc-c---CccCC----cccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 11100000000 000000 0 00000 000111224678899999999999999999999999973
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=349.10 Aligned_cols=286 Identities=24% Similarity=0.473 Sum_probs=215.2
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc--hHHHHHHHHHHHHhc-----CCCCeeEeeeeeeccCCCc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLC-----GGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~E~~~l~~l~-----~h~~iv~~~~~~~~~~~~~ 109 (338)
.++|++.+.||+|+||+||+|.+..+++.||+|+++... ...+.+|+.+++.+. .|+||+++++.+.. ...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~--~~~ 173 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF--RNH 173 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE--TTE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc--CCe
Confidence 457999999999999999999999999999999997543 356778999998884 56799999999955 467
Q ss_pred cEEEEeeecCCcccccc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCc--eEEEecccccc
Q 019642 110 PSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEF 182 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~--~~l~dfg~~~~ 182 (338)
.++|||++.+ +|.+++ ..+++..++.++.|++.||.|||+.||+|+||||+|||++.+ +. +||+|||++..
T Consensus 174 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~-~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 174 ICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQ-GRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEEEECCCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESST-TSCCEEECCCTTCEE
T ss_pred EEEEEeccCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccC-CCcceEEeeccccee
Confidence 8999999986 444443 248999999999999999999999999999999999999987 44 99999999865
Q ss_pred ccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcc
Q 019642 183 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262 (338)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
... ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..|| .+.+..+.+..+.+.++.+....+....
T Consensus 252 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf-~~~~~~~~l~~i~~~~~~p~~~~~~~~~ 327 (429)
T 3kvw_A 252 EHQ--RVYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLL-PGEDEGDQLACMIELLGMPSQKLLDASK 327 (429)
T ss_dssp TTC--CCCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHTBT
T ss_pred cCC--cccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCCHHHHHhhh
Confidence 432 2334578999999999987 67899999999999999999999887 5566677788888887776544332110
Q ss_pred ccc--cC----cchhhh----------------hccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHh
Q 019642 263 HLE--LD----PQLDAL----------------VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 320 (338)
Q Consensus 263 ~~~--~~----~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell 320 (338)
... .. +..... .......+....+........++++.+||++||+.||++|||++|+|
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L 407 (429)
T 3kvw_A 328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQAL 407 (429)
T ss_dssp THHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHh
Confidence 000 00 000000 00000000011111112233578899999999999999999999999
Q ss_pred cCCCcchhhh
Q 019642 321 AHPYFAQVRA 330 (338)
Q Consensus 321 ~hp~~~~~~~ 330 (338)
+||||++...
T Consensus 408 ~Hpw~~~~~~ 417 (429)
T 3kvw_A 408 RHPWLRRRLP 417 (429)
T ss_dssp TSTTTC----
T ss_pred CChhhccCCC
Confidence 9999998643
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=344.13 Aligned_cols=253 Identities=24% Similarity=0.430 Sum_probs=202.8
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHHH-HHHhcCCCCeeEeeeeeeccCCC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKI-LQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~~-l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
..++|++.+.||+|+||.||+|.+..+++.||+|++++.. ...+..|..+ ++.+ +||||+++++.+.+ ..
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~~~~--~~ 112 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQT--AD 112 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCCEEEEEEC--SS
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEe--CC
Confidence 4578999999999999999999999999999999986432 2334556665 3455 89999999999955 56
Q ss_pred ccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc-
Q 019642 109 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH- 184 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~- 184 (338)
..++||||+.|++|..++ ..+++..++.++.|++.||.|||++|++|+||||+|||++.+ +.+||+|||++....
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCCBCGGGBC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC-CCEEEeeCcccccccc
Confidence 889999999999998776 358999999999999999999999999999999999999988 899999999987633
Q ss_pred CCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccc
Q 019642 185 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264 (338)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
.........||+.|+|||++.+ ..++.++|+||||+++|+|++|..||.. .+..+....+... .
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~--~------------ 255 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNK--P------------ 255 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCC-SBHHHHHHHHHHS--C------------
T ss_pred CCCccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhc--c------------
Confidence 2334455679999999999987 6789999999999999999999999942 2323333322210 0
Q ss_pred ccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCH----HHHhcCCCcchhhhc
Q 019642 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA----REAMAHPYFAQVRAA 331 (338)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~----~ell~hp~~~~~~~~ 331 (338)
...+..++.++.+||.+||+.||++||++ .++++||||+++.+.
T Consensus 256 -----------------------~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~ 303 (373)
T 2r5t_A 256 -----------------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWD 303 (373)
T ss_dssp -----------------------CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred -----------------------cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence 00112378999999999999999999987 699999999987654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=335.63 Aligned_cols=258 Identities=21% Similarity=0.361 Sum_probs=192.8
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccch-----HHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-----KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
...++|++.+.||+|+||+||+|.+..+++.||+|.++.... ..+.++...++.+ +||||+++++++.+ ...
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~--~~~ 80 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV-DCPFTVTFYGALFR--EGD 80 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSS
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeec--cCC
Confidence 446899999999999999999999999999999999874321 2233344445556 99999999999955 557
Q ss_pred cEEEEeeecCCcccccc-------CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 110 PSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
.++||||+++ ++..++ ..+++..++.++.|++.||.|||++ |++|+||||+||+++.+ +.++|+|||++.
T Consensus 81 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~ 158 (290)
T 3fme_A 81 VWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINAL-GQVKMCDFGISG 158 (290)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTT-CCEEBCCC----
T ss_pred EEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCC-CCEEEeecCCcc
Confidence 8999999986 443332 3599999999999999999999998 99999999999999988 799999999997
Q ss_pred cccCCCcceeeecccccccccccc---CcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhh
Q 019642 182 FYHPGKEYNVRVASRYFKGPELLV---DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 258 (338)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
............+++.|+|||++. ....++.++||||||+++|+|++|..||...................
T Consensus 159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------ 232 (290)
T 3fme_A 159 YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP------ 232 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC------
T ss_pred cccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCC------
Confidence 765555555567899999999972 33578899999999999999999999995433433333332221000
Q ss_pred hhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
......+++++.++|.+||+.||++|||+.|+++||||+......
T Consensus 233 -----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~~~ 277 (290)
T 3fme_A 233 -----------------------------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKG 277 (290)
T ss_dssp -----------------------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSC
T ss_pred -----------------------------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCcccc
Confidence 001122689999999999999999999999999999998765443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=354.39 Aligned_cols=253 Identities=26% Similarity=0.453 Sum_probs=202.2
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
..++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++.. ...
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~--~~~ 222 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQT--HDR 222 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEEEE--TTE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEEee--CCE
Confidence 347899999999999999999999999999999998642 234567799999998 89999999999955 457
Q ss_pred cEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 110 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
.++||||+.+++|...+ ..+++..++.++.|++.||.|||+ .||+|+||||+|||++.+ +.+||+|||++.....
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSS-SCEEECCCCCCCTTCC
T ss_pred EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCC-CCEEEccCCCceeccC
Confidence 89999999999997776 458999999999999999999998 999999999999999988 8999999999875332
Q ss_pred -CCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccc
Q 019642 186 -GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264 (338)
Q Consensus 186 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.. .+.......+... ..
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~-~~------------ 366 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILME-EI------------ 366 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHC-CC------------
T ss_pred CCcccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHHhC-CC------------
Confidence 233344678999999999977 6789999999999999999999999943 2222222222110 00
Q ss_pred ccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC-----CHHHHhcCCCcchhhhc
Q 019642 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAA 331 (338)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~~ 331 (338)
..+..+++++.+||.+||+.||++|| |++|+++||||+++...
T Consensus 367 ------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~ 414 (446)
T 4ejn_A 367 ------------------------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ 414 (446)
T ss_dssp ------------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred ------------------------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence 01123689999999999999999999 99999999999987543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=337.07 Aligned_cols=257 Identities=25% Similarity=0.423 Sum_probs=205.6
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----------hHHHHHHHHHHHHhcCCCCeeEeeeeeecc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLCGGPNVVKLLDIVRDQ 105 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 105 (338)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+|+.+++++ +||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEEESS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEEcCC
Confidence 368999999999999999999999999999999986432 23477899999999 999999999998543
Q ss_pred CCCccEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCC--CceEEEecccc
Q 019642 106 HSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLA 180 (338)
Q Consensus 106 ~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~--~~~~l~dfg~~ 180 (338)
..++||||+.+++|.+.+. .+++..++.++.|++.||.|||++|++|+||||+||+++.+. ..++|+|||++
T Consensus 88 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 88 ---DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp ---SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred ---ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 3789999999998877653 589999999999999999999999999999999999998752 35999999999
Q ss_pred ccccCCCcceeeecccccccccccc--CcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhh
Q 019642 181 EFYHPGKEYNVRVASRYFKGPELLV--DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 258 (338)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
.............+++.|+|||++. +...++.++||||||+++|+|++|..||............+...... ....
T Consensus 165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~- 242 (322)
T 2ycf_A 165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN-FIPE- 242 (322)
T ss_dssp EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCC-CCHH-
T ss_pred eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccc-cCch-
Confidence 7665443334457899999999974 23578899999999999999999999995443332222222111000 0000
Q ss_pred hhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
....+++++.+||.+||+.||++|||+.++|+||||++...
T Consensus 243 -------------------------------~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~ 283 (322)
T 2ycf_A 243 -------------------------------VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 283 (322)
T ss_dssp -------------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHH
T ss_pred -------------------------------hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHH
Confidence 00126899999999999999999999999999999987643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=335.98 Aligned_cols=267 Identities=22% Similarity=0.368 Sum_probs=201.0
Q ss_pred eccCCcEEEE-EeeeecCceeEEEEEEcCCCceEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 34 FSDQDDYEVV-RKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 34 ~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
....++|++. +.||+|+||+||+|.+..+++.||+|+++.. ..+.+.+|+.++.++.+||||+++++++.+ ...
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~--~~~ 85 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE--EDR 85 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTE
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCE
Confidence 3446789995 7899999999999999999999999998643 356788999999996589999999999965 467
Q ss_pred cEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCC--CceEEEecccccccc
Q 019642 110 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEFYH 184 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~--~~~~l~dfg~~~~~~ 184 (338)
.++||||+.+++|.+++ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+. ..++|+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 89999999999988876 4589999999999999999999999999999999999998762 239999999986543
Q ss_pred CCC--------cceeeeccccccccccccC----cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCH----------HH
Q 019642 185 PGK--------EYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH----------DQ 242 (338)
Q Consensus 185 ~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~----------~~ 242 (338)
... ......+++.|+|||++.+ ...++.++||||||+++|+|++|..||....... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 211 1223458999999999864 1357899999999999999999999995432211 00
Q ss_pred HHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 243 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
...+.+.... .... ........+++++.+||.+||+.||++|||+.|+|+|
T Consensus 246 ~~~~~~~i~~-----------------------~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 246 QNMLFESIQE-----------------------GKYE------FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHH-----------------------CCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHhc-----------------------cCcc------cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0001000000 0000 0000001268899999999999999999999999999
Q ss_pred CCcchhhhc
Q 019642 323 PYFAQVRAA 331 (338)
Q Consensus 323 p~~~~~~~~ 331 (338)
|||++....
T Consensus 297 p~~~~~~~~ 305 (316)
T 2ac3_A 297 PWVQGCAPE 305 (316)
T ss_dssp TTCC-----
T ss_pred hhhcCCCCc
Confidence 999986543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=327.80 Aligned_cols=254 Identities=23% Similarity=0.475 Sum_probs=186.2
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
..++|++.+.||+|+||.||+|.+..+++.|++|.+... ..+.+.+|+.+++++ +||||+++++++.+ ...
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 85 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFED--SNY 85 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEEC--SSE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEcc--CCe
Confidence 357899999999999999999999999999999998642 236688999999999 99999999999955 567
Q ss_pred cEEEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 110 PSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
.++||||+.+++|..++ ..+++..++.++.|++.||.+||++|++|+||||+||+++.+ +.++|+|||++.....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRN-MNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTT-CCEEECCCTTCEECC-
T ss_pred EEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CCEEEEeecceeeccC
Confidence 89999999999988775 348999999999999999999999999999999999999988 8999999999876542
Q ss_pred C-CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccc
Q 019642 186 G-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264 (338)
Q Consensus 186 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
. .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...... ...... .
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~----~------------- 225 (278)
T 3cok_A 165 PHEKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK-NTLNKV----V------------- 225 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------C----C-------------
T ss_pred CCCcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHH-HHHHHH----h-------------
Confidence 2 22234568899999999877 67889999999999999999999998432211 110000 0
Q ss_pred ccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
. .....+..++.++.++|.+||+.||++|||+.++++||||.+.....
T Consensus 226 --------------~------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 273 (278)
T 3cok_A 226 --------------L------ADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTK 273 (278)
T ss_dssp --------------S------SCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC------
T ss_pred --------------h------cccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCCCcc
Confidence 0 00011233789999999999999999999999999999999876544
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=334.81 Aligned_cols=285 Identities=29% Similarity=0.552 Sum_probs=221.9
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEc-CCCceEEEEEecccc-----hHHHHHHHHHHHHhc--CCCCeeEeeeeeec--
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINV-NTNERCIIKILKPVK-----KKKIKREIKILQNLC--GGPNVVKLLDIVRD-- 104 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~--~h~~iv~~~~~~~~-- 104 (338)
...++|++.+.||+|+||.||+|.+. .+++.||+|+++... ...+.+|+.+++.+. .||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 34589999999999999999999995 678899999986322 335678888887774 79999999998852
Q ss_pred -cCCCccEEEEeeecCCcccccc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecc
Q 019642 105 -QHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG 178 (338)
Q Consensus 105 -~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg 178 (338)
......++||||+.+ +|..++ ..+++..++.++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||
T Consensus 88 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~-~~~kl~Dfg 165 (326)
T 1blx_A 88 TDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFG 165 (326)
T ss_dssp CSSEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECSCC
T ss_pred cCCCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCC-CCEEEecCc
Confidence 234578899999995 665554 238999999999999999999999999999999999999988 899999999
Q ss_pred ccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhh
Q 019642 179 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 258 (338)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
++.............+++.|+|||++.+ ..++.++||||||+++|+|++|..|| ...+..+.+..+.+..+.+....+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~ 243 (326)
T 1blx_A 166 LARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLPGEEDW 243 (326)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred ccccccCCCCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHHcCCCCcccC
Confidence 9876554444455678999999999977 67899999999999999999999998 444556666777777666554444
Q ss_pred hhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhccc
Q 019642 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 333 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 333 (338)
........ .........+. ......++..+.+||.+||+.||++|||+.|+|+||||+++.....
T Consensus 244 ~~~~~~~~-----~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~ 308 (326)
T 1blx_A 244 PRDVALPR-----QAFHSKSAQPI-----EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 308 (326)
T ss_dssp CTTCSSCG-----GGSCCCCCCCG-----GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred ccccccch-----hhhcccCcchh-----hhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhhh
Confidence 32211110 00000001111 1122347899999999999999999999999999999999876544
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=352.83 Aligned_cols=255 Identities=25% Similarity=0.397 Sum_probs=211.3
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
...++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+..|+.+++++ +||||+++++++.+ ..
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~--~~ 258 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFET--KT 258 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SS
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEee--CC
Confidence 3458999999999999999999999999999999998632 235678899999999 99999999999955 56
Q ss_pred ccEEEEeeecCCccccccC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 109 TPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
..++||||+.|++|..++. .+++..++.++.||+.||.|||++||+|+||||+||+++.+ +.+||+|||++.
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~-g~vkL~DFGla~ 337 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDD-GNVRISDLGLAV 337 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCTTCE
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCC-CCEEEeecceee
Confidence 7899999999999976652 48999999999999999999999999999999999999988 899999999997
Q ss_pred cccCCCc-ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCC--HHHHHH-HHHHhCCchhhh
Q 019642 182 FYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVK-IAKVLGTDELNA 257 (338)
Q Consensus 182 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~--~~~~~~-~~~~~~~~~~~~ 257 (338)
....... .....||+.|+|||++.+ ..++.++|+||||+++|+|++|..||...... ...+.. +.. ..
T Consensus 338 ~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~--~~----- 409 (543)
T 3c4z_A 338 ELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE--QA----- 409 (543)
T ss_dssp ECCTTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH--CC-----
T ss_pred eccCCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh--cc-----
Confidence 7654433 233489999999999987 67899999999999999999999999543221 111111 111 00
Q ss_pred hhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCC-----HHHHhcCCCcchhhhc
Q 019642 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAA 331 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt-----~~ell~hp~~~~~~~~ 331 (338)
...+..+++++.+||++||+.||++||+ ++++++||||+++.+.
T Consensus 410 ------------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~ 458 (543)
T 3c4z_A 410 ------------------------------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR 458 (543)
T ss_dssp ------------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred ------------------------------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence 0011237899999999999999999995 5899999999987643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=327.22 Aligned_cols=250 Identities=24% Similarity=0.409 Sum_probs=199.3
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
.++|++.+.||+|+||.||+|.+..+++.|++|++... ..+.+.+|+.+++.+ +||||+++++++.. ....
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~ 86 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQVIST--PTDF 86 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEEEEEec--CCeE
Confidence 47899999999999999999999999999999998642 245678999999999 89999999999855 5678
Q ss_pred EEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 111 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
++||||+.+++|.+++ ..+++..++.++.|++.||.+||++|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTT-SCEEECCCCGGGCCCC--
T ss_pred EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCC-CCEEEeecccccccCCCc
Confidence 9999999999998876 358999999999999999999999999999999999999988 799999999997765544
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......+++.|+|||.+.+....+.++|+||||+++|+|++|..||.. .+.......+... .
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~--~--------------- 227 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGG--V--------------- 227 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHC--C---------------
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHhhcC--c---------------
Confidence 445567899999999998744456899999999999999999999842 2211111111110 0
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
...+..++.++.++|.+||+.||++|||+.++++||||++.
T Consensus 228 --------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 228 --------------------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp --------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred --------------------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 00112268899999999999999999999999999999865
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=363.87 Aligned_cols=255 Identities=23% Similarity=0.382 Sum_probs=213.4
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~------~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
..++|++.+.||+|+||.||+|.+..+++.||+|+++. .....+..|..++..+.+||+|+++++.+.+ ...
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~--~~~ 416 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDR 416 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC--SSE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe--CCE
Confidence 45789999999999999999999999999999999864 2345577899999988789999999999954 567
Q ss_pred cEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc-C
Q 019642 110 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-P 185 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~-~ 185 (338)
+++||||+.+++|..++ ..+++..++.++.||+.||.|||++||+|+||||+|||++.+ +.+||+|||++.... .
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~-g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSS-SCEEECCCTTCEECCCT
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCC-CcEEEeecceeeccccC
Confidence 89999999999998876 459999999999999999999999999999999999999998 899999999987532 2
Q ss_pred CCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 186 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
........||+.|+|||++.+ ..++.++|+||||+++|+|++|..||. +.+..+....+... .
T Consensus 496 ~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~-~~~~~~~~~~i~~~--~------------- 558 (674)
T 3pfq_A 496 GVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFE-GEDEDELFQSIMEH--N------------- 558 (674)
T ss_dssp TCCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHSS--C-------------
T ss_pred CcccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCC-CCCHHHHHHHHHhC--C-------------
Confidence 334445679999999999977 688999999999999999999999984 33333333332210 0
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCH-----HHHhcCCCcchhhhcc
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA-----REAMAHPYFAQVRAAE 332 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~-----~ell~hp~~~~~~~~~ 332 (338)
...+..+++++.+||++||+.||++||++ +||++||||+++.+..
T Consensus 559 ----------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~ 608 (674)
T 3pfq_A 559 ----------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 608 (674)
T ss_dssp ----------------------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHH
T ss_pred ----------------------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHH
Confidence 00112379999999999999999999997 9999999999886543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=333.28 Aligned_cols=268 Identities=23% Similarity=0.394 Sum_probs=209.2
Q ss_pred hhceeeeeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc--cchHHHHHHHHHHHHhcCCCCeeEeeeeeec
Q 019642 27 NVSSYVIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNVVKLLDIVRD 104 (338)
Q Consensus 27 ~~~~~~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 104 (338)
.+....+....++|++.+.||+|+||.||+|.+..+++.|++|++.. .....+.+|+.+++++.+||||+++++++..
T Consensus 13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 34444556678999999999999999999999999999999999864 3457788999999999789999999999866
Q ss_pred cC----CCccEEEEeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEE
Q 019642 105 QH----SKTPSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI 175 (338)
Q Consensus 105 ~~----~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~ 175 (338)
.. ....++||||+.+++|.+++. .+++..++.++.|++.||.+||++|++|+||||+||+++.+ +.++|+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~-~~~kl~ 171 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN-AEVKLV 171 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-CCEEEC
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCC-CCEEEe
Confidence 43 457899999999999988763 48999999999999999999999999999999999999988 899999
Q ss_pred eccccccccCCC-cceeeeccccccccccccC----cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHh
Q 019642 176 DWGLAEFYHPGK-EYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 250 (338)
Q Consensus 176 dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~ 250 (338)
|||++....... ......+++.|+|||++.. ...++.++||||||+++|+|++|..||... +.......+...
T Consensus 172 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~- 249 (326)
T 2x7f_A 172 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM-HPMRALFLIPRN- 249 (326)
T ss_dssp CCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHS-
T ss_pred eCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHhhcC-
Confidence 999987654322 2334578999999999863 256889999999999999999999998422 222222111110
Q ss_pred CCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 251 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
.. .......+++.+.+||.+||..||++|||+.++++||||++.+.
T Consensus 250 ~~----------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 295 (326)
T 2x7f_A 250 PA----------------------------------PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN 295 (326)
T ss_dssp CC----------------------------------CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred cc----------------------------------ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence 00 00012236899999999999999999999999999999998765
Q ss_pred c
Q 019642 331 A 331 (338)
Q Consensus 331 ~ 331 (338)
.
T Consensus 296 ~ 296 (326)
T 2x7f_A 296 E 296 (326)
T ss_dssp H
T ss_pred c
Confidence 4
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=330.44 Aligned_cols=254 Identities=25% Similarity=0.424 Sum_probs=206.4
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
.++|++.+.||+|+||.||++.+..+++.|++|.++.. ..+.+.+|+.+++++ +||||+++++++.+ ....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-KHENIVTLEDIYES--TTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhC-CCCCeeehhhhccc--CCEEEEE
Confidence 46899999999999999999999999999999998743 345678999999999 99999999999854 5678999
Q ss_pred EeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEe---cCCCCceEEEeccccccccCCC
Q 019642 114 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 114 ~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli---~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
|||+.+++|.+.+ ..+++..++.++.|++.||.+||+.|++|+||||+||++ +.+ +.++|+|||++..... .
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~-~~~kl~Dfg~~~~~~~-~ 162 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEEN-SKIMITDFGLSKMEQN-G 162 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTT-CCEEBCSCSTTCCCCC-B
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCC-CCEEEccCCcceecCC-C
Confidence 9999999987775 458999999999999999999999999999999999999 444 7899999999865432 2
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||.. .+.......+.+....
T Consensus 163 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~--------------- 225 (304)
T 2jam_A 163 IMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGYYE--------------- 225 (304)
T ss_dssp TTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHCCCC---------------
T ss_pred ccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCC---------------
Confidence 2334568999999999877 6789999999999999999999999843 2222222222211000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
........+++++.+||.+||+.||++|||+.|+|+||||.+...
T Consensus 226 ------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (304)
T 2jam_A 226 ------------------FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTA 270 (304)
T ss_dssp ------------------CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred ------------------CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence 000111237899999999999999999999999999999987543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=328.05 Aligned_cols=255 Identities=23% Similarity=0.422 Sum_probs=211.1
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
...++|++.+.||+|+||.||++.+..+++.+++|++... ..+.+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~ 88 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFED--ND 88 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SS
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeecc--CC
Confidence 4567999999999999999999999999999999998643 245678899999999 99999999999954 56
Q ss_pred ccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 109 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
..++||||+.+++|.+++ ..+++..++.++.|++.||.+||++|++|+||||+||+++.+ +.++|+|||.+.....
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEY 167 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECCS
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCC-CCEEEEeccCceeccc
Confidence 789999999999988876 458999999999999999999999999999999999999988 8999999999876542
Q ss_pred C-CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccc
Q 019642 186 G-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264 (338)
Q Consensus 186 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
. .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||... ...+....+.. +.
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~--~~------------ 231 (294)
T 2rku_A 168 DGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETS-CLKETYLRIKK--NE------------ 231 (294)
T ss_dssp TTCCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHT--TC------------
T ss_pred CccccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhh--cc------------
Confidence 2 23344578999999999877 67899999999999999999999998422 21221111110 00
Q ss_pred ccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
...+..+++.+.++|.+||+.||++|||+.|+++||||++...+.
T Consensus 232 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~ 276 (294)
T 2rku_A 232 -----------------------YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 276 (294)
T ss_dssp -----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred -----------------------CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence 001123688999999999999999999999999999999876544
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=343.21 Aligned_cols=288 Identities=24% Similarity=0.402 Sum_probs=214.4
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc--hHHHHHHHHHHHHhcC-------CCCeeEeeeeeecc--
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCG-------GPNVVKLLDIVRDQ-- 105 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~E~~~l~~l~~-------h~~iv~~~~~~~~~-- 105 (338)
.++|++.+.||+|+||+||+|.+..+++.||+|+++... .+.+.+|+.+++.+.+ |+||+++++.+...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 478999999999999999999999999999999997543 4667889999999942 78899999998632
Q ss_pred CCCccEEEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEecCCC-----------
Q 019642 106 HSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEL----------- 169 (338)
Q Consensus 106 ~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~NIli~~~~----------- 169 (338)
.....++||||++++++..+. ..+++..++.++.|++.||.|||++ |++|+||||+|||++.+.
T Consensus 116 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~ 195 (397)
T 1wak_A 116 NGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEAT 195 (397)
T ss_dssp TEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC
T ss_pred CCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhH
Confidence 345789999999777776654 3489999999999999999999998 999999999999998662
Q ss_pred -------------------------------------CceEEEeccccccccCCCcceeeeccccccccccccCcCCCCC
Q 019642 170 -------------------------------------RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 212 (338)
Q Consensus 170 -------------------------------------~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 212 (338)
..++|+|||++...... .....+|+.|+|||++.+ ..++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~ 272 (397)
T 1wak_A 196 EWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIG-SGYNT 272 (397)
T ss_dssp ---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHT-SCCCT
T ss_pred HHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcC-CCCCc
Confidence 27999999999765432 344578999999999987 67899
Q ss_pred cchhHHHHHHHHHHHhcCCCCcCCCC-----CHHHHHHHHHHhCCchhhhhhhcccc-ccCcchhhhhccccCCCCccc-
Q 019642 213 SLDMWSLGCMFAGMIFRKEPFFYGHD-----NHDQLVKIAKVLGTDELNAYLNKYHL-ELDPQLDALVGRHSRKPWSKF- 285 (338)
Q Consensus 213 ~~DvwslG~~l~~lltg~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~- 285 (338)
++||||||+++|+|++|..||..... ..+.+..+.+.++..+...+...... .+..............++...
T Consensus 273 ~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (397)
T 1wak_A 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFE 352 (397)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHH
T ss_pred HHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhH
Confidence 99999999999999999999954332 34456666676666543332211100 000000000000000000000
Q ss_pred ---ccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcch
Q 019642 286 ---INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 327 (338)
Q Consensus 286 ---~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 327 (338)
.....+...++.+.+||.+||+.||++|||+.|+|+||||++
T Consensus 353 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 353 VLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp HHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred hhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 000011224567899999999999999999999999999974
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=327.51 Aligned_cols=255 Identities=24% Similarity=0.493 Sum_probs=209.2
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~-----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
.++|++.+.||+|+||.||+|.+..+++.|++|++.. ...+.+.+|+.+++++ +||||+++++++.+ ....+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~ 97 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILED--SSSFY 97 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-cCCCccEEEEEEeC--CCeEE
Confidence 4789999999999999999999999999999999853 2356788999999999 99999999999855 56789
Q ss_pred EEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC--CCceEEEeccccccccCC
Q 019642 112 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 112 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~--~~~~~l~dfg~~~~~~~~ 186 (338)
++||++.+++|.+.+ ..+++..++.++.|++.||.+||++|++|+||||+||+++.+ ...++|+|||++......
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 999999999887665 469999999999999999999999999999999999999764 247999999999876555
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||.. .+..+....+........
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~------------ 242 (287)
T 2wei_A 178 TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFD------------ 242 (287)
T ss_dssp SSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCC------------
T ss_pred CccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCC------------
Confidence 44455568899999999876 488999999999999999999999843 222222222211000000
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
......+++++.++|.+||+.||++|||+.|+|+||||++...
T Consensus 243 ---------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 285 (287)
T 2wei_A 243 ---------------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (287)
T ss_dssp ---------------------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred ---------------------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence 0001226899999999999999999999999999999998754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=325.87 Aligned_cols=250 Identities=23% Similarity=0.455 Sum_probs=208.0
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
..++|++.+.||+|+||.||+|.+..+++.|++|++... ....+.+|+.+++++ +||||+++++++.+ ...
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 88 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYFHD--RKR 88 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEEEc--CCE
Confidence 347899999999999999999999999999999998532 245688999999999 99999999999955 567
Q ss_pred cEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 110 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
.++||||+.+++|.+.+ ..+++..++.++.|++.||.+||++|++|+||||+||+++.+ +.++|+|||++......
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYK-GELKIADFGWSVHAPSL 167 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT-CCEEECCCTTCEECSSS
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCC-CCEEEecccccccCccc
Confidence 89999999999887776 358999999999999999999999999999999999999988 79999999998655432
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||... +..+....+.. ..
T Consensus 168 -~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~---~~------------- 228 (284)
T 2vgo_A 168 -RRRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSP-SHTETHRRIVN---VD------------- 228 (284)
T ss_dssp -CBCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHT---TC-------------
T ss_pred -ccccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCC-CHhHHHHHHhc---cc-------------
Confidence 2344578999999999887 67899999999999999999999998422 22222111111 00
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
...+..+++++.++|.+||+.||++|||+.++++||||++..
T Consensus 229 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 229 ---------------------LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp ---------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred ---------------------cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 001123689999999999999999999999999999998764
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=326.75 Aligned_cols=248 Identities=18% Similarity=0.234 Sum_probs=200.5
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
.++|++.+.||+|+||+||+|.+..+++.|++|.++.. ....+.+|+..+..+.+||||+++++++.+ ....+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~--~~~~~ 87 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE--DDHML 87 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE--TTEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEE
Confidence 46899999999999999999999999999999998642 345677899999988789999999999955 45789
Q ss_pred EEEeeecCCcccccc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC----------------
Q 019642 112 LIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE---------------- 168 (338)
Q Consensus 112 lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~---------------- 168 (338)
+||||+.+++|.+++ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 999999999998886 348999999999999999999999999999999999999743
Q ss_pred --CCceEEEeccccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHH
Q 019642 169 --LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 246 (338)
Q Consensus 169 --~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~ 246 (338)
...++|+|||.+...... ....+++.|+|||++.+...++.++||||||+++|+|++|..++... .....+
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~~~~ 240 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQWHEI 240 (289)
T ss_dssp --CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HHHHHH
T ss_pred CCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hHHHHH
Confidence 247999999998765432 23468999999999987456778999999999999999998765221 111111
Q ss_pred HHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcc
Q 019642 247 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 326 (338)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~ 326 (338)
.+. . ....+..+++++.++|.+||+.||++|||+.|+++||||+
T Consensus 241 ~~~--~----------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~ 284 (289)
T 1x8b_A 241 RQG--R----------------------------------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284 (289)
T ss_dssp HTT--C----------------------------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-
T ss_pred HcC--C----------------------------------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhh
Confidence 110 0 0011223789999999999999999999999999999998
Q ss_pred hhh
Q 019642 327 QVR 329 (338)
Q Consensus 327 ~~~ 329 (338)
+..
T Consensus 285 ~~~ 287 (289)
T 1x8b_A 285 SAS 287 (289)
T ss_dssp ---
T ss_pred hhc
Confidence 753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=333.37 Aligned_cols=253 Identities=24% Similarity=0.431 Sum_probs=210.4
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
...++|++.+.||+|+||.||++.+..+++.+++|++... ..+.+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~ 114 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFED--ND 114 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SS
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEec--CC
Confidence 3457999999999999999999999999999999998643 345678899999999 99999999999955 56
Q ss_pred ccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 109 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
..++||||+.+++|.+++ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++.....
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEY 193 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECCS
T ss_pred eEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCC-CCEEEeeccCceeccc
Confidence 789999999999988876 458999999999999999999999999999999999999988 8999999999876542
Q ss_pred -CCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccc
Q 019642 186 -GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264 (338)
Q Consensus 186 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
........+++.|+|||++.+ ..++.++||||||+++|+|++|..||... ...+....+... .
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~--~------------ 257 (335)
T 2owb_A 194 DGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETS-CLKETYLRIKKN--E------------ 257 (335)
T ss_dssp TTCCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHHT--C------------
T ss_pred CcccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCC-CHHHHHHHHhcC--C------------
Confidence 223344578999999999977 67899999999999999999999998432 222222211110 0
Q ss_pred ccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
...+..+++++.+||.+||+.||++|||+.|+|+||||.+...
T Consensus 258 -----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 258 -----------------------YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp -----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred -----------------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 0011236889999999999999999999999999999988654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=330.67 Aligned_cols=287 Identities=28% Similarity=0.513 Sum_probs=208.6
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEeeeeeecc--------
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQ-------- 105 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-------- 105 (338)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.... .+.+.+|+.+++++ +||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECTTSCBCCC--
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhc-CCCCeeEEEEecccccccccccc
Confidence 589999999999999999999999999999999986543 35678899999999 999999999987432
Q ss_pred ----CCCccEEEEeeecCCccccccC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccc
Q 019642 106 ----HSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
Q Consensus 106 ----~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~ 179 (338)
.....++||||+.+ +|.+++. .+++..++.++.|++.||.+||++|++|+||||+||+++.+.+.++|+|||+
T Consensus 89 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~ 167 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGL 167 (320)
T ss_dssp --CCSCSEEEEEEECCSE-EHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred ccccccCceeEEeeccCC-CHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCcc
Confidence 23567899999985 6766654 4899999999999999999999999999999999999986547999999999
Q ss_pred cccccCCC----cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchh
Q 019642 180 AEFYHPGK----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL 255 (338)
Q Consensus 180 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (338)
+....... ......++..|+|||.+.+...++.++|+||||+++|+|++|..||. ..+..+....+.........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~-~~~~~~~~~~~~~~~~~~~~ 246 (320)
T 2i6l_A 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFA-GAHELEQMQLILESIPVVHE 246 (320)
T ss_dssp CBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHHSCCCCH
T ss_pred ccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCCch
Confidence 87653221 22334568889999998765678999999999999999999999984 33444455555544433222
Q ss_pred hhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhccc
Q 019642 256 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 333 (338)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 333 (338)
........ .......... .....+. ......++.++.+||.+||+.||++|||+.|+|+||||+....+..
T Consensus 247 ~~~~~~~~-~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~~ 317 (320)
T 2i6l_A 247 EDRQELLS-VIPVYIRNDM-TEPHKPL-----TQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMD 317 (320)
T ss_dssp HHHHHHHT-TSCHHHHHHT-TSCCCCH-----HHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC---
T ss_pred hhhhhhhh-cCcccccccc-cCCCCCh-----hHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCccC
Confidence 21111000 0000000000 0000000 0111237899999999999999999999999999999998776653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=333.78 Aligned_cols=250 Identities=27% Similarity=0.410 Sum_probs=202.9
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
.+.|++.+.||+|+||+||+|.+..+++.||+|.+.... .+.+.+|+.+++++ +||||+++++++.. ....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~ 129 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLR--EHTA 129 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE--CCeE
Confidence 457999999999999999999999999999999986422 24578899999999 99999999999965 4578
Q ss_pred EEEEeeecCCccccc---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 111 SLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
++||||+.|+.+..+ ...+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++.....
T Consensus 130 ~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~-- 206 (348)
T 1u5q_A 130 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAP-- 206 (348)
T ss_dssp EEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT-TEEEECCCTTCBSSSS--
T ss_pred EEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEeeccCceecCC--
Confidence 899999986543333 2469999999999999999999999999999999999999988 8999999999876542
Q ss_pred cceeeeccccccccccccC--cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 188 EYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
.....|++.|+|||++.+ ...++.++||||||+++|+|++|..||... +....+..+......
T Consensus 207 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~-~~~~~~~~~~~~~~~------------- 271 (348)
T 1u5q_A 207 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESP------------- 271 (348)
T ss_dssp -BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCC-------------
T ss_pred -CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhcCCC-------------
Confidence 234578999999999852 357889999999999999999999998432 222222222110000
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
......+++.+.+||.+||+.||++|||++++++||||....
T Consensus 272 ----------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 272 ----------------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp ----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence 001122688999999999999999999999999999997654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=335.00 Aligned_cols=254 Identities=24% Similarity=0.443 Sum_probs=196.6
Q ss_pred eeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCC--CCeeEeeeeeecc
Q 019642 33 IFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGG--PNVVKLLDIVRDQ 105 (338)
Q Consensus 33 i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h--~~iv~~~~~~~~~ 105 (338)
|...+++|++.+.||+|+||.||++.+ .+++.||+|++.... .+.+.+|+.+++++ +| |||+++++++..
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~iv~~~~~~~~- 80 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKIIRLYDYEIT- 80 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHH-TTTCTTBCCEEEEEEC-
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhh-hhcCCceEEEeeeEee-
Confidence 345678999999999999999999987 468899999986422 35678899999999 54 999999999854
Q ss_pred CCCccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccc
Q 019642 106 HSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
Q Consensus 106 ~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~ 182 (338)
....++||| +.+++|.+++ ..+++..++.++.|++.||.|||++|++|+||||+|||++. +.+||+|||++..
T Consensus 81 -~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~--~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 81 -DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--GMLKLIDFGIANQ 156 (343)
T ss_dssp -SSEEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET--TEEEECCCSSSCC
T ss_pred -CCEEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC--CcEEEeecccccc
Confidence 568899999 4566776665 45899999999999999999999999999999999999974 5899999999976
Q ss_pred ccCCCc---ceeeeccccccccccccC----------cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHH
Q 019642 183 YHPGKE---YNVRVASRYFKGPELLVD----------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 249 (338)
Q Consensus 183 ~~~~~~---~~~~~~~~~y~aPE~~~~----------~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~ 249 (338)
...... .....||+.|+|||++.+ ...++.++||||||+++|+|++|..||....+....+.. .
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---~ 233 (343)
T 3dbq_A 157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA---I 233 (343)
T ss_dssp C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH---H
T ss_pred cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHH---H
Confidence 543322 234578999999999853 246888999999999999999999999533332222221 1
Q ss_pred hCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 250 LGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
..... ....+...+.++.+||.+||+.||++|||+.|+|+||||+..
T Consensus 234 ~~~~~--------------------------------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 234 IDPNH--------------------------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp HCTTS--------------------------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred hcCCc--------------------------------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 11100 001112256789999999999999999999999999999754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=332.49 Aligned_cols=265 Identities=20% Similarity=0.357 Sum_probs=187.7
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
...++|++.+.||+|+||.||+|.+..+++.||+|.+... ..+.+.+|+.+++++ +||||+++++++.. ....
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~ 88 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-HHPNIVSYYTSFVV--KDEL 88 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCC-CCTTBCCEEEEEES--SSCE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhc-CCCCEeeEEEEEee--cCCc
Confidence 3468999999999999999999999989999999998642 345677899999999 89999999999955 4578
Q ss_pred EEEEeeecCCccccccC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccc
Q 019642 111 SLIFEYVNSTDFKVLYP-----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~~-----------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~ 179 (338)
++||||+.+++|.+++. .+++..++.++.|++.||.+||++|++|+||||+||+++.+ +.++|+|||+
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~ 167 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGED-GSVQIADFGV 167 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-CCEEECCCHH
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCC-CCEEEEeccc
Confidence 89999999999887763 38999999999999999999999999999999999999988 8999999999
Q ss_pred cccccCCC------cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCc
Q 019642 180 AEFYHPGK------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 253 (338)
Q Consensus 180 ~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 253 (338)
+....... ......+++.|+|||++.+...++.++||||||+++|+|++|..||..... ......... ..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~~~~---~~ 243 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP-MKVLMLTLQ---ND 243 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG-GGHHHHHHT---SS
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCch-hhHHHHHhc---cC
Confidence 86553221 122346889999999987645689999999999999999999999843322 222111110 00
Q ss_pred hhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 254 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
.. ..............+++++.++|.+||+.||++|||+.++++||||++....
T Consensus 244 ~~------------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 297 (303)
T 2vwi_A 244 PP------------------------SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK 297 (303)
T ss_dssp CC------------------------CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred CC------------------------ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence 00 0000000111123378899999999999999999999999999999987654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=340.31 Aligned_cols=256 Identities=25% Similarity=0.436 Sum_probs=198.9
Q ss_pred eeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcC-CCCeeEeeeeeeccC
Q 019642 33 IFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCG-GPNVVKLLDIVRDQH 106 (338)
Q Consensus 33 i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~-h~~iv~~~~~~~~~~ 106 (338)
+....++|++.+.||+|+||+||++.+.. ++.||+|++... ..+.+.+|+.+++++.+ ||||+++++++..
T Consensus 51 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-- 127 (390)
T 2zmd_A 51 ISVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-- 127 (390)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--
T ss_pred ccccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec--
Confidence 34455679999999999999999999765 889999998643 23567899999999953 6999999999855
Q ss_pred CCccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 107 SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
....++||| +.+++|.+++ ..+++..++.++.|++.||.|||+.||+|+||||+|||++. +.+||+|||++...
T Consensus 128 ~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~--~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 128 DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--GMLKLIDFGIANQM 204 (390)
T ss_dssp SSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS--SCEEECCCSSSCCC
T ss_pred CCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC--CeEEEEecCccccc
Confidence 456899999 5667777665 35889999999999999999999999999999999999964 58999999999765
Q ss_pred cCCC---cceeeeccccccccccccCc----------CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHh
Q 019642 184 HPGK---EYNVRVASRYFKGPELLVDL----------QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 250 (338)
Q Consensus 184 ~~~~---~~~~~~~~~~y~aPE~~~~~----------~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~ 250 (338)
.... ......||+.|+|||++.+. ..++.++||||||+++|+|++|..||....+....+..+ +
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~---~ 281 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---I 281 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH---H
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHH---h
Confidence 4332 12345799999999998641 368889999999999999999999995433322222221 1
Q ss_pred CCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 251 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
.... .. ..+...+.++.+||.+||+.||++|||+.|+|+||||+...
T Consensus 282 ~~~~------------------------~~--------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 282 DPNH------------------------EI--------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp CTTS------------------------CC--------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred Cccc------------------------cC--------CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 1100 00 01112478899999999999999999999999999998654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=334.76 Aligned_cols=271 Identities=23% Similarity=0.405 Sum_probs=210.5
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccch--------------------HHHHHHHHHHHHhcCCCCee
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--------------------KKIKREIKILQNLCGGPNVV 96 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--------------------~~~~~E~~~l~~l~~h~~iv 96 (338)
.++|++.+.||+|+||.||+|.+ +++.||+|.+..... +.+.+|+.+++++ +||||+
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~ 106 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KNEYCL 106 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-CCTTBC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-CCCCcc
Confidence 47999999999999999999998 899999999863211 7789999999999 899999
Q ss_pred EeeeeeeccCCCccEEEEeeecCCccccc------c-----CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeE
Q 019642 97 KLLDIVRDQHSKTPSLIFEYVNSTDFKVL------Y-----PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVM 164 (338)
Q Consensus 97 ~~~~~~~~~~~~~~~lv~e~~~~~~l~~~------~-----~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIl 164 (338)
++++++.+ ....++||||+.+++|.++ + ..+++..++.++.|++.||.+||+ .|++|+||+|+||+
T Consensus 107 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 107 TCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp CCSEEEES--SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred eEEEEEee--CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 99999955 4678999999999999887 3 348999999999999999999999 99999999999999
Q ss_pred ecCCCCceEEEeccccccccCCCcceeeeccccccccccccCcCCCCC-cchhHHHHHHHHHHHhcCCCCcCCCCCHHHH
Q 019642 165 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY-SLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 243 (338)
Q Consensus 165 i~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~DvwslG~~l~~lltg~~pf~~~~~~~~~~ 243 (338)
++.+ +.++|+|||.+...... ......+++.|+|||++.+...++. ++||||||+++|+|++|..||.......+..
T Consensus 185 ~~~~-~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 185 MDKN-GRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp ECTT-SCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred EcCC-CcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 9988 89999999999765433 3344578999999999987435555 9999999999999999999995444434333
Q ss_pred HHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCC
Q 019642 244 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323 (338)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp 323 (338)
..+... ........ .... .+............+++++.+||.+||+.||++|||+.|+++||
T Consensus 263 ~~i~~~--~~~~~~~~-------~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp 324 (348)
T 2pml_X 263 NNIRTK--NIEYPLDR-------NHFL---------YPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324 (348)
T ss_dssp HHHTSC--CCCCCCSS-------SSST---------TTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred HHHhcc--CcCCccch-------hhhh---------ccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 332111 00000000 0000 00000000111234789999999999999999999999999999
Q ss_pred Ccchhhhcc
Q 019642 324 YFAQVRAAE 332 (338)
Q Consensus 324 ~~~~~~~~~ 332 (338)
||++.+...
T Consensus 325 ~f~~~~~~~ 333 (348)
T 2pml_X 325 WLADTNIED 333 (348)
T ss_dssp GGTTCCHHH
T ss_pred cccCCCHHH
Confidence 999886544
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=324.92 Aligned_cols=257 Identities=25% Similarity=0.410 Sum_probs=209.0
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
...++|++.+.||+|+||.||++.+..+++.|++|.+... ..+.+.+|+.+++++ +||||+++++++.+.....
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGTE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCce
Confidence 3468999999999999999999999999999999998642 245678999999999 9999999999887665678
Q ss_pred cEEEEeeecCCccccccC-------CCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCCeEecCCCCceEEEec
Q 019642 110 PSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQG-----IMHRDVKPHNVMIDHELRKLRLIDW 177 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dikp~NIli~~~~~~~~l~df 177 (338)
.++||||+.+++|.+++. .+++..++.++.|++.||.+||+.| ++|+||||+||+++.+ +.++|+||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~-~~~kl~df 160 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDF 160 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSS-SCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCC-CCEEEecC
Confidence 899999999999988763 2899999999999999999999999 9999999999999988 89999999
Q ss_pred cccccccCCCc-ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhh
Q 019642 178 GLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 256 (338)
Q Consensus 178 g~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (338)
|.+........ .....+++.|+|||++.+ ..++.++|+||||+++|+|++|..||... +..+....+... ...
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~i~~~-~~~--- 234 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAF-SQKELAGKIREG-KFR--- 234 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHT-CCC---
T ss_pred chheeeccccccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCccc-CHHHHHHHHhhc-ccc---
Confidence 99876543322 223468899999999977 57889999999999999999999998422 222222222110 000
Q ss_pred hhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 257 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
..+..+++++.++|.+||+.||++|||+.|+|+|+|+.+....
T Consensus 235 --------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~ 277 (279)
T 2w5a_A 235 --------------------------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHH 277 (279)
T ss_dssp --------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGSC
T ss_pred --------------------------------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhccc
Confidence 0112368999999999999999999999999999999987653
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=334.52 Aligned_cols=280 Identities=24% Similarity=0.429 Sum_probs=210.6
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc--hHHHHHHHHHHHHhcCCCC-----eeEeeeeeeccCCCc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPN-----VVKLLDIVRDQHSKT 109 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~E~~~l~~l~~h~~-----iv~~~~~~~~~~~~~ 109 (338)
.++|++.+.||+|+||+||+|.+..+++.||+|+++... ......|+.+++.+..|++ ++++++.+.. ...
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~--~~~ 130 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF--RNH 130 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--TTE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--CCc
Confidence 478999999999999999999999999999999997543 3556789999998855664 8999998855 467
Q ss_pred cEEEEeeecCCcccccc-----CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCCeEecC-CCCceEEEeccccc
Q 019642 110 PSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCH--SQGIMHRDVKPHNVMIDH-ELRKLRLIDWGLAE 181 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~NIli~~-~~~~~~l~dfg~~~ 181 (338)
.++||||+++ +|.+++ ..+++..++.++.|++.||.||| +.||+|+||||+|||++. ..+.+||+|||++.
T Consensus 131 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 131 LCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred eEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 8999999986 555544 34899999999999999999999 579999999999999954 23789999999997
Q ss_pred cccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 182 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
.... ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..|| .+.+..+.+..+.+..+.+....+...
T Consensus 210 ~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~ 285 (382)
T 2vx3_A 210 QLGQ--RIYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLF-SGANEVDQMNKIVEVLGIPPAHILDQA 285 (382)
T ss_dssp ETTC--CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred eccc--ccccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 6543 2334678999999999987 67999999999999999999999998 455666777777777776543332110
Q ss_pred cccccCcchhhhhccccCCCCc-----------------cccc------------ccCCCC----CChhHHHHHHHhcCC
Q 019642 262 YHLELDPQLDALVGRHSRKPWS-----------------KFIN------------ADNQHL----VSPEAIDFLDKLLRY 308 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~------------~~~~~~----~s~~l~~li~~~L~~ 308 (338)
+.....+.......|. .+.. ...... .++++.+||.+||+.
T Consensus 286 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 359 (382)
T 2vx3_A 286 ------PKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY 359 (382)
T ss_dssp ------TTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred ------HHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence 0001111100000000 0000 000000 114789999999999
Q ss_pred CcCCcCCHHHHhcCCCcchhh
Q 019642 309 DHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 309 dP~~Rpt~~ell~hp~~~~~~ 329 (338)
||++|||+.|+|+||||++..
T Consensus 360 dP~~Rpta~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 360 DPKTRIQPYYALQHSFFKKTA 380 (382)
T ss_dssp CTTTSCCHHHHTTSGGGCC--
T ss_pred ChhhCCCHHHHhcCcccccCC
Confidence 999999999999999998764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=328.10 Aligned_cols=259 Identities=25% Similarity=0.425 Sum_probs=205.9
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
....++|++.+.||+|+||.||+|.+..+++.+++|++... ..+.+.+|+.+++.+ +||||+++++++.. ....
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~ 91 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-DHPYIVKLLGAYYH--DGKL 91 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--C-CE
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcC-CCCCEeeeeeeeee--CCeE
Confidence 34568999999999999999999999999999999998643 346678899999999 99999999999965 4578
Q ss_pred EEEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 111 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
++||||+.+++|..++ ..+++..++.++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||++......
T Consensus 92 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLE-GDIRLADFGVSAKNLKT 170 (302)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-SCEEECCCHHHHHHHHH
T ss_pred EEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCC-CCEEEEECCCCcccccc
Confidence 9999999999988765 459999999999999999999999999999999999999988 79999999987432211
Q ss_pred -Ccceeeecccccccccccc----CcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 187 -KEYNVRVASRYFKGPELLV----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 187 -~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
.......+++.|+|||++. ....++.++|+||||+++|+|++|..||.. .+.......+... ..+
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~-~~~-------- 240 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE-LNPMRVLLKIAKS-DPP-------- 240 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHS-CCC--------
T ss_pred ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCcc-CCHHHHHHHHhcc-CCc--------
Confidence 1223356889999999984 235788999999999999999999999843 2222222221110 000
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
....+..++.++.++|.+||+.||++|||+.++++||||++....
T Consensus 241 -------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 285 (302)
T 2j7t_A 241 -------------------------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN 285 (302)
T ss_dssp -------------------------CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCC
T ss_pred -------------------------ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccc
Confidence 000112268899999999999999999999999999999987653
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=329.21 Aligned_cols=258 Identities=24% Similarity=0.411 Sum_probs=205.6
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
...++|++.+.||+|+||.||+|.+..+++.|++|.+... ..+.+.+|+.+++++ +||||+++++++.. ....++|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 102 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQC-DSPHVVKYYGSYFK--NTDLWIV 102 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTC-CCTTBCCEEEEEEE--TTEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEe--CCEEEEE
Confidence 4568999999999999999999999999999999998743 456788999999999 99999999999855 4578999
Q ss_pred EeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-c
Q 019642 114 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E 188 (338)
Q Consensus 114 ~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-~ 188 (338)
|||+.+++|.+++ ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+....... .
T Consensus 103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~ 181 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTE-GHAKLADFGVAGQLTDTMAK 181 (314)
T ss_dssp EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECBTTBSC
T ss_pred eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCC-CCEEEeecccchhhhhhccc
Confidence 9999999998876 359999999999999999999999999999999999999988 799999999987654332 2
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
.....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||... +.......+... ...
T Consensus 182 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~-~~~--------------- 243 (314)
T 3com_A 182 RNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADI-HPMRAIFMIPTN-PPP--------------- 243 (314)
T ss_dssp BCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHS-CCC---------------
T ss_pred cCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHhcC-CCc---------------
Confidence 334578899999999877 57899999999999999999999998432 211111111100 000
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
....+..+++.+.++|.+||+.||++|||+.++++||||++.....
T Consensus 244 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~ 289 (314)
T 3com_A 244 ------------------TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289 (314)
T ss_dssp ------------------CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCGG
T ss_pred ------------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcch
Confidence 0001122688999999999999999999999999999999875443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=331.71 Aligned_cols=257 Identities=21% Similarity=0.333 Sum_probs=202.3
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC--
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK-- 108 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~-- 108 (338)
.++|++.+.||+|+||.||+|.+..+++.||+|+++... ...+.+|+.+++++ +||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeeccCCCCc
Confidence 578999999999999999999999999999999987432 23577899999999 999999999998654322
Q ss_pred ccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 109 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
..++||||+.+++|.+++ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++.....
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETT-SCEEECCCSCC-----
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCC-CCEEEeeccCcccccc
Confidence 458999999999998886 359999999999999999999999999999999999999988 8999999999876543
Q ss_pred CC----cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 186 GK----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 186 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
.. ......|++.|+|||++.+ ..++.++||||||+++|+|++|..||.. .+..+............. .
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~-~~~~~~~~~~~~~~~~~~-~----- 240 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTG-DSPVSVAYQHVREDPIPP-S----- 240 (311)
T ss_dssp -------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHCCCCCH-H-----
T ss_pred cccccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHhcCCCCCc-c-----
Confidence 22 1223468999999999987 6789999999999999999999999832 222222222211111100 0
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
.....+++++.++|.+||+.||++||++.++++|+|++....
T Consensus 241 ---------------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 241 ---------------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp ---------------------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred ---------------------------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 001227899999999999999999999999999999986543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=324.48 Aligned_cols=255 Identities=26% Similarity=0.407 Sum_probs=210.8
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
....+.|++.+.||+|+||.||+|.+..+++.|++|++... ..+.+.+|+.+++.+ +||||+++++++.. ...
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 94 (303)
T 3a7i_A 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLK--DTK 94 (303)
T ss_dssp ECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTE
T ss_pred CChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEec--CCe
Confidence 34567899999999999999999999999999999998643 346788999999999 99999999999865 457
Q ss_pred cEEEEeeecCCccccccC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 110 PSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
.++||||+.+++|.+++. .+++..++.++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 95 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 95 LWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp EEEEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECBTTB
T ss_pred EEEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCC-CCEEEeecccceecCccc
Confidence 899999999999988874 48999999999999999999999999999999999999988 899999999987654332
Q ss_pred -cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 188 -EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 188 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||... ........+... ..
T Consensus 174 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~-~~-------------- 236 (303)
T 3a7i_A 174 IKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSEL-HPMKVLFLIPKN-NP-------------- 236 (303)
T ss_dssp CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHS-CC--------------
T ss_pred cccCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCc-CHHHHHHHhhcC-CC--------------
Confidence 2334578899999999977 67889999999999999999999998422 211111111110 00
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
......++..+.++|.+||+.||++|||+.++++||||.....
T Consensus 237 ---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 279 (303)
T 3a7i_A 237 ---------------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK 279 (303)
T ss_dssp ---------------------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred ---------------------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCC
Confidence 0011236899999999999999999999999999999977543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=339.03 Aligned_cols=286 Identities=21% Similarity=0.328 Sum_probs=210.8
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
...++|++.+.||+|+||+||++.+..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ....
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~ 106 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYS--DGEI 106 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEE--TTEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEE--CCEE
Confidence 4467999999999999999999999999999999998643 245678999999999 99999999999965 4578
Q ss_pred EEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 111 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
++||||+.+++|.+++ ..+++..++.++.|++.||.|||+. |++|+||||+||+++.+ +.++|+|||++......
T Consensus 107 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT-CCEEECCCCCCHHHHHH
T ss_pred EEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCC-CCEEEEECCCCcccccc
Confidence 9999999999998886 3599999999999999999999996 99999999999999988 89999999998654322
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHh--CCchhhhhhh----
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL--GTDELNAYLN---- 260 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~---- 260 (338)
......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.... ........... +.........
T Consensus 186 -~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPD--AKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp -C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCC--HHHHHHHHC------------------
T ss_pred -cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHhcccccccCCCCCCCcccCC
Confidence 2234578999999999987 678999999999999999999999995322 22222111110 0000000000
Q ss_pred ----ccccccC--cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 261 ----KYHLELD--PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 261 ----~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
....... .............. ........++.++.+||.+||+.||++|||++|+|+||||++.....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 335 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEP----PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 335 (360)
T ss_dssp ------------CCCHHHHHHHHHHSC----CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSC
T ss_pred CcccccccCCCCcccchhhhhHHhccC----CCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhh
Confidence 0000000 00000000000000 01112233688999999999999999999999999999999876543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=335.25 Aligned_cols=257 Identities=23% Similarity=0.426 Sum_probs=205.4
Q ss_pred CCcEEEEEeeeecCceeEEEEEEc---CCCceEEEEEeccc-------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~-------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
.++|++.+.||+|+||+||++.+. .+++.||+|+++.. ....+.+|+.+++.+.+||||+++++.+..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 130 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 130 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--
Confidence 379999999999999999999984 58899999998642 245567899999999789999999999855
Q ss_pred CCccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 107 SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
....++||||+.+++|.+++ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++...
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEF 209 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEESCSSEEEEC
T ss_pred CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CcEEEeeCCCCeec
Confidence 45788999999999998876 459999999999999999999999999999999999999988 89999999998754
Q ss_pred cCCC--cceeeeccccccccccccCc-CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhh
Q 019642 184 HPGK--EYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 260 (338)
Q Consensus 184 ~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.... ......||+.|+|||++.+. ..++.++||||||+++|+|++|..||....................
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~------- 282 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE------- 282 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC-------
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC-------
Confidence 3221 22334689999999998752 3578999999999999999999999954322211111111100000
Q ss_pred ccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC-----CHHHHhcCCCcchhhh
Q 019642 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRA 330 (338)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~ 330 (338)
...+..++..+.+||.+||..||++|| |+.|+++||||+.+.+
T Consensus 283 ---------------------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~ 330 (355)
T 1vzo_A 283 ---------------------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 330 (355)
T ss_dssp ---------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred ---------------------------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence 001123688999999999999999999 9999999999998754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=340.10 Aligned_cols=264 Identities=18% Similarity=0.206 Sum_probs=191.5
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHHHHHHhc-CCCCeeEee-------eeee
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLC-GGPNVVKLL-------DIVR 103 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~~l~~l~-~h~~iv~~~-------~~~~ 103 (338)
.+|++.+.||+|+||+||+|.+..+++.||+|+++... .+.+.+|+.+++.+. +||||++++ +.+.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 35999999999999999999999999999999987532 345678877777774 499988865 3332
Q ss_pred ccCC---------------CccEEEEeeecCCccccccC----CCCHHHH------HHHHHHHHHHHHHHHHCCceeccC
Q 019642 104 DQHS---------------KTPSLIFEYVNSTDFKVLYP----TLTDYDI------RYYIYELLKALDYCHSQGIMHRDV 158 (338)
Q Consensus 104 ~~~~---------------~~~~lv~e~~~~~~l~~~~~----~~~~~~~------~~i~~qi~~~l~~lH~~~i~H~di 158 (338)
.... ...++||||+. ++|.+++. .++...+ ..++.|++.||.|||++|++|+||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 2211 34799999999 78877764 2455555 677799999999999999999999
Q ss_pred CCCCeEecCCCCceEEEeccccccccCCCcceeeeccccccccccccC-cCCCCCcchhHHHHHHHHHHHhcCCCCcCCC
Q 019642 159 KPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD-LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 237 (338)
Q Consensus 159 kp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwslG~~l~~lltg~~pf~~~~ 237 (338)
||+|||++.+ +.+||+|||++..... ......+++.|+|||++.+ ...++.++||||||+++|+|++|..||....
T Consensus 221 kp~NIll~~~-~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 297 (371)
T 3q60_A 221 TPDNLFIMPD-GRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297 (371)
T ss_dssp SGGGEEECTT-SCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred CHHHEEECCC-CCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence 9999999988 8999999999976532 2224567799999999964 2468999999999999999999999994332
Q ss_pred CCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHH
Q 019642 238 DNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 317 (338)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ 317 (338)
.... . .. .. ..................+++.+.+||.+||+.||++|||+.
T Consensus 298 ~~~~---------------~---~~--------~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 348 (371)
T 3q60_A 298 PGIK---------------G---SW--------KR---PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPL 348 (371)
T ss_dssp TTCT---------------T---CC--------CB---CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHH
T ss_pred cccc---------------c---ch--------hh---hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHH
Confidence 1100 0 00 00 000000000011111234799999999999999999999999
Q ss_pred HHhcCCCcchhhhcccc
Q 019642 318 EAMAHPYFAQVRAAESS 334 (338)
Q Consensus 318 ell~hp~~~~~~~~~~~ 334 (338)
++|+||||+++....++
T Consensus 349 e~l~hp~f~~~~~~~~~ 365 (371)
T 3q60_A 349 EAMETPEFLQLQNEISS 365 (371)
T ss_dssp HHTTSHHHHHHHHHHHH
T ss_pred HHhcCHHHHHHHHHHhh
Confidence 99999999998776544
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=331.61 Aligned_cols=286 Identities=25% Similarity=0.472 Sum_probs=212.1
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCC-ceEEEEEeccc--chHHHHHHHHHHHHhcCCCC------eeEeeeeeeccCC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTN-ERCIIKILKPV--KKKKIKREIKILQNLCGGPN------VVKLLDIVRDQHS 107 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~------iv~~~~~~~~~~~ 107 (338)
.++|++.+.||+|+||+||+|.+..++ +.||+|+++.. ..+.+.+|+.+++.+ .|++ ++.+++++.. .
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~--~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKI-KEKDKENKFLCVLMSDWFNF--H 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHH-HHHCTTSCSCBCCEEEEEEE--T
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHH-hhcCCCCceeEEEeeeeeee--C
Confidence 579999999999999999999998776 68999998753 345677899999998 5544 8888888854 4
Q ss_pred CccEEEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEe------------------
Q 019642 108 KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI------------------ 165 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli------------------ 165 (338)
...++||||++++++..+. ..+++..++.++.|++.||.|||++|++|+||||+||++
T Consensus 95 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~ 174 (355)
T 2eu9_A 95 GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174 (355)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred CeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccc
Confidence 5789999999777666554 248999999999999999999999999999999999999
Q ss_pred -cCCCCceEEEeccccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHH
Q 019642 166 -DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 244 (338)
Q Consensus 166 -~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~ 244 (338)
+.+ +.++|+|||++..... ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||. ..+..+...
T Consensus 175 ~~~~-~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~-~~~~~~~~~ 249 (355)
T 2eu9_A 175 SVKN-TSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQ-THENREHLV 249 (355)
T ss_dssp EESC-CCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHH
T ss_pred ccCC-CcEEEeecCccccccc--cccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCCC-CCCHHHHHH
Confidence 334 7899999999976432 2334578999999999987 678999999999999999999999984 444455566
Q ss_pred HHHHHhCCchhhhhhhccccc--------cCc--chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC
Q 019642 245 KIAKVLGTDELNAYLNKYHLE--------LDP--QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 314 (338)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~--------~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 314 (338)
.+.+..+..+........... +.. ......... ..+.... .......+.++.+||.+||+.||++||
T Consensus 250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKEN-CKPLKSY--MLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHH-CCCGGGG--CSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHcCCCcHHHhhhccchhhhcccccccccccchhcccccc-CCccccc--ccccchhHHHHHHHHHHHhcCChhhCc
Confidence 666666554332221110000 000 000000000 0000000 011111356899999999999999999
Q ss_pred CHHHHhcCCCcchhhhccc
Q 019642 315 TAREAMAHPYFAQVRAAES 333 (338)
Q Consensus 315 t~~ell~hp~~~~~~~~~~ 333 (338)
|+.|+|+||||+++.....
T Consensus 327 t~~e~l~hp~f~~~~~~~~ 345 (355)
T 2eu9_A 327 TLAEALLHPFFAGLTPEER 345 (355)
T ss_dssp CHHHHTTSGGGGGCCHHHH
T ss_pred CHHHHhcChhhcCCChhhc
Confidence 9999999999999865433
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=344.17 Aligned_cols=253 Identities=18% Similarity=0.259 Sum_probs=196.3
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhc--CCCCeeEee-------
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLC--GGPNVVKLL------- 99 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~--~h~~iv~~~------- 99 (338)
...++|++.+.||+|+||+||+|.+..+++.||+|++... ..+.+.+|+.+++.+. +||||++++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 3457899999999999999999999999999999998632 2366789995554443 799999998
Q ss_pred eeeeccCC----------C-----ccEEEEeeecCCccccccC---CCCH-------HHHHHHHHHHHHHHHHHHHCCce
Q 019642 100 DIVRDQHS----------K-----TPSLIFEYVNSTDFKVLYP---TLTD-------YDIRYYIYELLKALDYCHSQGIM 154 (338)
Q Consensus 100 ~~~~~~~~----------~-----~~~lv~e~~~~~~l~~~~~---~~~~-------~~~~~i~~qi~~~l~~lH~~~i~ 154 (338)
+++.+.+. . ..+++|||++ ++|.+++. .+++ ..++.++.|++.||.|||++|++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 228 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 228 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECCS-EEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEeccC-CCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 55433211 1 3789999995 68877764 2444 77888999999999999999999
Q ss_pred eccCCCCCeEecCCCCceEEEeccccccccCCCcceeeeccccccccccccCc----------CCCCCcchhHHHHHHHH
Q 019642 155 HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL----------QDYDYSLDMWSLGCMFA 224 (338)
Q Consensus 155 H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------~~~~~~~DvwslG~~l~ 224 (338)
|+||||+|||++.+ +.+||+|||++.... .......| +.|+|||++.+. ..++.++||||||+++|
T Consensus 229 HrDikp~NIll~~~-~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 229 HTYLRPVDIVLDQR-GGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp CSCCCGGGEEECTT-CCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCC-CCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 99999999999988 899999999997533 23334456 999999999873 27899999999999999
Q ss_pred HHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHH
Q 019642 225 GMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 304 (338)
Q Consensus 225 ~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~ 304 (338)
+|++|..||..... .. . ..... .....+++++.+||.+
T Consensus 305 elltg~~Pf~~~~~-~~------------~---------------~~~~~--------------~~~~~~~~~~~~li~~ 342 (377)
T 3byv_A 305 WIWCADLPITKDAA-LG------------G---------------SEWIF--------------RSCKNIPQPVRALLEG 342 (377)
T ss_dssp HHHHSSCCC-------C------------C---------------SGGGG--------------SSCCCCCHHHHHHHHH
T ss_pred HHHHCCCCCccccc-cc------------c---------------hhhhh--------------hhccCCCHHHHHHHHH
Confidence 99999999832110 00 0 00000 0012378999999999
Q ss_pred hcCCCcCCcCCHHHHhcCCCcchhhhcccc
Q 019642 305 LLRYDHQDRLTAREAMAHPYFAQVRAAESS 334 (338)
Q Consensus 305 ~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~ 334 (338)
||+.||++|||+.|+++||||+++.....+
T Consensus 343 ~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~ 372 (377)
T 3byv_A 343 FLRYPKEDRLLPLQAMETPEYEQLRTELSA 372 (377)
T ss_dssp HTCSSGGGCCCHHHHHTSHHHHHHHHHHHH
T ss_pred HcCCCchhCCCHHHHhhChHHHHHHHHHHH
Confidence 999999999999999999999998765544
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=326.86 Aligned_cols=283 Identities=24% Similarity=0.484 Sum_probs=210.4
Q ss_pred CCcEEEEEeeeecCceeEEEEEE-cCCCceEEEEEecccc--hHHHHHHHHHHHHhcCCC------CeeEeeeeeeccCC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGIN-VNTNERCIIKILKPVK--KKKIKREIKILQNLCGGP------NVVKLLDIVRDQHS 107 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~~aiK~~~~~~--~~~~~~E~~~l~~l~~h~------~iv~~~~~~~~~~~ 107 (338)
.++|++.+.||+|+||+||+|.+ ..+++.||+|+++... .+.+.+|+.+++.+ +|+ +++++++++.. .
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~i~~~~~~~~~--~ 89 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHL-NTTDPNSTFRCVQMLEWFEH--H 89 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHH-HHHCTTCTTCBCCEEEEEEE--T
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHh-hhcCCCCceeeEeeeccccc--C
Confidence 47999999999999999999998 5688999999987543 45678899999988 444 59999999855 4
Q ss_pred CccEEEEeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC--------------
Q 019642 108 KTPSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-------------- 168 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~-------------- 168 (338)
...++||||+ ++++.+++. .+++..++.++.|++.||.|||++|++|+||||+||+++..
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 5889999999 555555542 47899999999999999999999999999999999999863
Q ss_pred ----CCceEEEeccccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHH
Q 019642 169 ----LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 244 (338)
Q Consensus 169 ----~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~ 244 (338)
.+.++|+|||++..... ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||. ..+..+...
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~-~~~~~~~~~ 244 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFP-THDSKEHLA 244 (339)
T ss_dssp EEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCC-CSCHHHHHH
T ss_pred ccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCC-CCChHHHHH
Confidence 26799999999876432 2234578999999999987 678999999999999999999999984 445555566
Q ss_pred HHHHHhCCchhhhhhhccccc--------cCc--chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC
Q 019642 245 KIAKVLGTDELNAYLNKYHLE--------LDP--QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 314 (338)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~--------~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 314 (338)
.+....+..+...+....... +.. ......... ..+.... .......++++.+||.+||+.||++||
T Consensus 245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRA-CKPLKEF--MLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHH-CCCGGGG--CSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhc-Ccchhhh--cccchhhHHHHHHHHHHHhCcCccccc
Confidence 666666544332221111000 000 000000000 0000000 011122457899999999999999999
Q ss_pred CHHHHhcCCCcchhhh
Q 019642 315 TAREAMAHPYFAQVRA 330 (338)
Q Consensus 315 t~~ell~hp~~~~~~~ 330 (338)
|+.|+++||||++++.
T Consensus 322 t~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 322 TLREALKHPFFDLLKK 337 (339)
T ss_dssp CHHHHTTSGGGGGGGC
T ss_pred CHHHHhcCHHHHHHhc
Confidence 9999999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=324.40 Aligned_cols=261 Identities=18% Similarity=0.305 Sum_probs=196.2
Q ss_pred hhceeeeeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeee
Q 019642 27 NVSSYVIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDI 101 (338)
Q Consensus 27 ~~~~~~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~ 101 (338)
......+....++|++.+.||+|+||+||+|.+ +++.||+|++.... .+.+.+|+.+++++ +||||++++++
T Consensus 26 ~~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~ 102 (309)
T 3p86_A 26 AMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFMGA 102 (309)
T ss_dssp ------CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC-CCTTBCCEEEE
T ss_pred CCCcccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEE
Confidence 334444556678999999999999999999976 68889999986432 34577899999999 89999999999
Q ss_pred eeccCCCccEEEEeeecCCccccccCC------CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCeEecCCCCceE
Q 019642 102 VRDQHSKTPSLIFEYVNSTDFKVLYPT------LTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLR 173 (338)
Q Consensus 102 ~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~~~~~~ 173 (338)
+.+ ....++||||+.+++|.+++.. +++..++.++.|++.||.|||++| ++|+||||+||+++.+ +.++
T Consensus 103 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~-~~~k 179 (309)
T 3p86_A 103 VTQ--PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK-YTVK 179 (309)
T ss_dssp ECS--TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTT-CCEE
T ss_pred EEE--CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCC-CcEE
Confidence 954 4578999999999999888743 899999999999999999999999 9999999999999988 8999
Q ss_pred EEeccccccccCCC-cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCC
Q 019642 174 LIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 252 (338)
Q Consensus 174 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 252 (338)
|+|||++....... ......|++.|+|||++.+ ..++.++||||||+++|+|++|..||.. .+..+....+.....
T Consensus 180 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~-~~~~~~~~~~~~~~~- 256 (309)
T 3p86_A 180 VCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGN-LNPAQVVAAVGFKCK- 256 (309)
T ss_dssp ECCCC-----------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTT-SCHHHHHHHHHHSCC-
T ss_pred ECCCCCCccccccccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCC-
Confidence 99999986543322 2334578999999999987 6789999999999999999999999842 222222221111000
Q ss_pred chhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc--CCCcchhhh
Q 019642 253 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA--HPYFAQVRA 330 (338)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~--hp~~~~~~~ 330 (338)
....+..+++++.+||.+||+.||++|||+.++++ .+++++...
T Consensus 257 ----------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 257 ----------------------------------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp ----------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred ----------------------------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 00112237899999999999999999999999998 566665433
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=325.47 Aligned_cols=255 Identities=26% Similarity=0.428 Sum_probs=203.5
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
.++|++.+.||+|+||.||++.+..+++.+++|+++.. ....+.+|+.+++++ +||||+++++++.+.....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC---C
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCCe
Confidence 47899999999999999999999999999999998642 245688999999999 8999999999986665668
Q ss_pred cEEEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 110 PSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
.++||||+.++....+. ..+++..++.++.|++.||.+||++|++|+||||+||+++.+ +.++|+|||.+.....
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~-~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 83 MYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTG-GTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECCT
T ss_pred EEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCC-CcEEeeccccccccCc
Confidence 89999999987333221 358999999999999999999999999999999999999988 8999999999876542
Q ss_pred C---CcceeeeccccccccccccCcC-CCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 186 G---KEYNVRVASRYFKGPELLVDLQ-DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 186 ~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
. .......+++.|+|||++.+.. ..+.++||||||+++|+|++|..||.. .+..+....+... .
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~i~~~--~--------- 229 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGKG--S--------- 229 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHC--C---------
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC-chHHHHHHHHhcC--C---------
Confidence 2 2223456899999999987622 347799999999999999999999842 2222222211110 0
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
...+..+++.+.+||.+||+.||++|||+.|+++||||++....
T Consensus 230 --------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 230 --------------------------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273 (305)
T ss_dssp --------------------------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred --------------------------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence 00112368899999999999999999999999999999876543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=325.14 Aligned_cols=256 Identities=25% Similarity=0.413 Sum_probs=198.3
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEeeeeeecc---------
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--------- 105 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--------- 105 (338)
.++|++.+.||+|+||.||+|.+..+++.|++|.+... ..+.+.+|+.+++++ +||||+++++.+.+.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchhhhhcc
Confidence 46899999999999999999999999999999998643 245678899999999 999999999987542
Q ss_pred --CCCccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccc
Q 019642 106 --HSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
Q Consensus 106 --~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~ 179 (338)
.....++||||+.+++|.+++. .+++..++.++.|++.||.+||++|++|+||||+||+++.+ +.++|+|||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~ 162 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDES-RNVKIGDFGL 162 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCCCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCC-CCEEEeeCcc
Confidence 2356889999999999988873 37888999999999999999999999999999999999988 7999999999
Q ss_pred cccccCC---------------CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHH
Q 019642 180 AEFYHPG---------------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 244 (338)
Q Consensus 180 ~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~ 244 (338)
+...... .......+++.|+|||++.+...++.++||||||+++|+|++ ||....+......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~ 239 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHH
Confidence 8655321 122335688999999999875578999999999999999997 5532111111111
Q ss_pred HHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCC
Q 019642 245 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 324 (338)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 324 (338)
.+. .. . .. .........++.+.++|.+||+.||++|||+.++++|||
T Consensus 240 ~~~---~~-~---------~~--------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (303)
T 1zy4_A 240 KLR---SV-S---------IE--------------------FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGW 286 (303)
T ss_dssp HHH---ST-T---------CC--------------------CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSC
T ss_pred hcc---cc-c---------cc--------------------cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCC
Confidence 110 00 0 00 000112235778999999999999999999999999999
Q ss_pred cchhhh
Q 019642 325 FAQVRA 330 (338)
Q Consensus 325 ~~~~~~ 330 (338)
|+....
T Consensus 287 ~~~~~~ 292 (303)
T 1zy4_A 287 LPVKHQ 292 (303)
T ss_dssp SCCCCH
T ss_pred cCCCCh
Confidence 986543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=322.16 Aligned_cols=251 Identities=21% Similarity=0.353 Sum_probs=196.4
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
.++|++.+.||+|+||.||+|.+..+++.||+|.+... ..+.+.+|+.+++++ +||||+++++++.. ....
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~--~~~~ 86 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVDEE--DDCY 86 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEEEC--SSEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEeeee--CCeE
Confidence 47899999999999999999999999999999987432 235678899999999 99999999999854 5678
Q ss_pred EEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 111 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
++||||+.+++|.+++ ..+++..++.++.|++.||.+||++|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSN-KTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCSSSTTC----
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEEeCCCcccccccc
Confidence 9999999999998886 358999999999999999999999999999999999999988 899999999987654332
Q ss_pred --cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 188 --EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 188 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||... +........ .......
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~-~~~~~~~~~---~~~~~~~--------- 231 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGE-TAVSIAIKH---IQDSVPN--------- 231 (294)
T ss_dssp ---------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCSS-CHHHHHHHH---HSSCCCC---------
T ss_pred ccccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHH---hhccCCC---------
Confidence 2233568999999999987 67899999999999999999999999432 221111111 1110000
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
........+++.+.++|.+||+.||++||+..+.+.++|.
T Consensus 232 --------------------~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 232 --------------------VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp --------------------HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred --------------------cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence 0001122378999999999999999999965555555543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=322.41 Aligned_cols=257 Identities=22% Similarity=0.369 Sum_probs=199.7
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEe
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 115 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e 115 (338)
+|.....||+|+||.||+|.+..+++.|++|.+... ..+.+.+|+.+++.+ +||||+++++++.. ....++|||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e 99 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHKNIVQYLGSFSE--NGFIKIFME 99 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTC-CCTTBCCEEEEEEE--TTEEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhC-CCCCEeeEeeEEEe--CCcEEEEEE
Confidence 344445899999999999999999999999998643 246688999999999 99999999999955 457889999
Q ss_pred eecCCccccccC------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-c
Q 019642 116 YVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E 188 (338)
Q Consensus 116 ~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-~ 188 (338)
|+.+++|.+++. .+++..++.++.|++.||.+||++|++|+||||+||+++...+.++|+|||.+....... .
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence 999999888763 356888999999999999999999999999999999999844899999999987654322 2
Q ss_pred ceeeeccccccccccccCc-CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 189 YNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
.....+++.|+|||++.+. ..++.++|+||||+++|+|++|..||............... ...
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~--------------- 243 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM-FKV--------------- 243 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH-HCC---------------
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc-ccc---------------
Confidence 2345688999999998653 23789999999999999999999999533222221111100 000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhccc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 333 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 333 (338)
....+..+++++.++|.+||+.||++|||+.++|+||||+.....+.
T Consensus 244 -------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~ 290 (295)
T 2clq_A 244 -------------------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKK 290 (295)
T ss_dssp -------------------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC------
T ss_pred -------------------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccccCC
Confidence 00112237899999999999999999999999999999998765443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=332.43 Aligned_cols=292 Identities=25% Similarity=0.419 Sum_probs=212.4
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhc----------CCCCeeEeeeeee
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLC----------GGPNVVKLLDIVR 103 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~----------~h~~iv~~~~~~~ 103 (338)
..++|++.+.||+|+||+||+|.+..+++.||+|++... ....+.+|+.+++++. .||||+++++++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 457999999999999999999999999999999998753 3456788999999883 1789999999986
Q ss_pred ccC--CCccEEEEeeecCCcccccc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEecCC-----CC
Q 019642 104 DQH--SKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHE-----LR 170 (338)
Q Consensus 104 ~~~--~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~NIli~~~-----~~ 170 (338)
... ....+++||++ +++|.+++ ..+++..++.++.|++.||.|||++ |++|+||||+||+++.+ .+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence 532 23688999999 66666654 2489999999999999999999998 99999999999999532 24
Q ss_pred ceEEEeccccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCC-----CHHHHHH
Q 019642 171 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD-----NHDQLVK 245 (338)
Q Consensus 171 ~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~-----~~~~~~~ 245 (338)
.++|+|||++..... ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||..... ..+.+..
T Consensus 176 ~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 252 (373)
T 1q8y_A 176 QIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252 (373)
T ss_dssp EEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eEEEcccccccccCC--CCCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHH
Confidence 799999999876543 2334578999999999987 6789999999999999999999999954321 3345666
Q ss_pred HHHHhCCchhhhhhhccccccCcchhhhhccccCCC-C--ccc--ccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHh
Q 019642 246 IAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKP-W--SKF--INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 320 (338)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~--~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell 320 (338)
+.+.++..+...+....................... + ... .....+..+++++.+||.+||+.||++|||+.|+|
T Consensus 253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 332 (373)
T 1q8y_A 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 332 (373)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHh
Confidence 666666544332211110000000000000000000 0 000 00011122467899999999999999999999999
Q ss_pred cCCCcchhhhc
Q 019642 321 AHPYFAQVRAA 331 (338)
Q Consensus 321 ~hp~~~~~~~~ 331 (338)
+||||++....
T Consensus 333 ~hp~f~~~~~~ 343 (373)
T 1q8y_A 333 NHPWLKDTLGM 343 (373)
T ss_dssp TCGGGTTCTTC
T ss_pred hChhhhcccCc
Confidence 99999987543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=328.35 Aligned_cols=248 Identities=20% Similarity=0.319 Sum_probs=200.6
Q ss_pred cCCcEEEEEeeeecCceeEEEEE-----EcCCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGI-----NVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
..++|++.+.||+|+||.||+|. +..+++.||+|.++... .+.+.+|+.+++++.+||||+++++++.+.
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~- 98 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 98 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC-
Confidence 46899999999999999999998 45667899999987532 345889999999998899999999998654
Q ss_pred CCccEEEEeeecCCccccccCC----------------------------------------------------------
Q 019642 107 SKTPSLIFEYVNSTDFKVLYPT---------------------------------------------------------- 128 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~~~---------------------------------------------------------- 128 (338)
....++||||+.+++|.+++..
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 3457899999999998777521
Q ss_pred -----------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC---cceeeec
Q 019642 129 -----------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---EYNVRVA 194 (338)
Q Consensus 129 -----------~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~ 194 (338)
+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++....... ......+
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC-CcEEEEeccceeeecccccchhccccCC
Confidence 7889999999999999999999999999999999999988 789999999997653322 2233467
Q ss_pred cccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhh
Q 019642 195 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL 273 (338)
Q Consensus 195 ~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (338)
|+.|+|||++.+ ..++.++||||||+++|+|++ |..||............+... ...
T Consensus 258 t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~-------------------- 315 (359)
T 3vhe_A 258 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG-TRM-------------------- 315 (359)
T ss_dssp CGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT-CCC--------------------
T ss_pred CceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcC-CCC--------------------
Confidence 888999999877 678999999999999999998 999985433333222222111 000
Q ss_pred hccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 274 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
..+..+++++.++|.+||+.||++|||+.|+++|
T Consensus 316 ---------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 316 ---------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp ---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 0112268899999999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=320.69 Aligned_cols=257 Identities=19% Similarity=0.317 Sum_probs=187.2
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccch-----HHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-----KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
...++|++.+.||+|+||.||+|.+..+++.||+|++..... +.+..+..+++.+ +||||+++++++.. ...
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~--~~~ 98 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH-DCPYIVQCFGTFIT--NTD 98 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEEC--SSE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCceeeEEEEEec--CCc
Confidence 345789999999999999999999999999999999864321 2233344456666 99999999999955 457
Q ss_pred cEEEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 110 PSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
.++||||++ +++..+. ..+++..++.++.|++.||.|||++ |++|+||||+||+++.+ +.++|+|||++....
T Consensus 99 ~~lv~e~~~-~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 99 VFIAMELMG-TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER-GQIKLCDFGISGRLV 176 (318)
T ss_dssp EEEEECCCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTT-SCEEECCCTTC----
T ss_pred EEEEEeccC-CcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCC-CCEEEEECCCchhcc
Confidence 899999994 4444333 4699999999999999999999995 99999999999999988 799999999987665
Q ss_pred CCCcceeeeccccccccccccC----cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhh
Q 019642 185 PGKEYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 260 (338)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.........+++.|+|||++.+ ...++.++||||||+++|+|++|..||.......+....+...... .
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~------ 249 (318)
T 2dyl_A 177 DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP-L------ 249 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC-C------
T ss_pred CCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC-C------
Confidence 4444455678999999999852 2568899999999999999999999995444433333333221000 0
Q ss_pred ccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
......+++++.++|.+||+.||++|||+.++++||||++...
T Consensus 250 ---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (318)
T 2dyl_A 250 ---------------------------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET 292 (318)
T ss_dssp ---------------------------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHH
T ss_pred ---------------------------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhccc
Confidence 0011226899999999999999999999999999999987653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=322.60 Aligned_cols=252 Identities=19% Similarity=0.323 Sum_probs=203.1
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
..++|++.+.||+|+||+||+|.+..+++.|++|.+... ..+.+.+|+.+++++ +||||+++++++.+ ....++
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~l 84 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-EHPNVLKFIGVLYK--DKRLNF 84 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCcCcccEEEEEec--CCeeEE
Confidence 458999999999999999999999999999999988643 345678999999999 89999999999965 467889
Q ss_pred EEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 113 IFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 113 v~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
||||+.+++|.+++ ..+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++........
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVREN-KNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTT-SCEEECCCTTCEECC----
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCC-CCEEEeecccceecccccc
Confidence 99999999998876 358999999999999999999999999999999999999988 8999999999876533221
Q ss_pred c---------------eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCc
Q 019642 189 Y---------------NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 253 (338)
Q Consensus 189 ~---------------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 253 (338)
. ....||+.|+|||++.+ ..++.++||||||+++|+|++|..|+...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~--------- 233 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG--------- 233 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS---------
T ss_pred cccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh---------
Confidence 1 13468999999999987 6889999999999999999999988843211100000
Q ss_pred hhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 254 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
...... .....+..+++.+.+++.+||+.||++|||+.++++ ++..+.
T Consensus 234 --------------~~~~~~------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~ 281 (310)
T 3s95_A 234 --------------LNVRGF------------LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLR 281 (310)
T ss_dssp --------------BCHHHH------------HHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred --------------hhhhcc------------ccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHH
Confidence 000000 001112337889999999999999999999999987 555554
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=326.66 Aligned_cols=264 Identities=25% Similarity=0.425 Sum_probs=183.6
Q ss_pred ccCCcEEEEE-eeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeecc--CCCccE
Q 019642 35 SDQDDYEVVR-KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSKTPS 111 (338)
Q Consensus 35 ~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~~~ 111 (338)
.-.++|++.+ .||+|+||+||+|.+..+++.||+|++... ....+|+..+.+..+||||+++++++... .....+
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 3457899965 599999999999999999999999998753 33344555544444999999999998652 234578
Q ss_pred EEEeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC--CCceEEEecccccccc
Q 019642 112 LIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYH 184 (338)
Q Consensus 112 lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~--~~~~~l~dfg~~~~~~ 184 (338)
+||||+.+++|.+++. .+++..++.++.|++.||.|||++|++|+||||+||+++.+ .+.++|+|||++....
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 9999999999887762 48999999999999999999999999999999999999763 2569999999987654
Q ss_pred CCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccc
Q 019642 185 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264 (338)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
.. ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||....... .............
T Consensus 183 ~~-~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~---------- 249 (336)
T 3fhr_A 183 QN-ALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQA-ISPGMKRRIRLGQ---------- 249 (336)
T ss_dssp -----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------------
T ss_pred cc-ccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchh-hhhhHHHhhhccc----------
Confidence 32 2344577999999999866 678899999999999999999999994322211 1000000000000
Q ss_pred ccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
. .........+++++.+||.+||+.||++|||+.|+|+||||++....+
T Consensus 250 -------------~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 298 (336)
T 3fhr_A 250 -------------Y------GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP 298 (336)
T ss_dssp --------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSC
T ss_pred -------------c------ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCC
Confidence 0 000011123789999999999999999999999999999998765433
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=313.93 Aligned_cols=245 Identities=16% Similarity=0.339 Sum_probs=199.4
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
.+.++|++.+.||+|+||+||+|.+. +++.||+|++... ..+.+.+|+.+++++ +||||+++++++.+ ....++
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 82 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLE--QAPICL 82 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEECS--SSSEEE
T ss_pred eChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhC-CCCCEeeEEEEEec--CCceEE
Confidence 34579999999999999999999986 5677999998753 456789999999999 89999999999954 457899
Q ss_pred EEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-
Q 019642 113 IFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 187 (338)
Q Consensus 113 v~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~- 187 (338)
||||+.+++|.+++. .+++..++.++.|++.||.+||++|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 83 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG-GCEEECCTTGGGGBCCHHH
T ss_pred EEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCC-CCEEecccccccccccccc
Confidence 999999999988763 38999999999999999999999999999999999999888 789999999987654322
Q ss_pred -cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 188 -EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 188 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
......+++.|+|||++.+ ..++.++|+||||+++|+|++ |..||. ..+..+....+....
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~-~~~~~~~~~~~~~~~--------------- 224 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYE-NRSNSEVVEDISTGF--------------- 224 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHHHTTC---------------
T ss_pred ccccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCC-CCCHHHHHHHHhcCc---------------
Confidence 1222345678999999876 678999999999999999999 888883 222222222221110
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
....+..+++++.+++.+||+.||++|||+.+++++
T Consensus 225 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 225 ---------------------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp ---------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 001122268899999999999999999999999976
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=321.64 Aligned_cols=253 Identities=26% Similarity=0.417 Sum_probs=206.1
Q ss_pred eeeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc---------hHHHHHHHHHHHHhc-CCCCeeEeeee
Q 019642 32 VIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQNLC-GGPNVVKLLDI 101 (338)
Q Consensus 32 ~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---------~~~~~~E~~~l~~l~-~h~~iv~~~~~ 101 (338)
......++|++.+.||+|+||.||+|.+..+++.||+|.++... ...+.+|+.+++++. .||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 33455689999999999999999999999999999999986432 245678999999994 26999999999
Q ss_pred eeccCCCccEEEEeeecC-Ccccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEec
Q 019642 102 VRDQHSKTPSLIFEYVNS-TDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW 177 (338)
Q Consensus 102 ~~~~~~~~~~lv~e~~~~-~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~df 177 (338)
+.. ....+++||++.+ ++|.+++ ..+++..++.++.|++.||.|||+.|++|+||||+||+++.+.+.+||+||
T Consensus 117 ~~~--~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 117 FER--PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp EEC--SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred Eec--CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 955 4678899999976 7777765 458999999999999999999999999999999999999954489999999
Q ss_pred cccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhh
Q 019642 178 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 257 (338)
Q Consensus 178 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
|++...... ......+++.|+|||++.+....+.++||||||+++|+|++|..||... .. ... +.
T Consensus 195 g~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~----~~---~~~--~~----- 259 (320)
T 3a99_A 195 GSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----EE---IIR--GQ----- 259 (320)
T ss_dssp TTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----HH---HHH--CC-----
T ss_pred ccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh----hh---hhc--cc-----
Confidence 998765432 2334578999999999877445578999999999999999999998321 10 000 00
Q ss_pred hhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
...+..+++++.+||.+||+.||++|||++|+++||||++....
T Consensus 260 ------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~ 303 (320)
T 3a99_A 260 ------------------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 303 (320)
T ss_dssp ------------------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred ------------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCc
Confidence 00112378999999999999999999999999999999987543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=321.13 Aligned_cols=245 Identities=16% Similarity=0.297 Sum_probs=196.9
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCc---eEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
...++|++.+.||+|+||+||+|.+..+++ .||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ .
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~ 122 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNIIRLEGVVTR--G 122 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECG--G
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--C
Confidence 456799999999999999999999986555 4999998753 245678899999999 89999999999954 5
Q ss_pred CccEEEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 108 KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
...++||||+.+++|.+++ ..+++..++.++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++...
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN-LVCKVSDFGLSRVL 201 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCSSCEEC
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCC-CCEEECCCCccccc
Confidence 5789999999999998886 358999999999999999999999999999999999999988 89999999999765
Q ss_pred cCCCc----ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhh
Q 019642 184 HPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAY 258 (338)
Q Consensus 184 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
..... .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.. .+..+....+.....
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~~~~~------- 272 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWN-MTNRDVISSVEEGYR------- 272 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTT-SCHHHHHHHHHTTCC-------
T ss_pred ccCccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHcCCC-------
Confidence 43321 122345668999999976 678899999999999999999 9999832 222222222211100
Q ss_pred hhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
...+..+++++.++|.+||+.||++|||+.++++
T Consensus 273 -----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 273 -----------------------------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp -----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0012237899999999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=319.53 Aligned_cols=267 Identities=24% Similarity=0.416 Sum_probs=199.5
Q ss_pred hhceeeeeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcC-CCCeeEeee
Q 019642 27 NVSSYVIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCG-GPNVVKLLD 100 (338)
Q Consensus 27 ~~~~~~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~-h~~iv~~~~ 100 (338)
+++.-.+....++|++.+.||+|+||.||++.+. +++.||+|++... ..+.+.+|+.+++++.+ ||||+++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 3344455667789999999999999999999875 5888999998642 23567889999999953 699999999
Q ss_pred eeeccCCCccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEec
Q 019642 101 IVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW 177 (338)
Q Consensus 101 ~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~df 177 (338)
++.. ....+++|| +.+++|.+++ ..+++..++.++.|++.||.+||++|++|+||||+||+++. +.++|+||
T Consensus 96 ~~~~--~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~--~~~kL~Df 170 (313)
T 3cek_A 96 YEIT--DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--GMLKLIDF 170 (313)
T ss_dssp EEEC--SSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET--TEEEECCC
T ss_pred Eeec--CCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC--CeEEEeec
Confidence 9855 457899999 5666776665 45899999999999999999999999999999999999975 68999999
Q ss_pred cccccccCCCc---ceeeeccccccccccccCc----------CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHH
Q 019642 178 GLAEFYHPGKE---YNVRVASRYFKGPELLVDL----------QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 244 (338)
Q Consensus 178 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~----------~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~ 244 (338)
|++........ .....+++.|+|||++.+. ..++.++||||||+++|+|++|..||....+......
T Consensus 171 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 250 (313)
T 3cek_A 171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 250 (313)
T ss_dssp SSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH
T ss_pred cccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHH
Confidence 99876543221 2345689999999998641 3678899999999999999999999954333222222
Q ss_pred HHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCC
Q 019642 245 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 324 (338)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 324 (338)
.. ..... . ...+...++++.++|.+||+.||++|||+.|+|+|||
T Consensus 251 ~~---~~~~~------------------------~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 251 AI---IDPNH------------------------E--------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp HH---HCTTS------------------------C--------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HH---Hhccc------------------------c--------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 11 11100 0 0011225788999999999999999999999999999
Q ss_pred cchhhhcccc
Q 019642 325 FAQVRAAESS 334 (338)
Q Consensus 325 ~~~~~~~~~~ 334 (338)
|+....+..+
T Consensus 296 ~~~~~~~~~~ 305 (313)
T 3cek_A 296 VQIQTHPVNQ 305 (313)
T ss_dssp HHCC------
T ss_pred ccCCCCchhh
Confidence 9987655443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=322.63 Aligned_cols=258 Identities=17% Similarity=0.313 Sum_probs=186.5
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCCCc---eEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeecc
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ 105 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 105 (338)
....++|++.+.||+|+||+||+|.+..++. .||+|+++.. ..+.+.+|+.+++++ +||||+++++++...
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHVAKLVGVSLRS 97 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-CCCceehhhceeecc
Confidence 3456799999999999999999999877665 7999998642 346688999999999 999999999998654
Q ss_pred CCC----ccEEEEeeecCCccccccC---------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCce
Q 019642 106 HSK----TPSLIFEYVNSTDFKVLYP---------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKL 172 (338)
Q Consensus 106 ~~~----~~~lv~e~~~~~~l~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~ 172 (338)
... ..+++|||+.+++|..++. .+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.+
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~-~~~ 176 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED-MTV 176 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-SCE
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC-CCE
Confidence 322 2389999999999987762 48999999999999999999999999999999999999988 899
Q ss_pred EEEeccccccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHH
Q 019642 173 RLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK 248 (338)
Q Consensus 173 ~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~ 248 (338)
+|+|||++........ .....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||. ..+..+....+..
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~-~~~~~~~~~~~~~ 254 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYA-GIENAEIYNYLIG 254 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCGGGHHHHHHT
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCcc-ccChHHHHHHHhc
Confidence 9999999976543322 223455678999999877 678999999999999999999 888873 3333322222211
Q ss_pred HhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCC-------HHHHhc
Q 019642 249 VLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-------AREAMA 321 (338)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt-------~~ell~ 321 (338)
... ...+..+++++.++|.+||+.||++||| ++++++
T Consensus 255 ~~~------------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 255 GNR------------------------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp TCC------------------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC------------------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 000 0112237899999999999999999999 889999
Q ss_pred CCCcchhhhc
Q 019642 322 HPYFAQVRAA 331 (338)
Q Consensus 322 hp~~~~~~~~ 331 (338)
|||+......
T Consensus 299 ~~~~~~~~~~ 308 (323)
T 3qup_A 299 HLSVLSTSQD 308 (323)
T ss_dssp C---------
T ss_pred HhhhcCCCCC
Confidence 9999886544
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=333.39 Aligned_cols=274 Identities=19% Similarity=0.324 Sum_probs=207.5
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
...++|++.+.||+|+||+||+|.+..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++........
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCCCeEEEeeccCCCCee
Confidence 3467999999999999999999999999999999998742 346677999999999 89999999999977666678
Q ss_pred EEEEeeecCCccccccCC------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEe----cCCCCceEEEecccc
Q 019642 111 SLIFEYVNSTDFKVLYPT------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHELRKLRLIDWGLA 180 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli----~~~~~~~~l~dfg~~ 180 (338)
++||||+.+++|.+++.. +++..++.++.|++.||.|||+.|++|+||||+||++ +.+ +.+||+|||++
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~-~~~kL~DFG~a 163 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQ-SVYKLTDFGAA 163 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSC-EEEEECCGGGC
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCc-eeEEEecCCCc
Confidence 999999999999888753 8999999999999999999999999999999999998 544 67999999999
Q ss_pred ccccCCCcceeeeccccccccccccCc-------CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCc
Q 019642 181 EFYHPGKEYNVRVASRYFKGPELLVDL-------QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 253 (338)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 253 (338)
.............+++.|+|||++.+. ..++.++||||||+++|+|++|..||............+.+.....
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 243 (396)
T 4eut_A 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (396)
T ss_dssp EECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred eEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence 876655555556789999999998541 3567899999999999999999999964333222222222222221
Q ss_pred hhhhhhhccccccCcchhhhhccccCCCCccc--ccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 254 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
+...+.........+ ..|... ........++..+.++|.+||+.||++|||+.|+++
T Consensus 244 p~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 244 PSGAISGVQKAENGP-----------IDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp CTTCCEEEECSTTCC-----------EEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CcccchhheeccCCC-----------cccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 111110000000000 000000 000111224567899999999999999999999865
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=327.51 Aligned_cols=263 Identities=19% Similarity=0.321 Sum_probs=183.3
Q ss_pred eeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc----hHHHHHHHH-HHHHhcCCCCeeEeeeeeeccCC
Q 019642 33 IFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIK-ILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 33 i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~E~~-~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
.....++|++.+.||+|+||.||+|.+..+++.||+|.++... ...+..|+. +++.+ +||||+++++++.. .
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~-~h~niv~~~~~~~~--~ 93 (327)
T 3aln_A 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS-DCPYIVQFYGALFR--E 93 (327)
T ss_dssp ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSC-CCTTBCCEEEEEEC--S
T ss_pred cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcC-CCCcEeeeeeEEEe--C
Confidence 3455689999999999999999999999999999999986532 234455665 44455 99999999999965 4
Q ss_pred CccEEEEeeecCCccccc-------cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEecCCCCceEEEeccc
Q 019642 108 KTPSLIFEYVNSTDFKVL-------YPTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~NIli~~~~~~~~l~dfg~ 179 (338)
...++||||+.++....+ ...+++..++.++.|++.||.+||+. |++|+||||+||+++.+ +.+||+|||+
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~ 172 (327)
T 3aln_A 94 GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS-GNIKLCDFGI 172 (327)
T ss_dssp SEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETT-TEEEECCCSS
T ss_pred CceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCC-CCEEEccCCC
Confidence 578899999997432222 24589999999999999999999999 99999999999999988 8999999999
Q ss_pred cccccCCCcceeeecccccccccccc---CcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhh
Q 019642 180 AEFYHPGKEYNVRVASRYFKGPELLV---DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 256 (338)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (338)
+.............+++.|+|||++. ....++.++||||||+++|+|++|..||.......+....
T Consensus 173 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----------- 241 (327)
T 3aln_A 173 SGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQ----------- 241 (327)
T ss_dssp SCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CC-----------
T ss_pred ceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHH-----------
Confidence 97665444444457899999999983 2256889999999999999999999998432211111000
Q ss_pred hhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 257 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
....... .........+++++.+||.+||+.||++|||+.++++||||.+..+.
T Consensus 242 --------------------~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 295 (327)
T 3aln_A 242 --------------------VVKGDPP-QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEER 295 (327)
T ss_dssp --------------------CCCSCCC-CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHS
T ss_pred --------------------HhcCCCC-CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhh
Confidence 0000000 00111123378999999999999999999999999999999887544
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=326.01 Aligned_cols=246 Identities=18% Similarity=0.293 Sum_probs=197.9
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEc-------CCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeec
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINV-------NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRD 104 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 104 (338)
..++|++.+.||+|+||.||+|.+. .++..||+|+++... .+.+.+|+.+++.+.+||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3579999999999999999999875 345679999987532 34578999999999789999999999954
Q ss_pred cCCCccEEEEeeecCCccccccC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEe
Q 019642 105 QHSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 165 (338)
Q Consensus 105 ~~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli 165 (338)
....++||||+.+++|.+++. .++...++.++.|++.||.|||++|++|+||||+||++
T Consensus 159 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 159 --DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236 (370)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred --CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence 567899999999999987752 37889999999999999999999999999999999999
Q ss_pred cCCCCceEEEeccccccccCCC---cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHH
Q 019642 166 DHELRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHD 241 (338)
Q Consensus 166 ~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~ 241 (338)
+.+ +.+||+|||++....... ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.. .+..+
T Consensus 237 ~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~~-~~~~~ 313 (370)
T 2psq_A 237 TEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEE 313 (370)
T ss_dssp CTT-CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGG
T ss_pred CCC-CCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCCC-CCHHH
Confidence 988 899999999997654322 1222356778999999987 679999999999999999999 8888832 22222
Q ss_pred HHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 242 QLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
....+.... ....+..+++++.++|.+||+.||++|||+.|+++
T Consensus 314 ~~~~~~~~~------------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 357 (370)
T 2psq_A 314 LFKLLKEGH------------------------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357 (370)
T ss_dssp HHHHHHTTC------------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCC------------------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 222111100 00112236889999999999999999999999987
Q ss_pred C
Q 019642 322 H 322 (338)
Q Consensus 322 h 322 (338)
+
T Consensus 358 ~ 358 (370)
T 2psq_A 358 D 358 (370)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=316.73 Aligned_cols=262 Identities=19% Similarity=0.345 Sum_probs=198.5
Q ss_pred cCCcEEEEEeeeecCceeEEEEE----EcCCCceEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~---~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
..++|++.+.||+|+||+||+|. +..+++.||+|.+.... .+.+.+|+.+++++ +||||+++++++......
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECHHHHT
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCC
Confidence 46899999999999999999998 56789999999987544 34678999999999 899999999998665556
Q ss_pred ccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 109 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
..++||||+.+++|.+++. .+++..++.++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++....
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~-~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLP 165 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCCCSCC---
T ss_pred ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCC-CeEEEccCccccccc
Confidence 7899999999999988763 38999999999999999999999999999999999999988 899999999997654
Q ss_pred CCCc----ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhh
Q 019642 185 PGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 260 (338)
Q Consensus 185 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.... .....++..|+|||++.+ ..++.++||||||+++|+|++|..|+... .. ...+..+.........
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~---~~---~~~~~~~~~~~~~~~~ 238 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSP---PA---EFMRMIGNDKQGQMIV 238 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSH---HH---HHHHHHCTTCCTHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCC---hH---HHHhhhcCccccchhH
Confidence 3321 122345667999999977 67899999999999999999999988321 11 1111111111000000
Q ss_pred ccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
........... ....+..+++++.++|.+||+.||++|||+.|+++
T Consensus 239 -------~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 239 -------FHLIELLKNNG--------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp -------HHHHHHHHTTC--------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -------HHHHHHHhccC--------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00000000000 01112347899999999999999999999999985
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=327.99 Aligned_cols=250 Identities=17% Similarity=0.273 Sum_probs=198.2
Q ss_pred cCCcEEEEEeeeecCceeEEEEE-----EcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGI-----NVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
..++|++.+.||+|+||+||+|. +..+++.||+|.++.. ....+.+|+.+++++ +||||+++++++.+
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~-- 145 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQ-- 145 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC-CCCCCCeEEEEEec--
Confidence 35789999999999999999999 4557789999998643 234577899999999 99999999999954
Q ss_pred CCccEEEEeeecCCccccccC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC--CCceEE
Q 019642 107 SKTPSLIFEYVNSTDFKVLYP----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRL 174 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~--~~~~~l 174 (338)
....++||||+.+++|.+++. .++...++.++.|++.||.|||++|++|+||||+|||++.+ ...+||
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence 556789999999999988762 38999999999999999999999999999999999999854 146999
Q ss_pred EeccccccccC---CCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHh
Q 019642 175 IDWGLAEFYHP---GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVL 250 (338)
Q Consensus 175 ~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~ 250 (338)
+|||++..... ........+++.|+|||++.+ ..++.++||||||+++|+|++ |..||. ..+..+....+....
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~-~~~~~~~~~~i~~~~ 303 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYP-SKSNQEVLEFVTSGG 303 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSST-TCCHHHHHHHHHTTC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHcCC
Confidence 99999865421 122233467889999999877 678999999999999999998 888883 223222222221100
Q ss_pred CCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcc
Q 019642 251 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 326 (338)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~ 326 (338)
. ...+..+++.+.+||.+||+.||++|||+.+++++.++.
T Consensus 304 -~-----------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 304 -R-----------------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp -C-----------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -C-----------------------------------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 0 001123688999999999999999999999999987654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=310.29 Aligned_cols=245 Identities=16% Similarity=0.281 Sum_probs=198.8
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
...++|++.+.||+|+||.||+|.+. ++..||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ....++
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 80 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKL-SHPKLVKFYGVCSK--EYPIYI 80 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSEEE
T ss_pred echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhC-CCCCEeeEEEEEcc--CCceEE
Confidence 34689999999999999999999765 5677999998753 456788999999999 89999999999944 567899
Q ss_pred EEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 113 IFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 113 v~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
||||+.+++|.+++. .+++..++.++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||.+........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTT-CCEEECCTTCEEECCTTCE
T ss_pred EEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCC-CCEEEccCccceecchhhh
Confidence 999999999888763 48999999999999999999999999999999999999988 8999999999876543322
Q ss_pred --ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 189 --YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 189 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
.....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||. ..+..+....+....
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~~~~~~--------------- 222 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYD-LYTNSEVVLKVSQGH--------------- 222 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTT-TSCHHHHHHHHHTTC---------------
T ss_pred hcccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCcc-ccChHHHHHHHHcCC---------------
Confidence 122345667999999876 578899999999999999999 998983 222222222211100
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
....+...++++.++|.+||+.||++|||+.+++++
T Consensus 223 ---------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 223 ---------------------RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp ---------------------CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 001112268899999999999999999999999975
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=314.27 Aligned_cols=251 Identities=15% Similarity=0.246 Sum_probs=202.0
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc-cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
..++|++.+.||+|+||.||+|.+..+++.||+|++.. ...+.+.+|+..++.+.+|++++++++++.. ....++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCC--CceeEEEE
Confidence 35789999999999999999999999999999999864 3456688999999999889999999999854 56789999
Q ss_pred eeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCC----CceEEEeccccccccCC
Q 019642 115 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL----RKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 115 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~----~~~~l~dfg~~~~~~~~ 186 (338)
||+ +++|.+++. .+++..++.++.|++.||.|||++|++|+||||+||+++.+. ..++|+|||++......
T Consensus 86 e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred Eec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 999 888887763 499999999999999999999999999999999999997651 23999999999765433
Q ss_pred Cc--------ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCC--CHHHHHHHHHHhCCchhh
Q 019642 187 KE--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--NHDQLVKIAKVLGTDELN 256 (338)
Q Consensus 187 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~--~~~~~~~~~~~~~~~~~~ 256 (338)
.. .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||..... .......+..........
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred cccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHH
Confidence 21 234568999999999877 6789999999999999999999999954322 122222222211111111
Q ss_pred hhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 257 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
.. ...+++++.+++.+||+.||++|||+.++++.
T Consensus 244 ~~--------------------------------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 244 EL--------------------------------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HH--------------------------------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred HH--------------------------------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 00 01268999999999999999999999999763
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=313.47 Aligned_cols=246 Identities=21% Similarity=0.327 Sum_probs=204.6
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeec------------
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRD------------ 104 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~------------ 104 (338)
.++|++.+.||+|+||.||+|.+..+++.|++|.++... ..+.+|+.+++++ +||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~ 87 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-EKAEREVKALAKL-DHVNIVHYNGCWDGFDYDPETSSKNS 87 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-GGGHHHHHHHHHC-CCTTBCCEEEEEEEEEEC--------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-HHHHHHHHHHHhC-CCCCEEEEeeeEeccccCcccccccc
Confidence 468999999999999999999999999999999987543 4577899999999 99999999998754
Q ss_pred --cCCCccEEEEeeecCCcccccc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEec
Q 019642 105 --QHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW 177 (338)
Q Consensus 105 --~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~df 177 (338)
......++||||+.+++|.+++ ..+++..++.++.|++.||.+||++|++|+||||+||+++.+ +.++|+||
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Df 166 (284)
T 2a19_B 88 SRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT-KQVKIGDF 166 (284)
T ss_dssp -CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCC
T ss_pred cccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC-CCEEECcc
Confidence 1134578999999999998876 358999999999999999999999999999999999999988 89999999
Q ss_pred cccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhh
Q 019642 178 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 257 (338)
Q Consensus 178 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
|++.............+++.|+|||++.+ ..++.++|+||||+++|+|++|..|+.. .. .....+...
T Consensus 167 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~------~~-~~~~~~~~~---- 234 (284)
T 2a19_B 167 GLVTSLKNDGKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFE------TS-KFFTDLRDG---- 234 (284)
T ss_dssp TTCEESSCCSCCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHH------HH-HHHHHHHTT----
T ss_pred hhheeccccccccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchh------HH-HHHHHhhcc----
Confidence 99877665544455678999999999977 6789999999999999999999988731 10 110000000
Q ss_pred hhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
..+..++.++.++|.+||+.||++|||+.|++++.+.-.-
T Consensus 235 -------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 235 -------------------------------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp -------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred -------------------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 0112268899999999999999999999999999775443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=309.73 Aligned_cols=246 Identities=16% Similarity=0.310 Sum_probs=190.2
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
..+.++|++.+.||+|+||.||+|.+ +++.+++|+++.. ..+.+.+|+.+++.+ +||||+++++++.+
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-- 77 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRGVCLK-- 77 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEEEECC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEEec--
Confidence 35678999999999999999999987 4788999998642 235678899999999 89999999999954
Q ss_pred CCccEEEEeeecCCcccccc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCCeEecCC-------CCceEE
Q 019642 107 SKTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQG---IMHRDVKPHNVMIDHE-------LRKLRL 174 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~-------~~~~~l 174 (338)
....++||||+.+++|..++ ..+++..++.++.|++.||.+||++| ++|+||||+||+++.. .+.++|
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 78 EPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp C--CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred CCceEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 45789999999999998887 45999999999999999999999999 8999999999999862 378999
Q ss_pred EeccccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCch
Q 019642 175 IDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 254 (338)
Q Consensus 175 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (338)
+|||++....... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||... +.......... ..
T Consensus 158 ~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~--~~-- 230 (271)
T 3dtc_A 158 TDFGLAREWHRTT-KMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGI-DGLAVAYGVAM--NK-- 230 (271)
T ss_dssp CCCCC--------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTTS-CHHHHHHHHHT--SC--
T ss_pred ccCCccccccccc-ccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHhhhc--CC--
Confidence 9999997654332 234578999999999877 67899999999999999999999998422 21111111100 00
Q ss_pred hhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 255 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
.....+..+++.+.++|.+||+.||++|||+.|++++
T Consensus 231 -------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 231 -------------------------------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp -------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 0001122368999999999999999999999999874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=320.14 Aligned_cols=248 Identities=20% Similarity=0.326 Sum_probs=199.7
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEc-----CCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
..++|++.+.||+|+||.||+|.+. .++..||+|.++.. ..+.+.+|+.+++++.+||||+++++++..
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee--
Confidence 4579999999999999999999973 45678999998643 346688999999999789999999999955
Q ss_pred CCccEEEEeeecCCccccccCC--------------------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 019642 107 SKTPSLIFEYVNSTDFKVLYPT--------------------------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKP 160 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~~~--------------------------~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp 160 (338)
....++||||+.+++|.+++.. +++..++.++.|++.||.|||++|++|+||||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 200 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 5678999999999999877632 68899999999999999999999999999999
Q ss_pred CCeEecCCCCceEEEeccccccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCC
Q 019642 161 HNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYG 236 (338)
Q Consensus 161 ~NIli~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~ 236 (338)
+||+++.+ +.++|+|||++........ .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...
T Consensus 201 ~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 201 RNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp GGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hhEEEcCC-CcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999988 8999999999876543322 223456778999999877 678999999999999999998 99998543
Q ss_pred CCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCH
Q 019642 237 HDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 316 (338)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~ 316 (338)
..... .......... ...+..+++++.++|.+||+.||++|||+
T Consensus 279 ~~~~~-~~~~~~~~~~-----------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 322 (344)
T 1rjb_A 279 PVDAN-FYKLIQNGFK-----------------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSF 322 (344)
T ss_dssp CCSHH-HHHHHHTTCC-----------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CcHHH-HHHHHhcCCC-----------------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCH
Confidence 33322 2221110000 01112368999999999999999999999
Q ss_pred HHHhcCC
Q 019642 317 REAMAHP 323 (338)
Q Consensus 317 ~ell~hp 323 (338)
.+++++-
T Consensus 323 ~~l~~~l 329 (344)
T 1rjb_A 323 PNLTSFL 329 (344)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999863
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=315.55 Aligned_cols=248 Identities=20% Similarity=0.304 Sum_probs=201.1
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEE-----cCCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeecc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGIN-----VNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQ 105 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 105 (338)
...++|++.+.||+|+||.||+|.+ ..+++.|++|.++... .+.+.+|+.+++++.+||||+++++++.+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~- 98 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI- 98 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec-
Confidence 3457999999999999999999985 4567899999987542 45678999999999889999999999954
Q ss_pred CCCccEEEEeeecCCccccccC---------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeE
Q 019642 106 HSKTPSLIFEYVNSTDFKVLYP---------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 164 (338)
Q Consensus 106 ~~~~~~lv~e~~~~~~l~~~~~---------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIl 164 (338)
....++||||+.+++|.+++. .+++..++.++.|++.||.+||++|++|+||||+||+
T Consensus 99 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 177 (313)
T 1t46_A 99 -GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (313)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred -CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEE
Confidence 557899999999999987762 3899999999999999999999999999999999999
Q ss_pred ecCCCCceEEEeccccccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCH
Q 019642 165 IDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNH 240 (338)
Q Consensus 165 i~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~ 240 (338)
++.+ +.++|+|||++........ .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.......
T Consensus 178 ~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 178 LTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp EETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred EcCC-CCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 9988 8999999999876644332 122356778999999877 678999999999999999999 998984433332
Q ss_pred HHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHh
Q 019642 241 DQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 320 (338)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell 320 (338)
.....+..... ...+..+++++.++|.+||+.||++|||+.|++
T Consensus 256 ~~~~~~~~~~~------------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 299 (313)
T 1t46_A 256 KFYKMIKEGFR------------------------------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299 (313)
T ss_dssp HHHHHHHHTCC------------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHhccCCC------------------------------------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 22222111100 001123689999999999999999999999999
Q ss_pred cC
Q 019642 321 AH 322 (338)
Q Consensus 321 ~h 322 (338)
++
T Consensus 300 ~~ 301 (313)
T 1t46_A 300 QL 301 (313)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=324.00 Aligned_cols=247 Identities=18% Similarity=0.316 Sum_probs=199.6
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCC-------CceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeee
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNT-------NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVR 103 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 103 (338)
...++|++.+.||+|+||+||+|.+..+ +..||+|+++... ...+.+|+.+++++.+||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 3457999999999999999999997543 3579999987532 3557899999999988999999999995
Q ss_pred ccCCCccEEEEeeecCCccccccC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeE
Q 019642 104 DQHSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 164 (338)
Q Consensus 104 ~~~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIl 164 (338)
. ....++||||+.+++|.+++. .+++..++.++.|++.||.+||+.|++|+||||+||+
T Consensus 146 ~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 146 Q--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 223 (382)
T ss_dssp S--SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred c--CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEE
Confidence 4 567899999999999988762 3899999999999999999999999999999999999
Q ss_pred ecCCCCceEEEeccccccccCCC---cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCH
Q 019642 165 IDHELRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNH 240 (338)
Q Consensus 165 i~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~ 240 (338)
++.+ +.+||+|||++....... ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||. ..+..
T Consensus 224 l~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~-~~~~~ 300 (382)
T 3tt0_A 224 VTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYP-GVPVE 300 (382)
T ss_dssp ECTT-CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSST-TCCHH
T ss_pred EcCC-CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCC-CCCHH
Confidence 9988 899999999997654322 2233456788999999987 678999999999999999999 888883 22222
Q ss_pred HHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHh
Q 019642 241 DQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 320 (338)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell 320 (338)
+....+.... ....+..+++++.++|.+||+.||++|||+.|++
T Consensus 301 ~~~~~~~~~~------------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 344 (382)
T 3tt0_A 301 ELFKLLKEGH------------------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 344 (382)
T ss_dssp HHHHHHHTTC------------------------------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHcCC------------------------------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 2222111100 0011223789999999999999999999999999
Q ss_pred cC
Q 019642 321 AH 322 (338)
Q Consensus 321 ~h 322 (338)
++
T Consensus 345 ~~ 346 (382)
T 3tt0_A 345 ED 346 (382)
T ss_dssp HH
T ss_pred HH
Confidence 85
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=312.41 Aligned_cols=245 Identities=18% Similarity=0.306 Sum_probs=196.8
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
...++|++.+.||+|+||+||++.+. ++..|++|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ....++
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 96 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTK--QRPIFI 96 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEECS--SSSEEE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcC-CCCCEeeEEEEEec--CCCeEE
Confidence 45679999999999999999999765 6778999998754 467788999999999 89999999999944 567899
Q ss_pred EEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 113 IFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 113 v~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
||||+.+++|.+++ ..+++..++.++.|++.||.+||++|++|+||||+||+++.+ +.++|+|||++........
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp EECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTT-SCEEECSTTGGGGBCCHHH
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCC-CCEEEcccccccccccccc
Confidence 99999999988876 359999999999999999999999999999999999999988 7999999999876543211
Q ss_pred --ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 189 --YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 189 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
.....+++.|+|||++.+ ..++.++|+||||+++|+|++ |..||.. .+..+....+.+...
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~-------------- 239 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYER-FTNSETAEHIAQGLR-------------- 239 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHTTCC--------------
T ss_pred ccccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccc-cChhHHHHHHhcccC--------------
Confidence 122345678999999987 578999999999999999998 9999832 222222222211100
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
...+...++.+.++|.+||+.||++|||+.++++|
T Consensus 240 ----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 240 ----------------------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp ----------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 01112268899999999999999999999999975
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=307.97 Aligned_cols=246 Identities=18% Similarity=0.289 Sum_probs=198.3
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc----------hHHHHHHHHHHHHhcCCCCeeEeeeeee
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----------KKKIKREIKILQNLCGGPNVVKLLDIVR 103 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----------~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 103 (338)
....++|++.+.||+|+||+||+|.+..+++.||+|++.... .+.+.+|+.+++++ +||||+++++++.
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~ 93 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLMH 93 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEEET
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhheeec
Confidence 345689999999999999999999999999999999985322 15688999999999 8999999999984
Q ss_pred ccCCCccEEEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCeEecCCCCc-----e
Q 019642 104 DQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRK-----L 172 (338)
Q Consensus 104 ~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~~~~-----~ 172 (338)
+. .++||||+.+++|.+.+ ..+++..++.++.|++.||.|||++| ++|+||||+||+++.+ +. +
T Consensus 94 ~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~-~~~~~~~~ 168 (287)
T 4f0f_A 94 NP----PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSL-DENAPVCA 168 (287)
T ss_dssp TT----TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCC-CTTCSCCE
T ss_pred CC----CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEecc-CCCCceeE
Confidence 42 36999999999886654 35899999999999999999999999 9999999999999876 44 9
Q ss_pred EEEeccccccccCCCcceeeeccccccccccccC-cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhC
Q 019642 173 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD-LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 251 (338)
Q Consensus 173 ~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~ 251 (338)
+|+|||++..... ......+++.|+|||++.+ ...++.++||||||+++|+|++|..||.................+
T Consensus 169 kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 246 (287)
T 4f0f_A 169 KVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246 (287)
T ss_dssp EECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred EeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence 9999999875432 3344678999999999843 245788999999999999999999999544433332222211111
Q ss_pred CchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 252 TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
.. ...+..+++++.++|.+||+.||++|||+.++++
T Consensus 247 ~~----------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 247 LR----------------------------------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CC----------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC----------------------------------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00 0112237899999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=332.24 Aligned_cols=261 Identities=21% Similarity=0.337 Sum_probs=194.3
Q ss_pred eeeeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 31 YVIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 31 ~~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
.++.....+|.+.+.||+|+||+|+. ....+++.||||.+.........+|+.+++.+.+||||+++++++.+ ....
T Consensus 17 ~~~~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~--~~~~ 93 (432)
T 3p23_A 17 SVVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKD--RQFQ 93 (432)
T ss_dssp -CEEETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEE--TTEE
T ss_pred CcEEEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec--CCEE
Confidence 34455667899999999999999764 34568899999999876666678899999998779999999999854 5678
Q ss_pred EEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC----CCceEEEecccccc
Q 019642 111 SLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----LRKLRLIDWGLAEF 182 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~----~~~~~l~dfg~~~~ 182 (338)
++|||++.+ +|.+++. ..++..++.++.|++.||.|||++||+|+||||+||+++.+ ...++|+|||++..
T Consensus 94 ~lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 94 YIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EEEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EEEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 999999986 5555542 24555678899999999999999999999999999999532 23578999999976
Q ss_pred ccCCC----cceeeeccccccccccccC--cCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchh
Q 019642 183 YHPGK----EYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDEL 255 (338)
Q Consensus 183 ~~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (338)
..... ......||+.|+|||++.+ ...++.++||||||+++|+|++ |..||.... ....... .+....
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~--~~~~~~~---~~~~~~ 247 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL--QRQANIL---LGACSL 247 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT--THHHHHH---TTCCCC
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh--HHHHHHH---hccCCc
Confidence 54332 2233568999999999874 2467889999999999999999 888883221 1111111 111000
Q ss_pred hhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 256 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
.. .......+..+.+||.+||+.||++|||+.++++||||.++..
T Consensus 248 ~~------------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~ 292 (432)
T 3p23_A 248 DC------------------------------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK 292 (432)
T ss_dssp TT------------------------------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHH
T ss_pred cc------------------------------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHH
Confidence 00 0000113556899999999999999999999999999987643
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=318.20 Aligned_cols=247 Identities=19% Similarity=0.297 Sum_probs=198.3
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc-cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEe
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 115 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e 115 (338)
.++|++.+.||+|+||+||+|.+..+++.||+|++.. ...+.+.+|+.+++++.+||||+++++++.+ ....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC--GKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE--TTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEec--CCccEEEEE
Confidence 4799999999999999999999999999999999864 3445688999999999889999999999855 467899999
Q ss_pred eecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCc-----eEEEeccccccccCC
Q 019642 116 YVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK-----LRLIDWGLAEFYHPG 186 (338)
Q Consensus 116 ~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~-----~~l~dfg~~~~~~~~ 186 (338)
|+ +++|.+++ ..+++..++.++.|++.||.|||+.|++|+||||+||+++.+ +. ++|+|||++......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~-~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRP-GNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCG-GGTCTTSEEECCCTTCEESBCT
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccC-CCCCCceEEEEEcccceeeecC
Confidence 99 78887775 359999999999999999999999999999999999999877 55 999999999765432
Q ss_pred Cc--------ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCC--HHHHHHHHHHhCCchhh
Q 019642 187 KE--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKVLGTDELN 256 (338)
Q Consensus 187 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~ 256 (338)
.. .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||...... .+....+..........
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 242 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIE 242 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHH
Confidence 21 234578999999999987 67899999999999999999999999543221 12222221111000000
Q ss_pred hhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 257 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
.. ...++ ++.+++..||+.||.+||+++++++
T Consensus 243 ~~--------------------------------~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 243 VL--------------------------------CENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HH--------------------------------TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HH--------------------------------hccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 00 00134 8999999999999999999999886
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=317.06 Aligned_cols=256 Identities=22% Similarity=0.313 Sum_probs=198.9
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHH--hcCCCCeeEeeeeeecc--CCCccE
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQN--LCGGPNVVKLLDIVRDQ--HSKTPS 111 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~--l~~h~~iv~~~~~~~~~--~~~~~~ 111 (338)
..++|++.+.||+|+||+||+|.+ +++.||+|++..........|.+++.. + +||||+++++.+... .....+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l-~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVML-RHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCC-CCTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhc-cCcCeeeEEEeeccccCCCceeE
Confidence 457999999999999999999987 688999999988777777888888887 5 899999999986543 234688
Q ss_pred EEEeeecCCccccccC--CCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 112 LIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCH--------SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 112 lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH--------~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
+||||+.+++|.+++. .+++..++.++.|++.||.||| +.|++|+||||+||+++.+ +.+||+|||++.
T Consensus 83 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~a~ 161 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN-GQCCIADLGLAV 161 (301)
T ss_dssp EEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTT-SCEEECCCTTCE
T ss_pred EehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCC-CCEEEeeCCCee
Confidence 9999999999998875 4899999999999999999999 9999999999999999988 899999999986
Q ss_pred cccCCCc-----ceeeeccccccccccccCcC-----CCCCcchhHHHHHHHHHHHhc----------CCCCcCCCCCHH
Q 019642 182 FYHPGKE-----YNVRVASRYFKGPELLVDLQ-----DYDYSLDMWSLGCMFAGMIFR----------KEPFFYGHDNHD 241 (338)
Q Consensus 182 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~-----~~~~~~DvwslG~~l~~lltg----------~~pf~~~~~~~~ 241 (338)
....... .....||+.|+|||++.+.. .++.++||||||+++|+|++| ..||........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~ 241 (301)
T 3q4u_A 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241 (301)
T ss_dssp EEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred ecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCc
Confidence 6543322 12247899999999987632 344689999999999999999 788754433322
Q ss_pred HHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 242 QLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
............... . ...........++++.++|.+||+.||++|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~-----------------------~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 242 SFEDMRKVVCVDQQR-----------------------P---NIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CHHHHHHHHTTSCCC-----------------------C---CCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred chhhhhHHHhccCCC-----------------------C---CCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 222222221111000 0 00000001114578999999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=316.14 Aligned_cols=249 Identities=23% Similarity=0.410 Sum_probs=196.7
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc---------hHHHHHHHHHHHHhc---CCCCeeEeeeeee
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQNLC---GGPNVVKLLDIVR 103 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---------~~~~~~E~~~l~~l~---~h~~iv~~~~~~~ 103 (338)
..++|++.+.||+|+||.||+|.+..+++.||+|+++... ...+.+|+.++.++. +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 3578999999999999999999999999999999986432 233557999999885 6999999999985
Q ss_pred ccCCCccEEEEee-ecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccc
Q 019642 104 DQHSKTPSLIFEY-VNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
Q Consensus 104 ~~~~~~~~lv~e~-~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~ 179 (338)
. ....+++||+ +.+++|.+++. .+++..++.++.|++.||.+||++|++|+||||+||+++...+.++|+|||+
T Consensus 109 ~--~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 109 T--QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp ------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred c--CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 4 4577899999 78888888763 5899999999999999999999999999999999999994448999999999
Q ss_pred cccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhh
Q 019642 180 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259 (338)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
+...... ......++..|+|||++.+....+.++||||||+++|+|++|..||... . .+.. ..
T Consensus 187 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~---~~~~--~~------- 249 (312)
T 2iwi_A 187 GALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD----Q---EILE--AE------- 249 (312)
T ss_dssp CEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----H---HHHH--TC-------
T ss_pred hhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh----H---HHhh--hc-------
Confidence 8765533 3344568999999999876444566899999999999999999998321 1 0000 00
Q ss_pred hccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
...+..++.++.++|.+||+.||++|||+.|+++||||++..+.
T Consensus 250 ----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~ 293 (312)
T 2iwi_A 250 ----------------------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAED 293 (312)
T ss_dssp ----------------------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC----
T ss_pred ----------------------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhc
Confidence 00112368999999999999999999999999999999987653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=314.57 Aligned_cols=243 Identities=14% Similarity=0.255 Sum_probs=198.1
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCC-------ceEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEeeeeeec
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTN-------ERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRD 104 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~~aiK~~~~~---~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 104 (338)
...++|++.+.||+|+||+||+|.+..++ ..|++|.+... ..+.+.+|+.+++++ +||||+++++++.+
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-SHKHLVLNYGVCVC 83 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTS-CCTTBCCEEEEECC
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEe
Confidence 34689999999999999999999998877 46999998643 346688999999999 89999999999955
Q ss_pred cCCCccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCc--------e
Q 019642 105 QHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--------L 172 (338)
Q Consensus 105 ~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~--------~ 172 (338)
....++||||+.+++|.+++. .+++..++.++.|++.||.|||++|++|+||||+||+++.+ +. +
T Consensus 84 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~~~~~~~~~ 160 (289)
T 4fvq_A 84 --GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIRE-EDRKTGNPPFI 160 (289)
T ss_dssp --TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEEC-CBGGGTBCCEE
T ss_pred --CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecC-Cccccccccee
Confidence 456789999999999988873 28999999999999999999999999999999999999877 44 9
Q ss_pred EEEeccccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCC
Q 019642 173 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 252 (338)
Q Consensus 173 ~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 252 (338)
+|+|||.+..... .....+++.|+|||++.+...++.++||||||+++|+|++|..|++...+.......... .
T Consensus 161 kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~---~ 234 (289)
T 4fvq_A 161 KLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED---R 234 (289)
T ss_dssp EECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT---T
T ss_pred eeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc---c
Confidence 9999999865432 233457889999999987567899999999999999999977666544433322221110 0
Q ss_pred chhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 253 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
. ..+...++++.++|.+||+.||++|||+.+++++
T Consensus 235 ~-----------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 235 H-----------------------------------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp C-----------------------------------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred C-----------------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0 0111257789999999999999999999999985
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=319.02 Aligned_cols=258 Identities=14% Similarity=0.199 Sum_probs=195.7
Q ss_pred eeccCCcEEEEEeeeecCceeEEEEEEcCC-----CceEEEEEecccchHHHHHHHHHHHHhc--------------CCC
Q 019642 33 IFSDQDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPVKKKKIKREIKILQNLC--------------GGP 93 (338)
Q Consensus 33 i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~E~~~l~~l~--------------~h~ 93 (338)
-....++|++.+.||+|+||+||+|.+..+ ++.||+|++.... .....|+.+++++. +||
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ 108 (364)
T 3op5_A 30 TDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-GPLFTELKFYQRAAKPEQIQKWIRTRKLKYL 108 (364)
T ss_dssp ECTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC-HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCC
T ss_pred eccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc-hhHHHHHHHHHhhhhhHHHHHHHHHhhccCC
Confidence 345678999999999999999999998765 5789999986543 23445555555443 599
Q ss_pred CeeEeeeeeeccCC--CccEEEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEec-
Q 019642 94 NVVKLLDIVRDQHS--KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID- 166 (338)
Q Consensus 94 ~iv~~~~~~~~~~~--~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~- 166 (338)
||+++++++..... ...++||||+ +++|.+++ ..+++..++.++.|++.||.|||++|++|+||||+|||++
T Consensus 109 ~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 109 GVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY 187 (364)
T ss_dssp CSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES
T ss_pred CCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec
Confidence 99999999865422 4578999999 88888776 4599999999999999999999999999999999999998
Q ss_pred -CCCCceEEEeccccccccCCCc--------ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCC
Q 019642 167 -HELRKLRLIDWGLAEFYHPGKE--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 237 (338)
Q Consensus 167 -~~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~ 237 (338)
.+ +.+||+|||++........ .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||....
T Consensus 188 ~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 188 KNP-DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp SCT-TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CCC-CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 55 8999999999965532211 123358999999999987 678999999999999999999999996444
Q ss_pred CCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHH
Q 019642 238 DNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 317 (338)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ 317 (338)
.............. ......... . .....+++++.+++..||+.||++||++.
T Consensus 266 ~~~~~~~~~~~~~~-~~~~~~~~~-----------~---------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~ 318 (364)
T 3op5_A 266 KDPKYVRDSKIRYR-ENIASLMDK-----------C---------------FPAANAPGEIAKYMETVKLLDYTEKPLYE 318 (364)
T ss_dssp TCHHHHHHHHHHHH-HCHHHHHHH-----------H---------------SCTTCCCHHHHHHHHHHHTCCTTCCCCHH
T ss_pred cCHHHHHHHHHHhh-hhHHHHHHH-----------h---------------cccccCHHHHHHHHHHHhcCCCCCCCCHH
Confidence 44333322221111 111111000 0 00122689999999999999999999999
Q ss_pred HHhc
Q 019642 318 EAMA 321 (338)
Q Consensus 318 ell~ 321 (338)
++++
T Consensus 319 ~l~~ 322 (364)
T 3op5_A 319 NLRD 322 (364)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9885
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=319.38 Aligned_cols=247 Identities=18% Similarity=0.309 Sum_probs=198.4
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEc-----CCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeec
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRD 104 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 104 (338)
....++|++.+.||+|+||.||+|.+. .+++.||+|+++... .+.+.+|+.+++++ +||||+++++++.+
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAV 121 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcc
Confidence 345689999999999999999999987 345889999987543 35678899999999 99999999999954
Q ss_pred cCCCccEEEEeeecCCcccccc---------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 019642 105 QHSKTPSLIFEYVNSTDFKVLY---------------------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRD 157 (338)
Q Consensus 105 ~~~~~~~lv~e~~~~~~l~~~~---------------------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~d 157 (338)
....++||||+.+++|.+++ ..+++..++.++.|++.||.|||++|++|+|
T Consensus 122 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 122 --GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred --CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 56789999999999998775 3488899999999999999999999999999
Q ss_pred CCCCCeEecCCCCceEEEeccccccccCCC---cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCC
Q 019642 158 VKPHNVMIDHELRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPF 233 (338)
Q Consensus 158 ikp~NIli~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf 233 (338)
|||+||+++.+ +.++|+|||++....... ......+++.|+|||++.+ ..++.++|+||||+++|+|++ |..||
T Consensus 200 lkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 200 LATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp CSGGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCcceEEECCC-CeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999988 799999999986543221 2233467888999999877 678999999999999999999 99898
Q ss_pred cCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCc
Q 019642 234 FYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 313 (338)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 313 (338)
.. .+..+....+.+. .. ...+..+++++.++|.+||+.||++|
T Consensus 278 ~~-~~~~~~~~~~~~~-~~-----------------------------------~~~~~~~~~~l~~li~~~l~~~p~~R 320 (343)
T 1luf_A 278 YG-MAHEEVIYYVRDG-NI-----------------------------------LACPENCPLELYNLMRLCWSKLPADR 320 (343)
T ss_dssp TT-SCHHHHHHHHHTT-CC-----------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred CC-CChHHHHHHHhCC-Cc-----------------------------------CCCCCCCCHHHHHHHHHHcccCcccC
Confidence 42 2222222211110 00 00112378999999999999999999
Q ss_pred CCHHHHhcC
Q 019642 314 LTAREAMAH 322 (338)
Q Consensus 314 pt~~ell~h 322 (338)
||+.+++++
T Consensus 321 ps~~~~~~~ 329 (343)
T 1luf_A 321 PSFCSIHRI 329 (343)
T ss_dssp CCHHHHHHH
T ss_pred CCHHHHHHH
Confidence 999999863
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=315.91 Aligned_cols=246 Identities=17% Similarity=0.292 Sum_probs=198.2
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEc-----CCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeecc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQ 105 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 105 (338)
...++|++.+.||+|+||.||+|.+. .+++.|++|+++... .+.+.+|+.+++++ +||||+++++++.+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~- 97 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NHPHVIKLYGACSQ- 97 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS-
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCceeeEEEEEec-
Confidence 45689999999999999999999884 445889999987532 35678899999999 99999999999854
Q ss_pred CCCccEEEEeeecCCccccccC---------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 019642 106 HSKTPSLIFEYVNSTDFKVLYP---------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDV 158 (338)
Q Consensus 106 ~~~~~~lv~e~~~~~~l~~~~~---------------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di 158 (338)
....++||||+.+++|.+++. .+++..++.++.|++.||.|||++|++|+||
T Consensus 98 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di 176 (314)
T 2ivs_A 98 -DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDL 176 (314)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred -CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccccc
Confidence 567899999999999987763 2788999999999999999999999999999
Q ss_pred CCCCeEecCCCCceEEEeccccccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCc
Q 019642 159 KPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 234 (338)
Q Consensus 159 kp~NIli~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~ 234 (338)
||+||+++.+ +.++|+|||++........ .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.
T Consensus 177 kp~NIli~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 177 AARNILVAEG-RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp SGGGEEEETT-TEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred chheEEEcCC-CCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999988 8999999999876543322 222356778999999877 678999999999999999999 998983
Q ss_pred CCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC
Q 019642 235 YGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 314 (338)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 314 (338)
. .+.......+... . ....+..+++++.++|.+||+.||++||
T Consensus 255 ~-~~~~~~~~~~~~~-~-----------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rp 297 (314)
T 2ivs_A 255 G-IPPERLFNLLKTG-H-----------------------------------RMERPDNCSEEMYRLMLQCWKQEPDKRP 297 (314)
T ss_dssp T-CCGGGHHHHHHTT-C-----------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred C-CCHHHHHHHhhcC-C-----------------------------------cCCCCccCCHHHHHHHHHHccCChhhCc
Confidence 2 2222222111110 0 0011123789999999999999999999
Q ss_pred CHHHHhcC
Q 019642 315 TAREAMAH 322 (338)
Q Consensus 315 t~~ell~h 322 (338)
|+.+++++
T Consensus 298 s~~~l~~~ 305 (314)
T 2ivs_A 298 VFADISKD 305 (314)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=323.81 Aligned_cols=244 Identities=21% Similarity=0.365 Sum_probs=197.1
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
+.++|++.+.||+|+||.||+|.+..+++.||+|.++... ...+.+|+.+++++ +||||+++++++.. ....+
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~~ 188 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQ--KQPIY 188 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECS--SSSCE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEec--CCCcE
Confidence 4579999999999999999999999999999999987532 24577899999999 99999999999954 45789
Q ss_pred EEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 112 LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 112 lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
+||||+.+++|.+++. .++...+..++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++.......
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~-~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEK-NVLKISDFGMSREEADGV 267 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCGGGCEECTTSE
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCC-CcEEECcCCCceecCCCc
Confidence 9999999999888763 48999999999999999999999999999999999999988 899999999987543221
Q ss_pred cc---eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccc
Q 019642 188 EY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263 (338)
Q Consensus 188 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
.. ....++..|+|||++.+ ..++.++||||||+++|+|++ |..||.. .+..+....+.. ..
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~-~~~~~~~~~~~~-~~------------ 332 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYPN-LSNQQTREFVEK-GG------------ 332 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTT-SCHHHHHHHHHT-TC------------
T ss_pred eeecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHc-CC------------
Confidence 11 11234667999999876 578899999999999999998 8888832 222221111110 00
Q ss_pred cccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
+ ...+..+++++.++|.+||+.||++|||+.++++
T Consensus 333 ---------------~--------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 333 ---------------R--------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp ---------------C--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------C--------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0 0012236889999999999999999999999975
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=311.16 Aligned_cols=244 Identities=18% Similarity=0.342 Sum_probs=201.0
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
..++|++.+.||+|+||+||+|.+..++..|++|.+... ..+.+.+|+.+++++ +||||+++++++.+ ....++|
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v 87 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--EPPFYII 87 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcc--CCCEEEE
Confidence 467999999999999999999999999999999998754 346688999999999 89999999999954 5678999
Q ss_pred EeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 114 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 114 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
|||+.+++|.+++. .+++..++.++.|++.||.+||++|++|+||||+||+++.+ +.++|+|||.+........
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGG-GCEEECCCCGGGTSCSSSS
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCC-CCEEEccCccceeccCCcc
Confidence 99999999988763 38999999999999999999999999999999999999888 7899999999976543332
Q ss_pred --ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 189 --YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 189 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
.....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||. ..+.......+....
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~-~~~~~~~~~~~~~~~--------------- 229 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYP-GIDLSQVYELLEKDY--------------- 229 (288)
T ss_dssp EEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSST-TCCGGGHHHHHHTTC---------------
T ss_pred ccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHhccC---------------
Confidence 222456778999999977 678999999999999999999 888873 222222222111100
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
....+..+++.+.++|.+||+.||++|||+.++++
T Consensus 230 ---------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 230 ---------------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp ---------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 00112237899999999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=313.24 Aligned_cols=249 Identities=20% Similarity=0.317 Sum_probs=200.9
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEE-----cCCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeecc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGIN-----VNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQ 105 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 105 (338)
...++|++.+.||+|+||+||+|.+ ..+++.||+|+++... .+.+.+|+.+++++.+||||+++++++...
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 3468999999999999999999985 3567899999987532 345788999999997799999999998554
Q ss_pred CCCccEEEEeeecCCccccccCC-------------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEec
Q 019642 106 HSKTPSLIFEYVNSTDFKVLYPT-------------------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 166 (338)
Q Consensus 106 ~~~~~~lv~e~~~~~~l~~~~~~-------------------~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~ 166 (338)
....+++|||+.+++|.+++.. +++..++.++.|++.||.+||+.|++|+||||+||+++
T Consensus 104 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 104 -GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 182 (316)
T ss_dssp -TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred -CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC
Confidence 3458999999999999887632 78899999999999999999999999999999999999
Q ss_pred CCCCceEEEeccccccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHH
Q 019642 167 HELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQ 242 (338)
Q Consensus 167 ~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~ 242 (338)
.+ +.++|+|||++........ .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.........
T Consensus 183 ~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 260 (316)
T 2xir_A 183 EK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260 (316)
T ss_dssp GG-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred CC-CCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence 87 7899999999976543322 223456788999999877 678999999999999999998 99998543333332
Q ss_pred HHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 243 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
...+...... ..+..+++++.++|.+||+.||++|||+.++++|
T Consensus 261 ~~~~~~~~~~------------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 261 CRRLKEGTRM------------------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHTCCC------------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhccCccC------------------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2222211000 0112268899999999999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=309.12 Aligned_cols=246 Identities=21% Similarity=0.362 Sum_probs=188.5
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCC---CceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
....++|++.+.||+|+||.||+|.+..+ +..|++|..+... .+.+.+|+.+++++ +||||+++++++.+
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-- 87 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE-- 87 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCccceEEEEEcc--
Confidence 34568999999999999999999998654 4569999976432 35678899999999 99999999999833
Q ss_pred CCccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccc
Q 019642 107 SKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~ 182 (338)
...++||||+.+++|.+++. .+++..++.++.|++.||.+||++|++|+||||+||+++.+ +.++|+|||++..
T Consensus 88 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 88 -NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRY 165 (281)
T ss_dssp -SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECC------
T ss_pred -CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCC-CCEEECccccccc
Confidence 45789999999999988763 48999999999999999999999999999999999999988 8999999999876
Q ss_pred ccCCCc--ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhh
Q 019642 183 YHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259 (338)
Q Consensus 183 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
...... .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.. .+..+....+.....
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~-~~~~~~~~~i~~~~~-------- 235 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGER-------- 235 (281)
T ss_dssp -------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCC--------
T ss_pred cCcccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCc-CCHHHHHHHHHcCCC--------
Confidence 543322 223456678999999876 678999999999999999997 8888843 222222222211000
Q ss_pred hccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
...+..+++++.++|.+||+.||++|||+.+++++
T Consensus 236 ----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 236 ----------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp ----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00122378999999999999999999999999874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=318.71 Aligned_cols=263 Identities=19% Similarity=0.316 Sum_probs=203.0
Q ss_pred ccCCcEEEEEeeeecCceeEEEEE----EcCCCceEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~---~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
.+.++|++.+.||+|+||.||+|. +..+++.|++|.+.... .+.+.+|+.+++++ +||||+++++++.....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCC
Confidence 456899999999999999999998 56789999999987543 34578999999999 99999999999876666
Q ss_pred CccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 108 KTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
...++||||+.+++|.+++. .+++..++.++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||++...
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESE-AHVKIADFGLAKLL 177 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCGGGCEEC
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCC-CCEEEcccccceec
Confidence 78899999999999988763 48999999999999999999999999999999999999988 89999999999766
Q ss_pred cCCCc----ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhh
Q 019642 184 HPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259 (338)
Q Consensus 184 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
..... .....++..|+|||++.+ ..++.++||||||+++|+|++|..||..... ...............
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~------~~~~~~~~~~~~~~~ 250 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSA------EFLRMMGCERDVPAL 250 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH------HHHHHCC----CCHH
T ss_pred ccCCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccc------hhhhhcccccccccH
Confidence 43332 223456778999999877 5788999999999999999999999842111 111110000000000
Q ss_pred hccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
........... ....+..+++++.++|.+||+.||++|||+.+++++
T Consensus 251 --------~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 251 --------SRLLELLEEGQ--------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp --------HHHHHHHHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------HHHHHHhhccc--------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00000000000 011123478999999999999999999999999654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=331.09 Aligned_cols=257 Identities=21% Similarity=0.299 Sum_probs=192.3
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
.-.+.|.+.+.||+|+||+||.+ ...+++.||||.+.....+.+.+|+.+++++.+||||+++++++.+ ....++||
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~lv~ 88 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETT--DRFLYIAL 88 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEEEE
T ss_pred hhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec--CCeEEEEE
Confidence 34567888899999999999875 4567999999998876677788999999987689999999999854 56789999
Q ss_pred eeecCCccccccCCC----------CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC------------CCce
Q 019642 115 EYVNSTDFKVLYPTL----------TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE------------LRKL 172 (338)
Q Consensus 115 e~~~~~~l~~~~~~~----------~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~------------~~~~ 172 (338)
||+++ +|.+++... ++..++.++.|++.||.|||++|++|+||||+||+++.. ...+
T Consensus 89 E~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 89 ELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp CCCSE-EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred ecCCC-CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 99975 777776321 222456799999999999999999999999999999753 2589
Q ss_pred EEEeccccccccCCCc-----ceeeeccccccccccccC------cCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCH
Q 019642 173 RLIDWGLAEFYHPGKE-----YNVRVASRYFKGPELLVD------LQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNH 240 (338)
Q Consensus 173 ~l~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~ 240 (338)
+|+|||++........ .....||+.|+|||++.+ ...++.++||||||+++|+|++ |..||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 9999999976644321 223478999999999865 2468899999999999999999 899984322211
Q ss_pred HHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHh
Q 019642 241 DQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 320 (338)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell 320 (338)
..+... ..... .. .......+++++.++|.+||+.||++|||+.+++
T Consensus 248 ---~~i~~~--~~~~~------------------------~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil 294 (434)
T 2rio_A 248 ---SNIIRG--IFSLD------------------------EM----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 294 (434)
T ss_dssp ---HHHHHT--CCCCC------------------------CC----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ---HHHhcC--CCCcc------------------------cc----cccccccchHHHHHHHHHHhhCChhhCCCHHHHH
Confidence 111110 00000 00 0000112467899999999999999999999999
Q ss_pred cCCCcchh
Q 019642 321 AHPYFAQV 328 (338)
Q Consensus 321 ~hp~~~~~ 328 (338)
+||||...
T Consensus 295 ~hp~f~~~ 302 (434)
T 2rio_A 295 RHPLFWPK 302 (434)
T ss_dssp TSGGGSCH
T ss_pred hCCccCCc
Confidence 99999754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=316.57 Aligned_cols=259 Identities=14% Similarity=0.141 Sum_probs=195.5
Q ss_pred eeccCCcEEEEEeeeecCceeEEEEEEcC---CCceEEEEEecccc--------------hHHHHHHHHHHHHhcCCCCe
Q 019642 33 IFSDQDDYEVVRKVGRGKYSEVFEGINVN---TNERCIIKILKPVK--------------KKKIKREIKILQNLCGGPNV 95 (338)
Q Consensus 33 i~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~--------------~~~~~~E~~~l~~l~~h~~i 95 (338)
-....++|++.+.||+|+||.||+|.+.. ++..+++|+..... ...+.+|+..++.+ +||||
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ni 110 (345)
T 2v62_A 32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLGI 110 (345)
T ss_dssp ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCCC
T ss_pred ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccCc
Confidence 34557899999999999999999999987 78899999986432 12355677778887 99999
Q ss_pred eEeeeeeecc--CCCccEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCC-
Q 019642 96 VKLLDIVRDQ--HSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL- 169 (338)
Q Consensus 96 v~~~~~~~~~--~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~- 169 (338)
+++++++... .....++||||+ +++|.+++. .+++..++.++.|++.||.|||++|++|+||||+||+++.+.
T Consensus 111 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 111 PLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp CCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSST
T ss_pred ceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCC
Confidence 9999998652 246789999999 889988875 489999999999999999999999999999999999998761
Q ss_pred CceEEEeccccccccCCC--------cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHH
Q 019642 170 RKLRLIDWGLAEFYHPGK--------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 241 (338)
Q Consensus 170 ~~~~l~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~ 241 (338)
+.++|+|||++....... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||........
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 389999999996553211 1134578999999999987 6789999999999999999999999954444444
Q ss_pred HHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 242 QLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
................. .. ......+++++.++|.+||+.||++|||+.++++
T Consensus 269 ~~~~~~~~~~~~~~~~~------------~~---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 269 AVQTAKTNLLDELPQSV------------LK---------------WAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHHHHTTTHHH------------HH---------------HSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHhhcccccHHH------------Hh---------------hccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 33332222111100000 00 0001127899999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=311.70 Aligned_cols=260 Identities=22% Similarity=0.351 Sum_probs=199.4
Q ss_pred CCcEEEEEeeeecCceeEEEEE----EcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
.++|++.+.||+|+||.||+|. +..+++.||+|.++.. ..+.+.+|+.+++++ +||||+++++++......
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCc
Confidence 4679999999999999999998 5678999999998743 346788999999999 899999999999776557
Q ss_pred ccEEEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 109 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
..++||||+.+++|.+++ ..+++..++.++.|++.||.+||++|++|+||||+||+++.+ +.++|+|||++....
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIE 177 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCTTCEECC
T ss_pred eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCC-CCEEECccccccccc
Confidence 789999999999998886 359999999999999999999999999999999999999988 899999999997665
Q ss_pred CCCc----ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhh
Q 019642 185 PGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 260 (338)
Q Consensus 185 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.... .....++..|+|||++.+ ..++.++|+||||+++|+|++|..|+.. .........+.........
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~------~~~~~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSS------PMALFLKMIGPTHGQMTVT 250 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGS------HHHHHHHHHCSCCGGGHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcc------hhhHHhhccCCcccccCHH
Confidence 4332 223456777999999877 5788999999999999999999988621 1111111111111000000
Q ss_pred ccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
.......... ....+..+++++.++|.+||+.||++|||+.++++
T Consensus 251 --------~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 251 --------RLVNTLKEGK--------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp --------HHHHHHHTTC--------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred --------HHHHHHhccC--------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 0000000000 01122347899999999999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=319.38 Aligned_cols=271 Identities=18% Similarity=0.236 Sum_probs=198.1
Q ss_pred eeeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccch--HHHHHHHHHHHHhcCCCCeeEeeeeeeccC--C
Q 019642 32 VIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLCGGPNVVKLLDIVRDQH--S 107 (338)
Q Consensus 32 ~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--~ 107 (338)
-+....++|++.+.||+|+||+||+|.+. ++.||+|+++.... .....|+.+++++ +||||+++++++.... .
T Consensus 18 n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 18 NLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp CEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSS
T ss_pred ccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcC-CCCCchhhcceeccCCCCC
Confidence 34556789999999999999999999874 78999999875443 3345688888898 8999999999997643 2
Q ss_pred CccEEEEeeecCCcccccc--CCCCHHHHHHHHHHHHHHHHHHHHC----------CceeccCCCCCeEecCCCCceEEE
Q 019642 108 KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQ----------GIMHRDVKPHNVMIDHELRKLRLI 175 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~----------~i~H~dikp~NIli~~~~~~~~l~ 175 (338)
...++||||+.+++|.+++ ..+++..++.++.|++.||.|||+. |++|+||||+||+++.+ +.+||+
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~-~~~kL~ 173 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIA 173 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTT-CCEEEC
T ss_pred ceEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCC-CeEEEc
Confidence 3478999999999998887 3589999999999999999999999 99999999999999988 899999
Q ss_pred eccccccccCCCc---ceeeeccccccccccccCc----CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHH
Q 019642 176 DWGLAEFYHPGKE---YNVRVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 248 (338)
Q Consensus 176 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~----~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~ 248 (338)
|||++........ .....+|+.|+|||++.+. ..++.++||||||+++|+|++|..||....+.... .....
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~ 252 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML-PFEEE 252 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC-TTHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc-chhhh
Confidence 9999976543322 2235689999999998762 24556889999999999999999998543221100 00000
Q ss_pred HhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 249 VLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
....+....... .............. ......++++.+||.+||+.||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~-----------~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 253 IGQHPSLEDMQE-----------VVVHKKKRPVLRDY---WQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HCSSCCHHHHHH-----------HHTTSCCCCCCCGG---GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hccCCchhhhhh-----------hhhcccCCCCcccc---ccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 001111111000 00000000000000 011113456999999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=313.95 Aligned_cols=247 Identities=19% Similarity=0.287 Sum_probs=199.4
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCc-----eEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeecc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNE-----RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ 105 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 105 (338)
...++|++.+.||+|+||.||+|.+..+++ .|++|.++.. ..+.+.+|+.+++++.+||||+++++++..
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 121 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH- 121 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec-
Confidence 446899999999999999999999877654 7999998754 245678999999999789999999999954
Q ss_pred CCCccEEEEeeecCCccccccC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC
Q 019642 106 HSKTPSLIFEYVNSTDFKVLYP-----------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 168 (338)
Q Consensus 106 ~~~~~~lv~e~~~~~~l~~~~~-----------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~ 168 (338)
....++||||+.+++|.+++. .+++..++.++.|++.||.|||++|++|+||||+||+++.+
T Consensus 122 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 122 -GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred -CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence 567899999999999887752 37899999999999999999999999999999999999988
Q ss_pred CCceEEEeccccccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHH
Q 019642 169 LRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLV 244 (338)
Q Consensus 169 ~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~ 244 (338)
+.++|+|||++........ .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||....... ...
T Consensus 201 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~~ 277 (333)
T 2i1m_A 201 -HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-KFY 277 (333)
T ss_dssp -GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-HHH
T ss_pred -CeEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-HHH
Confidence 8999999999876533222 222456778999999877 678999999999999999998 888884333322 222
Q ss_pred HHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 245 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
........ ...+...++.+.++|.+||+.||++|||+.++++
T Consensus 278 ~~~~~~~~-----------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 278 KLVKDGYQ-----------------------------------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHTCC-----------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcCCC-----------------------------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 22111000 0011225889999999999999999999999997
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=314.54 Aligned_cols=245 Identities=18% Similarity=0.308 Sum_probs=192.0
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceE----EEEEecc----cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERC----IIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~----aiK~~~~----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
...++|++.+.||+|+||+||+|.+..+++.+ ++|.++. ...+.+.+|+.+++++ +||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~- 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS- 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHC-CBTTBCCEEEEEESS-
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC-
Confidence 44689999999999999999999988777654 7777643 2356788999999999 999999999999653
Q ss_pred CCccEEEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccc
Q 019642 107 SKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~ 182 (338)
..+++++++.+++|.+++ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++..
T Consensus 90 --~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 90 --TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKL 166 (327)
T ss_dssp --SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCTTHHHH
T ss_pred --CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCC-CCEEEccCcceeE
Confidence 367999999999988775 348999999999999999999999999999999999999988 8999999999976
Q ss_pred ccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhh
Q 019642 183 YHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAY 258 (338)
Q Consensus 183 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
...... .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.. .+..+....+... ..
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~-~~------ 237 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKG-ER------ 237 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTT-CC------
T ss_pred ccCCcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccC-CCHHHHHHHHHcC-CC------
Confidence 643322 222345778999999987 678999999999999999999 9999832 2222221111110 00
Q ss_pred hhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
...+..++.++.+++.+||+.||++|||+.+++++
T Consensus 238 -----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 238 -----------------------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp -----------------------------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred -----------------------------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 00112268899999999999999999999999975
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=308.49 Aligned_cols=256 Identities=20% Similarity=0.293 Sum_probs=203.1
Q ss_pred hhhceeeeeccCCcEEEEEeeeecCceeEEEEEEcCC---CceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEe
Q 019642 26 WNVSSYVIFSDQDDYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKL 98 (338)
Q Consensus 26 ~~~~~~~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~ 98 (338)
..+...++.....+|++.+.||+|+||+||+|.+..+ ...+++|.++... .+.+.+|+.+++++ +||||+++
T Consensus 13 ~~~~~~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~ 91 (298)
T 3f66_A 13 QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSL 91 (298)
T ss_dssp HHHGGGBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCC
T ss_pred hhhhheecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhC-CCCCEeee
Confidence 3556777888888999999999999999999986543 3458899887532 35678899999999 89999999
Q ss_pred eeeeeccCCCccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEE
Q 019642 99 LDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRL 174 (338)
Q Consensus 99 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l 174 (338)
++++... ....+++|||+.+++|.+++. .+++..++.++.|++.||.+||++|++|+||||+||+++.+ +.++|
T Consensus 92 ~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl 169 (298)
T 3f66_A 92 LGICLRS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK-FTVKV 169 (298)
T ss_dssp CEEECCS-SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CCEEE
T ss_pred eeEEEcC-CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCC-CCEEE
Confidence 9986443 456789999999999988863 38899999999999999999999999999999999999988 89999
Q ss_pred EeccccccccCCC-----cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHH
Q 019642 175 IDWGLAEFYHPGK-----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 249 (338)
Q Consensus 175 ~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~ 249 (338)
+|||++....... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..|++...+..+....+...
T Consensus 170 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
T 3f66_A 170 ADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 248 (298)
T ss_dssp CSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTT
T ss_pred CcccccccccccchhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcC
Confidence 9999987553322 1223456778999999977 678999999999999999999666655554444433332221
Q ss_pred hCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 250 LGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
.. ...+..+++.+.+++.+||+.||++|||+.++++
T Consensus 249 ~~------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 249 RR------------------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp CC------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC------------------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 0011226889999999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=307.33 Aligned_cols=257 Identities=20% Similarity=0.309 Sum_probs=206.7
Q ss_pred HhhhceeeeeccCCcEEEEEeeeecCceeEEEEEEcCCCc---eEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeE
Q 019642 25 FWNVSSYVIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKPVK----KKKIKREIKILQNLCGGPNVVK 97 (338)
Q Consensus 25 ~~~~~~~~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~ 97 (338)
.......++....-.|.+.+.||+|+||+||+|.+..++. .+++|.++... .+.+.+|+.+++++ +||||++
T Consensus 8 ~~~~~~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~ 86 (298)
T 3pls_A 8 LAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVLA 86 (298)
T ss_dssp HHHTGGGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCC
T ss_pred HhhhhheEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhC-CCCCeee
Confidence 3456667777777889999999999999999999765554 79999987533 35677899999999 9999999
Q ss_pred eeeeeeccCCCccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceE
Q 019642 98 LLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR 173 (338)
Q Consensus 98 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~ 173 (338)
+++++.+.. ...+++|||+.+++|.+++. .+++..++.++.|++.||.+||++|++|+||||+||+++.+ +.++
T Consensus 87 ~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~-~~~k 164 (298)
T 3pls_A 87 LIGIMLPPE-GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDES-FTVK 164 (298)
T ss_dssp CCEEECCSS-SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CCEE
T ss_pred EEEEEecCC-CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-CcEE
Confidence 999986543 34589999999999888763 48899999999999999999999999999999999999988 8999
Q ss_pred EEeccccccccCC-----CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHH
Q 019642 174 LIDWGLAEFYHPG-----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 248 (338)
Q Consensus 174 l~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~ 248 (338)
|+|||++...... .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..|++...+..+....+..
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~ 243 (298)
T 3pls_A 165 VADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243 (298)
T ss_dssp ECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT
T ss_pred eCcCCCcccccCCcccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc
Confidence 9999998654322 12233456788999999977 67899999999999999999987787655554443333222
Q ss_pred HhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 249 VLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
.... ..+..+++.+.+++.+||+.||++|||+.++++
T Consensus 244 ~~~~------------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 244 GRRL------------------------------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp TCCC------------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCC------------------------------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1100 012236889999999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=306.47 Aligned_cols=249 Identities=16% Similarity=0.270 Sum_probs=196.3
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc-cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
..++|++.+.||+|+||.||+|.+..+++.||+|++.. ...+.+.+|+.+++.+ +|++++..+..+.. .....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~-~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMM-QGGVGIPTIRWCGA-EGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHH-TTSTTCCCEEEEEE-ETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHh-hcCCCCCccccccC-CCCceEEEE
Confidence 46899999999999999999999999999999999764 3446788999999999 66666555555433 245778999
Q ss_pred eeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEec---CCCCceEEEeccccccccCCC
Q 019642 115 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 115 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~---~~~~~~~l~dfg~~~~~~~~~ 187 (338)
||+ +++|.+++. .+++..++.++.|++.||.|||++|++|+||||+||+++ .+ +.++|+|||++.......
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~-~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKG-NLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGT-TCEEECCCTTCEECBCTT
T ss_pred Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCC-CeEEEeeCCCcccccccc
Confidence 999 778877653 599999999999999999999999999999999999995 44 789999999987654332
Q ss_pred c--------ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCC--CHHHHHHHHHHhCCchhhh
Q 019642 188 E--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--NHDQLVKIAKVLGTDELNA 257 (338)
Q Consensus 188 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~ 257 (338)
. .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||..... .......+...........
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred cccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH
Confidence 2 234578999999999987 6789999999999999999999999954321 1222222222110000000
Q ss_pred hhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
....+++++.++|.+||+.||++|||+.++++
T Consensus 242 --------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 242 --------------------------------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp --------------------------------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred --------------------------------HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 01126899999999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=303.91 Aligned_cols=244 Identities=16% Similarity=0.328 Sum_probs=198.2
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
+.++|++.+.||+|+||.||++.+. +++.|++|.++.. ..+.+.+|+.+++++ +||||+++++++.+ ....+++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 81 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLE--QAPICLV 81 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTC-CCTTBCCEEEEECS--SSSCEEE
T ss_pred chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEcc--CCCeEEE
Confidence 4579999999999999999999986 6778999998754 456788999999999 99999999999954 4578999
Q ss_pred EeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC--
Q 019642 114 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-- 187 (338)
Q Consensus 114 ~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-- 187 (338)
|||+.+++|.+++. .+++..++.++.|++.||.+||++|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGG-GCEEECCTTGGGGBCCHHHH
T ss_pred EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCC-CCEEEccccccccccccccc
Confidence 99999999988763 48999999999999999999999999999999999999887 789999999987653221
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
......++..|+|||++.+ ..++.++|+||||+++|+|++ |..||.. .+..+....+....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~i~~~~---------------- 222 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGF---------------- 222 (267)
T ss_dssp STTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTC----------------
T ss_pred ccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCC-CCHHHHHHHHhcCC----------------
Confidence 1122345678999999876 678999999999999999999 8888832 22222222221100
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
....+..+++.+.+++.+||+.||++|||+.+++++
T Consensus 223 --------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 223 --------------------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp --------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 001112268899999999999999999999999874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=307.26 Aligned_cols=248 Identities=20% Similarity=0.316 Sum_probs=190.1
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
....++|++.+.||+|+||.||+|.+..+++.|++|+++... .+.+.+|+.+++++ +||||+++++++.. .
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~--~ 106 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGEI--D 106 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEE--T
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEee--C
Confidence 344689999999999999999999999999999999986432 25678899999999 99999999999955 4
Q ss_pred CccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 108 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
...+++|||+.+++|.+++ ..+++..++.++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||++....
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSAD-DFAYLVDFGIASATT 185 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECSCCC-----
T ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCC-CCEEEecCccCcccc
Confidence 5789999999999998886 359999999999999999999999999999999999999988 899999999986654
Q ss_pred CCC--cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcc
Q 019642 185 PGK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262 (338)
Q Consensus 185 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
... ......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||... ........... ....
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~~~~-~~~~-------- 253 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGD--QLSVMGAHINQ-AIPR-------- 253 (309)
T ss_dssp -----------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSC--HHHHHHHHHHS-CCCC--------
T ss_pred ccccccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCc--hHHHHHHHhcc-CCCC--------
Confidence 322 2234568899999999877 67899999999999999999999998421 11111111110 0000
Q ss_pred ccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC-CHHHHhc
Q 019642 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-TAREAMA 321 (338)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-t~~ell~ 321 (338)
.......+++++.++|.+||+.||++|| |++++++
T Consensus 254 ------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 254 ------------------------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp ------------------------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ------------------------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 0011223788999999999999999999 8888875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=312.78 Aligned_cols=247 Identities=19% Similarity=0.298 Sum_probs=197.5
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEc-------CCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeee
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINV-------NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVR 103 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 103 (338)
...++|++.+.||+|+||.||+|.+. .++..||+|+++... .+.+.+|+.+++++.+||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 34689999999999999999999975 456789999987532 3457889999999988999999999995
Q ss_pred ccCCCccEEEEeeecCCccccccC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeE
Q 019642 104 DQHSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 164 (338)
Q Consensus 104 ~~~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIl 164 (338)
+ ....++||||+.+++|.+++. .++...++.++.|++.||.|||+.|++|+||||+||+
T Consensus 112 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 112 Q--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189 (334)
T ss_dssp S--SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred c--CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEE
Confidence 4 567899999999999987763 2788999999999999999999999999999999999
Q ss_pred ecCCCCceEEEeccccccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCH
Q 019642 165 IDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNH 240 (338)
Q Consensus 165 i~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~ 240 (338)
++.+ +.++|+|||++........ .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||. ..+..
T Consensus 190 l~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~-~~~~~ 266 (334)
T 2pvf_A 190 VTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYP-GIPVE 266 (334)
T ss_dssp ECTT-CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSST-TCCHH
T ss_pred EcCC-CCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcC-cCCHH
Confidence 9988 8999999999876543322 222355778999999876 578899999999999999999 998883 22222
Q ss_pred HHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHh
Q 019642 241 DQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 320 (338)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell 320 (338)
+....+..... ...+..++.++.++|.+||+.||++|||+.+++
T Consensus 267 ~~~~~~~~~~~------------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 310 (334)
T 2pvf_A 267 ELFKLLKEGHR------------------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310 (334)
T ss_dssp HHHHHHHHTCC------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHhcCCC------------------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 22222111000 001123689999999999999999999999998
Q ss_pred cC
Q 019642 321 AH 322 (338)
Q Consensus 321 ~h 322 (338)
++
T Consensus 311 ~~ 312 (334)
T 2pvf_A 311 ED 312 (334)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=307.53 Aligned_cols=242 Identities=21% Similarity=0.307 Sum_probs=190.5
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
.+.++|++.+.||+|+||+||++.+ .++.|++|.+... ..+.+.+|+.+++++ +||||+++++++. ...++|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~----~~~~lv 77 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRV-NHPNIVKLYGACL----NPVCLV 77 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHC-CCTTBCCEEEBCT----TTTEEE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcC-CCCCcCeEEEEEc----CCcEEE
Confidence 3567999999999999999999986 4788999998754 356688999999999 9999999999884 247899
Q ss_pred EeeecCCccccccC------CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 114 FEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHS---QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 114 ~e~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
|||+.+++|.+++. .++...+..++.|++.||.|||+ +|++|+||||+||+++.+...+||+|||++....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 99999999988763 36889999999999999999999 8999999999999998873458999999986543
Q ss_pred CCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccc
Q 019642 185 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264 (338)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
.. .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||................ +.
T Consensus 158 ~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~------------ 221 (307)
T 2eva_A 158 TH--MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN-GT------------ 221 (307)
T ss_dssp ---------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT-TC------------
T ss_pred cc--cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc-CC------------
Confidence 22 233468999999999977 678999999999999999999999995433332221111100 00
Q ss_pred ccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
. ......+++.+.++|.+||+.||++|||+.++++
T Consensus 222 --------------~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 222 --------------R--------PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp --------------C--------CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------C--------CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0 0011236899999999999999999999999987
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=314.72 Aligned_cols=244 Identities=16% Similarity=0.277 Sum_probs=193.6
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCce----EEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNER----CIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
..++|++.+.||+|+||+||+|.+..+++. +++|.+... ....+.+|+.+++++ +||||+++++++.+
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--- 86 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DHAHIVRLLGLCPG--- 86 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC-CCTTBCCEEEEECB---
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC---
Confidence 467999999999999999999999888776 677766432 234567899999999 99999999998843
Q ss_pred CccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 108 KTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
...++||||+.+++|.+++. .+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++...
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~-~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSP-SQVQVADFGVADLL 165 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSS-SCEEECSCSGGGGS
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCC-CeEEECCCCccccc
Confidence 45789999999999877762 48899999999999999999999999999999999999988 89999999999876
Q ss_pred cCCC---cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhh
Q 019642 184 HPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259 (338)
Q Consensus 184 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
.... ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||... ...+....+... .
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~-~-------- 234 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGL-RLAEVPDLLEKG-E-------- 234 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-CTTHHHHHHHTT-C--------
T ss_pred CcccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCcccc-CHHHHHHHHHcC-C--------
Confidence 4332 2233456778999999977 678999999999999999999 99998432 222221111110 0
Q ss_pred hccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
....+..++.++.++|.+||+.||++|||+.+++++
T Consensus 235 ---------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 235 ---------------------------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ---------------------------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ---------------------------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000111257788999999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=313.02 Aligned_cols=254 Identities=19% Similarity=0.343 Sum_probs=202.4
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEc-----CCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeecc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQ 105 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 105 (338)
...++|++.+.||+|+||.||+|.+. .+++.|++|.+.... ...+.+|+.+++.+ +||||+++++++.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~- 99 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ- 99 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECS-
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCEeeeEEEEcc-
Confidence 34578999999999999999999876 357889999987432 34577899999999 99999999999954
Q ss_pred CCCccEEEEeeecCCccccccC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCce
Q 019642 106 HSKTPSLIFEYVNSTDFKVLYP-------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKL 172 (338)
Q Consensus 106 ~~~~~~lv~e~~~~~~l~~~~~-------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~ 172 (338)
....++||||+.+++|.+++. .++...++.++.|++.||.+||++|++|+||||+||+++.+ +.+
T Consensus 100 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~-~~~ 177 (322)
T 1p4o_A 100 -GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTV 177 (322)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT-CCE
T ss_pred -CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCC-CeE
Confidence 557899999999999988763 36889999999999999999999999999999999999988 899
Q ss_pred EEEeccccccccCCC---cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHH
Q 019642 173 RLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK 248 (338)
Q Consensus 173 ~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~ 248 (338)
+|+|||++....... ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||. ..+.......+..
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~-~~~~~~~~~~~~~ 255 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQ-GLSNEQVLRFVME 255 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTT-TSCHHHHHHHHHT
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccc-cCCHHHHHHHHHc
Confidence 999999987553322 1223356788999999877 678999999999999999999 788873 2222222221111
Q ss_pred HhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC------
Q 019642 249 VLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH------ 322 (338)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h------ 322 (338)
. .. ...+..+++.+.++|.+||+.||++|||+.|++++
T Consensus 256 ~-~~-----------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 256 G-GL-----------------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp T-CC-----------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred C-Cc-----------------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 0 00 00112378999999999999999999999999987
Q ss_pred CCcchhhh
Q 019642 323 PYFAQVRA 330 (338)
Q Consensus 323 p~~~~~~~ 330 (338)
|+|+++..
T Consensus 300 ~~~~~~~~ 307 (322)
T 1p4o_A 300 PGFREVSF 307 (322)
T ss_dssp TTHHHHCS
T ss_pred cCCccccc
Confidence 77766543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=304.06 Aligned_cols=246 Identities=23% Similarity=0.382 Sum_probs=195.9
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcC---CCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVN---TNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
....++|++.+.||+|+||+||+|.+.. ++..|++|.++.. ..+.+.+|+.+++++ +||||+++++++.+
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-- 84 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHPHIVKLIGIIEE-- 84 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHH-CCTTBCCEEEEECS--
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhC-CCCCcceEEEEEcC--
Confidence 4557899999999999999999998654 3446999998753 346678899999999 99999999999844
Q ss_pred CCccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccc
Q 019642 107 SKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~ 182 (338)
...++||||+.+++|.+++. .+++..++.++.|++.||.+||++|++|+||||+||+++.+ +.++|+|||++..
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASP-ECVKLGDFGLSRY 162 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEET-TEEEECCCCGGGC
T ss_pred -CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCC-CcEEeCccCCCcc
Confidence 34689999999999988763 48999999999999999999999999999999999999988 8999999999876
Q ss_pred ccCCCc--ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhh
Q 019642 183 YHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259 (338)
Q Consensus 183 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
...... .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.... ..+....+......
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~-~~~~~~~~~~~~~~------- 233 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLE-NKDVIGVLEKGDRL------- 233 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-GGGHHHHHHHTCCC-------
T ss_pred cccccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCC-hHHHHHHHhcCCCC-------
Confidence 543321 223456778999999876 678999999999999999998 999984322 22222221110000
Q ss_pred hccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
..+..+++.+.++|.+||+.||++|||+.+++++
T Consensus 234 -----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 234 -----------------------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp -----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 0112268899999999999999999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=310.48 Aligned_cols=247 Identities=24% Similarity=0.436 Sum_probs=189.6
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
..++|++.+.||+|+||.||+|.+..+++.||+|.++.. ....+.+|+.+++++ +||||+++++++.. ...
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~ 106 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIE--DNE 106 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEE--TTE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEc--CCc
Confidence 346899999999999999999999999999999998642 235678899999999 99999999999965 457
Q ss_pred cEEEEeeecCCccccccC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccc
Q 019642 110 PSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~ 182 (338)
.++||||+.+++|.+++. .+++..++.++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||++..
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~-~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRF 185 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCC-----
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCC-CCEEEEeccceee
Confidence 889999999999987763 38999999999999999999999999999999999999988 8999999999876
Q ss_pred ccCCC-cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 183 YHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 183 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
..... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...................+
T Consensus 186 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 256 (310)
T 2wqm_A 186 FSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP-------- 256 (310)
T ss_dssp -------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC--------
T ss_pred ecCCCccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC--------
Confidence 54322 2233568899999999877 6789999999999999999999999954333322222111100000
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
......+++++.++|.+||+.||++|||+.++++
T Consensus 257 --------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 257 --------------------------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp --------------------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0011236889999999999999999999999997
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=316.54 Aligned_cols=258 Identities=19% Similarity=0.330 Sum_probs=200.2
Q ss_pred hceeeeeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEeeeeeec
Q 019642 28 VSSYVIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRD 104 (338)
Q Consensus 28 ~~~~~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 104 (338)
.+...+....++|++.+.||+|+||.||++.+..+++.||+|.+... ..+.+.+|+.+++.+ +||||+++++++..
T Consensus 19 ~~g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 97 (317)
T 2buj_A 19 FQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNILRLVAYCLR 97 (317)
T ss_dssp EEEEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEE
T ss_pred ecccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEe
Confidence 34556667779999999999999999999999999999999988543 345678999999999 99999999999863
Q ss_pred c--CCCccEEEEeeecCCccccccC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEE
Q 019642 105 Q--HSKTPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI 175 (338)
Q Consensus 105 ~--~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~ 175 (338)
. .....++||||+.+++|.+++. .+++..++.++.|++.||.+||++|++|+||||+||+++.+ +.++|+
T Consensus 98 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~-~~~kl~ 176 (317)
T 2buj_A 98 ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDE-GQPVLM 176 (317)
T ss_dssp EETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEEC
T ss_pred ccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCC-CCEEEE
Confidence 2 2347789999999999877653 48999999999999999999999999999999999999988 799999
Q ss_pred eccccccccCCCc----------ceeeeccccccccccccCcC--CCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHH
Q 019642 176 DWGLAEFYHPGKE----------YNVRVASRYFKGPELLVDLQ--DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 243 (338)
Q Consensus 176 dfg~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~--~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~ 243 (338)
|||.+........ .....+++.|+|||++.+.. .++.++||||||+++|+|++|..||..........
T Consensus 177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 256 (317)
T 2buj_A 177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256 (317)
T ss_dssp CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH
T ss_pred ecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh
Confidence 9998765321110 11234688999999986532 36899999999999999999999983110000000
Q ss_pred HHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 244 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
..... ... .......+++++.++|.+||+.||++|||+.+++++
T Consensus 257 ~~~~~---------------------------~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 257 ALAVQ---------------------------NQL--------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HHHHH---------------------------CC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHhh---------------------------ccC--------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 00000 000 000112368999999999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=339.98 Aligned_cols=281 Identities=22% Similarity=0.328 Sum_probs=206.1
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeec----cCCC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRD----QHSK 108 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~----~~~~ 108 (338)
.++|++.+.||+|+||+||+|.+..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.. ....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCceeeeecccccccCCC
Confidence 47899999999999999999999999999999998643 245578899999999 99999999998754 2256
Q ss_pred ccEEEEeeecCCccccccC------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCC--CceEEEecccc
Q 019642 109 TPSLIFEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLA 180 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~--~~~~l~dfg~~ 180 (338)
..++||||+.+++|..++. .+++..++.++.|++.||.|||+.|++|+||||+||+++.+. ..++|+|||.+
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 7789999999999988763 488999999999999999999999999999999999998662 24899999999
Q ss_pred ccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhh
Q 019642 181 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 260 (338)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.............+++.|+|||++.+ ..++.++||||||+++|+|++|..||...... ..+............
T Consensus 172 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~----~~~~~~i~~~~~~~~-- 244 (676)
T 3qa8_A 172 KELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQP----VQWHGKVREKSNEHI-- 244 (676)
T ss_dssp CBTTSCCCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH----HHSSTTCC------C--
T ss_pred cccccccccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccch----hhhhhhhhcccchhh--
Confidence 87765555556688999999999877 68899999999999999999999999432111 000000000000000
Q ss_pred ccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhccc
Q 019642 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 333 (338)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 333 (338)
......... ................+++.+.++|.+||+.||++|||+.++++||||+.+...-.
T Consensus 245 ----~~~~~l~g~----~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 245 ----VVYDDLTGA----VKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp ----CSCCCCSSS----CCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred ----hhhhhhccc----cccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 000000000 00000000011122236788999999999999999999999999999998865443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=305.78 Aligned_cols=248 Identities=15% Similarity=0.304 Sum_probs=188.0
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
....++|++.+.||+|+||+||+|.+.. .+++|+++... .+.+.+|+.+++++ +||||++++++.. ..
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~---~~ 92 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYST---AP 92 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEC---SS
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCcEEEEEeecc---CC
Confidence 3457899999999999999999997543 59999986432 35678999999999 9999999999652 34
Q ss_pred ccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 109 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
..++||||+.+++|.+.+. .+++..++.++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||++....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHED-NTVKIGDFGLATEKS 171 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-TEEEECCCC------
T ss_pred ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC-CCEEEccceeccccc
Confidence 5789999999999987763 48999999999999999999999999999999999999988 899999999986543
Q ss_pred C---CCcceeeeccccccccccccC--cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhh
Q 019642 185 P---GKEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259 (338)
Q Consensus 185 ~---~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
. ........+++.|+|||++.. ...++.++||||||+++|+|++|..||.... ..+.............
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~----- 245 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIEMVGRGSLSP----- 245 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC-CHHHHHHHHHHTSCCC-----
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc-hHHHHHHHhcccccCc-----
Confidence 2 122234568999999999862 2567889999999999999999999995433 3333333222111100
Q ss_pred hccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
.. ......+++.+.+||.+||+.||++|||+.++++
T Consensus 246 ---------------------~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 246 ---------------------DL-----SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp ---------------------CT-----TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------ch-----hhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00 0011236899999999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=317.16 Aligned_cols=247 Identities=17% Similarity=0.281 Sum_probs=196.7
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceE--EEEEecc----cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERC--IIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~--aiK~~~~----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
...++|++.+.||+|+||.||+|.+..++..+ ++|.++. ...+.+.+|+.+++++.+||||+++++++.+ ..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee--CC
Confidence 34589999999999999999999998888865 8888764 2345688899999999789999999999955 46
Q ss_pred ccEEEEeeecCCccccccC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCC
Q 019642 109 TPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL 169 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 169 (338)
..++||||+.+++|.+++. .+++..++.++.|++.||.+||++|++|+||||+||+++.+
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~- 178 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN- 178 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG-
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC-
Confidence 7899999999999887762 48999999999999999999999999999999999999988
Q ss_pred CceEEEeccccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHH
Q 019642 170 RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK 248 (338)
Q Consensus 170 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~ 248 (338)
+.++|+|||++.............+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.. .+..+....+..
T Consensus 179 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~-~~~~~~~~~~~~ 256 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQ 256 (327)
T ss_dssp GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHGGG
T ss_pred CeEEEcccCcCccccccccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCC-CcHHHHHHHhhc
Confidence 7999999999864433233334466788999999876 578899999999999999998 9999832 221111111100
Q ss_pred HhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 249 VLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
. .....+..+++++.++|.+||+.||++|||+.+++++
T Consensus 257 ~------------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 257 G------------------------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp T------------------------------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C------------------------------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0 0001122368999999999999999999999999975
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=310.29 Aligned_cols=249 Identities=18% Similarity=0.314 Sum_probs=190.1
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcC---CCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeecc
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVN---TNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQ 105 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 105 (338)
....++|++.+.||+|+||.||+|.+.. ++..||+|.++... .+.+.+|+.+++++ +||||+++++++...
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEM 108 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEC-
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC-CCCCeeeeeEEEeec
Confidence 3456899999999999999999998765 45689999986432 35578899999999 899999999998664
Q ss_pred CCC---ccEEEEeeecCCcccccc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceE
Q 019642 106 HSK---TPSLIFEYVNSTDFKVLY---------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR 173 (338)
Q Consensus 106 ~~~---~~~lv~e~~~~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~ 173 (338)
... ..+++|||+.+++|..++ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~-~~~k 187 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD-MTVC 187 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTT-SCEE
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-CcEE
Confidence 332 458999999999998776 348999999999999999999999999999999999999988 7999
Q ss_pred EEeccccccccCCC---cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHH
Q 019642 174 LIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKV 249 (338)
Q Consensus 174 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~ 249 (338)
|+|||++....... ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||. ..+.......+...
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~-~~~~~~~~~~~~~~ 265 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYP-GVQNHEMYDYLLHG 265 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSST-TCCGGGHHHHHHTT
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCc-cCCHHHHHHHHHcC
Confidence 99999987654322 1223456778999999977 678999999999999999999 777773 33332222222110
Q ss_pred hCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 250 LGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
.. ...+..+++++.++|.+||+.||++|||+.+++++
T Consensus 266 ~~------------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 266 HR------------------------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CC------------------------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CC------------------------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 00112378999999999999999999999999874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=305.31 Aligned_cols=250 Identities=16% Similarity=0.270 Sum_probs=191.9
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc-cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
...++|++.+.||+|+||+||+|.+..+++.||+|++.. .....+.+|+.+++.+ +|++++..+..+... ....+++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~~-~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMM-QGGVGIPTIRWCGAE-GDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHH-TTSTTCCCEEEEEEE-TTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHh-cCCCCCCeeeeecCC-CCceEEE
Confidence 345899999999999999999999999999999998653 3445688999999999 666666555554332 4577899
Q ss_pred EeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEe---cCCCCceEEEeccccccccCC
Q 019642 114 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 114 ~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli---~~~~~~~~l~dfg~~~~~~~~ 186 (338)
|||+ +++|.+++ ..+++..++.++.|++.||.|||++|++|+||||+||++ +.+ +.++|+|||++......
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~-~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKG-NLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGT-TCEEECCCTTCEECBCT
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCC-CeEEEecCccceeccCc
Confidence 9999 77877765 359999999999999999999999999999999999999 555 78999999999765433
Q ss_pred Cc--------ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCC--HHHHHHHHHHhCCchhh
Q 019642 187 KE--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKVLGTDELN 256 (338)
Q Consensus 187 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~ 256 (338)
.. .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||...... ......+..........
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred ccCccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence 22 234578999999999987 67899999999999999999999999543221 12222221111000000
Q ss_pred hhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 257 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
. ....+++++.++|.+||+.||++|||+.++++
T Consensus 241 ~--------------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 241 V--------------------------------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp H--------------------------------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred h--------------------------------hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 0 00126899999999999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=309.75 Aligned_cols=264 Identities=16% Similarity=0.252 Sum_probs=202.0
Q ss_pred eeeeeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 30 SYVIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 30 ~~~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
..-+....++|++.+.||+|+||+||+|.+ .+++.||+|.+.... .+.+.+|+.+++.+ +||||+++++++.+
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~-- 106 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFC-RHPHLVSLIGFCDE-- 106 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSC-CCTTBCCEEEECCC--
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcC--
Confidence 334455678999999999999999999986 468899999876433 45678999999999 89999999999854
Q ss_pred CCccEEEEeeecCCccccccC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccc
Q 019642 107 SKTPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~ 179 (338)
....++||||+.+++|.+++. .+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||+
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~ 185 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDEN-FVPKITDFGI 185 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTT-CCEEECCCTT
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCC-CCEEEeeccc
Confidence 567899999999999988873 38899999999999999999999999999999999999988 8999999999
Q ss_pred cccccCCC---cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCH--HHHHHHHHHhCCch
Q 019642 180 AEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTDE 254 (338)
Q Consensus 180 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~--~~~~~~~~~~~~~~ 254 (338)
+....... ......|++.|+|||++.+ ..++.++||||||+++|+|++|+.||....... ..............
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred ccccccccccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 87543221 2233468999999999877 678999999999999999999999995432211 01110000000000
Q ss_pred hhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 255 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
... ..++ ..........+..+.+++.+||+.||++|||+.|++++
T Consensus 265 ~~~-------~~~~----------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 265 LEQ-------IVDP----------------NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp CCS-------SSSS----------------SCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHH-------hcCh----------------hhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000 0000 00001112245679999999999999999999999975
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=303.11 Aligned_cols=243 Identities=17% Similarity=0.253 Sum_probs=195.6
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
...++|++.+.||+|+||+||+|.+ +++.+|+|+++... .+.+.+|+.+++++ +||||+++++++.+.....
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 83 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPAPH 83 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTSSS
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCCCC
Confidence 3467999999999999999999987 48889999987432 35678899999999 9999999999997765578
Q ss_pred cEEEEeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCeEecCCCCceEEEecccccc
Q 019642 110 PSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~~~~~~l~dfg~~~~ 182 (338)
.++||||+.+++|.+++. .+++..++.++.|++.||.|||+.| ++|+||||+||+++.+ +.++|+|||++..
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~-~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDED-MTARISMADVKFS 162 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTT-SCEEEEGGGSCCT
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCC-cceeEEeccceee
Confidence 899999999999988873 3899999999999999999999999 9999999999999988 7899999888754
Q ss_pred ccCCCcceeeeccccccccccccCcC--CCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhh
Q 019642 183 YHPGKEYNVRVASRYFKGPELLVDLQ--DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 260 (338)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.. .....+|+.|+|||++.+.. ..+.++||||||+++|+|++|..||.. .+..+...........
T Consensus 163 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~-~~~~~~~~~~~~~~~~-------- 229 (271)
T 3kmu_A 163 FQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD-LSNMEIGMKVALEGLR-------- 229 (271)
T ss_dssp TS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTT-SCHHHHHHHHHHSCCC--------
T ss_pred ec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccc-cChHHHHHHHHhcCCC--------
Confidence 32 22346789999999987632 233379999999999999999999842 2222222221110000
Q ss_pred ccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
...+..+++++.++|.+||+.||++|||+.++++
T Consensus 230 ---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 230 ---------------------------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp ---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0112237899999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=304.92 Aligned_cols=247 Identities=17% Similarity=0.313 Sum_probs=198.5
Q ss_pred eccCCcEEEEE-eeeecCceeEEEEEEc--CCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 34 FSDQDDYEVVR-KVGRGKYSEVFEGINV--NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 34 ~~~~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
....++|.+.+ .||+|+||.||+|.+. .++..|++|+++.. ..+.+.+|+.+++++ +||||+++++++..
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-- 81 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-- 81 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES--
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEecC--
Confidence 34567888887 9999999999999864 46788999998753 245678999999999 99999999999833
Q ss_pred CCccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccc
Q 019642 107 SKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~ 182 (338)
...++||||+.+++|.+++. .+++..++.++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||++..
T Consensus 82 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 82 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR-HYAKISDFGLSKA 159 (287)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET-TEEEECCCTTCEE
T ss_pred -CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCC-CCEEECcccceee
Confidence 35789999999999988763 48999999999999999999999999999999999999988 8999999999876
Q ss_pred ccCCCc----ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhh
Q 019642 183 YHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNA 257 (338)
Q Consensus 183 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
...... .....+++.|+|||++.+ ..++.++|+||||+++|+|++ |..||.. .+..+....+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~i~~~~------- 230 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKK-MKGPEVMAFIEQGK------- 230 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTT-CCTHHHHHHHHTTC-------
T ss_pred eccCcceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHhcCC-------
Confidence 643322 122345788999999876 578899999999999999998 9999843 23333222221100
Q ss_pred hhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCC
Q 019642 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp 323 (338)
....+..+++++.++|.+||+.||++|||+.+++++.
T Consensus 231 -----------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 231 -----------------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp -----------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred -----------------------------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 0011223789999999999999999999999999873
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=301.71 Aligned_cols=242 Identities=17% Similarity=0.315 Sum_probs=197.0
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
..++|++.+.||+|+||.||+|.+. ++..|++|.++.. ..+.+.+|+.+++++ +||||+++++++.+ ...++|
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~~~~v 85 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ---EPIYII 85 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhC-CCcCcceEEEEEcC---CCcEEE
Confidence 3579999999999999999999865 5678999998753 457788999999999 99999999999843 357899
Q ss_pred EeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 114 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 114 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
|||+.+++|.+++. .+++..+..++.|++.||.+||++|++|+||||+||+++.+ +.++|+|||.+........
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT-LSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECSSSCE
T ss_pred EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCC-CCEEECCCcccccccCccc
Confidence 99999999998885 48999999999999999999999999999999999999987 8999999999876543321
Q ss_pred --ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 189 --YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 189 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
.....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||. ..+..+....+.+..
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~-~~~~~~~~~~~~~~~--------------- 227 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYP-GMTNPEVIQNLERGY--------------- 227 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSST-TCCHHHHHHHHHTTC---------------
T ss_pred ccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCc-ccCHHHHHHHHhccc---------------
Confidence 122345678999999876 578899999999999999999 888883 222222222211100
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
....+..+++++.+++.+||+.||++|||+.++++
T Consensus 228 ---------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 228 ---------------------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp ---------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00111237899999999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=305.16 Aligned_cols=249 Identities=17% Similarity=0.300 Sum_probs=196.4
Q ss_pred eeeeeccCCcEEEEE-eeeecCceeEEEEEE--cCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeee
Q 019642 30 SYVIFSDQDDYEVVR-KVGRGKYSEVFEGIN--VNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDI 101 (338)
Q Consensus 30 ~~~i~~~~~~y~~~~-~lg~G~~g~V~~~~~--~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~ 101 (338)
...+..+.++|++.+ .||+|+||+||+|.+ ..+++.|++|+++... .+.+.+|+.+++.+ +||||++++++
T Consensus 8 ~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 86 (291)
T 1xbb_A 8 PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGI 86 (291)
T ss_dssp ---CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEE
T ss_pred cceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEE
Confidence 334455678999999 999999999999954 5667899999987432 45688999999999 99999999999
Q ss_pred eeccCCCccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecc
Q 019642 102 VRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG 178 (338)
Q Consensus 102 ~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg 178 (338)
+. ....++||||+.+++|.+++ ..+++..++.++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||
T Consensus 87 ~~---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg 162 (291)
T 1xbb_A 87 CE---AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFG 162 (291)
T ss_dssp EE---SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCT
T ss_pred EC---CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCC-CcEEEccCC
Confidence 83 34678999999999998876 348999999999999999999999999999999999999988 899999999
Q ss_pred ccccccCCCcc----eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCc
Q 019642 179 LAEFYHPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTD 253 (338)
Q Consensus 179 ~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (338)
++......... ....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||.. .+..+ ..........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~-~~~~~~~~~~- 238 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSE-VTAMLEKGER- 238 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHH-HHHHHHTTCC-
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCCC-CCHHH-HHHHHHcCCC-
Confidence 98765433321 12345678999999876 568899999999999999999 9999842 22222 1111110000
Q ss_pred hhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 254 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
...+..+++++.++|.+||+.||++|||+.++++
T Consensus 239 ----------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 239 ----------------------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp ----------------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0011237899999999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=315.70 Aligned_cols=259 Identities=14% Similarity=0.184 Sum_probs=200.5
Q ss_pred ceeeeeccCCcEEEEEeeeecCceeEEEEEEcC--------CCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeE---
Q 019642 29 SSYVIFSDQDDYEVVRKVGRGKYSEVFEGINVN--------TNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVK--- 97 (338)
Q Consensus 29 ~~~~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~--- 97 (338)
...+.....++|++.+.||+|+||.||+|.+.. .++.||+|.+... +.+.+|+.+++++ +||||++
T Consensus 33 g~~i~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--~~~~~E~~~l~~l-~h~niv~~~~ 109 (352)
T 2jii_A 33 GTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQNFFQRA-AKPLQVNKWK 109 (352)
T ss_dssp TCEEECTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--STHHHHHHHHHHH-CCHHHHHHHH
T ss_pred CceeecccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--chHHHHHHHHHHh-cccchhhhhh
Confidence 344445667899999999999999999999987 4889999998744 5678999999999 8999887
Q ss_pred ------------eeeeeeccCCCccEEEEeeecCCcccccc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 019642 98 ------------LLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKP 160 (338)
Q Consensus 98 ------------~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp 160 (338)
+++++.. .....++||||+ +++|.+++ ..+++..++.++.|++.||.|||++|++|+||||
T Consensus 110 ~~~~~~~~~i~~~~~~~~~-~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp 187 (352)
T 2jii_A 110 KLYSTPLLAIPTCMGFGVH-QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTA 187 (352)
T ss_dssp HHTTCTTCSCCCCCEEEEE-TTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCG
T ss_pred hhccCCccCccchhhcccc-CCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCH
Confidence 4455433 246789999999 88888876 3589999999999999999999999999999999
Q ss_pred CCeEecCCCC--ceEEEeccccccccCCC--------cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcC
Q 019642 161 HNVMIDHELR--KLRLIDWGLAEFYHPGK--------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRK 230 (338)
Q Consensus 161 ~NIli~~~~~--~~~l~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~ 230 (338)
+||+++.+ + .++|+|||++....... ......+++.|+|||++.+ ..++.++||||||+++|+|++|.
T Consensus 188 ~NIl~~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~ 265 (352)
T 2jii_A 188 ENIFVDPE-DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGF 265 (352)
T ss_dssp GGEEEETT-EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSC
T ss_pred HHEEEcCC-CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCC
Confidence 99999987 5 89999999996553221 1123478999999999887 67899999999999999999999
Q ss_pred CCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCc
Q 019642 231 EPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 310 (338)
Q Consensus 231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP 310 (338)
.||.......+............. ... .........+++++.++|.+||+.||
T Consensus 266 ~pf~~~~~~~~~~~~~~~~~~~~~-~~~--------------------------~~~~~~~~~~~~~l~~li~~~l~~dp 318 (352)
T 2jii_A 266 LPWTNCLPNTEDIMKQKQKFVDKP-GPF--------------------------VGPCGHWIRPSETLQKYLKVVMALTY 318 (352)
T ss_dssp CTTGGGTTCHHHHHHHHHHHHHSC-CCE--------------------------ECTTSCEECCCHHHHHHHHHHHTCCT
T ss_pred CCcccCCcCHHHHHHHHHhccCCh-hhh--------------------------hhhccccCCCcHHHHHHHHHHHhCCh
Confidence 999655434444333322111000 000 00000011268999999999999999
Q ss_pred CCcCCHHHHhc
Q 019642 311 QDRLTAREAMA 321 (338)
Q Consensus 311 ~~Rpt~~ell~ 321 (338)
++|||+.++++
T Consensus 319 ~~Rps~~~l~~ 329 (352)
T 2jii_A 319 EEKPPYAMLRN 329 (352)
T ss_dssp TCCCCHHHHHH
T ss_pred hhCCCHHHHHH
Confidence 99999999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=327.70 Aligned_cols=244 Identities=17% Similarity=0.339 Sum_probs=200.0
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
..++|++.+.||+|+||.||+|.+..++..||+|.++.. ..+.+.+|+.+++++ +||||+++++++.. ....++|
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~--~~~~~lv 294 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--EPPFYII 294 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSCEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhc-CCCCEeeEEEEEec--CCcEEEE
Confidence 456899999999999999999999999999999998753 457788999999999 99999999999954 4578999
Q ss_pred EeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 114 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 114 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
|||+.+++|.+++. .+++..+..++.|++.||.|||++|++|+||||+|||++.+ +.+||+|||++........
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGEN-HLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG-GCEEECCTTCEECCTTCCE
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCC-CcEEEeecccceeccCCce
Confidence 99999999988762 48899999999999999999999999999999999999988 8999999999976543221
Q ss_pred --ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 189 --YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 189 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
.....++..|+|||++.+ ..++.++||||||+++|+|++ |..||. ..+..+....+....
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~-~~~~~~~~~~~~~~~--------------- 436 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYP-GIDLSQVYELLEKDY--------------- 436 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSST-TCCGGGHHHHHHTTC---------------
T ss_pred eecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHcCC---------------
Confidence 112345678999999876 678999999999999999999 888873 323222222111100
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
....+..+++++.+||.+||+.||++|||+.++++
T Consensus 437 ---------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 437 ---------------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp ---------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 00112237899999999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=309.46 Aligned_cols=244 Identities=18% Similarity=0.312 Sum_probs=190.9
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceE----EEEEecc----cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERC----IIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~----aiK~~~~----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
...++|++.+.||+|+||+||+|.+..+++.+ ++|.+.. ...+.+.+|+.+++++ +||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~- 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS- 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEESS-
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEecC-
Confidence 44689999999999999999999998888765 5665542 3456788999999999 999999999998653
Q ss_pred CCccEEEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccc
Q 019642 107 SKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~ 182 (338)
..+++++++.+++|.+++ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++..
T Consensus 90 --~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 90 --TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKL 166 (327)
T ss_dssp --SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCTTC---
T ss_pred --CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCC-CCEEEccCcceeE
Confidence 367999999999988776 348999999999999999999999999999999999999988 8999999999976
Q ss_pred ccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhh
Q 019642 183 YHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAY 258 (338)
Q Consensus 183 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||.. .+..+....+... ..
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~~~-~~------ 237 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKG-ER------ 237 (327)
T ss_dssp -------------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTT-CC------
T ss_pred ccCccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcC-CC------
Confidence 543222 222345778999999987 678999999999999999999 9999832 2222222211110 00
Q ss_pred hhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
...+..++.++.++|.+||+.||++|||+.|+++
T Consensus 238 -----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 238 -----------------------------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp -----------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0012226889999999999999999999999997
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=313.01 Aligned_cols=252 Identities=17% Similarity=0.283 Sum_probs=195.9
Q ss_pred ccCCcEEEEEeeeecCceeEEEEE-----EcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeecc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGI-----NVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ 105 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 105 (338)
...++|++.+.||+|+||.||+|. +..+++.||+|.+... ....+.+|+.+++++ +||||+++++++..
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~- 104 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQ- 104 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS-
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC-CCCCCCeEEEEEcC-
Confidence 456899999999999999999998 5567889999998643 235678899999999 99999999999954
Q ss_pred CCCccEEEEeeecCCccccccC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC--CCceE
Q 019642 106 HSKTPSLIFEYVNSTDFKVLYP----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLR 173 (338)
Q Consensus 106 ~~~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~--~~~~~ 173 (338)
....++||||+.+++|.+++. .+++..++.++.|++.||.+||++|++|+||||+||+++.+ ...++
T Consensus 105 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 105 -SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred -CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 456789999999999988762 38899999999999999999999999999999999999843 25699
Q ss_pred EEeccccccccCCC---cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHH
Q 019642 174 LIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKV 249 (338)
Q Consensus 174 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~ 249 (338)
|+|||++....... ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.. .+..+....+...
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~ 261 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTSG 261 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHTT
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC-cCHHHHHHHHhcC
Confidence 99999986543222 1223456788999999877 678999999999999999998 8888832 2222222211110
Q ss_pred hCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcch
Q 019642 250 LGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 327 (338)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 327 (338)
.. ...+..+++.+.++|.+||+.||++|||+.+++++.|+..
T Consensus 262 -~~-----------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 262 -GR-----------------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp -CC-----------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CC-----------------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 00 0011237889999999999999999999999999987654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=318.83 Aligned_cols=245 Identities=18% Similarity=0.322 Sum_probs=187.0
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEc---CCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
...++|++.+.||+|+||.||+|.+. .++..||+|.++.. ..+.+.+|+.+++++ +||||+++++++.. .
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~ 118 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTK--S 118 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--S
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEee--C
Confidence 34568999999999999999999876 46778999998743 245678999999999 99999999999954 5
Q ss_pred CccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 108 KTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
...++||||+.+++|.+++. .+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++...
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN-LVCKVSDFGLGRVL 197 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCC------
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCC-CCEEECcCcccccc
Confidence 67899999999999988863 48999999999999999999999999999999999999988 89999999998765
Q ss_pred cCCCc----ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhh
Q 019642 184 HPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAY 258 (338)
Q Consensus 184 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
..... .....++..|+|||++.+ ..++.++||||||+++|++++ |..||... +..+....+.....
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~-~~~~~~~~i~~~~~------- 268 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIKAVDEGYR------- 268 (373)
T ss_dssp ----------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTC-CHHHHHHHHHTTEE-------
T ss_pred ccCCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCC-------
Confidence 43221 111234668999999877 678999999999999999998 99998432 22222221111000
Q ss_pred hhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
...+..++..+.++|.+||+.||++|||+.++++
T Consensus 269 -----------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 269 -----------------------------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp -----------------------------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 0011226889999999999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=321.52 Aligned_cols=242 Identities=17% Similarity=0.324 Sum_probs=196.2
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
.+.++|++.+.||+|+||.||+|.+. ++.||||+++.. ..+.+.+|+.+++++ +||||+++++++... ....++|
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~~~~~iv 265 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEE-KGGLYIV 265 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTC-CCTTBCCEEEEEECT-TSCEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhc-cCCCEEEEEEEEEcC-CCceEEE
Confidence 34579999999999999999999874 779999999754 456788999999999 999999999997553 2368999
Q ss_pred EeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 114 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 114 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
|||+.+++|.+++. .+++..+..++.|++.||.|||++|++|+||||+|||++.+ +.+||+|||++......
T Consensus 266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-SCEEECCCTTCEECC----
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCC-CCEEEeeCCCccccccc--
Confidence 99999999988873 27899999999999999999999999999999999999988 89999999998754322
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
.....++..|+|||++.+ ..++.++||||||+++|+|++ |..||... +..+....+.+..
T Consensus 343 ~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~-~~~~~~~~i~~~~----------------- 403 (450)
T 1k9a_A 343 QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGY----------------- 403 (450)
T ss_dssp ----CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTS-CTTTHHHHHHTTC-----------------
T ss_pred ccCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCC-----------------
Confidence 222356788999999977 679999999999999999998 99998432 2222222211100
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
....+..+++++.++|.+||+.||++|||+.++++
T Consensus 404 -------------------~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 404 -------------------KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp -------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 00112237899999999999999999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=322.38 Aligned_cols=243 Identities=15% Similarity=0.289 Sum_probs=198.5
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
...++|++.+.||+|+||.||+|.+. ++..||||.++.. ..+.+.+|+.+++++ +||||+++++++. ....++
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~---~~~~~l 259 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVT---KEPIYI 259 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEC---SSSCEE
T ss_pred echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhC-CCCCEeeEEEEEe---CCccEE
Confidence 34578999999999999999999875 4678999998753 467789999999999 9999999999984 346789
Q ss_pred EEeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 113 IFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 113 v~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
||||+.+++|.+++. .++...+..++.|++.||.|||++|++|+||||+|||++.+ +.+||+|||++.......
T Consensus 260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS-LVCKIADFGLARVIEDNE 338 (454)
T ss_dssp EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTT-CCEEECSTTGGGGBCCHH
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCC-CcEEEeeCCCceEcCCCc
Confidence 999999999988874 48899999999999999999999999999999999999988 899999999997654321
Q ss_pred c--ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccc
Q 019642 188 E--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264 (338)
Q Consensus 188 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
. .....++..|+|||++.. ..++.++||||||+++|+|++ |..||. +.+..+....+......
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~-~~~~~~~~~~i~~~~~~------------ 404 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYP-GMSNPEVIRALERGYRM------------ 404 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSST-TCCHHHHHHHHHHTCCC------------
T ss_pred eeccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHcCCCC------------
Confidence 1 122345678999999976 678999999999999999999 999983 33333333322221000
Q ss_pred ccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
..+..+++++.++|.+||+.||++|||+.++++
T Consensus 405 ------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 405 ------------------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp ------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 011236899999999999999999999999975
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=303.34 Aligned_cols=242 Identities=26% Similarity=0.416 Sum_probs=188.1
Q ss_pred CCcEEEE-EeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeec--cCCCccEEE
Q 019642 37 QDDYEVV-RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRD--QHSKTPSLI 113 (338)
Q Consensus 37 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~~~lv 113 (338)
.++|.+. +.||+|+||.||++.+..+++.||+|+++. .....+|+.++.++.+||||+++++++.. ......++|
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 93 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 93 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEE
Confidence 4678887 779999999999999999999999999874 45677899998666699999999999854 224578999
Q ss_pred EeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC--CCceEEEeccccccccCC
Q 019642 114 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 114 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~--~~~~~l~dfg~~~~~~~~ 186 (338)
|||+.+++|.+++. .+++..++.++.|++.||.|||++|++|+||||+||+++.. .+.++|+|||++....
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-- 171 (299)
T 3m2w_A 94 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-- 171 (299)
T ss_dssp ECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT--
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc--
Confidence 99999999887762 48999999999999999999999999999999999999873 3789999999885422
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
+ ..++.++||||||+++|+|++|..||....... ..... .
T Consensus 172 -------------------~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~---------~---------- 211 (299)
T 3m2w_A 172 -------------------G-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-ISPGM---------K---------- 211 (299)
T ss_dssp -------------------T-CGGGGHHHHHHHHHHHHHHHHSSCSCCC--------CCS---------C----------
T ss_pred -------------------c-ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh-hhHHH---------H----------
Confidence 1 356779999999999999999999994321110 00000 0
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
........ .........+++++.+||.+||+.||++|||+.|+|+||||++....+
T Consensus 212 --------~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~ 267 (299)
T 3m2w_A 212 --------TRIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 267 (299)
T ss_dssp --------CSSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSC
T ss_pred --------HHHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCC
Confidence 00000000 000000123789999999999999999999999999999998876543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=309.12 Aligned_cols=260 Identities=21% Similarity=0.346 Sum_probs=197.8
Q ss_pred CCcEEEEEeeeecCceeEEEEE----EcCCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
.+.|++.+.||+|+||+||++. +..+++.||+|+++... .+.+.+|+.+++++ +||||+++++++.+....
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTTT
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhC-CCcchhhEEEEEecCCCc
Confidence 3456999999999999997775 44578899999987543 45578999999999 899999999999876667
Q ss_pred ccEEEEeeecCCccccccC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 109 TPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
..++||||+.+++|.+++. .+++..++.++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||++......
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~-~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCGGGCEECCTT
T ss_pred eEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCC-CCEEECCcccccccccc
Confidence 8899999999999998874 48999999999999999999999999999999999999988 89999999999776543
Q ss_pred Cc----ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcc
Q 019642 187 KE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262 (338)
Q Consensus 187 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
.. .....++..|+|||++.+ ..++.++||||||+++|+|++|..||.... .. ..............
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~---~~---~~~~~~~~~~~~~~--- 257 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPP---TK---FLELIGIAQGQMTV--- 257 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHH---HH---HHHHHCSCCHHHHH---
T ss_pred ccccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccccc---hh---hhhhhcccccchhH---
Confidence 32 223456778999999977 578899999999999999999999983211 11 00111100000000
Q ss_pred ccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
........... ....+..+++++.+||++||+.||++|||+.++++
T Consensus 258 -----~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 258 -----LRLTELLERGE--------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp -----HHHHHHHHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----HHHHHHHhccc--------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 00000000000 01112337899999999999999999999999985
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=316.85 Aligned_cols=284 Identities=18% Similarity=0.287 Sum_probs=197.9
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHH--HhcCCCCeeEeeeeeec---cCCCc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQ--NLCGGPNVVKLLDIVRD---QHSKT 109 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~--~l~~h~~iv~~~~~~~~---~~~~~ 109 (338)
.+.++|++.+.||+|+||.||+|.+ +++.||+|+++.........|.++.. .+ +||||+++++.+.. .....
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLM-EHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECTTSCEE
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhc-cCcchhhheecccccccCCCce
Confidence 4568999999999999999999966 78999999998766666666665544 35 89999999975532 23345
Q ss_pred cEEEEeeecCCcccccc--CCCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCCeEecCCCCceEEEecc
Q 019642 110 PSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQ---------GIMHRDVKPHNVMIDHELRKLRLIDWG 178 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---------~i~H~dikp~NIli~~~~~~~~l~dfg 178 (338)
.++||||+.+++|.+++ ...++..++.++.|++.||.|||+. |++|+||||+|||++.+ +.+||+|||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~-~~~kL~DFG 165 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND-GTCVISDFG 165 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT-SCEEECCCT
T ss_pred EEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC-CcEEEeecc
Confidence 78999999999998887 3578889999999999999999999 99999999999999988 899999999
Q ss_pred ccccccCCC---------cceeeeccccccccccccCc------CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHH
Q 019642 179 LAEFYHPGK---------EYNVRVASRYFKGPELLVDL------QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 243 (338)
Q Consensus 179 ~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~------~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~ 243 (338)
++....... ......||+.|+|||++.+. ..++.++||||||+++|+|++|..||+......+..
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 997654321 11234689999999998752 245678999999999999999988886654432211
Q ss_pred HHHHHHhCCchhhhhhhccccccCcchhhhhc-cccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHH---
Q 019642 244 VKIAKVLGTDELNAYLNKYHLELDPQLDALVG-RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA--- 319 (338)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~el--- 319 (338)
.......+....... ...... .......... ......+++++.+||.+||+.||++|||+.|+
T Consensus 246 ~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~ 312 (336)
T 3g2f_A 246 MAFQTEVGNHPTFED-----------MQVLVSREKQRPKFPEA--WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER 312 (336)
T ss_dssp CTTHHHHCSSCCHHH-----------HHHHHTTSCCCCCCCTT--CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HhhhcccCCCchHHH-----------HHhhhcccccCCCCCcc--cccccchHHHHHHHHHHHhcCChhhCcchHHHHHH
Confidence 111111111000000 000000 0000000000 00011135579999999999999999999999
Q ss_pred ---hcCCCcchhhhccccc
Q 019642 320 ---MAHPYFAQVRAAESSR 335 (338)
Q Consensus 320 ---l~hp~~~~~~~~~~~~ 335 (338)
+.++|-++-..++.+.
T Consensus 313 L~~ll~~~~~~~~~~~~~~ 331 (336)
T 3g2f_A 313 MAELMMIWERNKSVSPTAH 331 (336)
T ss_dssp HHHHHHCCCC---------
T ss_pred HHHHHHHHHhcccCCCccc
Confidence 5578888776666554
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=313.46 Aligned_cols=265 Identities=18% Similarity=0.243 Sum_probs=200.1
Q ss_pred eeeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 32 VIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 32 ~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
.+....++|++.+.||+|+||+||+|.+ .+++.||+|.+.... ...+.+|+.+++.+ +||||+++++++.. .
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~ 99 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT--P 99 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTC-CCTTBCCCCEEECC--S
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhc-cCCCccceEEEEec--C
Confidence 3445678999999999999999999974 468899999987432 33688999999999 89999999999954 5
Q ss_pred CccEEEEeeecCCccccccC-------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCCeEecCCCCceEEEec
Q 019642 108 KTPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHELRKLRLIDW 177 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~~~l~df 177 (338)
...++||||+.+++|.+++. .+++..++.++.|++.||.|||+. |++|+||||+||+++.+ +.++|+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~-~~~kl~Df 178 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDF 178 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTT-CCEEECCC
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCC-CCEEeccC
Confidence 57789999999999987763 289999999999999999999999 99999999999999988 89999999
Q ss_pred cccccccCCCc--ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCC----CCCHHHHHHHHHHhC
Q 019642 178 GLAEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG----HDNHDQLVKIAKVLG 251 (338)
Q Consensus 178 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~----~~~~~~~~~~~~~~~ 251 (338)
|++........ .....|++.|+|||++.+ ..++.++||||||+++|+|++|..||... ...............
T Consensus 179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 3uim_A 179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257 (326)
T ss_dssp SSCEECCSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred ccccccCcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence 99976543322 233458999999999876 56899999999999999999999999310 000000000000000
Q ss_pred CchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 252 TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
.. ......... .........+..+.+++.+||+.||++|||+.|+++|-.-
T Consensus 258 ~~---------------~~~~~~~~~--------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 258 EK---------------KLEALVDVD--------LQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp SC---------------CSTTSSCTT--------CTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred ch---------------hhhhhcChh--------hccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 00 000000000 0001111234679999999999999999999999987543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=314.16 Aligned_cols=243 Identities=15% Similarity=0.239 Sum_probs=195.4
Q ss_pred eeccCCcEEEEEeeeecCceeEEEE-----EEcCCCceEEEEEecccchHHHHHHHHHHHHhcC---CCCeeEeeeeeec
Q 019642 33 IFSDQDDYEVVRKVGRGKYSEVFEG-----INVNTNERCIIKILKPVKKKKIKREIKILQNLCG---GPNVVKLLDIVRD 104 (338)
Q Consensus 33 i~~~~~~y~~~~~lg~G~~g~V~~~-----~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~---h~~iv~~~~~~~~ 104 (338)
+....++|++.+.||+|+||+||+| .+..+++.||+|+++......+..|+.+++.+ + |+|++++++.+..
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l-~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERL-KPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHS-CGGGGGGBCCEEEEEEC
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHh-hhhhhhhhhhhheeeec
Confidence 3445689999999999999999999 46778999999999988888899999999988 5 8999999999855
Q ss_pred cCCCccEEEEeeecCCccccccC--------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecC---------
Q 019642 105 QHSKTPSLIFEYVNSTDFKVLYP--------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--------- 167 (338)
Q Consensus 105 ~~~~~~~lv~e~~~~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~--------- 167 (338)
....++||||+.+++|.+++. .+++..++.++.|++.||.|||++||+|+||||+|||++.
T Consensus 139 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 139 --QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp --SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC----
T ss_pred --CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccc
Confidence 457789999999999988762 4999999999999999999999999999999999999987
Q ss_pred --CCCceEEEecccccccc---CCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHH
Q 019642 168 --ELRKLRLIDWGLAEFYH---PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 242 (338)
Q Consensus 168 --~~~~~~l~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~ 242 (338)
+ +.+||+|||++.... .........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....+....
T Consensus 217 ~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 294 (365)
T 3e7e_A 217 DLS-AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK 294 (365)
T ss_dssp --C-TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE
T ss_pred ccc-CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCccccCCCCcee
Confidence 5 799999999996543 2233344578999999999987 56899999999999999999999998432110000
Q ss_pred HHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 243 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
. .. .. .....++.+.+++..||+.+|.+|++..+.+.+
T Consensus 295 -----------------------~----~~--------~~-------~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 295 -----------------------P----EG--------LF-------RRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp -----------------------E----CS--------CC-------TTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred -----------------------e----ch--------hc-------cccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 0 00 00 000136778999999999999999765555543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=311.19 Aligned_cols=253 Identities=20% Similarity=0.331 Sum_probs=184.6
Q ss_pred ceeeeeccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEeeeeeec-
Q 019642 29 SSYVIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRD- 104 (338)
Q Consensus 29 ~~~~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 104 (338)
....+.....+|++.+.||+|+||.||+|.+..+++.||+|.+.... .+.+.+|+.+++++.+||||+++++++..
T Consensus 19 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 19 VGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp TTCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred hcceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 34455566779999999999999999999999999999999885433 45678899999999559999999998842
Q ss_pred -----cCCCccEEEEeeecCCcccccc------CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCeEecCCCCc
Q 019642 105 -----QHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRK 171 (338)
Q Consensus 105 -----~~~~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~~~~ 171 (338)
......+++|||+.| +|.+++ ..+++..++.++.|++.||.|||+.| ++|+||||+||+++.+ +.
T Consensus 99 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~-~~ 176 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCKG-QLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ-GT 176 (337)
T ss_dssp TTTSTTSSEEEEEEEECCSE-EHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTT-SC
T ss_pred ccccccCCceEEEEEEecCC-CHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCC-CC
Confidence 223457899999985 444433 34999999999999999999999999 9999999999999988 79
Q ss_pred eEEEeccccccccCCCcc-------------eeeecccccccccccc--CcCCCCCcchhHHHHHHHHHHHhcCCCCcCC
Q 019642 172 LRLIDWGLAEFYHPGKEY-------------NVRVASRYFKGPELLV--DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 236 (338)
Q Consensus 172 ~~l~dfg~~~~~~~~~~~-------------~~~~~~~~y~aPE~~~--~~~~~~~~~DvwslG~~l~~lltg~~pf~~~ 236 (338)
++|+|||++......... ....+++.|+|||++. ....++.++||||||+++|+|++|..||...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 999999999765432221 1345889999999983 2256888999999999999999999998321
Q ss_pred CCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCH
Q 019642 237 HDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 316 (338)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~ 316 (338)
.. . ...... .........+..+.+||.+||+.||++|||+
T Consensus 257 ~~-~---~~~~~~------------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 296 (337)
T 3ll6_A 257 AK-L---RIVNGK------------------------------------YSIPPHDTQYTVFHSLIRAMLQVNPEERLSI 296 (337)
T ss_dssp -------------------------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCH
T ss_pred hH-H---HhhcCc------------------------------------ccCCcccccchHHHHHHHHHccCChhhCcCH
Confidence 11 0 000000 0001112256789999999999999999999
Q ss_pred HHHhcCC
Q 019642 317 REAMAHP 323 (338)
Q Consensus 317 ~ell~hp 323 (338)
.|++++-
T Consensus 297 ~e~l~~l 303 (337)
T 3ll6_A 297 AEVVHQL 303 (337)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999873
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=307.34 Aligned_cols=247 Identities=15% Similarity=0.278 Sum_probs=191.9
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCCC----ceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeecc
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTN----ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQ 105 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 105 (338)
....++|++.+.||+|+||+||+|.+..++ ..|++|.++... ...+.+|+.+++++ +||||+++++++..
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~- 117 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISK- 117 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS-
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEec-
Confidence 345689999999999999999999886553 359999987432 34577899999999 99999999999844
Q ss_pred CCCccEEEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 106 HSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 106 ~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
....++||||+.+++|.+++ ..+++..++.++.|++.||.+||++|++|+||||+||+++.+ +.++|+|||++.
T Consensus 118 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 118 -YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN-LVCKVSDFGLSR 195 (333)
T ss_dssp -SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCCCC--
T ss_pred -CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCC-CcEEECCCCcch
Confidence 56789999999999998876 348999999999999999999999999999999999999988 899999999987
Q ss_pred cccCCCc----ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhh
Q 019642 182 FYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELN 256 (338)
Q Consensus 182 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (338)
....... .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||... +..+....+.....
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~-~~~~~~~~~~~~~~----- 268 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWEL-SNHEVMKAINDGFR----- 268 (333)
T ss_dssp ---------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHHTTCC-----
T ss_pred hhccccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccC-CHHHHHHHHHCCCc-----
Confidence 6543221 122345678999999877 678999999999999999999 99998432 22222221111000
Q ss_pred hhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 257 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
...+..+++.+.++|.+||+.||++||++.+++++
T Consensus 269 -------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 269 -------------------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp -------------------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -------------------------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00112368899999999999999999999999874
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=309.97 Aligned_cols=256 Identities=20% Similarity=0.294 Sum_probs=193.1
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhc-CCCCeeEeeeeeeccCC--CccEEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLC-GGPNVVKLLDIVRDQHS--KTPSLI 113 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~-~h~~iv~~~~~~~~~~~--~~~~lv 113 (338)
.++|++.+.||+|+||.||+|.+. ++.||+|++..........|.+++..+. +||||+++++++..... ...++|
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 113 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLI 113 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEE
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEE
Confidence 468999999999999999999874 8899999998766666666766666542 89999999999866432 578999
Q ss_pred EeeecCCccccccC--CCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 114 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQ--------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 114 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~--------~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
|||+.+++|.+++. .+++..++.++.|++.||.|||+. |++|+||||+||+++.+ +.+||+|||++...
T Consensus 114 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~-~~~kl~Dfg~a~~~ 192 (337)
T 3mdy_A 114 TDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKF 192 (337)
T ss_dssp ECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT-SCEEECCCTTCEEC
T ss_pred EeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC-CCEEEEeCCCceee
Confidence 99999999988873 589999999999999999999999 99999999999999988 79999999998665
Q ss_pred cCCCc-----ceeeeccccccccccccCcCCCCCc------chhHHHHHHHHHHHhc----------CCCCcCCCCCHHH
Q 019642 184 HPGKE-----YNVRVASRYFKGPELLVDLQDYDYS------LDMWSLGCMFAGMIFR----------KEPFFYGHDNHDQ 242 (338)
Q Consensus 184 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~------~DvwslG~~l~~lltg----------~~pf~~~~~~~~~ 242 (338)
..... .....||+.|+|||++.+ ...+.. +||||||+++|+|++| ..||.........
T Consensus 193 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~ 271 (337)
T 3mdy_A 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDE-SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271 (337)
T ss_dssp C---------CCSSCSCGGGCCHHHHTT-CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccccccccCCCCCCccCcceeChhhccc-ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCc
Confidence 43222 123478999999999976 344443 9999999999999999 6666432222111
Q ss_pred HHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 243 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
............. .... ........+++++.++|.+||+.||++|||+.+++++
T Consensus 272 ~~~~~~~~~~~~~-----------------------~~~~---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 272 YEDMREIVCIKKL-----------------------RPSF---PNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp HHHHHHHHTTSCC-----------------------CCCC---CGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhhhHHHHhhhcc-----------------------Cccc---cccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 1211111111000 0000 0000111256789999999999999999999999985
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=302.08 Aligned_cols=242 Identities=16% Similarity=0.319 Sum_probs=190.0
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
...++|++.+.||+|+||+||++.+ +++.|++|.++.. ..+.+.+|+.+++++ +||||+++++++... ....++|
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~~~~lv 93 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEE-KGGLYIV 93 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTC-CCTTBCCEEEEECCC---CCEEE
T ss_pred CChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcC-CCceEEE
Confidence 3468999999999999999999976 4889999998754 456788999999999 899999999987543 3468999
Q ss_pred EeeecCCccccccCC-----CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 114 FEYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 114 ~e~~~~~~l~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
|||+.+++|.+++.. +++..++.++.|++.||.+||++|++|+||||+||+++.+ +.++|+|||++......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-SCEEECCCCC---------
T ss_pred EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCC-CcEEEeecccccccccc--
Confidence 999999999888743 8899999999999999999999999999999999999988 79999999998754322
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
.....+++.|+|||++.+ ..++.++|+||||+++|+|++ |..||... +..+....+...
T Consensus 171 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~-~~~~~~~~~~~~------------------ 230 (278)
T 1byg_A 171 QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKG------------------ 230 (278)
T ss_dssp -----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CGGGHHHHHTTT------------------
T ss_pred ccCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHhcC------------------
Confidence 223467788999999876 678999999999999999998 99898422 222221111000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
.....+..+++.+.++|.+||+.||++|||+.++++
T Consensus 231 ------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 231 ------------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 000112237899999999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=314.75 Aligned_cols=252 Identities=19% Similarity=0.307 Sum_probs=189.6
Q ss_pred eeeeeccCCcEEEEEeeeecCceeEEEEEEcCCC---ceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeee
Q 019642 30 SYVIFSDQDDYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIV 102 (338)
Q Consensus 30 ~~~i~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 102 (338)
...+......|++.+.||+|+||+||+|.+..++ ..+++|.++.. ..+.+.+|+.+++++ +||||+++++++
T Consensus 81 ~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~ 159 (373)
T 3c1x_A 81 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGIC 159 (373)
T ss_dssp TTBCCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEE
T ss_pred ccccChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEE
Confidence 3344455567999999999999999999875433 46899988642 245678899999999 999999999986
Q ss_pred eccCCCccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecc
Q 019642 103 RDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG 178 (338)
Q Consensus 103 ~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg 178 (338)
... ....++||||+.+++|.+++. .+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||
T Consensus 160 ~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kL~DFG 237 (373)
T 3c1x_A 160 LRS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK-FTVKVADFG 237 (373)
T ss_dssp CCC-SSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCC-
T ss_pred EcC-CCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCC-CCEEEeecc
Confidence 443 346789999999999988873 37889999999999999999999999999999999999988 899999999
Q ss_pred ccccccCCC-----cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhc-CCCCcCCCCCHHHHHHHHHHhCC
Q 019642 179 LAEFYHPGK-----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR-KEPFFYGHDNHDQLVKIAKVLGT 252 (338)
Q Consensus 179 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg-~~pf~~~~~~~~~~~~~~~~~~~ 252 (338)
++....... ......+++.|+|||++.+ ..++.++||||||+++|+|++| ..|| ...+..+....+.+. .
T Consensus 238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~-~~~~~~~~~~~~~~~--~ 313 (373)
T 3c1x_A 238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPY-PDVNTFDITVYLLQG--R 313 (373)
T ss_dssp --------------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSC-TTSCSSCHHHHHHTT--C
T ss_pred ccccccccccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCC-CCCCHHHHHHHHHcC--C
Confidence 987553322 1123456678999999877 6789999999999999999994 5555 433333322222110 0
Q ss_pred chhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 253 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
....+..+++.+.++|.+||+.||++|||+.+++++
T Consensus 314 ----------------------------------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 314 ----------------------------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp ----------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000122368899999999999999999999999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=319.99 Aligned_cols=250 Identities=18% Similarity=0.315 Sum_probs=197.6
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
...++|++.+.||+|+||.||+|.+.. +..||+|.++.. ..+.+.+|+.+++++ +||||+++++++.+ ...++
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~---~~~~i 255 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYI 255 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEE
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEcC---CceEE
Confidence 345789999999999999999999864 466999998753 456789999999999 99999999999844 46789
Q ss_pred EEeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 113 IFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 113 v~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
||||+.+++|.+++. .+++..+..++.|++.||.|||++|++|+||||+|||++.+ +.+||+|||++.......
T Consensus 256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNE 334 (452)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCTTC------
T ss_pred EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCC-CCEEECCCccceecCCCc
Confidence 999999999988874 38999999999999999999999999999999999999987 799999999997654322
Q ss_pred c--ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccc
Q 019642 188 E--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264 (338)
Q Consensus 188 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
. .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||. +....+....+.....
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~-~~~~~~~~~~i~~~~~------------- 399 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYP-GMVNREVLDQVERGYR------------- 399 (452)
T ss_dssp --------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSST-TCCHHHHHHHHHTTCC-------------
T ss_pred eecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHcCCC-------------
Confidence 1 122345678999999876 678999999999999999999 888883 3333332222211000
Q ss_pred ccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc--CCCcchh
Q 019642 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA--HPYFAQV 328 (338)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~--hp~~~~~ 328 (338)
...+..+++.+.++|.+||+.||++|||++++++ ..++...
T Consensus 400 -----------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 400 -----------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp -----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred -----------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 0012237899999999999999999999999987 4666554
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=304.08 Aligned_cols=263 Identities=19% Similarity=0.343 Sum_probs=199.2
Q ss_pred ccCCcEEEEEeeeecCceeEEEEE----EcCCCceEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~---~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
...++|++.+.||+|+||.||++. +..+++.||+|.+.... .+.+.+|+.+++++ +||||+++++++.....
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTC-CCTTBCCEEEEECC---
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEecCC
Confidence 345789999999999999999998 46689999999987543 35678999999999 99999999999876655
Q ss_pred CccEEEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 108 KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
...++||||+.+++|.+++ ..+++..++.++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||++...
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~-~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKVL 195 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCTTCEEC
T ss_pred CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCC-CcEEEecCcchhhc
Confidence 6789999999999998876 348999999999999999999999999999999999999988 89999999999766
Q ss_pred cCCCc----ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhh
Q 019642 184 HPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259 (338)
Q Consensus 184 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
..... .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||... .....+..+........
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~------~~~~~~~~~~~~~~~~~ 268 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSP------PAEFMRMIGNDKQGQMI 268 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSH------HHHHHHHHCTTCCTHHH
T ss_pred cccccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCC------HHHHHHhhccccchhhh
Confidence 43322 122345677999999877 56889999999999999999999887311 11111112211110000
Q ss_pred hccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
. ..+.......... ..+..+++++.++|.+||+.||++|||+.++++
T Consensus 269 ~-------~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 269 V-------FHLIELLKNNGRL--------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp H-------HHHHHHHHTTCCC--------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred H-------HHHHHHhhcCCCC--------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 0000000000000 112337899999999999999999999999985
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=306.28 Aligned_cols=257 Identities=19% Similarity=0.258 Sum_probs=199.2
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHh-cCCCCeeEeeeeeeccCC--CccEEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNL-CGGPNVVKLLDIVRDQHS--KTPSLI 113 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l-~~h~~iv~~~~~~~~~~~--~~~~lv 113 (338)
.++|++.+.||+|+||.||+|.+ +++.||+|+++......+.+|.++++.+ .+||||+++++++..... ...++|
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv 118 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 118 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEE
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEE
Confidence 36899999999999999999987 5899999999887778888999999883 289999999999866432 278999
Q ss_pred EeeecCCccccccC--CCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 114 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCH--------SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 114 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH--------~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
|||+.+++|.+++. .+++..++.++.|++.||.+|| +.|++|+||||+||+++.+ +.++|+|||++...
T Consensus 119 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~ 197 (342)
T 1b6c_B 119 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRH 197 (342)
T ss_dssp ECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTT-SCEEECCCTTCEEE
T ss_pred EeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCC-CCEEEEECCCceec
Confidence 99999999988874 5899999999999999999999 8999999999999999988 79999999998765
Q ss_pred cCCCc-----ceeeeccccccccccccCcCC-----CCCcchhHHHHHHHHHHHhc----------CCCCcCCCCCHHHH
Q 019642 184 HPGKE-----YNVRVASRYFKGPELLVDLQD-----YDYSLDMWSLGCMFAGMIFR----------KEPFFYGHDNHDQL 243 (338)
Q Consensus 184 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~-----~~~~~DvwslG~~l~~lltg----------~~pf~~~~~~~~~~ 243 (338)
..... .....+++.|+|||++.+... ++.++||||||+++|+|++| ..||..........
T Consensus 198 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~ 277 (342)
T 1b6c_B 198 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277 (342)
T ss_dssp ETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccH
Confidence 44332 233478999999999876322 23689999999999999999 77875433222222
Q ss_pred HHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 244 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
..+.+........ .... ........++.+.++|.+||+.||++|||+.+++++
T Consensus 278 ~~~~~~~~~~~~~-----------------------~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 278 EEMRKVVCEQKLR-----------------------PNIP---NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp HHHHHHHTTSCCC-----------------------CCCC---GGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHhC-----------------------CCCc---ccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 2222221110000 0000 000011135679999999999999999999999976
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=316.83 Aligned_cols=248 Identities=19% Similarity=0.302 Sum_probs=195.3
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc-cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEe
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 115 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e 115 (338)
.++|++.+.||+|+||.||+|.+..+++.||||+++. .....+..|+.+++.+.++++++.+..++.. ....++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~--~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVE--GDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEE--TTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEee--CCEEEEEEE
Confidence 5799999999999999999999999999999998764 3445688999999999555666666555533 457789999
Q ss_pred eecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEec---CCCCceEEEeccccccccCCCc
Q 019642 116 YVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 116 ~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~---~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
|+ +++|.+++ ..+++..++.++.||+.||.|||++||+|+||||+|||++ .+ +.+||+|||++........
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~-~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA-NQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGT-TCEEECCCTTCEECBCTTT
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCC-CeEEEEeCCcceeccCCcc
Confidence 99 77777765 3599999999999999999999999999999999999994 55 7899999999976543322
Q ss_pred --------ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCC--HHHHHHHHHHhCCchhhhh
Q 019642 189 --------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKVLGTDELNAY 258 (338)
Q Consensus 189 --------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~ 258 (338)
.....|++.|+|||++.+ ..++.++||||||+++|+|++|..||...... ...+..+............
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHH
T ss_pred ccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHH
Confidence 124578999999999987 67899999999999999999999999543322 1222222221111111100
Q ss_pred hhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
...+++++.+||..||+.||++||++.+|++
T Consensus 241 --------------------------------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 241 --------------------------------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp --------------------------------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred --------------------------------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0126889999999999999999999998865
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=300.71 Aligned_cols=247 Identities=18% Similarity=0.285 Sum_probs=188.4
Q ss_pred eeccCCcEEEEEeeeecCceeEEEEEEcC-CCc--eEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeee
Q 019642 33 IFSDQDDYEVVRKVGRGKYSEVFEGINVN-TNE--RCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVR 103 (338)
Q Consensus 33 i~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~--~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 103 (338)
.....++|++.+.||+|+||+||+|.+.. +++ .|++|.++.. ..+.+.+|+.+++++ +||||+++++++.
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 91 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVL 91 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEEC
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEc
Confidence 34556899999999999999999998643 333 6899988642 245678999999999 9999999999985
Q ss_pred ccCCCccEEEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccc
Q 019642 104 DQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
Q Consensus 104 ~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~ 179 (338)
.. ..++||||+.+++|.+.+ ..+++..++.++.|++.||.+||++|++|+||||+||+++.+ +.++|+|||+
T Consensus 92 ~~---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~-~~~kl~Dfg~ 167 (291)
T 1u46_A 92 TP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR-DLVKIGDFGL 167 (291)
T ss_dssp SS---SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCTT
T ss_pred cC---CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCC-CCEEEccccc
Confidence 53 378999999999988776 348999999999999999999999999999999999999988 8999999999
Q ss_pred cccccCCCc----ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCch
Q 019642 180 AEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDE 254 (338)
Q Consensus 180 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (338)
+........ .....++..|+|||++.+ ..++.++|+||||+++|+|++ |..||.. .+..+....+... ..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~-~~-- 242 (291)
T 1u46_A 168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKE-GE-- 242 (291)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTS-CC--
T ss_pred cccccccccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCccc-CCHHHHHHHHHcc-CC--
Confidence 876643322 122456778999999876 568899999999999999999 9999842 2222222211110 00
Q ss_pred hhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 255 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
....+..+++++.++|.+||+.||++|||+.++++
T Consensus 243 --------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 243 --------------------------------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp --------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00011237899999999999999999999999997
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=321.86 Aligned_cols=250 Identities=18% Similarity=0.318 Sum_probs=200.8
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
...++|++.+.||+|+||.||+|.+.. +..||||+++.. ..+.+.+|+.+++++ +||||+++++++.+ ...++
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~---~~~~l 338 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYI 338 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEE
T ss_pred cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEee---ccceE
Confidence 345789999999999999999998864 466999998753 456789999999999 99999999999844 46789
Q ss_pred EEeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 113 IFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 113 v~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
||||+.+++|.+++. .+++..+..++.||+.||.|||++|++|+||||+|||++.+ +.+||+|||++.......
T Consensus 339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNE 417 (535)
T ss_dssp EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCTTSTTTCCCHH
T ss_pred eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCC-CcEEEcccccceecCCCc
Confidence 999999999988874 38999999999999999999999999999999999999887 799999999997654221
Q ss_pred --cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccc
Q 019642 188 --EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264 (338)
Q Consensus 188 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
......++..|+|||++.+ ..++.++||||||+++|+|++ |..||. .....+....+.+...
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~-~~~~~~~~~~i~~~~~------------- 482 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYP-GMVNREVLDQVERGYR------------- 482 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSST-TCCHHHHHHHHHTTCC-------------
T ss_pred eecccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHcCCC-------------
Confidence 1122345678999999876 678999999999999999999 888883 3333332222211000
Q ss_pred ccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC--CCcchh
Q 019642 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH--PYFAQV 328 (338)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h--p~~~~~ 328 (338)
...+..+++++.+||.+||+.||++|||+++|++. .++...
T Consensus 483 -----------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 483 -----------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp -----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred -----------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 00112378999999999999999999999999873 565543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=314.75 Aligned_cols=248 Identities=17% Similarity=0.243 Sum_probs=184.3
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCC-CCee------------
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGG-PNVV------------ 96 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h-~~iv------------ 96 (338)
...+|...+.||+|+||+||+|.+..+++.||||+++.. ..+.+.+|+.+++.+ .| ++..
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l-~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL-RGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGS-TTCCSHHHHHHHTCBCCCC
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhh-ccCCCHHHHHHhcccccch
Confidence 344699999999999999999999999999999998732 245688999999988 54 3211
Q ss_pred ---------EeeeeeeccC---CCccEEEEeeecCCccccccC----------CCCHHHHHHHHHHHHHHHHHHHHCCce
Q 019642 97 ---------KLLDIVRDQH---SKTPSLIFEYVNSTDFKVLYP----------TLTDYDIRYYIYELLKALDYCHSQGIM 154 (338)
Q Consensus 97 ---------~~~~~~~~~~---~~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~i~~qi~~~l~~lH~~~i~ 154 (338)
.+...+.... ....+++|+.+. ++|.+++. .+++..+..++.|++.||.|||++||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ii 233 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 233 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECCS-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehhc-CCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 1111111111 234566666654 55655541 267778899999999999999999999
Q ss_pred eccCCCCCeEecCCCCceEEEeccccccccCCCcceeeecccccccccccc---------CcCCCCCcchhHHHHHHHHH
Q 019642 155 HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV---------DLQDYDYSLDMWSLGCMFAG 225 (338)
Q Consensus 155 H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---------~~~~~~~~~DvwslG~~l~~ 225 (338)
|+||||+|||++.+ +.+||+|||++...... .....| +.|+|||++. ....++.++||||||+++|+
T Consensus 234 HrDiKp~NILl~~~-~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 234 HTYLRPVDIVLDQR-GGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp CSCCCGGGEEECTT-CCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecC-CeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 99999999999998 78999999998754322 333456 9999999983 22467889999999999999
Q ss_pred HHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHh
Q 019642 226 MIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKL 305 (338)
Q Consensus 226 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~ 305 (338)
|++|+.||..... .+ .....+ .....+++++.+||.+|
T Consensus 310 lltg~~Pf~~~~~-~~---------------------------~~~~~~--------------~~~~~~~~~~~~li~~~ 347 (413)
T 3dzo_A 310 IWCADLPNTDDAA-LG---------------------------GSEWIF--------------RSCKNIPQPVRALLEGF 347 (413)
T ss_dssp HHHSSCCCCTTGG-GS---------------------------CSGGGG--------------SSCCCCCHHHHHHHHHH
T ss_pred HHHCCCCCCCcch-hh---------------------------hHHHHH--------------hhcccCCHHHHHHHHHH
Confidence 9999999932110 00 000000 01113789999999999
Q ss_pred cCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 306 LRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 306 L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
|+.||++|||+.++++||||+++.+.
T Consensus 348 l~~dP~~Rpt~~~~l~~~~~~~~~~~ 373 (413)
T 3dzo_A 348 LRYPKEDRLLPLQAMETPEYEQLRTE 373 (413)
T ss_dssp TCSSGGGSCCHHHHTTSHHHHHHHHH
T ss_pred ccCChhhCcCHHHHHhCHHHHHHHHH
Confidence 99999999999999999999987543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=323.39 Aligned_cols=241 Identities=17% Similarity=0.300 Sum_probs=190.4
Q ss_pred CcEEEE-EeeeecCceeEEEEEE--cCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 38 DDYEVV-RKVGRGKYSEVFEGIN--VNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 38 ~~y~~~-~~lg~G~~g~V~~~~~--~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
..+.+. +.||+|+||.||+|.+ ..+++.||||+++... .+.+.+|+.+++++ +||||+++++++.. ..
T Consensus 368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~---~~ 443 (635)
T 4fl3_A 368 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA---ES 443 (635)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC-CCTTBCCEEEEEES---SS
T ss_pred hhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec---CC
Confidence 345554 4899999999999954 4567889999987532 46788999999999 89999999999843 34
Q ss_pred cEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 110 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
.++||||+.+++|.+++ ..+++..++.++.||+.||.|||++||+|+||||+|||++.+ +.+||+|||++......
T Consensus 444 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~-~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 444 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRAD 522 (635)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCTTHHHHTTC-
T ss_pred EEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCC-CCEEEEEcCCccccccC
Confidence 78999999999998886 358999999999999999999999999999999999999988 89999999999765433
Q ss_pred Cc----ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 187 KE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 187 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
.. .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||. +.+..+....+.... .
T Consensus 523 ~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~-~~~~~~~~~~i~~~~-~--------- 590 (635)
T 4fl3_A 523 ENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYR-GMKGSEVTAMLEKGE-R--------- 590 (635)
T ss_dssp ------------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSST-TCCHHHHHHHHHTTC-C---------
T ss_pred ccccccccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHcCC-C---------
Confidence 21 222345678999999976 679999999999999999998 999983 333222222221110 0
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
...+..+++++.++|.+||+.||++|||+.++++
T Consensus 591 --------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 591 --------------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp --------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --------------------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 0112237899999999999999999999999985
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=321.54 Aligned_cols=243 Identities=16% Similarity=0.310 Sum_probs=192.9
Q ss_pred cCCcEEEEE-eeeecCceeEEEEEEc--CCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 36 DQDDYEVVR-KVGRGKYSEVFEGINV--NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 36 ~~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
..+++.+.+ .||+|+||.||+|.+. .++..||||+++.. ..+.+.+|+.+++++ +||||+++++++.. .
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~---~ 408 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA---E 408 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTC-CCTTBCCEEEEEES---S
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEecc---C
Confidence 445667666 8999999999999875 35567999998753 356788999999999 99999999999854 3
Q ss_pred ccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 109 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
..++||||+.+++|.+++. .+++..+..++.|++.||.|||++|++|+||||+|||++.+ +.+||+|||++....
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~-~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNR-HYAKISDFGLSKALG 487 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCCSTTTTCC
T ss_pred CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCC-CcEEEeeccCccccc
Confidence 5899999999999988763 48999999999999999999999999999999999999988 899999999997654
Q ss_pred CCCc----ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhh
Q 019642 185 PGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259 (338)
Q Consensus 185 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
.... .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||. ..+..+....+.+...
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~-~~~~~~~~~~i~~~~~-------- 557 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYK-KMKGPEVMAFIEQGKR-------- 557 (613)
T ss_dssp --------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCSHHHHHHHHTTCC--------
T ss_pred CCCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCC-CCCHHHHHHHHHcCCC--------
Confidence 3221 112234578999999976 679999999999999999998 999984 3333333332211100
Q ss_pred hccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
...+..+++++.++|.+||+.||++|||+.++++
T Consensus 558 ----------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 558 ----------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp ----------------------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred ----------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0112237899999999999999999999999864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=297.57 Aligned_cols=251 Identities=18% Similarity=0.272 Sum_probs=191.8
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
.|...+.||+|+||+||+|.+ +++.|++|.+... ..+.+.+|+.+++++ +||||+++++++.+ ....+
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~ 106 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QHENLVELLGFSSD--GDDLC 106 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSCE
T ss_pred ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CCCCeEEEEEEEec--CCceE
Confidence 344558999999999999975 6789999998632 245688999999999 99999999999954 45789
Q ss_pred EEEeeecCCccccccC------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 112 LIFEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 112 lv~e~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
++|||+.+++|.+++. .+++..++.++.|++.||.+||+.|++|+||||+||+++.+ +.++|+|||++.....
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~ 185 (307)
T 2nru_A 107 LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEA-FTAKISDFGLARASEK 185 (307)
T ss_dssp EEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECCS
T ss_pred EEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCC-CcEEEeeccccccccc
Confidence 9999999999887753 48999999999999999999999999999999999999988 8999999999876543
Q ss_pred CCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhC--Cchhhhhhh
Q 019642 186 GKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG--TDELNAYLN 260 (338)
Q Consensus 186 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 260 (338)
... .....+++.|+|||++.+ .++.++|+||||+++|+|++|..||....... ....+.+... ......+..
T Consensus 186 ~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 262 (307)
T 2nru_A 186 FAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLLDIKEEIEDEEKTIEDYID 262 (307)
T ss_dssp CSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS-BTTHHHHHHHTTSCCHHHHSC
T ss_pred ccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchH-HHHHHHHHhhhhhhhhhhhcc
Confidence 222 223468999999999865 47899999999999999999999985432221 1111111110 011111100
Q ss_pred ccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
... ...+...+..+.+++.+||+.||++|||+.+++++
T Consensus 263 ---------------~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 263 ---------------KKM---------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp ---------------SSC---------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ---------------ccc---------cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000 00111145779999999999999999999999864
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=303.11 Aligned_cols=247 Identities=19% Similarity=0.248 Sum_probs=184.1
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----------hHHHHHHHHHHHHhc--------CCCCee
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLC--------GGPNVV 96 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----------~~~~~~E~~~l~~l~--------~h~~iv 96 (338)
..++|++.+.||+|+||+||+|.+ +++.||+|+++... .+.+.+|+.+++.+. .||||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 357899999999999999999987 68999999987432 267889999999994 366666
Q ss_pred Eeeeee-----------------ecc-----------CCCccEEEEeeecCCc-ccccc-CCCCHHHHHHHHHHHHHHHH
Q 019642 97 KLLDIV-----------------RDQ-----------HSKTPSLIFEYVNSTD-FKVLY-PTLTDYDIRYYIYELLKALD 146 (338)
Q Consensus 97 ~~~~~~-----------------~~~-----------~~~~~~lv~e~~~~~~-l~~~~-~~~~~~~~~~i~~qi~~~l~ 146 (338)
++.+.+ .+. .....++||||+.+++ +..+. ..+++..++.++.|++.||.
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 666543 220 1467899999998885 44444 34899999999999999999
Q ss_pred HHH-HCCceeccCCCCCeEecCCCC--------------------ceEEEeccccccccCCCcceeeecccccccccccc
Q 019642 147 YCH-SQGIMHRDVKPHNVMIDHELR--------------------KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 205 (338)
Q Consensus 147 ~lH-~~~i~H~dikp~NIli~~~~~--------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~ 205 (338)
||| ++||+|+||||+|||++.+ + .+||+|||++...... ...||+.|+|||++.
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~-~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKT-SLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEEC-SCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGC
T ss_pred HHHHhCCEeECCCCHHHEEEecc-CCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhc
Confidence 999 9999999999999999887 4 8999999999865432 458999999999998
Q ss_pred CcCCCCCcchhHHHHHH-HHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcc
Q 019642 206 DLQDYDYSLDMWSLGCM-FAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSK 284 (338)
Q Consensus 206 ~~~~~~~~~DvwslG~~-l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (338)
+. . +.++||||+|.+ .+++++|..||............+........ .
T Consensus 251 g~-~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------~---- 299 (336)
T 2vuw_A 251 GD-G-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT-------------------------K---- 299 (336)
T ss_dssp CC-S-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSS-------------------------C----
T ss_pred CC-C-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCc-------------------------c----
Confidence 73 3 889999998777 67788888887210000000111110000000 0
Q ss_pred cccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHh-cCCCcc
Q 019642 285 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM-AHPYFA 326 (338)
Q Consensus 285 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell-~hp~~~ 326 (338)
........+++++.+||++||+.| |++|+| +||||+
T Consensus 300 -~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 300 -CNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp -CCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred -cchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 000001125789999999999977 999999 999995
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=317.88 Aligned_cols=243 Identities=22% Similarity=0.389 Sum_probs=193.6
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCC---CceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
.++|++.+.||+|+||.||+|.+..+ +..+++|..+... .+.+.+|+.+++++ +||||+++++++.+ ..
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~---~~ 464 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE---NP 464 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SS
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEec---Cc
Confidence 46899999999999999999998653 4579999876432 35678899999999 99999999999843 45
Q ss_pred cEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 110 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
.++||||+.+++|.+++. .+++..+..++.|++.||.|||++|++|+||||+|||++.+ +.+||+|||++.....
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~-~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMED 543 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCCCCCCSCCC
T ss_pred eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCC-CCEEEEecCCCeecCC
Confidence 789999999999988763 48999999999999999999999999999999999999988 8999999999976543
Q ss_pred CCc--ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcc
Q 019642 186 GKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262 (338)
Q Consensus 186 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
... .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||. +.+..+....+......
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~-~~~~~~~~~~i~~~~~~---------- 611 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQ-GVKNNDVIGRIENGERL---------- 611 (656)
T ss_dssp ----------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHHHHTCCC----------
T ss_pred CcceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHcCCCC----------
Confidence 322 222455678999999876 678999999999999999997 888883 33333333222211000
Q ss_pred ccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
..+..+++.+.++|.+||+.||++|||+.++++.
T Consensus 612 --------------------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 612 --------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0112378999999999999999999999999863
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=299.24 Aligned_cols=243 Identities=19% Similarity=0.308 Sum_probs=189.9
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
...++|++.+.||+|+||.||+|.+.. .+++|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ...
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~ 103 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENVVLFMGACMS--PPH 103 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTC-CCTTBCCCCEEEEC--SSC
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcC-CCCCEeEEEEEEec--CCc
Confidence 446899999999999999999998754 4899988632 234567899999999 99999999999965 456
Q ss_pred cEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 110 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
.+++|||+.+++|.+++. .+++..++.++.|++.||.+||++|++|+||||+||+++. +.++|+|||++.....
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~--~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN--GKVVITDFGLFSISGV 181 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----CCEECCCSCCC----
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeC--CCEEEeecCCcccccc
Confidence 899999999999988874 3899999999999999999999999999999999999983 6899999998764421
Q ss_pred ------CCcceeeeccccccccccccC--------cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhC
Q 019642 186 ------GKEYNVRVASRYFKGPELLVD--------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 251 (338)
Q Consensus 186 ------~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~ 251 (338)
........+++.|+|||++.+ ...++.++||||||+++|+|++|..||.. .+.......+.....
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~-~~~~~~~~~~~~~~~ 260 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEAIIWQMGTGMK 260 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS-CCHHHHHHHHHTTCC
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHhccCCC
Confidence 122233458899999999864 23578899999999999999999999842 222222211111000
Q ss_pred CchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 252 TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
.......++.++.++|.+||+.||++|||+.++++
T Consensus 261 -----------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 261 -----------------------------------PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp -----------------------------------CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred -----------------------------------CCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00011126889999999999999999999999987
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=282.25 Aligned_cols=222 Identities=14% Similarity=0.144 Sum_probs=175.7
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
++|++.+.||+|+||.||+|.+..+++.||+|++.... .+.+.+|+..+.++ +||||+++++++.+ ....+
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~--~~~~~ 107 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVHT--RAGGL 107 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEE--TTEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEEE--CCcEE
Confidence 68999999999999999999999999999999987532 25688999999999 99999999999965 46789
Q ss_pred EEEeeecCCccccccCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcce
Q 019642 112 LIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 190 (338)
Q Consensus 112 lv~e~~~~~~l~~~~~~-~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~ 190 (338)
+||||+.|++|.+++.. .....+..++.|++.||.|||++|++|+||||+||+++.+ +.++|++++
T Consensus 108 lv~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~-g~~kl~~~~------------ 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSID-GDVVLAYPA------------ 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETT-SCEEECSCC------------
T ss_pred EEEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCC-CCEEEEecc------------
Confidence 99999999999888754 5667788999999999999999999999999999999988 788887433
Q ss_pred eeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcch
Q 019642 191 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 270 (338)
Q Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (338)
|++ .++.++||||||+++|+|++|..||....... .+.
T Consensus 175 -------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~-~~~-------------------------- 212 (286)
T 3uqc_A 175 -------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRS-GLA-------------------------- 212 (286)
T ss_dssp -------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCC-CSE--------------------------
T ss_pred -------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcch-hhH--------------------------
Confidence 222 36789999999999999999999994221100 000
Q ss_pred hhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 271 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
... ....... .........+++++.++|.+||+.||++| |+.|+++.
T Consensus 213 -~~~-~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 213 -PAE-RDTAGQP--IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp -ECC-BCTTSCB--CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred -HHH-HHhccCC--CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 000 0000000 00001122378999999999999999999 99999873
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=320.53 Aligned_cols=241 Identities=22% Similarity=0.316 Sum_probs=194.5
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcC-CCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC---
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVN-TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK--- 108 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~--- 108 (338)
.++|++.+.||+|+||+||++.+.. +++.|++|++.... ...+.+|+.+++++ +||||+++++++......
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEeecCCCCCc
Confidence 3799999999999999999999976 78999999886432 34567899999999 899999999999664321
Q ss_pred ccEEEEeeecCCccccccC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 109 TPSLIFEYVNSTDFKVLYP-TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
..++||||+.+++|...+. .+++..++.++.|++.||.|||++||+|+||||+||+++.+ .+||+|||++......
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~--~~kl~DFG~a~~~~~~- 234 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE--QLKLIDLGAVSRINSF- 234 (681)
T ss_dssp EEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS--CEEECCCTTCEETTCC-
T ss_pred eeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC--cEEEEecccchhcccC-
Confidence 1689999999999988764 59999999999999999999999999999999999999875 7999999999765433
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
....||+.|+|||++.+ .++.++||||||+++|+|++|..||...... ...
T Consensus 235 --~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-------------------------~~~ 285 (681)
T 2pzi_A 235 --GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYVD-------------------------GLP 285 (681)
T ss_dssp --SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETTEECS-------------------------SCC
T ss_pred --CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCcccccc-------------------------ccc
Confidence 34578999999999876 3488999999999999999998776311000 000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
. .......++.+.++|.+||+.||++||+..+.+.|+|+.-..
T Consensus 286 ~-------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 286 E-------------------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp T-------------------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred c-------------------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 0 000001367899999999999999999999999999886543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-33 Score=264.27 Aligned_cols=179 Identities=20% Similarity=0.149 Sum_probs=125.8
Q ss_pred eeecCceeEEEEEEcCCCceEEEEEeccc-------------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 46 VGRGKYSEVFEGINVNTNERCIIKILKPV-------------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 46 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-------------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
.+.|+.|.+..++..-.|+.+++|++... ..+.+.+|+++|+++..|+||+++++++.+ +...||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed--~~~~yL 319 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN--AQSGWL 319 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC--SSEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE--CCEEEE
Confidence 44566666666666667899999998532 135588999999999889999999999954 668999
Q ss_pred EEeeecCCccccccCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC-Cc
Q 019642 113 IFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KE 188 (338)
Q Consensus 113 v~e~~~~~~l~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~-~~ 188 (338)
||||+.|++|.+.+.. +++ ..++.||+.||.|+|++||+||||||+|||++.+ +.+||+|||+++..... ..
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~---~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~d-g~vKL~DFGlAr~~~~~~~~ 395 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDR---EKILGSLLRSLAALEKQGFWHDDVRPWNVMVDAR-QHARLIDFGSIVTTPQDCSW 395 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCH---HHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTT-SCEEECCCTTEESCC---CC
T ss_pred EEecCCCCcHHHHHHhCCCCCH---HHHHHHHHHHHHHHHHCCceeccCchHhEEECCC-CCEEEeecccCeeCCCCCcc
Confidence 9999999999998754 554 3588999999999999999999999999999988 89999999998765432 23
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCC
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 232 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~p 232 (338)
....+||+.|+|||++.+ .+..++|+||+|++++.+.++..+
T Consensus 396 ~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp SHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred ccCceechhhccHHHhCC--CCCCcccccccccchhhhccccch
Confidence 344679999999999876 467789999999998877655443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.4e-27 Score=218.64 Aligned_cols=180 Identities=17% Similarity=0.231 Sum_probs=137.3
Q ss_pred EEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 41 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 41 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
...+.||+|+||.||++ ...+..+++|...... .+.+.+|+.+++++ +||||+++..+... ...
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~--~~~ 413 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-KDFGIPAPYIFDVD--LDN 413 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-GGGTCCCCCEEEEE--TTT
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-CCCCcCceEEEEEe--CCc
Confidence 34668999999999999 4467788888753211 23478999999999 99999944444332 345
Q ss_pred cEEEEeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc-
Q 019642 110 PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE- 188 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~- 188 (338)
.++||||+.+++|.+++.. +..++.|++.||.|||++||+|+||||+|||++. .+||+|||+++.......
T Consensus 414 ~~lVmE~~~ggsL~~~l~~-----~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~---~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 414 KRIMMSYINGKLAKDVIED-----NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK---DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp TEEEEECCCSEEHHHHSTT-----CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS---SEEECCCTTCEECCCHHHH
T ss_pred cEEEEECCCCCCHHHHHHH-----HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC---eEEEEECccCEECCCcccc
Confidence 6899999999999999876 6689999999999999999999999999999998 799999999987654321
Q ss_pred -------ceeeeccccccccccccCc-CCCCCcchhHHHHHHHHHHHhcCCCC
Q 019642 189 -------YNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPF 233 (338)
Q Consensus 189 -------~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~lltg~~pf 233 (338)
.....||+.|+|||++... ..++..+|+||..+-..+-+.++.+|
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 1245789999999998641 24667789999998888888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.1e-24 Score=182.69 Aligned_cols=138 Identities=19% Similarity=0.274 Sum_probs=112.0
Q ss_pred EEEeeeecCceeEEEEEEcCCCceEEEEEeccc---------------------chHHHHHHHHHHHHhcCCCCeeEeee
Q 019642 42 VVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---------------------KKKKIKREIKILQNLCGGPNVVKLLD 100 (338)
Q Consensus 42 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---------------------~~~~~~~E~~~l~~l~~h~~iv~~~~ 100 (338)
+.+.||+|+||.||+|.+ .+++.||+|.++.. ....+.+|+.+++++ + | +++.+
T Consensus 94 ~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l-~--~-~~v~~ 168 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-Q--G-LAVPK 168 (282)
T ss_dssp EEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-T--T-SSSCC
T ss_pred ecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc-c--C-CCcCe
Confidence 339999999999999999 88999999998632 234578999999999 4 4 55555
Q ss_pred eeeccCCCccEEEEeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccc
Q 019642 101 IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
Q Consensus 101 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~ 180 (338)
.+.. ...++||||+.|++|.. +.. .....++.|++.||.+||+.|++|+||||+|||++ + +.++|+|||++
T Consensus 169 ~~~~---~~~~lvmE~~~g~~L~~-l~~---~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~-~~vkl~DFG~a 239 (282)
T 1zar_A 169 VYAW---EGNAVLMELIDAKELYR-VRV---ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-E-EGIWIIDFPQS 239 (282)
T ss_dssp EEEE---ETTEEEEECCCCEEGGG-CCC---SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-T-TEEEECCCTTC
T ss_pred EEec---cceEEEEEecCCCcHHH-cch---hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-C-CcEEEEECCCC
Confidence 5432 35689999999999988 322 33457999999999999999999999999999999 5 89999999998
Q ss_pred ccccCCCcceeeecccccccccccc
Q 019642 181 EFYHPGKEYNVRVASRYFKGPELLV 205 (338)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~ 205 (338)
.. +..+.|||.+.
T Consensus 240 ~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 240 VE------------VGEEGWREILE 252 (282)
T ss_dssp EE------------TTSTTHHHHHH
T ss_pred eE------------CCCCCHHHHHH
Confidence 53 23467888764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=7.2e-22 Score=167.33 Aligned_cols=136 Identities=18% Similarity=0.195 Sum_probs=107.8
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCce--EEEEEecccc---------------------------hHHHHHHHHHHH
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNER--CIIKILKPVK---------------------------KKKIKREIKILQ 87 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--~aiK~~~~~~---------------------------~~~~~~E~~~l~ 87 (338)
+.-|++.+.||+|+||.||+|.+..+++. ||+|+++... ...+.+|+..+.
T Consensus 46 ~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 125 (258)
T 1zth_A 46 GYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLE 125 (258)
T ss_dssp TSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHH
T ss_pred CCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHH
Confidence 44588999999999999999998778888 9999875321 125778999999
Q ss_pred HhcCCCCe--eEeeeeeeccCCCccEEEEeeecC-C----ccccccCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCC
Q 019642 88 NLCGGPNV--VKLLDIVRDQHSKTPSLIFEYVNS-T----DFKVLYPTLTDYDIRYYIYELLKALDYCH-SQGIMHRDVK 159 (338)
Q Consensus 88 ~l~~h~~i--v~~~~~~~~~~~~~~~lv~e~~~~-~----~l~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dik 159 (338)
++ .|+++ +.+++. ...++||||+++ + +|.+.....++..+..++.|++.+|.+|| +.|++|+|||
T Consensus 126 ~l-~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlk 198 (258)
T 1zth_A 126 RA-KEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLS 198 (258)
T ss_dssp HH-HHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCS
T ss_pred HH-HhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence 99 66643 334432 246899999953 3 55554433445678889999999999999 9999999999
Q ss_pred CCCeEecCCCCceEEEecccccc
Q 019642 160 PHNVMIDHELRKLRLIDWGLAEF 182 (338)
Q Consensus 160 p~NIli~~~~~~~~l~dfg~~~~ 182 (338)
|+|||++. .++|+|||++..
T Consensus 199 p~NILl~~---~~~liDFG~a~~ 218 (258)
T 1zth_A 199 EYNIMYID---KVYFIDMGQAVT 218 (258)
T ss_dssp TTSEEESS---SEEECCCTTCEE
T ss_pred HHHEEEcC---cEEEEECccccc
Confidence 99999987 799999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.75 E-value=2.6e-18 Score=151.35 Aligned_cols=133 Identities=16% Similarity=0.250 Sum_probs=98.7
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----------------hH--------HHHHHHHHHHHhcCC
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------------KK--------KIKREIKILQNLCGG 92 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----------------~~--------~~~~E~~~l~~l~~h 92 (338)
--|++.+.||+|++|.||+|.+. +|+.||||+++... .. ....|...+.++ .+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL-~~ 172 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL-YE 172 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH-HH
T ss_pred CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH-Hh
Confidence 34899999999999999999874 68999999875310 00 123466667776 33
Q ss_pred CCe--eEeeeeeeccCCCccEEEEeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCC
Q 019642 93 PNV--VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR 170 (338)
Q Consensus 93 ~~i--v~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~ 170 (338)
..+ +..++. ...++||||++|.++..+... +....++.|++.+|.+||+.|++|+||||.|||++.+ +
T Consensus 173 ~gv~vp~p~~~------~~~~LVME~i~G~~L~~l~~~---~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~d-g 242 (397)
T 4gyi_A 173 EGFPVPEPIAQ------SRHTIVMSLVDALPMRQVSSV---PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREE-K 242 (397)
T ss_dssp TTCSCCCEEEE------ETTEEEEECCSCEEGGGCCCC---SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEE-E
T ss_pred cCCCCCeeeec------cCceEEEEecCCccHhhhccc---HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCC-C
Confidence 333 222222 123699999999988776432 2345688999999999999999999999999999776 3
Q ss_pred ----------ceEEEecccccc
Q 019642 171 ----------KLRLIDWGLAEF 182 (338)
Q Consensus 171 ----------~~~l~dfg~~~~ 182 (338)
.+.|+||+.+..
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEE
T ss_pred CcccccccccceEEEEeCCccc
Confidence 389999997754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=2.9e-13 Score=114.62 Aligned_cols=137 Identities=18% Similarity=0.237 Sum_probs=109.9
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc---cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
+.|++...++.|+.+.||++.. .+..+++|.... .....+.+|+.+++.+.++..+++++++..+ ....++||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~ 89 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNLLM 89 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCceEEEE
Confidence 4688999999999999999864 367899999864 3455689999999999667778888888754 45788999
Q ss_pred eeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 019642 115 EYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHS-------------------------------------------- 150 (338)
Q Consensus 115 e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~-------------------------------------------- 150 (338)
|++.|.++...... ......++.++..+|..||+
T Consensus 90 e~i~G~~l~~~~~~--~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T 3tm0_A 90 SEADGVLCSEEYED--EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp ECCSSEEHHHHCCT--TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred EecCCeehhhccCC--cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence 99999998876432 22334678899999999998
Q ss_pred ---------------CCceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 151 ---------------QGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 151 ---------------~~i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
..++|+|++|.||+++.+ ..+.|+||+.+.
T Consensus 168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~lIDwe~a~ 212 (263)
T 3tm0_A 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT-EEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCceEECCCCCcCcEEEECC-cEEEEEEchhcc
Confidence 448999999999999865 456799998774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.35 E-value=9.2e-12 Score=105.11 Aligned_cols=136 Identities=18% Similarity=0.156 Sum_probs=100.4
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCC-eeEeeeeeeccCCCccEEEEe
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPN-VVKLLDIVRDQHSKTPSLIFE 115 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~-iv~~~~~~~~~~~~~~~lv~e 115 (338)
...|.+....+.|..+.||++.. .++..+++|.........+..|+.+++.+..+.- +++++.+... ....++|||
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~--~~~~~~v~e 95 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLG 95 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccC--CCCCEEEEE
Confidence 45677655545666699999853 5677899999776555668899999999955522 5667777643 356789999
Q ss_pred eecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCC-------------------------------------------
Q 019642 116 YVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQG------------------------------------------- 152 (338)
Q Consensus 116 ~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~------------------------------------------- 152 (338)
++.|.++. ...... ..++.++...|..||+..
T Consensus 96 ~i~G~~l~--~~~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (264)
T 1nd4_A 96 EVPGQDLL--SSHLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 170 (264)
T ss_dssp CCSSEETT--TSCCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred ecCCcccC--cCcCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence 99999885 333332 356677778888888643
Q ss_pred ---------------ceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 153 ---------------IMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 153 ---------------i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
++|+|++|.||+++.+ +.+.|+||+.+.
T Consensus 171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~liD~~~a~ 213 (264)
T 1nd4_A 171 FARLKARMPDGEDLVVTHGDACLPNIMVENG-RFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETT-EEEEECCCTTCE
T ss_pred HHHHHHhcCCCCCeEEECCCCCCCcEEEECC-cEEEEEcchhcc
Confidence 9999999999999876 556799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.24 E-value=9.6e-11 Score=103.75 Aligned_cols=140 Identities=19% Similarity=0.330 Sum_probs=106.4
Q ss_pred EEEEeeeecCceeEEEEEEcCCCceEEEEEec--cc----chHHHHHHHHHHHHhcC-CCCeeEeeeeeeccCC-CccEE
Q 019642 41 EVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PV----KKKKIKREIKILQNLCG-GPNVVKLLDIVRDQHS-KTPSL 112 (338)
Q Consensus 41 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~--~~----~~~~~~~E~~~l~~l~~-h~~iv~~~~~~~~~~~-~~~~l 112 (338)
..++.|+.|.++.||++... +..+++|... .. ....+.+|..+++.+.. +..+++++..+.+... +..++
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 34778999999999998653 4578888765 32 23567889999999943 3457788887754321 45789
Q ss_pred EEeeecCCcccc-ccCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 019642 113 IFEYVNSTDFKV-LYPTLTDYDIRYYIYELLKALDYCHS----------------------------------------- 150 (338)
Q Consensus 113 v~e~~~~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~----------------------------------------- 150 (338)
|||++.|..+.+ ....++......++.++...|..||+
T Consensus 119 vme~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 119 IMEFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp EEECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred EEEecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 999999998853 45668888899999999999999997
Q ss_pred -----------------CCceeccCCCCCeEecCCCC-ceEEEecccccc
Q 019642 151 -----------------QGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEF 182 (338)
Q Consensus 151 -----------------~~i~H~dikp~NIli~~~~~-~~~l~dfg~~~~ 182 (338)
..++|+|+++.||+++.+.+ .+.|+||+.+..
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999987633 368999998854
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.13 E-value=7.4e-11 Score=102.01 Aligned_cols=186 Identities=17% Similarity=0.227 Sum_probs=122.0
Q ss_pred EEeeeecCceeEEEEEEcCCCceEEEEEeccc-chHHHHHHHHHHHHhcCCCC--eeEeeeeeeccC-CCccEEEEeeec
Q 019642 43 VRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPN--VVKLLDIVRDQH-SKTPSLIFEYVN 118 (338)
Q Consensus 43 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~E~~~l~~l~~h~~--iv~~~~~~~~~~-~~~~~lv~e~~~ 118 (338)
++.++.|..+.||++. ..+++|+.... ....+..|..+++.+..+.. +++++....... ....++||+++.
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 3458999999999863 45889986543 34668899999998844333 334444332221 124578999999
Q ss_pred CCcccc-ccCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q 019642 119 STDFKV-LYPTLTDYDIRYYIYELLKALDYCHS----------------------------------------------- 150 (338)
Q Consensus 119 ~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~----------------------------------------------- 150 (338)
|..+.. ....++.++...++.++...+..||+
T Consensus 100 G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 179 (304)
T 3sg8_A 100 GVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRD 179 (304)
T ss_dssp CEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHH
T ss_pred CeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHH
Confidence 998874 34567888888899999999998886
Q ss_pred -----------CCceeccCCCCCeEecCC-CCceEEEeccccccccCCCcceeeeccccccccccc----cCcC------
Q 019642 151 -----------QGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL----VDLQ------ 208 (338)
Q Consensus 151 -----------~~i~H~dikp~NIli~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~------ 208 (338)
..++|+|++|.||+++.+ ...+.++||+.+....+............-..|+.. ...+
T Consensus 180 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~ 259 (304)
T 3sg8_A 180 ILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPT 259 (304)
T ss_dssp HHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHH
T ss_pred HHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHH
Confidence 136999999999999874 256889999987643221110000000000111111 0000
Q ss_pred ---CCCCcchhHHHHHHHHHHHhcCCCC
Q 019642 209 ---DYDYSLDMWSLGCMFAGMIFRKEPF 233 (338)
Q Consensus 209 ---~~~~~~DvwslG~~l~~lltg~~pf 233 (338)
......+.|++|.+++.+.+|..+|
T Consensus 260 ~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 260 VLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0112368999999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=1.4e-07 Score=81.34 Aligned_cols=134 Identities=18% Similarity=0.252 Sum_probs=94.9
Q ss_pred EEeeeecCceeEEEEEEcCCCceEEEEEeccc-chHHHHHHHHHHHHhcCC-C-CeeEeeeeeeccCCCccEEEEeeecC
Q 019642 43 VRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGG-P-NVVKLLDIVRDQHSKTPSLIFEYVNS 119 (338)
Q Consensus 43 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~E~~~l~~l~~h-~-~iv~~~~~~~~~~~~~~~lv~e~~~~ 119 (338)
.+.++.|....||+. +..+++|+.... ....+..|..+++.+..+ + .+++.+.+... .....+++|+++.|
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCceEEEEeccCC
Confidence 456788888999987 466888885432 345688999999999543 2 24555555432 24567899999999
Q ss_pred Cccccc-cCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------------
Q 019642 120 TDFKVL-YPTLTDYDIRYYIYELLKALDYCHSQ----------------------------------------------- 151 (338)
Q Consensus 120 ~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~----------------------------------------------- 151 (338)
..+... ...++..+...++.++...|..||+.
T Consensus 98 ~~l~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 177 (306)
T 3tdw_A 98 QILGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQ 177 (306)
T ss_dssp EECHHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHH
T ss_pred eECchhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHH
Confidence 988662 34556666666666666666666642
Q ss_pred -------------CceeccCCCCCeEecC---CCCceEEEecccccc
Q 019642 152 -------------GIMHRDVKPHNVMIDH---ELRKLRLIDWGLAEF 182 (338)
Q Consensus 152 -------------~i~H~dikp~NIli~~---~~~~~~l~dfg~~~~ 182 (338)
.++|+|++|.||+++. +...+.|+||+.+..
T Consensus 178 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 178 SYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2489999999999987 324458999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.73 E-value=7e-08 Score=81.69 Aligned_cols=133 Identities=14% Similarity=0.105 Sum_probs=95.5
Q ss_pred eeeecCce-eEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeecCCccc
Q 019642 45 KVGRGKYS-EVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK 123 (338)
Q Consensus 45 ~lg~G~~g-~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~ 123 (338)
.+..|..+ .||+......+..+++|.-.......+..|...++.+..+-.+++++.+..+ ....++|||++.|.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~--~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRT--PDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEE--CCeEEEEEEeeCCcccc
Confidence 34445554 6898877777788999987766667788999999999655457778887754 45678999999998776
Q ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC----------------------------------------------------
Q 019642 124 VLYPTLTDYDIRYYIYELLKALDYCHSQ---------------------------------------------------- 151 (338)
Q Consensus 124 ~~~~~~~~~~~~~i~~qi~~~l~~lH~~---------------------------------------------------- 151 (338)
...... ......+..++...|..||+.
T Consensus 109 ~~~~~~-~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 187 (272)
T 4gkh_A 109 QVLEEY-PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLL 187 (272)
T ss_dssp HHHHHC-GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTC
T ss_pred ccccCC-HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcc
Confidence 554221 122334555566666666621
Q ss_pred ------CceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 152 ------GIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 152 ------~i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
.++|+|+.+.||+++.+ +.+-|+||+.+.
T Consensus 188 ~~~~~~~l~HGDl~~~Nil~~~~-~~~~viDwe~a~ 222 (272)
T 4gkh_A 188 PFSPDSVVTHGDFSLDNLIFDEG-KLIGCIDVGRVG 222 (272)
T ss_dssp CCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCE
T ss_pred cccCCcEEEcCCCCCCeEEEECC-eEEEEEECcccc
Confidence 16899999999999876 566799999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=7.8e-07 Score=78.37 Aligned_cols=85 Identities=13% Similarity=0.138 Sum_probs=58.8
Q ss_pred EEEEEee-eecCceeEEEEEEc--C----CCceEEEEEecccc------hHHHHHHHHHHHHhcCC--CCeeEeeeeeec
Q 019642 40 YEVVRKV-GRGKYSEVFEGINV--N----TNERCIIKILKPVK------KKKIKREIKILQNLCGG--PNVVKLLDIVRD 104 (338)
Q Consensus 40 y~~~~~l-g~G~~g~V~~~~~~--~----~~~~~aiK~~~~~~------~~~~~~E~~~l~~l~~h--~~iv~~~~~~~~ 104 (338)
....+.| +.|..+.+|+.... . ++..+++|...... ...+..|..+++.+..+ -.+++++.+..+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 4556778 88888999987643 1 15678899865432 25678899999988654 356777776643
Q ss_pred cC-CCccEEEEeeecCCcccc
Q 019642 105 QH-SKTPSLIFEYVNSTDFKV 124 (338)
Q Consensus 105 ~~-~~~~~lv~e~~~~~~l~~ 124 (338)
.. ....++|||++.|..+..
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp STTTSSCEEEEECCCCBCCCB
T ss_pred CCccCCceEEEEecCCCChhh
Confidence 21 135689999999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=5.6e-06 Score=74.04 Aligned_cols=75 Identities=17% Similarity=0.210 Sum_probs=49.7
Q ss_pred EEEeeeecCceeEEEEEEcCCCceEEEEEeccc----------chHHHHHHHHHHHHhcCC-C-CeeEeeeeeeccCCCc
Q 019642 42 VVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----------KKKKIKREIKILQNLCGG-P-NVVKLLDIVRDQHSKT 109 (338)
Q Consensus 42 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----------~~~~~~~E~~~l~~l~~h-~-~iv~~~~~~~~~~~~~ 109 (338)
..+.||.|..+.||++....+++.+++|...+. ..+....|.++++.+... | .+++++.+- . ..
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~--~~ 109 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T--EM 109 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T--TT
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C--Cc
Confidence 367899999999999976656788999975432 234567899999988443 3 344555432 2 34
Q ss_pred cEEEEeeecCC
Q 019642 110 PSLIFEYVNST 120 (338)
Q Consensus 110 ~~lv~e~~~~~ 120 (338)
.++|||++.+.
T Consensus 110 ~~lvmE~l~g~ 120 (397)
T 2olc_A 110 AVTVMEDLSHL 120 (397)
T ss_dssp TEEEECCCTTS
T ss_pred cEEEEEeCCCc
Confidence 57999999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.02 E-value=5.3e-05 Score=65.11 Aligned_cols=79 Identities=18% Similarity=0.162 Sum_probs=60.2
Q ss_pred EEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCC--CCeeEeeeeeeccCCCccEEEEeee
Q 019642 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGG--PNVVKLLDIVRDQHSKTPSLIFEYV 117 (338)
Q Consensus 40 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h--~~iv~~~~~~~~~~~~~~~lv~e~~ 117 (338)
..-.+.|+.|....+|+... ++..+++|.........+..|...++.|... ..+++++..... ....++|||++
T Consensus 38 i~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~--~g~~~lvme~l 113 (312)
T 3jr1_A 38 IKHKEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNS--QGHSFLLLEAL 113 (312)
T ss_dssp CCEEEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC--SSEEEEEEECC
T ss_pred eeeeEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeec--CCceEEEEEec
Confidence 34467899999999999864 4667889987766667788999999988543 467777776643 35688999999
Q ss_pred cCCcc
Q 019642 118 NSTDF 122 (338)
Q Consensus 118 ~~~~l 122 (338)
.|..+
T Consensus 114 ~G~~~ 118 (312)
T 3jr1_A 114 NKSKN 118 (312)
T ss_dssp CCCCC
T ss_pred cCCCC
Confidence 88754
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.98 E-value=3.3e-05 Score=67.34 Aligned_cols=77 Identities=14% Similarity=0.186 Sum_probs=44.3
Q ss_pred EEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCC-CCeeEeeeeeec----cCCCccEEEEeee
Q 019642 43 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGG-PNVVKLLDIVRD----QHSKTPSLIFEYV 117 (338)
Q Consensus 43 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h-~~iv~~~~~~~~----~~~~~~~lv~e~~ 117 (338)
.+.|+.|..+.||++... +..+++|.... ....+..|..+++.+..+ -.+++++..... ...+..+++|+++
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~-~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHR-PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EEECC----CEEEEEEET--TEEEEEEEECS-CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeeccccccCcEEEEEeC--CCCEEEEecCC-CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 456666778899998653 33588998875 344556677777766422 134444432100 1134568999999
Q ss_pred cCCcc
Q 019642 118 NSTDF 122 (338)
Q Consensus 118 ~~~~l 122 (338)
.|..+
T Consensus 114 ~G~~~ 118 (346)
T 2q83_A 114 EGRPF 118 (346)
T ss_dssp CCBCC
T ss_pred cCccC
Confidence 98654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.93 E-value=5.7e-05 Score=64.71 Aligned_cols=71 Identities=11% Similarity=0.078 Sum_probs=46.5
Q ss_pred EEeeeecCceeEEEEEEcCCCceEEEEEecccch--HHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeee-cC
Q 019642 43 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-NS 119 (338)
Q Consensus 43 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~-~~ 119 (338)
.+.|+.|....+|++ ..+++|+...... -....|..+++.+..+.-.++++... .. .-++++|++ +|
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~--~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PA--TGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TT--TCCEEEECCTTC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CC--CCEEEEeecCCC
Confidence 778989999999998 4688898764321 12356888888875443335665543 22 235899999 77
Q ss_pred Cccc
Q 019642 120 TDFK 123 (338)
Q Consensus 120 ~~l~ 123 (338)
.++.
T Consensus 93 ~~l~ 96 (301)
T 3dxq_A 93 QTMS 96 (301)
T ss_dssp EECC
T ss_pred ccCC
Confidence 6553
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.84 E-value=0.0001 Score=63.64 Aligned_cols=140 Identities=16% Similarity=0.199 Sum_probs=81.1
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc-cchHHHHHHHHHHHHhcCCC-CeeEeeeeeec----cCCCccEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGP-NVVKLLDIVRD----QHSKTPSL 112 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~-~~~~~~~~E~~~l~~l~~h~-~iv~~~~~~~~----~~~~~~~l 112 (338)
+..-.+.|+.|....+|+.... ++ .+++|.... .....+..|..+++.+..+. .+++++..... ...+..++
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~ 100 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA 100 (322)
T ss_dssp CEEEEEEECC---EEEEEEEES-SC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred cceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEE
Confidence 3445677888888999998653 33 688998876 34567788999998885432 13444432100 01234678
Q ss_pred EEeeecCCcccccc------------------CCC--------CHHHHHH---------------HHHHHHHHHHHHHH-
Q 019642 113 IFEYVNSTDFKVLY------------------PTL--------TDYDIRY---------------YIYELLKALDYCHS- 150 (338)
Q Consensus 113 v~e~~~~~~l~~~~------------------~~~--------~~~~~~~---------------i~~qi~~~l~~lH~- 150 (338)
+++++.|..+.... ..+ ....-.. +...+...+..+++
T Consensus 101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~ 180 (322)
T 2ppq_A 101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH 180 (322)
T ss_dssp EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence 99999887543210 011 0000000 00113334455543
Q ss_pred ------CCceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 151 ------QGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 151 ------~~i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
.+++|+|+++.||+++.+ +.+.++||+.+.
T Consensus 181 ~~~~~~~~liHgDl~~~Nil~~~~-~~~~lIDf~~a~ 216 (322)
T 2ppq_A 181 WPKDLPAGVIHADLFQDNVFFLGD-ELSGLIDFYFAC 216 (322)
T ss_dssp CCCSSCEEEECSCCCGGGEEEETT-EEEEECCCTTCE
T ss_pred CcccCCcccCCCCCCccCEEEeCC-ceEEEecchhcc
Confidence 368999999999999876 445799999774
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00022 Score=56.94 Aligned_cols=91 Identities=10% Similarity=-0.023 Sum_probs=56.8
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEecCCCCceEEEeccccccccCCCcceeeecccccccccccc
Q 019642 127 PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 205 (338)
Q Consensus 127 ~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~ 205 (338)
.+++++++|.++.|.+.+|.-+-. +.-...=+.|..|++..+ |.|.+.+ +.+ ......+.|||...
T Consensus 44 ~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~d-G~V~f~~-~~s-----------~~~~~~~~~pe~~~ 110 (229)
T 2yle_A 44 QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRD-GAVTLAP-AAD-----------DAGEPPPVAGKLGY 110 (229)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETT-SCEEECC-C-----------------------CCSS
T ss_pred CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecC-Cceeccc-ccc-----------cccccCCCChhhcc
Confidence 579999999999999999877632 221223344688888877 7776553 111 01233566888753
Q ss_pred CcCCCCCcchhHHHHHHHHHHHhcCCC
Q 019642 206 DLQDYDYSLDMWSLGCMFAGMIFRKEP 232 (338)
Q Consensus 206 ~~~~~~~~~DvwslG~~l~~lltg~~p 232 (338)
...+.+.-|||||+++|.-+--..|
T Consensus 111 --~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 111 --SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred --ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 3566788999999999999954444
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00025 Score=63.87 Aligned_cols=75 Identities=15% Similarity=0.163 Sum_probs=53.0
Q ss_pred EEEeeeecCceeEEEEEEcC-------CCceEEEEEecccch-HHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 42 VVRKVGRGKYSEVFEGINVN-------TNERCIIKILKPVKK-KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 42 ~~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~-~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
-++.|+.|....+|++.... ++..+++|+...... ..+..|..+++.+..+.-.+++++.+ .+ .+|
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~--~~----g~v 150 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF--SG----GRL 150 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE--TT----EEE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe--CC----CEE
Confidence 35678888889999997643 257899999854222 56678999999986554446677665 22 289
Q ss_pred EeeecCCcc
Q 019642 114 FEYVNSTDF 122 (338)
Q Consensus 114 ~e~~~~~~l 122 (338)
+||++|..+
T Consensus 151 ~e~l~G~~l 159 (429)
T 1nw1_A 151 EEYIPSRPL 159 (429)
T ss_dssp ECCCCEEEC
T ss_pred EEEeCCccc
Confidence 999987554
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.66 E-value=8.7e-05 Score=66.79 Aligned_cols=78 Identities=13% Similarity=0.128 Sum_probs=44.8
Q ss_pred HCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcceeeec--cccccccccccCcC--CCCCcchhHHHHHHHHH
Q 019642 150 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA--SRYFKGPELLVDLQ--DYDYSLDMWSLGCMFAG 225 (338)
Q Consensus 150 ~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~~~~~--~~~y~aPE~~~~~~--~~~~~~DvwslG~~l~~ 225 (338)
...++|||++|.||+++.+ + +.++||+.+....+......... ...|.+|+...... ......++.+....++.
T Consensus 231 ~~~liHGDl~~~Nil~~~~-~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQD-S-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSS-C-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCC-C-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 4579999999999999887 4 99999998864322111111111 12355555432100 11123445566777776
Q ss_pred HHhc
Q 019642 226 MIFR 229 (338)
Q Consensus 226 lltg 229 (338)
.+++
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00026 Score=62.56 Aligned_cols=137 Identities=14% Similarity=0.205 Sum_probs=83.5
Q ss_pred CcEEEEEeeeecCceeEEEEEEcC-------CCceEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVN-------TNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
+..+ ++.|..|-...+|++.... +++.+++|+.... ......+|..+++.+..+.-.++++..+ ++
T Consensus 51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~--~~-- 125 (379)
T 3feg_A 51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF--PE-- 125 (379)
T ss_dssp GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc--CC--
Confidence 4454 4567778888899987642 3578999986432 3455668999999886555556777765 22
Q ss_pred ccEEEEeeecCCcccccc------------------------CC-CC--HHHHHHHHHHHHH------------------
Q 019642 109 TPSLIFEYVNSTDFKVLY------------------------PT-LT--DYDIRYYIYELLK------------------ 143 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~------------------------~~-~~--~~~~~~i~~qi~~------------------ 143 (338)
.+||||+.|..+..-. .+ .. ..++.++..++..
T Consensus 126 --g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 203 (379)
T 3feg_A 126 --GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLK 203 (379)
T ss_dssp --EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHH
T ss_pred --ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHH
Confidence 2899999987654210 00 11 2344444443321
Q ss_pred -HHHHHH----HC----CceeccCCCCCeEecCC---CCceEEEeccccc
Q 019642 144 -ALDYCH----SQ----GIMHRDVKPHNVMIDHE---LRKLRLIDWGLAE 181 (338)
Q Consensus 144 -~l~~lH----~~----~i~H~dikp~NIli~~~---~~~~~l~dfg~~~ 181 (338)
.+..|. .. .++|+|+.+.||+++.+ .+.+.++||..+.
T Consensus 204 ~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 204 DEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 223332 22 48999999999999765 3578999999875
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.0014 Score=55.59 Aligned_cols=78 Identities=14% Similarity=0.078 Sum_probs=55.8
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc---chHHHHHHHHHHHHhcCCC--CeeEeeeeeeccCCCccE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGP--NVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~E~~~l~~l~~h~--~iv~~~~~~~~~~~~~~~ 111 (338)
+....-++.+|.|..+.||+... .+|+.+++|+.... ....+..|...|+.|.... .+++++..- ..+
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~------~~~ 86 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD------DRT 86 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE------TTE
T ss_pred CCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc------Cce
Confidence 45677789999999999999874 57889999986532 2346788999999984332 344444432 236
Q ss_pred EEEeeecCCc
Q 019642 112 LIFEYVNSTD 121 (338)
Q Consensus 112 lv~e~~~~~~ 121 (338)
++||++.+..
T Consensus 87 lv~e~l~~~~ 96 (288)
T 3f7w_A 87 LAMEWVDERP 96 (288)
T ss_dssp EEEECCCCCC
T ss_pred EEEEeecccC
Confidence 8999987653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00017 Score=62.63 Aligned_cols=75 Identities=11% Similarity=0.047 Sum_probs=39.4
Q ss_pred EEeeeecCcee-EEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCC-CeeEeeeeeeccCCCccEEEEeeecCC
Q 019642 43 VRKVGRGKYSE-VFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGP-NVVKLLDIVRDQHSKTPSLIFEYVNST 120 (338)
Q Consensus 43 ~~~lg~G~~g~-V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~-~iv~~~~~~~~~~~~~~~lv~e~~~~~ 120 (338)
.+.|+.|.... +|+... .++..+++|...+.....+..|+.+++.+..+. .+++++..- .... +++||++++.
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d--~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEE--HARG--LLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEE--TTTT--EEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeec--CCCC--EEEEeeCCCc
Confidence 44565555444 566642 235667777655433245667888888885432 245555542 2222 6899998765
Q ss_pred cc
Q 019642 121 DF 122 (338)
Q Consensus 121 ~l 122 (338)
.+
T Consensus 98 ~l 99 (333)
T 3csv_A 98 LF 99 (333)
T ss_dssp BH
T ss_pred ch
Confidence 44
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.0011 Score=59.98 Aligned_cols=79 Identities=16% Similarity=0.228 Sum_probs=51.7
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHH--HHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEe
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK--IKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 115 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e 115 (338)
+... ++.|+.|-...+|++.....+..+++|+..+..... -..|..+++.|..+.-.+++++.+ .+ ..|||
T Consensus 109 ~~~~-i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~----G~v~e 181 (458)
T 2qg7_A 109 DSLE-FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--TN----GRIEE 181 (458)
T ss_dssp TTEE-EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT----EEEEE
T ss_pred cCeE-EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC----eEEEE
Confidence 3444 567888888999999765445788899875432211 258999999995544446777766 21 26999
Q ss_pred eecCCccc
Q 019642 116 YVNSTDFK 123 (338)
Q Consensus 116 ~~~~~~l~ 123 (338)
|+.|..+.
T Consensus 182 ~I~G~~l~ 189 (458)
T 2qg7_A 182 FMDGYALS 189 (458)
T ss_dssp CCCSEECC
T ss_pred eeCCccCC
Confidence 99886553
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0015 Score=56.39 Aligned_cols=76 Identities=17% Similarity=0.259 Sum_probs=48.9
Q ss_pred EeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCC-CeeEeeeeeecc----CCCccEEEEee
Q 019642 44 RKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGP-NVVKLLDIVRDQ----HSKTPSLIFEY 116 (338)
Q Consensus 44 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~-~iv~~~~~~~~~----~~~~~~lv~e~ 116 (338)
..++ |....||++.. .+|+.+++|...+. ....+..|..+++.+..+. .+++++.. ... ..+..+++|++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEEEEC
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEEEEe
Confidence 3455 77888998753 34667999998743 4567788999998885332 24444443 110 12345789999
Q ss_pred ecCCcc
Q 019642 117 VNSTDF 122 (338)
Q Consensus 117 ~~~~~l 122 (338)
++|..+
T Consensus 109 i~G~~~ 114 (328)
T 1zyl_A 109 VGGRQF 114 (328)
T ss_dssp CCCEEC
T ss_pred cCCCCC
Confidence 988654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.31 E-value=0.0011 Score=58.35 Aligned_cols=75 Identities=15% Similarity=0.185 Sum_probs=46.4
Q ss_pred EEEeeeecCceeEEEEEEcC--------CCceEEEEEecccchH--HHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 42 VVRKVGRGKYSEVFEGINVN--------TNERCIIKILKPVKKK--KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 42 ~~~~lg~G~~g~V~~~~~~~--------~~~~~aiK~~~~~~~~--~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
-...|+.|....+|++.... .+..+++|+....... ....|..+++.+..+.-.++++... . -+
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~----~~ 110 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N----GG 110 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T----TE
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C----Cc
Confidence 35677888888999987543 1367889987543221 2367888998885443345666544 2 25
Q ss_pred EEEeeecCCcc
Q 019642 112 LIFEYVNSTDF 122 (338)
Q Consensus 112 lv~e~~~~~~l 122 (338)
+||+++.|..+
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999988654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0098 Score=51.63 Aligned_cols=70 Identities=7% Similarity=0.170 Sum_probs=43.0
Q ss_pred ecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCC--CCeeEeeeeeec----cCCCccEEEEeeecCCc
Q 019642 48 RGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGG--PNVVKLLDIVRD----QHSKTPSLIFEYVNSTD 121 (338)
Q Consensus 48 ~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h--~~iv~~~~~~~~----~~~~~~~lv~e~~~~~~ 121 (338)
.|....||+... .++ .+++|+...... ..|+..++.|..+ |.+++++..... ......+++|+++.|..
T Consensus 33 ~g~~N~vy~v~~-~~g-~~vLK~~~~~~~---~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~~ 107 (339)
T 3i1a_A 33 ADTNAFAYQADS-ESK-SYFIKLKYGYHD---EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPN 107 (339)
T ss_dssp SCSSCEEEEEEC-SSC-EEEEEEEECSSC---CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCCB
T ss_pred CccccceEEEEe-CCC-CEEEEEecCccc---hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCCc
Confidence 334678999864 344 889998765432 4677777776432 224555543111 12356789999999876
Q ss_pred c
Q 019642 122 F 122 (338)
Q Consensus 122 l 122 (338)
+
T Consensus 108 ~ 108 (339)
T 3i1a_A 108 G 108 (339)
T ss_dssp T
T ss_pred C
Confidence 5
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.50 E-value=0.0076 Score=53.92 Aligned_cols=75 Identities=16% Similarity=0.193 Sum_probs=50.3
Q ss_pred EEEeeeecCceeEEEEEEcCC-------CceEEEEEecccch--HHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 42 VVRKVGRGKYSEVFEGINVNT-------NERCIIKILKPVKK--KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 42 ~~~~lg~G~~g~V~~~~~~~~-------~~~~aiK~~~~~~~--~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
-++.+..|-...+|++..... +..+++|+...... -...+|..+++.+..+.-.+++++.+ . -+.
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~----~~~ 147 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P----EGR 147 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T----TEE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C----CCE
Confidence 356677788889999876521 57789998654221 12357999999886554456666544 2 258
Q ss_pred EEeeecCCcc
Q 019642 113 IFEYVNSTDF 122 (338)
Q Consensus 113 v~e~~~~~~l 122 (338)
||+|+.|..+
T Consensus 148 I~efI~G~~l 157 (424)
T 3mes_A 148 IEEFIDGEPL 157 (424)
T ss_dssp EEECCCSEEC
T ss_pred EEEEeCCccC
Confidence 9999998764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.00 E-value=0.049 Score=48.40 Aligned_cols=29 Identities=31% Similarity=0.517 Sum_probs=24.0
Q ss_pred ceeccCCCCCeEecC-----CCCceEEEeccccc
Q 019642 153 IMHRDVKPHNVMIDH-----ELRKLRLIDWGLAE 181 (338)
Q Consensus 153 i~H~dikp~NIli~~-----~~~~~~l~dfg~~~ 181 (338)
++|+|+.+.||++.. +...+.++||..+.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 679999999999942 33679999999885
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=85.30 E-value=0.98 Score=35.92 Aligned_cols=122 Identities=10% Similarity=0.137 Sum_probs=77.6
Q ss_pred HHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeec-CCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 019642 81 REIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN-STDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVK 159 (338)
Q Consensus 81 ~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~-~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dik 159 (338)
.|+..+.. .+|+.+.. .+-.. .+.+.+.++.-. +.++.. ++..+....++++.+|+....++ ..-+|--+.
T Consensus 35 ~el~LL~~--~~~~Fl~~-~I~e~--eD~v~~~y~~~~~~~~f~~-ik~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~ 106 (215)
T 4ann_A 35 HLMYLLEQ--HSPYFIDA-ELTEL--RDSFQIHYDINDNHTPFDN-IKSFTKNEKLRYLLNIKNLEEVN--RTRYTFVLA 106 (215)
T ss_dssp GGGGGGGS--CCTTBCCE-EEEEC--SSEEEEEECCCTTSEEGGG-GGGSCHHHHHHHHHHGGGGGGGG--GSSEECCCS
T ss_pred HHHHHHhc--cCCcccce-EEEEc--ccEEEEEEEcCcccCCHHH-HHhcCHHHHHHHHHHHHHHHHHh--cCceEEEEe
Confidence 45666653 68888865 33322 234334444333 223443 67789999999999999876433 345788899
Q ss_pred CCCeEecCCCCceEEEeccccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCC
Q 019642 160 PHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 233 (338)
Q Consensus 160 p~NIli~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf 233 (338)
|+|++++.+ +.+++.-.|....+. |. ..+...=.-..=+++..+++++..|
T Consensus 107 P~NL~f~~~-~~p~i~~RGik~~l~----------------P~------~~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 107 PDELFFTRD-GLPIAKTRGLQNVVD----------------PL------PVSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp GGGEEECTT-SCEEESCCEETTTBS----------------CC------CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred cceEEEcCC-CCEEEEEccCccCCC----------------CC------CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 999999999 889998877653221 11 1111122234667888888888887
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.36 E-value=1.3 Score=35.36 Aligned_cols=121 Identities=17% Similarity=0.183 Sum_probs=73.5
Q ss_pred HHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEeeecCC-ccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 019642 82 EIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST-DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKP 160 (338)
Q Consensus 82 E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~-~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp 160 (338)
++..+.. .||++..-+. .+ ++.+.+.++.-.+. ++. .+...+....++++.+|+.... -|...-+|--+.|
T Consensus 41 e~~lL~~--~~~~f~~~I~--~~--eD~~~i~y~~~~~~~~f~-~i~~~~~~eKlrll~nl~~L~~-~~~~~r~tf~l~P 112 (219)
T 4ano_A 41 ELEVLKE--VDPCIVRDID--VS--EDEVKVVIKPPSSFLTFA-AIRKTTLLSRIRAAIHLVSKVK-HHSARRLIFIVCP 112 (219)
T ss_dssp GGGGGGG--SCSSSEEEEE--EC--SSEEEEEEECCTTCEEHH-HHHTSCHHHHHHHHHHHHHHHS-SCCSSSEECCCCG
T ss_pred HHHHHhc--cCCCCCeEEE--Ee--CCEEEEEEEcCcccCcHH-HHHhcCHHHHHHHHHHHHHHHH-HhhhCceeEEEeC
Confidence 4455553 6888833333 22 33434444443233 333 4467899999999888887554 1224567889999
Q ss_pred CCeEecCCCCceEEEeccccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCC
Q 019642 161 HNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 233 (338)
Q Consensus 161 ~NIli~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf 233 (338)
+|++++.+ +.+++.-.|.-..+ +|.. .+...=+-..=+++..++.++..|
T Consensus 113 ~NL~f~~~-~~p~i~hRGi~~~l----------------pP~e------~~ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 113 ENLMFNRA-LEPFFLHVGVKESL----------------PPDE------WDDERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp GGEEECTT-CCEEESCCEETTTB----------------SSCS------CCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred ceEEEeCC-CcEEEEEcCCcccC----------------CCCC------CCHHHHHHHHHHHHHHHHcCCCCH
Confidence 99999998 89999988865322 2211 111111224667777888777776
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=84.34 E-value=9.6 Score=32.46 Aligned_cols=136 Identities=17% Similarity=0.205 Sum_probs=72.7
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeee-----------------
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDI----------------- 101 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~----------------- 101 (338)
+.+.++....|..| ||.+.. ++..++||.......+.+-.++...-.+ ..|+..-+.-.
T Consensus 70 ~v~~I~~s~~Gstg-vff~~t--d~~~~VVK~s~~l~~E~l~s~LA~~LGl-piP~~Riv~~~~~E~~e~~~~L~~~~~~ 145 (342)
T 1cja_A 70 QFKGIERSEKGTEG-LFFVET--ESGVFIVKRSTNIESETFCSLLCMRLGL-HAPKVRVVSSNSEEGTNMLECLAAIDKS 145 (342)
T ss_dssp GEEEEEECCSTTSC-EEEEEE--SSCEEEEECCTTHHHHHHHHHHHHHHTC-CCCCEEEEESSSHHHHHHHHHHHHHCSS
T ss_pred CeeEEEeccCCCCC-eEEEEe--CCCEEEEeCcHHHHHHHHHHHHHHHhCC-CCCCeeEEeeCcHHHHHHHHHHHHhhhh
Confidence 48888888777655 555544 4778899954322111122222222222 33432222210
Q ss_pred ---eeccCCCccEEEEeeecCCccccccCC-----CCHHHHHHHHHHH--HHHHHHHHHCC-----ceeccCCCCCeEec
Q 019642 102 ---VRDQHSKTPSLIFEYVNSTDFKVLYPT-----LTDYDIRYYIYEL--LKALDYCHSQG-----IMHRDVKPHNVMID 166 (338)
Q Consensus 102 ---~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~i~~qi--~~~l~~lH~~~-----i~H~dikp~NIli~ 166 (338)
..........++|+|..|..|...... +.++. ..++ +-++..+..++ +.+..-+++|||++
T Consensus 146 ~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~~----~k~LG~Ii~FDi~InN~DR~Pl~W~n~GN~~NIL~~ 221 (342)
T 1cja_A 146 FRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKST----MQQLGSLMALDVIVNNSDRLPIAWTNEGNLDNIMLS 221 (342)
T ss_dssp SCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHH----HHHHHHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEE
T ss_pred hHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCHHH----HHhhchhheehhhhcCCccCcccccCCCChhheEEe
Confidence 011112234589999998877665432 33222 3332 23445555442 22234689999998
Q ss_pred CCCCceEEEecccccc
Q 019642 167 HELRKLRLIDWGLAEF 182 (338)
Q Consensus 167 ~~~~~~~l~dfg~~~~ 182 (338)
.+.+.+.++|-+.+..
T Consensus 222 ~~n~~~~~IDhn~af~ 237 (342)
T 1cja_A 222 ERGATVVPIDSKIIPL 237 (342)
T ss_dssp SBTTCEEECSCCCCCC
T ss_pred CCCCeEEEEcCCcccc
Confidence 8756789999888753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 338 | ||||
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-96 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-59 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-57 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-55 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-55 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-55 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-54 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-54 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-54 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-54 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-53 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-53 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-53 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-52 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-50 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-50 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-49 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-49 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-49 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-48 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-45 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-45 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-45 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-42 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-40 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-39 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-38 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-38 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-36 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-36 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-35 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-35 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-35 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-34 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-34 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-34 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-34 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-34 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-33 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-32 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-32 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-32 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-32 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-31 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-30 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-30 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-29 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-28 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-27 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-27 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-27 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-18 |
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 287 bits (734), Expect = 2e-96
Identities = 229/306 (74%), Positives = 274/306 (89%), Gaps = 1/306 (0%)
Query: 25 FWNVSSYVI-FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREI 83
+W+ S+V+ + +QDDY++VRK+GRGKYSEVFE IN+ NE+ ++KILKPVKKKKIKREI
Sbjct: 21 YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREI 80
Query: 84 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 143
KIL+NL GGPN++ L DIV+D S+TP+L+FE+VN+TDFK LY TLTDYDIR+Y+YE+LK
Sbjct: 81 KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK 140
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 203
ALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG+EYNVRVASRYFKGPEL
Sbjct: 141 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 200
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
LVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV+IAKVLGT++L Y++KY+
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
+ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDKLLRYDHQ RLTAREAM HP
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 320
Query: 324 YFAQVR 329
YF V
Sbjct: 321 YFYTVV 326
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 1e-63
Identities = 92/305 (30%), Positives = 146/305 (47%), Gaps = 21/305 (6%)
Query: 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPN 94
+ Y + +G G + V++ ++ E IK + K+ RE++I++ L N
Sbjct: 17 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQIMRKL-DHCN 74
Query: 95 VVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKA 144
+V+L K L+ +YV T ++V TL ++ Y+Y+L ++
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 145 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 204
L Y HS GI HRD+KP N+++D + L+L D+G A+ G+ + SRY++ PEL+
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 194
Query: 205 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264
DY S+D+WS GC+ A ++ + P F G DQLV+I KVLGT
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 324
+ + + PW+K PEAI +LL Y RLT EA AH +
Sbjct: 254 YTEFKFP----QIKAHPWTKVFRPR----TPPEAIALCSRLLEYTPTARLTPLEACAHSF 305
Query: 325 FAQVR 329
F ++R
Sbjct: 306 FDELR 310
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-59
Identities = 60/309 (19%), Positives = 117/309 (37%), Gaps = 20/309 (6%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGP 93
DD+E + ++G G VF+ + + K++ P + +I RE+++L P
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS-P 64
Query: 94 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHS 150
+V S+ E+++ + + + + ++K L Y
Sbjct: 65 YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 151 Q-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 209
+ IMHRDVKP N++++ ++L D+G++ N V +R + PE L
Sbjct: 123 KHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQG-TH 179
Query: 210 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DELNAYLNKYH 263
Y D+WS+G M + P +L+ +V G
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323
+D + + ++ + S E DF++K L + +R ++ M H
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299
Query: 324 YFAQVRAAE 332
+ + A E
Sbjct: 300 FIKRSDAEE 308
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-57
Identities = 85/309 (27%), Positives = 155/309 (50%), Gaps = 21/309 (6%)
Query: 33 IFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQN 88
+F Y + +G G Y V + R IK + P + ++ REIKIL
Sbjct: 3 VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 62
Query: 89 LCGGPNVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVL-YPTLTDYDIRYYIYELLKA 144
N++ + DI+R + K L+ + + +K+L L++ I Y++Y++L+
Sbjct: 63 FRH-ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121
Query: 145 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKG 200
L Y HS ++HRD+KP N++++ L++ D+GLA P ++ VA+R+++
Sbjct: 122 LKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180
Query: 201 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 260
PE++++ + Y S+D+WS+GC+ A M+ + P F G DQL I +LG+
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNC 239
Query: 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 320
+L+ L + + ++ PW++ +A+D LDK+L ++ R+ +A+
Sbjct: 240 IINLKARNYLLS-LPHKNKVPWNRLFPN-----ADSKALDLLDKMLTFNPHKRIEVEQAL 293
Query: 321 AHPYFAQVR 329
AHPY Q
Sbjct: 294 AHPYLEQYY 302
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 3e-55
Identities = 86/304 (28%), Positives = 149/304 (49%), Gaps = 26/304 (8%)
Query: 41 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--------KKIKREIKILQNLCGG 92
E + +G G+++ V++ + NTN+ IK +K + + REIK+LQ L
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH- 59
Query: 93 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCH 149
PN++ LLD H SL+F+++ + ++ LT I+ Y+ L+ L+Y H
Sbjct: 60 PNIIGLLDA--FGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 117
Query: 150 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 208
I+HRD+KP+N+++D L+L D+GLA F P + Y +V +R+++ PELL +
Sbjct: 118 QHWILHRDLKPNNLLLDENGV-LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR 176
Query: 209 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268
Y +DMW++GC+ A ++ R PF G + DQL +I + LGT + + L
Sbjct: 177 MYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328
+ G +S + +D + L ++ R+TA +A+ YF+
Sbjct: 236 TFKSFPGIPLHHIFSA---------AGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286
Query: 329 RAAE 332
Sbjct: 287 PGPT 290
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 3e-55
Identities = 90/307 (29%), Positives = 150/307 (48%), Gaps = 27/307 (8%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGG 92
YE + K+G+G + EVF+ + T ++ +K + +K+ REIKILQ L
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KH 68
Query: 93 PNVVKLLDIVRDQHSK------TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLK 143
NVV L++I R + S + L+F++ +L T +I+ + LL
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-----YNVRVASRYF 198
L Y H I+HRD+K NV+I + L+L D+GLA + K Y RV + ++
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 199 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 258
+ PELL+ +DY +D+W GC+ A M R P G+ QL I+++ G+ +
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 318
N + EL +L+ + + K + ++ P A+D +DKLL D R+ + +
Sbjct: 247 PNVDNYELYEKLELV-----KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301
Query: 319 AMAHPYF 325
A+ H +F
Sbjct: 302 ALNHDFF 308
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 4e-55
Identities = 89/302 (29%), Positives = 163/302 (53%), Gaps = 23/302 (7%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGG 92
++++ V K+G G Y V++ N T E +K ++ + + REI +L+ L
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH- 60
Query: 93 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYC 148
PN+VKLLD++ ++ L+FE+++ K + + I+ Y+++LL+ L +C
Sbjct: 61 PNIVKLLDVIHTENKLY--LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDL 207
HS ++HRD+KP N++I+ E ++L D+GLA + P + Y V + +++ PE+L+
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 208 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267
+ Y ++D+WSLGC+FA M+ R+ F G DQL +I + LGT + + +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALF-PGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 233
Query: 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 327
P + +R+ +SK + + + L ++L YD R++A+ A+AHP+F
Sbjct: 234 PDYKPSFPKWARQDFSKVVPP-----LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
Query: 328 VR 329
V
Sbjct: 289 VT 290
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 178 bits (451), Expect = 2e-54
Identities = 89/299 (29%), Positives = 156/299 (52%), Gaps = 23/299 (7%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGG 92
+ Y + K+G G Y V++ N N E +K ++ K REI IL+ L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH- 59
Query: 93 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCH 149
N+VKL D++ + L+FE+++ K+L L + ++ +LL + YCH
Sbjct: 60 SNIVKLYDVIHTKKRLV--LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 150 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQ 208
+ ++HRD+KP N++I+ E L++ D+GLA + P ++Y + + +++ P++L+ +
Sbjct: 118 DRRVLHRDLKPQNLLINREGE-LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 209 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268
Y ++D+WS+GC+FA M+ P F G DQL++I ++LGT + N L P
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGT-PLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL---P 232
Query: 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 327
+ D + PW F+ + ID L K+L+ D R+TA++A+ H YF +
Sbjct: 233 KYDPNFTVYEPLPWESFLKG-----LDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 2e-54
Identities = 86/306 (28%), Positives = 159/306 (51%), Gaps = 21/306 (6%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCG 91
+ Y ++ VG G Y V ++ T + IK L + K+ RE+++L+++
Sbjct: 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 76
Query: 92 GPNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVL-YPTLTDYDIRYYIYELLKALD 146
NV+ LLD+ + L+ ++ + K++ + L + I++ +Y++LK L
Sbjct: 77 -ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 147 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 206
Y H+ GI+HRD+KP N+ ++ + +++D+GLA E V +R+++ PE++++
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCEL-KILDFGLA--RQADSEMTGYVVTRWYRAPEVILN 192
Query: 207 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266
Y ++D+WS+GC+ A MI K F G D+ DQL +I KV GT ++ + +
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLF-KGSDHLDQLKEIMKVTGTPPAE-FVQRLQSDE 250
Query: 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 326
+ +K ++ + SP A++ L+K+L D + R+TA EA+AHPYF
Sbjct: 251 AKNYMKGLPELEKKDFASILTN-----ASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305
Query: 327 QVRAAE 332
+ E
Sbjct: 306 SLHDTE 311
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 6e-54
Identities = 85/301 (28%), Positives = 148/301 (49%), Gaps = 21/301 (6%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGG 92
YE + K+G G Y VF+ N T+E +K ++ + REI +L+ L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH- 60
Query: 93 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 149
N+V+L D++ +L+FE+ + F L ++ ++++LLK L +CH
Sbjct: 61 KNIVRLHDVLHSDK--KLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 150 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 208
S+ ++HRD+KP N++I+ +L ++GLA F P + Y+ V + +++ P++L +
Sbjct: 119 SRNVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 209 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268
Y S+DMWS GC+FA + P F G+D DQL +I ++LGT + + L P
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL---P 234
Query: 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328
+ + ++ D L LL+ + R++A EA+ HPYF+
Sbjct: 235 DYKPYPMYPATTSLVNVVPK-----LNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289
Query: 329 R 329
Sbjct: 290 C 290
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 178 bits (452), Expect = 7e-54
Identities = 70/307 (22%), Positives = 137/307 (44%), Gaps = 46/307 (14%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---PVKKKKIKREIKILQNLCGGPN 94
D Y+++ ++G G + V + T + K + P+ K +K EI I+ L P
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPK 87
Query: 95 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHS 150
++ L D D++ LI E+++ + +++ ++ Y+ + + L + H
Sbjct: 88 LINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145
Query: 151 QGIMHRDVKPHNVMIDH-ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 209
I+H D+KP N+M + + +++ID+GLA +P + V A+ F PE++ D +
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DREP 204
Query: 210 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 269
+ DMW++G + ++ P F G D+ + L + + + +A+ +
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSP-FAGEDDLETLQNVKRCDWEFDEDAFSS--------- 254
Query: 270 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329
VSPEA DF+ LL+ + + RLT +A+ HP+
Sbjct: 255 ------------------------VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290
Query: 330 AAESSRT 336
+ +SR
Sbjct: 291 SNLTSRI 297
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 3e-53
Identities = 86/307 (28%), Positives = 153/307 (49%), Gaps = 21/307 (6%)
Query: 33 IFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQ 87
I+ + Y+ + VG G Y V + T R +K L + K+ RE+++L+
Sbjct: 13 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 88 NLCGGPNVVKLLDIVRDQHS---KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELL 142
++ NV+ LLD+ S + ++ D + LTD +++ IY++L
Sbjct: 73 HMKH-ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 131
Query: 143 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 202
+ L Y HS I+HRD+KP N+ ++ + +++D+GLA H E VA+R+++ PE
Sbjct: 132 RGLKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLA--RHTDDEMTGYVATRWYRAPE 188
Query: 203 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262
++++ Y+ ++D+WS+GC+ A ++ + F G D+ DQL I +++GT
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322
+ +L + FI +P A+D L+K+L D R+TA +A+AH
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIG------ANPLAVDLLEKMLVLDSDKRITAAQALAH 301
Query: 323 PYFAQVR 329
YFAQ
Sbjct: 302 AYFAQYH 308
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 174 bits (441), Expect = 5e-53
Identities = 70/311 (22%), Positives = 123/311 (39%), Gaps = 57/311 (18%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------------KKKIKREIK 84
++YE +GRG S V I+ T + +KI+ ++ +E+
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 85 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLY--PTLTDYDIRYYIYEL 141
IL+ + G PN+++L D L+F+ + + F L TL++ + R + L
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 119
Query: 142 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 201
L+ + H I+HRD+KP N+++D ++ ++L D+G + PG++ + + P
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178
Query: 202 ELL-----VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 256
E++ + Y +DMWS G + ++ P F+ L I
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-FWHRKQMLMLRMIMS-------- 229
Query: 257 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 316
Y D S D + + L Q R TA
Sbjct: 230 ---GNYQFGSPEWDD----------------------YSDTVKDLVSRFLVVQPQKRYTA 264
Query: 317 REAMAHPYFAQ 327
EA+AHP+F Q
Sbjct: 265 EEALAHPFFQQ 275
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 5e-53
Identities = 66/297 (22%), Positives = 127/297 (42%), Gaps = 45/297 (15%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNV 95
+ Y + +GRG++ V + ++ + + K +K + +K+EI IL N+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNI 63
Query: 96 VKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL---YPTLTDYDIRYYIYELLKALDYCHSQ 151
+ L + +IFE+++ D F+ + L + +I Y++++ +AL + HS
Sbjct: 64 LHLHESFESMEE--LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 152 GIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 210
I H D++P N++ +++I++G A PG + + + + PE+
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH-DVV 180
Query: 211 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 270
+ DMWSLG + ++ P F N + I T + A+
Sbjct: 181 STATDMWSLGTLVYVLLSGINP-FLAETNQQIIENIMNAEYTFDEEAFKE---------- 229
Query: 271 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 327
+S EA+DF+D+LL + + R+TA EA+ HP+ Q
Sbjct: 230 -----------------------ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 1e-52
Identities = 86/307 (28%), Positives = 146/307 (47%), Gaps = 28/307 (9%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCI-IKILKPVK-----KKKIKREIKILQNLCG 91
YE V ++G G Y +VF+ ++ R + +K ++ RE+ +L++L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 92 G--PNVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELL 142
PNVV+L D+ + + L+FE+V+ L P + I+ +++LL
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 143 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 202
+ LD+ HS ++HRD+KP N+++ + +L D+GLA Y V + +++ PE
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQI-KLADFGLARIYSFQMALTSVVVTLWYRAPE 185
Query: 203 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262
+L+ Y +D+WS+GC+FA M RK P F G + DQL KI V+G +
Sbjct: 186 VLLQ-SSYATPVDLWSVGCIFAEMFRRK-PLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322
L S +P KF+ + D L K L ++ R++A A++H
Sbjct: 244 ALP-----RQAFHSKSAQPIEKFVTD-----IDELGKDLLLKCLTFNPAKRISAYSALSH 293
Query: 323 PYFAQVR 329
PYF +
Sbjct: 294 PYFQDLE 300
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 174 bits (441), Expect = 3e-52
Identities = 63/301 (20%), Positives = 121/301 (40%), Gaps = 46/301 (15%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPN 94
D Y++ ++G G + V T K + K+ +++EI+ + L P
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH-PT 84
Query: 95 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYCHS 150
+V L D D + +I+E+++ + + +++ + Y+ ++ K L + H
Sbjct: 85 LVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 151 QGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 209
+H D+KP N+M + +L+LID+GL P + V + F PE+ +
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG-KP 201
Query: 210 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 269
Y DMWS+G + ++ P F G ++ + L + + +A+
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSP-FGGENDDETLRNVKSCDWNMDDSAFSG--------- 251
Query: 270 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329
+S + DF+ KLL D R+T +A+ HP+
Sbjct: 252 ------------------------ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287
Query: 330 A 330
A
Sbjct: 288 A 288
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 6e-52
Identities = 70/300 (23%), Positives = 125/300 (41%), Gaps = 43/300 (14%)
Query: 38 DDYEVVRKV-GRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVV 96
DDY+V +V G G +V + N T E+ +K+L+ K +RE+++ P++V
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIV 68
Query: 97 KLLDIVRDQHS--KTPSLIFEYVNSTDF-----KVLYPTLTDYDIRYYIYELLKALDYCH 149
+++D+ + ++ K ++ E ++ + T+ + + + +A+ Y H
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128
Query: 150 SQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 207
S I HRDVKP N++ + L+L D+G A+ + Y+ PE+L
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP- 187
Query: 208 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267
+ YD S DMWSLG + ++ PF Y + + +
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAISPGMKTRI----------------- 229
Query: 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 327
R +F N + VS E + LL+ + R+T E M HP+ Q
Sbjct: 230 -----------RMGQYEFPNPEWSE-VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 5e-51
Identities = 66/303 (21%), Positives = 127/303 (41%), Gaps = 51/303 (16%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK---REIKILQNLCGGP 93
+D +E++ ++G G + +V++ N T+ K++ +++++ EI IL + P
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH-P 69
Query: 94 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCH 149
N+VKLLD +++ ++ E+ + LT+ I+ + L AL+Y H
Sbjct: 70 NIVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 150 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLV--- 205
I+HRD+K N++ + ++L D+G++ + + + + + Y+ PE+++
Sbjct: 128 DNKIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 186
Query: 206 -DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264
+ YDY D+WSLG M + P + + L+KIAK L
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPP-HHELNPMRVLLKIAKS----------EPPTL 235
Query: 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 324
+ S DFL K L + R T + + HP+
Sbjct: 236 AQPSR------------------------WSSNFKDFLKKCLEKNVDARWTTSQLLQHPF 271
Query: 325 FAQ 327
Sbjct: 272 VTV 274
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 1e-50
Identities = 66/300 (22%), Positives = 117/300 (39%), Gaps = 49/300 (16%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGP 93
+D+++V+ +G G Y EV +N T E +KI+ + + IK+EI I + L
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHE 63
Query: 94 NVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHS 150
NVVK R L EY F + P + + D + + ++L+ + Y H
Sbjct: 64 NVVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 151 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDL 207
GI HRD+KP N+++D L++ D+GLA + N + + PELL
Sbjct: 122 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 208 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267
+ + +D+WS G + M+ + + + Q K
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGE-LPWDQPSDSCQEYSDWK------------------- 220
Query: 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 327
+ PW K + + L K+L + R+T + ++ +
Sbjct: 221 ------EKKTYLNPWKK---------IDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 2e-50
Identities = 65/297 (21%), Positives = 122/297 (41%), Gaps = 53/297 (17%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCG 91
+D+E+ R +G+GK+ V+ + +K+L + + +++RE++I +L
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYC 148
PN+++L D LI EY + YI EL AL YC
Sbjct: 66 -PNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 122
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 208
HS+ ++HRD+KP N+++ L++ D+G + + P + + PE++ +
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGE-LKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEG-R 179
Query: 209 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268
+D +D+WSLG + + K P F + + +I++V T
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISRVEFTFP-------------- 224
Query: 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325
V+ A D + +LL+++ R RE + HP+
Sbjct: 225 -----------------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 1e-49
Identities = 68/313 (21%), Positives = 125/313 (39%), Gaps = 47/313 (15%)
Query: 28 VSSYVIFSD-QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREI 83
+ S V D + Y K+G+G V+ ++V T + I+ + KK+ I EI
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 84 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYEL 141
+++ PN+V LD ++ EY+ + + + I E
Sbjct: 69 LVMREN-KNPNIVNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCREC 125
Query: 142 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKG 200
L+AL++ HS ++HRD+K N+++ + ++L D+G + + + V + Y+
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184
Query: 201 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 260
PE++ + Y +D+WSLG M MI + P + + L IA
Sbjct: 185 PEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPP-YLNENPLRALYLIAT----------NG 232
Query: 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 320
L+ +L S DFL++ L D + R +A+E +
Sbjct: 233 TPELQNPEKL------------------------SAIFRDFLNRCLDMDVEKRGSAKELL 268
Query: 321 AHPYFAQVRAAES 333
H + + S
Sbjct: 269 QHQFLKIAKPLSS 281
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 3e-49
Identities = 73/306 (23%), Positives = 144/306 (47%), Gaps = 18/306 (5%)
Query: 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQN 88
F+ Y+ ++ +G G V + + IK L K+ RE+ +++
Sbjct: 13 FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC 72
Query: 89 LCGGPNVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKA 144
+ N++ LL++ Q + + L+ E +++ +V+ L + Y +Y++L
Sbjct: 73 VNH-KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG 131
Query: 145 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 204
+ + HS GI+HRD+KP N+++ + +++D+GLA V +RY++ PE++
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 205 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD-----ELNAYL 259
+ Y ++D+WS+GC+ M+ K F G D DQ K+ + LGT +
Sbjct: 191 LG-MGYKENVDIWSVGCIMGEMVRHK-ILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
Query: 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 319
+ ++E P+ L ++++ L + +A D L K+L D R++ +A
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 320 MAHPYF 325
+ HPY
Sbjct: 309 LQHPYI 314
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 164 bits (417), Expect = 4e-49
Identities = 71/311 (22%), Positives = 124/311 (39%), Gaps = 57/311 (18%)
Query: 33 IFSDQD---DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK------KKIKREI 83
+F D + +R++G G + V+ +V +E IK + K + I +E+
Sbjct: 7 LFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEV 66
Query: 84 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYE 140
+ LQ L PN ++ +H T L+ EY + +V L + +I +
Sbjct: 67 RFLQKLRH-PNTIQYRGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHG 123
Query: 141 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 200
L+ L Y HS ++HRDVK N+++ ++L D+G A P + V + Y+
Sbjct: 124 ALQGLAYLHSHNMIHRDVKAGNILLSEPGL-VKLGDFGSASIMAPANSF---VGTPYWMA 179
Query: 201 PELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 258
PE+++ + + YD +D+WSLG + RK P F + L IA+
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQ---------- 228
Query: 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 318
N+ S +F+D L+ QDR T+
Sbjct: 229 -NESPALQSGH------------------------WSEYFRNFVDSCLQKIPQDRPTSEV 263
Query: 319 AMAHPYFAQVR 329
+ H + + R
Sbjct: 264 LLKHRFVLRER 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (411), Expect = 3e-48
Identities = 73/307 (23%), Positives = 127/307 (41%), Gaps = 47/307 (15%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCGG 92
+D Y+ +G G +SEV + T + IK + K+ ++ EI +L +
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KH 66
Query: 93 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLKALDYCH 149
PN+V L DI LI + V+ + F + T+ D I+++L A+ Y H
Sbjct: 67 PNIVALDDIYESG--GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 150 SQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 207
GI+HRD+KP N++ E K+ + D+GL++ PG + + + PE+L
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ- 183
Query: 208 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267
+ Y ++D WS+G + ++ P FY ++ +I K
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPP-FYDENDAKLFEQILKA------------------ 224
Query: 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 327
W +S A DF+ L+ D + R T +A+ HP+ A
Sbjct: 225 ------EYEFDSPYWDD---------ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269
Query: 328 VRAAESS 334
A + +
Sbjct: 270 DTALDKN 276
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 3e-47
Identities = 66/305 (21%), Positives = 120/305 (39%), Gaps = 58/305 (19%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGG 92
+DYEV+ +G G Y + + + + K L +K+ + E+ +L+ L
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-H 62
Query: 93 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLY------PTLTDYDIRYYIYELLKAL 145
PN+V+ D + D+ + T ++ EY D V+ L + + + +L AL
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 146 DYCHSQG-----IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFK 199
CH + ++HRD+KP NV +D + ++L D+GLA + + V + Y+
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 200 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259
PE + Y+ D+WSLGC+ + P F + KI +
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPP-FTAFSQKELAGKIRE----------- 228
Query: 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 319
G+ R P+ S E + + ++L R + E
Sbjct: 229 ---------------GKFRRIPYR----------YSDELNEIITRMLNLKDYHRPSVEEI 263
Query: 320 MAHPY 324
+ +P
Sbjct: 264 LENPL 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 2e-45
Identities = 71/309 (22%), Positives = 126/309 (40%), Gaps = 61/309 (19%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCG 91
+D++ + +G G +S V + T+ IKIL+ K + RE ++ L
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD---FKVLYPTLTDYDIRYYIYELLKALDYC 148
P VKL +D Y + + + + + R+Y E++ AL+Y
Sbjct: 68 -PFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLV 205
H +GI+HRD+KP N++++ ++ +++ D+G A+ P + N V + + PELL
Sbjct: 125 HGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 206 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265
+ + S D+W+LGC+ ++ P F + + KI K+ +
Sbjct: 184 E-KSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQKIIKL-------------EYD 228
Query: 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA------ 319
+ P+A D ++KLL D RL E
Sbjct: 229 FPEK------------------------FFPKARDLVEKLLVLDATKRLGCEEMEGYGPL 264
Query: 320 MAHPYFAQV 328
AHP+F V
Sbjct: 265 KAHPFFESV 273
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 2e-45
Identities = 64/312 (20%), Positives = 117/312 (37%), Gaps = 61/312 (19%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQ 87
+ Y+V +G G + V+ GI V+ N IK ++ + ++ E+ +L+
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 88 NLCGG-PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELL 142
+ G V++LLD S LI E + L + R + +++L
Sbjct: 63 KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 143 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 202
+A+ +CH+ G++HRD+K N++ID +L+LID+G Y +R + PE
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPE 179
Query: 203 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262
+ + + S +WSLG + M+ PF + + + +
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------------------IIRG 219
Query: 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322
+ + VS E + L DR T E H
Sbjct: 220 QVFFRQR------------------------VSSECQHLIRWCLALRPSDRPTFEEIQNH 255
Query: 323 PYFAQVRAAESS 334
P+ V + +
Sbjct: 256 PWMQDVLLPQET 267
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 3e-45
Identities = 69/314 (21%), Positives = 133/314 (42%), Gaps = 56/314 (17%)
Query: 33 IFSDQ---DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIK 80
+F + D Y+ ++G G+++ V + +T + K +K + ++ I+
Sbjct: 2 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 61
Query: 81 REIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYY 137
RE+ IL+ + PNV+ L ++ ++ LI E V DF +LT+ + +
Sbjct: 62 REVSILKEIQH-PNVITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEF 118
Query: 138 IYELLKALDYCHSQGIMHRDVKPHNVMIDHE---LRKLRLIDWGLAEFYHPGKEYNVRVA 194
+ ++L + Y HS I H D+KP N+M+ ++++ID+GLA G E+
Sbjct: 119 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFG 178
Query: 195 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 254
+ F PE++ + + DMWS+G + ++ PF G + L ++ V
Sbjct: 179 TPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQETLANVSAV----- 231
Query: 255 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 314
+ +S S A DF+ +LL D + R+
Sbjct: 232 -------------------NYEFEDEYFSN---------TSALAKDFIRRLLVKDPKKRM 263
Query: 315 TAREAMAHPYFAQV 328
T ++++ HP+
Sbjct: 264 TIQDSLQHPWIKPK 277
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 3e-44
Identities = 55/298 (18%), Positives = 114/298 (38%), Gaps = 51/298 (17%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPN 94
+ ++GRG + V++G++ T L+ K +++ K E ++L+ L PN
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PN 69
Query: 95 VVKLLDIVRD--QHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCH 149
+V+ D + K L+ E + S K + + +R + ++LK L + H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 150 SQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 207
++ I+HRD+K N+ I +++ D GLA V + + F PE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFMAPEMY--E 186
Query: 208 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267
+ YD S+D+++ G M + P+ + ++ D
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-----------GVKPASFD 235
Query: 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325
PE + ++ +R + +R + ++ + H +F
Sbjct: 236 KV------------------------AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 8e-43
Identities = 63/302 (20%), Positives = 120/302 (39%), Gaps = 53/302 (17%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCG 91
+D+ + + +G+G + +VF TN+ IK LK + E ++L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYC 148
P + + + + + + EY+N D +Y E++ L +
Sbjct: 62 HPFLTHMFCTFQTKEN--LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 119
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 207
HS+GI++RD+K N+++D + ++ D+G+ E + N + + PE+L+
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG- 177
Query: 208 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267
Q Y++S+D WS G + M+ + P F+G D + I
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSP-FHGQDEEELFHSI--------------------- 215
Query: 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR-EAMAHPYFA 326
R + +++ EA D L KL + + RL R + HP F
Sbjct: 216 --------RMDNPFYPRWL--------EKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 259
Query: 327 QV 328
++
Sbjct: 260 EI 261
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 149 bits (377), Expect = 1e-42
Identities = 70/307 (22%), Positives = 123/307 (40%), Gaps = 55/307 (17%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCG 91
+D+ V R +GRG + EV+ +T + +K L + + E +L +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 92 G--PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALD 146
G P +V + S I + +N D + ++ D+R+Y E++ L+
Sbjct: 64 GDCPFIVCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121
Query: 147 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 206
+ H++ +++RD+KP N+++D +R+ D GLA + K + + + PE+L
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQK 179
Query: 207 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266
YD S D +SLGCM ++ P F H D+ E++ +EL
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSP-FRQHKTKDKH----------EIDRMTLTMAVEL 228
Query: 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMA 321
SPE L+ LL+ D RL A+E
Sbjct: 229 PDS------------------------FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264
Query: 322 HPYFAQV 328
P+F +
Sbjct: 265 SPFFRSL 271
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 142 bits (358), Expect = 5e-40
Identities = 70/328 (21%), Positives = 129/328 (39%), Gaps = 33/328 (10%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKKIKREIKILQNL-------- 89
Y +VRK+G G +S V+ ++ N +KI++ V + + EIK+LQ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 90 --CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDF------KVLYPTLTDYDIRYYIYEL 141
G +++KLLD + ++ + + K + + ++ +L
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 142 LKALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS---RY 197
L LDY H GI+H D+KP NV+++ LI +A+ + S R
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 198 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF-----FYGHDNHDQLVKIAKVLGT 252
++ PE+L+ + D+WS C+ +I F + D + +I ++LG
Sbjct: 195 YRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 253
Query: 253 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHL-----VSPEAIDFLDKLLR 307
N + L+ S+ + + + + E DFL +L+
Sbjct: 254 LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 313
Query: 308 YDHQDRLTAREAMAHPYFAQVRAAESSR 335
D + R A + HP+ E R
Sbjct: 314 LDPRKRADAGGLVNHPWLKDTLGMEEIR 341
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 136 bits (344), Expect = 9e-39
Identities = 58/301 (19%), Positives = 104/301 (34%), Gaps = 50/301 (16%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLC 90
D YE+ +G G SEV ++ + +K+L+ P + +RE + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL- 64
Query: 91 GGPNVVKLLDIVRDQHSKTPS--LIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKAL 145
P +V + D + P ++ EYV+ + + +T I + +AL
Sbjct: 65 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 124
Query: 146 DYCHSQGIMHRDVKPHNVMIDHELR---KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 202
++ H GI+HRDVKP N+MI I +A+ + + + + + PE
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 203 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262
D D++SLGC+ ++ + P F G +
Sbjct: 185 QARG-DSVDARSDVYSLGCVLYEVLTGEPP-FTGDSPVSVAYQHV--------------- 227
Query: 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322
R P S +S + + K L + ++R M
Sbjct: 228 -------------REDPIPPSARHEG-----LSADLDAVVLKALAKNPENRYQTAAEMRA 269
Query: 323 P 323
Sbjct: 270 D 270
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 2e-38
Identities = 44/301 (14%), Positives = 111/301 (36%), Gaps = 54/301 (17%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLC 90
V +++G G + V++G + +K+L P + + K E+ +L+
Sbjct: 6 PDGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 91 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLY---PTLTDYDIRYYIYELLKALD 146
N++ + +++ ++ + + L+ + + + +D
Sbjct: 63 H-VNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 147 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPEL 203
Y H++ I+HRD+K +N+ + +L +++ D+GLA + S + PE+
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 204 LVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261
+ Y + D+++ G + ++ + P + +N DQ++ +
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQIIFM--------------- 221
Query: 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321
VGR P + ++ + + L+ +R + +A
Sbjct: 222 ------------VGRGYLSPDLSKVRSN----CPKAMKRLMAECLKKKRDERPLFPQILA 265
Query: 322 H 322
Sbjct: 266 S 266
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 3e-38
Identities = 58/310 (18%), Positives = 127/310 (40%), Gaps = 54/310 (17%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPVK-------KKKIKREIKILQ 87
+++E+++ +G G Y +VF + +T + +K+LK + + E ++L+
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 88 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYDIRYYIYELLKALD 146
++ P +V L + + L + + T+++++ Y+ E++ AL+
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 147 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPEL 203
+ H GI++RD+K N+++D + L D+GL++ + + Y+ Y +
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
+D ++D WSLG + ++ P F + +I++ + E
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASP-FTVDGEKNSQAEISRRILKSEP-------- 253
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TARE 318
P+ + + S A D + +LL D + RL A E
Sbjct: 254 -----------------PYPQEM--------SALAKDLIQRLLMKDPKKRLGCGPRDADE 288
Query: 319 AMAHPYFAQV 328
H +F ++
Sbjct: 289 IKEHLFFQKI 298
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 135 bits (341), Expect = 6e-38
Identities = 56/305 (18%), Positives = 113/305 (37%), Gaps = 59/305 (19%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCG 91
D++++R +G G + V + + +K+LK + + E +L +
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-T 62
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYC 148
P ++++ +D I +Y+ + ++Y E+ AL+Y
Sbjct: 63 HPFIIRMWGTFQDAQQIFM--IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 208
HS+ I++RD+KP N+++D +++ D+G A++ + + PE++ +
Sbjct: 121 HSKDIIYRDLKPENILLDKNGH-IKITDFGFAKYVP--DVTYTLCGTPDYIAPEVVST-K 176
Query: 209 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268
Y+ S+D WS G + M+ P FY + KI
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTP-FYDSNTMKTYEKILN-------------------- 215
Query: 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHP 323
P+ + + D L +L+ D RL + HP
Sbjct: 216 ------AELRFPPF-----------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 258
Query: 324 YFAQV 328
+F +V
Sbjct: 259 WFKEV 263
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 8e-38
Identities = 59/303 (19%), Positives = 109/303 (35%), Gaps = 52/303 (17%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCG 91
+D++ ++ +G+G + +V T +KIL+ E ++LQN
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 92 GPNVVKLLDIVRD-QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHS 150
P + L + T+ R+Y E++ AL+Y HS
Sbjct: 65 -PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 151 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 210
+ +++RD+K N+M+D + +++ D+GL + +++ DY
Sbjct: 124 RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 211 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 270
++D W LG + M+ + P FY D+ I
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLP-FYNQDHERLFELI------------------------ 217
Query: 271 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYF 325
+ + + SPEA L LL+ D + RL A+E M H +F
Sbjct: 218 -----LMEEIRFPRTL--------SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
Query: 326 AQV 328
+
Sbjct: 265 LSI 267
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 1e-36
Identities = 53/325 (16%), Positives = 106/325 (32%), Gaps = 77/325 (23%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNER-----CIIKILK----PVKKKKIKREIKIL 86
+++ E + +G G + +V ++ +K+LK +++ + E+K++
Sbjct: 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 94
Query: 87 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD------------------------- 121
L N+V LL S LIFEY D
Sbjct: 95 TQLGSHENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 122 -FKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180
+ LT D+ + Y++ K +++ + +HRD+ NV++ H +++ D+GLA
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV-VKICDFGLA 211
Query: 181 EFYHPGKEYNVR---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 237
Y VR + PE L + Y D+WS G + + + G
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270
Query: 238 DNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPE 297
K+ + N + ++ + E
Sbjct: 271 PVDANFYKLIQ-----------NGFKMDQPFY------------------------ATEE 295
Query: 298 AIDFLDKLLRYDHQDRLTAREAMAH 322
+ +D + R + +
Sbjct: 296 IYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 1e-36
Identities = 39/293 (13%), Positives = 101/293 (34%), Gaps = 50/293 (17%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-PVKKKKIKREIKILQNLCGGPN 94
+ + ++++ +G+G++ +V G + +K +K + E ++ L N
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRH-SN 61
Query: 95 VVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLY----PTLTDYDIRYYIYELLKALDYCH 149
+V+LL ++ ++ ++ EY+ + L L + + ++ +A++Y
Sbjct: 62 LVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 150 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 209
+HRD+ NV++ + ++ D+GL + + + + PE L + +
Sbjct: 121 GNNFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE-KK 176
Query: 210 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 269
+ D+WS G + + + D + ++ K Y ++
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------GYKMDAPDG 224
Query: 270 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322
P + + D R + +
Sbjct: 225 ------------------------CPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 131 bits (329), Expect = 6e-36
Identities = 59/303 (19%), Positives = 114/303 (37%), Gaps = 55/303 (18%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK------REIKILQNLCG 91
D ++ ++ +G G + V + + +KIL K K+K E +ILQ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 92 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYDIRYYIYELLKALDYCHS 150
P +VKL +D + + + + ++ R+Y +++ +Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 151 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 210
+++RD+KP N++ID + +++ D+G A+ + PE+++ + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILS-KGY 215
Query: 211 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 270
+ ++D W+LG + M PFF D Q+ +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFF--ADQPIQIYEK------------------------ 249
Query: 271 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYF 325
+ + S F S + D L LL+ D R + H +F
Sbjct: 250 ---IVSGKVRFPSHF---------SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
Query: 326 AQV 328
A
Sbjct: 298 ATT 300
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 1e-35
Identities = 49/302 (16%), Positives = 104/302 (34%), Gaps = 54/302 (17%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 93
++ + K+G+G + EV+ G T R IK LKP + + +E ++++ L
Sbjct: 15 PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRH-E 72
Query: 94 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYC 148
+V+L +V ++ ++ EY++ L + ++ + Y
Sbjct: 73 KLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPELLVD 206
+HRD++ N+++ L ++ D+GLA + + PE +
Sbjct: 130 ERMNYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188
Query: 207 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266
+ D+WS G + + + + G N + L ++ Y +
Sbjct: 189 -GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV------------ERGYRMPC 235
Query: 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE--AMAHPY 324
P+ D + + R + ++R T A Y
Sbjct: 236 PPE------------------------CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
Query: 325 FA 326
F
Sbjct: 272 FT 273
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 5e-35
Identities = 43/300 (14%), Positives = 102/300 (34%), Gaps = 52/300 (17%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 93
++ ++V ++G G++ EV+ G N + + +K LK + E +++ L
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH-Q 68
Query: 94 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYC 148
+V+L +V + +I EY+ + LT + ++ + + +
Sbjct: 69 RLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG-PELLVDL 207
+ +HRD++ N+++ L ++ D+GLA + A K ++
Sbjct: 126 EERNYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 208 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267
+ D+WS G + ++ + G N + + + + Y +
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------GYRMVRP 232
Query: 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE--AMAHPYF 325
E + + +DR T ++ +F
Sbjct: 233 DN------------------------CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 6e-35
Identities = 42/301 (13%), Positives = 92/301 (30%), Gaps = 56/301 (18%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IKILKPVK------KKKIKREIKIL 86
+ D ++ K+G G + V G + + + +K LKP RE+ +
Sbjct: 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 87 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELL 142
+L N+++L +V K ++ E + Y ++
Sbjct: 66 HSLDH-RNLIRLYGVVLTPPMK---MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 143 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFK 199
+ + Y S+ +HRD+ N+++ +++ D+GL ++ V +
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 200 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259
+ + + ++ D W G M + + G + L KI K
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK----------- 229
Query: 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 319
L + + + + + +DR T
Sbjct: 230 EGERLPRPED------------------------CPQDIYNVMVQCWAHKPEDRPTFVAL 265
Query: 320 M 320
Sbjct: 266 R 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 3e-34
Identities = 45/312 (14%), Positives = 95/312 (30%), Gaps = 65/312 (20%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNL 89
D +D + +G G + +V + R I + + E+++L L
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67
Query: 90 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------------------FKVLYPTLT 130
PN++ LL +H L EY + TL+
Sbjct: 68 GHHPNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 131 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 190
+ ++ ++ + +DY + +HRD+ N+++ ++ D+GL+ +
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKT 184
Query: 191 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 250
+ + E L Y + D+WS G + ++ + G + K+
Sbjct: 185 MGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL---- 239
Query: 251 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 310
Y LE E D + + R
Sbjct: 240 --------PQGYRLEKPLN------------------------CDDEVYDLMRQCWREKP 267
Query: 311 QDRLTAREAMAH 322
+R + + +
Sbjct: 268 YERPSFAQILVS 279
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 5e-34
Identities = 42/295 (14%), Positives = 99/295 (33%), Gaps = 50/295 (16%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 93
D + V+++G G++ V G +N ++ IK ++ + ++ E +++ L P
Sbjct: 3 DPSELTFVQEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAMSEEDFIEEAEVMMKLSH-P 60
Query: 94 NVVKLLDIVRDQHSKTPSLIFEYVNSTD----FKVLYPTLTDYDIRYYIYELLKALDYCH 149
+V+L + +Q L+FE++ + + ++ + + Y
Sbjct: 61 KLVQLYGVCLEQAP--ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 150 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR--VASRYFKGPELLVDL 207
++HRD+ N ++ +++ D+G+ F + + + PE+
Sbjct: 119 EACVIHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF- 176
Query: 208 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267
Y D+WS G + + + + N + + I+
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST------------------- 217
Query: 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322
G KP L S ++ + +DR +
Sbjct: 218 -------GFRLYKP----------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 124 bits (313), Expect = 5e-34
Identities = 48/307 (15%), Positives = 102/307 (33%), Gaps = 50/307 (16%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVV 96
+ Y + RK+G G + +++ G ++ E IK+ K ++ E KI + + GG +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIP 66
Query: 97 KLLDIVRDQHSKTPSLIFEYVNSTD---FKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 153
+ + ++ E + + F + + +++ ++Y HS+
Sbjct: 67 TIRWCGAEGDY--NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 124
Query: 154 MHRDVKPHNVMIDHELRKLRL--IDWGLAEFYHPGKEYNVR--------VASRYFKGPEL 203
+HRDVKP N ++ + + ID+GLA+ Y + + + +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
+ + D+ SLG + + G + K +
Sbjct: 185 HLG-IEQSRRDDLESLGYVLMYFNLGS-LPWQGLKAATKRQKYER--------------- 227
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA---REAM 320
S K S I + E +L+ D+ R+
Sbjct: 228 -------------ISEKKMSTPIEVLCKG-YPSEFATYLNFCRSLRFDDKPDYSYLRQLF 273
Query: 321 AHPYFAQ 327
+ + Q
Sbjct: 274 RNLFHRQ 280
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 5e-34
Identities = 47/295 (15%), Positives = 107/295 (36%), Gaps = 50/295 (16%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 93
D D ++++G G++ V G IK++K + + + E K++ NL
Sbjct: 2 DPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH-E 59
Query: 94 NVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCH 149
+V+L + Q + +I EY+ N L + ++ +A++Y
Sbjct: 60 KLVQLYGVCTKQ--RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 150 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKGPELLVDL 207
S+ +HRD+ N +++ + +++ D+GL+ + + + + PE+L+
Sbjct: 118 SKQFLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY- 175
Query: 208 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267
+ D+W+ G + + + + N + IA+
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ------------------- 216
Query: 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322
G +P HL S + + +R T + +++
Sbjct: 217 -------GLRLYRP----------HLASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 9e-34
Identities = 53/299 (17%), Positives = 105/299 (35%), Gaps = 53/299 (17%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-------KKIKREIKILQN 88
++ E+ R +G G++ +V +GI ++ + +K K +K +E ++
Sbjct: 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 64
Query: 89 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKA 144
P++VKL+ ++ + +I E + + +L + Y Y+L A
Sbjct: 65 F-DHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120
Query: 145 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV-RVASRYFKGPEL 203
L Y S+ +HRD+ NV++ ++L D+GL+ + Y +
Sbjct: 121 LAYLESKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263
++ + + + D+W G ++ F G N+D + +I N
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI------------ENGER 227
Query: 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322
L + P P + K YD R E A
Sbjct: 228 LPMPPN------------------------CPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 121 bits (305), Expect = 6e-33
Identities = 42/293 (14%), Positives = 104/293 (35%), Gaps = 48/293 (16%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKKIKREIKILQNLCGGP 93
++ D + K+G G+Y EV+EG+ + +K LK ++ ++ +E +++ + P
Sbjct: 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-P 73
Query: 94 NVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLY----PTLTDYDIRYYIYELLKALDYC 148
N+V+LL + + +I E++ L ++ + Y ++ A++Y
Sbjct: 74 NLVQLLGVCTREPPFY--IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 131
Query: 149 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVDL 207
+ +HRD+ N ++ +++ D+GL+ + +
Sbjct: 132 EKKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 208 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267
+ D+W+ G + + + G D Q+ ++ + Y +E
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLE-----------KDYRMERP 238
Query: 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 320
+ + + +++ DR + E
Sbjct: 239 EG------------------------CPEKVYELMRACWQWNPSDRPSFAEIH 267
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 121 bits (303), Expect = 1e-32
Identities = 45/303 (14%), Positives = 94/303 (31%), Gaps = 56/303 (18%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-------KKIKREIKILQN 88
D ++ + +G G++ EV G +R I +K +K + E I+
Sbjct: 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 83
Query: 89 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKA 144
PNV+ L +V +I E++ + T + + +
Sbjct: 84 FDH-PNVIHLEGVVTKST--PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140
Query: 145 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 204
+ Y +HRD+ N++++ L ++ D+GL+ F ++ K P
Sbjct: 141 MKYLADMNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 199
Query: 205 VD-----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259
+ + + D+WS G + ++ E ++ N D + I +
Sbjct: 200 TAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ----------- 248
Query: 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 319
L P +D + + D R +
Sbjct: 249 ---DYRLPPPMD----------------------CPSALHQLMLDCWQKDRNHRPKFGQI 283
Query: 320 MAH 322
+
Sbjct: 284 VNT 286
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 1e-32
Identities = 51/317 (16%), Positives = 98/317 (30%), Gaps = 70/317 (22%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEG-----INVNTNERCIIKILKPVK----KKKIKREIKIL 86
++ + +G G + +V E I + +K+LKP ++ + E+K+L
Sbjct: 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 80
Query: 87 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD---------------------FKVL 125
L N+V LL +I EY D +
Sbjct: 81 SYLGNHMNIVNLLGACTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 126 YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185
L D+ + Y++ K + + S+ +HRD+ N+++ H ++ D+GLA
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-KICDFGLARDIKN 197
Query: 186 GKEYNVRVASRYFKG--PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 243
Y V+ +R + Y + D+WS G + + G +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257
Query: 244 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLD 303
K+ K + + E D +
Sbjct: 258 YKMIK-----------EGFRMLSPEH------------------------APAEMYDIMK 282
Query: 304 KLLRYDHQDRLTAREAM 320
D R T ++ +
Sbjct: 283 TCWDADPLKRPTFKQIV 299
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 120 bits (301), Expect = 2e-32
Identities = 38/231 (16%), Positives = 90/231 (38%), Gaps = 20/231 (8%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KPVKKKKIKREIKILQNLCGGPNVVKL 98
Y+V R++G G + +FEG N+ N++ IK + +++ E + + L G + +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 99 LDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMH 155
Q L+ + + + +L + + ++L + H + +++
Sbjct: 67 YYF--GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 124
Query: 156 RDVKPHNVMIDHELRK----LRLIDWGLAEFYHPG--------KEYNVRVASRYFKGPEL 203
RD+KP N +I K + ++D+G+ +FY +E + +
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 204 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 254
+ ++ D+ +LG +F + + G K ++ +
Sbjct: 185 HLG-REQSRRDDLEALGHVFMYFLRGS-LPWQGLKAATNKQKYERIGEKKQ 233
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 3e-32
Identities = 47/318 (14%), Positives = 107/318 (33%), Gaps = 58/318 (18%)
Query: 33 IFSDQDDYEVV-RKVGRGKYSEVFEGINVNTNERCI--IKILKPVKKKK----IKREIKI 85
+F +D+ + ++G G + V +G+ ++ IK+LK +K + RE +I
Sbjct: 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62
Query: 86 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLY---PTLTDYDIRYYIYEL 141
+ L P +V+L+ + + + L+ E K L + ++ ++++
Sbjct: 63 MHQL-DNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 118
Query: 142 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR---YF 198
+ Y + +HRD+ NV++ + ++ D+GL++ Y ++
Sbjct: 119 SMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLK 177
Query: 199 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 258
++ + + D+WS G + + + + + I
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI------------ 225
Query: 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 318
+E P+ PE + Y +DR
Sbjct: 226 EQGKRMECPPE------------------------CPPELYALMSDCWIYKWEDRPDFLT 261
Query: 319 ---AMAHPYFAQVRAAES 333
M Y++ E
Sbjct: 262 VEQRMRACYYSLASKVEG 279
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 4e-31
Identities = 45/301 (14%), Positives = 102/301 (33%), Gaps = 57/301 (18%)
Query: 37 QDDYEVVRKVGRGKYSEVFEGINVNTNER----CIIKILKPVKKKK----IKREIKILQN 88
+ +++ ++ +G G + V++G+ + E+ IK L+ K I E ++ +
Sbjct: 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67
Query: 89 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY----DIRYYIYELLKA 144
+ P+V +LL I + LI + + D + + ++ K
Sbjct: 68 VDN-PHVCRLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 145 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGP 201
++Y + ++HRD+ NV++ +++ D+GLA+ ++ +
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 202 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261
E ++ + Y + D+WS G ++ + G + + K
Sbjct: 183 ESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK------------G 229
Query: 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321
L P + + + K D R RE +
Sbjct: 230 ERLPQPPI------------------------CTIDVYMIMVKCWMIDADSRPKFRELII 265
Query: 322 H 322
Sbjct: 266 E 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 1e-30
Identities = 45/301 (14%), Positives = 95/301 (31%), Gaps = 58/301 (19%)
Query: 44 RKVGRGKYSEVFEGI--NVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPNVV 96
+++G G + V +G + +KILK P K ++ E ++Q L P +V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIV 71
Query: 97 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGI 153
+++ I + L+ E + D +I ++++ + Y
Sbjct: 72 RMIGICEAES---WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 154 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPELLVDLQD 209
+HRD+ NV++ + ++ D+GL++ + Y + PE +
Sbjct: 129 VHRDLAARNVLLVTQHY-AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YK 186
Query: 210 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 269
+ D+WS G + + + G + + K +
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK------------GERMGCPAG 234
Query: 270 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE--AMAHPYFAQ 327
E D ++ YD ++R Y+
Sbjct: 235 ------------------------CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270
Query: 328 V 328
V
Sbjct: 271 V 271
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (286), Expect = 3e-30
Identities = 47/320 (14%), Positives = 95/320 (29%), Gaps = 78/320 (24%)
Query: 37 QDDYEVVRKVGRGKYSEVFEG-----INVNTNERCIIKILKPVK----KKKIKREIKILQ 87
+++ E VR +G G + VF+ + +K+LK + +RE ++
Sbjct: 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 71
Query: 88 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK------------------------ 123
PN+VKLL + K L+FEY+ D
Sbjct: 72 EFDN-PNIVKLLGV--CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128
Query: 124 ---VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180
P L+ + ++ + Y + +HRD+ N ++ + +++ D+GL+
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV-VKIADFGLS 187
Query: 181 EFYHPGKEYNV--RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 238
+ Y A P + Y D+W+ G + + +YG
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247
Query: 239 NHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEA 298
+ + + + + L E
Sbjct: 248 HEEVIYYV------------RDGNILACPEN------------------------CPLEL 271
Query: 299 IDFLDKLLRYDHQDRLTARE 318
+ + DR +
Sbjct: 272 YNLMRLCWSKLPADRPSFCS 291
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 3e-29
Identities = 54/312 (17%), Positives = 108/312 (34%), Gaps = 56/312 (17%)
Query: 27 NVSSYVIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IKILKPVKK----KKI 79
V VI +GRG + V+ G ++ + + I +K L + +
Sbjct: 16 AVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 75
Query: 80 KREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIR 135
E I+++ PNV+ LL I P ++ Y+ D + T D+
Sbjct: 76 LTEGIIMKDFSH-PNVLSLLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHNPTVKDLI 133
Query: 136 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS 195
+ ++ K + + S+ +HRD+ N M+D + +++ D+GLA + + +V +
Sbjct: 134 GFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKT 192
Query: 196 RY-----FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 250
+ E L Q + D+WS G + ++ R P + + D V + +
Sbjct: 193 GAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-- 249
Query: 251 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 310
GR +P + + K
Sbjct: 250 ------------------------GRRLLQP----------EYCPDPLYEVMLKCWHPKA 275
Query: 311 QDRLTAREAMAH 322
+ R + E ++
Sbjct: 276 EMRPSFSELVSR 287
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 4e-28
Identities = 39/302 (12%), Positives = 97/302 (32%), Gaps = 57/302 (18%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNER----CIIKILKPV----KKKKIKREIKILQ 87
+ +G G++ EV++G+ ++ + IK LK ++ E I+
Sbjct: 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 64
Query: 88 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLK 143
N+++L ++ +I EY+ + + + + +
Sbjct: 65 QFSH-HNIIRLEGVISKYKPMM--IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 121
Query: 144 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFK 199
+ Y + +HRD+ N++++ L ++ D+GL+ E + +
Sbjct: 122 GMKYLANMNYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 200 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259
PE + + S D+WS G + ++ E ++ NH+ + I
Sbjct: 181 APEAISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAI------------N 227
Query: 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 319
+ + L + + + + R +
Sbjct: 228 DGFRLPTPMD------------------------CPSAIYQLMMQCWQQERARRPKFADI 263
Query: 320 MA 321
++
Sbjct: 264 VS 265
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 2e-27
Identities = 48/328 (14%), Positives = 108/328 (32%), Gaps = 71/328 (21%)
Query: 26 WNVSSYVIFSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCI-----IKILKP----VKK 76
++ S + +D ++ + +GRG + +V E ++ +K+LK +
Sbjct: 3 YDASKWEF--PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 60
Query: 77 KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---------- 126
+ + E+KIL ++ NVV LL ++ L
Sbjct: 61 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 120
Query: 127 --------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG 178
LT + Y +++ K +++ S+ +HRD+ N+++ + +++ D+G
Sbjct: 121 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFG 179
Query: 179 LAEFYHPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 234
LA + +Y + R+ ++ + + Y D+WS G + + +
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPY 237
Query: 235 YGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLV 294
G ++ + K +
Sbjct: 238 PGVKIDEEFCRRLK-----------EGTRMRAPDY------------------------T 262
Query: 295 SPEAIDFLDKLLRYDHQDRLTAREAMAH 322
+PE + + R T E + H
Sbjct: 263 TPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 4e-27
Identities = 48/324 (14%), Positives = 104/324 (32%), Gaps = 72/324 (22%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKIL 86
++ + R++G+G + V+EG+ R IK + + + E ++
Sbjct: 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 77
Query: 87 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-------------YPTLTDYD 133
+ +VV+LL +V + +I E + D K +
Sbjct: 78 KEF-NCHHVVRLLGVV--SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 134 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---N 190
+ E+ + Y ++ +HRD+ N M+ + +++ D+G+ + Y
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGG 193
Query: 191 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 250
+ + PE L D + D+WS G + + E + G N L +
Sbjct: 194 KGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV---- 248
Query: 251 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 310
+ L+ + + +Y+
Sbjct: 249 --------MEGGLLDKPDN------------------------CPDMLFELMRMCWQYNP 276
Query: 311 QDRLTAREAMA------HPYFAQV 328
+ R + E ++ P F +V
Sbjct: 277 KMRPSFLEIISSIKEEMEPGFREV 300
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 5e-27
Identities = 43/319 (13%), Positives = 100/319 (31%), Gaps = 71/319 (22%)
Query: 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNE-------RCIIKILKPVKKKK----IKREIK 84
+D + + +G G + +V + ++ + +K+LK +K + E++
Sbjct: 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEME 70
Query: 85 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL------------------- 125
+++ + N++ LL +I EY + + +
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 126 YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185
L+ D+ Y++ + ++Y S+ +HRD+ NV++ + ++ D+GLA H
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM-KIADFGLARDIHH 187
Query: 186 GKEYNVRVASRYFKGPELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 243
Y R L D Y + D+WS G + + + G +
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247
Query: 244 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLD 303
+ + ++ + E +
Sbjct: 248 KLL------------KEGHRMDKPSN------------------------CTNELYMMMR 271
Query: 304 KLLRYDHQDRLTAREAMAH 322
R T ++ +
Sbjct: 272 DCWHAVPSQRPTFKQLVED 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 4e-26
Identities = 50/306 (16%), Positives = 100/306 (32%), Gaps = 42/306 (13%)
Query: 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQ-NLCGGPNVV 96
+ +G+G++ EV+ G E +KI +++ RE +I Q + N++
Sbjct: 3 RTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENIL 60
Query: 97 KLLDIVRDQHSKTPS--LIFEYVNSTD-FKVLY-PTLTDYDIRYYIYELLKALDYCHSQ- 151
+ + L+ +Y F L T+T + L + H +
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 152 -------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-----NVRVASRYFK 199
I HRD+K N+++ + D GLA + + N RV ++ +
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 200 GPELL-----VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 254
PE+L + + D++++G +F + R D + + E
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 255 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 314
++ +V +P N + + + RL
Sbjct: 240 --------------EMRKVVCEQKLRP--NIPNRWQSCEALRVMAKIMRECWYANGAARL 283
Query: 315 TAREAM 320
TA
Sbjct: 284 TALRIK 289
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 78.7 bits (193), Expect = 6e-18
Identities = 31/203 (15%), Positives = 69/203 (33%), Gaps = 34/203 (16%)
Query: 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------------VKKKKIKREIKILQ 87
+ + +G GK S VF + C++K K + I
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 88 NLCGGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKAL 145
+ KL + + + +++ E +++ + + + + +L+ +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRV----ENPDEVLDMILEEV 116
Query: 146 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEY----NVRVASRYFKG 200
+ +GI+H D+ +NV++ + +ID+ + E G +VR YF
Sbjct: 117 AKFYHRGIVHGDLSQYNVLVSE--EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS- 173
Query: 201 PELLVDLQDYDYSLDMWSLGCMF 223
+ Y D+ S
Sbjct: 174 -------RTYRTEKDINSAIDRI 189
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 338 | |||
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.54 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.17 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.07 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.41 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.34 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.29 |
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.9e-61 Score=419.93 Aligned_cols=297 Identities=76% Similarity=1.294 Sum_probs=265.8
Q ss_pred eccCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 34 FSDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
..+.++|++++.||+|+||+||+|++..+++.||+|+++....+.+.+|+.+++++..||||+++++++........++|
T Consensus 31 ~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 31 WGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 45678999999999999999999999999999999999988888899999999999669999999999987667789999
Q ss_pred EeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcceeee
Q 019642 114 FEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 193 (338)
Q Consensus 114 ~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 193 (338)
|||+.+++|....+.+++..++.++.||+.||.|||++||+|+||||+|||++.+.+.++|+|||++.............
T Consensus 111 ~e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~ 190 (328)
T d3bqca1 111 FEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV 190 (328)
T ss_dssp EECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCC
T ss_pred EeecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCcccccc
Confidence 99999999999999999999999999999999999999999999999999999775679999999998776666666778
Q ss_pred ccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhh
Q 019642 194 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL 273 (338)
Q Consensus 194 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (338)
+|+.|+|||.+.+...++.++|+||+|+++|+|++|..||....+..++...+.+.++.+....+.........+.....
T Consensus 191 ~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 270 (328)
T d3bqca1 191 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI 270 (328)
T ss_dssp SCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGT
T ss_pred cCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchh
Confidence 99999999999876678999999999999999999999998888888888888888888777777777777777766666
Q ss_pred hccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 274 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
........+...........+++++.+||++||+.||++|||++|+|+||||+++..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 271 LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp CCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred cccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 666666666666666666778999999999999999999999999999999998753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-60 Score=403.81 Aligned_cols=252 Identities=24% Similarity=0.401 Sum_probs=208.6
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
.++|++.+.||+|+||+||+|.+..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ....++
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~--~~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRRE--GNIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhC-CCCCEeeEeeeecc--CceeEE
Confidence 47899999999999999999999999999999998643 235678999999999 99999999999965 567899
Q ss_pred EEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC--
Q 019642 113 IFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-- 187 (338)
Q Consensus 113 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-- 187 (338)
||||+.+++|.+++. .+++..++.++.|++.||.|||++||+|+||||+|||++.+ +.+||+|||++.......
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~-~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECEETTEE
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCC-CCEEEccchhheeeccCCcc
Confidence 999999999988874 49999999999999999999999999999999999999988 799999999997654322
Q ss_pred -cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 188 -EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 188 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
......||+.|+|||++.+...++.++|||||||++|+|++|+.||....+..............
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~-------------- 225 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------------- 225 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT--------------
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------------
Confidence 23345799999999999874456788999999999999999999996544333222222110000
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcch
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 327 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 327 (338)
......+++++.+||.+||+.||++|||++|+|+||||++
T Consensus 226 ---------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 226 ---------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp ---------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ---------------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 0011227899999999999999999999999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-59 Score=396.69 Aligned_cols=248 Identities=25% Similarity=0.482 Sum_probs=210.6
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~------~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
-++|++.+.||+|+||+||+|.++.+++.||+|++.+ .....+.+|+.+++++ +||||+++++++.+ ....
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~ 81 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHD--ATRV 81 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEE--CCEE
Confidence 3689999999999999999999999999999999853 2356688999999999 99999999999965 5678
Q ss_pred EEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 111 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
++||||+.+++|..++ ..+++..++.++.|++.||.|||++||+|+||||+|||++.+ +.+||+|||++......
T Consensus 82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~-~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAPSS- 159 (263)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCCSCSCCCCC-
T ss_pred EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCC-CCEeecccceeeecCCC-
Confidence 9999999999998876 469999999999999999999999999999999999999988 89999999999765433
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+.+. .
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~-~~~~~~~~~~i~~~--~--------------- 220 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV--E--------------- 220 (263)
T ss_dssp CCEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTT--C---------------
T ss_pred cccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCC-CCCHHHHHHHHHcC--C---------------
Confidence 3345679999999999988 678999999999999999999999983 33333333222110 0
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
...+..+++++.+||.+||+.||++|||++|+|+||||++-
T Consensus 221 --------------------~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 221 --------------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp --------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred --------------------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence 00122378999999999999999999999999999999754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-59 Score=400.89 Aligned_cols=252 Identities=26% Similarity=0.456 Sum_probs=212.8
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc---cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
.++|++.+.||+|+||+||+|.+..+++.||+|+++. ...+.+.+|+.+++++ +||||+++++++.+ ...+++|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLV--GDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhC-CCCCEeeEeEEEEE--CCEEEEE
Confidence 5689999999999999999999999999999999863 3456688999999999 99999999999965 4578999
Q ss_pred EeeecCCcccccc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC-Ccce
Q 019642 114 FEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYN 190 (338)
Q Consensus 114 ~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~-~~~~ 190 (338)
|||+.+++|..+. ..+++..++.++.|++.||.|||++||+|+||||+|||++.+ +++||+|||++...... ....
T Consensus 96 mEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~-~~vkl~DFG~a~~~~~~~~~~~ 174 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRS 174 (293)
T ss_dssp EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSTTCCBC
T ss_pred EEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCC-CcEeeccchhheeecccccccc
Confidence 9999999998876 459999999999999999999999999999999999999988 89999999999876433 3345
Q ss_pred eeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcch
Q 019642 191 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 270 (338)
Q Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (338)
...||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+.... ...
T Consensus 175 ~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~-~~~~~~~~~~~~~~~-~~~---------------- 235 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYL-NENPLRALYLIATNG-TPE---------------- 235 (293)
T ss_dssp CCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHHC-SCC----------------
T ss_pred ccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCC-CCCHHHHHHHHHhCC-CCC----------------
Confidence 5679999999999987 678999999999999999999999994 333333333322211 000
Q ss_pred hhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 271 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
...+..+++++.+||.+||+.||++|||++|+|+||||+..
T Consensus 236 -----------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 236 -----------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp -----------------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -----------------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 01112378999999999999999999999999999999754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-58 Score=389.89 Aligned_cols=251 Identities=21% Similarity=0.409 Sum_probs=205.0
Q ss_pred CCcE-EEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeecc--CCC
Q 019642 37 QDDY-EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSK 108 (338)
Q Consensus 37 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~ 108 (338)
.++| ++.++||+|+||+||+|.+..+++.||+|.+... ..+.+.+|+++++++ +||||+++++++.+. ...
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~ 85 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKK 85 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCE
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccccCC
Confidence 3455 7888999999999999999999999999998642 235678999999999 899999999998653 345
Q ss_pred ccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 109 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
.+++||||+.+++|.+++ ..+++..++.++.|++.||.|||++| |+|+||||+|||++...+.+||+|||+++..
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 688999999999998876 45999999999999999999999998 9999999999999764489999999999754
Q ss_pred cCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccc
Q 019642 184 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263 (338)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
.. .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||....+.......+........
T Consensus 166 ~~-~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~--------- 233 (270)
T d1t4ha_ 166 RA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS--------- 233 (270)
T ss_dssp CT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG---------
T ss_pred cC-CccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcc---------
Confidence 43 33345689999999999865 5899999999999999999999999543332222222211000000
Q ss_pred cccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcc
Q 019642 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 326 (338)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~ 326 (338)
.+...++++.+||.+||+.||++|||++|+|+||||+
T Consensus 234 --------------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 234 --------------------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp --------------------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred --------------------------cCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 0112688999999999999999999999999999996
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-58 Score=393.14 Aligned_cols=249 Identities=25% Similarity=0.427 Sum_probs=197.4
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
.++|++.+.||+|+||+||+|+++.+++.||+|.++... .+.+.+|+.+++++ +||||+++++++.+.....++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEEE
Confidence 478999999999999999999999999999999986432 34578899999999 999999999999776667789
Q ss_pred EEEeeecCCcccccc-------CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCCeEecCCCCceEEEeccc
Q 019642 112 LIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQG-----IMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
Q Consensus 112 lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dikp~NIli~~~~~~~~l~dfg~ 179 (338)
+||||+.+++|.+++ ..+++..++.++.|++.||.|||+.| |+|+||||+|||++.+ +.+||+|||+
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~-~~vkl~DFG~ 160 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGL 160 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTT-SCEEECCHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCC-CcEEEeeccc
Confidence 999999999998876 34999999999999999999999976 9999999999999988 8999999999
Q ss_pred cccccCCC-cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhh
Q 019642 180 AEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 258 (338)
Q Consensus 180 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
+....... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||. +.+..+....+... ...
T Consensus 161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~-~~~~~~~~~~i~~~-~~~----- 232 (269)
T d2java1 161 ARILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFT-AFSQKELAGKIREG-KFR----- 232 (269)
T ss_dssp HHHC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHT-CCC-----
T ss_pred eeecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCC-CCCHHHHHHHHHcC-CCC-----
Confidence 98765433 2344678999999999977 678999999999999999999999983 33333322222110 000
Q ss_pred hhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 259 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
..+..+|+++.+||++||+.||++|||++|+|+|||+
T Consensus 233 ------------------------------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 233 ------------------------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp ------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ------------------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 0112378999999999999999999999999999995
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.1e-58 Score=402.06 Aligned_cols=255 Identities=24% Similarity=0.434 Sum_probs=216.0
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
++|++.+.||+|+||+||+|.+..+++.||+|++.... .+.+.+|+.+++++ +||||+++++++.+ ...+++||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~~ivm 102 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFED--DNEMVMIY 102 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEE--TTEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEEEEE
Confidence 58999999999999999999999999999999987533 45678999999999 99999999999965 56889999
Q ss_pred eeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC-CCceEEEeccccccccCCCcc
Q 019642 115 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEY 189 (338)
Q Consensus 115 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~-~~~~~l~dfg~~~~~~~~~~~ 189 (338)
||+.|++|.+++ ..+++..++.++.||+.||.|||++|++|+||||+|||++.+ .+.+||+|||++.........
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 182 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence 999999987765 248999999999999999999999999999999999999642 378999999999887766666
Q ss_pred eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcc
Q 019642 190 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 269 (338)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+.........
T Consensus 183 ~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~-~~~~~~~~~~i~~~~~~~~~-------------- 246 (350)
T d1koaa2 183 KVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFG-GENDDETLRNVKSCDWNMDD-------------- 246 (350)
T ss_dssp EEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCCSCC--------------
T ss_pred ceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCCCCCc--------------
Confidence 77889999999999987 678999999999999999999999983 44444444444332111100
Q ss_pred hhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhh
Q 019642 270 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 330 (338)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 330 (338)
.....+|+++.+||.+||+.||++|||++|+|+||||++...
T Consensus 247 -------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 247 -------------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp -------------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred -------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 011227899999999999999999999999999999987654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-58 Score=398.66 Aligned_cols=254 Identities=27% Similarity=0.460 Sum_probs=195.4
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
.+.|++.+.||+|+||+||+|.+..+++.||+|++... ....+.+|+.+++++ +||||+++++++.+ ....++
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~--~~~~~l 84 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALDDIYES--GGHLYL 84 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEEE
Confidence 36799999999999999999999999999999998643 234567899999999 99999999999955 567899
Q ss_pred EEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecC--CCCceEEEeccccccccCCC
Q 019642 113 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 113 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~--~~~~~~l~dfg~~~~~~~~~ 187 (338)
||||+.|++|.+++ ..+++..+..++.|++.||.|||++|++|+||||+||++.. +.+.+||+|||++.......
T Consensus 85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 99999999998776 35999999999999999999999999999999999999953 33789999999998766555
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.. .+..+....+.+....
T Consensus 165 ~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~--------------- 227 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYE--------------- 227 (307)
T ss_dssp --------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHTTCCC---------------
T ss_pred eeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHhccCCC---------------
Confidence 5556789999999999987 6789999999999999999999999942 2222222222211000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
........+|+++.+||.+||+.||++|||++|+|+||||++.
T Consensus 228 ------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 228 ------------------FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp ------------------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred ------------------CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 0011123378999999999999999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-58 Score=392.55 Aligned_cols=252 Identities=29% Similarity=0.496 Sum_probs=209.4
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~------~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
.++|++.+.||+|+||+||+|.+..+++.||||+++. ...+.+.+|+.+++++ +||||+++++++.+ ....
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~--~~~~ 83 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQD--DEKL 83 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEEC--SSEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEE--CCEE
Confidence 3689999999999999999999999999999999863 2345688999999999 99999999999955 5678
Q ss_pred EEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 111 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
++||||+.+++|.+++ +.+++..++.++.|++.||.|||++||+|+||||+|||++.+ +.+||+|||++.......
T Consensus 84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~-~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED-MHIQITDFGTAKVLSPES 162 (288)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECC---
T ss_pred EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCC-ceEEecccccceecccCC
Confidence 9999999999997775 469999999999999999999999999999999999999988 899999999997664322
Q ss_pred ---cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccc
Q 019642 188 ---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264 (338)
Q Consensus 188 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+....+.+. .
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~-~~~~~~~~~~i~~~--~------------ 226 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQKIIKL--E------------ 226 (288)
T ss_dssp -------CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHTT--C------------
T ss_pred cccccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCC-CcCHHHHHHHHHcC--C------------
Confidence 2334579999999999987 678999999999999999999999984 33333333322110 0
Q ss_pred ccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHH------HhcCCCcchhhhc
Q 019642 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE------AMAHPYFAQVRAA 331 (338)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~e------ll~hp~~~~~~~~ 331 (338)
...+..+++++.+||++||+.||++|||++| +++||||+++.+.
T Consensus 227 -----------------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~ 276 (288)
T d1uu3a_ 227 -----------------------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 276 (288)
T ss_dssp -----------------------CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred -----------------------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHH
Confidence 0012237999999999999999999999998 5889999988643
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-57 Score=392.68 Aligned_cols=257 Identities=26% Similarity=0.451 Sum_probs=212.7
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc---------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
.++|++.+.||+|+||+||+|++..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ .
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~ 85 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYEN--K 85 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--S
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--C
Confidence 36799999999999999999999999999999998532 246688999999999 99999999999955 5
Q ss_pred CccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCC---CceEEEeccccc
Q 019642 108 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL---RKLRLIDWGLAE 181 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~---~~~~l~dfg~~~ 181 (338)
...++||||+.+++|.+++ +.+++..++.++.|++.||.|||+.|++|+||||+||+++.+. ..+|++|||++.
T Consensus 86 ~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 86 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 6889999999999998876 4599999999999999999999999999999999999997652 269999999998
Q ss_pred cccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 182 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
............+++.|+|||++.+ ..++.++||||+||++|+|++|..||. +.+..+.+..+........
T Consensus 166 ~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~-~~~~~~~~~~i~~~~~~~~------- 236 (293)
T d1jksa_ 166 KIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAVNYEFE------- 236 (293)
T ss_dssp ECTTSCBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHTTCCCCC-------
T ss_pred hcCCCccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCC-CCCHHHHHHHHHhcCCCCC-------
Confidence 7766555566789999999999987 678999999999999999999999984 3333333333322111000
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
......+|+++.+||++||+.||++|||++|+|+||||++....
T Consensus 237 --------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 280 (293)
T d1jksa_ 237 --------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 280 (293)
T ss_dssp --------------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC----
T ss_pred --------------------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChh
Confidence 00112278999999999999999999999999999999876543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9e-58 Score=401.71 Aligned_cols=254 Identities=26% Similarity=0.479 Sum_probs=214.8
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
.++|++++.||+|+||+||+|.+..+++.||+|+++... ...+.+|+.+++++ +||||++++++|.+ ...+++|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~--~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFED--KYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEEC--SSEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEEEE
Confidence 357999999999999999999999999999999987533 45678899999999 99999999999954 5688999
Q ss_pred EeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecC-CCCceEEEeccccccccCCCc
Q 019642 114 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-ELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 114 ~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~-~~~~~~l~dfg~~~~~~~~~~ 188 (338)
|||+.|++|.+.+. .+++.+++.++.||+.||.|||++||+|+||||+|||++. ..+.+||+|||++........
T Consensus 105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 99999999976542 4899999999999999999999999999999999999974 347999999999988877666
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++|..|| .+.+..+.+..+.......
T Consensus 185 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf-~~~~~~~~~~~i~~~~~~~--------------- 247 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPF-AGEDDLETLQNVKRCDWEF--------------- 247 (352)
T ss_dssp EEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSS-CCSSHHHHHHHHHHCCCCC---------------
T ss_pred eeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCCCC---------------
Confidence 677889999999999987 67999999999999999999999998 3334344444333211110
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
.......+++++.+||++||+.||++|||+.|+|+||||++.
T Consensus 248 ------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 248 ------------------DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp ------------------CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ------------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 011122379999999999999999999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-58 Score=392.52 Aligned_cols=253 Identities=26% Similarity=0.427 Sum_probs=209.0
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
.+.|++++.||+|+||+||+|++..+++.||+|+++.. ..+.+.+|+++++++ +||||+++++++.+ ....++|
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~--~~~~~lv 87 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYY--ENNLWIL 87 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEee--CCeEEEE
Confidence 46799999999999999999999999999999998643 345688999999999 99999999999965 4678999
Q ss_pred EeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC-Cc
Q 019642 114 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KE 188 (338)
Q Consensus 114 ~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~-~~ 188 (338)
|||+.+++|..++ ..+++..++.++.|++.||.|||++||+|+||||+|||++.+ +.+||+|||++...... ..
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~-~~~Kl~DFG~a~~~~~~~~~ 166 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQR 166 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECHHHHHH
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCC-CCEEEEechhhhccCCCccc
Confidence 9999999998774 349999999999999999999999999999999999999988 89999999998654322 12
Q ss_pred ceeeeccccccccccccC----cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccc
Q 019642 189 YNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
.....||+.|+|||++.. ...++.++|||||||++|+|++|..||. +.+..+.+..+......
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~-~~~~~~~~~~i~~~~~~------------ 233 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH-ELNPMRVLLKIAKSEPP------------ 233 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTT-TSCGGGHHHHHHHSCCC------------
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCC-CCCHHHHHHHHHcCCCC------------
Confidence 334679999999999842 2468899999999999999999999984 33333443333221000
Q ss_pred ccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
....+..+++++.+||.+||+.||++|||++|+|+||||+..
T Consensus 234 ----------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 234 ----------------------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp ----------------------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred ----------------------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 001112378999999999999999999999999999999753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-58 Score=404.09 Aligned_cols=286 Identities=21% Similarity=0.325 Sum_probs=214.0
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
..++|++++.||+|+||+||+|.+..+++.||+|+++.. ..+.+.+|+.+++++ +||||++++++|.+ ...++
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~--~~~~~ 80 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYS--DGEIS 80 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEEC--SSEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEE
Confidence 357999999999999999999999999999999998642 245688999999999 99999999999965 56789
Q ss_pred EEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 112 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 112 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
+||||+.+++|..++ ..+++..++.++.|++.||.|||+ +||+||||||+|||++.+ +.+||+|||++......
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT-CCEEECCCCCCHHHHHH-
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCC-CCEEEeeCCCccccCCC-
Confidence 999999999998886 359999999999999999999997 599999999999999988 89999999999765432
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc------
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK------ 261 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 261 (338)
......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.................+..........
T Consensus 159 ~~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 159 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp TC---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred ccccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 2234689999999999988 689999999999999999999999996655444433332222222111000000
Q ss_pred --ccccc--CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 262 --YHLEL--DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 262 --~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
..... ................ .......+|.++.+||.+||+.||++|||++|+|+||||++....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~ 307 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPP----PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 307 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCC----CCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred cccccccccchhHHHHHhhhhccCC----ccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCcc
Confidence 00000 0000000000000000 111122368899999999999999999999999999999987654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.3e-57 Score=383.53 Aligned_cols=254 Identities=26% Similarity=0.427 Sum_probs=212.4
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc------------hHHHHHHHHHHHHhcCCCCeeEeeeeeec
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------------KKKIKREIKILQNLCGGPNVVKLLDIVRD 104 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 104 (338)
.++|++.+.||+|+||+||+|++..+++.||+|+++... .+.+.+|+.+++++..||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 479999999999999999999999999999999986421 23577899999999559999999999955
Q ss_pred cCCCccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 105 QHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 105 ~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
....++||||+.+++|.+++ ..+++..++.++.||+.||.|||++||+|+||||+||+++.+ +.+||+|||++.
T Consensus 82 --~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~-~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 --NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD-MNIKLTDFGFSC 158 (277)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCE
T ss_pred --CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCC-CCeEEccchhee
Confidence 56899999999999998877 469999999999999999999999999999999999999988 899999999998
Q ss_pred cccCCCcceeeeccccccccccccC-----cCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhh
Q 019642 182 FYHPGKEYNVRVASRYFKGPELLVD-----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 256 (338)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (338)
............||+.|+|||.+.+ ...++.++||||+|+++|+|++|+.||. +.+..+....+...-....
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~-~~~~~~~~~~i~~~~~~~~-- 235 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-HRKQMLMLRMIMSGNYQFG-- 235 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCCCC--
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCC-CCCHHHHHHHHHhCCCCCC--
Confidence 8766555566789999999999853 2357889999999999999999999994 3333333333322110000
Q ss_pred hhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcch
Q 019642 257 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 327 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 327 (338)
......+|+++++||.+||+.||++|||++|+|+||||++
T Consensus 236 -------------------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 236 -------------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp -------------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred -------------------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 0011227999999999999999999999999999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-57 Score=393.87 Aligned_cols=277 Identities=28% Similarity=0.519 Sum_probs=221.9
Q ss_pred EEEeeeecCceeEEEEEEcCCCceEEEEEecccc--------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 42 VVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 42 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
.++.||+|+||+||+|.+..+++.||||+++... .+.+.+|+.+++++ +||||+++++++.+ ...+++|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~--~~~~~iv 78 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGH--KSNISLV 78 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECC--TTCCEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeecc--CCceeeh
Confidence 4689999999999999999999999999986321 24578999999999 99999999999955 5678999
Q ss_pred EeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-cc
Q 019642 114 FEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EY 189 (338)
Q Consensus 114 ~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-~~ 189 (338)
|||+.++++..+.. .+++..++.++.||+.||+|||++|++|+||||+|||++.+ +.+||+|||++....... ..
T Consensus 79 mE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~-~~~KL~DFG~a~~~~~~~~~~ 157 (299)
T d1ua2a_ 79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAY 157 (299)
T ss_dssp EECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCCGGGSTTTSCCCCC
T ss_pred hhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCC-CccccccCccccccCCCcccc
Confidence 99999998776653 48999999999999999999999999999999999999988 899999999997654332 33
Q ss_pred eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcc
Q 019642 190 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 269 (338)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
....+|+.|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+.+..+.+.++.+....+...........
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf-~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL-PGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCC-CCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence 44578999999999877567899999999999999999999776 56677788888888888766554433222111111
Q ss_pred hhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 270 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
... ..........+.+++++.+||++||+.||++||||+|+|+||||++.+.+.
T Consensus 237 ~~~---------~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~ 290 (299)
T d1ua2a_ 237 FKS---------FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT 290 (299)
T ss_dssp CCC---------CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred hcc---------CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCC
Confidence 000 000000111224789999999999999999999999999999999877544
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-56 Score=390.73 Aligned_cols=251 Identities=26% Similarity=0.465 Sum_probs=212.6
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
-++|++++.||+|+||+||+|++..+++.||+|++++. ..+.+.+|+.+++++ +||||+++++++.+ ...+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~--~~~~ 80 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQT--HDRL 80 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEEC--SSEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeeecc--cccc
Confidence 46899999999999999999999999999999998632 346678999999999 89999999999955 5688
Q ss_pred EEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC-C
Q 019642 111 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-G 186 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~-~ 186 (338)
++||||+.|++|..++ ..+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.... .
T Consensus 81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~-g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCSCCTT
T ss_pred ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCC-CCEEEeecccccccccCC
Confidence 9999999999998776 459999999999999999999999999999999999999998 8999999999986543 3
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.......||+.|+|||++.+ ..++.++|+|||||++|+|++|..||. +.+..+....+.. +..
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~-~~~~~~~~~~i~~--~~~------------- 222 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHERLFELILM--EEI------------- 222 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHH--CCC-------------
T ss_pred cccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCC-CcCHHHHHHHHhc--CCC-------------
Confidence 34455789999999999988 678999999999999999999999984 3332222222211 000
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC-----CHHHHhcCCCcchhhh
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRA 330 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~ 330 (338)
..+..+|+++.+||++||++||++|+ +++|+++||||+++.+
T Consensus 223 ----------------------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~ 269 (337)
T d1o6la_ 223 ----------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred ----------------------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence 01223799999999999999999999 4999999999988643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.2e-57 Score=389.69 Aligned_cols=247 Identities=27% Similarity=0.415 Sum_probs=205.6
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
.|++++.||+|+||+||+|.+..+++.||||+++... .+.+.+|+.+++++ +||||+++++++.+ ....++
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~--~~~~~i 92 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLR--EHTAWL 92 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEE--CCEEEE
Confidence 5999999999999999999999999999999986432 24578899999999 99999999999965 467899
Q ss_pred EEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcc
Q 019642 113 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189 (338)
Q Consensus 113 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~ 189 (338)
||||+.++++..+. ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++..... .
T Consensus 93 v~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~-~~~Kl~DFG~a~~~~~---~ 168 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAP---A 168 (309)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT-TEEEECCCTTCBSSSS---B
T ss_pred EEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCC-CCEEEeecccccccCC---C
Confidence 99999999886554 469999999999999999999999999999999999999988 8999999999976543 2
Q ss_pred eeeeccccccccccccCc--CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 190 NVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
....||+.|+|||++.+. ..++.++|||||||++|+|++|..||.. .+..+.+..+......
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~-~~~~~~~~~i~~~~~~--------------- 232 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQNESP--------------- 232 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCCC---------------
T ss_pred CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCC---------------
Confidence 346799999999998642 4588999999999999999999999843 2223333322211000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
...+..+|+++.+||.+||+.||++|||++|+|+||||.+-
T Consensus 233 --------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 233 --------------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp --------------------CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred --------------------CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 00112368999999999999999999999999999999753
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-56 Score=387.69 Aligned_cols=284 Identities=29% Similarity=0.535 Sum_probs=226.4
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCC-CceEEEEEeccc-----chHHHHHHHHHHHHhc--CCCCeeEeeeeeecc---
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNT-NERCIIKILKPV-----KKKKIKREIKILQNLC--GGPNVVKLLDIVRDQ--- 105 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~--~h~~iv~~~~~~~~~--- 105 (338)
.++|++++.||+|+||+||+|++..+ ++.||||+++.. ......+|+.+++.+. +||||+++++++...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47999999999999999999999765 667999998532 2345678888888774 799999999998532
Q ss_pred CCCccEEEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 106 HSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 106 ~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
.....+++||++.++++.... ..+++..++.++.|++.||.|||++||+|+||||+|||++.. +.+||+|||++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~-~~~kl~dfg~~~ 164 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLAR 164 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECSCCSCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCC-CCeeecchhhhh
Confidence 335788999999998765443 358999999999999999999999999999999999999988 799999999987
Q ss_pred cccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 182 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
............||+.|+|||++.+ ..++.++||||+||++|+|++|..|| .+.+..+.+..+.+..+.+....+...
T Consensus 165 ~~~~~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (305)
T d1blxa_ 165 IYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLPGEEDWPRD 242 (305)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred hhcccccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCC-CCCCHHHHHHHHHHhhCCCchhccccc
Confidence 6655555566789999999999987 78999999999999999999999998 455667778888888887665544322
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhccc
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 333 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 333 (338)
..... .........+. ......+++++.+||++||+.||++|||+.|+|+||||+++..++.
T Consensus 243 ~~~~~-----~~~~~~~~~~~-----~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~ke 304 (305)
T d1blxa_ 243 VALPR-----QAFHSKSAQPI-----EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 304 (305)
T ss_dssp CSSCG-----GGSCCCCCCCG-----GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred ccchh-----hhhccccccch-----hhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhhCC
Confidence 21111 00111111111 1123347899999999999999999999999999999999976653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-56 Score=386.69 Aligned_cols=282 Identities=30% Similarity=0.610 Sum_probs=224.0
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
++|++++.||+|+||+||+|.+..+++.||+|+++.. ..+.+.+|+++++++ +||||+++++++.+ ....++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~~--~~~~~i 78 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHT--ENKLYL 78 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEEecccccc--ccceeE
Confidence 6999999999999999999999999999999998632 256688999999999 99999999999965 467899
Q ss_pred EEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC-C
Q 019642 113 IFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-K 187 (338)
Q Consensus 113 v~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~-~ 187 (338)
||||+.++++.... ..+++..++.++.|++.||.|||++||+|+||||+|||++.+ +.+||+|||.+...... .
T Consensus 79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~-~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECSTTHHHHHCCCSB
T ss_pred EEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeeccc-CcceeccCCcceeccCCcc
Confidence 99999987665443 359999999999999999999999999999999999999988 79999999999766433 3
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......||+.|+|||++.....++.++|+||+|+++|+|++|+.|| .+.+..+.+..+....+.+....+......
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--- 233 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF-PGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 233 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTTSTTGGGS---
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCC-CCCCHHHHHHHHHHhcCCCchhhccccccc---
Confidence 4445689999999999877667889999999999999999999998 455666677777776666443333211110
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
+........ +...........+++++.+||++||+.||++|||++|+|+||||++++.+-
T Consensus 234 ~~~~~~~~~-----~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~ 293 (298)
T d1gz8a_ 234 PDYKPSFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293 (298)
T ss_dssp TTCCTTSCC-----CCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred ccccccccc-----ccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCCC
Confidence 000000000 000001112234789999999999999999999999999999999987653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.2e-56 Score=387.68 Aligned_cols=249 Identities=22% Similarity=0.452 Sum_probs=211.2
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~------~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
++|++++.||+|+||+||+|+++.+++.||+|+++. ...+.+.+|+.+++++ +||||+++++++.+ ...++
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~~ 80 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQD--AQQIF 80 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEEC--SSEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEee--CCeee
Confidence 689999999999999999999999999999999863 2346688999999999 99999999999955 56889
Q ss_pred EEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 112 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 112 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
+||||+.|+++...+ ..+++..++.++.||+.||.|||++||+|+||||+|||++.+ +.+||+|||++......
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~-g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT-SCEEECCCSSCEECSSC--
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCC-CCEEEecCccceEeccc--
Confidence 999999999987776 458999999999999999999999999999999999999988 89999999999776432
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+... ..
T Consensus 158 ~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~-~~~~~~~~~~i~~~--~~--------------- 218 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFY-DSNTMKTYEKILNA--EL--------------- 218 (316)
T ss_dssp BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHHC--CC---------------
T ss_pred cccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCC-CcCHHHHHHHHHcC--CC---------------
Confidence 334689999999999877 678999999999999999999999994 33333333332221 00
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC-----CHHHHhcCCCcchhhhc
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAA 331 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~~ 331 (338)
..+..+++++.++|.+||..||++|+ |++++|+||||+++.+.
T Consensus 219 --------------------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~ 266 (316)
T d1fota_ 219 --------------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 266 (316)
T ss_dssp --------------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred --------------------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence 01123789999999999999999996 99999999999987543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-56 Score=388.84 Aligned_cols=254 Identities=25% Similarity=0.461 Sum_probs=214.1
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc--hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
.++|++.+.||+|+||+||+|.+..+++.||+|+++... ...+.+|+.+++.+ +||||+++++++.+ ...+|+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~--~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFES--MEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEE--TTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhC-CCCCCCeEEEEEEE--CCEEEEEE
Confidence 478999999999999999999999999999999997544 34577999999999 99999999999965 46789999
Q ss_pred eeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC-CCceEEEeccccccccCCCcc
Q 019642 115 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEY 189 (338)
Q Consensus 115 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~-~~~~~l~dfg~~~~~~~~~~~ 189 (338)
||+.|++|.+.+. .+++.+++.++.||+.||.|||++||+|+||||+|||++.+ ...++|+|||++.........
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~ 160 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcc
Confidence 9999999988763 48999999999999999999999999999999999999753 358999999999877666666
Q ss_pred eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcc
Q 019642 190 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 269 (338)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
....+++.|+|||...+ ..++.++|||||||++|+|++|..||. ..+..+.+..+.+.....+..
T Consensus 161 ~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~-~~~~~~~~~~i~~~~~~~~~~------------- 225 (321)
T d1tkia_ 161 RLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFL-AETNQQIIENIMNAEYTFDEE------------- 225 (321)
T ss_dssp EEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHHTCCCCCHH-------------
T ss_pred cccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCCCCChh-------------
Confidence 66789999999999877 678999999999999999999999983 333344444433321111111
Q ss_pred hhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 270 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
....+|+++.+||++||..||++|||++|+|+||||++-
T Consensus 226 --------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 226 --------------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp --------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred --------------------hccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 011278999999999999999999999999999999753
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-56 Score=390.64 Aligned_cols=282 Identities=31% Similarity=0.529 Sum_probs=228.0
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeecc----CCCccEEEE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----HSKTPSLIF 114 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~----~~~~~~lv~ 114 (338)
+|+..+.||+|+||+||+|.+..+++.||||+++... ....+|+.+++++ +||||++++++|... +..++++||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-SSCCHHHHHHHHC-CCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-hHHHHHHHHHHhc-CCCCCCcEEEEEEecCccCCceEEEEEE
Confidence 7999999999999999999999999999999987543 2345799999999 999999999998542 334678999
Q ss_pred eeecCCcccccc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 115 EYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 115 e~~~~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
||++++++..+. ..+++..++.++.|++.||+|||++||+||||||+|||++.+...+||+|||++........
T Consensus 99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~ 178 (350)
T d1q5ka_ 99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178 (350)
T ss_dssp ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC
T ss_pred eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCcc
Confidence 999987554432 35999999999999999999999999999999999999998756899999999987766666
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
.....|++.|+|||.+.+...++.++||||+||++|+|++|..|| ...+..+.+..+.+.++.+....+..........
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf-~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~ 257 (350)
T d1q5ka_ 179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF-PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 257 (350)
T ss_dssp CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CC
T ss_pred cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCC-CCCCHHHHHHHHHHHhCCChHHhhhhhccchhhc
Confidence 666789999999999887678999999999999999999999998 4556677888888888887666554333222111
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
... .....+ ........+++++.+||.+||+.||++|||+.|+|+||||+++...
T Consensus 258 ~~~----~~~~~~----~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 312 (350)
T d1q5ka_ 258 KFP----QIKAHP----WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312 (350)
T ss_dssp CCC----CCCCCC----GGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred ccc----ccccCc----hhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence 111 001111 1122233478999999999999999999999999999999988654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.1e-56 Score=388.87 Aligned_cols=250 Identities=23% Similarity=0.394 Sum_probs=212.1
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~------~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
.++|++++.||+|+||+||+|+++.+++.||+|+++. ...+.+.+|+.+++.+ +||||+++++++.+ ....
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~ 116 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKD--NSNL 116 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeeccccccc--cccc
Confidence 3789999999999999999999999999999999863 2345678999999999 99999999999955 5678
Q ss_pred EEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 111 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
++||||+.++++...+ ..+++..++.++.||+.||.|||++||+|+||||+|||++.+ +.+||+|||++......
T Consensus 117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~-g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECSSC-
T ss_pred ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCC-CCEEeeeceeeeecccc-
Confidence 9999999999987776 469999999999999999999999999999999999999988 89999999999876533
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+.......+... ..
T Consensus 195 -~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~-~~~~~~~~~~i~~~--~~-------------- 255 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF-ADQPIQIYEKIVSG--KV-------------- 255 (350)
T ss_dssp -BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHC--CC--------------
T ss_pred -cccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCC-CcCHHHHHHHHhcC--CC--------------
Confidence 334679999999999987 678999999999999999999999994 33333333333221 00
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC-----CHHHHhcCCCcchhhhc
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAA 331 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~~ 331 (338)
..+..+++++.+||++||+.||++|+ |++++++||||+++.+.
T Consensus 256 ---------------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~ 303 (350)
T d1rdqe_ 256 ---------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp ---------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred ---------------------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHH
Confidence 01223799999999999999999995 99999999999987643
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-55 Score=390.05 Aligned_cols=254 Identities=26% Similarity=0.419 Sum_probs=206.2
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc------chHHHHHHHH---HHHHhcCCCCeeEeeeeeeccCC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIK---ILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~E~~---~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
-++|++.+.||+|+||+||+|.+..+++.||+|++.+. ....+.+|.. +++.+ +||||+++++++.+ .
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~--~ 79 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHT--P 79 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEEC--S
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEE--C
Confidence 47899999999999999999999999999999998632 2233445544 44444 79999999999955 5
Q ss_pred CccEEEEeeecCCccccccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 108 KTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
..+++||||+.|++|..++. .+++..++.++.||+.||.|||++|++|+||||+|||++.+ +.+||+|||++....
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~-g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFS 158 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-SCEEECCCTTCEECS
T ss_pred CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCC-CcEEEeeeceeeecC
Confidence 67899999999999988763 58999999999999999999999999999999999999988 899999999998665
Q ss_pred CCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccc
Q 019642 185 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 264 (338)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
.. ......||+.|+|||++.+...++.++|||||||++|+|++|..||...... +.. .+.+.....
T Consensus 159 ~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~-~~~~~~~~~----------- 224 (364)
T d1omwa3 159 KK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-DKH-EIDRMTLTM----------- 224 (364)
T ss_dssp SS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS-CHH-HHHHHSSSC-----------
T ss_pred CC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH-HHH-HHHHhcccC-----------
Confidence 43 3344679999999999976567899999999999999999999999543221 111 111111100
Q ss_pred ccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCC-----HHHHhcCCCcchhhh
Q 019642 265 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRA 330 (338)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt-----~~ell~hp~~~~~~~ 330 (338)
....+..+|+++.+||.+||+.||++||| |+|+++||||+++.+
T Consensus 225 ----------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~ 273 (364)
T d1omwa3 225 ----------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 273 (364)
T ss_dssp ----------------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred ----------------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence 01112347999999999999999999999 799999999998754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-56 Score=390.93 Aligned_cols=259 Identities=25% Similarity=0.424 Sum_probs=207.7
Q ss_pred CcEEEEE-eeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCCCeeEeeeeeec--cCCCccEEEE
Q 019642 38 DDYEVVR-KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRD--QHSKTPSLIF 114 (338)
Q Consensus 38 ~~y~~~~-~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~~~lv~ 114 (338)
++|++.+ .||+|+||+||+|.+..+++.||||+++. ...+.+|+.++.++.+||||++++++|.+ .....+|+||
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivm 88 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 88 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC--cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEE
Confidence 6899876 59999999999999999999999999874 45678899998777689999999999865 2345789999
Q ss_pred eeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC--CCceEEEeccccccccCCC
Q 019642 115 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 115 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~--~~~~~l~dfg~~~~~~~~~ 187 (338)
||+.|++|.+++. .+++.+++.++.|++.||.|||++||+||||||+|||++.. .+.+||+|||++.......
T Consensus 89 Ey~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~ 168 (335)
T d2ozaa1 89 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168 (335)
T ss_dssp ECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC
T ss_pred ECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCC
Confidence 9999999988762 48999999999999999999999999999999999999763 3679999999998776666
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......||+.|+|||++.+ ..++.++|||||||++|+|+||+.||.... .......+........
T Consensus 169 ~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~-~~~~~~~~~~~i~~~~------------- 233 (335)
T d2ozaa1 169 SLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNH-GLAISPGMKTRIRMGQ------------- 233 (335)
T ss_dssp CCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETT-CC--------CCCSCS-------------
T ss_pred ccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCC-HHHHHHHHHHHHhcCC-------------
Confidence 6666789999999999877 678999999999999999999999994322 2221111111100000
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
. .+.......+|+++.+||++||+.||++|||+.|+|+||||.+..
T Consensus 234 --------------~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 234 --------------Y--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp --------------S--SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred --------------C--CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 0 000001112789999999999999999999999999999997543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-55 Score=381.03 Aligned_cols=250 Identities=25% Similarity=0.449 Sum_probs=208.6
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc------cchHHHHHHHHHHH-HhcCCCCeeEeeeeeeccCCCcc
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQ-NLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~------~~~~~~~~E~~~l~-~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
++|++.+.||+|+||+||+|.++.+++.||||++++ .....+..|..++. .+ +||||+++++++.+ ....
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~-~hp~Iv~~~~~~~~--~~~~ 78 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-EHPFLTHMFCTFQT--KENL 78 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHT-TCTTBCCEEEEEEC--SSEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhC-CCCcEEEEEEEEcc--CCce
Confidence 689999999999999999999999999999999863 22345566777665 45 99999999999955 5678
Q ss_pred EEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC-
Q 019642 111 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG- 186 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~- 186 (338)
++||||+.+++|..++ ..+++.+++.++.||+.||.|||++|++|+||||+|||++.+ +.+||+|||++......
T Consensus 79 yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~-~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 79 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD-GHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCTT
T ss_pred eEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCC-Cceeccccchhhhccccc
Confidence 9999999999999887 469999999999999999999999999999999999999988 89999999999765433
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+.. +..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~-~~~~~~~~~~i~~--~~~------------- 220 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFH-GQDEEELFHSIRM--DNP------------- 220 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHH--CCC-------------
T ss_pred ccccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCC-CCCHHHHHHHHHc--CCC-------------
Confidence 33444679999999999988 678999999999999999999999993 3333333332211 110
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHH-HHhcCCCcchhhh
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR-EAMAHPYFAQVRA 330 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~-ell~hp~~~~~~~ 330 (338)
..+..+|+++.+||++||+.||++|||+. ++++||||+++..
T Consensus 221 ----------------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~ 263 (320)
T d1xjda_ 221 ----------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 263 (320)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred ----------------------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCH
Confidence 01123799999999999999999999996 8999999998754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.9e-55 Score=377.18 Aligned_cols=276 Identities=30% Similarity=0.570 Sum_probs=219.4
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
++|+++++||+|+||+||+|.++ +++.||||+++.. ..+.+.+|+.+++++ +||||+++++.+.+ ....++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~~i 77 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHT--KKRLVL 77 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEEC--SSCEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEeeeeeccc--CCceeE
Confidence 69999999999999999999985 7899999998643 245788999999999 99999999999955 567889
Q ss_pred EEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-c
Q 019642 113 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E 188 (338)
Q Consensus 113 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-~ 188 (338)
+||++.++++..+. ..+++..++.++.||+.||.|||+.||+|+||||+|||++.+ +.+|++|||.+....... .
T Consensus 78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~-~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC----
T ss_pred EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCC-CCEEecccccceecccCccc
Confidence 99999998877665 359999999999999999999999999999999999999998 899999999987764332 3
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
.....+++.|+|||.+.+...++.++|+||||+++|+|++|+.|| .+.+..+.+..+....+.+....+........
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-- 233 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF-PGVSEADQLMRIFRILGTPNSKNWPNVTELPK-- 233 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT--
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCC-CCCCHHHHHHHHHHhhCCCChhhccchhhhhh--
Confidence 344578999999999987678899999999999999999999998 45556677777777777765554432221110
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcch
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 327 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 327 (338)
...........+ .......+++++.+||++||++||++|||++|+|+||||++
T Consensus 234 -~~~~~~~~~~~~-----~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 234 -YDPNFTVYEPLP-----WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp -CCTTCCCCCCCC-----GGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred -cccccccccCcc-----hhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 011111111111 12223447899999999999999999999999999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-55 Score=373.63 Aligned_cols=248 Identities=27% Similarity=0.443 Sum_probs=204.7
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc---------hHHHHHHHHHHHHhc-CCCCeeEeeeeeeccC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQNLC-GGPNVVKLLDIVRDQH 106 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---------~~~~~~E~~~l~~l~-~h~~iv~~~~~~~~~~ 106 (338)
.++|++.+.||+|+||+||+|.+..+++.||||+++... ...+.+|+.+++++. .||||+++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-- 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-- 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee--
Confidence 478999999999999999999999999999999986321 233668999999994 38999999999955
Q ss_pred CCccEEEEeeecC-Ccccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccc
Q 019642 107 SKTPSLIFEYVNS-TDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
Q Consensus 107 ~~~~~lv~e~~~~-~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~ 182 (338)
....++||||+.+ +++..++ ..+++..++.++.|++.||.|||++|++|+||||+|||++.+.+.+||+|||++..
T Consensus 81 ~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 81 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence 5678999999976 4555544 46999999999999999999999999999999999999997657999999999976
Q ss_pred ccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcc
Q 019642 183 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262 (338)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.. .. .+.+ +.
T Consensus 161 ~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~----~~---~i~~--~~---------- 220 (273)
T d1xwsa_ 161 LKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DE---EIIR--GQ---------- 220 (273)
T ss_dssp CCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS----HH---HHHH--CC----------
T ss_pred ccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC----ch---HHhh--cc----------
Confidence 543 2334567999999999997755567889999999999999999999932 11 1100 00
Q ss_pred ccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
...+..+|+++.+||++||+.||++|||++|+|+||||+++..+
T Consensus 221 -------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~p 264 (273)
T d1xwsa_ 221 -------------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 264 (273)
T ss_dssp -------------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred -------------------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCCC
Confidence 01122379999999999999999999999999999999987543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-54 Score=370.67 Aligned_cols=279 Identities=30% Similarity=0.543 Sum_probs=225.8
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 112 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~l 112 (338)
++|+++++||+|+||+||+|.+..+++.||||+++.. ....+.+|+.+++.+ +||||+++++++.+ ....++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~--~~~~~i 78 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHS--DKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-CcCCEEeecccccc--ccceeE
Confidence 6899999999999999999999999999999998632 245678999999999 99999999999955 557889
Q ss_pred EEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC-c
Q 019642 113 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E 188 (338)
Q Consensus 113 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-~ 188 (338)
+++++.++++..+. +.+++..++.++.|++.||+|||++||+|+||||+|||++.+ +.+||+|||.+....... .
T Consensus 79 v~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~-~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSCCSC
T ss_pred EeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccC-CceeeeecchhhcccCCCcc
Confidence 99999999877664 458999999999999999999999999999999999999988 799999999997765433 3
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
.....+++.|+|||++.+...++.++||||+||++|+|++|+.||+.+.+..+....+....+.+....+..........
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 33456778899999988756689999999999999999999999988888888888777777765544433222111110
Q ss_pred chhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 269 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
.... .............+++++.+||++||+.||++||||+|+|+||||++.
T Consensus 238 ~~~~--------~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 238 PYPM--------YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCC--------CCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred cccc--------ccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 0000 000011112233478999999999999999999999999999999875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-54 Score=378.43 Aligned_cols=283 Identities=31% Similarity=0.550 Sum_probs=215.8
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccC----C
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH----S 107 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~----~ 107 (338)
.++|++++.||+|+||+||+|.+..+++.||||+++... .+.+.+|+.+++.+ +||||++++++|.... .
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCcccccc
Confidence 579999999999999999999999999999999987422 34577899999999 9999999999996543 2
Q ss_pred CccEEEEeeecCCcccccc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 108 KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
...++||||++ .++.... ..+++..++.++.|++.||.|||++||+|+||||+|||++.+ +.++++|||++.....
T Consensus 96 ~~~~lv~e~~~-~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~-~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 96 TDFYLVMPFMG-TDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED-CELKILDFGLARQADS 173 (346)
T ss_dssp CCCEEEEECCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECCS
T ss_pred ceEEEEEeccc-ccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccc-cccccccccceeccCC
Confidence 35799999994 5555554 469999999999999999999999999999999999999998 8999999999976543
Q ss_pred CCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccc
Q 019642 186 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 265 (338)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
......+|+.|+|||++.+...++.++||||+||++|+|++|..|| .+.+..+.+.......+.+....+..... .
T Consensus 174 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 249 (346)
T d1cm8a_ 174 --EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF-KGSDHLDQLKEIMKVTGTPPAEFVQRLQS-D 249 (346)
T ss_dssp --SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHTCSC-H
T ss_pred --ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCC-CCCChHHHHHHHHhccCCCcHHHHhhhcc-h
Confidence 3345679999999999987667899999999999999999999998 45556666777777666654433221111 1
Q ss_pred cCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 266 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
................+. .....+++++.+||++||..||++|||+.|+|+||||+++...
T Consensus 250 ~~~~~~~~~~~~~~~~~~-----~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 250 EAKNYMKGLPELEKKDFA-----SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310 (346)
T ss_dssp HHHHHHHHSCCCCCCCGG-----GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred hhhhhhccCCcccccchH-----HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence 111111111111111111 1223478999999999999999999999999999999987644
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-54 Score=375.16 Aligned_cols=289 Identities=30% Similarity=0.488 Sum_probs=220.3
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccC----
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---- 106 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~-----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~---- 106 (338)
..++|+++++||+|+||+||+|.+..+++.||||++.. .....+.+|+.+++++ +|||++++++++....
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC------
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-cCCCccceEeeeeccccccc
Confidence 35899999999999999999999999999999999753 2345678999999999 9999999999885432
Q ss_pred --CCccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 107 --SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 107 --~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
....+++||++.++++.... ..+++..++.++.|++.||.|||++||+|+||||+|||++.+ +.+||+|||++.
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~-~~~kl~dfg~~~ 165 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLAR 165 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCTTCE
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCC-CcEEeeecceee
Confidence 34688999999988876554 359999999999999999999999999999999999999998 899999999996
Q ss_pred cccCCC-----cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhh
Q 019642 182 FYHPGK-----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 256 (338)
Q Consensus 182 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (338)
...... ......||+.|+|||++.+...++.++||||+|+++|+|++|+.|| .+.+..+.+..+.+..+.....
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM-QGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCC-CCCCHHHHHHHHHHhcCCCChh
Confidence 654322 2233468999999999987668999999999999999999999888 4556667777777777765544
Q ss_pred hhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 257 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
.+............... ................++++.+||.+||+.||++|||++|+|+||||+..+.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~ 315 (318)
T d3blha1 245 VWPNVDNYELYEKLELV-----KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 315 (318)
T ss_dssp TSTTCCCC-------CC-----SSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCC
T ss_pred hccccchhhhhhhhccc-----ccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCC
Confidence 33222111111110000 000000000000111467889999999999999999999999999999765544
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-54 Score=382.01 Aligned_cols=283 Identities=25% Similarity=0.476 Sum_probs=213.6
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeecc----CCC
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----HSK 108 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~----~~~ 108 (338)
++|++++.||+|+||+||+|++..+++.||||+++.. ..+.+.+|+.+++++ +||||++++++|... ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEecccccccCc
Confidence 6799999999999999999999999999999998642 234578999999999 999999999999654 336
Q ss_pred ccEEEEeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 109 TPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
.+|+||||+.++++......+++..++.++.||+.||.|||++||+|+||||+|||++.+ +.++++|||++........
T Consensus 96 ~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~-~~~kl~df~~~~~~~~~~~ 174 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFM 174 (355)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCCCC---------
T ss_pred eeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccc-cceeeechhhhhccccccc
Confidence 889999999999999888899999999999999999999999999999999999999988 7899999999877666666
Q ss_pred ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCc
Q 019642 189 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 268 (338)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
.....+|+.|+|||++.+ ..++.++||||+||++++|++|+.|| .+.+.......+....+.+....+.....
T Consensus 175 ~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~----- 247 (355)
T d2b1pa1 175 MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPCPEFMKKLQP----- 247 (355)
T ss_dssp ------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHTTSCH-----
T ss_pred cccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCC-CCCCHHHHHHHHHHhccCCCHHHHHHhhh-----
Confidence 666789999999999987 68999999999999999999999888 45566667777777776654443322111
Q ss_pred chhhhhccccC---CCCccc-------ccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 269 QLDALVGRHSR---KPWSKF-------INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 269 ~~~~~~~~~~~---~~~~~~-------~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
........... ..+... ........+++++.+||++||+.||++||||+|+|+||||++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 10100000000 000000 00001112467899999999999999999999999999998743
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-53 Score=372.07 Aligned_cols=288 Identities=28% Similarity=0.530 Sum_probs=216.8
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC--Cc
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS--KT 109 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~--~~ 109 (338)
-+++|++++.||+|+||+||+|.+..+++.||||+++... .+.+.+|+.+++.+ +||||+++++++..... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeeccccccc
Confidence 3578999999999999999999999999999999987533 34577899999999 99999999999865422 12
Q ss_pred cEEEEeeecCCcccccc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 110 PSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
.+++++++.+++|.+++ ..+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus 85 ~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~-~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDH 163 (345)
T ss_dssp CEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECCGGG
T ss_pred eEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCC-CCEEEcccCceeeccCCC
Confidence 34556677788888776 469999999999999999999999999999999999999988 899999999987653322
Q ss_pred ----cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccc
Q 019642 188 ----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 263 (338)
Q Consensus 188 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
......|++.|+|||++.....++.++||||+|+++|+|++|..|| .+.+..+...........+..........
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF-PGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCC-CCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 2344578999999999866577899999999999999999999998 44455556666666665544433221111
Q ss_pred cccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhcc
Q 019642 264 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 332 (338)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 332 (338)
...... ..........++.. ....+++++.+||.+||+.||++|||++|+|+||||++.....
T Consensus 243 ~~~~~~-~~~~~~~~~~~~~~-----~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~ 305 (345)
T d1pmea_ 243 LKARNY-LLSLPHKNKVPWNR-----LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 305 (345)
T ss_dssp HHHHHH-HHTSCCCCCCCHHH-----HCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred hhhhcc-cccCCccCCCCHHH-----hCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCc
Confidence 100000 00000001111111 1223788999999999999999999999999999999765544
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-53 Score=365.59 Aligned_cols=245 Identities=17% Similarity=0.330 Sum_probs=204.3
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc--cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
+.++|++.+.||+|+||+||+|.+..+++.||||+++. ...+.+.+|+.+++++ +||||+++++++.+ ....+++
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~~iv 91 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--EPPFYII 91 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSCEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhC-CCCCEecCCccEee--CCeeEEE
Confidence 34789999999999999999999999999999999874 3456789999999999 99999999999954 5678999
Q ss_pred EeeecCCcccccc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 114 FEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 114 ~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
|||+.++++..++ ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++........
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~-~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCCTTTCCSSSS
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCC-CcEEEccccceeecCCCCc
Confidence 9999999987775 348999999999999999999999999999999999999988 8999999999976644332
Q ss_pred --ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 189 --YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 189 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.....+++.|+|||++.+ ..++.++||||||+++|+|++|..||+...+.......+....
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~---------------- 233 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---------------- 233 (287)
T ss_dssp EEETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC----------------
T ss_pred eeeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC----------------
Confidence 222457889999999877 6789999999999999999998888865554333322221100
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
....+..+++++.+||.+||+.||++|||++|+++
T Consensus 234 --------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 234 --------------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp --------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 00112237899999999999999999999999976
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=362.97 Aligned_cols=249 Identities=16% Similarity=0.310 Sum_probs=206.4
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc--cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
+.++|++.+.||+|+||+||+|.+. +++.||||+++. ...+.+.+|+.+++++ +||||+++++++.+ ...++|
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~---~~~~iv 85 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ---EPIYII 85 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhC-CCCCEeEEEeeecc---CCeEEE
Confidence 3579999999999999999999875 677899999874 3456789999999999 99999999998743 356899
Q ss_pred EeeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc
Q 019642 114 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
Q Consensus 114 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~ 188 (338)
|||+.+++|.+++. .+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++........
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~-~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT-LSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECSSSCE
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecc-cceeeccccceEEccCCcc
Confidence 99999999987663 48999999999999999999999999999999999999988 8999999999987654332
Q ss_pred --ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 189 --YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 189 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.....+++.|+|||++.+ ..++.++||||||+++|+|+||..|++...+..+....+.....
T Consensus 165 ~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~--------------- 228 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--------------- 228 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---------------
T ss_pred ccccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC---------------
Confidence 223467889999999876 67899999999999999999987777655554444333321100
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc--CCCcch
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA--HPYFAQ 327 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~--hp~~~~ 327 (338)
...+..+++++.+||.+||+.||++|||++++++ ++||.+
T Consensus 229 ---------------------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 229 ---------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp ---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------------------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 0112237899999999999999999999999998 788864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-53 Score=358.60 Aligned_cols=250 Identities=15% Similarity=0.328 Sum_probs=197.2
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc--cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
+.++|++.+.||+|+||+||+|.+. +++.||||+++. ...+.+.+|+.+++++ +||||+++++++.. ....++|
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~--~~~~~lv 78 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLE--QAPICLV 78 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSCEEE
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhc-CCCCcccccceecc--CCceEEE
Confidence 4578999999999999999999875 567899999874 3457789999999999 99999999999955 4578999
Q ss_pred EeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc-
Q 019642 114 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE- 188 (338)
Q Consensus 114 ~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~- 188 (338)
|||+.+++|.+++ ..+++..+..++.|++.||.|||+++++||||||+|||++.+ +.+||+|||+++.......
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGG-GCEEECSCC-----------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCC-CCeEecccchheeccCCCce
Confidence 9999999998875 238899999999999999999999999999999999999988 8999999999976543322
Q ss_pred -ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 189 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 189 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
.....||+.|+|||++.+ ..++.++||||||+++|+|+|+..|++...+..+....+......
T Consensus 158 ~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~--------------- 221 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL--------------- 221 (263)
T ss_dssp -------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC---------------
T ss_pred eecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC---------------
Confidence 223567899999999987 679999999999999999999766765555544444433221110
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
..+...++++.+||.+||+.||++|||++|+++| |+++.
T Consensus 222 ---------------------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~--L~~i~ 260 (263)
T d1sm2a_ 222 ---------------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ--LAEIA 260 (263)
T ss_dssp ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred ---------------------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH--HHHHH
Confidence 0112268899999999999999999999999987 55543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=370.52 Aligned_cols=284 Identities=29% Similarity=0.542 Sum_probs=218.1
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccC---CC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---SK 108 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~---~~ 108 (338)
.++|++++.||+|+||+||+|++..+++.||||+++.. ..+.+.+|+.+++++ +|||++++++++.... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeccccccC
Confidence 57899999999999999999999999999999998643 234578999999999 9999999999985432 23
Q ss_pred ccEEEEeeecCCcccccc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 109 TPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
..+++|+++.+++|.+++ +++++..++.++.||+.||.|||++||+|+||||+|||++.+ +.++++|||.+....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~-~~~kl~dfg~a~~~~-- 172 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-CELKILDFGLARHTD-- 172 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCC----CCT--
T ss_pred ceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccc-ccccccccchhcccC--
Confidence 446677888899998886 459999999999999999999999999999999999999998 899999999986543
Q ss_pred CcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 187 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.......|++.|+|||+..+...++.++||||||+++|+|++|..|| .+.+.......+.+..+..............
T Consensus 173 ~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~- 250 (348)
T d2gfsa1 173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAELLKKISSES- 250 (348)
T ss_dssp GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH-
T ss_pred cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCChHHhhhccchh-
Confidence 33344678899999999887667899999999999999999999998 4556666677777766664433322111100
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhhhc
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 331 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 331 (338)
...........+... .......+++++.+||++||+.||++|||+.|+|+||||++...+
T Consensus 251 ---~~~~~~~~~~~~~~~--~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~ 310 (348)
T d2gfsa1 251 ---ARNYIQSLTQMPKMN--FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310 (348)
T ss_dssp ---HHHHHTTSCCCCCCC--HHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred ---hhhhhhhcccCCCcc--hhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCC
Confidence 000000000000000 011123478999999999999999999999999999999987543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=364.72 Aligned_cols=247 Identities=20% Similarity=0.335 Sum_probs=199.9
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCc-----eEEEEEecc----cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNE-----RCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~aiK~~~~----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
+.++|++.+.||+|+||+||+|.+..+++ .||+|.+.. .....+.+|+.++.++.+||||+++++++.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-- 112 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 112 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee--
Confidence 34789999999999999999999876543 689998753 2345688999999998789999999999955
Q ss_pred CCccEEEEeeecCCccccccC--------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 019642 107 SKTPSLIFEYVNSTDFKVLYP--------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKP 160 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~~--------------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp 160 (338)
....++||||+.+++|.+++. .+++..++.++.|++.||.|||++||+||||||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp 192 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 192 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCch
Confidence 567899999999999987762 278899999999999999999999999999999
Q ss_pred CCeEecCCCCceEEEeccccccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCC
Q 019642 161 HNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYG 236 (338)
Q Consensus 161 ~NIli~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~ 236 (338)
+||+++.+ +.+||+|||+++....... .....+|+.|+|||++.+ ..++.++|||||||++|+|+| |..||..
T Consensus 193 ~Nill~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf~~- 269 (325)
T d1rjba_ 193 RNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPG- 269 (325)
T ss_dssp GGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTT-
T ss_pred hccccccC-CeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCCCC-
Confidence 99999988 8999999999976543332 223467899999999877 689999999999999999998 8888843
Q ss_pred CCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCH
Q 019642 237 HDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 316 (338)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~ 316 (338)
.+....+..+.+.-.. ...+..+++++.+||.+||+.||++|||+
T Consensus 270 ~~~~~~~~~~~~~~~~-----------------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPt~ 314 (325)
T d1rjba_ 270 IPVDANFYKLIQNGFK-----------------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSF 314 (325)
T ss_dssp CCCSHHHHHHHHTTCC-----------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCHHHHHHHHHhcCCC-----------------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCH
Confidence 3333333332221000 01122378999999999999999999999
Q ss_pred HHHhcC
Q 019642 317 REAMAH 322 (338)
Q Consensus 317 ~ell~h 322 (338)
+||++|
T Consensus 315 ~ei~~~ 320 (325)
T d1rjba_ 315 PNLTSF 320 (325)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999975
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.6e-52 Score=358.09 Aligned_cols=252 Identities=22% Similarity=0.356 Sum_probs=196.2
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC--C
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS--K 108 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~--~ 108 (338)
.++|++.+.||+|+||+||+|.+..+++.||+|+++... ...+.+|+.+++.+ +||||+++++++...+. .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECSSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccCCCc
Confidence 578999999999999999999999999999999986422 34578999999999 99999999999876433 3
Q ss_pred ccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 109 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
.+++||||+.|++|.... +.+++..++.++.|++.||.|||++|++|+||||+|||++.+ +..+++|||.+.....
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~-~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT-SCEEECCCTTCEECC-
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcc-ccceeehhhhhhhhcc
Confidence 578999999999988776 369999999999999999999999999999999999999988 7899999998765432
Q ss_pred CC----cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhc
Q 019642 186 GK----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 261 (338)
Q Consensus 186 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
.. ......||+.|+|||++.+ ..++.++||||||+++|+|+||..||. +.+..+.+..+.......
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~-~~~~~~~~~~~~~~~~~~-------- 233 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFT-GDSPVSVAYQHVREDPIP-------- 233 (277)
T ss_dssp ---------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHCCCCC--------
T ss_pred ccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCC-CcCHHHHHHHHHhcCCCC--------
Confidence 22 2334578999999999977 678999999999999999999999983 333333333322210000
Q ss_pred cccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCc
Q 019642 262 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 325 (338)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 325 (338)
.......+|+++.+||.+||++||++||+..+.|.|+|.
T Consensus 234 -------------------------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 234 -------------------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp -------------------------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred -------------------------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 011123379999999999999999999944444456654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-53 Score=358.36 Aligned_cols=246 Identities=15% Similarity=0.314 Sum_probs=194.5
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCcc
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 110 (338)
+.++|++.+.||+|+||+||+|... ..||||+++.. ..+.+.+|+.+++++ +||||+++++++.+ ...
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~---~~~ 78 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYSTA---PQL 78 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTC-CCTTBCCEEEEECS---SSC
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEec---cEE
Confidence 3578999999999999999999743 35999998632 245688999999999 99999999998633 357
Q ss_pred EEEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCC
Q 019642 111 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
Q Consensus 111 ~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~ 186 (338)
++||||+.+++|.+++ ..+++..+..++.|++.||.|||++||+|+||||+|||++.+ +.+||+|||++......
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~-~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHED-LTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-SSEEECCCCCSCC----
T ss_pred EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCC-CCEEEccccceeecccc
Confidence 8999999999998876 348999999999999999999999999999999999999988 89999999998765432
Q ss_pred C---cceeeeccccccccccccCc--CCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHh-CCchhhhhhh
Q 019642 187 K---EYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL-GTDELNAYLN 260 (338)
Q Consensus 187 ~---~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 260 (338)
. ......||+.|+|||++.+. ..++.++||||||+++|+|+||+.||.. .+....+....... ..+...
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~-~~~~~~~~~~~~~~~~~p~~~---- 232 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN-INNRDQIIFMVGRGYLSPDLS---- 232 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT-CCCHHHHHHHHHHTSCCCCGG----
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCC-CChHHHHHHHHhcCCCCCcch----
Confidence 2 23345789999999998642 3578999999999999999999999843 33333333322211 111100
Q ss_pred ccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
..+..+++++.+||.+||+.||++|||+.|++++
T Consensus 233 ----------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 233 ----------------------------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp ----------------------------GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1122378999999999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=352.65 Aligned_cols=244 Identities=18% Similarity=0.322 Sum_probs=201.7
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc--cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEE
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 113 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv 113 (338)
+.++|++.++||+|+||+||+|++ ++++.||||+++. ...+.+.+|+.+++++ +||||+++++++.+ ....++|
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l-~HpnIv~~~g~~~~--~~~~~iv 77 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTK--QRPIFII 77 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEECC--SSSEEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCHHHHHHHHHHHHhc-CCCceeeEEEEEee--CCceEEE
Confidence 357999999999999999999997 4778899999874 3567889999999999 99999999999954 4678999
Q ss_pred EeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCc-
Q 019642 114 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE- 188 (338)
Q Consensus 114 ~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~- 188 (338)
|||+.++++..++ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++........
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~-~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTT-CCEEECCCSSCCBCSSSSCC
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCC-CcEEECcchhheeccCCCce
Confidence 9999999887774 358999999999999999999999999999999999999988 8999999999976543332
Q ss_pred -ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcccccc
Q 019642 189 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 266 (338)
Q Consensus 189 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.....+|+.|+|||++.+ ..++.++||||||+++|+|+| |+.|| ...+..+....+.+...
T Consensus 157 ~~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf-~~~~~~~~~~~i~~~~~--------------- 219 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPY-ERFTNSETAEHIAQGLR--------------- 219 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTSCHHHHHHHHHTTCC---------------
T ss_pred eecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCC-CCCCHHHHHHHHHhCCC---------------
Confidence 223568889999999987 678999999999999999998 78887 33333333322221100
Q ss_pred CcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 267 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
...+...++++.+||++||+.||++|||++++++|
T Consensus 220 ---------------------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 220 ---------------------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp ---------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 01122368899999999999999999999999987
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-52 Score=358.79 Aligned_cols=245 Identities=17% Similarity=0.294 Sum_probs=187.9
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCCc---eEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
+.++|++.+.||+|+||+||+|.+..+++ .||||.+... ..+.+.+|+.+++++ +||||+++++++.. ..
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~--~~ 100 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTK--ST 100 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--SS
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCCccEEEEEee--CC
Confidence 34789999999999999999999876654 5888887542 235688999999999 99999999999954 46
Q ss_pred ccEEEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 109 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
..++||||+.+++|..++. .+++.++..++.|++.||.|||++|++||||||+|||++.+ +.+||+|||++....
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~-~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSN-LVCKVSDFGLSRFLE 179 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCC-------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCC-CcEEECCcccceEcc
Confidence 7899999999999987652 48999999999999999999999999999999999999988 899999999997654
Q ss_pred CCCcc------eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhh
Q 019642 185 PGKEY------NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNA 257 (338)
Q Consensus 185 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
..... ....+|+.|+|||.+.+ ..++.++|||||||++|+|+| |..||. ..+..+....+.+...
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~-~~~~~~~~~~i~~~~~------ 251 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYW-DMTNQDVINAIEQDYR------ 251 (299)
T ss_dssp ----------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHHHTTCC------
T ss_pred CCCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCC-CCCHHHHHHHHHcCCC------
Confidence 33221 12346889999999877 688999999999999999998 888883 2232222222211000
Q ss_pred hhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
...+..+++++.+||.+||+.||++|||+.|++++
T Consensus 252 ------------------------------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 252 ------------------------------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp ------------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ------------------------------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 00122378999999999999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-52 Score=355.66 Aligned_cols=254 Identities=17% Similarity=0.322 Sum_probs=202.9
Q ss_pred eccCCcEEEEE-eeeecCceeEEEEEEcC--CCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 34 FSDQDDYEVVR-KVGRGKYSEVFEGINVN--TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 34 ~~~~~~y~~~~-~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
+...++|.+.+ +||+|+||+||+|.+.. ++..||||+++... .+.+.+|+.+++++ +||||+++++++.+
T Consensus 4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~-- 80 (285)
T d1u59a_ 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-- 80 (285)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES--
T ss_pred eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhC-CCCCEeeEeeeecc--
Confidence 34567899998 49999999999998754 45579999987432 35688999999999 99999999999854
Q ss_pred CCccEEEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccc
Q 019642 107 SKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~ 182 (338)
..+++||||+++++|.+++ ..+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++..
T Consensus 81 -~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~-~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 81 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR-HYAKISDFGLSKA 158 (285)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET-TEEEECCCTTCEE
T ss_pred -CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccC-Cceeeccchhhhc
Confidence 3578999999999998874 248999999999999999999999999999999999999988 8999999999977
Q ss_pred ccCCCc----ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhh
Q 019642 183 YHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNA 257 (338)
Q Consensus 183 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
...... .....+|+.|+|||++.+ ..++.++||||||+++|+|+| |..||. ..+..+....+.+...
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~-~~~~~~~~~~i~~~~~------ 230 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYK-KMKGPEVMAFIEQGKR------ 230 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTT-TCCTHHHHHHHHTTCC------
T ss_pred ccccccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCC-CCCHHHHHHHHHcCCC------
Confidence 654332 123457889999999877 678999999999999999998 899984 3333333332211000
Q ss_pred hhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHH---hcCCCcchhhh
Q 019642 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA---MAHPYFAQVRA 330 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~el---l~hp~~~~~~~ 330 (338)
...++.+++++.+||.+||+.||++|||+.++ |+|+|+.-...
T Consensus 231 ------------------------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~ 276 (285)
T d1u59a_ 231 ------------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276 (285)
T ss_dssp ------------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred ------------------------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhc
Confidence 01123378999999999999999999999888 56787754433
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-52 Score=354.62 Aligned_cols=250 Identities=18% Similarity=0.311 Sum_probs=203.5
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
.++|++.+.||+|+||+||+|.+..+ +.||||+++.. ..+.+.+|+.+++++ +||||+++++++.+ ...++||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~---~~~~lv~ 90 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIVT 90 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhc-ccCCEeEEEEEEec---CCeEEEE
Confidence 47899999999999999999998655 56999998743 356799999999999 99999999999843 3468999
Q ss_pred eeecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC--
Q 019642 115 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-- 187 (338)
Q Consensus 115 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~-- 187 (338)
||+.++++...+. .+++.++..++.||+.||.|||++|++|+||||+|||++.+ +++||+|||++.......
T Consensus 91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~-~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCTTC--------
T ss_pred EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCC-CcEEEcccchhhhccCCCce
Confidence 9999998877653 48999999999999999999999999999999999999988 899999999997654332
Q ss_pred cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccC
Q 019642 188 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 267 (338)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
......+++.|+|||++.+ ..++.++||||||+++|+|++|..|++......+.+..+.+....
T Consensus 170 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~--------------- 233 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM--------------- 233 (285)
T ss_dssp ------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---------------
T ss_pred eeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC---------------
Confidence 2233568899999999977 678999999999999999999888886665555444443221100
Q ss_pred cchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc--CCCcchhh
Q 019642 268 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA--HPYFAQVR 329 (338)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~--hp~~~~~~ 329 (338)
..+..+++++.+||.+||+.||++|||+++|++ ++||.+..
T Consensus 234 ---------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 234 ---------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred ---------------------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 112237899999999999999999999999998 89998764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-52 Score=354.43 Aligned_cols=252 Identities=19% Similarity=0.353 Sum_probs=197.2
Q ss_pred cCCcEEEE-EeeeecCceeEEEEEEc--CCCceEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 36 DQDDYEVV-RKVGRGKYSEVFEGINV--NTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 36 ~~~~y~~~-~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
+...+.+. ++||+|+||+||+|.+. .+++.||||+++.. ..+.+.+|+.+++++ +||||+++++++..
T Consensus 4 d~~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~--- 79 (277)
T d1xbba_ 4 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA--- 79 (277)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEES---
T ss_pred chhhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-CCCCCceEEEEecc---
Confidence 33445555 46999999999999764 45678999998642 245688999999999 99999999999844
Q ss_pred CccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 108 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
...++||||+.+++|.+++ ..+++..+..++.||+.||.|||++|++|+||||+|||++.+ +.+||+|||++....
T Consensus 80 ~~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~-~~~kl~DFGla~~~~ 158 (277)
T d1xbba_ 80 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALR 158 (277)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCTTCEECC
T ss_pred CCEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccccc-Ccccccchhhhhhcc
Confidence 3468999999999998876 359999999999999999999999999999999999999988 899999999997654
Q ss_pred CCCcc----eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhh
Q 019642 185 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259 (338)
Q Consensus 185 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
..... ....||+.|+|||++.+ ..++.++||||||+++|+|++ |..||. +.+..+....+.+ +.
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~-~~~~~~~~~~i~~--~~------- 227 (277)
T d1xbba_ 159 ADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYR-GMKGSEVTAMLEK--GE------- 227 (277)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSST-TCCHHHHHHHHHT--TC-------
T ss_pred ccccccccccccCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCC-CCCHHHHHHHHHc--CC-------
Confidence 33221 22467889999999877 678999999999999999998 899983 2232222222211 00
Q ss_pred hccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHH---hcCCCcchhhh
Q 019642 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA---MAHPYFAQVRA 330 (338)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~el---l~hp~~~~~~~ 330 (338)
+ ...+..+++++.+||.+||+.||++|||+++| |+|+|+.-+++
T Consensus 228 -------------------~--------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~e 274 (277)
T d1xbba_ 228 -------------------R--------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274 (277)
T ss_dssp -------------------C--------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred -------------------C--------CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcCCC
Confidence 0 01122378999999999999999999999998 46776655543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-52 Score=359.51 Aligned_cols=258 Identities=22% Similarity=0.420 Sum_probs=206.8
Q ss_pred CCcEEEEEeeeecCceeEEEEEEc---CCCceEEEEEeccc-------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~-------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
-++|++.+.||+|+||+||+|.+. .+++.||+|.++.. ..+.+.+|+.+++++.+||||+++++.+.+
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~-- 100 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 100 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc--
Confidence 478999999999999999999874 46899999998632 345678899999999666999999999955
Q ss_pred CCccEEEEeeecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 107 SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
....+++|||+.+++|...+ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++...
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~-~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEF 179 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEESCSSEEEEC
T ss_pred CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCC-CCEEEeeccchhhh
Confidence 45789999999999998776 458899999999999999999999999999999999999998 89999999998765
Q ss_pred cCCC--cceeeeccccccccccccCcC-CCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhh
Q 019642 184 HPGK--EYNVRVASRYFKGPELLVDLQ-DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 260 (338)
Q Consensus 184 ~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.... ......+++.|+|||.+.+.. .++.++|||||||++|+|++|..||.... ..+....+.+.....
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~-~~~~~~~i~~~~~~~------- 251 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG-EKNSQAEISRRILKS------- 251 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT-SCCCHHHHHHHHHHC-------
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcccC-------
Confidence 3322 234467899999999986533 57889999999999999999999984332 222222222111000
Q ss_pred ccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcC-----CHHHHhcCCCcchhhhc
Q 019642 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAA 331 (338)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~~ 331 (338)
....+..+++++.+||++||++||++|| |++|+++||||+++...
T Consensus 252 --------------------------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~ 301 (322)
T d1vzoa_ 252 --------------------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD 301 (322)
T ss_dssp --------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred --------------------------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHH
Confidence 0001223799999999999999999999 58999999999987644
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=347.32 Aligned_cols=245 Identities=15% Similarity=0.281 Sum_probs=192.7
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCC----ceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTN----ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
..+.|++.+.||+|+||+||+|.+..++ ..||||.++... ...+.+|+.+++++ +||||+++++++.+ .
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~~--~ 81 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISK--Y 81 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--S
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhc-CCCCEeeeeEEEec--C
Confidence 3467999999999999999999876554 469999986432 34578999999999 99999999999954 4
Q ss_pred CccEEEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 108 KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
...+++|||+.++++.... ..+++.++..++.|++.||.|||++||+|+||||+|||++.+ +.+||+|||+++..
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~-~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVL 160 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCCCC----
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCC-CeEEEcccchhhcc
Confidence 5788999999999887654 459999999999999999999999999999999999999998 89999999999765
Q ss_pred cCCCc----ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhh
Q 019642 184 HPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 259 (338)
Q Consensus 184 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
..... .....||+.|+|||++.+ ..++.++||||||+++|+|++|..|++...+..+....+.+...
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~-------- 231 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-------- 231 (283)
T ss_dssp -------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC--------
T ss_pred cCCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC--------
Confidence 43321 223457889999999877 68999999999999999999987787655444433332211100
Q ss_pred hccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 260 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
...+..+++++.++|.+||+.||++|||+.||++
T Consensus 232 ----------------------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 232 ----------------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp ----------------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------------------------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 0112236889999999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=349.18 Aligned_cols=248 Identities=20% Similarity=0.318 Sum_probs=192.0
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcC-----CCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
.++|++.+.||+|+||.||+|.+.. +++.||+|.++.. ..+.+..|...+.++.+|+||+.+++.+... .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-~ 90 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G 90 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-T
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC-C
Confidence 4789999999999999999999754 3467999998643 2345677888888887899999999987544 3
Q ss_pred CccEEEEeeecCCccccccC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC
Q 019642 108 KTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 168 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~ 168 (338)
...++||||+.+++|.+++. .+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence 56789999999999988752 37889999999999999999999999999999999999988
Q ss_pred CCceEEEeccccccccCCC---cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHH
Q 019642 169 LRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 245 (338)
Q Consensus 169 ~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~ 245 (338)
+.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..|++...+..+.+..
T Consensus 171 -~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~ 248 (299)
T d1ywna1 171 -NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248 (299)
T ss_dssp -GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred -CcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 899999999997654322 2233578999999999987 68999999999999999999976544444443333333
Q ss_pred HHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 246 IAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
....-... ..+..+++++.++|.+||+.||++|||++|+++|
T Consensus 249 ~~~~~~~~-----------------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 249 RLKEGTRM-----------------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHTCCC-----------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCC-----------------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 22211100 1122368999999999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=343.36 Aligned_cols=247 Identities=21% Similarity=0.394 Sum_probs=189.6
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCC---ceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCc
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 109 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 109 (338)
.++|++.+.||+|+||+||+|.+..++ ..||+|.++... .+.+.+|+.+++++ +||||+++++++.+ ..
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~---~~ 81 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE---NP 81 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS---SS
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec---Ce
Confidence 468999999999999999999986543 468888876432 35578999999999 99999999999843 46
Q ss_pred cEEEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccC
Q 019642 110 PSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
Q Consensus 110 ~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~ 185 (338)
.++||||+.++++..++ ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++.....
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~-~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMED 160 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECC---------
T ss_pred EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCC-CcEEEccchhheeccC
Confidence 79999999999887764 358999999999999999999999999999999999999998 8999999999976543
Q ss_pred CC--cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcc
Q 019642 186 GK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262 (338)
Q Consensus 186 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
.. ......+|+.|+|||++.+ ..++.++||||||+++|+|++ |..|| ...+..+....+.....
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~-~~~~~~~~~~~i~~~~~----------- 227 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRIENGER----------- 227 (273)
T ss_dssp ----------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTT-TTCCGGGHHHHHHTTCC-----------
T ss_pred CcceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCC-CCCCHHHHHHHHHcCCC-----------
Confidence 32 2233567889999999977 689999999999999999998 77776 33333333333221100
Q ss_pred ccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchh
Q 019642 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 328 (338)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 328 (338)
...+..+++++.+||.+||+.||++|||+.||+++ +..+
T Consensus 228 -------------------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~--L~~i 266 (273)
T d1mp8a_ 228 -------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ--LSTI 266 (273)
T ss_dssp -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHH
T ss_pred -------------------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH--HHHH
Confidence 01123378999999999999999999999999987 4444
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-50 Score=347.78 Aligned_cols=243 Identities=18% Similarity=0.320 Sum_probs=192.9
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCc----eEEEEEecc----cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
.++|++++.||+|+||+||+|.+..+++ +||+|.++. ...+.+.+|+.+++++ +||||+++++++.+.
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~--- 83 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS--- 83 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHC-CCTTBCCEEEEEESS---
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC---
Confidence 4689999999999999999999987776 578887753 2356789999999999 999999999998653
Q ss_pred ccEEEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccccc
Q 019642 109 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~ 184 (338)
..++++|++.+++|.+.+ ..+++..+..++.||+.||.|||++||+|+||||+||+++.+ +.+||+|||++....
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~-~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKLLG 162 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCCSHHHHTT
T ss_pred CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCC-CCeEeeccccceecc
Confidence 467888999888776554 359999999999999999999999999999999999999998 899999999998764
Q ss_pred CCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhh
Q 019642 185 PGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 260 (338)
Q Consensus 185 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.... .....||+.|+|||++.+ ..++.++||||||+++|+|+| |..|| ...+..+....+.+....
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~-~~~~~~~~~~~i~~~~~~-------- 232 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPY-DGIPASEISSILEKGERL-------- 232 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTSCGGGHHHHHHHTCCC--------
T ss_pred cccccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCC-CCCCHHHHHHHHHcCCCC--------
Confidence 4332 223457899999999887 679999999999999999999 66666 333333333222211000
Q ss_pred ccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
..++.+++++.+||.+||+.||++|||+.|+++|
T Consensus 233 ----------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 233 ----------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp ----------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 0122368999999999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-51 Score=351.95 Aligned_cols=248 Identities=17% Similarity=0.283 Sum_probs=200.8
Q ss_pred ccCCcEEEEEeeeecCceeEEEEEEcCCCce--EEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 35 SDQDDYEVVRKVGRGKYSEVFEGINVNTNER--CIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
.+.++|++.+.||+|+||+||+|.+..++.. ||||.++.. ..+.+.+|+++++++.+||||+++++++.+ ..
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec--CC
Confidence 3568999999999999999999999888775 667776432 345688999999998679999999999965 46
Q ss_pred ccEEEEeeecCCcccccc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCC
Q 019642 109 TPSLIFEYVNSTDFKVLY-------------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL 169 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 169 (338)
..++||||+.+++|.+++ ..+++..+..++.|++.||.|||+.|++||||||+|||++.+
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~- 163 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN- 163 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG-
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC-
Confidence 789999999999998876 348999999999999999999999999999999999999988
Q ss_pred CceEEEeccccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHH
Q 019642 170 RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 249 (338)
Q Consensus 170 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~ 249 (338)
+.+||+|||++.............+|..|+|||.+.+ ..++.++||||||+++|+|++|..|++...+..+....+.+.
T Consensus 164 ~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~ 242 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242 (309)
T ss_dssp GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred CceEEccccccccccccccccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence 7999999999976554444445578899999999977 678999999999999999999877655554433333222110
Q ss_pred hCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 250 LGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
. ....+..+++++.+||.+||+.||++|||+.||+++
T Consensus 243 ~------------------------------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 243 Y------------------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp C------------------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C------------------------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0 001122378999999999999999999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-50 Score=337.49 Aligned_cols=246 Identities=16% Similarity=0.330 Sum_probs=193.0
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEe
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 115 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e 115 (338)
.++|++.+.||+|+||.||+|.+ +++.||||+++.. ..+.+.+|+.+++++ +||||+++++++.+.. ..+++|||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~-~~~~lv~e 81 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEK-GGLYIVTE 81 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTC-CCTTBCCEEEEECCC---CCEEEEC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEecC-CcEEEEEe
Confidence 46899999999999999999987 4778999999754 356789999999999 9999999999885432 45799999
Q ss_pred eecCCccccccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCCcce
Q 019642 116 YVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 190 (338)
Q Consensus 116 ~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~~~~ 190 (338)
|+.+++|.+++. .+++..+..++.||+.||.|||+.+++|+||||+||+++.+ +.++|+|||++...... ..
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~-~~~kl~dfg~s~~~~~~--~~ 158 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLTKEASST--QD 158 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-SCEEECCCCC-----------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCC-CCEeecccccceecCCC--Cc
Confidence 999999998863 28999999999999999999999999999999999999998 89999999999764432 23
Q ss_pred eeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhccccccCcc
Q 019642 191 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 269 (338)
Q Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
...++..|+|||++.+ ..++.++||||||+++|+|+| |..|| ...+..+....+.+.
T Consensus 159 ~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~-~~~~~~~~~~~i~~~-------------------- 216 (262)
T d1byga_ 159 TGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPY-PRIPLKDVVPRVEKG-------------------- 216 (262)
T ss_dssp ---CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSC-TTSCGGGHHHHHTTT--------------------
T ss_pred cccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCC-CCCCHHHHHHHHHcC--------------------
Confidence 3567889999999977 679999999999999999998 56665 333333333322110
Q ss_pred hhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCCCcchhh
Q 019642 270 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 329 (338)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 329 (338)
. ....+..+++++.+||++||+.||++|||+.+++++ |+++.
T Consensus 217 --------~--------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~--L~~i~ 258 (262)
T d1byga_ 217 --------Y--------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ--LEHIK 258 (262)
T ss_dssp --------C--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred --------C--------CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH--HHHHH
Confidence 0 001122378999999999999999999999999874 55443
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-49 Score=343.21 Aligned_cols=245 Identities=18% Similarity=0.296 Sum_probs=198.8
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcC-----CCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
..++|++.+.||+|+||+||+|.+.. +++.||||.++... .+.+.+|+.+++++ +||||+++++++..
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~-- 87 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAV-- 87 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhc-CCCCcccceeeecc--
Confidence 45789999999999999999998753 56789999987432 45688999999999 99999999999954
Q ss_pred CCccEEEEeeecCCccccccC---------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 019642 107 SKTPSLIFEYVNSTDFKVLYP---------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVK 159 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~~---------------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dik 159 (338)
....+++|||+.+++|.+++. .++...+..++.|++.||.|||++|++|||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK 167 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence 567889999999999887652 27888999999999999999999999999999
Q ss_pred CCCeEecCCCCceEEEeccccccccCCC---cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCC
Q 019642 160 PHNVMIDHELRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 236 (338)
Q Consensus 160 p~NIli~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~ 236 (338)
|+|||++.+ +.+||+|||++....... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..|++..
T Consensus 168 p~NILld~~-~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 168 TRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp GGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ccceEECCC-CcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 999999988 899999999987553322 2233567889999999987 68999999999999999999997655455
Q ss_pred CCCHHHHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCH
Q 019642 237 HDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 316 (338)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~ 316 (338)
.+..+....+.+... ...+..+++++.+||.+||+.||++|||+
T Consensus 246 ~~~~e~~~~v~~~~~------------------------------------~~~p~~~~~~~~~li~~cl~~~P~~RPt~ 289 (301)
T d1lufa_ 246 MAHEEVIYYVRDGNI------------------------------------LACPENCPLELYNLMRLCWSKLPADRPSF 289 (301)
T ss_dssp SCHHHHHHHHHTTCC------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCHHHHHHHHHcCCC------------------------------------CCCCccchHHHHHHHHHHcCCChhHCcCH
Confidence 554444433221100 00122378999999999999999999999
Q ss_pred HHHhc
Q 019642 317 REAMA 321 (338)
Q Consensus 317 ~ell~ 321 (338)
.||++
T Consensus 290 ~ev~~ 294 (301)
T d1lufa_ 290 CSIHR 294 (301)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99965
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=337.68 Aligned_cols=244 Identities=19% Similarity=0.291 Sum_probs=188.5
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCC-C--ceEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNT-N--ERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-~--~~~aiK~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
+.++|++.+.||+|+||.||+|....+ + ..||||++++. ..+.+.+|+.+++++ +||||+++++++.+
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~-- 82 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLT-- 82 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee--
Confidence 357899999999999999999986433 3 36899988642 235688999999999 99999999999954
Q ss_pred CCccEEEEeeecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecccccc
Q 019642 107 SKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~ 182 (338)
...++||||+.++++.+.+ ..+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++..
T Consensus 83 -~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~-~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 83 -PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR-DLVKIGDFGLMRA 160 (273)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCTTCEE
T ss_pred -cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccc-cceeeccchhhhh
Confidence 3568999999999887665 359999999999999999999999999999999999999998 7999999999987
Q ss_pred ccCCCcc----eeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHHHHHHHHHHhCCchhhh
Q 019642 183 YHPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNA 257 (338)
Q Consensus 183 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
....... ....++..|+|||++.+ ..++.++||||||+++|+|+| |..|| .+.+..+....+.+. +
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf-~~~~~~~~~~~i~~~-~------ 231 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPW-IGLNGSQILHKIDKE-G------ 231 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHHTS-C------
T ss_pred cccCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCC-CCcCHHHHHHHHHhC-C------
Confidence 6443321 22356778999999987 678999999999999999998 89887 334433333332210 0
Q ss_pred hhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
.....+..+++++.+||.+||+.||++|||+.||++
T Consensus 232 ----------------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 232 ----------------------------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp ----------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 000112337899999999999999999999999963
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-49 Score=339.26 Aligned_cols=245 Identities=18% Similarity=0.343 Sum_probs=193.0
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEcCCC-------ceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeec
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINVNTN-------ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRD 104 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 104 (338)
+.++|++.+.||+|+||.||+|++..++ ..||||+++... ...+.+|...+.++.+||||+++++++.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 3479999999999999999999876554 469999986532 35577899999988789999999999955
Q ss_pred cCCCccEEEEeeecCCcccccc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEe
Q 019642 105 QHSKTPSLIFEYVNSTDFKVLY-------------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 165 (338)
Q Consensus 105 ~~~~~~~lv~e~~~~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli 165 (338)
....++||||+.++++.+++ ..+++..++.++.|++.||.|||+.|++||||||+|||+
T Consensus 91 --~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 91 --DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 168 (299)
T ss_dssp --SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred --CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence 56789999999999998876 248999999999999999999999999999999999999
Q ss_pred cCCCCceEEEeccccccccCCC---cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHh-cCCCCcCCCCCHH
Q 019642 166 DHELRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHD 241 (338)
Q Consensus 166 ~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~llt-g~~pf~~~~~~~~ 241 (338)
+.+ +.+||+|||++....... ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..|| .+.+...
T Consensus 169 ~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~-~~~~~~~ 245 (299)
T d1fgka_ 169 TED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVPVEE 245 (299)
T ss_dssp CTT-CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCHHH
T ss_pred cCC-CCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCC-CCCCHHH
Confidence 998 899999999987654332 2233568889999999977 689999999999999999998 56665 3333332
Q ss_pred HHHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 242 QLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
....+.. +. ....+..+++++.+||.+||+.||++|||+.||++
T Consensus 246 ~~~~i~~--~~----------------------------------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 246 LFKLLKE--GH----------------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHT--TC----------------------------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHc--CC----------------------------------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 2221111 00 00112237899999999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=338.30 Aligned_cols=247 Identities=20% Similarity=0.313 Sum_probs=203.5
Q ss_pred cCCcEEEEEeeeecCceeEEEEEEc-----CCCceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccC
Q 019642 36 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 106 (338)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 106 (338)
..++|++.+.||+|+||.||+|.+. .+++.||||.++.. ....+.+|+.+++++.+||||+++++++.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~-- 98 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee--
Confidence 3479999999999999999999863 46678999998753 234578899999999779999999999954
Q ss_pred CCccEEEEeeecCCccccccC---------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEe
Q 019642 107 SKTPSLIFEYVNSTDFKVLYP---------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 165 (338)
Q Consensus 107 ~~~~~lv~e~~~~~~l~~~~~---------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli 165 (338)
....+++|||+.++++..++. .+++..+..++.||+.||+|||++|++|+||||+||++
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence 457899999999999877752 38899999999999999999999999999999999999
Q ss_pred cCCCCceEEEeccccccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHH
Q 019642 166 DHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 242 (338)
Q Consensus 166 ~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~ 242 (338)
+.+ +.++++|||.+........ .....+|+.|+|||++.+ ..++.++||||||+++|+|+|+..|++...+..+.
T Consensus 179 ~~~-~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 179 THG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp ETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred ccc-CcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 988 8999999999976654322 233577899999999977 68999999999999999999976776666665555
Q ss_pred HHHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 243 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
+..+.+.-..+ ..+..+++++.+||.+||+.||++|||++||++
T Consensus 257 ~~~~i~~~~~~-----------------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 257 FYKMIKEGFRM-----------------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHHTCCC-----------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCCCC-----------------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 54443321110 112236899999999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=338.14 Aligned_cols=252 Identities=19% Similarity=0.311 Sum_probs=205.1
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcC-----CCceEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEeeeeeeccCC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 107 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 107 (338)
.++|++.+.||+|+||+||+|.+.. +++.||||.++... ...+.+|+.+++++ +||||+++++.+.. .
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~--~ 95 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ--G 95 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECS--S
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc-CCCCEeeeeeEEec--C
Confidence 4899999999999999999998753 35789999987532 23478999999999 89999999999954 5
Q ss_pred CccEEEEeeecCCccccccC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEE
Q 019642 108 KTPSLIFEYVNSTDFKVLYP-------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRL 174 (338)
Q Consensus 108 ~~~~lv~e~~~~~~l~~~~~-------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l 174 (338)
...++||||+.+++|..++. .++...+..++.|++.||.|||+++++|+||||+|||++.+ +++||
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~-~~~Kl 174 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKI 174 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT-CCEEE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCC-ceEEE
Confidence 57899999999999987752 36888999999999999999999999999999999999988 89999
Q ss_pred EeccccccccCCCc---ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhC
Q 019642 175 IDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 251 (338)
Q Consensus 175 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~ 251 (338)
+|||++........ .....+++.|+|||.+.+ ..++.++||||||+++|+|+||..|++.+.+..+.+..+.+...
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~ 253 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 253 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC
Confidence 99999876543222 233467899999999877 67889999999999999999997555555555444443322100
Q ss_pred CchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc------CCCc
Q 019642 252 TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA------HPYF 325 (338)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~------hp~~ 325 (338)
...+..+++.+.++|.+||+.||++|||+.+|++ +|+|
T Consensus 254 ------------------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~ 297 (308)
T d1p4oa_ 254 ------------------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297 (308)
T ss_dssp ------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTH
T ss_pred ------------------------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 0112237899999999999999999999999998 7888
Q ss_pred chhh
Q 019642 326 AQVR 329 (338)
Q Consensus 326 ~~~~ 329 (338)
++++
T Consensus 298 ~~~~ 301 (308)
T d1p4oa_ 298 REVS 301 (308)
T ss_dssp HHHC
T ss_pred cCCC
Confidence 7653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=334.64 Aligned_cols=244 Identities=20% Similarity=0.313 Sum_probs=192.2
Q ss_pred cEEEEEeeeecCceeEEEEEEcCCC---ceEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccE
Q 019642 39 DYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 111 (338)
Q Consensus 39 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 111 (338)
.+...+.||+|+||+||+|.+..++ ..||||.++.. ..+.+.+|+++++++ +||||+++++++... ....+
T Consensus 28 ~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~-~~~~~ 105 (311)
T d1r0pa_ 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRS-EGSPL 105 (311)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEET-TTEEE
T ss_pred eeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEec-CCceE
Confidence 4444788999999999999986543 35899998642 235688999999999 899999999987543 34678
Q ss_pred EEEeeecCCccccccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEeccccccccCCC
Q 019642 112 LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 112 lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~~~~~ 187 (338)
+||||++++++.+++. ..+...+..++.|++.||.|||+.+++||||||+|||++.+ +.+||+|||++.......
T Consensus 106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~-~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKE 184 (311)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CCEEECSSGGGCCTTTTT
T ss_pred EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCC-CCEEEecccchhhccccc
Confidence 9999999999988763 37788899999999999999999999999999999999988 899999999997654332
Q ss_pred c-----ceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHhCCchhhhhhhcc
Q 019642 188 E-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 262 (338)
Q Consensus 188 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
. .....+|+.|+|||.+.+ ..++.++||||||+++|+|++|..||....+..+....+.+. .
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g--~---------- 251 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--R---------- 251 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT--C----------
T ss_pred cccceecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--C----------
Confidence 1 222467889999999877 678999999999999999999888886544333322222110 0
Q ss_pred ccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 263 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
+ ...+..+++++.+||.+||+.||++|||+.||++|
T Consensus 252 ----------------~--------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 252 ----------------R--------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp ----------------C--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------C--------CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0 01122368899999999999999999999999988
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-47 Score=328.38 Aligned_cols=255 Identities=16% Similarity=0.257 Sum_probs=193.3
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc-cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEe
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 115 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e 115 (338)
+++|++.+.||+|+||+||+|.+..+++.||||++.. .....+..|+++++.+.+|++|+.+...+.+ ....++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~--~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE--GDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEE--TTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEec--CCEEEEEEE
Confidence 4689999999999999999999999999999998764 3445688999999999444445555555533 457789999
Q ss_pred eecCCcccccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCC--CCceEEEeccccccccCCC---
Q 019642 116 YVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPGK--- 187 (338)
Q Consensus 116 ~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~--~~~~~l~dfg~~~~~~~~~--- 187 (338)
|++++...... ..+++..+..++.|++.||+|||++||+|+||||+|||++.. ...++|+|||++.......
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 163 (299)
T d1ckia_ 84 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163 (299)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred EcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence 99777555443 469999999999999999999999999999999999998542 2579999999997764322
Q ss_pred -----cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHH--HHHHHHHHhCCchhhhhhh
Q 019642 188 -----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD--QLVKIAKVLGTDELNAYLN 260 (338)
Q Consensus 188 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 260 (338)
......||+.|+|||++.+ ..++.++||||||+++|+|++|..||........ ............+.+.
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 239 (299)
T d1ckia_ 164 HIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV--- 239 (299)
T ss_dssp BCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH---
T ss_pred ceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH---
Confidence 1233478999999999987 6799999999999999999999999954322111 1111111000000000
Q ss_pred ccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHH---HhcCCCcc
Q 019642 261 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE---AMAHPYFA 326 (338)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~e---ll~hp~~~ 326 (338)
....+++++.+||..||+.||++||++.+ +|+|+|.+
T Consensus 240 -----------------------------~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 240 -----------------------------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp -----------------------------HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred -----------------------------hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 01127899999999999999999999874 56777654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.4e-47 Score=338.69 Aligned_cols=291 Identities=23% Similarity=0.375 Sum_probs=207.6
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhc----------CCCCeeEeeeeeecc
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLC----------GGPNVVKLLDIVRDQ 105 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~----------~h~~iv~~~~~~~~~ 105 (338)
++|+++++||+|+||+||+|++..+++.||||+++.. ..+...+|+.+++.+. .|+||+++++++...
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 5799999999999999999999999999999999754 2456788999998873 358899999998765
Q ss_pred CCCccEEEEeeecCCccccc------cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEecCCC-----CceE
Q 019642 106 HSKTPSLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEL-----RKLR 173 (338)
Q Consensus 106 ~~~~~~lv~e~~~~~~l~~~------~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~~~-----~~~~ 173 (338)
.....+++++++........ ...+++..++.++.|++.||.|||+ .||+|+||||+|||++.+. ..++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~k 172 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK 172 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceee
Confidence 55566677776654432211 2458999999999999999999998 8999999999999997652 1489
Q ss_pred EEeccccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCC-----CHHHHHHHHH
Q 019642 174 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD-----NHDQLVKIAK 248 (338)
Q Consensus 174 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~-----~~~~~~~~~~ 248 (338)
++|||.+.... .......+|+.|+|||++.+ ..++.++|+||+|+++++|++|+.||..... ..+.+.....
T Consensus 173 l~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~ 249 (362)
T d1q8ya_ 173 IADLGNACWYD--EHYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249 (362)
T ss_dssp ECCCTTCEETT--BCCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred Eeecccccccc--cccccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHH
Confidence 99999986543 23345679999999999987 6789999999999999999999999853322 2344555666
Q ss_pred HhCCchhhhhhhccccccCcchhhhhccccCC---CCccc--ccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcCC
Q 019642 249 VLGTDELNAYLNKYHLELDPQLDALVGRHSRK---PWSKF--INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 323 (338)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~--~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~hp 323 (338)
.++..+.......................... +.... .........++++.+||.+||+.||++||||+|+|+||
T Consensus 250 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp 329 (362)
T d1q8ya_ 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHP 329 (362)
T ss_dssp HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCG
T ss_pred HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 66664433322111000000000000000000 00000 00011122467899999999999999999999999999
Q ss_pred Ccchhhhc
Q 019642 324 YFAQVRAA 331 (338)
Q Consensus 324 ~~~~~~~~ 331 (338)
||++....
T Consensus 330 ~f~~~~~~ 337 (362)
T d1q8ya_ 330 WLKDTLGM 337 (362)
T ss_dssp GGTTCTTC
T ss_pred ccCCCCCc
Confidence 99977544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.2e-46 Score=320.98 Aligned_cols=249 Identities=15% Similarity=0.258 Sum_probs=196.3
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecc-cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEEe
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 115 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~e 115 (338)
+++|++.+.||+|+||+||+|++..+++.||+|+++. .....+.+|++.++.+.+|+|++.+++++.. ....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeec--CCccEEEEE
Confidence 5789999999999999999999999999999999754 3456688999999999667999999999854 567889999
Q ss_pred eecCCcccccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecC----CCCceEEEeccccccccCCC
Q 019642 116 YVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH----ELRKLRLIDWGLAEFYHPGK 187 (338)
Q Consensus 116 ~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~----~~~~~~l~dfg~~~~~~~~~ 187 (338)
+++ ++|...+ ..++...+..++.|++.||.+||++|++|+||||+||+++. ..+.++|+|||+++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 82 LLG-PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp CCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred ecC-CCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 995 4554443 35999999999999999999999999999999999999964 23689999999997654321
Q ss_pred --------cceeeeccccccccccccCcCCCCCcchhHHHHHHHHHHHhcCCCCcCCCCC--HHHHHHHHHHhCCchhhh
Q 019642 188 --------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKVLGTDELNA 257 (338)
Q Consensus 188 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~lltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~ 257 (338)
......||+.|+|||++.+ ..++.++||||||+++|+|++|..||...... ......+...........
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 239 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred cccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHH
Confidence 1223468999999999987 67999999999999999999999999532221 222222222111111111
Q ss_pred hhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhc
Q 019642 258 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 321 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~ 321 (338)
. ...+++++.+++..|++.+|++||+.+.+.+
T Consensus 240 l--------------------------------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 240 L--------------------------------CAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp H--------------------------------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred h--------------------------------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 0 1126889999999999999999999877654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-47 Score=327.02 Aligned_cols=255 Identities=19% Similarity=0.213 Sum_probs=190.4
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEecccchHHHHHHHHHH--HHhcCCCCeeEeeeeeeccCC--CccEEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKIL--QNLCGGPNVVKLLDIVRDQHS--KTPSLI 113 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l--~~l~~h~~iv~~~~~~~~~~~--~~~~lv 113 (338)
++|.+.+.||+|+||+||+|.. +++.||||+++.........|.+++ ..+ +||||+++++++.+... ...++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcceEEEEE
Confidence 5799999999999999999975 6889999999876666655565554 456 89999999999876533 357899
Q ss_pred EeeecCCccccccC--CCCHHHHHHHHHHHHHHHHHHHH--------CCceeccCCCCCeEecCCCCceEEEeccccccc
Q 019642 114 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHS--------QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
Q Consensus 114 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~--------~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~~ 183 (338)
|||+.+++|..++. .+++..+..++.|++.||.|+|+ +||+|+||||+|||++.+ +.+||+|||++...
T Consensus 80 ~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~-~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTT-SCEEECCCTTCEEE
T ss_pred EecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCC-CCeEEEecCccccc
Confidence 99999999998875 68999999999999999999996 599999999999999988 89999999998766
Q ss_pred cCCC-----cceeeeccccccccccccCcC-----CCCCcchhHHHHHHHHHHHhcCCCCcCCCCCHH----------HH
Q 019642 184 HPGK-----EYNVRVASRYFKGPELLVDLQ-----DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD----------QL 243 (338)
Q Consensus 184 ~~~~-----~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DvwslG~~l~~lltg~~pf~~~~~~~~----------~~ 243 (338)
.... ......||+.|+|||++.+.. .++.++||||||+++|+|+||..||........ ..
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 4332 223457899999999986522 256689999999999999999887743221110 11
Q ss_pred HHHHHHhCCchhhhhhhccccccCcchhhhhccccCCCCcccccccCCCCCChhHHHHHHHhcCCCcCCcCCHHHHhcC
Q 019642 244 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 322 (338)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ell~h 322 (338)
..+.+..... ..+.+. ............+.+++.+||+.||++|||+.||+++
T Consensus 239 ~~~~~~~~~~-----------------------~~~p~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 239 EEMRKVVCEQ-----------------------KLRPNI---PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHHHHHHTTS-----------------------CCCCCC---CGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcc-----------------------ccCCCC---CcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1111111110 000000 0000011123568999999999999999999999873
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=4.7e-25 Score=176.47 Aligned_cols=166 Identities=18% Similarity=0.210 Sum_probs=119.7
Q ss_pred EEEEEeeeecCceeEEEEEEcCCCceEEEEEecccc---------------------hHHHHHHHHHHHHhcCCCCeeEe
Q 019642 40 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------------------KKKIKREIKILQNLCGGPNVVKL 98 (338)
Q Consensus 40 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---------------------~~~~~~E~~~l~~l~~h~~iv~~ 98 (338)
+.+.++||+|+||+||+|.+. +++.||||+++... ......|...+.++ .+++++..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~v~~~ 79 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-QGLAVPKV 79 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-TTSSSCCE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-cCCCcceE
Confidence 467899999999999999875 68899999865210 12245688889998 88999888
Q ss_pred eeeeeccCCCccEEEEeeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEecCCCCceEEEecc
Q 019642 99 LDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG 178 (338)
Q Consensus 99 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~~~l~dfg 178 (338)
++.. ..+++||++++..+.. ++......++.|++.+|.+||++|++|+||||+|||++.+ .++|+|||
T Consensus 80 ~~~~------~~~lvme~~~~~~~~~----l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~--~~~liDFG 147 (191)
T d1zara2 80 YAWE------GNAVLMELIDAKELYR----VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE--GIWIIDFP 147 (191)
T ss_dssp EEEE------TTEEEEECCCCEEGGG----CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT--EEEECCCT
T ss_pred EEec------CCEEEEEeeccccccc----hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC--CEEEEECC
Confidence 7753 1369999999877654 3445567889999999999999999999999999999975 58999999
Q ss_pred ccccccCCCcceeeeccccccccccccCcCCCCCcchhHHHHHH
Q 019642 179 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCM 222 (338)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~ 222 (338)
.+................. .-.+.+ . ..++.++|+||+.--
T Consensus 148 ~a~~~~~~~~~~~l~rd~~-~~~~~f-~-r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 148 QSVEVGEEGWREILERDVR-NIITYF-S-RTYRTEKDINSAIDR 188 (191)
T ss_dssp TCEETTSTTHHHHHHHHHH-HHHHHH-H-HHHCCCCCHHHHHHH
T ss_pred CcccCCCCCcHHHHHHHHH-HHHHHH-c-CCCCCcccHHHHHHH
Confidence 9865432211100000000 001111 1 457889999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.54 E-value=3.1e-07 Score=75.22 Aligned_cols=137 Identities=18% Similarity=0.239 Sum_probs=90.9
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCCccEEEE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 114 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~lv~ 114 (338)
+.|++++..+-++.+.||+.. .+++.+++|..... ....+..|...++.+..+-.+++++.+..+ .+..++||
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~--~~~~~lv~ 89 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNLLM 89 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEec--CCceEEEE
Confidence 567777766555567899874 45666788876543 234577899999988555456777776643 45678999
Q ss_pred eeecCCccccccCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 019642 115 EYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHS-------------------------------------------- 150 (338)
Q Consensus 115 e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~-------------------------------------------- 150 (338)
+++.|.++........ ....++.++...+..||+
T Consensus 90 ~~l~G~~~~~~~~~~~--~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T d1j7la_ 90 SEADGVLCSEEYEDEQ--SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp ECCSSEEHHHHTTTCS--CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSH
T ss_pred Eecccccccccccccc--cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHH
Confidence 9999988755432211 112233334444444441
Q ss_pred ---------C------CceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 151 ---------Q------GIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 151 ---------~------~i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
. .++|+|+.|.||+++.+ +.+.|+||+.+.
T Consensus 168 ~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~lIDwe~a~ 212 (263)
T d1j7la_ 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHSCCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCE
T ss_pred HHHHHHHHhcCCcCCcEEEEeeccCcceeecCC-ceEEEeechhcc
Confidence 1 26899999999999876 555799999874
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.17 E-value=7.4e-06 Score=66.33 Aligned_cols=128 Identities=18% Similarity=0.162 Sum_probs=83.6
Q ss_pred eeeecCc-eeEEEEEEcCCCceEEEEEecccchHHHHHHHHHHHHhcCCC-CeeEeeeeeeccCCCccEEEEeeecCCcc
Q 019642 45 KVGRGKY-SEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGP-NVVKLLDIVRDQHSKTPSLIFEYVNSTDF 122 (338)
Q Consensus 45 ~lg~G~~-g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~E~~~l~~l~~h~-~iv~~~~~~~~~~~~~~~lv~e~~~~~~l 122 (338)
.+..|.. +.||+... .++..+++|.........+..|...++.+..+. .+++++....+ ....++||+++.|.++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~--~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeeccc--ccceEEEEEeeecccc
Confidence 4445553 67898864 456678899887777777889999999885432 35566666543 4567899999998776
Q ss_pred ccccCCCCHHHHHHHHHHHHHH---------------------------------------------------HHHHHHC
Q 019642 123 KVLYPTLTDYDIRYYIYELLKA---------------------------------------------------LDYCHSQ 151 (338)
Q Consensus 123 ~~~~~~~~~~~~~~i~~qi~~~---------------------------------------------------l~~lH~~ 151 (338)
.... ..... ...++... +..+.+.
T Consensus 94 ~~~~--~~~~~---~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 168 (255)
T d1nd4a_ 94 LSSH--LAPAE---KVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKAR 168 (255)
T ss_dssp TTSC--CCHHH---HHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHT
T ss_pred cccc--ccHHH---HHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHh
Confidence 5432 11111 11122222 2222222
Q ss_pred -------CceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 152 -------GIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 152 -------~i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
.++|+|+.|.||+++.+ ..+.|+||+.+.
T Consensus 169 ~~~~~~~~liHgD~~~~Nvl~~~~-~~~~iID~~~~~ 204 (255)
T d1nd4a_ 169 MPDGEDLVVTHGDACLPNIMVENG-RFSGFIDCGRLG 204 (255)
T ss_dssp CCSSCCEEEECSSCCGGGEEEETT-EEEEECCCTTCE
T ss_pred CCccCCceEEeCCCCCcceEEeCC-ceEEEEEchhcc
Confidence 27899999999999876 556799999874
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.07 E-value=1.3e-05 Score=69.32 Aligned_cols=75 Identities=16% Similarity=0.187 Sum_probs=49.1
Q ss_pred EEeeeecCceeEEEEEEcCCCceEEEEEecc----------cchHHHHHHHHHHHHhcCC--CCeeEeeeeeeccCCCcc
Q 019642 43 VRKVGRGKYSEVFEGINVNTNERCIIKILKP----------VKKKKIKREIKILQNLCGG--PNVVKLLDIVRDQHSKTP 110 (338)
Q Consensus 43 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~----------~~~~~~~~E~~~l~~l~~h--~~iv~~~~~~~~~~~~~~ 110 (338)
.+.||.|....||++.+..+++.+++|.-.+ ...++...|...++.+..+ ..+++++.+- . ...
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~--~~~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T--EMA 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T--TTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--C--CCC
Confidence 5578999999999998877788899996432 1234566788888877543 2355555442 2 345
Q ss_pred EEEEeeecCCc
Q 019642 111 SLIFEYVNSTD 121 (338)
Q Consensus 111 ~lv~e~~~~~~ 121 (338)
+++||++.+..
T Consensus 107 ~lvmE~L~~~~ 117 (392)
T d2pula1 107 VTVMEDLSHLK 117 (392)
T ss_dssp EEEECCCTTSE
T ss_pred EEEEeccCCcc
Confidence 68999997654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.41 E-value=0.00048 Score=59.24 Aligned_cols=80 Identities=14% Similarity=0.169 Sum_probs=55.5
Q ss_pred CCcEEEEEeeeecCceeEEEEEEcC-------CCceEEEEEecc-cchHHHHHHHHHHHHhcCCCCeeEeeeeeeccCCC
Q 019642 37 QDDYEVVRKVGRGKYSEVFEGINVN-------TNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 108 (338)
Q Consensus 37 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 108 (338)
.++.++ +.|+.|-.-.+|++.... ..+.+.+++... ...-...+|..+++.+..+.-.++++..+ ++
T Consensus 42 ~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~--~~-- 116 (395)
T d1nw1a_ 42 LEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF--SG-- 116 (395)
T ss_dssp GGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE--TT--
T ss_pred ccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc--CC--
Confidence 355664 578888889999987653 245677887652 23334568999999986665566888877 22
Q ss_pred ccEEEEeeecCCccc
Q 019642 109 TPSLIFEYVNSTDFK 123 (338)
Q Consensus 109 ~~~lv~e~~~~~~l~ 123 (338)
..|+||+.|..+.
T Consensus 117 --g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 117 --GRLEEYIPSRPLS 129 (395)
T ss_dssp --EEEECCCCEEECC
T ss_pred --ceEEEEeccccCC
Confidence 4899999886553
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.34 E-value=0.00046 Score=57.64 Aligned_cols=130 Identities=16% Similarity=0.149 Sum_probs=75.5
Q ss_pred cCceeEEEEEEcCCCceEEEEEeccc--chHHHHHHHHHHHHhcCCC-CeeEeeeee---eccCCCccEEEEeeecCCcc
Q 019642 49 GKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGP-NVVKLLDIV---RDQHSKTPSLIFEYVNSTDF 122 (338)
Q Consensus 49 G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~E~~~l~~l~~h~-~iv~~~~~~---~~~~~~~~~lv~e~~~~~~l 122 (338)
+.-..||++.. .+|..+++|+.++. ..+++..|...+..|..+. .++.....- ........+.+++++.|..+
T Consensus 33 s~EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 33 SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred cccceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 33468999864 57888999998764 5677889999999885331 122221110 00123456778898887654
Q ss_pred cccc------------------C--------C-------------------CCHH---HHHHHHHHHHHHHHHHH----H
Q 019642 123 KVLY------------------P--------T-------------------LTDY---DIRYYIYELLKALDYCH----S 150 (338)
Q Consensus 123 ~~~~------------------~--------~-------------------~~~~---~~~~i~~qi~~~l~~lH----~ 150 (338)
.... . . ++.. .....+.++...+...- .
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence 3211 0 0 1111 11222233333332221 1
Q ss_pred CCceeccCCCCCeEecCCCCceEEEecccccc
Q 019642 151 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
Q Consensus 151 ~~i~H~dikp~NIli~~~~~~~~l~dfg~~~~ 182 (338)
.+++|+|+.+.|||++.+ ..++||+.+..
T Consensus 192 ~~liHgDlh~~NvL~~~~---~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG---PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS---EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeCC---ceEEechhccc
Confidence 258999999999999754 45899998753
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.29 E-value=0.0002 Score=59.64 Aligned_cols=141 Identities=16% Similarity=0.178 Sum_probs=75.5
Q ss_pred CcEEEEEeeeecCceeEEEEEEcCCCceEEEEEeccc-chHHHHHHHHHHHHhcCC-CCeeEeeeee----eccCCCccE
Q 019642 38 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGG-PNVVKLLDIV----RDQHSKTPS 111 (338)
Q Consensus 38 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~E~~~l~~l~~h-~~iv~~~~~~----~~~~~~~~~ 111 (338)
++..-.+.|..|---+.|+.... .+ .+++|++.+. ..+.+..|+.++..|.++ ..++...... ...-.....
T Consensus 18 g~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~ 95 (316)
T d2ppqa1 18 GSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 95 (316)
T ss_dssp CCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred CCceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCCCCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccc
Confidence 34555677777877889998643 33 5899998753 567778888888888432 1122222111 001112334
Q ss_pred EEEeeecCCcccccc------------------C--------CCC------------------HHHHHHHHHHHHHHHHH
Q 019642 112 LIFEYVNSTDFKVLY------------------P--------TLT------------------DYDIRYYIYELLKALDY 147 (338)
Q Consensus 112 lv~e~~~~~~l~~~~------------------~--------~~~------------------~~~~~~i~~qi~~~l~~ 147 (338)
.++.+..+....... . ... .......+......+..
T Consensus 96 ~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 175 (316)
T d2ppqa1 96 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 175 (316)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred eeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhc
Confidence 555555554332211 0 000 00111122222232333
Q ss_pred HHH----CCceeccCCCCCeEecCCCCceEEEeccccc
Q 019642 148 CHS----QGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
Q Consensus 148 lH~----~~i~H~dikp~NIli~~~~~~~~l~dfg~~~ 181 (338)
.+. .|++|+|+.++||+++.+ ...-++||+.+.
T Consensus 176 ~~~~~L~~giIHgDl~~dNvl~~~~-~v~gvIDF~~~~ 212 (316)
T d2ppqa1 176 HWPKDLPAGVIHADLFQDNVFFLGD-ELSGLIDFYFAC 212 (316)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETT-EEEEECCCTTCE
T ss_pred cCccccccccccCCcchhhhhcccc-cceeEecccccc
Confidence 222 369999999999999987 556899999875
|